PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Date, D; Das, R; Narla, G; Simon, DI; Jain, MK; Mahabeleshwar, GH				Date, Dipali; Das, Riku; Narla, Goutham; Simon, Daniel I.; Jain, Mukesh K.; Mahabeleshwar, Ganapati H.			Kruppel-like Transcription Factor 6 Regulates Inflammatory Macrophage Polarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellular Immune Response; Gene Regulation; Inflammation; Macrophages; Transcription Regulation; Kruppel-like Transcription Factor 6	DENDRITIC CELLS; ACTIVATION; MECHANISMS; PLASTICITY; DIVERSITY; DISEASE; HEALTH	Background: Macrophage polarization regulates human inflammatory disorders. Results: KLF6 is a novel transcriptional regulator of macrophage polarization. Conclusion: KLF6 regulates macrophage inflammatory gene expression by modulating functions of NF-B and PPAR. Significance: Pharmacological agents that modulate KLF6 signaling may allow for therapeutic gain in the treatment of inflammatory disorders. Accumulating evidence supports the importance of macrophage plasticity in a broad spectrum of biological processes operative in health and disease. A major locus of control regulating macrophage polarization is at the transcriptional level, and several major pathways have been elucidated in recent years. In this study, we identify the Kruppel-like transcription factor 6 (KLF6) as a molecular toggle controlling macrophage speciation. KLF6 expression was robustly induced by pro-inflammatory M1 stimuli (e.g. LPS and IFN-) and strongly suppressed by M2 stimuli (e.g. IL4 and IL-13) in human and murine macrophages. Gain- and loss-of-function studies suggest that KLF6 is required for optimal LPS-induced pro-inflammatory gene expression, acting cooperatively with NF-B. Furthermore, KLF6 inhibits anti-inflammatory gene expression by negatively regulating peroxisome proliferator-activated receptor expression in macrophages. Collectively, these observations identify KLF6 as a novel transcriptional regulator of macrophage polarization.	[Date, Dipali; Simon, Daniel I.; Jain, Mukesh K.; Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Harrington Heart & Vasc Inst, Case Cardiovasc Res Inst,Dept Med, Cleveland, OH 44106 USA; [Narla, Goutham] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Das, Riku] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Mahabeleshwar, GH (corresponding author), Case Cardiovasc Res Inst, 2103 Cornell Rd,Rm 4-524, Cleveland, OH 44106 USA.	ghm4@case.edu	Narla, Goutham/AAZ-5710-2020	Narla, Goutham/0000-0003-4098-4203	National Institutes of Health [HL097023, HL57506, HL72952, HL75427, HL76754, HL086548]; NHLBI [K99/R00]; American Heart Association [11SDG7390041]; Howard Hughes Medical Institute Physician-Scientist Early Career Award; Young Scientist Foundation; Harrington Distinguished Scholar Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072952, R00HL097023, R01HL057506, R01HL086548, R01HL119195, R01HL110630, R01HL076754, R37HL057506, K99HL097023, R01HL075427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Howard Hughes Medical Institute Physician-Scientist Early Career Award(Howard Hughes Medical Institute); Young Scientist Foundation; Harrington Distinguished Scholar Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL097023 (to G. H. M.), HL57506 MERIT Award (to D. I. S.), HL72952, HL75427, HL76754, and HL086548 (to M. K. J.), and R00 phase of K99/R00 Award from NHLBI Pathway to Independence Award (to the G. H. M. laboratory). This work was also supported by American Heart Association Scientist Development Grant 11SDG7390041 (to R. D.).; Supported by Howard Hughes Medical Institute Physician-Scientist Early Career Award, a grant from The Young Scientist Foundation, and Harrington Distinguished Scholar Award.	Andreoli V, 2010, IUBMB LIFE, V62, P896, DOI 10.1002/iub.396; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Cao ZX, 2010, BLOOD, V116, P4404, DOI 10.1182/blood-2010-05-285353; Davis Beckley K, 2013, Methods Mol Biol, V1031, P27, DOI 10.1007/978-1-62703-481-4_3; Hawiger J, 2001, IMMUNOL RES, V23, P99, DOI 10.1385/IR:23:2-3:099; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Leow CC, 2009, J BIOL CHEM, V284, P21057, DOI 10.1074/jbc.M109.001776; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Mahabeleshwar GH, 2011, IMMUNITY, V34, P715, DOI 10.1016/j.immuni.2011.04.014; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nayak L, 2013, AM J PATHOL, V182, P1696, DOI 10.1016/j.ajpath.2013.01.029; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ostuni R, 2011, EUR J IMMUNOL, V41, P2486, DOI 10.1002/eji.201141706; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1	26	87	95	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10318	10329		10.1074/jbc.M113.526749	http://dx.doi.org/10.1074/jbc.M113.526749			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24385430	hybrid, Green Published			2022-12-28	WOS:000334226400008
J	Rhodes, DV; Crump, KE; Makhlynets, O; Snyder, M; Ge, XC; Xu, P; Stubbe, J; Kitten, T				Rhodes, DeLacy V.; Crump, Katie E.; Makhlynets, Olga; Snyder, Melanie; Ge, Xiuchun; Xu, Ping; Stubbe, JoAnne; Kitten, Todd			Genetic Characterization and Role in Virulence of the Ribonucleotide Reductases of Streptococcus sanguinis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Bacterial Pathogenesis; Manganese; Ribonucleotide Reductase; Streptococcus; Infective Endocarditis	TYROSYL RADICAL COFACTOR; ESCHERICHIA-COLI; IN-VIVO; ENDOCARDITIS VIRULENCE; STAPHYLOCOCCUS-AUREUS; HIGH-LEVEL; MANGANESE; IRON; ENZYME; MAINTENANCE	Background: NrdEF ribonucleotide reductases are found in many bacterial pathogens and function in vitro with either iron or manganese cofactors. Results:Streptococcus sanguinis mutants lacking NrdEF or its manganese cofactor cannot grow aerobically or cause endocarditis. Conclusion: The manganese cofactor is essential for virulence. Significance: This work may explain why many NrdEF-containing bacteria require manganese for virulence and oxygen tolerance. Streptococcus sanguinis is a cause of infective endocarditis and has been shown to require a manganese transporter called SsaB for virulence and O-2 tolerance. Like certain other pathogens, S. sanguinis possesses aerobic class Ib (NrdEF) and anaerobic class III (NrdDG) ribonucleotide reductases (RNRs) that perform the essential function of reducing ribonucleotides to deoxyribonucleotides. The accompanying paper (Makhlynets, O., Boal, A. K., Rhodes, D. V., Kitten, T., Rosenzweig, A. C., and Stubbe, J. (2014) J. Biol. Chem. 289, 6259-6272) indicates that in the presence of O-2, the S. sanguinis class Ib RNR self-assembles an essential diferric-tyrosyl radical (Fe-2(III)-Y-center dot) in vitro, whereas assembly of a dimanganese-tyrosyl radical (Mn-2(III)-Y-center dot) cofactor requires NrdI, and Mn-2(III)-Y-center dot is more active than Fe-2(III)-Y-center dot with the endogenous reducing system of NrdH and thioredoxin reductase (TrxR1). In this study, we have shown that deletion of either nrdHEKF or nrdI completely abolishes virulence in an animal model of endocarditis, whereas nrdD mutation has no effect. The nrdHEKF, nrdI, and trxR1 mutants fail to grow aerobically, whereas anaerobic growth requires nrdD. The nrdJ gene encoding an O-2-independent adenosylcobalamin-cofactored RNR was introduced into the nrdHEKF, nrdI, and trxR1 mutants. Growth of the nrdHEKF and nrdI mutants in the presence of O-2 was partially restored. The combined results suggest that Mn-2(III)-Y-center dot-cofactored NrdF is required for growth under aerobic conditions and in animals. This could explain in part why manganese is necessary for virulence and O-2 tolerance in many bacterial pathogens possessing a class Ib RNR and suggests NrdF and NrdI may serve as promising new antimicrobial targets.	[Rhodes, DeLacy V.; Crump, Katie E.; Snyder, Melanie; Ge, Xiuchun; Xu, Ping; Kitten, Todd] Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Richmond, VA 23298 USA; [Makhlynets, Olga; Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stubbe, JoAnne] MIT, Dept Biol, Cambridge, MA 02139 USA	Virginia Commonwealth University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Stubbe, J (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	stubbe@mit.edu; tkitten@vcu.edu	Rhodes, DeLacy/GLS-9225-2022; Kitten, Todd/O-6531-2014	Rhodes, DeLacy/0000-0003-1945-3360; Kitten, Todd/0000-0001-6097-7583	National Institutes of Health [R56AI085195, K12GM093857, GM81393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081393, K12GM093857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R56AI085195 (to T. K.), K12GM093857 (to Paul B. Fisher for D. V. R. and K. E. C.), and GM81393 (to J.S.).	Anderson PJ, 2008, J BACTERIOL, V190, P1160, DOI 10.1128/JB.01386-07; ANDERSSON DI, 1989, J BACTERIOL, V171, P6726, DOI 10.1128/jb.171.12.6726-6733.1989; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; BLAKLEY RL, 1965, J BIOL CHEM, V240, P2173; BOOKER S, 1994, BIOCHEMISTRY-US, V33, P12676, DOI 10.1021/bi00208a019; BOOKER S, 1993, P NATL ACAD SCI USA, V90, P8352, DOI 10.1073/pnas.90.18.8352; Bor DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060033; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; BURNETTECURLEY D, 1995, INFECT IMMUN, V63, P4669, DOI 10.1128/IAI.63.12.4669-4674.1995; Callahan JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026403; Carlsson J, 1987, Oral Microbiol Immunol, V2, P15, DOI 10.1111/j.1399-302X.1987.tb00264.x; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; Collins HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055708; Cotruvo JA, 2008, P NATL ACAD SCI USA, V105, P14383, DOI 10.1073/pnas.0807348105; Cotruvo JA, 2013, J AM CHEM SOC, V135, P4027, DOI 10.1021/ja312457t; Cotruvo JA, 2012, METALLOMICS, V4, P1020, DOI 10.1039/c2mt20142a; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Crona M, 2011, J BIOL CHEM, V286, P33053, DOI 10.1074/jbc.M111.278119; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; DURACK DT, 1973, BRIT J EXP PATHOL, V54, P142; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Garcia-de-la-Maria C, 2013, ANTIMICROB AGENTS CH, V57, P2319, DOI 10.1128/AAC.01921-12; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hristova D, 2008, BIOCHEMISTRY-US, V47, P3989, DOI 10.1021/bi702408k; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; Johnston JW, 2004, INFECT IMMUN, V72, P5858, DOI 10.1128/IAI.72.10.5858-5867.2004; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; Kehl-Fie TE, 2013, INFECT IMMUN, V81, P3395, DOI 10.1128/IAI.00420-13; KILIAN M, 1981, INFECT IMMUN, V31, P868, DOI 10.1128/IAI.31.3.868-873.1981; KING DS, 1995, BIOCHEM BIOPH RES CO, V206, P731, DOI 10.1006/bbrc.1995.1103; Kirdis E, 2007, MICROB PATHOGENESIS, V43, P179, DOI 10.1016/j.micpath.2007.05.008; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohman GJS, 2010, BIOCHEMISTRY-US, V49, P1404, DOI 10.1021/bi902132u; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Makhlynets O, 2014, J BIOL CHEM, V289, P6259, DOI 10.1074/jbc.M113.533554; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; Moore SJ, 2012, BIOCHEM SOC T, V40, P581, DOI 10.1042/BST20120066; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Paik S, 2005, INFECT IMMUN, V73, P6064, DOI 10.1128/IAI.73.9.6064-6074.2005; Paik S, 2003, J BACTERIOL, V185, P5967, DOI 10.1128/JB.185.20.5967-5975.2003; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Roca I, 2008, J BACTERIOL, V190, P4849, DOI 10.1128/JB.00185-08; Rodriguez AM, 2011, MOL ORAL MICROBIOL, V26, P99, DOI 10.1111/j.2041-1014.2011.00606.x; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; RUSSEL M, 1985, J BACTERIOL, V163, P238, DOI 10.1128/JB.163.1.238-242.1985; Smith AJ, 2003, INFECT IMMUN, V71, P4842, DOI 10.1128/IAI.71.9.4842-4849.2003; SOCRANSKY SS, 1977, J PERIODONTAL RES, V12, P90, DOI 10.1111/j.1600-0765.1977.tb00112.x; STEEPER JR, 1970, ANAL BIOCHEM, V34, P123, DOI 10.1016/0003-2697(70)90092-8; Stolle P, 2010, FEBS J, V277, P4849, DOI 10.1111/j.1742-4658.2010.07885.x; Sztukowska M, 2002, MOL MICROBIOL, V44, P479, DOI 10.1046/j.1365-2958.2002.02892.x; Thuny F, 2012, LANCET, V379, P965, DOI 10.1016/S0140-6736(11)60755-1; Turner LS, 2009, INFECT IMMUN, V77, P4966, DOI 10.1128/IAI.00760-09; Turner LS, 2009, MICROBIOL-SGM, V155, P2573, DOI 10.1099/mic.0.024513-0; Wu CH, 2007, BIOCHEMISTRY-US, V46, P11577, DOI 10.1021/bi7012454; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhang Y, 2011, BIOCHEMISTRY-US, V50, P5615, DOI 10.1021/bi200348q	67	35	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6273	6287		10.1074/jbc.M113.533620	http://dx.doi.org/10.1074/jbc.M113.533620			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24381171	hybrid, Green Published			2022-12-28	WOS:000332015500079
J	Dakin, SG; Smith, RKW; Heinegard, D; Onnerfjord, P; Khabut, A; Dudhia, J				Dakin, Stephanie Georgina; Smith, Roger Kenneth Whealands; Heinegard, Dick; Onnerfjord, Patrik; Khabut, Areej; Dudhia, Jayesh			Proteomic Analysis of Tendon Extracellular Matrix Reveals Disease Stage- specific Fragmentation and Differential Cleavage of COMP ( Cartilage Oligomeric Matrix Protein)*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Extracellular Matrix; Inflammation; Mass Spectrometry (MS); Peptides; Proteomics; Tendon	DIGITAL FLEXOR TENDON; SHEATH SYNOVIAL-FLUID; ACHILLES-TENDON; PROTEIN COMP; DEGRADATION; METALLOPROTEINASE; COLLAGEN; INTERLEUKIN-1; PROTEOGLYCAN; EXERCISE	Background: Tendon disease is characterized by extensive remodeling of the extracellular matrix. Results: Novel COMP cleavage fragments were identified in both an in vitro inflammatory model and natural disease. Conclusion: Inflammatory mediators drive distinct COMP fragmentation at different stages of tendon disease. Significance: Novel COMP neo-terminal fragments provide opportunities for developing markers for tendon injury. During inflammatory processes the extracellular matrix (ECM) is extensively remodeled, and many of the constituent components are released as proteolytically cleaved fragments. These degradative processes are better documented for inflammatory joint diseases than tendinopathy even though the pathogenesis has many similarities. The aims of this study were to investigate the proteomic composition of injured tendons during early and late disease stages to identify disease-specific cleavage patterns of the ECM protein cartilage oligomeric matrix protein (COMP). In addition to characterizing fragments released in naturally occurring disease, we hypothesized that stimulation of tendon explants with proinflammatory mediators in vitro would induce fragments of COMP analogous to natural disease. Therefore, normal tendon explants were stimulated with IL-1 and prostaglandin E-2, and their effects on the release of COMP and its cleavage patterns were characterized. Analyses of injured tendons identified an altered proteomic composition of the ECM at all stages post injury, showing protein fragments that were specific to disease stage. IL-1 enhanced the proteolytic cleavage and release of COMP from tendon explants, whereas PGE(2) had no catabolic effect. Of the cleavage fragments identified in early stage tendon disease, two fragments were generated by an IL-1-mediated mechanism. These fragments provide a platform for the development of neo-epitope assays specific to injury stage for tendon disease.	[Dakin, Stephanie Georgina; Smith, Roger Kenneth Whealands; Dudhia, Jayesh] Royal Vet Coll, Dept Clin Sci & Serv, Hatfield AL9 7TA, Herts, England; [Heinegard, Dick; Onnerfjord, Patrik; Khabut, Areej] Lund Univ, Dept Clin Sci Lund, SE-22184 Lund, Sweden	University of London; University of London Royal Veterinary College; Lund University	Dakin, SG (corresponding author), Univ Oxford, Botnar Res Ctr, Inst Musculoskeletal Sci, Nuffield Orthopaed Ctr, Windmill Rd, Oxford OX3 7LD, England.	stephanie.dakin@ndorms.ox.ac.uk	Onnerfjord, Patrik/R-3131-2019	Onnerfjord, Patrik/0000-0002-2345-2937; Dudhia, Jayesh/0000-0002-2503-697X; Dakin, Stephanie Georgina/0000-0003-2470-1031	Biotechnology and Biological Sciences Research Council (BBSRC) UK; Ceva (France) [BB/F018258/1]; European Commission 7th Framework Program for Research; NanoDiaRa; Anamar Medical	Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ceva (France); European Commission 7th Framework Program for Research; NanoDiaRa; Anamar Medical	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) UK and Ceva (France) Grant BB/F018258/1. Part of this work was supported by the European Commission 7th Framework Program for Research, NanoDiaRa, and Anamar Medical.	Almekinders LC, 1998, MED SCI SPORT EXER, V30, P1183, DOI 10.1097/00005768-199808000-00001; ARNER EC, 1989, ARTHRITIS RHEUM, V32, P288, DOI 10.1002/anr.1780320310; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Avella CS, 2009, EQUINE VET J, V41, P449, DOI 10.2746/042516409X391042; Birch HL, 1998, EQUINE VET J, V30, P534, DOI 10.1111/j.2042-3306.1998.tb04530.x; Crevier-Denoix N, 1997, Equine Vet J Suppl, P23; Dakin SG, 2011, EQUINE VET J, V43, P418, DOI 10.1111/j.2042-3306.2010.00303.x; Dakin S. G., 2012, PLOS ONE, V7; Dickinson SC, 2003, MATRIX BIOL, V22, P267, DOI 10.1016/S0945-053X(03)00034-9; Dowling BA, 2000, EQUINE VET J, V32, P369, DOI 10.2746/042516400777591138; Dudhia J, 2007, AGING CELL, V6, P547, DOI 10.1111/j.1474-9726.2007.00307.x; Ganu V, 1998, ARTHRITIS RHEUM, V41, P2143, DOI 10.1002/1529-0131(199812)41:12<2143::AID-ART9>3.0.CO;2-P; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; Jarvinen M, 1997, SCAND J MED SCI SPOR, V7, P86; JOZSA L, 1989, ACTA ORTHOP SCAND, V60, P469, DOI 10.3109/17453678909149322; Ker RF, 2000, J EXP BIOL, V203, P1317; KNUDSEN PJ, 1986, J IMMUNOL, V137, P3189; Kozaci LD, 1997, ARTHRITIS RHEUM-US, V40, P164, DOI 10.1002/art.1780400121; Kujala UM, 2005, CLIN J SPORT MED, V15, P133, DOI 10.1097/01.jsm.0000165347.55638.23; Langberg H, 1999, J PHYSIOL-LONDON, V515, P919, DOI 10.1111/j.1469-7793.1999.919ab.x; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Ley C, 2011, CONNECT TISSUE RES, V52, P290, DOI 10.3109/03008207.2010.523803; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Millar NL, 2009, J BONE JOINT SURG BR, V91B, P417, DOI 10.1302/0301-620X.91B3.21652; Millar NL, 2010, AM J SPORT MED, V38, P2085, DOI 10.1177/0363546510372613; Miyatake S, 2008, J BIOMECH, V41, P884, DOI 10.1016/j.jbiomech.2007.10.018; Mort JS, 2003, BIOCHEM SOC SYMP, V70, P107, DOI 10.1042/bss0700107; Murphy R. J., 2013, BR J SPORTS MED, DOI 10.1136/bjsports-2013-092459.51; Neidhart M, 1997, BRIT J RHEUMATOL, V36, P1151; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Perez-Castro AV, 1999, J ORTHOP RES, V17, P139, DOI 10.1002/jor.1100170120; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367; Riley GP, 1996, ANN RHEUM DIS, V55, P109, DOI 10.1136/ard.55.2.109; SAXNE T, 1992, BRIT J RHEUMATOL, V31, P583; Schulze-Tanzil G, 2011, SCAND J MED SCI SPOR, V21, P337, DOI 10.1111/j.1600-0838.2010.01265.x; Shohani Behnaz, 2010, Iranian Biomedical Journal, V14, P158; Smith MRW, 2011, VET SURG, V40, P54, DOI 10.1111/j.1532-950X.2010.00751.x; Smith R K, 1999, Equine Vet J Suppl, P201; Smith RKW, 1997, MATRIX BIOL, V16, P255, DOI 10.1016/S0945-053X(97)90014-7; Smith RKW, 2002, COMP BIOCHEM PHYS A, V133, P1039, DOI 10.1016/S1095-6433(02)00148-4; Smith RKW, 2002, EQUINE VET J, V34, P726, DOI 10.2746/042516402776250423; Smith RKW, 2000, EQUINE VET J, V32, P52, DOI 10.2746/042516400777612053; STROCCHI R, 1991, FOOT ANKLE, V12, P100, DOI 10.1177/107110079101200207; Sztrolovics R, 1999, BIOCHEM J, V339, P571, DOI 10.1042/0264-6021:3390571; Thorpe CT, 2010, J BIOL CHEM, V285, P15674, DOI 10.1074/jbc.M109.077503; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Wilson AM, 2001, NATURE, V414, P895, DOI 10.1038/414895a	51	23	25	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4919	4927		10.1074/jbc.M113.511972	http://dx.doi.org/10.1074/jbc.M113.511972			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398684	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000331607900038
J	Manavalan, APC; Kober, A; Metso, J; Lang, I; Becker, T; Hasslitzer, K; Zandl, M; Fanaee-Danesh, E; Pippal, JB; Sachdev, V; Kratky, D; Stefulj, J; Jauhiainen, M; Panzenboeck, U				Manavalan, Anil Paul Chirackal; Kober, Alexandra; Metso, Jari; Lang, Ingrid; Becker, Tatjana; Hasslitzer, Karin; Zandl, Martina; Fanaee-Danesh, Elham; Pippal, Jyotsna Brijesh; Sachdev, Vinay; Kratky, Dagmar; Stefulj, Jasminka; Jauhiainen, Matti; Panzenboeck, Ute			Phospholipid Transfer Protein Is Expressed in Cerebrovascular Endothelial Cells and Involved in High Density Lipoprotein Biogenesis and Remodeling at the Blood- Brain Barrier*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain; Cholesterol; Endothelium; HDL; Nuclear Receptors; A; Blood-Brain Barrier; Cholesterol Efflux; LXRs; Pre- HDL	LIVER-X-RECEPTOR; PROLIFERATOR-ACTIVATED RECEPTOR; ENHANCES CHOLESTEROL EFFLUX; APOLIPOPROTEIN-A-I; ALZHEIMERS-DISEASE; LIPID-METABOLISM; STEROL TRANSPORT; HDL CHOLESTEROL; TRANSGENIC MICE; RISK-FACTOR	Background: Liver X receptor activation promotes formation of HDL-like particles at the blood-brain barrier (BBB). Results: Cerebrovascular endothelial cells express phospholipid transfer protein (PLTP) that transfers phospholipids, remodels HDL, and supports cellular cholesterol efflux. Conclusion: PLTP is involved in HDL genesis and remodeling at the BBB. Significance: We demonstrate a direct role of PLTP in HDL metabolism at the blood-brain interface. Phospholipid transfer protein (PLTP) is a key protein involved in biogenesis and remodeling of plasma HDL. Several neuroprotective properties have been ascribed to HDL. We reported earlier that liver X receptor (LXR) activation promotes cellular cholesterol efflux and formation of HDL-like particles in an established in vitro model of the blood-brain barrier (BBB) consisting of primary porcine brain capillary endothelial cells (pBCEC). Here, we report PLTP synthesis, regulation, and its key role in HDL metabolism at the BBB. We demonstrate that PLTP is highly expressed and secreted by pBCEC. In a polarized in vitro model mimicking the BBB, pBCEC secreted phospholipid-transfer active PLTP preferentially to the basolateral (brain parenchymal) compartment. PLTP expression levels and phospholipid transfer activity were enhanced (up to 2.5-fold) by LXR activation using 24(S)-hydroxycholesterol (a cerebral cholesterol metabolite) or TO901317 (a synthetic LXR agonist). TO901317 administration elevated PLTP activity in BCEC from C57/BL6 mice. Preincubation of HDL3 with human plasma-derived active PLTP resulted in the formation of smaller and larger HDL particles and enhanced the capacity of the generated HDL particles to remove cholesterol from pBCEC by up to 3-fold. Pre--HDL, detected by two-dimensional crossed immunoelectrophoresis, was generated from HDL3 in pBCEC-derived supernatants, and their generation was markedly enhanced (1.9-fold) upon LXR activation. Furthermore, RNA interference-mediated PLTP silencing (up to 75%) reduced both apoA-I-dependent (67%) and HDL3-dependent (30%) cholesterol efflux from pBCEC. Based on these findings, we propose that PLTP is actively involved in lipid transfer, cholesterol efflux, HDL genesis, and remodeling at the BBB.	[Manavalan, Anil Paul Chirackal; Kober, Alexandra; Becker, Tatjana; Hasslitzer, Karin; Zandl, Martina; Fanaee-Danesh, Elham; Pippal, Jyotsna Brijesh; Panzenboeck, Ute] Med Univ Graz, Inst Pathophysiol & Immunol, A-8010 Graz, Austria; [Lang, Ingrid] Med Univ Graz, Inst Cell Biol Histol & Embryol, A-8010 Graz, Austria; [Sachdev, Vinay; Kratky, Dagmar] Med Univ Graz, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Metso, Jari; Jauhiainen, Matti] Biomedicum, Natl Inst Hlth & Welf, FI-00290 Helsinki, Finland; [Stefulj, Jasminka] Rudjer Boskovic Inst, Dept Mol Biol, Zagreb 10000, Croatia	Medical University of Graz; Medical University of Graz; Medical University of Graz; Finland National Institute for Health & Welfare; University of Helsinki; Rudjer Boskovic Institute	Panzenboeck, U (corresponding author), Med Univ Graz, Inst Pathophysiol & Immunol, Heinrichstr 31a, A-8010 Graz, Austria.	ute.panzenboeck@medunigraz.at	Stefulj, Jasminka/A-1267-2011; Kratky, Dagmar/ABF-5699-2021; Sachdev, Vinay/D-1029-2018	Sachdev, Vinay/0000-0002-6221-4376; Panzenbock, Ute/0000-0002-0545-6758; Kratky, Dagmar/0000-0003-1357-7573; Stefulj, Jasminka/0000-0001-8593-9698; Lang-Olip, Ingrid/0000-0003-0403-4884; Zandl-Lang, Martina/0000-0003-0522-4372	Austrian Science Fund [DK-MCD W1226-B18, P24783 B19, SFB LIPOTOX F30, P38223P]; Medical University of Graz Doctoral College of Metabolic and Cardiovascular Diseases, Franz Lanyar Foundation [365]; Austrian Science Fund (FWF) [F 3004] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Medical University of Graz Doctoral College of Metabolic and Cardiovascular Diseases, Franz Lanyar Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund Grants DK-MCD W1226-B18 (to U. P. and D. K.), P24783 B19 (to U. P.), and SFB LIPOTOX F30 and P38223P (to D. K.), by the Medical University of Graz Doctoral College of Metabolic and Cardiovascular Diseases, Franz Lanyar Foundation 365 (to U. P.).	Albers JJ, 1996, INT J CLIN LAB RES, V26, P262, DOI 10.1007/BF02602960; Albers JJ, 2012, BBA-MOL CELL BIOL L, V1821, P345, DOI 10.1016/j.bbalip.2011.06.013; Ashida Y, 1999, SCAND J CLIN LAB INV, V59, P663, DOI 10.1080/00365519950185166; Balazs Z, 2004, J NEUROCHEM, V89, P939, DOI 10.1111/j.1471-4159.2004.02373.x; Beffert U, 1998, BRAIN RES REV, V27, P119, DOI 10.1016/S0165-0173(98)00008-3; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bowman G. L., 2012, CURR GERONTOL GERIAT, V2012; Cao GQ, 2002, J BIOL CHEM, V277, P39561, DOI 10.1074/jbc.M207187200; Desrumaux C, 2004, FASEB J, V18, P296, DOI 10.1096/fj.04-2400fje; Desrumaux C, 2013, NEUROPSYCHOPHARMACOL, V38, P817, DOI 10.1038/npp.2012.247; Dong WJ, 2009, J NEUROSCI RES, V87, P3176, DOI 10.1002/jnr.22137; Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Huuskonen J, 1998, J LIPID RES, V39, P2021; Huuskonen J, 2001, ATHEROSCLEROSIS, V155, P269, DOI 10.1016/S0021-9150(01)00447-6; Janis MT, 2005, BIOCHEM BIOPH RES CO, V331, P333, DOI 10.1016/j.bbrc.2005.03.164; Jauhiainen M, 2005, METHODS, V36, P97, DOI 10.1016/j.ymeth.2004.11.006; JAUHIAINEN M, 1993, J BIOL CHEM, V268, P4032; Kang JH, 2012, ENDOCR REV, V33, P715, DOI 10.1210/er.2011-1049; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Koch S, 2001, J LIPID RES, V42, P1143; Kontush A, 2004, BRAIN PATHOL, V14, P433; Kontush A, 2008, ARTERIOSCL THROM VAS, V28, P1418, DOI 10.1161/ATVBAHA.108.169714; Kratzer I, 2007, J CONTROL RELEASE, V117, P301, DOI 10.1016/j.jconrel.2006.11.020; Krimbou L, 2005, J LIPID RES, V46, P1668, DOI 10.1194/jlr.M500038-JLR200; LaDu MJ, 2000, ANN NY ACAD SCI, V903, P167, DOI 10.1111/j.1749-6632.2000.tb06365.x; Laffitte BA, 2003, MOL CELL BIOL, V23, P2182, DOI 10.1128/MCB.23.6.2182-2191.2003; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; MarquesVidal P, 1997, ATHEROSCLEROSIS, V133, P87, DOI 10.1016/S0021-9150(97)00120-2; Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7; Norata GD, 2005, INT J MOL MED, V16, P717; Olesen OF, 2000, BIOCHEM BIOPH RES CO, V270, P62, DOI 10.1006/bbrc.2000.2372; Oram JF, 2003, J BIOL CHEM, V278, P52379, DOI 10.1074/jbc.M310695200; Oram JF, 2008, J BIOL CHEM, V283, P11541, DOI 10.1074/jbc.M800117200; Panzenboeck U, 2002, J BIOL CHEM, V277, P42781, DOI 10.1074/jbc.M207601200; Panzenboeck U, 2006, INT J BIOCHEM CELL B, V38, P1314, DOI 10.1016/j.biocel.2006.01.013; Reitz C, 2010, ARCH NEUROL-CHICAGO, V67, P1491, DOI 10.1001/archneurol.2010.297; Riemens SC, 1998, DIABETOLOGIA, V41, P929, DOI 10.1007/s001250051009; Robciuc MR, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-59; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; SATTLER W, 1994, METHOD ENZYMOL, V233, P469; Scholler M, 2012, J CLIN ENDOCR METAB, V97, P2466, DOI 10.1210/jc.2011-2969; Scholler M, 2012, J CLIN ENDOCR METAB, V97, P437, DOI 10.1210/jc.2011-1942; Schweinzer C, 2011, J ALZHEIMERS DIS, V27, P341, DOI 10.3233/JAD-2011-110854; Settasatian N, 2001, J BIOL CHEM, V276, P26898, DOI 10.1074/jbc.M010708200; Singh-Manoux A, 2008, ARTERIOSCL THROM VAS, V28, P1556, DOI 10.1161/ATVBAHA.108.163998; Stefulj J, 2009, CIRC RES, V104, P600, DOI 10.1161/CIRCRESAHA.108.185066; TU AY, 1993, J BIOL CHEM, V268, P23098; Tu AY, 2001, DIABETES, V50, P1851, DOI 10.2337/diabetes.50.8.1851; Tzotzas T, 2009, OBES REV, V10, P403, DOI 10.1111/j.1467-789X.2009.00586.x; van Haperen R, 2000, ARTERIOSCL THROM VAS, V20, P1082, DOI 10.1161/01.ATV.20.4.1082; Vaya J, 2007, J NEUROCHEM, V102, P1727, DOI 10.1111/j.1471-4159.2007.04689.x; Vikstedt R, 2007, BIOCHEMISTRY-US, V46, P11979, DOI 10.1021/bi700833h; Vuletic S, 2005, J NEUROSCI RES, V80, P406, DOI 10.1002/jnr.20458; Vuletic S, 2003, J LIPID RES, V44, P1113, DOI 10.1194/jlr.M300046-JLR200; Vuletic S, 2009, BBA-MOL CELL RES, V1793, P584, DOI 10.1016/j.bbamcr.2009.01.010; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wang H., 2013, J ALZHEIMERS DIS, DOI 10.3233/JAD-130812; Yazdanyar A, 2011, CURR ATHEROSCLER REP, V13, P242, DOI 10.1007/s11883-011-0172-5; Yu CJ, 2010, BBA-MOL CELL BIOL L, V1801, P819, DOI 10.1016/j.bbalip.2010.05.001	61	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4683	4698		10.1074/jbc.M113.499129	http://dx.doi.org/10.1074/jbc.M113.499129			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24369175	Green Published, hybrid			2022-12-28	WOS:000331607900016
J	Peterson, SE; Loring, JF				Peterson, Suzanne E.; Loring, Jeanne F.			Genomic Instability in Pluripotent Stem Cells: Implications for Clinical Applications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Cell Differentiation; Cell Therapy; Embryonic Stem Cell; Genomics; Induced Pluripotent Stem Cells	COPY NUMBER VARIATION; CHROMOSOMAL-ABERRATIONS; GENE-EXPRESSION; SOMATIC-CELLS; HUMAN ES; MOSAICISM; CULTURE; BRAIN; HETEROGENEITY; ANEUPLOIDY	Human pluripotent stem cells (hPSCs) are known to acquire genomic changes as they proliferate and differentiate. Despite concerns that these changes will compromise the safety of hPSC-derived cell therapy, there is currently scant evidence linking the known hPSC genomic abnormalities with malignancy. For the successful use of hPSCs for clinical applications, we will need to learn to distinguish between innocuous genomic aberrations and those that may cause tumors. To minimize any effects of acquired mutations on cell therapy, we strongly recommend that cells destined for transplant be monitored throughout their preparation using a high-resolution method such as SNP genotyping.	[Loring, Jeanne F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Ctr Regenerat Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Loring, JF (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	jloring@scripps.edu	Loring, Jeanne/A-1620-2011	Loring, Jeanne/0000-0001-6226-9767	National Institutes of Health [5R33 MH087925-04, 1R21 DA032975-01]; California Institute for Regenerative Medicine (CIRM) [CL1-00502, TR01250, RM1-01717, TR3-05603, RB3-05022]; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA032975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants 5R33 MH087925-04 (to J. F. L.) and 1R21 DA032975-01 (to P. Sanna and J. F. L.). This work was also supported by California Institute for Regenerative Medicine (CIRM) Grants CL1-00502, TR01250, and RM1-01717 (to J. F. L.), TR3-05603 (to J. F. L. and T. Lane), and RB3-05022 (to J. Gottesfeld). This is the fourth article in the Thematic Minireview Series "Development of Human Therapeutics Based on Induced Pluripotent Stem Cell (iPSC) Technology."	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Ambartsumyan G, 2008, HUM MOL GENET, V17, pR10, DOI 10.1093/hmg/ddn170; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Arnhold S, 2004, INVEST OPHTH VIS SCI, V45, P4251, DOI 10.1167/iovs.03-1108; ATKIN NB, 1982, LANCET, V2, P1349; Bai H, 2012, STEM CELL RES, V8, P26, DOI 10.1016/j.scr.2011.08.002; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Baylis F, 2011, HASTINGS CTR REPORT, V43; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chen K, 2013, AM J MED GENET A, V161A, P1817, DOI 10.1002/ajmg.a.35957; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; Dion V, 2009, TRENDS GENET, V25, P288, DOI 10.1016/j.tig.2009.04.007; Doi D, 2012, STEM CELLS, V30, P935, DOI 10.1002/stem.1060; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Frumkin T, 2008, MOL CELL ENDOCRINOL, V282, P112, DOI 10.1016/j.mce.2007.11.009; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hulten MA, 2010, CURR GENOMICS, V11, P409, DOI 10.2174/138920210793176056; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Kaushal D, 2003, J NEUROSCI, V23, P5599; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lavon N, 2008, STEM CELLS, V26, P1874, DOI 10.1634/stemcells.2008-0156; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Looijenga LHJ, 2000, J PATHOL, V191, P187, DOI 10.1002/(SICI)1096-9896(200006)191:2<187::AID-PATH584>3.0.CO;2-T; Lund RJ, 2012, NAT REV GENET, V13, P732, DOI 10.1038/nrg3271; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; MacLean GA, 2012, P NATL ACAD SCI USA, V109, P17567, DOI 10.1073/pnas.1215468109; Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Mostert M, 2000, LAB INVEST, V80, P1055, DOI 10.1038/labinvest.3780110; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Perrat PN, 2013, SCIENCE, V340, P91, DOI 10.1126/science.1231965; Peterson SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023018; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Rajendran RS, 2007, DEV NEUROBIOL, V67, P1334, DOI 10.1002/dneu.20365; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; RODRIGUEZ E, 1993, GENE CHROMOSOME CANC, V8, P230, DOI 10.1002/gcc.2870080405; Ronen D, 2012, CURR OPIN GENET DEV, V22, P444, DOI 10.1016/j.gde.2012.09.003; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schneider DT, 2001, KLIN PADIATR, V213, P204, DOI 10.1055/s-2001-16852; Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015; Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203; Skotheim RI, 2002, CANCER RES, V62, P2359; Stolberg S. G., 1999, NEW YORK TIMES  1128; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Thomas Charles A, 2012, Front Biosci (Elite Ed), V4, P1663; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Varela C, 2012, J CLIN INVEST, V122, P569, DOI 10.1172/JCI46268; WANG N, 1980, CANCER RES, V40, P796; Weiss Rick, 2005, Washington Post, pA2; Werbowetski-Ogilvie TE, 2012, STEM CELLS, V30, P392, DOI 10.1002/stem.1017; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Yang S, 2008, GENE CHROMOSOME CANC, V47, P665, DOI 10.1002/gcc.20574; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Yurov YB, 2005, J HISTOCHEM CYTOCHEM, V53, P385, DOI 10.1369/jhc.4A6430.2005	71	86	92	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4578	4584		10.1074/jbc.R113.516419	http://dx.doi.org/10.1074/jbc.R113.516419			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24362040	Green Published, hybrid			2022-12-28	WOS:000331607900006
J	Fryer, LGD; Jones, B; Duncan, EJ; Hutchison, CE; Ozkan, T; Williams, PA; Alder, O; Nieuwdorp, M; Townley, AK; Mensenkamp, AR; Stephens, DJ; Dallinga-Thie, GM; Shoulders, CC				Fryer, Lee G. D.; Jones, Bethan; Duncan, Emma J.; Hutchison, Claire E.; Ozkan, Tozen; Williams, Paul A.; Alder, Olivia; Nieuwdorp, Max; Townley, Anna K.; Mensenkamp, Arjen R.; Stephens, David J.; Dallinga-Thie, Geesje M.; Shoulders, Carol C.			The Endoplasmic Reticulum Coat Protein II Transport Machinery Coordinates Cellular Lipid Secretion and Cholesterol Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Apolipoproteins; Cholesterol Regulation; Endoplasmic Reticulum (ER); Lipoprotein Secretion; Transcriptomics	STEROL-REGULATORY-ELEMENT; TRIGLYCERIDE TRANSFER PROTEIN; LOW-DENSITY-LIPOPROTEIN; CHYLOMICRON RETENTION DISEASE; APO-B SECRETION; APOLIPOPROTEIN-B; MESSENGER-RNA; FATTY-ACID; TRANSCRIPTIONAL REGULATION; NONFASTING TRIGLYCERIDES	Background: Sar1 mediates the onward transport of ER cargo. Results: Sar1B promotes VLDL secretion, whereas Sar1A antagonizes this activity, and a deficit of both reduces cholesterol biosynthesis. Conclusion: Sar1B independently of and through its lipoprotein secretion function promotes the expression of genes regulating cholesterol biosynthesis. Significance: Sar1B-mediated transport activities contribute to both the functional integrity of the ER membrane and blood cholesterol levels. Triglycerides and cholesterol are essential for life in most organisms. Triglycerides serve as the principal energy storage depot and, where vascular systems exist, as a means of energy transport. Cholesterol is essential for the functional integrity of all cellular membrane systems. The endoplasmic reticulum is the site of secretory lipoprotein production and de novo cholesterol synthesis, yet little is known about how these activities are coordinated with each other or with the activity of the COPII machinery, which transports endoplasmic reticulum cargo to the Golgi. The Sar1B component of this machinery is mutated in chylomicron retention disorder, indicating that this Sar1 isoform secures delivery of dietary lipids into the circulation. However, it is not known why some patients with chylomicron retention disorder develop hepatic steatosis, despite impaired intestinal fat malabsorption, and why very severe hypocholesterolemia develops in this condition. Here, we show that Sar1B also promotes hepatic apolipoprotein (apo) B lipoprotein secretion and that this promoting activity is coordinated with the processes regulating apoB expression and the transfer of triglycerides/cholesterol moieties onto this large lipid transport protein. We also show that although Sar1A antagonizes the lipoprotein secretion-promoting activity of Sar1B, both isoforms modulate the expression of genes encoding cholesterol biosynthetic enzymes and the synthesis of cholesterol de novo. These results not only establish that Sar1B promotes the secretion of hepatic lipids but also adds regulation of cholesterol synthesis to Sar1B's repertoire of transport functions.	[Fryer, Lee G. D.; Duncan, Emma J.; Hutchison, Claire E.; Ozkan, Tozen; Shoulders, Carol C.] Queen Mary Univ London, William Harvey Res Inst, Endocrinol Ctr, London EC1M 6BQ, England; [Fryer, Lee G. D.; Duncan, Emma J.; Hutchison, Claire E.; Ozkan, Tozen; Shoulders, Carol C.] Barts & London Queen Marys Sch Med & Dent, London EC1M 6BQ, England; [Fryer, Lee G. D.] Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Urooncol Res Grp, Cambridge CB2 ORE, England; [Fryer, Lee G. D.; Jones, Bethan; Williams, Paul A.; Alder, Olivia; Mensenkamp, Arjen R.; Shoulders, Carol C.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England; [Nieuwdorp, Max; Dallinga-Thie, Geesje M.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Townley, Anna K.; Stephens, David J.] Univ Bristol, Dept Biochem, Sch Med Sci, Bristol BS8 1TD, Avon, England	University of London; Queen Mary University London; University of London; Queen Mary University London; Cancer Research UK; CRUK Cambridge Institute; Imperial College London; University of Amsterdam; Academic Medical Center Amsterdam; University of Bristol	Fryer, LGD (corresponding author), Canc Res UK, Cambridge Res Inst, Cambridge CB2 ORE, England.	Lee.Fryer@cruk.cam.ac.uk; c.shoulders@qmul.ac.uk	Mensenkamp, Arjen/L-4520-2015; alder, olivia/H-7610-2016	Mensenkamp, Arjen/0000-0003-3805-877X; alder, olivia/0000-0002-7975-9727; Stephens, David/0000-0001-5297-3240; dallinga-thie, geesje/0000-0001-5412-5923	British Heart Foundation [PG/04/010/16596, FS/12/25/29569]; Medical Research Council plus a ZONMW/NWO VENI award; National Institute for Health Research; MRC [MC_U120074258, G117/554] Funding Source: UKRI; Medical Research Council [G117/554, MC_U120074258, 1224453] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council plus a ZONMW/NWO VENI award; National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funding from the British Heart Foundation Grants PG/04/010/16596 and FS/12/25/29569 and Medical Research Council plus a ZONMW/NWO VENI award (to M. N.). This work forms part of the research areas contributing to the translational research portfolio of the Cardiovascular Biomedical Research Unit at Barts, which is supported and funded by the National Institute for Health Research.	Alger HM, 2010, J BIOL CHEM, V285, P14267, DOI 10.1074/jbc.M110.118422; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Auton M, 2013, BIOCHEMISTRY-US, V52, P4324, DOI 10.1021/bi4006732; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Bennett MK, 2008, J BIOL CHEM, V283, P15628, DOI 10.1074/jbc.M800391200; BERR F, 1986, J LIPID RES, V27, P645; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; BOREN J, 1993, ARTERIOSCLER THROMB, V13, P1743, DOI 10.1161/01.ATV.13.12.1743; BOREN J, 1992, J BIOL CHEM, V267, P9858; BOREN J, 1994, J BIOL CHEM, V269, P25879; Brown AM, 1999, BBA-MOL CELL BIOL L, V1440, P253, DOI 10.1016/S1388-1981(99)00133-X; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Bu SY, 2010, J LIPID RES, V51, P3270, DOI 10.1194/jlr.M009407; Calandra S, 2011, J LIPID RES, V52, P1885, DOI 10.1194/jlr.R017855; Caldas H, 2003, HUM MOL GENET, V12, P2981, DOI 10.1093/hmg/ddg321; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Charcosset M, 2008, MOL GENET METAB, V93, P74, DOI 10.1016/j.ymgme.2007.08.120; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; CIANFLONE KM, 1990, J LIPID RES, V31, P2045; Clingman CC, 2013, WIRES RNA, V4, P387, DOI 10.1002/wrna.1167; Cuchel M, 1997, ARTERIOSCL THROM VAS, V17, P1910, DOI 10.1161/01.ATV.17.10.1910; Dannoura AH, 1999, ARTERIOSCL THROM VAS, V19, P2494, DOI 10.1161/01.ATV.19.10.2494; Datta S, 2005, J BIOL CHEM, V280, P3338, DOI 10.1074/jbc.M411222200; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Fisher EA, 2008, J LIPID RES, V49, P2149, DOI 10.1194/jlr.M800108-JLR200; Fleming JF, 1999, J BIOL CHEM, V274, P9509, DOI 10.1074/jbc.274.14.9509; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Gaylor JL, 2002, BIOCHEM BIOPH RES CO, V292, P1139, DOI 10.1006/bbrc.2001.2008; Griffin JL, 2001, FEBS LETT, V509, P263, DOI 10.1016/S0014-5793(01)03175-1; Guillou Herve, 2008, V49, P3, DOI 10.1007/978-1-4020-8831-5_1; Haggarty P, 2000, BRIT J NUTR, V83, P227, DOI 10.1017/S0007114500000295; Harada N, 2012, BIOCHEM BIOPH RES CO, V423, P128, DOI 10.1016/j.bbrc.2012.05.094; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iqbal J, 2008, J BIOL CHEM, V283, P19967, DOI 10.1074/jbc.M800398200; Ishimoto K, 2010, BIOCHEM J, V429, P347, DOI 10.1042/BJ20091511; Jiang XS, 2010, MOL CELL PROTEOMICS, V9, P1461, DOI 10.1074/mcp.M900548-MCP200; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; JONES PJH, 1994, J LIPID RES, V35, P1093; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Knebel B., 2012, PLOS ONE, V7; Kristiana I, 2008, BBA-MOL CELL BIOL L, V1781, P724, DOI 10.1016/j.bbalip.2008.08.006; Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004; Lee RG, 2013, J LIPID RES, V54, P602, DOI 10.1194/jlr.M029215; LEIPER JM, 1994, J BIOL CHEM, V269, P21951; LEVY E, 1987, J LIPID RES, V28, P1263; Liu Y, 2008, BBA-MOL CELL BIOL L, V1781, P97, DOI 10.1016/j.bbalip.2008.01.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus AF, 2012, BIOCHEM BIOPH RES CO, V426, P585, DOI 10.1016/j.bbrc.2012.08.131; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Lu XL, 2012, J MOL ENDOCRINOL, V48, P1, DOI 10.1530/JME-11-0132; Mann CJ, 1999, J MOL BIOL, V285, P391, DOI 10.1006/jmbi.1998.2298; Marijanovic Z, 2003, MOL ENDOCRINOL, V17, P1715, DOI 10.1210/me.2002-0436; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Nadanaka S, 2006, CELL STRUCT FUNCT, V31, P109, DOI 10.1247/csf.06015; Nagai M, 2002, BIOCHEM BIOPH RES CO, V295, P74, DOI 10.1016/S0006-291X(02)00623-X; Nagasawa S, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001974; Nagashima S, 2012, ARTERIOSCL THROM VAS, V32, P1824, DOI 10.1161/ATVBAHA.111.240754; NEMETH A, 1995, EUR J CLIN INVEST, V25, P271, DOI 10.1111/j.1365-2362.1995.tb01559.x; NGUYEN LB, 1990, J CLIN INVEST, V86, P923, DOI 10.1172/JCI114794; Nicodeme E, 1999, J BIOL CHEM, V274, P1986, DOI 10.1074/jbc.274.4.1986; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Okazaki H, 2006, J LIPID RES, V47, P1950, DOI 10.1194/jlr.M600224-JLR200; Olsen BN, 2013, BIOPHYS J, V105, P1838, DOI 10.1016/j.bpj.2013.08.042; Ouguerram K, 2012, ARTERIOSCL THROM VAS, V32, P1520, DOI 10.1161/ATVBAHA.112.245076; Palacio C. H., 2011, CASE REP TRANSPLANT, V2011; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Parini P, 2008, ARTERIOSCL THROM VAS, V28, P1200, DOI 10.1161/ATVBAHA.107.157172; Patterson MC, 2012, MOL GENET METAB, V106, P330, DOI 10.1016/j.ymgme.2012.03.012; Pehar M, 2012, J BIOL CHEM, V287, P22436, DOI 10.1074/jbc.C112.362871; Peretti N, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-24; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Pramfalk C, 2007, BIOCHEM BIOPH RES CO, V364, P402, DOI 10.1016/j.bbrc.2007.10.028; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Repa JJ, 2005, J LIPID RES, V46, P779, DOI 10.1194/jlr.M400475-JLR200; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schiavoni G, 2010, BBA-MOL CELL BIOL L, V1801, P587, DOI 10.1016/j.bbalip.2010.01.013; Schmidt HHJ, 2008, CLIN TRANSPLANT, V22, P180, DOI 10.1111/j.1399-0012.2007.00764.x; Sela D, 2012, J BIOL CHEM, V287, P23035, DOI 10.1074/jbc.M112.369504; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; Siddiqi SA, 2008, BIOCHEM J, V413, P333, DOI 10.1042/BJ20071469; Simons K., 2011, COLD SPRING HARBOR P, V3; So JS, 2012, CELL METAB, V16, P487, DOI 10.1016/j.cmet.2012.09.004; Sokolov A, 2010, J BIOL CHEM, V285, P29480, DOI 10.1074/jbc.M110.148254; Sorci-Thomas MG, 2012, ARTERIOSCL THROM VAS, V32, P2561, DOI 10.1161/ATVBAHA.112.300135; SPRING DJ, 1992, J BIOL CHEM, V267, P14839; STAMELLOS KD, 1993, J BIOL CHEM, V268, P12825; Strand BH, 2013, J NEUROL SCI, V324, P124, DOI 10.1016/j.jns.2012.10.018; Sudhop T, 2002, CIRCULATION, V106, P1943, DOI 10.1161/01.CIR.0000034044.95911.DC; Sudhop T, 2009, J LIPID RES, V50, P2117, DOI 10.1194/jlr.P900004-JLR200; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; TANAKA M, 1993, J BIOL CHEM, V268, P12713; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Temel RE, 2007, J LIPID RES, V48, P1618, DOI 10.1194/jlr.M700109-JLR200; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urano Y, 2008, P NATL ACAD SCI USA, V105, P16513, DOI 10.1073/pnas.0807450105; van der Kant R, 2013, J LIPID RES, V54, P2153, DOI 10.1194/jlr.M037325; Vargas NB, 2009, J LIPID RES, V50, P386, DOI 10.1194/jlr.M800316-JLR200; Welty FK, 2004, ARTERIOSCL THROM VAS, V24, P1703, DOI 10.1161/01.ATV.0000137975.14996.df; WELTY FK, 1995, CIRCULATION, V92, P2036, DOI 10.1161/01.CIR.92.8.2036; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200; Woudenberg J, 2010, HEPATOLOGY, V52, P623, DOI 10.1002/hep.23684; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783	117	33	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4244	4261		10.1074/jbc.M113.479980	http://dx.doi.org/10.1074/jbc.M113.479980			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24338480	hybrid, Green Published			2022-12-28	WOS:000331403800036
J	Yadav, B; Bhatnagar, S; Ahmad, MF; Jain, P; Pratyusha, VA; Kumar, P; Komath, SS				Yadav, Bhawna; Bhatnagar, Shilpi; Ahmad, Mohammad Faiz; Jain, Priyanka; Pratyusha, Vavilala A.; Kumar, Pravin; Komath, Sneha Sudha			First Step of Glycosylphosphatidylinositol (GPI) Biosynthesis Cross-talks with Ergosterol Biosynthesis and Ras Signaling in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; Fungi; Molecular Cell Biology; Ras; Sterol; Ergosterol Biosynthesis; Filamentation; GPI-N-Acetylglucosaminyltransferase Complex; Glycosylphosphatidyl Anchor Biosynthesis; Ras Signaling	CELL-WALL INTEGRITY; ANCHOR BIOSYNTHESIS; ANTIFUNGAL AGENTS; YEAST RAS; RESISTANCE; MANNOSYLTRANSFERASE; IDENTIFICATION; MORPHOGENESIS; TRANSCRIPTION; CONSTRUCTION	Background: GPI anchor is essential for virulence of C. albicans. Little is known about its GPI biosynthetic pathway. We explore roles of two GPI-N-acetylglucosaminyltransferase subunits catalyzing the first step. Results: Subunits GPI2 and GPI19 are negatively co-regulated, affecting Ras1 activity and ERG11 levels, respectively. Conclusion:GPI2/GPI19 levels affect morphogenesis and ergosterol biosynthesis. Significance:C. albicans can be targeted by modulation of cross-talk among major pathways. Candida albicans is a leading cause of fungal infections worldwide. It has several glycosylphosphatidylinositol (GPI)-anchored virulence factors. Inhibiting GPI biosynthesis attenuates its virulence. Building on our previous work, we explore the interaction of GPI biosynthesis in C. albicans with ergosterol biosynthesis and hyphal morphogenesis. This study is also the first report of transcriptional co-regulation existing between two subunits of the multisubunit enzyme complex, GPI-N-acetylglucosaminyltransferase (GPI-GnT), involved in the first step of GPI anchor biosynthesis in eukaryotes. Using mutational analysis, we show that the accessory subunits, GPI2 and GPI19, of GPI-GnT exhibit opposite effects on ergosterol biosynthesis and Ras signaling (which determines hyphal morphogenesis). This is because the two subunits negatively regulate one another; GPI19 mutants show up-regulation of GPI2, whereas GPI2 mutants show up-regulation of GPI19. Two different models were examined as follows. First, the two GPI-GnT subunits independently interact with ergosterol biosynthesis and Ras signaling. Second, the two subunits mutually regulate one another and thereby regulate sterol levels and Ras signaling. Analysis of double mutants of these subunits indicates that GPI19 controls ergosterol biosynthesis through ERG11 levels, whereas GPI2 determines the filamentation by cross-talk with Ras1 signaling. Taken together, this suggests that the first step of GPI biosynthesis talks to and regulates two very important pathways in C. albicans. This could have implications for designing new antifungal strategies.	[Yadav, Bhawna; Bhatnagar, Shilpi; Ahmad, Mohammad Faiz; Jain, Priyanka; Pratyusha, Vavilala A.; Kumar, Pravin; Komath, Sneha Sudha] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Komath, SS (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	sskomath@yahoo.com	KOMATH, SNEHA SUDHA/AAE-6359-2020; Pratyusha, Vavilala/AAE-6436-2021	KOMATH, SNEHA SUDHA/0000-0002-0491-7102; Pratyusha, Vavilala/0000-0002-2048-5047; KUMAR, PRAVIN/0000-0002-6264-4157	Department of Biotechnology; DBT-BUILDER program; University Grants Commission-Resource Networking (UGC-RNW) funds from the School of Life Sciences, Jawaharlal Nehru University; Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE) funds from Jawaharlal Nehru University; Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE); Council of Scientific and Industrial Research (CSIR)	Department of Biotechnology; DBT-BUILDER program; University Grants Commission-Resource Networking (UGC-RNW) funds from the School of Life Sciences, Jawaharlal Nehru University; Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE) funds from Jawaharlal Nehru University; Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by the Department of Biotechnology (to S. S. K.), and DBT-BUILDER program, University Grants Commission-Resource Networking (UGC-RNW) funds from the School of Life Sciences, Jawaharlal Nehru University, and Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE) funds from Jawaharlal Nehru University.; Recipient of a short term fellowship from Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE).; Supported by Senior and Junior Research fellowships from Council of Scientific and Industrial Research (CSIR).	Ashraf M, 2011, J BIOL CHEM, V286, P2543, DOI 10.1074/jbc.C110.178343; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Eisenhaber B, 2003, BIOESSAYS, V25, P367, DOI 10.1002/bies.10254; FONZI WA, 1993, GENETICS, V134, P717; Fujita M, 2004, J BIOL CHEM, V279, P51869, DOI 10.1074/jbc.M405232200; Gerami-Nejad M, 2004, YEAST, V21, P429, DOI 10.1002/yea.1080; Grimme SJ, 2004, MICROBIOL-SGM, V150, P3115, DOI 10.1099/mic.0.27254-0; Hayek P, 2010, MICROBIOL RES, V165, P250, DOI 10.1016/j.micres.2009.03.006; HITCHCOCK CA, 1990, BIOCHEM J, V266, P475, DOI 10.1042/bj2660475; Hnisz D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000889; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Kajiwara K, 2008, MOL BIOL CELL, V19, P2069, DOI 10.1091/mbc.E07-08-0740; Kathiravan MK, 2012, BIOORGAN MED CHEM, V20, P5678, DOI 10.1016/j.bmc.2012.04.045; Kawagoe K, 1996, BLOOD, V87, P3600, DOI 10.1182/blood.V87.9.3600.bloodjournal8793600; KELLY SL, 1995, BIOCHEM BIOPH RES CO, V207, P910, DOI 10.1006/bbrc.1995.1272; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; LEIDICH SD, 1995, J BIOL CHEM, V270, P13029, DOI 10.1074/jbc.270.22.13029; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Maeda Y, 1998, EMBO J, V17, P4920, DOI 10.1093/emboj/17.17.4920; Maesaki S, 1999, J ANTIMICROB CHEMOTH, V44, P27, DOI 10.1093/jac/44.1.27; Mansfield BE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001126; Martinez-Lopez R, 2004, MICROBIOL-SGM, V150, P3341, DOI 10.1099/mic.0.27320-0; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Morioka S, 2013, APPL MICROBIOL BIOT, V97, P4013, DOI 10.1007/s00253-012-4470-9; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Pasrija R, 2008, ANTIMICROB AGENTS CH, V52, P694, DOI 10.1128/AAC.00861-07; Plaine A, 2008, FUNGAL GENET BIOL, V45, P1404, DOI 10.1016/j.fgb.2008.08.003; Richard M, 2002, MOL MICROBIOL, V44, P841, DOI 10.1046/j.1365-2958.2002.02926.x; Richard ML, 2007, EUKARYOT CELL, V6, P119, DOI 10.1128/EC.00297-06; Sanglard D, 2003, ANTIMICROB AGENTS CH, V47, P2404, DOI 10.1128/AAC.47.8.2404-2412.2003; Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0; Sanyal K, 2004, P NATL ACAD SCI USA, V101, P11374, DOI 10.1073/pnas.0404318101; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Shukla S, 2011, EUKARYOT CELL, V10, P1357, DOI 10.1128/EC.05041-11; Singh P, 2009, BIOORGAN MED CHEM, V17, P3973, DOI 10.1016/j.bmc.2009.04.026; Sobering AK, 2004, CELL, V117, P637, DOI 10.1016/j.cell.2004.05.003; Sobering AK, 2003, MOL CELL BIOL, V23, P4983, DOI 10.1128/MCB.23.14.4983-4990.2003; Victoria GS, 2012, BIOCHEM J, V443, P619, DOI 10.1042/BJ20120143; Victoria GS, 2010, MICROBIOL-SGM, V156, P3041, DOI 10.1099/mic.0.039628-0; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zhu Y, 2009, MOL MICROBIOL, V74, P862, DOI 10.1111/j.1365-2958.2009.06898.x	45	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3365	3382		10.1074/jbc.M113.528802	http://dx.doi.org/10.1074/jbc.M113.528802			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24356967	Green Published, hybrid			2022-12-28	WOS:000331368700023
J	Cobb, NJ; Apostol, MI; Chen, SG; Smirnovas, V; Surewicz, WK				Cobb, Nathan J.; Apostol, Marcin I.; Chen, Shugui; Smirnovas, Vytautas; Surewicz, Witold K.			Conformational Stability of Mammalian Prion Protein Amyloid Fibrils Is Dictated by a Packing Polymorphism within the Core Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Neurodegenerative Diseases; Prions; Protein Aggregation; Protein Misfolding	SECONDARY STRUCTURE; STRUCTURAL BASIS; CONVERSION; ORGANIZATION; DISEASES; STRAINS; ABSENCE	Background: Prion strains are believed to be enciphered by distinct conformations of misfolded prion protein (PrP). Results: Strains of PrP amyloid with different conformational stabilities were found to have identical -sheet core regions but different steric zipper interfaces. Conclusion: Strain-specific differences in PrP amyloid stability are dictated by a packing polymorphism. Significance: These findings have implications for understanding the structural basis of prion strains. Mammalian prion strains are believed to arise from the propagation of distinct conformations of the misfolded prion protein PrPSc. One key operational parameter used to define differences between strains has been conformational stability of PrPSc as defined by resistance to thermal and/or chemical denaturation. However, the structural basis of these stability differences is unknown. To bridge this gap, we have generated two strains of recombinant human prion protein amyloid fibrils that show dramatic differences in conformational stability and have characterized them by a number of biophysical methods. Backbone amide hydrogen/deuterium exchange experiments revealed that, in sharp contrast to previously studied strains of infectious amyloid formed from the yeast prion protein Sup35, differences in -sheet core size do not underlie differences in conformational stability between strains of mammalian prion protein amyloid. Instead, these stability differences appear to be dictated by distinct packing arrangements (i.e. steric zipper interfaces) within the amyloid core, as indicated by distinct x-ray fiber diffraction patterns and large strain-dependent differences in hydrogen/deuterium exchange kinetics for histidine side chains within the core region. Although this study was limited to synthetic prion protein amyloid fibrils, a similar structural basis for strain-dependent conformational stability may apply to brain-derived PrPSc, especially because large strain-specific differences in PrPSc stability are often observed despite a similar size of the PrPSc core region.	[Cobb, Nathan J.; Apostol, Marcin I.; Chen, Shugui; Smirnovas, Vytautas; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Surewicz, Witold K.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Surewicz, Witold K.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, 2109 Adelbert Rd, Cleveland, OH 44106 USA.	witold.surewicz@case.edu	Smirnovas, Vytautas/O-6270-2018	Smirnovas, Vytautas/0000-0002-1829-5455	National Institutes of Health [NS044158, NS074317]; Research Council of Lithuania [MIP-030/2012]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074317, R01NS044158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Lithuania(Research Council of Lithuania (LMTLT)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS044158 and NS074317 (to W. K. S.).; Recipient of travel support from Research Council of Lithuania Grant MIP-030/2012. Present address: Dept. of Biothermodynamics and Drug Design, Vilnius University Institute of Biotechnology, Vilnius, Lithuania.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Anderson M, 2006, J MOL BIOL, V358, P580, DOI 10.1016/j.jmb.2006.02.007; Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+; Apetri AC, 2006, J AM CHEM SOC, V128, P11673, DOI 10.1021/ja063880b; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Baron GS, 2011, BIOCHEMISTRY-US, V50, P4479, DOI 10.1021/bi2003907; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Bett C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003280; Bett C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002522; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Chatani E, 2012, J BIOL CHEM, V287, P22827, DOI 10.1074/jbc.M111.333310; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Debelouchina GT, 2010, J AM CHEM SOC, V132, P10414, DOI 10.1021/ja102775u; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; Dzwolak W, 2004, PROTEIN SCI, V13, P1927, DOI 10.1110/ps.03607204; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hosszu LLP, 2005, BIOCHEMISTRY-US, V44, P16649, DOI 10.1021/bi051277k; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Jones EM, 2011, J BIOL CHEM, V286, P42777, DOI 10.1074/jbc.M111.302539; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Kraus A, 2013, ANNU REV MICROBIOL, V67, P543, DOI 10.1146/annurev-micro-092412-155735; Kuczius T, 1999, MOL MED, V5, P406, DOI 10.1007/BF03402129; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Miyagi M, 2008, ANAL CHEM, V80, P6481, DOI 10.1021/ac8009643; Miyagi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017055; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Serpell LC, 1999, METHOD ENZYMOL, V309, P526; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Surewicz WK, 2011, TOP CURR CHEM, V305, P135, DOI 10.1007/128_2011_165; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Tran DT, 2012, ANAL CHEM, V84, P1653, DOI 10.1021/ac202927p; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904	60	43	43	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2643	2650		10.1074/jbc.M113.520718	http://dx.doi.org/10.1074/jbc.M113.520718			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338015	hybrid, Green Published			2022-12-28	WOS:000333403000015
J	Jung, J; Byeon, IJL; DeLucia, M; Koharudin, LMI; Ahn, J; Gronenborn, AM				Jung, Jinwon; Byeon, In-Ja L.; DeLucia, Maria; Koharudin, Leonardus M. I.; Ahn, Jinwoo; Gronenborn, Angela M.			Binding of HIV-1 Vpr Protein to the Human Homolog of the Yeast DNA Repair Protein RAD23 (hHR23A) Requires Its Xeroderma Pigmentosum Complementation Group C Binding (XPCB) Domain as Well as the Ubiquitin-associated 2 (UBA2) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Base Excision Repair; HIV-1; NMR; Protein-Protein Interactions; Ubiquitination; Binding; UBA2; Vpr; XPCB; hHR23A	IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEOTIDE EXCISION-REPAIR; CELL-CYCLE ARREST; RECRUITING DCAF1/VPRBP; MUTATIONAL ANALYSIS; R VPR; G(2); COMPLEX; INTERACTS; GENE	Background: The HIV-1 accessory protein Vpr interacts with the human nucleotide excision repair protein hHR23A. Results: NMR and other biophysical/biochemical techniques were used to identify Vpr binding sites on hHR23A. Conclusion: hHR23A interacts with Vpr via two domains, XPCB and UBA2. Significance: The involvement of the hHR23A XPCB and UBA2 domains in Vpr binding suggests that cellular effects can be modulated by diverse mechanisms. The human homolog of the yeast DNA repair protein RAD23, hHR23A, has been found previously to interact with the human immunodeficiency virus, type 1 accessory protein Vpr. hHR23A is a modular protein containing an N-terminal ubiquitin-like (UBL) domain and two ubiquitin-associated domains (UBA1 and UBA2) separated by a xeroderma pigmentosum complementation group C binding (XPCB) domain. All domains are connected by flexible linkers. hHR23A binds ubiquitinated proteins and acts as a shuttling factor to the proteasome. Here, we show that hHR23A utilizes both the UBA2 and XPCB domains to form a stable complex with Vpr, linking Vpr directly to cellular DNA repair pathways and their probable exploitation by the virus. Detailed structural mapping of the Vpr contacts on hHR23A, by NMR, revealed substantial contact surfaces on the UBA2 and XPCB domains. In addition, Vpr binding disrupts an intramolecular UBL-UBA2 interaction. We also show that Lys-48-linked di-ubiquitin, when binding to UBA1, does not release the bound Vpr from the hHR23A-Vpr complex. Instead, a ternary hHR23AVprdi-Ub(K48) complex is formed, indicating that Vpr does not necessarily abolish hHR23A-mediated shuttling to the proteasome.	[Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Host Prot Interact, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA.	amg100@pitt.edu		Jung, Jinwon/0000-0002-7981-3316; Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [P50GM82251]; University of Pittsburgh Center For AIDS Research Pilot grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Center For AIDS Research Pilot grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P50GM82251 (to A. M. G.). This work was also supported by a University of Pittsburgh Center For AIDS Research Pilot grant (to J. A.).	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; BALLIET JW, 1994, VIROLOGY, V200, P623, DOI 10.1006/viro.1994.1225; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desrosiers RC, 1998, J VIROL, V72, P1431, DOI 10.1128/JVI.72.2.1431-1437.1998; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; Gragerov A, 1998, VIROLOGY, V245, P323, DOI 10.1006/viro.1998.9138; GUZDER SN, 1995, J BIOL CHEM, V270, P12973, DOI 10.1074/jbc.270.22.12973; Hartmann-Petersen R, 2004, CURR BIOL, V14, pR754, DOI 10.1016/j.cub.2004.09.012; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Kamionka M, 2004, PROTEIN SCI, V13, P2370, DOI 10.1110/ps.04824304; Keller R.L.J., 2005, OPTIMIZING PROCESS N; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; LANG SM, 1993, J VIROL, V67, P902, DOI 10.1128/JVI.67.2.902-912.1993; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lee JH, 2005, P NATL ACAD SCI USA, V102, P9144, DOI 10.1073/pnas.0502082102; Li G., 2010, PLOS ONE, V5; Li G, 2009, CURR HIV RES, V7, P178, DOI 10.2174/157016209787581436; Li L, 1997, MUTAT RES-DNA REPAIR, V383, P197, DOI 10.1016/S0921-8777(97)00002-5; Maciejewski MW, 2012, TOP CURR CHEM, V316, P49, DOI 10.1007/128_2011_185; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mansky LM, 2001, VIROLOGY, V282, P176, DOI 10.1006/viro.2000.0791; Masutani C, 1997, MOL CELL BIOL, V17, P6915, DOI 10.1128/MCB.17.12.6915; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Mobli M, 2007, J BIOMOL NMR, V39, P133, DOI 10.1007/s10858-007-9180-8; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Planelles V, 1996, J VIROL, V70, P2516, DOI 10.1128/JVI.70.4.2516-2524.1996; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 1997, MOL CELL BIOL, V17, P6924, DOI 10.1128/MCB.17.12.6924; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Transy C, 2009, CELL CYCLE, V8, P2489, DOI 10.4161/cc.8.16.9129; vanderSpek PJ, 1996, NUCLEIC ACIDS RES, V24, P2551, DOI 10.1093/nar/24.13.2551; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walters KJ, 2003, P NATL ACAD SCI USA, V100, P12694, DOI 10.1073/pnas.1634989100; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757, DOI 10.1128/MCB.13.12.7757; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Withers-Ward ES, 2000, BIOCHEMISTRY-US, V39, P14103, DOI 10.1021/bi0017071; WithersWard ES, 1997, J VIROL, V71, P9732, DOI 10.1128/JVI.71.12.9732-9742.1997; Zhao RY, 2011, J NEUROIMMUNE PHARM, V6, P216, DOI 10.1007/s11481-011-9261-z	64	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2577	2588		10.1074/jbc.M113.534453	http://dx.doi.org/10.1074/jbc.M113.534453			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24318982	Green Published, hybrid			2022-12-28	WOS:000333403000009
J	Kestler, C; Knobloch, G; Tessmer, I; Jeanclos, E; Schindelin, H; Gohla, A				Kestler, Christian; Knobloch, Gunnar; Tessmer, Ingrid; Jeanclos, Elisabeth; Schindelin, Hermann; Gohla, Antje			Chronophin Dimerization Is Required for Proper Positioning of Its Substrate Specificity Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mechanisms; Enzyme Structure; Pyridoxal Phosphate; Serine; Threonine Protein Phosphatase; X-ray Crystallography; Haloacid Dehalogenase Phosphatase; Phosphatase Dimerization; Pyridoxal Phosphatase; Substrate Specificity	PROTEIN-TYROSINE-PHOSPHATASE; PHOSPHOSERINE PHOSPHATASE; DEHALOGENASE SUPERFAMILY; CRYSTAL-STRUCTURE; RECEPTOR; DOMAIN; DIVERSIFICATION; 5'-NUCLEOTIDASE; DOWNSTREAM; APOPTOSIS	Background: The role of homodimerization in the family of C2a-capped HAD phosphatases is unknown. Results: Chronophin homodimerization is required for proper positioning of the substrate specificity loop and for substrate dephosphorylation. Conclusion: The specificity of chronophin is allosterically controlled by a homophilic intermolecular interaction. Significance: Our results reveal a general principle of how HAD hydrolase dimerization can contribute to substrate specificity. Mammalian phosphatases of the haloacid dehalogenase (HAD) superfamily have emerged as important regulators of physiology and disease. Many of these enzymes are stable homodimers; however, the role of their dimerization is largely unknown. Here, we explore the function of the obligatory homodimerization of chronophin, a mammalian HAD phosphatase known to dephosphorylate pyridoxal 5-phosphate (PLP) and serine/threonine-phosphorylated proteins. The exchange of two residues in the murine chronophin homodimerization interface (chronophin(A194K,A195K)) yields a constitutive monomer both in vitro and in cells. The catalytic activity of monomeric chronophin toward PLP is strongly impaired. X-ray crystallographic studies of chronophin(A194K,A195K) revealed that dimer formation is essential for an intermolecular arginine-arginine-tryptophan stacking interaction that positions a critical histidine residue in the substrate specificity loop of chronophin for PLP coordination. Analysis of all available crystal structures of HAD hydrolases that are grouped together with chronophin in the C2a-type structural subfamily uncovered a highly conserved mode of dimerization that results in intermolecular contacts involving the substrate specificity loop. Our results explain how the dimerization of HAD hydrolases contributes to their catalytic efficiency and substrate specificity.	[Kestler, Christian; Knobloch, Gunnar; Jeanclos, Elisabeth; Gohla, Antje] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Knobloch, Gunnar; Tessmer, Ingrid; Schindelin, Hermann; Gohla, Antje] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97078 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Gohla, A (corresponding author), Univ Wurzburg, Dept Pharmacol, Versbacher Str 9, D-97078 Wurzburg, Germany.	antje.gohla@virchow.uni-wuerzburg.de	Schindelin, Hermann/Q-2697-2019; Tessmer, Ingrid/O-2810-2013	Knobloch, Gunnar/0000-0001-7356-9386; Jeanclos, Elisabeth/0000-0001-5934-5490; Gohla, Antje/0000-0002-7442-1487	Deutsche Forschungsgemeinschaft [SFB688, FZ82]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants SFB688 (to A. G.) and FZ82 (to A. G., H. S., and I. T.).	Afonine PV, 2007, ACTA CRYSTALLOGR D, V63, P1194, DOI 10.1107/S0907444907046148; Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Biswas T, 2009, J BIOL CHEM, V284, P30594, DOI 10.1074/jbc.M109.012278; Boulanger RR, 2003, J BIOL CHEM, V278, P23497, DOI 10.1074/jbc.M301105200; Bowling FG, 2011, SEMIN CELL DEV BIOL, V22, P611, DOI 10.1016/j.semcdb.2011.05.003; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chin CN, 2005, FEBS LETT, V579, P3855, DOI 10.1016/j.febslet.2005.05.071; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; di Salvo Martino L, 2012, Front Biosci (Elite Ed), V4, P897, DOI 10.2741/E428; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Felts RL, 2007, BIOCHEMISTRY-US, V46, P11110, DOI 10.1021/bi701016m; FONDA ML, 1992, J BIOL CHEM, V267, P15978; Ghosh A, 2008, MOL CELL, V32, P478, DOI 10.1016/j.molcel.2008.09.021; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Hashimoto K, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035007; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Ivanovska J, 2013, INT J BIOCHEM CELL B, V45, P1720, DOI 10.1016/j.biocel.2013.05.013; Jang YM, 2003, J BIOL CHEM, V278, P50040, DOI 10.1074/jbc.M309619200; Jung SK, 2010, FASEB J, V24, P560, DOI 10.1096/fj.09-143891; Kim JE, 2008, EXP NEUROL, V211, P128, DOI 10.1016/j.expneurol.2008.01.029; Kim JE, 2010, GLIA, V58, P1937, DOI 10.1002/glia.21063; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lahiri SD, 2006, BIOORG CHEM, V34, P394, DOI 10.1016/j.bioorg.2006.09.007; Li CK, 2008, LINEAR MULTILINEAR A, V56, P1, DOI 10.1080/03081080701538074; Lu ZB, 2005, BIOCHEMISTRY-US, V44, P8684, DOI 10.1021/bi050009j; Lu ZB, 2009, J BIOL CHEM, V284, P1224, DOI 10.1074/jbc.M807056200; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mei G, 2005, FEBS J, V272, P16, DOI 10.1111/j.1432-1033.2004.04407.x; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; Pandya C, 2013, P NATL ACAD SCI USA, V110, pE3381, DOI 10.1073/pnas.1305519110; Pesi R, 2010, FEBS J, V277, P4863, DOI 10.1111/j.1742-4658.2010.07891.x; Rinaldo-Matthis A, 2002, NAT STRUCT BIOL, V9, P779, DOI 10.1038/nsb846; Roberts A, 2005, PROTEINS, V58, P790, DOI 10.1002/prot.20267; Roth HM, 2012, DNA REPAIR, V11, P286, DOI 10.1016/j.dnarep.2011.12.002; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seifried A, 2013, FEBS J, V280, P549, DOI 10.1111/j.1742-4658.2012.08633.x; Spychala J, 1999, EUR J BIOCHEM, V259, P851, DOI 10.1046/j.1432-1327.1999.00099.x; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tremblay LW, 2006, BIOCHEMISTRY-US, V45, P1183, DOI 10.1021/bi051842j; van der Wijk T, 2003, J BIOL CHEM, V278, P13968, DOI 10.1074/jbc.M300632200; Walchli S, 2005, BIOCHEM BIOPH RES CO, V331, P497, DOI 10.1016/j.bbrc.2005.03.196; Wallden K, 2007, BIOCHEMISTRY-US, V46, P13809, DOI 10.1021/bi7014794; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; Zhu H, 2007, VIROLOGY, V366, P126, DOI 10.1016/j.virol.2007.03.059; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200	54	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					3094	3103		10.1074/jbc.M113.536482	http://dx.doi.org/10.1074/jbc.M113.536482			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338687	hybrid, Green Published			2022-12-28	WOS:000333403000055
J	Lipscomb, GL; Schut, GJ; Thorgersen, MP; Nixon, WJ; Kelly, RM; Adams, MWW				Lipscomb, Gina L.; Schut, Gerrit J.; Thorgersen, Michael P.; Nixon, William J.; Kelly, Robert M.; Adams, Michael W. W.			Engineering Hydrogen Gas Production from Formate in a Hyperthermophile by Heterologous Production of an 18-Subunit Membrane-bound Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Enzymes; Genetics; Metabolic Engineering; Microbiology; Hydrogen; Hyperthermophiles	ARCHAEON PYROCOCCUS-FURIOSUS; SULFUR METABOLISM; SYSTEM; GENOME; FUELS; SURR	Background: Biohydrogen production from formate may aid in efficient chemical and fuel production using H-2 as the energy carrier. Results: The hyperthermophile Pyrococcus furiosus was engineered to convert formate to H-2. Conclusion: An 18-gene cluster can be inserted into the P. furiosus chromosome for active production of a membrane-bound system. Significance: This work demonstrates the versatility of this model organism for metabolic engineering purposes. Biohydrogen gas has enormous potential as a source of reductant for the microbial production of biofuels, but its low solubility and poor gas mass transfer rates are limiting factors. These limitations could be circumvented by engineering biofuel production in microorganisms that are also capable of generating H-2 from highly soluble chemicals such as formate, which can function as an electron donor. Herein, the model hyperthermophile, Pyrococcus furiosus, which grows optimally near 100 degrees C by fermenting sugars to produce H-2, has been engineered to also efficiently convert formate to H-2. Using a bacterial artificial chromosome vector, the 16.9-kb 18-gene cluster encoding the membrane-bound, respiratory formate hydrogen lyase complex of Thermococcus onnurineus was inserted into the P. furiosus chromosome and expressed as a functional unit. This enabled P. furiosus to utilize formate as well as sugars as an H-2 source and to do so at both 80 degrees and 95 degrees C, near the optimum growth temperature of the donor (T. onnurineus) and engineered host (P. furiosus), respectively. This accomplishment also demonstrates the versatility of P. furiosus for metabolic engineering applications.	[Lipscomb, Gina L.; Schut, Gerrit J.; Thorgersen, Michael P.; Nixon, William J.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Kelly, Robert M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University System of Georgia; University of Georgia; University of North Carolina; North Carolina State University	Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adams@bmb.uga.edu		Thorgersen, Michael/0000-0001-9552-762X; Kelly, Robert/0000-0002-0639-3592; Adams, Michael/0000-0002-9796-5014	United States Department of Energy as part of the Electrofuels Project of ARPA-E [DE-AR0000081]; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences [DE-FG05-95ER20175]	United States Department of Energy as part of the Electrofuels Project of ARPA-E(United States Department of Energy (DOE)); Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy as part of the Electrofuels Project of ARPA-E (DE-AR0000081) for strain construction and analysis and by the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences (DE-FG05-95ER20175) for strain characterization.	Adams MWW, 2001, J BACTERIOL, V183, P716, DOI 10.1128/JB.183.2.716-724.2001; Armaroli N, 2011, CHEMSUSCHEM, V4, P21, DOI 10.1002/cssc.201000182; Bae SS, 2012, BIOTECHNOL LETT, V34, P75, DOI 10.1007/s10529-011-0732-3; Basen M, 2012, MBIO, V3, DOI 10.1128/mBio.00053-12; Bridger SL, 2012, J BACTERIOL, V194, P4097, DOI 10.1128/JB.00439-12; Bridger SL, 2011, J BACTERIOL, V193, P6498, DOI 10.1128/JB.05445-11; Chandrayan SK, 2012, J BIOL CHEM, V287, P3257, DOI 10.1074/jbc.M111.290916; Crable Bryan R, 2011, Enzyme Res, V2011, P532536, DOI 10.4061/2011/532536; DURST HD, 1975, ANAL CHEM, V47, P1797, DOI 10.1021/ac60361a025; Farkas J, 2011, APPL ENVIRON MICROB, V77, P6343, DOI 10.1128/AEM.05057-11; Farkas JZ, 2012, J BIOL DYNAM, V6, P1, DOI 10.1080/17513758.2011.615464; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Hawkins AS, 2013, CURR OPIN BIOTECH, V24, P376, DOI 10.1016/j.copbio.2013.02.017; Hopkins RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026569; Kanjee U, 2013, ANNU REV MICROBIOL, V67, P65, DOI 10.1146/annurev-micro-092412-155708; Keller MW, 2013, P NATL ACAD SCI USA, V110, P5840, DOI 10.1073/pnas.1222607110; Kim YJ, 2010, NATURE, V467, P352, DOI 10.1038/nature09375; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Lipscomb GL, 2009, MOL MICROBIOL, V71, P332, DOI 10.1111/j.1365-2958.2008.06525.x; Lu W, 2011, SCIENCE, V332, P352, DOI 10.1126/science.1199098; Maeda T, 2012, MICROB BIOTECHNOL, V5, P214, DOI 10.1111/j.1751-7915.2011.00282.x; Merryman C, 2012, METAB ENG, V14, P196, DOI 10.1016/j.ymben.2012.02.005; Miyazaki R, 2013, APPL ENVIRON MICROB, V79, P4440, DOI 10.1128/AEM.00711-13; Moon YJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015420; Navarro RM, 2007, CHEM REV, V107, P3952, DOI 10.1021/cr0501994; Sabri S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-60; Sapra R, 2000, J BACTERIOL, V182, P3423, DOI 10.1128/JB.182.12.3423-3428.2000; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Schut GJ, 2013, FEMS MICROBIOL REV, V37, P182, DOI 10.1111/j.1574-6976.2012.00346.x; Schut GJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00163; Schut GJ, 2001, J BACTERIOL, V183, P7027, DOI 10.1128/JB.183.24.7027-7036.2001; Thorgersen MP, 2012, P NATL ACAD SCI USA, V109, P18547, DOI 10.1073/pnas.1208605109; Yang H, 2010, MOL MICROBIOL, V77, P1111, DOI 10.1111/j.1365-2958.2010.07275.x; Yoon SH, 2011, GENOME RES, V21, P1892, DOI 10.1101/gr.122218.111	34	33	34	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2873	2879		10.1074/jbc.M113.530725	http://dx.doi.org/10.1074/jbc.M113.530725			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24318960	Green Published, hybrid			2022-12-28	WOS:000333403000035
J	Vorontsov, II; Wu, Y; DeLucia, M; Minasov, G; Mehrens, J; Shuvalova, L; Anderson, WF; Ahn, J				Vorontsov, Ivan I.; Wu, Ying; DeLucia, Maria; Minasov, George; Mehrens, Jennifer; Shuvalova, Ludmilla; Anderson, Wayne F.; Ahn, Jinwoo			Mechanisms of Allosteric Activation and Inhibition of the Deoxyribonucleoside Triphosphate Triphosphohydrolase from Enterococcus faecalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric regulation; Enzyme catalysis; Nucleoside nucleotide metabolism; Site directed mutagenesis; X-ray crystallography; dNTPase; dNTP; HD domain; triphosphohydrolase	RESTRICTION FACTOR SAMHD1; HIV-1 INFECTION; DGTP TRIPHOSPHOHYDROLASE; DNTP TRIPHOSPHOHYDROLASE; POOLS; VIRULENCE; PROTEIN; GENE; EPIDEMIOLOGY; MUTAGENESIS	Background: EF1143 from Enterococcus faecalis is a deoxyribonucleoside triphosphate (dNTP) triphosphohydrolase. Results: Enzymatic studies and crystal structure of EF1143 bound to dNTPs show that dNTP binding at two adjacent allosteric sites can differentially modulate enzyme catalysis. Conclusion: EF1143 enzyme catalysis is differentially regulated by four dNTPs. Significance: Learning how the enzyme activity is regulated by substrates is fundamental for understanding enzyme catalysis and allostery. EF1143 from Enterococcus faecalis, a life-threatening pathogen that is resistant to common antibiotics, is a homo-tetrameric deoxyribonucleoside triphosphate (dNTP) triphosphohydrolase (dNTPase), converting dNTPs into the deoxyribonucleosides and triphosphate. The dNTPase activity of EF1143 is regulated by canonical dNTPs, which simultaneously act as substrates and activity modulators. Previous crystal structures of apo-EF1143 and the protein bound to both dGTP and dATP suggested allosteric regulation of its enzymatic activity by dGTP binding at four identical allosteric sites. However, whether and how other canonical dNTPs regulate the enzyme activity was not defined. Here, we present the crystal structure of EF1143 in complex with dGTP and dTTP. The new structure reveals that the tetrameric EF1143 contains four additional secondary allosteric sites adjacent to the previously identified dGTP-binding primary regulatory sites. Structural and enzyme kinetic studies indicate that dGTP binding to the first allosteric site, with nanomolar affinity, is a prerequisite for substrate docking and hydrolysis. Then, the presence of a particular dNTP in the second site either enhances or inhibits the dNTPase activity of EF1143. Our results provide the first mechanistic insight into dNTP-mediated regulation of dNTPase activity.	[Vorontsov, Ivan I.; Minasov, George; Shuvalova, Ludmilla; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Wu, Ying; DeLucia, Maria; Mehrens, Jennifer; Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA	Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Anderson, WF (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA.	wf-anderson@northwestern.edu; jahn@structbio.pitt.edu		Minasov, George/0000-0001-5460-3462	National Institutes of Health [U54 GM094585, P50GM082251]; University of Pittsburgh School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh School of Medicine(University of Pittsburgh); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant U54 GM094585 for the Midwest Center for Structural Genomics (to W. F. A.) and Grant P50GM082251 (to J. A.). This work was also supported by funds from the University of Pittsburgh School of Medicine (to J. A.).	Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DeLucia M, 2013, J BIOL CHEM, V288, P19116, DOI 10.1074/jbc.M113.469007; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; HOPKINS RL, 1985, J BIOL CHEM, V260, P6618; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kondo N, 2004, J BIOCHEM, V136, P221, DOI 10.1093/jb/mvh115; Kondo N, 2007, ACTA CRYSTALLOGR D, V63, P230, DOI 10.1107/S0907444906049262; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; KUNKEL TA, 1992, J BIOL CHEM, V267, P18251; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li ZP, 2011, APPL MICROBIOL BIOT, V91, P1203, DOI 10.1007/s00253-011-3407-z; Lopes MD, 2005, INT J FOOD MICROBIOL, V103, P191, DOI 10.1016/j.ijfoodmicro.2004.12.025; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAI H, 1990, J BIOL CHEM, V265, P4411; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Oganesyan V, 2007, ACTA CRYSTALLOGR F, V63, P369, DOI 10.1107/S1744309107018945; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; SARGENT RG, 1987, J BIOL CHEM, V262, P5546; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339; WURGLER SM, 1990, P NATL ACAD SCI USA, V87, P2740, DOI 10.1073/pnas.87.7.2740; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	41	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2815	2824		10.1074/jbc.M113.524207	http://dx.doi.org/10.1074/jbc.M113.524207			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338016	Green Published, hybrid			2022-12-28	WOS:000333403000030
J	Hasim, S; Hussin, NA; Alomar, F; Bidasee, KR; Nickerson, KW; Wilson, MA				Hasim, Sahar; Hussin, Nur Ahmad; Alomar, Fadhel; Bidasee, Keshore R.; Nickerson, Kenneth W.; Wilson, Mark A.			A Glutathione-independent Glyoxalase of the DJ-1 Superfamily Plays an Important Role in Managing Metabolically Generated Methylglyoxal in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; DJ-1; Glycolysis; Structural Biology; X-ray Crystallography; Hsp31; Glyoxalase; Methylglyoxal	RESOLUTION CRYSTAL-STRUCTURE; YEAST SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI HSP31; I ENZYME; PROTEIN; CHAPERONE; MODEL; MEMBER; ACID; IDENTIFICATION	Background: Glyoxalases are a varied group of enzymes that detoxify methylglyoxal by converting it to d-lactate. Results: The Candida albicans glyoxalase Glx3 is important for yeast growth, especially in glycerol. Conclusion: Many yeasts contain a novel group of glyoxalases that are not redundant with previously characterized enzymes. Significance: This is the first demonstration of physiologically relevant glutathione-independent glyoxalases in fungi. Methylglyoxal is a cytotoxic reactive carbonyl compound produced by central metabolism. Dedicated glyoxalases convert methylglyoxal to d-lactate using multiple catalytic strategies. In this study, the DJ-1 superfamily member ORF 19.251/GLX3 from Candida albicans is shown to possess glyoxalase activity, making this the first demonstrated glutathione-independent glyoxalase in fungi. The crystal structure of Glx3p indicates that the protein is a monomer containing the catalytic triad Cys(136)-His(137)-Glu(168). Purified Glx3p has an in vitro methylglyoxalase activity (K-m = 5.5 mm and k(cat) = 7.8 s(-1)) that is significantly greater than that of more distantly related members of the DJ-1 superfamily. A close Glx3p homolog from Saccharomyces cerevisiae (YDR533C/Hsp31) also has glyoxalase activity, suggesting that fungal members of the Hsp31 clade of the DJ-1 superfamily are all probable glutathione-independent glyoxalases. A homozygous glx3 null mutant in C. albicans strain SC5314 displays greater sensitivity to millimolar levels of exogenous methylglyoxal, elevated levels of intracellular methylglyoxal, and carbon source-dependent growth defects, especially when grown on glycerol. These phenotypic defects are complemented by restoration of the wild-type GLX3 locus. The growth defect of Glx3-deficient cells in glycerol is also partially complemented by added inorganic phosphate, which is not observed for wild-type or glucose-grown cells. Therefore, C. albicans Glx3 and its fungal homologs are physiologically relevant glutathione-independent glyoxalases that are not redundant with the previously characterized glutathione-dependent GLO1/GLO2 system. In addition to its role in detoxifying glyoxals, Glx3 and its close homologs may have other important roles in stress response.	[Hasim, Sahar; Hussin, Nur Ahmad; Nickerson, Kenneth W.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Wilson, Mark A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Wilson, Mark A.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Alomar, Fadhel; Bidasee, Keshore R.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Alomar, Fadhel; Bidasee, Keshore R.] Univ Nebraska Med Ctr, Redox Biol Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Nickerson, KW (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	knickerson1@unl.edu; mwilson13@unl.edu	Nickerson, Kenneth/V-9979-2019	Alomar, Fadhel Ahmed/0000-0003-0788-6919	Department of Energy Office of Biological and Environmental Research; National Institutes of Health from NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092999, P41GM103393] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Audrey Atkins (University of Nebraska-Lincoln), Wayne Riekhof (University of Nebraska-Lincoln), and Todd Holyoak (University of Waterloo) for useful discussions. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by National Institutes of Health Grant P41GM103393 from NIGMS.	AHMED MU, 1986, J BIOL CHEM, V261, P4889; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Bucala R, 1992, Adv Pharmacol, V23, P1; Carrio MM, 2001, FEBS LETT, V489, P29, DOI 10.1016/S0014-5793(01)02073-7; CASAZZA JP, 1984, J BIOL CHEM, V259, P231; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Chen XJ, 2000, INT REV CYTOL, V194, P197; Clugston SL, 1998, BIOCHEMISTRY-US, V37, P8754, DOI 10.1021/bi972791w; Cooper R A, 1975, Methods Enzymol, V41, P502; COOPER RA, 1970, FEBS LETT, V11, P273, DOI 10.1016/0014-5793(70)80546-4; Dakin HD, 1913, J BIOL CHEM, V14, P423; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Fioravanti E, 2008, BIOCHEMISTRY-US, V47, P11581, DOI 10.1021/bi800882v; Graille M, 2004, STRUCTURE, V12, P839, DOI 10.1016/S0969-2126(04)00113-3; GREEN ML, 1968, BIOCHEM J, V106, P267, DOI 10.1042/bj1060267; Guo PC, 2010, ACTA CRYSTALLOGR F, V66, P1557, DOI 10.1107/S1744309110039965; HALL SS, 1978, J AM CHEM SOC, V100, P5934, DOI 10.1021/ja00486a054; HALL SS, 1976, J AM CHEM SOC, V98, P7460, DOI 10.1021/ja00439a077; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwon K, 2013, FEBS J, V280, P3328, DOI 10.1111/febs.12321; Lages NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032749; Lakshminarasimhan M, 2010, J BIOL CHEM, V285, P29651, DOI 10.1074/jbc.M110.147934; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; Lucas JI, 2007, MOL BIOL EVOL, V24, P551, DOI 10.1093/molbev/msl186; LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P; Madzelan P, 2012, FEBS J, V279, P4111, DOI 10.1111/febs.12004; Martins AMTBS, 2001, FEBS LETT, V499, P41, DOI 10.1016/S0014-5793(01)02519-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCLELLAN AC, 1992, ANAL BIOCHEM, V206, P17, DOI 10.1016/S0003-2697(05)80005-3; Meyerhof O, 1934, BIOCHEM Z, V271, P89; MISRA K, 1995, BIOCHEM J, V305, P999, DOI 10.1042/bj3050999; Mujacic M, 2007, APPL ENVIRON MICROB, V73, P1014, DOI 10.1128/AEM.02429-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nickerson KW, 2006, APPL ENVIRON MICROB, V72, P3805, DOI 10.1128/AEM.02765-05; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PENNINCKX MJ, 1983, J BIOL CHEM, V258, P6030; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Premkumar L, 2011, J STRUCT BIOL, V176, P414, DOI 10.1016/j.jsb.2011.08.011; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; RICHARD JP, 1991, BIOCHEMISTRY-US, V30, P4581, DOI 10.1021/bi00232a031; Sastry MSR, 2009, PROTEIN SCI, V18, P1439, DOI 10.1002/pro.158; Sastry MSR, 2004, P NATL ACAD SCI USA, V101, P8587, DOI 10.1073/pnas.0403033101; Sastry MSR, 2002, J BIOL CHEM, V277, P46026, DOI 10.1074/jbc.M205800200; Scheijen J. L., 2013, CLIN CHEM LAB MED, V10; SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718; Skoneczna A, 2007, FREE RADICAL BIO MED, V42, P1409, DOI 10.1016/j.freeradbiomed.2007.01.042; Subedi KP, 2011, MOL MICROBIOL, V81, P926, DOI 10.1111/j.1365-2958.2011.07736.x; Synnott JM, 2010, EUKARYOT CELL, V9, P1734, DOI 10.1128/EC.00159-10; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; VANDERJAGT DL, 1993, BIOCHEM SOC T, V21, P522, DOI 10.1042/bst0210522; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Wilson MA, 2004, P NATL ACAD SCI USA, V101, P1531, DOI 10.1073/pnas.0308089100; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Zhao YH, 2003, PROTEIN SCI, V12, P2303, DOI 10.1110/ps.03121403	65	61	66	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1662	1674		10.1074/jbc.M113.505784	http://dx.doi.org/10.1074/jbc.M113.505784			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302734	Green Published, hybrid			2022-12-28	WOS:000332401700039
J	Soman, R; Yuan, JJ; Kuhn, A; Dalbey, RE				Soman, Raunak; Yuan, Jijun; Kuhn, Andreas; Dalbey, Ross E.			Polarity and Charge of the Periplasmic Loop Determine the YidC and Sec Translocase Requirement for the M13 Procoat Lep Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI INNER MEMBRANE; F1F0 ATP SYNTHASE; PROTON MOTIVE FORCE; ESCHERICHIA-COLI; SUBUNIT-C; TERMINAL DOMAINS; INSERTION; RESIDUES; BIOGENESIS; SUBSTRATE	During membrane biogenesis, the M13 procoat protein is inserted into the lipid bilayer in a strictly YidC-dependent manner with both the hydrophobic signal sequence and the membrane anchor sequence promoting translocation of the periplasmic loop via a hairpin mechanism. Here, we find that the translocase requirements can be altered for PClep in a predictable manner by changing the polarity and charge of the peptide region that is translocated across the membrane. When the polarity of the translocated peptide region is lowered and the charged residues in this region are removed, translocation of this loop region occurs largely by a YidC- and Sec-independent mechanism. When the polarity is increased to that of the wild-type procoat protein, the YidC insertase is essential for translocation. Further increasing the polarity, by adding charged residues, switches the insertion pathway to a YidC/Sec mechanism. Conversely, we find that increasing the hydrophobicity of the transmembrane segments of PClep can decrease the translocase requirement for translocation of the peptide chain. This study provides a framework to understand why the YidC and Sec machineries exist in parallel and demonstrates that the YidC insertase has a limited capacity to translocate a peptide chain on its own.	[Soman, Raunak; Yuan, Jijun; Dalbey, Ross E.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Kuhn, Andreas] Univ Hohenheim, Inst Microbiol & Mol Biol, D-70599 Stuttgart, Germany	University System of Ohio; Ohio State University; University Hohenheim	Dalbey, RE (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.	dalbey@chemistry.ohio-state.edu			National Science Foundation [MCB-1052033]; Deutsche Forschungsgemeinschaft [KU749/6]	National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by National Science Foundation Grant MCB-1052033 (to R. E. D.) and by Deutsche Forschungsgemeinschaft Grant KU749/6 (to A. K.).	ANDERSSON H, 1993, EMBO J, V12, P683, DOI 10.1002/j.1460-2075.1993.tb05702.x; CAO GQ, 1995, EMBO J, V14, P866, DOI 10.1002/j.1460-2075.1995.tb07068.x; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Chen MY, 2005, BIOCHEMISTRY-US, V44, P10741, DOI 10.1021/bi047418k; DALBEY RE, 1986, J BIOL CHEM, V261, P3844; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Deitermann S, 2005, J BIOL CHEM, V280, P39077, DOI 10.1074/jbc.M509647200; Delgado-Partin VM, 1998, J BIOL CHEM, V273, P9927, DOI 10.1074/jbc.273.16.9927; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Facey SJ, 2004, BBA-MOL CELL RES, V1694, P55, DOI 10.1016/j.bbamcr.2004.03.012; Froderberg L, 2003, MOL MICROBIOL, V47, P1015, DOI 10.1046/j.1365-2958.2003.03346.x; GELLER BL, 1985, J BIOL CHEM, V260, P3281; Kim SJ, 1999, J BIOL CHEM, V274, P4715, DOI 10.1074/jbc.274.8.4715; Klenner C, 2012, J BIOL CHEM, V287, P3769, DOI 10.1074/jbc.M111.307223; Kol S, 2009, J MOL BIOL, V390, P893, DOI 10.1016/j.jmb.2009.05.074; Kudva R, 2013, RES MICROBIOL, V164, P505, DOI 10.1016/j.resmic.2013.03.016; KUHN A, 1988, EUR J BIOCHEM, V177, P267, DOI 10.1111/j.1432-1033.1988.tb14372.x; KUHN A, 1990, EMBO J, V9, P2385, DOI 10.1002/j.1460-2075.1990.tb07413.x; KUHN A, 1990, J STRUCT BIOL, V104, P38, DOI 10.1016/1047-8477(90)90055-H; Miller J.H., 1972, EXPT MOL GENETICS; Neugebauer SA, 2012, J MOL BIOL, V417, P375, DOI 10.1016/j.jmb.2012.01.046; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; Robinson PJ, 2013, BBA-MOL CELL RES, V1833, P2781, DOI 10.1016/j.bbamcr.2013.07.003; ROHRER J, 1990, SCIENCE, V250, P1418, DOI 10.1126/science.2124001; Roos T, 2001, J BIOL CHEM, V276, P37909; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Schuenemann TA, 1999, J BIOL CHEM, V274, P6855, DOI 10.1074/jbc.274.11.6855; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Traxler B, 1996, J BIOL CHEM, V271, P12394, DOI 10.1074/jbc.271.21.12394; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Welte T, 2012, MOL BIOL CELL, V23, P464, DOI 10.1091/mbc.E11-07-0590; Xie K, 2007, BIOCHEMISTRY-US, V46, P15153, DOI 10.1021/bi701398y; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Zhu L, 2013, J BIOL CHEM, V288, P7704, DOI 10.1074/jbc.M112.429431; Zhu L, 2012, J MOL BIOL, V424, P354, DOI 10.1016/j.jmb.2012.09.026	42	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1023	1032		10.1074/jbc.M113.522250	http://dx.doi.org/10.1074/jbc.M113.522250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275657	hybrid, Green Published			2022-12-28	WOS:000330541200035
J	Neill, T; Torres, A; Buraschi, S; Owens, RT; Hoek, JB; Baffa, R; Iozzo, RV				Neill, Thomas; Torres, Annabel; Buraschi, Simone; Owens, Rick T.; Hoek, Jan B.; Baffa, Raffaele; Iozzo, Renato V.			Decorin Induces Mitophagy in Breast Carcinoma Cells via Peroxisome Proliferator- activated Receptor gamma Coactivator-1 alpha ( PGC-1 alpha) and Mitostatin*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Extracellular Matrix; Mitochondria; Proteoglycan; Receptor-tyrosine Kinase; Beclin 1; Mitochondrial Membrane Potential; Mitochondrial Respiratory Chain Complexes; Small Leucine-rich Proteoglycan	LEUCINE-RICH PROTEOGLYCANS; EPIDERMAL-GROWTH-FACTOR; CANCER GROWTH; COLLAGEN FIBRILLOGENESIS; TUMOR MICROENVIRONMENT; ANDROGEN RECEPTOR; METABOLISM; GENE; INHIBITION; THROMBOSPONDIN-1	Background: Decorin functions as a soluble tumor repressor via binding receptor-tyrosine kinases, such as Met, to curb rampant tumor neovascularization. Results: Decorin evokes tumor cell mitophagy through dynamic co-regulation of PGC-1 and mitostatin via physical interactions between PGC-1 and mitostatin Conclusion: Decorin requires mitostatin to evoke mitophagy as the underlying basis for angiogenic attenuation. Significance: We have identified mitostatin as a novel mitophagic effector. Tumor cell mitochondria are key biosynthetic hubs that provide macromolecules for cancer progression and angiogenesis. Soluble decorin protein core, hereafter referred to as decorin, potently attenuated mitochondrial respiratory complexes and mitochondrial DNA (mtDNA) in MDA-MB-231 breast carcinoma cells. We found a rapid and dynamic interplay between peroxisome proliferator-activated receptor coactivator-1 (PGC-1) and the decorin-induced tumor suppressor gene, mitostatin. This interaction stabilized mitostatin mRNA with concurrent accumulation of mitostatin protein. In contrast, siRNA-mediated abrogation of PGC-1-blocked decorin-evoked stabilization of mitostatin. Mechanistically, PGC-1 bound MITOSTATIN mRNA to achieve rapid stabilization. These processes were orchestrated by the decorin/Met axis, as blocking the Met-tyrosine kinase or knockdown of Met abrogated these responses. Furthermore, depletion of mitostatin blocked decorin- or rapamycin-evoked mitophagy, increased vascular endothelial growth factor A (VEGFA) production, and compromised decorin-evoked VEGFA suppression. Collectively, our findings underscore the complexity of PGC-1-mediated mitochondrial homeostasis and establish mitostatin as a key regulator of tumor cell mitophagy and angiostasis.	[Neill, Thomas; Torres, Annabel; Buraschi, Simone; Hoek, Jan B.; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Neill, Thomas; Torres, Annabel; Buraschi, Simone; Hoek, Jan B.; Iozzo, Renato V.] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Baffa, Raffaele] Thomas Jefferson Univ, Dept Urol, Philadelphia, PA 19107 USA; [Owens, Rick T.] LifeCell Corp, Branchburg, NJ 08876 USA	Jefferson University; Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Suite 336 Jefferson Alumni Hall, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020	Iozzo, Renato/0000-0002-5908-5112; Buraschi, Simone/0000-0002-4233-7627; Hoek, Jan/0000-0001-7127-4218	National Institutes of Health Grants [RO1 CA39481, RO1 CA47282, RO1 CA164462]; National Institutes of Health Training Grant [T32 AA07463]; Diversity Research Supplement National Institutes of Health Grant [CA39481-26S1]; NATIONAL CANCER INSTITUTE [R01CA047282, P30CA056036, R01CA164462, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diversity Research Supplement National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA164462 (to R. V. I.). This work is in partial fulfillment of the doctoral theses of T. Neill and A. Torres in Cell and Developmental Biology, Thomas Jefferson University.; Supported by National Institutes of Health Training Grant T32 AA07463.; Supported by a Diversity Research Supplement National Institutes of Health Grant CA39481-26S1.	Araki K, 2009, ONCOLOGY-BASEL, V77, P92, DOI 10.1159/000228253; Baghy K, 2013, FEBS J, V280, P2150, DOI 10.1111/febs.12215; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi XL, 2012, CARCINOGENESIS, V33, P326, DOI 10.1093/carcin/bgr293; Brandan E, 2013, MATRIX BIOL, V32, P289, DOI 10.1016/j.matbio.2013.03.007; Buraschi S, 2012, PLOS ONE, V7; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Cerqua C, 2010, EMBO REP, V11, P854, DOI 10.1038/embor.2010.151; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Dunkman AA, 2013, MATRIX BIOL, V32, P3, DOI 10.1016/j.matbio.2012.11.005; Fassan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019771; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; Ichii M, 2012, BLOOD, V119, P1683, DOI 10.1182/blood-2011-07-369199; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2011, BIOL EXTRACELL MATR, P197, DOI 10.1007/978-3-642-16555-9_6; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jarvinen TAH, 2010, P NATL ACAD SCI USA, V107, P21671, DOI 10.1073/pnas.1016233107; Kalas W, 2005, CANCER RES, V65, P8878, DOI 10.1158/0008-5472.CAN-05-1479; Khan GA, 2011, MOL ENDOCRINOL, V25, P1431, DOI 10.1210/me.2010-0426; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morrione A, 2013, FEBS J, V280, P2138, DOI 10.1111/febs.12149; Murphy-Ullrich JE, 2012, MATRIX BIOL, V31, P152, DOI 10.1016/j.matbio.2012.01.002; Neill T, 2013, FEBS J, V280, P2353, DOI 10.1111/febs.12148; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nikitovic D, 2012, J BIOL CHEM, V287, P33926, DOI 10.1074/jbc.R112.379602; Perdomo G, 2008, J BIOL CHEM, V283, P13700, DOI 10.1074/jbc.M707551200; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Roberts DD, 2012, MATRIX BIOL, V31, P162, DOI 10.1016/j.matbio.2012.01.005; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Schaefer L, 2012, CURR OPIN GENET DEV, V22, P56, DOI 10.1016/j.gde.2011.12.002; SCHMIDT B, 1983, J CELL BIOL, V96, P248, DOI 10.1083/jcb.96.1.248; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Seidler DG, 2012, CURR OPIN STRUC BIOL, V22, P578, DOI 10.1016/j.sbi.2012.07.012; Shintani K, 2008, ONCOL REP, V19, P1533; Sweetwyne MT, 2012, MATRIX BIOL, V31, P178, DOI 10.1016/j.matbio.2012.01.006; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Tralhao JG, 2003, FASEB J, V17, P464, DOI 10.1096/fj.02-0534fje; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Vecchione A, 2009, ONCOGENE, V28, P257, DOI 10.1038/onc.2008.381; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200	78	64	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4952	4968		10.1074/jbc.M113.512566	http://dx.doi.org/10.1074/jbc.M113.512566			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403067	Green Published, hybrid			2022-12-28	WOS:000331607900041
J	Ono, W; Hayashi, Y; Yokoyama, W; Kuroda, T; Kishimoto, H; Ito, I; Kimura, K; Akaogi, K; Waku, T; Yanagisawa, J				Ono, Wakana; Hayashi, Yuki; Yokoyama, Wataru; Kuroda, Takao; Kishimoto, Hiroyuki; Ito, Ichiaki; Kimura, Keiji; Akaogi, Kensuke; Waku, Tsuyoshi; Yanagisawa, Junn			The Nucleolar Protein Myb-binding Protein 1A ( MYBBP1A) Enhances p53 Tetramerization and Acetylation in Response to Nucleolar Disruption*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Nucleolus; p300; p53; Post-translational Modification; Stress Response	CELL-CYCLE ARREST; DNA-BINDING; TUMOR-SUPPRESSOR; POSTTRANSLATIONAL MODIFICATIONS; ACTIVATES P53; OLIGOMERIZATION DOMAIN; BREAST-CANCER; ACTINOMYCIN-D; RNA SYNTHESIS; MDM2	Background: Nucleolar disruption is involved in cellular stress response and is sufficient for p53 activation. p53 tetramerization is crucial to exert its activity. Results: The nucleolar protein MYBBP1A enhanced p53 tetramerization by directly interacting with p53. Conclusion: p53 tetramerization by MYBBP1A is indispensable for activating p53 under nucleolar stress. Significance: This is the first report to describe the possible mechanism underlying p53 tetramerization in cells under nucleolar stress. Tetramerization of p53 is crucial to exert its biological activity, and nucleolar disruption is sufficient to activate p53. We previously demonstrated that nucleolar stress induces translocation of the nucleolar protein MYBBP1A from the nucleolus to the nucleoplasm and enhances p53 activity. However, whether and how MYBBP1A regulates p53 tetramerization in response to nucleolar stress remain unclear. In this study, we demonstrated that MYBBP1A enhances p53 tetramerization, followed by acetylation under nucleolar stress. We found that MYBBP1A has two regions that directly bind to lysine residues of the p53 C-terminal regulatory domain. MYBBP1A formed a self-assembled complex that provided a molecular platform for p53 tetramerization and enhanced p300-mediated acetylation of the p53 tetramer. Moreover, our results show that MYBBP1A functions to enhance p53 tetramerization that is necessary for p53 activation, followed by cell death with actinomycin D treatment. Thus, we suggest that MYBBP1A plays a pivotal role in the cellular stress response.	[Ono, Wakana; Hayashi, Yuki; Yokoyama, Wataru; Kishimoto, Hiroyuki; Kimura, Keiji; Akaogi, Kensuke; Yanagisawa, Junn] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kuroda, Takao] Doshisha Univ, Grad Sch Brain Sci, Kyoto 6190225, Japan; [Kishimoto, Hiroyuki; Ito, Ichiaki; Yanagisawa, Junn] Univ Tsukuba, Life Sci Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Waku, Tsuyoshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tsukuba; Doshisha University; University of Tsukuba; University of Tokyo	Waku, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	twaku@mol.f.u-tokyo.ac.jp; junny@agbi.tsukuba.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science.	Akaogi K, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-65; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; BALAGURUMOORTHY P, 1995, P NATL ACAD SCI USA, V92, P8591, DOI 10.1073/pnas.92.19.8591; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Carter S, 2009, CURR OPIN GENET DEV, V19, P18, DOI 10.1016/j.gde.2008.11.010; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hainaut P, 2000, ADV CANCER RES, V77, P81; HALAZONETIS TD, 1993, EMBO J, V12, P5057, DOI 10.1002/j.1460-2075.1993.tb06199.x; Hanson S, 2005, ONCOGENE, V24, P1641, DOI 10.1038/sj.onc.1208351; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; IAPALUCCIESPINOZA S, 1979, FEBS LETT, V107, P281, DOI 10.1016/0014-5793(79)80390-7; Itahana Y, 2009, J BIOL CHEM, V284, P5158, DOI 10.1074/jbc.M805696200; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Kuroda T, 2011, EMBO J, V30, P1054, DOI 10.1038/emboj.2011.23; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Mateu MG, 1999, NAT STRUCT BIOL, V6, P191; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; MEEK DW, 2009, COLD SPRING HARB PER, V1; Meng XB, 2007, J BIOL CHEM, V282, P1570, DOI 10.1074/jbc.M607520200; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Munoz-Fontela C, 2011, CELL CYCLE, V10, P3701, DOI 10.4161/cc.10.21.17899; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nagaich AK, 1999, P NATL ACAD SCI USA, V96, P1875, DOI 10.1073/pnas.96.5.1875; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Ono W, 2013, BIOCHEM BIOPH RES CO, V434, P659, DOI 10.1016/j.bbrc.2013.04.006; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Poon GMK, 2007, J MOL BIOL, V365, P1217, DOI 10.1016/j.jmb.2006.10.051; Prives C, 1999, J PATHOL, V187, P112; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; Schumacher B, 2010, FEBS LETT, V584, P1443, DOI 10.1016/j.febslet.2010.02.065; Shi Dingding, 2012, Genes Cancer, V3, P240, DOI 10.1177/1947601912455199; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Warnock LJ, 2008, CANCER BIOL THER, V7, P1483, DOI 10.4161/cbt.7.9.6473; WATERMAN JLF, 1995, EMBO J, V14, P512, DOI 10.1002/j.1460-2075.1995.tb07027.x; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Weinberg RL, 2005, J MOL BIOL, V348, P589, DOI 10.1016/j.jmb.2005.03.014; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Wu SY, 2009, EMBO J, V28, P1246, DOI 10.1038/emboj.2009.83; Yamauchi T, 2008, GENES CELLS, V13, P27, DOI 10.1111/j.1365-2443.2007.01148.x; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zambetti GP, 2007, J CELL PHYSIOL, V213, P370, DOI 10.1002/jcp.21217; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	79	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4928	4940		10.1074/jbc.M113.474049	http://dx.doi.org/10.1074/jbc.M113.474049			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24375404	Green Published, hybrid			2022-12-28	WOS:000331607900039
J	Renaud, SJ; Kubota, K; Rumi, MAK; Soares, MJ				Renaud, Stephen J.; Kubota, Kaiyu; Rumi, M. A. Karim; Soares, Michael J.			The FOS Transcription Factor Family Differentially Controls Trophoblast Migration and Invasion*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Embryo Implantation; Placenta; Pregnancy; Reproduction; Trophoblast	ACTIVATING PROTEIN-1 FAMILY; GENE-EXPRESSION PROFILES; C-FOS; CELL-LINE; MATRIX METALLOPROTEINASES; EXTRAVILLOUS TROPHOBLAST; IN-VITRO; MICROARRAY ANALYSIS; BINDING AFFINITIES; SPIRAL ARTERIES	Background: Trophoblast cells invade the uterus during pregnancy to promote blood flow to the conceptus. Results: The transcription factor FOS inhibits trophoblast invasion, whereas FOS-like (FOSL)-1 promotes invasion. Conclusion: The intracellular balance of FOS family transcription factors modulates trophoblast invasive potential. Significance: Understanding the regulation of trophoblast invasion is crucial for determining the etiology of several placenta-associated obstetrical complications. Extravillous trophoblast invasion is a fundamental component of human placentation. Invading trophoblast cells promote blood flow to the conceptus by actively remodeling the uterine vasculature. The extent of trophoblast invasion is tightly regulated; aberrant invasion is linked with several obstetrical complications. However, the transcriptional networks responsible for controlling the extent of trophoblast invasion are not well defined. Previous studies have identified high levels of FOS (FOS, FOSB, FOS-like (FOSL) 1, and FOSL2) proteins in extravillous trophoblast cells. These proteins form part of the activating protein-1 (AP-1) transcription factor complex and are implicated in regulating gene networks controlling cellular invasion in diverse biological systems. Therefore, we hypothesized that FOS family proteins play a role in regulating trophoblast invasion. We assessed expression of FOS family proteins in trophoblast cell lines and human placentae at different gestational ages. FOS, FOSB, and FOSL1 proteins were robustly increased in trophoblast cells subject to wound-based migration assays as well as Matrigel-based invasion assays. FOS knockdown resulted in cessation of proliferation and an induction of migration and invasion concomitant with robust expression of matrix metalloproteinase (MMP) 1, MMP3, and MMP10. Conversely, FOSL1 knockdown abrogated trophoblast migration and invasion and inhibited the production of MMP1, MMP3, and MMP10. In human placenta, FOS was expressed in proximal anchoring villi in conjunction with phospho-ERK. FOSL1 was temporally expressed only in the distal-most extravillous trophoblast cells, which represent a migratory cell population. Therefore, FOS and FOSL1 exert opposing effects on trophoblast invasion.	[Renaud, Stephen J.; Kubota, Kaiyu; Rumi, M. A. Karim; Soares, Michael J.] Univ Kansas, Inst Reprod Hlth & Regenerat Med, Dept Pathol & Lab Med, Med Ctr, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Renaud, SJ (corresponding author), Univ Kansas, Inst Reprod Hlth & Regenerat Med, Dept Pathol & Lab Med, Med Ctr, MS3050,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	srenaud@kumc.edu; msoares@kumc.edu			National Institutes of Health Grant [HD20676]; Canadian Institutes of Health Research fellowship; American Heart Association; Japan Society for the Promotion of Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528, R01HD020676] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); American Heart Association(American Heart Association); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD20676 (to M. J. S.).; Supported by a Canadian Institutes of Health Research fellowship.; Supported by American Heart Association and Japan Society for the Promotion of Science postdoctoral fellowships.	AboagyeMathiesen G, 1996, CLIN DIAGN LAB IMMUN, V3, P14, DOI 10.1128/CDLI.3.1.14-22.1996; Anacker J, 2011, MOL HUM REPROD, V17, P637, DOI 10.1093/molehr/gar033; Andreolas C, 2008, INT J CANCER, V122, P1745, DOI 10.1002/ijc.23309; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; BALSALOBRE A, 1995, ONCOGENE, V11, P455; Bamberger AM, 2004, MOL HUM REPROD, V10, P223, DOI 10.1093/molehr/gah011; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bischof P, 2003, PLACENTA, V24, P155, DOI 10.1053/plac.2002.0890; Bischof P, 2001, Early Pregnancy, V5, P30; Borden P, 1997, CRIT REV EUKAR GENE, V7, P159, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.90; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Briese J, 2005, INT J GYNECOL PATHOL, V24, P265, DOI 10.1097/01.pgp.0000163023.49965.10; Brosens JJ, 2002, AM J OBSTET GYNECOL, V187, P1416, DOI 10.1067/mob.2002.127305; BRUSSELBACH S, 1995, ONCOGENE, V10, P79; Casalino L, 2003, MOL CELL BIOL, V23, P4401, DOI 10.1128/MCB.23.12.4401-4415.2003; CHAMBERLAIN SH, 1993, J CELL BIOCHEM, V52, P337, DOI 10.1002/jcb.240520310; Choy MY, 1998, HUM REPROD, V13, P2941, DOI 10.1093/humrep/13.10.2941; Cory G, 2011, METHODS MOL BIOL, V769, P25, DOI 10.1007/978-1-61779-207-6_2; Crowe David L., 2000, Molecular Cell Biology Research Communications, V3, P243, DOI 10.1006/mcbr.2000.0221; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; Fukushima K, 2008, PLACENTA, V29, P898, DOI 10.1016/j.placenta.2008.07.015; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Guller M, 2008, WORLD J GASTROENTERO, V14, P6339, DOI 10.3748/wjg.14.6339; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Highet AR, 2012, PLACENTA, V33, P586, DOI 10.1016/j.placenta.2012.04.003; HILL CS, 1994, EMBO J, V13, P5421, DOI 10.1002/j.1460-2075.1994.tb06877.x; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; Hu Y, 2010, PLACENTA, V31, P213, DOI 10.1016/j.placenta.2009.12.011; Huppertz B, 1998, CELL TISSUE RES, V291, P133; HUSSA RO, 1975, J CLIN ENDOCR METAB, V40, P401, DOI 10.1210/jcem-40-3-401; Kent LN, 2011, MOL CELL BIOL, V31, P4801, DOI 10.1128/MCB.05780-11; KOHLER PO, 1971, J CLIN ENDOCR METAB, V32, P683, DOI 10.1210/jcem-32-5-683; KOIZUMI T, 1994, CELL IMMUNOL, V155, P384, DOI 10.1006/cimm.1994.1131; KOVARY K, 1991, NEW BIOL, V3, P870; KOVARY K, 1991, MOL CELL BIOL, V11, P2451, DOI 10.1128/MCB.11.5.2451; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Lee DS, 2009, GENESIS, V47, P433, DOI 10.1002/dvg.20518; Lewis MP, 1996, PLACENTA, V17, P137, DOI 10.1016/S0143-4004(96)80006-3; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Marzioni D, 2010, PLACENTA, V31, P919, DOI 10.1016/j.placenta.2010.08.001; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; PAI SR, 1994, ANTICANCER RES, V14, P985; Parrales A, 2010, J CELL PHYSIOL, V222, P302, DOI 10.1002/jcp.21951; PATTILLO RA, 1968, CANCER RES, V28, P1231; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; Ramos-Nino ME, 2003, CANCER RES, V63, P3539; REICHMANN E, 1992, CELL, V71, P1103, DOI 10.1016/S0092-8674(05)80060-1; RYSECK RP, 1991, ONCOGENE, V6, P533; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schreiber M, 2000, DEVELOPMENT, V127, P4937; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Soundararajan Rama, 2004, Reprod Biol Endocrinol, V2, P15, DOI 10.1186/1477-7827-2-15; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Tantbirojn P, 2008, PLACENTA, V29, P639, DOI 10.1016/j.placenta.2008.04.008; Tarrade A, 2002, BIOL REPROD, V67, P1628, DOI 10.1095/biolreprod.101.001925; Tkach V, 2003, ONCOGENE, V22, P5045, DOI 10.1038/sj.onc.1206570; Westermarck J, 1997, ONCOGENE, V14, P2651, DOI 10.1038/sj.onc.1201111; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001; Zajchowski DA, 2001, CANCER RES, V61, P5168	67	79	86	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5025	5039		10.1074/jbc.M113.523746	http://dx.doi.org/10.1074/jbc.M113.523746			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24379408	Green Published, hybrid			2022-12-28	WOS:000331607900047
J	Imam, M; Singh, S; Kaushik, NK; Chauhan, VS				Imam, Maryam; Singh, Shailja; Kaushik, Naveen Kumar; Chauhan, Virander Singh			Plasmodium falciparum Merozoite Surface Protein 3 OLIGOMERIZATION, SELF-ASSEMBLY, AND HEME COMPLEX FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Erythrocyte; Heme; Infectious Diseases; Malaria	HISTIDINE-RICH PROTEIN; MALARIA VACCINE; CELL INTERACTIONS; FIBRIL FORMATION; BINDING SITES; INVASION; ERYTHROCYTES; PARASITE; PEPTIDE; PEROXIDASE	Merozoite surface protein 3 of Plasmodium falciparum, a 40-kDa protein that also binds heme, has been biophysically characterized for its tendency to form highly elongated oligomers. This study aims to systematically analyze the regions in MSP3 sequence involved in oligomerization and correlate its aggregation tendency with its high affinity for binding with heme. Through size exclusion chromatography, dynamic light scattering, and transmission electron microscopy, we have found that MSP3, previously known to form elongated oligomers, actually forms self-assembled filamentous structures that possess amyloid-like characteristics. By expressing different regions of MSP3, we observed that the previously described leucine zipper region at the C terminus of MSP3 may not be the only structural element responsible for oligomerization and that other peptide segments like MSP3(192-196) (YILGW) may also be required. MSP3 aggregates on incubation were transformed to long unbranched amyloid fibrils. Using immunostaining methods, we found that 5-15-m-long fibrillar structures stained by anti-MSP3 antibodies were attached to the merozoite surface and also associated with erythrocyte membrane. We also found MSP3 to bind several molecules of heme by UV spectrophotometry, HPLC, and electrophoresis. This study suggested that its ability to bind heme is somehow related to its inherent characteristics to form oligomers. Moreover, heme interaction with a surface protein like MSP3, which does not participate in hemozoin formation, may suggest a protective role against the heme released from unprocessed hemoglobin released after schizont egress. These studies point to the other roles that MSP3 may play during the blood stages of the parasite, in addition to be an important vaccine candidate.	[Imam, Maryam; Singh, Shailja; Kaushik, Naveen Kumar; Chauhan, Virander Singh] Int Ctr Genet Engn & Biotechnol, Malaria Res Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Chauhan, VS (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, POB 110504,Aruna Asaf Ali Marg, New Delhi 110067, India.	virander@icgeb.res.in	Chauhan, Virander S./K-5276-2019	Kaushik, Naveen Kumar/0000-0002-4710-4662	Department of Biotechnology; Council of Scientific and Industrial Research, Government of India fellowship; Innovative Young Biotechnologist Award, Department of Biotechnology; Indian Council of Medical Research, India	Department of Biotechnology; Council of Scientific and Industrial Research, Government of India fellowship; Innovative Young Biotechnologist Award, Department of Biotechnology; Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	This work was supported in part by the Department of Biotechnology.; Supported by a Council of Scientific and Industrial Research, Government of India fellowship.; Supported by an Innovative Young Biotechnologist Award, Department of Biotechnology.; Supported by the Indian Council of Medical Research, India.	Adda CG, 2009, MOL BIOCHEM PARASIT, V166, P159, DOI 10.1016/j.molbiopara.2009.03.012; AFT RL, 1984, J BIOL CHEM, V259, P301; Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; Austin JW, 1998, FEMS MICROBIOL LETT, V162, P295, DOI 10.1016/S0378-1097(98)00137-2; Balla J, 2005, MOL NUTR FOOD RES, V49, P1030, DOI 10.1002/mnfr.200500076; BANNISTER LH, 1986, CELL TISSUE RES, V245, P281, DOI 10.1007/BF00213933; BANNISTER LH, 1977, B WORLD HEALTH ORGAN, V55, P163; Baskakov IV, 2004, J BIOL CHEM, V279, P7671, DOI 10.1074/jbc.M310594200; Brandish PE, 1998, BIOCHEMISTRY-US, V37, P16898, DOI 10.1021/bi9814989; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; Campanale N, 2003, J BIOL CHEM, V278, P27354, DOI 10.1074/jbc.M303634200; Chauhan VS, 2010, HUM VACCINES, V6, P757, DOI 10.4161.hv.6.9.12468; Choi CYH, 1999, BIOCHEMISTRY-US, V38, P16916, DOI 10.1021/bi991665k; Clark ME, 2007, ENVIRON MICROBIOL, V9, P2844, DOI 10.1111/j.1462-2920.2007.01398.x; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Dworkin M, 1999, BIOESSAYS, V21, P590, DOI 10.1002/(SICI)1521-1878(199907)21:7<590::AID-BIES7>3.0.CO;2-E; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Gondeau C, 2009, MOL BIOCHEM PARASIT, V165, P153, DOI 10.1016/j.molbiopara.2009.01.015; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; HAYNES JD, 1976, NATURE, V263, P767, DOI 10.1038/263767a0; Hisaeda H, 2002, J INFECT DIS, V185, P657, DOI 10.1086/339187; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Huy NT, 2003, J BIOCHEM, V133, P693, DOI 10.1093/jb/mvg089; Imam M, 2011, CLIN VACCINE IMMUNOL, V18, P1221, DOI 10.1128/CVI.00064-11; Khodarahmi R, 2010, ARCH BIOCHEM BIOPHYS, V494, P205, DOI 10.1016/j.abb.2009.12.010; Kuhl T, 2013, ACS CHEM BIOL, V8, P1785, DOI 10.1021/cb400317x; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LETARTE PB, 1993, J NEUROSURG, V79, P252, DOI 10.3171/jns.1993.79.2.0252; Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363; Low A, 2007, BIOPOLYMERS, V87, P12, DOI 10.1002/bip.20764; Lundberg KM, 1997, CHEM BIOL, V4, P345, DOI 10.1016/S1074-5521(97)90125-3; Mashima R, 2002, J BIOL CHEM, V277, P14514, DOI 10.1074/jbc.M109386200; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Mills KE, 2002, MOL MICROBIOL, V43, P1401, DOI 10.1046/j.1365-2958.2002.02834.x; MORGAN WT, 1985, BIOCHEMISTRY-US, V24, P1496, DOI 10.1021/bi00327a031; Murali J, 2003, BIOCHEM CELL BIOL, V81, P51, DOI 10.1139/O03-009; Naiki H, 1999, METHOD ENZYMOL, V309, P305; OEUVRAY C, 1994, BLOOD, V84, P1594; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pathak S, 2011, ANTIMICROB AGENTS CH, V55, P2178, DOI 10.1128/AAC.01493-10; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Puentes A, 2005, BIOCHIMIE, V87, P461, DOI 10.1016/j.biochi.2005.01.001; Ravi LB, 2005, NEUROBIOL DIS, V19, P28, DOI 10.1016/j.nbd.2004.11.004; Rodriguez LE, 2005, PROTEIN SCI, V14, P1778, DOI 10.1110/ps.041304505; Saarimaa C, 2006, J BACTERIOL, V188, P7016, DOI 10.1128/JB.00608-06; Schneider EL, 2005, BIOCHEMISTRY-US, V44, P979, DOI 10.1021/bi048570p; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Sirima SB, 2007, VACCINE, V25, P2723, DOI 10.1016/j.vaccine.2006.05.090; Spycher C, 2003, J BIOL CHEM, V278, P35373, DOI 10.1074/jbc.M305851200; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Suliman HB, 2002, FREE RADICAL BIO MED, V32, P246, DOI 10.1016/S0891-5849(01)00797-3; Summers CA, 2000, PROTEIN SCI, V9, P2001, DOI 10.1110/ps.9.10.2001; Tham WH, 2009, INFECT IMMUN, V77, P2427, DOI 10.1128/IAI.00048-09; TSUTSUI K, 1982, J BIOL CHEM, V257, P3925; VINCENT SH, 1989, SEMIN HEMATOL, V26, P105; Walker JR, 2007, MOL MICROBIOL, V63, P629, DOI 10.1111/j.1365-2958.2006.05494.x; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yang XD, 2010, BIOCHIMIE, V92, P1287, DOI 10.1016/j.biochi.2010.06.001; Zhang XC, 2012, BIOCHEMISTRY-US, V51, P1380, DOI 10.1021/bi201880s	73	19	19	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3856	3868		10.1074/jbc.M113.520239	http://dx.doi.org/10.1074/jbc.M113.520239			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362023	Green Published, hybrid			2022-12-28	WOS:000331403800003
J	Liu, YQ; Sanchez-Tillo, E; Lu, XQ; Huang, L; Clem, B; Telang, S; Jenson, AB; Cuatrecasas, M; Chesney, J; Postigo, A; Dean, DC				Liu, Yongqing; Sanchez-Tillo, Ester; Lu, Xiaoqin; Huang, Li; Clem, Brian; Telang, Sucheta; Jenson, Alfred B.; Cuatrecasas, Miriam; Chesney, Jason; Postigo, Antonio; Dean, Douglas C.			The ZEB1 Transcription Factor Acts in a Negative Feedback Loop with miR200 Downstream of Ras and Rb1 to Regulate Bmi1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cancer Biology; Cell Signaling; Epithelial Mesenchymal Transition; Senescence	CELL SELF-RENEWAL; G(1) CONTROL; STEM-CELLS; H-RAS; CANCER; GENE; PROTEIN; GROWTH; EMT; PROLIFERATION	Ras mutations are frequent in cancer cells where they drive proliferation and resistance to apoptosis. However in primary cells, mutant Ras instead can cause oncogene-induced senescence, a tumor suppressor function linked to repression of the polycomb factor Bmi1, which normally regulates cell cycle inhibitory cyclin-dependent kinase inhibitors (cdki). It is unclear how Ras causes repression of Bmi1 in primary cells to suppress tumor formation while inducing the gene in cancer cells to drive tumor progression. Ras also induces the EMT transcription factor ZEB1 to trigger tumor invasion and metastasis. Beyond its well-documented role in EMT, ZEB1 is important for maintaining repression of cdki. Indeed, heterozygous mutation of ZEB1 is sufficient for elevated cdki expression, leading to premature senescence of primary cells. A similar phenotype is evident with Bmi1 mutation. We show that activation of Rb1 in response to mutant Ras causes dominant repression of ZEB1 in primary cells, but loss of the Rb1 pathway is a hallmark of cancer cells and in the absence of such Rb1 repression Ras induces ZEB1 in cancer cells. ZEB1 represses miR-200 in the context of a mutual repression loop. Because miR-200 represses Bmi1, induction of ZEB1 leads to induction of Bmi1. Rb1 pathway status then dictates the opposing effects of mutant Ras on the ZEB1-miR-200 loop in primary versus cancer cells. This loop not only triggers EMT, surprisingly we show it acts downstream of Ras to regulate Bmi1 expression and thus the critical decision between oncogene-induced senescence and tumor initiation.	[Liu, Yongqing; Clem, Brian; Telang, Sucheta; Jenson, Alfred B.; Chesney, Jason; Postigo, Antonio; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, James Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Liu, Yongqing; Lu, Xiaoqin; Huang, Li; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA; [Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Liu, Yongqing; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Birth Defects Ctr, Louisville, KY 40202 USA; [Sanchez-Tillo, Ester; Postigo, Antonio] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Grp Transcript Regulat Gene Express, Barcelona 08036, Spain; [Sanchez-Tillo, Ester; Postigo, Antonio] Inst Invest Biomed August Pi & Sunyer IDIBAPS, CIBERehd, Barcelona 08036, Spain; [Postigo, Antonio] ICREA, Barcelona 08010, Spain; [Cuatrecasas, Miriam] Ctr Diagnost Biomed CDB Hosp Clin, Dept Pathol, Barcelona, Spain; [Cuatrecasas, Miriam] IDIBAPS, Hosp Clin, Tumor Bank, Barcelona 08036, Spain; [Huang, Li] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Zhejiang University	Postigo, A (corresponding author), IDIBAPS, Grp Transcript Regulat Gene Express, Villarroel 170, Barcelona 08036, Spain.	idib412@clinic.ub.es; dcdean01@louisville.edu	Cuatrecasas, Miriam/C-9156-2019	Cuatrecasas, Miriam/0000-0003-3063-0110; Postigo, Antonio/0000-0003-4605-2634	National Institutes of Health [EY019113, EY018603, EY015636]; Research to Prevent Blindness, an NIH Center for Biomedical Research Excellence (COBRE) Program [P20 RR017702-09]; FOT; AVON-SAU; AECC; ACMCB; Fundacio La Marato de TV3;  [MEC/MICINN-BFU2010-15163]; NATIONAL CANCER INSTITUTE [R01CA149438] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017702] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018603, R21EY019113, R24EY015636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, an NIH Center for Biomedical Research Excellence (COBRE) Program; FOT; AVON-SAU; AECC; ACMCB; Fundacio La Marato de TV3; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	These studies were supported by Grants EY019113 and EY018603 from the National Institutes of Health (to D. C. D.), Research to Prevent Blindness, an NIH Center for Biomedical Research Excellence (COBRE) Program Grant P20 RR017702-09) (to Y. L.), NIH Core Grant EY015636, and FOT, AVON-SAU, AECC, MEC/MICINN-BFU2010-15163, ACMCB, and Fundacio La Marato de TV3 (to A. P.).	Ahn YH, 2012, J CLIN INVEST, V122, P3170, DOI 10.1172/JCI63608; Arima Y, 2012, J BIOL CHEM, V287, P7896, DOI 10.1074/jbc.M111.313759; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; Becker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004230; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Castellano E, 2010, CURR TOP MICROBIOL, V346, P143, DOI 10.1007/82_2010_56; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; D'Abaco GM, 2002, J CELL SCI, V115, P4607, DOI 10.1242/jcs.00161; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; El-Naggar S, 2009, MOL CELL BIOL, V29, P5710, DOI 10.1128/MCB.00197-09; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jun T., 1999, SCI STKE, V13, P1; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Liu Y, 2007, BIOCHEM J, V408, P79, DOI 10.1042/BJ20070344; Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015; Liu YF, 2013, STAT INTERFACE, V6, P1; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mao JH, 2004, GENE DEV, V18, P1800, DOI 10.1101/gad.1213804; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Proctor E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055820; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roybal JD, 2011, MOL CANCER RES, V9, P25, DOI 10.1158/1541-7786.MCR-10-0497; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Thomas DM, 2003, CANCER BIOL THER, V2, P124, DOI 10.4161/cbt.2.2.235; To MD, 2005, CELL CYCLE, V4, P1185, DOI 10.4161/cc.4.9.2039; Wang Z., 2011, PLOS ONE, V6; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007	54	28	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4116	4125		10.1074/jbc.M113.533505	http://dx.doi.org/10.1074/jbc.M113.533505			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24371144	Green Published, hybrid			2022-12-28	WOS:000331403800025
J	Sumita, K; Yoshino, H; Sasaki, M; Majd, N; Kahoud, ER; Takahashi, H; Takeuchi, K; Kuroda, T; Lee, S; Charest, PG; Takeda, K; Asara, JM; Firtel, RA; Anastasiou, D; Sasaki, AT				Sumita, Kazutaka; Yoshino, Hirofumi; Sasaki, Mika; Majd, Nazanin; Kahoud, Emily Rose; Takahashi, Hidenori; Takeuchi, Koh; Kuroda, Taruho; Lee, Susan; Charest, Pascale G.; Takeda, Kosuke; Asara, John M.; Firtel, Richard A.; Anastasiou, Dimitrios; Sasaki, Atsuo T.			Degradation of Activated K-Ras Orthologue via K-Ras-specific Lysine Residues Is Required for Cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cytokinesis; Dictyostelium; Molecular Cell Biology; Ras; Signaling; Ubiquitination	H-RAS; DICTYOSTELIUM DEVELOPMENT; PROMOTES TUMORIGENESIS; PROTEIN-DEGRADATION; SIGNAL-TRANSDUCTION; UBIQUITIN CHAINS; CELL-MOVEMENT; N-RAS; DIFFERENTIATION; CHEMOTAXIS	Mammalian cells encode three closely related Ras proteins, H-Ras, N-Ras, and K-Ras. Oncogenic K-Ras mutations frequently occur in human cancers, which lead to dysregulated cell proliferation and genomic instability. However, mechanistic role of the Ras isoform regulation have remained largely unknown. Furthermore, the dynamics and function of negative regulation of GTP-loaded K-Ras have not been fully investigated. Here, we demonstrate RasG, the Dictyostelium orthologue of K-Ras, is targeted for degradation by polyubiquitination. Both ubiquitination and degradation of RasG were strictly associated with RasG activity. High resolution tandem mass spectrometry (LC-MS/MS) analysis indicated that RasG ubiquitination occurs at C-terminal lysines equivalent to lysines found in human K-Ras but not in H-Ras and N-Ras homologues. Substitution of these lysine residues with arginines (4KR-RasG) diminished RasG ubiquitination and increased RasG protein stability. Cells expressing 4KR-RasG failed to undergo proper cytokinesis and resulted in multinucleated cells. Ectopically expressed human K-Ras undergoes polyubiquitin-mediated degradation in Dictyostelium, whereas human H-Ras and a Dictyostelium H-Ras homologue (RasC) are refractory to ubiquitination. Our results indicate the existence of GTP-loaded K-Ras orthologue-specific degradation system in Dictyostelium, and further identification of the responsible E3-ligase may provide a novel therapeutic approach against K-Ras-mutated cancers.	[Sumita, Kazutaka; Yoshino, Hirofumi; Sasaki, Mika; Majd, Nazanin; Sasaki, Atsuo T.] Univ Cincinnati, Coll Med, Brain Tumor Ctr,UC Canc Inst,Dept Internal Med, UC Neurosci Inst,Dept Neurosurg,Div Hematol Oncol, Cincinnati, OH 45267 USA; [Kahoud, Emily Rose; Takahashi, Hidenori; Asara, John M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Signal Transduct,Dept Med, Boston, MA 02215 USA; [Takeuchi, Koh] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Kuroda, Taruho] Mie Univ, Grad Sch Med, Dept Basic Med Sci, Tsu, Mie 5148507, Japan; [Lee, Susan; Charest, Pascale G.; Takeda, Kosuke; Firtel, Richard A.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Takeda, Kosuke] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Metab Med, Singapore 138667, Singapore; [Anastasiou, Dimitrios] Natl Inst Med Res, MRC, Div Physiol & Metab, London NW7 1AA, England	University System of Ohio; University of Cincinnati; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institute of Advanced Industrial Science & Technology (AIST); Mie University; University of California System; University of California San Diego; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); MRC National Institute for Medical Research	Sasaki, AT (corresponding author), Univ Cincinnati, Coll Med, Brain Tumor Ctr,UC Canc Inst,Dept Internal Med, UC Neurosci Inst,Dept Neurosurg,Div Hematol Oncol, Cincinnati, OH 45267 USA.	atsuo.sasaki@uc.edu	Takeuchi, Koh/B-4971-2010; Sumita, Kazutaka/AAI-1553-2019	Takeuchi, Koh/0000-0002-6227-4627; Sasaki, Atsuo/0000-0003-2963-4501; Anastasiou, Dimitrios/0000-0002-1269-843X; Kuroda, Taruho/0000-0001-6693-4496	National Institutes of Health [2P01CA120964, 5P30CA006516]; University of Cincinnati; Medical Research Council [MC_UP_1202/1] Funding Source: researchfish; MRC [MC_UP_1202/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA006516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants 2P01CA120964 (to J. M. A.) and 5P30CA006516 (to J. M. A.) and the University of Cincinnati (to A. T. S.).	Atkins BD, 2013, J CELL BIOL, V202, P231, DOI 10.1083/jcb.201301090; Baker DJ, 2013, NAT CELL BIOL, V15, P96, DOI 10.1038/ncb2643; Baker R, 2013, J BIOL CHEM, V288, P36856, DOI 10.1074/jbc.C113.525691; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; Bolourani P, 2006, MOL BIOL CELL, V17, P4543, DOI 10.1091/mbc.E05-11-1019; Bolourani P, 2010, EUKARYOT CELL, V9, P1728, DOI 10.1128/EC.00141-10; Charest PG, 2010, DEV CELL, V18, P737, DOI 10.1016/j.devcel.2010.03.017; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; FUKUI Y, 1990, J CELL BIOL, V110, P367, DOI 10.1083/jcb.110.2.367; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jaffer ZM, 2001, DEVELOPMENT, V128, P907; Jeong WJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002242; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Keller JW, 2007, ONCOGENE, V26, P3051, DOI 10.1038/sj.onc.1210103; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Khosla M, 1996, MOL CELL BIOL, V16, P4156; Kim HT, 2009, EMBO J, V28, P1867, DOI 10.1038/emboj.2009.115; Kim SE, 2009, J CELL SCI, V122, P842, DOI 10.1242/jcs.040493; Langenick J, 2008, J CELL SCI, V121, P3524, DOI 10.1242/jcs.036798; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mohanty S, 2001, GENE DEV, V15, P1435, DOI 10.1101/gad.871101; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Onishi M, 2013, J CELL BIOL, V202, P311, DOI 10.1083/jcb.201302001; Pfeifer GP, 2010, CURR BIOL, V20, pR344, DOI 10.1016/j.cub.2010.02.019; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; REYMOND CD, 1986, NATURE, V323, P340, DOI 10.1038/323340a0; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Sasaki AT, 2009, METHODS MOL BIOL, V571, P333, DOI 10.1007/978-1-60761-198-1_23; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Takeda K, 2007, J BIOL CHEM, V282, P11874, DOI 10.1074/jbc.M610984200; THIERY R, 1992, BIOCHEM CELL BIOL, V70, P1193, DOI 10.1139/o92-165; Tuxworth RI, 1997, J CELL BIOL, V138, P605, DOI 10.1083/jcb.138.3.605; van Engeland M, 2002, ONCOGENE, V21, P3792, DOI 10.1038/sj.onc.1205466; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Wang XS, 2011, CANCER DISCOV, V1, P35, DOI 10.1158/2159-8274.CD-10-0022; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Xu LZ, 2010, CURR BIOL, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Yang G, 2013, INT J CANCER, V133, P275, DOI 10.1002/ijc.28032; Zhang YJ, 2002, MOL CARCINOGEN, V35, P85, DOI 10.1002/mc.10076	53	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3950	3959		10.1074/jbc.M113.531178	http://dx.doi.org/10.1074/jbc.M113.531178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24338482	Green Published, hybrid			2022-12-28	WOS:000331403800011
J	Jiang, YQ; Zhang, M; Qian, YJ; Xu, ES; Zhang, J; Chen, XB				Jiang, Yuqian; Zhang, Min; Qian, Yingjuan; Xu, Enshun; Zhang, Jin; Chen, Xinbin			Rbm24, an RNA-binding Protein and a Target of p53, Regulates p21 Expression via mRNA Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cell Cycle; mRNA Decay; p53; RNA-binding Protein	CELL-CYCLE; RNPC1; GENE; PATHWAYS; ARREST; IDENTIFICATION; STABILIZATION; WAF1/CIP1; RADIATION; MEDIATOR	Background: Post-transcriptional regulation of p21 expression is still not fully understood. Results: Rbm24 is induced by p53 and serves as a mediator of p53 to regulate p21 expression via binding to its 3-UTR. Conclusion: Rbm24, an RNA-binding protein and a target of p53, enhances p21 expression via mRNA stability. Significance: A novel p53 target gene Rbm24 is identified to regulate p21 mRNA stability. p21, a cyclin-dependent kinase inhibitor, is necessary for proper control of the cell cycle and premature senescence. Thus, p21 expression needs to be tightly controlled. In this study, we found that Rbm24, an RNA-binding protein and a target gene of the p53 protein, can regulate p21 expression via mRNA stability. Specifically, we showed that Rbm24 is induced by DNA damage and Mdm2 inhibitor Nutlin-3. We also found that p53 protein binds to and activates the promoter of the Rbm24 gene. Moreover, we found that overexpression of Rbm24 increases, whereas knockdown of Rbm24 decreases, p21 mRNA and protein expression. In addition, we demonstrated that overexpression of Rbm24 enhances the half-life of p21 transcript. Consistent with this, we provided evidence that Rbm24 binds to the 3-untranslated region (3-UTR) of p21 transcript and an AU/U-rich element in the p21 3-UTR is necessary for Rbm24 to increase p21 expression. Finally, we showed that the RNA recognition motif in Rbm24 is required for binding to p21 transcript and subsequently for inducing p21 expression. Altogether, we uncovered that Rbm24 is a novel player in the p53 pathway, which may be explored to restore proper cell cycle control in p53-deficient tumors via p21.	[Jiang, Yuqian; Zhang, Min; Qian, Yingjuan; Xu, Enshun; Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu	jiang, yu/HGU-0029-2022		National Institutes of Health [CA076069, CA121137]; NATIONAL CANCER INSTITUTE [R29CA076069, R01CA081237, R01CA121137, R01CA076069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA076069 and CA121137.	Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; CHEN XB, 1995, CANCER RES, V55, P4257; Chen XL, 2012, J BIOL CHEM, V287, P34410, DOI 10.1074/jbc.M112.384990; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; Collins K, 1997, P NATL ACAD SCI USA, V94, P2776, DOI 10.1073/pnas.94.7.2776; Dohn Michael, 2003, Methods Mol Biol, V223, P221; DULIC V, 1993, P NATL ACAD SCI USA, V90, P11034, DOI 10.1073/pnas.90.23.11034; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Erhardt JA, 1998, J BIOL CHEM, V273, P23517, DOI 10.1074/jbc.273.36.23517; Hotte GJ, 2012, RADIAT RES, V177, P272, DOI 10.1667/RR2776.1; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; JOHANSEN FE, 1994, MOL CELL BIOL, V14, P5920, DOI 10.1128/MCB.14.9.5920; Joseph B, 1998, J BIOL CHEM, V273, P20511, DOI 10.1074/jbc.273.32.20511; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; KILEDJIAN M, 1995, EMBO J, V14, P4357, DOI 10.1002/j.1460-2075.1995.tb00110.x; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Maragh S, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-62; Miyamoto S, 2009, GENES CELLS, V14, P1241, DOI 10.1111/j.1365-2443.2009.01347.x; Poon KL, 2012, CARDIOVASC RES, V94, P418, DOI 10.1093/cvr/cvs095; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Scoumanne A, 2011, NUCLEIC ACIDS RES, V39, P213, DOI 10.1093/nar/gkq778; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Waggoner SA, 2009, J BIOL CHEM, V284, P9039, DOI 10.1074/jbc.M806986200; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wang YC, 1999, ONCOGENE, V18, P2643, DOI 10.1038/sj.onc.1202632; Wurth L, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/178525; Xu E, 2013, ONCOGENE, V32, P2169, DOI 10.1038/onc.2012.238; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zhang Jin, 2008, Curr Mol Med, V8, P845, DOI 10.2174/156652408786733748; Zhu JH, 1998, CANCER RES, V58, P5061	42	47	48	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3164	3175		10.1074/jbc.M113.524413	http://dx.doi.org/10.1074/jbc.M113.524413			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24356969	Green Published, hybrid			2022-12-28	WOS:000331368700006
J	Pereira, ER; Frudd, K; Awad, W; Hendershot, LM				Pereira, Ethel R.; Frudd, Karen; Awad, Walid; Hendershot, Linda M.			Endoplasmic Reticulum (ER) Stress and Hypoxia Response Pathways Interact to Potentiate Hypoxia-inducible Factor 1 (HIF-1) Transcriptional Activity on Targets Like Vascular Endothelial Growth Factor (VEGF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Endoplasmic Reticulum Stress; Gene Regulation; Hypoxia; Hypoxia-inducible Factor (HIF); Vascular Endothelial Growth Factor (VEGF)	UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; ANGIOGENESIS; PHOSPHORYLATION; ACTIVATION; EXPRESSION; HIF-1-ALPHA; CANCER; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; DISRUPTION	Background: The UPR and HIF signaling pathways are cytoprotective responses activated by inadequate cellular environments. Results: These pathways can cooperate to increase the expression of shared targets like VEGF. Conclusion: The UPR enhances HIF-1 transcriptional activity. Significance: The simultaneous activation of both pathways in tumors may result in greater vascularization. Cells respond to suboptimal microenvironments by activating stress signaling pathways, like the unfolded protein response and hypoxia-induced transcription factors HIF-1/2, to restore homeostasis. Both cytoprotective pathways have been well studied in isolation at the biochemical and molecular levels. Mounting evidence reveals that they can be activated simultaneously in tumor cells and, likely, in other tissues experiencing inadequate microenvironments and that they share some transcriptional targets, like the proangiogenic factor VEGFA. However, the potential interaction between these pathways is poorly understood. Cell culture experiments revealed that as a consequence of unfolded protein response activation, ATF4 bound to the human VEGFA promoter and activated its transcription, whereas HIF-1 did so in response to hypoxia. When both pathways were activated together, VEGFA transcripts were induced to a higher level than when either stress was applied alone. Surprisingly, this was not due to the combined actions of the stress pathway-specific transcription factors. Instead, we found that endoplasmic reticulum stress potentiated HIF-1 activity to transactivate VEGF expression as well as another well characterized target, BNIP3. These data reveal an unexpected interaction between two important cytoprotective responses that are likely to have significant consequences in environmentally compromised tissues and tumor cells.	[Pereira, Ethel R.; Frudd, Karen; Awad, Walid; Hendershot, Linda M.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; [Pereira, Ethel R.; Hendershot, Linda M.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38163 USA; [Frudd, Karen] Univ Bath, Bath BA2 7AY, Avon, England	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Bath	Hendershot, LM (corresponding author), 262 Danny Thomas Pl, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Pereira, Ethel/0000-0003-0562-4536; Frudd, Karen/0000-0002-3169-9454	National Institutes of Health [P01CA023099]; Hal and Alma Reagan Fellowship; Cancer Center Core Grant [CA21765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P01CA023099, P30CA021765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hal and Alma Reagan Fellowship; Cancer Center Core Grant; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01CA023099 (to L. M. H.). This work was also supported by the Hal and Alma Reagan Fellowship (to E. R. P.), by Cancer Center Core Grant CA21765, and by the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital.	Auf G, 2010, P NATL ACAD SCI USA, V107, P15553, DOI 10.1073/pnas.0914072107; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Butler PD, 2011, J SURG RES, V167, P151, DOI 10.1016/j.jss.2009.04.036; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CHANG CD, 1990, MOL CELL BIOL, V10, P3289, DOI 10.1128/MCB.10.7.3289; Drogat B, 2007, CANCER RES, V67, P6700, DOI 10.1158/0008-5472.CAN-06-3235; Dror V, 2008, J BIOL CHEM, V283, P9909, DOI 10.1074/jbc.M710601200; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Guzel E, 2011, BIOL REPROD, V85, P121, DOI 10.1095/biolreprod.110.089532; Hartwich J, 2013, J PEDIATR SURG, V48, P39, DOI 10.1016/j.jpedsurg.2012.10.016; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kwon SJ, 2005, CLIN CANCER RES, V11, P7607, DOI 10.1158/1078-0432.CCR-05-0981; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Mottet D, 2005, INT J CANCER, V117, P764, DOI 10.1002/ijc.21268; Oskolkova OV, 2008, BLOOD, V112, P330, DOI 10.1182/blood-2007-09-112870; Ozawa K, 2001, CANCER RES, V61, P4206; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roybal CN, 2005, J BIOL CHEM, V280, P20331, DOI 10.1074/jbc.M411275200; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Teitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019133; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Wang YG, 2012, CANCER RES, V72, P5396, DOI 10.1158/0008-5472.CAN-12-0474; Xu DZ, 2010, J BIOL CHEM, V285, P38944, DOI 10.1074/jbc.M110.160325	41	126	131	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3352	3364		10.1074/jbc.M113.507194	http://dx.doi.org/10.1074/jbc.M113.507194			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24347168	Green Published, hybrid			2022-12-28	WOS:000331368700022
J	Koshitani, Y; Tachibanaki, S; Kawamura, S				Koshitani, Yuki; Tachibanaki, Shuji; Kawamura, Satoru			Quantitative Aspects of cGMP Phosphodiesterase Activation in Carp Rods and Cones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heterotrimeric G-proteins; Phosphodiesterases; Photoreceptors; Phototransduction; Retina; cGMP Phosphodiesterase; Cones; Rods; Transducin	PHOTOTRANSDUCTION; TRANSDUCIN; PHOTORECEPTORS; PHOTORESPONSES; AMPLIFICATION	Background: Cones are less light-sensitive than rods. Results: The efficiency of cGMP phosphodiesterase (PDE) activation by transducin was similar in rods and cones, and PDE activity was determined by the lifetimes of activated visual pigment and transducin. Conclusion: PDE activation is less effective in cones due to lower amplification and shorter lifetimes of pigment and transducin. Significance: The lower light sensitivity of cones is partly explained. Cones are less light-sensitive than rods. We showed previously in carp that more light (>100-fold) is required in cones than in rods to activate 50% of cGMP phosphodiesterase (PDE). The lower effectiveness of PDE activation in carp cones is due partly to the fact that the activation rate of transducin (Tr) by light-activated visual pigment (R*) is 5-fold lower in carp cones than in rods. In this study, we tried to explain the remaining difference. First, we examined the efficiency of activation of PDE by activated Tr (Tr*). By activating PDE with known concentrations of the active (guanosine 5--(-thio)triphosphate (GTPS)-bound) form of Tr*, we found that Tr* activated PDE at a similar efficiency in rods and cones. Next, we examined the contribution of R* and Tr* lifetimes. In a comparison of PDE activation in the presence (with GTP) and absence (with GTPS) of Tr* inactivation, PDE activation required more light (and was therefore less effective) when Tr* was inactivated in both rod and cone membranes. This is probably because inactivation of Tr* shortened its lifetime, thereby reducing the number of activated PDE molecules. The effect of Tr* inactivation was larger in cones, probably because the lifetime of Tr* is shorter in cones than in rods. The shorter lifetimes of Tr* and R* in cones seem to explain the remaining difference in the effectiveness of PDE activation between rods and cones.	[Koshitani, Yuki; Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Suita, Osaka 5650871, Japan; [Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Kawamura, S (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, 1-3 Yamada Oka, Suita, Osaka 5650871, Japan.	kawamura@fbs.osaka-u.ac.jp			Japan Society for the Promotion of Science [20370060, 23227002, 22770150, 24570085]; Human Frontier Science Program grant; Naito Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program grant(Human Frontier Science Program); Naito Foundation(Naito Memorial Foundation)	This work was supported by Japan Society for the Promotion of Science Grants 20370060 and 23227002 (to S. K.) and Grants 22770150 and 24570085 (to S. T.), a Human Frontier Science Program grant (to S. K.), and the Naito Foundation (to S. T.).	BRUCKERT F, 1994, BIOCHEMISTRY-US, V33, P12625, DOI 10.1021/bi00208a013; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; DUMKE CL, 1994, J GEN PHYSIOL, V103, P1071, DOI 10.1085/jgp.103.6.1071; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; Golobokova EY, 2006, VISION RES, V46, P2287, DOI 10.1016/j.visres.2005.12.017; HARTWICK RA, 1975, J CHROMATOGR, V112, P651, DOI 10.1016/S0021-9673(00)99994-1; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Tachibanaki S, 1997, BIOCHEMISTRY-US, V36, P14173, DOI 10.1021/bi970932o; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Tachibanaki S, 2007, PHOTOCHEM PHOTOBIOL, V83, P19, DOI 10.1562/2006-02-28-IR-823; Tachibanaki S, 2012, J BIOL CHEM, V287, P41186, DOI 10.1074/jbc.M112.403717; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114	16	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2651	2657		10.1074/jbc.M113.495325	http://dx.doi.org/10.1074/jbc.M113.495325			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24344136	hybrid, Green Published			2022-12-28	WOS:000333403000016
J	Steed, PR; Fillingame, RH				Steed, P. Ryan; Fillingame, Robert H.			Residues in the Polar Loop of Subunit c in Escherichia coli ATP Synthase Function in Gating Proton Transport to the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP Synthase; F1F0-ATPase; Membrane Energetics; Membrane Transport; Proton Transport; Chemical Modifications Inhibiting Function; Cysteine Substitution Mutagenesis; Loops of Transmembrane Proteins; Subunit c	AQUEOUS ACCESS PATHWAYS; ROTOR RING; H+-ATPASE; EPSILON-SUBUNIT; CROSS-LINKING; ROTARY MOTOR; F1; BINDING; F-0; HELICES	Rotary catalysis in F1F0 ATP synthase is powered by proton translocation through the membrane-embedded F-0 sector. Proton binding and release occur in the middle of the membrane at Asp-61 on the second transmembrane helix (TMH) of subunit c, which folds in a hairpin-like structure with two TMHs. Previously, the aqueous accessibility of Cys substitutions in the transmembrane regions of subunit c was probed by testing the inhibitory effects of Ag+ or Cd2+ on function, which revealed extensive aqueous access in the region around Asp-61 and on the half of TMH2 extending to the cytoplasm. In the current study, we surveyed the Ag+ and Cd2+ sensitivity of Cys substitutions in the loop of the helical hairpin and used a variety of assays to categorize the mechanisms by which Ag+ or Cd2+ chelation with the Cys thiolates caused inhibition. We identified two distinct metal-sensitive regions in the cytoplasmic loop where function was inhibited by different mechanisms. Metal binding to Cys substitutions in the N-terminal half of the loop resulted in an uncoupling of F-1 from F-0 with release of F-1 from the membrane. In contrast, substitutions in the C-terminal half of the loop retained membrane-bound F-1 after metal treatment. In several of these cases, inhibition was shown to be due to blockage of passive H+ translocation through F-0 as assayed with F-0 reconstituted into liposomes. The results suggest that the C-terminal domain of the cytoplasmic loop may function in gating H+ translocation to the cytoplasm.	[Steed, P. Ryan; Fillingame, Robert H.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Dept Biomol Chem, 420 Henry Mall, Madison, WI 53706 USA.	rhfillin@wisc.edu		Steed, Ryan/0000-0001-5445-0080	National Institutes of Health from the United States Public Health Service [GM23105]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023105, R01GM023105] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM23105 from the United States Public Health Service.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AGGELER R, 1995, BBA-BIOENERGETICS, V1230, P62, DOI 10.1016/0005-2728(95)00040-P; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Barik S, 1996, Methods Mol Biol, V57, P203; Bell RA, 1999, ENVIRON TOXICOL CHEM, V18, P9, DOI [10.1897/1551-5028(1999)018&lt;0009:SCAGOS&gt;2.3.CO;2, 10.1002/etc.5620180103]; BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; Dmitriev OY, 2007, PROTEIN SCI, V16, P2118, DOI 10.1110/ps.072776307; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; Dong H, 2010, J BIOL CHEM, V285, P39811, DOI 10.1074/jbc.M110.175844; FILLINGAME RH, 1976, J BIOL CHEM, V251, P6630; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; FOSTER DL, 1982, J BIOL CHEM, V257, P2009; FRAGA D, 1991, J BACTERIOL, V173, P2639, DOI 10.1128/jb.173.8.2639-2643.1991; FRAGA D, 1989, J BIOL CHEM, V264, P6797; FRAGA D, 1994, J BIOL CHEM, V269, P7532; HATCH L, 1993, BIOCHIM BIOPHYS ACTA, V1141, P183, DOI 10.1016/0005-2728(93)90041-D; Hermolin J, 1999, J BIOL CHEM, V274, P17011, DOI 10.1074/jbc.274.24.17011; Ishmukhametov RR, 2005, BBA-BIOENERGETICS, V1706, P110, DOI 10.1016/j.bbabio.2004.09.012; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 2000, J BIOL CHEM, V275, P11355, DOI 10.1074/jbc.275.15.11355; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Krah A, 2010, BBA-BIOENERGETICS, V1797, P763, DOI 10.1016/j.bbabio.2010.04.014; Langemeyer L, 2007, BBA-BIOENERGETICS, V1767, P998, DOI 10.1016/j.bbabio.2007.05.007; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; MILLER MJ, 1989, J BIOL CHEM, V264, P305; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Moore KJ, 2008, J BIOL CHEM, V283, P13044, DOI 10.1074/jbc.M800900200; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Penefsky H S, 1979, Methods Enzymol, V56, P527; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2008, FEBS J, V275, P4850, DOI 10.1111/j.1742-4658.2008.06623.x; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; Reed P W, 1979, Methods Enzymol, V55, P435; Saroussi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043045; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Steed P. R., 2010, THESIS U WISCONSIN M; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Vincent OD, 2007, J BIOL CHEM, V282, P33788, DOI 10.1074/jbc.M706904200; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; WATTS SD, 1995, FEBS LETT, V368, P235, DOI 10.1016/0014-5793(95)00658-V; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Wiedenmann A, 2008, BBA-BIOENERGETICS, V1777, P1301, DOI 10.1016/j.bbabio.2008.06.008; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; ZHANG Y, 1995, J BIOL CHEM, V270, P24609, DOI 10.1074/jbc.270.41.24609; ZHANG Y, 1994, J BIOL CHEM, V269, P10221	65	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2127	2138		10.1074/jbc.M113.527879	http://dx.doi.org/10.1074/jbc.M113.527879			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24297166	Green Published, hybrid			2022-12-28	WOS:000331130200021
J	Lauer, ME; Aytekin, M; Comhair, SA; Loftis, J; Tian, LP; Farver, CF; Hascall, VC; Dweik, RA				Lauer, Mark E.; Aytekin, Metin; Comhair, Suzy A.; Loftis, Jacqueline; Tian, Liping; Farver, Carol F.; Hascall, Vincent C.; Dweik, Raed A.			Modification of Hyaluronan by Heavy Chains of Inter-alpha-Inhibitor in Idiopathic Pulmonary Arterial Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Extracellular Matrix; Glycobiology; Hyaluronate; Lung; Proteoglycan; TSG-6; Heavy Chain; Hyaluronan; Inter--inhibitor; Tumor Necrosis Factor-stimulated Gene 6	TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE-CELLS; LEUKOCYTE ADHESION; EXPRESSION; CD44; BIND	Background: Hyaluronan metabolism is altered in idiopathic pulmonary arterial hypertension lung tissue. Results: This hyaluronan is of a pathological form covalently modified by heavy chains from inter--inhibitor. Conclusion: The distribution of this matrix in regions of abnormal vascular remodeling implies a mechanistic role. Significance: Pathological hyaluronan matrices may direct inflammatory events and vascular changes in this disease. We previously reported an altered hyaluronan (HA) metabolism in idiopathic pulmonary arterial hypertension (IPAH) lung tissue and cultured smooth muscle cells. Hyaluronan was present in the smooth muscle cell layer surrounding the pulmonary vasculature and in plexigenic lesions. Additionally, cultured pulmonary artery smooth muscle cells produced spontaneous HA cable structures, without additional stimuli, that were leukocyte-adhesive. We now present evidence that the HA that accumulates in IPAH plexigenic lesions is a pathological form of HA in which heavy chains (HCs) from the serum-derived proteoglycan inter--inhibitor are covalently attached to the HA backbone to form a pathological HC-HA complex. CD45-positive leukocytes were identified within these HC-HA matrices. Elevated mRNA levels of the enzyme that transfers HCs to HA, known as tumor necrosis factor-stimulated gene 6, were detected in IPAH lung tissue.	[Lauer, Mark E.; Loftis, Jacqueline; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Aytekin, Metin] Erciyes Univ, Dept Med Biol, Fac Med, TR-38039 Kayseri, Turkey; [Aytekin, Metin] Erciyes Univ, Genome Stem Cell Ctr, TR-38039 Kayseri, Turkey; [Comhair, Suzy A.; Tian, Liping; Dweik, Raed A.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Farver, Carol F.] Cleveland Clin, Dept Pathol, Cleveland, OH 44195 USA; [Dweik, Raed A.] Cleveland Clin, Dept Pulm & Crit Care Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Erciyes University; Erciyes University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Dweik, RA (corresponding author), Cleveland Clin, Dept Pulm & Crit Care Med, Desk A-90, Cleveland, OH 44195 USA.	dweikr@ccf.org			National Institutes of Health from the NHLBI [P01HL107147, HL081064, HL103453, HL060917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060917, P01HL081064, P01HL103453, P01HL107147, R37HL060917] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL107147, HL081064, HL103453, and HL060917 from the NHLBI.	Aytekin M, 2008, AM J PHYSIOL-LUNG C, V295, pL789, DOI 10.1152/ajplung.90306.2008; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; El Chami H, 2012, PROG CARDIOVASC DIS, V55, P218, DOI 10.1016/j.pcad.2012.07.006; Kalay N, 2013, TOHOKU J EXP MED, V230, P7, DOI 10.1620/tjem.230.7; Kida D, 1999, J RHEUMATOL, V26, P1230; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; LEEPERWOODFORD SK, 1991, AM REV RESPIR DIS, V143, P1076, DOI 10.1164/ajrccm/143.5_Pt_1.1076; Lei Ye, 2002, Asian J Surg, V25, P203, DOI 10.1016/S1015-9584(09)60176-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Ohta-Ogo K, 2012, PATHOL INT, V62, P219, DOI 10.1111/j.1440-1827.2011.02779.x; Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793; Shi T, 2006, MOL PHARMACOL, V70, P129, DOI 10.1124/mol.105.020735; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang Q, 2013, VASC PHARMACOL, V58, P71, DOI 10.1016/j.vph.2012.07.006; Wilkins MR, 2012, EUR RESPIR REV, V21, P19, DOI 10.1183/09059180.00008411; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	21	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6791	6798		10.1074/jbc.M113.512491	http://dx.doi.org/10.1074/jbc.M113.512491			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24403074	Green Published, hybrid			2022-12-28	WOS:000332389400039
J	Makhlynets, O; Boal, AK; Rhodes, DV; Kitten, T; Rosenzweig, AC; Stubbe, J				Makhlynets, Olga; Boal, Amie K.; Rhodes, DeLacy V.; Kitten, Todd; Rosenzweig, Amy C.; Stubbe, JoAnne			Streptococcus sanguinis Class Ib Ribonucleotide Reductase HIGH ACTIVITY WITH BOTH IRON AND MANGANESE COFACTORS AND STRUCTURAL INSIGHTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Iron; Manganese; Pathogenesis; Ribonucleotide Reductase; Streptococcus; Activity; Endocarditis; Flavodoxin	TYROSYL RADICAL COFACTOR; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; NRDH-REDOXIN; CORYNEBACTERIUM-AMMONIAGENES; THIOREDOXIN REDUCTASE; MOLECULAR-REPLACEMENT; BACILLUS-ANTHRACIS; CRYSTAL-STRUCTURE; KINETIC-ANALYSIS	Background: Class Ib ribonucleotide reductase (RNR) is an essential enzyme for aerobic growth of S. sanguinis. Results: Its manganese form is 3.5-fold more active than the iron form when assayed with NrdH and thioredoxin reductase. Conclusion: This specific activity is the highest reported to date for the class Ib RNR. Significance: Our studies suggest why manganese is important in streptococcal pathogenesis. Streptococcus sanguinis is a causative agent of infective endocarditis. Deletion of SsaB, a manganese transporter, drastically reduces S. sanguinis virulence. Many pathogenic organisms require class Ib ribonucleotide reductase (RNR) to catalyze the conversion of nucleotides to deoxynucleotides under aerobic conditions, and recent studies demonstrate that this enzyme uses a dimanganese-tyrosyl radical (Mn-2(III)-Y-center dot) cofactor in vivo. The proteins required for S. sanguinis ribonucleotide reduction (NrdE and NrdF, and subunits of RNR; NrdH and TrxR, a glutaredoxin-like thioredoxin and a thioredoxin reductase; and NrdI, a flavodoxin essential for assembly of the RNR metallo-cofactor) have been identified and characterized. Apo-NrdF with Fe-II and O-2 can self-assemble a diferric-tyrosyl radical (Fe-2(III)-Y-center dot) cofactor (1.2 Y-center dot/(2)) and with the help of NrdI can assemble a Mn-2(III)-Y-center dot cofactor (0.9 Y-center dot/(2)). The activity of RNR with its endogenous reductants, NrdH and TrxR, is 5,000 and 1,500 units/mg for the Mn- and Fe-NrdFs (Fe-loaded NrdF), respectively. X-ray structures of S. sanguinis NrdI(ox) and Mn-2(II)-NrdF are reported and provide a possible rationale for the weak affinity (2.9 m) between them. These streptococcal proteins form a structurally distinct subclass relative to other Ib proteins with unique features likely important in cluster assembly, including a long and negatively charged loop near the NrdI flavin and a bulky residue (Thr) at a constriction in the oxidant channel to the NrdI interface. These studies set the stage for identifying the active form of S. sanguinis class Ib RNR in an animal model for infective endocarditis and establishing whether the manganese requirement for pathogenesis is associated with RNR.	[Makhlynets, Olga; Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stubbe, JoAnne] MIT, Dept Biol, Cambridge, MA 02139 USA; [Boal, Amie K.; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Boal, Amie K.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Kitten, Todd; Rosenzweig, Amy C.] Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Richmond, VA 23298 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwestern University; Northwestern University; Virginia Commonwealth University	Kitten, T (corresponding author), Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Richmond, VA 23298 USA.	tkitten@vcu.edu; amyr@northwestern.edu; stubbe@mit.edu	Johnson, Michael D. L./B-4352-2012; Rhodes, DeLacy/GLS-9225-2022; Kitten, Todd/O-6531-2014	Rhodes, DeLacy/0000-0003-1945-3360; Kitten, Todd/0000-0001-6097-7583	National Institutes of Health [GM81393, GM58518, R56AI085195, K12GM093857]; Pathway to Independence Award [K99/R00]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081393, R00GM100011, R01GM058518, K12GM093857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM81393 (to J.S.), GM58518 (to A.C.R.), R56AI085195 (to T.K.), and K12GM093857 (to Paul B. Fisher for D.V.R.) and Pathway to Independence Award K99/R00 (to A.K.B.).	Aravind L, 2000, J MOL MICROB BIOTECH, V2, P191; ARNER ESJ, 2000, CURRENT PROTOCOLS TO; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boal AK, 2012, BIOCHEMISTRY-US, V51, P3861, DOI 10.1021/bi201925t; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Chen L, 2011, MICROBIOL-SGM, V157, P13, DOI 10.1099/mic.0.039669-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CLIMENT I, 1991, BIOCHEMISTRY-US, V30, P5164, DOI 10.1021/bi00235a008; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cotruvo JA, 2008, P NATL ACAD SCI USA, V105, P14383, DOI 10.1073/pnas.0807348105; Cotruvo JA, 2013, J AM CHEM SOC, V135, P4027, DOI 10.1021/ja312457t; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Crona M, 2011, J BIOL CHEM, V286, P33053, DOI 10.1074/jbc.M111.278119; Crump K. E., 2013, MOL MICROBIOL UNPUB; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; Eftink MR, 1997, METHOD ENZYMOL, V278, P221; Eliasson R, 1996, J BIOL CHEM, V271, P26582, DOI 10.1074/jbc.271.43.26582; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Gustafsson TN, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413427; Hammerstad M., 2013, ACS CHEM BIOL, DOI 10.1021/cb400757h; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Huque Y, 2000, J BIOL CHEM, V275, P25365, DOI 10.1074/jbc.M002751200; Ingelman M, 1997, J MOL BIOL, V268, P147, DOI 10.1006/jmbi.1997.0957; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Johansson R, 2010, FEBS J, V277, P4265, DOI 10.1111/j.1742-4658.2010.07815.x; Jordan A, 1996, J BIOL CHEM, V271, P8779, DOI 10.1074/jbc.271.15.8779; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; LUDWIG ML, 1990, BIOCHEMISTRY-US, V29, P10364, DOI 10.1021/bi00497a011; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Minnihan EC, 2013, ACCOUNTS CHEM RES, V46, P2524, DOI 10.1021/ar4000407; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker MJ, 2014, BIOCHEMISTRY-US, V53, P766, DOI 10.1021/bi401056e; Phulera S, 2013, BIOCHEMISTRY-US, V52, P4056, DOI 10.1021/bi400191z; Rabinovitch I, 2010, J BACTERIOL, V192, P4963, DOI 10.1128/JB.00539-10; Rhodes DV, 2014, J BIOL CHEM, V289, P6273, DOI 10.1074/jbc.M113.533620; Roca I, 2008, J BACTERIOL, V190, P4849, DOI 10.1128/JB.00185-08; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; SCHELLENBERG KA, 1958, J BIOL CHEM, V231, P547; STEEPER JR, 1970, ANAL BIOCHEM, V34, P123, DOI 10.1016/0003-2697(70)90092-8; Stolle P, 2010, FEBS J, V277, P4849, DOI 10.1111/j.1742-4658.2010.07885.x; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; TENEYCK LF, 1985, METHOD ENZYMOL, V115, P324; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; Torrents E, 2005, P NATL ACAD SCI USA, V102, P17946, DOI 10.1073/pnas.0506410102; Van Laer K, 2013, J BIOL CHEM, V288, P7942, DOI 10.1074/jbc.M112.392688; WILLIAMS CH, 1967, J BIOL CHEM, V242, P5226; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125; Yang FD, 1997, J BACTERIOL, V179, P6408, DOI 10.1128/jb.179.20.6408-6415.1997; Zhang Y, 2011, BIOCHEMISTRY-US, V50, P5615, DOI 10.1021/bi200348q; ZHOU ZM, 1995, BIOCHEMISTRY-US, V34, P3183, DOI 10.1021/bi00010a007	68	30	30	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6259	6272		10.1074/jbc.M113.533554	http://dx.doi.org/10.1074/jbc.M113.533554			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24381172	Green Published, hybrid			2022-12-28	WOS:000332015500078
J	Purushothaman, A; Toole, BP				Purushothaman, Anurag; Toole, Bryan P.			Serglycin Proteoglycan Is Required for Multiple Myeloma Cell Adhesion, in Vivo Growth, and Vascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cd44; Chondroitin Sulfate; Glycosaminoglycan; Multiple Myeloma; Proteoglycan	AGGRESSIVE TUMOR PHENOTYPE; ENDOTHELIAL-CELLS; HEMATOPOIETIC-CELLS; SECRETORY GRANULE; PLASMA-CELLS; EXPRESSION; SYNDECAN-1; SULFATE; CD44; COMPLEXES	Background: Contribution of serglycin in myeloma pathobiology remains undefined. Results: Serglycin promotes myeloma cell adhesion to bone marrow components and serglycin knockdown in myeloma cells dramatically diminish tumor growth. Conclusion: Serglycin plays a crucial role in myeloma pathogenesis. Significance: Targeting serglycin may provide a novel therapeutic approach for multiple myeloma. Recently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly diagnosed MM patients. However, its contribution to the pathophysiology of MM is unknown. Here, we show that serglycin knockdown (by approximate to 85% compared with normal levels), using lentiviral shRNA, dramatically attenuated MM tumor growth in mice with severe combined immunodeficiency. Tumors formed from cells deficient in serglycin exhibited diminished levels of hepatocyte growth factor expression and impaired development of blood vessels, indicating that serglycin may affect tumor angiogenesis. Furthermore, knockdown of serglycin significantly decreased MM cell adhesion to bone marrow stromal cells and collagen I. Even though serglycin proteoglycan does not have a transmembrane domain, flow cytometry showed that serglycin is present on the MM cell surface, and attachment to the cell surface is, at least in part, dependent on its chondroitin sulfate side chains. Co-precipitation of serglycin from conditioned medium of MM cells using a CD44-Fc chimera suggests that CD44 is the cell surface-binding partner for serglycin, which therefore may serve as a major ligand for CD44 at various stages during myeloma progression. Finally, we demonstrate that serglycin mRNA expression in MM cells is up-regulated by activin, a predominant cytokine among those increased in MM patients with osteolytic lesions. These studies provide direct evidence for a critical role for serglycin in MM pathogenesis and show that targeting serglycin may provide a novel therapeutic approach for MM.	[Purushothaman, Anurag] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Purushothaman, Anurag] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Toole, Bryan P.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Toole, Bryan P.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Medical University of South Carolina; Medical University of South Carolina	Purushothaman, A (corresponding author), Univ Alabama Birmingham, Dept Pathol, Wallace Tumor Inst, 1824 6th Ave S,Room 602A, Birmingham, AL 35294 USA.	anuragp@uab.edu			National Institutes of Health [P30 AR48311, P30 AI027767, P30 AR46031]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311, P30AR046031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr. Ralph D. Sanderson (UAB) for his excellent support and discussions throughout this work. We also thank Dr. Erming Tian (University of Arkansas at Little Rock) for providing OPM-1, Delta 47, OCIMy5, and KMS-11 cell lines. We acknowledge Enid Keyser from the University of Alabama at Birmingham for assistance with flow analysis and the RDCC-CFCC core (supported by National Institutes of Health Grant P30 AR48311 and P30 AI027767). We also thank Ed Phillips (University of Alabama at Birmingham, High Resolution Imaging Facility) for assistance with fluorescence microscopy. Histology services were performed by the University of Alabama at Birmingham Center for Metabolic Bone Diseases Histomorphometry and Molecular Analysis Core Laboratory (supported by National Institutes of Health Grant P30 AR46031).	Abecassis I, 2003, EXP CELL RES, V291, P363, DOI 10.1016/j.yexcr.2003.08.006; Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Andersen NF, 2005, BRIT J HAEMATOL, V128, P210, DOI 10.1111/j.1365-2141.2004.05299.x; Bret C, 2009, BRIT J HAEMATOL, V145, P350, DOI 10.1111/j.1365-2141.2009.07633.x; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Falkowska-Hansen B, 2006, MOL CELL BIOCHEM, V287, P43, DOI 10.1007/s11010-005-9024-3; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Holt RU, 2008, HAEMATOLOGICA, V93, P619, DOI 10.3324/haematol.11867; HUMPHRIES DE, 1992, J BIOL CHEM, V267, P13558; Iwasaki T, 2002, BRIT J HAEMATOL, V116, P796, DOI 10.1046/j.0007-1048.2002.03364.x; Khotskaya YB, 2009, J BIOL CHEM, V284, P26085, DOI 10.1074/jbc.M109.018473; Kluppel M, 2010, PROG MOL BIOL TRANSL, V93, P113, DOI 10.1016/S1877-1173(10)93006-8; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; KOLSET SO, 1990, BIOCHIM BIOPHYS ACTA, V1032, P191, DOI 10.1016/0304-419X(90)90004-K; Kolset SO, 2008, GLYCOCONJUGATE J, V25, P305, DOI 10.1007/s10719-007-9073-9; Kulseth MA, 1999, BBA-GEN SUBJECTS, V1428, P225, DOI 10.1016/S0304-4165(99)00096-3; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Malla N, 2013, FEBS J, V280, P2870, DOI 10.1111/febs.12291; Meen AJ, 2011, J BIOL CHEM, V286, P2636, DOI 10.1074/jbc.M110.151944; Mitsiades CS, 2007, J CELL BIOCHEM, V101, P950, DOI 10.1002/jcb.21213; Neri P, 2012, CURR CANCER DRUG TAR, V12, P776, DOI 10.2174/156800912802429337; Niemann CU, 2007, LEUKEMIA, V21, P2406, DOI 10.1038/sj.leu.2404975; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2009, BIOFACTORS, V35, P61, DOI 10.1002/biof.11; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2012, J BIOL CHEM, V287, P41288, DOI 10.1074/jbc.M112.391417; Purushothaman A, 2011, J BIOL CHEM, V286, P30377, DOI 10.1074/jbc.M111.254789; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; RIDLEY RC, 1993, BLOOD, V81, P767; SALI A, 1993, J BIOL CHEM, V268, P9023; Sanderson RD, 2008, CLIN EXP METASTAS, V25, P149, DOI 10.1007/s10585-007-9125-3; Schick BP, 2010, PROG MOL BIOL TRANSL, V93, P235, DOI [10.1016/S1S77-1173(10)93011-1, 10.1016/S1877-1173(10)93011-1]; SCHICK BP, 1995, J CELL PHYSIOL, V165, P96, DOI 10.1002/jcp.1041650113; SCHICK BP, 1992, BIOCHEM J, V282, P651, DOI 10.1042/bj2820651; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Seidel C, 1998, BLOOD, V91, P806, DOI 10.1182/blood.V91.3.806.806_806_812; Sengupta S, 2003, ARTERIOSCL THROM VAS, V23, P69, DOI 10.1161/01.ATV.0000048701.86621.D0; SERAFIN WE, 1986, J BIOL CHEM, V261, P5017; Slomiany MG, 2009, CLIN CANCER RES, V15, P7593, DOI 10.1158/1078-0432.CCR-09-2317; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; ToyamaSorimachi N, 1997, J BIOL CHEM, V272, P26714, DOI 10.1074/jbc.272.42.26714; TOYAMASORIMACHI N, 1995, J BIOL CHEM, V270, P7437, DOI 10.1074/jbc.270.13.7437; Vallet S, 2010, P NATL ACAD SCI USA, V107, P5124, DOI 10.1073/pnas.0911929107; Winberg JO, 2000, J MOL BIOL, V304, P669, DOI 10.1006/jmbi.2000.4235; Zernichow L, 2006, J BIOL CHEM, V281, P26792, DOI 10.1074/jbc.M512889200	46	41	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5499	5509		10.1074/jbc.M113.532143	http://dx.doi.org/10.1074/jbc.M113.532143			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403068	Green Published, hybrid			2022-12-28	WOS:000332015500014
J	Wu, DD; Zhang, FQ; Hao, F; Chun, J; Xu, XM; Cui, MZ				Wu, Daniel Dongwei; Zhang, Fuqiang; Hao, Feng; Chun, Jerold; Xu, Xuemin; Cui, Mei-Zhen			Matricellular Protein Cyr61 Bridges Lysophosphatidic Acid and Integrin Pathways Leading to Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Migration; Protein Kinases; Signal Transduction; Signaling; Vascular Biology	FOCAL ADHESION KINASE; IMMEDIATE-EARLY GENE; SMOOTH-MUSCLE-CELLS; TISSUE GROWTH-FACTOR; HEPARAN-SULFATE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; BETA(1)A INTEGRINS; ENDOTHELIAL-CELLS; RECEPTOR; EXPRESSION	Background: The molecular mechanism of smooth muscle cell (SMC) migration, a crucial event in atherosclerosis, is not well understood. Results: The de novo matricellular protein Cyr61 bridges lysophosphatidic acid (LPA) and integrin pathways, activating focal adhesion kinase (FAK) and leading to cell migration. Conclusion: The LPA-Cyr61-integrin-FAK axis controls SMC migration. Significance: This study provides new insights into mechanisms underlying cell migration-related disorders. Lysophosphatidic acid (LPA), a potent bioactive lipid found in atherosclerotic lesions, markedly induces smooth muscle cell (SMC) migration, which is an important process in atherogenesis. Therefore, understanding the mechanism of LPA-induced SMC migration is important. Several microarray databases suggest that the matricellular protein Cyr61 is highly induced by LPA. We hypothesized that Cyr61 mediates LPA-induced cell migration. Our data show that LPA induced temporal and spatial expression of Cyr61, which promptly accumulated in the cellular Golgi apparatus and then translocated to the extracellular matrix. Cyr61 antibody blockade and siRNA inhibition both diminished LPA-induced SMC migration, indicating a novel regulatory role of Cyr61. SMCs derived from LPA receptor 1 (LPA(1)) knock-out mice lack the ability of Cyr61 induction and cell migration, supporting the concept that LPA(1) is required for Cyr61 expression and migration. By contrast, PPAR was not found to be involved in LPA-mediated effects. Furthermore, focal adhesion kinase (FAK), a nonreceptor tyrosine kinase important for regulating cell migration, was activated by LPA at a late time frame coinciding with Cyr61 accumulation. Interestingly, knockdown of Cyr61 blocked LPA-induced FAK activation, indicating that an LPA-Cyr61-FAK axis leads to SMC migration. Our results further demonstrate that plasma membrane integrins 61 and 3 transduced the LPA-Cyr61 signal toward FAK activation and migration. Taken together, these data reveal that de novo Cyr61 in the extracellular matrix bridges LPA and integrin pathways, which in turn, activate FAK, leading to cell migration. The current study provides new insights into mechanisms underlying cell migration-related disorders, including atherosclerosis, restenosis, and cancers.	[Wu, Daniel Dongwei; Zhang, Fuqiang; Hao, Feng; Xu, Xuemin; Cui, Mei-Zhen] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Zhang, Fuqiang] Jilin Univ, Coll Pharm, Dept Med Bioengn, Changchun 130021, Peoples R China; [Chun, Jerold] Scripps Res Inst, Dorris Neurosci Ctr, Mol & Cellular Neurosci Dept, La Jolla, CA 92037 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Jilin University; Scripps Research Institute	Cui, MZ (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, 2407 River Dr, Knoxville, TN 37996 USA.	cuim@utk.edu	Chun, Jerold/Y-4670-2019	xu, xuemin/0000-0002-7426-272X; Cui, Mei-Zhen/0000-0003-4745-6999	National Institutes of Health [HL107466, AG026640, NS082092]; American Health Assistance Foundation Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS082092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039596, R01AG026640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL107466 (to M. Z. C.), AG026640 (to X. X.), and NS082092 (to J. C.). This work was also supported by an American Health Assistance Foundation Grant (to X. X.)	Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Bennett G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-50; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; BROCK TA, 1985, HYPERTENSION, V7, pI105, DOI 10.1161/01.HYP.7.3_Pt_2.I105; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Cui MZ, 2011, CLIN LIPIDOL, V6, P413, DOI 10.2217/CLP.11.38; Fu MG, 2001, J BIOL CHEM, V276, P45888, DOI 10.1074/jbc.M105490200; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441; Grzeszkiewicz TM, 2001, J BIOL CHEM, V276, P21943, DOI 10.1074/jbc.M100978200; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; JAMIESON JD, 1966, P NATL ACAD SCI USA, V55, P424, DOI 10.1073/pnas.55.2.424; Jedsadayanmata A, 1999, J BIOL CHEM, V274, P24321, DOI 10.1074/jbc.274.34.24321; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kim J, 2006, CELL SIGNAL, V18, P1695, DOI 10.1016/j.cellsig.2006.01.009; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Marek I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-102; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moiseeva EP, 2001, CARDIOVASC RES, V52, P372, DOI 10.1016/S0008-6363(01)00399-6; Mutoh T, 2012, BRIT J PHARMACOL, V165, P829, DOI 10.1111/j.1476-5381.2011.01622.x; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Panchatcharam M, 2008, CIRC RES, V103, P662, DOI 10.1161/CIRCRESAHA.108.180778; Pendurthi UR, 2000, J BIOL CHEM, V275, P14632, DOI 10.1074/jbc.275.19.14632; Rother E, 2003, CIRCULATION, V108, P741, DOI 10.1161/01.CIR.0000083715.37658.C4; Sakai T, 1999, J BIOL CHEM, V274, P15480, DOI 10.1074/jbc.274.22.15480; Sakai T, 1998, J BIOL CHEM, V273, P19378, DOI 10.1074/jbc.273.31.19378; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; SIMMONS DL, 1989, P NATL ACAD SCI USA, V86, P1178, DOI 10.1073/pnas.86.4.1178; Simon MF, 2005, J BIOL CHEM, V280, P14656, DOI 10.1074/jbc.M412585200; Stortelers C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-387; Streblow DN, 2003, J BIOL CHEM, V278, P50456, DOI 10.1074/jbc.M307936200; Terada N, 2012, PROSTATE, V72, P966, DOI 10.1002/pros.21501; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Walsh CT, 2008, FASEB J, V22, P4011, DOI 10.1096/fj.08-113266; Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001; Witzenbichler B, 1999, J CLIN INVEST, V104, P1469, DOI 10.1172/JCI7251; Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	53	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5774	5783		10.1074/jbc.M113.533042	http://dx.doi.org/10.1074/jbc.M113.533042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24371135	Green Published, hybrid			2022-12-28	WOS:000332015500037
J	Li, M; Chang, S; Yang, LJ; Shi, JY; McFarland, K; Yang, X; Moller, A; Wang, CG; Zou, XQ; Chi, CW; Cui, JM				Li, Min; Chang, Shan; Yang, Longjin; Shi, Jingyi; McFarland, Kelli; Yang, Xiao; Moller, Alyssa; Wang, Chunguang; Zou, Xiaoqin; Chi, Chengwu; Cui, Jianmin			Conopeptide Vt3.1 Preferentially Inhibits BK Potassium Channels Containing beta 4 Subunits via Electrostatic Interactions*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Molecular Modeling; Peptide Interactions; Potassium Channels; Toxins; 4 Subunit; BK Channel; Activation; Conopeptide; Electrostatic Interaction	SCORPION PEPTIDE BLOCKER; LARGE-CONDUCTANCE; K+ CHANNELS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; CALCIUM; VOLTAGE; VENOM; CHARYBDOTOXIN; INACTIVATION	Background: BK channel function is differentially modulated by tissue-specific (1-4) subunits. Results: Conopeptide Vt3.1 preferentially inhibits neuronal BK channels containing the 4 subunit. Conclusion: Electrostatic interactions between Vt3.1 and the extracellular loop of 4 decrease voltage-dependent activation of the channel. Significance: Vt3.1 is an excellent tool for studying the structure, function, and roles in neurophysiology of BK channels. BK channel subunits (1-4) modulate the function of channels formed by slo1 subunits to produce tissue-specific phenotypes. The molecular mechanism of how the homologous subunits differentially alter BK channel functions and the role of different BK channel functions in various physiologic processes remain unclear. By studying channels expressed in Xenopus laevis oocytes, we show a novel disulfide-cross-linked dimer conopeptide, Vt3.1 that preferentially inhibits BK channels containing the 4 subunit, which is most abundantly expressed in brain and important for neuronal functions. Vt3.1 inhibits the currents by a maximum of 71%, shifts the G-V relation by 45 mV approximately half-saturation concentrations, and alters both open and closed time of single channel activities, indicating that the toxin alters voltage dependence of the channel. Vt3.1 contains basic residues and inhibits voltage-dependent activation by electrostatic interactions with acidic residues in the extracellular loops of the slo1 and 4 subunits. These results suggest a large interaction surface between the slo1 subunit of BK channels and the 4 subunit, providing structural insight into the molecular interactions between slo1 and 4 subunits. The results also suggest that Vt3.1 is an excellent tool for studying subunit modulation of BK channels and for understanding the physiological roles of BK channels in neurophysiology.	[Li, Min; Yang, Longjin; Wang, Chunguang; Chi, Chengwu] Tongji Univ, Inst Prot Res, Shanghai 200092, Peoples R China; [Li, Min; Shi, Jingyi; McFarland, Kelli; Yang, Xiao; Moller, Alyssa; Cui, Jianmin] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Chang, Shan; Zou, Xiaoqin] Univ Missouri, Dept Phys & Astron, Dept Biochem, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Chang, Shan; Zou, Xiaoqin] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Chi, Chengwu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Cui, Jianmin] Soochow Univ, Dept Pharmacol, Coll Pharmaceut Sci, Suzhou 215123, Peoples R China	Tongji University; Washington University (WUSTL); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Soochow University - China	Chi, CW (corresponding author), Tongji Univ, Inst Prot Res, 1239 Siping Rd, Shanghai 200092, Peoples R China.	zwqi@sibs.ac.cn; jcui@wustl.edu		Chang, Shan/0000-0001-7169-9398	National Institutes of Health [R01-HL70393, R01-NS060706]; Chinese Ministry of Science and Technology [2010CB529802]; National Science Foundation of China [31271143]; National Science Foundation [DBI-0953839]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL70393 and R01-NS060706. This work was also supported by Chinese Ministry of Science and Technology Grant 2010CB529802 (to M. L.), National Science Foundation of China Grant 31271143 (to J. C.), and National Science Foundation Career Award Grant DBI-0953839 (to X. Z.).	Bowersox SS, 1998, TOXICON, V36, P1651, DOI 10.1016/S0041-0101(98)00158-5; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Contreras GF, 2012, P NATL ACAD SCI USA, V109, P18991, DOI 10.1073/pnas.1216953109; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deng PY, 2013, NEURON, V77, P696, DOI 10.1016/j.neuron.2012.12.018; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Duray H., 1997, SCI MED, V4, P6; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; Fan CX, 2003, J BIOL CHEM, V278, P12624, DOI 10.1074/jbc.M210200200; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Garcia-Valdes J, 2001, FEBS LETT, V505, P369, DOI 10.1016/S0014-5793(01)02791-0; GIANGIACOMO KM, 1992, BIOCHEMISTRY-US, V31, P6719, DOI 10.1021/bi00144a011; Gruslova A, 2012, J GEN PHYSIOL, V139, P57, DOI 10.1085/jgp.201110698; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; Hanner M, 1997, P NATL ACAD SCI USA, V94, P2853, DOI 10.1073/pnas.94.7.2853; Kanjhan R, 2005, J PHARMACOL EXP THER, V314, P1353, DOI 10.1124/jpet.105.085928; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Lee US, 2009, J PHYSIOL-LONDON, V587, P1481, DOI 10.1113/jphysiol.2009.169243; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Liu GX, 2010, J GEN PHYSIOL, V135, P449, DOI 10.1085/jgp.201010417; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shi J, 2008, BIOPHYS J, V94, P3706, DOI 10.1529/biophysj.107.122150; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Tao J., 2011, PLOS ONE, V6; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wang J, 2005, BIOCHEMISTRY-US, V44, P10145, DOI 10.1021/bi050614m; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Windley MJ, 2011, MOL PHARMACOL, V80, P1, DOI 10.1124/mol.110.070540; Wu XC, 2010, PEPTIDES, V31, P1001, DOI 10.1016/j.peptides.2010.03.010; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Yao J, 2005, J BIOL CHEM, V280, P14819, DOI 10.1074/jbc.M412735200; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932	51	15	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4735	4742		10.1074/jbc.M113.535898	http://dx.doi.org/10.1074/jbc.M113.535898			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398688	Green Published, hybrid			2022-12-28	WOS:000331607900020
J	Rafikov, R; Dimitropoulou, C; Aggarwal, S; Kangath, A; Gross, C; Pardo, D; Sharma, S; Jezierska-Drutel, A; Patel, V; Snead, C; Lucas, R; Verin, A; Fulton, D; Catravas, JD; Black, SM				Rafikov, Ruslan; Dimitropoulou, Christiana; Aggarwal, Saurabh; Kangath, Archana; Gross, Christine; Pardo, Daniel; Sharma, Shruti; Jezierska-Drutel, Agnieszka; Patel, Vijay; Snead, Connie; Lucas, Rudolf; Verin, Alexander; Fulton, David; Catravas, John D.; Black, Stephen M.			Lipopolysaccharide- induced Lung Injury Involves the Nitration- mediated Activation of RhoA*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lung Injury; Post-translational Modification; Protein Structure; Recombinant Protein Expression; Redox Regulation; Superoxide Ion; Enzymology	MICROVASCULAR ENDOTHELIAL-CELLS; TYROSINE NITRATION; CRYSTAL-STRUCTURE; NITRIC-OXIDE; SUPEROXIDE-DISMUTASE; PROTEIN NITRATION; BARRIER FUNCTION; AIRWAY DISEASE; CDC42; PEROXYNITRITE	Background: The activation of RhoA is a critical event in acute lung injury (ALI), but the role of nitration in this process is unresolved. Results: The nitration of RhoA at Tyr(34) produced GEF-like conformational changes that stimulate RhoA by decreasing GDP binding. Conclusion: We have identified a new mechanism of RhoA activation. Significance: Preventing RhoA nitration may be useful for the management of ALI. Acute lung injury (ALI) is characterized by increased endothelial hyperpermeability. Protein nitration is involved in the endothelial barrier dysfunction in LPS-exposed mice. However, the nitrated proteins involved in this process have not been identified. The activation of the small GTPase RhoA is a critical event in the barrier disruption associated with LPS. Thus, in this study we evaluated the possible role of RhoA nitration in this process. Mass spectroscopy identified a single nitration site, located at Tyr(34) in RhoA. Tyr(34) is located within the switch I region adjacent to the nucleotide-binding site. Utilizing this structure, we developed a peptide designated NipR1 (nitration inhibitory peptide for RhoA 1) to shield Tyr(34) against nitration. TAT-fused NipR1 attenuated RhoA nitration and barrier disruption in LPS-challenged human lung microvascular endothelial cells. Further, treatment of mice with NipR1 attenuated vessel leakage and inflammatory cell infiltration and preserved lung function in a mouse model of ALI. Molecular dynamics simulations suggested that the mechanism by which Tyr(34) nitration stimulates RhoA activity was through a decrease in GDP binding to the protein caused by a conformational change within a region of Switch I, mimicking the conformational shift observed when RhoA is bound to a guanine nucleotide exchange factor. Stopped flow kinetic analysis was used to confirm this prediction. Thus, we have identified a new mechanism of nitration-mediated RhoA activation involved in LPS-mediated endothelial barrier dysfunction and show the potential utility of shielding peptides to prevent RhoA nitration in the management of ALI.	[Rafikov, Ruslan; Dimitropoulou, Christiana; Aggarwal, Saurabh; Kangath, Archana; Gross, Christine; Pardo, Daniel; Sharma, Shruti; Jezierska-Drutel, Agnieszka; Snead, Connie; Lucas, Rudolf; Verin, Alexander; Fulton, David; Catravas, John D.; Black, Stephen M.] Georgia Regents Univ, Vasc Biol Ctr, Program Pulm Vasc Dis, Augusta, GA 30912 USA; [Patel, Vijay] Georgia Regents Univ, Dept Surg, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Black, SM (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, 1459 Laney Walker Blvd,CB 3210-B, Augusta, GA 30912 USA.	sblack@gru.edu	Lucas, Rudolf/ABA-3011-2020; Rafikov, Ruslan/AAG-9352-2019	Rafikov, Ruslan/0000-0001-5950-4076; Sharma, Shruti/0000-0001-8200-108X; Lucas, Rudolf/0000-0003-3805-8868	National Institutes of Health [P01HL0101902]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL101902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01HL0101902.	Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Budge PJ, 2004, J VIROL, V78, P5015, DOI 10.1128/JVI.78.10.5015-5022.2004; Burg J, 2002, AM J PHYSIOL-LUNG C, V283, pL460, DOI 10.1152/ajplung.00249.2001; Buttenschoen K, 2008, LANGENBECK ARCH SURG, V393, P473, DOI 10.1007/s00423-008-0317-3; Carbajal JM, 1999, AM J PHYSIOL-CELL PH, V277, pC955, DOI 10.1152/ajpcell.1999.277.5.C955; Catravas JD, 2010, VASC PHARMACOL, V52, P175, DOI 10.1016/j.vph.2009.12.009; Choi JC, 2008, J KOREAN MED SCI, V23, P288, DOI 10.3346/jkms.2008.23.2.288; Ckless K, 2008, J IMMUNOL, V181, P4255, DOI 10.4049/jimmunol.181.6.4255; Dechend R, 2003, CIRCULATION, V108, P261, DOI 10.1161/01.CIR.0000083367.93022.78; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Goeckeler ZM, 2005, J BIOL CHEM, V280, P33083, DOI 10.1074/jbc.M503173200; Good PF, 1998, J NEUROPATH EXP NEUR, V57, P338, DOI 10.1097/00005072-199804000-00006; Groshaus HE, 2004, CRIT CARE, V8, P234, DOI 10.1186/cc2875; Guilgen G, 2011, BLOOD PURIFICAT, V32, P296, DOI 10.1159/000330327; Harrington EO, 2004, AM J PHYSIOL-LUNG C, V287, pL1091, DOI 10.1152/ajplung.00421.2003; Heo J, 2005, J BIOL CHEM, V280, P31003, DOI 10.1074/jbc.M504768200; Heo JY, 2006, BIOCHEMISTRY-US, V45, P14481, DOI 10.1021/bi0610101; Huang F, 2005, AM J PHYSIOL-LUNG C, V289, pL176, DOI 10.1152/ajplung.00003.2005; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Kallet Richard H, 2004, Respir Care, V49, P793; Knapp LT, 2001, BIOCHEM BIOPH RES CO, V286, P764, DOI 10.1006/bbrc.2001.5448; Kondrikov D, 2011, FREE RADICAL BIO MED, V50, P1689, DOI 10.1016/j.freeradbiomed.2011.03.020; Lerm M, 1999, INFECT IMMUN, V67, P496, DOI 10.1128/IAI.67.2.496-503.1999; Lucas R, 2012, P NATL ACAD SCI USA, V109, P2084, DOI 10.1073/pnas.1121075109; Magder S, 2006, J VASC RES, V43, P447, DOI 10.1159/000095162; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; McNichol BA, 2006, MOL MICROBIOL, V60, P939, DOI 10.1111/j.1365-2958.2006.05157.x; Quint P, 2006, FREE RADICAL BIO MED, V40, P453, DOI 10.1016/j.freeradbiomed.2005.08.045; Roupie E, 1999, INTENS CARE MED, V25, P920, DOI 10.1007/s001340050983; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Sharma S, 2008, AM J PHYSIOL-LUNG C, V294, pL46, DOI 10.1152/ajplung.00247.2007; Sharma S, 2010, VASC PHARMACOL, V52, P182, DOI 10.1016/j.vph.2009.11.010; Shen Q, 2009, CELL HEALTH CYTOSKEL, V1, P43; Shimizu T, 2000, J BIOL CHEM, V275, P18311, DOI 10.1074/jbc.M910274199; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Sugiura H, 2004, FREE RADICAL RES, V38, P49, DOI 10.1080/10715760310001633817; Visvikis O, 2010, BIOL CELL, V102, P377, DOI 10.1042/BC20090151; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; WIZEMANN TM, 1994, J LEUKOCYTE BIOL, V56, P759, DOI 10.1002/jlb.56.6.759; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zhang BL, 1998, J BIOL CHEM, V273, P25728, DOI 10.1074/jbc.273.40.25728	45	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4710	4722		10.1074/jbc.M114.547596	http://dx.doi.org/10.1074/jbc.M114.547596			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398689	Green Published, hybrid			2022-12-28	WOS:000331607900018
J	Yang, W; Park, IJ; Yun, H; Im, DU; Ock, S; Kim, J; Seo, SM; Shin, HY; Viollet, B; Kang, I; Choe, W; Kim, SS; Ha, J				Yang, Wookyeom; Park, In-Ja; Yun, Hee; Im, Dong-Uk; Ock, Sangmi; Kim, Jaetaek; Seo, Seon-Mi; Shin, Ha-Yeon; Viollet, Benoit; Kang, Insug; Choe, Wonchae; Kim, Sung-Soo; Ha, Joohun			AMP-activated Protein Kinase 2 and E2F1 Transcription Factor Mediate Doxorubicin-induced Cytotoxicity by Forming a Positive Signal Loop in Mouse Embryonic Fibroblasts and Non-carcinoma Cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Anticancer Drug; Cell Death; E2F Transcription Factor; Resveratrol; Doxorubicin	INDUCED CARDIOMYOCYTE APOPTOSIS; DNA-DAMAGE; GENOTOXIC STRESS; IN-VITRO; MICE; PHOSPHORYLATION; CARDIOTOXICITY; ADRIAMYCIN; INHIBITION; SUBUNIT	Background: Despite the central position in chemotherapy, the clinical application of doxorubicin is compromised by severe adverse effect in different organs. Results: Doxorubicin induces AMPK2 transcription, and AMPK2 in turn stabilizes E2F1 in non-carcinoma cells. Conclusion: AMPK2 and E2F1 mediate cytotoxicity of doxorubicin. Significance: AMPK2 might serve as a novel target for alleviating the cytotoxicity of doxorubicin. Doxorubicin is one of the most widely used anti-cancer drugs, but its clinical application is compromised by severe adverse effects in different organs including cardiotoxicity. In the present study we explored mechanisms of doxorubicin-induced cytotoxicity by revealing a novel role for the AMP-activated protein kinase 2 (AMPK2) in mouse embryonic fibroblasts (MEFs). Doxorubicin robustly induced the expression of AMPK2 in MEFs but slightly reduced AMPK1 expression. Our data support the previous notion that AMPK1 harbors survival properties under doxorubicin treatment. In contrast, analyses of Ampk2(-/-) MEFs, gene knockdown of AMPK2 by shRNA, and inhibition of AMPK2 activity with an AMPK inhibitor indicated that AMPK2 functions as a pro-apoptotic molecule under doxorubicin treatment. Doxorubicin induced AMPK2 at the transcription level via E2F1, a transcription factor that regulates apoptosis in response to DNA damage. E2F1 directly transactivated the Ampk2 gene promoter. In turn, AMPK2 significantly contributed to stabilization and activation of E2F1 by doxorubicin, forming a positive signal amplification loop. AMPK2 directly interacted with and phosphorylated E2F1. This signal loop was also detected in H9c2, C2C12, and ECV (human epithelial cells) cells as well as mouse liver under doxorubicin treatment. Resveratrol, which has been suggested to attenuate doxorubicin-induced cytotoxicity, significantly blocked induction of AMPK2 and E2F1 by doxorubicin, leading to protection of these cells. This signal loop appears to be non-carcinoma-specific because AMPK2 was not induced by doxorubicin in five different tested cancer cell lines. These results suggest that AMPK2 may serve as a novel target for alleviating the cytotoxicity of doxorubicin.	[Yang, Wookyeom; Park, In-Ja; Yun, Hee; Im, Dong-Uk; Seo, Seon-Mi; Shin, Ha-Yeon; Kang, Insug; Choe, Wonchae; Kim, Sung-Soo; Ha, Joohun] Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, Med Res Ctr, Seoul 130701, South Korea; [Yang, Wookyeom; Park, In-Ja; Yun, Hee; Im, Dong-Uk; Seo, Seon-Mi; Shin, Ha-Yeon; Kang, Insug; Choe, Wonchae; Kim, Sung-Soo; Ha, Joohun] Kyung Hee Univ, Sch Med, Inst Biomed Sci, Seoul 130701, South Korea; [Ock, Sangmi; Kim, Jaetaek] Chung Ang Univ, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Seoul 156755, South Korea; [Viollet, Benoit] Univ Paris 05, UMR8104, CNRS, INSERM,U1016,Inst Cochin, F-75014 Paris, France	Kyung Hee University; Kyung Hee University; Chung Ang University; Chung Ang University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ha, J (corresponding author), Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, Med Res Ctr, 1 Hoegi Dong, Seoul 130701, South Korea.	hajh@khu.ac.kr	Yang, Wookyeom/X-3939-2019; Viollet, Benoit/O-6927-2017; Kim, Jaetaek/AAE-7147-2020; Viollet, Benoit/N-2397-2019; Kim, Sung Soo/S-2540-2017	Yang, Wookyeom/0000-0002-3970-7973; Viollet, Benoit/0000-0002-0121-0224; Kim, Jaetaek/0000-0001-5247-0408; Viollet, Benoit/0000-0002-0121-0224; Kim, Sung Soo/0000-0002-6817-7668	National Research Foundation of Korea grant; Korea government (MSIP) [2012009447, 20120009381]	National Research Foundation of Korea grant(National Research Foundation of Korea); Korea government (MSIP)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government (MSIP; 2012009447 and 20120009381).	Arcamone F, 2000, BIOTECHNOL BIOENG, V67, P704, DOI 10.1002/(SICI)1097-0290(20000320)67:6<704::AID-BIT8>3.0.CO;2-L; Carcagno AL, 2009, IUBMB LIFE, V61, P537, DOI 10.1002/iub.197; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Furukawa Y, 2002, J BIOL CHEM, V277, P39760, DOI 10.1074/jbc.M200805200; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Gogada R, 2013, J BIOL CHEM, V288, P368, DOI 10.1074/jbc.M112.386102; Goirand F, 2007, J PHYSIOL-LONDON, V581, P1163, DOI 10.1113/jphysiol.2007.132589; Gu J, 2012, CARDIOVASC TOXICOL, V12, P341, DOI 10.1007/s12012-012-9178-7; HA J, 1994, J BIOL CHEM, V269, P22162; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Hamlaoui S, 2012, J PHYSIOL PHARMACOL, V63, P293; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lin WC, 2001, GENE DEV, V15, P1833; Lv X., 2012, PLOS ONE, V7; Minotti G, 1999, FASEB J, V13, P199, DOI 10.1096/fasebj.13.2.199; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Ozono E, 2009, GENES CELLS, V14, P89, DOI 10.1111/j.1365-2443.2008.01248.x; Pointon AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012733; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang SB, 2012, J BIOL CHEM, V287, P8001, DOI 10.1074/jbc.M111.315812; WEISS RB, 1992, SEMIN ONCOL, V19, P670; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Zhang C, 2011, CARDIOVASC RES, V90, P538, DOI 10.1093/cvr/cvr022; Zhu Q, 2010, MOL CELL BIOCHEM, V340, P275, DOI 10.1007/s11010-010-0428-3	52	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4839	4852		10.1074/jbc.M113.496315	http://dx.doi.org/10.1074/jbc.M113.496315			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398673	hybrid, Green Published			2022-12-28	WOS:000331607900031
J	Yueh, MF; Chen, SJ; Nguyen, N; Tukey, RH				Yueh, Mei-Fei; Chen, Shujuan; Nghia Nguyen; Tukey, Robert H.			Developmental Onset of Bilirubin-induced Neurotoxicity Involves Toll-like Receptor 2-dependent Signaling in Humanized UDP-glucuronosyltransferase1 Mice*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain; Glia; Neuroinflammation; Oxidative Stress; Toll-like Receptors (TLR); UDP-glucuronosyltransferase	PATTERN-RECOGNITION RECEPTORS; CENTRAL-NERVOUS-SYSTEM; INNATE IMMUNITY; NADPH OXIDASE; UGT1 LOCUS; CLINICAL-IMPLICATIONS; OXIDATIVE STRESS; CRIGLER-NAJJAR; LUNG INJURY; DISEASE	Background: Neonatal jaundice with dangerously high levels of serum bilirubin leads to neurological toxicity. Results: Toll-like receptor 2 signaling is essential for regulation of glia activation, neuroinflammation, and oxidative stress when neonatal mice experience severe hyperbilirubinemia. Conclusion: Toll-like receptor 2 signaling is linked to a protection mode against serum bilirubin-induced brain toxicity. Significance: Understanding how signaling from innate immunity contributes to bilirubin-induced pathology. Biological and signaling events that connect developmentally induced hyperbilirubinemia to bilirubin-induced neurological dysfunction (BIND) and CNS toxicity in humans are poorly understood. In mammals, UDP-glucuronosyltransferase 1A1 (UGT1A1) is the sole enzyme responsible for bilirubin glucuronidation, a rate-limiting step necessary for bilirubin metabolism and clearance. Humanized mice that express the entire UGT1 locus (hUGT1) and the UGT1A1 gene, develop neonatal hyperbilirubinemia, with 8-10% of hUGT1 mice succumbing to CNS damage, a phenotype that is presented by uncontrollable seizures. We demonstrate that neuroinflammation and reactive gliosis are prominent features of bilirubin brain toxicity, and a disturbed redox status resulting from activation of NADPH oxidase is an important contributing mechanism found in BIND. Using knock-out mice and primary brain cells, we connect a key pattern recognition receptor, Toll-like receptor 2 (TLR2), to hyperbilirubinemia-induced signaling. We illustrate a requirement for TLR2 signaling in regulating gliosis, proinflammatory mediators, and oxidative stress when neonatal mice encounter severe hyperbilirubinemia. TLR2-mediated gliosis strongly correlates with pronounced neuroinflammation in the CNS with up-regulation of TNF, IL-1, and IL-6, creating a pro-inflammatory CNS environment. Gene expression and immunohistochemistry staining show that hUGT1/Tlr2(-/-) mice fail to activate glial cells, proinflammatory cytokines, and stress response genes. In addition, bilirubin-induced apoptosis was significantly enhanced by blocking TLR2 signaling indicating its anti-apoptotic property. Consequently, a higher neonatal death rate (57.1%) in hUGT1/Tlr2(-/-) mice was observed when compared with hUGT1 mice (8.7%). These results suggest that TLR2 signaling and microglia neuroinflammation are linked to a repair and/or protection mode against BIND.	[Tukey, Robert H.] Univ Calif San Diego, Dept Chem & Biochem, Lab Environm Toxicol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, Lab Environm Toxicol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Tukey, RH (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Lab Environm Toxicol, La Jolla, CA 92093 USA.	rtukey@ucsd.edu		Chen, Shujuan/0000-0002-1068-195X	National Institutes of Health from the United States Public Health Service [P42ES010337, GM100481, GM086713]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086713, R01GM100481] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P42ES010337, GM100481, and GM086713 from the United States Public Health Service.	Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Boullier A, 2005, J LIPID RES, V46, P969, DOI 10.1194/jlr.M400496-JLR200; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen SJ, 2012, HEPATOLOGY, V56, P658, DOI 10.1002/hep.25671; Chen SJ, 2005, J BIOL CHEM, V280, P37547, DOI 10.1074/jbc.M506683200; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Chrissobolis S, 2008, TRENDS MOL MED, V14, P495, DOI 10.1016/j.molmed.2008.09.003; Cole JE, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/393946; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Fujiwara R, 2010, P NATL ACAD SCI USA, V107, P5024, DOI 10.1073/pnas.0913290107; Gaddis DE, 2013, J LEUKOCYTE BIOL, V93, P21, DOI 10.1189/jlb.0512220; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Glezer I, 2006, FASEB J, V20, P750, DOI 10.1096/fj.05-5234fje; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Hansen TWR, 2002, CLIN PERINATOL, V29, P765, DOI 10.1016/S0095-5108(02)00053-2; Hazen SL, 2008, J BIOL CHEM, V283, P15527, DOI 10.1074/jbc.R700054200; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Ionita MG, 2010, J INNATE IMMUN, V2, P307, DOI 10.1159/000314270; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Johnson L, 2011, SEMIN PERINATOL, V35, P101, DOI 10.1053/j.semperi.2011.02.003; Kadakol A, 2000, HUM MUTAT, V16, P297, DOI 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z; Kapitulnik J, 2004, MOL PHARMACOL, V66, P773, DOI 10.1124/mol.104.002832; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; M Ni, 2010, CURR PROTOC TOXICOL, V43; Millar NL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/436203; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Nguyen N, 2008, J BIOL CHEM, V283, P7901, DOI 10.1074/jbc.M709244200; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Pradillo JM, 2009, J NEUROCHEM, V109, P287, DOI 10.1111/j.1471-4159.2009.05972.x; Serrano F, 2003, BRAIN RES, V988, P193, DOI 10.1016/S0006-8993(03)03364-X; Tasaki K, 1997, BRAIN RES, V748, P267, DOI 10.1016/S0006-8993(96)01383-2; Turrin NP, 2004, NEUROBIOL DIS, V16, P321, DOI 10.1016/j.nbd.2004.03.010; Vartanian KB, 2010, TRANSL STROKE RES, V1, P252, DOI 10.1007/s12975-010-0033-5; Yueh MF, 2011, MOL PHARMACOL, V79, P1053, DOI 10.1124/mol.110.070649; Zelenka J, 2008, J CHROMATOGR B, V867, P37, DOI 10.1016/j.jchromb.2008.03.005	50	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4699	4709		10.1074/jbc.M113.518613	http://dx.doi.org/10.1074/jbc.M113.518613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403077	Green Published, hybrid			2022-12-28	WOS:000331607900017
J	Ouyang, WM; Torigoe, C; Fang, H; Xie, T; Frucht, DM				Ouyang, Weiming; Torigoe, Chikako; Fang, Hui; Xie, Tao; Frucht, David M.			Anthrax Lethal Toxin Inhibits Translation of Hypoxia-inducible Factor 1 alpha and Causes Decreased Tolerance to Hypoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; Bacterial Pathogenesis; Hypoxia; Hypoxia-inducible Factor; Infectious Diseases; MAP kinases (MAPKs); mTOR; Protein Stability; Toxins; Translation	HIPPEL-LINDAU PROTEIN; INNATE IMMUNITY; BACILLUS-ANTHRACIS; SIGNALING PATHWAYS; KEY MEDIATOR; FACTOR-1-ALPHA; HIF-1-ALPHA; KINASE; FAMILY; HIF	Background: Hypoxia is proposed as a mediator of anthrax lethal factor (LT)-induced pathology. Results: LT inhibits hypoxia-inducible factor 1 (HIF-1) translation and causes increased cellular toxicity in response to hypoxic stress. Conclusion: LT reduces HIF-1 translation, dysregulating host responses to hypoxia. Significance: Inhibition of HIF-1 translation is a novel mechanism underlying LT-induced pathology. Hypoxia is considered to be a contributor to the pathology associated with administration of anthrax lethal toxin (LT). However, we report here that serum lactate levels in LT-treated mice are reduced, a finding inconsistent with the anaerobic metabolism expected to occur during hypoxia. Reduced lactate levels are also observed in the culture supernatants of LT-treated cells. LT inhibits the accumulation of hypoxia-inducible factor (HIF)-1, a subunit of HIF-1, the master regulator directing cellular responses to hypoxia. The toxin has no effect on the transcription or protein turnover of HIF-1, but instead it acts to inhibit HIF-1 translation. LT treatment diminishes phosphorylation of eIF4B, eIF4E, and rpS6, critical components of the intracellular machinery required for HIF-1 translation. Moreover, blockade of MKK1/2-ERK1/2, but not p38 or JNK signaling, lowers HIF-1 protein levels in both normoxic and hypoxic conditions, consistent with a role for MKK1 and MKK2 as the major targets of LT responsible for the inhibition of HIF-1 translation. The physiological importance of the LT-induced translation blockade is demonstrated by the finding that LT treatment decreases the survival of hepatocyte cell lines grown in hypoxic conditions, an effect that is overcome by preinduction of HIF-1. Taken together, these data support a role for LT in dysregulating HIF-1 and thereby disrupting homeostatic responses to hypoxia, an environmental characteristic of certain tissues at baseline and/or during disseminated infection with Bacillus anthracis.	[Ouyang, Weiming; Torigoe, Chikako; Fang, Hui; Xie, Tao; Frucht, David M.] US FDA, Div Monoclonal Antibodies, Off Biotechnol Prod, Off Pharmaceut Sci,Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA)	Frucht, DM (corresponding author), US FDA, Div Monoclonal Antibodies, Off Biotechnol Prod, Off Pharmaceut Sci,Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA.	david.frucht@fda.hhs.gov			Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	This work was supported by a Medical Countermeasures Grant from the Food and Drug Administration.	Abi-Habib RJ, 2006, CLIN CANCER RES, V12, P7437, DOI 10.1158/1078-0432.CCR-06-2019; Abraham RT, 2003, CURR TOP MICROBIOL, V279, P299; Adams JM, 2009, ACTA PHYSIOL HUNG, V96, P19, DOI 10.1556/APhysiol.96.2009.1.2; Alfano RW, 2010, MOL CANCER THER, V9, P190, DOI 10.1158/1535-7163.MCT-09-0694; Artenstein AW, 2012, CLIN INFECT DIS, V54, P1148, DOI 10.1093/cid/cis017; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Bhatnagar R, 2001, CRIT REV MICROBIOL, V27, P167, DOI 10.1080/20014091096738; Bodart JF, 2002, CELL CYCLE, V1, P10, DOI 10.4161/cc.1.1.95; Bromberg-White JL, 2008, METHOD ENZYMOL, V438, P355, DOI 10.1016/S0076-6879(07)38025-7; Bromberg-White JL, 2011, INVEST OPHTH VIS SCI, V52, P8979, DOI 10.1167/iovs.11-7651; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Chun YS, 2002, J KOREAN MED SCI, V17, P581, DOI 10.3346/jkms.2002.17.5.581; Czibik G, 2009, CTS-CLIN TRANSL SCI, V2, P33, DOI 10.1111/j.1752-8062.2008.00077.x; D'Osualdo A, 2012, PIGM CELL MELANOMA R, V25, P5, DOI 10.1111/j.1755-148X.2011.00942.x; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Frankel AE, 2009, FRONT BIOSCI, V14, P4516, DOI 10.2741/3544; Frew BC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002659; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; Gorlach A, 2009, CURR PHARM DESIGN, V15, P3844, DOI 10.2174/138161209789649420; Golden HB, 2009, FRONT BIOSCI-LANDMRK, V14, P2335, DOI 10.2741/3382; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Keely S, 2014, MUCOSAL IMMUNOL, V7, P114, DOI 10.1038/mi.2013.29; Knaup KX, 2009, MOL CANCER RES, V7, P88, DOI 10.1158/1541-7786.MCR-08-0288; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Kong XG, 2007, J BIOL CHEM, V282, P15498, DOI 10.1074/jbc.M700704200; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liu L, 2009, MOL BIOL CELL, V20, P4885, DOI 10.1091/mbc.E09-07-0550; Liu SH, 2013, NATURE, V501, P63, DOI 10.1038/nature12510; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Malyshev I Iu, 2012, Patol Fiziol Eksp Ter, P42; Maxwell PH, 2001, ADV EXP MED BIOL, V502, P365; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Olson N, 2011, NITRIC OXIDE-BIOL CH, V25, P125, DOI 10.1016/j.niox.2010.12.010; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Ranganathan A, 2006, ARCH BIOCHEM BIOPHYS, V449, P8, DOI 10.1016/j.abb.2006.02.023; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Schepens B, 2005, NUCLEIC ACIDS RES, V33, P6884, DOI 10.1093/nar/gki1000; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sweeney DA, 2011, AM J RESP CRIT CARE, V184, P1333, DOI 10.1164/rccm.201102-0209CI; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Vollmer S, 2009, HEPATOLOGY, V50, P253, DOI 10.1002/hep.22928; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xia Y, 2012, EUR J MED CHEM, V49, P24, DOI 10.1016/j.ejmech.2012.01.033; Xie T, 2011, TOXINS, V3, P591, DOI 10.3390/toxins3060591; Xu LX, 2008, J IMMUNOL, V180, P4139, DOI 10.4049/jimmunol.180.6.4139; Xu LX, 2007, INT J BIOCHEM CELL B, V39, P20, DOI 10.1016/j.biocel.2006.08.010; Yeo EJ, 2004, BIOCHEM PHARMACOL, V68, P1061, DOI 10.1016/j.bcp.2004.02.040; Zhang J, 2010, PLOS ONE, V5; Zhou J, 2006, MOL BIOL CELL, V17, P1549, DOI 10.1091/mbc.E05-08-0770	58	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4180	4190		10.1074/jbc.M113.530006	http://dx.doi.org/10.1074/jbc.M113.530006			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366872	hybrid, Green Published			2022-12-28	WOS:000331403800031
J	Wang, H; Chen, Y; Lin, P; Li, L; Zhou, GS; Liu, GC; Logsdon, C; Jin, JP; Abbruzzese, JL; Tan, TH; Wang, HM				Wang, Hua; Chen, Yue; Lin, Ping; Li, Lei; Zhou, Guisheng; Liu, Guangchao; Logsdon, Craig; Jin, Jianping; Abbruzzese, James L.; Tan, Tse-Hua; Wang, Huamin			The CUL7/F-box and WD Repeat Domain Containing 8 (CUL7/Fbxw8) Ubiquitin Ligase Promotes Degradation of Hematopoietic Progenitor Kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; MAP Kinases (MAPKs); Pancreatic Cancer; Proteasome; Protein Phosphatase; Serine Threonine Protein Kinase; CUL7 Ubiquitin Ligase; Fbxw8; HPK1; PP4	STE20-RELATED PROTEIN-KINASE; CASPASE-MEDIATED CLEAVAGE; ADAPTER PROTEINS; POSITIVE REGULATOR; TUMOR-SUPPRESSOR; HPK1; ACTIVATION; TARGETS; CUL7; CRK	HPK1, a member of mammalian Ste20-like serine/threonine kinases, is lost in >95% pancreatic cancer through proteasome-mediated degradation. However, the mechanism of HPK1 loss has not been defined. The aims of this study are to identify the ubiquitin ligase and to examine the mechanisms that targets HPK1 degradation. We found that the CUL7/Fbxw8 ubiquitin ligase targeted HPK1 for degradation via the 26 S proteasome. The ubiquitination of HPK1 required its kinase activity and autophosphorylation. Wild-type protein phosphatase 4 (PP4), but not the phosphatase-dead PP4 mutant, PP4-RL, inhibits the interaction of Fbxw8 with HPK1 and Fbxw8-mediated ubiquitination of HPK1. In addition, we showed that Thr-355 of HPK1 is a key PP4 dephosphorylation site, through which CUL7/Fbxw8 ubiquitin ligase and PP4 regulates HPK1 stability. Knockdown of Fbxw8 restores endogenous HPK1 protein expression and inhibits cell proliferation of pancreatic cancer cells. Our study demonstrated that targeted degradation of HPK1 by the CUL7/Fbxw8 ubiquitin ligase constitutes a negative-feedback loop to restrain the activity of HPK1 and that CUL7/Fbxw8 ubiquitin ligase promotes pancreatic cancer cell proliferation. CUL7/Fbxw8 ubiquitin ligase-mediated HPK1 degradation revealed a direct link and novel role of CUL7/Fbxw8 ubiquitin ligase in the MAPK pathway, which plays a critical role in cell proliferation and differentiation.	[Wang, Hua; Abbruzzese, James L.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Chen, Yue; Lin, Ping; Li, Lei; Liu, Guangchao; Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Logsdon, Craig] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lin, Ping] Harbin Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Harbin 150081, Peoples R China; [Li, Lei] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Zhou, Guisheng] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Jin, Jianping] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Tan, Tse-Hua] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harbin Medical University; Naval Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Health Science Center Houston; National Health Research Institutes - Taiwan	Wang, HM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Unit 085, 1515 Holcombe Blvd, Houston, TX 77030 USA.	hmwang@mdanderson.org	Tan, Tse-Hua/ABD-7080-2021; Tan, Tse-Hua/E-3983-2010; Jin, Jianping/K-5002-2018	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; Jin, Jianping/0000-0003-4175-9104	National Institutes of Health [1R21CA149544-01A1]; G. S. Hogan Gastrointestinal Cancer Research Fund at The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672, R21CA149544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. S. Hogan Gastrointestinal Cancer Research Fund at The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health though Grant 1R21CA149544-01A1 and by the G. S. Hogan Gastrointestinal Cancer Research Fund at The University of Texas MD Anderson Cancer Center.	Anafi M, 1997, J BIOL CHEM, V272, P27804, DOI 10.1074/jbc.272.44.27804; Arnold R, 2005, MOL CELL BIOL, V25, P2364, DOI 10.1128/MCB.25.6.2364-2383.2005; Arnold R, 2001, J BIOL CHEM, V276, P14675, DOI 10.1074/jbc.M008343200; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Chen-Deutsch X, 2012, CELL CYCLE, V11, P1364, DOI 10.4161/cc.19765; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Jung P, 2007, P NATL ACAD SCI USA, V104, P11388, DOI 10.1073/pnas.0609467104; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Kim SS, 2007, CANCER RES, V67, P9616, DOI 10.1158/0008-5472.CAN-07-0644; Liang JJ, 2008, CLIN CANCER RES, V14, P7043, DOI 10.1158/1078-0432.CCR-08-0381; Ling P, 1999, MOL CELL BIOL, V19, P1359; Ling P, 2001, J BIOL CHEM, V276, P18908, DOI 10.1074/jbc.M101485200; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Liu SK, 2000, J IMMUNOL, V165, P1417, DOI 10.4049/jimmunol.165.3.1417; Mansour MR, 2013, J EXP MED, V210, P1545, DOI 10.1084/jem.20122516; Nagata Y, 1999, BLOOD, V93, P3347, DOI 10.1182/blood.V93.10.3347.410k06_3347_3354; Oehrl W, 1998, ONCOGENE, V17, P1893, DOI 10.1038/sj.onc.1202108; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Paradis V, 2013, GUT, V62, P911, DOI 10.1136/gutjnl-2012-302091; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Sauer K, 2001, J BIOL CHEM, V276, P45207, DOI 10.1074/jbc.M106811200; Sawasdikosol S, 2007, J BIOL CHEM, V282, P34693, DOI 10.1074/jbc.M707425200; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Wang H, 2009, CANCER RES, V69, P1063, DOI 10.1158/0008-5472.CAN-08-1751; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Wang ZW, 2012, EMBO REP, V13, P36, DOI 10.1038/embor.2011.231; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Yu J, 2001, MOL CELL BIOL, V21, P6102, DOI 10.1128/MCB.21.18.6102-6112.2001; Zhou GS, 2004, J BIOL CHEM, V279, P49551, DOI 10.1074/jbc.M410317200; Zhou GS, 1999, J BIOL CHEM, V274, P13133, DOI 10.1074/jbc.274.19.13133	40	36	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4009	4017		10.1074/jbc.M113.520106	http://dx.doi.org/10.1074/jbc.M113.520106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362026	Green Published, hybrid			2022-12-28	WOS:000331403800016
J	Li, TT; Liu, MX; Feng, X; Wang, Z; Das, I; Xu, YP; Zhou, X; Sun, YP; Guan, KL; Xiong, Y; Lei, QY				Li, Tingting; Liu, Mengxi; Feng, Xu; Wang, Zhen; Das, Indrani; Xu, Yanping; Zhou, Xin; Sun, Yiping; Guan, Kun-Liang; Xiong, Yue; Lei, Qun-Ying			Glyceraldehyde-3-phosphate Dehydrogenase Is Activated by Lysine 254 Acetylation in Response to Glucose Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Growth; Glycolysis; Histone Deacetylase; Lung Cancer; Metabolism; Acetylation; GAPDH; HDAC5; PCAF; Tumorigenesis	URACIL DNA GLYCOSYLASE; GENE-EXPRESSION; CANCER CELLS; GAPDH; PROTEIN; APOPTOSIS; PET; RNA	Background: Glyceraldehyde-3-phosphate dehydrogenase is a pivotal glycolytic enzyme and implicated in many human cancers. Results: GAPDH acetylation promotes its activity in response to glucose via the action of PCAF and HDAC5. Conclusion: GAPDH acetylation promotes cell proliferation and tumor growth. Significance: This study demonstrates a critical role of GAPDH acetylation in tumor growth and provides potential therapy target for cancer. The altered metabolism in most tumor cells consists of elevated glucose uptake and increased glycolysis even in the presence of high oxygen tension. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an obligatory enzyme in glycolysis. Here, we report that acetylation at lysine 254 (K254) increases GAPDH activity in response to glucose. Furthermore, acetylation of GAPDH (K254) is reversibly regulated by the acetyltransferase PCAF and the deacetylase HDAC5. Substitution of K254 to glutamine compromises the ability of GAPDH to support cell proliferation and tumor growth. Our study reveals a mechanism of GAPDH enzyme activity regulation by acetylation and its critical role in cellular regulation.	[Li, Tingting; Liu, Mengxi; Feng, Xu; Wang, Zhen; Xu, Yanping; Zhou, Xin; Sun, Yiping; Lei, Qun-Ying] Fudan Univ, Minist Educ, Key Lab Mol Med, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Li, Tingting; Liu, Mengxi; Feng, Xu; Wang, Zhen; Xu, Yanping; Zhou, Xin; Sun, Yiping; Lei, Qun-Ying] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China; [Li, Tingting; Liu, Mengxi; Feng, Xu; Wang, Zhen; Xu, Yanping; Zhou, Xin; Sun, Yiping; Guan, Kun-Liang; Xiong, Yue; Lei, Qun-Ying] Fudan Univ, Mol & Cell Biol Lab, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Li, Tingting; Liu, Mengxi; Feng, Xu; Wang, Zhen; Xu, Yanping; Zhou, Xin; Xiong, Yue] Fudan Univ, Sch Life Sci, Shanghai 200032, Peoples R China; [Das, Indrani] Harvard Univ, Harvard Coll, Cambridge, MA 02138 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92037 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92037 USA; [Xiong, Yue] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Fudan University; Fudan University; Fudan University; Fudan University; Harvard University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill	Lei, QY (corresponding author), Fudan Univ, Minist Educ, Key Lab Mol Med, Shanghai Med Coll, Shanghai 200032, Peoples R China.	qlei@fudan.edu.cn	Lei, Qun-Ying/J-1390-2017; Zhou, Xin/AAD-6937-2019; Guan, Kun-Liang/ADK-7088-2022; Liu, Mengxi/N-7308-2019	Lei, Qun-Ying/0000-0002-8547-8518; 	ABC 973 [2011CB910600, 2009CB918401]; NSFC [31071192, 81225016, 31271454]; Shanghai Key Basic Research Program [12JC1401100]; "100 Talents" Program of Shanghai Health [XBR2011041]; Shanghai Education Commission; Shanghai Outstanding Academic Leader [13XD1400600]; 985 Program, the Shanghai Leading Academic Discipline Project [B110]	ABC 973; NSFC(National Natural Science Foundation of China (NSFC)); Shanghai Key Basic Research Program; "100 Talents" Program of Shanghai Health; Shanghai Education Commission; Shanghai Outstanding Academic Leader; 985 Program, the Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by 973 (Grant 2011CB910600, 2009CB918401), NSFC (Grant 31071192, 81225016, 31271454), Shanghai Key Basic Research Program (12JC1401100), "100 Talents" Program of Shanghai Health (Grant XBR2011041), Scholar of "Dawn" Program of Shanghai Education Commission, and Shanghai Outstanding Academic Leader (Grant No. 13XD1400600) (to Q. Y. L.). This work was also supported by the 985 Program, the Shanghai Leading Academic Discipline Project (Project Number B110).	ALEXANDERBRIDGES M, 1992, ADV ENZYME REGUL, V32, P149; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Detterbeck FC, 2004, CHEST, V126, P1656, DOI 10.1378/chest.126.5.1656; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Huang QJ, 2011, J BIOL CHEM, V286, P42211, DOI 10.1074/jbc.M111.296905; Ishitani R, 1996, P NATL ACAD SCI USA, V93, P9937, DOI 10.1073/pnas.93.18.9937; Joo HY, 2012, BIOCHEM BIOPH RES CO, V424, P681, DOI 10.1016/j.bbrc.2012.07.006; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lu HZ, 2002, MOL THER, V6, P783, DOI 10.1006/mthe.2002.0813; Mankoff DA, 2007, CLIN CANCER RES, V13, P3460, DOI 10.1158/1078-0432.CCR-07-0074; MEYERSIEGLER K, 1992, CARCINOGENESIS, V13, P2127, DOI 10.1093/carcin/13.11.2127; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Nakagawa T, 2003, J BIOL CHEM, V278, P20395, DOI 10.1074/jbc.M210824200; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nicholls C, 2012, P NATL ACAD SCI USA, V109, P13308, DOI 10.1073/pnas.1206672109; Puzone R, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-97; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; STRAUSS LG, 1991, J NUCL MED, V32, P623; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Ventura M, 2010, INT J BIOCHEM CELL B, V42, P1672, DOI 10.1016/j.biocel.2010.06.014; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	30	61	65	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3775	3785		10.1074/jbc.M113.531640	http://dx.doi.org/10.1074/jbc.M113.531640			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362262	Green Published, hybrid			2022-12-28	WOS:000331368700057
J	Mast, N; Li, Y; Linger, M; Clark, M; Wiseman, J; Pikuleva, IA				Mast, Natalia; Li, Yong; Linger, Marlin; Clark, Matthew; Wiseman, Jeffrey; Pikuleva, Irina A.			Pharmacologic Stimulation of Cytochrome P450 46A1 and Cerebral Cholesterol Turnover in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Brain Metabolism; Cholesterol; Cholesterol Metabolism; Cytochrome P450	X-RECEPTOR; CRYSTAL-STRUCTURES; MASS-SPECTROMETRY; DRUG-INTERACTION; HDL-CHOLESTEROL; BRAIN; 24-HYDROXYLASE; BINDING; METABOLISM; ACTIVATION	Background: Elevation of cerebral cholesterol turnover in mice due to increased CYP46A1 expression has palliative effects on hallmarks of Alzheimer disease. Results: CYP46A1 could also be activated post-translationally by drugs in vitro and in vivo. Conclusion: CYP46A1 is a viable therapeutic target. Significance: Pharmacologic stimulation of CYP46A1 and cerebral cholesterol turnover may lead to new therapeutic strategies for the treatment of brain disorders. Cytochrome P450 46A1 (CYP46A1) is a brain-specific cholesterol 24-hydroxylase responsible for the majority of cholesterol elimination from the brain. Genetically increased CYP46A1 expression in mice leads to improved cognition and decreases manifestations of Alzheimer disease. We found that four pharmaceuticals (efavirenz (EFV), acetaminophen, mirtazapine, and galantamine) prescribed for indications unrelated to cholesterol maintenance increased CYP46A1 activity in vitro. We then evaluated the anti-HIV medication EFV for the mode of interaction with CYP46A1 and the effect on mice. We propose a model for CYP46A1 activation by EFV and show that EFV enhanced CYP46A1 activity and cerebral cholesterol turnover in animals with no effect on the levels of brain cholesterol. The doses of EFV administered to mice and required for the stimulation of their cerebral cholesterol turnover are a hundred times lower than those prescribed to HIV patients. At such small doses, EFV may be devoid of adverse effects elicited by high drug concentrations. CYP46A1 could be a novel therapeutic target and a tool to further investigate the physiological and medical significance of cerebral cholesterol turnover.	[Mast, Natalia; Li, Yong; Linger, Marlin; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Clark, Matthew; Wiseman, Jeffrey] Pharmatrope Ltd, Wayne, PA 19087 USA; [Clark, Matthew] Elsevier Life Sci, Philadelphia, PA 19103 USA; [Wiseman, Jeffrey] Univ Cincinnati, Ctr Drug Discovery, Cincinnati, OH 45219 USA	Case Western Reserve University; Reed Elsevier; Elsevier; University System of Ohio; University of Cincinnati	Pikuleva, IA (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Rm 303,2085 Adelbert Rd, Cleveland, OH 44106 USA.	iap8@case.edu		Pikuleva, Irina/0000-0001-9742-6232; Clark, Matthew/0000-0002-5648-6949; Clark, Matthew/0000-0002-9348-3528	United States Public Health Service Grant [GM62882]; Jules and Doris Stein Professorship from the Research to Prevent Blindness; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Jules and Doris Stein Professorship from the Research to Prevent Blindness; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by United States Public Health Service Grant GM62882 (to I. A. P). Computational predictions were made using Iron software sold commercially by Pharmatrope Ltd., which was founded by Matthew Clark and Jeffrey Wiseman.; Recipient of the Jules and Doris Stein Professorship from the Research to Prevent Blindness. To whom correspondence should be addressed: Dept. of Ophthalmology and Visual Sciences, Rm. 303, Case Western Reserve University, 2085 Adelbert Rd., Cleveland, OH 44106. Tel.: 216-368-3823; Fax: 216-368-3482; E-mail: iap8@case.edu.	Babiker A, 1998, BBA-LIPID LIPID MET, V1392, P333, DOI 10.1016/S0005-2760(98)00047-2; Bachmann K, 2004, PHARMACOL RES, V50, P237, DOI 10.1016/j.phrs.2004.03.005; Bjorkhem I, 2006, J INTERN MED, V260, P493, DOI 10.1111/j.1365-2796.2006.01725.x; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Blum CA, 2011, J MED CHEM, V54, P417, DOI 10.1021/jm100861p; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Cao GQ, 2004, DRUG NEWS PERSPECT, V17, P35, DOI 10.1358/dnp.2004.17.1.829024; Clark M, 2009, J CHEM INF MODEL, V49, P1901, DOI 10.1021/ci900132r; DAWSON JH, 1982, J BIOL CHEM, V257, P3606; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Faucette SR, 2007, J PHARMACOL EXP THER, V320, P72, DOI 10.1124/jpet.106.112136; GIGON PL, 1968, BIOCHEM BIOPH RES CO, V31, P558, DOI 10.1016/0006-291X(68)90514-7; Gotti D, 2012, HIV CLIN TRIALS, V13, P245, DOI 10.1310/hct1305-245; Haberle Johannes, 2011, Ther Clin Risk Manag, V7, P327, DOI 10.2147/TCRM.S12703; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Liao WL, 2011, J PROTEOME RES, V10, P241, DOI 10.1021/pr1008898; LUND E, 1989, SCAND J CLIN LAB INV, V49, P165, DOI 10.3109/00365518909105417; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Maioli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068534; Mast N, 2004, ARCH BIOCHEM BIOPHYS, V428, P99, DOI 10.1016/j.abb.2004.05.012; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Mast N, 2013, MOL PHARMACOL, V84, P86, DOI 10.1124/mol.113.085902; Mast N, 2013, J BIOL CHEM, V288, P4613, DOI 10.1074/jbc.M112.438754; Mast N, 2012, MOL PHARMACOL, V82, P824, DOI 10.1124/mol.112.080424; Mast N, 2011, INVEST OPHTH VIS SCI, V52, P594, DOI 10.1167/iovs.10-6021; Mast N, 2010, J BIOL CHEM, V285, P31783, DOI 10.1074/jbc.M110.143313; Mast N, 2010, BBA-MOL CELL BIOL L, V1801, P674, DOI 10.1016/j.bbalip.2010.03.005; Mast N, 2009, ARCH BIOCHEM BIOPHYS, V483, P81, DOI 10.1016/j.abb.2009.01.002; Matschinsky FM, 2011, HANDB EXP PHARMACOL, V203, P357, DOI 10.1007/978-3-642-17214-4_15; Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200; Ohyama Y, 2006, J BIOL CHEM, V281, P3810, DOI 10.1074/jbc.M505179200; POULOS TL, 1987, BIOCHEMISTRY-US, V26, P8165, DOI 10.1021/bi00399a022; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; REMMER H, 1966, MOL PHARMACOL, V2, P187; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Schenkman John B, 2006, Methods Mol Biol, V320, P11; Shafaati M, 2011, J INTERN MED, V270, P377, DOI 10.1111/j.1365-2796.2011.02389.x; Tohyama J, 2009, ATHEROSCLEROSIS, V204, P418, DOI 10.1016/j.atherosclerosis.2008.09.016; Treisman GJ, 2002, AIDS, V16, P1201, DOI 10.1097/00002030-200206140-00002; Vanmierlo T, 2011, NEUROBIOL AGING, V32, P1262, DOI 10.1016/j.neurobiolaging.2009.07.005; Vanmierlo T, 2010, J ALZHEIMERS DIS, V19, P117, DOI 10.3233/JAD-2010-1209; Wang MY, 2012, ANAL CHEM, V84, P5186, DOI 10.1021/ac300587v; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; White MA, 2008, ACTA CRYSTALLOGR D, V64, P487, DOI 10.1107/S0907444908004046	50	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3529	3538		10.1074/jbc.M113.532846	http://dx.doi.org/10.1074/jbc.M113.532846			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24352658	Green Published, hybrid			2022-12-28	WOS:000331368700037
J	Matsui, T; Han, XR; Yu, J; Yao, M; Tanaka, I				Matsui, Takashi; Han, Xuerong; Yu, Jian; Yao, Min; Tanaka, Isao			Structural Change in FtsZ Induced by Intermolecular Interactions between Bound GTP and the T7 Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Cell Division; Crystal Structure; Cytoskeleton; GTPase; FtsZ; Molecular Switch; Self-assembly	DIVISION PROTEIN FTSZ; MYCOBACTERIUM-TUBERCULOSIS; INHIBITOR PC190723; TUBULIN; FLEXIBILITY; HYDROLYSIS; PROTOFILAMENTS; CONFORMATIONS; ENERGETICS; MECHANISM	Background:SaFtsZ crystallizes in the form of assembled straight protofilaments, with large scale sliding/rotation of its subdomains relative to monomeric FtsZ. Results: Mutants of the T7 loop also crystallized as protofilaments, but the subdomain movement was quite variable. Conclusion: Subdomain movement is strongly correlated with intermolecular interactions via the T7 loop. Significance: Subdomain movement generates GTPase active protofilament and induces the straight to curved conformational change. FtsZ is a prokaryotic homolog of tubulin and is a key molecule in bacterial cell division. FtsZ with bound GTP polymerizes into tubulin-like protofilaments. Upon polymerization, the T7 loop of one subunit is inserted into the nucleotide-binding pocket of the second subunit, which results in GTP hydrolysis. Thus, the T7 loop is important for both polymerization and hydrolysis in the tubulin/FtsZ family. Although x-ray crystallography revealed both straight and curved conformations of tubulin, only a curved structure was known for FtsZ. Recently, however, FtsZ from Staphylococcus aureus has been shown to have a very different conformation from the canonical FtsZ structure. The present study was performed to investigate the structure of FtsZ from Staphylococcus aureus by mutagenesis experiments; the effects of amino acid changes in the T7 loop on the structure as well as on GTPase activity were studied. These analyses indicated that FtsZ changes its conformation suitable for polymerization and GTP hydrolysis by movement between N- and C-subdomains via intermolecular interactions between bound nucleotide and residues in the T7 loop.	[Matsui, Takashi; Han, Xuerong; Yu, Jian; Yao, Min; Tanaka, Isao] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan; [Matsui, Takashi] Toyama Univ, Inst Nat Med, Toyama 9300194, Japan	Hokkaido University; University of Toyama	Tanaka, I (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Kita 10,Nishi 8, Sapporo, Hokkaido 0600810, Japan.	tanaka@castor.sci.hokudai.ac.jp	yao, min/F-5287-2011; Yu, Jian/R-9906-2017	yao, min/0000-0003-1687-5904; Matsui, Takashi/0000-0002-4496-2389	Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science (JSPS) [24770088]	Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Young Scientists (B) 24770088.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreu JM, 2010, J BIOL CHEM, V285, P14239, DOI 10.1074/jbc.M109.094722; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; Chen YD, 2011, BIOCHEMISTRY-US, V50, P4675, DOI 10.1021/bi200106d; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; DeLano W, 2002, PYMOL 0 99; Elsen NL, 2012, J AM CHEM SOC, V134, P12342, DOI 10.1021/ja303564a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hsin J, 2012, P NATL ACAD SCI USA, V109, P9432, DOI 10.1073/pnas.1120761109; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leung AKW, 2004, J MOL BIOL, V342, P953, DOI 10.1016/j.jmb.2004.07.061; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Li Y, 2013, SCIENCE, V341, P392, DOI 10.1126/science.1239248; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Martin-Galiano AJ, 2010, J BIOL CHEM, V285, P22554, DOI 10.1074/jbc.M110.117127; Matsui T, 2012, ACTA CRYSTALLOGR D, V68, P1175, DOI 10.1107/S0907444912022640; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Natarajan K, 2013, BIOCHEMISTRY-US, V52, P3543, DOI 10.1021/bi400170f; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pecqueur L, 2012, P NATL ACAD SCI USA, V109, P12011, DOI 10.1073/pnas.1204129109; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Raymond A, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-37; Respicio L, 2008, TUBERCULOSIS, V88, P420, DOI 10.1016/j.tube.2008.03.001; Scheffers DJ, 2002, BIOCHEMISTRY-US, V41, P521, DOI 10.1021/bi011370i; Tan CM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003592; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	44	42	45	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3501	3509		10.1074/jbc.M113.514901	http://dx.doi.org/10.1074/jbc.M113.514901			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24347164	Green Published, hybrid			2022-12-28	WOS:000331368700034
J	Branagan, AM; Klein, JA; Jordan, CS; Morrical, SW				Branagan, Amy M.; Klein, Jenny A.; Jordan, Christian S.; Morrical, Scott W.			Control of Helicase Loading in the Coupled DNA Replication and Recombination Systems of Bacteriophage T4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; DNA Helicase; DNA Repair; DNA Replication; Homologous Recombination; D-loop; Mediator; Origin; R-loop; ssDNA-binding Protein	PROTEIN-PROTEIN INTERACTIONS; GENE 59 PROTEIN; BINDING-PROTEIN; T4 HELICASE; DEPENDENT REPLICATION; MEDIATOR PROTEINS; GENOME STABILITY; POLYMERASE GP43; FORK DNA; GP59	Background: Helicase loading protein Gp59 coordinates recombination-dependent DNA replication in bacteriophage T4. Results: A DNA binding-deficient mutant, Gp59-I87A, loads helicase normally onto ssDNA covered with the ssDNA-binding protein, Gp32. Conclusion: Gp59-Gp32 interactions control helicase loading onto D-loops during recombination-dependent replication. Significance: Helicase loading proteins work in concert with single-stranded DNA binding proteins to control the location and timing of helicase assembly in DNA replication, recombination, and repair. The Gp59 protein of bacteriophage T4 promotes DNA replication by loading the replicative helicase, Gp41, onto replication forks and recombination intermediates. Gp59 also blocks DNA synthesis by Gp43 polymerase until Gp41 is loaded, ensuring that synthesis is tightly coupled to unwinding. The distinct polymerase blocking and helicase loading activities of Gp59 likely involve different binding interactions with DNA and protein partners. Here, we investigate how interactions of Gp59 with DNA and Gp32, the T4 single-stranded DNA (ssDNA)-binding protein, are related to these activities. A previously characterized mutant, Gp59-I87A, exhibits markedly reduced affinity for ssDNA and pseudo-fork DNA substrates. We demonstrate that on Gp32-covered ssDNA, the DNA binding defect of Gp59-I87A is not detrimental to helicase loading and translocation. In contrast, on pseudo-fork DNA the I87A mutation is detrimental to helicase loading and unwinding in the presence or absence of Gp32. Other results indicate that Gp32 binding to lagging strand ssDNA relieves the blockage of Gp43 polymerase activity by Gp59, whereas the inhibition of Gp43 exonuclease activity is maintained. Our findings suggest that Gp59-Gp32 and Gp59-DNA interactions perform separate but complementary roles in T4 DNA metabolism; Gp59-Gp32 interactions are needed to load Gp41 onto D-loops, and other nucleoprotein structures containing clusters of Gp32. Gp59-DNA interactions are needed to load Gp41 onto nascent or collapsed replication forks lacking clusters of Gp32 and to coordinate bidirectional replication from T4 origins. The dual functionalities of Gp59 allow it to promote the initiation or re-start of DNA replication from a wide variety of recombination and replication intermediates.	[Branagan, Amy M.; Klein, Jenny A.; Jordan, Christian S.; Morrical, Scott W.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont	Morrical, SW (corresponding author), Univ Vermont, Coll Med, Dept Biochem, 89 Beaumont Ave, Burlington, VT 05405 USA.	smorrica@uvm.edu			National Institutes of Health [R01GM48847, T32ES07122]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM48847 (to S. W. M.).; Supported by National Institutes of Health Training Grant T32ES07122.	BARRY J, 1994, J BIOL CHEM, V269, P33049; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Bleuit JS, 2001, P NATL ACAD SCI USA, V98, P8298, DOI 10.1073/pnas.131007498; Branagan AM, 2012, J BIOL CHEM, V287, P19070, DOI 10.1074/jbc.M112.343830; Dudas KC, 2005, J BIOL CHEM, V280, P21561, DOI 10.1074/jbc.m502351200; Hardman CH, 1995, BIOCHEMISTRY-US, V34, P16596, DOI 10.1021/bi00051a007; Hinerman JM, 2012, J BIOL CHEM, V287, P18608, DOI 10.1074/jbc.M111.333476; Ishmael FT, 2003, J BIOL CHEM, V278, P3145, DOI 10.1074/jbc.M209858200; Ishmael FT, 2002, J BIOL CHEM, V277, P20555, DOI 10.1074/jbc.M111951200; Ishmael FT, 2001, J BIOL CHEM, V276, P25236, DOI 10.1074/jbc.M100783200; Jing DH, 1999, J BIOL CHEM, V274, P27287, DOI 10.1074/jbc.274.38.27287; Jones CE, 2004, J BIOL CHEM, V279, P25721, DOI 10.1074/jbc.M402128200; Jones CE, 2004, J BIOL CHEM, V279, P12067, DOI 10.1074/jbc.M313840200; Jones CE, 2001, P NATL ACAD SCI USA, V98, P8312, DOI 10.1073/pnas.121009398; Jones CE, 2000, J BIOL CHEM, V275, P27145; Jones JM, 2000, MOL MICROBIOL, V36, P519, DOI 10.1046/j.1365-2958.2000.01888.x; Kawakami H, 2010, BIOCHEM CELL BIOL, V88, P49, DOI [10.1139/o09-154, 10.1139/O09-154]; KODADEK T, 1990, J BIOL CHEM, V265, P20966; KOWALCZYKOWSKI SC, 1980, BIOPHYS J, V32, P403, DOI 10.1016/S0006-3495(80)84964-2; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; Lefebvre SD, 1999, J BIOL CHEM, V274, P22830, DOI 10.1074/jbc.274.32.22830; Liu J, 1999, J BIOL CHEM, V274, P25033, DOI 10.1074/jbc.274.35.25033; Liu J, 2006, J BIOL CHEM, V281, P26308, DOI 10.1074/jbc.M604349200; Liu J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-357; Ma YJ, 2004, J BIOL CHEM, V279, P19035, DOI 10.1074/jbc.M311738200; Maher RL, 2011, J CELL BIOCHEM, V112, P2672, DOI 10.1002/jcb.23211; MORRICAL SW, 1994, J BIOL CHEM, V269, P33069; Morrical SW, 1996, J BIOL CHEM, V271, P20198, DOI 10.1074/jbc.271.33.20198; Mueser TC, 2000, J MOL BIOL, V296, P597, DOI 10.1006/jmbi.1999.3438; Nelson SW, 2006, J BIOL CHEM, V281, P8697, DOI 10.1074/jbc.M512185200; PARSONS CA, 1992, P NATL ACAD SCI USA, V89, P5452, DOI 10.1073/pnas.89.12.5452; Reha-Krantz LJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1049, DOI 10.1016/j.bbapap.2009.06.012; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; Xi J, 2005, BIOCHEMISTRY-US, V44, P7747, DOI 10.1021/bi047296w; Xi J, 2005, BIOCHEMISTRY-US, V44, P2305, DOI 10.1021/bi0479508	37	3	3	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					3040	3054		10.1074/jbc.M113.505842	http://dx.doi.org/10.1074/jbc.M113.505842			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338568	Green Published, hybrid			2022-12-28	WOS:000333403000050
J	Okuda, H; Tatsumi, K; Morita, S; Shibukawa, Y; Korekane, H; Horii-Hayashi, N; Wada, Y; Taniguchi, N; Wanaka, A				Okuda, Hiroaki; Tatsumi, Kouko; Morita, Shoko; Shibukawa, Yukinao; Korekane, Hiroaki; Horii-Hayashi, Noriko; Wada, Yoshinao; Taniguchi, Naoyuki; Wanaka, Akio			Chondroitin Sulfate Proteoglycan Tenascin-R Regulates Glutamate Uptake by Adult Brain Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Astrocytes; Chondroitin Sulfate; Extracellular Matrix; Glutamate; Tenascin	EXTRACELLULAR-MATRIX; PERINEURONAL NETS; MICE DEFICIENT; RAT HIPPOCAMPUS; VISUAL-CORTEX; UP-REGULATION; D-SERINE; EXPRESSION; NEURONS; PLASTICITY	Background: CS-56 immunoreactivity reveals a subpopulation of astrocytes in the adult mouse cerebral cortex. Results: TNR mRNA was detected in CS-56-positive astrocytes, and TNR regulates astrocytic GLAST expression. Conclusion: TNR-expressing cells are a subpopulation of astrocytes and regulate extracellular glutamate homeostasis. Significance: Astrocytes in the adult mouse cerebral cortex exhibit a molecular and functional heterogeneity that could become future therapeutic targets in brain injury. In our previous study, the CS-56 antibody, which recognizes a chondroitin sulfate moiety, labeled a subset of adult brain astrocytes, yielding a patchy extracellular matrix pattern. To explore the molecular nature of CS-56-labeled glycoproteins, we purified glycoproteins of the adult mouse cerebral cortex using a combination of anion-exchange, charge-transfer, and size-exclusion chromatographies. One of the purified proteins was identified as tenascin-R (TNR) by mass spectrometric analysis. When we compared TNR mRNA expression patterns with the distribution patterns of CS-56-positive cells, TNR mRNA was detected in CS-56-positive astrocytes. To examine the functions of TNR in astrocytes, we first confirmed that cultured astrocytes also expressed TNR protein. TNR knockdown by siRNA expression significantly reduced glutamate uptake in cultured astrocytes. Furthermore, expression of mRNA and protein of excitatory amino acid transporter 1 (GLAST), which is a major component of astrocytic glutamate transporters, was reduced by TNR knockdown. Our results suggest that TNR is expressed in a subset of astrocytes and contributes to glutamate homeostasis by regulating astrocytic GLAST expression.	[Okuda, Hiroaki; Tatsumi, Kouko; Morita, Shoko; Wanaka, Akio] Nara Med Univ, Dept Anat & Neurosci, Kashihara, Nara 6348521, Japan; [Horii-Hayashi, Noriko] Nara Med Univ, Dept Anat & Cell Biol, Kashihara, Nara 6348521, Japan; [Shibukawa, Yukinao; Wada, Yoshinao] Osaka Med Ctr, Dept Mol Med, Izumi, Osaka 5941101, Japan; [Shibukawa, Yukinao; Wada, Yoshinao] Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan; [Korekane, Hiroaki; Taniguchi, Naoyuki] RIKEN, Syst Glycobiol Res Grp, Global Res Cluster, Wako, Saitama 3510198, Japan; [Korekane, Hiroaki; Taniguchi, Naoyuki] RIKEN Max Planck Joint Res Ctr, Wako, Saitama 3510198, Japan	Nara Medical University; Nara Medical University; Osaka Medical Center for Cancer & Cardiovascular Diseases; RIKEN; RIKEN	Okuda, H (corresponding author), Nara Med Univ, Fac Med, Dept Anat & Neurosci, Kashihara, Nara 6348521, Japan.	okuda@naramed-u.ac.jp	Taniguchi, Naoyuki/I-4182-2014; Wanaka, Akio/ABE-4671-2020; Wanaka, Akio/GPW-8926-2022; Taniguchi, Naoyuki/A-7086-2016; Okuda, Hiroaki/S-4959-2019; Wanaka, Akio/AAC-9754-2019; Okuda, Hiroaki/E-9418-2018	Taniguchi, Naoyuki/0000-0001-5889-5968; Okuda, Hiroaki/0000-0002-6252-9634; Wanaka, Akio/0000-0001-9951-9862; Okuda, Hiroaki/0000-0002-6252-9634; Takemura, Shoko/0000-0003-1872-4050	Japan Society for the Promotion of Science KAKENHI [24592141]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 24592141.	Abe K, 2000, BIOL PHARM BULL, V23, P204; Anderson CM, 2000, GLIA, V32, P1; Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; ASPBERG A, 1995, P NATL ACAD SCI USA, V92, P10590, DOI 10.1073/pnas.92.23.10590; Aspberg A, 1997, P NATL ACAD SCI USA, V94, P10116, DOI 10.1073/pnas.94.19.10116; Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Bezzi P, 1999, ADV EXP MED BIOL, V468, P69; Brenneke F, 2004, EPILEPSY RES, V58, P133, DOI 10.1016/j.eplepsyres.2004.01.005; Brenneke F, 2004, NEUROSCIENCE, V124, P841, DOI 10.1016/j.neuroscience.2003.11.037; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; Bruckner G, 2006, NEUROSCIENCE, V138, P365, DOI 10.1016/j.neuroscience.2005.11.068; Bruckner G, 2003, J CHEM NEUROANAT, V26, P37, DOI 10.1016/S0891-0618(03)00036-X; Bukalo O, 2001, NEUROSCIENCE, V104, P359, DOI 10.1016/S0306-4522(01)00082-3; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Carulli D, 2007, J COMP NEUROL, V501, P83, DOI 10.1002/cne.21231; CHIQUETEHRISMANN R, 1995, EXPERIENTIA, V51, P853, DOI 10.1007/BF01921736; CHIQUETEHRISMANN R, 1994, PERSPECT DEV NEUROBI, V2, P3; Coulter DA, 2012, GLIA, V60, P1215, DOI 10.1002/glia.22341; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Figiel M, 2003, EXP NEUROL, V183, P124, DOI 10.1016/S0014-4886(03)00134-1; Furuta A, 1997, J NEUROSCI, V17, P8363; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gurevicius K, 2004, MOL CELL NEUROSCI, V25, P515, DOI 10.1016/j.mcn.2003.12.001; Gutowski NJ, 1999, NEUROPATH APPL NEURO, V25, P207; Hagihara K, 1999, J COMP NEUROL, V410, P256; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Haunso A, 2000, BRAIN RES, V864, P142, DOI 10.1016/S0006-8993(00)02173-9; Hayashi N, 2007, BIOCHEM BIOPH RES CO, V364, P410, DOI 10.1016/j.bbrc.2007.10.040; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Horii-Hayashi N, 2010, NEUROSCI LETT, V483, P67, DOI 10.1016/j.neulet.2010.07.064; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Karus M, 2011, DEVELOPMENT, V138, P5321, DOI 10.1242/dev.067413; Kugler P, 2004, HIPPOCAMPUS, V14, P975, DOI 10.1002/hipo.20015; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Lander C, 1997, J NEUROSCI, V17, P1928; Liu YP, 2008, J NEUROCHEM, V105, P137, DOI 10.1111/j.1471-4159.2007.05118.x; Morellini F, 2010, CEREB CORTEX, V20, P2712, DOI 10.1093/cercor/bhq017; Nowicka D, 2009, EUR J NEUROSCI, V30, P2053, DOI 10.1111/j.1460-9568.2009.06996.x; Okuda H, 2007, FEBS LETT, V581, P4754, DOI 10.1016/j.febslet.2007.08.075; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Probstmeier R, 2000, BRAIN RES, V863, P42, DOI 10.1016/S0006-8993(00)02075-8; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Schlag BD, 1998, MOL PHARMACOL, V53, P355, DOI 10.1124/mol.53.3.355; Schousboe A, 2003, NEUROCHEM RES, V28, P347, DOI 10.1023/A:1022397704922; Swanson RA, 1997, J NEUROSCI, V17, P932; Verkhratsky A, 2007, J ANAT, V210, P651, DOI 10.1111/j.1469-7580.2007.00734.x; Viggiano D, 2000, NEUROREPORT, V11, P2087, DOI 10.1097/00001756-200007140-00006; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4; Weber P, 1999, J NEUROSCI, V19, P4245, DOI 10.1523/jneurosci.19-11-04245.1999; Wilson MT, 2000, J COMP NEUROL, V424, P532, DOI 10.1002/1096-9861(20000828)424:3<532::AID-CNE10>3.0.CO;2-Z; Wintergerst ES, 1996, NEUROSCI LETT, V209, P173, DOI 10.1016/0304-3940(96)12643-4; Wintergerst ES, 2001, J NEUROCYTOL, V30, P293, DOI 10.1023/A:1014452212067; Woodworth A, 2004, J BIOL CHEM, V279, P10413, DOI 10.1074/jbc.M312466200; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Xiao ZC, 1997, J BIOL CHEM, V272, P32092, DOI 10.1074/jbc.272.51.32092; Yamamoto A, 2007, DNA REPAIR, V6, P649, DOI 10.1016/j.dnarep.2006.12.006; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhuang ZY, 2010, J NEUROSCI, V30, P16015, DOI 10.1523/JNEUROSCI.0481-10.2010	58	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2620	2631		10.1074/jbc.M113.504787	http://dx.doi.org/10.1074/jbc.M113.504787			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24337573	hybrid, Green Published			2022-12-28	WOS:000333403000013
J	Oshiro, N; Rapley, J; Avruch, J				Oshiro, Noriko; Rapley, Joseph; Avruch, Joseph			Amino Acids Activate Mammalian Target of Rapamycin (mTOR) Complex 1 without Changing Rag GTPase Guanyl Nucleotide Charging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; GTPase; Insulin; Lysosomes; mTOR Complex (mTORC); Rag GTPase; Amino Acids; Raptor	TSC1-TSC2 COMPLEX; CELL-GROWTH; CRYSTAL-STRUCTURE; TUMOR-SUPPRESSOR; G-PROTEINS; RHEB; BINDING; SUFFICIENCY; PATHWAY; RAPTOR	Background: Signaling by mTOR complex 1 requires its amino acid-stimulated binding to Rag GTPase heterodimers. Results: mTOR complex 1-Rag binding in vitro is independent of Rag guanyl nucleotide charging, and withdrawal of amino acids from cells does not alter Rag GTP charging. Conclusion: Amino acids promote Rag binding to mTOR complex 1 without changing Rag GTP charging. Significance: Amino acids promote Rag-mTORC1 binding by undefined mechanisms. Activation of mammalian target of rapamycin complex 1 (mTORC1) by amino acids is mediated in part by the Rag GTPases, which bind the raptor subunit of mTORC1 in an amino acid-stimulated manner and promote mTORC1 interaction with Rheb-GTP, the immediate activator. Here we examine whether the ability of amino acids to regulate mTORC1 binding to Rag and mTORC1 activation is due to the regulation of Rag guanyl nucleotide charging. Rag heterodimers in vitro exhibit a very rapid, spontaneous exchange of guanyl nucleotides and an inability to hydrolyze GTP. Mutation of the Rag P-loop corresponding to Ras(Ser-17) abolishes guanyl nucleotide binding. Such a mutation in RagA or RagB inhibits, whereas in RagC or RagD it enhances, Rag heterodimer binding to mTORC1. The binding of wild-type and mutant Rag heterodimers to mTORC1 in vitro parallels that seen with transient expression, but binding to mTORC1 in vitro is entirely independent of Rag guanyl nucleotide charging. HeLa cells stably overexpressing wild-type or P-loop mutant RagC exhibit unaltered amino acid regulation of mTORC1. Despite amino acid-independent raptor binding to Rag, mTORC1 is inhibited by amino acid withdrawal as in parental cells. Rag heterodimers extracted from P-32-labeled whole cells, or just from the pool associated with the lysosomal membrane, exhibit constitutive [P-32]GTP charging that is unaltered by amino acid withdrawal. Thus, amino acids promote mTORC1 activation without altering Rag GTP charging. Raptor binding to Rag, although necessary, is not sufficient for mTORC1 activation. Additional amino acid-dependent steps couple Rag-mTORC1 to Rheb-GTP.	[Avruch, Joseph] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Med Serv, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Avruch, J (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Simches Res Bldg 6408,185 Cambridge St, Boston, MA 02114 USA.	avruch@molbio.mgh.harvard.edu			National Institutes of Health [R01CA73818, R37DK17776, P30DK057521]; NATIONAL CANCER INSTITUTE [R01CA073818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK017776, P30DK057521, P30DK040561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA73818, R37DK17776, and P30DK057521.	Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Boulter E, 2012, FASEB J, V26, P469, DOI 10.1096/fj.11-192252; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Foster R, 1996, MOL CELL BIOL, V16, P2689; Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011; Guillaumot P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010977; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hanker AB, 2010, ONCOGENE, V29, P380, DOI 10.1038/onc.2009.336; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Jeong JH, 2012, J BIOL CHEM, V287, P29648, DOI 10.1074/jbc.C112.384420; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Melser S, 2013, CELL METAB, V17, P719, DOI 10.1016/j.cmet.2013.03.014; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Nakashima A, 2007, BIOCHEM BIOPH RES CO, V361, P218, DOI 10.1016/j.bbrc.2007.07.011; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Wittinghofer A, 1996, TRENDS BIOCHEM SCI, V21, P488, DOI 10.1016/S0968-0004(96)10064-5; Zhang JW, 2013, NAT CELL BIOL, V15, P1186, DOI 10.1038/ncb2822; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	40	42	43	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2658	2674		10.1074/jbc.M113.528505	http://dx.doi.org/10.1074/jbc.M113.528505			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24337580	hybrid, Green Published			2022-12-28	WOS:000333403000017
J	McFarlane, MR; Liang, GS; Engelking, LJ				McFarlane, Matthew R.; Liang, Guosheng; Engelking, Luke J.			Insig Proteins Mediate Feedback Inhibition of Cholesterol Synthesis in the Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol Regulation; Dyslipidemia; Gene Knockout; Intestine; Lipid Absorption; Lipid Synthesis; Ezetimibe; HMG-CoA Reductase; Insig; SREBP	ELEMENT-BINDING PROTEIN-1C; FATTY-ACID SYNTHESIS; HMG COA REDUCTASE; PLASMA-CHOLESTEROL; LIPID-SYNTHESIS; LXR-ALPHA; MICE; LIVER; GENE; SREBP	Enterocytes are the only cell type that must balance the de novo synthesis and absorption of cholesterol, although the coordinate regulation of these processes is not well understood. Our previous studies demonstrated that enterocytes respond to the pharmacological blockade of cholesterol absorption by ramping up de novo sterol synthesis through activation of sterol regulatory element-binding protein-2 (SREBP-2). Here, we genetically disrupt both Insig1 and Insig2 in the intestine, two closely related proteins that are required for the feedback inhibition of SREBP and HMG-CoA reductase (HMGR). This double knock-out was achieved by generating mice with an intestine-specific deletion of Insig1 using Villin-Cre in combination with a germ line deletion of Insig2. Deficiency of both Insigs in enterocytes resulted in constitutive activation of SREBP and HMGR, leading to an 11-fold increase in sterol synthesis in the small intestine and producing lipidosis of the intestinal crypts. The intestine-derived cholesterol accumulated in plasma and liver, leading to secondary feedback inhibition of hepatic SREBP2 activity. Pharmacological blockade of cholesterol absorption was unable to further induce the already elevated activities of SREBP-2 or HMGR in Insig-deficient enterocytes. These studies confirm the essential role of Insig proteins in the sterol homeostasis of enterocytes.	[McFarlane, Matthew R.; Liang, Guosheng; Engelking, Luke J.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Engelking, Luke J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Engelking, LJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	luke.engelking@utsouthwestern.edu		McFarlane, Matthew/0000-0001-8690-5633; Engelking, Luke/0000-0002-1355-4964	National Institutes of Health [HL-20948, 2T32-DK-007745-16]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-20948.; Supported by National Institutes of Health Institutional Training Grant 2T32-DK-007745-16. To whom correspondence should be addressed: Dept. of Molecular Genetics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9046. Tel.: 214-648-3821; Fax: 214-648-8804; E-mail: luke.engelking@utsouthwestern.edu.	Braunstein EM, 2002, DEV DYNAM, V224, P90, DOI 10.1002/dvdy.10091; Chen GW, 2004, CHEM ENG J, V101, P101, DOI 10.1016/j.cej.2004.01.020; Churukian CJ, 1999, J HISTOTECHNOL, V22, P309; DIETSCHY JM, 1971, J CLIN INVEST, V50, P872, DOI 10.1172/JCI106559; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Engelking LJ, 2006, J CLIN INVEST, V116, P2356, DOI 10.1172/JCI28988; Engelking LJ, 2012, J LIPID RES, V53, P1359, DOI 10.1194/jlr.M027599; FEINGOLD KR, 1989, DIABETES, V38, P141, DOI 10.2337/diabetes.38.2.141; FEINGOLD KR, 1985, METABOLISM, V34, P1105, DOI 10.1016/0026-0495(85)90154-4; FEINGOLD KR, 1984, DIABETOLOGIA, V26, P234; Horton JD, 1999, J CLIN INVEST, V103, P1067, DOI 10.1172/JCI6246; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Repa JJ, 2005, J LIPID RES, V46, P779, DOI 10.1194/jlr.M400475-JLR200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwarz M, 1998, J LIPID RES, V39, P1833; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimomura I, 1997, P NATL ACAD SCI USA, V94, P12354, DOI 10.1073/pnas.94.23.12354; SPADY DK, 1983, J LIPID RES, V24, P303; STANGE EF, 1983, P NATL ACAD SCI-BIOL, V80, P5739, DOI 10.1073/pnas.80.18.5739; STANGE EF, 1983, J LIPID RES, V24, P72; Temel RE, 2012, CURR OPIN LIPIDOL, V23, P85, DOI 10.1097/MOL.0b013e3283508c21; Turley SD, 2010, AM J PHYSIOL-GASTR L, V299, pG1012, DOI 10.1152/ajpgi.00190.2010; van der Veen JN, 2009, J BIOL CHEM, V284, P19211, DOI 10.1074/jbc.M109.014860; van der Velde AE, 2010, CURR OPIN LIPIDOL, V21, P167, DOI 10.1097/MOL.0b013e3283395e45; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang DQH, 2007, ANNU REV PHYSIOL, V69, P221, DOI 10.1146/annurev.physiol.69.031905.160725; Xie CL, 2009, J LIPID RES, V50, P1316, DOI 10.1194/jlr.M900024-JLR200; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Ye J., 2011, COLD SPRING HARB PER, V3	47	27	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2148	2156		10.1074/jbc.M113.524041	http://dx.doi.org/10.1074/jbc.M113.524041			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24337570	Green Published, hybrid			2022-12-28	WOS:000331130200023
J	Esquivies, L; Blackler, A; Peran, M; Rodriguez-Esteban, C; Izpisua Belmonte, JC; Booker, E; Gray, PC; Ahn, C; Kwiatkowski, W; Choe, S				Esquivies, Luis; Blackler, Alissa; Peran, Macarena; Rodriguez-Esteban, Concepcion; Izpisua Belmonte, Juan Carlos; Booker, Evan; Gray, Peter C.; Ahn, Chihoon; Kwiatkowski, Witek; Choe, Senyon			Designer Nodal/BMP2 Chimeras Mimic Nodal Signaling, Promote Chondrogenesis, and Reveal a BMP2-like Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone Morphogenetic Protein (BMP); Cartilage Biology; Chondrogenesis; Protein Chimeras; Protein Structure; Nodal	STEM-CELLS; ACTIVIN-A; CRIPTO; BONE; DIFFERENTIATION; BETA	Background: Nodal is a TGF- superfamily member that plays important roles in development and diseases but is difficult to produce for biochemical studies. Results: Nodal promotes chondrogenesis, and Nodal/bone morphogenetic protein 2 chimeras function indistinguishably from Nodal but have BMP2-like structure. Conclusion: Nodal/BMP2 chimeras can substitute for Nodal in functional and structural studies. Significance: Nodal/BMP2 chimeras have therapeutic potential. Nodal, a member of the TGF- superfamily, plays an important role in vertebrate and invertebrate early development. The biochemical study of Nodal and its signaling pathway has been a challenge, mainly because of difficulties in producing the protein in sufficient quantities. We have developed a library of stable, chemically refoldable Nodal/BMP2 chimeric ligands (NB2 library). Three chimeras, named NB250, NB260, and NB264, show Nodal-like signaling properties including dependence on the co-receptor Cripto and activation of the Smad2 pathway. NB250, like Nodal, alters heart looping during the establishment of embryonic left-right asymmetry, and both NB250 and NB260, as well as Nodal, induce chondrogenic differentiation of human adipose-derived stem cells. This Nodal-induced differentiation is shown to be more efficient than BPM2-induced differentiation. Interestingly, the crystal structure of NB250 shows a backbone scaffold similar to that of BMP2. Our results show that these chimeric ligands may have therapeutic implications in cartilage injuries.	[Esquivies, Luis; Kwiatkowski, Witek; Choe, Senyon] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; [Blackler, Alissa; Booker, Evan; Gray, Peter C.; Choe, Senyon] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Peran, Macarena; Rodriguez-Esteban, Concepcion; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Peran, Macarena] Univ Jaen, Dept Hlth Sci, Jaen 23071, Spain; [Ahn, Chihoon] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon 350333, South Korea; [Ahn, Chihoon; Choe, Senyon] Gachon Univ Med & Sci, Joint Ctr Biosci, Lee Gil Ya Canc & Diabet Res Inst, Inchon 406840, South Korea	Salk Institute; Salk Institute; Salk Institute; Universidad de Jaen; Gachon University	Choe, S (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	choe@salk.edu	Peran, Macarena/I-5225-2016	Peran, Macarena/0000-0001-7562-2347	Jesse and Caryl Phillips Foundation Graduate Student Endowment; Spanish Ministry of Education (National Human Resources Mobility National Plan I-D+i); Clayton Medical Research Foundation, Inc.; Cancer Center [P30 CA014195-38]; World Class University [R32-10215]; Incheon Free Economy Zone of Korea; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Jesse and Caryl Phillips Foundation Graduate Student Endowment; Spanish Ministry of Education (National Human Resources Mobility National Plan I-D+i); Clayton Medical Research Foundation, Inc.; Cancer Center; World Class University; Incheon Free Economy Zone of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Jesse and Caryl Phillips Foundation Graduate Student Endowment.; Supported first by the Spanish Ministry of Education (National Human Resources Mobility National Plan I-D+i) and continued with a grant from Jaen University.; Supported by the Clayton Medical Research Foundation, Inc. and Cancer Center Core Grant P30 CA014195-38.; Supported by World Class University Program Grant R32-10215 and the Incheon Free Economy Zone of Korea (joint Center for Biosciences).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Allendorph GP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026402; Calvanese L, 2010, BIOPOLYMERS, V93, P1011, DOI 10.1002/bip.21517; Chea HK, 2005, DEV DYNAM, V234, P269, DOI 10.1002/dvdy.20549; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Gawa K, 2006, J IMMUNOL, V177, P6787, DOI 10.4049/jimmunol.177.10.6787; Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052; JIANG TX, 1993, DEV BIOL, V155, P545, DOI 10.1006/dbio.1993.1051; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelber JA, 2008, J BIOL CHEM, V283, P4490, DOI 10.1074/jbc.M704960200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lee JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024381; Merino R, 1999, DEVELOPMENT, V126, P2161; Montero JA, 2008, DEV BIOL, V321, P343, DOI 10.1016/j.ydbio.2008.06.022; Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004; Peran M, 2013, STEM CELL RES, V10, P464, DOI 10.1016/j.scr.2013.02.002; RIVIER C, 1991, ENDOCRINOLOGY, V129, P2463, DOI 10.1210/endo-129-5-2463; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x; SHIOZAKI M, 1992, P NATL ACAD SCI USA, V89, P1553, DOI 10.1073/pnas.89.5.1553; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0	27	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1788	1797		10.1074/jbc.M113.529180	http://dx.doi.org/10.1074/jbc.M113.529180			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24311780	hybrid, Green Published			2022-12-28	WOS:000332401700049
J	Guo, L; Ding, JJ; Guo, R; Hou, YJ; Wang, DC; Huang, L				Guo, Li; Ding, Jingjin; Guo, Rong; Hou, Yanjie; Wang, Da-Cheng; Huang, Li			Biochemical and Structural Insights into RNA Binding by Ssh10b, a Member of the Highly Conserved Sac10b Protein Family in Archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Crystal Structure; RNA-binding Protein; RNA Structure; RNA-Protein Interaction; Sac10b Family; Ssh10b; Sulfolobus shibatae	INITIATION-FACTOR 3; TRANSLATION INITIATION; CHROMATIN PROTEIN; MESSENGER-RNAS; CRYSTAL-STRUCTURE; DNA; ALBA; LEADERLESS; SIR2; S1	Background: Proteins of the Sac10b family are widespread in Archaea. Results: Ssh10b, a member of the Sac10b family from Sulfolobus shibatae, disrupts base pairing in structured RNA through interactions between adjacently bound protein dimers. Conclusion: Binding by Ssh10b destabilizes RNA secondary structure. Significance: Proteins of the Sac10b family may play a role in RNA transactions requiring destabilization of RNA secondary structure. Proteins of the Sac10b family are highly conserved in Archaea. Ssh10b, a member of the Sac10b family from the hyperthermophilic crenarchaeon Sulfolobus shibatae, binds to RNA in vivo. Here we show that binding by Ssh10b destabilizes RNA secondary structure. Structural analysis of Ssh10b in complex with a 25-bp RNA duplex containing local distortions reveals that Ssh10b binds the two RNA strands symmetrically as a tetramer with each dimer bound asymmetrically to a single RNA strand. Amino acid residues involved in double-stranded RNA binding are similar, but non-identical, to those in dsDNA binding. The dimer-dimer interaction mediated by the intermolecular -sheet appears to facilitate the destabilization of base pairing in the secondary structure of RNA. Our results suggest that proteins of the Sac10b family may play important roles in RNA transactions requiring destabilization of RNA secondary structure in Sulfolobus.	[Guo, Li; Guo, Rong; Huang, Li] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China; [Ding, Jingjin; Hou, Yanjie; Wang, Da-Cheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wang, DC (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	dcwang@ibp.ac.cn; huangl@sun.im.ac.cn		Ding, Jingjin/0000-0001-9941-7997	Photon Factory (High Energy Accelerator Research Organization, Tsukuba, Japan) [2011G044]	Photon Factory (High Energy Accelerator Research Organization, Tsukuba, Japan)	We thank the staff at beamline 17A of the Photon Factory (Grant 2011G044, High Energy Accelerator Research Organization, Tsukuba, Japan) for technical assistance during data collection.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aravind L, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r64; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEAR DG, 1976, P NATL ACAD SCI USA, V73, P1824, DOI 10.1073/pnas.73.6.1824; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Benelli D, 2003, MOL MICROBIOL, V50, P635, DOI 10.1046/j.1365-2958.2003.03721.x; Bini E, 2002, RNA, V8, P1129, DOI 10.1017/S1355838202021052; Cui Q, 2003, J BIOL CHEM, V278, P51015, DOI 10.1074/jbc.M308510200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espinoza CA, 2007, RNA, V13, P583, DOI 10.1261/rna.310307; Forterre P, 1999, MOL MICROBIOL, V32, P669, DOI 10.1046/j.1365-2958.1999.01366.x; FORTERRE P, 1995, CR ACAD SCI III-VIE, V318, P415; Gissot M, 2013, J MOL BIOL, V425, P1287, DOI 10.1016/j.jmb.2013.01.039; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; GROTE M, 1986, BIOCHIM BIOPHYS ACTA, V873, P405, DOI 10.1016/0167-4838(86)90090-7; Guo R, 2003, MOL MICROBIOL, V50, P1605, DOI 10.1046/j.1365-2958.2003.03793.x; Heinicke I, 2004, MOL GENET GENOMICS, V272, P76, DOI 10.1007/s00438-004-1033-5; HILBERS CW, 1985, BIOCHIMIE, V67, P685, DOI 10.1016/S0300-9084(85)80156-5; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jelinska C, 2010, BIOCHEM J, V427, P49, DOI 10.1042/BJ20091841; KOLB A, 1977, P NATL ACAD SCI USA, V74, P2379, DOI 10.1073/pnas.74.6.2379; KUCHINO Y, 1989, METHOD ENZYMOL, V180, P154; LANE D, 1992, MICROBIOL REV, V56, P509, DOI 10.1128/MMBR.56.4.509-528.1992; Laurens N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2330; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Liu Y., 2011, PLOS ONE, V6; Liu Y, 2009, J BACTERIOL, V191, P2315, DOI 10.1128/JB.01534-08; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; Mani J, 2011, PLOS ONE, V6; Marsh VL, 2005, J BIOL CHEM, V280, P21122, DOI 10.1074/jbc.M501280200; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Moll I, 2002, MOL MICROBIOL, V44, P1387, DOI 10.1046/j.1365-2958.2002.02971.x; Moll I, 1998, FEBS LETT, V436, P213, DOI 10.1016/S0014-5793(98)01131-4; Petrelli D, 2003, J MOL BIOL, V331, P541, DOI 10.1016/S0022-2836(03)00731-9; Poole AM, 1998, J MOL EVOL, V46, P1, DOI 10.1007/PL00006275; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Russell R, 2008, FRONT BIOSCI-LANDMRK, V13, P1, DOI 10.2741/2557; Schroeder R, 2002, CURR OPIN STRUC BIOL, V12, P296, DOI 10.1016/S0959-440X(02)00325-1; Slupska MM, 2001, J MOL BIOL, V309, P347, DOI 10.1006/jmbi.2001.4669; Tanaka T, 2012, J BIOL CHEM, V287, P10394, DOI 10.1074/jbc.M112.343210; Tedin K, 1997, MOL MICROBIOL, V25, P189, DOI 10.1046/j.1365-2958.1997.4421810.x; Tedin K, 1999, MOL MICROBIOL, V31, P67, DOI 10.1046/j.1365-2958.1999.01147.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijerina P, 2007, NAT PROTOC, V2, P2608, DOI 10.1038/nprot.2007.380; Tolstrup N, 2000, EXTREMOPHILES, V4, P175, DOI 10.1007/s007920070032; TZAREVA NV, 1994, FEBS LETT, V337, P189, DOI 10.1016/0014-5793(94)80271-8; Wang GG, 2003, PROTEIN SCI, V12, P2815, DOI 10.1110/ps.03325103; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; Weeks KM, 1997, CURR OPIN STRUC BIOL, V7, P336, DOI 10.1016/S0959-440X(97)80048-6; Wilce J, 2012, ADV EXP MED BIOL, V747, P91, DOI 10.1007/978-1-4614-3229-6_6; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xue H, 2000, J BACTERIOL, V182, P3929, DOI 10.1128/JB.182.14.3929-3933.2000; Zhao KH, 2003, J BIOL CHEM, V278, P26071, DOI 10.1074/jbc.M303666200	54	16	17	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1478	1490		10.1074/jbc.M113.521351	http://dx.doi.org/10.1074/jbc.M113.521351			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24307170	Green Published, hybrid			2022-12-28	WOS:000332401700024
J	Neacsu, CD; Ko, YP; Tagariello, A; Karlsen, KR; Neiss, WF; Paulsson, M; Wagener, R				Neacsu, Cristian Dan; Ko, Ya-Ping; Tagariello, Andreas; Karlsen, Kristina Rokenes; Neiss, Wolfram Friedrich; Paulsson, Mats; Wagener, Raimund			Matrilin-1 Is Essential for Zebrafish Development by Facilitating Collagen II Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cartilage; Collagen; Extracellular Matrix Proteins; Secretion; Zebrafish; Collagen II; Matrilin-1	EXTRACELLULAR-MATRIX PROTEINS; MICE LACKING; CHONDROCYTE MATURATION; CHONDROITIN SULFATE; AMINO-PROPEPTIDE; SITE-1 PROTEASE; IX COLLAGEN; CARTILAGE; PROCOLLAGEN; EXPRESSION	Background: Matrilin-1 is an abundant cartilage extracellular matrix protein. Results: Morpholino knockdown of matrilin-1 in zebrafish results in growth defects, disturbed craniofacial cartilage formation, and decreased collagen II deposition. Conclusion: Matrilin-1 is indispensible for zebrafish development, presumably by facilitating secretion of collagen II. Significance: These results challenge the concept that matrilins only function as extracellular adaptor proteins. Matrilin-1 is the prototypical member of the matrilin protein family and is highly expressed in cartilage. However, gene targeting of matrilin-1 in mouse did not lead to pronounced phenotypes. Here we used the zebrafish as an alternative model to study matrilin function in vivo. Matrilin-1 displays a multiphasic expression during zebrafish development. In an early phase, with peak expression at about 15 h post-fertilization, matrilin-1 is present throughout the zebrafish embryo with exception of the notochord. Later, when the skeleton develops, matrilin-1 is expressed mainly in cartilage. Morpholino knockdown of matrilin-1 results both in overall growth defects and in disturbances in the formation of the craniofacial cartilage, most prominently loss of collagen II deposition. In fish with mild phenotypes, certain cartilage extracellular matrix components were present, but the tissue did not show features characteristic for cartilage. The cells showed endoplasmic reticulum aberrations but no activation of XBP-1, a marker for endoplasmic reticulum stress. In severe phenotypes nearly all chondrocytes died. During the early expression phase the matrilin-1 knockdown had no effects on cell morphology, but increased cell death was observed. In addition, the broad deposition of collagen II was largely abolished. Interestingly, the early phenotype could be rescued by the co-injection of mRNA coding for the von Willebrand factor C domain of collagen II1a, indicating that the functional loss of this domain occurs as a consequence of matrilin-1 deficiency. The results show that matrilin-1 is indispensible for zebrafish cartilage formation and plays a role in the early collagen II-dependent developmental events.	[Neacsu, Cristian Dan; Ko, Ya-Ping; Paulsson, Mats; Wagener, Raimund] Univ Cologne, Ctr Biochem, Fac Med, D-50931 Cologne, Germany; [Paulsson, Mats; Wagener, Raimund] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Paulsson, Mats] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Tagariello, Andreas] Univ Hosp Erlangen, Inst Human Genet, D-91054 Erlangen, Germany; [Karlsen, Kristina Rokenes; Neiss, Wolfram Friedrich] Univ Cologne, Dept Anat 1, D-50924 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Erlangen Nuremberg; University of Cologne	Wagener, R (corresponding author), Univ Cologne, Inst Biochem 2, Fac Med, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	raimund.wagener@uni-koeln.de			Deutsche Forschungsgemeinschaft [WA1338/2-6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant WA1338/2-6 (to R. W. and M. P.).	Aszodi A, 1999, MOL CELL BIOL, V19, P7841; Baas D, 2009, MATRIX BIOL, V28, P490, DOI 10.1016/j.matbio.2009.07.004; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Chakravarti R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-83; Cotterill SL, 2005, HUM MUTAT, V26, P557, DOI 10.1002/humu.20263; Dale RM, 2011, DEV BIOL, V357, P518, DOI 10.1016/j.ydbio.2011.06.020; Ehlen HWA, 2009, J BIOL CHEM, V284, P21545, DOI 10.1074/jbc.M109.016568; FRENCH SW, 1972, EXP MOL PATHOL, V16, P16, DOI 10.1016/0014-4800(72)90017-2; Fresquet M, 2010, J BIOL CHEM, V285, P34048, DOI 10.1074/jbc.M110.154443; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Holmborn K, 2012, J BIOL CHEM, V287, P33905, DOI 10.1074/jbc.M112.401646; Huang CC, 2009, DEV BIOL, V332, P360, DOI 10.1016/j.ydbio.2009.06.003; Huang XM, 1999, DEV DYNAM, V216, P434, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<434::AID-DVDY11>3.3.CO;2-O; IRWIN MH, 1985, J CELL BIOL, V101, P814, DOI 10.1083/jcb.101.3.814; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Karen LP, 2004, INT J BIOCHEM CELL B, V36, P1005, DOI 10.1016/j.biocel.2004.01.011; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kimmel CB, 2001, DEV BIOL, V233, P239, DOI 10.1006/dbio.2001.0201; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klatt AR, 2011, INT J BIOCHEM CELL B, V43, P320, DOI 10.1016/j.biocel.2010.12.010; Klatt AR, 2001, J BIOL CHEM, V276, P17267, DOI 10.1074/jbc.M100587200; Ko YP, 2005, BIOCHEM J, V386, P367, DOI 10.1042/BJ20041486; Ko YP, 2004, MOL CELL BIOL, V24, P1691, DOI 10.1128/MCB.24.4.1691-1699.2004; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lele Z, 1997, MECH DEVELOP, V61, P89, DOI 10.1016/S0925-4773(96)00626-0; Leung AWL, 2010, DEV DYNAM, V239, P2319, DOI 10.1002/dvdy.22366; Malin D, 2009, J CELL SCI, V122, P995, DOI 10.1242/jcs.040378; Mangos S, 2010, DIS MODEL MECH, V3, P354, DOI 10.1242/dmm.003194; Mates L, 2004, MATRIX BIOL, V23, P195, DOI 10.1016/j.matbio.2004.05.003; Melville DB, 2011, DIS MODEL MECH, V4, P763, DOI 10.1242/dmm.007625; MULLERGLAUSER W, 1986, J CELL BIOL, V102, P1931, DOI 10.1083/jcb.102.5.1931; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nicolae C, 2007, J BIOL CHEM, V282, P22163, DOI 10.1074/jbc.M610994200; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Patra D, 2011, J BIOL CHEM, V286, P29227, DOI 10.1074/jbc.M110.208686; Roach HI, 2004, APOPTOSIS, V9, P265, DOI 10.1023/B:APPT.0000025803.17498.26; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; SANDELL LJ, 1994, DEV DYNAM, V199, P129, DOI 10.1002/aja.1001990206; SANDELL LJ, 1991, J CELL BIOL, V114, P1307, DOI 10.1083/jcb.114.6.1307; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schilling TF, 1997, DEVELOPMENT, V124, P2945; Telfer WR, 2010, HUM MOL GENET, V19, P2433, DOI 10.1093/hmg/ddq126; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; van der Weyden L, 2006, AM J PATHOL, V169, P515, DOI 10.2353/ajpath.2006.050981; Venditti R, 2012, SCIENCE, V337, P1668, DOI 10.1126/science.1224947; Vranka J, 2001, MATRIX BIOL, V20, P439, DOI 10.1016/S0945-053X(01)00148-2; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Weston J A, 1970, Adv Morphog, V8, P41; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069; Zoeller JJ, 2009, J BIOL CHEM, V284, P11728, DOI 10.1074/jbc.M808991200	58	11	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1505	1518		10.1074/jbc.M113.529933	http://dx.doi.org/10.1074/jbc.M113.529933			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24293366	Green Published, hybrid			2022-12-28	WOS:000332401700026
J	Rothwell, SW; Stansfeld, PJ; Bragg, L; Verkhratsky, A; North, RA				Rothwell, Simon W.; Stansfeld, Phillip J.; Bragg, Laricia; Verkhratsky, Alexej; North, R. Alan			Direct Gating of ATP-activated Ion Channels (P2X2 Receptors) by Lipophilic Attachment at the Outer End of the Second Transmembrane Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT P2X(2) RECEPTOR; BINDING-SITE; RESIDUES; PORE; IDENTIFICATION; SIMULATIONS; PROTEINS	The ionic pore of the P2X receptor passes through the central axis of six transmembrane (TM) helices, two from each of three subunits. Val(48) and Ile(328) are at the outer end of TM1 and TM2, respectively. Homology models of the open and closed states of P2X2 indicate that pore opening is associated with a large lateral displacement of Ile(328). In addition, molecular dynamics simulations suggest that lipids enter the interstices between the outer ends of the TM domains. The P2X2(I328C) receptor was activated by propyl-methanethiosulfonate (MTS) as effectively as by ATP, but cysteine substitutions elsewhere in TM2 had no such effect. Other lipophilic MTS compounds (methyl, ethyl, and tert-butylethyl) had a similar effect but not polar MTS. The properties of the conducting pathway opened by covalent attachment of propyl-MTS were the same as those opened by ATP, with respect to unitary conductance, rectification, and permeability of N-methyl-D-glucamine. The ATP-binding residue Lys(69) was not required for the action of propyl-MTS, although propyl-MTS did not open P2X2(K308A/I328C) receptors. The propyl-MTS did not open P2X2 receptors in which the Val(48) side chain was removed (P2X2(V48G/I328C)). The results suggest that an interaction between Val(48) and Ile(328) stabilizes the closed channel and that this is broken by covalent attachment of a larger lipophilic moiety at the I328C receptors. Lipid intercalation between the separating TM domains during channel opening would be facilitated in P2X2(I328C) receptors with attached propyl-MTS. The results are consistent with the channel opening mechanism proposed on the basis of closed and open crystal structures and permit the refinement of the position of the TMs within the bilayer.	[Rothwell, Simon W.; Verkhratsky, Alexej; North, R. Alan] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Bragg, Laricia; North, R. Alan] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PL, Lancs, England; [Stansfeld, Phillip J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Manchester; University of Manchester; University of Oxford	North, RA (corresponding author), Univ Manchester, Fac Med & Human Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.	r.a.north@manchester.ac.uk	Verkhratsky, Alexei/J-4527-2013; North, Richard/GQA-6156-2022; Stansfeld, Phillip James/AAA-9228-2020	Verkhratsky, Alexei/0000-0003-2592-9898; Stansfeld, Phillip James/0000-0001-8800-7669	Astra Zeneca studentship; Wellcome Trust [093140/Z/10/Z]; Biotechnology and Biological Sciences Research Council Grant [BB/I019855/1]; Biotechnology and Biological Sciences Research Council [B19456, BB/I019855/1, BBS/B/16011, BEP17032, BB/H000267/1, BB/L002558/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J010421/1] Funding Source: researchfish; BBSRC [BB/I019855/1, BB/L002558/1, BB/H000267/1] Funding Source: UKRI; EPSRC [EP/J010421/1] Funding Source: UKRI	Astra Zeneca studentship; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by an Astra Zeneca studentship, Wellcome Trust Grant 093140/Z/10/Z, and Biotechnology and Biological Sciences Research Council Grant BB/I019855/1.	Borghese CM, 2014, J NEUROCHEM, V128, P363, DOI 10.1111/jnc.12476; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Cao LS, 2007, J NEUROSCI, V27, P12916, DOI 10.1523/JNEUROSCI.4036-07.2007; Cao LS, 2009, J NEUROSCI, V29, P14257, DOI 10.1523/JNEUROSCI.4403-09.2009; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Egan TM, 1998, J NEUROSCI, V18, P2350; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Kawate T, 2011, J GEN PHYSIOL, V137, P579, DOI 10.1085/jgp.201010593; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2012, NEURON, V76, P51, DOI 10.1016/j.neuron.2012.09.024; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kubo Y, 2009, J PHYSIOL-LONDON, V587, P5317, DOI 10.1113/jphysiol.2009.179309; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Simpson RJ, 2009, BASIC METHODS PROTEI; Stansfeld PJ, 2013, STRUCTURE, V21, P810, DOI 10.1016/j.str.2013.03.005; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Stelmashenko O, 2012, MOL PHARMACOL, V82, P760, DOI 10.1124/mol.112.080903; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Weingarth M, 2013, J AM CHEM SOC, V135, P3983, DOI 10.1021/ja3119114; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658; Yan D, 2013, P NATL ACAD SCI USA, V110, P2228, DOI 10.1073/pnas.1222285110	31	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					618	626		10.1074/jbc.M113.529099	http://dx.doi.org/10.1074/jbc.M113.529099			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24273165	Green Published, hybrid			2022-12-28	WOS:000330541200003
J	Han, J; Hou, W; Goldstein, LA; Stolz, DB; Watkins, SC; Rabinowich, H				Han, Jie; Hou, Wen; Goldstein, Leslie A.; Stolz, Donna B.; Watkins, Simon C.; Rabinowich, Hannah			A Complex between Atg7 and Caspase-9 A NOVEL MECHANISM OF CROSS-REGULATION BETWEEN AUTOPHAGY AND APOPTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Autophagy; Caspase; Cell Death; Cellular Regulation	MEDIATED CLEAVAGE; CELL-DEATH; IN-VITRO; BECLIN 1; ACTIVATION; TRAIL; PATHWAY; DEGRADATION; INVOLVEMENT; MODULATION	Background: Several cross-talk mechanisms between autophagy and apoptosis have been identified, where the same protein plays a central role in the opposing processes. Results: This study identified a novel cross-talk mechanism involving an Atg7caspase-9 complex. Conclusion: Atg7 and caspase-9 mutually regulate each other's activity. Significance: The Atg7caspase-9 complex may determine the balance between autophagy and apoptosis in response to stress. Several cross-talk mechanisms between autophagy and apoptosis have been identified, in which certain co-regulators are shared, allowing the same protein to participate in these opposing processes. Our studies suggest that caspase-9 is a novel co-regulator of apoptosis and autophagy and that its caspase catalytic activity is dispensable for its autophagic role. We provide evidence that caspase-9 facilitates the early events leading to autophagosome formation; that it forms a complex with Atg7; that Atg7 is not a direct substrate for caspase-9 proteolytic activity; and that, depending on the cellular context, Atg7 represses the apoptotic capability of caspase-9, whereas the latter enhances the Atg7-mediated formation of light chain 3-II. The repression of caspase-9 apoptotic activity is mediated by its direct interaction with Atg7, and it is not related to the autophagic function of Atg7. We propose that the Atg7caspase-9 complex performs a dual function of linking caspase-9 to the autophagic process while keeping in check its apoptotic activity.	[Han, Jie; Hou, Wen; Goldstein, Leslie A.; Rabinowich, Hannah] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Stolz, Donna B.; Watkins, Simon C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Stolz, Donna B.; Watkins, Simon C.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rabinowich, H (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Res Pavil Rm G17c,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	rabinow@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	National Institutes of Health [RO1 CA134776]; Department of Defense [W81XWH-12-1-0228]; Pennsylvania Breast and Cervical Cancer Research Initiative; NATIONAL CANCER INSTITUTE [R01CA134776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Pennsylvania Breast and Cervical Cancer Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA134776. This work was also supported by Department of Defense Grant W81XWH-12-1-0228 and the Pennsylvania Breast and Cervical Cancer Research Initiative (to H. R.).	Arama E, 2007, PLOS BIOL, V5, P2745, DOI 10.1371/journal.pbio.0050251; Ben Moshe T, 2007, HEPATOLOGY, V45, P1014, DOI 10.1002/hep.21495; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; Cho DH, 2009, CANCER LETT, V274, P95, DOI 10.1016/j.canlet.2008.09.004; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Fujioka Y, 2008, J BIOL CHEM, V283, P1921, DOI 10.1074/jbc.M706214200; Gyrd-Hansen M, 2006, MOL CELL BIOL, V26, P7880, DOI 10.1128/MCB.00716-06; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Han J, 2007, J BIOL CHEM, V282, P16223, DOI 10.1074/jbc.M611186200; Han J, 2013, J BIOL CHEM, V288, P20315, DOI 10.1074/jbc.M113.461350; Han J, 2010, J BIOL CHEM, V285, P22473, DOI 10.1074/jbc.M109.081042; Han J, 2010, J BIOL CHEM, V285, P22461, DOI 10.1074/jbc.M109.086587; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hou W, 2008, AUTOPHAGY, V4, P940, DOI 10.4161/auto.6769; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Hou YCC, 2008, J CELL BIOL, V182, P1127, DOI 10.1083/jcb.200712091; Hu Q, 2013, J BIOL CHEM, V288, P15142, DOI 10.1074/jbc.M112.441568; Huh JR, 2004, PLOS BIOL, V2, P43, DOI 10.1371/journal.pbio.0020015; Jeong HS, 2011, BBA-MOL CELL RES, V1813, P80, DOI 10.1016/j.bbamcr.2010.09.016; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Launay S, 2005, ONCOGENE, V24, P5137, DOI 10.1038/sj.onc.1208524; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Leverrier S, 2011, CELL DEATH DIFFER, V18, P90, DOI 10.1038/cdd.2010.69; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li H, 2011, CANCER RES, V71, P3625, DOI 10.1158/0008-5472.CAN-10-4475; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Morizane Y, 2005, J BIOCHEM, V137, P125, DOI 10.1093/jb/mvi029; Murray TVA, 2008, J CELL SCI, V121, P3786, DOI 10.1242/jcs.024547; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Shen SS, 2012, AUTOPHAGY, V8, P1, DOI 10.4161/auto.8.1.16618; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Taherbhoy AM, 2011, MOL CELL, V44, P451, DOI 10.1016/j.molcel.2011.08.034; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; White EJ, 2011, AM J CANCER RES, V1, P362; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	61	69	71	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6485	6497		10.1074/jbc.M113.536854	http://dx.doi.org/10.1074/jbc.M113.536854			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24362031	Green Published, hybrid			2022-12-28	WOS:000332389400016
J	Yao, C; Yao, GQ; Sun, BH; Zhang, CQ; Tommasini, SM; Insogna, K				Yao, Chen; Yao, Gang-Qing; Sun, Ben-hua; Zhang, Changqing; Tommasini, Steven M.; Insogna, Karl			The Transcription Factor T-box 3 Regulates Colony-stimulating Factor 1-dependent Jun Dimerization Protein 2 Expression and Plays an Important Role in Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Osteoclast; Promoters; Signal Transduction; Transcription Factors	ULNAR-MAMMARY SYNDROME; TBX3; DIFFERENTIATION; CELLS; GENE; JDP2; BINDING; AP-1; BONE; SURVIVAL	Background: Colony-stimulating factor 1 (CSF1) and Jun dimerization protein 2 (JDP2) regulate osteoclastogenesis, but a molecular interaction between the two has not been reported. Results: CSF1 up-regulates JDP2 by inducing T-box 3 (Tbx3) binding to the JDP2 promoter, and suppressing Tbx3 expression impairs osteoclastogenesis. Conclusion: Tbx3 is a target for CSF1 in osteoclasts. Significance: Novel molecular targets for CSF1 in modulating osteoclastogenesis are described. Colony-stimulating factor 1 (CSF1) is known to promote osteoclast progenitor survival, but its roles in osteoclast differentiation and mature osteoclast function are less well understood. In a microarray screen, Jun dimerization protein 2 (JDP2) was identified as significantly induced by CSF1. Recent reports indicate that JDP2 is required for normal osteoclastogenesis and skeletal metabolism. Because there are no reports on the transcriptional regulation of this gene, the DNA sequence from -2612 to +682 bp (relative to the transcription start site) of the JDP2 gene was cloned, and promoter activity was analyzed. The T box-binding element (TBE) between -191 and -141 bp was identified as the cis-element responsible for CSF1-dependent JDP2 expression. Using degenerate PCR, Tbx3 was identified as the major isoform binding the TBE. Overexpression of Tbx3 induced JDP2 promoter activity, whereas suppressing Tbx3 expression substantially attenuated CSF1-induced transcription. Suppressing Tbx3 in osteoclast precursors reduced JDP2 expression and significantly impaired RANKL/CSF1-induced osteoclastogenesis. A MEK1/2-specific inhibitor was found to block CSF1-induced JDP2 expression. Consistent with these data, JDP2(-/-) mice were found to have increased bone mass. In summary, CSF1 up-regulates JDP2 expression by inducing Tbx3 binding to the JDP2 promoter. The downstream signaling cascade from activated c-Fms involves the MEK1/2-ERK1/2 pathway. Tbx3 plays an important role in osteoclastogenesis at least in part by regulating CSF1-dependent expression of JDP2.	[Yao, Chen; Sun, Ben-hua; Insogna, Karl] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Yao, Gang-Qing] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; [Tommasini, Steven M.] Yale Univ, Sch Med, Dept Orthoped, New Haven, CT 06520 USA; [Yao, Chen; Zhang, Changqing] Shanghai Jiao Tong Univ, Sch Med, Dept Orthoped, Shanghai Peoples Hosp 6, Shanghai 200233, Peoples R China	Yale University; Yale University; Yale University; Shanghai Jiao Tong University	Insogna, K (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA.	karl.insogna@yale.edu		Tommasini, Steven/0000-0001-5118-5867; Insogna, Karl/0000-0001-6973-5679; zhang, changqing/0000-0002-7408-4126	National Institutes of Health [DE12459, DK45228]; Yale Core Center for Musculoskeletal Disorders, a National Institutes of Health (NIAMD) [AR46032]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Core Center for Musculoskeletal Disorders, a National Institutes of Health (NIAMD); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DE12459 and DK45228. This work was also supported by the Yale Core Center for Musculoskeletal Disorders, a National Institutes of Health (NIAMD)-funded P30 Core Center (Grant AR46032).	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Aziz N, 1999, MOL CELL BIOL, V19, P1101; Bouyer P, 2007, ENDOCRINOLOGY, V148, P831, DOI 10.1210/en.2006-0547; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Coll M, 2002, STRUCTURE, V10, P343, DOI 10.1016/S0969-2126(02)00722-0; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; Deepak V, 2011, CELL BIOCHEM FUNCT, V29, P348, DOI 10.1002/cbf.1753; Deng HW, 2002, J CLIN ENDOCR METAB, V87, P5151, DOI 10.1210/jc.2002-020474; Fan WW, 2004, CANCER RES, V64, P5132, DOI 10.1158/0008-5472.CAN-04-0615; Foltz IN, 1997, J BIOL CHEM, V272, P3296, DOI 10.1074/jbc.272.6.3296; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Ghebranious N, 2008, J BONE MINER RES, V23, P1576, DOI 10.1359/JBMR.080503; Gosse SG, 2005, CELL SIGNAL, V17, P1352, DOI 10.1016/j.cellsig.2005.02.002; Govoni KE, 2009, J CELL BIOCHEM, V106, P482, DOI 10.1002/jcb.22035; Govoni KE, 2006, AM J PHYSIOL-ENDOC M, V291, pE128, DOI 10.1152/ajpendo.00592.2005; He ML, 1999, P NATL ACAD SCI USA, V96, P10212, DOI 10.1073/pnas.96.18.10212; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Jaworowski A, 1999, J BIOL CHEM, V274, P15127, DOI 10.1074/jbc.274.21.15127; JIMI E, 1995, ENDOCRINOLOGY, V136, P808, DOI 10.1210/en.136.2.808; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Kawaida R, 2003, J EXP MED, V197, P1029, DOI 10.1084/jem.20021321; Kawano T, 2013, BONE, V52, P70, DOI 10.1016/j.bone.2012.09.024; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Maruyama K, 2012, IMMUNITY, V37, P1024, DOI 10.1016/j.immuni.2012.08.022; Mowla S, 2011, BIOCHEM J, V433, P145, DOI 10.1042/BJ20100886; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Nakade K, 2009, J BIOL CHEM, V284, P10808, DOI 10.1074/jbc.M808333200; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Ostrovsky O, 2002, J BIOL CHEM, V277, P40043, DOI 10.1074/jbc.M205494200; Papakonstanti EA, 2008, J CELL SCI, V121, P4124, DOI 10.1242/jcs.032763; Postma AV, 2008, CIRC RES, V102, P1433, DOI 10.1161/CIRCRESAHA.107.168294; Rallis C, 2005, DEVELOPMENT, V132, P1961, DOI 10.1242/dev.01787; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; ROHRSCHNEIDER LR, 1989, ONCOGENE, V4, P1015; Sakai H, 2006, BONE, V39, P1290, DOI 10.1016/j.bone.2006.06.012; Sinha S, 2000, GENE, V258, P15, DOI 10.1016/S0378-1119(00)00417-0; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; TAKAHASHI N, 1991, ENDOCRINOLOGY, V128, P1792, DOI 10.1210/endo-128-4-1792; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yano T, 2011, J CELL BIOL, V193, P319, DOI 10.1083/jcb.201009100; Yao GQ, 2005, CALCIFIED TISSUE INT, V76, P371, DOI 10.1007/s00223-004-0099-8; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhao YX, 2007, P NATL ACAD SCI USA, V104, P9673, DOI 10.1073/pnas.0703407104	48	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6775	6790		10.1074/jbc.M113.499210	http://dx.doi.org/10.1074/jbc.M113.499210			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24394418	hybrid, Green Published			2022-12-28	WOS:000332389400038
J	Brinkman, DL; Konstantakopoulos, N; McInerney, BV; Mulvenna, J; Seymour, JE; Isbister, GK; Hodgson, WC				Brinkman, Diane L.; Konstantakopoulos, Nicki; McInerney, Bernie V.; Mulvenna, Jason; Seymour, Jamie E.; Isbister, Geoffrey K.; Hodgson, Wayne C.			Chironex fleckeri ( Box Jellyfish) Venom Proteins EXPANSION OF A CNIDARIAN TOXIN FAMILY THAT ELICITS VARIABLE CYTOLYTIC AND CARDIOVASCULAR EFFECTS*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Cardiovascular; Endotoxin; Protein Purification; Toxins; Cubozoa; Cytolytic; Jellyfish Toxin; Nematocyst; Venom	BACILLUS-THURINGIENSIS; PARTIAL-PURIFICATION; SEA WASP; MOLECULAR CHARACTERIZATION; INSECTICIDAL TOXIN; CRYSTAL-STRUCTURE; DELTA-ENDOTOXIN; CARYBDEA-ALATA; HABU-KURAGE; PREDICTION	Background: Box jellyfish produce a unique family of toxic venom proteins. Results: The toxins are structurally similar, yet two subgroups confer different cytolytic activities in red blood cells and cardiovascular effects in rats. Conclusion: Diversification within the toxin family may influence toxin function/specificity. Significance: Characterization of the toxins provides new insight into their potential roles in human envenoming. The box jellyfish Chironex fleckeri produces extremely potent and rapid-acting venom that is harmful to humans and lethal to prey. Here, we describe the characterization of two C. fleckeri venom proteins, CfTX-A (approximate to 40 kDa) and CfTX-B (approximate to 42 kDa), which were isolated from C. fleckeri venom using size exclusion chromatography and cation exchange chromatography. Full-length cDNA sequences encoding CfTX-A and -B and a third putative toxin, CfTX-Bt, were subsequently retrieved from a C. fleckeri tentacle cDNA library. Bioinformatic analyses revealed that the new toxins belong to a small family of potent cnidarian pore-forming toxins that includes two other C. fleckeri toxins, CfTX-1 and CfTX-2. Phylogenetic inferences from amino acid sequences of the toxin family grouped CfTX-A, -B, and -Bt in a separate clade from CfTX-1 and -2, suggesting that the C. fleckeri toxins have diversified structurally and functionally during evolution. Comparative bioactivity assays revealed that CfTX-1/2 (25 g kg(-1)) caused profound effects on the cardiovascular system of anesthetized rats, whereas CfTX-A/B elicited only minor effects at the same dose. Conversely, the hemolytic activity of CfTX-A/B (HU50 = 5 ng ml(-1)) was at least 30 times greater than that of CfTX-1/2. Structural homology between the cubozoan toxins and insecticidal three-domain Cry toxins (-endotoxins) suggests that the toxins have a similar pore-forming mechanism of action involving -helices of the N-terminal domain, whereas structural diversification among toxin members may modulate target specificity. Expansion of the cnidarian toxin family therefore provides new insights into the evolutionary diversification of box jellyfish toxins from a structural and functional perspective.	[Brinkman, Diane L.] Townsville Mail Ctr, Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Konstantakopoulos, Nicki; Isbister, Geoffrey K.; Hodgson, Wayne C.] Monash Univ, Dept Pharmacol, Monash Venom Grp, Melbourne, Vic 3800, Australia; [McInerney, Bernie V.] Macquarie Univ, Australian Proteome Anal Facil, Sydney, NSW 2109, Australia; [Mulvenna, Jason] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Seymour, Jamie E.] James Cook Univ, Fac Med Hlth & Mol Sci, Cairns 4870, Australia; [Isbister, Geoffrey K.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2308, Australia	Australian Institute of Marine Science; Monash University; Macquarie University; QIMR Berghofer Medical Research Institute; James Cook University; University of Newcastle	Brinkman, DL (corresponding author), Townsville Mail Ctr, Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	d.brinkman@aims.gov.au	Brinkman, Diane L/A-1084-2010; Isbister, Geoffrey K/G-8052-2015; Mulvenna, Jason/H-7110-2014	Brinkman, Diane L/0000-0002-6954-7667; Isbister, Geoffrey K/0000-0003-1519-7419; Mulvenna, Jason/0000-0003-3521-8061; McInerney, Bernie/0000-0002-2097-4393; Hodgson, Wayne/0000-0002-9919-0144	Herman Slade Foundation; National Health and Medical Research Council Clinical Career Development Fellowship	Herman Slade Foundation; National Health and Medical Research Council Clinical Career Development Fellowship	This research project was funded by a grant from the Herman Slade Foundation and facilitated by access to the Australian Proteome Analysis Facility supported under the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS).; Supported by a National Health and Medical Research Council Clinical Career Development Fellowship.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderluh G, 2000, BBA-PROTEIN STRUCT M, V1476, P372, DOI 10.1016/S0167-4838(99)00237-X; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bloom DA, 1998, TOXICON, V36, P1075, DOI 10.1016/S0041-0101(98)00096-8; Bravo A, 2002, J BIOL CHEM, V277, P23985, DOI 10.1074/jbc.C200263200; Brinkman D, 2008, TOXICON, V51, P853, DOI 10.1016/j.toxicon.2007.12.017; Brinkman D, 2007, TOXICON, V50, P850, DOI 10.1016/j.toxicon.2007.06.016; Brinkman DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047866; Brinkman DL, 2009, TOXICON, V54, P1162, DOI 10.1016/j.toxicon.2009.02.006; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Chen YJ, 2008, CURR OPIN STRUC BIOL, V18, P765, DOI 10.1016/j.sbi.2008.10.005; Chung JJ, 2001, TOXICON, V39, P981, DOI 10.1016/S0041-0101(00)00237-3; Currie BJ, 2005, MED J AUSTRALIA, V183, P631, DOI 10.5694/j.1326-5377.2005.tb00062.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Frazao B, 2012, MAR DRUGS, V10, P1812, DOI 10.3390/md10081812; Galitsky N, 2001, ACTA CRYSTALLOGR D, V57, P1101, DOI 10.1107/S0907444901008186; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gershwin L., 2005, Memoirs of the Queensland Museum, V51, P501; GROCHULSKI P, 1995, J MOL BIOL, V254, P447, DOI 10.1006/jmbi.1995.0630; Guo SY, 2009, J STRUCT BIOL, V168, P259, DOI 10.1016/j.jsb.2009.07.004; Jolliffe NA, 2006, J BIOL CHEM, V281, P23377, DOI 10.1074/jbc.M602678200; Konstantakopoulos Nicki, 2009, Journal of Pharmacological and Toxicological Methods, V59, P166, DOI 10.1016/j.vascn.2009.02.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewis C, 2009, ZOOTAXA, P59, DOI 10.11646/zootaxa.2030.1.5; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; LUMLEY J, 1988, MED J AUSTRALIA, V148, P527, DOI 10.5694/j.1326-5377.1988.tb99466.x; McClounan S, 2012, TOXICON, V60, P1335, DOI 10.1016/j.toxicon.2012.08.020; Mulvenna J, 2009, MOL CELL PROTEOMICS, V8, P109, DOI 10.1074/mcp.M800206-MCP200; Nagai H, 2003, J HEALTH SCI, V49, P337, DOI 10.1248/jhs.49.337; Nagai H, 2002, BIOSCI BIOTECH BIOCH, V66, P97, DOI 10.1271/bbb.66.97; Nagai H, 2000, BIOCHEM BIOPH RES CO, V275, P589, DOI 10.1006/bbrc.2000.3352; Nagai H, 2000, BIOCHEM BIOPH RES CO, V275, P582, DOI 10.1006/bbrc.2000.3353; Nugent T, 2011, BIOINFORMATICS, V27, P1438, DOI 10.1093/bioinformatics/btr096; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saggiomo SLA, 2012, TOXICON, V60, P391, DOI 10.1016/j.toxicon.2012.03.025; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Tang B, 2003, BIOCHEM BIOPH RES CO, V301, P1093, DOI 10.1016/S0006-291X(03)00084-6; Uechi G, 2010, TOXICON, V56, P1470, DOI 10.1016/j.toxicon.2010.09.002; Wong E. S., 2013, PLOS ONE, V8; Yanagihara AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051368	43	50	53	3	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4798	4812		10.1074/jbc.M113.534149	http://dx.doi.org/10.1074/jbc.M113.534149			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403082	Green Published, hybrid			2022-12-28	WOS:000331607900026
J	Sokolowska, M; Chen, LY; Eberlein, M; Martinez-Anton, A; Liu, YQ; Alsaaty, S; Qi, HY; Logun, C; Horton, M; Shelhamer, JH				Sokolowska, Milena; Chen, Li-Yuan; Eberlein, Michael; Martinez-Anton, Asuncion; Liu, Yueqin; Alsaaty, Sara; Qi, Hai-Yan; Logun, Carolea; Horton, Maureen; Shelhamer, James H.			Low Molecular Weight Hyaluronan Activates Cytosolic Phospholipase A(2)alpha and Eicosanoid Production in Monocytes and Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclooxygenase (COX) Pathway; Eicosanoid; Extracellular Matrix; Inflammation; Monocytes; Toll-like Receptors (TLR); Hyaluronan; Prostaglandin; cPLA2; Macrophage Polarization	INTESTINAL POLYPOSIS; SERUM HYALURONAN; NEGATIVE REGULATOR; INTERFERON-GAMMA; BINDING PROTEINS; RECEPTOR RHAMM; KNOCKOUT MICE; LUNG INJURY; GROUP IVA; A(2)	Hyaluronan (HA) is the major glycosaminoglycan in the extracellular matrix. During inflammation, there is an increased breakdown of HA, resulting in the accumulation of low molecular weight (LMW) HA and activation of monocytes and macrophages. Eicosanoids, derived from the cytosolic phospholipase A(2) group IVA (cPLA(2)) activation, are potent lipid mediators also attributed to acute and chronic inflammation. The aim of this study was to determine the effect of LMW HA on cPLA(2) activation, arachidonic acid (AA) release, and subsequent eicosanoid production and to examine the receptors and downstream mechanisms involved in these processes in monocytes and differently polarized macrophages. LMW HA was a potent stimulant of AA release in a time- and dose-dependent manner, induced cPLA(2), ERK1/2, p38, and JNK phosphorylation, as well as activated COX2 expression and prostaglandin (PG) E-2 production in primary human monocytes, murine RAW 264.7, and wild-type bone marrow-derived macrophages. Specific cPLA(2) inhibitor blocked HA-induced AA release and PGE(2) production in all of these cells. Using CD44, TLR4, TLR2, MYD88, RHAMM or STAB2 siRNA-transfected macrophages and monocytes, we found that AA release, cPLA(2), ERK1/2, p38, and JNK phosphorylation, COX2 expression, and PGE(2) production were activated by LMW HA through a TLR4/MYD88 pathway. Likewise, PGE(2) production and COX2 expression were blocked in Tlr4(-/-) and Myd88(-/-) mice, but not in Cd44(-/-) mice, after LMW HA stimulation. Moreover, we demonstrated that LMW HA activated the M1 macrophage phenotype with the unique cPLA(2)/COX2(high) and COX1/ALOX15/ALOX5/LTA4H(low) gene and PGE(2)/PGD(2)/15-HETEhigh and LXA(4)(low) eicosanoid profile. These findings reveal a novel link between HA-mediated inflammation and lipid metabolism.	[Sokolowska, Milena; Chen, Li-Yuan; Eberlein, Michael; Martinez-Anton, Asuncion; Liu, Yueqin; Alsaaty, Sara; Qi, Hai-Yan; Logun, Carolea; Shelhamer, James H.] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Horton, Maureen] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Johns Hopkins University	Shelhamer, JH (corresponding author), NIH, Dept Crit Care Med, Ctr Clin, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jshelhamer@cc.nih.gov	Chen, Liyuan/AAF-3864-2020; Martinez Anton, Asuncion/A-5806-2017	Martinez Anton, Asuncion/0000-0001-9758-5911; Eberlein, Michael/0000-0001-6108-2546; Sokolowska, Milena/0000-0001-9710-6685	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL010342] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL000182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CLINICAL CENTER	This work was supported, in whole or in part, by National Institutes of Health intramural program.	Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101; Anttila MA, 2000, CANCER RES, V60, P150; Austin JW, 2012, J NEUROCHEM, V122, P344, DOI 10.1111/j.1471-4159.2012.07789.x; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Boyce JA, 2008, CURR MOL MED, V8, P335, DOI 10.2174/156652408785160989; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Casas J, 2006, MOL BIOL CELL, V17, P155, DOI 10.1091/mbc.e05-06-0545; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chajara A, 2000, ARTERIOSCL THROM VAS, V20, P1480, DOI 10.1161/01.ATV.20.6.1480; Chen LY, 2008, AM J PHYSIOL-LUNG C, V295, pL326, DOI 10.1152/ajplung.00393.2007; Collins SL, 2011, AM J RESP CELL MOL, V45, P675, DOI 10.1165/rcmb.2010-0387OC; Cowman MK, 2011, ANAL BIOCHEM, V417, P50, DOI 10.1016/j.ab.2011.05.023; Lima IVD, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/946813; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B; Erickson M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/893947; Franz S, 2013, ACTA BIOMATER, V9, P5621, DOI 10.1016/j.actbio.2012.11.016; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; George J, 2004, CLIN CHIM ACTA, V348, P189, DOI 10.1016/j.cccn.2004.05.018; Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Giannattasio G, 2009, BBA-MOL CELL BIOL L, V1791, P92, DOI 10.1016/j.bbalip.2008.12.002; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Harris RE, 2005, ONCOL REP, V13, P559; He H, 2013, J BIOL CHEM, V288, P25792, DOI 10.1074/jbc.M113.479584; Hegen M, 2003, J EXP MED, V197, P1297, DOI 10.1084/jem.20030016; Hewson CA, 2012, J PHARMACOL EXP THER, V340, P656, DOI 10.1124/jpet.111.186379; Hong KH, 2001, P NATL ACAD SCI USA, V98, P3935, DOI 10.1073/pnas.051635898; Horton MR, 1998, J BIOL CHEM, V273, P35088, DOI 10.1074/jbc.273.52.35088; Isnard N, 2001, CELL BIOL INT, V25, P735, DOI 10.1006/cbir.2001.0759; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jiang YJ, 2003, MOL CELL BIOCHEM, V246, P31, DOI 10.1023/A:1023495626568; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kim MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072421; Kouvidi K, 2011, J BIOL CHEM, V286, P38509, DOI 10.1074/jbc.M111.275875; Kuang DM, 2007, BLOOD, V110, P587, DOI 10.1182/blood-2007-01-068031; Lee CW, 2010, J CELL BIOCHEM, V109, P1045, DOI 10.1002/jcb.22488; Lennon FE, 2011, AM J PHYSIOL-LUNG C, V301, pL137, DOI 10.1152/ajplung.00071.2010; Letsiou E, 2011, BBA-MOL CELL BIOL L, V1811, P370, DOI 10.1016/j.bbalip.2010.12.007; Liang JR, 2007, J IMMUNOL, V178, P2469, DOI 10.4049/jimmunol.178.4.2469; Liang JR, 2011, J ALLERGY CLIN IMMUN, V128, P403, DOI 10.1016/j.jaci.2011.04.006; Lundstrom SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033780; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; Maharjan AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026078; Mancini AD, 2011, INFLAMM RES, V60, P1083, DOI 10.1007/s00011-011-0385-7; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Marusic S, 2005, J EXP MED, V202, P841, DOI 10.1084/jem.20050665; Menter DG, 2010, CLIN CANCER RES, V16, P1384, DOI 10.1158/1078-0432.CCR-09-0788; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; Mine S, 2006, ENDOCR J, V53, P761, DOI 10.1507/endocrj.K05-119; Mosca M, 2007, J LEUKOCYTE BIOL, V82, P320, DOI 10.1189/jlb.0906576; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Murphy JF, 2005, FASEB J, V19, P446, DOI 10.1096/fj.03-1376fje; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Nagase T, 2002, NAT MED, V8, P480, DOI 10.1038/nm0502-480; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Pandey MS, 2013, J BIOL CHEM, V288, P14068, DOI 10.1074/jbc.M112.442889; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Pawliczak R, 2004, J BIOL CHEM, V279, P48550, DOI 10.1074/jbc.M408926200; Pawliczak R, 2002, AM J RESP CELL MOL, V27, P722, DOI 10.1165/rcmb.2002-0033OC; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Pivetta E, 2011, J CELL PHYSIOL, V226, P769, DOI 10.1002/jcp.22398; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Powell JD, 2005, IMMUNOL RES, V31, P207, DOI 10.1385/IR:31:3:207; Qi HY, 2005, J BIOL CHEM, V280, P38969, DOI 10.1074/jbc.M509352200; Riehl TE, 2012, AM J PHYSIOL-GASTR L, V302, pG309, DOI 10.1152/ajpgi.00248.2011; SAARI H, 1989, ANN RHEUM DIS, V48, P565, DOI 10.1136/ard.48.7.565; Sapirstein A, 2000, BBA-MOL CELL BIOL L, V1488, P139, DOI 10.1016/S1388-1981(00)00116-5; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sokolowska M, 2010, J ALLERGY CLIN IMMUN, V125, P1393, DOI 10.1016/j.jaci.2010.02.016; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; Tabata T, 2007, ENDOCR J, V54, P685, DOI 10.1507/endocrj.K05-120; Takaku K, 2000, J BIOL CHEM, V275, P34013, DOI 10.1074/jbc.C000586200; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Walters JN, 2011, CELL SIGNAL, V23, P1944, DOI 10.1016/j.cellsig.2011.07.002; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Weiser-Evans MCM, 2009, CANCER RES, V69, P1733, DOI 10.1158/0008-5472.CAN-08-3766; Woodrow G, 1996, NEPHROL DIAL TRANSPL, V11, P98; WU T, 1994, J CLIN INVEST, V93, P571, DOI 10.1172/JCI117009; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yagmur E, 2012, CLIN BIOCHEM, V45, P82, DOI 10.1016/j.clinbiochem.2011.10.016; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zaman A, 2005, AM J RESP CELL MOL, V33, P447, DOI 10.1165/rcmb.2004-0333OC; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342; Zhao H, 2010, J IMMUNOL, V184, P5308, DOI 10.4049/jimmunol.1000009; Zlobec I, 2008, GUT, V57, P1413, DOI 10.1136/gut.2007.141192	107	71	74	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4470	4488		10.1074/jbc.M113.515106	http://dx.doi.org/10.1074/jbc.M113.515106			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366870	Green Published, hybrid			2022-12-28	WOS:000331403800056
J	Connarn, JN; Assimon, VA; Reed, RA; Tse, E; Southworth, DR; Zuiderweg, ERP; Gestwicki, JE; Sun, DX				Connarn, Jamie N.; Assimon, Victoria A.; Reed, Rebecca A.; Tse, Eric; Southworth, Daniel R.; Zuiderweg, Erik R. P.; Gestwicki, Jason E.; Sun, Duxin			The Molecular Chaperone Hsp70 Activates Protein Phosphatase 5 (PP5) by Binding the Tetratricopeptide Repeat (TPR) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hsp90; NMR; Peptides; Protein Phosphatase; Protein-protein Interactions; Cancer Signaling; Co-chaperones; Heat Shock Protein 70; Split Luciferase; Tethered Binding	E3 UBIQUITIN LIGASE; SERINE/THREONINE PHOSPHATASES; PROTEIN-PHOSPHATASE-5; CHIP; CONFORMATION; COMPLEXES; MECHANISM; RESIDUES; ACTS	Background: Heat shock proteins bind TPR-containing proteins to facilitate client folding. Results: The TPR domain of PP5 and the C-terminal IEEVD of Hsp70 are important for binding. Conclusion: Hsp70 binds through the TPR domain and activates PP5 phosphatase activity. Significance: Small molecules to inhibit Hsp70-PP5 interaction may be an alternative approach for cancer therapy. Protein phosphatase 5 (PP5) is auto-inhibited by intramolecular interactions with its tetratricopeptide repeat (TPR) domain. Hsp90 has been shown to bind PP5 to activate its phosphatase activity. However, the functional implications of binding Hsp70 to PP5 are not yet clear. In this study, we find that both Hsp90 and Hsp70 bind to PP5 using a luciferase fragment complementation assay. A fluorescence polarization assay shows that Hsp90 (MEEVD motif) binds to the TPR domain of PP5 almost 3-fold higher affinity than Hsp70 (IEEVD motif). However, Hsp70 binding to PP5 stimulates higher phosphatase activity of PP5 than the binding of Hsp90. We find that PP5 forms a stable 1:1 complex with Hsp70, but the interaction appears asymmetric with Hsp90, with one PP5 binding the dimer. Solution NMR studies reveal that Hsc70 and PP5 proteins are dynamically independent in complex, tethered by a disordered region that connects the Hsc70 core and the IEEVD-TPR contact area. This tethered binding is expected to allow PP5 to carry out multi-site dephosphorylation of Hsp70-bound clients with a range of sizes and shapes. Together, these results demonstrate that Hsp70 recruits PP5 and activates its phosphatase activity which suggests dual roles for PP5 that might link chaperone systems with signaling pathways in cancer and development.	[Connarn, Jamie N.; Sun, Duxin] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Tse, Eric; Southworth, Daniel R.; Zuiderweg, Erik R. P.; Gestwicki, Jason E.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Assimon, Victoria A.; Reed, Rebecca A.; Southworth, Daniel R.; Gestwicki, Jason E.; Sun, Duxin] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA; [Assimon, Victoria A.; Tse, Eric; Southworth, Daniel R.; Gestwicki, Jason E.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sun, DX (corresponding author), Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Room 2020,428 Church St, Ann Arbor, MI 48109 USA.	duxins@med.umich.edu	Sun, Duxin/AAA-1774-2022		National Institutes of Health [CA120023, NS059690]; NATIONAL CANCER INSTITUTE [R01CA120023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG043266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health R01 Grants CA120023 and NS059690.	Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Amblard M, 2006, MOL BIOTECHNOL, V33, P239, DOI 10.1385/MB:33:3:239; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; BOLLEN M, 1992, CRIT REV BIOCHEM MOL, V27, P227, DOI 10.3109/10409239209082564; Chang L, 2010, J BIOL CHEM, V285, P21282, DOI 10.1074/jbc.M110.124149; Chen L, 1996, J BIOL CHEM, V271, P13077, DOI 10.1074/jbc.271.22.13077; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Cliff MJ, 2005, J MOL BIOL, V346, P717, DOI 10.1016/j.jmb.2004.12.017; Cliff MJ, 2006, STRUCTURE, V14, P415, DOI 10.1016/j.str.2005.12.009; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Golden T, 2008, CANCER METAST REV, V27, P169, DOI 10.1007/s10555-008-9125-z; Golden T, 2008, BBA-MOL BASIS DIS, V1782, P259, DOI 10.1016/j.bbadis.2008.01.004; Heinlein CA, 2001, ENDOCRINE, V14, P143, DOI 10.1385/ENDO:14:2:143; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jiang YQ, 2010, J BIOL CHEM, V285, P21023, DOI 10.1074/jbc.M110.103390; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Liu FH, 1999, J BIOL CHEM, V274, P34425, DOI 10.1074/jbc.274.48.34425; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Paulmurugan R, 2004, CANCER RES, V64, P2113, DOI 10.1158/0008-5472.CAN-03-2972; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Revington M, 2005, J MOL BIOL, V349, P163, DOI 10.1016/j.jmb.2005.03.033; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; Smith MC, 2013, BIOCHEMISTRY-US, V52, P5354, DOI 10.1021/bi4009209; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Wang L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201814; Wu SJ, 2001, BIOCHEM J, V359, P419, DOI 10.1042/0264-6021:3590419; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Zeke T, 2005, BIOCHEM J, V385, P45, DOI 10.1042/BJ20040690; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhou GF, 2004, J BIOL CHEM, V279, P46595, DOI 10.1074/jbc.M408320200; Zuo Z, 1999, BIOCHEMISTRY-US, V38, P8849, DOI 10.1021/bi990842e; Zuo Z, 1998, J BIOL CHEM, V273, P12250, DOI 10.1074/jbc.273.20.12250	41	28	32	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2908	2917		10.1074/jbc.M113.519421	http://dx.doi.org/10.1074/jbc.M113.519421			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24327656	hybrid, Green Published			2022-12-28	WOS:000333403000039
J	Jeong, JJ; Park, N; Kwon, YJ; Ye, DJ; Moon, A; Chun, YJ				Jeong, Jin-Joo; Park, Nahee; Kwon, Yeo-Jung; Ye, Dong-Jin; Moon, Aree; Chun, Young-Jin			Role of Annexin A5 in Cisplatin-induced Toxicity in Renal Cells MOLECULAR MECHANISM OF APOPTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Annexin; Kidney; Mitochondrial Apoptosis; Protein Translocation; siRNA; VDAC; Annexin A5; Cisplatin; Nephrotoxicity; Renal Epithelial Cell	CYTOCHROME-C RELEASE; DEPENDENT ANION CHANNEL; INDUCED NEPHROTOXICITY; VDAC; MITOCHONDRIA; BIOMARKERS; DEATH; DELTA; AIF; TRANSLOCATION	Annexin A5 belongs to a large family of calcium-binding and phospholipid-binding proteins and may act as an endogenous regulator of various pathophysiological processes. There is increasing evidence that annexin A5 is related to cytotoxicity, but the precise function of this protein has yet to be elucidated. In this study, we aimed to verify the function of annexin A5 in the apoptosis of renal epithelial cells. Real-time PCR and Western blot analysis, together with immunofluorescence analysis, showed that the expression of annexin A5 significantly increased in the presence of cisplatin in both human and rat renal epithelial cells. With regard to the mechanism of cisplatin-induced apoptosis, apoptosis-inducing factor (AIF) release into the cytosol was observed, and the underlying mechanism was identified as voltage-dependent anion channel (VDAC) oligomerization. Mitochondrial membrane potential ((m)) was found to be greatly disrupted in cisplatin-treated cells. Moreover, cisplatin strongly induced translocation of annexin A5 into mitochondria. To understand the functional significance of annexin A5 in renal cell death, we used a siRNA-mediated approach to knock down annexin A5. Annexin A5 depletion by siRNA led to decreased annexin A5 translocation into mitochondria and significantly reduced VDAC oligomerization and AIF release. Annexin A5 siRNA also increased cell viability compared with the control. Moreover, expression of annexin A5 was induced by other nephrotoxicants such as CdCl2 and bacitracin. Taken together, our data suggest that annexin A5 may play a crucial role in cisplatin-induced toxicity by mediating the mitochondrial apoptotic pathway via the induction and oligomerization of VDAC.	[Jeong, Jin-Joo; Park, Nahee; Kwon, Yeo-Jung; Ye, Dong-Jin; Chun, Young-Jin] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Moon, Aree] Duksung Womens Univ, Coll Pharm, Seoul 132714, South Korea	Chung Ang University; Duksung Women's University	Chun, YJ (corresponding author), Chung Ang Univ, Coll Pharm, 221 Heukseok Dong, Seoul 156756, South Korea.	yjchun@cau.ac.kr			Korea Food and Drug Administration (KFDA) [10182KFDA992-3202]	Korea Food and Drug Administration (KFDA)	This work was supported by Grant 10182KFDA992-3202 from the Korea Food and Drug Administration (KFDA).	Bogdanova N, 2007, HUM MOL GENET, V16, P573, DOI 10.1093/hmg/ddm017; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Chirino YI, 2009, EXP TOXICOL PATHOL, V61, P223, DOI 10.1016/j.etp.2008.09.003; Desoize B, 2002, CRIT REV ONCOL HEMAT, V42, P317, DOI 10.1016/S1040-8428(01)00219-0; Ea HK, 2008, ANN RHEUM DIS, V67, P1617, DOI 10.1136/ard.2008.087718; Fella K, 2005, PROTEOMICS, V5, P1914, DOI 10.1002/pmic.200401067; Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974; Giedroc DP, 2001, ANTIOXID REDOX SIGN, V3, P577, DOI 10.1089/15230860152542943; Hanigan Marie H, 2003, Cancer Ther, V1, P47; Hofstra L, 2007, EUR HEART J, V28, P2695, DOI 10.1093/eurheartj/ehm452; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kheifets V, 2006, J BIOL CHEM, V281, P23218, DOI 10.1074/jbc.M602075200; Kim SY, 2012, BIOMOL THER, V20, P268, DOI 10.4062/biomolther.2012.20.3.268; Lee WK, 2004, TOXICOL MECH METHOD, V14, P67, DOI 10.1080/15376520490257509; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Markoff A, 2005, AM J PHYSIOL-RENAL, V289, pF949, DOI 10.1152/ajprenal.00089.2005; Matsuda R, 2000, CLIN CHIM ACTA, V298, P29, DOI 10.1016/S0009-8981(00)00218-7; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Park MS, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134858; Ravassa S, 2007, EUR HEART J, V28, P2785, DOI 10.1093/eurheartj/ehm370; Ravassa S, 2010, CARDIOVASC RES, V88, P304, DOI 10.1093/cvr/cvq183; ROTHHUT B, 1995, EUR J BIOCHEM, V232, P865; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwacha MG, 2003, SHOCK, V20, P529, DOI 10.1097/01.shk.0000095059.62263.56; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Simsek B, 2008, PEDIATR NEPHROL, V23, P79, DOI 10.1007/s00467-007-0606-z; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; Toescu EC, 2000, PFLUG ARCH EUR J PHY, V440, P941, DOI 10.1007/s004240000390; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wang EJ, 2008, TOXICOLOGY, V246, P91, DOI 10.1016/j.tox.2007.12.031; Wong A, 2002, BIOCHEM BIOPH RES CO, V298, P750, DOI 10.1016/S0006-291X(02)02546-9; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205	36	33	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2469	2481		10.1074/jbc.M113.450163	http://dx.doi.org/10.1074/jbc.M113.450163			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24318879	Green Published, hybrid			2022-12-28	WOS:000331130200050
J	Niedzielska, M; Bodendorfer, B; Munch, S; Eichner, A; Derigs, M; da Costa, O; Schweizer, A; Neff, F; Nitschke, L; Sparwasser, T; Keyse, SM; Lang, R				Niedzielska, Magdalena; Bodendorfer, Barbara; Muench, Sandra; Eichner, Alexander; Derigs, Marcus; da Costa, Olivia; Schweizer, Astrid; Neff, Frauke; Nitschke, Lars; Sparwasser, Tim; Keyse, Stephen M.; Lang, Roland			Gene Trap Mice Reveal an Essential Function of Dual Specificity Phosphatase Dusp16/MKP-7 in Perinatal Survival and Regulation of Toll-like Receptor (TLR)-induced Cytokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokines; Interferon; Dendritic Cells; Endotoxin; Gene Knock-out; Innate Immunity; Macrophages; MAP Kinases (MAPKs); Dual Specificity Phosphatase; Gene Trap; Perinatal Lethality	PROTEIN-KINASE PHOSPHATASE; MAP KINASE; INTERLEUKIN-12 P40; IMMUNE-RESPONSES; INFLAMMATORY RESPONSES; ACTIVATION; INNATE; MKP-7; IL-12; ERK	MAPK activity is negatively regulated by members of the dual specificity phosphatase (Dusp) family, which differ in expression, substrate specificity, and subcellular localization. Here, we investigated the function of Dusp16/MKP-7 in the innate immune system. The Dusp16 isoforms A1 and B1 were inducibly expressed in macrophages and dendritic cells following Toll-like receptor stimulation. A gene trap approach was used to generate Dusp16-deficient mice. Homozygous Dusp16tp/tp mice developed without gross abnormalities but died perinatally. Fetal liver cells from Dusp16tp/tp embryos efficiently reconstituted the lymphoid and myeloid compartments with Dusp16-deficient hematopoietic cells. However, GM-CSF-induced proliferation of bone marrow progenitors in vitro was impaired in the absence of Dusp16. In vivo challenge with Escherichia coli LPS triggered higher production of IL-12p40 in mice with a Dusp16-deficient immune system. In vitro, Dusp16-deficient macrophages, but not dendritic cells, selectively overexpressed a subset of TLR-induced genes, including the cytokine IL-12. Dusp16-deficient fibroblasts showed enhanced activation of p38 and JNK MAPKs. In macrophages, pharmacological inhibition and siRNA knockdown of JNK1/2 normalized IL-12p40 secretion. Production of IL-10 and its inhibitory effect on IL-12 production were unaltered in Dusp16tp/tp macrophages. Altogether, the Dusp16 gene trap mouse model identifies an essential role in perinatal survival and reveals selective control of differentiation and cytokine production of myeloid cells by the MAPK phosphatase Dusp16.	[Niedzielska, Magdalena; Bodendorfer, Barbara; Derigs, Marcus; Lang, Roland] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany; [Eichner, Alexander; da Costa, Olivia; Sparwasser, Tim] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Schweizer, Astrid; Nitschke, Lars] Univ Erlangen Nurnberg, Dept Biol, Chair Genet, D-91058 Erlangen, Germany; [Neff, Frauke] Helmholtz Ctr Munich, Inst Pathol, D-85764 Neuherberg, Germany; [Muench, Sandra; Keyse, Stephen M.] Ninewells Hosp & Med Sch, Jacqui Wood Canc Ctr, Med Res Inst, Div Canc Res,Canc Res UK Stress Response Lab, Dundee DD1 9SY, Scotland	University of Erlangen Nuremberg; Technical University of Munich; University of Erlangen Nuremberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Dundee	Lang, R (corresponding author), Inst Clin Microbiol Immunol & Hyg, Wasserturmstr 3-5, D-91054 Erlangen, Germany.	roland.lang@uk-erlangen.de	Sparwasser, Tim/AAF-7085-2019; Keyse, Stephen M./B-9575-2009; Sparwasser, Tim D/AAA-4306-2022	Sparwasser, Tim/0000-0001-5645-902X; Keyse, Stephen M./0000-0002-5150-8221; Lang, Roland/0000-0003-0502-3677; Derigs, Marcus/0000-0002-2904-3894	Deutsche Forschungsgemeinschaft [SFB 643, TP A10]; Bayerische Forschungsstiftung; Cancer Research UK Program Grant CR-UK Stress Response Laboratory [C8227/A12053]; Cancer Research UK [12053] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayerische Forschungsstiftung; Cancer Research UK Program Grant CR-UK Stress Response Laboratory; Cancer Research UK(Cancer Research UK)	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 643, TP A10 (to R. L.) and a Bayerische Forschungsstiftung fellowship (to M. N.). Work in the Keyse laboratory was supported by Cancer Research UK Program Grant CR-UK Stress Response Laboratory C8227/A12053.	Al-Mutairi MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001192; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Cornell TT, 2010, INFECT IMMUN, V78, P2868, DOI 10.1128/IAI.00018-10; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Goodridge HS, 2003, IMMUNOLOGY, V109, P415, DOI 10.1046/j.1365-2567.2003.01689.x; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hammer M, 2005, EUR J IMMUNOL, V35, P2991, DOI 10.1002/eji.200526192; Hammer M, 2010, IMMUNOLOGY, V131, P395, DOI 10.1111/j.1365-2567.2010.03313.x; Huang J, 2011, J CHEMOTHERAPY, V23, P221, DOI 10.1179/joc.2011.23.4.221; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Katagiri C, 2005, J BIOL CHEM, V280, P14716, DOI 10.1074/jbc.M500200200; Kim KH, 2012, P NATL ACAD SCI USA, V109, P7729, DOI 10.1073/pnas.1120251109; Korhonen R, 2012, MOL IMMUNOL, V51, P219, DOI 10.1016/j.molimm.2012.03.019; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lang R, 2002, J IMMUNOL, V168, P3402, DOI 10.4049/jimmunol.168.7.3402; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Maruyama S, 2003, J IMMUNOL, V170, P997, DOI 10.4049/jimmunol.170.2.997; Masuda K, 2003, J BIOL CHEM, V278, P32448, DOI 10.1074/jbc.M213254200; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; Masuda K, 2010, BIOCHEM BIOPH RES CO, V393, P201, DOI 10.1016/j.bbrc.2010.01.097; Matsuguchi T, 2001, MOL CELL BIOL, V21, P6999, DOI 10.1128/MCB.21.20.6999-7009.2001; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Musikacharoen T, 2011, J BIOL CHEM, V286, P24896, DOI 10.1074/jbc.M111.245019; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Rodriguez N, 2010, J LEUKOCYTE BIOL, V88, P579, DOI 10.1189/jlb.0210083; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Tanoue T, 2001, J BIOL CHEM, V276, P26629, DOI 10.1074/jbc.M101981200; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Wiese M, 2010, J IMMUNOL METHODS, V353, P102, DOI 10.1016/j.jim.2009.12.002; Willoughby EA, 2005, J BIOL CHEM, V280, P25651, DOI 10.1074/jbc.M501926200; Xie J, 2005, EXP HEMATOL, V33, P564, DOI 10.1016/j.exphem.2005.03.001; Zhang W, 2013, EUR J IMMUNOL, V43, P258, DOI 10.1002/eji.201242697; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhou L, 2004, MOL CELL BIOL, V24, P2385, DOI 10.1128/MCB.24.6.2385-2396.2004	45	18	20	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2112	2126		10.1074/jbc.M113.535245	http://dx.doi.org/10.1074/jbc.M113.535245			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311790	Green Published, hybrid			2022-12-28	WOS:000331130200020
J	Wydeven, N; Posokhova, E; Xia, ZL; Martemyanov, KA; Wickman, K				Wydeven, Nicole; Posokhova, Ekaterina; Xia, Zhilian; Martemyanov, Kirill A.; Wickman, Kevin			RGS6, but Not RGS4, Is the Dominant Regulator of G Protein Signaling (RGS) Modulator of the Parasympathetic Regulation of Mouse Heart Rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Proteins; Gene Knockout; Heart; Patch Clamp Electrophysiology; Potassium Channels; RGS Proteins; GIRK; Kir3; Muscarinic; Sinoatrial Node	GTPASE-ACTIVATING PROTEINS; SICK SINUS SYNDROME; END RULE PATHWAY; I-KACH; PACEMAKER ACTIVITY; GIRK CHANNELS; K+-CHANNEL; EXPRESSION; ASSOCIATION; RECEPTORS	Parasympathetic activity decreases heart rate (HR) by inhibiting pacemaker cells in the sinoatrial node (SAN). Dysregulation of parasympathetic influence has been linked to sinus node dysfunction and arrhythmia. RGS (regulator of G protein signaling) proteins are negative modulators of the parasympathetic regulation of HR and the prototypical M-2 muscarinic receptor (M2R)-dependent signaling pathway in the SAN that involves the muscarinic-gated atrial K+ channel I-KACh. Both RGS4 and RGS6-G5 have been implicated in these processes. Here, we used Rgs4(-/-), Rgs6(-/-), and Rgs4(-/-):Rgs6(-/-) mice to compare the relative influence of RGS4 and RGS6 on parasympathetic regulation of HR and M2R-I-KACh-dependent signaling in the SAN. In retrogradely perfused hearts, ablation of RGS6, but not RGS4, correlated with decreased resting HR, increased heart rate variability, and enhanced sensitivity to the negative chronotropic effects of the muscarinic agonist carbachol. Similarly, loss of RGS6, but not RGS4, correlated with enhanced sensitivity of the M2R-I-KACh signaling pathway in SAN cells to carbachol and a significant slowing of M2R-I-KACh deactivation rate. Surprisingly, concurrent genetic ablation of RGS4 partially rescued some deficits observed in Rgs6(-/-) mice. These findings, together with those from an acute pharmacologic approach in SAN cells from Rgs6(-/-) and G5(-/-) mice, suggest that the partial rescue of phenotypes in Rgs4(-/-):Rgs6(-/-) mice is attributable to another R7 RGS protein whose influence on M2R-I-KACh signaling is masked by RGS4. Thus, RGS6-G5, but not RGS4, is the primary RGS modulator of parasympathetic HR regulation and SAN M2R-I-KACh signaling in mice.	[Wydeven, Nicole; Xia, Zhilian; Wickman, Kevin] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Posokhova, Ekaterina; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA	University of Minnesota System; University of Minnesota Twin Cities; Scripps Research Institute	Martemyanov, KA (corresponding author), Scripps Res Inst, Dept Neurosci, 130 Scripps Way,3C2, Jupiter, FL 33458 USA.	kirill@scripps.edu; wickm002@umn.edu		Wickman, Kevin/0000-0002-5179-9540	National Institutes of Health [HL105550, MH061933, DA007234]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL105550 (to K. W. and K. A. M.), MH061933 (to K. W.), and DA007234 (to N. W.).	Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Bettahi H, 2002, J BIOL CHEM, V277, P48282, DOI 10.1074/jbc.M209599200; Blazer LL, 2010, MOL PHARMACOL, V78, P524, DOI 10.1124/mol.110.065128; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Cifelli C, 2008, CIRC RES, V103, P527, DOI 10.1161/CIRCRESAHA.108.180984; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Dobrzynski H, 2007, CIRCULATION, V115, P1921, DOI 10.1161/CIRCULATIONAHA.106.616011; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; Fu Y, 2007, AM J PHYSIOL-HEART C, V292, pH2532, DOI 10.1152/ajpheart.01391.2006; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; Jaen C, 2006, J BIOL CHEM, V281, P34549, DOI 10.1074/jbc.M603177200; Kardestuncer T, 1998, FEBS LETT, V438, P285, DOI 10.1016/S0014-5793(98)01319-2; Kovoor P, 2001, J AM COLL CARDIOL, V37, P2136, DOI 10.1016/S0735-1097(01)01304-3; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mesirca P, 2013, J GEN PHYSIOL, V142, P113, DOI 10.1085/jgp.201310996; Mighiu AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00204; Mittmann C, 2002, CARDIOVASC RES, V55, P778, DOI 10.1016/S0008-6363(02)00459-5; Neubig RR, 2008, CIRC RES, V103, P444, DOI 10.1161/CIRCRESAHA.108.183384; Posokhova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076973; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Stewart A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00095; Vasan RS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S2; Vaseghi M, 2008, PROG CARDIOVASC DIS, V50, P404, DOI 10.1016/j.pcad.2008.01.003; Vashisth H., 2013, ACS CHEM BIOL, DOI 10.1021/cb400568g; Wang F, 2013, HEART RHYTHM, V10, P1500, DOI 10.1016/j.hrthm.2013.07.022; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; Wydeven N, 2012, P NATL ACAD SCI USA, V109, P21492, DOI 10.1073/pnas.1212019110; Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Yang YZ, 2010, AM J HUM GENET, V86, P872, DOI 10.1016/j.ajhg.2010.04.017; Zhang QL, 2002, J PHYSIOL-LONDON, V545, P355, DOI 10.1113/jphysiol.2002.032151	43	25	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2440	2449		10.1074/jbc.M113.520742	http://dx.doi.org/10.1074/jbc.M113.520742			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24318880	hybrid, Green Published			2022-12-28	WOS:000331130200047
J	Baile, MG; Sathappa, M; Lu, YW; Pryce, E; Whited, K; McCaffery, JM; Han, XL; Alder, NN; Claypool, SM				Baile, Matthew G.; Sathappa, Murugappan; Lu, Ya-Wen; Pryce, Erin; Whited, Kevin; McCaffery, J. Michael; Han, Xianlin; Alder, Nathan N.; Claypool, Steven M.			Unremodeled and Remodeled Cardiolipin Are Functionally Indistinguishable in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transfer Complex; Cardiolipin; Membrane Biogenesis; Membrane Lipids; Mitochondria; Mitochondrial Diseases; Phospholipid; Yeast	CYTOCHROME-C-OXIDASE; MULTIDIMENSIONAL MASS-SPECTROMETRY; BARTH-SYNDROME; MITOCHONDRIAL DYSFUNCTION; INTERMEMBRANE SPACE; PHOSPHOLIPASE A(2); RESPIRATORY-CHAIN; OXIDATIVE STRESS; ATP SYNTHASE; MEMBRANE	Background: The phospholipid cardiolipin undergoes acyl chain remodeling after biosynthesis, which has been hypothesized to optimize mitochondrial function. Results: cld1 yeast, containing unremodeled cardiolipin, have no mitochondrial morphology or oxidative phosphorylation defects. Conclusion: Cardiolipin remodeling is not required for optimal mitochondrial bioenergetic function in yeast. Significance: Cardiolipin remodeling may be important for presently unknown mitochondrial processes and/or have unappreciated physiological functions. After biosynthesis, an evolutionarily conserved acyl chain remodeling process generates a final highly homogeneous and yet tissue-specific molecular form of the mitochondrial lipid cardiolipin. Hence, cardiolipin molecules in different organisms, and even different tissues within the same organism, contain a distinct collection of attached acyl chains. This observation is the basis for the widely accepted paradigm that the acyl chain composition of cardiolipin is matched to the unique mitochondrial demands of a tissue. For this hypothesis to be correct, cardiolipin molecules with different acyl chain compositions should have distinct functional capacities, and cardiolipin that has been remodeled should promote cardiolipin-dependent mitochondrial processes better than its unremodeled form. However, functional disparities between different molecular forms of cardiolipin have never been established. Here, we interrogate this simple but crucial prediction utilizing the best available model to do so, Saccharomyces cerevisiae. Specifically, we compare the ability of unremodeled and remodeled cardiolipin, which differ markedly in their acyl chain composition, to support mitochondrial activities known to require cardiolipin. Surprisingly, defined changes in the acyl chain composition of cardiolipin do not alter either mitochondrial morphology or oxidative phosphorylation. Importantly, preventing cardiolipin remodeling initiation in yeast lacking TAZ1, an ortholog of the causative gene in Barth syndrome, ameliorates mitochondrial dysfunction. Thus, our data do not support the prevailing hypothesis that unremodeled cardiolipin is functionally distinct from remodeled cardiolipin, at least for the functions examined, suggesting alternative physiological roles for this conserved pathway.	[Baile, Matthew G.; Lu, Ya-Wen; Whited, Kevin; Claypool, Steven M.] Johns Hopkins Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA; [Sathappa, Murugappan; Alder, Nathan N.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Pryce, Erin; McCaffery, J. Michael] Johns Hopkins Univ, Integrated Imaging Ctr, Dept Biol, Baltimore, MD 21218 USA; [Han, Xianlin] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA	Johns Hopkins University; Johns Hopkins Medicine; University of Connecticut; Johns Hopkins University; Sanford Burnham Prebys Medical Discovery Institute	Claypool, SM (corresponding author), Johns Hopkins Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	sclaypo1@jhmi.edu	Lu, Ya-Wen/A-7813-2016; Sathappa, Murugappan/AAD-6709-2019	Lu, Ya-Wen/0000-0003-0479-1471; Sathappa, Murugappan/0000-0003-2146-1917; Baile, Matthew/0000-0002-2680-1178; Alder, Nathan/0000-0003-4474-7803; Claypool, Steven/0000-0001-5316-1623	National Institutes of Health [R00HL089185, 1R01HL108882]; NCRR [SRR022588A]; National Science Foundation [MCB-1024908]; intramural institutional research funds; Div Of Molecular and Cellular Bioscience [1330695] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022588] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108882, R00HL089185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); intramural institutional research funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R00HL089185 and 1R01HL108882 (to S. M. C.) and Grant SRR022588A from NCRR (to J. M. M.). This work was also supported by National Science Foundation Grant MCB-1024908 (to N. N. A.) and intramural institutional research funds (to X. H.).	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; [Anonymous], 2010, LIPID ANAL ISOLATION; Baile MG, 2013, MOL BIOL CELL, V24, P2008, DOI 10.1091/mbc.E13-03-0121; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Cao JS, 2009, AM J PHYSIOL-ENDOC M, V296, pE647, DOI 10.1152/ajpendo.90761.2008; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Cheng H, 2008, BIOCHEMISTRY-US, V47, P5869, DOI 10.1021/bi7023282; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; DAUM G, 1982, J BIOL CHEM, V257, P3028; de Kroon AIPM, 2013, PROG LIPID RES, V52, P374, DOI 10.1016/j.plipres.2013.04.006; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; EBLE KS, 1990, J BIOL CHEM, V265, P19434; FRY M, 1980, BIOCHEM BIOPH RES CO, V93, P1238, DOI 10.1016/0006-291X(80)90622-1; FRY M, 1981, J BIOL CHEM, V256, P1874; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Han XL, 2008, RAPID COMMUN MASS SP, V22, P2115, DOI 10.1002/rcm.3595; Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Jarosch E, 1996, J BIOL CHEM, V271, P17219, DOI 10.1074/jbc.271.29.17219; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Kiebish MA, 2012, J BIOL CHEM, V287, P25086, DOI 10.1074/jbc.M112.340521; Kim J, 2011, J LIPID RES, V52, P125, DOI 10.1194/jlr.M010520; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003; Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200; MACCECCHINI ML, 1979, P NATL ACAD SCI USA, V76, P343, DOI 10.1073/pnas.76.1.343; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Marom M, 2009, BIOCHEMISTRY-US, V48, P11185, DOI 10.1021/bi900998v; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Musatov A, 2006, FREE RADICAL BIO MED, V41, P238, DOI 10.1016/j.freeradbiomed.2006.03.018; OHASHI A, 1982, J BIOL CHEM, V257, P3042; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Panneels V, 2003, BIOCHEM BIOPH RES CO, V300, P65, DOI 10.1016/S0006-291X(02)02795-X; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; POYTON RO, 1975, J BIOL CHEM, V250, P762; RIEZMAN H, 1983, EMBO J, V2, P1105, DOI 10.1002/j.1460-2075.1983.tb01553.x; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064; Schlame M, 2012, CHEM PHYS LIPIDS, V165, P512, DOI 10.1016/j.chemphyslip.2012.03.001; Schwall CT, 2012, BBA-BIOENERGETICS, V1817, P1588, DOI 10.1016/j.bbabio.2012.04.015; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Soustek MS, 2011, HUM GENE THER, V22, P865, DOI 10.1089/hum.2010.199; Thorsness Mary K, 2002, Methods Mol Biol, V197, P177, DOI 10.1385/1-59259-284-8:177; TZAGOLOFF A, 1975, J BACTERIOL, V122, P826, DOI 10.1128/JB.122.3.826-831.1975; Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Whited K, 2013, HUM MOL GENET, V22, P483, DOI 10.1093/hmg/dds447; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	78	82	83	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1768	1778		10.1074/jbc.M113.525733	http://dx.doi.org/10.1074/jbc.M113.525733			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24285538	Green Published, hybrid			2022-12-28	WOS:000332401700047
J	Cramer, JM; Scarsdale, JN; Walavalkar, NM; Buchwald, WA; Ginder, GD; Williams, DC				Cramer, Jason M.; Scarsdale, J. Neel; Walavalkar, Ninad M.; Buchwald, William A.; Ginder, Gordon D.; Williams, David C., Jr.			Probing the Dynamic Distribution of Bound States for Methylcytosine-binding Domains on DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; DNA Binding Protein; DNA Methylation; Nuclear Magnetic Resonance; Protein Dynamics; MBD2; MBD3; Hydroxymethylated DNA; Residual Dipolar Couplings	PRIMARY ERYTHROID-CELLS; METHYL-CPG; CHEMICAL-SHIFTS; COMPLEX; NMR; PROTEINS; MBD2; TRANSCRIPTION; EXPRESSION; MBD3/NURD	Background: Although highly homologous to MBD2, the functional role of MBD3 remains in question. Results: MBD3 preferentially localizes to methylated and, to a lesser degree, unmethylated CpG dinucleotides. Conclusion: Dynamic distribution between methylated and unmethylated sites modifies the genomic localization of MBD3. Significance: Changes in the dynamic distribution on DNA dictate functional differences between MBD proteins. Although highly homologous to other methylcytosine-binding domain (MBD) proteins, MBD3 does not selectively bind methylated DNA, and thus the functional role of MBD3 remains in question. To explore the structural basis of its binding properties and potential function, we characterized the solution structure and binding distribution of the MBD3 MBD on hydroxymethylated, methylated, and unmethylated DNA. The overall fold of this domain is very similar to other MBDs, yet a key loop involved in DNA binding is more disordered than previously observed. Specific recognition of methylated DNA constrains the structure of this loop and results in large chemical shift changes in NMR spectra. Based on these spectral changes, we show that MBD3 preferentially localizes to methylated and, to a lesser degree, unmethylated cytosine-guanosine dinucleotides (CpGs), yet does not distinguish between hydroxymethylated and unmethylated sites. Measuring residual dipolar couplings for the different bound states clearly shows that the MBD3 structure does not change between methylation-specific and nonspecific binding modes. Furthermore, residual dipolar couplings measured for MBD3 bound to methylated DNA can be described by a linear combination of those for the methylation and nonspecific binding modes, confirming the preferential localization to methylated sites. The highly homologous MBD2 protein shows similar but much stronger localization to methylated as well as unmethylated CpGs. Together, these data establish the structural basis for the relative distribution of MBD2 and MBD3 on genomic DNA and their observed occupancy at active and inactive CpG-rich promoters.	[Cramer, Jason M.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Scarsdale, J. Neel] Virginia Commonwealth Univ, Ctr Study Biol Complex, Inst Struct Biol & Drug Design, Richmond, VA 23298 USA; [Scarsdale, J. Neel; Ginder, Gordon D.; Williams, David C., Jr.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Ginder, Gordon D.; Williams, David C., Jr.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA; [Ginder, Gordon D.; Williams, David C., Jr.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Ginder, Gordon D.; Williams, David C., Jr.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Walavalkar, Ninad M.; Buchwald, William A.; Ginder, Gordon D.; Williams, David C., Jr.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill	Williams, DC (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	david_willjr@med.unc.edu			National Institutes of Health [R01 GM098624, R01 DK029902]; NCI Cancer Center Core Support Grant [P30 CA016059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098264] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM098624 (to D. C. W.) and R01 DK029902 (to G. D. G.). NMR data were acquired using NMR instrumentation in the Virginia Commonwealth University Massey Cancer Center Structural Biology Core, and surface plasmon resonance data were acquired in the Virginia Commonwealth University Massey Cancer Center Flow Cytometry Core, both of which are supported, in part, by NCI Cancer Center Core Support Grant P30 CA016059.	Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Clore GM, 2002, J AM CHEM SOC, V124, P2866, DOI 10.1021/ja017712p; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Feng Q, 2001, GENE DEV, V15, P827; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; Gnanapragasam MN, 2011, P NATL ACAD SCI USA, V108, P7487, DOI 10.1073/pnas.1015341108; Gunther K, 2013, NUCLEIC ACIDS RES, V41, P3010, DOI 10.1093/nar/gkt035; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Kransdorf EP, 2006, BLOOD, V108, P2836, DOI 10.1182/blood-2006-04-016394; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Matsumoto M, 2008, GENE, V420, P125, DOI 10.1016/j.gene.2008.05.007; Mistrik P, 2004, ANAL BIOCHEM, V327, P271, DOI 10.1016/j.ab.2004.01.022; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Singal R, 2002, J BIOL CHEM, V277, P1897, DOI 10.1074/jbc.M105580200; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Williams DC, 2005, J BIOL CHEM, V280, P20775, DOI 10.1074/jbc.M501986200; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	30	41	44	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1294	1302		10.1074/jbc.M113.512236	http://dx.doi.org/10.1074/jbc.M113.512236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24307175	hybrid, Green Published			2022-12-28	WOS:000332401700009
J	Lee, J; Taneva, SG; Holland, BW; Tieleman, DP; Cornell, RB				Lee, Jaeyong; Taneva, Svetla G.; Holland, Bryan W.; Tieleman, D. Peter; Cornell, Rosemary B.			Structural Basis for Autoinhibition of CTP: Phosphocholine Cytidylyltransferase (CCT), the Regulatory Enzyme in Phosphatidylcholine Synthesis, by Its Membrane-binding Amphipathic Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Enzyme Inactivation; Enzyme Structure; Membrane Enzymes; Molecular Dynamics; Phosphatidylcholine; X-ray Crystallography; Amphipathic Helix	AMPHITROPIC ENZYME; DOMAIN; ALPHA; ACTIVATION; RESIDUES; DYNAMICS; CURVATURE; CATALYSIS; FEATURES; MOTIONS	Background: The CCT M-domain contains an autoinhibitory (AI) segment, but its mechanism was obscure. Results: The AI helix partly occludes active site access and engages a mobile loop (L2), impeding the dynamics of key catalytic lysine 122. Conclusion: Loop L2 is a key target of the AI clamp. Significance: This work reveals the nature of a regulatory off-switch in an enzyme regulated by membrane binding. CTP:phosphocholine cytidylyltransferase (CCT) interconverts between an inactive soluble and active membrane-bound form in response to changes in membrane lipid composition. Activation involves disruption of an inhibitory interaction between the E helices at the base of the active site and an autoinhibitory (AI) segment in the regulatory M domain and membrane insertion of the M domain as an amphipathic helix. We show that in the CCT soluble form the AI segment functions to suppress k(cat) and elevate the K-m for CTP. The crystal structure of a CCT dimer composed of the catalytic and AI segments reveals an AI-E interaction as a cluster of four amphipathic helices (two E and two AI helices) at the base of the active sites. This interaction corroborates mutagenesis implicating multiple hydrophobic residues within the AI segment that contribute to its silencing function. The AI-E interaction directs the turn at the C-terminal end of the AI helix into backbone-to-backbone contact with a loop (L2) at the opening to the active site, which houses the key catalytic residue, lysine 122. Molecular dynamics simulations suggest that lysine 122 side-chain orientations are constrained by contacts with the AI helix-turn, which could obstruct its engagement with substrates. This work deciphers how the CCT regulatory amphipathic helix functions as a silencing device.	[Lee, Jaeyong; Taneva, Svetla G.; Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Holland, Bryan W.; Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Simon Fraser University; Simon Fraser University; University of Calgary	Cornell, RB (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	cornell@sfu.ca	Tieleman, D. Peter/A-4790-2011	Tieleman, D. Peter/0000-0001-5507-0688	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Government of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Government of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan	We thank Dr. Mark Paetzel for use of equipment for purification and initial diffraction collection and for helpful advice. We are grateful to Ziwei Ding for construction of many plasmids and to Deidre de Jong-Wong for valuable technical assistance. Simulations used West-Grid/Compute Canada facilities. Diffraction was obtained at Beamlines 081D-1 and 08B1-1 at the Canadian Light Source, which is funded by the Canada Foundation for Innovation, the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Government of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnold RS, 1996, BIOCHEMISTRY-US, V35, P9917, DOI 10.1021/bi960397c; Arsenault DJ, 2013, J BIOL CHEM, V288, P633, DOI 10.1074/jbc.M112.347682; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5881, DOI 10.1021/bi00238a011; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Dennis MK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201715; Desamero R, 2003, BIOCHEMISTRY-US, V42, P2941, DOI 10.1021/bi026994i; Ding ZW, 2012, J BIOL CHEM, V287, P38980, DOI 10.1074/jbc.M112.402081; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; Friesen JA, 1999, J BIOL CHEM, V274, P13384, DOI 10.1074/jbc.274.19.13384; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Helmink BA, 2003, BIOCHEMISTRY-US, V42, P5043, DOI 10.1021/bi027431+; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang HKH, 2013, J MOL BIOL, V425, P1546, DOI 10.1016/j.jmb.2012.12.003; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Johnson JE, 1998, BIOCHEMISTRY-US, V37, P9509, DOI 10.1021/bi980340l; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kazanietz MG, 2011, STRUCTURE, V19, P144, DOI 10.1016/j.str.2011.01.004; Khajehpour M, 2007, BIOCHEMISTRY-US, V46, P4370, DOI 10.1021/bi602335x; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Leonard TA, 2011, CURR OPIN STRUC BIOL, V21, P785, DOI 10.1016/j.sbi.2011.07.006; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Malabanan MM, 2010, CURR OPIN STRUC BIOL, V20, P702, DOI 10.1016/j.sbi.2010.09.005; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Neumann P, 2008, P NATL ACAD SCI USA, V105, P17390, DOI 10.1073/pnas.0805027105; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pattridge KA, 2003, J BIOL CHEM, V278, P51863, DOI 10.1074/jbc.M306174200; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Sarri E, 2011, J BIOL CHEM, V286, P28632, DOI 10.1074/jbc.M111.267534; SOHAL PS, 1990, J BIOL CHEM, V265, P11746; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Taneva S, 2003, BIOCHEMISTRY-US, V42, P11768, DOI 10.1021/bi035234k; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Taneva SG, 2012, BBA-BIOMEMBRANES, V1818, P1173, DOI 10.1016/j.bbamem.2012.01.006; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; Veitch DP, 1998, EUR J BIOCHEM, V255, P227, DOI 10.1046/j.1432-1327.1998.2550227.x; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weidner A, 2009, J MOL CATAL B-ENZYM, V61, P88, DOI 10.1016/j.molcatb.2009.02.020; Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; YANG W, 1995, J BIOL CHEM, V270, P23951, DOI 10.1074/jbc.270.41.23951	62	31	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1742	1755		10.1074/jbc.M113.526970	http://dx.doi.org/10.1074/jbc.M113.526970			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24275660	Green Published, hybrid			2022-12-28	WOS:000332401700045
J	Naito-Matsui, Y; Takada, S; Kano, Y; Iyoda, T; Sugai, M; Shimizu, A; Inaba, K; Nitschke, L; Tsubata, T; Oka, S; Kozutsumi, Y; Takematsu, H				Naito-Matsui, Yuko; Takada, Shuhei; Kano, Yoshinobu; Iyoda, Tomonori; Sugai, Manabu; Shimizu, Akira; Inaba, Kayo; Nitschke, Lars; Tsubata, Takeshi; Oka, Shogo; Kozutsumi, Yasunori; Takematsu, Hiromu			Functional Evaluation of Activation-dependent Alterations in the Sialoglycan Composition of T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycobiology; Glycoconjugate; Lectin; Sialic Acid; T Cell; Germinal Center; Sialic Acid Modification; Siglec	N-GLYCOLYLNEURAMINIC ACID; B-CELL; PEANUT AGGLUTININ; ACETYLNEURAMINIC ACID; CD169(+) MACROPHAGES; BINDING-RECEPTOR; CUTTING EDGE; DYING CELLS; SIALOADHESIN; EXPRESSION	Background: Sialic acids play key roles in molecular recognition. Results: T-cell activation alters the principal sialic acid species profile, regulating expression of siglec ligands, T-cell activation per se, and T cell-B cell interactions. Conclusion: This activation-dependent change in the sialoglycan profile modulates immune responses. Significance: Pronounced changes in the sialoglycan profile not only serve as cellular markers but also reflect cellular functionality. Sialic acids (Sias) are often conjugated to the termini of cellular glycans and are key mediators of cellular recognition. Sias are nine-carbon acidic sugars, and, in vertebrates, the major species are N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc), differing in structure at the C5 position. Previously, we described a positive feedback loop involving regulation of Neu5Gc expression in mouse B cells. In this context, Neu5Gc negatively regulated B-cell proliferation, and Neu5Gc expression was suppressed upon activation. Similarly, resting mouse T cells expressed principally Neu5Gc, and Neu5Ac was induced upon activation. In the present work, we used various probes to examine sialoglycan expression by activated T cells in terms of the Sia species expressed and the linkages of Sias to glycans. Upon T-cell activation, sialoglycan expression shifted from Neu5Gc to Neu5Ac, and the linkage shifted from 2,6 to 2,3. These changes altered the expression levels of sialic acid-binding immunoglobulin-like lectin (siglec) ligands. Expression of sialoadhesin and Siglec-F ligands increased, and that of CD22 ligands decreased. Neu5Gc exerted a negative effect on T-cell activation, both in terms of the proliferative response and in the context of activation marker expression. Suppression of Neu5Gc expression in mouse T and B cells prevented the development of nonspecific CD22-mediated T cell-B cell interactions. Our results suggest that an activation-dependent shift from Neu5Gc to Neu5Ac and replacement of 2,6 by 2,3 linkages may regulate immune cell interactions at several levels.	[Naito-Matsui, Yuko; Takada, Shuhei; Kano, Yoshinobu; Kozutsumi, Yasunori; Takematsu, Hiromu] Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Sakyo Ku, Kyoto 6068501, Japan; [Iyoda, Tomonori; Inaba, Kayo] Kyoto Univ, Grad Sch Biostudies, Immunol Lab, Sakyo Ku, Kyoto 6068501, Japan; [Sugai, Manabu; Shimizu, Akira] Kyoto Univ Hosp, Dept Expt Therapeut, Translat Res Ctr, Sakyo Ku, Kyoto 6068507, Japan; [Nitschke, Lars] Univ Erlangen Nurnberg, Dept Biol, D-91058 Erlangen, Germany; [Tsubata, Takeshi] Tokyo Med & Dent Univ, Dept Immunol, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Oka, Shogo; Takematsu, Hiromu] Kyoto Univ, Dept Biol Chem, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto University; Kyoto University; University of Erlangen Nuremberg; Tokyo Medical & Dental University (TMDU); Kyoto University	Takematsu, H (corresponding author), Kyoto Univ, Grad Sch Med, Sakyo Ku, 53 Shogoin Kawahara, Tokyo 6068507, Japan.	htakema@pharm.kyoto-u.ac.jp	Tsubata, Takeshi/AAI-7489-2021	Tsubata, Takeshi/0000-0003-0760-1258; Sugai, Manabu/0000-0003-1668-7647; Takematsu, Hiromu/0000-0003-1689-9500	Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation; Suzuken Memorial Foundation; CREST, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25293069, 24659148, 24390073] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Suzuken Memorial Foundation; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Uehara Memorial Foundation; the Suzuken Memorial Foundation; and CREST, Japan Science and Technology Agency.	Amado M, 2004, J BIOL CHEM, V279, P36689, DOI 10.1074/jbc.M405629200; Angata T, 2001, J BIOL CHEM, V276, P45128, DOI 10.1074/jbc.M108573200; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Baum LG, 2009, IMMUNOL REV, V230, P5, DOI 10.1111/j.1600-065X.2009.00800.x; Bi SG, 2009, BBA-GEN SUBJECTS, V1790, P1599, DOI 10.1016/j.bbagen.2009.07.027; Buchlis G, 2013, J IMMUNOL, V191, P228, DOI 10.4049/jimmunol.1202905; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Chen GY, 2006, P NATL ACAD SCI USA, V103, P16894, DOI 10.1073/pnas.0607926103; Clark MC, 2012, ANN NY ACAD SCI, V1253, P58, DOI 10.1111/j.1749-6632.2011.06304.x; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; CROCKER PR, 1991, EMBO J, V10, P1661, DOI 10.1002/j.1460-2075.1991.tb07689.x; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; GILLESPIE W, 1993, J BIOL CHEM, V268, P3801; Grabie N, 2002, EUR J IMMUNOL, V32, P2766, DOI 10.1002/1521-4141(2002010)32:10<2766::AID-IMMU2766>3.0.CO;2-0; Gray E. E., 2012, PLOS ONE, V7; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; HATHCOCK KS, 1995, J IMMUNOL, V155, P4575; Hernandez JD, 2007, INT IMMUNOL, V19, P847, DOI 10.1093/intimm/dxm053; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Kidder D, 2013, J IMMUNOL, V190, P2593, DOI 10.4049/jimmunol.1201172; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Koyama S, 1996, GLYCOCONJUGATE J, V13, P353, DOI 10.1007/BF00731467; LASZLO G, 1993, J IMMUNOL, V150, P5252; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; LONDON J, 1978, J IMMUNOL, V121, P438; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Martinez-Pomares L, 2012, TRENDS IMMUNOL, V33, P66, DOI 10.1016/j.it.2011.11.001; Muerkoster S, 1999, BLOOD, V93, P4375, DOI 10.1182/blood.V93.12.4375.412k32_4375_4386; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Redelinghuys P, 2011, J BIOL CHEM, V286, P34522, DOI 10.1074/jbc.M111.243410; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; SCHAUER R, 1983, BIOCHEM SOC T, V11, P270, DOI 10.1042/bst0110270; SCHWARTZALBIEZ R, 1990, INT IMMUNOL, V2, P929, DOI 10.1093/intimm/2.10.929; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; SHAW L, 1988, BIOL CHEM H-S, V369, P477, DOI 10.1515/bchm3.1988.369.1.477; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Soto PC, 2010, J IMMUNOL, V184, P4185, DOI 10.4049/jimmunol.0903420; van den Berg TK, 2001, J IMMUNOL, V166, P3637, DOI 10.4049/jimmunol.166.6.3637; VARKI A, 1992, GLYCOBIOLOGY, V2, P25, DOI 10.1093/glycob/2.1.25; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; White SJ, 2001, J IMMUNOL, V167, P628, DOI 10.4049/jimmunol.167.2.628; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255	59	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1564	1579		10.1074/jbc.M113.523753	http://dx.doi.org/10.1074/jbc.M113.523753			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297165	Green Published, hybrid			2022-12-28	WOS:000332401700031
J	Pflieger, A; Jaillet, J; Petit, A; Auge-Gouillou, C; Renault, S				Pflieger, Aude; Jaillet, Jerome; Petit, Agnes; Auge-Gouillou, Corinne; Renault, Sylvaine			Target Capture during Mos1 Transposition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-Protein Interaction; Enzyme Mechanisms; Gene Transposable Elements; Genome Structure; Genomic Instability; Target Capture; Transposition	DNA TRANSPOSITION; RETROVIRAL INTEGRATION; SYNAPTIC COMPLEX; MARINER; GENE; MU; MECHANISM; INSERTION; EXCISION; ELEMENT	DNA transposition contributes to genomic plasticity. Target capture is a key step in the transposition process, because it contributes to the selection of new insertion sites. Nothing or little is known about how eukaryotic mariner DNA transposons trigger this step. In the case of Mos1, biochemistry and crystallography have deciphered several inverted terminal repeat-transposase complexes that are intermediates during transposition. However, the target capture complex is still unknown. Here, we show that the preintegration complex (i.e., the excised transposon) is the only complex able to capture a target DNA. Mos1 transposase does not support target commitment, which has been proposed to explain Mos1 random genomic integrations within host genomes. We demonstrate that the TA dinucleotide used as the target is crucial both to target recognition and in the chemistry of the strand transfer reaction. Bent DNA molecules are better targets for the capture when the target DNA is nicked two nucleotides apart from the TA. They improve strand transfer when the target DNA contains a mismatch near the TA dinucleotide.	[Pflieger, Aude; Jaillet, Jerome; Auge-Gouillou, Corinne; Renault, Sylvaine] Univ Tours, UFR Sci & Tech, UFR Pharm, EA Innovat Mol & Therapeut 6306, F-37200 Tours, France; [Petit, Agnes] Univ Tours, Ctr Etud Pathol Resp INSERM UMR 1100, UFR Med, F-37032 Tours 1, France; [Pflieger, Aude] CRIUCPQ, Grp Rech Hypertens Pulm, Quebec City, PQ G1V 4G5, Canada	Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Auge-Gouillou, C (corresponding author), Univ Tours, UFR Sci & Tech, UFR Pharm, EA Innovat Mol & Therapeut 6306, 31 Ave Monge, F-37200 Tours, France.	corinne.gouillou@univ-tours.fr; sylvaine.renault@univ-tours.fr	GOUILLOU, Corinne AUGE/T-2346-2018	GOUILLOU, Corinne AUGE/0000-0002-3340-5560; PETIT, AGNES/0000-0003-3214-807X; Renault, Sylvaine/0000-0002-6980-8855	Region Centre (InhDDE Project); University of Tours; Centre National de la Recherche Scientifique	Region Centre (InhDDE Project)(Region Centre-Val de Loire); University of Tours; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Region Centre (InhDDE Project), the University of Tours, and the Centre National de la Recherche Scientifique.	Auge-Gouillou C, 2005, MOL CELL BIOL, V25, P2861, DOI 10.1128/MCB.25.7.2861-2870.2005; Babatz TD, 2013, CURR OPIN GENET DEV, V23, P264, DOI 10.1016/j.gde.2013.02.007; BENJAMIN HW, 1989, CELL, V59, P373, DOI 10.1016/0092-8674(89)90298-5; Bouchet N., 2013, NUCL ACIDS RES, DOI 10.1093/nar/gkt874; Bouuaert CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053690; Bouuaert CC, 2011, MOL CELL BIOL, V31, P317, DOI 10.1128/MCB.01066-10; Bouuaert CC, 2010, GENETICA, V138, P473, DOI 10.1007/s10709-009-9391-x; Bouuaert CC, 2010, NUCLEIC ACIDS RES, V38, P190, DOI 10.1093/nar/gkp891; BRYAN G, 1990, GENETICS, V125, P103; Carpentier G, 2011, J MOL BIOL, V405, P892, DOI 10.1016/j.jmb.2010.11.032; Chalopin Domitille, 2012, Int J Evol Biol, V2012, P724519, DOI 10.1155/2012/724519; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Crenes G, 2010, GENETICA, V138, P509, DOI 10.1007/s10709-009-9387-6; Crenes G, 2009, MOL GENET GENOMICS, V281, P315, DOI 10.1007/s00438-008-0414-6; Cuypers MG, 2013, NUCLEIC ACIDS RES, V41, P2020, DOI 10.1093/nar/gks1295; Dawson A, 2003, MOL CELL, V11, P225, DOI 10.1016/S1097-2765(02)00798-0; Gradman RJ, 2008, MOL MICROBIOL, V67, P528, DOI 10.1111/j.1365-2958.2007.06056.x; Jaillet J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043365; Klenchin VA, 2008, NUCLEIC ACIDS RES, V36, P5855, DOI 10.1093/nar/gkn577; Krishnan L, 2012, J BIOL CHEM, V287, P40858, DOI 10.1074/jbc.R112.397760; Kuduvalli PN, 2001, EMBO J, V20, P924, DOI 10.1093/emboj/20.4.924; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lipkow K, 2004, J BIOL CHEM, V279, P48569, DOI 10.1074/jbc.M408759200; Lohe AR, 1997, P NATL ACAD SCI USA, V94, P1293, DOI 10.1073/pnas.94.4.1293; LOHE AR, 1995, MOL BIOL EVOL, V12, P62, DOI 10.1093/oxfordjournals.molbev.a040191; Lohe AR, 2000, GENETICS, V154, P647; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Matthews AGW, 2004, EMBO J, V23, P1198, DOI 10.1038/sj.emboj.7600131; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Montano SP, 2012, NATURE, V491, P413, DOI 10.1038/nature11602; Montano SP, 2011, CURR OPIN STRUC BIOL, V21, P370, DOI 10.1016/j.sbi.2011.03.004; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; Naigamwalla DZ, 1997, EMBO J, V16, P5227, DOI 10.1093/emboj/16.17.5227; Neiditch MB, 2001, MOL CELL BIOL, V21, P4302, DOI 10.1128/MCB.21.13.4302-4310.2001; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Plasterk R.H.A., 2002, MOBILE DNA, P519; Pribil PA, 2004, MOL MICROBIOL, V52, P1173, DOI 10.1111/j.1365-2958.2004.04046.x; Pribil PA, 2003, J MOL BIOL, V330, P247, DOI 10.1016/S0022-2836(03)00588-6; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Sakai J, 1997, CELL, V89, P205, DOI 10.1016/S0092-8674(00)80200-7; Shevchenko Y, 2002, NUCLEIC ACIDS RES, V30, P2469, DOI 10.1093/nar/30.11.2469; Sinzelle L, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-106; Tsai CL, 2003, NUCLEIC ACIDS RES, V31, P6180, DOI 10.1093/nar/gkg819; Vallin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030482; Wang W, 2000, INSECT MOL BIOL, V9, P145, DOI 10.1046/j.1365-2583.2000.00172.x; Yanagihara K, 2002, P NATL ACAD SCI USA, V99, P11317, DOI 10.1073/pnas.132403399; Zayed H, 2003, NUCLEIC ACIDS RES, V31, P2313, DOI 10.1093/nar/gkg341	48	6	6	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					100	111		10.1074/jbc.M113.523894	http://dx.doi.org/10.1074/jbc.M113.523894			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24269942	Green Published, hybrid			2022-12-28	WOS:000329370900009
J	Ptashne, M				Ptashne, Mark			The Chemistry of Regulation of Genes and Other Things	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Gene Regulation; Transcription; Nucleosome; Cooperativity; DNA-binding Protein; Activators; Repressors; Specificity; Genetic Switch; Recruitment	LAMBDA-PHAGE REPRESSOR; BACTERIOPHAGE-LAMBDA; DNA-BINDING; IMPOSING SPECIFICITY; TRANSCRIPTION ACTIVATOR; NUCLEOSOME OCCUPANCY; COOPERATIVE BINDING; RIGHT OPERATOR; CI-REPRESSOR; PROTEIN		Sloan Kettering Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Ptashne, M (corresponding author), Sloan Kettering Inst, New York, NY 10065 USA.							AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; ANDERSON WF, 1981, NATURE, V290, P754, DOI 10.1038/290754a0; BARBERIS A, 1995, CELL, V81, P359, DOI 10.1016/0092-8674(95)90389-5; Berrozpe G, 2013, CELL REP, V4, P445, DOI 10.1016/j.celrep.2013.07.001; BRENT R, 1985, CELL, V43, P729, DOI 10.1016/0092-8674(85)90246-6; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Brzovic PS, 2011, MOL CELL, V44, P942, DOI 10.1016/j.molcel.2011.11.008; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; BURZ DS, 1994, BIOCHEMISTRY-US, V33, P8406, DOI 10.1021/bi00194a004; BUSHMAN FD, 1988, CELL, V54, P191, DOI 10.1016/0092-8674(88)90551-X; CHADWICK P, 1970, COLD SPRING HARB SYM, V35, P283, DOI 10.1101/SQB.1970.035.01.038; Davidson EH, 2006, REG GEN GEN REG; Dodd IB, 2004, GENE DEV, V18, P344, DOI 10.1101/gad.1167904; Dodd IB, 2001, GENE DEV, V15, P3013, DOI 10.1101/gad.937301; EISEN H, 1970, P NATL ACAD SCI USA, V66, P855, DOI 10.1073/pnas.66.3.855; Farrell S, 1996, GENE DEV, V10, P2359, DOI 10.1101/gad.10.18.2359; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Furey TS, 2013, SCIENCE, V342, P705, DOI 10.1126/science.1246755; GILBERT W, 1967, P NATL ACAD SCI USA, V58, P2415, DOI 10.1073/pnas.58.6.2415; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; GINIGER E, 1987, NATURE, V330, P670, DOI 10.1038/330670a0; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; GRIFFITH J, 1986, NATURE, V322, P750, DOI 10.1038/322750a0; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P2236, DOI 10.1073/pnas.79.7.2236; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P7410, DOI 10.1073/pnas.79.23.7410; Hammachi F, 2012, CELL REPORTS, V1, P99, DOI 10.1016/j.celrep.2011.12.002; HEINEMAN.SF, 1970, P NATL ACAD SCI USA, V67, P1122, DOI 10.1073/pnas.67.3.1122; Hendrix R. W, 1983, LAMBDA 2; Herbig E, 2010, MOL CELL BIOL, V30, P2376, DOI 10.1128/MCB.01046-09; Hershey A. D., 1971, BACTERIOPHAGE LAMBDA, V2; HIMMELFARB HJ, 1990, CELL, V63, P1299, DOI 10.1016/0092-8674(90)90425-E; HOCHSCHILD A, 1983, CELL, V32, P319, DOI 10.1016/0092-8674(83)90451-8; HOCHSCHILD A, 1986, CELL, V44, P681, DOI 10.1016/0092-8674(86)90833-0; HOCHSCHILD A, 1986, CELL, V47, P807, DOI 10.1016/0092-8674(86)90523-4; Hopkins N., 1971, BACTERIOPHAGE LAMBDA, V2, P571; Islam K, 2013, P NATL ACAD SCI USA, V110, P16778, DOI 10.1073/pnas.1216365110; JOHNSON A, 1978, P NATL ACAD SCI USA, V75, P1783, DOI 10.1073/pnas.75.4.1783; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; KEEGAN L, 1986, SCIENCE, V231, P699, DOI 10.1126/science.3080805; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; LIN LL, 1989, J MOL BIOL, V210, P439, DOI 10.1016/0022-2836(89)90121-6; Little JW, 2010, CURR BIOL, V20, pR724, DOI 10.1016/j.cub.2010.06.028; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MA J, 1988, CELL, V55, P443, DOI 10.1016/0092-8674(88)90030-X; MA J, 1988, NATURE, V334, P631, DOI 10.1038/334631a0; Madhani H, 2007, YEAST MODEL CELLULAR; MANIATIS T, 1973, NATURE, V246, P133, DOI 10.1038/246133a0; MANIATIS T, 1974, NATURE, V250, P394, DOI 10.1038/250394a0; MANIATIS T, 1975, CELL, V5, P109, DOI 10.1016/0092-8674(75)90018-5; MANIATIS T, 1973, P NATL ACAD SCI USA, V70, P1531, DOI 10.1073/pnas.70.5.1531; Mapp AK, 2000, P NATL ACAD SCI USA, V97, P3930, DOI 10.1073/pnas.97.8.3930; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; MEYER BJ, 1980, J MOL BIOL, V139, P195, DOI 10.1016/0022-2836(80)90304-6; NEUBAUER Z, 1970, J MOL BIOL, V51, P1, DOI 10.1016/0022-2836(70)90265-2; PABO CO, 1979, P NATL ACAD SCI USA, V76, P1608, DOI 10.1073/pnas.76.4.1608; PABO CO, 1982, NATURE, V298, P443, DOI 10.1038/298443a0; PIRROTTA V, 1970, NATURE, V227, P41, DOI 10.1038/227041a0; PIRROTTA V, 1969, NATURE, V222, P541, DOI 10.1038/222541a0; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; PTASHNE M, 1967, NATURE, V214, P232, DOI 10.1038/214232a0; Ptashne M, 1998, CURR BIOL, V8, pR897; Ptashne M, 1998, CURR BIOL, V8, pR812, DOI 10.1016/S0960-9822(07)00508-8; Ptashne M, 2003, SCIENCE, V299, P1025, DOI 10.1126/science.1081519; PTASHNE M, 1967, P NATL ACAD SCI USA, V57, P306, DOI 10.1073/pnas.57.2.306; Ptashne M, 2001, ESSAYS BIOCHEM, V37, P1; Ptashne M, 2004, GENETIC SWITCH PHAGE; PTASHNE M, 2002, GENES SIGNALS; Ptashne M, 2007, CURR BIOL, V17, pR348, DOI 10.1016/j.cub.2007.03.030; Ptashne M, 2007, CURR BIOL, V17, pR394, DOI 10.1016/j.cub.2007.04.013; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Ptashne M, 2013, CELL, V153, P1180, DOI 10.1016/j.cell.2013.05.025; Ptashne M, 2013, P NATL ACAD SCI USA, V110, P7101, DOI 10.1073/pnas.1305399110; Ptashne M, 2013, FASEB J, V27, P1, DOI 10.1096/fj.13-0101ufm; Ptashne M, 2010, NATURE, V464, P487, DOI 10.1038/464487c; Ptashne M, 2009, CURR BIOL, V19, pR234, DOI 10.1016/j.cub.2009.02.015; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; REICHARDT L, 1971, P NATL ACAD SCI USA, V68, P2185, DOI 10.1073/pnas.68.9.2185; REICHARDT LF, 1975, J MOL BIOL, V93, P289, DOI 10.1016/0022-2836(75)90133-3; RUDEN DM, 1988, P NATL ACAD SCI USA, V85, P4262, DOI 10.1073/pnas.85.12.4262; RUDEN DM, 1991, NATURE, V350, P250, DOI 10.1038/350250a0; SAUER RT, 1982, NATURE, V298, P447, DOI 10.1038/298447a0; SAUER RT, 1979, NATURE, V279, P396, DOI 10.1038/279396a0; SCHMEISSNER U, 1980, P NATL ACAD SCI-BIOL, V77, P3191, DOI 10.1073/pnas.77.6.3191; STEINBERG RA, 1971, NATURE-NEW BIOL, V230, P76, DOI 10.1038/newbio230076a0; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Svenningsen SL, 2005, P NATL ACAD SCI USA, V102, P4465, DOI 10.1073/pnas.0409839102; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; TRIEZENBERG SJ, 1988, GENE DEV, V2, P730, DOI 10.1101/gad.2.6.730; Wang X, 2011, TRENDS GENET, V27, P487, DOI 10.1016/j.tig.2011.09.001; Wang X, 2011, NAT STRUCT MOL BIOL, V18, P507, DOI 10.1038/nsmb.2017; Wang X, 2010, CURR BIOL, V20, P868, DOI 10.1016/j.cub.2010.03.029; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; WHARTON RP, 1985, NATURE, V316, P601, DOI 10.1038/316601a0; Whipple FW, 1998, GENE DEV, V12, P2791, DOI 10.1101/gad.12.17.2791; WHIPPLE FW, 1994, GENE DEV, V8, P1212, DOI 10.1101/gad.8.10.1212; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x	105	27	31	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5417	5435		10.1074/jbc.X114.547323	http://dx.doi.org/10.1074/jbc.X114.547323			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24385432	hybrid, Green Published			2022-12-28	WOS:000332015500007
J	Wolfram, F; Kitova, EN; Robinson, H; Walvoort, MTC; Codee, JDC; Klassen, JS; Howell, PL				Wolfram, Francis; Kitova, Elena N.; Robinson, Howard; Walvoort, Marthe T. C.; Codee, Jeroen D. C.; Klassen, John S.; Howell, P. Lynne			Catalytic Mechanism and Mode of Action of the Periplasmic Alginate Epimerase AlgG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biofilm; Crystal Structure; Enzyme Catalysis; Polysaccharide; Pseudomonas aeruginosa; Alginate; Epimerase	VINELANDII MANNURONAN C-5-EPIMERASE; PSEUDOMONAS-AERUGINOSA ALGG; BIOSYNTHETIC GENE-CLUSTER; C-5 EPIMERASE; C5-MANNURONAN EPIMERASE; ERWINIA-CHRYSANTHEMI; PECTIN LYASE; ACID; PROTEIN; SEQUENCE	Background: The alginate epimerase AlgG converts mannuronate to its C5 epimer guluronate at the polymer level. Results: The structure of Pseudomonas syringae AlgG has been determined, and the protein has been functionally characterized. Conclusion: His(319) acts as the catalytic base, whereas Arg(345) neutralizes the negative charge of the carboxylate group during catalysis. Significance: This is the first structural characterization of a periplasmic alginate epimerase. Pseudomonas aeruginosa is an opportunistic pathogen that forms chronic biofilm infections in the lungs of cystic fibrosis patients. A major component of the biofilm during these infections is the exopolysaccharide alginate, which is synthesized at the inner membrane as a homopolymer of 1-4-linked -d-mannuronate. As the polymer passages through the periplasm, 22-44% of the mannuronate residues are converted to -l-guluronate by the C5-epimerase AlgG to produce a polymer of alternating -d-mannuronate and -l-guluronate blocks and stretches of polymannuronate. To understand the molecular basis of alginate epimerization, the structure of Pseudomonas syringae AlgG has been determined at 2.1- resolution, and the protein was functionally characterized. The structure reveals that AlgG is a long right-handed parallel -helix with an elaborate lid structure. Functional analysis of AlgG mutants suggests that His(319) acts as the catalytic base and that Arg(345) neutralizes the acidic group during the epimerase reaction. Water is the likely catalytic acid. Electrostatic surface potential and residue conservation analyses in conjunction with activity and substrate docking studies suggest that a conserved electropositive groove facilitates polymannuronate binding and contains at least nine substrate binding subsites. These subsites likely align the polymer in the correct register for catalysis to occur. The presence of multiple subsites, the electropositive groove, and the non-random distribution of guluronate in the alginate polymer suggest that AlgG is a processive enzyme. Moreover, comparison of AlgG and the extracellular alginate epimerase AlgE4 of Azotobacter vinelandii provides a structural rationale for the differences in their Ca2+ dependence.	[Wolfram, Francis; Howell, P. Lynne] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Kitova, Elena N.; Klassen, John S.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Kitova, Elena N.; Klassen, John S.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Robinson, Howard] Brookhaven Natl Lab, Photon Sci Div, Upton, NY 11973 USA; [Walvoort, Marthe T. C.; Codee, Jeroen D. C.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; University of Alberta; United States Department of Energy (DOE); Brookhaven National Laboratory; Leiden University; Leiden University - Excl LUMC; University of Toronto	Howell, PL (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	howell@sickkids.ca	Walvoort, Marthe/AAE-4468-2019; Walvoort, Marthe/ABE-8335-2020	Walvoort, Marthe/0000-0003-1101-2659; Klassen, John/0000-0002-3389-7112	National Center for Research Resources [P41RR012408]; National Institute of General Medical Sciences from the National Institutes of Health [P41GM103473]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, P41GM103473] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ana Mirela Neculai for substantial contributions to the initial studies on P. aeruginosa AlgG; Laura Riley, Joel Weadge, John C. C. Whitney, and Perrin Baker for helpful discussions; and Dustin J. Little and Jason Koo for technical assistance. Beam line X29 at the National Synchrotron Light Source is supported by the United States Department of Energy and by National Center for Research Resources Grant P41RR012408 and National Institute of General Medical Sciences Grant P41GM103473 from the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alberts B., 2002, MOL BIOL CELL, P1091; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boyd CD, 2012, J BACTERIOL, V194, P4406, DOI 10.1128/JB.00642-12; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Campa C, 2004, BIOCHEM J, V381, P155, DOI 10.1042/BJ20031265; CASWELL RC, 1989, GENE, V75, P127, DOI 10.1016/0378-1119(89)90389-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHITNIS CE, 1990, J BACTERIOL, V172, P2894, DOI 10.1128/jb.172.6.2894-2900.1990; Ciccarelli FD, 2002, TRENDS BIOCHEM SCI, V27, P59, DOI 10.1016/S0968-0004(01)02046-1; Creze C, 2008, J BIOL CHEM, V283, P18260, DOI 10.1074/jbc.M709931200; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Douthit SA, 2005, J BACTERIOL, V187, P4573, DOI 10.1128/JB.187.13.4573-4583.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ertesvag H, 1998, J BIOL CHEM, V273, P30927, DOI 10.1074/jbc.273.47.30927; ERTESVAG H, 1995, MOL MICROBIOL, V16, P719, DOI 10.1111/j.1365-2958.1995.tb02433.x; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; FRANKLIN MJ, 1994, J BACTERIOL, V176, P1821, DOI 10.1128/JB.176.7.1821-1830.1994; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Gimmestad M, 2003, J BACTERIOL, V185, P3515, DOI 10.1128/JB.185.12.3515-3523.2003; GORIN PAJ, 1966, CAN J CHEMISTRY, V44, P993, DOI 10.1139/v66-147; Hagner-McWhirter A, 2000, BIOCHEM J, V347, P69, DOI 10.1042/0264-6021:3470069; Hannesson HH, 1996, BIOCHEM J, V313, P589, DOI 10.1042/bj3130589; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; HAUG A, 1974, CARBOHYD RES, V32, P217, DOI 10.1016/S0008-6215(00)82100-X; Hoidal HK, 1999, J BIOL CHEM, V274, P12316, DOI 10.1074/jbc.274.18.12316; Holtan S, 2006, BIOCHEM J, V395, P319, DOI 10.1042/BJ20051804; Jerga A, 2006, BIOCHEMISTRY-US, V45, P552, DOI 10.1021/bi051862l; Jerga A, 2006, BIOCHEMISTRY-US, V45, P9138, DOI 10.1021/bi060748f; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitova EN, 2012, J AM SOC MASS SPECTR, V23, P431, DOI 10.1007/s13361-011-0311-9; Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARSEN B, 1971, CARBOHYD RES, V20, P225, DOI 10.1016/S0008-6215(00)81375-0; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; LINKER A, 1964, NATURE, V204, P187, DOI 10.1038/204187a0; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; Mikami B, 2012, ACTA CRYSTALLOGR D, V68, P1207, DOI 10.1107/S090744491202495X; Morea A, 2001, GENE, V278, P107, DOI 10.1016/S0378-1119(01)00685-0; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nyvall P, 2003, PLANT PHYSIOL, V133, P726, DOI 10.1104/pp.103.025981; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacheco B, 2009, J BIOL CHEM, V284, P1741, DOI 10.1074/jbc.M805479200; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; PenalozaVazquez A, 1997, J BACTERIOL, V179, P4464, DOI 10.1128/jb.179.14.4464-4472.1997; Pier GB, 2001, INFECT IMMUN, V69, P1895, DOI 10.1128/IAI.69.3.1895-1901.2001; PREISS J, 1962, J BIOL CHEM, V237, P309; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Ramstad MV, 2001, ENZYME MICROB TECH, V28, P57, DOI 10.1016/S0141-0229(00)00273-8; Rehm BH, 1996, J BACTERIOL, V178, P5884, DOI 10.1128/jb.178.20.5884-5889.1996; Roy C, 1999, J BACTERIOL, V181, P3705, DOI 10.1128/JB.181.12.3705-3709.1999; Rozeboom HJ, 2008, J BIOL CHEM, V283, P23819, DOI 10.1074/jbc.M804119200; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; SHERBROCKCOX V, 1984, CARBOHYD RES, V135, P147, DOI 10.1016/0008-6215(84)85012-0; SIMPSON JA, 1988, J GEN MICROBIOL, V134, P29; SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239; SKJAKBRAEK G, 1986, INT J BIOL MACROMOL, V8, P330, DOI 10.1016/0141-8130(86)90051-6; Sletmoen M, 2004, BIOMACROMOLECULES, V5, P1288, DOI 10.1021/bm0345211; Sun JX, 2006, ANAL CHEM, V78, P3010, DOI 10.1021/ac0522005; Svanem BIG, 2001, J BIOL CHEM, V276, P31542, DOI 10.1074/jbc.M102562200; Svanem BIG, 1999, J BACTERIOL, V181, P68, DOI 10.1128/JB.181.1.68-77.1999; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tonon T, 2008, J PHYCOL, V44, P1250, DOI 10.1111/j.1529-8817.2008.00580.x; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Valla S, 2001, BIOCHIMIE, V83, P819, DOI 10.1016/S0300-9084(01)01313-X; Vitali J, 1998, PLANT PHYSIOL, V116, P69, DOI 10.1104/pp.116.1.69; Walvoort MTC, 2012, ANGEW CHEM INT EDIT, V51, P4393, DOI 10.1002/anie.201108744; Wang WJ, 2003, ANAL CHEM, V75, P4945, DOI 10.1021/ac034300l; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	84	26	30	2	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6006	6019		10.1074/jbc.M113.533158	http://dx.doi.org/10.1074/jbc.M113.533158			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398681	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000332015500056
J	Ganapathy, S; Xiao, SW; Yang, M; Qi, M; Choi, DE; Ha, CS; Little, JB; Yuan, ZM				Ganapathy, Suthakar; Xiao, Shaowen; Yang, Mei; Qi, Min; Choi, Doo Eun; Ha, Chul S.; Little, John B.; Yuan, Zhi-Min			A Low-dose Arsenic-induced p53 Protein-mediated Metabolic Mechanism of Radiotherapy Protection*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; Glycolysis; Metabolism; p53; Signal Transduction	HYPOXIA-INDUCIBLE FACTORS; IN-VIVO	Background: Radiotherapy protection depends on a selective protection of normal tissues but not tumors. Results: We demonstrate that low doses of arsenic induce a p53/HIF-1-dependent metabolic reprogramming specific to normal cells, resulting in increased resistance to radiation toxicity. Conclusion: p53-mediated metabolic reprogramming can be explored for normal tissue protection. Significance: The use of low-dose arsenic for selective protection of normal tissues may have important therapeutic implications. Radiotherapy is the current frontline cancer treatment, but the resulting severe side effects often pose a significant threat to cancer patients, raising a pressing need for the development of effective strategies for radiotherapy protection. We exploited the distinct metabolic characteristics between normal and malignant cells for a metabolic mechanism of normal tissue protection. We showed that low doses of arsenic induce HIF-1, which activates a metabolic shift from oxidative phosphorylation to glycolysis, resulting in increased cellular resistance to radiation. Of importance is that low-dose arsenic-induced HIF-1 requires functional p53, limiting the glycolytic shift to normal cells. Using tumor-bearing mice, we provide proof of principle for selective normal tissue protection against radiation injury.	[Ganapathy, Suthakar; Yang, Mei; Choi, Doo Eun; Little, John B.; Yuan, Zhi-Min] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Xiao, Shaowen; Qi, Min; Ha, Chul S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiat Oncol, San Antonio, TX 78229 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; University of Texas Health San Antonio	Yuan, ZM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, SPH 1,Rm 509,655 Huntington Ave, Boston, MA 02115 USA.	zyuan@hsph.harvard.edu	Ha, C/GZL-9046-2022	yang, mei/0000-0001-9574-2282	NCI, National Institutes of Health [2 R01CA085679, RO1CA167814, RO1CA125144]; Morningside Foundation; Department of Energy [DOE 110976, 65089]; NATIONAL CANCER INSTITUTE [R01CA125144, R01CA183074, R01CA085679, R01CA167814] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Morningside Foundation; Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants 2 R01CA085679, RO1CA167814, and RO1CA125144. This work was also supported by the Morningside Foundation and by Department of Energy Grants DOE 110976 and 65089.	Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Corn PG, 2008, CANCER BIOL THER, V7, P265, DOI 10.4161/cbt.7.2.5745; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Ganapathy S., 2013, ONCOGENE; Giaccia AJ., 2006, RADIOBIOLOGY RADIOLO, P5; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; KASTAN MB, 1991, CANCER RES, V51, P6304; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Powell BL, 2011, EXPERT REV ANTICANC, V11, P1317, DOI [10.1586/era.11.128, 10.1586/ERA.11.128]; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	19	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5340	5347		10.1074/jbc.M113.531020	http://dx.doi.org/10.1074/jbc.M113.531020			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24391088	hybrid, Green Published			2022-12-28	WOS:000331607900074
J	Adeosun, SO; Hou, X; Zheng, BY; Stockmeier, C; Ou, XM; Paul, I; Mosley, T; Weisgraber, K; Wang, JM				Adeosun, Samuel O.; Hou, Xu; Zheng, Baoying; Stockmeier, Craig; Ou, Xiaoming; Paul, Ian; Mosley, Thomas; Weisgraber, Karl; Wang, Jun Ming			Cognitive Deficits and Disruption of Neurogenesis in a Mouse Model of Apolipoprotein E4 Domain Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Alzheimer Disease; ApoE; Apoptosis; BDNF; Neurogenesis; Protein Domains; Antagonistic Pleiotropy; Doublecortin; Learning and Memory	ADULT HIPPOCAMPAL NEUROGENESIS; INCREASED TAU PHOSPHORYLATION; ALZHEIMERS-DISEASE; E GENOTYPE; DENTATE GYRUS; TRANSGENIC MICE; E EPSILON-4; MEMORY PERFORMANCE; RECOGNITION MEMORY; APOE POLYMORPHISM	Background: Domain interaction may be the principal pathogenic feature of apoE4 in Alzheimer disease. Results: Young and old mice with mutations causing apoE4 domain interaction showed impaired cognition and a disruption in neurogenesis. Conclusion: Domain interaction mediates apoE4 neuro-pathologies and cognitive phenotype. Significance: Domain interaction is a viable prophylactic target against apoE4 cognitive phenotype and increased susceptibility to Alzheimer disease. Apolipoprotein E4 (apoE4) allele is the major genetic risk factor for sporadic Alzheimer disease (AD) due to the higher prevalence and earlier onset of AD in apoE4 carriers. Accumulating data suggest that the interaction between the N- and the C-terminal domains in the protein may be the main pathologic feature of apoE4. To test this hypothesis, we used Arg-61 mice, a model of apoE4 domain interaction, by introducing the domain interaction feature of human apoE4 into native mouse apoE. We carried out hippocampus-dependent learning and memory tests and related cellular and molecular assays on 12- and 3-month-old Arg-61 and age-matched background C57BL/6J mice. Learning and memory task performance were impaired in Arg-61 mice at both old and young ages compared with C57BL/6J mice. Surprisingly, young Arg-61 mice had more mitotic doublecortin-positive cells in the subgranular zone; mRNA levels of brain-derived neurotrophic factor (BDNF) and TrkB were also higher in 3-month-old Arg-61 hippocampus compared with C57BL/6J mice. These early-age neurotrophic and neurogenic (proliferative) effects in the Arg-61 mouse may be an inadequate compensatory but eventually detrimental attempt by the system to repair itself. This is supported by the higher cleaved caspase-3 levels in the young animals that not only persisted, but increased in old age, and the lower levels of doublecortin at old age in the hippocampus of Arg-61 mice. These results are consistent with human apoE4-dependent cognitive and neuro-pathologic changes, supporting the principal role of domain interaction in the pathologic effect of apoE4. Domain interaction is, therefore, a viable therapeutic/prophylactic target for cognitive impairment and AD in apoE4 subjects.	[Zheng, Baoying; Wang, Jun Ming] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Adeosun, Samuel O.; Hou, Xu; Wang, Jun Ming] Univ Mississippi, Med Ctr, Grad Program Neurosci, Jackson, MS 39216 USA; [Stockmeier, Craig; Ou, Xiaoming; Paul, Ian; Wang, Jun Ming] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Mosley, Thomas; Wang, Jun Ming] Univ Mississippi, Med Ctr, Memory Impairment & Neurodegenerat Dementia Ctr, Jackson, MS 39216 USA; [Weisgraber, Karl] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of California System; University of California San Francisco; The J David Gladstone Institutes	Wang, JM (corresponding author), Univ Mississippi, Med Ctr, Dept Pathol, 2500 N State St, Jackson, MS 39216 USA.	jwang@umc.edu		Adeosun, Samuel/0000-0002-2331-7911	National Institutes of Health Center [RR17701]; Alzheimer's Association Investigator Initiated Research Grant [133086]; Carraway foundation grant; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017701] Funding Source: NIH RePORTER	National Institutes of Health Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association Investigator Initiated Research Grant; Carraway foundation grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by a training grant in National Institutes of Health Center Grant RR17701 (to J. M. W.). This work was supported by Alzheimer's Association Investigator Initiated Research Grant133086 and a Carraway foundation grant (to J. M. W.).	Abbott AC, 2013, J ALZHEIMERS DIS, V34, P873, DOI 10.3233/JAD-121714; Acevedo SF, 2010, PEDIATR RES, V67, P293, DOI 10.1203/PDR.0b013e3181cb8e68; Adeosun SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050040; Akanmu MA, 2007, BEHAV BRAIN RES, V182, P88, DOI 10.1016/j.bbr.2007.05.006; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; [Anonymous], [No title captured]; Beffert U, 1999, MOL BRAIN RES, V68, P181, DOI 10.1016/S0169-328X(99)00073-X; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Bour A, 2008, BEHAV BRAIN RES, V193, P174, DOI 10.1016/j.bbr.2008.05.008; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Cedazo-Minguez A, 2003, J NEUROCHEM, V87, P1152, DOI 10.1046/j.1471-4159.2003.02088.x; Cerf E, 2011, FASEB J, V25, P1585, DOI 10.1096/fj.10-175976; Chen Q, 2008, NEUROBIOL DIS, V29, P316, DOI 10.1016/j.nbd.2007.09.005; Coras R, 2010, BRAIN, V133, P3359, DOI 10.1093/brain/awq215; Corder EH, 1996, ARCH NEUROL-CHICAGO, V53, P418, DOI 10.1001/archneur.1996.00550050048022; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; De Blasi S, 2009, EXP GERONTOL, V44, P224, DOI 10.1016/j.exger.2008.11.005; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dodart JC, 2005, P NATL ACAD SCI USA, V102, P1211, DOI 10.1073/pnas.0409072102; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Gang BZ, 2011, BRAIN RES, V1389, P183, DOI 10.1016/j.brainres.2011.03.039; Gibb GM, 2000, FEBS LETT, V485, P99, DOI 10.1016/S0014-5793(00)02196-7; Greenwood PM, 2005, NEUROPSYCHOLOGY, V19, P199, DOI 10.1037/0894-4105.19.2.199; Grootendorst J, 2005, BEHAV BRAIN RES, V159, P1, DOI 10.1016/j.bbr.2004.09.019; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Harris FM, 2004, J BIOL CHEM, V279, P44795, DOI 10.1074/jbc.M408127200; Hartman RE, 2001, EXP NEUROL, V170, P326, DOI 10.1006/exnr.2001.7715; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hashimoto Y, 2000, J NEUROSCI, V20, P8401, DOI 10.1523/JNEUROSCI.20-22-08401.2000; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Hwang IK, 2007, NEUROCHEM RES, V32, P1604, DOI 10.1007/s11064-007-9366-1; Hyman BT, 2011, ARCH NEUROL-CHICAGO, V68, P1062, DOI 10.1001/archneurol.2011.70; Inbar D, 2010, NEURODEGENER DIS, V7, P16, DOI 10.1159/000283477; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Jinno S, 1998, BRAIN RES, V814, P55, DOI 10.1016/S0006-8993(98)01075-0; Leung L, 2012, PLOS ONE, V7; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Lind J, 2006, NEUROSCI LETT, V396, P23, DOI 10.1016/j.neulet.2005.11.070; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Toledano MA, 2010, J ALZHEIMERS DIS, V20, P395, DOI 10.3233/JAD-2010-1388; Lovestone S, 1996, NEUROSCIENCE, V73, P1145, DOI 10.1016/0306-4522(96)00126-1; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mayeux R, 2001, NEUROBIOL AGING, V22, P683, DOI 10.1016/S0197-4580(01)00223-8; Michikawa M, 1998, J NEUROSCI RES, V54, P58, DOI 10.1002/(SICI)1097-4547(19981001)54:1<58::AID-JNR7>3.0.CO;2-G; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Negash S, 2009, NEUROPSYCHOLOGY, V23, P81, DOI 10.1037/a0014014; Nilsson LG, 2002, NEUROSCI BIOBEHAV R, V26, P841, DOI 10.1016/S0149-7634(02)00070-2; Paus M, 2013, BRAIN RES, V1497, P85, DOI 10.1016/j.brainres.2012.12.024; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Pomara N, 2005, ARCH GEN PSYCHIAT, V62, P209, DOI 10.1001/archpsyc.62.2.209; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Ready RE, 2011, AM J ALZHEIMERS DIS, V26, P463, DOI 10.1177/1533317511421921; REBECK GW, 1994, NEUROLOGY, V44, P1513, DOI 10.1212/WNL.44.8.1513; REBECK GW, 1993, NEURON, V11, P575; REED T, 1994, ARCH NEUROL-CHICAGO, V51, P1189, DOI 10.1001/archneur.1994.00540240033012; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Tesseur I, 2000, AM J PATHOL, V156, P951, DOI 10.1016/S0002-9440(10)64963-2; Tupler LA, 2007, NEUROBIOL AGING, V28, P1644, DOI 10.1016/j.neurobiolaging.2006.07.001; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Volz F, 2011, EPILEPSIA, V52, P1579, DOI 10.1111/j.1528-1167.2011.03086.x; Vuillermot S, 2011, GENES BRAIN BEHAV, V10, P589, DOI 10.1111/j.1601-183X.2011.00698.x; Vukovic J, 2013, J NEUROSCI, V33, P6603, DOI 10.1523/JNEUROSCI.3064-12.2013; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Wright RL, 2005, STRESS, V8, P151, DOI 10.1080/10253890500156663; Yu YX, 2009, HIPPOCAMPUS, V19, P1247, DOI 10.1002/hipo.20587; Zepa L., 2011, INT J ALZHEIMERS DIS, V2011; Zetterberg H, 2009, ALZHEIMERS DEMENT, V5, P75, DOI 10.1016/j.jalz.2008.10.005; Zhang C, 2007, EXP NEUROL, V204, P77, DOI 10.1016/j.expneurol.2006.09.018; Zhong N, 2008, ALZHEIMERS DEMENT, V4, P179, DOI 10.1016/j.jalz.2008.01.006; Zhong N, 2009, J BIOL CHEM, V284, P27273, DOI 10.1074/jbc.M109.014464; Zhu YG, 2012, GLIA, V60, P559, DOI 10.1002/glia.22289	102	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2946	2959		10.1074/jbc.M113.497909	http://dx.doi.org/10.1074/jbc.M113.497909			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24324264	Green Published, hybrid			2022-12-28	WOS:000333403000042
J	Tumelty, KE; Smith, BD; Nugent, MA; Layne, MD				Tumelty, Kathleen E.; Smith, Barbara D.; Nugent, Matthew A.; Layne, Matthew D.			Aortic Carboxypeptidase-like Protein (ACLP) Enhances Lung Myofibroblast Differentiation through Transforming Growth Factor beta Receptor-dependent and -independent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Myofibroblast; Pulmonary Fibrosis; SMAD Transcription Factor; Transforming Growth Factor (TGF); ACLP	IDIOPATHIC PULMONARY-FIBROSIS; ACTIVATES LATENT TGF-BETA-1; TGF-BETA; EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR; MESENCHYMAL TRANSITION; EMBRYONIC-DEVELOPMENT; IN-VIVO; CELLS; FIBROBLASTS	Background: Dysregulated fibroblast-to-myofibroblast transitions cause fibrotic diseases. Results: Aortic carboxypeptidase-like protein (ACLP) stimulates myofibroblast differentiation through activation of transforming growth factor receptor signaling. Conclusion: Eliminating ACLP activity reduces SMA expression and myofibroblast formation. Significance: Reducing ACLP function in fibrotic tissue may provide a novel strategy to reduce the rate of fibrotic disease progression. Idiopathic pulmonary fibrosis (IPF) is a chronic and fatal lung disease characterized by the overgrowth, hardening, and scarring of lung tissue. The exact mechanisms of how IPF develops and progresses are unknown. IPF is characterized by extracellular matrix remodeling and accumulation of active TGF, which promotes collagen expression and the differentiation of smooth muscle -actin (SMA)-positive myofibroblasts. Aortic carboxypeptidase-like protein (ACLP) is an extracellular matrix protein secreted by fibroblasts and myofibroblasts and is expressed in fibrotic human lung tissue and in mice with bleomycin-induced fibrosis. Importantly, ACLP knockout mice are significantly protected from bleomycin-induced fibrosis. The goal of this study was to identify the mechanisms of ACLP action on fibroblast differentiation. As primary lung fibroblasts differentiated into myofibroblasts, ACLP expression preceded SMA and collagen expression. Recombinant ACLP induced SMA and collagen expression in mouse and human lung fibroblasts. Knockdown of ACLP slowed the fibroblast-to-myofibroblast transition and partially reverted differentiated myofibroblasts by reducing SMA expression. We hypothesized that ACLP stimulates myofibroblast formation partly through activating TGF signaling. Treatment of fibroblasts with recombinant ACLP induced phosphorylation and nuclear translocation of Smad3. This phosphorylation and induction of SMA was dependent on TGF receptor binding and kinase activity. ACLP-induced collagen expression was independent of interaction with the TGF receptor. These findings indicate that ACLP stimulates the fibroblast-to-myofibroblast transition by promoting SMA expression via TGF signaling and promoting collagen expression through a TGF receptor-independent pathway.	[Tumelty, Kathleen E.; Smith, Barbara D.; Nugent, Matthew A.; Layne, Matthew D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Layne, MD (corresponding author), 72 E Concord St,K203, Boston, MA 02118 USA.	mlayne@bu.edu			National Institutes of Health [HL078869, HL078869-04S1]; Department of Biochemistry; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biochemistry; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL078869 and HL078869-04S1 (to M. D. L.). This work was also supported by Department of Biochemistry start-up funds.	Abderrahim-Ferkoune A, 2004, EXP CELL RES, V293, P219, DOI 10.1016/j.yexcr.2003.10.020; ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Ask Kjetil, 2006, Proc Am Thorac Soc, V3, P389, DOI 10.1513/pats.200602-021TK; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; DeMaio L, 2012, J PATHOL, V226, P633, DOI 10.1002/path.3016; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Dunsmore SE, 2004, J CLIN INVEST, V113, P180, DOI 10.1172/JCI200420782; FLAUMENHAFT R, 1993, J CELL BIOL, V120, P995, DOI 10.1083/jcb.120.4.995; Gagnon A, 2005, EXP CELL RES, V308, P265, DOI 10.1016/j.yexcr.2005.04.031; Garamszegi N, 2010, ONCOGENE, V29, P2368, DOI 10.1038/onc.2009.514; Gu L, 2007, ACTA PHARMACOL SIN, V28, P382, DOI 10.1111/j.1745-7254.2007.00468.x; Gusinjac A, 2011, METABOLISM, V60, P782, DOI 10.1016/j.metabol.2010.07.028; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Hinz B, 2006, EUR J CELL BIOL, V85, P175, DOI 10.1016/j.ejcb.2005.09.004; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; Horan GS, 2008, AM J RESP CRIT CARE, V177, P56, DOI 10.1164/rccm.200706-805OC; Hoyles RK, 2011, AM J RESP CRIT CARE, V183, P249, DOI 10.1164/rccm.201002-0279OC; Ith B, 2005, GENE EXPR PATTERNS, V5, P533, DOI 10.1016/j.modgep.2004.11.002; Kalajzic Z, 2008, BONE, V43, P501, DOI 10.1016/j.bone.2008.04.023; Khalil N, 2002, EXP LUNG RES, V28, P233, DOI 10.1080/019021402753570527; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Layne MD, 2001, MOL CELL BIOL, V21, P5256, DOI 10.1128/MCB.21.15.5256-5261.2001; Layne MD, 1998, J BIOL CHEM, V273, P15654, DOI 10.1074/jbc.273.25.15654; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Luchsinger LL, 2011, J BIOL CHEM, V286, P44116, DOI 10.1074/jbc.M111.276931; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; MURPHYULLRICH JE, 1992, MOL BIOL CELL, V3, P181, DOI 10.1091/mbc.3.2.181; RAGHOW R, 1989, J CLIN INVEST, V84, P1836, DOI 10.1172/JCI114369; Ramirez F, 2006, MATRIX BIOL, V25, P365, DOI 10.1016/j.matbio.2006.05.002; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Schissel SL, 2009, AM J PATHOL, V174, P818, DOI 10.2353/ajpath.2009.080856; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; SOBUE K, 1988, P NATL ACAD SCI USA, V85, P482, DOI 10.1073/pnas.85.2.482; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tumelty KE, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1348, DOI 10.1016/B978-0-12-382219-2.00303-3; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	54	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2526	2536		10.1074/jbc.M113.502617	http://dx.doi.org/10.1074/jbc.M113.502617			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24344132	hybrid, Green Published			2022-12-28	WOS:000333403000005
J	Adler, L; Chen, CH; Koutalos, Y				Adler, Leopold; Chen, Chunhe; Koutalos, Yiannis			Mitochondria Contribute to NADPH Generation in Mouse Rod Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence; Metabolism; Mitochondria; Photoreceptors; Retinoid; NADPH	MONOCARBOXYLATE TRANSPORT INHIBITION; RETINAL FUNCTION; OUTER SEGMENTS; AEROBIC GLYCOLYSIS; MAMMALIAN RETINA; LACTATE; CELLS; METABOLISM; GLUCOSE; EXPRESSION	Background: The major source of NADPH is considered to be the pentose phosphate pathway. Results: In isolated mouse rod photoreceptors, blocking metabolite entry into mitochondria substantially reduces NADPH generation. Mitochondrial metabolic substrates support NADPH generation. Conclusion: Mitochondria-linked pathways contribute substantially to NADPH generation in mouse rod photoreceptors. Significance: A wide range of photoreceptor cell functions depend on adequate NADPH supply. NADPH is the primary source of reducing equivalents in the cytosol. Its major source is considered to be the pentose phosphate pathway, but cytosolic NADP(+)-dependent dehydrogenases using intermediates of mitochondrial pathways for substrates have been known to contribute. Photoreceptors, a nonproliferating cell type, provide a unique model for measuring the functional utilization of NADPH at the single cell level. In these cells, NADPH availability can be monitored from the reduction of the all-trans-retinal generated by light to all-trans-retinol using single cell fluorescence imaging. We have used mouse rod photoreceptors to investigate the generation of NADPH by different metabolic pathways. In the absence of extracellular metabolic substrates, NADPH generation was severely compromised. Extracellular glutamine supported NADPH generation to levels comparable to those of glucose, but pyruvate and lactate were relatively ineffective. At low extracellular substrate concentrations, partial inhibition of ATP synthesis lowered, whereas suppression of ATP consumption augmented NADPH availability. Blocking pyruvate transport into mitochondria decreased NADPH availability, and addition of glutamine restored it. Our findings demonstrate that in a nonproliferating cell type, mitochondria-linked pathways can generate substantial amounts of NADPH and do so even when the pentose phosphate pathway is operational. Competing demands for ATP and NADPH at low metabolic substrate concentrations indicate a vulnerability to nutrient shortages. By supporting substantial NADPH generation, mitochondria provide alternative metabolic pathways that may support cell function and maintain viability under transient nutrient shortages. Such pathways may play an important role in protecting against retinal degeneration.	[Adler, Leopold; Chen, Chunhe; Koutalos, Yiannis] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Koutalos, Yiannis] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Koutalos, Y (corresponding author), Med Univ S Carolina, Dept Ophthalmol, 167 Ashley Ave, Charleston, SC 29425 USA.	koutalo@musc.edu			National Institutes of Health [R01-EY014850]; Research to Prevent Blindness (New York); National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources [C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (New York)(Research to Prevent Blindness (RPB)); National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-EY014850. This work was also supported by an unrestricted grant to the Department of Ophthalmology at Medical University of South Carolina from Research to Prevent Blindness (New York). This work was conducted in a facility constructed with support from National Institutes of Health Grant C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources.	Archibald RM, 1944, J BIOL CHEM, V154, P643; Bergersen L, 1999, NEUROSCIENCE, V90, P319, DOI 10.1016/S0306-4522(98)00427-8; Blakeley LR, 2011, INVEST OPHTH VIS SCI, V52, P3483, DOI 10.1167/iovs.10-6694; BLISS AF, 1951, ARCH BIOCHEM BIOPHYS, V31, P197, DOI 10.1016/0003-9861(51)90206-8; Bui BV, 2004, EUR J NEUROSCI, V20, P1525, DOI 10.1111/j.1460-9568.2004.03601.x; Bui BV, 2004, INVEST OPHTH VIS SCI, V45, P584, DOI 10.1167/iovs.03-0695; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Chen CH, 2002, BIOPHYS J, V83, P1403, DOI 10.1016/S0006-3495(02)73911-8; Chen CH, 2012, J BIOL CHEM, V287, P24662, DOI 10.1074/jbc.M112.354514; Chen CH, 2010, PHOTOCH PHOTOBIO SCI, V9, P1475, DOI 10.1039/c0pp00124d; Chen CH, 2009, INVEST OPHTH VIS SCI, V50, P3589, DOI 10.1167/iovs.08-3336; Chertov AO, 2011, J BIOL CHEM, V286, P34700, DOI 10.1074/jbc.M111.279752; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DEMONTIS GC, 1995, BIOPHYS J, V69, P439, DOI 10.1016/S0006-3495(95)79917-9; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; FUTTERMAN S, 1970, J NEUROCHEM, V17, P149, DOI 10.1111/j.1471-4159.1970.tb02195.x; Gospe SM, 2010, J CELL SCI, V123, P3639, DOI 10.1242/jcs.072389; HALESTRAP AP, 1975, BIOCHEM J, V148, P97, DOI 10.1042/bj1480097; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HSU SC, 1994, J BIOL CHEM, V269, P17954; HUBBARD R., 1971, Methods in Enzymology, V18C, P615, DOI 10.1016/S0076-6879(71)18045-7; Inoue K, 2002, J BIOL CHEM, V277, P39469, DOI 10.1074/jbc.M207072200; KAGAWA Y, 1966, J BIOL CHEM, V241, P2461; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Martin PM, 2007, INVEST OPHTH VIS SCI, V48, P3356, DOI 10.1167/iovs.06-0888; MATSCHINSKY FM, 1968, J NEUROCHEM, V15, P643, DOI 10.1111/j.1471-4159.1968.tb08963.x; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; NELSON DL, 2000, LEHNINGER PRINCIPLES, P558; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Poitry S, 2000, J NEUROSCI, V20, P1809; POITRYYAMATE CL, 1995, J NEUROSCI, V15, P5179; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Reidel B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002469; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; STEIN WH, 1954, J BIOL CHEM, V211, P915; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Tsina E, 2004, J GEN PHYSIOL, V124, P429, DOI 10.1085/jgp.200409078; Wada M, 2006, BRAIN RES, V1081, P92, DOI 10.1016/j.brainres.2006.01.084; Winkler BS, 1997, INVEST OPHTH VIS SCI, V38, P1569; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; WINKLER BS, 1977, INVEST OPHTH VIS SCI, V16, P766; Winkler BS, 2004, NEUROCHEM INT, V45, P311, DOI 10.1016/j.neuint.2003.08.017; Winkler BS, 2003, EXP EYE RES, V77, P327, DOI 10.1016/S0014-4835(03)00147-7; Winkler BS, 2003, EXP EYE RES, V76, P715, DOI 10.1016/S0014-4835(03)00052-6; WINKLER BS, 1986, EXP EYE RES, V42, P585, DOI 10.1016/0014-4835(86)90048-5; WINKLER BS, 1983, EXP EYE RES, V36, P581, DOI 10.1016/0014-4835(83)90052-0; WINKLER BS, 1986, EXP EYE RES, V43, P829, DOI 10.1016/S0014-4835(86)80013-6; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Zeevalk GD, 2000, J NEUROCHEM, V75, P1027, DOI 10.1046/j.1471-4159.2000.0751027.x	52	30	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1519	1528		10.1074/jbc.M113.511295	http://dx.doi.org/10.1074/jbc.M113.511295			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297174	hybrid, Green Published			2022-12-28	WOS:000332401700027
J	Zhou, FJ; Walker, SE; Mitchell, SF; Lorsch, JR; Hinnebusch, AG				Zhou, Fujun; Walker, Sarah E.; Mitchell, Sarah F.; Lorsch, Jon R.; Hinnebusch, Alan G.			Identification and Characterization of Functionally Critical, Conserved Motifs in the Internal Repeats and N-terminal Domain of Yeast Translation Initiation Factor 4B (yeIF4B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; Ribosomes; Translation Initiation Factors; Translation Regulation; Yeast; eIF4A; eIF4B; Translation Initiation; Yeast Translation	RNA RECOGNITION MOTIF; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; HELICASE ACTIVITY; SHUTTLE VECTORS; IN-VIVO; EIF4B; COMPLEX; PROTEIN; SELECTION	Background: The internal repeats and NTD of yeIF4B stimulate translation initiation. Results: The minimal number of repeats and conserved motifs in the repeat and NTD necessary for yeIF4B function was determined. Conclusion: Two repeats provide appreciable function, except when the NTD is missing or eIF4F function is limiting or compromised. Significance: The results provide a comprehensive description of functionally critical sequence elements in yeIF4B. eIF4B has been implicated in attachment of the 43 S preinitiation complex (PIC) to mRNAs and scanning to the start codon. We recently determined that the internal seven repeats (of approximate to 26 amino acids each) of Saccharomyces cerevisiae eIF4B (yeIF4B) compose the region most critically required to enhance mRNA recruitment by 43 S PICs in vitro and stimulate general translation initiation in yeast. Moreover, although the N-terminal domain (NTD) of yeIF4B contributes to these activities, the RNA recognition motif is dispensable. We have now determined that only two of the seven internal repeats are sufficient for wild-type (WT) yeIF4B function in vivo when all other domains are intact. However, three or more repeats are needed in the absence of the NTD or when the functions of eIF4F components are compromised. We corroborated these observations in the reconstituted system by demonstrating that yeIF4B variants with only one or two repeats display substantial activity in promoting mRNA recruitment by the PIC, whereas additional repeats are required at lower levels of eIF4A or when the NTD is missing. These findings indicate functional overlap among the 7-repeats and NTD domains of yeIF4B and eIF4A in mRNA recruitment. Interestingly, only three highly conserved positions in the 26-amino acid repeat are essential for function in vitro and in vivo. Finally, we identified conserved motifs in the NTD and demonstrate functional overlap of two such motifs. These results provide a comprehensive description of the critical sequence elements in yeIF4B that support eIF4F function in mRNA recruitment by the PIC.	[Zhou, Fujun; Hinnebusch, Alan G.] Eunice Kennedy Shriver NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Walker, Sarah E.; Mitchell, Sarah F.; Lorsch, Jon R.] Johns Hopkins Univ, Dept Biophys & Biophys Chem, Sch Med, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University	Lorsch, JR (corresponding author), Eunice Kennedy Shriver NICHD, Lab Mech & Regulat Prot Synth, NIH, Bldg 45,Rm 3AN44, Bethesda, MD 20892 USA.	jon.lorsch@nih.gov; ahinnebusch@nih.gov	Walker, Sarah/U-1609-2019	Walker, Sarah/0000-0002-9983-2485; Lorsch, Jon/0000-0002-4521-4999	National Institutes of Health; American Heart Association;  [GM62128]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Grant (to A. G. H. and F. Z.) and Grant GM62128 (to J. R. L.). This work was also supported by an American Heart Association postdoctoral fellowship (to S. E. W.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; ALTMANN M, 1993, EMBO J, V12, P3997, DOI 10.1002/j.1460-2075.1993.tb06077.x; ALTMANN M, 1995, EMBO J, V14, P3820, DOI 10.1002/j.1460-2075.1995.tb00051.x; Andreou A. Z., 2013, J MOL BIOL, DOI 10.1016/j.jmb.2013.09.027; Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; BLUM S, 1992, P NATL ACAD SCI USA, V89, P7664, DOI 10.1073/pnas.89.16.7664; BRENNER C, 1988, MOL CELL BIOL, V8, P3556, DOI 10.1128/MCB.8.8.3556; Cheng SJ, 2006, J BIOL CHEM, V281, P24351, DOI 10.1074/jbc.M605404200; Chiu WL, 2010, MOL CELL BIOL, V30, P4415, DOI 10.1128/MCB.00280-10; CIGAN AM, 1993, P NATL ACAD SCI USA, V90, P5350, DOI 10.1073/pnas.90.11.5350; COPPOLECCHIA R, 1993, EMBO J, V12, P4005, DOI 10.1002/j.1460-2075.1993.tb06078.x; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; METHOT N, 1994, MOL CELL BIOL, V14, P2307, DOI 10.1128/MCB.14.4.2307; Methot N, 1996, MOL CELL BIOL, V16, P5328; Methot N, 1996, RNA, V2, P38; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; NARANDA T, 1994, J BIOL CHEM, V269, P14465; Niederberger N, 1998, RNA, V4, P1259, DOI 10.1017/S1355838298980487; Nielsen KH, 2004, EMBO J, V23, P1166, DOI 10.1038/sj.emboj.7600116; Nielsen KH, 2011, NUCLEIC ACIDS RES, V39, P2678, DOI 10.1093/nar/gkq1206; oze A. R., 2011, J MOL BIOL, V412, P674; Park EH, 2013, J BIOL CHEM, V288, P2340, DOI 10.1074/jbc.M112.398537; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Rajagopal V, 2012, J BIOL CHEM, V287, P20301, DOI 10.1074/jbc.M112.347278; REID GA, 1982, J BIOL CHEM, V257, P3062; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Rozovsky N, 2008, RNA, V14, P2136, DOI 10.1261/rna.1049608; Schwer B, 1998, NUCLEIC ACIDS RES, V26, P803, DOI 10.1093/nar/26.3.803; SIKORSKI RS, 1989, GENETICS, V122, P19; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x; Walker SE, 2008, METHODS, V44, P81, DOI 10.1016/j.ymeth.2007.09.003; Walker SE, 2013, RNA, V19, P191, DOI 10.1261/rna.035881.112	37	7	7	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1704	1722		10.1074/jbc.M113.529370	http://dx.doi.org/10.1074/jbc.M113.529370			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24285537	Green Published, hybrid			2022-12-28	WOS:000332401700042
J	Ronchi, VP; Klein, JM; Edwards, DJ; Haas, AL				Ronchi, Virginia P.; Klein, Jennifer M.; Edwards, Daniel J.; Haas, Arthur L.			The Active Form of E6-associated protein (E6AP)/UBE3A Ubiquitin Ligase Is an Oligomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; ANGELMAN-SYNDROME; E6 ONCOPROTEIN; CHAIN FORMATION; HPV E6; DEGRADATION; BINDING; DOMAIN; E6-AP; UBE3A	Employing I-125-polyubiquitin chain formation as a functional readout of ligase activity, biochemical and biophysical evidence demonstrates that catalytically active E6-associated protein (E6AP)/UBE3A is an oligomer. Based on an extant structure previously discounted as an artifact of crystal packing forces, we propose that the fully active form of E6AP is a trimer, analysis of which reveals a buried surface of 7508 angstrom(2) and radially symmetric interacting residues that are conserved within the Hect (homologous to E6AP C terminus) ligase superfamily. An absolutely conserved interaction between Phe(727) and a hydrophobic pocket present on the adjacent subunit is critical for trimer stabilization because mutation disrupts the oligomer and decreases k(cat) 62-fold but fails to affect E2 similar to ubiquitin binding or subsequent formation of the Hect domain Cys(820) similar to ubiquitin thioester catalytic intermediate. Exogenous N-acetylphenylalanylamide reversibly antagonizes Phe(727)-dependent trimer formation and catalytic activity (K-i = 12 mM), as does a conserved alpha-helical peptide corresponding to residues 474-490 of E6AP isoform 1 (K-i = 22 mu M) reported to bind the hydrophobic pocket of other Hect ligases, presumably blocking Phe(727) intercalation and trimer formation. Conversely, oncogenic human papillomavirus-16/18 E6 protein significantly enhances E6AP catalytic activity by promoting trimer formation (K-activation = 1.5 nM) through the ability of E6 to form homodimers. Recombinant E6 protein additionally rescues the k(cat) defect of the Phe(727) mutation and that of a specific loss-of-function Angelman syndrome mutation that promotes trimer destabilization. The present findings codify otherwise disparate observations regarding the mechanism of E6AP and related Hect ligases in addition to suggesting therapeutic approaches for modulating ligase activity.	[Ronchi, Virginia P.; Klein, Jennifer M.; Edwards, Daniel J.; Haas, Arthur L.] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Stanley S Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Haas, AL (corresponding author), Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, 1901 Perdido St, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu			National Institutes of Health [GM034009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM034009 (to A. L. H.).	Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Be XB, 2001, BIOCHEMISTRY-US, V40, P1293, DOI 10.1021/bi0019592; Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; BeerRomero P, 1997, ONCOGENE, V14, P595, DOI 10.1038/sj.onc.1200872; Chan AL, 2013, BIOCHEMISTRY-US, V52, P3119, DOI 10.1021/bi301710c; Chen JJ, 1998, J BIOL CHEM, V273, P13537, DOI 10.1074/jbc.273.22.13537; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Cooper EM, 2004, J BIOL CHEM, V279, P41208, DOI 10.1074/jbc.M401302200; Dagli A, 2011, MOL SYNDROMOL, V2, P100, DOI 10.1159/000328837; Dai BB, 2010, CANCER RES, V70, P2951, DOI 10.1158/0008-5472.CAN-09-3909; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Elston RC, 1998, J GEN VIROL, V79, P371, DOI 10.1099/0022-1317-79-2-371; Fang P, 1999, HUM MOL GENET, V8, P129, DOI 10.1093/hmg/8.1.129; Flashner BM, 2013, NEUROMOL MED, V15, P339, DOI 10.1007/s12017-013-8222-5; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Gregianin E, 2013, EUR J NEUROL, V20, P1486, DOI 10.1111/ene.12220; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haas Arthur L., 2005, V301, P23; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Heer A, 2011, BIOCHEMISTRY-US, V50, P1376, DOI 10.1021/bi101941c; Huang HS, 2013, BEHAV BRAIN RES, V243, P79, DOI 10.1016/j.bbr.2012.12.052; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Huang YC, 2008, J BIOL CHEM, V283, P32880, DOI 10.1074/jbc.M805484200; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Jiang YH, 1999, AM J HUM GENET, V65, P1, DOI 10.1086/302473; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kao WH, 2000, J VIROL, V74, P6408, DOI 10.1128/JVI.74.14.6408-6417.2000; Kentsis A, 2002, P NATL ACAD SCI USA, V99, P15404, DOI 10.1073/pnas.202608799; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhnle S, 2013, P NATL ACAD SCI USA, V110, P8888, DOI 10.1073/pnas.1302792110; Lagrange M, 2005, J GEN VIROL, V86, P1001, DOI 10.1099/vir.0.80607-0; Lawson JS, 2009, BRIT J CANCER, V101, P1351, DOI 10.1038/sj.bjc.6605328; Levy ED, 2013, PROG MOL BIOL TRANSL, V117, P25, DOI 10.1016/B978-0-12-386931-9.00002-7; Liu YQ, 2009, J MOL BIOL, V386, P1123, DOI 10.1016/j.jmb.2009.01.018; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Maru Y, 1996, J BIOL CHEM, V271, P15353, DOI 10.1074/jbc.271.26.15353; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Matentzoglu K, 2008, BIOCHEM SOC T, V36, P797, DOI 10.1042/BST0360797; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; MEDCALF EA, 1993, ONCOGENE, V8, P2847; Muench P, 2010, CANCER RES, V70, P6913, DOI 10.1158/0008-5472.CAN-10-1307; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Nomine Y, 2003, BIOCHEMISTRY-US, V42, P4909, DOI 10.1021/bi026980c; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ogunjimi AA, 2010, J BIOL CHEM, V285, P6308, DOI 10.1074/jbc.M109.044537; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Pandya RK, 2010, J BIOL CHEM, V285, P5664, DOI 10.1074/jbc.M109.051805; Perica T, 2012, P NATL ACAD SCI USA, V109, P8127, DOI 10.1073/pnas.1120028109; Philpot BD, 2011, J NEURODEV DISORD, V3, P50, DOI 10.1007/s11689-010-9066-z; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Ronchi VP, 2012, METHODS MOL BIOL, V832, P197, DOI 10.1007/978-1-61779-474-2_14; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; Sato M, 2010, P NATL ACAD SCI USA, V107, P5611, DOI 10.1073/pnas.1001281107; Schaaf CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/hmg/ddr243; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Shirakura M, 2007, J VIROL, V81, P1174, DOI 10.1128/JVI.01684-06; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Spitkovsky D, 1996, ONCOGENE, V13, P1027; Streich FC, 2013, J BIOL CHEM, V288, P8209, DOI 10.1074/jbc.M113.451567; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Thomas M, 2013, VIROLOGY, V435, P357, DOI 10.1016/j.virol.2012.11.004; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Vargo MA, 2004, BIOCHEMISTRY-US, V43, P3327, DOI 10.1021/bi030245z; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327; Zanier K, 2005, J MOL BIOL, V349, P401, DOI 10.1016/j.jmb.2005.03.071; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zanier K, 2010, J MOL BIOL, V396, P90, DOI 10.1016/j.jmb.2009.11.022	90	43	47	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1033	1048		10.1074/jbc.M113.517805	http://dx.doi.org/10.1074/jbc.M113.517805			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24273172	Green Published, hybrid			2022-12-28	WOS:000330541200036
J	MacDonald, LC; Berger, BW				MacDonald, Logan C.; Berger, Bryan W.			A Polysaccharide Lyase from Stenotrophomonas maltophilia with a Unique, pH-regulated Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biofilm; Host-Pathogen Interactions; Hyaluronate; Multifunctional Enzymes; Polysaccharide	EXOTYPE ALGINATE LYASE; CHONDROITIN AC LYASE; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; HYALURONATE LYASE; ESCHERICHIA-COLI; GLUCURONAN LYASE; ACTION PATTERN; PURIFICATION; MECHANISM	Polysaccharide lyases (PLs) catalyze the depolymerization of anionic polysaccharides via a -elimination mechanism. PLs also play important roles in microbial pathogenesis, participating in bacterial invasion and toxin spread into the host tissue via degradation of the host extracellular matrix, or in microbial biofilm formation often associated with enhanced drug resistance. Stenotrophomonas maltophilia is a Gram-negative bacterium that is among the emerging multidrug-resistant organisms associated with chronic lung infections as well as with cystic fibrosis patients. A putative alginate lyase (Smlt1473) from S. maltophilia was heterologously expressed in Escherichia coli, purified in a one-step fashion via affinity chromatography, and activity as well as specificity determined for a range of polysaccharides. Interestingly, Smlt1473 catalyzed the degradation of not only alginate, but poly--d-glucuronic acid and hyaluronic acid as well. Furthermore, the pH optimum for enzymatic activity is substrate-dependent, with optimal hyaluronic acid degradation at pH 5, poly--d-glucuronic acid degradation at pH 7, and alginate degradation at pH 9. Analysis of the degradation products revealed that each substrate was cleaved endolytically into oligomers comprised predominantly of even numbers of sugar groups, with lower accumulation of trimers and pentamers. Collectively, these results imply that Smlt1473 is a multifunctional PL that exhibits broad substrate specificity, but utilizes pH as a mechanism to achieve selectivity.	[MacDonald, Logan C.; Berger, Bryan W.] Lehigh Univ, Program Bioengn, Bethlehem, PA 18015 USA; [Berger, Bryan W.] Lehigh Univ, Dept Chem Engn, Bethlehem, PA 18015 USA	Lehigh University; Lehigh University	Berger, BW (corresponding author), B320 Iacocca Hall,111 Res Dr, Bethlehem, PA 18015 USA.	bwb209@lehigh.edu	Berger, Bryan/D-7985-2014	Berger, Bryan/0000-0002-6135-8677	Lehigh University; Lehigh Valley Hospital; Faculty Innovation Grant (FIG); Div Of Chem, Bioeng, Env, & Transp Sys [1227924] Funding Source: National Science Foundation	Lehigh University; Lehigh Valley Hospital; Faculty Innovation Grant (FIG); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by Lehigh University, Lehigh Valley Hospital, and a Faculty Innovation Grant (FIG).	Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; [Anonymous], 2012, F225910 ASTM INT, DOI 10.1520/F2259-10R12E01; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bakkevig K, 2005, J BACTERIOL, V187, P8375, DOI 10.1128/JB.187.24.8375-8384.2005; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Botzki A, 2004, J BIOL CHEM, V279, P45990, DOI 10.1074/jbc.M406146200; BOYD A, 1993, GENE, V131, P1, DOI 10.1016/0378-1119(93)90662-M; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cescutti P, 2011, CARBOHYD RES, V346, P1916, DOI 10.1016/j.carres.2011.05.007; Da Costa A, 2001, APPL ENVIRON MICROB, V67, P5197, DOI 10.1128/AEM.67.11.5197-5203.2001; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Farrell EK, 2012, BIOCHEMISTRY-US, V51, P10259, DOI 10.1021/bi301425r; Fylstra D, 1998, INTERFACES, V28, P29, DOI 10.1287/inte.28.5.29; GACESA P, 1990, APPL ENVIRON MICROB, V56, P2265, DOI 10.1128/AEM.56.7.2265-2267.1990; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Gase K, 1998, BBA-GENE STRUCT EXPR, V1398, P86, DOI 10.1016/S0167-4781(98)00045-1; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Heyraud A, 1996, CARBOHYD RES, V291, P115; Hirayama Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000643; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; Hynes WL, 2000, FEMS MICROBIOL LETT, V183, P201, DOI 10.1111/j.1574-6968.2000.tb08958.x; Isogai A, 1998, CELLULOSE, V5, P153, DOI 10.1023/A:1009208603673; Jain S, 2005, INFECT IMMUN, V73, P6429, DOI 10.1128/IAI.73.10.6429-6436.2005; JANDIK KA, 1994, GLYCOBIOLOGY, V4, P289, DOI 10.1093/glycob/4.3.289; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Konno N, 2008, CELLULOSE, V15, P453, DOI 10.1007/s10570-007-9195-z; Konno N, 2006, CARBOHYD POLYM, V64, P589, DOI 10.1016/j.carbpol.2005.11.015; Konno N, 2009, APPL ENVIRON MICROB, V75, P101, DOI 10.1128/AEM.01749-08; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lee SI, 2012, APPL MICROBIOL BIOT, V95, P1643, DOI 10.1007/s00253-012-4266-y; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; Maruyama Y, 2005, J MOL BIOL, V350, P974, DOI 10.1016/j.jmb.2005.05.055; Mello LV, 2002, J BIOL CHEM, V277, P36678, DOI 10.1074/jbc.M205140200; Mikami B, 2012, ACTA CRYSTALLOGR D, V68, P1207, DOI 10.1107/S090744491202495X; Miyake O, 2003, PROTEIN EXPRES PURIF, V29, P33, DOI 10.1016/S1046-5928(03)00018-4; Ochiai A, 2010, J BIOL CHEM, V285, P24519, DOI 10.1074/jbc.M110.125450; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pompilio A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-102; PREISS J, 1962, J BIOL CHEM, V237, P309; PRESTON JF, 1992, J BACTERIOL, V174, P2039, DOI 10.1128/jb.174.6.2039-2042.1992; Ray B, 2006, CARBOHYD POLYM, V66, P408, DOI 10.1016/j.carbpol.2006.03.027; Sambrook J., 2001, MOL CLONING LAB MANU; Sebaihia M, 2006, J BACTERIOL, V188, P6002, DOI 10.1128/JB.01927-05; Shaya D, 2010, J BIOL CHEM, V285, P20051, DOI 10.1074/jbc.M110.101071; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Tahiri C, 2000, CELLULOSE, V7, P177, DOI 10.1023/A:1009276009711; TAYLOR KACC, 1995, APPL BIOCHEM BIOTECH, V53, P207, DOI 10.1007/BF02783496; Tondervik A, 2010, J BIOL CHEM, V285, P35284, DOI 10.1074/jbc.M110.162800; VONHEIJNE G, 1989, PROTEIN ENG, V2, P531, DOI 10.1093/protein/2.7.531; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Xiao L, 2006, WORLD J MICROB BIOT, V22, P81, DOI 10.1007/s11274-005-7713-4; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yoon HJ, 2000, PROTEIN EXPRES PURIF, V19, P84, DOI 10.1006/prep.2000.1226; Yoon HJ, 1999, J MOL BIOL, V290, P505, DOI 10.1006/jmbi.1999.2883; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c	68	19	22	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					312	325		10.1074/jbc.M113.489195	http://dx.doi.org/10.1074/jbc.M113.489195			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24257754	Green Published, hybrid			2022-12-28	WOS:000329370900027
J	Maxson, JE; Luty, SB; MacManiman, JD; Abel, ML; Druker, BJ; Tyner, JW				Maxson, Julia E.; Luty, Samuel B.; MacManiman, Jason D.; Abel, Melissa L.; Druker, Brian J.; Tyner, Jeffrey W.			Ligand Independence of the T618I Mutation in the Colony-stimulating Factor 3 Receptor (CSF3R) Protein Results from Loss of O-Linked Glycosylation and Increased Receptor Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Glycoprotein; Leukemia; Neutrophil; Receptor Modification; GCSFR T595I; Myeloproliferative Neoplasm	SEVERE CONGENITAL NEUTROPENIA; ACUTE MYELOID-LEUKEMIA; CHRONIC NEUTROPHILIC LEUKEMIA; SRC KINASE LYN; ACTIVATING MUTATION; GRANULOCYTE; INTERNALIZATION; DOMAIN; GENE; MICE	Background: We recently identified CSF3R mutations in chronic neutrophilic leukemia. The most common mutation, T618I, signals without ligand through an undefined mechanism. Results: CSF3R T618I abrogates an O-glycosylation event and increases receptor dimerization. Conclusion: The constitutive activity of CSF3R T618I may be explained by loss of O-glycosylation. Significance: This study illustrates the role of O-linked glycosylation in protein function and oncogenesis. Mutations in the CSF3 granulocyte colony-stimulating factor receptor CSF3R have recently been found in a large percentage of patients with chronic neutrophilic leukemia and, more rarely, in other types of leukemia. These CSF3R mutations fall into two distinct categories: membrane-proximal mutations and truncation mutations. Although both classes of mutation have exhibited the capacity for cellular transformation, several aspects of this transformation, including the kinetics, the requirement for ligand, and the dysregulation of downstream signaling pathways, have all been shown to be discrepant between the mutation types, suggesting distinct mechanisms of activation. CSF3R truncation mutations induce overexpression and ligand hypersensitivity of the receptor, likely because of the removal of motifs necessary for endocytosis and degradation. In contrast, little is known about the mechanism of activation of membrane-proximal mutations, which are much more commonly observed in chronic neutrophilic leukemia. In contrast with CSF3R truncation mutations, membrane-proximal mutations do not exhibit overexpression and are capable of signaling in the absence of ligand. We show that the Thr-615 and Thr-618 sites of membrane-proximal mutations are part of an O-linked glycosylation cluster. Mutation at these sites prevents O-glycosylation of CSF3R and increases receptor dimerization. This increased dimerization explains the ligand-independent activation of CSF3R membrane-proximal mutations. Cytokine receptor activation through loss of O-glycosylation represents a novel avenue of aberrant signaling. Finally, the combination of the CSF3R membrane proximal and truncation mutations, as has been reported in some patients, leads to enhanced cellular transformation when compared with either mutation alone, underscoring their distinct mechanisms of action.	[Maxson, Julia E.; Luty, Samuel B.; MacManiman, Jason D.; Abel, Melissa L.; Druker, Brian J.; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97239 USA; [Maxson, Julia E.; Luty, Samuel B.; MacManiman, Jason D.; Druker, Brian J.; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA; [Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Abel, Melissa L.; Druker, Brian J.] Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute	Tyner, JW (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Mailcode L592, Portland, OR 97239 USA.	tynerj@ohsu.edu		Druker, Brian/0000-0001-8331-8206; Tyner, Jeffrey/0000-0002-2133-0960	Howard Hughes Medical Institute; Training Program in Molecular Hematology, National Institutes of Health [5T32HL007781]; Leukemia and Lymphoma Society Fellow award; Medical Research Foundation; V Foundation for Cancer Research; William Lawrence and Blanche Hughes Fund; Gabrielle's Angel Foundation for Cancer Research; NCI, National Institutes of Health [4 R00CA151457-03]; NATIONAL CANCER INSTITUTE [R01CA183974, R00CA151457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Training Program in Molecular Hematology, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Fellow award(Leukemia and Lymphoma Society); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); V Foundation for Cancer Research; William Lawrence and Blanche Hughes Fund; Gabrielle's Angel Foundation for Cancer Research; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (to B. J. D.).; Supported by Training Program in Molecular Hematology, National Institutes of Health Grant 5T32HL007781, by a Leukemia and Lymphoma Society Fellow award, and by a Medical Research Foundation Early Clinical Investigator award.; Supported by the V Foundation for Cancer Research, by the William Lawrence and Blanche Hughes Fund, by the Gabrielle's Angel Foundation for Cancer Research, and by NCI, National Institutes of Health Grant 4 R00CA151457-03. To whom correspondence should be addressed: Dept. of Cell and Developmental Biology, Mailcode L592, Oregon Health and Science University, Portland, OR 97239. Tel.: 503-346-0603; Fax: 503-494-3688; E-mail: tynerj@ohsu.edu.	Aarts LHJ, 2004, BLOOD, V103, P571, DOI 10.1182/blood-2003-07-2250; Beekman R, 2013, HAEMATOLOGICA, V98, pE62, DOI 10.3324/haematol.2013.085050; Beekman R, 2012, BLOOD, V119, P5071, DOI 10.1182/blood-2012-01-406116; Corey SJ, 1998, J BIOL CHEM, V273, P3230, DOI 10.1074/jbc.273.6.3230; COREY SJ, 1994, P NATL ACAD SCI USA, V91, P4683, DOI 10.1073/pnas.91.11.4683; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; Forbes LV, 2002, ONCOGENE, V21, P5981, DOI 10.1038/sj.onc.1205767; Futami M, 2011, BLOOD, V118, P1077, DOI 10.1182/blood-2009-12-261636; Germeshausen M, 2007, BLOOD, V109, P93, DOI 10.1182/blood-2006-02-004275; Haniu M, 1996, BIOCHEMISTRY-US, V35, P13040, DOI 10.1021/bi960213u; Kimura A, 2004, J BIOL CHEM, V279, P6905, DOI 10.1074/jbc.C300496200; KODAMA S, 1993, EUR J BIOCHEM, V211, P903, DOI 10.1111/j.1432-1033.1993.tb17624.x; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Maxson JE, 2013, NEW ENGL J MED, V368, P1781, DOI 10.1056/NEJMoa1214514; Mehta HM, 2013, LEUKEMIA, V27, P2407, DOI 10.1038/leu.2013.164; NICHOLSON SE, 1994, P NATL ACAD SCI USA, V91, P2985, DOI 10.1073/pnas.91.8.2985; NISSEN C, 1994, EUR J CANCER, V30A, pS12; Pardanani A, 2013, LEUKEMIA, V27, P1870, DOI 10.1038/leu.2013.122; Plo I, 2009, J EXP MED, V206, P1701, DOI 10.1084/jem.20090693; TIAN SS, 1994, BLOOD, V84, P1760; van de Geijn GJM, 2004, BLOOD, V104, P667, DOI 10.1182/blood-2003-08-2913; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Ward AC, 1999, BLOOD, V93, P447, DOI 10.1182/blood.V93.2.447; Zhu QS, 2004, BLOOD, V103, P3305, DOI 10.1182/blood-2003-06-1861	25	42	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5820	5827		10.1074/jbc.M113.508440	http://dx.doi.org/10.1074/jbc.M113.508440			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403076	Green Published, hybrid			2022-12-28	WOS:000332015500041
J	Zimmerman, MW; McQueeney, KE; Isenberg, JS; Pitt, BR; Wasserloos, KA; Homanics, GE; Lazo, JS				Zimmerman, Mark W.; McQueeney, Kelley E.; Isenberg, Jeffrey S.; Pitt, Bruce R.; Wasserloos, Karla A.; Homanics, Gregg E.; Lazo, John S.			Protein-tyrosine Phosphatase 4A3 (PTP4A3) Promotes Vascular Endothelial Growth Factor Signaling and Enables Endothelial Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Cancer; Endothelial Cell; Endothelium; Phosphatase; Src; Vascular Endothelial Growth Factor (VEGF); PTP4A3 (PRL-3); Vascular Permeability	NITRIC-OXIDE; PRL-3; EXPRESSION; MIGRATION; INVASION; ANGIOGENESIS; METASTASIS; ACTIVATION; BEVACIZUMAB; DENSITY	Background: The Ptp4a gene family encodes cancer-associated phosphatases with poorly understood in vivo functions. Results: Mice deficient for PTP4A3 exhibit reduced tumor angiogenesis and decreased VEGF-mediated endothelial cell motility and vascular permeability. Conclusion: PTP4A3 has an important role in endothelial cell response to proangiogenic VEGF signaling. Significance: PTP4A3 appears to be an attractive molecular target for impeding angiogenesis in addition to tumor progression. Protein-tyrosine phosphatase 4A3 (PTP4A3) is highly expressed in multiple human cancers and is hypothesized to have a critical, albeit poorly defined, role in the formation of experimental tumors in mice. PTP4A3 is broadly expressed in many tissues so the cellular basis of its etiological contributions to carcinogenesis may involve both tumor and stromal cells. In particular, PTP4A3 is expressed in the tumor vasculature and has been proposed to be a direct target of vascular endothelial growth factor (VEGF) signaling in endothelial cells. We now provide the first in vivo experimental evidence that PTP4A3 participates in VEGF signaling and contributes to the process of pathological angiogenesis. Colon tumor tissue isolated from Ptp4a3-null mice revealed reduced tumor microvessel density compared with wild type controls. Additionally, vascular cells derived from Ptp4a3-null tissues exhibited decreased invasiveness in an ex vivo wound healing assay. When primary endothelial cells were isolated and cultured in vitro, Ptp4a3-null cells displayed greatly reduced migration compared with wild type cells. Exposure to VEGF led to an increase in Src phosphorylation in wild type endothelial cells, a response that was completely ablated in Ptp4a3-null cells. In loss-of-function studies, reduced VEGF-mediated migration was also observed when human endothelial cells were treated with a small molecule inhibitor of PTP4A3. VEGF-mediated in vivo vascular permeability was significantly attenuated in PTP4A3-deficient mice. These findings strongly support a role for PTP4A3 as an important contributor to endothelial cell function and as a multimodal target for cancer therapy and mitigating VEGF-regulated angiogenesis.	[Zimmerman, Mark W.; Pitt, Bruce R.; Homanics, Gregg E.; Lazo, John S.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [McQueeney, Kelley E.; Lazo, John S.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Isenberg, Jeffrey S.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15260 USA; [Isenberg, Jeffrey S.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Pitt, Bruce R.; Wasserloos, Karla A.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA; [Homanics, Gregg E.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lazo, JS (corresponding author), Univ Virginia, Dept Pharmacol, POB 800793, Charlottesville, VA 22908 USA.	lazo@virginia.edu		Homanics, Gregg/0000-0003-3641-8153	National Institute of Alcohol Abuse and Alcoholism [R37AA10422, F31AA019597]; National Institutes of Health Pharmacological Sciences Training Grant Predoctoral Fellowship [T32GM007055]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB017184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA010422, F31AA019597] Funding Source: NIH RePORTER	National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health Pharmacological Sciences Training Grant Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institute of Alcohol Abuse and Alcoholism Grant R37AA10422 and Fellowship F31AA019597 and National Institutes of Health Pharmacological Sciences Training Grant Predoctoral Fellowship T32GM007055.	Ahn JH, 2006, BIOORG MED CHEM LETT, V16, P2996, DOI 10.1016/j.bmcl.2006.02.060; Al-aidaroos AQO, 2013, J CLIN INVEST, V123, P3459, DOI 10.1172/JCI66824; Auerbach R, 2000, CANCER METAST REV, V19, P167, DOI 10.1023/A:1026574416001; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Fagerli UM, 2008, BLOOD, V111, P806, DOI 10.1182/blood-2007-07-101139; Fiordalisi JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064309; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Goo K, 2006, CANCER RES, V66, P9625, DOI 10.1158/0008-5472.CAN-06-0726; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Lian SY, 2013, BIOCHEM BIOPH RES CO, V430, P196, DOI 10.1016/j.bbrc.2012.11.036; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Liu H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-80; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Min G, 2013, BIOORG MED CHEM LETT, V23, P3769, DOI 10.1016/j.bmcl.2013.04.092; Ming J, 2009, PATHOLOGY, V41, P118, DOI 10.1080/00313020802579268; Mollevi DG, 2008, BRIT J CANCER, V99, P1718, DOI 10.1038/sj.bjc.6604747; Nagy J. A., 2012, COLD SPRING HARB PER, V2; Ooki A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-122; Parker BS, 2004, CANCER RES, V64, P7857, DOI 10.1158/0008-5472.CAN-04-1976; Preusser M, 2006, CANCER-AM CANCER SOC, V107, P162, DOI 10.1002/cncr.21973; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Rouleau C, 2006, MOL CANCER THER, V5, P219, DOI 10.1158/1535-7163.MCT-05-0289; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; St Croix B, 2000, SCIENCE, V289, P1197; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Sun ZY, 2012, J EXP MED, V209, P1363, DOI 10.1084/jem.20111343; Thompson HJ, 2002, CARCINOGENESIS, V23, P847, DOI 10.1093/carcin/23.5.847; Tyurina YY, 2011, RADIAT RES, V175, P610, DOI 10.1667/RR2297.1; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Xu J, 2011, PLOS ONE, V6; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zeng Q, 2003, CANCER RES, V63, P2716; Zimmerman MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058300	39	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5904	5913		10.1074/jbc.M113.480038	http://dx.doi.org/10.1074/jbc.M113.480038			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403062	Green Published, hybrid			2022-12-28	WOS:000332015500047
J	An, B; Abbonante, V; Yigit, S; Balduini, A; Kaplan, DL; Brodsky, B				An, Bo; Abbonante, Vittorio; Yigit, Sezin; Balduini, Alessandra; Kaplan, David L.; Brodsky, Barbara			Definition of the Native and Denatured Type II Collagen Binding Site for Fibronectin Using a Recombinant Collagen System*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Extracellular Matrix Proteins; Fibronectin; Protein Chimeras; Recombinant Protein Expression; Binding; Gelatin; Triple Helix	TRIPLE-HELICAL COLLAGEN; AMINO-ACID-SEQUENCE; CALF-SKIN COLLAGEN; STRUCTURAL-ANALYSIS; GLYCOPROTEIN-VI; ALPHA-CHAINS; PROTEIN; MATRIX; IDENTIFICATION; RECEPTORS	Background: Sequence requirements for triple-helical collagen to bind fibronectin are not fully understood. Results: Fibronectin affinity was conferred on a recombinant bacterial collagen by incorporating specific human collagen II sequences. Conclusion: The chimeric collagen defines the minimum collagen II sequence required for fibronectin affinity. Significance: This system is useful to investigate sequence/activity relationships for triple-helical collagen and to generate scalable bioactive materials. Interaction of collagen with fibronectin is important for extracellular matrix assembly and regulation of cellular processes. A fibronectin-binding region in collagen was identified using unfolded fragments, but it is not clear if the native protein binds fibronectin with the same primary sequence. A recombinant bacterial collagen is utilized to characterize the sequence requirement for fibronectin binding. Chimeric collagens were generated by inserting the putative fibronectin-binding region from human collagen into the bacterial collagen sequence. Insertion of a sufficient length of human sequence conferred fibronectin affinity. The minimum sequence requirement was identified as a 6-triplet sequence near the unique collagenase cleavage site and was the same in both triple-helix and denatured states. Denaturation of the chimeric collagen increased its affinity for fibronectin, as seen for mammalian collagens. The fibronectin binding recombinant collagen did not contain hydroxyproline, indicating hydroxyproline is not essential for binding. However, its absence may account, in part, for the higher affinity of the native chimeric protein and the lower affinity of the denatured protein compared with type II collagen. Megakaryocytes cultured on chimeric collagen with fibronectin affinity showed improved adhesion and differentiation, suggesting a strategy for generating bioactive materials in biomedical applications.	[An, Bo; Yigit, Sezin; Balduini, Alessandra; Kaplan, David L.; Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Abbonante, Vittorio; Balduini, Alessandra] Univ Pavia, San Matteo Fdn, IRCCS, Dept Mol Med,Biotechnol Res Labs, I-27100 Pavia, Italy	Tufts University; IRCCS Fondazione San Matteo; University of Pavia	Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu; barbara.brodsky@tufts.edu	Balduini, Alessandra/K-6802-2016; Abbonante, Vittorio/K-4028-2016; BALDUINI, ALESSANDRA/AAC-3363-2022; An, Bo/N-3466-2014; Abbonante, Vittorio/AAA-9303-2020	Balduini, Alessandra/0000-0003-3145-1245; Abbonante, Vittorio/0000-0001-8066-9895; BALDUINI, ALESSANDRA/0000-0003-3145-1245; An, Bo/0000-0002-1031-3380; Abbonante, Vittorio/0000-0001-8066-9895	National Institutes of Health Grant [EB011620]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant EB011620 (to B. B. and D. K.).	Akiyama S K, 1983, Monogr Pathol, V24, P55; An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085; Asselin J, 1999, BIOCHEM J, V339, P413, DOI 10.1042/0264-6021:3390413; Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002; DESSAU W, 1978, BIOCHEM J, V169, P55, DOI 10.1042/bj1690055; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; ENGVALL E, 1978, J EXP MED, V147, P1584, DOI 10.1084/jem.147.6.1584; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Erat MC, 2013, J BIOL CHEM, V288, P17441, DOI 10.1074/jbc.M113.469841; Erat MC, 2010, J BIOL CHEM, V285, P33764, DOI 10.1074/jbc.M110.139394; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; FIETZEK PP, 1973, EUR J BIOCHEM, V38, P396, DOI 10.1111/j.1432-1033.1973.tb03072.x; Fox NE, 2005, EXP HEMATOL, V33, P94, DOI 10.1016/j.exphem.2004.10.002; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; GUIDRY C, 1990, J BIOL CHEM, V265, P19230; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; Ingham KC, 2002, ARCH BIOCHEM BIOPHYS, V407, P217, DOI 10.1016/S0003-9861(02)00454-X; INGHAM KC, 1988, J BIOL CHEM, V263, P4624; Jiang F, 2002, BLOOD, V99, P3579, DOI 10.1182/blood.V99.10.3579; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200; Kielty C. M., 2002, CONNECTIVE TISSUE IT, P158; KLEINMAN HK, 1978, J BIOL CHEM, V253, P5642; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; LWEBUGAMUKASA JS, 1984, COLLAGEN REL RES, V4, P95; Malara A, 2011, BLOOD, V117, P2476, DOI 10.1182/blood-2010-06-288795; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Matsunaga T, 2012, ANN HEMATOL, V91, P1633, DOI 10.1007/s00277-012-1498-y; Mazharian A, 2010, BLOOD, V116, P793, DOI 10.1182/blood-2010-03-275990; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; Peng Y. Y., 2013, J BIOMED MAT RES A, DOI 10.1002/jbm.a.34898; Perret S, 2003, J BIOL CHEM, V278, P29873, DOI 10.1074/jbc.M304073200; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Piez K.A., 1984, EXTRACELLULAR MATRIX; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Sen TZ, 2005, BIOINFORMATICS, V21, P2787, DOI 10.1093/bioinformatics/bti408; Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Stultz CM, 2003, BIOPHYS J, V85, P2198, DOI 10.1016/S0006-3495(03)74645-1; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979	54	47	47	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4941	4951		10.1074/jbc.M113.530808	http://dx.doi.org/10.1074/jbc.M113.530808			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24375478	Green Published, hybrid			2022-12-28	WOS:000331607900040
J	Kim, YK; Kim, S; Shin, YJ; Hur, YS; Kim, WY; Lee, MS; Cheon, CI; Verma, DPS				Kim, Yun-Kyoung; Kim, Sunghan; Shin, Yun-jeong; Hur, Yoon-Sun; Kim, Woo-Young; Lee, Myung-Sok; Cheon, Choong-Ill; Verma, Desh Pal S.			Ribosomal Protein S6, a Target of Rapamycin, Is Involved in the Regulation of rRNA Genes by Possible Epigenetic Changes in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epigenetics; Histone Deacetylase; Ribosomal RNA (rRNA); Stress Response; TOR	POLYMERASE-I; HISTONE DEACETYLASES; NUCLEOLAR DOMINANCE; EXPRESSION; PHOSPHORYLATION; TRANSCRIPTION; KINASE; RDNA; LOCALIZATION; ASSOCIATION	The target of rapamycin (TOR) kinase pathway regulates various biological processes, including translation, synthesis of ribosomal proteins, and transcription of rRNA. The ribosomal protein S6 (RPS6) is one of the well known downstream components of the TOR pathway. Ribosomal proteins have been known to have diverse functions in regulating cellular metabolism as well as protein synthesis. So far, however, little is known about other possible role(s) of RPS6 in plants, besides being a component of the 40 S ribosomal subunit and acting as a target of TOR. Here, we report that RPS6 may have a novel function via interaction with histone deacetylase 2B (AtHD2B) that belongs to the plant-specific histone deacetylase HD2 family. RPS6 and AtHD2B were localized to the nucleolus. Co-expression of RPS6 and AtHD2B caused a change in the location of both RPS6 and AtHD2B to one or several nucleolar spots. ChIP analysis suggests that RPS6 directly interacts with the rRNA gene promoter. Protoplasts overexpressing both AtHD2B and RPS6 exhibited down-regulation of pre-18 S rRNA synthesis with a concomitant decrease in transcription of some of the ribosomal proteins, suggesting their direct role in ribosome biogenesis and plant development. This is consistent with the mutation in rps6b that results in reduction in 18 S rRNA transcription and decreased root growth. We propose that the interaction between RPS6 and AtHD2B brings about a change in the chromatin structure of rDNA and thus plays an important role in linking TOR signaling to rDNA transcription and ribosome biogenesis in plants.	[Kim, Yun-Kyoung; Shin, Yun-jeong; Hur, Yoon-Sun; Lee, Myung-Sok; Cheon, Choong-Ill] Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea; [Kim, Woo-Young] Sookmyung Womens Univ, Coll Pharm, Seoul 140742, South Korea; [Kim, Sunghan] Seoul Natl Univ, Dept Plant Sci, Seoul 151742, South Korea; [Kim, Sunghan; Verma, Desh Pal S.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Kim, Sunghan; Verma, Desh Pal S.] Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA	Sookmyung Women's University; Sookmyung Women's University; Seoul National University (SNU); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Cheon, CI (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Hyochangwon Gil 52, Seoul 140742, South Korea.	ccheon@sookmyung.ac.kr; verma.1@osu.edu	Kim, Sunghan/ABH-3874-2020	Kim, Sunghan/0000-0002-4955-8780	National Science Foundation [0726284]; National Research Foundation of Korea [201100300074, 2010-A0604-C00031]; Korean Government; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES027302] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Science Foundation Grant 0726284 (to D. P. S. V.), National Research Foundation of Korea Grant 201100300074 funded by the Korean Government (to Sookmyung MRC Center and C. I. C.), and National Research Foundation of Korea Grant 2010-A0604-C00031 (to S. K.).	Bartova E, 2010, J HISTOCHEM CYTOCHEM, V58, P391, DOI 10.1369/jhc.2009.955435; Berger AB, 2007, MOL CELL BIOL, V27, P8015, DOI 10.1128/MCB.01102-07; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Creff A, 2010, PLANT MOL BIOL, V73, P533, DOI 10.1007/s11103-010-9639-y; DOELLING JH, 1995, PLANT J, V8, P683, DOI 10.1046/j.1365-313X.1995.08050683.x; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; FLEISCHER S, 1983, EMBO J, V2, P2319, DOI 10.1002/j.1460-2075.1983.tb01740.x; FRANCO R, 1990, J BIOL CHEM, V265, P4321; Fumagalli S, 2000, COLD SPRING HARBOR M, V39, P695; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Ha CW, 2011, NUCLEIC ACIDS RES, V39, P1336, DOI 10.1093/nar/gkq895; Hagner PR, 2011, ONCOGENE, V30, P1531, DOI 10.1038/onc.2010.533; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; Lusser A, 1997, SCIENCE, V277, P88, DOI 10.1126/science.277.5322.88; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; Pracheil T, 2012, GENETICS, V190, P1325, DOI 10.1534/genetics.111.138305; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; Ren MZ, 2011, PLANT PHYSIOL, V155, P1367, DOI 10.1104/pp.110.169045; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Saez-Vasquez J, 2004, MOL CELL BIOL, V24, P7284, DOI 10.1128/MCB.24.16.7284-7297.2004; Santoro R, 2005, MOL CELL BIOL, V25, P2539, DOI 10.1128/MCB.25.7.2539-2546.2005; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; SUZUKI H, 1991, PLANT PHYSIOL, V95, P384, DOI 10.1104/pp.95.2.384; Tsang CK, 2010, CELL CYCLE, V9, P953, DOI 10.4161/cc.9.5.10876; Tsang CK, 2003, EMBO J, V22, P6045, DOI 10.1093/emboj/cdg578; Tucker S, 2010, CURR OPIN CELL BIOL, V22, P351, DOI 10.1016/j.ceb.2010.03.009; Turck F, 2004, PLANT PHYSIOL, V134, P1527, DOI 10.1104/pp.103.035873; Ueno Y, 2007, PLANT CELL, V19, P445, DOI 10.1105/tpc.106.042325; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Williams AJ, 2003, PLANT PHYSIOL, V132, P2086, DOI 10.1104/pp.103.022749; Wu KQ, 2003, PLANT J, V34, P241, DOI 10.1046/j.1365-313X.2003.01714.x; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhou CH, 2004, PLANT J, V38, P715, DOI 10.1111/j.1365-313X.2004.02083.x	45	49	50	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3901	3912		10.1074/jbc.M113.515015	http://dx.doi.org/10.1074/jbc.M113.515015			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24302738	Green Published, hybrid			2022-12-28	WOS:000331403800007
J	Tso, SC; Qi, XB; Gui, WJ; Wu, CY; Chuang, JL; Wernstedt-Asterholm, I; Morlock, LK; Owens, KR; Scherer, PE; Williams, NS; Tambar, UK; Wynn, RM; Chuang, DT				Tso, Shih-Chia; Qi, Xiangbing; Gui, Wen-Jun; Wu, Cheng-Yang; Chuang, Jacinta L.; Wernstedt-Asterholm, Ingrid; Morlock, Lorraine K.; Owens, Kyle R.; Scherer, Philipp E.; Williams, Noelle S.; Tambar, Uttam K.; Wynn, R. Max; Chuang, David T.			Structure-guided Development of Specific Pyruvate Dehydrogenase Kinase Inhibitors Targeting the ATP-binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Drug Development; Enzyme Inhibitors; Glucose Metabolism; Pyruvate Dehydrogenase Complex; Pyruvate Dehydrogenase Kinase; Hepatic Steatosis; Mitochondrial Protein Kinase; Structure-based Inhibitor Design	METABOLIC SWITCH; LIPOIC ACID; MECHANISMS; AZD7545; PYRUVATE-DEHYDROGENASE-KINASE-2; PHOSPHORYLATION; INACTIVATION; ADAPTATION; EXPRESSION; OXIDATION	Pyruvate dehydrogenase kinase isoforms (PDKs 1-4) negatively regulate activity of the mitochondrial pyruvate dehydrogenase complex by reversible phosphorylation. PDK isoforms are up-regulated in obesity, diabetes, heart failure, and cancer and are potential therapeutic targets for these important human diseases. Here, we employed a structure-guided design to convert a known Hsp90 inhibitor to a series of highly specific PDK inhibitors, based on structural conservation in the ATP-binding pocket. The key step involved the substitution of a carbonyl group in the parent compound with a sulfonyl in the PDK inhibitors. The final compound of this series, 2-[(2,4-dihydroxyphenyl)sulfonyl]isoindoline-4,6-diol, designated PS10, inhibits all four PDK isoforms with IC50 = 0.8 m for PDK2. The administration of PS10 (70 mg/kg) to diet-induced obese mice significantly augments pyruvate dehydrogenase complex activity with reduced phosphorylation in different tissues. Prolonged PS10 treatments result in improved glucose tolerance and notably lessened hepatic steatosis in the mouse model. The results support the pharmacological approach of targeting PDK to control both glucose and fat levels in obesity and type 2 diabetes.	[Tso, Shih-Chia; Qi, Xiangbing; Gui, Wen-Jun; Wu, Cheng-Yang; Chuang, Jacinta L.; Morlock, Lorraine K.; Owens, Kyle R.; Williams, Noelle S.; Tambar, Uttam K.; Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wernstedt-Asterholm, Ingrid; Scherer, Philipp E.; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Tambar, UK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	Uttam.Tambar@UTSouthwestern.edu; David.Chuang@UTSouthwestern.edu	Scherer, Philipp E/K-7819-2012; qi, xiangbing/A-4043-2019	Scherer, Philipp E/0000-0003-0680-3392; Wynn, Richard/0000-0002-1879-2136; Owens, Kyle/0000-0003-3076-053X; qi, xiangbing/0000-0002-7139-5164; Wernstedt Asterholm, Ingrid/0000-0002-0755-5784; Wu, Cheng-Yang/0000-0002-3582-083X	Department of Energy [DE-AC02-06CH11357]; Novo Nordisk Fonden [NNF12OC1016065] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026758, R01DK092921, R01DK055758, R56DK062306, R01DK062306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102604] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Crystal structures presented in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, operated under Department of Energy Contract DE-AC02-06CH11357.	Aicher TD, 2000, J MED CHEM, V43, P236, DOI 10.1021/jm990358+; Baker JC, 2000, J BIOL CHEM, V275, P15773, DOI 10.1074/jbc.M909488199; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Dymock BW, 2005, J MED CHEM, V48, P4212, DOI 10.1021/jm050355z; Feldman RI, 2009, CHEM BIOL DRUG DES, V74, P43, DOI 10.1111/j.1747-0285.2009.00833.x; Ferriero R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004986; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; Green T, 2008, J BIOL CHEM, V283, P15789, DOI 10.1074/jbc.M800311200; Harris RA, 1997, ADV ENZYME REGUL, V37, P271, DOI 10.1016/S0065-2571(96)00009-X; Hiromasa Y, 2008, BIOCHEMISTRY-US, V47, P2298, DOI 10.1021/bi701475f; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Jeoung NH, 2012, BIOCHEM J, V443, P829, DOI 10.1042/BJ20112197; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; Kato M, 2008, STRUCTURE, V16, P1849, DOI 10.1016/j.str.2008.10.010; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Knoechel TR, 2006, BIOCHEMISTRY-US, V45, P402, DOI 10.1021/bi051402s; Korotchkina LG, 2004, FREE RADICAL RES, V38, P1083, DOI 10.1080/10715760400004168; Kukimoto-Niino M, 2011, ACTA CRYSTALLOGR D, V67, P763, DOI 10.1107/S090744491102405X; Kung PP, 2010, J MED CHEM, V53, P499, DOI 10.1021/jm901209q; Kuzuya T, 2008, BIOCHEM BIOPH RES CO, V373, P94, DOI 10.1016/j.bbrc.2008.05.167; Li J, 2009, J BIOL CHEM, V284, P34458, DOI 10.1074/jbc.M109.065557; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Mayers RM, 2003, BIOCHEM SOC T, V31, P1165; Metelkin E, 2009, FEBS J, V276, P6942, DOI 10.1111/j.1742-4658.2009.07394.x; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Murray CW, 2010, J MED CHEM, V53, P5942, DOI 10.1021/jm100059d; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0; RANDLE PJ, 1995, P NUTR SOC, V54, P317, DOI 10.1079/PNS19950057; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; Rosa G, 2003, OBES RES, V11, P176, DOI 10.1038/oby.2003.28; Stacpoole PW, 1997, ARCH DIS CHILD, V77, P535, DOI 10.1136/adc.77.6.535; Steussy CN, 2001, J BIOL CHEM, V276, P37443, DOI 10.1074/jbc.M104285200; Tso SC, 2013, P NATL ACAD SCI USA, V110, P9728, DOI 10.1073/pnas.1303220110; Tuganova A, 2007, BIOCHEMISTRY-US, V46, P8592, DOI 10.1021/bi700650k; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27; WHITEHOUSE S, 1973, BIOCHEM J, V134, P651, DOI 10.1042/bj1340651; Wu PF, 1999, DIABETES, V48, P1593, DOI 10.2337/diabetes.48.8.1593; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200	50	70	73	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4432	4443		10.1074/jbc.M113.533885	http://dx.doi.org/10.1074/jbc.M113.533885			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24356970	Green Published, hybrid			2022-12-28	WOS:000331403800053
J	Khalaj, M; Abbasi, A; Yamanishi, H; Akiyama, K; Wakitani, S; Kikuchi, S; Hirose, M; Yuzuriha, M; Magari, M; Degheidy, HA; Abe, K; Ogura, A; Hashimoto, H; Kunieda, T				Khalaj, Maryam; Abbasi, Abdolrahim; Yamanishi, Hiroshi; Akiyama, Kouyou; Wakitani, Shuso; Kikuchi, Sotaro; Hirose, Michiko; Yuzuriha, Misako; Magari, Masaki; Degheidy, Heba A.; Abe, Kuniya; Ogura, Atsuo; Hashimoto, Hiroshi; Kunieda, Tetsuo			A Missense Mutation in Rev7 Disrupts Formation of Pol zeta, Impairing Mouse Development and Repair of Genotoxic Agent-induced DNA Lesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; DNA Polymerase; Embryo; Mouse Genetics; Mutant	PRIMORDIAL GERM-CELLS; CROSS-LINK REPAIR; POLYMERASE-ZETA; FANCONI-ANEMIA; EMBRYONIC LETHALITY; CHROMOSOMAL INSTABILITY; GENOMIC INSTABILITY; CATALYTIC SUBUNIT; MAMMALIAN-CELLS; B-CELLS	Background:Rev7 encodes a subunit of Pol for translesion DNA synthesis (TLS). Results: We found a Rev7 mutation in mice that causes developmental defects and increases susceptibility for genotoxicity. Conclusion:Rev7 is essential for mouse development through its function in cell proliferation. Significance: These findings demonstrate a unique function of Pol in development that is absent in other TLS polymerases. Repro22 is a mutant mouse produced via N-ethyl-N-nitrosourea-induced mutagenesis that shows sterility with germ cell depletion caused by defective proliferation of primordial germ cells, decreased body weight, and partial lethality during embryonic development. Using a positional cloning strategy, we identified a missense mutation in Rev7/Mad2l2 (Rev7(C70R)) and confirmed that the mutation is the cause of the defects in repro22 mice through transgenic rescue with normal Rev7. Rev7/Mad2l2 encodes a subunit of DNA polymerase (Pol), 1 of 10 translesion DNA synthesis polymerases known in mammals. The mutant REV7 did not interact with REV3, the catalytic subunit of Pol. Rev7(C70R/C70R) cells showed decreased proliferation, increased apoptosis, and arrest in S phase with extensive H2AX foci in nuclei that indicated accumulation of DNA damage after treatment with the genotoxic agent mitomycin C. The Rev7(C70R) mutation does not affect the mitotic spindle assembly checkpoint. These results demonstrated that Rev7 is essential in resolving the replication stalls caused by DNA damage during S phase. We concluded that Rev7 is required for primordial germ cell proliferation and embryonic viability and development through the translesion DNA synthesis activity of Pol preserving DNA integrity during cell proliferation, which is required in highly proliferating embryonic cells.	[Khalaj, Maryam; Abbasi, Abdolrahim; Yamanishi, Hiroshi; Wakitani, Shuso; Magari, Masaki] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Akiyama, Kouyou; Kunieda, Tetsuo] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Khalaj, Maryam; Abbasi, Abdolrahim] NIDDK, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA; [Kikuchi, Sotaro; Hashimoto, Hiroshi] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Hirose, Michiko; Yuzuriha, Misako; Abe, Kuniya; Ogura, Atsuo] RIKEN Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan; [Degheidy, Heba A.] US FDA, Div Biol, Silver Spring, MD 20993 USA	Okayama University; Okayama University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Yokohama City University; RIKEN; US Food & Drug Administration (FDA)	Abbasi, A (corresponding author), NIDDK, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA.	abbasiar@mail.nih.gov; tkunieda@cc.okayama-u.ac.jp	Ogura, Atsuo/J-3916-2014; MAGARI, Masaki/B-2555-2011	Ogura, Atsuo/0000-0003-0447-1988; Magari, Masaki/0000-0002-4624-0160; Hashimoto, Hiroshi/0000-0003-1503-6789	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported in part by grants from the Japan Society for the Promotion of Science.	Abbasi AR, 2009, GENOMICS, V94, P55, DOI 10.1016/j.ygeno.2009.04.001; Abe K, 1996, DEV BIOL, V180, P468, DOI 10.1006/dbio.1996.0320; Agoulnik AI, 2002, HUM MOL GENET, V11, P3047, DOI 10.1093/hmg/11.24.3047; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; Bertocci B, 2003, IMMUNITY, V19, P203, DOI 10.1016/S1074-7613(03)00203-6; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Chen M, 1996, NAT GENET, V12, P448, DOI 10.1038/ng0496-448; Cheung HW, 2006, CANCER RES, V66, P4357, DOI 10.1158/0008-5472.CAN-05-3602; Chun ACS, 2010, BIOCHEM SOC T, V38, P110, DOI 10.1042/BST0380110; Couronne O, 2003, GENOME RES, V13, P73, DOI 10.1101/gr.762503; Daly J, 2012, J IMMUNOL, V188, P5528, DOI 10.4049/jimmunol.1102629; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; Esposito G, 2000, CURR BIOL, V10, P1221, DOI 10.1016/S0960-9822(00)00726-0; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Gibbs PEM, 1998, P NATL ACAD SCI USA, V95, P6876, DOI 10.1073/pnas.95.12.6876; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Hara K, 2009, ACTA CRYSTALLOGR F, V65, P1302, DOI 10.1107/S1744309109046181; Hicks JK, 2010, MOL CELL BIOL, V30, P1217, DOI 10.1128/MCB.00993-09; Ho V, 2010, ENVIRON MOL MUTAGEN, V51, P552, DOI 10.1002/em.20573; Huang Xuan, 2006, Methods Mol Biol, V314, P73; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Lange SS, 2013, P NATL ACAD SCI USA, V110, pE687, DOI 10.1073/pnas.1217425110; Lange SS, 2012, NUCLEIC ACIDS RES, V40, P4473, DOI 10.1093/nar/gks054; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lessard C, 2007, HUM REPROD, V22, P159, DOI 10.1093/humrep/del322; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nadler JJ, 2000, GENESIS, V27, P117, DOI 10.1002/1526-968X(200007)27:3<117::AID-GENE40>3.0.CO;2-7; Okada T, 2005, MOL CELL BIOL, V25, P6103, DOI 10.1128/MCB.25.14.6103-6111.2005; Perry ACF, 1999, SCIENCE, V284, P1180, DOI 10.1126/science.284.5417.1180; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rimkus C, 2007, INT J CANCER, V120, P207, DOI 10.1002/ijc.22155; Saeki A, 2002, CANCER-AM CANCER SOC, V94, P2047, DOI 10.1002/cncr.10448; Saribasak H, 2012, J EXP MED, V209, P1075, DOI 10.1084/jem.20112234; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2; Schenten D, 2009, J EXP MED, V206, P477, DOI 10.1084/jem.20080669; Sharma S, 2012, NUCLEIC ACIDS RES, V40, P682, DOI 10.1093/nar/gkr769; Shima N, 2004, MOL CELL BIOL, V24, P10381, DOI 10.1128/MCB.24.23.10381-10389.2004; Takata K, 2009, EMBO J, V28, P313, DOI 10.1038/emboj.2008.303; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Watanabe N, 2013, J BIOL CHEM, V288, P10459, DOI 10.1074/jbc.M112.421966; Williams HL, 2012, MOL CELL, V47, P140, DOI 10.1016/j.molcel.2012.05.001; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Wittschieben JP, 2010, CANCER RES, V70, P2770, DOI 10.1158/0008-5472.CAN-09-4267; Wittschieben JP, 2006, CANCER RES, V66, P134, DOI 10.1158/0008-5472.CAN-05-2982; Wong JCY, 2003, HUM MOL GENET, V12, P2063, DOI 10.1093/hmg/ddg219	60	19	20	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3811	3824		10.1074/jbc.M113.514752	http://dx.doi.org/10.1074/jbc.M113.514752			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24356953	Green Published, hybrid			2022-12-28	WOS:000331368700060
J	Behnke, J; Hendershot, LM				Behnke, Julia; Hendershot, Linda M.			The Large Hsp70 Grp170 Binds to Unfolded Protein Substrates in Vivo with a Regulation Distinct from Conventional Hsp70s	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); ER Quality Control; Glycoprotein; Molecular Cell Biology; Molecular Chaperone; Protein Folding	IMMUNOGLOBULIN HEAVY-CHAIN; NUCLEOTIDE EXCHANGE FACTOR; BIP ATPASE MUTANTS; ENDOPLASMIC-RETICULUM; YEAST HSP110; MOLECULAR CHAPERONES; QUALITY-CONTROL; PEPTIDE BINDING; LIGHT-CHAINS; SECRETION	Background: Large Hsp70s are structurally similar to conventional Hsp70s but functionally less well understood. Results: The endoplasmic reticulum cognate Grp170 binds directly to substrates in vivo, which is modulated by structural elements characteristic for large Hsp70s. Conclusion: Grp170 serves as a nucleotide exchange factor and a chaperone. Significance: In addition to BiP another Hsp70 superfamily member fulfills ER chaperone functions. The Hsp70 superfamily is a ubiquitous chaperone class that includes conventional and large Hsp70s. BiP is the only conventional Hsp70 in the endoplasmic reticulum (ER) whose functions include: assisting protein folding, targeting misfolded proteins for degradation, and regulating the transducers of the unfolded protein response. The ER also possesses a single large Hsp70, the glucose-regulated protein of 170 kDa (Grp170). Like BiP it is an essential protein, but its cellular functions are not well understood. Here we show that Grp170 can bind directly to a variety of incompletely folded protein substrates in the ER, and as expected for a bona fide chaperone, it does not interact with folded secretory proteins. Our data demonstrate that Grp170 and BiP associate with similar molecular forms of two substrate proteins, but while BiP is released from unfolded substrates in the presence of ATP, Grp170 remains bound. In comparison to conventional Hsp70s, the large Hsp70s possess two unique structural features: an extended C-terminal -helical domain and an unstructured loop in the putative substrate binding domain with an unknown function. We find that in the absence of the -helical domain the interaction of Grp170 with substrates is reduced. In striking contrast, deletion of the unstructured loop results in increased binding to substrates, suggesting the presence of unique intramolecular mechanisms of control for the chaperone functions of large Hsp70s.	[Behnke, Julia; Hendershot, Linda M.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Hendershot, LM (corresponding author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274	National Institutes of Health [R01 GM54068]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; Boehringer Ingelheim Fonds Ph.D. fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Boehringer Ingelheim Fonds Ph.D. fellowship(Boehringer Ingelheim); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM54068 (to L. M. H.), the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital, and a Boehringer Ingelheim Fonds Ph.D. fellowship (to J. B.).	Andreasson C, 2010, J BIOL CHEM, V285, P12445, DOI 10.1074/jbc.M109.096735; Bando Y, 2000, AM J PHYSIOL-CELL PH, V278, pC1172, DOI 10.1152/ajpcell.2000.278.6.C1172; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Buck TM, 2013, J BIOL CHEM, V288, P18366, DOI 10.1074/jbc.M113.469882; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Craven A. R., 1997, TRENDS CELL BIOL, V7, P277; de Keyzer J, 2009, J BIOL CHEM, V284, P31564, DOI 10.1074/jbc.M109.055160; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Feigel MJ, 2013, MOL CELL, V51, P297, DOI 10.1016/j.molcel.2013.07.013; Finka A, 2013, CELL STRESS CHAPERON, V18, P591, DOI 10.1007/s12192-013-0413-3; GAUT JR, 1993, J BIOL CHEM, V268, P7248; Goeckeler JL, 2008, FEBS LETT, V582, P2393, DOI 10.1016/j.febslet.2008.05.047; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hebert DN, 2012, TRENDS BIOCHEM SCI, V37, P404, DOI 10.1016/j.tibs.2012.07.005; Hellman R, 1999, J CELL BIOL, V144, P21, DOI 10.1083/jcb.144.1.21; Hendershot L, 1996, P NATL ACAD SCI USA, V93, P5269, DOI 10.1073/pnas.93.11.5269; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; Howes J, 2012, J BIOL CHEM, V287, P8552, DOI 10.1074/jbc.M111.333286; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KNITTLER MR, 1992, EMBO J, V11, P1573, DOI 10.1002/j.1460-2075.1992.tb05202.x; Lee SJ, 1998, EXP MOL MED, V30, P159, DOI 10.1038/emm.1998.23; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; LIN HY, 1993, MOL BIOL CELL, V4, P1109, DOI 10.1091/mbc.4.11.1109; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Ozawa K, 2001, CANCER RES, V61, P4206; Park J, 2003, BIOCHEMISTRY-US, V42, P14893, DOI 10.1021/bi030122e; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Polier S, 2010, J MOL BIOL, V401, P696, DOI 10.1016/j.jmb.2010.07.004; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Schmidt BZ, 2005, AM J PHYSIOL-GASTR L, V289, pG444, DOI 10.1152/ajpgi.00237.2004; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Skowronek MH, 1998, P NATL ACAD SCI USA, V95, P1574, DOI 10.1073/pnas.95.4.1574; Spee P, 1999, BIOCHEMISTRY-US, V38, P10559, DOI 10.1021/bi990321r; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Vanhove M, 2001, IMMUNITY, V15, P105, DOI 10.1016/S1074-7613(01)00163-7; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Weitzmann A, 2007, FEBS J, V274, P5175, DOI 10.1111/j.1742-4658.2007.06039.x; Weitzmann A, 2006, FEBS LETT, V580, P5237, DOI 10.1016/j.febslet.2006.08.055; Xu XP, 2012, J BIOL CHEM, V287, P5661, DOI 10.1074/jbc.M111.275057	48	39	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2899	2907		10.1074/jbc.M113.507491	http://dx.doi.org/10.1074/jbc.M113.507491			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24327659	Green Published, hybrid			2022-12-28	WOS:000333403000038
J	Isaksen, T; Westereng, B; Aachmann, FL; Agger, JW; Kracher, D; Kittl, R; Ludwig, R; Haltrich, D; Eijsink, VGH; Horn, SJ				Isaksen, Trine; Westereng, Bjorge; Aachmann, Finn L.; Agger, Jane W.; Kracher, Daniel; Kittl, Roman; Ludwig, Roland; Haltrich, Dietmar; Eijsink, Vincent G. H.; Horn, Svein J.			A C4-oxidizing Lytic Polysaccharide Monooxygenase Cleaving Both Cellulose and Cello-oligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biofuel; Cellulase; Mass Spectrometry (MS); Metalloenzymes; NMR; AA10; AA9; CBM33; GH61; Lytic Polysaccharide Monooxygenase (LPMO)	CRYSTAL-STRUCTURE; PICHIA-PASTORIS; DEGRADATION; DEHYDROGENASE; NOMENCLATURE; OXIDATION; CLEAVAGE; ENZYMES; BINDING	Background: Lytic polysaccharide monooxygenases (LPMOs) are recently discovered enzymes that cleave polysaccharides. Results: We describe a novel LPMO and use a range of analytical methods to characterize its activity. Conclusion: Cellulose and cello-oligosaccharides are cleaved by oxidizing the sugar at the nonreducing end in the C4 position. Significance: This study provides unequivocal evidence for C4 oxidation of the nonreducing end sugar and demonstrates a novel LPMO substrate specificity. Lignocellulosic biomass is a renewable resource that significantly can substitute fossil resources for the production of fuels, chemicals, and materials. Efficient saccharification of this biomass to fermentable sugars will be a key technology in future biorefineries. Traditionally, saccharification was thought to be accomplished by mixtures of hydrolytic enzymes. However, recently it has been shown that lytic polysaccharide monooxygenases (LPMOs) contribute to this process by catalyzing oxidative cleavage of insoluble polysaccharides utilizing a mechanism involving molecular oxygen and an electron donor. These enzymes thus represent novel tools for the saccharification of plant biomass. Most characterized LPMOs, including all reported bacterial LPMOs, form aldonic acids, i.e., products oxidized in the C1 position of the terminal sugar. Oxidation at other positions has been observed, and there has been some debate concerning the nature of this position (C4 or C6). In this study, we have characterized an LPMO from Neurospora crassa (NcLPMO9C; also known as NCU02916 and NcGH61-3). Remarkably, and in contrast to all previously characterized LPMOs, which are active only on polysaccharides, NcLPMO9C is able to cleave soluble cello-oligosaccharides as short as a tetramer, a property that allowed detailed product analysis. Using mass spectrometry and NMR, we show that the cello-oligosaccharide products released by this enzyme contain a C4 gemdiol/keto group at the nonreducing end.	[Isaksen, Trine; Westereng, Bjorge; Agger, Jane W.; Eijsink, Vincent G. H.; Horn, Svein J.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Westereng, Bjorge] Univ Copenhagen, DK-1958 Frederiksberg C, Denmark; [Aachmann, Finn L.] Norwegian Univ Sci & Technol, Dept Biotechnol, NOBIPOL, N-7491 Trondheim, Norway; [Kracher, Daniel; Kittl, Roman; Ludwig, Roland; Haltrich, Dietmar] Univ Nat Resources & Life Sci, Dept Food Sci & Technol, BOKU, A-1190 Vienna, Austria	Norwegian University of Life Sciences; University of Copenhagen; Norwegian University of Science & Technology (NTNU); University of Natural Resources & Life Sciences, Vienna	Eijsink, VGH (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway.	vincent.eijsink@nmbu.no	Westereng, Bjørge/A-1688-2013; Haltrich, Dietmar/N-2624-2019; Agger, Jane Wittrup/AAF-8701-2020; Agger, Jane Wittrup/G-6783-2017; Kracher, Daniel/H-6667-2019; Agger, Jane Wittrup/B-7326-2015; Horn, Svein Jarle/C-6258-2008; Aachmann, Finn/G-4136-2015	Westereng, Bjørge/0000-0002-5141-7231; Haltrich, Dietmar/0000-0002-8722-8176; Agger, Jane Wittrup/0000-0002-7796-3089; Agger, Jane Wittrup/0000-0002-7796-3089; Kracher, Daniel/0000-0002-3856-3170; Agger, Jane Wittrup/0000-0002-7796-3089; Horn, Svein Jarle/0000-0002-1590-9001; Aachmann, Finn/0000-0003-1613-4663; Kittl, Roman/0000-0002-8923-481X; Ludwig, Roland/0000-0002-5058-5874	Norwegian Research Council [193817, 203402, 214613, 216162, 217708]; European Commission [FP7-KBBE-2013-7-613549]	Norwegian Research Council(Research Council of NorwayEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Norwegian Research Council Projects 193817, 203402, 214613, 216162, and 217708 and by the European Commission through the FP7-KBBE-2013-7-613549 project INDOX.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bey M, 2013, APPL ENVIRON MICROB, V79, P488, DOI 10.1128/AEM.02942-12; Cancilla MT, 1999, ANAL CHEM, V71, P3206, DOI 10.1021/ac9813484; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Flitsch A, 2013, ENZYME MICROB TECH, V52, P60, DOI 10.1016/j.enzmictec.2012.10.007; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Harreither W, 2011, APPL ENVIRON MICROB, V77, P1804, DOI 10.1128/AEM.02052-10; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Ifuku S, 2012, NANOSCALE, V4, P3308, DOI 10.1039/c2nr30383c; Kitago Y, 2007, J BIOL CHEM, V282, P35703, DOI 10.1074/jbc.M706835200; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kopper S, 2003, HELV CHIM ACTA, V86, P827, DOI 10.1002/hlca.200390083; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sygmund C, 2012, APPL ENVIRON MICROB, V78, P6161, DOI 10.1128/AEM.01503-12; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396; Xia YL, 2005, MAGN RESON CHEM, V43, P372, DOI 10.1002/mrc.1558; Zamocky M, 2008, PROTEIN EXPRES PURIF, V59, P258, DOI 10.1016/j.pep.2008.02.007	33	221	229	3	160	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2632	2642		10.1074/jbc.M113.530196	http://dx.doi.org/10.1074/jbc.M113.530196			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24324265	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000333403000014
J	Nguyen, LA; Kim, DH; Daly, MB; Allan, KC; Kim, B				Nguyen, Laura A.; Kim, Dong-Hyun; Daly, Michele B.; Allan, Kevin C.; Kim, Baek			Host SAMHD1 Protein Promotes HIV-1 Recombination in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV-1; Homologous Recombination; Macrophages; Nucleotide; Reverse Transcription; SAMHD1; Vpx	IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE MUTANT; RESTRICTION FACTOR SAMHD1; STRAND TRANSFER; DNTP UTILIZATION; DENDRITIC CELLS; DNA-SYNTHESIS; INFECTION; MECHANISM; DETERMINANTS	Background: Delaying DNA synthesis kinetics of HIV-1 reverse transcriptase by lowering dNTP concentrations elevates biochemical RNA template switch. Results: Degradation of SAMHD1 by Vpx, which increases dNTP levels, reduces HIV-1 template switching in macrophages, but not in CD4(+) T cells. Conclusion: Altering cellular dNTP levels directly affects in vivo HIV-1 template switching. Significance: Cellular dNTP abundance controlled by SAMHD1 contributes to HIV-1 template switching in macrophages. Template switching can occur during the reverse transcription of HIV-1. Deoxynucleotide triphosphate (dNTP) concentrations have been biochemically shown to impact HIV-1 reverse transcriptase (RT)-mediated strand transfer. Lowering the dNTP concentrations promotes RT pausing and RNA template degradation by RNase H activity of the RT, subsequently leading to strand transfer. Terminally differentiated/nondividing macrophages, which serve as a key HIV-1 reservoir, contain extremely low dNTP concentrations (20-50 nm), which results from the cellular dNTP hydrolyzing sterile motif and histidine aspartic domain containing protein 1 (SAMHD1) protein, when compared with activated CD4(+) T cells (2-5 m). In this study, we first observed that HIV-1 template switching efficiency was nearly doubled in human primary macrophages when compared with activated CD4(+) T cells. Second, SAMHD1 degradation by viral protein X (Vpx), which elevates cellular dNTP concentrations, decreased HIV-1 template switching efficiency in macrophages to the levels comparable with CD4(+) T cells. Third, differentiated SAMHD1 shRNA THP-1 cells have a 2-fold increase in HIV-1 template switching efficiency. Fourth, SAMHD1 degradation by Vpx did not alter HIV-1 template switching efficiency in activated CD4(+) T cells. Finally, the HIV-1 V148I RT mutant that is defective in dNTP binding and has DNA synthesis delay promoted RT stand transfer when compared with wild type RT, particularly at low dNTP concentrations. Here, we report that SAMHD1 regulation of the dNTP concentrations influences HIV-1 template switching efficiency, particularly in macrophages.	[Nguyen, Laura A.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Allan, Kevin C.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Kim, Dong-Hyun; Kim, Baek] Kyung Hee Univ, Coll Pharm, Seoul 130701, South Korea; [Daly, Michele B.; Kim, Baek] Emory Univ, Dept Pediat, Ctr Drug Discovery, Emory Ctr AIDS Res, Atlanta, GA 30322 USA	University of Rochester; University of Rochester; Kyung Hee University; Emory University	Kim, B (corresponding author), Emory Univ, Dept Pediat, Ctr Drug Discovery, 1760 Haygood Dr, Atlanta, GA 30322 USA.	baek.kim@emory.edu			National Institutes of Health [AI077401, AI049781]; Emory Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781, R56AI049781, R01AI077401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077401 and AI049781 (to B. K.). This work was also supported by the Emory Center for AIDS Research.	Baekelandt V, 2003, GENE THER, V10, P1933, DOI 10.1038/sj.gt.3302094; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Chen JB, 2005, J VIROL, V79, P9337, DOI 10.1128/JVI.79.14.9337-9340.2005; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Dapp MJ, 2009, J VIROL, V83, P11950, DOI 10.1128/JVI.01406-09; DESTEFANO JJ, 1993, NUCLEIC ACIDS RES, V21, P4330, DOI 10.1093/nar/21.18.4330; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Diamond TL, 2003, J BIOL CHEM, V278, P29913, DOI 10.1074/jbc.M211754200; Gao L, 2008, J BIOL CHEM, V283, P9196, DOI 10.1074/jbc.M710148200; Gao L, 2007, J BIOL CHEM, V282, P6222, DOI 10.1074/jbc.M610056200; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; GU ZX, 1995, J GEN VIROL, V76, P2601, DOI 10.1099/0022-1317-76-10-2601; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jamburuthugoda VK, 2008, J BIOL CHEM, V283, P9206, DOI 10.1074/jbc.M710149200; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; Kennedy EM, 2012, J BIOL CHEM, V287, P14280, DOI 10.1074/jbc.M112.348482; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kim JK, 1997, J BIOL CHEM, V272, P16769, DOI 10.1074/jbc.272.27.16769; KLATZMANN D, 1984, SCIENCE, V225, P59, DOI 10.1126/science.6328660; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Nguyen LA, 2012, J MOL BIOL, V415, P248, DOI 10.1016/j.jmb.2011.11.014; Nikolenko GN, 2004, J VIROL, V78, P8761, DOI 10.1128/JVI.78.16.8761-8770.2004; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Operario DJ, 2006, J BIOL CHEM, V281, P32113, DOI 10.1074/jbc.M604665200; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rigby ST, 2009, J MOL BIOL, V394, P694, DOI 10.1016/j.jmb.2009.10.036; Rigby ST, 2009, J MOL BIOL, V388, P30, DOI 10.1016/j.jmb.2009.02.029; Shen W, 2009, J BIOL CHEM, V284, P33883, DOI 10.1074/jbc.M109.055368; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; Svarovskaia ES, 2000, J VIROL, V74, P7171, DOI 10.1128/JVI.74.15.7171-7178.2000; Van Cor-Hosmer SK, 2010, VIROLOGY, V406, P253, DOI 10.1016/j.virol.2010.07.028; Wisniewski M, 2000, J BIOL CHEM, V275, P37664, DOI 10.1074/jbc.M007381200; Wisniewski M, 2000, P NATL ACAD SCI USA, V97, P11978, DOI 10.1073/pnas.210392297	46	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2489	2496		10.1074/jbc.C113.522326	http://dx.doi.org/10.1074/jbc.C113.522326			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24352659	hybrid, Green Published			2022-12-28	WOS:000333403000002
J	Vitaloni, M; Pulecio, J; Bilic, J; Kuebler, B; Laricchia-Robbio, L; Belmonte, JC				Vitaloni, Marianna; Pulecio, Julian; Bilic, Josipa; Kuebler, Bernd; Laricchia-Robbio, Leopoldo; Izpisua Belmonte, Juan Carlos			MicroRNAs Contribute to Induced Pluripotent Stem Cell Somatic Donor Memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computational Biology; Differentiation; Induced Pluripotent Stem (iPS) Cell; Induced Pluripotent Stem Cells; MicroRNA; Hematopoietic Progenitor Cell	EPIGENETIC MEMORY; HUMAN FIBROBLASTS; GENERATION; EXPRESSION; DIFFERENTIATION; MOUSE; EFFICIENT; IDENTIFICATION; PROGENITORS; DISCOVERY	Induced pluripotent stem cells (iPSCs) maintain during the first few culture passages a set of epigenetic marks and metabolites characteristic of their somatic cell of origin, a concept defined as epigenetic donor memory. These residual somatic features are lost over time after extensive culture passaging. Therefore, epigenetic donor memory may be responsible for the higher differentiation efficiency toward the tissue of origin observed in low passage iPSCs versus high passage iPSC or iPSCs derived from a different tissue source. Remarkably, there are no studies on the relevance of microRNA (miRNA) memory following reprogramming, despite the established role of these molecules in the context of pluripotency and differentiation. Using hematopoietic progenitors cells as a model, we demonstrated that miRNAs play a central role in somatic memory retention in iPSCs. Moreover, the comparison of the miRNA expression profiles among iPSCs from different sources allowed for the detection of a set of candidate miRNAs responsible for the higher differentiation efficiency rates toward blood progenitors observed in low passage iPSCs. Combining bioinformatic predictive algorithms with biological target validation, we identified miR-155 as a key player for the in vitro differentiation of iPSC toward hematopoietic progenitors. In summary, this study reveals that during the initial passages following reprogramming, iPSCs maintained the expression of a miRNA set exclusive to the original somatic population. Hence the use of these miRNAs might hold a direct application toward our understanding of the differentiation process of iPSCs toward hematopoietic progenitor cells.	[Vitaloni, Marianna; Pulecio, Julian; Bilic, Josipa; Kuebler, Bernd; Laricchia-Robbio, Leopoldo; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Salk Institute	Belmonte, JC (corresponding author), 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Kuebler, Bernd/K-2823-2017	Kuebler, Bernd/0000-0002-4472-871X; Vitaloni, Marianna/0000-0002-4250-3525; Bilic Zimmermann, Josipa/0000-0001-9642-6265; Pulecio, Julian/0000-0002-4455-8095	Fundacion Cellex; TERCEL-ISCIII-MINECO; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; California Institute for Regenerative Medicine	Fundacion Cellex; TERCEL-ISCIII-MINECO; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by grants from Fundacion Cellex, TERCEL-ISCIII-MINECO, the G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust, and the California Institute for Regenerative Medicine (to the Izpisua Belmonte laboratory).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Becker AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067003; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Bissels U, 2011, STEM CELLS, V29, P847, DOI 10.1002/stem.627; Calvanese V, 2012, NUCLEIC ACIDS RES, V40, P116, DOI 10.1093/nar/gkr685; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Chung YS, 2009, BLOOD, V114, P4968, DOI 10.1182/blood-2009-01-197780; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Giorgetti A, 2010, NAT PROTOC, V5, P811, DOI 10.1038/nprot.2010.16; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hertel J, 2012, RNA BIOL, V9, P231, DOI 10.4161/rna.18974; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jin P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-39; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lee SB, 2012, STEM CELLS, V30, P997, DOI 10.1002/stem.1074; Liao RX, 2008, J CELL BIOCHEM, V104, P805, DOI 10.1002/jcb.21668; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Merkerova M, 2010, STEM CELLS DEV, V19, P17, DOI 10.1089/scd.2009.0071; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Nishishita Naoki, 2011, J Stem Cells, V6, P101; O'Connell RM, 2012, CURR TOP DEV BIOL, V99, P145, DOI 10.1016/B978-0-12-387038-4.00006-9; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Rizzi R, 2012, CELL DEATH DIFFER, V19, P1162, DOI 10.1038/cdd.2011.205; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Woods NB, 2011, STEM CELLS, V29, P1158, DOI 10.1002/stem.657; Zheng W, 2011, MOL BIOTECHNOL, V47, P200, DOI 10.1007/s12033-010-9329-7	51	30	32	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2084	2098		10.1074/jbc.M113.538702	http://dx.doi.org/10.1074/jbc.M113.538702			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311783	hybrid, Green Published			2022-12-28	WOS:000331130200018
J	Yun, B; Lee, H; Ghosh, M; Cravatt, BF; Hsu, KL; Bonventre, JV; Ewing, H; Gelb, MH; Leslie, CC				Yun, Bogeon; Lee, HeeJung; Ghosh, Moumita; Cravatt, Benjamin F.; Hsu, Ku-Lung; Bonventre, Joseph V.; Ewing, Heather; Gelb, Michael H.; Leslie, Christina C.			Serine Hydrolase Inhibitors Block Necrotic Cell Death by Preventing Calcium Overload of the Mitochondria and Permeability Transition Pore Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arachidonic Acid; Calcium; CaMKII; Fatty Acid; Mitochondria; Mitochondrial Permeability Transition; Phospholipase A; Cyclosporin A; Pyrrophenone; Serine Hydrolase	CYTOSOLIC PHOSPHOLIPASE A(2); PROTEIN-KINASE-C; REPERFUSION INJURY; CYCLOSPORINE-A; OXIDATIVE STRESS; LUNG FIBROBLASTS; CA2+ UPTAKE; NECROSIS; MECHANISMS; UNIPORTER	Background: Mitochondrial calcium overload triggers permeability transition pore formation, fatty acid release, and necrotic cell death. Results: Pyrrophenone and KT195 inhibit cell death by blocking mitochondrial calcium uptake. Conclusion: Serine hydrolase inhibitors block mitochondrial calcium uptake but do not directly inhibit the enzyme releasing fatty acids during pore formation. Significance: Serine hydrolase inhibitors have potential to block necrotic cell death associated with disease. Perturbation of calcium signaling that occurs during cell injury and disease, promotes cell death. In mouse lung fibroblasts A23187 triggered mitochondrial permeability transition pore (MPTP) formation, lactate dehydrogenase (LDH) release, and necrotic cell death that were blocked by cyclosporin A (CsA) and EGTA. LDH release temporally correlated with arachidonic acid release but did not involve cytosolic phospholipase A(2) (cPLA(2)) or calcium-independent PLA(2). Surprisingly, release of arachidonic acid and LDH from cPLA(2)-deficient fibroblasts was inhibited by the cPLA(2) inhibitor pyrrophenone, and another serine hydrolase inhibitor KT195, by preventing mitochondrial calcium uptake. Inhibitors of calcium/calmodulin-dependent protein kinase II, a mitochondrial Ca2+ uniporter (MCU) regulator, also prevented MPTP formation and arachidonic acid release induced by A23187 and H2O2. Pyrrophenone blocked MCU-mediated mitochondrial calcium uptake in permeabilized fibroblasts but not in isolated mitochondria. Unlike pyrrophenone, the diacylglycerol analog 1-oleoyl-2-acetyl-sn-glycerol and CsA blocked cell death and arachidonic acid release not by preventing mitochondrial calcium uptake but by inhibiting MPTP formation. In fibroblasts stimulated with thapsigargin, which induces MPTP formation by a direct effect on mitochondria, LDH and arachidonic acid release were blocked by CsA and 1-oleoyl-2-acetyl-sn-glycerol but not by pyrrophenone or EGTA. Therefore serine hydrolase inhibitors prevent necrotic cell death by blocking mitochondrial calcium uptake but not the enzyme releasing fatty acids that occurs by a novel pathway during MPTP formation. This work reveals the potential for development of small molecule cell-permeable serine hydrolase inhibitors that block MCU-mediated mitochondrial calcium overload, MPTP formation, and necrotic cell death.	[Yun, Bogeon; Lee, HeeJung; Ghosh, Moumita; Leslie, Christina C.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Cravatt, Benjamin F.; Hsu, Ku-Lung] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Cravatt, Benjamin F.; Hsu, Ku-Lung] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Bonventre, Joseph V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Ewing, Heather; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Leslie, Christina C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Leslie, Christina C.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA	National Jewish Health; Scripps Research Institute; Scripps Research Institute; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Leslie, CC (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	lesliec@njhealth.org	Hsu, Ku-Lung/L-6256-2019; Hsu, Ku-Lung/J-2885-2014	Hsu, Ku-Lung/0000-0001-5620-3972; Hsu, Ku-Lung/0000-0001-5620-3972; gelb, michael/0000-0001-7000-5219	National Institutes of Health [HL61378, HL34303, HL50040, DA009789, DA033760, MH084512]; Hewitt Foundation Postdoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061378, R01HL050040, P01HL034303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789, R01DA033760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hewitt Foundation Postdoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL61378, HL34303, HL50040, DA009789, DA033760, and MH084512 and a Hewitt Foundation Postdoctoral Fellowship.	Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]; Baines CP, 2011, PEDIATR CARDIOL, V32, P258, DOI 10.1007/s00246-010-9880-9; Baines CP, 2010, ANNU REV PHYSIOL, V72, P61, DOI 10.1146/annurev-physiol-021909-135929; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barbayianni E, 2009, BIOORGAN MED CHEM, V17, P4833, DOI 10.1016/j.bmc.2009.03.069; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blum JL, 2011, TOXICOL IN VITRO, V25, P1001, DOI 10.1016/j.tiv.2011.03.014; Broekemeier KM, 2002, BIOCHEMISTRY-US, V41, P7771, DOI 10.1021/bi020157z; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Chinopoulos C, 2005, J BIOENERG BIOMEMBR, V37, P237, DOI 10.1007/s10863-005-6634-0; Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005; CROMPTON M, 1988, BIOCHEM J, V255, P357; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dong Z, 2006, ANNU REV PATHOL-MECH, V1, P405, DOI 10.1146/annurev.pathol.1.110304.100218; DUCHEN MR, 1993, CARDIOVASC RES, V27, P1790, DOI 10.1093/cvr/27.10.1790; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; GELB MH, 1985, BIOCHEMISTRY-US, V24, P1813, DOI 10.1021/bi00329a001; Ghosh M, 2004, AM J RESP CELL MOL, V30, P91, DOI 10.1165/rcmb.2003-0005OC; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; Gouriou Y, 2011, BIOCHIMIE, V93, P2060, DOI 10.1016/j.biochi.2011.08.001; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; Joiner MLA, 2012, NATURE, V491, P269, DOI 10.1038/nature11444; Kinsey GR, 2007, J PHARMACOL EXP THER, V321, P707, DOI 10.1124/jpet.107.119545; Knox CD, 2004, AM J PHYSIOL-GASTR L, V287, pG533, DOI 10.1152/ajpgi.00050.2004; Korge P, 1999, EUR J BIOCHEM, V265, P273, DOI 10.1046/j.1432-1327.1999.00724.x; Lemasters JJ, 1999, CARDIOVASC RES, V44, P470, DOI 10.1016/S0008-6363(99)00368-5; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Leslie CC, 2010, BIOCHIMIE, V92, P620, DOI 10.1016/j.biochi.2010.03.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Mcgee AM, 2011, BIOCHEM J, V433, P119, DOI 10.1042/BJ20101431; Mignen O, 2005, J CELL SCI, V118, P5615, DOI 10.1242/jcs.02663; Moon SH, 2012, J BIOL CHEM, V287, P29837, DOI 10.1074/jbc.M112.373654; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Ni Z, 2006, J BIOL CHEM, V281, P16245, DOI 10.1074/jbc.M513874200; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Noch E, 2009, CANCER BIOL THER, V8, P1791, DOI 10.4161/cbt.8.19.9762; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Parks RJ, 2018, METHODS MOL BIOL, V1782, P187, DOI [10.1007/978-1-61779-382-0_15, 10.1007/978-1-4939-7831-1_11]; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; PFEIFFER DR, 1979, J BIOL CHEM, V254, P1485; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; QIU ZH, 1994, J BIOL CHEM, V269, P19480; Raffaello A, 2012, CELL CALCIUM, V52, P16, DOI 10.1016/j.ceca.2012.04.006; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Salas MA, 2010, J MOL CELL CARDIOL, V48, P1298, DOI 10.1016/j.yjmcc.2009.12.015; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; Stewart A, 2002, J BIOL CHEM, V277, P29526, DOI 10.1074/jbc.M204856200; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003	68	27	28	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1491	1504		10.1074/jbc.M113.497651	http://dx.doi.org/10.1074/jbc.M113.497651			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297180	Green Published, hybrid			2022-12-28	WOS:000332401700025
J	Bosman, MCJ; Reis, CR; Schuringa, JJ; Vellenga, E; Quax, WJ				Bosman, Matthieu C. J.; Reis, Carlos R.; Schuringa, Jan J.; Vellenga, Edo; Quax, Wim J.			Decreased Affinity of Recombinant Human Tumor Necrosis Factor-related Apoptosis-inducing Ligand (rhTRAIL) D269H/E195R to Osteoprotegerin (OPG) Overcomes TRAIL Resistance Mediated by the Bone Microenvironment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-MYELOMA; DECOY RECEPTOR; DRUG-RESISTANCE; DEATH RECEPTORS; STEM-CELLS; CANCER; VARIANTS; DR5; APO2L/TRAIL; DISEASE	The bone marrow microenvironment provides important signals for the survival and proliferation of hematopoietic and malignant cells. In multiple myeloma, plasma cells are surrounded by stromal cells including osteoblasts. These stromal cells protect multiple myeloma cells from apoptosis induced by chemotherapeutic agents. Osteoprotegerin (OPG), a soluble receptor of the cytokine TNF-related apoptosis-inducing ligand (TRAIL), is secreted by osteoblasts and has been implicated in the prevention of cell death induced by TRAIL in malignant cells. Previously, we have designed death receptor-specific TRAIL variants that induce apoptosis exclusively via one of its death receptors. Here, we have studied in detail the interaction between recombinant human (rhTRAIL) variants and OPG. We show that a DR5-specific variant (rhTRAIL D269H/E195R) displays a significantly decreased affinity to OPG. Furthermore, this rhTRAIL variant shows a much higher activity when compared with rhTRAIL WT and retains its effectiveness in inducing cell death in multiple myeloma cell lines, in the presence of OPG secreted by stromal cells. We also demonstrate that stromal cells are largely insensitive to high concentrations of this rhTRAIL variant. In conclusion, rhTRAIL D269H/E195R is a potential therapy for multiple myeloma due to its high effectiveness and diminished binding to OPG.	[Bosman, Matthieu C. J.; Reis, Carlos R.; Quax, Wim J.] Univ Groningen, Groningen Res Inst Pharm, Dept Pharmaceut Biol, NL-9713 AV Groningen, Netherlands; [Bosman, Matthieu C. J.; Schuringa, Jan J.; Vellenga, Edo] Univ Groningen, Univ Med Ctr Groningen, Dept Expt Hematol, NL-9700 RB Groningen, Netherlands	University of Groningen; University of Groningen	Quax, WJ (corresponding author), Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	w.j.quax@rug.nl	Quax, Wim/K-2802-2012; Quax, Wim/O-2875-2019	Quax, Wim/0000-0002-5162-9947; Quax, Wim/0000-0002-5162-9947	University of Groningen; Technology Foundation STW; EFRO Drug Targeting Project; SNN; TI Pharma Project [T3-112]; Top Institute Pharma;  [STW-11056]	University of Groningen; Technology Foundation STW(Technologiestichting STW); EFRO Drug Targeting Project; SNN; TI Pharma Project; Top Institute Pharma; 	Supported by an Ubbo Emmius grant from the University of Groningen.; Supported by Grant STW-11056 funded by the Technology Foundation STW, the EFRO Drug Targeting Project funded by SNN, and TI Pharma Project T3-112 funded by the Top Institute Pharma. Present address: Dept. of Cell Biology, UT Southwestern Medical Center, Dallas, TX 75390-9039.	Donnenberg VS, 2005, J CLIN PHARMACOL, V45, P872, DOI 10.1177/0091270005276905; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Gasparian ME, 2009, APOPTOSIS, V14, P778, DOI 10.1007/s10495-009-0349-3; Gazitt Y, 1999, LEUKEMIA, V13, P1817, DOI 10.1038/sj.leu.2401501; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Holen I, 2006, CLIN SCI, V110, P279, DOI 10.1042/CS20050175; Huff CA, 2008, J CLIN ONCOL, V26, P2895, DOI 10.1200/JCO.2007.15.8428; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Lincz LF, 2001, LEUKEMIA, V15, P1650, DOI 10.1038/sj.leu.2402251; Locklin RM, 2007, LEUKEMIA, V21, P805, DOI 10.1038/sj.leu.2404518; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Matsui W, 2011, NATURE, V480, pS58, DOI 10.1038/480S58a; Mitsiades CS, 2001, BLOOD, V98, P795, DOI 10.1182/blood.V98.3.795; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Picarda G, 2012, AM J CANCER RES, V2, P45; Reis CR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.61; Reis CR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002808; Reis CR, 2009, BIOCHEMISTRY-US, V48, P2180, DOI 10.1021/bi801927x; Shipman CM, 2003, CANCER RES, V63, P912; Silvestris F, 2003, BRIT J HAEMATOL, V122, P39, DOI 10.1046/j.1365-2141.2003.04374.x; Truneh A, 2000, J BIOL CHEM, V275, P23319, DOI 10.1074/jbc.M910438199; Tur V, 2008, J BIOL CHEM, V283, P20560, DOI 10.1074/jbc.M800457200; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Van der Sloot AM, 2006, P NATL ACAD SCI USA, V103, P8634, DOI 10.1073/pnas.0510187103; Vitovski S, 2007, J BIOL CHEM, V282, P31601, DOI 10.1074/jbc.M706078200; Vitovski S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035830; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yones RJ, 2008, BIOL BLOOD MARROW TR, V14, P12, DOI 10.1016/j.bbmt.2007.10.012; Zinonos I, 2011, J BONE MINER RES, V26, P630, DOI 10.1002/jbmr.244	30	15	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1071	1078		10.1074/jbc.M113.491589	http://dx.doi.org/10.1074/jbc.M113.491589			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24280212	Green Published, hybrid			2022-12-28	WOS:000330541200039
J	Etzerodt, A; Rasmussen, MR; Svendsen, P; Chalaris, A; Schwarz, J; Galea, I; Moller, HJ; Moestrup, SK				Etzerodt, Anders; Rasmussen, Mie Rostved; Svendsen, Pia; Chalaris, Athena; Schwarz, Jeanette; Galea, Ian; Moller, Holger Jon; Moestrup, Soren Kragh			Structural Basis for Inflammation-driven Shedding of CD163 Ectodomain and Tumor Necrosis Factor-alpha in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOGLOBIN; HAPTOGLOBIN; DISINTEGRIN; ADAM17; BINDING; METALLOPROTEINASE; IDENTIFICATION; ENDOTOXIN; CLONING	The haptoglobin-hemoglobin receptor CD163 and proTNF-alpha are transmembrane macrophage proteins subjected to cleavage by the inflammation-responsive protease ADAM17. This leads to release of soluble CD163 (sCD163) and bioactive TNF-alpha. Sequence comparison of the juxtamembrane region identified similar palindromic sequences in human CD163 ((1044)Arg-Ser-Ser-Arg) and proTNF-alpha ((78)Arg-Ser-Ser-Ser-Arg). In proTNF-alpha the Arg-Ser-Ser-Ser-Arg sequence is situated next to the previously established ADAM17 cleavage site. Site-directed mutagenesis revealed that the sequences harbor essential information for efficient cleavage of the two proteins upon ADAM17 stimulation. This was further evidenced by analysis of mouse CD163 that, like CD163 in other non-primates, does not contain the palindromic CD163 sequence in the juxtamembrane region. Mouse CD163 resisted endotoxin-and phorbol ester-induced shedding, and ex vivo analysis of knock-in of the Arg-Ser-Ser-Arg sequence in mouse CD163 revealed a receptor shedding comparable with that of human CD163. In conclusion, we have identified an essential substrate motif for ADAM17-mediated CD163 and proTNF-alpha cleavage in macrophages. In addition, the present data indicate that CD163, by incorporation of this motif in late evolution, underwent a modification that allows for an instant down-regulation of surface CD163 expression and inhibition of hemoglobin uptake. This regulatory modality seems to have coincided with the evolution of an enhanced hemoglobin-protecting role of the haptoglobin-CD163 system in primates.	[Etzerodt, Anders; Rasmussen, Mie Rostved; Svendsen, Pia; Moestrup, Soren Kragh] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Chalaris, Athena; Schwarz, Jeanette] Univ Kiel, Dept Biochem, D-24118 Kiel, Germany; [Galea, Ian] Univ Southampton, Fac Med, Southampton SO17 1BJ, Hants, England; [Moller, Holger Jon; Moestrup, Soren Kragh] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus C, Denmark	Aarhus University; University of Kiel; University of Southampton; Aarhus University	Moestrup, SK (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 3, DK-8000 Aarhus C, Denmark.	skm@biokemi.au.dk	Etzerodt, Anders/E-2839-2013; Moestrup, Søren Kragh/A-1403-2014; Galea, Ian/B-7997-2011; Etzerodt, Anders/O-9860-2019; Moestrup, Søren Kragh/AAD-1735-2019	Etzerodt, Anders/0000-0002-6757-2068; Moestrup, Søren Kragh/0000-0003-3862-2107; Galea, Ian/0000-0002-1268-5102; Etzerodt, Anders/0000-0002-6757-2068; Rostved Bechshoft, Mie/0000-0002-6109-5221; Moller, Holger Jon/0000-0001-7687-5995	Danish Medical Research Council; Novo Nordisk Foundation; European Research Council [233312]; Lundbeck Foundation; Lundbeck Foundation [R54-2010-5637] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011537] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Danish Medical Research Council, the Novo Nordisk Foundation, the European Research Council (Advanced Grant for the TROJA program, Grant 233312), and the Lundbeck Foundation.	Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Delanghe J, 2000, CLIN CHIM ACTA, V291, P43, DOI 10.1016/S0009-8981(99)00194-1; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2352, DOI 10.1089/ars.2012.4834; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2254, DOI 10.1089/ars.2012.4605; Etzerodt A, 2012, J CONTROL RELEASE, V160, P72, DOI 10.1016/j.jconrel.2012.01.034; Etzerodt A, 2010, J LEUKOCYTE BIOL, V88, P1201, DOI 10.1189/jlb.0410235; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Hogger P, 2001, BIOCHEM BIOPH RES CO, V288, P841, DOI 10.1006/bbrc.2001.5845; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Kneidl J, 2012, CELL MICROBIOL, V14, P914, DOI 10.1111/j.1462-5822.2012.01766.x; KNYSZYNSKI A, 1971, EXPERIENTIA, V27, P838, DOI 10.1007/BF02136897; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Looze C, 2009, BIOCHEM BIOPH RES CO, V378, P433, DOI 10.1016/j.bbrc.2008.11.050; Maniecki MB, 2011, IMMUNOBIOLOGY, V216, P882, DOI 10.1016/j.imbio.2011.02.001; Manzanero S, 2012, METHODS MOL BIOL, V844, P177, DOI 10.1007/978-1-61779-527-5_12; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P293, DOI 10.1080/003655102760145852; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Moller HJ, 2010, IMMUNOBIOLOGY, V215, P406, DOI 10.1016/j.imbio.2009.05.003; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Nielsen MJ, 2013, J BIOL CHEM, V288, P18834, DOI 10.1074/jbc.M113.471060; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Stawikowska R, 2013, J BIOL CHEM, V288, P22871, DOI 10.1074/jbc.M113.462267; Thomsen JH, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/523652; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; WANG AM, 1985, SCIENCE, V228, P149, DOI 10.1126/science.3856324; Weaver LK, 2006, J LEUKOCYTE BIOL, V80, P26, DOI 10.1189/jlb.1205756; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221	33	58	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					778	788		10.1074/jbc.M113.520213	http://dx.doi.org/10.1074/jbc.M113.520213			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275664	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000330541200016
J	Li, JH; Daly, E; Campioli, E; Wabitsch, M; Papadopoulos, V				Li, Jiehan; Daly, Edward; Campioli, Enrico; Wabitsch, Martin; Papadopoulos, Vassilios			De Novo Synthesis of Steroids and Oxysterols in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P450SCC CYP11A1; LIVER-X-RECEPTORS; BILE-ACID METABOLISM; SIDE-CHAIN CLEAVAGE; ADIPOSE-TISSUE; BENZODIAZEPINE-RECEPTOR; CHOLESTEROL TRANSPORT; HUMAN CIRCULATION; GAMMA EXPRESSION; BINDING PROTEIN	Local production and action of cholesterol metabolites such as steroids or oxysterols within endocrine tissues are currently recognized as an important principle in the cell type- and tissue-specific regulation of hormone effects. In adipocytes, one of the most abundant endocrine cells in the human body, the de novo production of steroids or oxysterols from cholesterol has not been examined. Here, we demonstrate that essential components of cholesterol transport and metabolism machinery in the initial steps of steroid and/or oxysterol biosynthesis pathways are present and active in adipocytes. The ability of adipocyte CYP11A1 in producing pregnenolone is demonstrated for the first time, rendering adipocyte a steroidogenic cell. The oxysterol 27-hydroxycholesterol (27HC), synthesized by the mitochondrial enzyme CYP27A1, was identified as one of the major de novo adipocyte products from cholesterol and its precursor mevalonate. Inhibition of CYP27A1 activity or knockdown and deletion of the Cyp27a1 gene induced adipocyte differentiation, suggesting a paracrine or autocrine biological significance for the adipocyte-derived 27HC. These findings suggest that the presence of the 27HC biosynthesis pathway in adipocytes may represent a defense mechanism to prevent the formation of new fat cells upon overfeeding with dietary cholesterol.	McGill Univ Hlth Ctr, Res Inst, Montreal, PQ H3G 1A4, Canada; [Li, Jiehan; Papadopoulos, Vassilios] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1A4, Canada; [Campioli, Enrico; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; [Wabitsch, Martin] Univ Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89081 Ulm, Germany	McGill University; McGill University; McGill University; McGill University; Ulm University	Papadopoulos, V (corresponding author), McGill Univ Hlth Ctr, Res Inst, Montreal Gen Hosp, 1650 Cedar Ave,C10-148, Montreal, PQ H3G 1A4, Canada.	vassilios.papadopoulos@mcgill.ca	Papadopoulos, Vassilios/AAI-2613-2019	Papadopoulos, Vassilios/0000-0002-1183-8568	Fonds de Recherche du Quebec-Sante	Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	We thank M. Vindigni for expert technical assistance with the mass spectrometry studies and Drs. J. Fan, A. Midzak, and A. Batarseh for helpful discussions. We are grateful to GlaxoSmithKline for providing us the CYP27A1 inhibitor GI268267X. We also thank Drs. M. Ascoli (University of Iowa) for the MA-10 cells and D. B. Hales (Southern Illinois University) for the anti-STAR antiserum. The Research Institute of McGill University Health Centre is supported in part by a center grant from Fonds de Recherche du Quebec-Sante.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Azcoitia I, 2005, J NEURAL TRANSM, V112, P171, DOI 10.1007/s00702-004-0179-y; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Belanger C, 2002, HORM METAB RES, V34, P737, DOI 10.1055/s-2002-38265; Bieghs V, 2013, GASTROENTEROLOGY, V144, P167, DOI 10.1053/j.gastro.2012.09.062; BJORKHEM I, 1992, J LIPID RES, V33, P455; Bjorkhem I, 2002, CURR OPIN LIPIDOL, V13, P247, DOI 10.1097/00041433-200206000-00003; Briones AM, 2012, HYPERTENSION, V59, P1069, DOI 10.1161/HYPERTENSIONAHA.111.190223; Crosignani A, 2011, CLIN CHIM ACTA, V412, P2037, DOI 10.1016/j.cca.2011.07.028; Culty M, 2002, J ANDROL, V23, P439; Dieudonne MN, 2004, AM J PHYSIOL-CELL PH, V286, pC655, DOI 10.1152/ajpcell.00321.2003; Dubrac S, 2005, J LIPID RES, V46, P76, DOI 10.1194/jlr.M400219-JLR200; GREGOIRE F, 1990, BIOL CELL, V69, P215, DOI 10.1016/0248-4900(90)90348-7; GUARNERI P, 1992, P NATL ACAD SCI USA, V89, P5118, DOI 10.1073/pnas.89.11.5118; Guryev O, 2003, P NATL ACAD SCI USA, V100, P14754, DOI 10.1073/pnas.2336107100; Hummasti S, 2004, J LIPID RES, V45, P616, DOI 10.1194/jlr.M300312-JLR200; Jameson JL, 2004, J CLIN ENDOCR METAB, V89, P5927, DOI 10.1210/jc.2004-2047; Javitt NB, 2002, J LIPID RES, V43, P665; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; Kayes-Wandover KM, 2000, J CLIN ENDOCR METAB, V85, P2519, DOI 10.1210/jc.85.7.2519; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kha HT, 2004, J BONE MINER RES, V19, P830, DOI 10.1359/JBMR.040115; Kim GS, 2008, BIOCHEM BIOPH RES CO, V370, P264, DOI 10.1016/j.bbrc.2008.03.098; Kim WK, 2007, J BONE MINER RES, V22, P1711, DOI 10.1359/JBMR.070710; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Lalli E, 2003, MOL ENDOCRINOL, V17, P1445, DOI 10.1210/me.2003-0159; Lee JW, 2006, EXP EYE RES, V83, P465, DOI 10.1016/j.exer.2005.11.018; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Lyons MA, 2001, LIPIDS, V36, P701, DOI 10.1007/s11745-001-0775-8; MacKenzie SM, 2008, CLIN ENDOCRINOL, V69, P848, DOI 10.1111/j.1365-2265.2008.03262.x; Mandrup S, 1998, J BIOL CHEM, V273, P23897, DOI 10.1074/jbc.273.37.23897; Martin KO, 1997, J LIPID RES, V38, P1053; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Meaney S, 2001, J LIPID RES, V42, P70; Mellon SH, 2002, TRENDS ENDOCRIN MET, V13, P35, DOI 10.1016/S1043-2760(01)00503-3; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Nguyen MN, 2009, DRUG METAB DISPOS, V37, P761, DOI 10.1124/dmd.108.025619; Pagadala MR, 2012, AM J GASTROENTEROL, V107, P1859, DOI 10.1038/ajg.2012.320; Pandak WM, 2002, J BIOL CHEM, V277, P48158, DOI 10.1074/jbc.M205244200; Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004; Pikuleva IA, 1998, J BIOL CHEM, V273, P18153, DOI 10.1074/jbc.273.29.18153; Pikuleva IA, 1999, J BIOL CHEM, V274, P2045, DOI 10.1074/jbc.274.4.2045; Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Slominski A, 2005, CHEM BIOL, V12, P931, DOI 10.1016/j.chembiol.2005.06.010; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Thiboutot D, 2003, J INVEST DERMATOL, V120, P905, DOI 10.1046/j.1523-1747.2003.12244.x; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; TUCKEY RC, 1992, J STEROID BIOCHEM, V42, P883, DOI 10.1016/0960-0760(92)90097-3; Tuckey RC, 2011, DRUG METAB DISPOS, V39, P1577, DOI 10.1124/dmd.111.040071; Umetani M, 2011, TRENDS ENDOCRIN MET, V22, P130, DOI 10.1016/j.tem.2011.01.003; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; WADA A, 1992, J BIOL CHEM, V267, P22877; Wade FM, 2005, OBES RES, V13, P818, DOI 10.1038/oby.2005.93; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wamberg L, 2013, INT J OBESITY, V37, P651, DOI 10.1038/ijo.2012.112	65	65	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					747	764		10.1074/jbc.M113.534172	http://dx.doi.org/10.1074/jbc.M113.534172			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24280213	Green Published, hybrid			2022-12-28	WOS:000330541200014
J	Roy, S; Karmakar, M; Pearlman, E				Roy, Sanhita; Karmakar, Mausita; Pearlman, Eric			CD14 Mediates Toll-like Receptor 4 (TLR4) Endocytosis and Spleen Tyrosine Kinase (Syk) and Interferon Regulatory Transcription Factor 3 (IRF3) Activation in Epithelial Cells and Impairs Neutrophil Infiltration and Pseudomonas aeruginosa Killing in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEAL INFLAMMATION; LIPOPOLYSACCHARIDE LPS; INDEPENDENT PATHWAYS; TERMINAL KINASE; GENE-EXPRESSION; HOST-DEFENSE; EXOENZYME-S; MICE; INFECTION; KERATITIS	In the current study, we examined the role of CD14 in regulating LPS activation of corneal epithelial cells and Pseudomonas aeruginosa corneal infection. Our findings demonstrate that LPS induces Toll-like receptor 4 (TLR4) internalization in corneal epithelial cells and that blocking with anti-CD14 selectively inhibits TLR4 endocytosis, spleen tyrosine kinase (Syk) and IRF3 phosphorylation, and production of CCL5/RANTES and IFN-beta, but not IL-8. Using a murine model of P. aeruginosa corneal infection, we show that although infected CD14(-/-) corneas produce less CCL5, they exhibit significantly increased CXC chemokine production, neutrophil recruitment to the corneal stroma, and bacterial clearance than C57BL/6 mice. We conclude that CD14 has a critical role in mediating TLR4 signaling through IRF3 in resident corneal epithelial cells and macrophages and thereby modulates TLR4 cell surface activation of the MyD88/NF-kappa B/AP-1 pathway and production of CXC chemokines and neutrophil infiltration to infected tissues.	[Roy, Sanhita; Karmakar, Mausita; Pearlman, Eric] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44095 USA	Case Western Reserve University	Pearlman, E (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 10900 Euclid Ave, Cleveland, OH 44095 USA.	eric.pearlman@case.edu	Karmakar, Mausita/ABC-6480-2020	Karmakar, Mausita/0000-0002-6952-1731; ROY, SANHITA/0000-0002-0407-8177	National Institutes of Health [R01EY14362, P30EY11373]; Research to Prevent Blindness Foundation; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [P30EY011373, R01EY014362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY14362 and P30EY11373 (to E. P.). This work was also supported by the Research to Prevent Blindness Foundation and the Ohio Lions Eye Research Foundation.	Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Adhikary G, 2008, J LEUKOCYTE BIOL, V83, P991, DOI 10.1189/jlb.1107783; Benhnia MREI, 2005, J IMMUNOL, V174, P1539, DOI 10.4049/jimmunol.174.3.1539; Berenger BM, 2011, J LEUKOCYTE BIOL, V90, P189, DOI 10.1189/jlb.0510265; Bode JG, 2001, BIOL CHEM, V382, P1447, DOI 10.1515/BC.2001.178; Chinnery HR, 2009, J IMMUNOL, V182, P2738, DOI 10.4049/jimmunol.0803505; Dessing MC, 2007, AM J RESP CRIT CARE, V175, P604, DOI 10.1164/rccm.200606-824OC; Echchannaoui H, 2005, J LEUKOCYTE BIOL, V78, P705, DOI 10.1189/jlb.0205063; Epelman S, 2004, J IMMUNOL, V173, P2031, DOI 10.4049/jimmunol.173.3.2031; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Haziot A, 2001, J IMMUNOL, V166, P1075, DOI 10.4049/jimmunol.166.2.1075; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Johnson AC, 2008, J BIOL CHEM, V283, P3988, DOI 10.1074/jbc.M707264200; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KUSUNOKI T, 1995, J EXP MED, V182, P1673, DOI 10.1084/jem.182.6.1673; Metkar S, 2007, INFECT IMMUN, V75, P5415, DOI 10.1128/IAI.00601-07; Metkar S, 2012, J LEUKOCYTE BIOL, V92, P389, DOI 10.1189/jlb.0112011; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Pearlman E, 2013, INT REV IMMUNOL, V32, P4, DOI 10.3109/08830185.2012.749400; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Perera PY, 1997, J IMMUNOL, V158, P4422; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Roy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054245; Roy S, 2011, J BIOL CHEM, V286, P23753, DOI 10.1074/jbc.M111.219345; Sun Y, 2012, J IMMUNOL, V188, P1884, DOI 10.4049/jimmunol.1102148; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Talreja J, 2005, INFLAMMATION, V29, P170, DOI 10.1007/s10753-006-9014-y; TRINKAUSRANDALL V, 1991, INVEST OPHTH VIS SCI, V32, P603; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Wiersinga WJ, 2008, J INFECT DIS, V198, P1388, DOI 10.1086/592220; Wilkinson TS, 2009, AM J PATHOL, V174, P1338, DOI 10.2353/ajpath.2009.080746; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	38	32	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1174	1182		10.1074/jbc.M113.523167	http://dx.doi.org/10.1074/jbc.M113.523167			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275652	Green Published, hybrid			2022-12-28	WOS:000330541200048
J	Jia, LJ; Chisari, M; Maktabi, MH; Sobieski, C; Zhou, H; Konopko, AM; Martin, BR; Mennerick, SJ; Blumer, KJ				Jia, Lixia; Chisari, Mariangela; Maktabi, Mohammad H.; Sobieski, Courtney; Zhou, Hao; Konopko, Aaron M.; Martin, Brent R.; Mennerick, Steven J.; Blumer, Kendall J.			A Mechanism Regulating G Protein- coupled Receptor Signaling That Requires Cycles of Protein Palmitoylation and Depalmitoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptors (GPCR); Heterotrimeric G Proteins; Neurobiology; Potassium Channels; RGS Proteins; G Protein-coupled Receptor	SMALL-MOLECULE INHIBITION; POTASSIUM CHANNELS; FATTY-ACYLATION; PLASMA-MEMBRANE; GIRK CHANNELS; LOCALIZATION; MODULATION; ACTIVATION; TARGETS; RGS7	Background: The functions of palmitate turnover in signal transduction are poorly understood. Results: Inhibiting palmitate turnover on R7BP redistributed R7BP-R7 RGS complexes from the plasma membrane to endomembranes, dissociated them from GIRK channels, and delayed G(i/o) deactivation and channel closure. Conclusion: Palmitate turnover on R7BP promotes GIRK channel deactivation. Significance: Inhibiting palmitate turnover on R7BP could enhance GIRK activity in neurological disorders. Reversible attachment and removal of palmitate or other long-chain fatty acids on proteins has been hypothesized, like phosphorylation, to control diverse biological processes. Indeed, palmitate turnover regulates Ras trafficking and signaling. Beyond this example, however, the functions of palmitate turnover on specific proteins remain poorly understood. Here, we show that a mechanism regulating G protein-coupled receptor signaling in neuronal cells requires palmitate turnover. We used hexadecyl fluorophosphonate or palmostatin B to inhibit enzymes in the serine hydrolase family that depalmitoylate proteins, and we studied R7 regulator of G protein signaling (RGS)-binding protein (R7BP), a palmitoylated allosteric modulator of R7 RGS proteins that accelerate deactivation of G(i/o) class G proteins. Depalmitoylation inhibition caused R7BP to redistribute from the plasma membrane to endomembrane compartments, dissociated R7BP-bound R7 RGS complexes from G(i/o)-gated G protein-regulated inwardly rectifying K+ (GIRK) channels and delayed GIRK channel closure. In contrast, targeting R7BP to the plasma membrane with a polybasic domain and an irreversibly attached lipid instead of palmitate rendered GIRK channel closure insensitive to depalmitoylation inhibitors. Palmitate turnover therefore is required for localizing R7BP to the plasma membrane and facilitating G(i/o) deactivation by R7 RGS proteins on GIRK channels. Our findings broaden the scope of biological processes regulated by palmitate turnover on specific target proteins. Inhibiting R7BP depalmitoylation may provide a means of enhancing GIRK activity in neurological disorders.	[Jia, Lixia; Maktabi, Mohammad H.; Zhou, Hao; Blumer, Kendall J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Chisari, Mariangela; Sobieski, Courtney; Mennerick, Steven J.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Chisari, Mariangela] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Konopko, Aaron M.; Martin, Brent R.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Michigan System; University of Michigan	Blumer, KJ (corresponding author), Washington Univ, Sch Med, Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	kblumer@wustl.edu	Martin, Brent/B-4370-2012; Mennerick, Steven/O-2806-2017	Martin, Brent/0000-0002-7136-2397; Mennerick, Steven/0000-0003-0868-0664	National Institutes of Health [R01GM44592, R01HL075632, R01MH78823, R00CA151460]; International Promotion of Young Researchers "Montalcini Program" grant from the Italian Ministry of Education, University and Research; RNAi Consortium (Broad Institute); Children's Discovery Institute (Washington University School of Medicine); NATIONAL CANCER INSTITUTE [R00CA151460] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Promotion of Young Researchers "Montalcini Program" grant from the Italian Ministry of Education, University and Research; RNAi Consortium (Broad Institute); Children's Discovery Institute (Washington University School of Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM44592 and R01HL075632 (to K.J.B.), R01MH78823 (to S.J.M.), and R00CA151460 (to B. R. M.). This work was also supported by the International Promotion of Young Researchers "Montalcini Program" grant from the Italian Ministry of Education, University and Research (to M. C.), the RNAi Consortium (Broad Institute), and the Children's Discovery Institute (Washington University School of Medicine).	Adibekian A, 2012, J AM CHEM SOC, V134, P10345, DOI 10.1021/ja303400u; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Chen CA, 2000, J BIOL CHEM, V275, P23516, DOI 10.1074/jbc.M003439200; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; Chisari M, 2009, J NEUROPHYSIOL, V102, P1254, DOI 10.1152/jn.00346.2009; Dekker FJ, 2011, BIOORGAN MED CHEM, V19, P1376, DOI 10.1016/j.bmc.2010.11.025; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Dowal L, 2011, BLOOD, V118, pE62, DOI 10.1182/blood-2011-05-353078; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Duncan JA, 2002, J BIOL CHEM, V277, P31740, DOI 10.1074/jbc.M202505200; Fukata Y, 2013, J CELL BIOL, V202, P145, DOI 10.1083/jcb.201302071; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; Greaves J, 2012, J BIOL CHEM, V287, P37330, DOI 10.1074/jbc.M112.389098; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Jayaraman M, 2009, TRENDS PHARMACOL SCI, V30, P17, DOI 10.1016/j.tips.2008.10.002; Jia LX, 2011, J BIOL CHEM, V286, P13695, DOI 10.1074/jbc.M110.193763; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Lane SR, 1997, J NEUROCHEM, V69, P1864; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; LU JY, 1995, J BIOL CHEM, V270, P7251, DOI 10.1074/jbc.270.13.7251; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Marin EP, 2012, CIRC RES, V110, P1336, DOI 10.1161/CIRCRESAHA.112.269514; Marker CL, 2005, J NEUROSCI, V25, P3551, DOI 10.1523/JNEUROSCI.4899-04.2005; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mase Y, 2012, J BIOL CHEM, V287, P19537, DOI 10.1074/jbc.M112.353888; Merrick BA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006007; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Rusch M, 2011, ANGEW CHEM INT EDIT, V50, P9838, DOI 10.1002/anie.201102967; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549; Xu J, 2012, BLOOD, V119, P1032, DOI 10.1182/blood-2011-06-358960; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329; Zhang MM, 2010, P NATL ACAD SCI USA, V107, P8627, DOI 10.1073/pnas.0912306107; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19977, DOI 10.1073/pnas.1214337109	47	29	29	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6249	6257		10.1074/jbc.M113.531475	http://dx.doi.org/10.1074/jbc.M113.531475			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24385443	hybrid, Green Published			2022-12-28	WOS:000332015500077
J	Riekhof, WR; Wu, WI; Jones, JL; Nikrad, M; Chan, MM; Loewen, CJR; Voelker, DR				Riekhof, Wayne R.; Wu, Wen-I; Jones, Jennifer L.; Nikrad, Mrinalini; Chan, Mallory M.; Loewen, Christopher J. R.; Voelker, Dennis R.			An Assembly of Proteins and Lipid Domains Regulates Transport of Phosphatidylserine to Phosphatidylserine Decarboxylase 2 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Endosomes; Glycerophospholipid; Lipid Transport; Membrane Biogenesis; Phosphatidic Acid; Phosphatidylethanolamine; Phosphatidylserine; Yeast	BINDING-PROTEINS; NULL ALLELE; FFAT MOTIF; YEAST; GENE; PHOSPHATIDYLETHANOLAMINE; MITOCHONDRIA; TRAFFICKING; METABOLISM; COMPLEXES	Background: The machinery for interorganelle phosphatidylserine (PtdSer) transport is poorly defined at the molecular level. Results: Molecular interaction studies identify specific protein-protein and protein-lipid interactions in PtdSer transport. Conclusion: A protein and lipid interaction network defines key participants in PS transport to the locus of PtdSer-decarboxylase 2. Significance: This study identifies important molecular participants involved in non-vesicular phospholipid traffic. Saccharomyces cerevisiae uses multiple biosynthetic pathways for the synthesis of phosphatidylethanolamine. One route involves the synthesis of phosphatidylserine (PtdSer) in the endoplasmic reticulum (ER), the transport of this lipid to endosomes, and decarboxylation by PtdSer decarboxylase 2 (Psd2p) to produce phosphatidylethanolamine. Several proteins and protein motifs are known to be required for PtdSer transport to occur, namely the Sec14p homolog PstB2p/Pdr17p; a PtdIns 4-kinase, Stt4p; and a C2 domain of Psd2p. The focus of this work is on defining the protein-protein and protein-lipid interactions of these components. PstB2p interacts with a protein encoded by the uncharacterized gene YPL272C, which we name Pbi1p (PstB2p-interacting 1). PstB2p, Psd2, and Pbi1p were shown to be lipid-binding proteins specific for phosphatidic acid. Pbi1p also interacts with the ER-localized Scs2p, a binding determinant for several peripheral ER proteins. A complex between Psd2p and PstB2p was also detected, and this interaction was facilitated by a cryptic C2 domain at the extreme N terminus of Psd2p (C2-1) as well the previously characterized C2 domain of Psd2p (C2-2). The predicted N-terminal helical region of PstB2p was necessary and sufficient for promoting the interaction with both Psd2p and Pbi1p. Taken together, these results support a model for PtdSer transport involving the docking of a PtdSer donor membrane with an acceptor via specific protein-protein and protein-lipid interactions. Specifically, our model predicts that this process involves an acceptor membrane complex containing the C2 domains of Psd2p, PstB2p, and Pbi1p that ligate to Scs2p and phosphatidic acid present in the donor membrane, forming a zone of apposition that facilitates PtdSer transfer.	[Riekhof, Wayne R.; Wu, Wen-I; Jones, Jennifer L.; Nikrad, Mrinalini; Chan, Mallory M.; Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Cell Biol Program, Denver, CO 80206 USA; [Loewen, Christopher J. R.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	National Jewish Health; University of British Columbia	Voelker, DR (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	voelkerd@njhealth.org			National Institutes of Health [5R37 GM32453, GM081461, F32 GM076798]; American Cancer Society [PF-06-288-01-CSM]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032453, F32GM076798, R37GM032453, R01GM081461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R37 GM32453 and GM081461 (to D. R. V.) and F32 GM076798 (to W. R. R.). This work was also supported by American Cancer Society Great-West Postdoctoral Fellowship Award PF-06-288-01-CSM (to W. R. R.).	ACHLEITNER G, 1995, J BIOL CHEM, V270, P29836; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babu M, 2012, NATURE, V489, P585, DOI 10.1038/nature11354; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Choi JY, 2005, ANAL BIOCHEM, V347, P165, DOI 10.1016/j.ab.2005.03.017; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gulshan K, 2010, MOL BIOL CELL, V21, P443, DOI 10.1091/mbc.E09-06-0519; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kitamura H, 2002, J BIOL CHEM, V277, P33720, DOI 10.1074/jbc.M205672200; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Nguyen TT, 2012, TRAFFIC, V13, P880, DOI 10.1111/j.1600-0854.2012.01352.x; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Trotter PJ, 1998, J BIOL CHEM, V273, P13189, DOI 10.1074/jbc.273.21.13189; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wu WI, 2000, J BIOL CHEM, V275, P14446, DOI 10.1074/jbc.275.19.14446; Wu WI, 2004, J BIOL CHEM, V279, P6635, DOI 10.1074/jbc.M311570200; Wu WI, 2001, J BIOL CHEM, V276, P7114, DOI 10.1074/jbc.M010278200	38	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5809	5819		10.1074/jbc.M113.518217	http://dx.doi.org/10.1074/jbc.M113.518217			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24366873	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000332015500040
J	Bakele, M; Joos, M; Burdi, S; Allgaier, N; Poschel, S; Fehrenbacher, B; Schaller, M; Marcos, V; Kummerle-Deschner, J; Rieber, N; Borregaard, N; Yazdi, A; Hector, A; Hartl, D				Bakele, Martina; Joos, Melanie; Burdi, Sofia; Allgaier, Nicolas; Poeschel, Simone; Fehrenbacher, Birgit; Schaller, Martin; Marcos, Veronica; Kuemmerle-Deschner, Jasmin; Rieber, Nikolaus; Borregaard, Niels; Yazdi, Amir; Hector, Andreas; Hartl, Dominik			Localization and Functionality of the Inflammasome in Neutrophils*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Inflammation; Innate Immunity; Pathogen-associated Molecular Pattern (PAMP); Toll-like Receptor (TLR); Immunity; Neutrophils	SECRETORY VESICLES; ACTIVE IL-1-BETA; SERINE PROTEASES; GENERATION; INTERLEUKIN-1-BETA; ACTIVATION; GRANULES; CLEAVAGE; IMMUNITY; IL-1-SS	Background: The inflammasome generates IL-1 family proteins, but its role in neutrophils is poorly understood. Results: Neutrophils store key inflammasome components in distinct intracellular compartments and release IL-1 and IL-18, but not IL-1 or IL-33. Conclusion: Neutrophils store inflammasome components in intracellular compartments. Significance: Targeting the inflammasome in neutrophils represents a future anti-inflammatory strategy. Neutrophils represent the major fraction of circulating immune cells and are rapidly recruited to sites of infection and inflammation. The inflammasome is a multiprotein complex that regulates the generation of IL-1 family proteins. The precise subcellular localization and functionality of the inflammasome in human neutrophils are poorly defined. Here we demonstrate that highly purified human neutrophils express key components of the NOD-like receptor family, pyrin domain containing 3 (NLRP3), and absent in melanoma 2 (AIM2) inflammasomes, particularly apoptosis-associated speck-like protein containing a CARD (ASC), AIM2, and caspase-1. Subcellular fractionation and microscopic analyses further showed that inflammasome components were localized in the cytoplasm and also noncanonically in secretory vesicle and tertiary granule compartments. Whereas IL-1 and IL-18 were expressed at the mRNA level and released as protein, highly purified neutrophils neither expressed nor released IL-1 at baseline or upon stimulation. Upon inflammasome activation, highly purified neutrophils released substantially lower levels of IL-1 protein compared with partially purified neutrophils. Serine proteases and caspases were differentially involved in IL-1 release, depending on the stimulus. Spontaneous activation of the NLRP3 inflammasome in neutrophils in vivo affected IL-1, but not IL-18 release. In summary, these studies show that human neutrophils express key components of the inflammasome machinery in distinct intracellular compartments and release IL-1 and IL-18, but not IL-1 or IL-33 protein. Targeting the neutrophil inflammasome may represent a future therapeutic strategy to modulate neutrophilic inflammatory diseases, such as cystic fibrosis, rheumatoid arthritis, or sepsis.	[Bakele, Martina; Joos, Melanie; Burdi, Sofia; Allgaier, Nicolas; Poeschel, Simone; Kuemmerle-Deschner, Jasmin; Rieber, Nikolaus; Hector, Andreas; Hartl, Dominik] Univ Tubingen, Dept Pediat, D-72076 Tubingen, Germany; [Fehrenbacher, Birgit; Schaller, Martin; Yazdi, Amir] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; [Marcos, Veronica] Univ Munich, Dept Pediat, D-80539 Munich, Germany; [Borregaard, Niels] Natl Univ Hosp, Granulocyte Res Lab, Dept Hematol, Finsen Ctr, DK-2100 Copenhagen, Denmark	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich	Hartl, D (corresponding author), Univ Tubingen, Childrens Hosp, D-72076 Tubingen, Germany.	dominik.hartl@med.uni-tuebingen.de		Hector, Andreas/0000-0002-5745-4746	German Research Foundation Deutsche Forschungsgemeinschaft Emmy Noether Programme [HA 5274/3-1]; Fritz-Thyssen-Foundation; German Society of Pediatric Pneumology; PINA e. V.; Novartis Foundation;  [CRC/SFB685]	German Research Foundation Deutsche Forschungsgemeinschaft Emmy Noether Programme(German Research Foundation (DFG)); Fritz-Thyssen-Foundation; German Society of Pediatric Pneumology; PINA e. V.; Novartis Foundation(Novartis); 	This work was supported by the German Research Foundation Deutsche Forschungsgemeinschaft Emmy Noether Programme HA 5274/3-1 to D. H.), the Fritz-Thyssen-Foundation (to A. H. and D. H.) the CRC/SFB685 at Tubingen, the German Society of Pediatric Pneumology (to D. H. and V. M.), PINA e. V. (to D. H.), and the Novartis Foundation (to D. H.).	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Basran A, 2013, J LEUKOCYTE BIOL, V93, P7, DOI 10.1189/jlb.0512250; Berger M, 2012, J BIOL CHEM, V287, P19409, DOI 10.1074/jbc.M112.353557; BLACK RA, 1988, J BIOL CHEM, V263, P9437; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Clemmensen SN, 2011, EUR J HAEMATOL, V86, P517, DOI 10.1111/j.1600-0609.2011.01601.x; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Dahlgren C, 2001, J LEUKOCYTE BIOL, V69, P57; Gross O, 2012, METHODS MOL BIOL, V844, P199, DOI 10.1007/978-1-61779-527-5_15; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Hager M, 2010, J INTERN MED, V268, P25, DOI 10.1111/j.1365-2796.2010.02237.x; Hartl D, 2012, J CYST FIBROS, V11, P363, DOI 10.1016/j.jcf.2012.07.003; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; IRMLER M, 1995, J EXP MED, V181, P1917, DOI 10.1084/jem.181.5.1917; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; KJELDSEN L, 1993, BLOOD, V82, P3183; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kono H, 2012, J IMMUNOL, V189, P3734, DOI 10.4049/jimmunol.1200136; Kuemmerle-Deschner JB, 2011, ARTHRITIS RHEUM-US, V63, P840, DOI 10.1002/art.30149; Mankan AK, 2012, EUR J IMMUNOL, V42, P710, DOI 10.1002/eji.201141921; Mollinedo F, 1999, IMMUNOL TODAY, V20, P535, DOI 10.1016/S0167-5699(99)01500-5; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Park H, 2012, NAT REV IMMUNOL, V12, P570, DOI 10.1038/nri3261; Parker Lisa C., 2009, V517, P191, DOI 10.1007/978-1-59745-541-1_12; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Robertson SE, 2006, EUR J IMMUNOL, V36, P722, DOI 10.1002/eji.200535402; Rorvig S, 2013, J LEUKOCYTE BIOL, V94, P711, DOI 10.1189/jlb.1212619; Sabroe I, 2004, BIOCHEM SOC T, V32, P468, DOI 10.1042/BST0320468; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Schreiber A, 2012, J AM SOC NEPHROL, V23, P470, DOI 10.1681/ASN.2010080892; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sokolovska A, 2013, NAT IMMUNOL, V14, P543, DOI 10.1038/ni.2595; Tamassia N, 2012, EUR J IMMUNOL, V42, P565, DOI 10.1002/eji.201242399; Udby Lene, 2007, V412, P35, DOI 10.1007/978-1-59745-467-4_4	41	101	103	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5320	5329		10.1074/jbc.M113.505636	http://dx.doi.org/10.1074/jbc.M113.505636			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398679	Green Published, hybrid			2022-12-28	WOS:000331607900072
J	Kolaja, K				Kolaja, Kyle			Stem Cells and Stem Cell-derived Tissues and Their Use in Safety Assessment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Cardiovascular; Drug Development; Drug Discovery; Embryonic Stem Cell; Hepatocyte; Induced Pluripotent Stem Cells; Neurons; Stem Cells; Toxicology	HEPATOCYTE-LIKE CELLS; LONG-TERM CULTURE; IN-VITRO; DEFINITIVE ENDODERM; DRUG TOXICITY; CARDIOMYOCYTES; DIFFERENTIATION; PREDICTION; CARDIOTOXICITY; NEURONS	Toxicology has long relied on animal models in a tedious approach to understanding risk of exposure to an uncharacterized molecule. Stem cell-derived tissues can be made in high purity, quality, and quantity to enable a new approach to this problem. Currently, stem cell-derived tissues are primarily generic genetic backgrounds; the future will see the integration of various genetic backgrounds and complex three-dimensional models to create truly unique in vitro organoids. This minireview focuses on the state of the art of a number of stem cell-derived tissues and details their application in toxicology.	Cellular Dynam Int, Montclair, NJ 07042 USA		Kolaja, K (corresponding author), Cellular Dynam Int, Montclair, NJ 07042 USA.	kyle@cellulardynamics.com		Kolaja, Kyle/0000-0003-1520-9037				Andersson H, 2010, J BIOTECHNOL, V150, P175, DOI 10.1016/j.jbiotec.2010.06.023; Babiarz JE, 2012, STEM CELLS DEV, V21, P1956, DOI 10.1089/scd.2011.0357; Bai XW, 2013, ANESTH ANALG, V116, P869, DOI 10.1213/ANE.0b013e3182860fc9; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Baxter MA, 2010, STEM CELL RES, V5, P4, DOI 10.1016/j.scr.2010.02.002; Boudou T, 2012, TISSUE ENG PT A, V18, P910, DOI [10.1089/ten.TEA.2011.0341, 10.1089/ten.tea.2011.0341]; Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Brolen G, 2010, J BIOTECHNOL, V145, P284, DOI 10.1016/j.jbiotec.2009.11.007; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280; Cohen JD, 2011, TOXICOL APPL PHARM, V257, P74, DOI 10.1016/j.taap.2011.08.020; Colleoni S, 2011, TOXICOL SCI, V124, P370, DOI 10.1093/toxsci/kfr245; Dick E, 2010, BIOCHEM SOC T, V38, P1037, DOI 10.1042/BST0381037; Dolci A, 2008, AM J CLIN PATHOL, V130, P688, DOI 10.1309/AJCPB66LRIIVMQDR; Duan YY, 2010, STEM CELLS, V28, P674, DOI 10.1002/stem.315; Ek M, 2007, BIOCHEM PHARMACOL, V74, P496, DOI 10.1016/j.bcp.2007.05.009; Farina M, 2011, TOXICOL APPL PHARM, V256, P405, DOI 10.1016/j.taap.2011.05.001; Force T, 2011, NAT REV DRUG DISCOV, V10, P111, DOI 10.1038/nrd3252; Genschow E, 2002, ATLA-ALTERN LAB ANIM, V30, P151, DOI 10.1177/026119290203000204; Guo L, 2011, TOXICOL SCI, V123, P281, DOI 10.1093/toxsci/kfr158; Han Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007155; Harrill JA, 2011, TOXICOL APPL PHARM, V256, P268, DOI 10.1016/j.taap.2011.02.013; Hurtt ME, 2004, BIRTH DEFECTS RES B, V71, P281, DOI 10.1002/bdrb.20017; Kamakura T, 2013, CIRC J, V77, P1307, DOI 10.1253/circj.CJ-12-0987; Kameoka S, 2014, TOXICOL SCI, V137, P76, DOI 10.1093/toxsci/kft239; Kleinstreuer NC, 2011, TOXICOL APPL PHARM, V257, P111, DOI 10.1016/j.taap.2011.08.025; Laposa RR, 2011, J CARDIOVASC PHARM, V58, P240, DOI 10.1097/FJC.0b013e31821823f5; Lappalainen RS, 2010, REGEN MED, V5, P749, DOI 10.2217/RME.10.58; Li WL, 2012, STEM CELLS, V30, P61, DOI 10.1002/stem.768; Liang HM, 2010, CELL PHYSIOL BIOCHEM, V25, P459, DOI 10.1159/000303051; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Mayshar Y, 2011, J CELL MOL MED, V15, P1393, DOI 10.1111/j.1582-4934.2010.01105.x; Misner DL, 2012, BRIT J PHARMACOL, V165, P2771, DOI 10.1111/j.1476-5381.2011.01756.x; Moore RN, 2009, STEM CELL RES, V3, P51, DOI 10.1016/j.scr.2009.04.004; Nagamoto Y, 2012, BIOMATERIALS, V33, P4526, DOI 10.1016/j.biomaterials.2012.03.011; Nakamura N, 2012, CELL REPROGRAM, V14, P171, DOI 10.1089/cell.2011.0064; Ni MW, 2012, J TOXICOL ENV HEAL A, V75, P1091, DOI 10.1080/15287394.2012.697840; Otsuji TG, 2010, STEM CELL RES, V4, P201, DOI 10.1016/j.scr.2010.01.002; Paci M, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-61; Panzica-Kelly JM, 2013, TOXICOL SCI, V131, P447, DOI 10.1093/toxsci/kfs293; Paquette JA, 2008, BIRTH DEFECTS RES B, V83, P104, DOI 10.1002/bdrb.20148; Pointon A, 2013, TOXICOL SCI, V132, P317, DOI 10.1093/toxsci/kft005; Ramasamy TS, 2013, TISSUE ENG PT A, V19, P360, DOI 10.1089/ten.tea.2012.0190; Rambhatla L, 2003, CELL TRANSPLANT, V12, P1, DOI 10.3727/000000003783985179; Rana P, 2012, TOXICOL SCI, V130, P117, DOI 10.1093/toxsci/kfs233; Raschi E, 2009, EXPERT OPIN DRUG MET, V5, P1005, DOI 10.1517/17425250903055070; Robinette Brian L, 2011, Front Neuroeng, V4, P1, DOI 10.3389/fneng.2011.00001; SCHARDEIN JL, 1985, ENVIRON HEALTH PERSP, V61, P55, DOI 10.2307/3430062; Scholz G, 1999, TOXICOL IN VITRO, V13, P675, DOI 10.1016/S0887-2333(99)00046-6; Seiler A, 2002, ALTEX-ALTERN TIEREXP, V19, P55; Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348; Shirahashi H, 2004, CELL TRANSPLANT, V13, P197, DOI 10.3727/000000004783984016; Shiraki N, 2008, GENES CELLS, V13, P731, DOI 10.1111/j.1365-2443.2008.01201.x; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; Soderdahl T, 2007, TOXICOL IN VITRO, V21, P929, DOI 10.1016/j.tiv.2007.01.021; Sorensen AT, 2011, EXP NEUROL, V229, P274, DOI 10.1016/j.expneurol.2011.02.008; Spielmann H, 2009, ATLA-ALTERN LAB ANIM, V37, P641, DOI 10.1177/026119290903700609; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomas CE, 2012, EXPERT OPIN DRUG DIS, V7, P109, DOI 10.1517/17460441.2012.651122; Whitemarsh RCM, 2012, TOXICOL SCI, V126, P426, DOI 10.1093/toxsci/kfr354; Willems E, 2009, PEDIATR CARDIOL, V30, P635, DOI 10.1007/s00246-009-9409-2; Williams ES, 2009, CRIT REV TOXICOL, V39, P553, DOI 10.1080/10408440903036056; Xu XH, 2013, STEM CELL RES, V10, P213, DOI 10.1016/j.scr.2012.11.005; Yla-Outinen Laura, 2010, Front Neuroeng, V3, DOI 10.3389/fneng.2010.00111	67	22	24	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4555	4561		10.1074/jbc.R113.481028	http://dx.doi.org/10.1074/jbc.R113.481028			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24362027	hybrid, Green Published			2022-12-28	WOS:000331607900003
J	Abe, T; Kojima, M; Akanuma, S; Iwashita, H; Yamazaki, T; Okuyama, R; Ichikawa, K; Umemura, M; Nakano, H; Takahashi, S; Takahashi, Y				Abe, Takanori; Kojima, Masaki; Akanuma, Satoshi; Iwashita, Hiromi; Yamazaki, Takashi; Okuyama, Ryuichi; Ichikawa, Kenji; Umemura, Mariko; Nakano, Haruo; Takahashi, Shigeru; Takahashi, Yuji			N-terminal Hydrophobic Amino Acids of Activating Transcription Factor 5 (ATF5) Protein Confer Interleukin 1 beta (IL-1 beta)-induced Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heat Shock Protein; Interleukin; Protein Degradation; Stress Response; Transcription Factors; Interleukin	SERUM-AMYLOID-A; STRUCTURE PREDICTION; TRANSLATIONAL CONTROL; QUALITY CONTROL; MESSENGER-RNA; GENE PROMOTER; NITRIC-OXIDE; STRESS; DEGRADATION; PROTEASOME	Activating transcription factor 5 (ATF5) is a stress-response transcription factor that responds to amino acid limitation and exposure to cadmium chloride (CdCl2) and sodium arsenite (NaAsO2). The N-terminal amino acids contribute to the destabilization of the ATF5 protein in steady-state conditions and serve as a stabilization domain in the stress response after CdCl2 or NaAsO2 exposure. In this study, we show that interleukin 1 (IL-1), a proinflammatory cytokine, increases the expression of ATF5 protein in HepG2 hepatoma cells in part by stabilizing the ATF5 protein. The N-terminal domain rich in hydrophobic amino acids that is predicted to form a hydrophobic network was responsible for destabilization in steady-state conditions and served as an IL-1 response domain. Furthermore, IL-1 increased the translational efficiency of ATF5 mRNA via the 5 UTR and phosphorylation of the eukaryotic translation initiation factor 2 (eIF2). ATF5 knockdown in HepG2 cells up-regulated the IL-1-induced expression of the serum amyloid A 1 (SAA1) and SAA2 genes. Our results show that the N-terminal hydrophobic amino acids play an important role in the regulation of ATF5 protein expression in IL-1-mediated immune response and that ATF5 is a negative regulator for IL-1-induced expression of SAA1 and SAA2 in HepG2 cells.	[Abe, Takanori; Iwashita, Hiromi; Yamazaki, Takashi; Okuyama, Ryuichi; Ichikawa, Kenji; Umemura, Mariko; Nakano, Haruo; Takahashi, Shigeru; Takahashi, Yuji] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Environm Mol Physiol, Hachioji, Tokyo 1920392, Japan; [Kojima, Masaki] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Bioinformat, Hachioji, Tokyo 1920392, Japan; [Akanuma, Satoshi] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Extremophiles, Hachioji, Tokyo 1920392, Japan	Tokyo University of Pharmacy & Life Sciences; Tokyo University of Pharmacy & Life Sciences; Tokyo University of Pharmacy & Life Sciences	Takahashi, S (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	shigeru@ls.toyaku.ac.jp	Ichikawa, Kenji/AAW-1613-2021		Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Angelastro JM, 2003, J NEUROSCI, V23, P4590; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Chan JY, 2012, DIABETOLOGIA, V55, P2999, DOI 10.1007/s00125-012-2657-3; Chen CH, 2008, J NUTR, V138, P674, DOI 10.1093/jn/138.4.674; Chuang HC, 2008, AM J PATHOL, V173, P1397, DOI 10.2353/ajpath.2008.080440; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; de Groot NS, 2012, METHODS MOL BIOL, V819, P199, DOI 10.1007/978-1-61779-465-0_14; Dluzen D, 2011, J BIOL CHEM, V286, P7705, DOI 10.1074/jbc.M110.207639; Faty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034031; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Janer A, 2006, J CELL BIOL, V174, P65, DOI 10.1083/jcb.200511045; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Kubota H, 2009, J BIOCHEM, V146, P609, DOI 10.1093/jb/mvp139; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Li GF, 2011, J BIOL CHEM, V286, P20251, DOI 10.1074/jbc.M110.211771; Liu XJ, 2012, J BIOL CHEM, V287, P19599, DOI 10.1074/jbc.M112.363622; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Mijaljica D, 2007, CELL MOL LIFE SCI, V64, P581, DOI 10.1007/s00018-007-6395-5; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; NISHIZAWA M, 1992, FEBS LETT, V299, P36, DOI 10.1016/0014-5793(92)80094-W; Oliver BL, 2005, J CELL PHYSIOL, V204, P45, DOI 10.1002/jcp.20261; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Patel H, 1998, SCAND J IMMUNOL, V48, P410; Pati D, 1999, MOL CELL BIOL, V19, P5001; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SELLAR GC, 1994, BIOCHEM BIOPH RES CO, V200, P202, DOI 10.1006/bbrc.1994.1434; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200; Thorn CF, 2003, EUR J IMMUNOL, V33, P2630, DOI 10.1002/eji.200323985; Uekusa H, 2009, BIOCHEM BIOPH RES CO, V380, P673, DOI 10.1016/j.bbrc.2009.01.158; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verma G, 2010, APOPTOSIS, V15, P864, DOI 10.1007/s10495-010-0498-4; Wang Q, 2009, MOL CELL BIOCHEM, V324, P183, DOI 10.1007/s11010-008-9997-9; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Watatani Y, 2007, LIFE SCI, V80, P879, DOI 10.1016/j.lfs.2006.11.013; WHITEHEAD AS, 1992, J BIOL CHEM, V267, P3862; Yamada T, 1999, CLIN CHEM LAB MED, V37, P381, DOI 10.1515/CCLM.1999.063; Yamazaki T, 2010, LIFE SCI, V87, P294, DOI 10.1016/j.lfs.2010.07.006; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	55	7	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3888	3900		10.1074/jbc.M113.491217	http://dx.doi.org/10.1074/jbc.M113.491217			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24379400	Green Published, hybrid			2022-12-28	WOS:000331403800006
J	Asuni, AA; Gray, B; Bailey, J; Skipp, P; Perry, VH; O'Connor, V				Asuni, Ayodeji A.; Gray, Bryony; Bailey, Joanne; Skipp, Paul; Perry, V. Hugh; O'Connor, Vincent			Analysis of the Hippocampal Proteome in ME7 Prion Disease Reveals a Predominant Astrocytic Signature and Highlights the Brain-restricted Production of Clusterin in Chronic Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Astrocytes; Mass Spectrometry (MS); mRNA; Neurobiology; Prions; ME7; Neurodegeneration; Prion; iTRAQ	BOVINE SPONGIFORM ENCEPHALOPATHY; PRP KNOCKOUT MICE; CEREBROSPINAL-FLUID; APOLIPOPROTEIN-J; PLASMA CLUSTERIN; NEUROLOGICAL DISORDERS; INFLAMMATORY RESPONSE; SYSTEMIC INFLAMMATION; REACTIVE ASTROCYTES; TRANSGENIC MICE	Prion diseases are characterized by accumulation of misfolded protein, gliosis, synaptic dysfunction, and ultimately neuronal loss. This sequence, mirroring key features of Alzheimer disease, is modeled well in ME7 prion disease. We used iTRAQ(TM)/mass spectrometry to compare the hippocampal proteome in control and late-stage ME7 animals. The observed changes associated with reactive glia highlighted some specific proteins that dominate the proteome in late-stage disease. Four of the up-regulated proteins (GFAP, high affinity glutamate transporter (EAAT-2), apo-J (Clusterin), and peroxiredoxin-6) are selectively expressed in astrocytes, but astrocyte proliferation does not contribute to their up-regulation. The known functional role of these proteins suggests this response acts against protein misfolding, excitotoxicity, and neurotoxic reactive oxygen species. A recent convergence of genome-wide association studies and the peripheral measurement of circulating levels of acute phase proteins have focused attention on Clusterin as a modifier of late-stage Alzheimer disease and a biomarker for advanced neurodegeneration. Since ME7 animals allow independent measurement of acute phase proteins in the brain and circulation, we extended our investigation to address whether changes in the brain proteome are detectable in blood. We found no difference in the circulating levels of Clusterin in late-stage prion disease when animals will show behavioral decline, accumulation of misfolded protein, and dramatic synaptic and neuronal loss. This does not preclude an important role of Clusterin in late-stage disease, but it cautions against the assumption that brain levels provide a surrogate peripheral measure for the progression of brain degeneration.	[Asuni, Ayodeji A.; Gray, Bryony; Bailey, Joanne; Perry, V. Hugh; O'Connor, Vincent] Univ Southampton, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England; [Skipp, Paul] Univ Southampton, Ctr Prote Res, Southampton SO17 1BJ, Hants, England	University of Southampton; University of Southampton	Asuni, AA (corresponding author), Univ Southampton, Ctr Biol Sci, Fac Nat & Environm Sci, Bldg 85,Univ Rd,Highfield Campus, Southampton SO17 1BJ, Hants, England.	a.a.asuni@soton.ac.uk	Perry, V. Hugh/Y-2935-2019; Asuni, Ayodeji/F-4285-2011	Asuni, Ayodeji/0000-0003-3488-6893; O'Connor, Vincent/0000-0003-3185-5709	Medical Research Council [G0501636]; MRC [G0501636] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0501636.	Aguzzi A, 2004, NAT CELL BIOL, V6, P290, DOI 10.1038/ncb0404-290; Asuni AA, 2010, NEUROSCIENCE, V165, P662, DOI 10.1016/j.neuroscience.2009.10.047; Asuni AA, 2008, BRAIN RES, V1233, P1, DOI 10.1016/j.brainres.2008.07.083; Baig S, 2012, J ALZHEIMERS DIS, V28, P337, DOI 10.3233/JAD-2011-110473; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Boggs LN, 1996, J NEUROCHEM, V67, P1324; Brown AR, 2004, NEUROPATH APPL NEURO, V30, P555, DOI 10.1111/j.1365-2990.2004.00565.x; BURKEY BF, 1991, J LIPID RES, V32, P1039; CAMPBELL IL, 1994, J VIROL, V68, P2383, DOI 10.1128/JVI.68.4.2383-2387.1994; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Charnay Y, 2012, BRAIN RES BULL, V88, P434, DOI 10.1016/j.brainresbull.2012.05.006; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Chiesa R, 2000, P NATL ACAD SCI USA, V97, P5574, DOI 10.1073/pnas.97.10.5574; Choong LY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011030; Chueh FY, 2011, CELL SIGNAL, V23, P1170, DOI 10.1016/j.cellsig.2011.03.004; Chung C, 2013, J NEUROCHEM, V126, P146, DOI 10.1111/jnc.12245; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Cunningham C, 2005, J VIROL, V79, P5174, DOI 10.1128/JVI.79.8.5174-5184.2005; Cunningham C, 2005, NEUROBIOL DIS, V18, P258, DOI 10.1016/j.nbd.2004.08.015; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; DaRocha-Souto B, 2011, J NEUROPATH EXP NEUR, V70, P360, DOI 10.1097/NEN.0b013e318217a118; DeSouza L, 2005, J PROTEOME RES, V4, P377, DOI 10.1021/pr049821j; Devauchelle V, 2006, J IMMUNOL, V177, P6471, DOI 10.4049/jimmunol.177.9.6471; DIEDRICH JF, 1991, P NATL ACAD SCI USA, V88, P375, DOI 10.1073/pnas.88.2.375; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Filali H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-399; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Fukuda I, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-36; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i; Garland P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047552; Gill C, 2011, AAPS J, V13, P309, DOI 10.1208/s12248-011-9269-6; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Grasbon-Frodl E, 2004, ACTA NEUROPATHOL, V108, P476, DOI 10.1007/s00401-004-0913-4; Gray B. C., 2006, THESIS U SOUTHAMPTON; Gray BC, 2009, NEUROBIOL DIS, V35, P63, DOI 10.1016/j.nbd.2009.04.001; Hazzaa SM, 2010, PATHOL ONCOL RES, V16, P101, DOI 10.1007/s12253-009-9196-3; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Hilton KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068062; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Ijsselstijn L, 2011, J PROTEOME RES, V10, P2006, DOI 10.1021/pr101221h; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jeffrey M, 2004, CURR TOP MICROBIOL, V284, P65; JEFFREY M, 1995, NEUROPATH APPL NEURO, V21, P41, DOI 10.1111/j.1365-2990.1995.tb01027.x; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Kempster S, 2004, NEUROREPORT, V15, P1735, DOI 10.1097/01.wnr.0000134990.97051.22; Kercher L, 2004, AM J PATHOL, V165, P2055, DOI 10.1016/S0002-9440(10)63256-7; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Kopacek J, 2000, J VIROL, V74, P411, DOI 10.1128/JVI.74.1.411-417.2000; Lafon-Cazal M, 2003, J BIOL CHEM, V278, P24438, DOI 10.1074/jbc.M211980200; Larvie M., 2012, J BIOMED BIOTECHNOL, V2012, P1; Lepore AC, 2008, EXP NEUROL, V211, P423, DOI 10.1016/j.expneurol.2008.02.020; Lewicki H, 2003, J VIROL, V77, P3799, DOI 10.1128/JVI.77.6.3799-3808.2003; Lima FRS, 2007, J NEUROCHEM, V103, P2164, DOI 10.1111/j.1471-4159.2007.04904.x; LIPTON SA, 1994, ANN NY ACAD SCI, V738, P382; Liu X, 2000, GENOMICS, V65, P283, DOI 10.1006/geno.2000.6170; Luccarini I, 2012, NEUROSCI LETT, V506, P94, DOI 10.1016/j.neulet.2011.10.056; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Majer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003002; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Maragakis NJ, 2004, GLIA, V45, P133, DOI 10.1002/glia.10310; Matsubara E, 1996, BIOCHEM J, V316, P671, DOI 10.1042/bj3160671; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morris RJ, 2006, FEBS LETT, V580, P5565, DOI 10.1016/j.febslet.2006.07.053; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Newsom DM, 2011, COMP IMMUNOL MICROB, V34, P387, DOI 10.1016/j.cimid.2011.06.001; Nilselid AM, 2006, NEUROCHEM INT, V48, P718, DOI 10.1016/j.neuint.2005.12.005; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Pan T, 2005, J VIROL, V79, P934, DOI 10.1128/JVI.79.2.934-943.2005; PASINETTI GM, 1994, J COMP NEUROL, V339, P387, DOI 10.1002/cne.903390307; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Phelan SA, 2003, FREE RADICAL BIO MED, V35, P1110, DOI 10.1016/S0891-5849(03)00462-3; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Prusiner SB, 1996, COLD SPRING HARB SYM, V61, P473; Puntener U, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-146; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; Raeber AJ, 1999, P NATL ACAD SCI USA, V96, P3987, DOI 10.1073/pnas.96.7.3987; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; Rashmi RN, 2012, NUCLEUS-PHILA, V3, P172, DOI 10.4161/nucl.19090; Rosenberg ME, 2002, MOL CELL BIOL, V22, P1893, DOI 10.1128/MCB.22.6.1893-1902.2002; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sasaki K, 2002, ACTA NEUROPATHOL, V103, P199, DOI 10.1007/s004010100456; Schjeide BMM, 2011, ARCH GEN PSYCHIAT, V68, P207, DOI 10.1001/archgenpsychiatry.2010.196; Schrijvers EMC, 2011, JAMA-J AM MED ASSOC, V305, P1322, DOI 10.1001/jama.2011.381; Schurmann B, 2011, J ALZHEIMERS DIS, V25, P421, DOI 10.3233/JAD-2011-110251; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Silajdzic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050237; Siskova Z, 2009, AM J PATHOL, V175, P1610, DOI 10.2353/ajpath.2009.090372; Sleegers K, 2010, TRENDS GENET, V26, P84, DOI 10.1016/j.tig.2009.12.004; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stoop MP, 2008, PROTEOMICS, V8, P1576, DOI 10.1002/pmic.200700446; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; Teeling JL, 2007, BRAIN BEHAV IMMUN, V21, P836, DOI 10.1016/j.bbi.2007.01.012; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Vranova HP, 2010, J NEURAL TRANSM, V117, P1177, DOI 10.1007/s00702-010-0462-z; Wagner W, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-38; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Williams A, 1997, EXP NEUROL, V144, P433, DOI 10.1006/exnr.1997.6424; WITTE DP, 1993, AM J PATHOL, V143, P763; Wyatt AR, 2011, CELL MOL LIFE SCI, V68, P3919, DOI [10.1007/s00018-011-0684-8, 10.1007/s00018-011-0684-8)]; Xing YY, 2012, J ALZHEIMERS DIS, V29, P515, DOI 10.3233/JAD-2011-111844; Yang JW, 2005, J PROTEOME RES, V4, P768, DOI 10.1021/pr049774v; Yu HR, 2010, PEDIATR CARDIOL, V31, P1151, DOI 10.1007/s00246-010-9769-7; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200	112	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4532	4545		10.1074/jbc.M113.502690	http://dx.doi.org/10.1074/jbc.M113.502690			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366862	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000331403800060
J	Mazalouskas, MD; Godoy-Ruiz, R; Weber, DJ; Zimmer, DB; Honkanen, RE; Wadzinski, BE				Mazalouskas, Matthew D.; Godoy-Ruiz, Raquel; Weber, David J.; Zimmer, Danna B.; Honkanen, Richard E.; Wadzinski, Brian E.			Small G Proteins Rac1 and Ras Regulate Serine/Threonine Protein Phosphatase 5 (PP5).Extracellular Signal-Regulated Kinase (ERK) Complexes Involved in the Feedback Regulation of Raf1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ERK; MAP Kinases (MAPKs); Rac; Raf; Ras; S100 Proteins; MEK; PP5; Feedback Phosphorylation; Small G Protein	TETRATRICOPEPTIDE REPEAT DOMAIN; POSITIVE REGULATION; PHOSPHORYLATION; ACTIVATION; BINDING; EXPRESSION; PATHWAY; PP5; TRANSDUCTION; 2A	Background: PP5 binds HSP90 and regulates cell growth and stress-induced signaling pathways. Results: PP5 associates with ERKs in a manner facilitated, in part, by HSP90. Rac1 and Ras regulate PP5ERK1/2 complexes. Conclusion: PP5 and ERK play a role in the feedback phosphorylation of PP5-associated Raf1. Significance: Differential responsiveness of PP5-ERK1 and PP5-ERK2 interactions to oncogenic small G proteins may contribute to particular tumor traits. Serine/threonine protein phosphatase 5 (PP5, PPP5C) is known to interact with the chaperonin heat shock protein 90 (HSP90) and is involved in the regulation of multiple cellular signaling cascades that control diverse cellular processes, such as cell growth, differentiation, proliferation, motility, and apoptosis. Here, we identify PP5 in stable complexes with extracellular signal-regulated kinases (ERKs). Studies using mutant proteins reveal that the formation of PP5ERK1 and PP5ERK2 complexes partially depends on HSP90 binding to PP5 but does not require PP5 or ERK1/2 activity. However, PP5 and ERK activity regulates the phosphorylation state of Raf1 kinase, an upstream activator of ERK signaling. Whereas expression of constitutively active Rac1 promotes the assembly of PP5ERK1/2 complexes, acute activation of ERK1/2 fails to influence the phosphatase-kinase interaction. Introduction of oncogenic HRas (HRas(V12)) has no effect on PP5-ERK1 binding but selectively decreases the interaction of PP5 with ERK2, in a manner that is independent of PP5 and MAPK/ERK kinase (MEK) activity, yet paradoxically requires ERK2 activity. Additional studies conducted with oncogenic variants of KRas4B reveal that KRas(L61), but not KRas(V12), also decreases the PP5-ERK2 interaction. The expression of wild type HRas or KRas proteins fails to reduce PP5-ERK2 binding, indicating that the effect is specific to HRas(V12) and KRas(L61) gain-of-function mutations. These findings reveal a novel, differential responsiveness of PP5-ERK1 and PP5-ERK2 interactions to select oncogenic Ras variants and also support a role for PP5ERK complexes in regulating the feedback phosphorylation of PP5-associated Raf1.	[Mazalouskas, Matthew D.; Wadzinski, Brian E.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Godoy-Ruiz, Raquel; Weber, David J.; Zimmer, Danna B.] Univ Maryland, Sch Med, Ctr Biomol Therapeut, Baltimore, MD 20102 USA; [Godoy-Ruiz, Raquel; Weber, David J.; Zimmer, Danna B.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 20102 USA; [Honkanen, Richard E.] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA	Vanderbilt University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of South Alabama	Wadzinski, BE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 424 RRB, Nashville, TN 37232 USA.	brian.wadzinski@vanderbilt.edu	Weber, David J/B-5349-2011; Godoy Ruiz, Raquel/GOH-1617-2022	Weber, David J/0000-0002-8824-1110; GODOY-RUIZ, RAQUEL/0000-0003-4569-0781	National Institutes of Health [GM051366, CA60750, T32 GM08554, CA107331]; Center for Biomolecular Therapeutics at the University of Maryland School of Medicine; Institute for Bioscience and Biotechnology Research; NATIONAL CANCER INSTITUTE [R01CA060750, R01CA107331, R29CA060750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051366, T32GM008554, T32GM007628, R01GM051366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Biomolecular Therapeutics at the University of Maryland School of Medicine; Institute for Bioscience and Biotechnology Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM051366 (to B. E. W.), CA60750 (to R. E. H.), T32 GM08554 (to M. D. M.), and CA107331 (to D. J. W.). This work was also supported by funds from the Center for Biomolecular Therapeutics at the University of Maryland School of Medicine and the Institute for Bioscience and Biotechnology Research.	Aceves-Luquero CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006124; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Aebersold DM, 2004, MOL CELL BIOL, V24, P10000, DOI 10.1128/MCB.24.22.10000-10015.2004; Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Amable L, 2011, J BIOL CHEM, V286, P40413, DOI 10.1074/jbc.M111.244053; AMBURGEY JC, 1995, J BIOMOL NMR, V6, P171, DOI 10.1007/BF00211781; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Borthwick EB, 2001, FEBS LETT, V491, P279, DOI 10.1016/S0014-5793(01)02177-9; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Buhrman G, 2011, J BIOL CHEM, V286, P3323, DOI 10.1074/jbc.M110.193854; Chatterjee A, 2010, J BIOL CHEM, V285, P3872, DOI 10.1074/jbc.M109.088427; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; Chiang CW, 2011, BIOCHEM J, V433, P187, DOI 10.1042/BJ20100247; Cliff MJ, 2005, J MOL BIOL, V346, P717, DOI 10.1016/j.jmb.2004.12.017; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Deng Y, 2013, J CLIN INVEST, V123, P1202, DOI 10.1172/JCI63034; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Farhan H, 2010, J CELL BIOL, V189, P997, DOI 10.1083/jcb.200912082; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Garai A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003004; Golden T, 2004, CANCER LETT, V215, P95, DOI 10.1016/j.canlet.2004.03.027; Golden T, 2008, BBA-MOL BASIS DIS, V1782, P259, DOI 10.1016/j.bbadis.2008.01.004; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; Illert AL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.373464; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; Krens SFG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-196; Landar A, 1998, BIOCHEMISTRY-US, V37, P17429, DOI 10.1021/bi9817921; Lefloch R, 2008, MOL CELL BIOL, V28, P511, DOI 10.1128/MCB.00800-07; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Li J, 2006, BIOCHEM BIOPH RES CO, V345, P1425, DOI 10.1016/j.bbrc.2006.05.051; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nguyen LK, 2013, FEBS J, V280, P751, DOI 10.1111/j.1742-4658.2012.08522.x; Ni L, 2007, ASSAY DRUG DEV TECHN, V5, P645, DOI 10.1089/adt.2007.079; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Radtke S, 2013, J CELL SCI, V126, P2381, DOI 10.1242/jcs.115832; Roberts MS, 2003, J BIOL CHEM, V278, P1975, DOI 10.1074/jbc.M208607200; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Shao J, 2002, BIOCHEMISTRY-US, V41, P6770, DOI 10.1021/bi025737a; Shao Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.137; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Sinclair C, 1999, J BIOL CHEM, V274, P23666, DOI 10.1074/jbc.274.33.23666; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Soroka J, 2012, MOL CELL, V45, P517, DOI 10.1016/j.molcel.2011.12.031; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Swingle Mark, 2007, V365, P23; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; Szomolay B, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-26; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Uversky Vladimir N, 2013, F1000 Biol Rep, V5, P1, DOI 10.3410/B5-1; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; von Thun A, 2012, J CELL SCI, V125, P1465, DOI 10.1242/jcs.092916; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Wegner Adam M., 2007, V365, P61; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yamaguchi F, 2012, J BIOL CHEM, V287, P13787, DOI 10.1074/jbc.M111.329771; Yamaguchi Y, 2002, CURR BIOL, V12, P1353, DOI 10.1016/S0960-9822(02)01034-5; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Yung YV, 2000, J BIOL CHEM, V275, P15799, DOI 10.1074/jbc.M910060199; Zhang J, 2005, MOL CELL BIOL, V25, P9910, DOI 10.1128/MCB.25.22.9910-9919.2005	78	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4219	4232		10.1074/jbc.M113.518514	http://dx.doi.org/10.1074/jbc.M113.518514			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24371145	Green Published, hybrid			2022-12-28	WOS:000331403800034
J	Lowman, DW; Greene, RR; Bearden, DW; Kruppa, MD; Pottier, M; Monteiro, MA; Soldatov, DV; Ensley, HE; Cheng, SC; Netea, MG; Williams, DL				Lowman, Douglas W.; Greene, Rachel R.; Bearden, Daniel W.; Kruppa, Michael D.; Pottier, Max; Monteiro, Mario A.; Soldatov, Dmitriy V.; Ensley, Harry E.; Cheng, Shih-Chin; Netea, Mihai G.; Williams, David L.			Novel Structural Features in Candida albicans Hyphal Glucan Provide a Basis for Differential Innate Immune Recognition of Hyphae Versus Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; Carbohydrate Structure; Host-Pathogen Interactions; Immunology; NMR; Glucan; Hyphae; Immune Function	SYNTHESIZED IN-VITRO; X-RAY; CYTOKINE PRODUCTION; PACKING ANALYSIS; BETA-GLUCANS; DECTIN-1; (1->3)-BETA-D-GLUCAN; INDUCTION; PARAMYLON; RESPONSES	Background: The human innate immune system can discriminate between Candida albicans yeast and hyphal forms. Results:C. albicans hyphae possess glucan structures that are unique to the hyphae and are not found in yeast. Conclusion: Hyphal glucan elicits robust immune responses. Significance: These data provide a structural basis for differential immune recognition of C. albicans yeast versus hyphae. The innate immune system differentially recognizes Candida albicans yeast and hyphae. It is not clear how the innate immune system effectively discriminates between yeast and hyphal forms of C. albicans. Glucans are major components of the fungal cell wall and key fungal pathogen-associated molecular patterns. C. albicans yeast glucan has been characterized; however, little is known about glucan structure in C. albicans hyphae. Using an extraction procedure that minimizes degradation of the native structure, we extracted glucans from C. albicans hyphal cell walls. H-1 NMR data analysis revealed that, when compared with reference (13,16) -linked glucans and C. albicans yeast glucan, hyphal glucan has a unique cyclical or closed chain structure that is not found in yeast glucan. GC/MS analyses showed a high abundance of 3- and 6-linked glucose units when compared with yeast -glucan. In addition to the expected (13), (16), and 3,6 linkages, we also identified a 2,3 linkage that has not been reported previously in C. albicans. Hyphal glucan induced robust immune responses in human peripheral blood mononuclear cells and macrophages via a Dectin-1-dependent mechanism. In contrast, C. albicans yeast glucan was a much less potent stimulus. We also demonstrated the capacity of C. albicans hyphal glucan, but not yeast glucan, to induce IL-1 processing and secretion. This finding provides important evidence for understanding the immune discrimination between colonization and invasion at the mucosal level. When taken together, these data provide a structural basis for differential innate immune recognition of C. albicans yeast versus hyphae.	[Lowman, Douglas W.; Greene, Rachel R.; Ensley, Harry E.; Williams, David L.] E Tennessee State Univ, Dept Surg, Johnson City, TN 37614 USA; [Kruppa, Michael D.] E Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA; [Greene, Rachel R.] E Tennessee State Univ, Dept Chem, Johnson City, TN 37614 USA; [Lowman, Douglas W.] AppRidge Int LLC, Telford, TN 37690 USA; [Bearden, Daniel W.] NIST, Div Chem Sci, Hollings Marine Lab, Charleston, SC 29412 USA; [Pottier, Max; Monteiro, Mario A.; Soldatov, Dmitriy V.] Univ Guelph, Dept Chem, Guelph, ON NIG 2W1, Canada; [Cheng, Shih-Chin; Netea, Mihai G.] Radboud Univ Nijmegen, Dept Internal Med, NL-6525 GA Nijmeger, Netherlands; [Cheng, Shih-Chin; Netea, Mihai G.] Radboud Univ Nijmegen, Nijmegen Inst Infect Inflammat & Immun, NL-6525 GA Nijmeger, Netherlands	East Tennessee State University; East Tennessee State University; East Tennessee State University; National Institute of Standards & Technology (NIST) - USA; University of Guelph; Radboud University Nijmegen; Radboud University Nijmegen	Williams, DL (corresponding author), E Tennessee State Univ, Dept Surg, Campus Box 70575, Johnson City, TN 37614 USA.	williamd@etsu.edu	Cheng, Shih-Chin/H-4567-2015; Netea, Mihai/N-5155-2014; CHENG, SHIH-CHIN/M-3773-2019; Kruppa, Michael D/B-6052-2009	Cheng, Shih-Chin/0000-0003-1251-8774; CHENG, SHIH-CHIN/0000-0003-1251-8774; Kruppa, Michael D/0000-0002-1747-2333; Bearden, Daniel/0000-0003-0330-8513	National Institutes of Health [NIHGM53522]; Natural Science and Engineering Research Council (NSERC); CFI/MRI; Vici grant of the Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFI/MRI; Vici grant of the Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant NIHGM53522 (to D. L. W.). This was also supported by the Natural Science and Engineering Research Council (NSERC; to M. A. M.) and a CFI/MRI grant for x-ray diffractometer (to D. S.). D. W. L. is an employee of AppRidge International; however, no funds were provided by AppRidge for this research, nor does D. W. L. have any competing interests or conflicts of interest related to this research.; Supported by a Vici grant of the Netherlands Organization for Scientific Research (to M. G. N.).	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Ancian B, 1997, J MAGN RESON, V125, P348, DOI 10.1006/jmre.1997.1112; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; Beaussart A, 2012, ACS NANO, V6, P10950, DOI 10.1021/nn304505s; Bi LK, 2010, J BIOL CHEM, V285, P25969, DOI 10.1074/jbc.M110.131300; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; BREEDVELD MW, 1990, APPL ENVIRON MICROB, V56, P2080, DOI 10.1128/AEM.56.7.2080-2086.1990; Brown G. D., 2009, CHEM BIOCH BIOL 1 3, P677; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2003, IMMUNITY, V19, P311, DOI 10.1016/S1074-7613(03)00233-4; Brown J, 2007, PROTEIN SCI, V16, P1042, DOI 10.1110/ps.072791207; Cambi A, 2008, J BIOL CHEM, V283, P20590, DOI 10.1074/jbc.M709334200; CAVANAGH J, 1991, J MAGN RESON, V91, P429, DOI 10.1016/0022-2364(91)90209-C; Chauhan Neeraj, 2002, P159; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; CHUAH CT, 1983, MACROMOLECULES, V16, P1375, DOI 10.1021/ma00242a020; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; CLARKE AE, 1960, BIOCHIM BIOPHYS ACTA, V44, P161, DOI 10.1016/0006-3002(60)91534-1; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; DESLANDES Y, 1980, MACROMOLECULES, V13, P1466, DOI 10.1021/ma60078a020; ENSLEY HE, 1994, CARBOHYD RES, V258, P307, DOI 10.1016/0008-6215(94)84098-9; Esteban A, 2011, P NATL ACAD SCI USA, V108, P14270, DOI 10.1073/pnas.1111415108; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fulton W. S., 1980, GELLING MECH RELATIO, P385; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gil ML, 2006, MICROBES INFECT, V8, P2299, DOI 10.1016/j.micinf.2006.03.014; GOPAL PK, 1984, J GEN MICROBIOL, V130, P3295; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; HISAMATSU M, 1983, CARBOHYD RES, V121, P31, DOI 10.1016/0008-6215(83)84003-8; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Kapteyn JC, 2000, MOL MICROBIOL, V35, P601, DOI 10.1046/j.1365-2958.2000.01729.x; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim YT, 2000, CARBOHYD RES, V328, P331, DOI 10.1016/S0008-6215(00)00105-1; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Kobayashi K, 2010, CARBOHYD POLYM, V80, P491, DOI 10.1016/j.carbpol.2009.12.009; Kruppa M, 2011, GLYCOBIOLOGY, V21, P1173, DOI 10.1093/glycob/cwr051; Kulicke WM, 1997, CARBOHYD RES, V297, P135, DOI 10.1016/S0008-6215(96)00273-X; Li DM, 2009, FUNGAL GENET BIOL, V46, P731, DOI 10.1016/j.fgb.2009.06.008; Lowman DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027614; Lowman DW, 2011, CARBOHYD RES, V346, P2752, DOI 10.1016/j.carres.2011.09.029; Lowman DW, 2003, CARBOHYD RES, V338, P1491, DOI 10.1016/S0008-6215(03)00169-1; Lowman DW, 2001, J AGR FOOD CHEM, V49, P4188, DOI 10.1021/jf010435l; MARCHESSAULT RH, 1977, CAN J CHEM, V55, P300, DOI 10.1139/v77-045; Moyes DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026580; Mueller A, 2000, GLYCOBIOLOGY, V10, P339, DOI 10.1093/glycob/10.4.339; Muller A, 1997, CARBOHYD RES, V299, P203, DOI 10.1016/S0008-6215(97)00004-9; MULLER A, 1994, MICROBIOS, V79, P253; Nett J, 2006, CURR OPIN MICROBIOL, V9, P340, DOI 10.1016/j.mib.2006.06.007; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; NORWOOD TJ, 1990, J MAGN RESON, V87, P488, DOI 10.1016/0022-2364(90)90306-T; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pelosi L, 2003, BIOCHEMISTRY-US, V42, P6264, DOI 10.1021/bi0340550; Pelosi L, 2006, CARBOHYD POLYM, V66, P199, DOI 10.1016/j.carbpol.2006.03.003; Ramage G., 2012, INT J MICROBIOL, V2012; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; SAWARDEKER JS, 1965, ANAL CHEM, V37, P1602, DOI 10.1021/ac60231a048; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Shaw AA, 1996, J MAGN RESON SER A, V120, P110, DOI 10.1006/jmra.1996.0105; Shibata N, 2007, BIOCHEM J, V404, P365, DOI 10.1042/BJ20070081; van de Veerdonk FL, 2011, EUR J IMMUNOL, V41, P2260, DOI 10.1002/eji.201041226; Vasur J, 2010, J AM CHEM SOC, V132, P1724, DOI 10.1021/ja909129b; Wada M, 2008, POWDER DIFFR, V23, P92, DOI 10.1154/1.2912442; Wagner R, 1996, J MAGN RESON SER A, V123, P119, DOI 10.1006/jmra.1996.0222; Williams DL, 2005, TOXICOLOGY OF 1- 3-BETA-GLUCANS: GLUCANS AS A MARKER FOR FUNGAL EXPOSURE, P1; WILLIAMS DL, 1991, CARBOHYD RES, V219, P203, DOI 10.1016/0008-6215(91)89052-H; WILLIAMSON G, 1992, J BACTERIOL, V174, P7941, DOI 10.1128/JB.174.24.7941-7947.1992	71	82	83	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3432	3443		10.1074/jbc.M113.529131	http://dx.doi.org/10.1074/jbc.M113.529131			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24344127	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000331368700028
J	Mealer, RG; Murray, AJ; Shahani, N; Subramaniam, S; Snyder, SH				Mealer, Robert G.; Murray, Alexandra J.; Shahani, Neelam; Subramaniam, Srinivasa; Snyder, Solomon H.			Rhes, a Striatal-selective Protein Implicated in Huntington Disease, Binds Beclin-1 and Activates Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Bcl-2; Huntington Disease; mTOR; Neurodegenerative Diseases; Beclin-1; Rhes	MUTANT-HUNTINGTIN; MTOR; PHOSPHORYLATION; INHIBITION; CLEARANCE; MODEL	Background: The striatal-specific protein Rhes is implicated in the selective pathology of HD. Results: Rhes binds Beclin-1 and activates autophagy, a lysosomal degradation pathway critical in aging and neurodegeneration. Conclusion: Rhes-induced autophagy occurs independent of mTOR and JNK-1 signaling and is inhibited by huntingtin. Significance: The restricted expression of Rhes and its effect on autophagy may explain the selective striatal pathology and delayed onset of HD. The protein mutated in Huntington disease (HD), mutant huntingtin (mHtt), is expressed throughout the brain and body. However, the pathology of HD is characterized by early and dramatic destruction selectively of the striatum. We previously reported that the striatal-specific protein Rhes binds mHtt and enhances its cytotoxicity. Moreover, Rhes-deleted mice are dramatically protected from neurodegeneration and motor dysfunction in mouse models of HD. We now report a function of Rhes in autophagy, a lysosomal degradation pathway implicated in aging and HD neurodegeneration. In PC12 cells, deletion of endogenous Rhes decreases autophagy, whereas Rhes overexpression activates autophagy. These effects are independent of mTOR and opposite in the direction predicted by the known activation of mTOR by Rhes. Rhes robustly binds the autophagy regulator Beclin-1, decreasing its inhibitory interaction with Bcl-2 independent of JNK-1 signaling. Finally, co-expression of mHtt blocks Rhes-induced autophagy activation. Thus, the isolated pathology and delayed onset of HD may reflect the striatal-selective expression and changes in autophagic activity of Rhes.	[Mealer, Robert G.; Murray, Alexandra J.; Snyder, Solomon H.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Shahani, Neelam; Subramaniam, Srinivasa] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Scripps Research Institute	Subramaniam, S (corresponding author), Scripps Res Inst, Dept Neurosci, 130 Scripps Way 3C1, Jupiter, FL 33458 USA.	ssubrama@scripps.edu; ssnyder@jhmi.edu		Bender, Alexandra/0000-0002-6980-3878	National Institutes of Health from USPHS [MH18501]; Cure Huntington's Disease Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612, R01MH018501, R37MH018501] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; Cure Huntington's Disease Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH18501 from USPHS (to S. H. S.) and a grant from the Cure Huntington's Disease Initiative (to S. H. S.).	Baiamonte BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053606; Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Bang S, 2012, NEUROSCI LETT, V521, P142, DOI 10.1016/j.neulet.2012.05.073; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Choi BR, 2013, NEUROSCIENCE, V253, P214, DOI 10.1016/j.neuroscience.2013.08.043; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Harrison LM, 2013, NEUROSCIENCE, V236, P21, DOI 10.1016/j.neuroscience.2012.12.062; Jimenez-Sanchez M, 2012, PROG NEUROBIOL, V97, P67, DOI 10.1016/j.pneurobio.2011.08.013; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Li XJ, 2011, NEUROBIOL DIS, V43, P4, DOI 10.1016/j.nbd.2010.11.018; Lu BX, 2013, FASEB J, V27, P1820, DOI 10.1096/fj.12-219220; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Mealer RG, 2013, J NEUROSCI, V33, P4206, DOI 10.1523/JNEUROSCI.3730-12.2013; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nagata E, 2004, NEUROREPORT, V15, P1325, DOI 10.1097/01.wnr.0000127073.66692.8f; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Salminen A, 2009, TRENDS MOL MED, V15, P217, DOI 10.1016/j.molmed.2009.03.004; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Sbodio JI, 2013, CELL REP, V4, P890, DOI 10.1016/j.celrep.2013.08.001; Seredenina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022231; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Snyder SH, 2012, EUR J NEURODEGEN DIS, V1, P89; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Subramaniam S, 2012, NAT NEUROSCI, V15, P191, DOI 10.1038/nn.2994; Subramaniam S, 2011, NEUROPHARMACOLOGY, V60, P1187, DOI 10.1016/j.neuropharm.2010.10.025; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Vargiu P, 2004, ONCOGENE, V23, P559, DOI 10.1038/sj.onc.1207161; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zheng S, 2010, PLOS GENET, V6; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	86	91	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3547	3554		10.1074/jbc.M113.536912	http://dx.doi.org/10.1074/jbc.M113.536912			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24324270	Green Published, hybrid			2022-12-28	WOS:000331368700039
J	Landry, MC; Champagne, C; Boulanger, MC; Jette, A; Fuchs, M; Dziengelewski, C; Lavoie, JN				Landry, Marie-Claude; Champagne, Claudia; Boulanger, Marie-Chloe; Jette, Alexandra; Fuchs, Margit; Dziengelewski, Claire; Lavoie, Josee N.			A Functional Interplay between the Small GTPase Rab11a and Mitochondria-shaping Proteins Regulates Mitochondrial Positioning and Polarization of the Actin Cytoskeleton Downstream of Src Family Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Cytoskeleton; Mitochondria; Rab; Src; Trafficking; Viral Protein; Ad E4orf4; Drp1; Rab11-FIP; Podosome	ADENOVIRUS E4ORF4 PROTEIN; DYNAMIN-RELATED PROTEIN-1; TRANS-GOLGI NETWORK; CELL-DEATH PATHWAYS; MAMMALIAN-CELLS; MEDIATED PHOSPHORYLATION; RECYCLING ENDOSOME; P53-INDEPENDENT APOPTOSIS; ENDOPLASMIC-RETICULUM; ENDOCYTIC TRANSPORT	It is believed that mitochondrial dynamics is coordinated with endosomal traffic rates during cytoskeletal remodeling, but the mechanisms involved are largely unknown. The adenovirus early region 4 ORF4 protein (E4orf4) subverts signaling by Src family kinases (SFK) to perturb cellular morphology, membrane traffic, and organellar dynamics and to trigger cell death. Using E4orf4 as a model, we uncovered a functional connection between mitochondria-shaping proteins and the small GTPase Rab11a, a key regulator of polarized transport via recycling endosomes. We found that E4orf4 induced dramatic changes in the morphology of mitochondria along with their mobilization at the vicinity of a polarized actin network typifying E4orf4 action, in a manner controlled by SFK and Rab11a. Mitochondrial remodeling was associated with increased proximity between Rab11a and mitochondrial membranes, changes in fusion-fission dynamics, and mitochondrial relocalization of the fission factor dynamin-related protein 1 (Drp1), which was regulated by the Rab11a effector protein FIP1/RCP. Knockdown of FIP1/RCP or inhibition of Drp1 markedly impaired mitochondrial remodeling and actin assembly, involving Rab11a-mediated mitochondrial dynamics in E4orf4-induced signaling. A similar mobilization of mitochondria near actin-rich structures was mediated by Rab11 and Drp1 in viral Src-transformed cells and contributed to the biogenesis of podosome rosettes. These findings suggest a role for Rab11a in the trafficking of Drp1 to mitochondria upon SFK activation and unravel a novel functional interplay between Rab11a and mitochondria during reshaping of the cell cytoskeleton, which would facilitate mitochondria redistribution near energy-requiring actin-rich structures.	[Landry, Marie-Claude; Champagne, Claudia; Boulanger, Marie-Chloe; Jette, Alexandra; Fuchs, Margit; Dziengelewski, Claire; Lavoie, Josee N.] Univ Laval, Ctr Rech Canc, Ctr Rech, Ctr Hosp Univ Quebec, Quebec City, PQ G1R 3S3, Canada; [Lavoie, Josee N.] Univ Laval, Dept Biol Mol Biochim Med & Pathol, Quebec City, PQ G1V 0A6, Canada	Laval University; Laval University	Lavoie, JN (corresponding author), Univ Laval, Ctr Rech Canc, Ctr Rech, Ctr Hosp Univ Quebec, Quebec City, PQ G1R 3S3, Canada.	josee.lavoie@crhdq.ulaval.ca		Lavoie, Josee N/0000-0001-6912-1132	Canadian Institutes of Health Research [MOP-49450]; Natural Sciences and Engineering Research Council [RF:RGPIN371663]; Fond de la Recherche en Sante du Quebec; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fond de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Canadian Institutes of Health Research Operating Grant MOP-49450 (to J. N. L.) and by the Natural Sciences and Engineering Research Council Grant RF:RGPIN371663 (to J. N. L.).; Supported by a Studentship from the Fond de la Recherche en Sante du Quebec. Present address: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Ontario M5G 1X5, Canada.; Supported by a summer studentship from the Natural Sciences and Engineering Research Council.	Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005; Baixauli F, 2011, EMBO J, V30, P1238, DOI 10.1038/emboj.2011.25; Bilodeau N, 2010, J PROTEOME RES, V9, P708, DOI 10.1021/pr900481b; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonekamp NA, 2010, EXP CELL RES, V316, P3454, DOI 10.1016/j.yexcr.2010.07.020; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Champagne C, 2004, J BIOL CHEM, V279, P25905, DOI 10.1074/jbc.M400933200; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cristea IM, 2004, CHEM PHYS LIPIDS, V129, P133, DOI 10.1016/j.chemphyslip.2004.02.002; Degli Esposti M, 2009, MOL BIOL CELL, V20, P600, DOI 10.1091/mbc.E08-09-0925; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; Frittoli E, 2011, EUR J CELL BIOL, V90, P108, DOI 10.1016/j.ejcb.2010.04.007; Gabriel AM, 2009, INT J BIOCHEM CELL B, V41, P2062, DOI 10.1016/j.biocel.2009.02.002; Gingras MC, 2002, MOL CELL BIOL, V22, P41, DOI 10.1128/MCB.22.1.41-56.2002; Gokool S, 2007, TRAFFIC, V8, P1873, DOI 10.1111/j.1600-0854.2007.00652.x; Gould GW, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002186; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Green DR, 2011, CELL, V147, DOI 10.1016/j.cell.2011.10.036; Harbour ME, 2010, J CELL SCI, V123, P3703, DOI 10.1242/jcs.071472; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Hebert-Chatelain E, 2013, INT J BIOCHEM CELL B, V45, P90, DOI 10.1016/j.biocel.2012.08.014; Hebert-Chatelain E, 2012, BBA-BIOENERGETICS, V1817, P718, DOI 10.1016/j.bbabio.2012.01.014; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Imoto M, 1998, J CELL SCI, V111, P1341; Jing JA, 2010, MOL BIOL CELL, V21, P3041, DOI 10.1091/mbc.E10-04-0313; Jing J, 2009, HISTOL HISTOPATHOL, V24, P1171, DOI 10.14670/HH-24.1171; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; JONES HW, 1971, OBSTET GYNECOL, V38, P945; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kamimoto T, 1998, J BIOL CHEM, V273, P1044, DOI 10.1074/jbc.273.2.1044; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Landry MC, 2006, B CANCER, V93, P921; Landry MC, 2009, MOL BIOL CELL, V20, P4091, DOI 10.1091/mbc.E09-01-0057; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; Lavoie JN, 2000, J CELL BIOL, V150, P1037, DOI 10.1083/jcb.150.5.1037; Lavoie JN, 2010, CELL SIGNAL, V22, P1604, DOI 10.1016/j.cellsig.2010.04.007; Lim JE, 2005, NAT GENET, V37, P1270, DOI 10.1038/ng1659; Lindsay AJ, 2004, J CELL SCI, V117, P4365, DOI 10.1242/jcs.01280; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Marcellus RC, 2000, J VIROL, V74, P7869, DOI 10.1128/JVI.74.17.7869-7877.2000; Mitra K, 2012, J CELL BIOL, V197, P487, DOI 10.1083/jcb.201110058; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Moissoglu K, 2003, J BIOL CHEM, V278, P47946, DOI 10.1074/jbc.M302720200; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; MORRIS RL, 1993, J CELL SCI, V104, P917; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Ouasti S, 2007, CELL DEATH DIFFER, V14, P453, DOI 10.1038/sj.cdd.4402043; Pechkovsky A, 2013, P NATL ACAD SCI USA, V110, pE1724, DOI 10.1073/pnas.1220282110; Peden AA, 2004, MOL BIOL CELL, V15, P3530, DOI 10.1091/mbc.E03-12-0918; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Robert A, 2002, J CELL BIOL, V158, P519, DOI 10.1083/jcb.200201106; Robert A, 2006, MOL BIOL CELL, V17, P3329, DOI 10.1091/mbc.E05-12-1146; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Saltel F, 2011, EUR J CELL BIOL, V90, P100, DOI 10.1016/j.ejcb.2010.05.011; Sanchez-Madrid F, 2007, TRENDS IMMUNOL, V28, P193, DOI 10.1016/j.it.2007.03.007; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; Santel A, 2001, J CELL SCI, V114, P867; Saraste J, 2007, MOL BIOL CELL, V18, P1430, DOI 10.1091/mbc.E06-10-0933; Schiel JA, 2013, TRENDS CELL BIOL, V23, P319, DOI 10.1016/j.tcb.2013.02.003; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Sharp TM, 2010, CURR OPIN INFECT DIS, V23, P464, DOI 10.1097/QCO.0b013e32833dcebd; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Shin HW, 1997, J BIOCHEM-TOKYO, V122, P525; Shtrichman R, 1999, P NATL ACAD SCI USA, V96, P10080, DOI 10.1073/pnas.96.18.10080; Shtrichman R, 1998, J VIROL, V72, P2975, DOI 10.1128/JVI.72.4.2975-2982.1998; Smadja-Lamere N, 2008, J BIOL CHEM, V283, P34352, DOI 10.1074/jbc.M803364200; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tamura Y, 2011, CELL, V145, DOI 10.1016/j.cell.2011.06.018; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van IJzendoorn SCD, 2006, J CELL SCI, V119, P1679, DOI 10.1242/jcs.02948; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	110	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2230	2249		10.1074/jbc.M113.516351	http://dx.doi.org/10.1074/jbc.M113.516351			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302731	Green Published, hybrid			2022-12-28	WOS:000331130200030
J	Lauer, JL; Bhowmick, M; Tokmina-Roszyk, D; Lin, Y; Van Doren, SR; Fields, GB				Lauer, Janelle L.; Bhowmick, Manishabrata; Tokmina-Roszyk, Dorota; Lin, Yan; Van Doren, Steven R.; Fields, Gregg B.			The Role of Collagen Charge Clusters in the Modulation of Matrix Metalloproteinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Extracellular Matrix Proteins; Matrix Metalloproteinase (MMP); Protease; Protein Folding; Charge Clusters; Collagenolysis Mechanism; Triple Helix	TRIPLE-HELICAL COLLAGEN; I COLLAGEN; MODEL PEPTIDES; CLEAVAGE SITE; ELECTROSTATIC INTERACTIONS; FLUOROGENIC SUBSTRATE; STRUCTURAL INSIGHTS; SEQUENCE DEPENDENCE; THERMAL-STABILITY; DOMAIN RESIDUES	Members of the matrix metalloproteinase (MMP) family selectively cleave collagens in vivo. Several substrate structural features that direct MMP collagenolysis have been identified. The present study evaluated the role of charged residue clusters in the regulation of MMP collagenolysis. A series of 10 triple-helical peptide (THP) substrates were constructed in which either Lys-Gly-Asp or Gly-Asp-Lys motifs replaced Gly-Pro-Hyp (where Hyp is 4-hydroxy-l-proline) repeats. The stabilities of THPs containing the two different motifs were analyzed, and kinetic parameters for substrate hydrolysis by six MMPs were determined. A general trend for virtually all enzymes was that, as Gly-Asp-Lys motifs were moved from the extreme N and C termini to the interior next to the cleavage site sequence, k(cat)/K-m values increased. Additionally, all Gly-Asp-Lys THPs were as good or better substrates than the parent THP in which Gly-Asp-Lys was not present. In turn, the Lys-Gly-Asp THPs were also always better substrates than the parent THP, but the magnitude of the difference was considerably less compared with the Gly-Asp-Lys series. Of the MMPs tested, MMP-2 and MMP-9 most greatly favored the presence of charged residues with preference for the Gly-Asp-Lys series. Lys-Gly-(Asp/Glu) motifs are more commonly found near potential MMP cleavage sites than Gly-(Asp/Glu)-Lys motifs. As Lys-Gly-Asp is not as favored by MMPs as Gly-Asp-Lys, the Lys-Gly-Asp motif appears advantageous over the Gly-Asp-Lys motif by preventing unwanted MMP hydrolysis. More specifically, the lack of Gly-Asp-Lys clusters may diminish potential MMP-2 and MMP-9 collagenolytic activity. The present study indicates that MMPs have interactions spanning the P-23-P-23 subsites of collagenous substrates.	[Lauer, Janelle L.; Bhowmick, Manishabrata; Tokmina-Roszyk, Dorota; Fields, Gregg B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Lauer, Janelle L.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Bhowmick, Manishabrata; Tokmina-Roszyk, Dorota; Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Van Doren, Steven R.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Texas System; University of Texas Health San Antonio; Max Planck Society; Torrey Pines Institute for Molecular Studies, Florida; University of Missouri System; University of Missouri Columbia	Fields, GB (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	gfields@tpims.org		Van Doren, Steven/0000-0003-2838-4598	National Institutes of Health [CA98799]; NHLBI [268201000036C]; NIDCR Craniofacial Oral Biology Student Training in Academic Research Program [DE14318]; Multiple Sclerosis National Research Institute; Robert A. Welch Foundation; Texas Higher Education Science and Technology Acquisition and Retention Program; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR Craniofacial Oral Biology Student Training in Academic Research Program; Multiple Sclerosis National Research Institute; Robert A. Welch Foundation(The Welch Foundation); Texas Higher Education Science and Technology Acquisition and Retention Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA98799 (to G. B. F.), Contract 268201000036C from the NHLBI (to G. B. F.), and Grant DE14318 from the NIDCR Craniofacial Oral Biology Student Training in Academic Research Program (to J. L. L.). This work was also supported by the Multiple Sclerosis National Research Institute, the Robert A. Welch Foundation, and the Texas Higher Education Science and Technology Acquisition and Retention Program (all to G. B. F.).	Ackerman MS, 1999, J BIOL CHEM, V274, P7668, DOI 10.1074/jbc.274.12.7668; AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Akers WJ, 2012, BIOCONJUGATE CHEM, V23, P656, DOI 10.1021/bc300027y; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Arnold LH, 2011, J BIOL CHEM, V286, P45073, DOI 10.1074/jbc.M111.285213; Arnold WV, 1998, J BIOL CHEM, V273, P31822, DOI 10.1074/jbc.273.48.31822; BACHINGER HP, 1991, INT J BIOL MACROMOL, V13, P152, DOI 10.1016/0141-8130(91)90040-2; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Bertini I, 2009, J BIOL CHEM, V284, P12821, DOI 10.1074/jbc.M809627200; Bhaskaran R, 2008, J BIOL CHEM, V283, P21779, DOI 10.1074/jbc.M709966200; Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x; BIRKEDALHANSEN H, 1985, J BIOL CHEM, V260, P6411; Cerofolini L, 2013, J BIOL CHEM, V288, P30659, DOI 10.1074/jbc.M113.477240; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Falconi M, 2003, J COMPUT AID MOL DES, V17, P837, DOI 10.1023/B:JCAM.0000021883.44532.75; Fallas JA, 2012, J BIOL CHEM, V287, P8039, DOI 10.1074/jbc.M111.296574; FAN P, 1993, BIOCHEMISTRY-US, V32, P13299, DOI 10.1021/bi00211a043; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fields GB, 1996, BIOPOLYMERS, V40, P345, DOI 10.1002/(SICI)1097-0282(1996)40:4<345::AID-BIP1>3.0.CO;2-W; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; Fields GB, 2010, METHODS MOL BIOL, V622, P393, DOI 10.1007/978-1-60327-299-5_24; Fields Gregg B., 2008, P827, DOI 10.1007/978-0-387-69057-5_39; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; GROSS J, 1980, COLLAGENASE NORMAL P, P11; HASTY KA, 1993, MATRIX, V13, P181, DOI 10.1016/S0934-8832(11)80001-6; Jaisson S, 2006, CHEM BIOL, V13, P149, DOI 10.1016/j.chembiol.2005.11.005; Jaisson S, 2007, MATRIX BIOL, V26, P190, DOI 10.1016/j.matbio.2006.10.008; Jalan AA, 2013, BIOMACROMOLECULES, V14, P179, DOI 10.1021/bm3015818; Knapinska A, 2012, CHEMBIOCHEM, V13, P2002, DOI 10.1002/cbic.201200298; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Lauer-Fields JL, 2008, J BIOL CHEM, V283, P20087, DOI 10.1074/jbc.M801438200; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lauer-Fields JL, 2000, J CHROMATOGR A, V890, P117, DOI 10.1016/S0021-9673(00)00396-4; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Lauer-Fields JL, 2001, BIOCHEMISTRY-US, V40, P5795, DOI 10.1021/bi0101190; Li YJ, 2005, J AM CHEM SOC, V127, P10490, DOI 10.1021/ja052801d; Liu XY, 1996, BIOCHEMISTRY-US, V35, P4306, DOI 10.1021/bi952270d; Lu KG, 2013, J MOL BIOL, V425, P1815, DOI 10.1016/j.jmb.2013.02.002; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Mikhailova M, 2012, MATRIX BIOL, V31, P380, DOI 10.1016/j.matbio.2012.10.001; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R; Nerenberg PS, 2008, J MOL BIOL, V382, P246, DOI 10.1016/j.jmb.2008.07.009; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Palmier MO, 2007, ANAL BIOCHEM, V371, P43, DOI 10.1016/j.ab.2007.07.008; Palmier MO, 2010, J BIOL CHEM, V285, P30918, DOI 10.1074/jbc.M110.136903; Patterson ML, 2001, FEBS LETT, V503, P158, DOI 10.1016/S0014-5793(01)02723-5; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Persikov AV, 2000, BIOPOLYMERS, V55, P436, DOI 10.1002/1097-0282(2000)55:6<436::AID-BIP1019>3.0.CO;2-D; Ravikumar KM, 2008, PROTEINS, V72, P1320, DOI 10.1002/prot.22026; Ravikumar KM, 2007, J MECH MATER STRUCT, V2, P999, DOI 10.2140/jomms.2007.2.999; Robichaud TK, 2011, J BIOL CHEM, V286, P37535, DOI 10.1074/jbc.M111.273391; Salsas-Escat R, 2010, PROTEINS, V78, P325, DOI 10.1002/prot.22545; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Taddese S, 2010, BBA-PROTEINS PROTEOM, V1804, P731, DOI 10.1016/j.bbapap.2009.11.014; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023; WELGUS HG, 1981, J BIOL CHEM, V256, P9516; Williams KE, 2009, MATRIX BIOL, V28, P373, DOI 10.1016/j.matbio.2009.04.009; WU H, 1990, P NATL ACAD SCI USA, V87, P5888, DOI 10.1073/pnas.87.15.5888; Xiao JX, 2010, J BIOL CHEM, V285, P34181, DOI 10.1074/jbc.M110.128355; Xu XP, 2009, BIOCHEMISTRY-US, V48, P5822, DOI 10.1021/bi900513h; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979	82	8	8	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1981	1992		10.1074/jbc.M113.513408	http://dx.doi.org/10.1074/jbc.M113.513408			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24297171	hybrid, Green Published			2022-12-28	WOS:000331130200010
J	Ableser, MJ; Penuela, S; Lee, J; Shao, Q; Laird, DW				Ableser, Mark J.; Penuela, Silvia; Lee, Jack; Shao, Qing; Laird, Dale W.			Connexin43 Reduces Melanoma Growth within a Keratinocyte Microenvironment and during Tumorigenesis in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Connexin; Gap Junctions; Keratinocytes; Melanoma; Tumor Suppressor Gene	JUNCTIONAL INTERCELLULAR COMMUNICATION; C6 GLIOMA-CELLS; GAP-JUNCTION; SUPPRESSIVE FUNCTION; ENDOTHELIAL-CELLS; TUMOR-SUPPRESSOR; PLASMA-MEMBRANE; LIVER-TUMORS; E-CADHERIN; EXPRESSION	Background: Cx43 is a gap junction protein that is highly expressed in the epidermis. Results: Ectopic expression of Cx43 in gap junctional intercellular communication-deficient melanomas reduces growth in keratinocyte co-cultures and tumorigenicity assays. Conclusion: Cx43 acts as a tumor suppressor during melanoma tumorigenesis. Significance: Cx43 may serve as a potential therapeutic target for melanomas. Connexins (Cx) have been identified as tumor suppressors or enhancers, a distinction that appears to be dependent on the type and stage of disease. However, the role of connexins in melanoma tumorigenesis and their status during cancer onset and progression remain controversial and unclear. Here, we show that the aggressive B16-BL6 mouse melanoma cell line expresses low basal levels of Cx26 and Cx43, rendering them gap junctional intercellular communication-deficient as elucidated by immunofluorescence, Western blotting, and dye transfer studies. Following ectopic expression of green fluorescent protein-tagged Cx26 and Cx43 in these connexin-deficient melanomas, punctate gap junction-like plaques were evident at sites of cell-cell apposition, and the incidence of dye transfer was significantly increased similar to connexin-rich keratinocytes. We found that the expression of Cx43, but not Cx26, significantly reduced cellular proliferation and anchorage-independent growth from control melanomas, whereas migration was unaffected. Additionally, melanomas expressing Cx43 displayed significantly reduced growth within the in situ-like microenvironment of keratinocytes, despite a lack of heterocellular gap junctional intercellular communication between the two cell types. Furthermore, when grown in vivo in the chicken chorioallantoic membrane, primary tumors derived from Cx43-expressing melanomas were significantly smaller than controls, whereas Cx26-expressing melanomas produced tumors similar to controls. Collectively, these results suggest that Cx43, and not Cx26, can act as a tumor suppressor during melanoma tumorigenesis.	[Ableser, Mark J.; Penuela, Silvia; Shao, Qing; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; [Lee, Jack; Laird, Dale W.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, Dent Sci Bldg 00077, London, ON N6A 5C1, Canada.	dale.laird@schulich.uwo.ca	Laird, Dale W/AAL-2407-2020; Penuela, Silvia/A-6961-2010; Laird, Dale w/E-4176-2015	Laird, Dale W/0000-0002-4568-3285; Penuela, Silvia/0000-0003-4829-5517; 	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from the Canadian Institutes of Health Research (to D. W. L.).	Bagnato A, 2004, CANCER RES, V64, P1436, DOI 10.1158/0008-5472.CAN-03-2344; CHEN SC, 1995, CELL GROWTH DIFFER, V6, P681; Cronier L, 2009, ANTIOXID REDOX SIGN, V11, P323, DOI 10.1089/ars.2008.2153; EGHBALI B, 1991, P NATL ACAD SCI USA, V88, P10701, DOI 10.1073/pnas.88.23.10701; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Falk MM, 2000, J CELL SCI, V113, P4109; Fu CT, 2004, J BIOL CHEM, V279, P36943, DOI 10.1074/jbc.M403952200; Girolamo F, 2006, MED SCI MONITOR, V12, pBR21; Haass NK, 2005, J INVEST DERM SYMP P, V10, P153, DOI 10.1111/j.1087-0024.2005.200407.x; Haass NK, 2004, J MOL HISTOL, V35, P309; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Hirschi KK, 1996, CELL GROWTH DIFFER, V7, P861; Hsu MY, 2000, J CELL SCI, V113, P1535; Hsu MY, 2000, AM J PATHOL, V156, P1515, DOI 10.1016/S0002-9440(10)65023-7; Huang RP, 1998, CANCER RES, V58, P5089; Ionta M, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-22; Ito A, 2000, J CLIN INVEST, V105, P1189, DOI 10.1172/JCI8257; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kalra J, 2006, CARCINOGENESIS, V27, P2528, DOI 10.1093/carcin/bgl110; Kieken F, 2009, CIRC RES, V104, P1103, DOI 10.1161/CIRCRESAHA.108.190454; King TJ, 2004, CANCER RES, V64, P7191, DOI 10.1158/0008-5472.CAN-04-0624; KRUTOVSKIKH V, 1994, INT J CANCER, V56, P87; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 2001, MICROSC RES TECHNIQ, V52, P263, DOI 10.1002/1097-0029(20010201)52:3<263::AID-JEMT1012>3.0.CO;2-Q; Langlois S, 2010, CANCER RES, V70, P4222, DOI 10.1158/0008-5472.CAN-09-3281; Leithe E, 2009, J CELL SCI, V122, P3883, DOI 10.1242/jcs.053801; Loewenstein W R, 1992, Semin Cell Biol, V3, P59; LOEWENSTEIN WR, 1966, NATURE, V209, P1248, DOI 10.1038/2091248a0; Masuda M, 2001, ANAT RECORD, V262, P137, DOI 10.1002/1097-0185(20010201)262:2<137::AID-AR1018>3.0.CO;2-2; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Mesnil M, 2005, BBA-BIOMEMBRANES, V1719, P125, DOI 10.1016/j.bbamem.2005.11.004; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Omori Y, 1999, CARCINOGENESIS, V20, P1913, DOI 10.1093/carcin/20.10.1913; Penuela S, 2012, J BIOL CHEM, V287, P29184, DOI 10.1074/jbc.M112.377176; Pollmann MA, 2005, BREAST CANCER RES, V7, pR522, DOI 10.1186/bcr1042; Princen F, 2001, CARCINOGENESIS, V22, P507, DOI 10.1093/carcin/22.3.507; Qin H, 2002, J BIOL CHEM, V277, P29132, DOI 10.1074/jbc.M200797200; Richard G, 2000, EXP DERMATOL, V9, P77, DOI 10.1034/j.1600-0625.2000.009002077.x; Saito-Katsuragi M, 2007, CANCER, V110, P1162, DOI 10.1002/cncr.22894; Sato H, 2007, J MEMBRANE BIOL, V216, P17, DOI 10.1007/s00232-007-9020-5; Seiberg M, 2000, EXP CELL RES, V254, P25, DOI 10.1006/excr.1999.4692; SHIH IM, 1994, AM J PATHOL, V145, P837; Sohl G, 2003, CELL COMMUN ADHES, V10, P173, DOI 10.1080/15419060390262877; Stoletov K, 2013, J CELL SCI, V126, P904, DOI 10.1242/jcs.112748; Su YA, 2000, MOL CARCINOGEN, V28, P119, DOI 10.1002/1098-2744(200006)28:2<119::AID-MC8>3.0.CO;2-N; Temme A, 1997, CURR BIOL, V7, P713, DOI 10.1016/S0960-9822(06)00302-2; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Thomas T, 2004, J BIOL CHEM, V279, P19157, DOI 10.1074/jbc.M314117200; VALYINAGY IT, 1993, LAB INVEST, V69, P152; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; YAMAOKA K, 1995, J HEPATOL, V22, P536, DOI 10.1016/0168-8278(95)80447-1; Zhang YW, 2003, CANCER RES, V63, P1623; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883; Zucker SN, 2013, J CELL PHYSIOL, V228, P853, DOI 10.1002/jcp.24235	55	34	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1592	1603		10.1074/jbc.M113.507228	http://dx.doi.org/10.1074/jbc.M113.507228			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297173	hybrid, Green Published			2022-12-28	WOS:000332401700033
J	Aoki, R; Hiraide, Y; Yamakawa, H; Fujita, Y				Aoki, Rina; Hiraide, Yuto; Yamakawa, Hisanori; Fujita, Yuichi			A Novel "Oxygen-induced" Greening Process in a Cyanobacterial Mutant Lacking the Transcriptional Activator ChlR Involved in Low-oxygen Adaptation of Tetrapyrrole Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyanobacteria; Hypoxia; Photosynthesis; Photosynthetic Pigments; Photosystem II; Chlorophyll; Greening; Transcriptional Regulator	PHOTOSYSTEM-II COMPLEX; CHLOROPHYLL BIOSYNTHESIS; PROTOCHLOROPHYLLIDE REDUCTION; DIFFERENTIAL OPERATION; EXPRESSION; ENZYME; GENES; STOICHIOMETRY; ARABIDOPSIS; REGULATOR	Background: ChlR activates the transcription of genes encoding low-oxygen-type enzymes in response to hypoxia in cyanobacteria. Results: The chlR-lacking mutant showed a novel oxygen-induced greening process upon exposure to air. Conclusion: The contents of photosystems were correlated well with the chlorophyll contents in the greening process. Significance: Oxygen-induced greening provides a promising alternative system to investigate the biogenesis of photosystems. ChlR activates the transcription of the chlA(II)-ho2-hemN operon in response to low-oxygen conditions in the cyanobacterium Synechocystis sp. PCC 6803. Three genes in the operon encode low-oxygen-type enzymes to bypass three oxygen-dependent reactions in tetrapyrrole biosynthesis. A chlR-lacking mutant, chlR, shows poor photoautotrophic growth due to low chlorophyll (Chl) content under low-oxygen conditions, which is caused by no induction of the operon. Here, we characterized the processes of etiolation of chlR cells in low-oxygen conditions and the subsequent regreening of the etiolated cells upon exposure to oxygen, by HPLC, Western blotting, and low-temperature fluorescence spectra. The Chl content of the etiolated chlR cells incubated under low-oxygen conditions for 7 days was only 10% of that of the wild-type with accumulation of almost all intermediates of the magnesium branch of Chl biosynthesis. Both photosystem I (PSI) and photosystem II (PSII) were significantly decreased, accompanied by a preferential decrease of antenna Chl in PSI. Upon exposure to oxygen, the etiolated chlR cells resumed to produce Chl after a short lag (approximate to 2 h), and the level at 72 h was 80% of that of the wild-type. During this novel oxygen-induced greening process, the PSI and PSII contents were largely increased in parallel with the increase in Chl contents. After 72 h, the PSI content reached approximate to 50% of the wild-type level in contrast to the full recovery of PSII. chlR provides a promising alternative system to investigate the biogenesis of PSI and PSII.	[Aoki, Rina; Hiraide, Yuto; Yamakawa, Hisanori; Fujita, Yuichi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Nagoya University	Fujita, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	fujita@agr.nagoya-u.ac.jp	Fujita, Yuichi/G-8908-2013		Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency; Japan Society for the Promotion of Sciences (JSPS) for Japanese Junior Scientists;  [19570036];  [20200063];  [23370020];  [12J00105]	Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency; Japan Society for the Promotion of Sciences (JSPS) for Japanese Junior Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; 	This work was supported by Grants-in-aid for Scientific Research 19570036, 20200063, and 23370020 (to Y. F.) and 12J00105 (to R. A.) and the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency.; Supported by a fellowship from the Japan Society for the Promotion of Sciences (JSPS) for Japanese Junior Scientists.	Adam Z, 2011, PLANT MOL BIOL, V76, P221, DOI 10.1007/s11103-010-9693-5; Aoki R, 2012, J BIOL CHEM, V287, P13500, DOI 10.1074/jbc.M112.346205; Aoki R, 2011, PLANT CELL PHYSIOL, V52, P1744, DOI 10.1093/pcp/pcr108; Boehm M, 2011, J BIOL CHEM, V286, P14812, DOI 10.1074/jbc.M110.207944; Cahoon AB, 2000, PLANT CELL, V12, P559, DOI 10.1105/tpc.12.4.559; Czarnecki O, 2012, J EXP BOT, V63, P1675, DOI 10.1093/jxb/err437; FUJITA Y, 1992, PLANT CELL PHYSIOL, V33, P81; FUJITA Y, 1990, PLANT CELL PHYSIOL, V31, P145; Fujita Y, 1996, PLANT CELL PHYSIOL, V37, P411, DOI 10.1093/oxfordjournals.pcp.a028962; Fujita Y., 2003, PORPHYRIN HDB CHLORO, P109, DOI DOI 10.1016/B978-0-08-092387-1.50010-2; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; GOLDBERG I, 1970, Journal of Cell Biology, V44, P563, DOI 10.1083/jcb.44.3.563; Goto T, 2010, PLANT CELL PHYSIOL, V51, P650, DOI 10.1093/pcp/pcq023; HOOBER JK, 1976, J CELL BIOL, V70, P326, DOI 10.1083/jcb.70.2.326; Kada S, 2003, PLANT MOL BIOL, V51, P225, DOI 10.1023/A:1021195226978; Komenda J, 2012, CURR OPIN PLANT BIOL, V15, P245, DOI 10.1016/j.pbi.2012.01.017; Kopecna J, 2013, PLANTA, V237, P497, DOI 10.1007/s00425-012-1761-4; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Matsumoto F, 2004, PLANT PHYSIOL, V135, P2379, DOI 10.1104/pp.104.042408; MELIS A, 1980, P NATL ACAD SCI-BIOL, V77, P4712, DOI 10.1073/pnas.77.8.4712; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; Minamizaki K, 2008, J BIOL CHEM, V283, P2684, DOI 10.1074/jbc.M708954200; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Ohad I, 1974, Methods Enzymol, V32, P865; Ohnishi N, 2008, PHOTOSYNTH RES, V98, P315, DOI 10.1007/s11120-008-9344-8; PONTOPPIDAN B, 1994, EUR J BIOCHEM, V225, P529, DOI 10.1111/j.1432-1033.1994.00529.x; Reinbothe C, 2010, TRENDS PLANT SCI, V15, P614, DOI 10.1016/j.tplants.2010.07.002; Rudiger W, 2012, ADV PHOTOSYNTH RESP, V34, P175, DOI 10.1007/978-94-007-1579-0_8; Stenbaek A, 2008, FEBS LETT, V582, P2773, DOI 10.1016/j.febslet.2008.07.006; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tanaka R, 2011, BBA-BIOENERGETICS, V1807, P968, DOI 10.1016/j.bbabio.2011.01.002; Vothknecht UC, 1996, P NATL ACAD SCI USA, V93, P9287, DOI 10.1073/pnas.93.17.9287; Wu QG, 1995, PLANT MOL BIOL, V29, P933, DOI 10.1007/BF00014967; Yamazaki S, 2006, PLANT PHYSIOL, V142, P911, DOI 10.1104/pp.106.086090; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	38	12	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1841	1851		10.1074/jbc.M113.495358	http://dx.doi.org/10.1074/jbc.M113.495358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297184	Green Published, hybrid			2022-12-28	WOS:000332401700053
J	Bondar, A; Lazar, J				Bondar, Alexey; Lazar, Josef			Dissociated G alpha(GTP) and G beta gamma Protein Subunits Are the Major Activated Form of Heterotrimeric Gi/o Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adrenergic Receptor; Cell Signaling; Heterotrimeric G Proteins; Membrane Proteins; Microscopic Imaging; Plasma Membrane; Potassium Channels; Two-photon Polarization Microscopy	STRUCTURAL BASIS; RECEPTOR; ALPHA; GTP; COMPLEX; CONFORMATIONS; TRANSLOCATION; EFFECTOR; CELLS	Background: The nature of the activated form of heterotrimeric Gi/o proteins is unclear. Results: Non-modified Gi/o heterotrimers dissociate upon activation, whereas fluorescently labeled Gi/o heterotrimers dissociate or rearrange depending on fluorescent protein localization. Conclusion: Dissociated G(GTP) and G subunits represent the major activated form of Gi/o proteins. Significance: The identification of the Gi/o protein activated form is crucial for the elucidation of signaling mechanisms and rational drug design. Although most heterotrimeric G proteins are thought to dissociate into G and G subunits upon activation, the evidence in the Gi/o family has long been inconsistent and contradictory. The Gi/o protein family mediates inhibition of cAMP production and regulates the activity of ion channels. On the basis of experimental evidence, both heterotrimer dissociation and rearrangement have been postulated as crucial steps of Gi/o protein activation and signal transduction. We have now investigated the process of Gi/o activation in living cells directly by two-photon polarization microscopy and indirectly by observations of G protein-coupled receptor kinase-derived polypeptides. Our observations of existing fluorescently labeled and non-modified Gi/o constructs indicate that the molecular mechanism of Gi/o activation is affected by the presence and localization of the fluorescent label. All investigated non-labeled, non-modified Gi/o complexes dissociate extensively upon activation. The dissociated subunits can activate downstream effectors and are thus likely to be the major activated Gi/o form. Constructs of Gi/o subunits fluorescently labeled at the N terminus (GAP43-CFP-Gi/o) seem to faithfully reproduce the behavior of the non-modified Gi/o subunits. Gi constructs labeled within the helical domain (Gi-L91-YFP) largely do not dissociate upon activation, yet still activate downstream effectors, suggesting that the dissociation seen in non-modified Gi/o proteins is not required for downstream signaling. Our results appear to reconcile disparate published data and settle a long running dispute.	[Bondar, Alexey; Lazar, Josef] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Bondar, Alexey; Lazar, Josef] Acad Sci Czech Republ, Inst Nanobiol, Nove Hrady 37333, Czech Republic; [Bondar, Alexey; Lazar, Josef] Acad Sci Czech Republ, Struct Biol Global Change Res Ctr, Nove Hrady 37333, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Czech Academy of Sciences	Bondar, A (corresponding author), Univ South Bohemia, Zamek 136, Nove Hrady 37333, Czech Republic.	bondar@nh.cas.cz	Lazar, Josef/AAI-7246-2020; Bondar, Alexey/G-9459-2014; Lazar, Josef/H-7487-2014; Lazar, Josef/D-8523-2012	Bondar, Alexey/0000-0002-1980-2930; Lazar, Josef/0000-0002-6285-3995; Lazar, Josef/0000-0002-8579-8589	European Commission [PIRG-GA-2007-209789]; Czech Government [AVOZ60870520]; University of South Bohemia Grant Agency [141/2013/P]; University of South Bohemia fellowship; Industrial Property Office of the Czech Republic;  [P205/13-10799S]	European Commission(European CommissionEuropean Commission Joint Research Centre); Czech Government; University of South Bohemia Grant Agency; University of South Bohemia fellowship; Industrial Property Office of the Czech Republic; 	This work was supported by European Commission FP7 Marie Curie International Reintegration Grant PIRG-GA-2007-209789 "MemSensors" (to J. L.), by Czech Government Institutional Grant AVOZ60870520 (to J. L.), by Grant P205/13-10799S (to J. L.), by University of South Bohemia Grant Agency Grant 141/2013/P (to A. B.), and by a University of South Bohemia fellowship (to A. B.). Patent 302233, covering the method of 2PPM, device and applications, has been awarded by the Industrial Property Office of the Czech Republic (to J. L.). A Patent Cooperation Treaty (PCT) application has been filed (by J. L.). J. L. is a founder and owner of Innovative Bioimaging, LLC.	Azpiazu I, 2006, CELL SIGNAL, V18, P1190, DOI 10.1016/j.cellsig.2005.09.007; Berlin S, 2011, J BIOL CHEM, V286, P33223, DOI 10.1074/jbc.M111.271056; Berlin S, 2010, J BIOL CHEM, V285, P6179, DOI 10.1074/jbc.M109.085944; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Chidiac P, 1999, J BIOL CHEM, V274, P19639, DOI 10.1074/jbc.274.28.19639; Chisari M, 2009, PLOS ONE, V4, pA181, DOI 10.1371/journal.pone.0007797; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Digby GJ, 2008, J PHYSIOL-LONDON, V586, P3325, DOI 10.1113/jphysiol.2008.153965; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; FUNG BKK, 1983, J BIOL CHEM, V258, P495; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Hommers LG, 2010, J BIOL CHEM, V285, P8227, DOI 10.1074/jbc.M109.015388; KATADA T, 1984, J BIOL CHEM, V259, P3578; Lambert NA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125re5; Lazar J, 2011, NAT METHODS, V8, P684, DOI [10.1038/NMETH.1643, 10.1038/nmeth.1643]; Leaney JL, 2002, J BIOL CHEM, V277, P28803, DOI 10.1074/jbc.M204683200; LEVITZKI A, 1988, SCIENCE, V241, P800, DOI 10.1126/science.2841758; Levitzki A, 2002, CHEMBIOCHEM, V3, P815, DOI 10.1002/1439-7633(20020902)3:9<815::AID-CBIC815>3.0.CO;2-E; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Vilardaga JP, 2009, MOL ENDOCRINOL, V23, P590, DOI 10.1210/me.2008-0204; Vorobiov D, 2000, J BIOL CHEM, V275, P4166, DOI 10.1074/jbc.275.6.4166; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; Yuan CJ, 2007, J BIOL CHEM, V282, P19938, DOI 10.1074/jbc.M700396200	34	16	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1271	1281		10.1074/jbc.M113.493643	http://dx.doi.org/10.1074/jbc.M113.493643			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24307173	Green Published, hybrid			2022-12-28	WOS:000332401700007
J	Lee, CF; Lai, HL; Lee, YC; Chien, CL; Chern, Y				Lee, Chien-fei; Lai, Hsin-Lin; Lee, Yi-Chao; Chien, Chen-Li; Chern, Yijuang			The A(2A) Adenosine Receptor Is a Dual Coding Gene A NOVEL MECHANISM OF GENE USAGE AND SIGNAL TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenosine Receptor; AP1 Transcription Factor; Gene Regulation; Hypoxia; Protein Kinase A (PKA); A2A Adenosine Receptor; Alternative Reading Frame; Dual Coding Gene; Overlapping Reading Frame	NERVE GROWTH-FACTOR; OVERLAPPING READING FRAME; NF-KAPPA-B; MESSENGER-RNA; HUNTINGTONS-DISEASE; ALTERNATIVE USAGE; INITIATION CODONS; PC12 CELLS; TRANSLATION; PROTEIN	Background:Adora2a encodes A(2A) adenosine receptor (A(2A)R) and a new protein (uORF5) translated from an out-of-frame AUG. Results: uORF5 exists in tissues where the Adora2a transcript is detected and is up-regulated by A(2A)R activation. uORF5 suppresses AP1-mediated transcription. Conclusion:Adora2a encodes two distinct proteins (A(2A)R and uORF5) in an A(2A)R-dependent manner. Significance: uORF5 may participate in the functions of A(2A)R during pathophysiological conditions. The A(2A) adenosine receptor (A(2A)R) is a G protein-coupled receptor and a major target of caffeine. The A(2A)R gene encodes alternative transcripts that are initiated from at least two independent promoters. The different transcripts of the A(2A)R gene contain the same coding region and 3-untranslated region and different 5-untranslated regions that are highly conserved among species. We report here that in addition to the production of the A(2A)R protein, translation from an upstream, out-of-frame AUG of the rat A(2A)R gene produces a 134-amino acid protein (designated uORF5). An anti-uORF5 antibody recognized a protein of the predicted size of uORF5 in PC12 cells and rat brains. Up-regulation of A(2A)R transcripts by hypoxia led to increased levels of both the A(2A)R and uORF5 proteins. Moreover, stimulation of A(2A)R increased the level of the uORF5 protein via post-transcriptional regulation. Expression of the uORF5 protein suppressed the AP1-mediated transcription promoted by nerve growth factor and modulated the expression of several proteins that were implicated in the MAPK pathway. Taken together, our results show that the rat A(2A)R gene encodes two distinct proteins (A(2A)R and uORF5) in an A(2A)R-dependent manner. Our study reveals a new example of the complexity of the mammalian genome and provides novel insights into the function of A(2A)R.	[Lee, Chien-fei; Chien, Chen-Li; Chern, Yijuang] Natl Yang Ming Univ, Sch Life Sci, Inst Neurosci, Taipei 112, Taiwan; [Lee, Chien-fei; Lai, Hsin-Lin; Lee, Yi-Chao; Chien, Chen-Li; Chern, Yijuang] Acad Sinica, Inst Biomed Sci, Div Neurosci, Taipei 115, Taiwan; [Chern, Yijuang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan; [Lee, Yi-Chao] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 110, Taiwan; [Lee, Yi-Chao] Taipei Med Univ, Ph D Program Neural Regenerat Med, Taipei 110, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Taipei Medical University; Taipei Medical University; Taipei Medical University	Chern, Y (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	bmychern@ibms.sinica.edu.tw	chern, yijuang/S-7013-2018	chern, yijuang/0000-0002-5842-5429; Lee, Yi-Chao/0000-0003-3451-183X	National Science Council [NSC96-2321-B-001-015, NSC97-2321-B-001-012, 100-2320-B-001-0110MY3]; Institute of Biomedical Sciences of Academia Sinica	National Science Council(Ministry of Science and Technology, Taiwan); Institute of Biomedical Sciences of Academia Sinica(Academia Sinica - Taiwan)	This work was supported by National Science Council Grants NSC96-2321-B-001-015, NSC97-2321-B-001-012, and 100-2320-B-001-0110MY3 and the Institute of Biomedical Sciences of Academia Sinica.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BARRELL BG, 1976, NATURE, V264, P34, DOI 10.1038/264034a0; Bergeron D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.472654; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BROWN HJ, 1995, EMBO J, V14, P124, DOI 10.1002/j.1460-2075.1995.tb06982.x; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; Chen WS, 2001, MOL CELL BIOL, V21, P4636, DOI 10.1128/MCB.21.14.4636-4646.2001; Cheng HC, 2002, J BIOL CHEM, V277, P33930, DOI 10.1074/jbc.M201206200; CHERN YJ, 1993, MOL PHARMACOL, V44, P950; Chiang MC, 2009, HUM MOL GENET, V18, P2929, DOI 10.1093/hmg/ddp230; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Chung WY, 2007, PLOS COMPUT BIOL, V3, P855, DOI 10.1371/journal.pcbi.0030091; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Emanuel RL, 1998, ENDOCRINOLOGY, V139, P2831, DOI 10.1210/en.139.6.2831; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fukamachi K, 2002, J BIOL CHEM, V277, P43549, DOI 10.1074/jbc.C200502200; GINTY DD, 1991, J BIOL CHEM, V266, P15325; Grummt M. V. K. M., 2006, THESIS U HEIDELBERG; Harlow E., 1988, ANTIBODIES LAB MANUA, P59; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; HUYNEN MA, 1993, J THEOR BIOL, V165, P251, DOI 10.1006/jtbi.1993.1188; Impellizzeri D, 2011, EUR J PHARMACOL, V668, P305, DOI 10.1016/j.ejphar.2011.06.049; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jagadish N, 2005, BIOCHEM J, V389, P73, DOI 10.1042/BJ20041577; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Kobayashi S, 1999, J BIOL CHEM, V274, P20358, DOI 10.1074/jbc.274.29.20358; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; Koizumi S, 2009, J GASTROENTEROL, V44, P419, DOI 10.1007/s00535-009-0028-8; Konrad FM, 2013, FASEB J, V27, P3524, DOI 10.1096/fj.13-228122; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Kulisevsky J, 2012, EUR NEUROL, V67, P4, DOI 10.1159/000331768; Lambrecht N, 2000, J BIOL CHEM, V275, P4041, DOI 10.1074/jbc.275.6.4041; Lee J, 2002, NUCLEIC ACIDS RES, V30, P5110, DOI 10.1093/nar/gkf664; Lee YC, 1999, J NEUROCHEM, V73, P1790, DOI 10.1046/j.1471-4159.1999.0731790.x; Leibovich SJ, 2002, AM J PATHOL, V160, P2231, DOI 10.1016/S0002-9440(10)61170-4; Liang H, 2006, GENOME RES, V16, P190, DOI 10.1101/gr.4246506; Lukashev D, 2004, J IMMUNOL, V173, P21, DOI 10.4049/jimmunol.173.1.21; McColl SR, 2005, FASEB J, V19, P187, DOI 10.1096/fj.05-4804fje; Moore CC, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-141; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; Noto S, 1998, FEBS LETT, V441, P127, DOI 10.1016/S0014-5793(98)01530-0; Okazaki S, 1998, BIOCHEM BIOPH RES CO, V250, P347, DOI 10.1006/bbrc.1998.9331; OPPENHEIM DS, 1980, GENETICS, V95, P785; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Pinna A, 1997, BRAIN RES, V759, P41, DOI 10.1016/S0006-8993(97)00214-X; Ribrioux S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-122; Satoh S, 1999, EUR J NEUROSCI, V11, P1587, DOI 10.1046/j.1460-9568.1999.00569.x; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; SHAW DC, 1978, NATURE, V272, P510, DOI 10.1038/272510a0; Sun WC, 2010, VET IMMUNOL IMMUNOP, V135, P289, DOI 10.1016/j.vetimm.2009.12.001; Svenningsson P, 1999, PROG NEUROBIOL, V59, P355, DOI 10.1016/S0301-0082(99)00011-8; Tong L, 1996, J NEUROSCI RES, V45, P1, DOI 10.1002/(SICI)1097-4547(19960701)45:1<1::AID-JNR1>3.0.CO;2-I; Vanderperre B, 2011, FASEB J, V25, P2373, DOI 10.1096/fj.10-173815; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; VonLubitz DKJE, 1995, EUR J PHARMACOL, V287, P295, DOI 10.1016/0014-2999(95)00498-X; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; WEAVER DR, 1993, MOL BRAIN RES, V20, P313, DOI 10.1016/0169-328X(93)90058-W; WEAVER DR, 1992, AM J PHYSIOL, V263, pF991, DOI 10.1152/ajprenal.1992.263.6.F991; Xu H, 2010, CELL RES, V20, P445, DOI 10.1038/cr.2010.25	66	21	25	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1257	1270		10.1074/jbc.M113.509059	http://dx.doi.org/10.1074/jbc.M113.509059			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24293369	Green Published, hybrid			2022-12-28	WOS:000332401700006
J	Ramadoss, P; Abraham, BJ; Tsai, L; Zhou, YM; Costa-e-Sousa, RH; Ye, FL; Bilban, M; Zhao, KJ; Hollenberg, AN				Ramadoss, Preeti; Abraham, Brian J.; Tsai, Linus; Zhou, Yiming; Costa-e-Sousa, Ricardo H.; Ye, Felix; Bilban, Martin; Zhao, Keji; Hollenberg, Anthony N.			Novel Mechanism of Positive versus Negative Regulation by Thyroid Hormone Receptor beta 1 (TR beta 1) Identified by Genome-wide Profiling of Binding Sites in Mouse Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Immunoprecipitation (ChIP); Nuclear Receptors; Thyroid Hormone; Transcription Regulation; Transcription Target Genes; ChIP-seq; TRb1; Thyroid Hormone Receptor; gpd2; thrsp	RETINOID-X-RECEPTOR; GENE-EXPRESSION; NUCLEAR RECEPTOR; IN-VIVO; RESPONSE ELEMENT; TRANSCRIPTION FACTOR; ACID; PROTEIN; BIOTINYLATION; ACTIVATION	Background: Examining the TR1 cistrome in mouse liver is critical to understanding thyroid hormone signaling. Results: Novel mechanisms of positive versus negative regulation by biotinylated TR1 were identified. Conclusion: TR1 regulates transcription by changes in relative binding and use of preferred binding motifs. Significance: This study demonstrates that a mechanism other than differential co-regulator recruitment is involved in transcriptional regulation by TR1 Triiodothyronine (T3) regulates key metabolic processes in the liver through the thyroid hormone receptor, TR1. However, the number of known target genes directly regulated by TR1 is limited, and the mechanisms by which positive and especially negative transcriptional regulation occur are not well understood. To characterize the TR1 cistrome in vivo, we expressed a biotinylated TR1 in hypo- and hyperthyroid mouse livers, used ChIP-seq to identify genomic TR1 targets, and correlated these data with gene expression changes. As with other nuclear receptors, the majority of TR1 binding sites were not in proximal promoters but in the gene body of known genes. Remarkably, T3 can dictate changes in TR1 binding, with strong correlation to T3-induced gene expression changes, suggesting that differential TR1 binding regulates transcriptional outcome. Additionally, DR-4 and DR-0 motifs were significantly enriched at binding sites where T3 induced an increase or decrease in TR1 binding, respectively, leading to either positive or negative regulation by T3. Taken together, the results of this study provide new insights into the mechanisms of transcriptional regulation by TR1 in vivo.	[Ramadoss, Preeti; Tsai, Linus; Zhou, Yiming; Costa-e-Sousa, Ricardo H.; Ye, Felix; Hollenberg, Anthony N.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA; [Abraham, Brian J.; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Bilban, Martin] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Bilban, Martin] Med Univ Vienna, Core Facil, Core Facil Genom, A-1090 Vienna, Austria	Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Medical University of Vienna; Medical University of Vienna	Hollenberg, AN (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, 330 Brookline Ave, Boston, MA 02115 USA.	thollenb@bidmc.harvard.edu	Abraham, Brian/C-2230-2019	Abraham, Brian/0000-0001-8085-3027; Bilban, Martin/0000-0001-7043-7142; Tsai, Linus/0000-0002-0134-6949; Costa e Sousa, Ricardo Henrique/0000-0002-0443-6392	National Institutes of Health [DK-091941, DK-056123]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056123, R21DK091941, R56DK056123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-091941 and DK-056123 (to A. N. H.).	ADAN RAH, 1992, J BIOL CHEM, V267, P3771; Alonso M, 2009, ENDOCRINOLOGY, V150, P3927, DOI 10.1210/en.2009-0093; Astapova I, 2013, BBA-GEN SUBJECTS, V1830, P3876, DOI 10.1016/j.bbagen.2012.07.001; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; BERRODIN TJ, 1992, MOL ENDOCRINOL, V6, P1468, DOI 10.1210/me.6.9.1468; BODENNER DL, 1991, J BIOL CHEM, V266, P21666; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; Chatonnet F, 2013, P NATL ACAD SCI USA, V110, pE766, DOI 10.1073/pnas.1210626110; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chong HK, 2010, NUCLEIC ACIDS RES, V38, P6007, DOI 10.1093/nar/gkq397; Costa-e-Sousa RH, 2012, ENDOCRINOLOGY, V153, P5049, DOI 10.1210/en.2012-1504; DARLING DS, 1989, MOL ENDOCRINOL, V3, P1359, DOI 10.1210/mend-3-9-1359; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Forrest D, 2000, THYROID, V10, P41, DOI 10.1089/thy.2000.10.41; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; HOLLENBERG AN, 1995, MOL ENDOCRINOL, V9, P540, DOI 10.1210/me.9.5.540; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAZAR MA, 1991, MOL CELL BIOL, V11, P5005, DOI 10.1128/MCB.11.10.5005; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Machado DS, 2009, P NATL ACAD SCI USA, V106, P9441, DOI 10.1073/pnas.0903227106; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Ortiga-Carvalho TM, 2005, J CLIN INVEST, V115, P2517, DOI 10.1172/JCI24109; Paquette MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-634; PETTY KJ, 1990, J BIOL CHEM, V265, P7395; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramadoss P, 2009, MOL ENDOCRINOL, V23, P827, DOI 10.1210/me.2008-0264; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SAMUELS HH, 1988, J CLIN INVEST, V81, P957, DOI 10.1172/JCI113449; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; SONG C, 1994, P NATL ACAD SCI USA, V91, P10809, DOI 10.1073/pnas.91.23.10809; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Viens A, 2004, ANAL BIOCHEM, V325, P68, DOI 10.1016/j.ab.2003.10.015; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; Weitzel JM, 2003, J MOL ENDOCRINOL, V31, P291, DOI 10.1677/jme.0.0310291; Weitzel JM, 2001, EUR J BIOCHEM, V268, P4095, DOI 10.1046/j.1432-1327.2001.02332.x; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Yuan C, 2012, ENDOCRINOLOGY, V153, P501, DOI 10.1210/en.2011-1325; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; ZILZ ND, 1990, J BIOL CHEM, V265, P8136	57	71	71	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1313	1328		10.1074/jbc.M113.521450	http://dx.doi.org/10.1074/jbc.M113.521450			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24288132	hybrid, Green Published			2022-12-28	WOS:000332401700011
J	You, JS; Lincoln, HC; Kim, CR; Frey, JW; Goodman, CA; Zhong, XP; Hornberger, TA				You, Jae-Sung; Lincoln, Hannah C.; Kim, Chan-Ran; Frey, John W.; Goodman, Craig A.; Zhong, Xiao-Ping; Hornberger, Troy A.			The Role of Diacylglycerol Kinase zeta and Phosphatidic Acid in the Mechanical Activation of Mammalian Target of Rapamycin (mTOR) Signaling and Skeletal Muscle Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mechanotransduction; mTOR; Phosphatidic Acid; Phospholipase D; Skeletal Muscle; Diacylglycerol Kinase; Hypertrophy	PHOSPHOLIPASE-D; PHOSPHOINOSITIDE 3-KINASE; PROTEIN; COMPLEX; PHOSPHORYLATION; LOCALIZATION; DIFFERENTIATION; IDENTIFICATION; RESISTANCE; INHIBITOR	Background: Diacylglycerol kinases (DGKs) synthesize phosphatidic acid (PA), and PA can activate growth-regulatory mTOR signaling. Results: The isoform of DGK is necessary for a mechanically induced increase in PA-mTOR signaling, and overexpression of DGK induces skeletal muscle hypertrophy. Conclusion: PA synthesized by DGK regulates the mechanical activation of mTOR signaling and hypertrophy. Significance: DGK is a potential target for treating muscle atrophy/wasting. The activation of mTOR signaling is essential for mechanically induced changes in skeletal muscle mass, and previous studies have suggested that mechanical stimuli activate mTOR (mammalian target of rapamycin) signaling through a phospholipase D (PLD)-dependent increase in the concentration of phosphatidic acid (PA). Consistent with this conclusion, we obtained evidence which further suggests that mechanical stimuli utilize PA as a direct upstream activator of mTOR signaling. Unexpectedly though, we found that the activation of PLD is not necessary for the mechanically induced increases in PA or mTOR signaling. Motivated by this observation, we performed experiments that were aimed at identifying the enzyme(s) that promotes the increase in PA. These experiments revealed that mechanical stimulation increases the concentration of diacylglycerol (DAG) and the activity of DAG kinases (DGKs) in membranous structures. Furthermore, using knock-out mice, we determined that the isoform of DGK (DGK) is necessary for the mechanically induced increase in PA. We also determined that DGK significantly contributes to the mechanical activation of mTOR signaling, and this is likely driven by an enhanced binding of PA to mTOR. Last, we found that the overexpression of DGK is sufficient to induce muscle fiber hypertrophy through an mTOR-dependent mechanism, and this event requires DGK kinase activity (i.e. the synthesis of PA). Combined, these results indicate that DGK, but not PLD, plays an important role in mechanically induced increases in PA and mTOR signaling. Furthermore, this study suggests that DGK could be a fundamental component of the mechanism(s) through which mechanical stimuli regulate skeletal muscle mass.	[You, Jae-Sung; Hornberger, Troy A.] Univ Wisconsin, Sch Vet Med, Program Cellular & Mol Biol, Madison, WI 53706 USA; [You, Jae-Sung; Lincoln, Hannah C.; Kim, Chan-Ran; Frey, John W.; Goodman, Craig A.; Hornberger, Troy A.] Univ Wisconsin, Dept Comparat Biosci, Sch Vet Med, Madison, WI 53706 USA; [Zhong, Xiao-Ping] Duke Univ, Med Ctr, Div Allergy & Immunol, Dept Pediat, Durham, NC 27710 USA; [Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Duke University; Duke University	Hornberger, TA (corresponding author), Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr, Madison, WI 53706 USA.	thornb1@svm.vetmed.wisc.edu	You, Jae-Sung/ABF-6763-2020; Goodman, Craig/H-8085-2019	You, Jae-Sung/0000-0001-7791-8563; Goodman, Craig/0000-0002-5874-7743; Hornberger, Troy/0000-0002-2349-1899	National Institutes of Health [AR057347]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079088, R01AI076357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR057347 (to T. A. H.).	Abramovici H, 2007, CELL MOTIL CYTOSKEL, V64, P549, DOI 10.1002/cm.20204; Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; Baldanzi G, 2010, CELL DEATH DIFFER, V17, P1059, DOI 10.1038/cdd.2009.210; Ballou LM, 2003, FEBS LETT, V550, P51, DOI 10.1016/S0014-5793(03)00816-0; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; CLELAND PJF, 1989, J BIOL CHEM, V264, P17704; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; ElBawab S, 1996, J LIPID RES, V37, P2098; Evangelisti C, 2006, J CELL PHYSIOL, V209, P370, DOI 10.1002/jcp.20744; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; FOLCH J, 1957, J BIOL CHEM, V226, P497; GOLDBERG AL, 1975, MED SCI SPORT EXER, V7, P185; Goodman CA, 2013, MOL ENDOCRINOL, V27, P1946, DOI 10.1210/me.2013-1194; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; Gorentla BK, 2011, BLOOD, V117, P4022, DOI 10.1182/blood-2010-08-300731; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Hornberger TA, 2006, J CELL BIOCHEM, V97, P1207, DOI 10.1002/jcb.20671; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Hornberger TA, 2011, INT J BIOCHEM CELL B, V43, P1267, DOI 10.1016/j.biocel.2011.05.007; Hurley BF, 2011, SPORTS MED, V41, P289, DOI 10.2165/11585920-000000000-00000; Jaafar R, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-55; Jacobs B. L., 2013, J MUSCLE RES CELL MO, DOI 10.1007/s10974-013-9367-4; Jacobs BL, 2013, J PHYSIOL-LONDON, V591, P4611, DOI 10.1113/jphysiol.2013.256339; Jiang Y, 2000, BIOCHEM PHARMACOL, V59, P763, DOI 10.1016/S0006-2952(99)00395-0; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mendoza GJA, 2001, MOL THER, V3, P565, DOI 10.1006/mthe.2001.0292; Nelson CD, 2007, SCIENCE, V315, P663, DOI 10.1126/science.1134562; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; Rincon E, 2007, MOL CELL PROTEOMICS, V6, P1073, DOI 10.1074/mcp.M700047-MCP200; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sato T, 2013, MOL CELL BIOL, V33, P136, DOI 10.1128/MCB.00869-12; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Thalacker-Mercer A, 2013, PHYSIOL GENOMICS, V45, P499, DOI 10.1152/physiolgenomics.00167.2012; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Yanase Y, 2010, BIOCHEM J, V425, P179, DOI 10.1042/BJ20091122; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; You JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047258; Zhao K, 2012, J LIPID RES, V53, P2102, DOI 10.1194/jlr.M027557; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	56	97	103	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1551	1563		10.1074/jbc.M113.531392	http://dx.doi.org/10.1074/jbc.M113.531392			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302719	hybrid, Green Published			2022-12-28	WOS:000332401700030
J	Kolb, KE; Hein, PP; Landick, R				Kolb, Kellie E.; Hein, Pyae P.; Landick, Robert			Antisense Oligonucleotide-stimulated Transcriptional Pausing Reveals RNA Exit Channel Specificity of RNA Polymerase and Mechanistic Contributions of NusA and RfaH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR NUSA; OPERON LEADER REGION; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; TRIGGER LOOP; THERMODYNAMIC PARAMETERS; ALLOSTERIC CONTROL; STRUCTURAL BASIS; RNA/DNA HYBRID; HAIRPIN	Transcript elongation by bacterial RNA polymerase (RNAP) is thought to be regulated at pause sites by open versus closed positions of the RNAP clamp domain, pause-suppressing regulators like NusG and RfaH that stabilize the closed-clamp RNAP conformation, and pause-enhancing regulators like NusA and exit channel nascent RNA structures that stabilize the open clamp RNAP conformation. However, the mutual effects of these protein and RNA regulators on RNAP conformation are incompletely understood. For example, it is unknown whether NusA directly interacts with exit channel duplexes and whether formation of exit channel duplexes and RfaH binding compete by favoring the open and closed RNAP conformations. We report new insights into these mechanisms using antisense oligonucleotide mimics of a pause RNA hairpin from the leader region of the his biosynthetic operon of enteric bacteria like Escherichia coli. By systematically varying the structure and length of the oligonucleotide mimic, we determined that full pause stabilization requires an RNA-RNA duplex of at least 8 bp or a DNA-RNA duplex of at least 11 bp; RNA-RNA duplexes were more effective than DNA-RNA. NusA stimulation of pausing was optimal with 10-bp RNA-RNA duplexes and was aided by single-stranded RNA upstream of the duplex but was significantly reduced with DNA-RNA duplexes. Our results favor direct NusA stabilization of exit channel duplexes, which consequently affect RNAP clamp conformation. Effects of RfaH, which suppresses oligo-stabilization of pausing, were competitive with antisense oligonucleotide concentration, suggesting that RfaH and exit channel duplexes compete via opposing effects on RNAP clamp conformation.	[Kolb, Kellie E.; Hein, Pyae P.; Landick, Robert] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Landick, Robert] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Landick, R (corresponding author), Univ Wisconsin, Dept Biochem, 1550 Linden Dr, Madison, WI 53706 USA.	landick@biochem.wisc.edu			National Institutes of Health [GM39660]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM39660 (to R. L.).	Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 1998, GENE DEV, V12, P3110, DOI 10.1101/gad.12.19.3110; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Belogurov GA, 2010, MOL MICROBIOL, V76, P286, DOI 10.1111/j.1365-2958.2010.07056.x; Belogurov GA, 2009, EMBO J, V28, P112, DOI 10.1038/emboj.2008.268; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Chan CL, 1997, J MOL BIOL, V268, P37, DOI 10.1006/jmbi.1997.0934; Cisse II, 2012, NAT STRUCT MOL BIOL, V19, P623, DOI 10.1038/nsmb.2294; DOCKBREGEON AC, 1989, J MOL BIOL, V209, P459, DOI 10.1016/0022-2836(89)90010-7; FARNHAM PJ, 1982, CELL, V29, P945, DOI 10.1016/0092-8674(82)90457-3; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Ha KS, 2010, J MOL BIOL, V401, P708, DOI 10.1016/j.jmb.2010.06.036; Hein PP, 2011, BIOCHEMISTRY-US, V50, P7002, DOI 10.1021/bi200437q; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Kireeva M, 2010, BBA-GENE REGUL MECH, V1799, P389, DOI 10.1016/j.bbagrm.2010.01.007; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Kyzer S, 2007, J BIOL CHEM, V282, P19020, DOI 10.1074/jbc.M701483200; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Landick R, 1996, METHOD ENZYMOL, V274, P334; LANDICK R, 1984, J BIOL CHEM, V259, P1550; LANDICK R, 1985, P NATL ACAD SCI USA, V82, P4663, DOI 10.1073/pnas.82.14.4663; Malinen AM, 2012, NUCLEIC ACIDS RES, V40, P7442, DOI 10.1093/nar/gks383; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Mooney RA, 2009, J MOL BIOL, V391, P341, DOI 10.1016/j.jmb.2009.05.078; Nakano S, 1999, NUCLEIC ACIDS RES, V27, P2957, DOI 10.1093/nar/27.14.2957; Nayak D, 2013, MOL CELL, V50, P882, DOI 10.1016/j.molcel.2013.05.015; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Owczarzy R, 2004, BIOCHEMISTRY-US, V43, P3537, DOI 10.1021/bi034621r; Owczarzy R, 2008, BIOCHEMISTRY-US, V47, P5336, DOI 10.1021/bi702363u; Pan T, 1999, P NATL ACAD SCI USA, V96, P9545, DOI 10.1073/pnas.96.17.9545; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Peters JM, 2011, J MOL BIOL, V412, P793, DOI 10.1016/j.jmb.2011.03.036; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Shankar S, 2007, MOL CELL, V27, P914, DOI 10.1016/j.molcel.2007.07.025; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Svetlov V, 2007, NUCLEIC ACIDS RES, V35, P5694, DOI 10.1093/nar/gkm600; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770; Wang DG, 1997, P NATL ACAD SCI USA, V94, P8433, DOI 10.1073/pnas.94.16.8433; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Worbs M, 2001, MOL CELL, V7, P1177, DOI 10.1016/S1097-2765(01)00262-3; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yakhnin AV, 2008, P NATL ACAD SCI USA, V105, P16131, DOI 10.1073/pnas.0808842105; Yang XA, 2010, RNA BIOL, V7, P272, DOI 10.4161/rna.7.3.12021; Yang X, 2009, EMBO REP, V10, P997, DOI 10.1038/embor.2009.155; Zhang JW, 2010, NAT STRUCT MOL BIOL, V17, P99, DOI 10.1038/nsmb.1732; Zhang Jinwei, 2009, P206, DOI 10.1039/9781847559982-00206	56	39	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1151	1163		10.1074/jbc.M113.521393	http://dx.doi.org/10.1074/jbc.M113.521393			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275665	Green Published, hybrid			2022-12-28	WOS:000330541200046
J	Mitsunobu, H; Zhu, B; Lee, SJ; Tabor, S; Richardson, CC				Mitsunobu, Hitoshi; Zhu, Bin; Lee, Seung-Joo; Tabor, Stanley; Richardson, Charles C.			Flap Endonuclease Activity of Gene 6 Exonuclease of Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; DNA Damage; DNA Repair; DNA Replication; DNA-Protein Interaction; RNA Processing; Bacteriophage T7; Gene 6 Exonuclease; Okazaki Fragment; Flap Endonuclease	SINGLE-STRANDED-DNA; DEOXYRIBONUCLEIC-ACID; ESCHERICHIA-COLI; BINDING-PROTEIN; STRUCTURAL BASIS; DISPLACEMENT SYNTHESIS; SUBSTRATE-SPECIFICITY; REPLICATION FORK; 3'-FLAP POCKET; I-TASSER	Background: Flap endonucleases remove 5-single-stranded DNA termini. Results: T7 gene 6 exonuclease is a flap endonuclease that cleaves 5-single-stranded termini one nucleotide into the duplex. Conclusion: The flap endonuclease activity catalyzes the removal 5-single-stranded tails arising from duplex DNA. Significance: The specificity of gene 6 protein identifies it as a flap endonuclease that can remove unusual structures of recombination and replication. Flap endonucleases remove flap structures generated during DNA replication. Gene 6 protein of bacteriophage T7 is a 5-3-exonuclease specific for dsDNA. Here we show that gene 6 protein also possesses a structure-specific endonuclease activity similar to known flap endonucleases. The flap endonuclease activity is less active relative to its exonuclease activity. The major cleavage by the endonuclease activity occurs at a position one nucleotide into the duplex region adjacent to a dsDNA-ssDNA junction. The efficiency of cleavage of the flap decreases with increasing length of the 5-overhang. A 3-single-stranded tail arising from the same end of the duplex as the 5-tail inhibits gene 6 protein flap endonuclease activity. The released flap is not degraded further, but the exonuclease activity then proceeds to hydrolyze the 5-terminal strand of the duplex. T7 gene 2.5 single-stranded DNA-binding protein stimulates the exonuclease and also the endonuclease activity. This stimulation is attributed to a specific interaction between the two proteins because Escherichia coli single-stranded DNA binding protein does not produce this stimulatory effect. The ability of gene 6 protein to remove 5-terminal overhangs as well as to remove nucleotides from the 5-termini enables it to effectively process the 5-termini of Okazaki fragments before they are ligated.	[Mitsunobu, Hitoshi; Zhu, Bin; Lee, Seung-Joo; Tabor, Stanley; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave,C2-219, Boston, MA 02115 USA.	ccr@hms.harvard.edu			National Institutes of Health [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C. C. R.)	Alberts B., 1980, MECH STUDIES DNA REP; Allawi HT, 2003, J MOL BIOL, V328, P537, DOI 10.1016/S0022-2836(03)00351-6; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; CENTER MS, 1970, P NATL ACAD SCI USA, V65, P242, DOI 10.1073/pnas.65.1.242; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; CHASE JW, 1974, J BIOL CHEM, V249, P4553; CHASE JW, 1974, J BIOL CHEM, V249, P4545; Dervan JJ, 2002, P NATL ACAD SCI USA, V99, P8542, DOI 10.1073/pnas.082241699; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; ENGLER MJ, 1983, J BIOL CHEM, V258, P1197; ENGLER MJ, 1983, J BIOL CHEM, V258, P1165; Finger L David, 2012, Subcell Biochem, V62, P301, DOI 10.1007/978-94-007-4572-8_16; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Friedrich-Heineken E, 2004, NUCLEIC ACIDS RES, V32, P2520, DOI 10.1093/nar/gkh576; Garforth SJ, 1997, NUCLEIC ACIDS RES, V25, P3801, DOI 10.1093/nar/25.19.3801; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Ghosh S, 2009, J BIOL CHEM, V284, P30339, DOI 10.1074/jbc.M109.024059; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Grasby JA, 2012, TRENDS BIOCHEM SCI, V37, P74, DOI 10.1016/j.tibs.2011.10.003; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; KERR C, 1972, J BIOL CHEM, V247, P311; KERR C, 1972, J BIOL CHEM, V247, P305; KERR C, 1975, VIROLOGY, V65, P281, DOI 10.1016/0042-6822(75)90031-8; KIM YT, 1993, P NATL ACAD SCI USA, V90, P10173, DOI 10.1073/pnas.90.21.10173; Kong DC, 1997, J BIOL CHEM, V272, P8380; KONG DC, 1994, J BACTERIOL, V176, P5904, DOI 10.1128/jb.176.19.5904-5911.1994; Kornberg A., 1992, DNA REPLICATION, P403; LECHNER RL, 1983, J BIOL CHEM, V258, P1174; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; LEE M, 1974, J VIROL, V14, P1040, DOI 10.1128/JVI.14.5.1040-1048.1974; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; LYAMICHEV V, 1993, SCIENCE, V260, P778, DOI 10.1126/science.7683443; Marintcheva B, 2006, J BIOL CHEM, V281, P25831, DOI 10.1074/jbc.M604601200; MASAMUNE Y, 1971, J BIOL CHEM, V246, P2692; MASKER W, 1992, J BACTERIOL, V174, P155, DOI 10.1128/jb.174.1.155-160.1992; MILLER RC, 1976, J MOL BIOL, V101, P223, DOI 10.1016/0022-2836(76)90374-0; MURANTE RS, 1994, J BIOL CHEM, V269, P1191; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; NAKAI H, 1988, J BIOL CHEM, V263, P9831; Patel N, 2012, NUCLEIC ACIDS RES, V40, P4507, DOI 10.1093/nar/gks051; POWLING A, 1974, MOL GEN GENET, V134, P173, DOI 10.1007/BF00268418; Rezende LF, 2003, J BIOL CHEM, V278, P29098, DOI 10.1074/jbc.M303374200; Rezende LF, 2002, J BIOL CHEM, V277, P50643, DOI 10.1074/jbc.M207359200; ROBERTS L, 1982, BIOCHEMISTRY-US, V21, P6000, DOI 10.1021/bi00266a042; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SADOWSKI PD, 1970, J VIROL, V6, P149, DOI 10.1128/JVI.6.2.149-155.1970; SADOWSKI PD, 1971, J BIOL CHEM, V246, P200; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; SERWER P, 1990, J MOL BIOL, V215, P287, DOI 10.1016/S0022-2836(05)80347-X; SHINOZAKI K, 1978, NUCLEIC ACIDS RES, V5, P4245, DOI 10.1093/nar/5.11.4245; SHINOZAKI K, 1977, MOL GEN GENET, V154, P263, DOI 10.1007/BF00571281; Sobhy MA, 2013, CELL REP, V3, P1785, DOI 10.1016/j.celrep.2013.05.001; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; STUDIER FW, 1969, VIROLOGY, V39, P562, DOI 10.1016/0042-6822(69)90104-4; TABOR S, 1987, J BIOL CHEM, V262, P15330; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; WHITE JH, 1987, J BIOL CHEM, V262, P8851; Williams R, 2007, J MOL BIOL, V371, P34, DOI 10.1016/j.jmb.2007.04.063; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu B, 2012, P NATL ACAD SCI USA, V109, P8050, DOI 10.1073/pnas.1205990109	69	7	7	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5860	5875		10.1074/jbc.M113.538611	http://dx.doi.org/10.1074/jbc.M113.538611			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24394415	Green Published, hybrid			2022-12-28	WOS:000332015500044
J	An, HT; Kim, J; Yoo, S; Ko, J				An, Hyoung-Tae; Kim, Jeonghan; Yoo, Seungmin; Ko, Jesang			Small Leucine Zipper Protein (sLZIP) Negatively Regulates Skeletal Muscle Differentiation via Interaction with alpha-Actinin-4*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Differentiation; Gene Transcription; Muscle; Myogenesis; Transcription Repressor; Actinin-4; sLZIP	CREATINE-KINASE GENE; MYOBLAST DIFFERENTIATION; TRANSCRIPTIONAL ACTIVITY; CELL MOTILITY; EXPRESSION; MEF2; ENHANCER; ALPHA; LOCALIZATION; ASSOCIATION	Background: Cooperation between transcription factors and myogenic regulatory factors is important for skeletal muscle differentiation. Results: sLZIP inhibits expression of muscle-specific genes during myogenesis via disruption of an association between -actinin-4 and MEF2. Conclusion: A novel myogenesis regulatory mechanism of sLZIP is characterized. Significance: sLZIP can be used as a therapeutic target for treatment of muscle diseases. The small leucine zipper protein (sLZIP) plays a role in transcriptional regulation in various types of cells. However, the role of sLZIP in myogenesis is unknown. We identified -actinin-4 (ACTN4) as a sLZIP-binding protein. ACTN4 functions as a transcriptional regulator of myocyte enhancer factor (MEF)2, which plays a critical role in expression of muscle-specific genes during skeletal muscle differentiation. We found that ACTN4 translocates to the nucleus, induces myogenic gene expression, and promotes myotube formation during myogenesis. The myogenic process is controlled by an association between myogenic factors and MEF2 transcription factors. ACTN4 increased expression of muscle-specific proteins via interaction with MEF2. However, sLZIP decreased myogenic gene expression and myotube formation during myogenesis via disruption of the association between ACTN4 and MEF2. ACTN4 increased the promoter activities of myogenic genes, whereas sLZIP abrogated the effect of ACTN4 on transcriptional activation of myogenic genes in myoblasts. The C terminus of sLZIP is required for interaction with the C terminus of ACTN4, based on deletion mutant analysis, and sLZIP plays a role in regulation of MEF2 transactivation via interaction with ACTN4. Our results indicate that sLZIP negatively regulates skeletal muscle differentiation via interaction with ACTN4 and that sLZIP can be used as a therapeutic target molecule for treatment of muscle hypertrophy and associated diseases.	[An, Hyoung-Tae; Kim, Jeonghan; Yoo, Seungmin; Ko, Jesang] Korea Univ, Div Life Sci, Seoul 136701, South Korea	Korea University	Ko, J (corresponding author), Korea Univ, Div Life Sci, 5-1 Anam Dong, Seoul 136701, South Korea.	jesangko@korea.ac.kr		An, Hyoung-Tae/0000-0002-0732-2083	Basic Research Laboratory Program through the National Research Foundation of Korea (NRF) [2009-0087099]; Ministry of Education, Science, and Technology	Basic Research Laboratory Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Research Laboratory Program (2009-0087099) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology.	ALBAGLICURIEL O, 1993, DIFFERENTIATION, V52, P201, DOI 10.1111/j.1432-0436.1993.tb00632.x; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; CassarMalek I, 1996, J BIOL CHEM, V271, P11392, DOI 10.1074/jbc.271.19.11392; CASSARMALEK I, 1994, ONCOGENE, V9, P2197; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Delgado I, 2003, GENOMICS, V82, P109, DOI 10.1016/S0888-7543(03)00104-6; Goffart S, 2006, CURR GENET, V49, P125, DOI 10.1007/s00294-005-0043-0; Haberland M, 2007, MOL CELL BIOL, V27, P518, DOI 10.1128/MCB.01415-06; Han JH, 2000, TRENDS CARDIOVAS MED, V10, P19, DOI 10.1016/S1050-1738(00)00039-6; Hayashida Y, 2005, CANCER RES, V65, P8836, DOI 10.1158/0008-5472.CAN-05-0718; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; HORLICK RA, 1989, MOL CELL BIOL, V9, P2396, DOI 10.1128/MCB.9.6.2396; Jang SY, 2012, CANCER LETT, V314, P185, DOI 10.1016/j.canlet.2011.09.028; JAYNES JB, 1986, MOL CELL BIOL, V6, P2855, DOI 10.1128/MCB.6.8.2855; Kang H, 2011, J BIOL CHEM, V286, P42072, DOI 10.1074/jbc.M111.272302; Kang H, 2009, MOL ENDOCRINOL, V23, P1746, DOI 10.1210/me.2009-0009; Khurana S, 2012, J BIOL CHEM, V287, P35418, DOI 10.1074/jbc.M112.401364; Kumeta M, 2010, J CELL SCI, V123, P1020, DOI 10.1242/jcs.059568; Lin Q, 1998, DEVELOPMENT, V125, P4565; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; MILLAKE DB, 1989, NUCLEIC ACIDS RES, V17, P6725, DOI 10.1093/nar/17.16.6725; MILLER JB, 1990, J CELL BIOL, V111, P1149, DOI 10.1083/jcb.111.3.1149; Passaquin AC, 1998, BRIT J PHARMACOL, V124, P1751, DOI 10.1038/sj.bjp.0702036; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Shao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013921; Sumitani S, 2002, ENDOCRINOLOGY, V143, P820, DOI 10.1210/en.143.3.820; SUZUKI E, 1995, MOL CELL BIOL, V15, P3415; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; TOMBES RM, 1985, CELL, V41, P325, DOI 10.1016/0092-8674(85)90085-6; WALLIMANN T, 1994, MOL CELL BIOCHEM, V133, P193, DOI 10.1007/BF01267955; WALLIMANN T, 1985, J CELL BIOL, V100, P1063, DOI 10.1083/jcb.100.4.1063; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YOUSSOUFIAN H, 1990, AM J HUM GENET, V47, P62	36	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4969	4979		10.1074/jbc.M113.515395	http://dx.doi.org/10.1074/jbc.M113.515395			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24375477	hybrid, Green Published			2022-12-28	WOS:000331607900042
J	Chowdhury, NP; Mowafy, AM; Demmer, JK; Upadhyay, V; Koelzer, S; Jayamani, E; Kahnt, J; Hornung, M; Demmer, U; Ermler, U; Buckel, W				Chowdhury, Nilanjan Pal; Mowafy, Amr M.; Demmer, Julius K.; Upadhyay, Vikrant; Koelzer, Sebastian; Jayamani, Elamparithi; Kahnt, Joerg; Hornung, Marco; Demmer, Ulrike; Ermler, Ulrich; Buckel, Wolfgang			Studies on the Mechanism of Electron Bifurcation Catalyzed by Electron Transferring Flavoprotein ( Etf) and Butyryl- CoA Dehydrogenase ( Bcd) of Acidaminococcus fermentans*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transfer Complex; Coenzyme A; Crystal Structure; Electron Transfer; Energy Metabolism; Enzyme Mechanisms	IRON-SULFUR PROTEIN; 2-HYDROXYGLUTARYL-COA DEHYDRATASE; 4-HYDROXYBUTYRYL-COA DEHYDRATASE; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; PURIFICATION; FERREDOXIN; NADH; COENZYME; MODEL	Background: Flavin-based electron bifurcation explains the energy metabolism of anaerobic microorganisms. Results: Kinetic, structural, and spectral data revealed a detailed picture of the bifurcation process. Conclusion: NADH reduces -FAD of Etf, which bifurcates one electron to Bcd via -FAD and the other to ferredoxin. Repetition leads to reduction of crotonyl-CoA. Significance: The mechanism can be extended to other bifurcating systems. Electron bifurcation is a fundamental strategy of energy coupling originally discovered in the Q-cycle of many organisms. Recently a flavin-based electron bifurcation has been detected in anaerobes, first in clostridia and later in acetogens and methanogens. It enables anaerobic bacteria and archaea to reduce the low-potential [4Fe-4S] clusters of ferredoxin, which increases the efficiency of the substrate level and electron transport phosphorylations. Here we characterize the bifurcating electron transferring flavoprotein (Etf(Af)) and butyryl-CoA dehydrogenase (Bcd(Af)) of Acidaminococcus fermentans, which couple the exergonic reduction of crotonyl-CoA to butyryl-CoA to the endergonic reduction of ferredoxin both with NADH. Etf(Af) contains one FAD (-FAD) in subunit and a second FAD (-FAD) in subunit . The distance between the two isoalloxazine rings is 18 . The Etf(Af)-NAD(+) complex structure revealed -FAD as acceptor of the hydride of NADH. The formed -FADH(-) is considered as the bifurcating electron donor. As a result of a domain movement, -FAD is able to approach -FADH(-) by about 4 and to take up one electron yielding a stable anionic semiquinone, -FAD(?), which donates this electron further to Dh-FAD of Bcd(Af) after a second domain movement. The remaining non-stabilized neutral semiquinone, -FADH(center dot), immediately reduces ferredoxin. Repetition of this process affords a second reduced ferredoxin and Dh-FADH(-) that converts crotonyl-CoA to butyryl-CoA.	[Chowdhury, Nilanjan Pal; Mowafy, Amr M.; Koelzer, Sebastian; Jayamani, Elamparithi; Hornung, Marco; Buckel, Wolfgang] Univ Marburg, Fachbereich Biol, Lab Mikrobiol, D-35032 Marburg, Germany; [Chowdhury, Nilanjan Pal; Mowafy, Amr M.; Koelzer, Sebastian; Jayamani, Elamparithi; Hornung, Marco; Buckel, Wolfgang] Univ Marburg, SYNMIKRO, D-35032 Marburg, Germany; [Chowdhury, Nilanjan Pal; Mowafy, Amr M.; Demmer, Julius K.; Jayamani, Elamparithi; Kahnt, Joerg; Hornung, Marco; Buckel, Wolfgang] Max Planck Inst Terr Mikrobiol, D-35043 Marburg, Germany; [Mowafy, Amr M.] Mansoura Univ, Fac Sci, Mansoura 35516, Egypt; [Demmer, Julius K.; Upadhyay, Vikrant; Demmer, Ulrike; Ermler, Ulrich] Max Planck Inst Biophys, D-60438 Frankfurt, Germany	Philipps University Marburg; Philipps University Marburg; Max Planck Society; Egyptian Knowledge Bank (EKB); Mansoura University; Max Planck Society	Buckel, W (corresponding author), Univ Marburg, Fachbereich Biol, Lab Mikrobiol, D-35032 Marburg, Germany.	buckel@staff.uni-marburg.de	Mowafy, Amr M./AAN-8736-2020; Chowdhury, Nilanjan Pal/AAE-5125-2021	Mowafy, Amr/0000-0001-7949-2316; Demmer, Julius K./0000-0002-5232-3069; Pal Chowdhury, Nilanjan/0000-0002-7645-3706	Max-Planck Society; German Research Foundation (DFG); SYNMIKRO of the Philipps-Universitat Marburg	Max-Planck Society(Max Planck Society); German Research Foundation (DFG)(German Research Foundation (DFG)); SYNMIKRO of the Philipps-Universitat Marburg	This work was supported by grants from the Max-Planck Society, the German Research Foundation (DFG), and SYNMIKRO of the Philipps-Universitat Marburg.	Aboulnaga EH, 2013, J BACTERIOL, V195, P3704, DOI 10.1128/JB.00321-13; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Bertsch J, 2013, J BIOL CHEM, V288, P11304, DOI 10.1074/jbc.M112.444919; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Boiangiu CD, 2005, J MOL MICROB BIOTECH, V10, P105, DOI 10.1159/000091558; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCKEL W, 1986, METHOD ENZYMOL, V125, P547; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Chang YJ, 2010, STAND GENOMIC SCI, V3, P1, DOI 10.4056/sigs.1002553; Cinkaya I, 1997, BIOL CHEM, V378, P843, DOI 10.1515/bchm.1997.378.8.843; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DJORDJEVIC S, 1995, BIOCHEMISTRY-US, V34, P2163, DOI 10.1021/bi00007a009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGEL PC, 1971, BIOCHEM J, V125, P879, DOI 10.1042/bj1250879; Hans M, 2002, BIOCHEMISTRY-US, V41, P5873, DOI 10.1021/bi020033m; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Herrmann T. G. E, 2008, THESIS PHILIPPS U MA; Hetzel M, 2003, EUR J BIOCHEM, V270, P902, DOI 10.1046/j.1432-1033.2003.03450.x; Imkamp F, 2007, J BACTERIOL, V189, P8145, DOI 10.1128/JB.01017-07; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kolzer S., 2008, THESIS PHILIPPS U MA; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; Leys D, 2003, NAT STRUCT BIOL, V10, P219, DOI 10.1038/nsb894; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; MAYHEW SG, 1969, J BIOL CHEM, V244, P794; MITCHELL P, 1975, FEBS LETT, V59, P137, DOI 10.1016/0014-5793(75)80359-0; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Muh U, 1996, BIOCHEMISTRY-US, V35, P11710, DOI 10.1021/bi9601363; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURTHY HMK, 1988, J BIOL CHEM, V263, P18430; NAKOS G, 1971, BIOCHIM BIOPHYS ACTA, V227, P576, DOI 10.1016/0005-2744(71)90008-8; Naser U, 2005, BIOORG CHEM, V33, P53, DOI 10.1016/j.bioorg.2004.09.001; Parthasarathy A, 2011, BIOCHEMISTRY-US, V50, P3540, DOI 10.1021/bi1020056; Roberts DL, 1999, BIOCHEMISTRY-US, V38, P1977, DOI 10.1021/bi9820917; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Sato K, 2003, J BIOCHEM, V134, P719, DOI 10.1093/jb/mvg199; Sato K, 2013, J BIOCHEM, V153, P565, DOI 10.1093/jb/mvt026; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sousa FL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0088; Thamer W, 2003, ARCH MICROBIOL, V179, P197, DOI 10.1007/s00203-003-0517-8; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Toogood HS, 2005, J BIOL CHEM, V280, P30361, DOI 10.1074/jbc.M505562200; Wang SN, 2013, APPL ENVIRON MICROB, V79, P6176, DOI 10.1128/AEM.02015-13; WHITFIELD CD, 1974, J BIOL CHEM, V249, P2801; WILLIAMSON G, 1982, J BIOL CHEM, V257, P4314; WOHLFARTH G, 1985, ARCH MICROBIOL, V142, P128, DOI 10.1007/BF00447055; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104; ZIEGENHORN J, 1976, CLIN CHEM, V22, P151	54	78	79	3	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5145	5157		10.1074/jbc.M113.521013	http://dx.doi.org/10.1074/jbc.M113.521013			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24379410	Green Published, hybrid			2022-12-28	WOS:000331607900057
J	Israel, BA; Kodali, VK; Thorpe, C				Israel, Benjamin A.; Kodali, Vamsi K.; Thorpe, Colin			Going through the Barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Disulfide; Enzyme Mechanisms; Oxidase; Oxidation-Reduction; Protein Folding; Redox; Sulfhydryl; QSOX; Quiescin Sulfhydryl Oxidase	QUIESCIN-SULFHYDRYL OXIDASE; DISULFIDE BOND FORMATION; ENDOPLASMIC-RETICULUM; REDOX PROPERTIES; EGG-WHITE; LIVER-REGENERATION; HUMAN PROTEIN; CXXC-MOTIF; FLAVIN; DSBA	Background: QSOX enzymes are medically important catalysts of disulfide bond generation. Results: Mechanistic studies of the three redox centers in QSOX revealed an unexpected thermodynamic mismatch in the reaction coordinate. Conclusion: QSOX circumvents this thermodynamic barrier using a mixed disulfide intermediate that links distal redox centers. Significance: The strategy of coupling disulfide exchanges appears to be exploited by other enzymes of oxidative protein folding. The quiescin sulfhydryl oxidase (QSOX) family of enzymes generates disulfide bonds in peptides and proteins with the reduction of oxygen to hydrogen peroxide. Determination of the potentials of the redox centers in Trypanosoma brucei QSOX provides a context for understanding catalysis by this facile oxidant of protein thiols. The CXXC motif of the thioredoxin domain is comparatively oxidizing (E-0 of -144 mV), consistent with an ability to transfer disulfide bonds to a broad range of thiol substrates. In contrast, the proximal CXXC disulfide in the ERV (essential for respiration and vegetative growth) domain of TbQSOX is strongly reducing (E-0 of -273 mV), representing a major apparent thermodynamic barrier to overall catalysis. Reduction of the oxidizing FAD cofactor (E-0 of -153 mV) is followed by the strongly favorable reduction of molecular oxygen. The role of a mixed disulfide intermediate between thioredoxin and ERV domains was highlighted by rapid reaction studies in which the wild-type CGAC motif in the thioredoxin domain of TbQSOX was replaced by the more oxidizing CPHC or more reducing CGPC sequence. Mixed disulfide bond formation is accompanied by the generation of a charge transfer complex with the flavin cofactor. This provides thermodynamic coupling among the three redox centers of QSOX and avoids the strongly uphill mismatch between the formal potentials of the thioredoxin and ERV disulfides. This work identifies intriguing mechanistic parallels between the eukaryotic QSOX enzymes and the DsbA/B system catalyzing disulfide bond generation in the bacterial periplasm and suggests that the strategy of linked disulfide exchanges may be exploited in other catalysts of oxidative protein folding.	[Israel, Benjamin A.; Kodali, Vamsi K.; Thorpe, Colin] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA	University of Delaware	Thorpe, C (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	cthorpe@udel.edu	Kodali, Vamsi/A-8530-2010	Kodali, Vamsi/0000-0001-8941-9761	National Institutes of Health [GM26643, 1-T32-GM08550]; United States Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008550, R01GM026643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM26643 (to C. T.) and 1-T32-GM08550, a United States Public Health Service training grant (to B. A. I.).	Alon A, 2012, NATURE, V488, P414, DOI 10.1038/nature11267; Alon A, 2010, FEBS LETT, V584, P1521, DOI 10.1016/j.febslet.2010.03.001; Antwi K, 2009, J PROTEOME RES, V8, P4722, DOI 10.1021/pr900414f; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Benayoun B, 2001, J BIOL CHEM, V276, P13830, DOI 10.1074/jbc.M010933200; Brohawn SG, 2003, BIOCHEMISTRY-US, V42, P11074, DOI 10.1021/bi0301385; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chambers JE, 2010, J BIOL CHEM, V285, P29200, DOI 10.1074/jbc.M110.156596; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Codding JA, 2012, BIOCHEMISTRY-US, V51, P4226, DOI 10.1021/bi300394w; Coppock DL, 2006, ANTIOXID REDOX SIGN, V8, P300, DOI 10.1089/ars.2006.8.300; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; Dmitrenko O, 2008, J SULFUR CHEM, V29, P415, DOI 10.1080/17415990802105739; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; GORELICK RJ, 1986, BIOCHEMISTRY-US, V25, P7092, DOI 10.1021/bi00370a050; Hagiwara T, 1996, THROMB HAEMOSTASIS, V76, P253; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Heckler EJ, 2008, BBA-MOL CELL RES, V1783, P567, DOI 10.1016/j.bbamcr.2007.10.002; Heckler EJ, 2008, BIOCHEMISTRY-US, V47, P4955, DOI 10.1021/bi702522q; Hoober KL, 1999, BIOCHEMISTRY-US, V38, P3211, DOI 10.1021/bi9820816; Hoober KL, 1999, J BIOL CHEM, V274, P31759, DOI 10.1074/jbc.274.45.31759; Hoober KL, 1999, J BIOL CHEM, V274, P22147, DOI 10.1074/jbc.274.32.22147; Hoober KL, 1996, J BIOL CHEM, V271, P30510, DOI 10.1074/jbc.271.48.30510; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Ilani T, 2013, SCIENCE, V341, P74, DOI 10.1126/science.1238279; Inaba K, 2006, P NATL ACAD SCI USA, V103, P287, DOI 10.1073/pnas.0507570103; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Inaba K, 2009, EMBO J, V28, P779, DOI 10.1038/emboj.2009.21; Jaje J, 2007, BIOCHEMISTRY-US, V46, P13031, DOI 10.1021/bi7016975; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Jonda S, 1999, EMBO J, V18, P3271, DOI 10.1093/emboj/18.12.3271; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Katchman BA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3407; Katchman BA, 2011, MOL CANCER RES, V9, P1621, DOI 10.1158/1541-7786.MCR-11-0018; Kodali VK, 2010, ANTIOXID REDOX SIGN, V13, P1217, DOI 10.1089/ars.2010.3098; Kodali VK, 2010, BIOCHEMISTRY-US, V49, P2075, DOI 10.1021/bi902222s; LEES WJ, 1993, J ORG CHEM, V58, P642, DOI 10.1021/jo00055a016; Lewin A, 2008, BIOCHEM J, V414, P81, DOI 10.1042/BJ20080356; Limor-Waisberg K, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-70; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; Mebazaa A, 2012, EUR HEART J, V33, P2317, DOI 10.1093/eurheartj/ehs162; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Ouyang X, 2005, CANCER RES, V65, P6773, DOI 10.1158/0008-5472.CAN-05-1948; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Raje S, 2003, BIOCHEMISTRY-US, V42, P4560, DOI 10.1021/bi030003z; Rancy PC, 2008, BIOCHEMISTRY-US, V47, P12047, DOI 10.1021/bi801604x; Regeimbal J, 2002, J BIOL CHEM, V277, P32706, DOI 10.1074/jbc.M205433200; Rudolf J, 2013, BIOCHEM J, V454, P181, DOI 10.1042/BJ20130360; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; Sevier CS, 2012, ANTIOXID REDOX SIGN, V16, P800, DOI 10.1089/ars.2011.4450; SIEDLER F, 1993, BIOCHEMISTRY-US, V32, P7488, DOI 10.1021/bi00080a021; Soloviev M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057327; Song H, 2009, ONCOGENE, V28, P3307, DOI 10.1038/onc.2009.181; STANKOVICH MT, 1976, BIOCHIM BIOPHYS ACTA, V452, P335, DOI 10.1016/0005-2744(76)90183-2; Tapley TL, 2007, J BIOL CHEM, V282, P10263, DOI 10.1074/jbc.M611541200; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; THORPE C, 1976, J BIOL CHEM, V251, P3553; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; WALSH C, 1978, BIOCHEMISTRY-US, V17, P1942, DOI 10.1021/bi00603a022; Wang WZ, 2007, BIOCHEMISTRY-US, V46, P3246, DOI 10.1021/bi602499t; Williams C H Jr, 1979, Methods Enzymol, V62, P185; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; WOOD PM, 1988, BIOCHEM J, V253, P287, DOI 10.1042/bj2530287; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	74	11	11	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5274	5284		10.1074/jbc.M113.536219	http://dx.doi.org/10.1074/jbc.M113.536219			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24379406	Green Published, hybrid			2022-12-28	WOS:000331607900068
J	Qi, SQ; O'Hayre, M; Gutkind, JS; Hurley, JH				Qi, Shiqian; O'Hayre, Morgan; Gutkind, J. Silvio; Hurley, James H.			Structural and Biochemical Basis for Ubiquitin Ligase Recruitment by Arrestin-related Domain-containing Protein-3 ( ARRDC3)*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Isothermal Titration Calorimetry; Protein Crystallization; Ubiquitin; Ubiquitin Ligase	WW DOMAIN; NEDD4; ENAC; TRAFFICKING; ENDOCYTOSIS; MECHANISMS; AFFINITY; COMPLEX; FAMILY	Background: ARRDC proteins bind ubiquitin ligases and are involved in receptor down-regulation. Results: ARRDC3 recruitment of Nedd4 is explained. Conclusion: The first PPXY motif of ARRDC3 binds to the third WW domain of Nedd4 with high affinity, whereas other domains also contribute. Significance: The structure explains aspects of high affinity recognition. After protracted stimulation, the 2-adrenergic receptor and many other G-protein-coupled receptors are ubiquitinated and down-regulated. Arrestin-related domain-containing protein-3 (ARRDC3) has been proposed to recruit the ubiquitin ligase Nedd4 to the 2-adrenergic receptor. ARRDC3 contains two PPXY motifs that could potentially interact with any of the four WW domains of Nedd4. Here we dissect the interaction determinants. ARRDC3 PPXY-Nedd4 WW dissociation constants vary from unmeasurable to K-d = 3 m for the third WW domain of Nedd4 binding to the first PPXY motif of ARRDC3. Structures of the uncomplexed and PPXY1-bound WW3 domain were determined at 1.1 and 1.7 resolution. The structures revealed conformational changes upon binding and the hydrogen bonding network in exquisite detail. Tight packing of ARRDC3 Val-352, part of a 3(10) helix at the C terminus of PPXY1, is important for high affinity binding to WW3. Although no single WW domain is strictly essential for the binding of Nedd4 and ARRDC3 expressed in HEK293 cells, high affinity binding of full-length ARRDC3 and Nedd4 is driven by the avid interaction of both PPXY motifs with either the WW2-WW3 or WW3-WW4 combinations, with K-d values as low as 300 nm.	[Qi, Shiqian; Hurley, James H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Qi, Shiqian; Hurley, James H.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [O'Hayre, Morgan; Gutkind, J. Silvio] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Hurley, JH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	jimhurley@berkeley.edu	Qi, Shiqian/P-9177-2014; Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482; Qi, Shiqian/0000-0002-7589-8877	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. Martin-Serrano and F. Bouamr for DNA constructs. We thank M. Ragusa for experimental advice. Crystallographic data were collected at the SE Regional Collaborative Access Team 22-ID and 22-BM beamlines at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract W-31-109-Eng-38 and was supported by the United States Department of Energy Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bobby R, 2013, BBA-PROTEINS PROTEOM, V1834, P1632, DOI 10.1016/j.bbapap.2013.04.031; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kanelis V, 2006, STRUCTURE, V14, P543, DOI 10.1016/j.str.2005.11.018; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lott JS, 2002, BIOCHEM J, V361, P481, DOI 10.1042/0264-6021:3610481; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meiyappan M, 2007, J MOL BIOL, V372, P970, DOI 10.1016/j.jmb.2007.06.064; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Patwari P, 2011, CELL METAB, V14, P671, DOI 10.1016/j.cmet.2011.08.011; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Shea FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050557; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x	36	52	54	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4743	4752		10.1074/jbc.M113.527473	http://dx.doi.org/10.1074/jbc.M113.527473			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24379409	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000331607900021
J	Ziegler, AN; Chidambaram, S; Forbes, BE; Wood, TL; Levison, SW				Ziegler, Amber N.; Chidambaram, Shravanthi; Forbes, Briony E.; Wood, Teresa L.; Levison, Steven W.			Insulin- like Growth Factor- II ( IGF- II) and IGF- II Analogs with Enhanced Insulin Receptor- a Binding Affinity Promote Neural Stem Cell Expansion*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Insulin; Neurodevelopment; Receptor Tyrosine Kinase; Stem Cells; Central Nervous System; Insulin Receptor; Self-renewal	CEREBROSPINAL-FLUID; EXPRESSION; PROTEINS; ISOFORM; SITE; DETERMINANTS; MECHANISM; NEURONS; FLOW	Background: IGF-II promotes neural stem cell (NSC) proliferation and self-renewal. Results: IGF-II analogs are useful for elucidating the receptors responsible for NSC expansion. Conclusion: F19A expands NSCs via IR-A. Significance: IGF-II promotes stemness of NSCs via the IR-A and not through activation of either the IGF-1R or the IGF-2R. The objective of this study was to employ genetically engineered IGF-II analogs to establish which receptor(s) mediate the stemness promoting actions of IGF-II on mouse subventricular zone neural precursors. Neural precursors from the subventricular zone were propagated in vitro in culture medium supplemented with IGF-II analogs. Cell growth and identity were analyzed using sphere generation and further analyzed by flow cytometry. F19A, an analog of IGF-II that does not bind the IGF-2R, stimulated an increase in the proportion of neural stem cells (NSCs) while decreasing the proportion of the later stage progenitors at a lower concentration than IGF-II. V43M, which binds to the IGF-2R with high affinity but which has low binding affinity to the IGF-1R and to the A isoform of the insulin receptor (IR-A) failed to promote NSC growth. The positive effects of F19A on NSC growth were unaltered by the addition of a functional blocking antibody to the IGF-1R. Altogether, these data lead to the conclusion that IGF-II promotes stemness of NSCs via the IR-A and not through activation of either the IGF-1R or the IGF-2R.	[Ziegler, Amber N.; Chidambaram, Shravanthi; Wood, Teresa L.; Levison, Steven W.] Rutgers Biomed & Hlth Sci, Dept Neurol & Neurosci, Newark, NJ 07103 USA; [Forbes, Briony E.] Flinders Univ S Australia, Discipline Med Biochem, Ctr Neurosci, Adelaide, SA 5001, Australia	Rutgers State University New Brunswick; Rutgers State University Medical Center; Flinders University South Australia	Levison, SW (corresponding author), Rutgers Biomed & Hlth Sci, Dept Neurol & Neurosci, Canc Ctr H1226, 205 S Orange Ave, Newark, NJ 07103 USA.	steve.levison@Rutgers.edu	Forbes, Briony/R-1838-2019; Levison, Steven W./Q-6903-2019	Levison, Steven W./0000-0002-1264-7309; Chidambaram, Shravanthi/0000-0001-8746-3101; Wood, Teresa/0000-0002-4480-660X; Forbes, Briony/0000-0003-4360-9927	National Institutes of Health [R21 NS076874, F31 NS065607]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076874, F31NS065607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 NS076874 (to S. W. L. and T. L. W.) and F31 NS065607 (to A. N. Z.).	Agis-Balboa RC, 2011, EMBO J, V30, P4071, DOI 10.1038/emboj.2011.293; Alagappan D, 2009, ASN NEURO, V1, DOI 10.1042/AN20090002; Alvino CL, 2009, J BIOL CHEM, V284, P7656, DOI 10.1074/jbc.M808061200; Blum G, 2000, BIOCHEMISTRY-US, V39, P15705, DOI 10.1021/bi001516y; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Brown J, 2009, VITAM HORM, V80, P699, DOI 10.1016/S0083-6729(08)00625-0; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; Brown J, 2009, TRENDS BIOCHEM SCI, V34, P612, DOI 10.1016/j.tibs.2009.07.003; Buono KD, 2012, DEV NEUROSCI-BASEL, V34, P449, DOI 10.1159/000345155; Carrick FE, 2001, J BIOL CHEM, V276, P27120, DOI 10.1074/jbc.M101317200; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; DEMEYTS P, 1994, HORM RES, V42, P152, DOI 10.1159/000184188; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Jung S, 2010, STEM CELLS DEV, V19, P831, DOI 10.1089/scd.2009.0093; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Liang L, 2010, ENDOCRINOLOGY, V151, P741, DOI 10.1210/en.2009-0705; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Morcavallo A, 2012, J BIOL CHEM, V287, P11422, DOI 10.1074/jbc.M111.252478; Morcavallo A, 2011, MOL ENDOCRINOL, V25, P1456, DOI 10.1210/me.2010-0484; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Owen-Lynch PJ, 2003, BRAIN, V126, P623, DOI 10.1093/brain/awg058; Pandini G, 2003, J BIOL CHEM, V278, P42178, DOI 10.1074/jbc.M304980200; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Sacco A, 2009, ENDOCRINOLOGY, V150, P3594, DOI 10.1210/en.2009-0377; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Silverberg GD, 2001, NEUROLOGY, V57, P1763, DOI 10.1212/WNL.57.10.1763; Walter HJ, 1999, ENDOCRINOLOGY, V140, P520, DOI 10.1210/en.140.1.520; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Ziegler AN, 2012, STEM CELLS, V30, P1265, DOI 10.1002/stem.1095	38	34	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4626	4633		10.1074/jbc.M113.537597	http://dx.doi.org/10.1074/jbc.M113.537597			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398690	Green Published, hybrid			2022-12-28	WOS:000331607900010
J	Hyvarinen, S; Uchida, K; Varjosalo, M; Jokela, R; Jokiranta, TS				Hyvarinen, Satu; Uchida, Koji; Varjosalo, Markku; Jokela, Reija; Jokiranta, T. Sakari			Recognition of Malondialdehyde-modified Proteins by the C Terminus of Complement Factor H Is Mediated via the Polyanion Binding Site and Impaired by Mutations Found in Atypical Hemolytic Uremic Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Complement System; Innate Immunity; Oxidative Stress; Pathogenesis; Protein Chemical Modification; CFH; aHUS; Malondialdehyde; Surface Recognition; Thrombotic Microangiopathy	LOW-DENSITY-LIPOPROTEIN; ACETALDEHYDE ADDUCTS; ALTERNATIVE PATHWAY; LIPID-PEROXIDATION; OXIDATIVE STRESS; APOPTOTIC CELLS; MOLECULAR-BASIS; END-PRODUCTS; SIALIC-ACID; C3B	Background: Malondialdehyde (MDA) released during oxidative stress modifies proteins covalently. Results: The C terminus of complement regulator factor H binds negative patches on MDA-modified proteins, and aHUS-related mutations affect the interaction. Conclusion: Defects in factor H binding to MDA-modified surfaces might allow deleterious complement activation on them. Significance: MDA-modifications are potentially a new factor in aHUS pathogenesis. Atypical hemolytic uremic syndrome (aHUS) is a severe thrombotic microangiopathy characterized by uncontrolled complement activation against endothelial and blood cells. Mutations in the C-terminal target recognition domains 19-20 of complement regulator factor H (FH) are strongly associated with aHUS, but the mechanisms triggering disease onset have remained unresolved. Here we report that several aHUS-related mutations alter the binding of FH19-20 to proteins where lysines have reacted with malondialdehyde (MDA). Although FH19-20 did not interact with MDA-modified hexylamine, lysine-containing peptides, or a proteolytically degraded protein, it bound to MDA-modified polylysine. This suggests that FH19-20 recognizes only clustered MDA adducts. Binding of MDA-modified BSA to FH19-20 was ionic by nature, depended on positive residues of FH19-20, and competed with the polyanions heparin and DNA. This could not be explained with the mainly neutral adducts known to form in MDA modification. When positive charges of lysines were eliminated by acetic anhydride instead of MDA, the acetylated BSA started to bind FH19-20. Together, these results indicate that negative charges on the modified proteins dominate the interaction with FH19-20. This is beneficial for the physiological function of FH because by binding to the negative charges of the modified target, FH could prevent excess complement activation initiated by naturally occurring antibodies recognizing MDA epitopes with multiple different structures. We propose that oxidative stress leading to formation of MDA adducts is a common feature for triggers of aHUS and that failure of FH in protecting MDA-modified surfaces from complement activation is involved in the pathogenesis of the disease.	[Hyvarinen, Satu; Jokiranta, T. Sakari] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00290 Helsinki, Finland; [Hyvarinen, Satu; Jokiranta, T. Sakari] Univ Helsinki, Res Programs Unit, FIN-00290 Helsinki, Finland; [Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Varjosalo, Markku] Univ Helsinki, Inst Biotechnol, FIN-00790 Helsinki, Finland; [Jokela, Reija] Aalto Univ, Sch Chem Technol, Dept Chem, Organ Chem Lab, FIN-02150 Espoo, Finland	University of Helsinki; University of Helsinki; Nagoya University; University of Helsinki; Aalto University	Jokiranta, TS (corresponding author), Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, POB 21 Haartmaninkatu 3, Helsinki 00014, Finland.	sakari.jokiranta@helsinki.fi	Varjosalo, Markku/K-6424-2015	Varjosalo, Markku/0000-0002-1340-9732; Uchida, Koji/0000-0003-3894-5299	Sigrid Juselius Foundation; Academy of Finland [128646, 255922, 259793]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	This work was supported by research grants from the Sigrid Juselius Foundation and by Academy of Finland Grants 128646, 255922, and 259793.	Balla J, 2007, ANTIOXID REDOX SIGN, V9, P2119, DOI 10.1089/ars.2007.1787; Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Cheng ZY, 2007, CHEM REV, V107, P748, DOI 10.1021/cr040077w; Clark SJ, 2013, J IMMUNOL, V190, P2049, DOI 10.4049/jimmunol.1201751; Duryee MJ, 2010, FREE RADICAL BIO MED, V49, P1480, DOI 10.1016/j.freeradbiomed.2010.08.001; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FEARON DT, 1978, P NATL ACAD SCI USA, V75, P1971, DOI 10.1073/pnas.75.4.1971; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Frimat M, 2013, BLOOD, V122, P282, DOI 10.1182/blood-2013-03-489245; Giustarini D, 2009, CRIT REV CL LAB SCI, V46, P241, DOI 10.3109/10408360903142326; HABERLAND ME, 1988, SCIENCE, V241, P215, DOI 10.1126/science.2455346; HALVORSON MR, 1993, ALCOHOL, V10, P409, DOI 10.1016/0741-8329(93)90029-N; HECKER M, 1987, ARCH BIOCHEM BIOPHYS, V254, P124, DOI 10.1016/0003-9861(87)90088-9; Ilhan N, 2002, CLIN BIOCHEM, V35, P393, DOI 10.1016/S0009-9120(02)00336-3; Ishii T, 2006, CHEM RES TOXICOL, V19, P122, DOI 10.1021/tx050231p; Ishii T, 2008, BIOCHEM BIOPH RES CO, V371, P28, DOI 10.1016/j.bbrc.2008.03.140; Itakura K, 1996, CHEM PHYS LIPIDS, V84, P75, DOI 10.1016/S0009-3084(96)02624-2; Jareno EJ, 1998, FREE RADICAL BIO MED, V24, P503, DOI 10.1016/S0891-5849(97)00168-8; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jozsi M, 2007, MOL IMMUNOL, V44, P2697, DOI 10.1016/j.molimm.2006.12.001; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kearley ML, 1999, CHEM RES TOXICOL, V12, P100, DOI 10.1021/tx980132u; KOISTINEN V, 1989, COMPLEMENT INFLAMMAT, V6, P270, DOI 10.1159/000463102; Leffler J, 2010, J BIOL CHEM, V285, P3766, DOI 10.1074/jbc.M109.045427; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Loirat C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-60; MAGGI E, 1994, KIDNEY INT, V46, P869, DOI 10.1038/ki.1994.344; Makou E, 2013, BIOCHEMISTRY-US, V52, P3949, DOI 10.1021/bi4003452; MICHALEK MT, 1988, J IMMUNOL, V140, P1581; MICHALEK MT, 1988, J IMMUNOL, V140, P1588; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Morris JM, 1998, BRIT J OBSTET GYNAEC, V105, P1195, DOI 10.1111/j.1471-0528.1998.tb09974.x; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; Parra T, 1998, J LAB CLIN MED, V131, P63, DOI 10.1016/S0022-2143(98)90078-6; Perez-Caballero D, 2001, AM J HUM GENET, V68, P478, DOI 10.1086/318201; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rolla R, 2000, HEPATOLOGY, V31, P878, DOI 10.1053/he.2000.5373; Salis A, 2011, LANGMUIR, V27, P11597, DOI 10.1021/la2024605; SALONEN JT, 1992, LANCET, V339, P883, DOI 10.1016/0140-6736(92)90926-T; Schutt F, 2003, INVEST OPHTH VIS SCI, V44, P3663, DOI 10.1167/iovs.03-0172; Shanmugam N, 2008, DIABETES, V57, P879, DOI 10.2337/db07-1204; Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182; SHECHTER I, 1981, J LIPID RES, V22, P63; Suresh DR, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-61; TABACHNICK M, 1960, J BIOL CHEM, V235, P1051; Thiele Geoffrey M., 2008, V447, P235, DOI 10.1007/978-1-59745-242-7_17; Tuma DJ, 1996, HEPATOLOGY, V23, P872, DOI 10.1002/hep.510230431; Virella G, 2000, CLIN IMMUNOL, V95, P135, DOI 10.1006/clim.2000.4857; Wang CG, 2013, INT IMMUNOL, V25, P575, DOI 10.1093/intimm/dxt022; WANG CY, 1995, KIDNEY INT, V47, P927, DOI 10.1038/ki.1995.138; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Xu DS, 1997, CHEM RES TOXICOL, V10, P978, DOI 10.1021/tx970069t; Yamada S, 2001, J LIPID RES, V42, P1187; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271	59	24	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4295	4306		10.1074/jbc.M113.527416	http://dx.doi.org/10.1074/jbc.M113.527416			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24344133	hybrid, Green Published			2022-12-28	WOS:000331403800040
J	Kahlert, C; Melo, SA; Protopopov, A; Tang, JB; Seth, S; Koch, M; Zhang, JH; Weitz, J; Chin, L; Futreal, A; Kalluri, R				Kahlert, Christoph; Melo, Sonia A.; Protopopov, Alexei; Tang, Jiabin; Seth, Sahil; Koch, Moritz; Zhang, Jianhua; Weitz, Juergen; Chin, Lynda; Futreal, Andrew; Kalluri, Raghu			Identification of Double-stranded Genomic DNA Spanning All Chromosomes with Mutated KRAS and p53 DNA in the Serum Exosomes of Patients with Pancreatic Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromosomes; DNA; Exosomes; p53; Pancreatic Cancer; Serum; KRAS; Double-stranded genomic DNA; Mutations	TUMOR; MICROVESICLES; CELLS; VESICLES; MICROENVIRONMENT; FORM	Exosomes are small vesicles (50-150 nm) of endocytic origin that are released by many different cell types. Exosomes in the tumor microenvironment may play a key role in facilitating cell-cell communication. Exosomes are reported to predominantly contain RNA and proteins. In this study, we investigated whether exosomes from pancreatic cancer cells and serum from patients with pancreatic ductal adenocarcinoma contain genomic DNA. Our results provide evidence that exosomes contain >10-kb fragments of double-stranded genomic DNA. Mutations in KRAS and p53 can be detected using genomic DNA from exosomes derived from pancreatic cancer cell lines and serum from patients with pancreatic cancer. In addition, using whole genome sequencing, we demonstrate that serum exosomes from patients with pancreatic cancer contain genomic DNA spanning all chromosomes. These results indicate that serum-derived exosomes can be used to determine genomic DNA mutations for cancer prediction, treatment, and therapy resistance.	[Kahlert, Christoph; Melo, Sonia A.; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, Houston, TX 77030 USA; [Kahlert, Christoph; Chin, Lynda] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, D-69120 Heidelberg, Germany; [Protopopov, Alexei; Tang, Jiabin; Seth, Sahil; Zhang, Jianhua] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Koch, Moritz; Weitz, Juergen] Tech Univ Dresden, Dept Gen Visceral & Thorac Surg, D-01307 Dresden, Germany; [Chin, Lynda; Futreal, Andrew] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77054 USA	University of Texas System; UTMD Anderson Cancer Center; Ruprecht Karls University Heidelberg; University of Texas System; UTMD Anderson Cancer Center; Technische Universitat Dresden; University of Texas System; UTMD Anderson Cancer Center	Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rkalluri@MDAnderson.org	Seth, Sahil/I-5809-2019; Weitz, Juergen/L-7136-2018; MELO, SONIA/H-8972-2013; Kalluri, Raghu/E-2677-2015	Seth, Sahil/0000-0003-4579-3959; MELO, SONIA/0000-0002-2291-4263; Kalluri, Raghu/0000-0002-2190-547X	Institutional Core Grant for High Resolution Electron Microscopy Facility; NATIONAL CANCER INSTITUTE [R01CA125550, R01CA155370, U01CA151925, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081576, R01DK055001] Funding Source: NIH RePORTER	Institutional Core Grant for High Resolution Electron Microscopy Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Metastasis Research Center at the MD Anderson Cancer Center and Cancer Prevention and Research Institute of Texas were supported by Institutional Core Grant CA16672 for High Resolution Electron Microscopy Facility.	Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Choi DS, 2011, PROTEOMICS, V11, P2745, DOI 10.1002/pmic.201100022; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Kosaka Nobuyoshi, 2013, Frontiers in Genetics, V4, P173, DOI 10.3389/fgene.2013.00173; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Lau C, 2013, J BIOL CHEM, V288, P26888, DOI 10.1074/jbc.M113.452458; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Mouliere F, 2012, EXPERT OPIN BIOL TH, V12, pS209, DOI 10.1517/14712598.2012.688023; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pinzani P, 2010, METHODS, V50, P302, DOI 10.1016/j.ymeth.2010.02.004; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Xi RB, 2011, P NATL ACAD SCI USA, V108, pE1128, DOI 10.1073/pnas.1110574108	23	654	690	4	86	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3869	3875		10.1074/jbc.C113.532267	http://dx.doi.org/10.1074/jbc.C113.532267			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24398677	Green Published, hybrid			2022-12-28	WOS:000331403800004
J	Pasupuleti, V; Du, WN; Gupta, Y; Yeh, IJ; Montano, M; Magi-Galuzzi, C; Welford, SM				Pasupuleti, Vinay; Du, Weinan; Gupta, Yashi; Yeh, I-Ju; Montano, Monica; Magi-Galuzzi, Cristina; Welford, Scott M.			Dysregulated D-dopachrome Tautomerase, a Hypoxia-inducible Factor-dependent Gene, Cooperates with Macrophage Migration Inhibitory Factor in Renal Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Gene Regulation; Hypoxia; Hypoxia-inducible Factor (HIF); Kidney; DDT; MIF; Clear Cell Renal Cell Carcinoma; VHL; von Hippel-Lindau	FACTOR MIF; CANCER CELLS; GROWTH; CARCINOMA; ACTIVATION; EXPRESSION; CYTOKINE; HOMOLOG; SURVIVAL; PATHWAY	Background: DDT is a novel member of the MIF cytokine family with overlapping functions. Results: DDT is a direct HIF target gene that is expressed widely in renal carcinoma and contributes to tumorigenesis. Conclusion: DDT has greater tumor-promoting properties than MIF and may compensate for MIF inhibition. Significance: Efforts to inhibit MIF signaling in cancer need to target DDT as well. Clear cell renal cell carcinomas (ccRCCs) are characterized by biallelic loss of the von Hippel-Lindau tumor suppressor and subsequent constitutive activation of the hypoxia-inducible factors, whose transcriptional programs dictate major phenotypic attributes of kidney tumors. We recently described a role for the macrophage migration inhibitory factor (MIF) in ccRCC as an autocrine-signaling molecule with elevated expression in tumor tissues and in the circulation of patients that has potent tumor cell survival effects. MIF is a pleiotropic cytokine implicated in a variety of diseases and cancers and is the target of both small molecule and antibody-based therapies currently in clinical trials. Recent work by others has described D-dopachrome tautomerase (DDT) as a functional homologue of MIF with a similar genomic structure and expression patterns. Thus, we sought to determine a role for DDT in renal cancer. We find that DDT expression mirrors MIF expression in ccRCC tumor sections with high correlation and that, mechanistically, DDT is a novel hypoxia-inducible gene and direct target of HIF1 and HIF2. Functionally, DDT and MIF demonstrate a significant overlap in controlling cell survival, tumor formation, and tumor and endothelial cell migration. However, DDT inhibition consistently displayed more severe effects on most phenotypes. Accordingly, although dual inhibition of DDT and MIF demonstrated additive effects in vitro, DDT plays a dominant role in tumor growth in vivo. Together, our findings identify DDT as a functionally redundant but more potent cytokine to MIF in cancer and suggest that current attempts to inhibit MIF signaling may fail because of DDT compensation.	[Pasupuleti, Vinay; Du, Weinan; Gupta, Yashi; Welford, Scott M.] Case Western Reserve Univ, Dept Radiat Oncol, Sch Med, Cleveland, OH 44106 USA; [Gupta, Yashi] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA; [Yeh, I-Ju; Montano, Monica] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Magi-Galuzzi, Cristina] Cleveland Clin Fdn, Dept Anat Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Welford, SM (corresponding author), Case Western Reserve Univ, Dept Radiat Oncol, Sch Med, BRB325,10900 Euclid Ave, Cleveland, OH 44106 USA.	scott.welford@case.edu	Pasupuleti, Vinay/G-1316-2013	Welford, Scott/0000-0002-9579-4223	American Cancer Society [121762-RSG-12-097-01-CCG]; Concern Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Concern Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by American Cancer Society Grant 121762-RSG-12-097-01-CCG) and by a grant from the Concern Foundation for Cancer Research.	ACS Cancer Facts and Figures, 2012, ACS CANC FACTS FIG; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; Baron N, 2011, J NEUROSCI RES, V89, P711, DOI 10.1002/jnr.22595; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Brock SE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378299; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Coleman AM, 2008, J IMMUNOL, V181, P2330, DOI 10.4049/jimmunol.181.4.2330; Dessein AF, 2010, CANCER RES, V70, P4644, DOI 10.1158/0008-5472.CAN-09-3828; Drabkin HA, 2012, CURR OPIN PHARMACOL, V12, P742, DOI 10.1016/j.coph.2012.08.002; Du W, 2013, ONCOGENE, V32, P1469, DOI 10.1038/onc.2012.143; ERICSSON JL, 1966, VIRCHOWS ARCH A, V341, P204, DOI 10.1007/BF00961071; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Hussain F, 2013, MOL CANCER THER, V12, P1223, DOI 10.1158/1535-7163.MCT-12-0988; Jorgensen WL, 2010, BIOORG MED CHEM LETT, V20, P7033, DOI 10.1016/j.bmcl.2010.09.118; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kerschbaumer RJ, 2012, J BIOL CHEM, V287, P7446, DOI 10.1074/jbc.M111.329664; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Lisy K, 2008, CELL DEATH DIFFER, V15, P642, DOI 10.1038/sj.cdd.4402315; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Meyer-Siegler KL, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-34; Najjar YG, 2012, THER ADV MED ONCOL, V4, P183, DOI 10.1177/1758834012443725; Nguyen MT, 2003, J IMMUNOL, V170, P3337, DOI 10.4049/jimmunol.170.6.3337; Patiar S, 2006, ENDOCR-RELAT CANCER, V13, pS61, DOI 10.1677/erc.1.01290; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Xin D, 2010, MOL CANCER RES, V8, P1601, DOI 10.1158/1541-7786.MCR-10-0101	39	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3713	3723		10.1074/jbc.M113.500694	http://dx.doi.org/10.1074/jbc.M113.500694			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24356968	Green Published, hybrid			2022-12-28	WOS:000331368700052
J	Kelleher, ZT; Sha, YG; Foster, MW; Foster, WM; Forrester, MT; Marshall, HE				Kelleher, Zachary T.; Sha, Yonggang; Foster, Matthew W.; Foster, W. Michael; Forrester, Michael T.; Marshall, Harvey E.			Thioredoxin-mediated Denitrosylation Regulates Cytokine-induced Nuclear Factor kappa B (NF-kappa B) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lung Injury; NF-B; Nitric Oxide; S-nitrosylation; Thioredoxin	S-NITROSYLATION; INTERACTING PROTEIN; NOS2 REGULATION; IDENTIFICATION; INFLAMMATION; REDUCTION; CYSTEINE; STRESS; LUNG	Background: S-nitrosylation inhibits mediators of the immune response including the transcription factor NF-B (p50/p65). Results: Exogenous and endogenous inhibitors of thioredoxin prevent p65 denitrosylation and downstream activation of NF-B. Conclusion: Thioredoxin activates inflammatory signaling through targeted denitrosylation of NF-B. Significance: Mechanisms that augment protein S-nitrosylation can be utilized to suppress the immune response. S-nitrosylation of nuclear factor B (NF-B) on the p65 subunit of the p50/p65 heterodimer inhibits NF-B DNA binding activity. We have recently shown that p65 is constitutively S-nitrosylated in the lung and that LPS-induced injury elicits a decrease in SNO-p65 levels concomitant with NF-B activation in the respiratory epithelium and initiation of the inflammatory response. Here, we demonstrate that TNF-mediated activation of NF-B in the respiratory epithelium similarly induces p65 denitrosylation. This process is mediated by the denitrosylase thioredoxin (Trx), which becomes activated upon cytokine-induced degradation of thioredoxin-interacting protein (Txnip). Similarly, inhibition of Trx activity in the lung attenuates LPS-induced SNO-p65 denitrosylation, NF-B activation, and airway inflammation, supporting a pathophysiological role for this mechanism in lung injury. These data thus link stimulus-coupled activation of NF-B to a specific, protein-targeted denitrosylation mechanism and further highlight the importance of S-nitrosylation in the regulation of the immune response.	[Kelleher, Zachary T.; Sha, Yonggang; Foster, Matthew W.; Foster, W. Michael; Marshall, Harvey E.] Duke Univ Med Ctr, Dept Med, Div Pulm Allergy & Crit Care Med, Durham, NC 27710 USA; [Forrester, Michael T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Duke University; Harvard University; Massachusetts General Hospital	Marshall, HE (corresponding author), Duke Univ Med Ctr, Rm 201,MSRB,Box 2613, Durham, NC 27710 USA.	harvey.marshall@dm.duke.edu			National Institutes of Health [HL106121, HL 081672, HL092994]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106121, R01HL092994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL106121 (to M. W. F. and H. E. M.), HL 081672 (to W. M. F.), and HL092994 (H. E. M.).	Ando K, 2008, NUCLEIC ACIDS RES, V36, P4327, DOI 10.1093/nar/gkn416; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2010, BIOCHEMISTRY-US, V49, P6963, DOI 10.1021/bi100619k; Forrester MT, 2009, J BIOL CHEM, V284, P36160, DOI 10.1074/jbc.M109.057729; Harper R, 2001, AM J RESP CELL MOL, V25, P178, DOI 10.1165/ajrcmb.25.2.4471; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Hollingsworth JW, 2007, AM J RESP CELL MOL, V37, P248, DOI 10.1165/rcmb.2006-0363OC; Into T, 2008, MOL CELL BIOL, V28, P1338, DOI 10.1128/MCB.01412-07; Ito T, 2011, J BIOL CHEM, V286, P11179, DOI 10.1074/jbc.M110.201780; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kelleher ZT, 2007, J BIOL CHEM, V282, P30667, DOI 10.1074/jbc.M705929200; Kelleher ZT, 2011, AM J PHYSIOL-LUNG C, V301, pL327, DOI 10.1152/ajplung.00463.2010; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Kwon HJ, 2010, J IMMUNOL, V185, P3980, DOI 10.4049/jimmunol.1000990; Marshall HE, 2009, AM J RESP CRIT CARE, V180, P11, DOI 10.1164/rccm.200807-1186OC; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; Nishida M, 2011, P NATL ACAD SCI USA, V108, P6662, DOI 10.1073/pnas.1017640108; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nishizawa K, 2011, CARCINOGENESIS, V32, P1459, DOI 10.1093/carcin/bgr137; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Yoshihara E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1127; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321	26	58	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					3066	3072		10.1074/jbc.M113.503938	http://dx.doi.org/10.1074/jbc.M113.503938			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338024	Green Published, hybrid			2022-12-28	WOS:000333403000052
J	Klier, M; Andes, FT; Deitmer, JW; Becker, HM				Klier, Michael; Andes, Fabian T.; Deitmer, Joachim W.; Becker, Holger M.			Intracellular and Extracellular Carbonic Anhydrases Cooperate Non-enzymatically to Enhance Activity of Monocarboxylate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ion-sensitive Electrodes; Lactic Acid; pH Regulation; Protein Complexes; Protein Expression; Proton-collecting Antenna; Transport Metabolon; Xenopus Oocytes	CENTRAL-NERVOUS-SYSTEM; XENOPUS-LAEVIS OOCYTES; LACTATE TRANSPORT; ENERGY-METABOLISM; O-18 EXCHANGE; ADULT BRAIN; II BINDS; CELLS; IV; BICARBONATE	Background: Monocarboxylate transporters (MCTs) mediate the shuttling of high-energy metabolites between different cells. Results: Transport activity of MCTs is augmented by intracellular and extracellular carbonic anhydrases (CAs). Conclusion: Intracellular and extracellular CAs can work in concert to ensure rapid shuttling of metabolites across the cell membrane. Significance: CAs play a pivotal role as regulators of metabolite transport in different tissues. Proton-coupled monocarboxylate transporters (MCTs) are carriers of high-energy metabolites such as lactate, pyruvate, and ketone bodies and are expressed in most tissues. It has previously been shown that transport activity of MCT1 and MCT4 is enhanced by the cytosolic carbonic anhydrase II (CAII) independent of its catalytic activity. We have now studied the influence of the extracellular, membrane-bound CAIV on transport activity of MCT1/4, heterologously expressed in Xenopus oocytes. Coexpression of CAIV with MCT1 and MCT4 resulted in a significant increase in MCT transport activity, even in the nominal absence of CO2/HCO<sub arrange="stack">3<sup arrange="stack">-. CAIV-mediated augmentation of MCT activity was independent of the CAIV catalytic function, since application of the CA-inhibitor ethoxyzolamide or coexpression of the catalytically inactive mutant CAIV-V165Y did not suppress CAIV-mediated augmentation of MCT transport activity. The interaction required CAIV at the extracellular surface, since injection of CAIV protein into the oocyte cytosol did not augment MCT transport function. The effects of cytosolic CAII (injected as protein) and extracellular CAIV (expressed) on MCT transport activity, were additive. Our results suggest that intra- and extracellular carbonic anhydrases can work in concert to ensure rapid shuttling of metabolites across the cell membrane.	[Klier, Michael; Deitmer, Joachim W.] Univ Kaiserslautern, Dept Biol, Div Gen Zool, D-67653 Kaiserslautern, Germany; [Klier, Michael; Andes, Fabian T.; Becker, Holger M.] Univ Kaiserslautern, Dept Biol, Div Zool Membrane Transport, D-67653 Kaiserslautern, Germany	University of Kaiserslautern; University of Kaiserslautern	Becker, HM (corresponding author), Univ Kaiserslautern, Dept Biol, Div Zool Membrane Transport, POB 3049, D-67653 Kaiserslautern, Germany.	h.becker@biologie.uni-kl.de	Becker, Holger/AAB-4322-2020		Deutsche Forschungsgemeinschaft through the Graduate Research School [GRK 830, DE 231/24-1, DE 231/24-2]; Landesschwerpunkt Membrantransport; Stiftung Rheinland-Pfalz fur Innovation [961-386261/957]	Deutsche Forschungsgemeinschaft through the Graduate Research School(German Research Foundation (DFG)); Landesschwerpunkt Membrantransport; Stiftung Rheinland-Pfalz fur Innovation	The work was funded by the Deutsche Forschungsgemeinschaft (to M. K.) through the Graduate Research School (GRK 830), and (to J. W. D.) (DE 231/24-1,2), by the Landesschwerpunkt Membrantransport (to H. M. B. and J. W. D.), and the Stiftung Rheinland-Pfalz fur Innovation (to H. M. B.) (961-386261/957).	Almquist J, 2010, J COMPUT SCI SYST BI, V3, P107, DOI DOI 10.4172/JCSB.1000066; Alvarez BV, 2003, BIOCHEMISTRY-US, V42, P12321, DOI 10.1021/bi0353124; Becker HM, 2004, BIOPHYS J, V86, P235, DOI 10.1016/S0006-3495(04)74099-0; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; Becker HM, 2007, J BIOL CHEM, V282, P13508, DOI 10.1074/jbc.M700066200; Becker HM, 2014, SUBCELL BIOCHEM, V75, P105, DOI 10.1007/978-94-007-7359-2_7; Becker HM, 2011, P NATL ACAD SCI USA, V108, P3071, DOI 10.1073/pnas.1014293108; Becker HM, 2010, J MEMBRANE BIOL, V234, P125, DOI 10.1007/s00232-010-9240-y; Bergersen L, 2002, NEUROCHEM RES, V27, P89, DOI 10.1023/A:1014806723147; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Deitmer JW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00291; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; GHANDOUR MS, 1981, J NEUROCHEM, V36, P195; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hassan MI, 2013, BIOORGAN MED CHEM, V21, P1570, DOI 10.1016/j.bmc.2012.04.044; Johnson D. E., 2009, DRUG DESIGN ZINC ENZ; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Klier M, 2011, J BIOL CHEM, V286, P27781, DOI 10.1074/jbc.M111.255331; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; Li XJ, 2006, BIOCHEMISTRY-US, V45, P2414, DOI 10.1021/bi051132d; MAGISTRETTI PJ, 1993, DEV NEUROSCI-BASEL, V15, P306, DOI 10.1159/000111349; MAREN TH, 1967, PHYSIOL REV, V47, P595, DOI 10.1152/physrev.1967.47.4.595; Martinez Cristian, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00027; McMurtrie HL, 2004, J ENZYM INHIB MED CH, V19, P231, DOI 10.1080/14756360410001704443; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; OKUYAMA T, 1995, ARCH BIOCHEM BIOPHYS, V320, P315, DOI 10.1016/0003-9861(95)90015-2; OKUYAMA T, 1992, P NATL ACAD SCI USA, V89, P1315, DOI 10.1073/pnas.89.4.1315; OSBORNE WRA, 1975, ANAL BIOCHEM, V64, P297, DOI 10.1016/0003-2697(75)90434-0; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; Pellerin L., 2010, DIABETES METAB S, V36, P59; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pushkin A, 2004, J PHYSIOL-LONDON, V559, P55, DOI 10.1113/jphysiol.2004.065110; Ro HA, 2004, J BIOL CHEM, V279, P37115, DOI 10.1074/jbc.M403099200; Schneider HP, 2013, P NATL ACAD SCI USA, V110, P1494, DOI 10.1073/pnas.1221213110; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Sterling D, 2002, J BIOL CHEM, V277, P25239, DOI 10.1074/jbc.M202562200; Stridh MH, 2012, J PHYSIOL-LONDON, V590, P2333, DOI 10.1113/jphysiol.2011.220152; SULTEMEYER DF, 1990, PLANT PHYSIOL, V94, P1250, DOI 10.1104/pp.94.3.1250; Supuran C.T., 2009, DRUG DESIGN ZINC ENZ, DOI [10.1002/9780470508169.ch22, DOI 10.1002/9780470508169]; Svichar N, 2006, GLIA, V53, P241, DOI 10.1002/glia.20277; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Vaughan-Jones RD, 2002, J PHYSIOL-LONDON, V541, P139, DOI 10.1113/jphysiol.2001.013267; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Wilson MC, 2002, J BIOL CHEM, V277, P3666, DOI 10.1074/jbc.M109658200; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; ZHU XL, 1990, J BIOL CHEM, V265, P8795	54	39	39	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2765	2775		10.1074/jbc.M113.537043	http://dx.doi.org/10.1074/jbc.M113.537043			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338019	Green Published, hybrid			2022-12-28	WOS:000333403000026
J	Matthews, LA; Selvaratnam, R; Jones, DR; Akimoto, M; McConkey, BJ; Melacini, G; Duncker, BP; Guarne, A				Matthews, Lindsay A.; Selvaratnam, Rajeevan; Jones, Darryl R.; Akimoto, Madoka; McConkey, Brendan J.; Melacini, Giuseppe; Duncker, Bernard P.; Guarne, Alba			A Novel Non-canonical Forkhead-associated (FHA) Domain-binding Interface Mediates the Interaction between Rad53 and Dbf4 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Checkpoint Control; DNA Damage Response; DNA Replication; NMR; Protein Domains; Protein-Protein Interactions; Yeast Genetics	DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; KINASE; PHOSPHORYLATION; COMPLEX; RECOGNITION; SPECIFICITY; RESISTANCE; SLD3; GENE	Background: The interaction between the checkpoint kinase Rad53 and Dbf4 is critical to suppress late origin firing and to stabilize stalled forks during replication stress. Results: The FHA1 domain of Rad53 interacts with the BRCT domain of Dbf4 through a novel non-canonical interface. Conclusion: FHA domains gain specificity by engaging multiple binding interfaces. Significance: Understanding how FHA domains interact with their binding partners is key to elucidate how they relay information along signaling pathways. Forkhead-associated (FHA) and BRCA1 C-terminal (BRCT) domains are overrepresented in DNA damage and replication stress response proteins. They function primarily as phosphoepitope recognition modules but can also mediate non-canonical interactions. The latter are rare, and only a few have been studied at a molecular level. We have identified a crucial non-canonical interaction between the N-terminal FHA1 domain of the checkpoint effector kinase Rad53 and the BRCT domain of the regulatory subunit of the Dbf4-dependent kinase that is critical to suppress late origin firing and to stabilize stalled forks during replication stress. The Rad53-Dbf4 interaction is phosphorylation-independent and involves a novel non-canonical interface on the FHA1 domain. Mutations within this surface result in hypersensitivity to genotoxic stress. Importantly, this surface is not conserved in the FHA2 domain of Rad53, suggesting that the FHA domains of Rad53 gain specificity by engaging additional interaction interfaces beyond their phosphoepitope-binding site. In general, our results point to FHA domains functioning as complex logic gates rather than mere phosphoepitope-targeting modules.	[Matthews, Lindsay A.; Melacini, Giuseppe; Guarne, Alba] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Selvaratnam, Rajeevan; Akimoto, Madoka; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4K1, Canada; [Jones, Darryl R.; McConkey, Brendan J.; Duncker, Bernard P.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3H1, Canada	McMaster University; McMaster University; University of Waterloo	Guarne, A (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada.	guarnea@mcmaster.ca		Selvaratnam, Rajeevan/0000-0003-4457-616X; Duncker, Bernard/0000-0002-6055-9522	Canadian Institutes of Health Research [MOP-67189, MOP-68897]; Natural Sciences and Engineering Research Council [RGPIN 238392]; McMaster-Waterloo Bioinformatics Program; Canadian Institutes of Health Research; Ontario Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); McMaster-Waterloo Bioinformatics Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by Canadian Institutes of Health Research Grants MOP-67189 (to A. G.) and MOP-68897 (to G. M.), Natural Sciences and Engineering Research Council Grant RGPIN 238392 (to B. P. D.), the McMaster-Waterloo Bioinformatics Program (to B. P. D., B. J. M., and A. G.), a Canadian Institutes of Health Research doctoral scholarship (to L. A. M.), and Ontario Graduate Scholarship doctoral awards (to D. R. J. and R. S.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Aucher W, 2010, MOL CELL PROTEOMICS, V9, DOI 10.1074/mcp.M110.003319; Branzei D, 2006, EXP CELL RES, V312, P2654, DOI 10.1016/j.yexcr.2006.06.012; Chen YC, 2013, GENETICS, V194, P389, DOI 10.1534/genetics.113.149740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diaz-Moreno I, 2005, J BIOL CHEM, V280, P7925, DOI 10.1074/jbc.M412422200; Duch A, 2011, J BIOL CHEM, V286, P2486, DOI 10.1074/jbc.M110.190843; Duncker BP, 2002, P NATL ACAD SCI USA, V99, P16087, DOI 10.1073/pnas.252093999; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gabrielse C, 2006, GENETICS, V173, P541, DOI 10.1534/genetics.106.057521; Goddard D., 2008, SPARKY 3; Gunasekara N, 2012, BIOCHEM BIOPH RES CO, V421, P832, DOI 10.1016/j.bbrc.2012.04.098; Hagn F, 2011, NAT STRUCT MOL BIOL, V18, P1086, DOI 10.1038/nsmb.2114; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; Jones DR, 2010, CELL CYCLE, V9, P2018, DOI 10.4161/cc.9.10.11752; Kihara M, 2000, J BIOL CHEM, V275, P35051, DOI 10.1074/jbc.M003491200; KITADA K, 1992, GENETICS, V131, P21; Kobayashi M, 2010, J BIOL CHEM, V285, P10087, DOI 10.1074/jbc.M109.054106; Labib K, 2011, PHILOS T R SOC B, V366, P3554, DOI 10.1098/rstb.2011.0071; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Leung CCY, 2011, CELL CYCLE, V10, P2461, DOI 10.4161/cc.10.15.16312; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Li XX, 2012, J BIOL CHEM, V287, P9137, DOI 10.1074/jbc.M111.311860; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Matthews LA, 2013, CELL CYCLE, V12, P1180, DOI 10.4161/cc.24416; Matthews LA, 2012, J BIOL CHEM, V287, P2378, DOI 10.1074/jbc.M111.233973; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; Selvaratnam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048707; Stead BE, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-36; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Tong YF, 2010, P NATL ACAD SCI USA, V107, P20346, DOI 10.1073/pnas.1009008107; Varrin AE, 2005, MOL CELL BIOL, V25, P7494, DOI 10.1128/MCB.25.17.7494-7504.2005; Walters KJ, 2001, METHOD ENZYMOL, V339, P238, DOI 10.1016/S0076-6879(01)39316-3; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Yongkiettrakul S, 2004, BIOCHEMISTRY-US, V43, P3862, DOI 10.1021/bi036195f; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Zhang W, 2008, MOL CELL, V31, P1, DOI 10.1016/j.molcel.2008.06.009	42	13	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2589	2599		10.1074/jbc.M113.517060	http://dx.doi.org/10.1074/jbc.M113.517060			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24285546	Green Published, hybrid			2022-12-28	WOS:000333403000010
J	Gutekunst, K; Chen, X; Schreiber, K; Kaspar, U; Makam, S; Appel, J				Gutekunst, Kirstin; Chen, Xi; Schreiber, Karoline; Kaspar, Ursula; Makam, Srinivas; Appel, Jens			The Bidirectional NiFe-hydrogenase in Synechocystis sp PCC 6803 Is Reduced by Flavodoxin and Ferredoxin and Is Essential under Mixotrophic, Nitrate-limiting Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergy; Cyanobacteria; Hydrogenase; Photosynthesis; Physiology; Redox	PHOTOSYNTHETIC MICROBIAL MATS; CATALYTIC-PROPERTIES; PHYTOPLANKTON; CYANOBACTERIA; EVOLUTION; SUBUNIT; PROCHLOROCOCCUS; LOCALIZATION; RESPIRATION; NITROGEN	Cyanobacteria are able to use solar energy for the production of hydrogen. It is generally accepted that cyanobacterial NiFe-hydrogenases are reduced by NAD(P)H. This is in conflict with thermodynamic considerations, as the midpoint potentials of NAD(P)H do not suffice to support the measured hydrogen production under physiological conditions. We show that flavodoxin and ferredoxin directly reduce the bidirectional NiFe-hydrogenase of Synechocystis sp. PCC 6803 in vitro. A merodiploid ferredoxin-NADP reductase mutant produced correspondingly more photohydrogen. We furthermore found that the hydrogenase receives its electrons via pyruvate:flavodoxin/ferredoxin oxidoreductase (PFOR)-flavodoxin/ferredoxin under fermentative conditions, enabling the cells to gain ATP. These results strongly support that the bidirectional NiFe-hydrogenases in cyanobacteria function as electron sinks for low potential electrons from photosystem I and as a redox balancing device under fermentative conditions. However, the selective advantage of this enzyme is not known. No strong phenotype of mutants lacking the hydrogenase has been found. Because bidirectional hydrogenases are widespread in aquatic nutrient-rich environments that are capable of triggering phytoplankton blooms, we mimicked those conditions by growing cells in the presence of increased amounts of dissolved organic carbon and dissolved organic nitrogen. Under these conditions the hydrogenase was found to be essential. As these conditions close the two most important sinks for reduced flavodoxin/ferredoxin (CO2-fixation and nitrate reduction), this discovery further substantiates the connection between flavodoxin/ferredoxin and the NiFe-hydrogenase.	[Gutekunst, Kirstin; Chen, Xi; Schreiber, Karoline; Kaspar, Ursula; Appel, Jens] Univ Kiel, Inst Bot, D-24118 Kiel, Germany; [Makam, Srinivas] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Appel, Jens] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	University of Kiel; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Gutekunst, K (corresponding author), Univ Kiel, Inst Bot, Bot Garten 5, D-24118 Kiel, Germany.	kgutekunst@bot.uni-kiel.de		Gutekunst, Kirstin/0000-0003-4366-423X; Appel, Jens/0000-0002-0658-7899	Airbus; Faculty of Mathematics of the University of Kiel; Cluster of Excellence "The Future Ocean"; FAZIT-Stiftung; Deutsche Bundesstiftung Umwelt; Brian and Kelly Swette Foundation; Faculty of Natural Sciences of the University of Kiel	Airbus; Faculty of Mathematics of the University of Kiel; Cluster of Excellence "The Future Ocean"; FAZIT-Stiftung; Deutsche Bundesstiftung Umwelt; Brian and Kelly Swette Foundation; Faculty of Natural Sciences of the University of Kiel	This work was supported by Airbus, the Faculty of Mathematics and Natural Sciences of the University of Kiel for the support of female scientists, the Cluster of Excellence "The Future Ocean," FAZIT-Stiftung, Deutsche Bundesstiftung Umwelt, and the Brian and Kelly Swette Foundation.	Amador-Noguez D, 2011, APPL ENVIRON MICROB, V77, P7984, DOI 10.1128/AEM.05374-11; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Appel J, 1996, BBA-PROTEIN STRUCT M, V1298, P141, DOI 10.1016/S0167-4838(96)00176-8; Aubert-Jousset E, 2011, FEBS J, V278, P4035, DOI 10.1111/j.1742-4658.2011.08308.x; Barz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013846; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BIGGINS J, 1969, J BACTERIOL, V99, P570, DOI 10.1128/JB.99.2.570-575.1969; Bronk DA, 2007, BIOGEOSCIENCES, V4, P283, DOI 10.5194/bg-4-283-2007; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Burow LC, 2013, ISME J, V7, P817, DOI 10.1038/ismej.2012.150; Burow LC, 2012, ISME J, V6, P863, DOI 10.1038/ismej.2011.142; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; de Graef MR, 1999, J BACTERIOL, V181, P2351, DOI 10.1128/JB.181.8.2351-2357.1999; Munoz-Marin MD, 2013, P NATL ACAD SCI USA, V110, P8597, DOI 10.1073/pnas.1221775110; Demuez M, 2007, FEMS MICROBIOL LETT, V275, P113, DOI 10.1111/j.1574-6968.2007.00868.x; Eckert C, 2012, J BIOL CHEM, V287, P43502, DOI 10.1074/jbc.M112.392407; FUJITA Y, 1965, ARCH BIOCHEM BIOPHYS, V111, P619, DOI 10.1016/0003-9861(65)90243-2; Germer F, 2009, J BIOL CHEM, V284, P36462, DOI 10.1074/jbc.M109.028795; Gutthann F, 2007, BBA-BIOENERGETICS, V1767, P161, DOI 10.1016/j.bbabio.2006.12.003; Hoehler TM, 2001, NATURE, V412, P324, DOI 10.1038/35085554; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; HOUCHINS JP, 1981, J BACTERIOL, V146, P215, DOI 10.1128/JB.146.1.215-221.1981; KENTEMICH T, 1989, Z NATURFORSCH C, V44, P384; Kothari A, 2012, J BIOTECHNOL, V162, P105, DOI 10.1016/j.jbiotec.2012.04.017; Llama MJ, 1978, BIOCHEM SOC T, V6, P1337, DOI 10.1042/bst0061337; Long MN, 2007, J BIOL INORG CHEM, V12, P62, DOI 10.1007/s00775-006-0162-1; McNeely K, 2011, APPL ENVIRON MICROB, V77, P2435, DOI 10.1128/AEM.02792-10; Meuer J, 1999, EUR J BIOCHEM, V265, P325, DOI 10.1046/j.1432-1327.1999.00738.x; Montesinos ML, 1997, J BACTERIOL, V179, P853, DOI 10.1128/jb.179.3.853-862.1997; Moore LR, 2013, P NATL ACAD SCI USA, V110, P8323, DOI 10.1073/pnas.1305998110; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; NEUER G, 1982, BIOCHIM BIOPHYS ACTA, V716, P358, DOI 10.1016/0304-4165(82)90028-9; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Oesterhelt C, 2007, PLANT J, V51, P500, DOI 10.1111/j.1365-313X.2007.03159.x; Palagyi-Meszaros LS, 2009, FEBS J, V276, P164, DOI 10.1111/j.1742-4658.2008.06770.x; Poncelet M, 1998, MOL MICROBIOL, V28, P813, DOI 10.1046/j.1365-2958.1998.00844.x; Rinta-Kanto JM, 2012, ENVIRON MICROBIOL, V14, P228, DOI 10.1111/j.1462-2920.2011.02602.x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Schmitz O, 2002, BBA-BIOENERGETICS, V1554, P66, DOI 10.1016/S0005-2728(02)00214-1; SCHMITZ O, 1995, EUR J BIOCHEM, V233, P266, DOI 10.1111/j.1432-1033.1995.266_1.x; Schmitz O, 1996, FEMS MICROBIOL LETT, V135, P97; SCHNEIDER K, 1984, EUR J BIOCHEM, V142, P75, DOI 10.1111/j.1432-1033.1984.tb08252.x; Serebryakova LT, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1370, DOI 10.1134/S0006297906120133; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1016/S0168-6445(97)00056-9; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Tittel J, 2003, P NATL ACAD SCI USA, V100, P12776, DOI 10.1073/pnas.2130696100; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wetz MS, 2004, MAR ECOL PROG SER, V272, P49, DOI 10.3354/meps272049; Wetz MS, 2003, LIMNOL OCEANOGR, V48, P1808, DOI 10.4319/lo.2003.48.5.1808; Winkler M, 2009, J BIOL CHEM, V284, P36620, DOI 10.1074/jbc.M109.053496; Zubkov MV, 2008, NATURE, V455, P224, DOI 10.1038/nature07236; Zubkov MV, 2003, APPL ENVIRON MICROB, V69, P1299, DOI 10.1128/AEM.69.2.1299-1304.2003	52	77	83	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1930	1937		10.1074/jbc.M113.526376	http://dx.doi.org/10.1074/jbc.M113.526376			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311779	Green Published, hybrid			2022-12-28	WOS:000331130200005
J	Zhang, Q; Liu, B; Cheng, Y; Meng, QS; Xia, TT; Jiang, L; Chen, SH; Liu, Y; Guo, FF				Zhang, Qian; Liu, Bin; Cheng, Ying; Meng, Qingshu; Xia, Tingting; Jiang, Lei; Chen, Shanghai; Liu, Yong; Guo, Feifan			Leptin Signaling Is Required for Leucine Deprivation-enhanced Energy Expenditure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Energy Metabolism; Hypothalamus; Leptin; STAT3; Uncoupling Proteins; Fat Loss; Leucine Deprivation	RECEPTOR MESSENGER-RNA; DIET-INDUCED OBESITY; HIGH-FAT; PLASMA LEPTIN; FOOD-INTAKE; LONG FORM; GLUCOSE-TOLERANCE; NERVOUS-SYSTEM; AMINO-ACID; L-ARGININE	Background: Leucine deprivation decreases fat mass via enhancing energy expenditure; the involvement of leptin signaling is unknown. Results: Leucine deprivation promoted leptin signaling, and the increased energy expenditure was blocked in leptin signaling-disrupted mice. Conclusion: Leptin signaling is required for leucine deprivation-increased energy expenditure. Significance: Our studies reveal a physiological mechanism linking leptin signaling with leucine deprivation-enhanced energy expenditure. Leptin signaling in the hypothalamus is crucial in energy homeostasis. We have previously shown that dietary deprivation of the essential amino acid leucine in mice stimulates fat loss by increasing energy expenditure. The involvement of leptin signaling in this regulation, however, has not been reported. Here, we show that leucine deprivation promotes leptin signaling in mice maintained on an otherwise normal diet and restores leptin responses in mice maintained on a high fat diet, a regimen known to induce leptin resistance. In addition, we found that leucine deprivation stimulated energy expenditure, and fat loss was largely blocked in db/db mice homozygous for a mutation in leptin receptor and a knock-in mouse line Y3F with abrogation of leptin receptor Tyr(1138)-mediated signal transducer and activator transcript 3 signaling. Overall, our studies describe a novel link between hypothalamic leptin signaling and stimulation of energy expenditure under leucine deprivation.	[Zhang, Qian; Liu, Bin; Cheng, Ying; Meng, Qingshu; Xia, Tingting; Jiang, Lei; Chen, Shanghai; Liu, Yong; Guo, Feifan] Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci,Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Liu, Y (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci,Grad Sch, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	luiy@sibs.ac.cn; ffguo@sibs.ac.cn	Zhang, Qian/B-5047-2019; Xia, Tingting/K-9894-2016	Zhang, Qian/0000-0003-3032-9088; LIU, YONG/0000-0001-7771-4181	Ministry of Science and Technology of China 973 Program [2010CB912502, 2009CB919001]; National Natural Science Foundation [81130076, 31271269, 81100615]; Key Program of Shanghai Scientific and Technological Innovation Action Plan [13JC1409000]; Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-EW-R-09]; Chinese Academy of Sciences [2011KIP307]	Ministry of Science and Technology of China 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Program of Shanghai Scientific and Technological Innovation Action Plan; Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by the Ministry of Science and Technology of China 973 Program 2010CB912502 and 2009CB919001, National Natural Science Foundation Grants 81130076, 31271269, and 81100615, Key Program of Shanghai Scientific and Technological Innovation Action Plan Grant 13JC1409000, Knowledge Innovation Program of Chinese Academy of Sciences Grant KSCX2-EW-R-09, Chinese Academy of Sciences Project 2011KIP307.	Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bates SH, 2004, DIABETES, V53, P3067, DOI 10.2337/diabetes.53.12.3067; Bewick GA, 2009, DIABETES, V58, P840, DOI 10.2337/db08-1428; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Cheng Y, 2011, MOL ENDOCRINOL, V25, P1624, DOI 10.1210/me.2011-0028; Cheng Y, 2010, DIABETES, V59, P17, DOI 10.2337/db09-0929; Chuang SM, 2011, INT UROGYNECOL J, V22, P1381, DOI 10.1007/s00192-011-1468-2; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cristino L, 2013, P NATL ACAD SCI USA, V110, pE2229, DOI 10.1073/pnas.1219485110; Dardeno TA, 2010, FRONT NEUROENDOCRIN, V31, P377, DOI 10.1016/j.yfrne.2010.06.002; Du FY, 2000, J NUTR, V130, P514, DOI 10.1093/jn/130.3.514; Dube MG, 2002, DIABETES, V51, P1729, DOI 10.2337/diabetes.51.6.1729; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Fu WJJ, 2005, J NUTR, V135, P714, DOI 10.1093/jn/135.4.714; Fukuda M, 2011, CELL METAB, V13, P331, DOI 10.1016/j.cmet.2011.01.016; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Gong Y, 2007, J BIOL CHEM, V282, P31019, DOI 10.1074/jbc.M702838200; Huang BW, 2004, DIABETES OBES METAB, V6, P120, DOI 10.1111/j.1462-8902.2004.00323.x; Huang H, 2013, ENDOCRINOLOGY, V154, P3660, DOI 10.1210/en.2013-1343; Huang H, 2012, NAT NEUROSCI, V15, P1391, DOI 10.1038/nn.3207; Hwa JJ, 1997, AM J PHYSIOL-REG I, V272, pR1204, DOI 10.1152/ajpregu.1997.272.4.R1204; Jiang L, 2008, P NATL ACAD SCI USA, V105, P18619, DOI 10.1073/pnas.0804589105; Kasaoka S, 2004, NUTRITION, V20, P991, DOI 10.1016/j.nut.2004.08.006; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Kim YW, 2006, DIABETES, V55, P716, DOI 10.2337/diabetes.55.03.06.db05-0917; Kloek C, 2002, J BIOL CHEM, V277, P41547, DOI 10.1074/jbc.M205148200; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lee YC, 2006, LIFE SCI, V78, P1155, DOI 10.1016/j.lfs.2005.06.009; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Lin HY, 2005, DIABETES, V54, P1717, DOI 10.2337/diabetes.54.6.1717; Lynch CJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE621, DOI 10.1152/ajpendo.00462.2005; Mao XB, 2011, MOL BIOL REP, V38, P3201, DOI 10.1007/s11033-010-9992-6; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Roh C, 2003, AM J PHYSIOL-ENDOC M, V284, pE322, DOI 10.1152/ajpendo.00230.2002; Sahu A, 2004, ENDOCRINOLOGY, V145, P2613, DOI 10.1210/en.2004-0032; Shapiro A, 2008, AM J PHYSIOL-REG I, V295, pR1370, DOI 10.1152/ajpregu.00195.2008; Shapiro A, 2011, BRIT J NUTR, V106, P390, DOI 10.1017/S000711451100033X; Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; Winnicki M, 2002, CIRCULATION, V106, P289, DOI 10.1161/01.CIR.0000025241.01418.4D; Xia TT, 2012, DIABETES, V61, P2461, DOI 10.2337/db11-1278; You J, 2010, MOL CELL BIOL, V30, P1650, DOI 10.1128/MCB.01307-09; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	52	17	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1779	1787		10.1074/jbc.M113.528943	http://dx.doi.org/10.1074/jbc.M113.528943			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302741	Green Published, hybrid			2022-12-28	WOS:000332401700048
J	Herrmann, J; Berberich, H; Hartmann, J; Beyer, S; Davies, K; Koch, J				Herrmann, Julia; Berberich, Hannah; Hartmann, Jessica; Beyer, Steffen; Davies, Karen; Koch, Joachim			Homo-oligomerization of the Activating Natural Killer Cell Receptor NKp30 Ectodomain Increases Its Binding Affinity for Cellular Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-INFECTED CELLS; NK CELLS; CYTOTOXICITY RECEPTOR; T-CELLS; CRYSTAL-STRUCTURE; LEUKEMIA-CELLS; IMMUNOGLOBULIN SUPERFAMILY; HIV-1 INFECTION; NKP46 RECEPTOR; TUMOR	The natural cytotoxicity receptors, comprised of three type I membrane proteins NKp30, NKp44, and NKp46, are a unique set of activating proteins expressed mainly on the surface of natural killer (NK) cells. Among these, NKp30 is a major receptor targeting virus-infected cells, malignantly transformed cells, and immature dendritic cells. To date, only few cellular ligands of NKp30 have been discovered, and the molecular details of ligand recognition by NKp30 are poorly understood. Within the current study, we found that the ectodomain of NKp30 forms functional homo-oligomers that mediate high affinity binding to its corresponding cellular ligand B7-H6. Notably, this homo-oligomerization is strongly promoted by the stalk domain of NKp30. Based on these data, we suggest that homo-oligomerization of NKp30 in the plasma membrane of NK cells, which might be favored by IL-2-dependent up-regulation of NKp30 expression, provides a way to improve recognition and lysis of target cells by NK cells.	[Herrmann, Julia; Berberich, Hannah; Hartmann, Jessica; Beyer, Steffen; Koch, Joachim] Inst Tumor Biol & Expt Therapy, NK Cell Biol, D-60596 Frankfurt, Germany; [Davies, Karen] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany	Max Planck Society	Koch, J (corresponding author), Inst Biomed Res, Georg Speyer Haus,Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany.	joachim.koch@gsh.uni-frankfurt.de	Hartmann, Jessica/AAL-8849-2021	Hartmann, Jessica/0000-0001-9372-8954; Davies, Karen/0000-0002-3207-9337	German Federal Ministry of Health (BMG); Ministry of Higher Education, Research, and the Arts of the State of Hessen (HMWK)	German Federal Ministry of Health (BMG); Ministry of Higher Education, Research, and the Arts of the State of Hessen (HMWK)	We thank Dr. Roy Mariuzza (University of Maryland, Rockville, MD) for critical reading of the manuscript and helpful discussions. Moreover, we kindly acknowledge Dr. Carsten Watzl (IfADo), Dr. Andreas Diefenbach (University of Freiburg, Germany), Dr. Alexander Steinle (Goethe-University, Frankfurt am Main, Germany), and Dr. Imre Berger (EMBL, Grenoble, France) for providing cells, reagents, and related technical advice. The Georg-Speyer-Haus is supported jointly by the German Federal Ministry of Health (BMG) and the Ministry of Higher Education, Research, and the Arts of the State of Hessen (HMWK).	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Andersen PS, 2001, J BIOL CHEM, V276, P49125, DOI 10.1074/jbc.M109396200; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Binici J, 2014, CELL MOL LIFE SCI, V71, P1829, DOI 10.1007/s00018-013-1522-y; Binici J, 2013, J BIOL CHEM, V288, P34295, DOI 10.1074/jbc.M113.483602; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; Cantoni C, 2003, STRUCTURE, V11, P725, DOI 10.1016/S0969-2126(03)00095-9; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Correia DV, 2011, BLOOD, V118, P992, DOI 10.1182/blood-2011-02-339135; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Fauriat C, 2007, BLOOD, V109, P323, DOI 10.1182/blood-2005-08-027979; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Foster CE, 2003, J BIOL CHEM, V278, P46081, DOI 10.1074/jbc.M308491200; Funke J, 2011, AIDS REV, V13, P67; Garcia-Iglesias T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-186; Garg A, 2006, J IMMUNOL, V177, P6192, DOI 10.4049/jimmunol.177.9.6192; Garrity D, 2005, P NATL ACAD SCI USA, V102, P7641, DOI 10.1073/pnas.0502439102; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Grave L, 2012, PROTEIN EXPRES PURIF, V86, P142, DOI 10.1016/j.pep.2012.09.016; Groth A, 2011, J INNATE IMMUN, V3, P344, DOI 10.1159/000327014; Hartmann J, 2012, J BIOL CHEM, V287, P31527, DOI 10.1074/jbc.M111.304238; Hudspeth K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00069; Hudspeth K, 2012, BLOOD, V119, P4013, DOI 10.1182/blood-2011-11-390153; Jarahian M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002195; Jarahian M, 2009, J VIROL, V83, P8108, DOI 10.1128/JVI.00211-09; Jaron-Mendelson M, 2012, J IMMUNOL, V188, P6165, DOI 10.4049/jimmunol.1102496; Joyce MG, 2011, P NATL ACAD SCI USA, V108, P6223, DOI 10.1073/pnas.1100622108; Kaifu T, 2011, CELL MOL LIFE SCI, V68, P3531, DOI 10.1007/s00018-011-0802-7; Kajitani K, 2012, BREAST CANCER RES TR, V134, P139, DOI 10.1007/s10549-011-1944-x; Kloess S, 2010, EUR J IMMUNOL, V40, P3255, DOI 10.1002/eji.201040568; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Li YL, 2011, J EXP MED, V208, P703, DOI 10.1084/jem.20102548; Lisnic VJ, 2010, CURR OPIN MICROBIOL, V13, P530, DOI 10.1016/j.mib.2010.05.011; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; Mamessier E, 2011, J CLIN INVEST, V121, P3609, DOI 10.1172/JCI45816; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Mavoungou E, 2007, J INFECT DIS, V195, P1521, DOI 10.1086/515579; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Pietra G, 2012, CANCER RES, V72, P1407, DOI 10.1158/0008-5472.CAN-11-2544; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Reiners KS, 2013, BLOOD, V121, P3658, DOI 10.1182/blood-2013-01-476606; ROSENBERG SA, 1986, ANNU REV IMMUNOL, V4, P681, DOI 10.1146/annurev.immunol.4.1.681; Seidel E, 2012, CELL MOL LIFE SCI, V69, P3911, DOI 10.1007/s00018-012-1001-x; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Tang Q, 2008, J IMMUNOL, V181, P4507, DOI 10.4049/jimmunol.181.7.4507; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Watzl Carsten, 2010, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109bs90; Wehner R, 2011, J INNATE IMMUN, V3, P258, DOI 10.1159/000323923	67	7	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					765	777		10.1074/jbc.M113.514786	http://dx.doi.org/10.1074/jbc.M113.514786			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275655	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000330541200015
J	Snyder, GA; Deredge, D; Waldhuber, A; Fresquez, T; Wilkins, DZ; Smith, PT; Durr, S; Cirl, C; Jiang, JS; Jennings, W; Luchetti, T; Snyder, N; Sundberg, EJ; Wintrode, P; Miethke, T; Xiao, TS				Snyder, Greg A.; Deredge, Daniel; Waldhuber, Anna; Fresquez, Theresa; Wilkins, David Z.; Smith, Patrick T.; Durr, Susi; Cirl, Christine; Jiang, Jiansheng; Jennings, William; Luchetti, Timothy; Snyder, Nathaniel; Sundberg, Eric J.; Wintrode, Patrick; Miethke, Thomas; Xiao, T. Sam			Crystal Structures of the Toll/Interleukin-1 Receptor (TIR) Domains from the Brucella Protein TcpB and Host Adaptor TIRAP Reveal Mechanisms of Molecular Mimicry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; SUBVERSION; FAMILY; INTERFERENCE; DIMERIZATION; RECRUITMENT; SYSTEM	The Toll/IL-1 receptor (TIR) domains are crucial innate immune signaling modules. Microbial TIR domain-containing proteins inhibit Toll-like receptor (TLR) signaling through molecular mimicry. The TIR domain-containing protein TcpB from Brucella inhibits TLR signaling through interaction with host adaptor proteins TIRAP/Mal and MyD88. To characterize the microbial mimicry of host proteins, we have determined the X-ray crystal structures of the TIR domains from the Brucella protein TcpB and the host adaptor protein TIRAP. We have further characterized homotypic interactions of TcpB using hydrogen/deuterium exchange mass spectrometry and heterotypic TcpB and TIRAP interaction by co-immunoprecipitation and NF-kappa B reporter assays. The crystal structure of the TcpB TIR domain reveals the microtubule-binding site encompassing the BB loop as well as a symmetrical dimer mediated by the DD and EE loops. This dimerization interface is validated by peptide mapping through hydrogen/deuterium exchange mass spectrometry. The human TIRAP TIR domain crystal structure reveals a unique N-terminal TIR domain fold containing a disulfide bond formed by Cys89 and Cys134. A comparison between the TcpB and TIRAP crystal structures reveals substantial conformational differences in the region that encompasses the BB loop. These findings underscore the similarities and differences in the molecular features found in the microbial and host TIR domains, which suggests mechanisms of bacterial mimicry of host signaling adaptor proteins, such as TIRAP.	[Snyder, Greg A.; Fresquez, Theresa; Smith, Patrick T.; Jiang, Jiansheng; Jennings, William; Luchetti, Timothy; Snyder, Nathaniel; Xiao, T. Sam] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Deredge, Daniel; Wintrode, Patrick] Univ Maryland Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Waldhuber, Anna; Durr, Susi; Cirl, Christine] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-81675 Munich, Germany; [Wilkins, David Z.; Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Med, Inst Human Virol, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Miethke, Thomas] Heidelberg Univ, Med Fac Mannheim, Inst Med Microbiol & Hyg, D-68167 Mannheim, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore; Technical University of Munich; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Ruprecht Karls University Heidelberg	Snyder, GA (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	Gsnyder@som.umaryland.edu; Thomas.Miethke@medma.uni-heidelberg.de; Xiaot@niaid.nih.gov	Xiao, Tsan Sam/A-8590-2010	Xiao, Tsan Sam/0000-0001-9688-475X; Jiang, Jiansheng/0000-0003-0964-5481; Sundberg, Eric/0000-0003-0478-3033; Snyder, Nathaniel/0000-0001-5643-8747	Division of Intramural Research, NIAID, National Institutes of Health; Deutsche Forschungsgemeinschaft [MI471/6-1]	Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in whole or in part, by the Division of Intramural Research, NIAID, National Institutes of Health (to T. S. X.).; Supported by Deutsche Forschungsgemeinschaft Grant MI471/6-1.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alaidarous M, 2014, J BIOL CHEM, V289, P654, DOI 10.1074/jbc.M113.523274; Campos MA, 2004, INFECT IMMUN, V72, P176, DOI 10.1128/IAI.72.1.176-186.2004; Chaudhary A, 2012, BIOCHEM BIOPH RES CO, V417, P299, DOI 10.1016/j.bbrc.2011.11.104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Cirl C, 2010, INT J MED MICROBIOL, V300, P396, DOI 10.1016/j.ijmm.2010.04.001; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kaplan-Turkoz B, 2013, FEBS LETT, V587, P3412, DOI 10.1016/j.febslet.2013.09.007; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kissner TL, 2011, J BIOL CHEM, V286, P31385, DOI 10.1074/jbc.M110.204982; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Low LY, 2007, BIOCHEM BIOPH RES CO, V356, P481, DOI 10.1016/j.bbrc.2007.03.003; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Radhakrishnan GK, 2011, BIOCHEM J, V439, P79, DOI 10.1042/BJ20110577; Radhakrishnan GK, 2010, BIOCHEM BIOPH RES CO, V397, P59, DOI 10.1016/j.bbrc.2010.05.056; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Rana RR, 2011, MICROB PATHOGENESIS, V51, P89, DOI 10.1016/j.micpath.2011.05.004; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Sengupta D, 2010, J IMMUNOL, V184, P956, DOI 10.4049/jimmunol.0902008; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Snyder G, 2010, J IMMUNOL, V184; Snyder GA, 2014, CURR PHARM DESIGN, V20, P1244, DOI 10.2174/13816128113199990069; Snyder GA, 2013, P NATL ACAD SCI USA, V110, P6985, DOI 10.1073/pnas.1215770110; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Xiao TS, 2010, J CLIN IMMUNOL, V30, P638, DOI 10.1007/s10875-010-9435-0; Yadav M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001120; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419	43	53	60	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					669	679		10.1074/jbc.M113.523407	http://dx.doi.org/10.1074/jbc.M113.523407			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275656	hybrid, Green Published			2022-12-28	WOS:000330541200007
J	Takahashi, K; Takabayashi, A; Tanaka, A; Tanaka, R				Takahashi, Kaori; Takabayashi, Atsushi; Tanaka, Ayumi; Tanaka, Ryouichi			Functional Analysis of Light-harvesting-like Protein 3 (LIL3) and Its Light-harvesting Chlorophyll-binding Motif in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAB-LIKE PROTEINS; SYNECHOCYSTIS-SP PCC-6803; SP PCC 6803; CRYSTAL-STRUCTURE; PHOTOSYSTEM-II; COMPLEX; A/B; FERROCHELATASE; LOCALIZATION; INVOLVEMENT	The light-harvesting complex (LHC) constitutes the major light-harvesting antenna of photosynthetic eukaryotes. LHC contains a characteristic sequence motif, termed LHC motif, consisting of 25-30 mostly hydrophobic amino acids. This motif is shared by a number of transmembrane proteins from oxygenic photoautotrophs that are termed light-harvesting-like (LIL) proteins. To gain insights into the functions of LIL proteins and their LHC motifs, we functionally characterized a plant LIL protein, LIL3. This protein has been shown previously to stabilize geranylgeranyl reductase (GGR), a key enzyme in phytol biosynthesis. It is hypothesized that LIL3 functions to anchor GGR to membranes. First, we conjugated the transmembrane domain of LIL3 or that of ascorbate peroxidase to GGR and expressed these chimeric proteins in an Arabidopsis mutant lacking LIL3 protein. As a result, the transgenic plants restored phytol-synthesizing activity. These results indicate that GGR is active as long as it is anchored to membranes, even in the absence of LIL3. Subsequently, we addressed the question why the LHC motif is conserved in the LIL3 sequences. We modified the transmembrane domain of LIL3, which contains the LHC motif, by substituting its conserved amino acids (Glu-171, Asn-174, and Asp-189) with alanine. As a result, the Arabidopsis transgenic plants partly recovered the phytol-biosynthesizing activity. However, in these transgenic plants, the LIL3-GGR complexes were partially dissociated. Collectively, these results indicate that the LHC motif of LIL3 is involved in the complex formation of LIL3 and GGR, which might contribute to the GGR reaction.	[Takahashi, Kaori; Takabayashi, Atsushi; Tanaka, Ayumi; Tanaka, Ryouichi] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Takabayashi, Atsushi; Tanaka, Ayumi; Tanaka, Ryouichi] Japan Core Res Evolutionary Sci & Technol, Sapporo, Hokkaido 0600819, Japan	Hokkaido University	Tanaka, R (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Kita Ku, N19W8, Sapporo, Hokkaido 0600819, Japan.	rtanaka@lowtem.hokudai.ac.jp	Tanaka, Ayumi/D-9003-2012; Tanaka, Ryouichi/A-4030-2012; Takabayashi, Atsushi/G-1998-2011; Takabayashi, Atsushi/AAH-6025-2020	Tanaka, Ryouichi/0000-0002-5858-5326; Takabayashi, Atsushi/0000-0003-1100-7462; Takabayashi, Atsushi/0000-0003-1100-7462	Ministry of Education, Culture, Sports, Science and Technology, Japan; Institute of Low Temperature Science, Hokkaido University;  [23570042]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute of Low Temperature Science, Hokkaido University; 	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan, by Grant-in-Aid for Scientific Research 23570042, and by a leadership research grant from the Institute of Low Temperature Science, Hokkaido University (to R. T.).	Adamska I, 2001, J BIOL CHEM, V276, P8582, DOI 10.1074/jbc.M010447200; Adamska I, 1999, EUR J BIOCHEM, V260, P453, DOI 10.1046/j.1432-1327.1999.00178.x; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; Funk C, 1999, NATO ASI 3 HIGH TECH, V64, P103; GREEN BR, 1995, PHOTOSYNTH RES, V44, P139, DOI 10.1007/BF00018304; GREEN BR, 1991, TRENDS BIOCHEM SCI, V16, P181, DOI 10.1016/0968-0004(91)90072-4; GREEN BR, 1994, PHOTOSYNTH RES, V39, P149, DOI 10.1007/BF00029382; Heddad M, 2000, P NATL ACAD SCI USA, V97, P3741, DOI 10.1073/pnas.050391397; Heddad M, 2006, PLANT PHYSIOL, V142, P75, DOI 10.1104/pp.106.081489; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hernandez-Prieto MA, 2011, BBA-BIOENERGETICS, V1807, P1143, DOI 10.1016/j.bbabio.2011.05.002; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Keller Y, 1998, EUR J BIOCHEM, V251, P413, DOI 10.1046/j.1432-1327.1998.2510413.x; Kufryk G, 2008, PHOTOSYNTH RES, V95, P135, DOI 10.1007/s11120-007-9244-3; Kunugi M, 2013, J BIOL CHEM, V288, P19330, DOI 10.1074/jbc.M113.462663; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Martins BM, 2001, J BIOL CHEM, V276, P44108, DOI 10.1074/jbc.M104759200; Neilson JAD, 2010, GENOME, V53, P68, DOI [10.1139/G09-081, 10.1139/g09-081]; Promnares K, 2006, J BIOL CHEM, V281, P32705, DOI 10.1074/jbc.M606360200; Rizza A, 2011, NEW PHYTOL, V190, P896, DOI 10.1111/j.1469-8137.2010.03637.x; Rossini S, 2006, PLANT PHYSIOL, V141, P1264, DOI 10.1104/pp.106.083055; Salvi D, 2011, METHODS MOL BIOL, V775, P189, DOI 10.1007/978-1-61779-237-3_10; Salvi Daniel, 2008, V432, P19, DOI 10.1007/978-1-59745-028-7_2; Sasaki D, 2011, J MOL BIOL, V409, P543, DOI 10.1016/j.jmb.2011.04.002; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; Sobotka R, 2011, PLANT PHYSIOL, V155, P1735, DOI 10.1104/pp.110.167528; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Storm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055569; Storm P, 2008, PHOTOSYNTH RES, V98, P479, DOI 10.1007/s11120-008-9368-0; Tanaka R, 1999, PLANT PHYSIOL, V120, P695, DOI 10.1104/pp.120.3.695; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Vavilin D, 2007, J BIOL CHEM, V282, P37660, DOI 10.1074/jbc.M707133200; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yao D, 2007, J BIOL CHEM, V282, P267, DOI 10.1074/jbc.M605463200; Yoshimura K, 1999, BIOCHEM J, V338, P41, DOI 10.1042/0264-6021:3380041	42	34	37	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					987	999		10.1074/jbc.M113.525428	http://dx.doi.org/10.1074/jbc.M113.525428			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275650	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000330541200033
J	Dai, HM; Pang, YP; Ramirez-Alvarado, M; Kaufmann, SH				Dai, Haiming; Pang, Yuan-Ping; Ramirez-Alvarado, Marina; Kaufmann, Scott H.			Evaluation of the BH3-only Protein Puma as a Direct Bak Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bcl-2 Family Proteins; Cell Death; Mitochondrial Apoptosis; Molecular Cell Biology; Bak; Puma; Oligomerization	OUTER-MEMBRANE PERMEABILIZATION; COLORECTAL-CANCER CELLS; BCL-2 FAMILY-MEMBERS; INDUCED APOPTOSIS; BH3 DOMAINS; DNA-DAMAGE; MITOCHONDRIAL APOPTOSIS; CONFORMATIONAL-CHANGES; CYTOKINE DEPRIVATION; NEURONAL APOPTOSIS	Interactions among Bcl-2 family proteins play critical roles in cellular life and death decisions. Previous studies have established the BH3-only proteins Bim, tBid, and Noxa as direct activators that are able to directly initiate the oligomerization and activation of Bak and/or Bax. Earlier studies of Puma have yielded equivocal results, with some concluding that it also acts as a direct activator and other studies suggesting that it acts solely as a sensitizer BH3-only protein. In the present study we examined the interaction of Puma BH3 domain or full-length protein with Bak by surface plasmon resonance, assessed Bak oligomerization status by cross-linking followed by immunoblotting, evaluated the ability of the Puma BH3 domain to induce Bak-mediated permeabilization of liposomes and mitochondria, and determined the effect of wild type and mutant Puma on cell viability in a variety of cellular contexts. Results of this analysis demonstrate high affinity (K-D = 26 +/- 5 nm) binding of the Puma BH3 domain to purified Bak ex vivo, leading to Bak homo-oligomerization and membrane permeabilization. Mutations in Puma that inhibit (L141E/M144E/L148E) or enhance (M144I/A145G) Puma BH3 binding to Bak also produce corresponding alterations in Bak oligomerization, Bak-mediated membrane permeabilization and, in a cellular context, Bak-mediated killing. Collectively, these results provide strong evidence that Puma, like Bim, Noxa, and tBid, is able to act as a direct Bak activator.	[Dai, Haiming; Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; [Pang, Yuan-Ping; Kaufmann, Scott H.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Ramirez-Alvarado, Marina] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Kaufmann, SH (corresponding author), Mayo Clin, Div Oncol Res, Gonda 19-212,200 1st St SW, Rochester, MN 55905 USA.	Kaufmann.scott@mayo.edu		Pang, Yuan-Ping/0000-0003-0838-2560; Dai, Haiming/0000-0002-0484-7407; Kaufmann, Scott/0000-0002-4900-7145; Ramirez-Alvarado, Marina/0000-0003-2325-6773	National Institutes of Health [R01 CA166704]; NATIONAL CANCER INSTITUTE [R01CA166741, P30CA015083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA166704.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Adjei PN, 1996, J CLIN INVEST, V98, P2588, DOI 10.1172/JCI119078; Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bernstein AI, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-2; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412; Clybouw C, 2011, BLOOD, V118, P4120, DOI 10.1182/blood-2011-04-347096; Concannon CG, 2007, ONCOGENE, V26, P1681, DOI 10.1038/sj.onc.1209974; Creagh EM, 2001, BIOCHEM SOC T, V29, P696, DOI 10.1042/0300-5127:0290696; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Dai HM, 2009, J BIOL CHEM, V284, P18311, DOI 10.1074/jbc.M109.004770; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Ding HS, 2011, BLOOD, V118, DOI 10.1182/blood-2011-02-334870; Du H, 2011, J BIOL CHEM, V286, P491, DOI 10.1074/jbc.M110.167148; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Edwards AL, 2013, CHEM BIOL, V20, P888, DOI 10.1016/j.chembiol.2013.06.007; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Ekoff M, 2007, BLOOD, V110, P3209, DOI 10.1182/blood-2007-02-073957; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Ewen CL, 2012, CELL DEATH DIFFER, V19, P28, DOI 10.1038/cdd.2011.153; Fadeel B, 1999, FASEB J, V13, P1647, DOI 10.1096/fasebj.13.13.1647; Fischer SF, 2008, P NATL ACAD SCI USA, V105, P3035, DOI 10.1073/pnas.0706913105; Follis AV, 2013, NAT CHEM BIOL, V9, P163, DOI [10.1038/NCHEMBIO.1166, 10.1038/nchembio.1166]; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Ghosh AP, 2009, J NEUROPATH EXP NEUR, V68, P747, DOI 10.1097/NEN.0b013e3181a9d524; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Gray DHD, 2012, IMMUNITY, V37, P451, DOI 10.1016/j.immuni.2012.05.030; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Happo L, 2010, BLOOD, V116, P5256, DOI 10.1182/blood-2010-04-280818; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Jabbour AM, 2010, BLOOD, V115, P344, DOI 10.1182/blood-2009-07-230730; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017; Killian BJ, 2009, J MOL BIOL, V389, P315, DOI 10.1016/j.jmb.2009.04.003; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Mesa RA, 2005, BLOOD, V106, P318, DOI 10.1182/blood-2004-09-3523; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Michalak EM, 2009, CELL DEATH DIFFER, V16, P684, DOI 10.1038/cdd.2008.195; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oh KJ, 2010, J BIOL CHEM, V285, P28924, DOI 10.1074/jbc.M110.135293; Pang YP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00257; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Vela L, 2013, J BIOL CHEM, V288, P4935, DOI 10.1074/jbc.M112.422204; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yu H, 2010, BLOOD, V115, P3472, DOI 10.1182/blood-2009-10-248278; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhang YJ, 2009, MOL BIOL CELL, V20, P3077, DOI 10.1091/mbc.E08-11-1109	79	48	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					89	99		10.1074/jbc.M113.505701	http://dx.doi.org/10.1074/jbc.M113.505701			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24265320	hybrid, Green Published			2022-12-28	WOS:000329370900008
J	Liu, YY; Kim, H; Liang, JC; Lu, WS; Ouyang, B; Liu, D; Zhou, SY				Liu, Yinyin; Kim, Hyeung; Liang, Jiancong; Lu, Weisi; Ouyang, Bin; Liu, Dan; Zhou Songyang			The Death-inducer Obliterator 1 ( Dido1) Gene Regulates Embryonic Stem Cell Self- renewal*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Embryonic Stem Cell; Signal Transduction; Stem Cells; Transcription Factors; Transcription Regulation; Pluripotency; Self-renewal	PROTEIN-INTERACTION NETWORK; OPEN CHROMATIN; IN-VITRO; TRANSCRIPTIONAL NETWORK; SIGNALING PATHWAYS; HISTONE H3K4ME3; PHD FINGER; PLURIPOTENCY; NANOG; EXPRESSION	Background:Dido1 plays important roles in development. Results:Dido1 inhibition led to ES cell differentiation, and its expression promoted ES cell self-renewal. Conclusion: Dido1 participates in ES cell maintenance and forms feedback and feedforward loops with canonical ES cell factors such as Nanog and Oct4. Significance: Dido1 represents a new factor in the ES cell regulatory circuitry for maintaining self-renewal of ES cells. The regulatory network of factors that center on master transcription factors such as Oct4, Nanog, and Sox2 help maintain embryonic stem (ES) cells and ensure their pluripotency. The target genes of these master transcription factors define the ES cell transcriptional landscape. In this study, we report our findings that Dido1, a target of canonical transcription factors such as Oct4, Sox2, and Nanog, plays an important role in regulating ES cell maintenance. We found that depletion of Dido1 in mouse ES cells led to differentiation, and ectopic expression of Dido1 inhibited differentiation induced by leukemia inhibitory factor withdrawal. We further demonstrated that whereas Nanog and Oct4 could occupy the Dido1 locus and promote its transcription, Dido1 could also target to the loci of pluripotency factors such as Nanog and Oct4 and positively regulate their expression. Through this feedback and feedforward loop, Dido1 is able to regulate self-renewal of mouse ES cells	[Lu, Weisi; Ouyang, Bin; Zhou Songyang] Sun Yat Sen Univ, Affiliated Hosp 1, Key Lab Gene Engn,Minist Educ, Sch Life Sci,Sun Yat Sen Univ Baylor Coll Med Joi, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Weisi; Ouyang, Bin; Zhou Songyang] Sun Yat Sen Univ, Affiliated Hosp 1, Key Lab Reprod Med Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yinyin; Kim, Hyeung; Liang, Jiancong; Liu, Dan; Zhou Songyang] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Zhou Songyang] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA	Sun Yat Sen University; Sun Yat Sen University; Baylor College of Medicine; Baylor College of Medicine	Liu, D (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	danl@bcm.edu; songyang@bcm.edu	Liang, Jiancong/AAC-1321-2022; Lu, Weisi/Q-2357-2015	Liang, Jiancong/0000-0002-7215-4346; Lu, Weisi/0000-0001-6039-6009	National Basic Research Program (973 Program) [2010CB945401, 2012CB911201]; National Natural Science Foundation of China [NSFC 91019020, 91213302]; National Institutes of Health (NIH)/NIGMS [GM081627]; NIH/NCI [CA133249, GM095599]; Welch Foundation [Q-1673]; Dan L. Duncan Cancer Center [P30CA125123]; Administrative and Genome-wide RNAi Screens Cores IDDRC [P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123, R01CA133249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627, R01GM095599] Funding Source: NIH RePORTER	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH)/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Welch Foundation(The Welch Foundation); Dan L. Duncan Cancer Center; Administrative and Genome-wide RNAi Screens Cores IDDRC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Basic Research Program (973 Program Grants 2010CB945401 and 2012CB911201), National Natural Science Foundation of China Grants NSFC 91019020 and 91213302, National Institutes of Health (NIH)/NIGMS Grant GM081627, NIH/NCI Grants CA133249 and GM095599, and Welch Foundation Grant Q-1673. This work was also supported by Genome-wide RNAi Screening and Analysis shared resource of the Dan L. Duncan Cancer Center Grant (P30CA125123), and the Administrative and Genome-wide RNAi Screens Cores IDDRC P30HD024064.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Futterer A, 2012, CELL DEATH DIFFER, V19, P132, DOI 10.1038/cdd.2011.62; Futterer A, 2005, J CLIN INVEST, V115, P2351, DOI 10.1172/JCI24177; Garcia-Domingo D, 2003, MOL CELL BIOL, V23, P3216, DOI 10.1128/MCB.23.9.3216-3225.2003; Garcia-Domingo D, 1999, P NATL ACAD SCI USA, V96, P7992, DOI 10.1073/pnas.96.14.7992; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gatchalian J, 2013, CELL REP, V4, P148, DOI 10.1016/j.celrep.2013.06.014; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Prieto I, 2009, CHROMOSOMA, V118, P617, DOI 10.1007/s00412-009-0223-7; Rojas AM, 2005, FEBS J, V272, P3505, DOI 10.1111/j.1742-4658.2005.04759.x; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Santiveri CM, 2013, J BIOMOL NMR, V56, P183, DOI 10.1007/s10858-013-9726-x; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trachana V, 2007, P NATL ACAD SCI USA, V104, P2691, DOI 10.1073/pnas.0611132104; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wan M, 2013, J BIOL CHEM, V288, P5039, DOI 10.1074/jbc.M112.424515; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang Y, 2008, ACTA PHARMACOL SIN, V29, P349, DOI 10.1111/j.1745-7254.2008.00762.x; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	52	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4778	4786		10.1074/jbc.M113.486290	http://dx.doi.org/10.1074/jbc.M113.486290			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24347171	Green Published, hybrid			2022-12-28	WOS:000331607900024
J	Tian, XY; Tian, YF; Gawlak, G; Sarich, N; Wu, TH; Birukova, AA				Tian, Xinyong; Tian, Yufeng; Gawlak, Grzegorz; Sarich, Nicolene; Wu, Tinghuai; Birukova, Anna A.			Control of Vascular Permeability by Atrial Natriuretic Peptide via a GEF-H1-dependent Mechanism*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Dysfunction; Lung Injury; Microtubules; Permeability; Rho GTPases; Signal Transduction; Vascular Biology	EXCHANGE FACTOR GEF-H1; ACUTE LUNG INJURY; ACTIN ORGANIZATION; ENDOTHELIAL-CELLS; KINASE; MICROTUBULES; ACTIVATION; INHIBITION; BINDING; RHOA	Background: Regulation of vascular permeability by microtubule (MT)-associated proteins is not well understood. Results: ANP promoted MT peripheral growth and protected endothelial barrier via Rac-PAK1-dependent inactivation of GEF-H1 and consequent suppression of Rho signaling. Conclusion: A PAK1-GEF-H1 dependent mechanism mediates endothelial barrier protection by ANP. Significance: Modulation of GEF-H1 activity represents a novel approach in prevention of pathologic vascular leak. Microtubule (MT) dynamics is involved in a variety of cell functions, including control of the endothelial cell (EC) barrier. Release of Rho-specific nucleotide exchange factor GEF-H1 from microtubules activates the Rho pathway of EC permeability. In turn, pathologic vascular leak can be prevented by treatment with atrial natriuretic peptide (ANP). This study investigated a novel mechanism of vascular barrier protection by ANP via modulation of GEF-H1 function. In pulmonary ECs, ANP suppressed thrombin-induced disassembly of peripheral MT and attenuated Rho signaling and cell retraction. ANP effects were mediated by the Rac1 GTPase effector PAK1. Activation of Rac1-PAK1 promoted PAK1 interaction with the Rho activator GEF-H1, inducing phosphorylation of total and MT-bound GEF-H1 and leading to attenuation of Rho-dependent actin remodeling. In vivo, ANP attenuated lung injury caused by excessive mechanical ventilation and TRAP peptide (TRAP/HTV), which was further exacerbated in ANP(-/-) mice. The protective effects of ANP against TRAP/HTV-induced lung injury were linked to the increased pool of stabilized MT and inactivation of Rho signaling via ANP-induced, PAK1-dependent inhibitory phosphorylation of GEF-H1. This study demonstrates a novel protective mechanism of ANP against pathologic hyperpermeability and suggests a novel pharmacological intervention for the prevention of increased vascular leak via PAK1-dependent modulation of GEF-H1 activity.	[Tian, Xinyong; Tian, Yufeng; Gawlak, Grzegorz; Sarich, Nicolene; Wu, Tinghuai; Birukova, Anna A.] Univ Chicago, Dept Med, Sect Pulm & Crit Med, Lung Injury Ctr, Chicago, IL 60637 USA	University of Chicago	Birukova, AA (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Med, Lung Injury Ctr, 5841 S Maryland Ave,Off N-613, Chicago, IL 60637 USA.	abirukov@medicine.bsd.uchicago.edu			National Institutes of Health, NHLBI, Public Health Service [HL89257, HL107920]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107920, R01HL089257, R56HL107920] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI, Public Health Service; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Public Health Service Grants HL89257 and HL107920.	Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Baxter GF, 2004, BASIC RES CARDIOL, V99, P71, DOI 10.1007/s00395-004-0457-8; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2005, J CELL PHYSIOL, V204, P934, DOI 10.1002/jcp.20359; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Birukova AA, 2010, TRANSL RES, V155, P44, DOI 10.1016/j.trsl.2009.09.002; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Chen WG, 2008, AM J PHYSIOL-LUNG C, V295, pL575, DOI 10.1152/ajplung.00428.2007; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Dubrovskyi O, 2012, FEBS LETT, V586, P2294, DOI 10.1016/j.febslet.2012.06.016; Dudek SM, 2007, CELL SIGNAL, V19, P1754, DOI 10.1016/j.cellsig.2007.03.011; Essler M, 2000, J IMMUNOL, V164, P6543, DOI 10.4049/jimmunol.164.12.6543; Furst R, 2005, CIRC RES, V96, P43, DOI 10.1161/01.RES.0000151983.01148.06; Groeneveld ABJ, 2002, VASC PHARMACOL, V39, P247, DOI 10.1016/S1537-1891(03)00013-2; Gupta RP, 1999, ARCH BIOCHEM BIOPHYS, V365, P268, DOI 10.1006/abbi.1999.1165; Irwin DC, 2005, AM J PHYSIOL-LUNG C, V288, pL849, DOI 10.1152/ajplung.00294.2004; Jacobson JR, 2007, CURR DRUG TARGETS, V8, P509, DOI 10.2174/138945007780362719; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Klinger JR, 2006, EXP CELL RES, V312, P401, DOI 10.1016/j.yexcr.2005.11.001; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Kosoff R, 2013, J BIOL CHEM, V288, P974, DOI 10.1074/jbc.M112.422295; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; Mirzapolazova T, 2007, EUR RESPIR J, V30, P429, DOI 10.1183/09031936.00154206; Murohara T, 1999, J CARDIOVASC PHARM, V34, P870, DOI 10.1097/00005344-199912000-00015; Nagae S, 2013, GENES CELLS, V18, P387, DOI 10.1111/gtc.12044; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Shivanna M, 2009, EXP EYE RES, V89, P950, DOI 10.1016/j.exer.2009.08.004; Tasaka S, 2005, AM J RESP CELL MOL, V32, P504, DOI 10.1165/rcmb.2004-0009OC; Tian XY, 2012, FASEB J, V26, P3862, DOI 10.1096/fj.12-207746; Waheed F, 2013, MOL BIOL CELL, V24, P1068, DOI 10.1091/mbc.E12-09-0661; Xing JJ, 2011, J APPL PHYSIOL, V110, P213, DOI 10.1152/japplphysiol.00284.2010; Xing JJ, 2010, MICROVASC RES, V79, P56, DOI 10.1016/j.mvr.2009.11.006; Yamahashi Y, 2011, J BIOL CHEM, V286, P44576, DOI 10.1074/jbc.M111.267021; Yoshimura Y, 2011, BIOCHEM BIOPH RES CO, V408, P322, DOI 10.1016/j.bbrc.2011.04.032; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200	48	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5168	5183		10.1074/jbc.M113.493924	http://dx.doi.org/10.1074/jbc.M113.493924			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24352660	hybrid, Green Published			2022-12-28	WOS:000331607900059
J	Kohler, TP; Gisch, N; Binsker, U; Schlag, M; Darm, K; Volker, U; Zahringer, U; Hammerschmidt, S				Kohler, Thomas P.; Gisch, Nicolas; Binsker, Ulrike; Schlag, Martin; Darm, Katrin; Voelker, Uwe; Zaehringer, Ulrich; Hammerschmidt, Sven			Repeating Structures of the Major Staphylococcal Autolysin Are Essential for the Interaction with Human Thrombospondin 1 and Vitronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Extracellular Matrix Proteins; Pathogenesis; Staphylococcus; Thrombospondin; Autolysin; Repeats; Vitronectin	ADHESIVE MATRIX MOLECULES; EXTRACELLULAR ADHERENCE PROTEIN; STREPTOCOCCUS-PNEUMONIAE; SOLUBLE FIBRIN; AUREUS; BINDING; HOST; EPIDERMIDIS; IDENTIFICATION; COLONIZATION	Human thrombospondin 1 (hTSP-1) is a matricellular glycoprotein facilitating bacterial adherence to and invasion into eukaryotic cells. However, the bacterial adhesin(s) remain elusive. In this study, we show a dose-dependent binding of soluble hTSP-1 to Gram-positive but not Gram-negative bacteria. Diminished binding of soluble hTSP-1 to proteolytically pretreated staphylococci suggested a proteinaceous nature of potential bacterial adhesin(s) for hTSP-1. A combination of separation of staphylococcal surface proteins by two-dimensional gel electrophoresis with a ligand overlay assay with hTSP-1 and identification of the target protein by mass spectrometry revealed the major staphylococcal autolysin Atl as a bacterial binding protein for hTSP-1. Binding experiments with heterologously expressed repeats of the AtlE amidase from Staphylococcus epidermidis suggest that the repeating sequences (R1(ab)-R2(ab)) of the N-acetyl-muramoyl-l-alanine amidase of Atl are essential for binding of hTSP-1. Atl has also been identified previously as a staphylococcal vitronectin (Vn)-binding protein. Similar to the interaction with hTSP-1, the R1(ab)-R2(ab) repeats of Atl are shown here to be crucial for the interaction of Atl with the complement inhibition and matrix protein Vn. Competition assays with hTSP-1 and Vn revealed the R1(ab)-R2(ab) repeats of AtlE as the common binding domain for both host proteins. Furthermore, Vn competes with hTSP-1 for binding to Atl repeats and vice versa. In conclusion, this study identifies the Atl repeats as bacterial adhesive structures interacting with the human glycoproteins hTSP-1 and Vn. Finally, this study provides insight into the molecular interplay between hTSP-1 and Vn, respectively, and a bacterial autolysin.	[Kohler, Thomas P.; Binsker, Ulrike; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Genet Microorganisms, D-17487 Greifswald, Germany; [Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Funct Genom, D-17487 Greifswald, Germany; [Darm, Katrin] Ernst Moritz Arndt Univ Greifswald, Dept Otorhinolaryngol Head & Neck Surg, D-17487 Greifswald, Germany; [Gisch, Nicolas; Zaehringer, Ulrich] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Bioanalyt Chem, D-23845 Borstel, Germany; [Schlag, Martin] Univ Tubingen, Dept Microbial Genet, D-72076 Tubingen, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Forschungszentrum Borstel; Eberhard Karls University of Tubingen	Hammerschmidt, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Genet Microorganisms, Friedrich Ludwig Jahn Str 15a, D-17487 Greifswald, Germany.	sven.hammerschmidt@uni-greifswald.de	Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681; Gisch, Nicolas/0000-0003-3260-5269; Volker, Uwe/0000-0002-5689-3448	Deutsche Forschungsgemeinschaft [SFB TRR 34, DFG HA 3125/2-1, ZA 149/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB TRR 34, Project C10 (to S. H.), DFG HA 3125/2-1, and ZA 149/6-1.	ASCH AS, 1986, P NATL ACAD SCI USA, V83, P2904, DOI 10.1073/pnas.83.9.2904; Attali C, 2008, INFECT IMMUN, V76, P466, DOI 10.1128/IAI.01261-07; BAENZIGE.NL, 1971, P NATL ACAD SCI USA, V68, P240, DOI 10.1073/pnas.68.1.240; BERGER H, 1982, J BACTERIOL, V152, P1241; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bertling A, 2012, ARTERIOSCL THROM VAS, V32, P1979, DOI 10.1161/ATVBAHA.112.246249; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Burian M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010040; Calzada MJ, 2003, J BIOL CHEM, V278, P40679, DOI 10.1074/jbc.M302014200; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; CHHATWAL GS, 1987, INFECT IMMUN, V55, P1878, DOI 10.1128/IAI.55.8.1878-1883.1987; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Geisbrecht BV, 2005, J BIOL CHEM, V280, P17243, DOI 10.1074/jbc.M412311200; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; HERRMANN M, 1991, INFECT IMMUN, V59, P279, DOI 10.1128/IAI.59.1.279-288.1991; HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693; Hirschhausen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040353; Hirschhausen N, 2010, CELL MICROBIOL, V12, P1746, DOI 10.1111/j.1462-5822.2010.01506.x; Hussain M, 2008, INFECT IMMUN, V76, P5615, DOI 10.1128/IAI.00480-08; Hussain M, 2008, J CLIN MICROBIOL, V46, P470, DOI 10.1128/JCM.01425-07; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; JAFFE EA, 1985, BLOOD, V65, P79; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Johannessen M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00056; Kang MS, 2013, J BIOL CHEM, V288, P20520, DOI 10.1074/jbc.M113.454462; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Krauel K, 2012, BLOOD, V120, P3345, DOI 10.1182/blood-2012-06-434985; Li DQ, 2001, CURR MICROBIOL, V42, P361, DOI 10.1007/s002840010230; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lundberg F, 1997, J MED MICROBIOL, V46, P285, DOI 10.1099/00222615-46-4-285; MACK D, 1994, INFECT IMMUN, V62, P3244, DOI 10.1128/IAI.62.8.3244-3253.1994; Mack D, 1999, INFECT IMMUN, V67, P1004, DOI 10.1128/IAI.67.2.1004-1008.1999; Mann B, 2006, INFECT IMMUN, V74, P821, DOI 10.1128/IAI.74.2.821-829.2006; Masiuk H, 2010, J CLIN MICROBIOL, V48, P1527, DOI 10.1128/JCM.02094-09; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Narizhneva NV, 2005, FASEB J, V19, P1158, DOI 10.1096/fj.04-3310fje; Nebrich G, 2007, ELECTROPHORESIS, V28, P1607, DOI 10.1002/elps.200600656; Niemann S, 2004, CIRCULATION, V110, P193, DOI 10.1161/01.CIR.0000134486.93030.E7; Niemann S, 2009, THROMB HAEMOSTASIS, V102, P735, DOI 10.1160/TH09-01-0049; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Paterson GK, 2010, MOL MICROBIOL, V77, P1, DOI 10.1111/j.1365-2958.2010.07190.x; Preissner KT, 2011, SEMIN THROMB HEMOST, V37, P408, DOI 10.1055/s-0031-1276590; PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P189; RAUGI GJ, 1987, AM J PATHOL, V129, P364; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Tang MX, 2011, MOL CELL BIOCHEM, V346, P49, DOI 10.1007/s11010-010-0590-7; Thiele T, 2012, J PROTEOMICS, V76, P297, DOI 10.1016/j.jprot.2012.04.057; Vazquez V, 2011, J BIOL CHEM, V286, P29797, DOI 10.1074/jbc.M110.214981; Voss S, 2012, MOL ORAL MICROBIOL, V27, P246, DOI 10.1111/j.2041-1014.2012.00654.x; Voss S, 2013, J BIOL CHEM, V288, P15614, DOI 10.1074/jbc.M112.443507; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; Yanagisawa N, 2001, J MED MICROBIOL, V50, P712, DOI 10.1099/0022-1317-50-8-712; Zoll S, 2012, J BACTERIOL, V194, P3789, DOI 10.1128/JB.00331-12; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	67	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4070	4082		10.1074/jbc.M113.521229	http://dx.doi.org/10.1074/jbc.M113.521229			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24371140	Green Published, hybrid			2022-12-28	WOS:000331403800021
J	Yoon, JH; Choi, WI; Jeon, BN; Koh, DI; Kim, MK; Kim, MH; Kim, J; Hur, SS; Kim, KS; Hur, MW				Yoon, Jae-Hyeon; Choi, Won-Il; Jeon, Bu-Nam; Koh, Dong-In; Kim, Min-Kyeong; Kim, Myung-Hwa; Kim, Jungho; Hur, Sujin Susanne; Kim, Kyung-Sup; Hur, Man-Wook			Human Kruppel-related 3 (HKR3) Is a Novel Transcription Activator of Alternate Reading Frame (ARF) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ARF; Cell Cycle; Cell Proliferation; p300; p53; Transcription; FBI-1; HKR3; POZ	TUMOR-SUPPRESSOR GENE; REPRESSES TRANSCRIPTION; BREAST-CANCER; P53; BINDS; PATHWAYS; PROTEIN; LOCUS; FBI-1; MDM2	HKR3 (Human Kruppel-related 3) is a novel POK (POZ-domain Kruppel-like zinc-finger) family transcription factor. Recently, some of the POK (POZ-domain Kruppel-like zinc finger) family proteins have been shown to play roles in cell cycle arrest, apoptosis, cell proliferation, and oncogenesis. We investigated whether HKR3, an inhibitor of cell proliferation and an uncharacterized POK family protein, could regulate the cell cycle by controlling expression of genes within the p53 pathway (ARF-MDM2-TP53-p21WAF/CDKN1A). HKR3 potently activated the transcription of the tumor suppressor gene ARF by acting on the proximal promoter region (bp, -149 approximate to+53), which contains Sp1 and FBI-1 binding elements (FREs). HKR3 interacted with the co-activator p300 to activate ARF transcription, which increased the acetylation of histones H3 and H4 within the proximal promoter. Oligonucleotide pull-down assays and ChIP assays revealed that HKR3 interferes with the binding of the proto-oncogenic transcription repressor FBI-1 to proximal FREs, thus derepressing ARF transcription.	[Yoon, Jae-Hyeon; Choi, Won-Il; Jeon, Bu-Nam; Koh, Dong-In; Kim, Min-Kyeong; Kim, Myung-Hwa; Kim, Kyung-Sup; Hur, Man-Wook] Yonsei Univ, Severance Biomed Sci Inst, Dept Biochem & Mol Biol, Brain Korea PLUS Project Med Sci 21,Sch Med, Seoul 120752, South Korea; [Kim, Jungho] Sogang Univ, Dept Life Res, Seoul 121742, South Korea; [Hur, Sujin Susanne] Sookmyung Girls High Sch, Seoul 135505, South Korea	Yonsei University; Sogang University	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, 50 Yon Sei Ro, Seoul 120752, South Korea.	mwhur2@yuhs.ac		CHOI, WONIL/0000-0002-4837-0436; Hur, Man-Wook/0000-0002-3416-1334; Kim, Kyung-sup/0000-0001-8483-8537	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A090815]; DOYAK Research Grant [2011-0028817]; MRC Research Grant from the National Research Foundation of Korea (NRF) of the Korean Government (MSIP) [NRF-2011-0030086]	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; DOYAK Research Grant; MRC Research Grant from the National Research Foundation of Korea (NRF) of the Korean Government (MSIP)	This work was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A090815), and was also supported by the DOYAK Research Grant (2011-0028817, to M.-W. H.) and MRC Research Grant (NRF-2011-0030086) from the National Research Foundation of Korea (NRF) of the Korean Government (MSIP).	Ameyar-Zazoua M, 2005, ONCOGENE, V24, P2298, DOI 10.1038/sj.onc.1208424; Bauer A, 2001, GENE CHROMOSOME CANC, V31, P228, DOI 10.1002/gcc.1139; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Choi WI, 2009, J BIOL CHEM, V284, P12633, DOI 10.1074/jbc.M809794200; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Jeon BN, 2009, J BIOL CHEM, V284, P17935, DOI 10.1074/jbc.M809559200; Juven-Gershon T, 1999, MOL MED, V5, P71, DOI 10.1007/BF03402141; Kim MK, 2013, J BIOL CHEM, V288, P7053, DOI 10.1074/jbc.M112.416297; Kim MH, 2007, CELL PHYSIOL BIOCHEM, V20, P703, DOI 10.1159/000110431; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Koh DI, 2009, J BIOL CHEM, V284, P19856, DOI 10.1074/jbc.M109.025817; Kuo ML, 2003, CANCER RES, V63, P1046; Lee KM, 2012, ONCOGENE, V31, P1442, DOI 10.1038/onc.2011.331; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maris JM, 1997, EUR J CANCER, V33, P1991, DOI 10.1016/S0959-8049(97)00279-7; Modestou M, 2001, CANCER RES, V61, P3145; Moll UM, 2003, MOL CANCER RES, V1, P1001; Morrison DJ, 1999, NUCLEIC ACIDS RES, V27, P1251, DOI 10.1093/nar/27.5.1251; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Pessler F, 1997, MOL CELL BIOL, V17, P3786, DOI 10.1128/MCB.17.7.3786; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Silva J, 2003, J PATHOL, V199, P289, DOI 10.1002/path.1297; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Yarbrough WG, 2002, CANCER RES, V62, P1171; Yarosh W, 2008, CANCER RES, V68, P693, DOI 10.1158/0008-5472.CAN-07-5012; Zeng YX, 2011, CANCER RES, V71, P2781, DOI 10.1158/0008-5472.CAN-10-3483; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	41	6	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4018	4031		10.1074/jbc.M113.526855	http://dx.doi.org/10.1074/jbc.M113.526855			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24382891	hybrid, Green Published			2022-12-28	WOS:000331403800017
J	Dahlberg, CL; Juo, P				Dahlberg, Caroline L.; Juo, Peter			The WD40-repeat Proteins WDR-20 and WDR-48 Bind and Activate the Deubiquitinating Enzyme USP-46 to Promote the Abundance of the Glutamate Receptor GLR-1 in the Ventral Nerve Cord of Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caenorhabditis elegans; Deubiquitination; Glutamate Receptors Ionotropic (AMPA; NMDA); Neurons; Synapses; Ubiquitin	C-ELEGANS; UBIQUITIN LIGASE; DEGRADATION; TRAFFICKING; ENDOCYTOSIS; PLASTICITY; LOCALIZATION; PROTEASOME; PATHWAYS; SUBUNIT	Background: USP-46 deubiquitinates the C. elegans glutamate receptor GLR-1. Results: WDR-20 and WDR-48 bind and activate USP-46 in vitro and increase the abundance of GLR-1 in neurons. Conclusion: WD40-repeat proteins stimulate USP-46 activity, resulting in increased GLR-1 stability in neurons and alterations in glutamate-dependent behavior. Significance: WD40-repeat protein regulation of DUB activity is important for glutamate receptor trafficking in vivo. Ubiquitin-mediated endocytosis and degradation of glutamate receptors controls their synaptic abundance and is implicated in modulating synaptic strength. The deubiquitinating enzymes (DUBs) that function in the nervous system are beginning to be defined, but the mechanisms that control DUB activity in vivo are understood poorly. We found previously that the DUB USP-46 deubiquitinates the Caenorhabditis elegans glutamate receptor GLR-1 and prevents its degradation in the lysosome. The WD40-repeat (WDR) proteins WDR20 and WDR48/UAF1 have been shown to bind to USP46 and stimulate its catalytic activity in other systems. Here we identify the C. elegans homologs of these WDR proteins and show that C. elegans WDR-20 and WDR-48 can bind and stimulate USP-46 catalytic activity in vitro. Overexpression of these activator proteins in vivo increases the abundance of GLR-1 in the ventral nerve cord, and this effect is further enhanced by coexpression of USP-46. Biochemical characterization indicates that this increase in GLR-1 abundance correlates with decreased levels of ubiquitin-GLR-1 conjugates, suggesting that WDR-20, WDR-48, and USP-46 function together to deubiquitinate and stabilize GLR-1 in neurons. Overexpression of WDR-20 and WDR-48 results in alterations in locomotion behavior consistent with increased glutamatergic signaling, and this effect is blocked in usp-46 loss-of-function mutants. Conversely, wdr-20 and wdr-48 loss-of-function mutants exhibit changes in locomotion behavior that are consistent with decreased glutamatergic signaling. We propose that WDR-20 and WDR-48 form a complex with USP-46 and stimulate the DUB to deubiquitinate and stabilize GLR-1 in vivo.	[Dahlberg, Caroline L.; Juo, Peter] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA	Tufts University	Juo, P (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, 150 Harrison Ave, Boston, MA 02111 USA.	peter.juo@tufts.edu	Dahlberg, Caroline/AAP-1285-2021; Juo, Peter/CJY-3695-2022	Juo, Peter/0000-0002-3039-2266	National Institutes of Health [R01NS059953, 5K12GM074869]; Natalie V. Zucker Research Grant; Tufts Center for Neuroscience Research [P30NS047243]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM074869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059953, P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natalie V. Zucker Research Grant; Tufts Center for Neuroscience Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS059953 (to P. J.) and 5K12GM074869 (Training in Education and Critical Research Skills Postdoctoral Program) (to C. L. D.). This work was also supported by a Natalie V. Zucker Research Grant (to C. L. D.) and the Tufts Center for Neuroscience Research Grant P30NS047243.	Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Cheeseman Iain M, 2005, Sci STKE, V2005, ppl1, DOI 10.1126/stke.2662005pl1; Chun DK, 2008, MOL BIOL CELL, V19, P2682, DOI 10.1091/mbc.E07-11-1120; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Emtage L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004613; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Fu AKY, 2011, NAT NEUROSCI, V14, P181, DOI 10.1038/nn.2715; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Imai S., 2012, PLOS ONE, V7; Joo HY, 2011, J BIOL CHEM, V286, P7190, DOI 10.1074/jbc.M110.158311; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Juo P, 2007, MOL BIOL CELL, V18, P3883, DOI 10.1091/mbc.E06-09-0818; Kanga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038071; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kouranti I, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000471; Kowalski JR, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/892749; Kowalski JR, 2011, J NEUROSCI, V31, P1341, DOI 10.1523/JNEUROSCI.4765-10.2011; Li X, 2013, ONCOGENE, V32, P471, DOI 10.1038/onc.2012.66; Lin A, 2011, J NEUROCHEM, V119, P27, DOI 10.1111/j.1471-4159.2011.07221.x; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lussier MP, 2012, P NATL ACAD SCI USA, V109, P19426, DOI 10.1073/pnas.1217477109; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; McCloskey RJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003092; Moretti J, 2012, J BIOL CHEM, V287, P29429, DOI 10.1074/jbc.M112.366807; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Park EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004284; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Schaefer H, 2006, MOL BIOL CELL, V17, P1250, DOI 10.1091/mbc.E05-08-0794; Schwarz LA, 2012, MOL CELL NEUROSCI, V49, P387, DOI 10.1016/j.mcn.2011.08.006; Schwarz LA, 2010, J NEUROSCI, V30, P16718, DOI 10.1523/JNEUROSCI.3686-10.2010; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Strange K, 2007, NAT PROTOC, V2, P1003, DOI 10.1038/nprot.2007.143; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wang R, 2012, NEURON, V75, P838, DOI 10.1016/j.neuron.2012.06.038; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	54	25	33	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3444	3456		10.1074/jbc.M113.507541	http://dx.doi.org/10.1074/jbc.M113.507541			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24356955	hybrid, Green Published			2022-12-28	WOS:000331368700029
J	Di Bernardini, E; Campagnolo, P; Margariti, A; Zampetaki, A; Karamariti, E; Hu, YH; Xu, QB				Di Bernardini, Elisabetta; Campagnolo, Paola; Margariti, Andriana; Zampetaki, Anna; Karamariti, Eirini; Hu, Yanhua; Xu, Qingbo			Endothelial Lineage Differentiation from Induced Pluripotent Stem Cells Is Regulated by MicroRNA-21 and Transforming Growth Factor beta 2 (TGF-beta 2) Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Induced Pluripotent Stem Cells; MicroRNA; Transforming Growth Factor Beta (TGFbeta); Vascular Endothelial Growth Factor (VEGF)	SMOOTH-MUSCLE; ANGIOGENESIS; EXPRESSION; MODULATION; INDUCTION	Background: Induced pluripotent stem cells (iPSCs) constitute an attractive source of cells for regenerative medicine. Results: MicroRNA-21 mediates endothelial differentiation derived from iPSCs in presence of VEGF. Conclusion: MicroRNA-21 and TGF-2 signaling pathways regulate iPSC differentiation to endothelial lineage. Significance: Elucidation of the molecular mechanisms underlying microRNA-21-regulated iPSC differentiation might provide the basic information for stem cell therapy of vascular diseases. Finding a suitable cell source for endothelial cells (ECs) for cardiovascular regeneration is a challenging issue for regenerative medicine. In this paper, we describe a novel mechanism regulating induced pluripotent stem cells (iPSC) differentiation into ECs, with a particular focus on miRNAs and their targets. We first established a protocol using collagen IV and VEGF to drive the functional differentiation of iPSCs into ECs and compared the miRNA signature of differentiated and undifferentiated cells. Among the miRNAs overrepresented in differentiated cells, we focused on microRNA-21 (miR-21) and studied its role in iPSC differentiation. Overexpression of miR-21 in predifferentiated iPSCs induced EC marker up-regulation and in vitro and in vivo capillary formation; accordingly, inhibition of miR-21 produced the opposite effects. Importantly, miR-21 overexpression increased TGF-2 mRNA and secreted protein level, consistent with the strong up-regulation of TGF-2 during iPSC differentiation. Indeed, treatment of iPSCs with TGF-2 induced EC marker expression and in vitro tube formation. Inhibition of SMAD3, a downstream effector of TGF-2, strongly decreased VE-cadherin expression. Furthermore, TGF-2 neutralization and knockdown inhibited miR-21-induced EC marker expression. Finally, we confirmed the PTEN/Akt pathway as a direct target of miR-21, and we showed that PTEN knockdown is required for miR-21-mediated endothelial differentiation. In conclusion, we elucidated a novel signaling pathway that promotes the differentiation of iPSC into functional ECs suitable for regenerative medicine applications.	[Di Bernardini, Elisabetta; Campagnolo, Paola; Margariti, Andriana; Zampetaki, Anna; Karamariti, Eirini; Hu, Yanhua; Xu, Qingbo] Kings Coll London, BHF Ctr, Div Cardiovasc, London SE5 9NU, England	University of London; King's College London	Xu, QB (corresponding author), Kings Coll London, BHF Ctr, Div Cardiovasc, 125 Coldharbour Ln, London SE5 9NU, England.	qingbo.xu@kcl.ac.uk	Campagnolo, Paola/F-7149-2015; Margariti, Andriana/AAH-5318-2019	Campagnolo, Paola/0000-0002-8957-3969; Zampetaki, Anna/0000-0002-7257-8624	Marie Curie initial training network fellowship from the European Union; British Heart Foundation; British Heart Foundation [RG/09/004/27647, FS/13/18/30207] Funding Source: researchfish	Marie Curie initial training network fellowship from the European Union; British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by a Marie Curie initial training network fellowship from the European Union and a grant from British Heart Foundation.	Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; Bian ZM, 2007, EXP EYE RES, V84, P812, DOI 10.1016/j.exer.2006.12.016; Campagnolo P, 2010, CIRCULATION, V121, P1735, DOI 10.1161/CIRCULATIONAHA.109.899252; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Daubman S, 2010, CIRC RES, V106, P423, DOI 10.1161/RES.0b013e3181d61a0d; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; FISHMAN AP, 1982, ANN NY ACAD SCI, V401, P1, DOI 10.1111/j.1749-6632.1982.tb25702.x; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gilbert S.F., 2000, DEV BIOL; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Hibino N, 2012, J THORAC CARDIOV SUR, V143, P696, DOI 10.1016/j.jtcvs.2011.06.046; Itoh F, 2012, BLOOD, V119, P5320, DOI 10.1182/blood-2011-12-395772; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kane NM, 2010, ARTERIOSCL THROM VAS, V30, P1389, DOI 10.1161/ATVBAHA.110.204800; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Kong J, 2012, PLOS ONE, V7; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Liu LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026285; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Ma J, 2012, CLIN EXP OPHTHALMOL, V40, pE76, DOI 10.1111/j.1442-9071.2011.02618.x; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; Massague J, 2000, GENE DEV, V14, P627; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Nowak G, 2004, CIRCULATION, V110, P3699, DOI 10.1161/01.CIR.0000143626.16576.51; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Okamoto H., 2012, PLOS ONE, V7; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Sabatel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016979; Sandoo A, 2010, OPEN CARDIOVASC MED, V4, P302, DOI 10.2174/1874192401004010302; Shin KK, 2012, BIOCHEM BIOPH RES CO, V422, P633, DOI 10.1016/j.bbrc.2012.05.040; Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Wu FS, 2009, BIOCHEM BIOPH RES CO, V386, P549, DOI 10.1016/j.bbrc.2009.06.075; Xia C, 2006, J CELL PHYSIOL, V209, P56, DOI 10.1002/jcp.20707; Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50; Xue GD, 2012, CANCER DISCOV, V2, P248, DOI 10.1158/2159-8290.CD-11-0270; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhu SK, 2013, CIRC RES, V112, P152, DOI 10.1161/CIRCRESAHA.112.280016	45	71	71	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3383	3393		10.1074/jbc.M113.495531	http://dx.doi.org/10.1074/jbc.M113.495531			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24356956	Green Published, hybrid			2022-12-28	WOS:000331368700024
J	Liu, F; Wang, XB; Hu, GQ; Wang, Y; Zhou, JL				Liu, Fang; Wang, Xiaobo; Hu, Guoqing; Wang, Yong; Zhou, Jiliang			The Transcription Factor TEAD1 Represses Smooth Muscle-specific Gene Expression by Abolishing Myocardin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Smooth Muscle; Tissue-specific Transcription Factors; Transcription Factors; Vascular Biology; Vascular Smooth Muscle Cells; TEAD1; Smooth Muscle Phenotypic Modulation; Transcriptional regulation	SERUM RESPONSE FACTOR; ENHANCER FACTOR-I; ALPHA-ACTIN PROMOTER; CELL DIFFERENTIATION; ARTERIAL INJURY; MCAT ELEMENTS; PROTEIN; GROWTH; ACTIVATION; INDUCTION	Background: The function of TEAD1 in the expression of smooth muscle-specific genes is unknown. Results: TEAD1 is induced after arterial injury and suppresses the expression of smooth muscle-specific genes by abolishing myocardin function. Conclusion: TEAD1 is a novel repressor for smooth muscle contractile gene expression. Significance: This study provides novel evidence that TEAD1 is critical for promoting phenotypic switching in smooth muscle cells. The TEAD (transcriptional enhancer activator domain) proteins share an evolutionarily conserved DNA-binding TEA domain, which binds to the MCAT cis-acting regulatory element. Previous studies have shown that TEAD proteins are involved in regulating the expression of smooth muscle -actin. However, it remains undetermined whether TEAD proteins play a broader role in regulating expression of other genes in vascular smooth muscle cells. In this study, we show that the expression of TEAD1 is significantly induced during smooth muscle cell phenotypic modulation and negatively correlates with smooth muscle-specific gene expression. We further demonstrate that TEAD1 plays a novel role in suppressing expression of smooth muscle-specific genes, including smooth muscle -actin, by abolishing the promyogenic function of myocardin, a key mediator of smooth muscle differentiation. Mechanistically, we found that TEAD1 competes with myocardin for binding to serum response factor (SRF), resulting in disruption of myocardin and SRF interactions and thereby attenuating expression of smooth muscle-specific genes. This study provides the first evidence demonstrating that TEAD1 is a novel general repressor of smooth muscle-specific gene expression through interfering with myocardin binding to SRF.	[Liu, Fang; Hu, Guoqing; Wang, Yong; Zhou, Jiliang] Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Wang, Xiaobo] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	University System of Georgia; Augusta University; Albany Medical College	Zhou, JL (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	jizhou@gru.edu	Wang, Xiaobo/J-4312-2014; Wang, Xiaobo/S-2476-2019	Wang, Xiaobo/0000-0001-6044-914X; Wang, Yong/0000-0001-6602-0491	National Institutes of Health from NHLBI [HL109605]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109605] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL109605 from NHLBI (to J. Z.).	Anbanandam A, 2006, P NATL ACAD SCI USA, V103, P17225, DOI 10.1073/pnas.0607171103; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; CLOWES AW, 1983, LAB INVEST, V49, P327; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Gan Q, 2007, CIRC RES, V101, P883, DOI 10.1161/CIRCRESAHA.107.154831; Gupta M, 2001, J BIOL CHEM, V276, P10413, DOI 10.1074/jbc.M008625200; Gupta MP, 1997, MOL CELL BIOL, V17, P3924, DOI 10.1128/MCB.17.7.3924; Herring BP, 2007, CIRC RES, V101, P856, DOI 10.1161/CIRCRESAHA.107.164053; Hu GQ, 2010, J BIOL CHEM, V285, P11800, DOI 10.1074/jbc.M109.079384; Jacquemin P, 1998, DEV DYNAM, V212, P423, DOI 10.1002/(SICI)1097-0177(199807)212:3<423::AID-AJA10>3.0.CO;2-1; KARNS LR, 1995, J BIOL CHEM, V270, P410, DOI 10.1074/jbc.270.1.410; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; MAR JH, 1988, P NATL ACAD SCI USA, V85, P6404, DOI 10.1073/pnas.85.17.6404; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Mizuno T, 2012, ONCOGENE, V31, P5117, DOI 10.1038/onc.2012.5; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pasquet S, 2006, J BIOL CHEM, V281, P34406, DOI 10.1074/jbc.M602282200; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; RINDT H, 1993, J BIOL CHEM, V268, P5332; Swartz EA, 1998, AM J PHYSIOL-CELL PH, V275, pC608, DOI 10.1152/ajpcell.1998.275.2.C608; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang XB, 2012, ARTERIOSCL THROM VAS, V32, P2662, DOI 10.1161/ATVBAHA.112.254730; Wang XB, 2011, J BIOL CHEM, V286, P41589, DOI 10.1074/jbc.M111.250878; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; YASUNAMI M, 1995, J BIOL CHEM, V270, P18649, DOI 10.1074/jbc.270.31.18649; Yoshida T, 2008, ARTERIOSCL THROM VAS, V28, P8, DOI 10.1161/ATVBAHA.107.155788; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhou JL, 2010, J BIOL CHEM, V285, P23175, DOI 10.1074/jbc.M110.109868; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229; Zhou JL, 2008, J BIOL CHEM, V283, P35383, DOI 10.1074/jbc.M805489200; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200	34	32	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3308	3316		10.1074/jbc.M113.515817	http://dx.doi.org/10.1074/jbc.M113.515817			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24344135	Green Published, hybrid			2022-12-28	WOS:000331368700018
J	Watanabe, H; Yamasaki, K; Honda, S				Watanabe, Hideki; Yamasaki, Kazuhiko; Honda, Shinya			Tracing Primordial Protein Evolution through Structurally Guided Stepwise Segment Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Phage Display; Protein Design; Protein Engineering; Protein Evolution; Protein Structure; Artificial Protein; Chignolin; Primordial Protein	BETA-HAIRPIN; PEPTIDE; DYNAMICS; DISPLAY; BINDING; DESIGN; GENES; EXCHANGE; SCAFFOLD; DOMAINS	Background: Evolutionary protein design provides a deeper understanding of how primordial proteins emerged. Results: An evolutionary model is proposed on the basis of structurally guided stepwise segment elongation. Conclusion: The structural guidance facilitates structural organization and gain-of-function of a generated 25-residue artificial protein. Significance: This study provides insights into how primordial protein evolution may have been promoted by structural guidance. The understanding of how primordial proteins emerged has been a fundamental and longstanding issue in biology and biochemistry. For a better understanding of primordial protein evolution, we synthesized an artificial protein on the basis of an evolutionary hypothesis, segment-based elongation starting from an autonomously foldable short peptide. A 10-residue protein, chignolin, the smallest foldable polypeptide ever reported, was used as a structural support to facilitate higher structural organization and gain-of-function in the development of an artificial protein. Repetitive cycles of segment elongation and subsequent phage display selection successfully produced a 25-residue protein, termed AF.2A1, with nanomolar affinity against the Fc region of immunoglobulin G. AF.2A1 shows exquisite molecular recognition ability such that it can distinguish conformational differences of the same molecule. The structure determined by NMR measurements demonstrated that AF.2A1 forms a globular protein-like conformation with the chignolin-derived -hairpin and a tryptophan-mediated hydrophobic core. Using sequence analysis and a mutation study, we discovered that the structural organization and gain-of-function emerged from the vicinity of the chignolin segment, revealing that the structural support served as the core in both structural and functional development. Here, we propose an evolutionary model for primordial proteins in which a foldable segment serves as the evolving core to facilitate structural and functional evolution. This study provides insights into primordial protein evolution and also presents a novel methodology for designing small sized proteins useful for industrial and pharmaceutical applications.	[Watanabe, Hideki; Yamasaki, Kazuhiko; Honda, Shinya] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Honda, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	s.honda@aist.go.jp	Watanabe, Hideki/M-2711-2018; Yamasaki, Kazuhiko/L-7108-2018; Honda, Shinya/K-6894-2016	Watanabe, Hideki/0000-0002-9561-4077; Yamasaki, Kazuhiko/0000-0003-0320-9697; Honda, Shinya/0000-0002-7878-3944	Ministry of Education, Culture, Sports, Science and Technology; New Energy and Industrial Technology Development Organization of Japan; Grants-in-Aid for Scientific Research [23510273, 26350968] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for young scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology and by grant program "Development of New Functional Antibody Technologies" from New Energy and Industrial Technology Development Organization of Japan. All authors are inventors on a patent pending using aspects of this system.	BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BLAKE CCF, 1978, NATURE, V273, P267, DOI 10.1038/273267a0; BLANCO FJ, 1994, NAT STRUCT BIOL, V1, P584, DOI 10.1038/nsb0994-584; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P6922, DOI 10.1021/bi00242a016; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Chao FA, 2013, NAT CHEM BIOL, V9, P81, DOI [10.1038/NCHEMBIO.1138, 10.1038/nchembio.1138]; Cochran AG, 2001, J AM CHEM SOC, V123, P625, DOI 10.1021/ja003369x; Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898; Curnow P, 2011, P NATL ACAD SCI USA, V108, P14133, DOI 10.1073/pnas.1012594108; Davis CM, 2012, J AM CHEM SOC, V134, P14476, DOI 10.1021/ja3046734; de Bono S, 2005, P NATL ACAD SCI USA, V102, P1396, DOI 10.1073/pnas.0407298102; Dias RLA, 2006, J AM CHEM SOC, V128, P2726, DOI 10.1021/ja057513w; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Goddard T. D., 2006, SPARKY VERSION 3; Hatfield MPD, 2010, J PHYS CHEM B, V114, P3028, DOI 10.1021/jp910465e; Herman RE, 2007, J BIOL CHEM, V282, P9813, DOI 10.1074/jbc.M610722200; Honda S, 2004, STRUCTURE, V12, P1507, DOI 10.1016/j.str.2004.05.022; Honda S, 2000, J MOL BIOL, V295, P269, DOI 10.1006/jmbi.1999.3346; Honda S, 2008, J AM CHEM SOC, V130, P15327, DOI 10.1021/ja8030533; Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Kanmert D, 2011, BIOCHEMISTRY-US, V50, P981, DOI 10.1021/bi101549n; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Kim S, 2012, ANGEW CHEM INT EDIT, V51, P1890, DOI 10.1002/anie.201107894; Kurniawan NA, 2012, J AM CHEM SOC, V134, P10200, DOI 10.1021/ja302943m; Kuwata K, 2001, NAT STRUCT BIOL, V8, P151, DOI 10.1038/84145; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lo Surdo P, 2004, NAT STRUCT MOL BIOL, V11, P382, DOI 10.1038/nsmb745; Nagao C, 2005, P NATL ACAD SCI USA, V102, P18950, DOI 10.1073/pnas.0509163102; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; ORBAN J, 1994, BIOCHEMISTRY-US, V33, P5702, DOI 10.1021/bi00185a006; Raschke TM, 1999, NAT STRUCT BIOL, V6, P825; Riechmann L, 2000, P NATL ACAD SCI USA, V97, P10068, DOI 10.1073/pnas.170145497; Riechmann L, 2006, J MOL BIOL, V363, P460, DOI 10.1016/j.jmb.2006.08.031; Roy S, 2009, J PHYS CHEM B, V113, P7315, DOI 10.1021/jp8106793; Salgado EN, 2010, P NATL ACAD SCI USA, V107, P1827, DOI 10.1073/pnas.0906852107; Satoh D, 2006, FEBS LETT, V580, P3422, DOI 10.1016/j.febslet.2006.05.015; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; SEIDEL HM, 1992, SCIENCE, V257, P1489, DOI 10.1126/science.1523407; Soding J, 2003, BIOESSAYS, V25, P837, DOI 10.1002/bies.10321; Tabata S, 2008, J BIOL CHEM, V283, P8893, DOI 10.1074/jbc.M709793200; Terada T, 2008, PROTEINS, V73, P621, DOI 10.1002/prot.22100; Thies MJW, 2001, J MOL BIOL, V309, P1077, DOI 10.1006/jmbi.2001.4707; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; van der Gulik P, 2009, J THEOR BIOL, V261, P531, DOI 10.1016/j.jtbi.2009.09.004; van Lieshout JFT, 2012, APPL BIOCHEM BIOTECH, V167, P2039, DOI 10.1007/s12010-012-9674-z; Vehlow C, 2011, BIOINFORMATICS, V27, P1573, DOI 10.1093/bioinformatics/btr163; WOODWARD C, 1993, TRENDS BIOCHEM SCI, V18, P359, DOI 10.1016/0968-0004(93)90086-3; Xu WX, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2911693	53	11	15	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3394	3404		10.1074/jbc.M113.530592	http://dx.doi.org/10.1074/jbc.M113.530592			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24356963	Green Published, hybrid			2022-12-28	WOS:000331368700025
J	Liu, MX; Seo, JM; Allegood, J; Bi, X; Zhu, XW; Boudyguina, E; Gebre, AK; Avni, D; Shah, D; Sorci-Thomas, MG; Thomas, MJ; Shelness, GS; Spiegel, S; Parks, JS				Liu, Mingxia; Seo, Jeongmin; Allegood, Jeremy; Bi, Xin; Zhu, Xuewei; Boudyguina, Elena; Gebre, Abraham K.; Avni, Dorit; Shah, Dharika; Sorci-Thomas, Mary G.; Thomas, Michael J.; Shelness, Gregory S.; Spiegel, Sarah; Parks, John S.			Hepatic Apolipoprotein M (ApoM) Overexpression Stimulates Formation of Larger ApoM/Sphingosine 1-Phosphateenriched Plasma High Density Lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apolipoproteins; Hepatocyte; High Density Lipoprotein (HDL); Liver; Sphingolipid; ApoM; Sphingosine 1-Phosphate	REVERSE CHOLESTEROL TRANSPORT; PRE-BETA-HDL; RECEPTOR-RELATED PROTEIN; SPHINGOSINE 1-PHOSPHATE; SELECTIVE UPTAKE; TRANSGENIC MICE; A-I; ACYLTRANSFERASE REACTION; SCAVENGER RECEPTOR; SR-BI	Background: ApoM overexpression in nonhepatic cells generates larger nascent HDLs. Results: Hepatocyte-specific apoM transgenic mice have larger plasma HDLs and hepatocytes that generate larger nascent HDLs and increased S1P secretion. Conclusion: Hepatocyte-specific apoM overexpression facilitates large apoM/S1P-enriched HDL formation by promoting large nascent HDL formation and stimulating sphingolipid synthesis and S1P secretion. Significance: Hepatic apoM regulates HDL and S1P production. Apolipoprotein M (apoM), a lipocalin family member, preferentially associates with plasma HDL and binds plasma sphingosine 1-phosphate (S1P), a signaling molecule active in immune homeostasis and endothelial barrier function. ApoM overexpression in ABCA1-expressing HEK293 cells stimulated larger nascent HDL formation, compared with cells that did not express apoM; however, the in vivo role of apoM in HDL metabolism remains poorly understood. To test whether hepatic apoM overexpression increases plasma HDL size, we generated hepatocyte-specific apoM transgenic (APOM Tg) mice, which had an approximate to 3-5-fold increase in plasma apoM levels compared with wild-type mice. Although HDL cholesterol concentrations were similar to wild-type mice, APOM Tg mice had larger plasma HDLs enriched in apoM, cholesteryl ester, lecithin:cholesterol acyltransferase, and S1P. Despite the presence of larger plasma HDLs in APOM Tg mice, in vivo macrophage reverse cholesterol transport capacity was similar to that in wild-type mice. APOM Tg mice had an approximate to 5-fold increase in plasma S1P, which was predominantly associated with larger plasma HDLs. Primary hepatocytes from APOM Tg mice generated larger nascent HDLs and displayed increased sphingolipid synthesis and S1P secretion. Inhibition of ceramide synthases in hepatocytes increased cellular S1P levels but not S1P secretion, suggesting that apoM is rate-limiting in the export of hepatocyte S1P. Our data indicate that hepatocyte-specific apoM overexpression generates larger nascent HDLs and larger plasma HDLs, which preferentially bind apoM and S1P, and stimulates S1P biosynthesis for secretion. The unique apoM/S1P-enriched plasma HDL may serve to deliver S1P to extrahepatic tissues for atheroprotection and may have other as yet unidentified functions.	[Liu, Mingxia; Seo, Jeongmin; Bi, Xin; Zhu, Xuewei; Boudyguina, Elena; Gebre, Abraham K.; Sorci-Thomas, Mary G.; Shelness, Gregory S.; Parks, John S.] Wake Forest Sch Med, Dept Pathol Lipid Sci, Winston Salem, NC 27157 USA; [Shah, Dharika; Thomas, Michael J.; Parks, John S.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Allegood, Jeremy; Avni, Dorit; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA	Wake Forest University; Wake Forest University; Virginia Commonwealth University	Parks, JS (corresponding author), Wake Forest Sch Med, Dept Pathol, Sect Lipid Sci, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jparks@wakehealth.edu		Sorci-Thomas, Mary/0000-0002-6464-5006; Avni, Dorit/0000-0002-0444-881X	National Institutes of Health NCI Center [5P30CA12197]; North Carolina Biotechnology Center [2007-IDG-1021]; National Institutes of Health NCI Cancer Center [P30 CA016059]; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA061774, P30CA016059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119962, R01HL112270, P01HL049373, R01HL064163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880, R37GM043880] Funding Source: NIH RePORTER	National Institutes of Health NCI Center; North Carolina Biotechnology Center; National Institutes of Health NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge Karen Klein (Translational Science Institute, Wake Forest School of Medicine) for editing the manuscript. LDL receptor-related protein antibody was generously provided by Dr. Joachim Herz (University of Texas Southwestern Medical Center), and ldlA-SR-BI-expressing cells were generously provided by Dr. Monty Krieger (Massachusetts Institute of Technology). Mass spectrometry analyses in Fig. 6 were performed at the Mass Spectrometer Facility, Comprehensive Cancer Center, Wake Forest University, and were supported, in part, by National Institutes of Health NCI Center Grant 5P30CA12197. The TSQ Discovery Max LC-MS/MS was acquired through a North Carolina Biotechnology Center Grant 2007-IDG-1021 (to M. J. T.). Sphingolipid analyses were performed at the Lipidomics Facility, Department of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, and were supported, in part, by funding to the Massey Cancer Center from National Institutes of Health NCI Cancer Center Support Grant P30 CA016059.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Ahnstrom J, 2007, J LIPID RES, V48, P1754, DOI 10.1194/jlr.M700103-JLR200; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; BARTER PJ, 1982, BIOCHEM J, V208, P1; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Brundert M, 2005, ARTERIOSCL THROM VAS, V25, P143, DOI 10.1161/01.ATV.0000149381.16166.c6; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; CARR TP, 1992, ARTERIOSCLER THROMB, V12, P1274, DOI 10.1161/01.ATV.12.11.1274; Christoffersen C, 2008, J BIOL CHEM, V283, P18765, DOI 10.1074/jbc.M800695200; Christoffersen C, 2008, J BIOL CHEM, V283, P1839, DOI 10.1074/jbc.M704576200; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Christoffersen C, 2010, CIRC RES, V106, P1624, DOI 10.1161/CIRCRESAHA.109.211086; Chung Soonkyu, 2010, J Biol Chem, V285, P12197, DOI 10.1074/jbc.M109.096933; Dahlback B, 2009, CELL MOL LIFE SCI, V66, P559, DOI 10.1007/s00018-009-8764-8; Egom EE, 2013, CURR OPIN LIPIDOL, V24, P351, DOI 10.1097/MOL.0b013e328361f822; Elsoe S, 2013, BBA-MOL CELL BIOL L, V1831, P1287, DOI 10.1016/j.bbalip.2013.04.009; Elsoe S, 2012, ATHEROSCLEROSIS, V221, P91, DOI 10.1016/j.atherosclerosis.2011.11.031; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Fiske CH, 1925, J BIOL CHEM, V66, P375; GLOMSET JA, 1968, J LIPID RES, V9, P155; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Jiang XC, 2003, J BIOL CHEM, V278, P49072, DOI 10.1074/jbc.M304274200; Karuna R, 2011, ATHEROSCLEROSIS, V219, P855, DOI 10.1016/j.atherosclerosis.2011.08.049; KORITNIK DL, 1983, J LIPID RES, V24, P1639; Kurano M, 2013, ATHEROSCLEROSIS, V229, P102, DOI 10.1016/j.atherosclerosis.2013.04.024; Lee MH, 2010, J LIPID RES, V51, P2619, DOI 10.1194/jlr.M003988; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Mineo C, 2012, CIRC RES, V111, P1079, DOI 10.1161/CIRCRESAHA.111.258673; Mitra P, 2007, METHOD ENZYMOL, V434, P257, DOI 10.1016/S0076-6879(07)34014-7; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; Mulya A, 2010, J LIPID RES, V51, P514, DOI 10.1194/jlr.M002162; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Nielsen LB, 2009, TRENDS ENDOCRIN MET, V20, P66, DOI 10.1016/j.tem.2008.11.003; Nofer JR, 2008, J CLIN LIPIDOL, V2, P4, DOI 10.1016/j.jacl.2007.11.002; Obinata H, 2012, SEMIN IMMUNOPATHOL, V34, P73, DOI 10.1007/s00281-011-0287-3; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Puri V, 2003, J BIOL CHEM, V278, P20961, DOI 10.1074/jbc.M300304200; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Santamarina-Fojo S, 2000, CURR OPIN LIPIDOL, V11, P267, DOI 10.1097/00041433-200006000-00007; Scheek S, 1997, P NATL ACAD SCI USA, V94, P11179, DOI 10.1073/pnas.94.21.11179; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; SUBBAIAH PV, 1993, J BIOL CHEM, V268, P20156; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Temel RE, 2010, CELL METAB, V12, P96, DOI 10.1016/j.cmet.2010.05.011; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Vaisman BL, 2001, J CLIN INVEST, V108, P303; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Vassiliou G, 2004, ARTERIOSCL THROM VAS, V24, P1669, DOI 10.1161/01.ATV.0000134295.09932.60; Vassiliou G, 2001, J BIOL CHEM, V276, P48823, DOI 10.1074/jbc.M103954200; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; WANG E, 1991, J BIOL CHEM, V266, P14486; Wilkerson BA, 2012, J BIOL CHEM, V287, P44645, DOI 10.1074/jbc.M112.423426; Witting SR, 2003, J BIOL CHEM, V278, P40121, DOI 10.1074/jbc.M305193200; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Yatomi Y, 1997, J BIOCHEM, V121, P969; Yazdanyar A, 2011, CURR ATHEROSCLER REP, V13, P242, DOI 10.1007/s11883-011-0172-5	68	57	60	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2801	2814		10.1074/jbc.M113.499913	http://dx.doi.org/10.1074/jbc.M113.499913			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24318881	hybrid, Green Published			2022-12-28	WOS:000333403000029
J	Effenberger, KA; Anderson, DD; Bray, WM; Prichard, BE; Ma, NC; Adams, MS; Ghosh, AK; Jurica, MS				Effenberger, Kerstin A.; Anderson, David D.; Bray, Walter M.; Prichard, Beth E.; Ma, Nianchun; Adams, Matthew S.; Ghosh, Arun K.; Jurica, Melissa S.			Coherence between Cellular Responses and in Vitro Splicing Inhibition for the Anti-tumor Drug Pladienolide B and Its Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Drug Action; Enzyme Inhibitors; Nucleus; RNA Splicing	SF3B; SPLICEOSTATIN; SUBSTANCES; MUTATIONS; DISCOVERY; CULTURE; TARGET; E7107	Pladienolide B (PB) is a potent cancer cell growth inhibitor that targets the SF3B1 subunit of the spliceosome. There is considerable interest in the compound as a potential chemotherapeutic, as well as a tool to study SF3B1 function in splicing and cancer development. The molecular structure of PB, a bacterial natural product, contains a 12-member macrolide ring with an extended epoxide-containing side chain. Using a novel concise enantioselective synthesis, we created a series of PB structural analogs and the structurally related compound herboxidiene. We show that two methyl groups in the PB side chain, as well as a feature of the macrolide ring shared with herboxidiene, are required for splicing inhibition in vitro. Unexpectedly, we find that the epoxy group contributes only modestly to PB potency and is not absolutely necessary for activity. The orientations of at least two chiral centers off the macrolide ring have no effect on PB activity. Importantly, the ability of analogs to inhibit splicing in vitro directly correlated with their effects in a series of cellular assays. Those effects likely arise from inhibition of some, but not all, endogenous splicing events in cells, as previously reported for the structurally distinct SF3B1 inhibitor spliceostatin A. Together, our data support the idea that the impact of PB on cells is derived from its ability to impair the function of SF3B1 in splicing and also demonstrate that simplification of the PB scaffold is feasible.	[Effenberger, Kerstin A.; Prichard, Beth E.; Adams, Matthew S.; Jurica, Melissa S.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Effenberger, Kerstin A.; Prichard, Beth E.; Adams, Matthew S.; Jurica, Melissa S.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [Bray, Walter M.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Anderson, David D.; Ma, Nianchun; Ghosh, Arun K.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Anderson, David D.; Ma, Nianchun; Ghosh, Arun K.] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Jurica, MS (corresponding author), Dept Mol Cell & Dev Biol, 1156 High St, Santa Cruz, CA 95064 USA.	mjurica@ucsc.edu			National Institutes of Health [R01CA136762, 1S10RR022455]; University of California Cancer Research Coordinating Committee; California Institute for Quantitative Biosciences (QB3); United States Department of State; American Chemical Society Division of Medicinal Chemistry; American Foundation for Pharmaceutical Education; NATIONAL CANCER INSTITUTE [R01CA136762] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Cancer Research Coordinating Committee(University of California System); California Institute for Quantitative Biosciences (QB3); United States Department of State; American Chemical Society Division of Medicinal Chemistry(American Chemical Society); American Foundation for Pharmaceutical Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA136762 (to M. S. J.) and 1S10RR022455. This work was also supported by the University of California Cancer Research Coordinating Committee, the California Institute for Quantitative Biosciences (QB3), and the United States Department of State.; Supported by predoctoral fellowships from the American Chemical Society Division of Medicinal Chemistry and the American Foundation for Pharmaceutical Education.	Albert BJ, 2009, MOL CANCER THER, V8, P2308, DOI 10.1158/1535-7163.MCT-09-0051; Allende-Vega N, 2013, ONCOGENE, V32, P1, DOI 10.1038/onc.2012.38; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Eskens FALM, 2013, CLIN CANCER RES, V19, P6296, DOI 10.1158/1078-0432.CCR-13-0485; Fan LY, 2011, ACS CHEM BIOL, V6, P582, DOI 10.1021/cb100356k; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; Furumai R, 2010, CANCER SCI, V101, P2483, DOI 10.1111/j.1349-7006.2010.01686.x; Gao Y, 2013, CHEMBIOCHEM, V14, P49, DOI 10.1002/cbic.201200558; Ghosh AK, 2012, ORG LETT, V14, P4730, DOI 10.1021/ol301886g; Ghosh AK, 2011, ORG LETT, V13, P66, DOI 10.1021/ol102549a; Gundluru MK, 2011, MEDCHEMCOMM, V2, P904, DOI 10.1039/c1md00040c; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Hasegawa M, 2011, ACS CHEM BIOL, V6, P229, DOI 10.1021/cb100248e; Hong D. S., 2013, INVEST NEW DRUGS, DOI 10. 1007/s10637-013-0046-5; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lagisetti C, 2009, J MED CHEM, V52, P6979, DOI 10.1021/jm901215m; Lamond AI, 2011, COLD SPRING HARB PER, V3; Liu X., 2013, J NANOMATER, V2013, DOI DOI 10.1155/2013/902538; Liu XY, 2013, J NAT PROD, V76, P685, DOI 10.1021/np300913h; Mizui Y, 2004, J ANTIBIOT, V57, P188, DOI 10.7164/antibiotics.57.188; Muller S, 2011, ORG LETT, V13, P3940, DOI 10.1021/ol201464m; Nakajima H, 1996, J ANTIBIOT, V49, P1204; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Roybal GA, 2010, NUCLEIC ACIDS RES, V38, P6664, DOI 10.1093/nar/gkq494; Sakai T, 2004, J ANTIBIOT, V57, P173, DOI 10.7164/antibiotics.57.173; Sakai Y, 2002, J ANTIBIOT, V55, P863, DOI 10.7164/antibiotics.55.863; Schulze CJ, 2013, CHEM BIOL, V20, P285, DOI 10.1016/j.chembiol.2012.12.007; SEKIASANO M, 1994, J ANTIBIOT, V47, P1395, DOI 10.7164/antibiotics.47.1395; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Villa R, 2013, J MED CHEM, V56, P6576, DOI 10.1021/jm400861t; Villa R, 2012, ORG LETT, V14, P5396, DOI 10.1021/ol3023006; Yokoi A, 2011, FEBS J, V278, P4870, DOI 10.1111/j.1742-4658.2011.08387.x; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	39	54	55	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1938	1947		10.1074/jbc.M113.515536	http://dx.doi.org/10.1074/jbc.M113.515536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302718	Green Published, hybrid			2022-12-28	WOS:000331130200006
J	Feng, YL; Wu, HX; Xu, YX; Zhang, ZM; Liu, T; Lin, X; Feng, XH				Feng, Yili; Wu, Hongxing; Xu, Yongxian; Zhang, Zhengmao; Liu, Ting; Lin, Xia; Feng, Xin-Hua			Zinc Finger Protein 451 Is a Novel Smad Corepressor in Transforming Growth Factor-beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Signal Transduction; SMAD Transcription Factor; Transcription Repressor; Transforming Growth Factor (TGF); Zinc Finger	TRANSCRIPTIONAL ACTIVATION; MEDIATED INDUCTION; C-MYC; COACTIVATORS; SMAD4/DPC4; REPRESSION; P15(INK4B); MECHANISM; CBP/P300; PROMOTER	ZNF451 is a transcriptional cofactor localized to promyelocytic leukemia bodies. Here, we present evidence demonstrating that ZNF451 physically interacts with Smad3/4 and functionally inhibits TGF- signaling. Increased expression of ZNF451 attenuates TGF--induced growth inhibitory and gene transcriptional responses, whereas depletion of ZNF451 enhances TGF- responses. Mechanistically, ZNF451 blocks the ability of Smad3/4 to recruit p300 in response to TGF-, which causes reduction of histone H3K9 acetylation on the promoters of TGF- target genes. Taken together, ZNF451 acts as a transcriptional corepressor for Smad3/4 and negatively regulates TGF- signaling.	[Feng, Yili; Wu, Hongxing; Xu, Yongxian; Liu, Ting; Feng, Xin-Hua] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Zhengmao; Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Zhang, Zhengmao; Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA	Zhejiang University; Baylor College of Medicine; Baylor College of Medicine	Feng, XH (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	xfeng@bcm.edu	Zhang, Zhengmao/C-4566-2014; Huang, Xiaoyan/N-2561-2014	Zhang, Zhengmao/0000-0002-7968-9968; Feng, Yili/0000-0002-7143-9956; ZHANG, ZHENGMAO/0000-0003-4035-0331	NSFC [31090360]; MOST [2012CB966600, 2011CB910501]; NSFZ [Z2110591]; Project 985; Fundamental Research Funds for the Central Universities; National Institutes of Health [R01GM63773, R01AR053591, R01CA108454, R01DK073932]; NATIONAL CANCER INSTITUTE [R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	NSFC(National Natural Science Foundation of China (NSFC)); MOST; NSFZ; Project 985; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NSFC Grant 31090360, MOST Grants 2012CB966600 and 2011CB910501, NSFZ Grant Z2110591, Project 985, the Fundamental Research Funds for the Central Universities. National Institutes of Health Grants R01GM63773, R01AR053591, R01CA108454, and R01DK073932.	Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Alliston T, 2005, J BIOL CHEM, V280, P24227, DOI 10.1074/jbc.M414305200; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chan HM, 2001, J CELL SCI, V114, P2363; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Chen YG, 2004, CELL RES, V14, P441, DOI 10.1038/sj.cr.7290246; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; Datto MB, 1997, MOL CELL BIOL, V17, P2030, DOI 10.1128/MCB.17.4.2030; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Karvonen U, 2008, J MOL BIOL, V382, P585, DOI 10.1016/j.jmb.2008.07.016; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Salovaara R, 2002, GUT, V51, P56, DOI 10.1136/gut.51.1.56; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Stroschein SL, 1999, J BIOL CHEM, V274, P9431, DOI 10.1074/jbc.274.14.9431; Tascilar M, 2001, CLIN CANCER RES, V7, P4115; Wang DG, 2008, CANCER RES, V68, P783, DOI 10.1158/0008-5472.CAN-07-0008; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323	30	22	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2072	2083		10.1074/jbc.M113.526905	http://dx.doi.org/10.1074/jbc.M113.526905			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324267	Green Published, hybrid			2022-12-28	WOS:000331130200017
J	Dalmasso, AP; Goldish, D; Benson, BA; Tsai, AK; Wasiluk, KR; Vercellotti, GM				Dalmasso, Agustin P.; Goldish, Daniel; Benson, Barbara A.; Tsai, Alexander K.; Wasiluk, Karen R.; Vercellotti, Gregory M.			Interleukin-4 Induces Up-regulation of Endothelial Cell Claudin-5 through Activation of FoxO1 ROLE IN PROTECTION FROM COMPLEMENT-MEDIATED INJURY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARRIER FUNCTION; DIFFERENTIAL REGULATION; MOLECULAR-ORGANIZATION; SIGNALING MECHANISMS; VASCULAR ENDOTHELIUM; NATURAL ANTIBODIES; TIGHT JUNCTIONS; IL-4; RESISTANCE; APOPTOSIS	Injury to endothelial cells (ECs) often results in cell retraction and gap formation. When caused by antigen aggregation or complement, this injury can be prevented by pretreatment of the ECs with IL-4, suggesting that IL-4 modifies the intercellular junction. Therefore, we investigated the effects of IL-4 on expression of intercellular junction proteins and whether such effects are required for IL-4-induced resistance of ECs against complement-mediated injury. We found that IL-4 induces up-regulation of the junction protein claudin-5 in porcine ECs through activation of Jak/STAT6 and phosphorylation and translocation of FoxO1 from the nucleus to the cytoplasm. Increased claudin-5 expression resulted in increased transmembrane electrical resistance of the endothelial monolayer and participated in IL-4-induced protection of the ECs from complement injury. Down-regulation of FoxO1 using siRNA by itself caused up-regulation of claudin-5 expression and partial protection from cytotoxicity. This protection was enhanced by stimulation with IL-4. We previously reported that increased phospholipid synthesis and mitochondrial protection were required for IL-4-induced resistance of ECs against complement injury and now we demonstrate a contribution of claudin-5 expression in IL-4-induced protection.	Univ Minnesota, Dept Surg, Sch Med, Minneapolis, MN 55455 USA; [Dalmasso, Agustin P.] Univ Minnesota, Dept Lab Med & Pathol, Sch Med, Minneapolis, MN 55455 USA; [Vercellotti, Gregory M.] Univ Minnesota, Dept Med, Sch Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Dalmasso, AP (corresponding author), Univ Minnesota, Dept Surg, MMC 220,420 Delaware St SE, Minneapolis, MN 55455 USA.	dalma001@umn.edu			National Institutes of Health [RO1 HL062195]; Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota; Sangart, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota; Sangart, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant RO1 HL062195 (to A. P. D.) and by the Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota. G. M. V. is a recipient of research funds and is a consultant for Sangart, Inc.	Balla J, 2007, ANTIOXID REDOX SIGN, V9, P2119, DOI 10.1089/ars.2007.1787; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Becker PM, 2001, AM J PHYSIOL-LUNG C, V281, pL1500, DOI 10.1152/ajplung.2001.281.6.L1500; Black SM, 2008, TRANSPL P, V40, P638, DOI 10.1016/j.transproceed.2008.02.013; Black SM, 2006, J IMMUNOL, V177, P7355, DOI 10.4049/jimmunol.177.10.7355; Black SM, 2011, XENOTRANSPLANTATION, V18, P343, DOI 10.1111/j.1399-3089.2011.00678.x; Black SM, 2010, EUR J IMMUNOL, V40, P803, DOI 10.1002/eji.200939488; Burek M, 2010, ARTERIOSCL THROM VAS, V30, P298, DOI 10.1161/ATVBAHA.109.197582; Dalmasso Agustin P., 2002, P139; Dalmasso AP, 1996, XENOTRANSPLANTATION, V3, P54, DOI 10.1111/j.1399-3089.1996.tb00119.x; Dalmasso AP, 2000, J IMMUNOL, V164, P3764, DOI 10.4049/jimmunol.164.7.3764; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Fontijn RD, 2008, AM J PHYSIOL-HEART C, V294, pH891, DOI 10.1152/ajpheart.01248.2007; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Grehan JF, 2005, J IMMUNOL, V175, P1903, DOI 10.4049/jimmunol.175.3.1903; Grehan JF, 2005, AM J TRANSPLANT, V5, P712, DOI 10.1111/j.1600-6143.2005.00771.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Huang HJ, 2011, BBA-MOL CELL RES, V1813, P1961, DOI 10.1016/j.bbamcr.2011.01.007; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Li ZG, 2009, CELL MOL IMMUNOL, V6, P415, DOI 10.1038/cmi.2009.53; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Otterbein LE, 2009, RESP CARE, V54, P925, DOI 10.4187/002013209793800394; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; SAADI S, 1995, J EXP MED, V181, P21, DOI 10.1084/jem.181.1.21; Steele AJ, 2010, BLOOD, V116, P4569, DOI 10.1182/blood-2009-09-245811; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Van Itallie CM, 2005, J CELL SCI, V118, P1427, DOI 10.1242/jcs.01735; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Yuan L., 2012, J BIOL CHEM, V287; Zhao Y, 2011, J MOL CELL BIOL, V3, P276, DOI 10.1093/jmcb/mjr013	37	22	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					838	847		10.1074/jbc.M113.455766	http://dx.doi.org/10.1074/jbc.M113.455766			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24280217	Green Published, hybrid			2022-12-28	WOS:000330541200021
J	Salinas, S; Zussy, C; Loustalot, F; Henaff, D; Menendez, G; Morton, PE; Parsons, M; Schiavo, G; Kremer, EJ				Salinas, Sara; Zussy, Charleine; Loustalot, Fabien; Henaff, Daniel; Menendez, Guillermo; Morton, Penny E.; Parsons, Maddy; Schiavo, Giampietro; Kremer, Eric J.			Disruption of the Coxsackievirus and Adenovirus Receptor-Homodimeric Interaction Triggers Lipid Microdomain- and Dynamin-dependent Endocytosis and Lysosomal Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL RETROGRADE TRANSPORT; CELL-ADHESION MOLECULES; CENTRAL-NERVOUS-SYSTEM; MEDIATED ENDOCYTOSIS; CHOLERA-TOXIN; IN-VITRO; VIRUS; INTERNALIZATION; FIBER; CAR	The coxsackievirus and adenovirus receptor (CAR) serves as a docking factor for some adenovirus (AdV) types and group B coxsackieviruses. Its role in AdV internalization is unclear as studies suggest that its intracellular domain is dispensable for some AdV infection. We previously showed that in motor neurons, AdV induced CAR internalization and co-transport in axons, suggesting that CAR was linked to endocytic and long-range transport machineries. Here, we characterized the mechanisms of CAR endocytosis in neurons and neuronal cells. We found that CAR internalization was lipid microdomain-, actin-, and dynamin-dependent, and subsequently followed by CAR degradation in lysosomes. Moreover, ligands that disrupted the homodimeric CAR interactions in its D1 domains triggered an internalization cascade involving sequences in its intracellular tail.	[Salinas, Sara; Zussy, Charleine; Loustalot, Fabien; Henaff, Daniel; Kremer, Eric J.] Univ Montpellier I, CNRS UMR 5535, Inst Genet Mol Montpellier, Montpellier, France; [Salinas, Sara; Zussy, Charleine; Loustalot, Fabien; Henaff, Daniel; Kremer, Eric J.] Univ Montpellier 2, CNRS UMR 5535, Inst Genet Mol Montpellier, Montpellier, France; [Morton, Penny E.; Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Menendez, Guillermo; Schiavo, Giampietro] Canc Res UK London Res Inst, Mol NeuroPathobiol Lab, London WC2A 3PX, England; [Salinas, Sara; Kremer, Eric J.] INSERM, F-75654 Paris 13, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of London; King's College London; Cancer Research UK; Institut National de la Sante et de la Recherche Medicale (Inserm)	Salinas, S (corresponding author), Univ Montpellier I, CNRS UMR 5535, Inst Genet Mol Montpellier, Montpellier, France.	sara.salinas@igmm.cnrs.fr; eric.kremer@igmm.cnrs.fr	Salinas, Sara/O-1150-2019; Parsons, Maddy/B-2203-2013; Salinas, Sara/O-1856-2013; Kremer, Eric J/D-3734-2013; Kremer, EJ/P-9838-2019	Salinas, Sara/0000-0003-4492-2093; Parsons, Maddy/0000-0002-2021-8379; Salinas, Sara/0000-0003-4492-2093; Kremer, EJ/0000-0001-6114-7530; Schiavo, Giampietro/0000-0002-4319-8745	European Community [222992-BrainCAV]; French Agence National de la Recherche; E-Rare; Fondation de France; Association pour la Recherche sur la Sclerose Amyotrophique Laterale (ARSLa); Association Francaise contre les Myopathies; Cancer Research UK; UK Motor Neuron Disease Association; Chemical Biology Center; Imperial College London, UK	European Community(European Commission); French Agence National de la Recherche(French National Research Agency (ANR)); E-Rare; Fondation de France(Fondation de France); Association pour la Recherche sur la Sclerose Amyotrophique Laterale (ARSLa); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Cancer Research UK(Cancer Research UK); UK Motor Neuron Disease Association; Chemical Biology Center; Imperial College London, UK	This work was supported in part by European Community 7th Framework Program FP7/2007-2013 Grant 222992-BrainCAV, the French Agence National de la Recherche, E-Rare, the Fondation de France, the Association pour la Recherche sur la Sclerose Amyotrophique Laterale (ARSLa), and the Association Francaise contre les Myopathies.; Supported by Cancer Research UK, Chemical Biology Center, Imperial College London, UK, and the UK Motor Neuron Disease Association.	AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; Boulware MI, 2007, J NEUROSCI, V27, P9941, DOI 10.1523/JNEUROSCI.1647-07.2007; Bru T, 2010, VIRUSES-BASEL, V2, P2134, DOI 10.3390/v2092134; Burckhardt CJ, 2011, CELL HOST MICROBE, V10, P105, DOI 10.1016/j.chom.2011.07.006; Carcea I, 2010, J NEUROSCI, V30, P15317, DOI 10.1523/JNEUROSCI.1821-10.2010; Carvajal-Gonzalez JM, 2012, P NATL ACAD SCI USA, V109, P3820, DOI 10.1073/pnas.1117949109; Castellani V, 2004, MOL CELL NEUROSCI, V26, P89, DOI 10.1016/j.mcn.2004.01.010; Chillon M, 2001, HUM GENE THER, V12, P1815, DOI 10.1089/104303401750476302; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; de Ory F, 2013, J MED VIROL, V85, P554, DOI 10.1002/jmv.23470; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Diaz F, 2009, P NATL ACAD SCI USA, V106, P11143, DOI 10.1073/pnas.0811227106; Drayman N, 2013, CELL HOST MICROBE, V14, P63, DOI 10.1016/j.chom.2013.05.005; Ewers H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004721; Excoffon KJDA, 2003, J VIROL, V77, P2559, DOI 10.1128/JVI.77.4.2559-2567.2003; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Farmer C, 2009, EXP CELL RES, V315, P2637, DOI 10.1016/j.yexcr.2009.06.008; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Franker MAM, 2013, J CELL SCI, V126, P2319, DOI 10.1242/jcs.115030; Freimuth P, 2008, CURR TOP MICROBIOL, V323, P67; Gonnord P, 2012, SEMIN CELL DEV BIOL, V23, P154, DOI 10.1016/j.semcdb.2011.11.002; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Gralinski LE, 2009, J VIROL, V83, P9398, DOI 10.1128/JVI.00954-09; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; He YN, 2001, NAT STRUCT BIOL, V8, P874, DOI 10.1038/nsb1001-874; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Huang KC, 2007, FEBS LETT, V581, P2702, DOI 10.1016/j.febslet.2007.05.019; Huang YC, 2013, J CLIN VIROL, V57, P300, DOI 10.1016/j.jcv.2013.03.017; Ibanez CF, 2007, TRENDS CELL BIOL, V17, P519, DOI 10.1016/j.tcb.2007.09.003; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kosulin K, 2007, J VIROL, V81, P7629, DOI 10.1128/JVI.00355-07; Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Lajoie P, 2009, J CELL MOL MED, V13, P3218, DOI 10.1111/j.1582-4934.2009.00732.x; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Lortat-Jacob H, 2001, J BIOL CHEM, V276, P9009, DOI 10.1074/jbc.M009304200; Meier O, 2003, J GENE MED, V5, P451, DOI 10.1002/jgm.409; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Moore ML, 2003, J VIROL, V77, P10060, DOI 10.1128/JVI.77.18.10060-10070.2003; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Ohka S, 2004, J VIROL, V78, P7186, DOI 10.1128/JVI.78.13.7186-7198.2004; Ohka S, 2009, J VIROL, V83, P4995, DOI 10.1128/JVI.02225-08; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Patzke C, 2010, J NEUROSCI, V30, P2897, DOI 10.1523/JNEUROSCI.5725-09.2010; Paxinos G., 2003, MOUSE BRAIN STEREOTA, p[22, 30]; Payne CK, 2007, TRAFFIC, V8, P389, DOI 10.1111/j.1600-0854.2007.00540.x; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Persaud-Sawin DA, 2009, J LIPID RES, V50, P759, DOI 10.1194/jlr.D800037-JLR200; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Restani L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003087; Richart SM, 2003, J VIROL, V77, P3307, DOI 10.1128/JVI.77.5.3307-3311.2003; Sakisaka T, 2005, J CELL SCI, V118, P5407, DOI 10.1242/jcs.02672; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395; Salinas S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000442; Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schafer MKE, 2010, FEBS LETT, V584, P4475, DOI 10.1016/j.febslet.2010.10.011; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Schoelm G, 2008, J VIROL, V82, P3192, DOI 10.1128/JVI.02393-07; Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Soudais C, 2000, J VIROL, V74, P10639, DOI 10.1128/JVI.74.22.10639-10649.2000; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Takahashi T, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/245090; Tamanini A, 2006, J VIROL, V80, P11241, DOI 10.1128/JVI.00721-06; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor Anne M., 2006, V321, P167; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; Verdino P, 2010, SCIENCE, V329, P1210, DOI 10.1126/science.1187996; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang XH, 1999, J VIROL, V73, P2559, DOI 10.1128/JVI.73.3.2559-2562.1999; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Xie JS, 2006, J VIROL, V80, P11833, DOI 10.1128/JVI.00857-06; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	80	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					680	695		10.1074/jbc.M113.518365	http://dx.doi.org/10.1074/jbc.M113.518365			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24273169	Green Published, hybrid			2022-12-28	WOS:000330541200008
J	Bialkowska, AB; Liu, Y; Nandan, MO; Yang, VW				Bialkowska, Agnieszka B.; Liu, Yang; Nandan, Mandayam O.; Yang, Vincent W.			A Colon Cancer-derived Mutant of Kruppel-like Factor 5 (KLF5) Is Resistant to Degradation by Glycogen Synthase Kinase 3 beta (GSK3 beta) and the E3 Ubiquitin Ligase F-box and WD Repeat Domain-containing 7 alpha (FBW7 alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cyclin d1; Mutant; Promoters; Protein Stability; Transcription Factors	TRANSCRIPTION FACTOR; COLORECTAL CANCERS; EPITHELIAL-CELLS; BETA-CATENIN; CHROMOSOMAL INSTABILITY; MUTATIONS; KRUPPEL-LIKE-FACTOR-5; TUMORIGENESIS; INACTIVATION; ACETYLATION	Background: Stability of KLF5 is regulated by GSK3- and FBW7-mediated proteasomal degradation. Results: Colon cancer-derived P301S KLF5 mutant is degradation-resistant due to the inability to interact with FBW7. Conclusion: Residue 301 of KLF5 is critical for the proper recognition by FBW7 that is involved in the degradation of KLF5. Significance: Our results suggest that the P301S KLF5 mutant is potentially oncogenic in colon cancer. Kruppel-like factor 5 (KLF5) is a zinc finger transcription factor that is highly expressed in the crypt epithelial cells of the intestine and plays a critical role in regulating proliferation of both normal intestinal epithelial cells and colorectal cancer cells. Stability of the KLF5 is mediated by proteasomal degradation via phosphorylation by glycogen synthase kinase 3 (GSK3) and recognition by F-box and WD repeat domain-containing 7 (FBW7) of a phosphodegron sequence surrounding serine 303 in KLF5. A genomic analysis of colorectal cancer tissues identified a somatic mutation (P301S) in KLF5 within the phosphodegron sequence. We hypothesized that due to its close proximity to the phosphodegron sequence, the P301S mutation may affect signaling that is involved in proper KLF5 degradation. We demonstrated that the P301S KLF5 mutant has a longer half-life than wild type (WT) KLF5. Furthermore, P301S KLF5 has a higher transcriptional activity than WT KLF5 as demonstrated by luciferase assays using cyclin D1 and CDC2 promoter constructs. In contrast to WT KLF5, P301S KLF5 does not physically interact with FBW7. Concomitantly, the P301S KLF5 mutant displays reduced levels of phosphorylation at serine 303 in comparison with WT KLF5. These results of our study indicate that amino acid residue 301 of KLF5 is critical for proper recognition of the phosphodegron sequence by FBW7 and that the P301S mutation inhibits this recognition, leading to a degradation-resistant protein with elevated levels and enhanced transcriptional activity. These findings raise a potentially oncogenic role for the P301S KLF5 mutant in colorectal cancer.	[Bialkowska, Agnieszka B.; Liu, Yang; Nandan, Mandayam O.; Yang, Vincent W.] SUNY Stony Brook, Sch Med, Dept Med, Stony Brook, NY 11794 USA; [Yang, Vincent W.] SUNY Stony Brook, Sch Med, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Yang, VW (corresponding author), SUNY Stony Brook, Sch Med, Dept Med, HSC T-16,Rm 020, Stony Brook, NY 11794 USA.	vincent.yang@stonybrookmedicine.edu		Mandayam, Nandan/0000-0002-4061-9348	National Institutes of Health [DK052230, CA084197]; NATIONAL CANCER INSTITUTE [R01CA084197, R01CA172113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052230, R01DK093680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK052230 and CA084197 (to V. W. Y.).	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Burgess AW, 2011, EXP CELL RES, V317, P2748, DOI 10.1016/j.yexcr.2011.08.010; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chen CS, 2004, GENE, V330, P133, DOI 10.1016/j.gene.2004.01.014; Davis H., 2013, GUT; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Du JX, 2007, J BIOL CHEM, V282, P4782, DOI 10.1074/jbc.M603413200; Ekstrand AI, 2010, FAM CANCER, V9, P125, DOI 10.1007/s10689-009-9293-1; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Kemp Z, 2005, CANCER RES, V65, P11361, DOI 10.1158/0008-5472.CAN-05-2565; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; McConnell BB, 2009, CANCER RES, V69, P4125, DOI 10.1158/0008-5472.CAN-08-4402; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Mori D, 2003, GENE, V304, P163, DOI 10.1016/S0378-1119(02)01203-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nandan MO, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-63; Nandan MO, 2005, FEBS LETT, V579, P4757, DOI 10.1016/j.febslet.2005.07.053; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Simi L, 2008, AM J CLIN PATHOL, V130, P247, DOI 10.1309/LWDY1AXHXUULNVHQ; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Yang YZ, 2008, J BIOL CHEM, V283, P18812, DOI 10.1074/jbc.M801384200; Zhang J, 2011, GASTROENTEROLOGY, V141, P50, DOI 10.1053/j.gastro.2011.05.010; Zhang ZP, 2003, NUCLEIC ACIDS RES, V31, P2196, DOI 10.1093/nar/gkg310; Zhao D, 2012, CARCINOGENESIS, V33, P59, DOI 10.1093/carcin/bgr242; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040	35	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5997	6005		10.1074/jbc.M113.508549	http://dx.doi.org/10.1074/jbc.M113.508549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398687	Green Published, hybrid			2022-12-28	WOS:000332015500055
J	Reyes, FC; Buono, RA; Roschzttardtz, H; Di Rubbo, S; Yeun, LH; Russinova, E; Otegui, MS				Reyes, Francisca C.; Buono, Rafael A.; Roschzttardtz, Hannetz; Di Rubbo, Simone; Yeun, Li Huey; Russinova, Eugenia; Otegui, Marisa S.			A Novel Endosomal Sorting Complex Required for Transport ( ESCRT) Component in Arabidopsis thaliana Controls Cell Expansion and Development*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Growth; Endosomes; Enzyme Purification; Gene Silencing; Membrane Trafficking; Plant; Protein Motifs; Protein Purification	AAA-TYPE ATPASE; STRUCTURAL BASIS; PROTEIN; VPS4; MACHINERY; SUBUNIT; LOCALIZATION; RECOGNITION; EXPRESSION; VTA1	Background: ESCRT mediates membrane remodeling in cellular processes such as endosomal sorting. The ATPase SKD1/VPS4 is essential for ESCRT function. Results: PROS is a plant-specific ESCRT component that increases SKD1/VPS4 ATPase activity and is required for cell expansion. Conclusion: Plants have evolved specific ESCRT components that are required for normal development. Significance: Diversification of ESCRT components in eukaryotes may provide additional regulatory mechanisms for ESCRT-dependent processes. ESCRT proteins mediate membrane remodeling and scission events and are essential for endosomal sorting of plasma membrane proteins for degradation. We have identified a novel, plant-specific ESCRT component called PROS (POSITIVE REGULATOR OF SKD1) in Arabidopsis thaliana. PROS has a strong positive effect on the in vitro ATPase activity of SKD1 (also known as Vacuolar Protein Sorting 4 or VPS4), a critical component required for ESCRT-III disassembly and endosomal vesiculation. PROS interacts with both SKD1 and the SKD1-positive regulator LIP5/VTA1. We have identified a putative MIM domain within PROS that mediate the interaction with the MIT domain of SKD1. Interestingly, whereas MIM domains are commonly found at the C terminus of ESCRT-III subunits, the PROS MIM domain is internal. The heterologous expression of PROS in yeast mutant cells lacking Vta1p partially rescues endosomal sorting defects. PROS is expressed in most tissues and cells types in Arabidopsis thaliana. Silencing of PROS leads to reduced cell expansion and abnormal organ growth.	[Reyes, Francisca C.; Buono, Rafael A.; Roschzttardtz, Hannetz; Yeun, Li Huey; Otegui, Marisa S.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Reyes, Francisca C.] Univ Andres Bello, Ctr Biotecnol Vegetal, Santiago 8370146, Chile; [Di Rubbo, Simone; Russinova, Eugenia] VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Di Rubbo, Simone; Russinova, Eugenia] Univ Ghent, B-9052 Ghent, Belgium; [Di Rubbo, Simone; Russinova, Eugenia] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Otegui, Marisa S.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Universidad Andres Bello; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Wisconsin System; University of Wisconsin Madison	Otegui, MS (corresponding author), B119,Birge Hall,430 Lincoln Dr, Madison, WI 53706 USA.	otegui@wisc.edu		Otegui, Marisa/0000-0003-4699-6950; Andrade Buono, Rafael/0000-0002-6675-3836; Russinova, Eugenia/0000-0002-0569-1977	NSF Grant [MCB1157824]; Marie-Curie Initial Training Network Bravissimo [PITN-GA-2008-215118]; Div Of Molecular and Cellular Bioscience [1157824] Funding Source: National Science Foundation	NSF Grant(National Science Foundation (NSF)); Marie-Curie Initial Training Network Bravissimo; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF Grant MCB1157824 (to M. S. O.) and by the Marie-Curie Initial Training Network Bravissimo (PITN-GA-2008-215118; to E. R. and S. D. R.).	Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Babst M, 2011, TRAFFIC, V12, P1298, DOI 10.1111/j.1600-0854.2011.01230.x; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Fyfe I, 2011, J BIOL CHEM, V286, P34262, DOI 10.1074/jbc.M111.266411; Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Haas TJ, 2007, PLANT CELL, V19, P1295, DOI 10.1105/tpc.106.049346; Henne WM, 2012, CELL, V151, P356, DOI 10.1016/j.cell.2012.08.039; Katsiarimpa A, 2013, PLANT CELL, V25, P2236, DOI 10.1105/tpc.113.113399; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Richardson LGL, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00020; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Rusten TE, 2012, NAT CELL BIOL, V14, P38, DOI 10.1038/ncb2381; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shahriari M, 2011, PLANT MOL BIOL, V76, P85, DOI 10.1007/s11103-011-9770-4; Shahriari M, 2010, PLANT J, V64, P71, DOI 10.1111/j.1365-313X.2010.04310.x; Shim JH, 2006, J CELL BIOL, V172, P1045, DOI 10.1083/jcb.200509041; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Skalicky JJ, 2012, J BIOL CHEM, V287, P43910, DOI 10.1074/jbc.M112.417899; Spitzer C, 2006, DEVELOPMENT, V133, P4679, DOI 10.1242/dev.02654; Spitzer C, 2009, PLANT CELL, V21, P749, DOI 10.1105/tpc.108.064865; Stauffer DR, 2001, J CELL SCI, V114, P2383; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8; Winter V, 2006, TRENDS PLANT SCI, V11, P115, DOI 10.1016/j.tplants.2006.01.008; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013; Yang D, 2010, STRUCTURE, V18, P976, DOI 10.1016/j.str.2010.04.014; Yang ZZ, 2012, J BIOL CHEM, V287, P43899, DOI 10.1074/jbc.M112.390724; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	40	38	40	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4980	4988		10.1074/jbc.M113.529685	http://dx.doi.org/10.1074/jbc.M113.529685			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24385429	hybrid, Green Published			2022-12-28	WOS:000331607900043
J	Romasanta, PN; Curto, LM; Urtasun, N; Sarratea, MB; Chiappini, S; Miranda, MV; Delfino, JM; Mariuzza, RA; Fernandez, MM; Malchiodi, EL				Romasanta, Pablo N.; Curto, Lucrecia M.; Urtasun, Nicolas; Sarratea, Maria B.; Chiappini, Santiago; Miranda, Maria V.; Delfino, Jose M.; Mariuzza, Roy A.; Fernandez, Marisa M.; Malchiodi, Emilio L.			A Positive Cooperativity Binding Model between Ly49 Natural Killer Cell Receptors and the Viral Immunoevasin m157 KINETIC AND THERMODYNAMIC STUDIES*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Innate Immunity; Natural Killer (NK) Cell; Surface Plasmon Resonance (SPR); Thermodynamics; Viral Immunology; Ly49; Fluorescence Anisotropy; m157; Murine Cytomegalovirus	SURFACE-PLASMON RESONANCE; CLASS-I LIGAND; CRYSTAL-STRUCTURE; HEAT-CAPACITY; NK CELLS; CYTOMEGALOVIRUS; RECOGNITION; COMPLEX; MHC; PROTEINS	Background: m157 is a cytomegalovirus immunoevasin that binds Ly49 natural killer cell receptors. Results: Kinetic and thermodynamic analyses revealed the mechanism underlying the Ly49/m157 interaction. Conclusion: The binding mechanism is characterized by positive cooperativity and conformational selection. Significance: This mechanism provides a biophysical framework for interpreting crystal structures of Ly49 receptors. Natural killer (NK) cells discriminate between healthy and virally infected or transformed cells using diverse surface receptors that are both activating and inhibitory. Among them, the homodimeric Ly49 NK receptors, which can adopt two distinct conformations (backfolded and extended), are of particular importance for detecting cells infected with mouse cytomegalovirus (CMV) via recognition of the viral immunoevasin m157. The interaction of m157 with activating (Ly49H) and inhibitory (Ly49I) receptors governs the spread of mouse CMV. We carried out kinetic and thermodynamic experiments to elucidate the Ly49/m157 binding mechanism. Combining surface plasmon resonance, fluorescence anisotropy, and circular dichroism (CD), we determined that the best model to describe both the Ly49H/m157 and Ly49I/m157 interactions is a conformational selection mechanism where only the extended conformation of Ly49 (Ly49*) is able to bind the first m157 ligand followed by binding of the Ly49*/m157 complex to the second m157. The interaction is characterized by strong positive cooperativity such that the second m157 binds the Ly49 homodimer with a 1000-fold higher sequential constant than the first m157 (approximate to 10(8)versus approximate to 10(5) m(-1)). Using far-UV CD, we obtained evidence for a conformational change in Ly49 upon binding m157 that could explain the positive cooperativity. The rate-limiting step of the overall mechanism is a conformational transition in Ly49 from its backfolded to extended form. The global thermodynamic parameters from the initial state (backfolded Ly49 and m157) to the final state (Ly49*/(m157)(2)) are characterized by an unfavorable enthalpy that is compensated by a favorable entropy, making the interaction spontaneous.	[Fernandez, Marisa M.; Malchiodi, Emilio L.] Univ Buenos Aires, Catedra Inmunol, CONICET, RA-1113 Buenos Aires, DF, Argentina; [Fernandez, Marisa M.; Malchiodi, Emilio L.] Univ Buenos Aires, CONICET, Inst Estudios Inmunidad Humoral IDEHU, RA-1113 Buenos Aires, DF, Argentina; [Urtasun, Nicolas; Miranda, Maria V.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Microbiol Ind & Biotecnol, RA-1113 Buenos Aires, DF, Argentina; [Curto, Lucrecia M.; Delfino, Jose M.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Curto, Lucrecia M.; Delfino, Jose M.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Quim & Fisicoquim Biol IQUIFIB, RA-1113 Buenos Aires, DF, Argentina; [Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Malchiodi, EL (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Catedra Inmunol, Junin 956 4To P, RA-1113 Buenos Aires, DF, Argentina.	emalchio@ffyb.uba.ar		Malchiodi, Emilio/0000-0001-7501-3330; Fernandez, Marisa/0000-0002-7480-5907; Curto, Lucrecia/0000-0002-4335-5309; Urtasun, Nicolas/0000-0001-9307-7194; Romasanta, Pablo/0000-0002-2842-8952	National Institutes of Health [AI47990]; Fogarty International Center [TW007972]; University of Buenos Aires; National Research Council of Argentina (CONICET); Agencia Nacional de Promocion Cientifica y Tecnica [PICT-2010-373, PICT-2007-0632, PICT-2010-0460, PICT-2008-1139, PICT-2010-0657]; International Centre for Genetic Engineering and Biotechnology [CRP/ARG09-02]; FOGARTY INTERNATIONAL CENTER [R03TW007972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of Buenos Aires(University of Buenos Aires); National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); International Centre for Genetic Engineering and Biotechnology; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI47990 (to R. A. M.) and TW007972 from the Fogarty International Center (to E. L. M.). This work was also supported by the University of Buenos Aires, the National Research Council of Argentina (CONICET), and Agencia Nacional de Promocion Cientifica y Tecnica Grants PICT-2010-373 (to M. M. F.), PICT-2007-0632 (to J. M. D.), PICT-2010-0460 (to L. M. C.) and PICT-2008-1139 and PICT-2010-0657 (to E. L. M.).; Supported by International Centre for Genetic Engineering and Biotechnology Grant CRP/ARG09-02. To whom correspondence should be addressed: Catedra de Inmunologia and IDEHU, CONICET-UBA, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires, Junin 956 4to P, 1113 Buenos Aires, Argentina. Tel.: 5411-4964-8259; Fax: 5411-4964-0024; E-mail: emalchio@ffyb.uba.ar.	Adams EJ, 2007, P NATL ACAD SCI USA, V104, P10128, DOI 10.1073/pnas.0703735104; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Back J, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00055; Back J, 2009, IMMUNITY, V31, P598, DOI 10.1016/j.immuni.2009.07.007; Berry R, 2013, NAT IMMUNOL, V14, P699, DOI 10.1038/ni.2605; CANTOR CR, 1980, BIOPHYSICAL CHEM 3, P849; Chen J, 2011, J MOL BIOL, V410, P343, DOI 10.1016/j.jmb.2011.05.018; Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8; Corbett AJ, 2011, J IMMUNOL, V186, P1713, DOI 10.4049/jimmunol.1003308; Creighton T. E., 2010, PHYS CHEM BASIS MOL, P91; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Dam J, 2006, J MOL BIOL, V362, P102, DOI 10.1016/j.jmb.2006.07.005; DE LA CRUZ EM, 1995, BIOCHEMISTRY-US, V34, P5452, DOI 10.1021/bi00016a016; Deng L, 2008, J BIOL CHEM, V283, P16840, DOI 10.1074/jbc.M801526200; Deng L, 2006, SEMIN IMMUNOL, V18, P159, DOI 10.1016/j.smim.2006.03.004; Desrosiers MP, 2005, NAT GENET, V37, P593, DOI 10.1038/ng1564; Dighe A, 2005, J IMMUNOL, V175, P6820, DOI 10.4049/jimmunol.175.10.6820; Dimasi N, 2002, J MOL BIOL, V320, P573, DOI 10.1016/S0022-2836(02)00498-9; Gutfreund H, 1995, KINETICS LIFE SCI RE, P236; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hill T. L., 1985, COOPERATIVITY THEORY, P59; Kielczewska A, 2009, J EXP MED, V206, P515, DOI 10.1084/jem.20080954; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lisnic VJ, 2010, CURR OPIN MICROBIOL, V13, P530, DOI 10.1016/j.mib.2010.05.011; LOHMAN TM, 1986, CRIT REV BIOCHEM MOL, V19, P191, DOI 10.3109/10409238609084656; McQueen KL, 2002, CURR OPIN IMMUNOL, V14, P615, DOI 10.1016/S0952-7915(02)00380-1; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Myszka DG, 1997, BIOPHYS CHEM, V64, P127, DOI 10.1016/S0301-4622(96)02230-2; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; OShannessy DJ, 1996, ANAL BIOCHEM, V236, P275, DOI 10.1006/abio.1996.0167; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Press W.H., 1999, NUMERICAL RECIPES C, P801; Pyzik M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/641702; Schmid FX., 1989, SPECTRAL METHODS CHA, P251; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Tsai CJ, 2001, PROTEINS, V44, P418, DOI 10.1002/prot.1107; Weber G., 1992, PROTEIN INTERACTIONS, P1; Winzor DJ, 2006, J MOL RECOGNIT, V19, P389, DOI 10.1002/jmr.799; Xie XF, 2007, J VIROL, V81, P229, DOI 10.1128/JVI.00997-06; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zhou HX, 2010, Q REV BIOPHYS, V43, P219, DOI 10.1017/S0033583510000120	48	7	7	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5083	5096		10.1074/jbc.M113.532929	http://dx.doi.org/10.1074/jbc.M113.532929			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24379405	hybrid, Green Published			2022-12-28	WOS:000331607900052
J	Suzuki, H; Raska, M; Yamada, K; Moldoveanu, Z; Julian, BA; Wyatt, RJ; Tomino, Y; Gharavi, AG; Novak, J				Suzuki, Hitoshi; Raska, Milan; Yamada, Koshi; Moldoveanu, Zina; Julian, Bruce A.; Wyatt, Robert J.; Tomino, Yasuhiko; Gharavi, Ali G.; Novak, Jan			Cytokines Alter IgA1 O- Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycosylation; Immunology; Kidney; Mucosal Immunology; Nephrology; IgA Nephropathy; IgA1; O-Glycans	GALACTOSE-DEFICIENT IGA1; HUMAN MESANGIAL CELLS; HENOCH-SCHONLEIN PURPURA; IGA1-CONTAINING IMMUNE-COMPLEXES; RESONANCE MASS-SPECTROMETRY; HUMAN SERUM IGA1; MURINE B-CELLS; HINGE REGION; TNF-ALPHA; CARBOHYDRATE-COMPOSITION	Background: IgA1-producing cells of IgA nephropathy patients secrete IgA1 with galactose-deficient O-glycans; these IgA1 molecules form nephritogenic immune complexes. Results: Cytokines IL-6 and IL-4 accentuate IgA1 galactose deficiency via modulation of key glycosyltransferases. Conclusion: Some cytokines alter IgA1 O-glycosylation and increase production of nephritogenic IgA1 glycoforms. Significance: These data provide a mechanism explaining increased immune-complex formation in IgA nephropathy patients. IgA nephropathy (IgAN), the most common primary glomerulonephritis, is characterized by renal immunodeposits containing IgA1 with galactose-deficient O-glycans (Gd-IgA1). These immunodeposits originate from circulating immune complexes consisting of anti-glycan antibodies bound to Gd-IgA1. As clinical disease onset and activity of IgAN often coincide with mucosal infections and dysregulation of cytokines, we hypothesized that cytokines may affect IgA1 O-glycosylation. We used IgA1-secreting cells derived from the circulation of IgAN patients and healthy controls and assessed whether IgA1 O-glycosylation is altered by cytokines. Of the eight cytokines tested, only IL-6 and, to a lesser degree, IL-4 significantly increased galactose deficiency of IgA1; changes in IgA1 O-glycosylation were robust for the cells from IgAN patients. These cytokines reduced galactosylation of the O-glycan substrate directly via decreased expression of the galactosyltransferase C1GalT1 and, indirectly, via increased expression of the sialyltransferase ST6GalNAc-II, which prevents galactosylation by C1GalT1. These findings were confirmed by siRNA knockdown of the corresponding genes and by in vitro enzyme reactions. In summary, IL-6 and IL-4 accentuated galactose deficiency of IgA1 via coordinated modulation of key glycosyltransferases. These data provide a mechanism explaining increased immune-complex formation and disease exacerbation during mucosal infections in IgAN patients.	[Suzuki, Hitoshi; Raska, Milan; Yamada, Koshi; Moldoveanu, Zina; Julian, Bruce A.; Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Suzuki, Hitoshi; Yamada, Koshi; Tomino, Yasuhiko] Juntendo Univ, Fac Med, Tokyo 1138421, Japan; [Raska, Milan] Palacky Univ, Olomouc 77900, Czech Republic; [Wyatt, Robert J.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38103 USA; [Gharavi, Ali G.] Columbia Univ, New York, NY 10032 USA	University of Alabama System; University of Alabama Birmingham; Juntendo University; Palacky University Olomouc; University of Tennessee System; University of Tennessee Health Science Center; Columbia University	Novak, J (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 845 19th St S,BBRB 761A, Birmingham, AL 35294 USA.	jannovak@uab.edu	Raska, Milan/E-9813-2013	Raska, Milan/0000-0002-8572-7246; Wyatt, Robert/0000-0001-6077-0259	National Institutes of Health [DK082753, DK078244, DK083663, GM098539]; IGA Nephropathy Foundation of America; European Social Fund [CZ.1.07/2.3.00/20.0164]; Ministry of School, Youth, and Sport [LH11046]; Czech Science Foundation [GAP302/10/1055]; Grant Agency of the Ministry of Health, Czech Republic [NT11081]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082753, R56DK078244, R21DK083663, R01DK078244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IGA Nephropathy Foundation of America; European Social Fund(European Social Fund (ESF)); Ministry of School, Youth, and Sport; Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Ministry of Health, Czech Republic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK082753, DK078244, DK083663, and GM098539. This work was also supported by a grant from the IGA Nephropathy Foundation of America and by Grants CZ.1.07/2.3.00/20.0164 (European Social Fund), LH11046 (Ministry of School, Youth, and Sport), GAP302/10/1055 (Czech Science Foundation), and NT11081 (Grant Agency of the Ministry of Health, Czech Republic).	Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; ALLEN AC, 1995, CLIN EXP IMMUNOL, V100, P470; ANDRE PM, 1990, J CLIN LAB ANAL, V4, P115, DOI 10.1002/jcla.1860040208; BAENZIGER J, 1974, J BIOL CHEM, V249, P7270; Beerman I, 2007, NAT CLIN PRACT NEPHR, V3, P325, DOI 10.1038/ncpneph0492; Bellur SS, 2011, NEPHROL DIAL TRANSPL, V26, P2533, DOI 10.1093/ndt/gfq812; BENNETT WM, 1983, KIDNEY INT, V23, P393, DOI 10.1038/ki.1983.32; BERGER J, 1968, J UROL NEPHROL, V74, P694; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; Camilla R, 2011, CLIN J AM SOC NEPHRO, V6, P1903, DOI 10.2215/CJN.11571210; CHEN A, 1994, J PATHOL, V173, P119, DOI 10.1002/path.1711730208; Chintalacharuvu SR, 1997, J IMMUNOL, V159, P2327; Chintalacharuvu SR, 2000, CYTOKINE, V12, P1182, DOI 10.1006/cyto.2000.0699; CONLEY ME, 1980, J CLIN INVEST, V66, P1432, DOI 10.1172/JCI109998; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Emancipator S.N., 1998, HEPTINSTALLS PATHOLO, P479; EMANCIPATOR SN, 1989, LAB INVEST, V60, P168; Emancipator SN, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1579, DOI 10.1016/B978-012491543-5/50096-6; EVANS SS, 1993, J CELL BIOL, V123, P1889, DOI 10.1083/jcb.123.6.1889; Feehally J, 2010, J AM SOC NEPHROL, V21, P1791, DOI 10.1681/ASN.2010010076; FIELD MC, 1989, BIOCHEM SOC T, V17, P1034, DOI 10.1042/bst0171034; FUJIHASHI K, 1991, J CLIN INVEST, V88, P248, DOI 10.1172/JCI115284; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Glassock RJ, 2008, CLEV CLIN J MED, V75, P569, DOI 10.3949/ccjm.75.8.569; Glassock RJ, 2011, CURR OPIN NEPHROL HY, V20, P153, DOI 10.1097/MNH.0b013e3283436f5c; Gomes MM, 2010, BIOCHEMISTRY-US, V49, P5671, DOI 10.1021/bi9019498; GOMEZGUERRERO C, 1994, J IMMUNOL, V153, P5247; Goodrich ME, 1999, IMMUNOL LETT, V67, P11, DOI 10.1016/S0165-2478(98)00112-6; Hastings MC, 2010, CLIN J AM SOC NEPHRO, V5, P2069, DOI 10.2215/CJN.03270410; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.00591.x; HOLAN V, 1992, IMMUNOLOGY, V75, P176; Huston MM, 1996, J IMMUNOL, V156, P1392; ITOH K, 1995, J IMMUNOL, V154, P4341; Iwase H, 1998, J CHROMATOGR B, V709, P145, DOI 10.1016/S0378-4347(98)00050-4; JENNETTE JC, 1988, AM J KIDNEY DIS, V12, P348, DOI 10.1016/S0272-6386(88)80022-2; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Julian BA, 2007, CONTRIB NEPHROL, V157, P19, DOI 10.1159/000102284; Julian BA, 2009, PROTEOM CLIN APPL, V3, P1029, DOI 10.1002/prca.200800243; Kiryluk K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002765; Kiryluk K, 2011, KIDNEY INT, V80, P79, DOI 10.1038/ki.2011.16; Kiryluk Krzysztof, 2010, Pediatr Nephrol, V25, P2257, DOI 10.1007/s00467-010-1500-7; KISHIMOTO T, 1992, CIBA F SYMP, V167, P5; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Lai KN, 2009, NEPHROL DIAL TRANSPL, V24, P62, DOI 10.1093/ndt/gfn441; Lau KK, 2007, PEDIATR NEPHROL, V22, P2067, DOI 10.1007/s00467-007-0623-y; Leung JCK, 2003, NEPHROL DIAL TRANSPL, V18, P36, DOI 10.1093/ndt/18.1.36; Leung JCK, 2002, J LAB CLIN MED, V140, P398, DOI 10.1067/mlc.2002.129338; Leung JCK, 2002, J CLIN LAB ANAL, V16, P11, DOI 10.1002/jcla.2035; Leung JCK, 2000, J AM SOC NEPHROL, V11, P241, DOI 10.1681/ASN.V112241; Leung JCK, 2008, NEPHROL DIAL TRANSPL, V23, P72, DOI 10.1093/ndt/gfm581; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; MESTECKY J, 1993, CONTRIB NEPHROL, V104, P172; Mestecky J, 2013, ANNU REV PATHOL-MECH, V8, P217, DOI 10.1146/annurev-pathol-011110-130216; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Moore JS, 2007, MOL IMMUNOL, V44, P2598, DOI 10.1016/j.molimm.2006.12.011; Moura IC, 2004, J AM SOC NEPHROL, V15, P622, DOI 10.1097/01.ASN.0000115401.07980.0C; Novak J, 2005, KIDNEY INT, V67, P504, DOI 10.1111/j.1523-1755.2005.67107.x; Novak J, 2002, KIDNEY INT, V62, P465, DOI 10.1046/j.1523-1755.2002.00477.x; Novak J, 2001, J CLIN IMMUNOL, V21, P310, DOI 10.1023/A:1012284402054; Novak J, 2007, CONTRIB NEPHROL, V157, P134; Novak J, 2012, SEMIN IMMUNOPATHOL, V34, P365, DOI 10.1007/s00281-012-0306-z; Novak J, 2011, NEPHROL DIAL TRANSPL, V26, P3451, DOI 10.1093/ndt/gfr448; Raska M, 2007, J MOL BIOL, V369, P69, DOI 10.1016/j.jmb.2007.03.002; Renfrow MB, 2007, ANAL BIOANAL CHEM, V389, P1397, DOI 10.1007/s00216-007-1500-z; Renfrow MB, 2005, J BIOL CHEM, V280, P19136, DOI 10.1074/jbc.M411368200; Rostoker G, 1998, CLIN EXP IMMUNOL, V114, P468; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; Shimozato S, 2008, NEPHROL DIAL TRANSPL, V23, P1931, DOI 10.1093/ndt/gfm913; Smith AC, 2006, J AM SOC NEPHROL, V17, P1192, DOI 10.1681/ASN.2005101115; Smith AC, 2006, J AM SOC NEPHROL, V17, P3520, DOI 10.1681/ASN.2006060658; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; TAKAGI M, 1995, J EXP MED, V181, P889, DOI 10.1084/jem.181.3.889; Takahashi K, 2012, J PROTEOME RES, V11, P692, DOI 10.1021/pr200608q; Takahashi K, 2010, MOL CELL PROTEOMICS, V9, P2545, DOI 10.1074/mcp.M110.001834; Tam KY, 2009, KIDNEY INT, V75, P1330, DOI 10.1038/ki.2009.71; Tamouza H, 2012, KIDNEY INT, V82, P1284, DOI 10.1038/ki.2012.192; Tarelli E, 2004, CARBOHYD RES, V339, P2329, DOI 10.1016/j.carres.2004.07.011; TOMANA M, 1978, ANAL BIOCHEM, V89, P110, DOI 10.1016/0003-2697(78)90731-5; TOMANA M, 1972, IMMUNOCHEMISTRY, V9, P933, DOI 10.1016/0019-2791(72)90166-8; TOMANA M, 1976, IMMUNOCHEMISTRY, V13, P325, DOI 10.1016/0019-2791(76)90342-6; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Tomana M, 1997, KIDNEY INT, V52, P509, DOI 10.1038/ki.1997.361; TUCCI A, 1992, J IMMUNOL, V148, P2778; Wada Y, 2010, MOL CELL PROTEOMICS, V9, P719, DOI 10.1074/mcp.M900450-MCP200; Xie XH, 2009, PEDIATR RES, V65, P156, DOI 10.1203/PDR.0b013e318191f5c6; Xu WF, 2005, J INTERF CYTOK RES, V25, P113, DOI 10.1089/jir.2005.25.113; Yamada K, 2010, NEPHROL DIAL TRANSPL, V25, P3890, DOI 10.1093/ndt/gfq325; Yu XQ, 2012, NAT GENET, V44, P178, DOI 10.1038/ng.1047; Zhao N, 2012, KIDNEY INT, V82, P790, DOI 10.1038/ki.2012.197	96	98	107	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5330	5339		10.1074/jbc.M113.512277	http://dx.doi.org/10.1074/jbc.M113.512277			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398680	hybrid, Green Published			2022-12-28	WOS:000331607900073
J	Landry, AP; Ding, HG				Landry, Aaron P.; Ding, Huangen			Redox Control of Human Mitochondrial Outer Membrane Protein MitoNEET [2Fe-2S] Clusters by Biological Thiols and Hydrogen Peroxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Hydrogen Peroxide; Iron-Sulfur Protein; Redox Regulation; Thioredoxin	IRON-SULFUR CLUSTER; DRUG TARGET MITONEET; THIOREDOXIN REDUCTASE; DISULFIDE INTERCHANGE; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BINDING-SITE; IDENTIFICATION; OXIDATION	Background: MitoNEET is a target of the type II diabetes drug pioglitazone and contains a [2Fe-2S] cluster. Results: The mitoNEET [2Fe-2S] cluster can be reduced by biological thiols and reversibly oxidized by hydrogen peroxide. Conclusion: The redox state of mitoNEET [2Fe-2S] clusters can be regulated by thiols and oxidative signals. Significance: MitoNEET may act as a redox sensor to modulate mitochondrial functions. The human mitochondrial outer membrane protein mitoNEET is a novel target of the type II diabetes drug pioglitazone. The C-terminal cytosolic domain of mitoNEET hosts a redox-active [2Fe-2S] cluster via an unusual ligand arrangement of three cysteine residues and one histidine residue. Here we report that human mitoNEET [2Fe-2S] clusters are fully reduced when expressed in Escherichia coli cells. In vitro studies show that purified mitoNEET [2Fe-2S] clusters can be partially reduced by monothiols such as reduced glutathione, l-cysteine or N-acetyl-l-cysteine and fully reduced by dithiothreitol or the E. coli thioredoxin/thioredoxin reductase system under anaerobic conditions. Importantly, thiol-reduced mitoNEET [2Fe-2S] clusters can be reversibly oxidized by hydrogen peroxide without disruption of the clusters in vitro and in E. coli cells, indicating that mitoNEET may act as a sensor of oxidative signals to regulate mitochondrial functions via its [2Fe-2S] clusters. Furthermore, the binding of the type II diabetes drug pioglitazone in mitoNEET effectively inhibits the thiol-mediated reduction of [2Fe-2S] clusters, suggesting that pioglitazone may modulate the function of mitoNEET by blocking the thiol-mediated reduction of [2Fe-2S] clusters in the protein.	[Landry, Aaron P.; Ding, Huangen] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Ding, HG (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	hding@lsu.edu	Ding, Huangen/AAJ-8550-2020	Ding, Huangen/0000-0002-4815-7336	NCI, National Institutes of Health [R01CA107494]; American Heart Association [13GRNT16890014]; Louisiana Board of Regents graduate scholarship; NATIONAL CANCER INSTITUTE [R01CA107494] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); Louisiana Board of Regents graduate scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant R01CA107494. This work was also supported by American Heart Association Grant 13GRNT16890014 and by a Louisiana Board of Regents graduate scholarship.	Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; Arif W, 2011, BIOCHEMISTRY-US, V50, P5806, DOI 10.1021/bi200546s; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bak DW, 2013, BIOCHEMISTRY-US, V52, P4687, DOI 10.1021/bi400540m; Bak DW, 2009, BIOCHEMISTRY-US, V48, P10193, DOI 10.1021/bi9016445; Baxter EL, 2011, P NATL ACAD SCI USA, V108, P5266, DOI 10.1073/pnas.1017604108; Baxter EL, 2012, P NATL ACAD SCI USA, V109, P1955, DOI 10.1073/pnas.1116369109; Bieganski RM, 2011, J MOL GRAPH MODEL, V29, P965, DOI 10.1016/j.jmgm.2011.04.001; Chang NC, 2012, AUTOPHAGY, V8, P856, DOI 10.4161/auto.20054; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Conlan AR, 2011, ACTA CRYSTALLOGR D, V67, P516, DOI 10.1107/S0907444911011577; Conlan AR, 2009, J MOL BIOL, V392, P143, DOI 10.1016/j.jmb.2009.06.079; Crack JC, 2012, CURR OPIN CHEM BIOL, V16, P35, DOI 10.1016/j.cbpa.2012.02.009; Dai SD, 2000, SCIENCE, V287, P655, DOI 10.1126/science.287.5453.655; Dicus MM, 2010, J AM CHEM SOC, V132, P2037, DOI 10.1021/ja909359g; Ding HG, 2005, J BIOL CHEM, V280, P30432, DOI 10.1074/jbc.M504638200; Ding HG, 1997, P NATL ACAD SCI USA, V94, P8445, DOI 10.1073/pnas.94.16.8445; Ding HG, 1996, J BIOL CHEM, V271, P33173, DOI 10.1074/jbc.271.52.33173; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Eaton P, 2006, FREE RADICAL BIO MED, V40, P1889, DOI 10.1016/j.freeradbiomed.2005.12.037; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Geldenhuys WJ, 2013, CURR MED CHEM, V20, P1662; Geldenhuys WJ, 2011, BIOORG MED CHEM LETT, V21, P5498, DOI 10.1016/j.bmcl.2011.06.111; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; Iwasaki T, 2009, J AM CHEM SOC, V131, P13659, DOI 10.1021/ja903228w; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Lin JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026977; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Quijano C, 1997, BIOCHEM J, V322, P167, DOI 10.1042/bj3220167; Ren B, 2009, J BIOL CHEM, V284, P4829, DOI 10.1074/jbc.M807943200; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; SZAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011, DOI 10.1021/ja00526a042; Tan GQ, 2012, BIOMETALS, V25, P1177, DOI 10.1007/s10534-012-9580-4; Tirrell TF, 2009, BIOCHEMISTRY-US, V48, P4747, DOI 10.1021/bi900028r; Veine DM, 1998, PROTEIN SCI, V7, P1441, DOI 10.1002/pro.5560070621; Walters EM, 2009, BIOCHEMISTRY-US, V48, P1016, DOI 10.1021/bi802074p; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wiley SE, 2013, EMBO MOL MED, V5, P904, DOI 10.1002/emmm.201201429; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Yonutas HM, 2013, CURR DRUG TARGETS, V14, P733, DOI 10.2174/1389450111314070003; Zhou T, 2010, BIOCHEMISTRY-US, V49, P9604, DOI 10.1021/bi101168c; Zschauer TC, 2013, ANTIOXID REDOX SIGN, V18, P1053, DOI 10.1089/ars.2012.4822; Zuris JA, 2012, J BIOL CHEM, V287, P11649, DOI 10.1074/jbc.M111.319731; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	57	46	48	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4307	4315		10.1074/jbc.M113.542050	http://dx.doi.org/10.1074/jbc.M113.542050			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24403080	hybrid, Green Published			2022-12-28	WOS:000331403800041
J	Tripathi, A; Dewan, PC; Siddique, SA; Varadarajan, R				Tripathi, Arti; Dewan, Pooja C.; Siddique, Shahbaz A.; Varadarajan, Raghavan			MazF-induced Growth Inhibition and Persister Generation in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Cell Death; Mutant; Protein Degradation; Protein Synthesis; Toxin-Antitoxin; Inactive; Active-site Mutant; Bacteriostasis; Antibiotic Tolerance	TOXIN-ANTITOXIN SYSTEMS; PROGRAMMED CELL-DEATH; BACTERIAL PERSISTENCE; CONTROLLED EXPRESSION; PROTEIN-SYNTHESIS; MESSENGER-RNAS; CLEAVAGE; PLASMID; LON; TRANSLATION	Background: MazEF is a chromosomally encoded bacterial toxin-antitoxin system whose cellular role is controversial. Results: Expression of chromosomal MazF inhibits cell killing by multiple antibiotics in a Lon and ClpP dependent manner. Conclusion: MazF is involved in reversible growth inhibition and bacterial drug tolerance. Significance: Inactive, active-site toxin mutants yield functional insights by selectively activating the corresponding WT toxin in vivo. Toxin-antitoxin systems are ubiquitous in nature and present on the chromosomes of both bacteria and archaea. MazEF is a type II toxin-antitoxin system present on the chromosome of Escherichia coli and other bacteria. Whether MazEF is involved in programmed cell death or reversible growth inhibition and bacterial persistence is a matter of debate. In the present work the role of MazF in bacterial physiology was studied by using an inactive, active-site mutant of MazF, E24A, to activate WT MazF expression from its own promoter. The ectopic expression of E24A MazF in a strain containing WT mazEF resulted in reversible growth arrest. Normal growth resumed on inhibiting the expression of E24A MazF. MazF-mediated growth arrest resulted in an increase in survival of bacterial cells during antibiotic stress. This was studied by activation of mazEF either by overexpression of an inactive, active-site mutant or pre-exposure to a sublethal dose of antibiotic. The MazF-mediated persistence phenotype was found to be independent of RecA and dependent on the presence of the ClpP and Lon proteases. This study confirms the role of MazEF in reversible growth inhibition and persistence.	[Tripathi, Arti; Dewan, Pooja C.; Siddique, Shahbaz A.; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Varadarajan, Raghavan] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560004, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	varadar@mbu.iisc.ernet.in	Tripathi, Arti/J-6047-2019	Tripathi, Arti/0000-0002-1515-7102	Department of Biotechnology and Department of Science and Technology, Government of India	Department of Biotechnology and Department of Science and Technology, Government of India	The work was supported by grants from the Department of Biotechnology and Department of Science and Technology, Government of India (to R. V.).	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bajaj K, 2005, P NATL ACAD SCI USA, V102, P16221, DOI 10.1073/pnas.0505089102; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Brzozowska I, 2013, PLASMID, V70, P33, DOI 10.1016/j.plasmid.2013.01.007; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Cohen NR, 2013, CELL HOST MICROBE, V13, P632, DOI 10.1016/j.chom.2013.05.009; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Dwyer DJ, 2012, MOL CELL, V46, P561, DOI 10.1016/j.molcel.2012.04.027; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Engelberg-Kulka H, 2004, TRENDS MICROBIOL, V12, P66, DOI 10.1016/j.tim.2003.12.008; Falla TJ, 1998, ANTIMICROB AGENTS CH, V42, P3282, DOI 10.1128/AAC.42.12.3282; Frampton R, 2012, J BIOL CHEM, V287, P5340, DOI 10.1074/jbc.M111.286856; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hansen S., 2012, PLOS ONE, V7; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kasari V, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-45; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; Kwan BW, 2013, ANTIMICROB AGENTS CH, V57, P1468, DOI 10.1128/AAC.02135-12; Li GY, 2006, J MOL BIOL, V357, P139, DOI 10.1016/j.jmb.2005.12.035; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; Munoz-Gomez AJ, 2004, FEBS LETT, V567, P316, DOI 10.1016/j.febslet.2004.05.005; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Peters JE, 2003, J BACTERIOL, V185, P2017, DOI 10.1128/JB.185.6.2017-2021.2003; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Schlacher K, 2005, MOL CELL, V17, P561, DOI 10.1016/j.molcel.2005.01.006; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Tripathi A, 2012, P NATL ACAD SCI USA, V109, P12497, DOI 10.1073/pnas.1121217109; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; UZAN M, 1976, BIOCHEM BIOPH RES CO, V69, P751, DOI 10.1016/0006-291X(76)90939-6; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Wang NR, 2007, ANAL BIOCHEM, V371, P173, DOI 10.1016/j.ab.2007.07.017; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200	65	66	72	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4191	4205		10.1074/jbc.M113.510511	http://dx.doi.org/10.1074/jbc.M113.510511			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24375411	hybrid, Green Published			2022-12-28	WOS:000331403800032
J	Joseph, B; Korkhov, VM; Yulikov, M; Jeschke, G; Bordignon, E				Joseph, Benesh; Korkhov, Vladimir M.; Yulikov, Maxim; Jeschke, Gunnar; Bordignon, Enrica			Conformational Cycle of the Vitamin B-12 ABC Importer in Liposomes Detected by Double Electron-Electron Resonance (DEER)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Electron Paramagnetic Resonance (EPR); Liposomes; Membrane Bilayer; Membrane Proteins; DEER; Detergent; Peldor	X-RAY-STRUCTURE; DISTANCE MEASUREMENTS; SPIN LABELS; BTUCD-F; PARAMAGNETIC-RESONANCE; ASPARTATE TRANSPORTER; EPR SPECTROSCOPY; NITROXIDE; MECHANISM; DYNAMICS	Background: Type II ABC importers transport diverse substrates into the cell. Results: EPR on BtuCD-F in liposomes shows the response of cytoplasmic gate II during nucleotide cycle in the presence of substrate. Conclusion: The cytoplasmic gate II closes with substrate and ATP as in the x-ray structure. Substrate can be released after hydrolysis. Significance: There is new insight into the mechanism of transport in membranes. Double electron-electron resonance is used here to investigate intermediates of the transport cycle of the Escherichia coli vitamin B-12 ATP-binding cassette importer BtuCD-F. Previously, we showed the ATP-induced opening of the cytoplasmic gate I in TM5 helices, later confirmed by the AMP-PNP-bound BtuCD-F crystal structure. Here, other key residues are analyzed in TM10 helices (positions 307 and 322) and in the cytoplasmic gate II, i.e. the loop between TM2 and TM3 (positions 82 and 85). Without BtuF, binding of ATP induces detectable changes at positions 307 and 85 in BtuCD in liposomes. Together with BtuF, ATP triggers the closure of the cytoplasmic gate II in liposomes (reported by both positions 82 and 85). This forms a sealed cavity in the translocation channel in agreement with the AMP-PNPBtuCD-F x-ray structure. When vitamin B-12 and AMP-PNP are simultaneously present, the extent of complex formation is reduced, but the short 82-82 interspin distance detected indicates that the substrate does not affect the closed conformation of this gate. The existence of the BtuCD-F complex under these conditions is verified with spectroscopically orthogonal nitroxide and Gd(III)-based labels. The cytoplasmic gate II remains closed also in the vanadate-trapped state, but it reopens in the ADP-bound state of the complex. Therefore, we suggest that the substrate likely trapped in ATPBtuCD-F can be released after ATP hydrolysis but before the occluded ADP-bound conformation is reached.	[Joseph, Benesh; Yulikov, Maxim; Jeschke, Gunnar; Bordignon, Enrica] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Korkhov, Vladimir M.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bordignon, E (corresponding author), ETH, Phys Chem Lab, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	enrica.bordignon@phys.chem.ethz.ch	Yulikov, Maxim/AAU-3685-2020; Joseph, Benesh/AAK-9039-2020; JOSEPH, BENESH/K-4628-2016	Joseph, Benesh/0000-0003-4968-889X; JOSEPH, BENESH/0000-0003-4968-889X; Jeschke, Gunnar/0000-0001-6853-8585; Korkhov, Volodymyr/0000-0002-0962-9433; Bordignon, Enrica/0000-0003-2450-5161	Swiss Federal Institute of Technology in Zurich [ETH-21 09-1]	Swiss Federal Institute of Technology in Zurich	This work was supported by Research Grant ETH-21 09-1 from the Swiss Federal Institute of Technology in Zurich (to G. J. and E. B.).	Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Dalmas O, 2012, J AM CHEM SOC, V134, P16360, DOI 10.1021/ja3069038; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Denning EJ, 2013, CHEM PHYS LIPIDS, V169, P57, DOI 10.1016/j.chemphyslip.2013.02.007; Endeward B, 2009, J AM CHEM SOC, V131, P15246, DOI 10.1021/ja904808n; Garbuio L, 2013, J PHYS CHEM B, V117, P3145, DOI 10.1021/jp401806g; Georgieva ER, 2013, NAT STRUCT MOL BIOL, V20, P215, DOI 10.1038/nsmb.2494; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Grote M, 2008, BIOPHYS J, V95, P2924, DOI 10.1529/biophysj.108.132456; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; Hanelt I, 2013, NAT STRUCT MOL BIOL, V20, P210, DOI 10.1038/nsmb.2471; Hellmich UA, 2012, J AM CHEM SOC, V134, P5857, DOI 10.1021/ja211007t; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2013, PROG NUCL MAG RES SP, V72, P42, DOI 10.1016/j.pnmrs.2013.03.001; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Kaminker I, 2012, PHYS CHEM CHEM PHYS, V14, P4355, DOI 10.1039/c2cp40219j; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lueders P, 2013, J PHYS CHEM B, V117, P2061, DOI 10.1021/jp311287t; Lueders P, 2011, J PHYS CHEM LETT, V2, P604, DOI 10.1021/jz200073h; Mittal A, 2012, J BIOL CHEM, V287, P20395, DOI 10.1074/jbc.M112.359794; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Polyhach Y, 2012, PHYS CHEM CHEM PHYS, V14, P10762, DOI 10.1039/c2cp41520h; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Rice AJ, 2013, J BIOL CHEM, V288, P21228, DOI 10.1074/jbc.M113.483495; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Steinhoff HJ, 1997, BIOPHYS J, V73, P3287, DOI 10.1016/S0006-3495(97)78353-X; Tschaggelar R, 2009, J MAGN RESON, V200, P81, DOI 10.1016/j.jmr.2009.06.007; Vigonsky E, 2013, P NATL ACAD SCI USA, V110, P5440, DOI 10.1073/pnas.1213598110; Woo JS, 2012, NAT STRUCT MOL BIOL, V19, P1310, DOI 10.1038/nsmb.2417; Yulikov M, 2012, PHYS CHEM CHEM PHYS, V14, P10732, DOI 10.1039/c2cp40282c; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	39	47	47	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3176	3185		10.1074/jbc.M113.512178	http://dx.doi.org/10.1074/jbc.M113.512178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362024	hybrid, Green Published			2022-12-28	WOS:000331368700007
J	Vidilaseris, K; Morriswood, B; Kontaxis, G; Dong, G				Vidilaseris, Keni; Morriswood, Brooke; Kontaxis, Georg; Dong, Gang			Structure of the TbBILBO1 Protein N-terminal Domain from Trypanosoma brucei Reveals an Essential Requirement for a Conserved Surface Patch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytoskeleton; Infectious Diseases; Molecular Cell Biology; Nuclear Magnetic Resonance; Parasite; Protein Structure; Structural Biology; Trypanosoma brucei; TbBILBO1; Flagellar Pocket Collar	CELL-SURFACE; SYSTEM; CYTOSKELETON; POLARITY	Background: TbBILBO1 is the only known component of the flagellar pocket collar, a cytoskeletal structure in the parasite Trypanosoma brucei.Results: The TbBILBO1 N-terminal domain has a ubiquitin-like fold with a conserved surface patch; overexpression of constructs with a mutagenized patch is lethal. Conclusion: The conserved surface patch is essential for TbBILBO1 function. Significance: The surface patch is a potential therapeutic target. TbBILBO1 is the only known component of the flagellar pocket collar, a cytoskeletal barrier element found in trypanosomes. The N-terminal domain (NTD) of TbBILBO1 was found to be dispensable for targeting of the protein in vivo. However, overexpression of constructs lacking the NTD caused complete growth inhibition, implying an essential requirement for this domain. A high resolution structure of the NTD of TbBILBO1 showed that it forms a ubiquitin-like fold with a conserved surface patch. Mutagenesis of this patch recapitulated the phenotypic effects of deleting the entire domain and was found to cause cell death. The surface patch on the NTD of TbBILBO1 is therefore a potential drug target.	[Vidilaseris, Keni; Dong, Gang] Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Morriswood, Brooke; Kontaxis, Georg] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Morriswood, B (corresponding author), Univ Vienna, Max F Perutz Labs, Waehringer Guertel 18, A-1030 Vienna, Austria.	brooke.morriswood@univie.ac.at; gang.dong@meduniwien.ac.at	Vidilaseris, Keni/Q-1243-2019; Morriswood, Brooke/AAY-9714-2020	Vidilaseris, Keni/0000-0002-6453-6600; Morriswood, Brooke/0000-0001-7031-3801; Dong, Gang/0000-0001-9745-8103	Max F. Perutz Laboratories; Austrian Science Fund [P24383-B21]; Osterreichischer Austauschdienst (OeAD) graduate scholarship; Austrian Science Fund (FWF) [P 24383] Funding Source: researchfish	Max F. Perutz Laboratories; Austrian Science Fund(Austrian Science Fund (FWF)); Osterreichischer Austauschdienst (OeAD) graduate scholarship; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by funding from the Max F. Perutz Laboratories and Grant P24383-B21 from the Austrian Science Fund (to G. D.).; Supported by an Osterreichischer Austauschdienst (OeAD) graduate scholarship during 2009-2012.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Baker N, 2013, TRENDS PARASITOL, V29, P110, DOI 10.1016/j.pt.2012.12.005; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Esson HJ, 2012, EUKARYOT CELL, V11, P761, DOI 10.1128/EC.05287-11; Garner TP, 2011, BIOCHEMISTRY-US, V50, P9076, DOI 10.1021/bi201137e; Goldshmidt H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000731; Grunfelder CG, 2002, TRAFFIC, V3, P547, DOI 10.1034/j.1600-0854.2002.30805.x; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hirano Y, 2005, J BIOL CHEM, V280, P9653, DOI 10.1074/jbc.M409823200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Martin MB, 2001, J MED CHEM, V44, P909, DOI 10.1021/jm0002578; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi J, 2008, J CELL SCI, V121, P3062, DOI 10.1242/jcs.030643; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Welburn SC, 2012, ADV PARASIT, V79, P299, DOI 10.1016/B978-0-12-398457-9.00004-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012; Zucca M, 2013, CURR MED CHEM, V20, P502	27	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3724	3735		10.1074/jbc.M113.529032	http://dx.doi.org/10.1074/jbc.M113.529032			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362019	hybrid, Green Published			2022-12-28	WOS:000331368700053
J	Huang, YL; Morales-Rosado, J; Ray, J; Myers, TG; Kho, T; Lu, MF; Munford, RS				Huang, Ying-ling; Morales-Rosado, Joel; Ray, Jessica; Myers, Timothy G.; Kho, Terry; Lu, Mingfang; Munford, Robert S.			Toll-like Receptor Agonists Promote Prolonged Triglyceride Storage in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Triglyceride Lipase; Lipid Droplet; Lipolysis; Lipopolysaccharide (LPS); Macrophages; Toll-like Receptors (TLR); Triglyceride; ACSL; DGAT2; Acyl-CoA Synthetase	FOAM CELL-FORMATION; COA SYNTHETASE 1; ACYL-COA; LIPID-METABOLISM; FATTY-ACID; BACTERIAL LIPOPOLYSACCHARIDE; MURINE MACROPHAGES; KETONE-BODIES; TRIACSIN C; ACCUMULATION	Background: How microbial agonists induce macrophages to store triglycerides (TAG) for prolonged periods was not known. Results: Toll-like receptor (TLR)1/2, TLR3, and TLR4 agonists increased fatty acid uptake, increased TAG synthesis, and decreased lipolysis, augmenting TAG storage for 72 h. Conclusion: TAG retention is an active, multifaceted, and long lasting response to sensing microbes. Significance: Prolonged TAG storage contributes to foam cell formation. Macrophages in infected tissues may sense microbial molecules that significantly alter their metabolism. In a seeming paradox, these critical host defense cells often respond by increasing glucose catabolism while simultaneously storing fatty acids (FA) as triglycerides (TAG) in lipid droplets. We used a load-chase strategy to study the mechanisms that promote long term retention of TAG in murine and human macrophages. Toll-like receptor (TLR)1/2, TLR3, and TLR4 agonists all induced the cells to retain TAG for 3 days. Prolonged TAG retention was accompanied by the following: (a) enhanced FA uptake and FA incorporation into TAG, with long lasting increases in acyl-CoA synthetase long 1 (ACSL1) and diacylglycerol acyltransferase-2 (DGAT2), and (b) decreases in lipolysis and FA -oxidation that paralleled a prolonged drop in adipose triglyceride lipase (ATGL). TLR agonist-induced TAG storage is a multifaceted process that persists long after most early pro-inflammatory responses have subsided and may contribute to the formation of lipid-laden macrophages in infected tissues.	[Huang, Ying-ling; Morales-Rosado, Joel; Ray, Jessica; Kho, Terry; Lu, Mingfang; Munford, Robert S.] NIAID, Antibacterial Host Def Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Myers, Timothy G.] NIAID, Genom Technol Sect, Res Technol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Munford, RS (corresponding author), 9000 Rockville Pike,MC3206, Bethesda, MD 20892 USA.	robertmunford@gmail.com		Myers, Timothy Gene/0000-0002-7059-5906; Morales-Rosado, Joel A./0000-0002-7710-2211	National Institutes of Health, Division of Intramural Research, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001138, ZICAI001051] Funding Source: NIH RePORTER	National Institutes of Health, Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, Division of Intramural Research, NIAID.	Adler-Wailes DC, 2010, ENDOCRINOLOGY, V151, P2097, DOI 10.1210/en.2009-1364; Arias-Barrau E, 2009, METHODS MOL BIOL, V580, P233, DOI 10.1007/978-1-60761-325-1_13; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Feingold KR, 2012, J LEUKOCYTE BIOL, V92, P829, DOI 10.1189/jlb.1111537; Feingold KR, 2010, ATHEROSCLEROSIS, V209, P81, DOI 10.1016/j.atherosclerosis.2009.08.042; FUNK JL, 1993, ATHEROSCLEROSIS, V98, P67, DOI 10.1016/0021-9150(93)90224-I; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Kazemi MR, 2005, ARTERIOSCL THROM VAS, V25, P1220, DOI 10.1161/01.ATV.0000159163.52632.1b; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Li LO, 2010, BBA-MOL CELL BIOL L, V1801, P246, DOI 10.1016/j.bbalip.2009.09.024; LOIKE JD, 1993, J IMMUNOL, V150, P1951; Lu MF, 2003, J EXP MED, V197, P1745, DOI 10.1084/jem.20030420; Maurya MR, 2013, J LIPID RES, V54, P2525, DOI 10.1194/jlr.M040212; MUNFORD RS, 1992, J IMMUNOL METHODS, V148, P115, DOI 10.1016/0022-1759(92)90164-O; Namatame I, 1999, J BIOCHEM-TOKYO, V125, P319, DOI 10.1093/oxfordjournals.jbchem.a022289; Newsholme E A, 1976, Biochem Soc Symp, P61; NEWSHOLME P, 1987, BIOCHEM J, V242, P631, DOI 10.1042/bj2420631; NEWSHOLME P, 1989, BIOCHEM J, V261, P211, DOI 10.1042/bj2610211; NEWSHOLME P, 1986, BIOCHEM J, V239, P121, DOI 10.1042/bj2390121; Nicolaou G, 2012, J ATHEROSCLER THROMB, V19, P137, DOI 10.5551/jat.10249; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; Nye C, 2008, TRENDS ENDOCRIN MET, V19, P356, DOI 10.1016/j.tem.2008.08.003; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Rubinow KB, 2013, J BIOL CHEM, V288, P9957, DOI 10.1074/jbc.M113.458372; Saraswathi V, 2009, ARTERIOSCL THROM VAS, V29, P1937, DOI 10.1161/ATVBAHA.109.195362; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200	34	68	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					3001	3012		10.1074/jbc.M113.524587	http://dx.doi.org/10.1074/jbc.M113.524587			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24337578	Green Published, hybrid			2022-12-28	WOS:000333403000047
J	Eberhardt, M; Nakajima, J; Klinger, AB; Neacsu, C; Huhne, K; O'Reilly, AO; Kist, AM; Lampe, AK; Fischer, K; Gibson, J; Nau, C; Winterpacht, A; Lampert, A				Eberhardt, Mirjam; Nakajima, Julika; Klinger, Alexandra B.; Neacsu, Cristian; Huehne, Kathrin; O'Reilly, Andrias O.; Kist, Andreas M.; Lampe, Anne K.; Fischer, Kerstin; Gibson, Jane; Nau, Carla; Winterpacht, Andreas; Lampert, Angelika			Inherited Pain SODIUM CHANNEL NAV1.7 A1632T MUTATION CAUSES ERYTHROMELALGIA DUE TO A SHIFT OF FAST INACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Neurophysiology; Pain; Patch Clamp; Site-directed Mutagenesis; Sodium Channels; Erythromelalgia; Hyperexcitability; Mosaicism	GATED SODIUM-CHANNEL; CRYSTAL-STRUCTURE; PRIMARY ERYTHERMALGIA; DISORDER MUTATIONS; CHANNELOPATHIES; ERYTHROMELALGIA	Inherited erythromelalgia (IEM) causes debilitating episodic neuropathic pain characterized by burning in the extremities. Inherited paroxysmal extreme pain disorder (PEPD) differs in its clinical picture and affects proximal body areas like the rectal, ocular, or jaw regions. Both pain syndromes have been linked to mutations in the voltage-gated sodium channel Nav1.7. Electrophysiological characterization shows that IEM-causing mutations generally enhance activation, whereas mutations leading to PEPD alter fast inactivation. Previously, an A1632E mutation of a patient with overlapping symptoms of IEM and PEPD was reported (Estacion, M., Dib-Hajj, S. D., Benke, P. J., Te Morsche, R. H., Eastman, E. M., Macala, L. J., Drenth, J. P., and Waxman, S. G. (2008) NaV1.7 Gain-of-function mutations as a continuum. A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J. Neurosci. 28, 11079-11088), displaying a shift of both activation and fast inactivation. Here, we characterize a new mutation of Nav1.7, A1632T, found in a patient suffering from IEM. Although transfection of A1632T in sensory neurons resulted in hyperexcitability and spontaneous firing of dorsal root ganglia (DRG) neurons, whole-cell patch clamp of transfected HEK cells revealed that Nav1.7 activation was unaltered by the A1632T mutation but that steady-state fast inactivation was shifted to more depolarized potentials. This is a characteristic normally attributed to PEPD-causing mutations. In contrast to the IEM/PEPD crossover mutation A1632E, A1632T failed to slow current decay (i.e. open-state inactivation) and did not increase resurgent currents, which have been suggested to contribute to high-frequency firing in physiological and pathological conditions. Reduced fast inactivation without increased resurgent currents induces symptoms of IEM, not PEPD, in the new Nav1.7 mutation, A1632T. Therefore, persistent and resurgent currents are likely to determine whether a mutation in Nav1.7 leads to IEM or PEPD.	[Eberhardt, Mirjam; Klinger, Alexandra B.; Neacsu, Cristian; O'Reilly, Andrias O.; Kist, Andreas M.; Lampert, Angelika] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Eberhardt, Mirjam] Hannover Med Sch, Dept Anesthesiol & Intens Care Med, D-30625 Hannover, Germany; [Nakajima, Julika; Huehne, Kathrin; Winterpacht, Andreas; Lampert, Angelika] Univ Erlangen Nurnberg, Dept Human Genet, D-91054 Hannover, Germany; [Lampe, Anne K.] Western Gen Hosp, South Eastotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Fischer, Kerstin; Nau, Carla] Univ Erlangen Nurnberg, Dept Anesthesiol, D-91054 Erlangen, Germany; [Gibson, Jane] Whytemans Brae Hosp, Fife Rheumat Dis Unit, Kirkcaldy KY1 2ND, Fife, Scotland; [Nau, Carla] Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care, D-23538 Lubeck, Germany; [Lampert, Angelika] Univ Aachen, Rheinisch Westfal Tech Hsch, Inst Physiol, D-52074 Aachen, Germany	University of Erlangen Nuremberg; Hannover Medical School; University of Erlangen Nuremberg; University of Edinburgh; University of Erlangen Nuremberg; University of Kiel; Schleswig Holstein University Hospital; RWTH Aachen University	Lampert, A (corresponding author), Rhein Westfal TH Aachen, Inst Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.	alampert@ukaachen.de	O'Reilly, Andrias/AAC-7628-2022; Kist, Andreas/AAU-3236-2021; Lampert, Angelika/F-7198-2010	O'Reilly, Andrias/0000-0003-3449-2368; Kist, Andreas/0000-0003-3643-7776; Lampert, Angelika/0000-0001-6319-6272	Deutsche Forschungsgemeinschaft (DFG) [LA2740/2-1]; ELAN-Fonds (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung, Fonds fur Forschung und Lehre des Klinikums der Friedrich-Alexander-Universitat Erlangen-Nurnberg) [11.05.30.1]; Dr. Ernst und Anita Bauer Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); ELAN-Fonds (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung, Fonds fur Forschung und Lehre des Klinikums der Friedrich-Alexander-Universitat Erlangen-Nurnberg); Dr. Ernst und Anita Bauer Stiftung	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant LA2740/2-1 (to A. L.), by ELAN-Fonds (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung, Fonds fur Forschung und Lehre des Klinikums der Friedrich-Alexander-Universitat Erlangen-Nurnberg, Ref. No.: 11.05.30.1) (to A. L. and C. N.), and by the Dr. Ernst und Anita Bauer Stiftung (to M. E.).	Ahn HS, 2010, EUR J PAIN, V14, P944, DOI 10.1016/j.ejpain.2010.03.007; Catterall WA, 2003, PHARMACOL REV, V55, P575, DOI 10.1124/pr.55.4.7; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Cheng XD, 2011, PROG MOL BIOL TRANSL, V101, P1, DOI 10.1016/B978-0-12-387685-0.00001-9; Choi JS, 2010, BRAIN, V133, P1823, DOI 10.1093/brain/awq114; Cummins TR, 2009, NAT PROTOC, V4, P1103, DOI 10.1038/nprot.2009.91; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Drenth JPH, 2005, J INVEST DERMATOL, V124, P1333, DOI 10.1111/j.0022-202X.2005.23737.x; Estacion M, 2008, J NEUROSCI, V28, P11079, DOI 10.1523/JNEUROSCI.3443-08.2008; Fertleman CR, 2007, NEUROLOGY, V69, P586, DOI 10.1212/01.wnl.0000268065.16865.5f; Grieco TM, 2005, NEURON, V45, P233, DOI 10.1016/j.neuron.2004.12.035; Han CY, 2006, ANN NEUROL, V59, P553, DOI 10.1002/ana.20776; Hoeijmakers JGJ, 2012, BRAIN, V135, P345, DOI 10.1093/brain/awr349; Jarecki BW, 2008, J PHYSIOL-LONDON, V586, P4137, DOI 10.1113/jphysiol.2008.154906; Jarecki BW, 2010, J CLIN INVEST, V120, P369, DOI 10.1172/JCI40801; Lampert A, 2010, PFLUG ARCH EUR J PHY, V460, P249, DOI 10.1007/s00424-009-0779-3; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Takahashi K, 2007, NEUROPEDIATRICS, V38, P157, DOI 10.1055/s-2007-990265; Theile JW, 2011, MOL PHARMACOL, V80, P724, DOI 10.1124/mol.111.072751; Theile JW, 2011, J PHYSIOL-LONDON, V589, P597, DOI 10.1113/jphysiol.2010.200915; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai CJ, 2013, J MOL BIOL, V425, P4074, DOI 10.1016/j.jmb.2013.06.036; Waxman SG, 2007, NAT NEUROSCI, V10, P405, DOI 10.1038/nn1857; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wu MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083412	31	51	53	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1971	1980		10.1074/jbc.M113.502211	http://dx.doi.org/10.1074/jbc.M113.502211			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311784	Green Published, hybrid			2022-12-28	WOS:000331130200009
J	Srivastav, S; Ball, WB; Gupta, P; Giri, J; Ukil, A; Das, PK				Srivastav, Supriya; Ball, Writoban Basu; Gupta, Purnima; Giri, Jayeeta; Ukil, Anindita; Das, Pijush K.			Leishmania donovani Prevents Oxidative Burst-mediated Apoptosis of Host Macrophages through Selective Induction of Suppressors of Cytokine Signaling (SOCS) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MICE LACKING SUPPRESSOR; TYROSINE PHOSPHATASES; CELL-DEATH; INFECTION; EGR-1; INACTIVATION; STIMULATION; THIOREDOXIN; LYMPHOCYTES	One of the mechanisms for establishment of infection employed by intra-macrophage pathogen-like Leishmania is inhibition of oxidative burst-mediated macrophage apoptosis to protect their niche for survival and replication. We tried to elucidate the underlying mechanism for this by using H2O2 for induction of apoptosis. Leishmania donovani-infected macrophages were much more resistant to H2O2-mediated apoptosis compared with control. Although infected cells were capable of comparable reactive oxygen species production, there was less activation of the downstream cascade consisting of caspase-3 and -7 and cleaved poly(ADP)-ribose polymerase. Suppressors of cytokine signaling (SOCS) 1 and 3 proteins and reactive oxygen species scavenging enzyme thioredoxin, known to be involved in stabilization of protein-tyrosine phosphatases, were found to be induced during infection. Induction of SOCS proteins may be mediated by Egr1, and silencing of Socs1 and -3 either alone or in combination resulted in reduced thioredoxin levels, enhanced activation of caspases, and increased apoptosis of infected macrophages. The induction of protein-tyrosine phosphatases, thioredoxin, SOCS, and Egr1 in L. donovani-infected macrophages was found to be unaffected by H2O2 treatment. SOCS knocked down cells also displayed decreased parasite survival thus marking reduction in disease progression. Taken together, these results suggest that L. donovani may exploit SOCS for subverting macrophage apoptotic machinery toward establishing its replicative niche inside the host.	[Srivastav, Supriya; Ball, Writoban Basu; Das, Pijush K.] CSIR Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata 700032, India; [Gupta, Purnima; Giri, Jayeeta; Ukil, Anindita] Univ Calcutta, Dept Biochem, Kolkata 700019, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Calcutta	Das, PK (corresponding author), CSIR Indian Inst Chem Biol, 4 Raja SC Mullick Rd, Kolkata 700032, India.	pijushdas@iicb.res.in	Gupta, Purnima/AAP-8717-2020	GIRI, JAYEETA/0000-0002-2688-7274; Basu Ball, Writoban/0000-0001-7678-126X; Gupta, Purnima/0000-0003-4389-3024	Council of Scientific and Industrial Research [BSC 0206, BSC 0114]; J. C. Bose Fellowship (Department of Science and Technology), Government of India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); J. C. Bose Fellowship (Department of Science and Technology), Government of India(Department of Science & Technology (India))	This work was supported by Network Project Grant BSC 0206 and Supra Institutional Project Grant BSC 0114 from the Council of Scientific and Industrial Research and the J. C. Bose Fellowship (Department of Science and Technology), Government of India.	Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Bhattacharyya S, 2009, ONCOGENE, V28, P1285, DOI 10.1038/onc.2008.479; Campanella M, 2004, J BIOL CHEM, V279, P18440, DOI 10.1074/jbc.M309494200; Carratelli CR, 2002, FEMS MICROBIOL LETT, V215, P69, DOI 10.1016/S0378-1097(02)00910-2; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Didier C, 2001, FREE RADICAL BIO MED, V31, P585, DOI 10.1016/S0891-5849(01)00617-7; Duval D, 2000, FASEB J, V14, P1577, DOI 10.1096/fj.14.11.1577; Eley A, 2005, HUM REPROD, V20, P2601, DOI 10.1093/humrep/dei082; Fiorentini C, 2003, CELL DEATH DIFFER, V10, P147, DOI 10.1038/sj.cdd.4401151; Fu MG, 2003, BIOCHEM J, V370, P1019, DOI 10.1042/BJ20021503; Gao LY, 2000, TRENDS MICROBIOL, V8, P306, DOI 10.1016/S0966-842X(00)01784-4; Grassme H, 2001, APOPTOSIS, V6, P441, DOI 10.1023/A:1012485506972; Hoffmann KMV, 1997, J BIOL CHEM, V272, P27505, DOI 10.1074/jbc.272.44.27505; Horta Maria Fatima, 2012, J Parasitol Res, V2012, P203818, DOI 10.1155/2012/203818; LIND L, 1992, EXP CLIN ENDOCRINOL, V99, P87, DOI 10.1055/s-0029-1211142; Lisi S, 2005, J EUKARYOT MICROBIOL, V52, P211, DOI 10.1111/j.1550-7408.2005.00026.x; Lodge R, 2006, CELL MICROBIOL, V8, P1922, DOI 10.1111/j.1462-5822.2006.00758.x; Madonna S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.69; Maillet A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.185; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; MOORE KJ, 1994, J IMMUNOL, V152, P2930; MURRAY HW, 1981, J EXP MED, V153, P1302, DOI 10.1084/jem.153.5.1302; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; Nash PB, 1998, J IMMUNOL, V160, P1824; Oh J, 2009, ONCOGENE, V28, P3145, DOI 10.1038/onc.2009.169; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Puhr M, 2009, CANCER RES, V69, P7375, DOI 10.1158/0008-5472.CAN-09-0806; Qian YR, 2012, MOL MED REP, V5, P452, DOI 10.3892/mmr.2011.672; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Schaumburg F, 2006, PARASITOLOGY, V132, pS69, DOI 10.1017/S0031182006000874; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Sinai AP, 2004, INT J PARASITOL, V34, P381, DOI 10.1016/j.ijpara.2003.11.009; Somanna A, 2002, J BIOL CHEM, V277, P25305, DOI 10.1074/jbc.M203034200; Srivastav S, 2012, J IMMUNOL, V189, P924, DOI 10.4049/jimmunol.1102845; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Sukumaran SK, 2004, INFECT IMMUN, V72, P6012, DOI 10.1128/IAI.72.10.6012-6022.2004; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Wilson ME, 1998, J IMMUNOL, V161, P6148; Wu Y, 2013, CLIN EXP PHARMACOL P, V40, P626, DOI 10.1111/1440-1681.12141; Xiong H, 2012, MOL CARCINOGEN, V51, P174, DOI 10.1002/mc.20777; Yamamoto K, 2005, CLIN EXP IMMUNOL, V142, P268, DOI 10.1111/j.1365-2249.2005.02922.x; Zimmermann S, 2006, J IMMUNOL, V176, P1840, DOI 10.4049/jimmunol.176.3.1840	48	38	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1092	1105		10.1074/jbc.M113.496323	http://dx.doi.org/10.1074/jbc.M113.496323			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275663	Green Published, hybrid			2022-12-28	WOS:000330541200041
J	Kim, C; Kim, W; Lee, H; Ji, E; Choe, YJ; Martindale, JL; Akamatsu, W; Okano, H; Kim, HS; Nam, SW; Gorospe, M; Lee, EK				Kim, Chongtae; Kim, Wook; Lee, Heejin; Ji, Eunbyul; Choe, Yun-Jeong; Martindale, Jennifer L.; Akamatsu, Wado; Okano, Hideyuki; Kim, Ho-Shik; Nam, Suk Woo; Gorospe, Myriam; Lee, Eun Kyung			The RNA-binding Protein HuD Regulates Autophagosome Formation in Pancreatic beta Cells by Promoting Autophagy-related Gene 5 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; RNA-binding Protein; RNA Metabolism; RNA Turnover; RNA-Protein Interaction	GAP-43 MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; NEURITE OUTGROWTH; PC12 CELLS; TRANSLATION; OVEREXPRESSION; LIPIDATION; STARVATION; ROLES; ATG5	Tight regulation of autophagy is critical for the fate of pancreatic beta cells. The autophagy protein ATG5 is essential for the formation of autophagosomes by promoting the lipidation of microtubule-associated protein LC3 (light chain 3). However, little is known about the mechanisms that regulate ATG5 expression levels. In this study, we investigated the regulation of ATG5 expression by HuD. The association of HuD with ATG5 mRNA was analyzed by ribonucleoprotein complex immunoprecipitation and biotin pulldown assays. HuD expression levels in pancreatic beta cells were knocked down via siRNA, elevated by overexpression of a HuD-expressing plasmid. The expression levels of HuD, ATG5, LC3, and -actin were determined by Western blot and quantitative RT-PCR analysis. Autophagosome formation was assessed by fluorescence microscopy in GFP-LC3-expressing cells and in pancreatic tissues from WT and HuD-null mice. We identified ATG5 mRNA as a post-transcriptional target of the mammalian RNA-binding protein HuD in pancreatic beta cells. HuD associated with the 3-UTR of the ATG5 mRNA. Modulating HuD abundance did not alter ATG5 mRNA levels, but HuD silencing decreased ATG5 mRNA translation, and, conversely, HuD overexpression enhanced ATG5 mRNA translation. Through its effect on ATG5, HuD contributed to the lipidation of LC3 and the formation of LC3-positive autophagosomes. In keeping with this regulatory paradigm, HuD-null mice displayed lower ATG5 and LC3 levels in pancreatic beta cells. Our results reveal HuD to be an inducer of ATG5 expression and hence a critical regulator of autophagosome formation in pancreatic beta cells.	[Kim, Chongtae; Lee, Heejin; Ji, Eunbyul; Choe, Yun-Jeong; Kim, Ho-Shik; Lee, Eun Kyung] Catholic Univ Korea, Coll Med, Dept Biochem, Seoul 137701, South Korea; [Nam, Suk Woo] Catholic Univ Korea, Coll Med, Dept Pathol, Seoul 137701, South Korea; [Kim, Wook] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea; [Martindale, Jennifer L.; Gorospe, Myriam] NIA, Genet Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Akamatsu, Wado; Okano, Hideyuki] Keio Univ, Grad Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan	Catholic University of Korea; Catholic University of Korea; Ajou University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Keio University	Lee, EK (corresponding author), Catholic Univ Korea, Coll Med, Dept Biochem, 222 Banpodaero, Seoul 137701, South Korea.	leeek@catholic.ac.kr	Okano, Hideyuki/I-7584-2019; Martindale, Jennifer Luethy/AAD-1963-2022	Martindale, Jennifer Luethy/0000-0002-3234-6861	National Research Foundation of Korea [20110013116, 012M3A9D1054517, 2012R1A1A1041352]; Korean government; Intramural Research Program of NIA, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000511] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government); Intramural Research Program of NIA, National Institutes of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Research Foundation of Korea Grants 20110013116 and 012M3A9D1054517 (to E. K. L.) and 2012R1A1A1041352 (to W. K.) funded by the Korean government and by funds from the Intramural Research Program of NIA, National Institutes of Health (to J. L. M. and M. G.).	Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102; Anderson KD, 2000, J NEUROCHEM, V75, P1103, DOI 10.1046/j.1471-4159.2000.0751103.x; Anderson KD, 2001, EXP NEUROL, V168, P250, DOI 10.1006/exnr.2000.7599; Antic D, 1999, GENE DEV, V13, P449, DOI 10.1101/gad.13.4.449; Beckel-Mitchener AC, 2002, J BIOL CHEM, V277, P27996, DOI 10.1074/jbc.M201982200; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Bolognani F, 2007, NEUROBIOL LEARN MEM, V87, P635, DOI 10.1016/j.nlm.2006.11.004; Choe YJ, 2012, ONCOL REP, V28, P2049, DOI 10.3892/or.2012.2034; Chung SM, 1996, J BIOL CHEM, V271, P11518, DOI 10.1074/jbc.271.19.11518; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Deschenes-Furry J, 2003, J BIOL CHEM, V278, P5710, DOI 10.1074/jbc.M209383200; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Florey O, 2012, TRENDS CELL BIOL, V22, P374, DOI 10.1016/j.tcb.2012.04.005; Fu LL, 2012, INT J BIOCHEM CELL B, V44, P733, DOI 10.1016/j.biocel.2012.02.004; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; George MD, 2000, MOL BIOL CELL, V11, P969, DOI 10.1091/mbc.11.3.969; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Huang YP, 2012, CELL CYCLE, V11, P1247, DOI 10.4161/cc.11.6.19670; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kasashima K, 1999, GENES CELLS, V4, P667, DOI 10.1046/j.1365-2443.1999.00292.x; Keil E, 2013, CELL DEATH DIFFER, V20, P321, DOI 10.1038/cdd.2012.129; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee EK, 2012, MOL CELL, V45, P826, DOI 10.1016/j.molcel.2012.01.016; Lee EK, 2010, NAT STRUCT MOL BIOL, V17, P732, DOI 10.1038/nsmb.1815; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lin NY, 2013, ANN RHEUM DIS, V72, P761, DOI 10.1136/annrheumdis-2012-201671; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Noureddine MA, 2005, HUM GENET, V117, P27, DOI 10.1007/s00439-005-1259-2; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Ratti A, 2008, J BIOL CHEM, V283, P7531, DOI 10.1074/jbc.M706082200; SADOT E, 1995, J CELL SCI, V108, P2857; Sukseree S, 2013, BIOCHEM BIOPH RES CO, V430, P689, DOI 10.1016/j.bbrc.2012.11.090; Tanida I, 2011, MICROBIOL IMMUNOL, V55, P1, DOI 10.1111/j.1348-0421.2010.00271.x; Tekirdag KA, 2013, AUTOPHAGY, V9, P374, DOI 10.4161/auto.23117; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Xu JZ, 2012, AUTOPHAGY, V8, P873, DOI 10.4161/auto.19629	45	30	30	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					112	121		10.1074/jbc.M113.474700	http://dx.doi.org/10.1074/jbc.M113.474700			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24275661	hybrid, Green Published			2022-12-28	WOS:000329370900010
J	Ghatak, S; Bogatkevich, GS; Atnelishvili, I; Akter, T; Feghali-Bostwick, C; Hoffman, S; Fresco, VM; Fuchs, JC; Visconti, RP; Markwald, RR; Padhye, SB; Silver, RM; Hascall, VC; Misra, S				Ghatak, Shibnath; Bogatkevich, Galina S.; Atnelishvili, Ilia; Akter, Tanjina; Feghali-Bostwick, Carol; Hoffman, Stanley; Fresco, Victor M.; Fuchs, John C.; Visconti, Richard P.; Markwald, Roger R.; Padhye, Subhas B.; Silver, Richard M.; Hascall, Vincent C.; Misra, Suniti			Overexpression of c-Met and CD44v6 Receptors Contributes to Autocrine TGF-beta 1 Signaling in Interstitial Lung Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cd44; Collagen; Fibroblast; Pulmonary Fibrosis; Transforming Growth Factor beta (TGFbeta)	HEPATOCYTE GROWTH-FACTOR; SCLERODERMA DERMAL FIBROBLASTS; BRONCHOALVEOLAR LAVAGE FLUID; CONSTITUTIVELY REGULATES ACTIVATION; PROGRESSIVE SYSTEMIC-SCLEROSIS; FACTOR-BETA; GENE-EXPRESSION; PHOSPHOINOSITIDE 3-KINASE; COLORECTAL-CANCER; HYALURONIC-ACID	Background: CD44v6 and c-Met contribute to TGF-1 signaling in interstitial lung disease (ILD). Results: CD44v6/TGF-1 signaling regulates activation of ILD fibroblasts, whereas the HGF/Met pathway down-regulates the activation. Conclusion: Overexpression of HGF in ILD fibroblasts sustains the TGF-1-regulated CD44v6 expression that promotes collagen synthesis. Physiological concentrations of HGF are insufficient to influence its antifibrotic effect in these cells. Significance: These results should provide CD44v6 as new drug target to treat ILD. The hepatocyte growth factor (HGF) and the HGF receptor Met pathway are important in the pathogenesis of interstitial lung disease (ILD). Alternatively spliced isoforms of CD44 containing variable exon 6 (CD44v6) and its ligand hyaluronan (HA) alter cellular function in response to interaction between CD44v6 and HGF. TGF-1 is the crucial cytokine that induces fibrotic action in ILD fibroblasts (ILDFbs). We have identified an autocrine TGF-1 signaling that up-regulates both Met and CD44v6 mRNA and protein expression. Western blot analysis, flow cytometry, and immunostaining revealed that CD44v6 and Met colocalize in fibroblasts and in tissue sections from ILD patients and in lungs of bleomycin-treated mice. Interestingly, cell proliferation induced by TGF-1 is mediated through Met and CD44v6. Further, cell proliferation mediated by TGF-1/CD44v6 is ERK-dependent. In contrast, action of Met on ILDFb proliferation does not require ERK but does require p38(MAPK). ILDFbs were sorted into CD44v6(+)/Met(+) and CD44v6(-)/Met(+) subpopulations. HGF inhibited TGF-1-stimulated collagen-1 and -smooth muscle cell actin expression in both of these subpopulations by interfering with TGF-1 signaling. HGF alone markedly stimulated CD44v6 expression, which in turn regulated collagen-1 synthesis. Our data with primary lung fibroblast cultures with respect to collagen-1, CD44v6, and Met expressions were supported by immunostaining of lung sections from bleomycin-treated mice and from ILD patients. These results define the relationships between CD44v6, Met, and autocrine TGF-1 signaling and the potential modulating influence of HGF on TGF-1-induced CD44v6-dependent fibroblast function in ILD fibrosis.	[Ghatak, Shibnath; Fresco, Victor M.; Fuchs, John C.; Visconti, Richard P.; Markwald, Roger R.; Misra, Suniti] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Bogatkevich, Galina S.; Atnelishvili, Ilia; Akter, Tanjina; Feghali-Bostwick, Carol; Hoffman, Stanley; Silver, Richard M.] Med Univ S Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Padhye, Subhas B.] Univ Pune, Abeda Inamdar Coll, Interdisciplinary Sci & Technol Res Acad, Pune 411001, Maharashtra, India; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA	Medical University of South Carolina; Medical University of South Carolina; Savitribai Phule Pune University; Cleveland Clinic Foundation	Ghatak, S (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	ghatak@musc.edu; misra@musc.edu	Visconti, Richard/AAY-3360-2020		Multidisciplinary Clinical Research Center [39919];  [1R03CA167722-01A1];  [P20RR021949];  [P20RR016434];  [P20RR16461-05];  [RO1-HL033756-24];  [P01HL107147];  [1P30AR050953];  [EPS 0903795]; NATIONAL CANCER INSTITUTE [R03CA167722] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062, TL1TR000061] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021949, P20RR016461, P20RR016434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033756, P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050953] Funding Source: NIH RePORTER	Multidisciplinary Clinical Research Center; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by 1R03CA167722-01A1 (to S. M. and S. G.); P20RR021949 (to S. G.), P20RR016434 (to S. M., S. G., and R. R. M.), P20RR16461-05 (to S. G. and R. R. M), RO1-HL033756-24 (to S. M., S. G., and R. R. M.), P01HL107147 and 1P30AR050953 (to V. C. H.), EPS 0903795 (to S. M.), and Multidisciplinary Clinical Research Center 39919 (to S. G. and S. M.).	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; BJERMER L, 1987, BRIT MED J, V295, P803, DOI 10.1136/bmj.295.6602.803; Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P3468, DOI 10.1002/art.22874; Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P2432, DOI 10.1002/art.22713; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Dai CS, 2004, J AM SOC NEPHROL, V15, P2637, DOI 10.1097/01.ASN.0000139479.09658.EE; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; FLOEGE J, 1993, KIDNEY INT, V43, pS47; Forbes SJ, 2004, GASTROENTEROLOGY, V126, P955, DOI 10.1053/j.gastro.2004.02.025; Foster LC, 1998, J BIOL CHEM, V273, P20341, DOI 10.1074/jbc.273.32.20341; Freitas JP, 1996, DERMATOLOGY, V192, P46, DOI 10.1159/000246314; Ghatak S, 2010, J BIOL CHEM, V285, P19821, DOI 10.1074/jbc.M110.104273; Ghatak S, 2008, CONNECT TISSUE RES, V49, P265, DOI 10.1080/03008200802147845; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; GOHDA E, 1992, CELL BIOL INT REP, V16, P917, DOI 10.1016/S0309-1651(06)80171-2; Han DC, 2000, AM J PHYSIOL-RENAL, V278, pF628, DOI 10.1152/ajprenal.2000.278.4.F628; He S, 2010, BRIT J DERMATOL, V162, P538, DOI 10.1111/j.1365-2133.2009.09511.x; HEIDER KH, 1993, J CELL BIOL, V120, P227, DOI 10.1083/jcb.120.1.227; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hsu E, 2011, ARTHRITIS RHEUM-US, V63, P783, DOI 10.1002/art.30159; Ihn H, 2001, ARTHRITIS RHEUM, V44, P474, DOI 10.1002/1529-0131(200102)44:2<474::AID-ANR67>3.3.CO;2-R; Inoue T, 2002, FASEB J, V16, P268, DOI 10.1096/fj.02-0442fje; Ishida T, 2000, SURG TODAY, V30, P28, DOI 10.1007/PL00010042; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jinnin M, 2006, BIOCHEM BIOPH RES CO, V343, P904, DOI 10.1016/j.bbrc.2006.03.037; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P3540, DOI 10.1093/nar/gki648; Jinnin M, 2005, J INVEST DERMATOL, V124, P324, DOI 10.1111/j.0022-202X.2004.23601.x; Kajihara I, 2012, BIOSCI TRENDS, V6, P136, DOI 10.5582/bst.2012.v6.3.136; Kawaguchi Y, 1999, J RHEUMATOL, V26, P1012; Kawaguchi Y, 2002, J RHEUMATOL, V29, P1877; KIKUCHI K, 1992, BIOCHEM BIOPH RES CO, V187, P45, DOI 10.1016/S0006-291X(05)81456-1; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Laprise P, 2004, J CELL PHYSIOL, V199, P32, DOI 10.1002/jcp.10432; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; LEVESQUE H, 1991, BRIT J DERMATOL, V124, P423; Lewington AJP, 2000, AM J PHYSIOL-REG I, V278, pR247, DOI 10.1152/ajpregu.2000.278.1.R247; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; MAEDA J, 1995, AM J RESP CRIT CARE, V152, P1587, DOI 10.1164/ajrccm.152.5.7582299; Matsumoto K, 2001, KIDNEY INT, V59, P2023, DOI 10.1046/j.1523-1755.2001.00717.x; Matsumoto K, 2000, CURR OPIN NEPHROL HY, V9, P395, DOI 10.1097/00041552-200007000-00011; MATSUMOTO K, 1992, J BIOL CHEM, V267, P24917; Misra S, 1999, P NATL ACAD SCI USA, V96, P5814, DOI 10.1073/pnas.96.10.5814; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Misra S, 1998, J BIOL CHEM, V273, P26638, DOI 10.1074/jbc.273.41.26638; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Misra S, 2013, BIOORGAN MED CHEM, V21, P2551, DOI 10.1016/j.bmc.2013.02.033; Misra S, 2011, FEBS J, V278, P1429, DOI 10.1111/j.1742-4658.2011.08071.x; Misra S, 2009, J BIOL CHEM, V284, P12432, DOI 10.1074/jbc.M806772200; MIYAKE K, 1990, J EXP MED, V172, P69, DOI 10.1084/jem.172.1.69; MIYAZAWA K, 1994, J BIOL CHEM, V269, P8966; Mizuno S, 2004, AM J PHYSIOL-RENAL, V286, pF134, DOI 10.1152/ajprenal.00199.2003; Mizuno S, 2001, KIDNEY INT, V59, P1304, DOI 10.1046/j.1523-1755.2001.0590041304.x; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Mucsi I, 1996, J BIOL CHEM, V271, P16567, DOI 10.1074/jbc.271.28.16567; Nakano N, 1998, HYPERTENSION, V32, P444, DOI 10.1161/01.HYP.32.3.444; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Neumayer R, 1999, DIS COLON RECTUM, V42, P50, DOI 10.1007/BF02235182; Ono I, 2004, J SURG RES, V120, P47, DOI 10.1016/j.jss.2003.08.242; Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552; Phan SH, 2003, AM J RESP CELL MOL, V29, pS87; Sano N, 2001, NEPHRON, V89, P416, DOI 10.1159/000046113; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Shukla MN, 2009, AM J RESP CELL MOL, V40, P643, DOI 10.1165/rcmb.2008-0217OC; Stern JB, 2000, CRIT CARE MED, V28, P2326, DOI 10.1097/00003246-200007000-00024; STERZEL RB, 1993, KIDNEY INT, V43, pS26; Takada S, 1996, TRANSPLANT INT, V9, P151, DOI 10.1007/BF00336393; Tokunou M, 2001, AM J PATHOL, V158, P1451, DOI 10.1016/S0002-9440(10)64096-5; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001; Wielenga VJM, 1998, SCAND J GASTROENTERO, V33, P82; WIELENGA VJM, 1993, CANCER RES, V53, P4754; Wielenga VJM, 2000, ADV CANCER RES, V77, P169; Yamada Y, 2004, CLIN EXP METASTAS, V21, P57, DOI 10.1023/B:CLIN.0000017203.71293.e0; Yamanouchi H, 1998, RESP MED, V92, P273, DOI 10.1016/S0954-6111(98)90108-1; YANAGITA K, 1992, BIOCHEM BIOPH RES CO, V182, P802, DOI 10.1016/0006-291X(92)91803-X; Yang JW, 2003, AM J PATHOL, V163, P621, DOI 10.1016/S0002-9440(10)63689-9; Yang JW, 2002, J AM SOC NEPHROL, V13, P96, DOI 10.1681/ASN.V13196; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	87	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7856	7872		10.1074/jbc.M113.505065	http://dx.doi.org/10.1074/jbc.M113.505065			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24324260	Green Published, hybrid			2022-12-28	WOS:000332761500051
J	Bagnall, J; Leedale, J; Taylor, SE; Spiller, DG; White, MRH; Sharkey, KJ; Bearon, RN; See, V				Bagnall, James; Leedale, Joseph; Taylor, Sarah E.; Spiller, David G.; White, Michael R. H.; Sharkey, Kieran J.; Bearon, Rachel N.; See, Violaine			Tight Control of Hypoxia-inducible Factor-alpha Transient Dynamics Is Essential for Cell Survival in Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Hypoxia; Hypoxia-inducible Factor; Imaging; Mathematical Modeling; Negative Feedback Loop; p53; Prolyl Hydroxylase	P53-MDM2 FEEDBACK LOOP; PROLYL HYDROXYLASES; RESPONSIVE ELEMENT; INDIVIDUAL CELLS; GENE-EXPRESSION; OXYGEN SENSOR; HIF-ALPHA; HIF-1-ALPHA; DEGRADATION; FACTOR-1-ALPHA	Background: Hypoxia inducible factor- (HIF-) is the main transcription factor activated in low oxygen conditions. Results: Single cell imaging reveals pulses in nuclear levels of HIF-. Conclusion: The transient nature of the HIF- nuclear accumulation is required to avoid cell death. Significance: The duration of HIF- response depends on cellular oxygenation, and can encode information and dictate cell fate. Intracellular signaling involving hypoxia-inducible factor (HIF) controls the adaptive responses to hypoxia. There is a growing body of evidence demonstrating that intracellular signals encode temporal information. Thus, the dynamics of protein levels, as well as protein quantity and/or localization, impacts on cell fate. We hypothesized that such temporal encoding has a role in HIF signaling and cell fate decisions triggered by hypoxic conditions. Using live cell imaging in a controlled oxygen environment, we observed transient 3-h pulses of HIF-1 and -2 expression under continuous hypoxia. We postulated that the well described prolyl hydroxylase (PHD) oxygen sensors and HIF negative feedback regulators could be the origin of the pulsatile HIF dynamics. We used iterative mathematical modeling and experimental analysis to scrutinize which parameter of the PHD feedback could control HIF timing and we probed for the functional redundancy between the three main PHD proteins. We identified PHD2 as the main PHD responsible for HIF peak duration. We then demonstrated that this has important consequences, because the transient nature of the HIF pulse prevents cell death by avoiding transcription of p53-dependent pro-apoptotic genes. We have further shown the importance of considering HIF dynamics for coupling mathematical models by using a described HIF-p53 mathematical model. Our results indicate that the tight control of HIF transient dynamics has important functional consequences on the cross-talk with key signaling pathways controlling cell survival, which is likely to impact on HIF targeting strategies for hypoxia-associated diseases such as tumor progression and ischemia.	[Bagnall, James; Taylor, Sarah E.; Spiller, David G.; White, Michael R. H.; See, Violaine] Univ Liverpool, Ctr Cell Imaging, Inst Integrat Biol, Liverpool L69 7ZL, Merseyside, England; [Leedale, Joseph; Sharkey, Kieran J.; Bearon, Rachel N.] Univ Liverpool, Dept Math Sci, Liverpool L69 7ZL, Merseyside, England	University of Liverpool; University of Liverpool	Bearon, RN (corresponding author), Univ Liverpool, Peach St, Liverpool L69 7ZL, Merseyside, England.	rbearon@liverpool.ac.uk		Bearon, Rachel/0000-0001-8461-0823; White, Michael/0000-0002-3617-3232; Spiller, David Geoffrey/0000-0003-2502-6787; Bagnall, James/0000-0003-1735-5855; Leedale, Joseph/0000-0001-9010-4126; Sharkey, Kieran/0000-0002-7210-9246	Biotechnology and Biological Sciences Research Council; University of Liverpool; Medical Research Council; BBSRC [BB/F005938/2, BB/F005938/1] Funding Source: UKRI; MRC [MR/K015931/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C520471/1, BB/F005938/1, BB/F005938/2] Funding Source: researchfish; Medical Research Council [1261183, MR/K015931/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Liverpool; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Recipient of a Biotechnology and Biological Sciences Research Council doctoral training studentship.; Holds University of Liverpool studentship.; Recipient of a Medical Research Council capacity building studentship.	Andre H, 2008, J BIOL CHEM, V283, P29375, DOI 10.1074/jbc.M805919200; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Blagosklonny MV, 2001, ONCOGENE, V20, P395, DOI 10.1038/sj.onc.1204055; Brahimi-Horn MC, 2007, ESSAYS BIOCHEM, V43, P165, DOI 10.1042/bse0430165; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Dayan F, 2009, J THEOR BIOL, V259, P304, DOI 10.1016/j.jtbi.2009.03.009; Demidenko ZN, 2005, ONCOGENE, V24, P4829, DOI 10.1038/sj.onc.1208636; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Grimm C, 2005, SEMIN CELL DEV BIOL, V16, P531, DOI 10.1016/j.semcdb.2005.03.004; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Henze AT, 2010, CANCER RES, V70, P357, DOI 10.1158/0008-5472.CAN-09-1876; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Hunziker A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-94; Kohn KW, 2004, MOL BIOL CELL, V15, P3042, DOI 10.1091/mbc.e03-12-0897; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Moroz E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005077; Mukherjee T, 2011, SCIENCE, V332, P1210, DOI 10.1126/science.1199643; Nguyen LK, 2013, J CELL SCI, V126, P1454, DOI 10.1242/jcs.119974; Pellegrin P, 2002, MOL BIOL CELL, V13, P570, DOI 10.1091/mbc.01-06-0280; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Piret JP, 2002, BIOCHEM PHARMACOL, V64, P889, DOI 10.1016/S0006-2952(02)01155-3; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Schmierer B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-139; Shen H, 2006, J R SOC INTERFACE, V3, P787, DOI 10.1098/rsif.2006.0137; Sowter HM, 2001, CANCER RES, V61, P6669; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Tan M, 2008, ONCOGENE, V27, P1404, DOI 10.1038/sj.onc.1210780; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005	39	38	40	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5549	5564		10.1074/jbc.M113.500405	http://dx.doi.org/10.1074/jbc.M113.500405			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24394419	Green Published, hybrid			2022-12-28	WOS:000332015500021
J	Pedragosa-Badia, X; Sliwoski, GR; Nguyen, ED; Lindner, D; Stichel, J; Kaufmann, KW; Meiler, J; Beck-Sickinger, AG				Pedragosa-Badia, Xavier; Sliwoski, Gregory R.; Elizabeth Dong Nguyen; Lindner, Diana; Stichel, Jan; Kaufmann, Kristian W.; Meiler, Jens; Beck-Sickinger, Annette G.			Pancreatic Polypeptide Is Recognized by Two Hydrophobic Domains of the Human Y-4 Receptor Binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-Helix Receptor; Computer Modeling; G Protein-coupled Receptors (GPCR); Molecular Modeling; Neuropeptide; Binding Pocket; Comparative Model; Pancreatic Polypeptide	NEUROPEPTIDE-Y RECEPTOR; PROTEIN-COUPLED RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; ANGSTROM CRYSTAL-STRUCTURE; OPIOID RECEPTOR; PEPTIDE YY; STRUCTURE PREDICTION; LIGAND-BINDING; HIGH-AFFINITY; ANTAGONIST	Background: The Y4R is involved in regulation of food intake and gastrointestinal transport. Results: Mutagenesis studies revealed several residues displaying a significant loss of potency for hPP. Conclusion: Tops of TM2, TM6, and TM7 interact with the hY(4)R native agonist hPP. Significance: Characterizing the structure of the Y4R binding pocket is crucial for the development of new anti-obesity drugs. Structural characterization of the human Y-4 receptor (hY(4)R) interaction with human pancreatic polypeptide (hPP) is crucial, not only for understanding its biological function but also for testing treatment strategies for obesity that target this interaction. Here, the interaction of receptor mutants with pancreatic polypeptide analogs was studied through double-cycle mutagenesis. To guide mutagenesis and interpret results, a three-dimensional comparative model of the hY(4)R-hPP complex was constructed based on all available class A G protein-coupled receptor crystal structures and refined using experimental data. Our study reveals that residues of the hPP and the hY(4)R form a complex network consisting of ionic interactions, hydrophobic interactions, and hydrogen binding. Residues Tyr(2.64), Asp(2.68), Asn(6.55), Asn(7.32), and Phe(7.35) of Y4R are found to be important in receptor activation by hPP. Specifically, Tyr(2.64) interacts with Tyr(27) of hPP through hydrophobic contacts. Asn(7.32) is affected by modifications on position Arg(33) of hPP, suggesting a hydrogen bond between these two residues. Likewise, we find that Phe(7.35) is affected by modifications of hPP at positions 33 and 36, indicating interactions between these three amino acids. Taken together, we demonstrate that the top of transmembrane helix 2 (TM2) and the top of transmembrane helices 6 and 7 (TM6-TM7) form the core of the peptide binding pocket. These findings will contribute to the rational design of ligands that bind the receptor more effectively to produce an enhanced agonistic or antagonistic effect.	[Pedragosa-Badia, Xavier; Lindner, Diana; Stichel, Jan; Beck-Sickinger, Annette G.] Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biochem, D-04103 Leipzig, Germany; [Sliwoski, Gregory R.; Elizabeth Dong Nguyen; Kaufmann, Kristian W.; Meiler, Jens] Vanderbilt Univ, Med Ctr, Struct Biol Ctr, Nashville, TN 37232 USA	Leipzig University; Vanderbilt University	Meiler, J (corresponding author), Vanderbilt Univ, Struct Biol Ctr, 5144B Biosci MRB3,465 21st Ave South, Nashville, TN 37232 USA.	jens@meilerlab.org; beck-sickinger@uni-leipzig.de	Lindner, Diana/AAL-9856-2021	Lindner, Diana/0000-0001-5477-769X; Nguyen, Elizabeth/0000-0002-2798-6581; Meiler, Jens/0000-0001-8945-193X	National Institutes of Health [R01 GM080403, R01 MH090192, R01 DK020593, R01 GM099842, R01 DK097376]; German Research Foundation [SFB 610/3-A1, BE 1264-11]; National Science Foundation [0742762, OISE 1157751]; Vanderbilt Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, R01DK097376, P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, T32GM008320, R01GM080403, R01GM099842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090192] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1305874] Funding Source: National Science Foundation; Office Of Internatl Science &Engineering [1157751] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Vanderbilt Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM080403, R01 MH090192, R01 DK020593, and R01 GM099842 and Grant R01 DK097376 (to J. M. and A. B.-S.). This work was also supported by German Research Foundation Grants SFB 610/3-A1 and BE 1264-11 (to A. B.-S), National Science Foundation Grant Career 0742762 (to J. M.), a pilot and feasibility study from the Vanderbilt Diabetes Research and Training Center, and National Science Foundation Award OISE 1157751 to explore international collaboration.	Alexander N., 2011, 1 IEEE INT C COMP AD; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BARD JA, 1995, J BIOL CHEM, V270, P26762, DOI 10.1074/jbc.270.45.26762; BECKSICKINGER AG, 1994, EUR J BIOCHEM, V225, P947, DOI 10.1111/j.1432-1033.1994.0947b.x; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Eckard CP, 2001, MOLECULES, V6, P448, DOI 10.3390/60500448; Ekblad E, 2002, PEPTIDES, V23, P251, DOI 10.1016/S0196-9781(01)00601-5; Findeisen M, 2011, CHEMMEDCHEM, V6, P1081, DOI 10.1002/cmdc.201100089; Gehlert DR, 1997, PEPTIDES, V18, P397, DOI 10.1016/S0196-9781(96)00346-4; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kanno T, 2001, PEPTIDES, V22, P405, DOI 10.1016/S0196-9781(01)00350-3; Klco JM, 2006, J BIOL CHEM, V281, P12010, DOI 10.1074/jbc.M600548200; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lerch M, 2002, J MOL BIOL, V322, P1117, DOI 10.1016/S0022-2836(02)00889-6; Li JB, 2010, PEPTIDES, V31, P1706, DOI 10.1016/j.peptides.2010.06.011; Lindner D, 2008, NUTRITION, V24, P907, DOI 10.1016/j.nut.2008.06.025; Lindner D, 2008, BIOCHEMISTRY-US, V47, P5905, DOI 10.1021/bi800181k; LUNDELL I, 1995, J BIOL CHEM, V270, P29123, DOI 10.1074/jbc.270.49.29123; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Merten N, 2007, J BIOL CHEM, V282, P7543, DOI 10.1074/jbc.M608902200; Misra S, 2004, J PHARMACOL EXP THER, V311, P1154, DOI 10.1124/jpet.104.071415; Misura KMS, 2005, PROTEINS, V59, P15, DOI 10.1002/prot.20376; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Pedragosa Badia X., 2013, FRONT ENDOCRINOL, DOI 10.3389/fendo.2013.00005; Perry B, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2011.21; Raman B, 2001, NUCLEIC ACIDS RES, V29, P3377, DOI 10.1093/nar/29.16.3377; Rathmann D, 2013, ANAL BIOCHEM, V439, P173, DOI 10.1016/j.ab.2013.04.015; Rathmann D, 2012, J BIOL CHEM, V287, P32181, DOI 10.1074/jbc.M112.349852; Sainsbury A, 2003, MOL CELL BIOL, V23, P5225, DOI 10.1128/MCB.23.15.5225-5233.2003; Sautel M, 1996, MOL PHARMACOL, V50, P285; SAUTEL M, 1995, MOL CELL ENDOCRINOL, V112, P215, DOI 10.1016/0303-7207(95)03603-5; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sjodin P, 2006, BIOCHEM J, V393, P161, DOI 10.1042/BJ20050708; Sylte I, 1999, BIOORGAN MED CHEM, V7, P2737, DOI 10.1016/S0968-0896(99)00229-1; Tautermann CS, 2011, ACS MED CHEM LETT, V2, P414, DOI 10.1021/ml100247s; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tough IR, 2006, J PHARMACOL EXP THER, V319, P20, DOI 10.1124/jpet.106.106500; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Walker MW, 1997, PEPTIDES, V18, P609, DOI 10.1016/S0196-9781(97)00070-3; WALKER P, 1994, J BIOL CHEM, V269, P2863; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wraith A, 2000, GENOME RES, V10, P302, DOI 10.1101/gr.10.3.302; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zhang L, 2011, PHARMACOL THERAPEUT, V131, P91, DOI 10.1016/j.pharmthera.2011.03.011; Zhang R, 2012, ACTA PHARMACOL SIN, V33, P372, DOI 10.1038/aps.2011.173	58	23	23	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5846	5859		10.1074/jbc.M113.502021	http://dx.doi.org/10.1074/jbc.M113.502021			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24375409	Green Published, hybrid			2022-12-28	WOS:000332015500043
J	Runager, K; Bektas, M; Berkowitz, P; Rubenstein, DS				Runager, Kasper; Bektas, Meryem; Berkowitz, Paula; Rubenstein, David S.			Targeting O-Glycosyltransferase (OGT) to Promote Healing of Diabetic Skin Wounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; O-GlcNAc; siRNA; Skin; Wound Healing	BETA-D-GLUCOSAMINIDASE; GLCNAC; GLUCOSE; STREPTOZOTOCIN; GLYCOSYLATION; EXPRESSION; P135	Background: Increased intracellular protein O-GlcNAc modification may contribute to delayed wound healing in diabetes. Results: Hyperglycemia increases intracellular protein O-GlcNAc modification and delays wound healing in keratinocytes. Targeted knockdown of OGT altered rates of wound closure. Conclusion: OGT knockdown accelerates wound healing under both normal and hyperglycemic culture conditions. Significance: OGT may represent a novel druggable target for promoting healing of diabetic wounds. Non-healing wounds are a significant source of morbidity. This is particularly true for diabetic patients, who tend to develop chronic skin wounds. O-GlcNAc modification of serine and threonine residues is a common regulatory post-translational modification analogous to protein phosphorylation; increased intracellular protein O-GlcNAc modification has been observed in diabetic and hyperglycemic states. Two intracellular enzymes, UDP-N-acetylglucosamine-polypeptide -N-acetylglucosaminyl transferase (OGT) and O-GlcNAc-selective N-acetyl--d-glucosaminidase (OGA), mediate addition and removal, respectively, of N-acetylglucosamine (GlcNAc) from intracellular protein substrates. Alterations in O-GlcNAc modification of intracellular proteins is linked to diabetes, and the increased levels of protein O-GlcNAc modification observed in diabetic tissues may in part explain some of the observed underlying pathophysiology that contributes to delayed wound healing. We have previously shown that increasing protein O-GlcNAc modification by overexpression of OGT in murine keratinocytes results in elevated protein O-GlcNAc modification and a hyperadhesive phenotype. This study was undertaken to explore the hypothesis that increased O-GlcNAc modification of cellular proteins in diabetic skin could contribute to the delayed wound healing observed in patients with diabetic skin ulcers. In the present study, we show that human keratinocytes cultured under hyperglycemic conditions display increased levels of O-GlcNAc modification as well as a delay in the rate of wound closure in vitro. We further show that specific knockdown of OGT by RNA interference (RNAi) reverses this effect, thereby opening up the opportunity for OGT-targeted therapies to promote wound healing in diabetic patients.	[Runager, Kasper; Bektas, Meryem; Berkowitz, Paula; Rubenstein, David S.] Univ N Carolina, Sch Med, Dept Dermatol, Chapel Hill, NC 27599 USA; [Rubenstein, David S.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Rubenstein, David S.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Rubenstein, DS (corresponding author), Univ N Carolina, Sch Med, Dept Dermatol, Ste 405 Mary Ellen Jones Bldg CB 7287, Chapel Hill, NC 27599 USA.	druben@med.unc.edu		Bektas, Meryem/0000-0001-8080-7557	National Institutes of Health [RO1 AI49427]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI49427 (to D. S. R.). David S. Rubenstein is an inventor on a patent on compositions and methods for targeting OGT and promoting wound healing. Kasper Runager has contributed to the above referenced invention and has a percentage share. Neither licensing agreements nor financial benefit have accrued to either individual.	Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hu PQ, 2006, J BIOL CHEM, V281, P12786, DOI 10.1074/jbc.M511702200; Jensen RV, 2013, CARDIOVASC RES, V97, P369, DOI 10.1093/cvr/cvs337; Konrad RJ, 2000, BIOCHEM BIOPH RES CO, V267, P26, DOI 10.1006/bbrc.1999.1895; Konrad RJ, 2001, BIOCHEM J, V356, P31, DOI 10.1042/0264-6021:3560031; Konrad RJ, 2001, BIOCHEM BIOPH RES CO, V288, P1136, DOI 10.1006/bbrc.2001.5902; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Park K, 2010, DIABETES, V59, P1845, DOI 10.2337/db09-1086; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Wang CM, 2007, DIABETES, V56, P2809, DOI 10.2337/db07-0613	16	9	11	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5462	5466		10.1074/jbc.M113.513952	http://dx.doi.org/10.1074/jbc.M113.513952			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398691	Green Published, hybrid			2022-12-28	WOS:000332015500010
J	Zhang, Q; Liu, XG; Gao, WQ; Li, PS; Hou, JL; Li, JW; Wong, JM				Zhang, Qiao; Liu, Xiaoguang; Gao, Wenqi; Li, Pishun; Hou, Jingli; Li, Jiwen; Wong, Jiemin			Differential Regulation of the Ten-Eleven Translocation (TET) Family of Dioxygenases by O-Linked beta-N-Acetylglucosamine Transferase (OGT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Methylation; Glucose Metabolism; Histone Modification; O-GlcNAcylation; Protein Export; TET3	ACTIVE DNA DEMETHYLATION; EMBRYONIC STEM-CELLS; GLCNAC TRANSFERASE; TETRATRICOPEPTIDE REPEATS; MAMMALIAN DNA; PROTEINS; 5-HYDROXYMETHYLCYTOSINE; NUCLEAR; METHYLATION; METHYLTRANSFERASES	Background: TET proteins have been shown to target OGT to chromatin, but whether OGT regulates the TET proteins is not clear. Results: OGT regulates the subcellular localization and enzymatic activity of TET3 but not TET1 and TET2. Conclusion: The TET family of proteins is differentially regulated by OGT. Significance: We reveal a potential mechanism by which glucose metabolism regulates TET3 activity. The ten-eleven translocation (TET) family of dioxygenases (TET1/2/3) converts 5-methylcytosine to 5-hydroxymethylcytosine and provides a vital mechanism for DNA demethylation. However, how TET proteins are regulated is largely unknown. Here we report that the O-linked -GlcNAc (O-GlcNAc) transferase (OGT) is not only a major TET3-interacting protein but also regulates TET3 subcellular localization and enzymatic activity. OGT catalyzes the O-GlcNAcylation of TET3, promotes TET3 nuclear export, and, consequently, inhibits the formation of 5-hydroxymethylcytosine catalyzed by TET3. Although TET1 and TET2 also interact with and can be O-GlcNAcylated by OGT, neither their subcellular localization nor their enzymatic activity are affected by OGT. Furthermore, we show that the nuclear localization and O-GlcNAcylation of TET3 are regulated by glucose metabolism. Our study reveals the differential regulation of TET family proteins by OGT and a novel link between glucose metabolism and DNA epigenetic modification.	[Zhang, Qiao; Liu, Xiaoguang; Gao, Wenqi; Li, Pishun; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Zhang, Qiao; Liu, Xiaoguang; Gao, Wenqi; Li, Pishun; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Hou, Jingli] Shanghai Jiao Tong Univ, Instrumental Anal Ctr, Shanghai 200240, Peoples R China	East China Normal University; East China Normal University; Shanghai Jiao Tong University	Wong, JM (corresponding author), E China Normal Univ, Inst Biomed Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	jmweng@bio.ecnu.edu.cn		LIU, XIAOGUANG/0000-0001-6977-5128; Wong, Jiemin/0000-0002-5311-842X	Ministry of Science and Technology of China [2010CB944903, 2009CB918402, 2009CB825601]; National Natural Science Foundation of China [90919025, 30871381]; Science Technology Commission of Shanghai Municipality [11DZ2260300]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by Ministry of Science and Technology of China Grants 2010CB944903, 2009CB918402, and 2009CB825601); by National Natural Science Foundation of China Grants 90919025 and 30871381, and by Science Technology Commission of Shanghai Municipality Grant 11DZ2260300.	Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gao Y, 2000, ARCH BIOCHEM BIOPHYS, V383, P296, DOI 10.1006/abbi.2000.2094; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shi FT, 2013, J BIOL CHEM, V288, P20776, DOI 10.1074/jbc.M113.460386; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xiao P, 2013, BIOCHEM BIOPH RES CO, V439, P373, DOI 10.1016/j.bbrc.2013.08.075	33	100	105	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5986	5996		10.1074/jbc.M113.524140	http://dx.doi.org/10.1074/jbc.M113.524140			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24394411	hybrid, Green Published			2022-12-28	WOS:000332015500054
J	Fujita, K; Takashi, Y; Obuchi, E; Kitahara, K; Suganuma, T				Fujita, Kiyotaka; Takashi, Yukari; Obuchi, Eriko; Kitahara, Kanefumi; Suganuma, Toshihiko			Characterization of a Novel beta-L- Arabinofuranosidase in Bifidobacterium longum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Cloning; Enzyme Catalysis; Enzyme Kinetics; Glycosidases; Hydrolases; Hydroxyproline; Mutagenesis; Protein Expression	STRUCTURAL CHARACTERIZATION; PECTIC POLYSACCHARIDE; RHAMNOGALACTURONAN-II; IDENTIFICATION; PROTEIN; FAMILY; OLIGOSACCHARIDES; RETICULATUM; EXTENSIN	Background: -l-Arabinofuranosyl linkages are found in many plant biopolymers, but the degradation enzyme has never been found. Results: A novel -l-arabinofuranosidase was found in Bifidobacterium longum. Conclusion: -l-Arabinofuranosidase plays a key role in Bifidobacterium longum for -l-arabinooligosaccharide usage. Significance: The members of the DUF1680 family might be used for the degradation of plant biopolymers. Pfam DUF1680 (PF07944) is an uncharacterized protein family conserved in many species of bacteria, actinomycetes, fungi, and plants. Previously, we cloned and characterized the hypBA2 gene as a -l-arabinobiosidase in Bifidobacterium longum JCM 1217. In this study, we cloned a DUF1680 family member, the hypBA1 gene, which constitutes a gene cluster with hypBA2. HypBA1 is a novel -l-arabinofuranosidase that liberates l-arabinose from the l-arabinofuranose (Araf)-1,2-Araf disaccharide. HypBA1 also transglycosylates 1-alkanols with retention of the anomeric configuration. Mutagenesis and azide rescue experiments indicated that Glu-338 is a critical residue for catalytic activity. This study provides the first characterization of a DUF1680 family member, which defines a new family of glycoside hydrolases, the glycoside hydrolase family 127.	[Fujita, Kiyotaka; Takashi, Yukari; Obuchi, Eriko; Kitahara, Kanefumi; Suganuma, Toshihiko] Kagoshima Univ, Fac Agr, Kagoshima 8900065, Japan	Kagoshima University	Fujita, K (corresponding author), Kagoshima Univ, Fac Agr, Kagoshima 8900065, Japan.	kfujita@ms.kagoshima-u.ac.jp		Fujita, Kiyotaka/0000-0002-3780-3750	Japan Society for the Promotion of Science [22780094]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-aid for Young Scientists (B) 22780094 from the Japan Society for the Promotion of Science. This paper is a resubmission of an earlier paper (doi: 10.1074/jbc.M111.248690) that was withdrawn on September 16, 2013.	BIAVATI B, 1982, INT J SYST BACTERIOL, V32, P358, DOI 10.1099/00207713-32-3-358; Brecker L, 2005, CARBOHYD RES, V340, P657, DOI 10.1016/j.carres.2005.01.006; Cao W, 2006, CARBOHYD POLYM, V66, P149, DOI 10.1016/j.carbpol.2006.02.034; Cardoso SM, 2002, CARBOHYD RES, V337, P917, DOI 10.1016/S0008-6215(02)00082-4; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Fujita K, 2011, J BIOL CHEM, V286, P5143, DOI 10.1074/jbc.M110.190512; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Fushinobu S, 2010, BIOSCI BIOTECH BIOCH, V74, P2374, DOI 10.1271/bbb.100494; Gray W.R., 1967, METHODS ENZYMOL, V11, P139, DOI [10.1016/S0076-6879(67)11014-8, DOI 10.1016/S0076-6879(67)11014-8]; HOLMES EW, 1979, ANAL BIOCHEM, V93, P167, DOI 10.1016/S0003-2697(79)80060-3; JOSELEAU JP, 1977, CARBOHYD RES, V58, P165, DOI 10.1016/S0008-6215(00)83412-6; Kawaguchi H, 2009, APPL ENVIRON MICROB, V75, P3419, DOI 10.1128/AEM.02912-08; KIELISZEWSKI MJ, 1994, PLANT J, V5, P849, DOI 10.1046/j.1365-313X.1994.5060849.x; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Konishi M, 2004, J NAT PROD, V67, P1309, DOI 10.1021/np040008c; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; Miyake H, 2002, J BIOCHEM, V131, P587, DOI 10.1093/oxfordjournals.jbchem.a003138; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Parche S, 2007, J MOL MICROB BIOTECH, V12, P9, DOI 10.1159/000096455; Pastell H, 2009, J AGR FOOD CHEM, V57, P8598, DOI 10.1021/jf901397b; Perez S, 2003, BIOCHIMIE, V85, P109, DOI 10.1016/S0300-9084(03)00053-1; ROY D, 1990, J APPL BACTERIOL, V69, P739, DOI 10.1111/j.1365-2672.1990.tb01571.x; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Shallom D, 2005, BIOCHEMISTRY-US, V44, P387, DOI 10.1021/bi048059w; Souto ML, 2005, J NAT PROD, V68, P420, DOI 10.1021/np040164j; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Suzuki Y, 2004, J JPN SOC HORTIC SCI, V73, P574, DOI 10.2503/jjshs.73.574; WHITCOMBE AJ, 1995, CARBOHYD RES, V271, P15, DOI 10.1016/0008-6215(94)00002-W; York WS, 1996, CARBOHYD RES, V285, P99, DOI 10.1016/0008-6215(96)00029-8; Yoshimoto M, 2005, JARQ-JPN AGR RES Q, V39, P37, DOI 10.6090/jarq.39.37	32	33	33	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5240	5249		10.1074/jbc.M113.528711	http://dx.doi.org/10.1074/jbc.M113.528711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24385433	Green Published, hybrid			2022-12-28	WOS:000331607900065
J	Antoniou, A; Mastroyiannopoulos, NP; Uney, JB; Phylactou, LA				Antoniou, Antonis; Mastroyiannopoulos, Nikolaos P.; Uney, James B.; Phylactou, Leonidas A.			miR-186 Inhibits Muscle Cell Differentiation through Myogenin Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Differentiation; Gene Regulation; MicroRNA; Muscle; Myogenesis; Myogenin	MOLECULAR REGULATION; SATELLITE CELLS; GENE; EXPRESSION; MOUSE; TARGET; MYOD; IDENTIFICATION; PROLIFERATION; NETWORKS	The complex process of skeletal muscle differentiation is organized by the myogenic regulatory factors (MRFs), Myf5, MyoD, Myf6, and myogenin, where myogenin plays a critical role in the regulation of the final stage of muscle differentiation. In an effort to investigate the role microRNAs (miRNAs) play in regulating myogenin, a bioinformatics approach was used and six miRNAs (miR-182, miR-186, miR-135, miR-491, miR-329, and miR-96) were predicted to bind the myogenin 3-untranslated region (UTR). However, luciferase assays showed only miR-186 inhibited translation and 3-UTR mutagenesis analysis confirmed this interaction was specific. Interestingly, the expression of miR-186 mirrored that of its host gene, ZRANB2, during development. Functional studies demonstrated that miR-186 overexpression inhibited the differentiation of C2C12 and primary muscle cells. Our findings therefore identify miR-186 as a novel regulator of myogenic differentiation.	[Antoniou, Antonis; Mastroyiannopoulos, Nikolaos P.; Phylactou, Leonidas A.] Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, CY-1683 Nicosia, Cyprus; [Uney, James B.] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England	University of Bristol	Phylactou, LA (corresponding author), Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, 6 Int Airport Ave, CY-1683 Nicosia, Cyprus.	laphylac@cing.ac.cy		Phylactou, Leonidas/0000-0002-1377-211X	A. G. Leventis Foundation; Biotechnology and Biological Sciences Research Council [BB/J016489/1, BB/F022298/1] Funding Source: researchfish; BBSRC [BB/F022298/1, BB/J016489/1] Funding Source: UKRI	A. G. Leventis Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an A. G. Leventis Foundation grant and scholarship (to L. A. P. and A. A., respectively).	Adams DJ, 2001, J CELL BIOL, V154, P25, DOI 10.1083/jcb.200010059; Adams DJ, 2000, CYTOGENET CELL GENET, V88, P68, DOI 10.1159/000015487; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berghella L, 2008, GENE DEV, V22, P2125, DOI 10.1101/gad.468508; Bostjancic E, 2009, DIS MARKERS, V27, P255, DOI 10.3233/DMA-2009-0671; BRAUN T, 1989, EMBO J, V8, P3617, DOI 10.1002/j.1460-2075.1989.tb08535.x; BRENNAN TJ, 1990, J CELL BIOL, V110, P929, DOI 10.1083/jcb.110.4.929; Bryan BA, 2005, MOL CELL BIOL, V25, P11089, DOI 10.1128/MCB.25.24.11089-11101.2005; Cai JC, 2013, CANCER RES, V73, P756, DOI 10.1158/0008-5472.CAN-12-2651; Callis TE, 2008, EXP BIOL MED, V233, P131, DOI 10.3181/0709-MR-237; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Crist CG, 2012, CELL STEM CELL, V11, P118, DOI 10.1016/j.stem.2012.03.011; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; EDMONDSON DG, 1990, GENE DEV, V4, P1450, DOI 10.1101/gad.4.8.1450; Faralli H, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/836374; Flynn J. M., 2010, PLOS ONE, V5; Fuso A, 2010, CELL CYCLE, V9, P3965, DOI 10.4161/cc.9.19.13193; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Huang ZQ, 2012, BIOCHEM BIOPH RES CO, V423, P265, DOI 10.1016/j.bbrc.2012.05.106; Isik Meltem, 2010, Silence, V1, P5, DOI 10.1186/1758-907X-1-5; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu QC, 2012, J MOL CELL BIOL, V4, P386, DOI 10.1093/jmcb/mjs045; Mastroyiannopoulos NP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029896; Meadows E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016184; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Myer A, 2001, DEV BIOL, V229, P340, DOI 10.1006/dbio.2000.9985; Park SJ, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/170208; Perdiguero E, 2009, EPIGENETICS-US, V4, P541, DOI 10.4161/epi.4.8.10258; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; Zhang H, 2011, CELL DEATH DIFFER, V18, P1702, DOI 10.1038/cdd.2011.28; Zhao P, 2002, J BIOL CHEM, V277, P30091, DOI 10.1074/jbc.M202668200; Zhou LY, 2008, J BIOL CHEM, V283, P28274, DOI 10.1074/jbc.M802663200	53	54	60	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3923	3935		10.1074/jbc.M113.507343	http://dx.doi.org/10.1074/jbc.M113.507343			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24385428	Green Published, hybrid			2022-12-28	WOS:000331403800009
J	Mouawad, F; Aoudjit, L; Jiang, RH; Szaszi, K; Takano, T				Mouawad, Flaviana; Aoudjit, Lamine; Jiang, Ruihua; Szaszi, Katalin; Takano, Tomoko			Role of Guanine Nucleotide Exchange Factor-H1 in Complement-mediated RhoA Activation in Glomerular Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; ERK; Guanine Nucleotide Exchange Factor (GEF); Podocytes; Rhoa	KINASE INHIBITOR; FACTOR GEF-H1; RECEPTOR; GTPASES; ACTIN; PODOCYTES; INJURY; RAC; PHOSPHORYLATION; NEPHROPATHY	Background: Disruption of the actin cytoskeleton-dependent structural integrity of glomerular epithelial cells (GEC) leads to glomerular dysfunction. Results: We have identified molecular mechanisms through which the injury-causing complement complex induces cytoskeletal changes in GEC. Conclusion: Complement-induced activation of the ERK/GEF-H1/RhoA pathway protects GEC from cell death. Significance: This study furthers our understanding of mechanisms underlying GEC foot process effacement and functional impairment in immune mediated glomerular diseases. Visceral glomerular epithelial cells (GEC), also known as podocytes, are vital for the structural and functional integrity of the glomerulus. The actin cytoskeleton plays a central role in maintaining GEC morphology. In a rat model of experimental membranous nephropathy (passive Heymann nephritis (PHN)), complement C5b-9-induced proteinuria was associated with the activation of the actin regulator small GTPase, RhoA. The mechanisms of RhoA activation, however, remained unknown. In this study, we explored the role of the epithelial guanine nucleotide exchange factor, GEF-H1, in complement-induced RhoA activation. Using affinity precipitation to monitor GEF activity, we found that GEF-H1 was activated in glomeruli isolated from rats with PHN. Complement C5b-9 also induced parallel activation of GEF-H1 and RhoA in cultured GEC. In GEC in which GEF-H1 was knocked down, both basal and complement-induced RhoA activity was reduced. On the other hand, GEF-H1 knockdown augmented complement-mediated cytolysis, suggesting a role for GEF-H1 and RhoA in protecting GEC from cell death. The MEK1/2 inhibitor, U0126, and mutation of the ERK-dependent phosphorylation site (T678A) prevented complement-induced GEF-H1 activation, indicating a role for the ERK pathway. Further, complement induced GEF-H1 and microtubule accumulation in the perinuclear region. However, both the perinuclear accumulation and the activation of GEF-H1 were independent of microtubules and myosin-mediated contractility, as shown using drugs that interfere with microtubule dynamics and myosin II activity. In summary, we have identified complement-induced ERK-dependent GEF-H1 activation as the upstream mechanism of RhoA stimulation, and this pathway has a protective role against cell death.	[Mouawad, Flaviana; Aoudjit, Lamine; Jiang, Ruihua; Takano, Tomoko] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ H3A 2B4, Canada; [Szaszi, Katalin] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	McGill University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Takano, T (corresponding author), McGill Univ, Ctr Hlth, Div Nephrol, 3775 Univ St,Rm 236, Montreal, PQ H3A 2B4, Canada.	tomoko.takano@mcgill.ca						Aoudjit L, 2003, AM J PHYSIOL-RENAL, V285, pF765, DOI 10.1152/ajprenal.00100.2003; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Benais-Pont G, 2003, J CELL BIOL, V160, P729, DOI 10.1083/jcb.200211047; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF660, DOI 10.1152/ajprenal.00437.2004; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF593, DOI 10.1152/ajprenal.00066.2005; CYBULSKY AV, 1995, AM J PHYSIOL-RENAL, V269, pF739, DOI 10.1152/ajprenal.1995.269.5.F739; Cybulsky AV, 1998, KIDNEY INT, V54, P360, DOI 10.1046/j.1523-1755.1998.00013.x; Cybulsky AV, 1999, AM J PATHOL, V155, P1701, DOI 10.1016/S0002-9440(10)65485-5; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Greger R, 2001, J AM SOC NEPHROL, V12, P1788; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200; Huber TB, 2009, J AM SOC NEPHROL, V20, P798, DOI 10.1681/ASN.2008080871; Ishikawa Y, 2006, HYPERTENSION, V47, P1075, DOI 10.1161/01.HYP.0000221605.94532.71; Ivanov AI, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-36; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jefferson J Ashley, 2010, Drug Discov Today Dis Models, V7, P27, DOI 10.1016/j.ddmod.2010.11.001; Kakiashvili E, 2011, J BIOL CHEM, V286, P9268, DOI 10.1074/jbc.M110.179903; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Kanda T, 2003, KIDNEY INT, V64, P2009, DOI 10.1046/j.1523-1755.2003.00300.x; Kang MG, 2009, P NATL ACAD SCI USA, V106, P3549, DOI 10.1073/pnas.0812861106; Kim JH, 2012, AM J PHYSIOL-RENAL, V302, pF103, DOI 10.1152/ajprenal.00419.2011; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Lindenmeyer MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011545; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1996, EXP NEPHROL, V4, P263; MUNDEL P, 1995, ANAT EMBRYOL, V192, P387; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Nishikimi T, 2004, J HYPERTENS, V22, P1787, DOI 10.1097/00004872-200409000-00024; Nishikimi T, 2007, J HYPERTENS, V25, P1053, DOI 10.1097/HJH.0b013e3280825440; Pang HP, 2005, AM J PHYSIOL-CELL PH, V289, pC982, DOI 10.1152/ajpcell.00364.2004; QUIGG RJ, 1988, KIDNEY INT, V34, P43, DOI 10.1038/ki.1988.143; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Samson T, 2007, J BIOL CHEM, V282, P15730, DOI 10.1074/jbc.M611197200; Seth A, 2003, BIOCHEMISTRY-US, V42, P3997, DOI 10.1021/bi026881z; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shibata S, 2006, J AM SOC NEPHROL, V17, P754, DOI 10.1681/ASN.2005050571; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Takano T, 2000, AM J PATHOL, V156, P2091, DOI 10.1016/S0002-9440(10)65080-8; Takano T, 2003, J PHARMACOL EXP THER, V305, P240, DOI 10.1124/jpet.102.043604; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Topham PS, 1999, KIDNEY INT, V55, P1763, DOI 10.1046/j.1523-1755.1999.00407.x; Waheed F, 2012, JOVE-J VIS EXP, DOI 10.3791/3932; Waheed F, 2013, MOL BIOL CELL, V24, P1068, DOI 10.1091/mbc.E12-09-0661; Wang LM, 2008, KIDNEY BLOOD PRESS R, V31, P111, DOI 10.1159/000121531; Worthmann K, 2012, NEPHROL DIAL TRANSPL, V27, P10; Zhang H, 2007, AM J PHYSIOL-RENAL, V293, pF148, DOI 10.1152/ajprenal.00294.2006; Zhu L, 2011, J AM SOC NEPHROL, V22, P1621, DOI 10.1681/ASN.2010111146	62	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4206	4218		10.1074/jbc.M113.506816	http://dx.doi.org/10.1074/jbc.M113.506816			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24356971	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000331403800033
J	Talwar, S; House, R; Sundaramurthy, S; Balasubramanian, S; Yu, H; Palanisamy, V				Talwar, Sudha; House, Reniqua; Sundaramurthy, Santhanalakshmi; Balasubramanian, Sundaravadivel; Yu, Hong; Palanisamy, Viswanathan			Inhibition of Caspases Protects Mice from Radiation-induced Oral Mucositis and Abolishes the Cleavage of RNA-binding Protein HuR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Caspase; Enzyme Inhibitors; MRNA Decay; RNA-binding Protein; HuR; Mucositis	MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; TRANSLATIONAL CONTROL; MEDIATED CLEAVAGE; CANCER; EXPRESSION; APOPTOSIS; PROMOTES; HEAD; NECK	Background: In oral mucositis, cleavage product-1 of RNA-binding protein HuR regulates cell death. Results: Activation of caspases initiates HuR cleavage modification and stabilizes BAX, thereby promoting apoptosis in oral mucositis. Conclusion: Inhibition of caspases reduced the severity of oral mucositis through HuR and the expression of BAX. Significance: This is the first study implicating the RNA-binding protein HuR in oral mucositis. The oral mucosal epithelium is typically insulted during chemotherapy and ionizing radiation (IR) therapy and disposed to mucositis, which creates painful inflammation and ulceration in the oral cavity. Oral mucositis alters gene expression patterns, inhibits cellular growth, and initiates cell death in the oral epithelial compartments. Such alterations are governed by several different factors, including transcription factors, RNA-binding proteins, and microRNAs. IR-induced post-transcriptional regulation of RNA-binding proteins exists but is poorly studied in clinically relevant settings. We herein report that the RNA-binding protein human antigen R (HuR) undergoes cleavage modification by caspase-3 following IR-induced oral mucositis and subsequently promotes the expression of the pro-apoptotic factor BAX (Bcl-2-associated X protein), as well as cell death. Further analyses revealed that the HuR cleavage product-1 (HuR-CP1) directly associates and stabilizes the BAX mRNA and concurrently activates the apoptotic pathway. On the other hand, a noncleavable isoform of HuR promotes the clonogenic capacity of primary oral keratinocytes and decreases the effect of IR-induced cell death. Additionally, specific inhibition of caspase-3 by a compound, NSC321205, increases the clonogenic capacity of primary oral keratinocytes and causes increased basal layer cellularity, thickened mucosa, and elevated epithelial cell growth in the tongues of mice with oral mucositis. This protective effect of NSC321205 is mediated by a decrease in caspase-3 activity and the consequent inhibition of HuR cleavage, which reduces the expression of BAX in mice with IR-induced oral mucositis. Thus, we have identified a new molecular mechanism of HuR in the regulation of mRNA turnover and apoptosis in oral mucositis, and our data suggest that blocking the cleavage of HuR enhances cellular growth in the oral epithelial compartment.	[Talwar, Sudha; House, Reniqua; Sundaramurthy, Santhanalakshmi; Yu, Hong; Palanisamy, Viswanathan] Med Univ S Carolina, Dept Craniofacial Biol, Coll Dent Med, Charleston, SC 29425 USA; [Talwar, Sudha; House, Reniqua; Sundaramurthy, Santhanalakshmi; Yu, Hong; Palanisamy, Viswanathan] Med Univ S Carolina, Ctr Oral Hlth Res, Coll Dent Med, Charleston, SC 29425 USA; [Balasubramanian, Sundaravadivel] Med Univ S Carolina, Coll Med, Dept Cardiol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Palanisamy, V (corresponding author), Med Univ S Carolina, Dept Craniofacial Biol, Charleston, SC 29425 USA.	visu@musc.edu		Palanisamy, Viswanathan/0000-0001-5128-2878	National Institutes of Health [R00DE018165, R01DE022776]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE017551, R01DE022776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R00DE018165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R00DE018165 and R01DE022776 (to V. P.).	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; Beauchamp P, 2010, CELL DEATH DIFFER, V17, P1588, DOI 10.1038/cdd.2010.34; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Chaudhuri L, 2012, ONCOGENE, V31, P1207, DOI 10.1038/onc.2011.325; Chen PL, 2011, ORAL ONCOL, V47, P831, DOI 10.1016/j.oraloncology.2011.06.012; Citrin D, 2010, ONCOLOGIST, V15, P360, DOI 10.1634/theoncologist.2009-S104; Costantino CL, 2009, CANCER RES, V69, P4567, DOI 10.1158/0008-5472.CAN-09-0371; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Feldman T, 2012, MOL CELL, V47, P585, DOI 10.1016/j.molcel.2012.06.007; Fernau NS, 2010, J BIOL CHEM, V285, P3896, DOI 10.1074/jbc.M109.081430; Han GW, 2013, NAT MED, V19, P421, DOI 10.1038/nm.3118; Henke M, 2011, J CLIN ONCOL, V29, P2815, DOI 10.1200/JCO.2010.32.4103; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Kitada S, 1996, ONCOGENE, V12, P187; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Kuwano Y, 2010, APOPTOSOME: AN UP-AND-COMING THERAPEUTICAL TOOL, P203, DOI 10.1007/978-90-481-3415-1_10; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Manakova S, 2003, TOXICOL IN VITRO, V17, P367, DOI 10.1016/S0887-2333(03)00024-9; Masuda K, 2011, EMBO J, V30, P1040, DOI 10.1038/emboj.2011.24; Mazan-Mamczarz K, 2008, ONCOGENE, V27, P6151, DOI 10.1038/onc.2008.215; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Nonzee NJ, 2008, CANCER-AM CANCER SOC, V113, P1446, DOI 10.1002/cncr.23714; Sonis ST, 2010, ORAL DIS, V16, P597, DOI 10.1111/j.1601-0825.2010.01681.x; Sonis SL, 2002, CRIT REV ORAL BIOL M, V13, P380, DOI 10.1177/154411130201300502; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Sonis Stephen T, 2007, J Support Oncol, V5, P3; Sonis ST, 2009, CORE EVID, V4, P199; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Talwar S, 2011, J BIOL CHEM, V286, P32333, DOI 10.1074/jbc.M111.255927; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305; von Roretz C, 2013, CELL DEATH DIFFER, V20, P154, DOI 10.1038/cdd.2012.111; Wang WG, 2001, MOL CELL BIOL, V21, P5889, DOI 10.1128/MCB.21.17.5889-5898.2001; Wu XY, 2012, INT J RADIAT ONCOL, V83, pE409, DOI 10.1016/j.ijrobp.2012.01.006; Yi J, 2010, NUCLEIC ACIDS RES, V38, P1547, DOI 10.1093/nar/gkp1114; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zheng CY, 2009, CLIN CANCER RES, V15, P4641, DOI 10.1158/1078-0432.CCR-09-0819	42	15	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3487	3500		10.1074/jbc.M113.504951	http://dx.doi.org/10.1074/jbc.M113.504951			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362034	hybrid, Green Published			2022-12-28	WOS:000331368700033
J	Ha, SW; Ju, D; Xie, YM				Ha, Seung-Wook; Ju, Donghong; Xie, Youming			Nuclear Import Factor Srp1 and Its Associated Protein Sts1 Couple Ribosome-bound Nascent Polypeptides to Proteasomes for Cotranslational Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Proteasome; Protein Degradation; Protein Dynamics; Protein Processing; Protein Turnover; Cotranslational Protein Degradation; Nuclear Import Factor Srp1; Ubiquitin-independent Degradation	NEWLY SYNTHESIZED PROTEINS; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; IN-VIVO; HOMEOSTATIC REGULATION; MEDIATED DEGRADATION; KARYOPHERIN-ALPHA; FEEDBACK-CIRCUIT; UBIQUITIN LIGASE; 26S PROTEASOME	Background: The mechanism underlying cotranslational protein degradation remains poorly understood. Results: The nuclear import factor Srp1 binds ribosome-bound nascent polypeptides. Sts1 mediates the interaction between Srp1 and the proteasome. Conclusion: Srp1 and Sts1 couple proteasomes to nascent polypeptides emerging from the ribosome for cotranslational degradation. Significance: This study unveils a novel role for Srp1 and Sts1 in cotranslational protein degradation. Cotranslational protein degradation plays an important role in protein quality control and proteostasis. Although ubiquitylation has been suggested to signal cotranslational degradation of nascent polypeptides, cotranslational ubiquitylation occurs at a low level, suggesting the existence of an alternative route for delivery of nascent polypeptides to the proteasome. Here we report that the nuclear import factor Srp1 (also known as importin or karyopherin ) is required for ubiquitin-independent cotranslational degradation of the transcription factor Rpn4. We further demonstrate that cotranslational protein degradation is generally impaired in the srp1-49 mutant. Srp1 binds nascent polypeptides emerging from the ribosome. The association of proteasomes with polysomes is weakened in srp1-49. The interaction between Srp1 and the proteasome is mediated by Sts1, a multicopy suppressor of srp1-49. The srp1-49 and sts1-2 mutants are hypersensitive to stressors that promote protein misfolding, underscoring the physiological function of Srp1 and Sts1 in degradation of misfolded nascent polypeptides. This study unveils a previously unknown role for Srp1 and Sts1 in cotranslational protein degradation and suggests a novel model whereby Srp1 and Sts1 cooperate to couple proteasomes to ribosome-bound nascent polypeptides.	[Xie, Youming] Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Oncol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University	Xie, YM (corresponding author), Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Oncol, 110 E Warren Ave, Detroit, MI 48201 USA.	xiey@karmanos.org			National Science Foundation [MCB-0816974]; Wayne State University	National Science Foundation(National Science Foundation (NSF)); Wayne State University	This work was supported in part by National Science Foundation Grant MCB-0816974 and by a fund from the Office of the Vice President for Research at Wayne State University (to Y. X.).	Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Chen L, 2011, J BIOL CHEM, V286, P3104, DOI 10.1074/jbc.M110.135863; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Enenkel C, 1996, P NATL ACAD SCI USA, V93, P12986, DOI 10.1073/pnas.93.23.12986; ENENKEL C, 1995, J BIOL CHEM, V270, P16499, DOI 10.1074/jbc.270.28.16499; GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0; Ha SW, 2012, BIOCHEM BIOPH RES CO, V419, P226, DOI 10.1016/j.bbrc.2012.01.152; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; James P, 1996, GENETICS, V144, P1425; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Ju DH, 2006, J BIOL CHEM, V281, P10657, DOI 10.1074/jbc.M513790200; Ju DH, 2004, BIOCHEM BIOPH RES CO, V321, P51, DOI 10.1016/j.bbrc.2004.06.105; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Ju DH, 2008, MOL CELL BIOL, V28, P1404, DOI 10.1128/MCB.01787-07; Ju DD, 2007, BBA-MOL CELL RES, V1773, P1672, DOI 10.1016/j.bbamcr.2007.04.012; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; KRIEG UC, 1989, J CELL BIOL, V109, P2033, DOI 10.1083/jcb.109.5.2033; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; LOEB JDJ, 1995, P NATL ACAD SCI USA, V92, P7647, DOI 10.1073/pnas.92.17.7647; Mahe Y, 1996, J BIOL CHEM, V271, P25167, DOI 10.1074/jbc.271.41.25167; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; PESTKA S, 1971, ANNU REV MICROBIOL, V25, P487, DOI 10.1146/annurev.mi.25.100171.002415; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; Romero-Perez L, 2007, J BIOL CHEM, V282, P35574, DOI 10.1074/jbc.M704857200; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Spirin A, 1986, RIBOSOME STRUCTURE P; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Wang F, 2013, MOL CELL, V50, P368, DOI 10.1016/j.molcel.2013.03.009; Wang L, 2004, J BIOL CHEM, V279, P55218, DOI 10.1074/jbc.M410085200; Wang XG, 2010, GENETICS, V184, P335, DOI 10.1534/genetics.109.112227; Wendler P, 2004, J BIOL CHEM, V279, P37751, DOI 10.1074/jbc.M403551200; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Xie YM, 2010, J MOL CELL BIOL, V2, P308, DOI 10.1093/jmcb/mjq030; YANO R, 1994, P NATL ACAD SCI USA, V91, P6880, DOI 10.1073/pnas.91.15.6880; YANO R, 1992, MOL CELL BIOL, V12, P5640, DOI 10.1128/MCB.12.12.5640; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 1996, J IMMUNOL, V157, P1823	50	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2701	2710		10.1074/jbc.M113.524926	http://dx.doi.org/10.1074/jbc.M113.524926			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338021	Green Published, hybrid			2022-12-28	WOS:000333403000020
J	Kim, J; Kwak, HJ; Cha, JY; Jeong, YS; Rhee, SD; Cheon, HG				Kim, Juyoung; Kwak, Hyun Jeong; Cha, Ji-Young; Jeong, Yun-Seung; Rhee, Sang Dahl; Cheon, Hyae Gyeong			The Role of Prolyl Hydroxylase Domain Protein (PHD) during Rosiglitazone-induced Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Adipogenesis; Diabetes; Kruppel-like Factor (KLF); Peroxisome Proliferator-activated Receptor (PPAR); Adipocyte Differentiation; GATA-3; PHD; PPAR; Rosiglitazone	PPAR-GAMMA; HIF-ALPHA; ADIPOGENESIS; EXPRESSION; HYPOXIA; BINDING; DESTRUCTION; INDUCTION; PATHWAY; OBESITY	Background: Rosiglitazone, a well known PPAR agonist, stimulates adipocyte differentiation. Results: In C3H10T1/2 cells, rosiglitazone induces prolyl hydroxylase domain proteins 1, 2, and 3, resulting in the degradation of anti-adipogenic proteins such as GATA-3, KLF-2, and TAZ. Conclusion: Three isoforms of the prolyl hydroxylase domain protein play a key role in rosiglitazone-induced adipocyte differentiation. Significance: Novel mechanisms involved in rosiglitazone-induced adipogenesis would provide a better understanding of adipocyte biology. Rosiglitazone, a well known insulin sensitizer, stimulates adipocyte differentiation via the activation of peroxisome proliferator-activated receptor (PPAR). Previous two-dimensional proteomics studies using C3H10T1/2 murine mesenchymal pluripotent stem cells revealed that prolyl hydroxylase domain protein (PHD) levels significantly increased during rosiglitazone-induced adipocyte differentiation (RIAD). In this study, we investigated the functional role played by PHD during RIAD. Three PHD isoforms (PHD1, 2, and 3) were found to be up-regulated in C3H10T1/2 cells during RIAD, whereas PHD knockdown and treatment with PHD inhibitors (dimethyloxalyl glycine or ethyl-3,4-dihydroxybenzoate) blocked RIAD. PHD inhibition was found to be associated with increases in the levels of anti-adipogenic proteins such as GATA-3, KLF-2, and transcriptional coactivator with PDZ binding motif (TAZ), with their reduced ubiquitination, suggesting that PHDs evoke the ubiquitination/proteasomal degradation of anti-adipogenic proteins. On the other hand, MG-132 (a proteasomal inhibitor) prevented the degradation of anti-adipogenic proteins and retarded RIAD. PPAR antagonists (bisphenol A diglycidyl ether or GW9662) blunted the effects of rosiglitazone on PHD regulation. Furthermore, putative PPAR binding sites were identified in the promoter region of PHDs by ChIP-PCR, implying that rosiglitazone may induce PHD up-regulation directly by PPAR activation. Consistent with in vitro results, oral administration of rosiglitazone to ob/ob mice for 2 weeks increased adipose PHD levels and decreased anti-adipogenic protein levels by increasing their ubiquitination. These results suggest that rosiglitazone increases PHD expression in a PPAR-dependent manner and that this leads to the commitment of anti-adipogenic proteins to the ubiquitination-proteasomal pathway and to the subsequent induction of adipocyte differentiation.	[Kim, Juyoung; Kwak, Hyun Jeong; Cheon, Hyae Gyeong] Gachon Univ, Sch Med, Dept Pharmacol, Inchon 406799, South Korea; [Cha, Ji-Young; Jeong, Yun-Seung] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Dept Mol Med, Inchon 406799, South Korea; [Rhee, Sang Dahl] Korea Res Inst Chem Technol, Bioorgan Sci Div, Taejon 305343, South Korea; [Cheon, Hyae Gyeong] Gil Med Ctr, Gachon Med Res Inst, Inchon 405760, South Korea	Gachon University; Gachon University; Korea Research Institute of Chemical Technology (KRICT); Gachon University	Cheon, HG (corresponding author), Gachon Univ, Sch Med, Dept Pharmacol, Yeonsu 3 Dong, Inchon 406799, South Korea.	hgcheon@gachon.ac.kr		Cha, JI-Young/0000-0002-8557-6214	Korean Government (Ministry of Education and Science Technology (MEST)) National Research Foundation of Korea (NRF) [2011-0013253]	Korean Government (Ministry of Education and Science Technology (MEST)) National Research Foundation of Korea (NRF)	This work was supported by the Korean Government (Ministry of Education and Science Technology (MEST)) National Research Foundation of Korea (NRF) Grant 2011-0013253.	Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Berchner-Pfannschmidt U, 2008, J BIOL CHEM, V283, P31745, DOI 10.1074/jbc.M804390200; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fang YP, 2013, BIOINFORMATICS, V29, P295, DOI 10.1093/bioinformatics/bts693; Floyd ZE, 2007, J CELL BIOCHEM, V101, P1545, DOI 10.1002/jcb.21266; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Irwin R, 2007, J CELL BIOCHEM, V100, P762, DOI 10.1002/jcb.21083; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kim KR, 2006, BIOCHEM PHARMACOL, V72, P446, DOI 10.1016/j.bcp.2006.05.005; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Lieb ME, 2002, BIOCHEM CELL BIOL, V80, P421, DOI 10.1139/O02-115; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Yagi K, 2004, BIOCHEM BIOPH RES CO, V321, P967, DOI 10.1016/j.bbrc.2004.07.055	29	11	13	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2755	2764		10.1074/jbc.M113.493650	http://dx.doi.org/10.1074/jbc.M113.493650			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338020	Green Published, hybrid			2022-12-28	WOS:000333403000025
J	Su, B; Ji, YS; Sun, XL; Liu, XH; Chen, ZY				Su, Bo; Ji, Yun-Song; Sun, Xu-lu; Liu, Xiang-Hua; Chen, Zhe-Yu			Brain-derived Neurotrophic Factor (BDNF)-induced Mitochondrial Motility Arrest and Presynaptic Docking Contribute to BDNF-enhanced Synaptic Transmission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain-derived Neurotrophic Factor (BDNF); Mitochondrial Transport; Signal Transduction; Synaptic Plasticity; TRP Channels	KINESIN HEAVY-CHAIN; HIPPOCAMPAL-NEURONS; NEUROTRANSMITTER RELEASE; EXCITATORY SYNAPSES; AXONAL-TRANSPORT; CORTICAL-NEURONS; DENDRITIC GROWTH; TRPC CHANNELS; INCREASES; SYNAPTOSOMES	Background: Appropriate mitochondrial transport and localization are highly associated with neuronal activities. Results: BDNF induces mitochondrial motility arrest via Miro1 binding with Ca2+, which facilitates BDNF-enhanced neurotransmitter release. Conclusion: BDNF-regulated mitochondrial motility is essential for BDNF-enhanced synaptic transmission. Significance: These results provide novel insights into the mechanistic link between BDNF-dependent mitochondrial motility and BDNF-mediated synaptic transmission. Appropriate mitochondrial transport and distribution are essential for neurons because of the high energy and Ca2+ buffering requirements at synapses. Brain-derived neurotrophic factor (BDNF) plays an essential role in regulating synaptic transmission and plasticity. However, whether and how BDNF can regulate mitochondrial transport and distribution are still unclear. Here, we find that in cultured hippocampal neurons, application of BDNF for 15 min decreased the percentage of moving mitochondria in axons, a process dependent on the activation of the TrkB receptor and its downstream PI3K and phospholipase-C signaling pathways. Moreover, the BDNF-induced mitochondrial stopping requires the activation of transient receptor potential canonical 3 and 6 (TRPC3 and TRPC6) channels and elevated intracellular Ca2+ levels. The Ca2+ sensor Miro1 plays an important role in this process. Finally, the BDNF-induced mitochondrial stopping leads to the accumulation of more mitochondria at presynaptic sites. Mutant Miro1 lacking the ability to bind Ca2+ prevents BDNF-induced mitochondrial presynaptic accumulation and synaptic transmission, suggesting that Miro1-mediated mitochondrial motility is involved in BDNF-induced mitochondrial presynaptic docking and neurotransmission. Together, these data suggest that mitochondrial transport and distribution play essential roles in BDNF-mediated synaptic transmission.	[Su, Bo; Ji, Yun-Song; Sun, Xu-lu; Liu, Xiang-Hua; Chen, Zhe-Yu] Shandong Univ, Dept Neurobiol, Sch Med, Shandong Prov Key Lab Mental Disorders, Jinan 250012, Shandong, Peoples R China	Shandong University	Chen, ZY (corresponding author), Shandong Univ, Dept Neurobiol, Sch Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	zheyuchen@sdu.edu.cn			National 973 Basic Research Program of China [2012CB911000]; National Natural Science Foundation of China [31130026, 31100968]; State Program of National Natural Science Foundation of China for Innovative Research Group [81321061]; China Postdoctoral Science Foundation [20110491590, 2012T50609]; Specialized Research Fund for the Doctoral Program of Higher Education [20100131120052]; Independent Innovation Foundation of Shandong University	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Innovation Foundation of Shandong University	This work was supported by National 973 Basic Research Program of China Grant 2012CB911000, National Natural Science Foundation of China Grants 31130026 and 31100968, State Program of National Natural Science Foundation of China for Innovative Research Group Grant 81321061, China Postdoctoral Science Foundation Grants 20110491590 and 2012T50609, Specialized Research Fund for the Doctoral Program of Higher Education 20100131120052, and the Independent Innovation Foundation of Shandong University.	Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Amaral MD, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/203536; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Billups B, 2002, J NEUROSCI, V22, P5840; Bradley J, 1999, BRAIN RES, V815, P140, DOI 10.1016/S0006-8993(98)01112-3; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chang KT, 2011, P NATL ACAD SCI USA, V108, P15456, DOI 10.1073/pnas.1106862108; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Chen S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002804; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Feng SJ, 2013, P NATL ACAD SCI USA, V110, P11011, DOI 10.1073/pnas.1309531110; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Graham S, 2010, J BIOL CHEM, V285, P23464, DOI 10.1074/jbc.M109.093500; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; He ZH, 2012, J NEUROSCI, V32, P9383, DOI 10.1523/JNEUROSCI.6363-11.2012; Henle SJ, 2011, J NEUROSCI, V31, P7016, DOI 10.1523/JNEUROSCI.0216-11.2011; HIROKAWA N, 1991, J CELL BIOL, V114, P295, DOI 10.1083/jcb.114.2.295; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Ivannikov MV, 2013, J MOL NEUROSCI, V49, P223, DOI 10.1007/s12031-012-9848-8; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Markham A, 2004, EUR J NEUROSCI, V20, P1189, DOI 10.1111/j.1460-9568.2004.03578.x; Markham A, 2012, EUR J NEUROSCI, V35, P366, DOI 10.1111/j.1460-9568.2011.07965.x; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Shin HY, 2010, PLOS ONE, V5; Tanaka K, 2011, J CELL SCI, V124, P2457, DOI 10.1242/jcs.086470; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Walsh B, 2001, J PHYSIOL-LONDON, V537, P971; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Zhao L, 2009, J CELL SCI, V122, P3123, DOI 10.1242/jcs.047712; Zhou J, 2008, NAT NEUROSCI, V11, P741, DOI 10.1038/nn.2127	52	57	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1213	1226		10.1074/jbc.M113.526129	http://dx.doi.org/10.1074/jbc.M113.526129			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302729	Green Published, hybrid			2022-12-28	WOS:000332401700003
J	Sun, F; Chen, HG; Li, W; Yang, X; Wang, X; Jiang, RC; Guo, ZY; Chen, HG; Huang, JT; Borowsky, AD; Qiu, Y				Sun, Feng; Chen, He-ge; Li, Wei; Yang, Xi; Wang, Xin; Jiang, Richeng; Guo, Zhiyong; Chen, Hegang; Huang, Jiaoti; Borowsky, Alexander D.; Qiu, Yun			Androgen Receptor Splice Variant AR3 Promotes Prostate Cancer via Modulating Expression of Autocrine/Paracrine Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Androgen Receptor; EMT; Insulin-like Growth Factor (IGF); MicroRNA; Prostate Cancer; mir-29; Splicing Variant	TYROSINE KINASE ETK/BMX; GROWTH-FACTOR-I; INTRAEPITHELIAL NEOPLASIA; MICRORNA EXPRESSION; CELL SUBPOPULATION; GENE-EXPRESSION; FULL-LENGTH; STEM-CELLS; MURINE; DIFFERENTIATION	Background: AR splice variants may play a critical role in prostate cancer. Results: AR3 modulates expression of tumor-promoting growth factors and promotes epithelial-mesenchymal transition, leading to development of prostatic intraepithelial neoplasia. Conclusion: AR3 promotes prostate cancer by modulating multiple tumor-associated autocrine/paracrine factors. Significance: Our findings provide new insights into mechanisms by which AR3 contributes to prostate cancer despite its heterogeneous expression pattern. Deregulation of androgen receptor (AR) splice variants has been implicated to play a role in prostate cancer development and progression. To understand their functions in prostate, we established a transgenic mouse model (AR3Tg) with targeted expression of the constitutively active and androgen-independent AR splice variant AR3 (a.k.a. AR-V7) in prostate epithelium. We found that overexpression of AR3 modulates expression of a number of tumor-promoting autocrine/paracrine growth factors (including Tgf2 and Igf1) and expands prostatic progenitor cell population, leading to development of prostatic intraepithelial neoplasia. In addition, we showed that some epithelial-mesenchymal transition-associated genes are up-regulated in AR3Tg prostates, suggesting that AR3 may antagonize AR activity and halt the differentiation process driven by AR and androgen. This notion is supported by our observations that the number of Ck5(+)/Ck8(+) intermediate cells is increased in AR3Tg prostates after castration, and expression of AR3 transgene in these intermediate cells compromises prostate epithelium regeneration upon androgen replacement. Our results demonstrate that AR3 is a driver of prostate cancer, at least in part, through modulating multiple tumor-promoting autocrine/paracrine factors.	[Sun, Feng; Chen, He-ge; Li, Wei; Yang, Xi; Wang, Xin; Jiang, Richeng; Guo, Zhiyong; Qiu, Yun] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Sun, Feng; Chen, He-ge; Li, Wei; Yang, Xi; Wang, Xin; Jiang, Richeng; Guo, Zhiyong; Qiu, Yun] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Chen, Hegang] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Huang, Jiaoti] Univ Calif Los Angeles, Dept Pathol & Lab Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Borowsky, Alexander D.] Univ Calif Davis, Ctr Comparat Med, Sacramento, CA 95817 USA; [Borowsky, Alexander D.] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Davis; University of California System; University of California Davis	Qiu, Y (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol, 655 W Baltimore St,BRB Rm 4-002, Baltimore, MD 21202 USA.	yqiu@som.umaryland.edu	Borowsky, Alexander D/S-5404-2017; chen, hege/GYV-5810-2022	Huang, Jiaoti/0000-0003-1195-1998	National Institutes of Health [CA106504]; Department of Defense [W81XWH-10-1-0309]; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA106504] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA106504 (to Y. Q.). This work was also supported by Department of Defense Grant W81XWH-10-1-0309 (to Y. Q.).	Ao MF, 2006, CANCER RES, V66, P8007, DOI 10.1158/0008-5472.CAN-05-4451; Blum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005722; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Chokkalingam AP, 2001, CANCER EPIDEM BIOMAR, V10, P421; Dai BJ, 2006, CANCER RES, V66, P8058, DOI 10.1158/0008-5472.CAN-06-1364; Dai BJ, 2010, CANCER RES, V70, P5587, DOI 10.1158/0008-5472.CAN-09-4610; DaSilva J, 2009, CANCER RES, V69, P7402, DOI 10.1158/0008-5472.CAN-08-4687; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; DiGiovanni J, 2000, P NATL ACAD SCI USA, V97, P3455, DOI 10.1073/pnas.97.7.3455; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Gregory CW, 2001, CANCER RES, V61, P2892; Guo S, 2011, PLOS ONE, V6; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Guo ZY, 2011, INT J BIOL SCI, V7, P815, DOI 10.7150/ijbs.7.815; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Han GZ, 2005, P NATL ACAD SCI USA, V102, P1151, DOI 10.1073/pnas.0408925102; Harman SM, 2000, J CLIN ENDOCR METAB, V85, P4258, DOI 10.1210/jc.85.11.4258; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Lin TH, 2013, J BIOL CHEM, V288, P19359, DOI 10.1074/jbc.M113.477216; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Mantzoros CS, 1997, BRIT J CANCER, V76, P1115, DOI 10.1038/bjc.1997.520; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Narayanan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013637; Niu Y, 2010, ONCOGENE, V29, P3593, DOI 10.1038/onc.2010.121; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Perry KT, 1997, PROSTATE, V33, P133, DOI 10.1002/(SICI)1097-0045(19971001)33:2<133::AID-PROS7>3.0.CO;2-L; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Scher HI, 2004, ENDOCR-RELAT CANCER, V11, P459, DOI 10.1677/erc.1.00525; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Stanbrough M, 2001, P NATL ACAD SCI USA, V98, P10823, DOI 10.1073/pnas.191235898; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Thomson AA, 1999, DEVELOPMENT, V126, P3693; Tsai HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049887; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Wolk A, 1998, J NATL CANCER I, V90, P911, DOI 10.1093/jnci/90.12.911; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yamashita S, 2012, NEOPLASIA, V14, P74, DOI 10.1593/neo.111436; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698	61	64	65	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1529	1539		10.1074/jbc.M113.492140	http://dx.doi.org/10.1074/jbc.M113.492140			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297183	Green Published, hybrid			2022-12-28	WOS:000332401700028
J	He, Y; Varadarajan, S; Munoz-Planillo, R; Burberry, A; Nakamura, Y; Nunez, G				He, Yuan; Varadarajan, Saranyaraajan; Munoz-Planillo, Raul; Burberry, Aaron; Nakamura, Yuumi; Nunez, Gabriel			3,4-Methylenedioxy-beta-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NALP3 INFLAMMASOME; CASPASE-1 ACTIVATION; NITROSTYRENE DERIVATIVES; P2X7 RECEPTOR; CELL-DEATH; INTERLEUKIN-1-BETA; IL-1-BETA; MECHANISM; CRYSTALS; DEUBIQUITINATION	The NLRP3 inflammasome is a critical component of the innate immune system. NLRP3 activation is induced by diverse stimuli associated with bacterial infection or tissue damage, but its inappropriate activation is involved in the pathogenesis of inherited and acquired inflammatory diseases. However, the mechanism by which NLRP3 is activated remains poorly understood. In this study, we explored the role of kinases in NLRP3 inflammasome activation by screening a kinase inhibitor library and identified 3,4-methylenedioxy-beta-nitrostyrene (MNS) as an inhibitor for NLRP3 inflammasome activation. Notably, MNS did not affect the activation of the NLRC4 or AIM2 (absent in melanoma 2) inflammasome. Mechanistically, MNS specifically prevented NLRP3-mediated ASC speck formation and oligomerization without blocking potassium efflux induced by NLRP3 agonists. Surprisingly, Syk kinase, the reported target of MNS, did not mediate the inhibitory activity of MNS on NLRP3 inflammasome activation. We also found that the nitrovinyl group of MNS is essential for the inhibitory activity of MNS. Immunoprecipitation, mass spectrometry, and mutation studies suggest that both the nucleotide binding oligomerization domain and the leucine-rich repeat domain of NLRP3 were the intracellular targets of MNS. Administration of MNS also inhibited NLRP3 ATPase activity in vitro, suggesting that MNS blocks the NLRP3 inflammasome by directly targeting NLRP3 or NLRP3-associated complexes. These studies identified a novel chemical probe for studying the molecular mechanism of NLRP3 inflammasome activation which may advance the development of novel strategies to treat diseases associated with abnormal activation of NLRP3 inflammasome.	[Nunez, Gabriel] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Comprehens Canc, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Dept Pathol, Sch Med, 1500 E Med Ctr Dr,Rm 4215 CC, Ann Arbor, MI 48109 USA.	gabriel.nunez@umich.edu	Nuñez, Gabriel/A-7160-2014; Nakamura, Yuumi/H-8459-2017	Nakamura, Yuumi/0000-0001-6256-8302; Varadarajan, Saranyaraajan/0000-0002-4473-9435	National Institutes of Health [R01AI063331, R01DK091191]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091191] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26713038] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI063331 and R01DK091191.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Coll RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029539; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Giubellino A, 2008, J MED CHEM, V51, P7459, DOI 10.1021/jm800523u; Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; He Y, 2013, EUR J IMMUNOL, V43, P1147, DOI 10.1002/eji.201243187; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kaap S, 2003, BIOCHEM PHARMACOL, V65, P603, DOI 10.1016/S0006-2952(02)01618-0; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kim JH, 2003, MOL PHARMACOL, V63, P1117, DOI 10.1124/mol.63.5.1117; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Lopez-Castejon G, 2012, EXPERT OPIN INV DRUG, V21, P995, DOI 10.1517/13543784.2012.690032; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Wang WY, 2007, BIOCHEM PHARMACOL, V74, P601, DOI 10.1016/j.bcp.2007.06.001; Wang WY, 2006, MOL PHARMACOL, V70, P1380, DOI 10.1124/mol.106.023986	47	161	173	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1142	1150		10.1074/jbc.M113.515080	http://dx.doi.org/10.1074/jbc.M113.515080			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265316	hybrid, Green Published			2022-12-28	WOS:000330541200045
J	Xu, CS; Chen, HY; Wang, X; Gao, JD; Che, YQ; Li, Y; Ding, F; Luo, AP; Zhang, SG; Liu, ZH				Xu, Chengshan; Chen, Hongyan; Wang, Xiang; Gao, Jidong; Che, Yiqun; Li, Yi; Ding, Fang; Luo, Aiping; Zhang, Shuguang; Liu, Zhihua			S100A14, a Member of the EF-hand Calcium-binding Proteins, Is Overexpressed in Breast Cancer and Acts as a Modulator of HER2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASES; TUMOR-CELLS; RECEPTOR; EXPRESSION; SURVIVAL; TRASTUZUMAB; RESISTANCE; INVASION; FAMILY	HER2 is overexpressed in 20-25% of breast cancers. Overexpression of HER2 is an adverse prognostic factor and correlates with decreased patient survival. HER2 stimulates breast tumorigenesis via a number of intracellular signaling molecules, including PI3K/AKT and MAPK/ERK. S100A14, one member of the S100 protein family, is significantly associated without come of breast cancer patients. Here, for the first time, we show that S100A14 and HER2 are coexpressed in invasive breast cancer specimens, and there is a significant correlation between the expression levels of the two proteins by immunohistochemistry. S100A14 and HER2 are colocalized in plasma membrane of breast cancer tissue cells and breast cancer cell lines BT474 and SK-BR3. We demonstrate that S100A14 binds directly to HER2 by co-immunoprecipitation and pull-down assays. Further study shows that residues 956-1154 of the HER2 intracellular domain and residue 83 of S100A14 are essential for the two proteins binding. Moreover, we observe a decrease of HER2 phosphorylation, downstream signaling, and HER2-stimulated cell proliferation in S100A14-silenced MCF-7, BT474, and SK-BR3 cells. Our findings suggest that S100A14 functions as a modulator of HER2 signaling and provide mechanistic evidence for its role in breast cancer progression.	[Xu, Chengshan; Chen, Hongyan; Li, Yi; Ding, Fang; Luo, Aiping; Zhang, Shuguang; Liu, Zhihua] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Wang, Xiang; Gao, Jidong] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Abdominal Surg, Beijing 100021, Peoples R China; [Che, Yiqun] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Clin Lab, Beijing 100021, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, HY (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	chenhongyan@cicams.ac.cn; liuzh@cicams.ac.cn		Wang, Xiang/0000-0002-0913-0501	National Basic Research Program of China [2011CB504205]; National Natural Science Foundation of China [81000954, 81130043]; Ministry of Education of China [20101106120012]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by National Basic Research Program of China Grant 2011CB504205, National Natural Science Foundation of China Grants 81000954 and 81130043, and Doctoral Fund of Ministry of Education of China Grant 20101106120012.	Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; Anan K, 1998, EUR J SURG ONCOL, V24, P28, DOI 10.1016/S0748-7983(98)80121-2; Arisio R, 2000, J CLIN PATHOL, V53, P846, DOI 10.1136/jcp.53.11.846; Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Bader AA, 2002, BREAST CANCER RES TR, V76, P11, DOI 10.1023/A:1020231300974; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chen HY, 2012, J BIOL CHEM, V287, P17109, DOI 10.1074/jbc.M111.326975; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Duverger O, 2008, J BIOL CHEM, V283, P20198, DOI 10.1074/jbc.M709562200; Erjala K, 2006, CLIN CANCER RES, V12, P4103, DOI 10.1158/1078-0432.CCR-05-2404; Fusun T, 2005, EXP ONCOL, V27, P145; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hernan R, 2003, CANCER RES, V63, P140; Jin QE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019375; Klingelhofer J, 2009, FEBS J, V276, P5936, DOI 10.1111/j.1742-4658.2009.07274.x; Leth-Larsen R, 2012, MOL MED, V18, P1109, DOI 10.2119/molmed.2012.00091; Li HB, 2004, BIOCHEM J, V381, P257, DOI 10.1042/BJ20040515; Luo WJ, 2008, J BIOL CHEM, V283, P8624, DOI 10.1074/jbc.M707860200; MITTRA I, 1995, J SURG ONCOL, V60, P106, DOI 10.1002/jso.2930600208; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Paruchuri V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001741; Pietas A, 2002, GENOMICS, V79, P513, DOI 10.1006/geno.2002.6744; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schneider J, 2003, BRIT J CANCER, V88, P96, DOI 10.1038/sj.bjc.6600656; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Sutterlin MW, 2000, ANTICANCER RES, V20, P5083; Tulchin N, 2010, AM J PATHOL, V176, P1203, DOI 10.2353/ajpath.2010.081063; Vimalachandran D, 2005, CANCER RES, V65, P3218, DOI 10.1158/0008-5472.CAN-04-4311; Wainberg ZA, 2010, CLIN CANCER RES, V16, P1509, DOI 10.1158/1078-0432.CCR-09-1112; Wang HY, 2010, ONCOL REP, V23, P45, DOI 10.3892/or_00000604; Wang YY, 2010, ANN SURG ONCOL, V17, P89, DOI 10.1245/s10434-009-0722-z; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zhang HY, 2012, MOL BIOL REP, V39, P199, DOI 10.1007/s11033-011-0726-1; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	43	42	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					827	837		10.1074/jbc.M113.469718	http://dx.doi.org/10.1074/jbc.M113.469718			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24285542	Green Published, hybrid			2022-12-28	WOS:000330541200020
J	Lee, HC; Narayanan, S; Park, SJ; Seong, SY; Hahn, YS				Lee, Hai-Chon; Narayanan, Sowmya; Park, Sung-Jae; Seong, Seung-Yong; Hahn, Young S.			Transcriptional Regulation of IFN- lambda Genes in Hepatitis C Virus- infected Hepatocytes via IRF-3IRF-7NF-kappa B Complex*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokines induction; Hepatitis c virus; Interferon; Transcription factors; Transcription promoter; Interferon regulatory factor; NF-B	THYMIC STROMAL LYMPHOPOIETIN; AIRWAY EPITHELIAL-CELLS; NF-KAPPA-B; INTERFERON-LAMBDA; IMMUNE-RESPONSES; EXPRESSION; RECEPTOR; REPLICATION; LIVER; CYTOKINES	Background:IFN- gene induction in hepatitis C virus infected hepatocytes is not well defined. Results: IRF-3, IRF-7, and NF-B transcribe type III IFNs. Treatment with IFN- reduced HCV RNA and miR122. Conclusion:IFN- gene regulation in HCV-infected hepatocytes is similar to immune cells. IFN- may exert antiviral activity by down-regulating miR122. Significance: Hepatocytes can produce IFN-, which may be effective against hepatitis C virus. Hepatitis C virus (HCV) infection in hepatocytes stimulates innate antiviral responses including the production of type III interferons (IFN-), including IL-28A, IL-28B, and IL-29. However, the molecular mechanism(s) regulating the expression of IFN- genes in HCV-infected hepatocytes remains undefined. In this study, we examined regulatory elements involved in the induction of IFN- genes following HCV infection in hepatocytes and further determined the binding of specific transcription factor(s) to promoter regions of IFN- genes. Our studies reveal that the regulatory portion for IL-28A, IL-28B, and IL-29 genes is localized to a 1-kb region in their respective promoters. Notably, interferon regulatory factor (IRF)-3 and -7 are the key transcriptional factors for the induction of IL-28A and IL-28B genes, whereas NF-B is an additional requirement for the induction of the IL-29 gene. Ligation of Toll-like receptors (TLR) 3, 7, 8, and 9, which also activate IRFs and NF-B, resulted in more robust production of IFN- than that observed with HCV infection, verifying the importance of TLR pathways in IFN- production. Furthermore, the addition of IFN- to HCV-infected hepatocytes decreased viral replication and produced a concurrent reduction in microRNA-122 (miR-122). The decrease in viral replication was enhanced by the co-administration of IFN- and miR-122 inhibitor (miRIDIAN), suggesting that such combinatorial therapies may be beneficial for the treatment of chronic HCV infection.	[Lee, Hai-Chon; Narayanan, Sowmya; Hahn, Young S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Dept Microbiol, Charlottesville, VA 22908 USA; [Lee, Hai-Chon] Seoul Natl Univ, Wide River Inst Immunol, Gangwon 200701, South Korea; [Park, Sung-Jae] Inje Univ, Coll Med, Dept Internal Med, Pusan 614735, South Korea; [Seong, Seung-Yong] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Dept Biomed Sci, Seoul 110799, South Korea	University of Virginia; Seoul National University (SNU); Inje University; Seoul National University (SNU)	Hahn, YS (corresponding author), Univ Virginia, Carter Immunol Ctr, POB 801386, Charlottesville, VA 22908 USA.	ysh5e@virginia.edu	Seong, Seung Yong/J-2764-2012	Seong, Seung Yong/0000-0002-3671-1029; NARAYANAN, SOWMYA/0000-0002-0725-9731	National Institutes of Health [AI098126, AI066328]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066328, R01AI098126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI098126 and AI066328 (to Y. S. H.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Bonjardim CA, 2005, MICROBES INFECT, V7, P569, DOI 10.1016/j.micinf.2005.02.001; Ding Q, 2012, EUR J IMMUNOL, V42, P2374, DOI 10.1002/eji.201242388; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Hou W, 2009, J VIROL, V83, P3834, DOI 10.1128/JVI.01773-08; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Lee HC, 2008, J IMMUNOL, V181, P5189, DOI 10.4049/jimmunol.181.8.5189; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Lee HC, 2013, HEPATOLOGY, V57, P1314, DOI 10.1002/hep.26128; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/JLB.1208761, 10.1189/jlb.1208761]; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Siegel R, 2011, J IMMUNOL, V187, P5636, DOI 10.4049/jimmunol.1003988; Tacke RS, 2012, HEPATOLOGY, V55, P343, DOI 10.1002/hep.24700; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Thomson SJP, 2009, P NATL ACAD SCI USA, V106, P11564, DOI 10.1073/pnas.0904477106; Wick G, 2013, ANNU REV IMMUNOL, V31, P107, DOI 10.1146/annurev-immunol-032712-095937; Yoshikawa T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00637; Zhu HZ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-80	26	34	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5310	5319		10.1074/jbc.M113.536102	http://dx.doi.org/10.1074/jbc.M113.536102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24385435	Green Published, hybrid			2022-12-28	WOS:000331607900071
J	Lee, Y; Villar, MT; Artigues, A; Beamer, LJ				Lee, Yingying; Villar, Maria T.; Artigues, Antonio; Beamer, Lesa J.			Promotion of Enzyme Flexibility by Dephosphorylation and Coupling to the Catalytic Mechanism of a Phosphohexomutase*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Biosynthesis; Enzyme Catalysis; Phosphorylation; Protein Dynamics; Pseudomonas aeruginosa; Hydrogen-Deuterium Exchange; Small Angle X-ray Scattering	PSEUDOMONAS-AERUGINOSA; ALLOSTERIC REGULATION; PHOSPHORYLATION; SUBSTRATE; EXCHANGE; PMM/PGM; KINASE; PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE; IDENTIFICATION; SUPERFAMILY	Background: Enzyme function involves both specific conformational change and intrinsic flexibility of proteins. Results: Dephosphorylation of a catalytic phosphoserine causes a global increase in flexibility of a phosphohexomutase. Conclusion: Increased flexibility following phosphoryl transfer is critical to catalytic mechanism. Significance: Other phosphotransfer enzymes may undergo changes in flexibility linked to dephosphorylation. The enzyme phosphomannomutase/phosphoglucomutase (PMM/PGM) from Pseudomonas aeruginosa catalyzes an intramolecular phosphoryl transfer across its phosphosugar substrates, which are precursors in the synthesis of exoproducts involved in bacterial virulence. Previous structural studies of PMM/PGM have established a key role for conformational change in its multistep reaction, which requires a dramatic 180 degrees reorientation of the intermediate within the active site. Here hydrogen-deuterium exchange by mass spectrometry and small angle x-ray scattering were used to probe the conformational flexibility of different forms of PMM/PGM in solution, including its active, phosphorylated state and the unphosphorylated state that occurs transiently during the catalytic cycle. In addition, the effects of ligand binding were assessed through use of a substrate analog. We found that both phosphorylation and binding of ligand produce significant effects on deuterium incorporation. Phosphorylation of the conserved catalytic serine has broad effects on residues in multiple domains and is supported by small angle x-ray scattering data showing that the unphosphorylated enzyme is less compact in solution. The effects of ligand binding are generally manifested near the active site cleft and at a domain interface that is a site of conformational change. These results suggest that dephosphorylation of the enzyme may play two critical functional roles: a direct role in the chemical step of phosphoryl transfer and secondly through propagation of structural flexibility. We propose a model whereby increased enzyme flexibility facilitates the reorientation of the reaction intermediate, coupling changes in structural dynamics with the unique catalytic mechanism of this enzyme.	[Lee, Yingying; Beamer, Lesa J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Beamer, Lesa J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Villar, Maria T.; Artigues, Antonio] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Kansas; University of Kansas Medical Center	Beamer, LJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	beamerl@missouri.edu			DOE Office of Biological and Environmental Research; National Institute of Health Project MINOS [R01GM105404]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of Health Project MINOS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank James Fraser, Jack Tanner, and Steven Van Doren for helpful discussions and Brian Mooney and Beverly DaGue of the University of Missouri Charles W. Gehrke Proteomics Center and Cristina Furdui for assistance with initial mass spectrometry. We thank Kevin Dyer for collecting the SAXS data through the SIBYLS mail-in program. Part of this work was conducted at the Advanced Light Source, a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy (DOE), Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies program, supported by DOE Office of Biological and Environmental Research. Additional support comes from the National Institute of Health Project MINOS (Grant R01GM105404).	Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; Hammes GG, 2011, BIOCHEMISTRY-US, V50, P10422, DOI 10.1021/bi201486f; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hamuro Y, 2002, J MOL BIOL, V323, P871, DOI 10.1016/S0022-2836(02)01003-3; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Lee Y, 2013, FEBS J, V280, P2622, DOI 10.1111/febs.12249; Lee YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045836; Liu X, 2013, STRUCTURE, V21, P342, DOI 10.1016/j.str.2013.01.004; Liu YH, 2009, J MOL BIOL, V391, P149, DOI 10.1016/j.jmb.2009.06.017; Luebbering EK, 2012, J MOL BIOL, V423, P831, DOI 10.1016/j.jmb.2012.08.013; Ma LY, 2012, ENVIRON MICROBIOL, V14, P1995, DOI 10.1111/j.1462-2920.2012.02753.x; Moorthy BS, 2012, J MOL BIOL, V417, P468, DOI 10.1016/j.jmb.2012.01.052; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Naught LE, 2005, BIOCHEMISTRY-US, V44, P6831, DOI 10.1021/bi0501380; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Nishitani Y, 2006, J BIOL CHEM, V281, P19740, DOI 10.1074/jbc.M600801200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prasannan CB, 2013, BIOCHEMISTRY-US, V52, P1998, DOI 10.1021/bi400117q; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; RAY WJ, 1964, J BIOL CHEM, V239, P1228; Regni C, 2004, STRUCTURE, V12, P55, DOI 10.1016/j.str.2003.11.015; Regni C, 2002, STRUCTURE, V10, P269, DOI 10.1016/S0969-2126(02)00705-0; Regni CA, 2000, ACTA CRYSTALLOGR D, V56, P761, DOI 10.1107/S0907444900004431; Regni C, 2006, ACTA CRYSTALLOGR F, V62, P722, DOI 10.1107/S1744309106025887; Regni C, 2006, J BIOL CHEM, V281, P15564, DOI 10.1074/jbc.M600590200; Sarma AVS, 2012, BIOCHEMISTRY-US, V51, P807, DOI 10.1021/bi201609n; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schramm AM, 2008, BIOCHEMISTRY-US, V47, P9154, DOI 10.1021/bi8005219; Schramm AM, 2010, PROTEIN SCI, V19, P1235, DOI 10.1002/pro.402; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Smith AJT, 2008, J AM CHEM SOC, V130, P15361, DOI 10.1021/ja803213p; Sours KM, 2008, J MOL BIOL, V379, P1075, DOI 10.1016/j.jmb.2008.04.044; Steichen JM, 2010, J BIOL CHEM, V285, P3825, DOI 10.1074/jbc.M109.061820; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Villar Maria T, 2010, Proteomica, V6, P63; Wei Y, 2013, BIOMOL NMR ASSIGN, DOI 10.1007/s12104-013-9511-5; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	41	15	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4674	4682		10.1074/jbc.M113.532226	http://dx.doi.org/10.1074/jbc.M113.532226			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403075	Green Published, hybrid			2022-12-28	WOS:000331607900015
J	Lindsey-Boltz, LA; Kemp, MG; Reardon, JT; Derocco, V; Iyer, RR; Modrich, P; Sancar, A				Lindsey-Boltz, Laura A.; Kemp, Michael G.; Reardon, Joyce T.; Derocco, Vanessa; Iyer, Ravi R.; Modrich, Paul; Sancar, Aziz			Coupling of Human DNA Excision Repair and the DNA Damage Checkpoint in a Defined in Vitro System*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Checkpoint Control; DNA Damage Response; DNA Nucleotide Excision Repair; p53; Protein Kinases	REPLICATION PROTEIN-A; ATR ACTIVATION; ATAXIA-TELANGIECTASIA; FUNCTIONAL-CHARACTERIZATION; H2AX PHOSPHORYLATION; UV-IRRADIATION; KINASE; TOPBP1; COMPLEXES; RPA	Background: Nucleotide excision repair and the ATR-mediated DNA damage checkpoint responses are genetically coupled. Results: We have analyzed the basic steps of ATR activation in a biochemically defined system. Conclusion: ATR signaling requires enlargement of the DNA excision gap by EXO1. Significance: The six excision repair factors, ATR-ATRIP, TopBP1, and EXO1 constitute the minimum essential set of proteins for ATR-activation upon UV-induced DNA damage. DNA repair and DNA damage checkpoints work in concert to help maintain genomic integrity. In vivo data suggest that these two global responses to DNA damage are coupled. It has been proposed that the canonical 30 nucleotide single-stranded DNA gap generated by nucleotide excision repair is the signal that activates the ATR-mediated DNA damage checkpoint response and that the signal is enhanced by gap enlargement by EXO1 (exonuclease 1) 5 to 3 exonuclease activity. Here we have used purified core nucleotide excision repair factors (RPA, XPA, XPC, TFIIH, XPG, and XPF-ERCC1), core DNA damage checkpoint proteins (ATR-ATRIP, TopBP1, RPA), and DNA damaged by a UV-mimetic agent to analyze the basic steps of DNA damage checkpoint response in a biochemically defined system. We find that checkpoint signaling as measured by phosphorylation of target proteins by the ATR kinase requires enlargement of the excision gap generated by the excision repair system by the 5 to 3 exonuclease activity of EXO1. We conclude that, in addition to damaged DNA, RPA, XPA, XPC, TFIIH, XPG, XPF-ERCC1, ATR-ATRIP, TopBP1, and EXO1 constitute the minimum essential set of factors for ATR-mediated DNA damage checkpoint response.	[Lindsey-Boltz, Laura A.; Kemp, Michael G.; Reardon, Joyce T.; Derocco, Vanessa; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Iyer, Ravi R.; Modrich, Paul] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Duke University; Howard Hughes Medical Institute	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	Aziz_Sancar@med.unc.edu	Lindsey-Boltz, Laura/A-3121-2010; Kemp, Michael G./AAT-1545-2021	Lindsey-Boltz, Laura/0000-0001-6493-8194; Kemp, Michael G./0000-0001-8203-0745; Modrich, Paul/0000-0001-8708-9885	National Institutes of Health [GM32833, GM45190]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190, R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM32833 (to A. S.) and GM45190 (to P. M.).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Choi JH, 2009, METHODS, V48, P3, DOI 10.1016/j.ymeth.2009.02.006; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clarke CAL, 2005, BIOCHEM J, V388, P705, DOI 10.1042/BJ20041966; D Bomgarden R, 2006, EMBO J, V25, P2605, DOI 10.1038/sj.emboj.7601123; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Duursma AM, 2013, MOL CELL, V50, P116, DOI 10.1016/j.molcel.2013.03.006; Giannattasio M, 2010, MOL CELL, V40, P50, DOI 10.1016/j.molcel.2010.09.004; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Hara R, 2003, MOL CELL BIOL, V23, P4121, DOI 10.1128/MCB.23.12.4121-4125.2003; Hassan BH, 2013, J BIOL CHEM, V288, P18903, DOI 10.1074/jbc.M113.475517; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Kemp MG, 2011, J BIOL CHEM, V286, P19237, DOI 10.1074/jbc.M111.235036; Kershnar E, 1998, J BIOL CHEM, V273, P34444, DOI 10.1074/jbc.273.51.34444; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Leroy C, 2001, EMBO J, V20, P2896, DOI 10.1093/emboj/20.11.2896; Lindsey-Boltz LA, 2012, J BIOL CHEM, V287, P36123, DOI 10.1074/jbc.M112.407825; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Marini F, 2006, P NATL ACAD SCI USA, V103, P17325, DOI 10.1073/pnas.0605446103; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Munoz DP, 2013, NUCLEIC ACIDS RES, V41, P2894, DOI 10.1093/nar/gks1478; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Navadgi-Patil VM, 2011, BIOCHEM SOC T, V39, P600, DOI 10.1042/BST0390600; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Novarina D, 2011, DNA REPAIR, V10, P751, DOI 10.1016/j.dnarep.2011.04.030; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Reardon JT, 2006, METHOD ENZYMOL, V408, P189, DOI 10.1016/S0076-6879(06)08012-8; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schaetzlein S, 2013, P NATL ACAD SCI USA, V110, pE2470, DOI 10.1073/pnas.1308512110; Sertic S, 2011, P NATL ACAD SCI USA, V108, P13647, DOI 10.1073/pnas.1108547108; Shiotani B, 2013, CELL REP, V3, P1651, DOI 10.1016/j.celrep.2013.04.018; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; vanOosterwijk MF, 1996, MOL CELL BIOL, V16, P4436; Vidal-Eychenie S, 2013, J CELL BIOL, V202, P421, DOI 10.1083/jcb.201304139; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	65	46	47	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5074	5082		10.1074/jbc.M113.542787	http://dx.doi.org/10.1074/jbc.M113.542787			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403078	hybrid, Green Published			2022-12-28	WOS:000331607900051
J	Jeong, SM; Lee, A; Lee, J; Haigis, MC				Jeong, Seung Min; Lee, Annie; Lee, Jaewon; Haigis, Marcia C.			SIRT4 Protein Suppresses Tumor Formation in Genetic Models of Myc-induced B Cell Lymphoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Glutamine; Mitochondria; Mitochondrial metabolism; Sirtuins	GLUTAMINE-METABOLISM; CALORIE RESTRICTION; CANCER-THERAPY; PROLIFERATION; INHIBITION; PHYSIOLOGY; ADDICTION; SIRTUINS; SURVIVAL	Background: Glutamine metabolism is essential for Myc-induced tumors. Results: SIRT4 regulates mitochondrial glutamine metabolism and the growth and survival of Burkitt lymphoma cells independent of Myc. Conclusion: SIRT4 has a tumor-suppressive role in Myc-induced B cell lymphoma. Significance: SIRT4 may be a potential target against Myc-driven and glutamine-dependent tumors. Glutamine metabolism plays an essential role for growth and proliferation of many cancer cells by providing metabolites for the maintenance of mitochondrial functions and macromolecular synthesis. Aberrant activation of the transcription factor c-Myc, e.g. caused by t(8;14) chromosomal translocation commonly found in Burkitt lymphoma, is a key driver of cellular glutamine metabolism in many tumors, highlighting the need to identify molecular mechanisms that can suppress glutamine usage in these cancers. Recently, the mitochondrial sirtuin SIRT4 has been reported to function as a tumor suppressor by regulating glutamine metabolism, suggesting that it might have therapeutic potential for treating glutamine-dependent cancers. Here, we report that SIRT4 represses Myc-induced B cell lymphomagenesis via inhibition of mitochondrial glutamine metabolism. We found that SIRT4 overexpression can dampen glutamine utilization even in Myc-driven human Burkitt lymphoma cells and inhibit glutamine-dependent proliferation of these cells. Importantly, SIRT4 overexpression sensitizes Burkitt lymphoma cells to glucose depletion and synergizes with pharmacological glycolysis inhibitors to induce cell death. Moreover, SIRT4 loss in a genetic mouse model of Myc-induced Burkitt lymphoma, E-Myc transgenic mouse, greatly accelerates lymphomagenesis and mortality. Indeed, E-Myc-induced B cell lymphoma cells from SIRT4 null mice exhibit increased glutamine uptake and glutamate dehydrogenase activity. Furthermore, we establish that SIRT4 regulates glutamine metabolism independent of Myc. Together, these results highlight the tumor-suppressive role of SIRT4 in Myc-induced B cell lymphoma and suggest that SIRT4 may be a potential target against Myc-induced and/or glutamine-dependent cancers.	[Jeong, Seung Min; Lee, Annie; Lee, Jaewon; Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Haigis, MC (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, SGM 329C,240 Longwood Ave, Boston, MA 02115 USA.	marcia_haigis@hms.harvard.edu		Lee, Jaewon/0000-0002-5677-2398	National Institutes of Health [R01 AG032375]; American Cancer Society; Ellison Medical Foundation; Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING [R01AG032375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG032375 (to M. C. H.).; Supported by the American Cancer Society New Scholar Award, Ellison Medical Foundation New Scholar Award, and the Glenn Foundation for Medical Research. To whom correspondence should be addressed: Dept. of Cell Biology, Harvard Medical School, SGM 329C, 240 Longwood Ave., Boston, MA 02115. Tel.: 617-432-6865; Fax: 617-432-6225; E-mail: marcia_haigis@hms.harvard.edu.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Dang CV, 2011, COLD SH Q B, V76, P369, DOI 10.1101/sqb.2011.76.011296; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Michalak EM, 2009, CELL DEATH DIFFER, V16, P684, DOI 10.1038/cdd.2008.195; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Papaldo P, 2003, J CLIN ONCOL, V21, P3462, DOI 10.1200/JCO.2003.03.034; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099	27	86	88	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4135	4144		10.1074/jbc.M113.525949	http://dx.doi.org/10.1074/jbc.M113.525949			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24368766	Green Published, hybrid			2022-12-28	WOS:000331403800027
J	Loibl, M; Klein, I; Prattes, M; Schmidt, C; Kappel, L; Zisser, G; Gungl, A; Krieger, E; Pertschy, B; Bergler, H				Loibl, Mathias; Klein, Isabella; Prattes, Michael; Schmidt, Claudia; Kappel, Lisa; Zisser, Gertrude; Gungl, Anna; Krieger, Elmar; Pertschy, Brigitte; Bergler, Helmut			The Drug Diazaborine Blocks Ribosome Biogenesis by Inhibiting the AAA-ATPase Drg1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Drug Action; Enzyme Inhibitors; Protein-Drug Interactions; Ribosome Assembly; AAA-ATPases; Diazaborine; Small Molecule Inhibitor	SACCHAROMYCES-CEREVISIAE; AFFINITY PURIFICATION; PROTEIN; YEAST; COMPLEX; MATURATION; REDUCTASE; SYSTEM; GENE	The drug diazaborine is the only known inhibitor of ribosome biogenesis and specifically blocks large subunit formation in eukaryotic cells. However, the target of this drug and the mechanism of inhibition were unknown. Here we identify the AAA-ATPase Drg1 as a target of diazaborine. Inhibitor binding into the second AAA domain of Drg1 requires ATP loading and results in inhibition of ATP hydrolysis in this site. As a consequence the physiological activity of Drg1, i.e. the release of Rlp24 from pre-60S particles, is blocked, and further progression of cytoplasmic preribosome maturation is prevented. Our results identify the first target of an inhibitor of ribosome biogenesis and provide the mechanism of inhibition of a key step in large ribosomal subunit formation.	[Loibl, Mathias; Klein, Isabella; Prattes, Michael; Schmidt, Claudia; Zisser, Gertrude; Gungl, Anna; Pertschy, Brigitte; Bergler, Helmut] Karl Franzens Univ Graz, Inst Mol Biowissensch, A-8010 Graz, Austria; [Krieger, Elmar] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat 260, NL-6500 HB Nijmegen, Netherlands	University of Graz; Radboud University Nijmegen	Bergler, H (corresponding author), Karl Franzens Univ Graz, Inst Mol Biowissensch, Humboldtstr 50-EG, A-8010 Graz, Austria.	helmut.bergler@uni-graz.at	Birnhuber, Anna/AAX-3065-2021	Birnhuber, Anna/0000-0002-8358-8377; Pertschy, Brigitte/0000-0003-3558-0191; Bergler, Helmut/0000-0002-7724-309X; Prattes, Michael/0000-0002-2526-9896; Kappel, Lisa/0000-0001-9633-9030; Klein, Isabella/0000-0001-5879-3777	European Union [289350]; Austrian Science Fund (FWF) [P21991, P26136]; Austrian Science Fund (FWF) [P 26136, P 21991] Funding Source: researchfish	European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant 289350 (to E. K.) and Austrian Science Fund (FWF) Grants P21991 and P26136 (to H. B.).	Baldock C, 1996, ACTA CRYSTALLOGR D, V52, P1181, DOI 10.1107/S0907444996005458; Bassler J, 2012, MOL CELL BIOL, V32, P4898, DOI 10.1128/MCB.00910-12; BERGLER H, 1994, J BIOL CHEM, V269, P5493; Bursavich MG, 2010, BIOORG MED CHEM LETT, V20, P1677, DOI 10.1016/j.bmcl.2010.01.058; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chou TF, 2011, AUTOPHAGY, V7, P1091, DOI 10.4161/auto.7.9.16489; GRASSBERGER MA, 1984, J MED CHEM, V27, P947, DOI 10.1021/jm00374a003; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kappel L, 2012, J CELL BIOL, V199, P771, DOI 10.1083/jcb.201205021; KATER MM, 1994, PLANT MOL BIOL, V25, P771, DOI 10.1007/BF00028873; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2012, METHODS MOL BIOL, V819, P405, DOI 10.1007/978-1-61779-465-0_25; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Levy CW, 2001, J MOL BIOL, V309, P171, DOI 10.1006/jmbi.2001.4643; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Muckstein U, 2002, BIOINFORMATICS, V18, pS153, DOI 10.1093/bioinformatics/18.suppl_2.S153; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Pertschy B, 2004, MOL CELL BIOL, V24, P6476, DOI 10.1128/MCB.24.14.6476-6487.2004; Pertschy B, 2007, MOL CELL BIOL, V27, P6581, DOI 10.1128/MCB.00668-07; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SCHMITT J, 1993, MOL BIOL REP, V18, P223, DOI 10.1007/BF01674434; SIKORSKI RS, 1989, GENETICS, V122, P19; THORSNESS PE, 1993, YEAST, V9, P1267, DOI 10.1002/yea.320091114; Waldron TT, 2003, BIOCHEMISTRY-US, V42, P5058, DOI 10.1021/bi034212v; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wendler F, 1997, J BIOL CHEM, V272, P27091, DOI 10.1074/jbc.272.43.27091; Zakalskiy A, 2002, J BIOL CHEM, V277, P26788, DOI 10.1074/jbc.M201515200	32	39	39	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3913	3922		10.1074/jbc.M113.536110	http://dx.doi.org/10.1074/jbc.M113.536110			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24371142	Green Published, hybrid			2022-12-28	WOS:000331403800008
J	Quinn, SR; Mangan, NE; Caffrey, BE; Gantier, MP; Williams, BRG; Hertzog, PJ; McCoy, CE; O'Neill, LAJ				Quinn, Susan R.; Mangan, Niamh E.; Caffrey, Brian E.; Gantier, Michael P.; Williams, Bryan R. G.; Hertzog, Paul J.; McCoy, Claire E.; O'Neill, Luke A. J.			The Role of Ets2 Transcription Factor in the Induction of MicroRNA-155 (miR-155) by Lipopolysaccharide and Its Targeting by Interleukin-10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ets Family Transcription Factor; Interleukin; Lipopolysaccharide (LPS); MicroRNA; Toll-like Receptors (TLR); Ets2; Interleukin 10; SHIP1; TLR4; miR-155	MACROPHAGES; LPS; CELLS; INFLAMMATION; STIMULATION; ACTIVATION; EXPRESSION; IMMUNITY; SHOCK; MICE	Background: miR-155 is strongly induced by LPS, a response inhibited by IL-10. Results: The Ets2 transcription factor is required for induction of miR-155 by LPS. IL-10 can subsequently decrease miR-155 via suppression of Ets2. Conclusion: Ets2 is an important transcription factor for regulation of miR-155. Significance: This study reports a detailed mechanism of induction of miR-155 and provides a new means of inhibition for IL-10 via suppression of Ets2. MicroRNA-155 (miR-155) is highly expressed in many cancers such as B cell lymphomas and myeloid leukemia and inflammatory disorders such as rheumatoid arthritis, atopic dermatitis, and multiple sclerosis. The role of miR-155 as both a promoter of inflammation and an oncogenic agent provides a clear need for miR-155 itself to be stringently regulated. We therefore investigated the transcriptional regulation of miR-155 in response to the respective pro- and anti-inflammatory mediators LPS and IL-10. Bioinformatic analysis revealed Ets binding sites on the miR-155 promoter, and we found that Ets2 is critical for miR-155 induction by LPS. Truncation and mutational analysis of the miR-155 promoter confirmed the role of the Ets2 binding site proximal to the transcription start site for LPS responsiveness. We observed increased binding of Ets2 to the miR-155 promoter and Ets2 deficient mice displayed decreased induction of miR-155 in response to LPS. IL-10 inhibited the induction of Ets2 mRNA and protein by LPS, thereby decreasing Ets2 function on the pri-155 promoter. We have thus identified Ets2 as a key novel regulator in both the positive and negative control of miR-155 in the inflammatory response.	[Quinn, Susan R.; McCoy, Claire E.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Mangan, Niamh E.; Gantier, Michael P.; Williams, Bryan R. G.; Hertzog, Paul J.; McCoy, Claire E.] Monash Univ, Monash Inst Med Res, Clayton, Vic 3168, Australia; [Caffrey, Brian E.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland	Trinity College Dublin; Monash University; Trinity College Dublin	Quinn, SR (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, 152-160 Pearse St, Dublin 2, Ireland.	quinns1@tcd.ie	Gantier, Michael/B-7512-2011; Williams, Bryan R. G./A-5021-2009; Hertzog, Paul J/I-7053-2013; Gantier, Michael/H-7954-2019	Gantier, Michael/0000-0003-3740-698X; Williams, Bryan R. G./0000-0002-4969-1151; Hertzog, Paul J/0000-0002-1373-8472; Gantier, Michael/0000-0003-3740-698X; O'Neill, Luke/0000-0002-4333-2748; Mangan, Niamh/0000-0003-3844-0709; McCoy, Claire/0000-0001-8710-896X	Science Foundation Ireland; Health Research Board/Marie Curie CoFund; European Research Council; Australian National Health and Medical Research Council; Australian Research Council; Victorian government	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board/Marie Curie CoFund; European Research Council(European Research Council (ERC)European Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian government	This work was supported by the Science Foundation Ireland, Health Research Board/Marie Curie CoFund, and the European Research Council. The Monash Institute of Medical Research was supported by the Australian National Health and Medical Research Council, Australian Research Council, Health Research Board/Marie Curie CoFund, and the Victorian government's operational infrastructure support program.	An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Blumenthal SG, 1999, J BIOL CHEM, V274, P12910, DOI 10.1074/jbc.274.18.12910; BOULUKOS KE, 1990, GENE DEV, V4, P401, DOI 10.1101/gad.4.3.401; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen YZ, 2013, J IMMUNOL, V190, P3687, DOI 10.4049/jimmunol.1203273; Cheung ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071336; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Dai YM, 2011, HUM REPROD, V26, P1882, DOI 10.1093/humrep/der118; Dittmer J, 1998, BBA-REV CANCER, V1377, pF1, DOI 10.1016/S0304-419X(97)00039-5; Escobar T, 2013, INVEST OPHTH VIS SCI, V54, P4017, DOI 10.1167/iovs.13-11937; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; RENNICK D, 1995, CLIN IMMUNOL IMMUNOP, V76, pS174, DOI 10.1016/S0090-1229(95)90144-2; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Sweet MJ, 1998, J INFLAMM, V48, P67; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Trabucchi M, 2010, ADV EXP MED BIOL, V700, P36, DOI 10.1007/978-1-4419-7823-3_4; WANG CY, 1992, J EXP MED, V175, P1391, DOI 10.1084/jem.175.5.1391; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	35	67	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4316	4325		10.1074/jbc.M113.522730	http://dx.doi.org/10.1074/jbc.M113.522730			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362029	Green Published, hybrid			2022-12-28	WOS:000331403800042
J	Sturrock, A; Mir-Kasimov, M; Baker, J; Rowley, J; Paine, R				Sturrock, Anne; Mir-Kasimov, Mustafa; Baker, Jessica; Rowley, Jesse; Paine, Robert			Key Role of MicroRNA in the Regulation of Granulocyte Macrophage Colony-stimulating Factor Expression in Murine Alveolar Epithelial Cells during Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Growth Factors; Lung Injury; Microarray; MicroRNA; Oxidative Stress; Array	INDUCED PULMONARY-FIBROSIS; INNATE IMMUNE-RESPONSE; GROWTH-FACTOR RECEPTOR; CSF-DEFICIENT MICE; ACUTE LUNG INJURY; GM-CSF; HYPEROXIC STRESS; TRANSGENIC MICE; GENE-REGULATION; INFLAMMATION	GM-CSF is an endogenous pulmonary cytokine produced by normal alveolar epithelial cells (AEC) that is a key defender of the alveolar space. AEC GM-CSF expression is suppressed by oxidative stress through alternations in mRNA turnover, an effect that is reversed by treatment with recombinant GM-CSF. We hypothesized that specific microRNA (miRNA) would play a key role in AEC GM-CSF regulation. A genome-wide miRNA microarray identified 19 candidate miRNA altered in primary AEC during oxidative stress with reversal by treatment with GM-CSF. Three of these miRNA (miR 133a, miR 133a*, and miR 133b) are also predicted to bind the GM-CSF 3-untranslated region (UTR). PCR for the mature miRNA confirmed induction during oxidative stress that was reversed by treatment with GM-CSF. Experiments using a GM-CSF 3-UTR reporter construct demonstrated that miR133a and miR133b effects on GM-CSF expression are through interactions with the GM-CSF 3-UTR. Using lentiviral transduction of specific mimics and inhibitors in primary murine AEC, we determined that miR133a and miR133b suppress GM-CSF expression and that their inhibition both reverses oxidant-induced suppression of GM-CSF expression and increases basal expression of GM-CSF in cells in normoxia. In contrast, these miRNAs are not active in regulation of GM-CSF expression in murine EL4 T cells. Thus, members of the miR133 family play key roles in regulation of GM-CSF expression through effects on mRNA turnover in AEC during oxidative stress. Increased understanding of GM-CSF gene regulation may provide novel miRNA-based interventions to augment pulmonary innate immune defense in lung injury.	[Sturrock, Anne; Mir-Kasimov, Mustafa; Paine, Robert] Dept Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Sturrock, Anne; Mir-Kasimov, Mustafa; Baker, Jessica; Rowley, Jesse; Paine, Robert] Univ Utah, Sch Med, Div Resp Crit Care & Occupat Pulm Med, Dept Med, Salt Lake City, UT 84132 USA; [Rowley, Jesse] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT 84132 USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Paine, R (corresponding author), Univ Utah, Sch Med, Div Resp Crit Care & Occupat Pulm Med, 26 North 1900 East,Rm 701, Salt Lake City, UT 84132 USA.	robert.paine@hsc.utah.edu			Department of Veterans Affairs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K01GM103806] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001777] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit Research Grant from the Department of Veterans Affairs (to R. P.).	Baleeiro CEO, 2006, AM J PHYSIOL-LUNG C, V291, pL1246, DOI 10.1152/ajplung.00016.2006; Baleeiro CEO, 2003, J IMMUNOL, V171, P955, DOI 10.4049/jimmunol.171.2.955; Ballinger MN, 2006, AM J RESP CELL MOL, V34, P766, DOI 10.1165/rcmb.2005-0246OC; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beck JM, 2009, INFECT IMMUN, V77, P1053, DOI 10.1128/IAI.00967-08; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Charbeneau RP, 2003, AM J PHYSIOL-LUNG C, V284, pL1103, DOI 10.1152/ajplung.00350.2002; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Christensen PJ, 2000, AM J PHYSIOL-LUNG C, V279, pL487, DOI 10.1152/ajplung.2000.279.3.L487; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Gonzalez RF, 1998, BBA-PROTEIN STRUCT M, V1429, P208, DOI 10.1016/S0167-4838(98)00231-3; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3; Han M, 2011, CURR OPIN CARDIOL, V26, P181, DOI 10.1097/HCO.0b013e328345983d; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Ikegami M, 1997, AM J PHYSIOL-LUNG C, V273, pL709, DOI 10.1152/ajplung.1997.273.4.L709; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; LeVine AM, 1999, J CLIN INVEST, V103, P563, DOI 10.1172/JCI5212; Li HL, 2012, MOL MED REP, V5, P1457, DOI 10.3892/mmr.2012.831; Liu LX, 2012, FEBS J, V279, P3800, DOI 10.1111/j.1742-4658.2012.08741.x; Mendez MP, 2006, AM J PHYSIOL-LUNG C, V290, pL962, DOI 10.1152/ajplung.00352.2005; Moore BB, 2000, J IMMUNOL, V165, P4032, DOI 10.4049/jimmunol.165.7.4032; Moriya Y, 2012, J HUM GENET, V57, P38, DOI 10.1038/jhg.2011.126; Nana-Sinkam SP, 2009, AM J RESP CRIT CARE, V179, P4, DOI 10.1164/rccm.200807-1042PP; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; OREILLY MA, 1989, AM J PHYSIOL, V257, pL385, DOI 10.1152/ajplung.1989.257.6.L385; OSBORNE CS, 1995, J IMMUNOL, V155, P226; Paine R, 2003, AM J PATHOL, V163, P2397, DOI 10.1016/S0002-9440(10)63594-8; Paine R, 2000, J IMMUNOL, V164, P2602, DOI 10.4049/jimmunol.164.5.2602; Pandit KV, 2011, TRANSL RES, V157, P191, DOI 10.1016/j.trsl.2011.01.012; PIGUET PF, 1993, EXP LUNG RES, V19, P579, DOI 10.3109/01902149309031729; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Reed JA, 1998, P ASSOC AM PHYSICIAN, V110, P321; Reed JAH, 1997, AM J PHYSIOL-LUNG C, V273, pL715, DOI 10.1152/ajplung.1997.273.4.L715; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Sotillo E, 2011, PHARMACOL THERAPEUT, V131, P18, DOI 10.1016/j.pharmthera.2011.04.006; Sturrock A, 2010, AM J PHYSIOL-LUNG C, V298, pL446, DOI 10.1152/ajplung.00161.2009; Tao J, 2012, ONCOL REP, V27, P1967, DOI 10.3892/or.2012.1711; Tomankova T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-159; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Villar AV, 2011, HEART, V97, P1132, DOI 10.1136/hrt.2010.220418; Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Yin VP, 2012, DEV BIOL, V365, P319, DOI 10.1016/j.ydbio.2012.02.018; Zhang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041478	51	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4095	4105		10.1074/jbc.M113.535922	http://dx.doi.org/10.1074/jbc.M113.535922			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24371146	Green Published, hybrid			2022-12-28	WOS:000331403800023
J	Syeda, R; Santos, JS; Montal, M				Syeda, Ruhma; Santos, Jose S.; Montal, Mauricio			Lipid Bilayer Modules as Determinants of K+ Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gating; Lipid Structure; Membrane Bilayer; Phospholipid; Potassium Channels; Asymmetric Lipid Bilayers; Gating Modifiers; Phosphoglycerides; Voltage-gated Channels	PHOSPHOLIPID SURFACE-CHARGE; VOLTAGE-SENSOR DOMAIN; MOLECULAR TEMPLATE; CRYSTAL-STRUCTURE; MEMBRANE-LIPIDS; FORCE-FIELD; PORE MODULE; INACTIVATION; BINDING; PIP2	Background: Lipid bilayer composition and asymmetry modulate K+ channel function by unknown mechanisms. Results: Lipid headgroups with exposed hydroxyls on the extracellular facing monolayer stabilize the channel open conformation irrespective of charge. Conclusion: Stabilization is mediated through a change of interfacial water structure. Significance: Lipid bilayer asymmetry and its individual monolayers emerge as crucial determinants of K+ channel gating. The crystal structure of the sensorless pore module of a voltage-gated K+ (Kv) channel showed that lipids occupy a crevice between subunits. We asked if individual lipid monolayers of the bilayer embody independent modules linked to channel gating modulation. Functional studies using single channel current recordings of the sensorless pore module reconstituted in symmetric and asymmetric lipid bilayers allowed us to establish the deterministic role of lipid headgroup on gating. We discovered that individual monolayers with headgroups that coat the bilayer-aqueous interface with hydroxyls stabilize the channel open conformation. The hydroxyl need not be at a terminal position and the effect is not dependent on the presence of phosphate or net charge on the lipid headgroup. Asymmetric lipid bilayers allowed us to determine that phosphoglycerides with glycerol or inositol on the extracellular facing monolayer stabilize the open conformation of the channel. This indirect effect is attributed to a change in water structure at the membrane interface. By contrast, inclusion of the positively charged lysyl-dioleoyl-phosphatidylglycerol exclusively on the cytoplasmic facing monolayer of the bilayer increases drastically the probability of finding the channel open. Such modulation is mediated by a -cation interaction between Phe-19 of the pore module and the lysyl moiety anchored to the phosphatidylglycerol headgroup. The new findings imply that the specific chemistry of the lipid headgroup and its selective location in either monolayer of the bilayer dictate the stability of the open conformation of a Kv pore module in the absence of voltage-sensing modules.	[Syeda, Ruhma; Santos, Jose S.; Montal, Mauricio] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Montal, M (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	mmontal@ucsd.edu			National Institutes of Health [GM-49711]; University of California, San Diego [RK-174C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-49711 and University of California, San Diego, Grant RK-174C (to M. M.). The results presented were reported at the 2010 Biophysical Society Meeting of the Membrane Biophysics Subgroup Symposia (San Francisco, CA, February 20-24, 2010).	Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Alvis SJ, 2003, BIOPHYS J, V85, P3828, DOI 10.1016/S0006-3495(03)74797-3; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; BELL JE, 1984, BIOPHYS J, V45, P279, DOI 10.1016/S0006-3495(84)84154-5; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; Butterwick JA, 2010, J MOL BIOL, V403, P591, DOI 10.1016/j.jmb.2010.09.012; Chakrapani S, 2008, STRUCTURE, V16, P398, DOI 10.1016/j.str.2007.12.015; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fischer W, 1999, INT J SYST BACTERIOL, V49, P653, DOI 10.1099/00207713-49-2-653; FORTE M, 1981, P NATL ACAD SCI-BIOL, V78, P7195, DOI 10.1073/pnas.78.11.7195; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Iwamoto M, 2013, P NATL ACAD SCI USA, V110, P749, DOI 10.1073/pnas.1217323110; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lundby A, 2006, J GEN PHYSIOL, V128, P293, DOI 10.1085/jgp.200609573; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Marius P, 2008, BIOPHYS J, V94, P1689, DOI 10.1529/biophysj.107.117507; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; MOCZYDLOWSKI E, 1985, J MEMBRANE BIOL, V83, P273, DOI 10.1007/BF01868701; MONTAL M, 1976, ANNU REV BIOPHYS BIO, V5, P119, DOI 10.1146/annurev.bb.05.060176.001003; MONTAL M, 1990, FASEB J, V4, P2623, DOI 10.1096/fasebj.4.9.1693348; MONTAL M, 1973, BIOCHIM BIOPHYS ACTA, V298, P750, DOI 10.1016/0005-2736(73)90092-8; Murzyn K, 2006, BIOINTERPHASES, V1, P98, DOI 10.1116/1.2354573; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Ostmeyer J, 2013, NATURE, V501, DOI 10.1038/nature12395; Pan JJ, 2012, BBA-BIOMEMBRANES, V1818, P2135, DOI 10.1016/j.bbamem.2012.05.007; Park JB, 2003, J GEN PHYSIOL, V121, P375, DOI 10.1085/jgp.200208746; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Rodriguez-Menchaca AA, 2012, P NATL ACAD SCI USA, V109, pE2399, DOI 10.1073/pnas.1207901109; ROTHMAN JE, 1977, J MOL BIOL, V110, P603, DOI 10.1016/S0022-2836(77)80114-9; Santos JS, 2006, J GEN PHYSIOL, V128, P283, DOI 10.1085/jgp.200609572; Santos JS, 2013, J BIOL CHEM, V288, P16619, DOI 10.1074/jbc.M113.468728; Santos JS, 2012, J BIOL CHEM, V287, P43063, DOI 10.1074/jbc.M112.415091; Santos JS, 2008, J GEN PHYSIOL, V132, P651, DOI 10.1085/jgp.200810077; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schmidt D, 2012, P NATL ACAD SCI USA, V109, P10352, DOI 10.1073/pnas.1204700109; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Syeda R, 2012, P NATL ACAD SCI USA, V109, P16917, DOI 10.1073/pnas.1205592109; Tirosh O, 1998, BIOPHYS J, V74, P1371, DOI 10.1016/S0006-3495(98)77849-X; Towey JJ, 2012, J PHYS CHEM B, V116, P13898, DOI 10.1021/jp3093034; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; van Dalen A, 2004, BBA-MOL CELL RES, V1694, P97, DOI 10.1016/j.bbamcr.2004.03.007; van der Cruijsen EAW, 2013, P NATL ACAD SCI USA, V110, P13008, DOI 10.1073/pnas.1305563110; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Weingarth M, 2013, J AM CHEM SOC, V135, P3983, DOI 10.1021/ja3119114; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Zaydman MA, 2013, P NATL ACAD SCI USA, V110, P13180, DOI 10.1073/pnas.1305167110; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhao W, 2007, BIOPHYS J, V92, P1114, DOI 10.1529/biophysj.106.086272; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022	63	6	6	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4233	4243		10.1074/jbc.M113.530055	http://dx.doi.org/10.1074/jbc.M113.530055			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362039	Green Published, hybrid			2022-12-28	WOS:000331403800035
J	Wong, W; Webb, AI; Olshina, MA; Infusini, G; Tan, YH; Hanssen, E; Catimel, B; Suarez, C; Condron, M; Angrisano, F; NebI, T; Kovar, DR; Baum, J				Wong, Wilson; Webb, Andrew I.; Olshina, Maya A.; Infusini, Giuseppe; Tan, Yan Hong; Hanssen, Eric; Catimel, Bruno; Suarez, Cristian; Condron, Melanie; Angrisano, Fiona; Neb, Thomas, I; Kovar, David R.; Baum, Jake			A Mechanism for Actin Filament Severing by Malaria Parasite Actin Depolymerizing Factor 1 via a Low Affinity Binding Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cofilin; Cytoskeleton; Electron Microscopy (EM); Malaria; Mass Spectrometry (MS); Plasmodium; Protein Cross-linking	CHEMICAL CROSS-LINKING; MASS-SPECTROMETRY; TOXOPLASMA-GONDII; LINKED PEPTIDES; MICROFILAMENT DYNAMICS; CRYSTAL-STRUCTURES; CYTOCHALASIN D; COFILIN; ADF/COFILIN; IDENTIFICATION	Actin depolymerizing factor (ADF)/cofilins are essential regulators of actin turnover in eukaryotic cells. These multifunctional proteins facilitate both stabilization and severing of filamentous (F)-actin in a concentration-dependent manner. At high concentrations ADF/cofilins bind stably to F-actin longitudinally between two adjacent actin protomers forming what is called a decorative interaction. Low densities of ADF/cofilins, in contrast, result in the optimal severing of the filament. To date, how these two contrasting modalities are achieved by the same protein remains uncertain. Here, we define the proximate amino acids between the actin filament and the malaria parasite ADF/cofilin, PfADF1 from Plasmodium falciparum. PfADF1 is unique among ADF/cofilins in being able to sever F-actin but do so without stable filament binding. Using chemical cross-linking and mass spectrometry (XL-MS) combined with structure reconstruction we describe a previously overlooked binding interface on the actin filament targeted by PfADF1. This site is distinct from the known binding site that defines decoration. Furthermore, total internal reflection fluorescence (TIRF) microscopy imaging of single actin filaments confirms that this novel low affinity site is required for F-actin severing. Exploring beyond malaria parasites, selective blocking of the decoration site with human cofilin (HsCOF1) using cytochalasin D increases its severing rate. HsCOF1 may therefore also use a decoration-independent site for filament severing. Thus our data suggest that a second, low affinity actin-binding site may be universally used by ADF/cofilins for actin filament severing.	[Wong, Wilson; Olshina, Maya A.; Tan, Yan Hong; Condron, Melanie; Angrisano, Fiona; Baum, Jake] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic 3052, Australia; [Webb, Andrew I.; Infusini, Giuseppe; Neb, Thomas, I] Walter & Eliza Hall Inst Med Res, Div Syst Biol & Personalised Med, Parkville, Vic 3052, Australia; [Wong, Wilson; Webb, Andrew I.; Olshina, Maya A.; Infusini, Giuseppe; Tan, Yan Hong; Condron, Melanie; Angrisano, Fiona; Neb, Thomas, I; Baum, Jake] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Hanssen, Eric] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Electron Microscopy Unit, Parkville, Vic 3010, Australia; [Suarez, Cristian; Kovar, David R.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Kovar, David R.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Catimel, Bruno] Austin Hosp, Olivia Newton John Canc & Wellness Ctr, Ludwig Inst Canc Res, Heidelberg, Vic 3084, Australia	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Chicago; University of Chicago; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; La Trobe University; Olivia Newton-John Cancer Research Institute; Ludwig Institute for Cancer Research	Baum, J (corresponding author), Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England.	jake.baum@imperial.ac.uk	Nebl, Thomas/N-1620-2017; Hanssen, Eric/A-7217-2013	Nebl, Thomas/0000-0003-4003-9340; Hanssen, Eric/0000-0002-4064-1844; Angrisano, Fiona/0000-0002-0457-5982; Baum, Jake/0000-0002-0275-352X; CATIMEL, Bruno/0000-0002-4350-6875; Wong, Wilson/0000-0003-1335-8047	National Health and Medical Research Council of Australia (NHMRC) [APP1024678]; Human Frontier Science Program (HFSP) Young Investigator Program [RGY0071/2011]; Australian Research Council (ARC) Discovery Project Grant [DP1094497]; Victorian State Government; Australian Government NHMRC IRIISS; NHMRC [APP1053801]; NHMRC Dora Lush Scholarship [APP1018002]; Oversea Research Experience Scholarship; University of Melbourne; Australian Society of Parasitology; Australian Research Council (ARC) [FT100100112]; Wellcome Trust [100993/Z/13/Z]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Human Frontier Science Program (HFSP) Young Investigator Program; Australian Research Council (ARC) Discovery Project Grant(Australian Research Council); Victorian State Government; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Dora Lush Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Oversea Research Experience Scholarship; University of Melbourne(University of Melbourne); Australian Society of Parasitology; Australian Research Council (ARC)(Australian Research Council); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported in part by National Health and Medical Research Council of Australia (NHMRC) Project Grant APP1024678 (to J. B.), Human Frontier Science Program (HFSP) Young Investigator Program Grant RGY0071/2011 (to J. B. and D. R. K.), and Australian Research Council (ARC) Discovery Project Grant DP1094497 (to B. C.), Victorian State Government Operational Infrastructure Support, and Australian Government NHMRC IRIISS.; Supported through Early Career Fellowship APP1053801 from the NHMRC.; Supported through NHMRC Dora Lush Scholarship APP1018002 and an Oversea Research Experience Scholarship and travel award provided by the University of Melbourne and the Australian Society of Parasitology, respectively.; Supported by Future Fellowship FT100100112 from the Australian Research Council (ARC) and currently supported by a New Investigator Award from the Wellcome Trust 100993/Z/13/Z. To whom correspondence should be addressed: Dept. of Life Sciences, Imperial College of Science, Technology and Medicine, London SW7 2AZ, United Kingdom. E-mail: jake.baum@imperial.ac.uk.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Back JW, 2003, J MOL BIOL, V331, P303, DOI 10.1016/S0022-2836(03)00721-6; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Chen Q, 2011, J CELL BIOL, V195, P485, DOI 10.1083/jcb.201103067; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Grintsevich EE, 2008, J MOL BIOL, V377, P395, DOI 10.1016/j.jmb.2007.12.073; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Mehta S, 2011, MOL BIOL CELL, V22, P1290, DOI 10.1091/mbc.E10-12-0939; Mehta S, 2010, J BIOL CHEM, V285, P6835, DOI 10.1074/jbc.M109.068155; Moriyama K, 1999, EMBO J, V18, P6752, DOI 10.1093/emboj/18.23.6752; Moriyama K, 2002, BIOCHEM J, V365, P147, DOI 10.1042/BJ20020231; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Nair UB, 2008, J MOL BIOL, V384, P848, DOI 10.1016/j.jmb.2008.09.082; Neidt EM, 2008, J BIOL CHEM, V283, P23872, DOI 10.1074/jbc.M803734200; Neuhauser N, 2012, MOL CELL PROTEOMICS, V11, P1500, DOI 10.1074/mcp.M112.020271; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Panchaud A, 2010, J PROTEOME RES, V9, P2508, DOI 10.1021/pr9011816; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schuler H, 2006, TRAFFIC, V7, P1433, DOI 10.1111/j.1600-0854.2006.00484.x; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; Shoji K, 2012, BIOCHEM BIOPH RES CO, V424, P52, DOI 10.1016/j.bbrc.2012.06.063; Singh BK, 2011, J BIOL CHEM, V286, P28256, DOI 10.1074/jbc.M111.211730; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Skillman KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002280; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Wang H, 2010, CYTOSKELETON, V67, P456, DOI 10.1002/cm.20458; Wong W, 2011, P NATL ACAD SCI USA, V108, P9869, DOI 10.1073/pnas.1018927108; Yadav R, 2011, J STRUCT BIOL, V176, P97, DOI 10.1016/j.jsb.2011.07.011; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097	45	19	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4043	4054		10.1074/jbc.M113.523365	http://dx.doi.org/10.1074/jbc.M113.523365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24371134	hybrid, Green Published			2022-12-28	WOS:000331403800019
J	Workman, E; Veith, A; Battle, DJ				Workman, Eileen; Veith, Alex; Battle, Daniel J.			U1A Regulates 3 ' Processing of the Survival Motor Neuron mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; Neurodegenerative Diseases; Polyadenylation; RNA Processing; RNA-binding Proteins; SMA; SMN; Spinal Muscular Atrophy; Survival Motor Neuron; U1A	SPINAL MUSCULAR-ATROPHY; POLYADENYLATION FACTOR CPSF-73; BINDING PROTEIN; SMN COMPLEX; SPECIFICITY FACTOR; SINGLE NUCLEOTIDE; A-PROTEIN; IDENTIFICATION; CLEAVAGE; SITE	Background: Insufficient expression of survival motor neuron (SMN), a protein involved in small nuclear ribonucleoprotein (snRNP) biogenesis, causes spinal muscular atrophy (SMA). Results: The U1A protein binds to and inhibits polyadenylation and cleavage of the SMN pre-mRNA. Conclusion: The U1A protein is a critical regulator of SMN expression. Significance: Understanding of the regulation of SMN expression is fundamental for developing treatments for SMA. Insufficient expression of the survival motor neuron (SMN) protein causes spinal muscular atrophy, a neurodegenerative disease characterized by loss of motor neurons. Despite the importance of maintaining adequate SMN levels, little is known about factors that control SMN expression, particularly 3 end processing of the SMN pre-mRNA. In this study, we identify the U1A protein as a key regulator of SMN expression. U1A, a component of the U1 snRNP, is known to inhibit polyadenylation upon direct binding to mRNA. We show that U1A binds directly and with high affinity and specificity to the SMN 3-UTR adjacent to the polyadenylation site, independent of the U1 snRNP (U1 small nuclear ribonucleoprotein). Binding of U1A inhibits polyadenylation of the SMN pre-mRNA by specifically inhibiting 3 cleavage by the cleavage and polyadenylation specificity factor. Expression of U1A in excess of U1 snRNA causes inhibition of SMN polyadenylation and decreases SMN protein levels. This work reveals a new mechanism for regulating SMN levels and provides new insight into the roles of U1A in 3 processing of mRNAs.	[Workman, Eileen; Veith, Alex; Battle, Daniel J.] Ohio State Univ, Dept Mol & Cellular Biochem, Wexner Med Ctr, Columbus, OH 43210 USA; [Battle, Daniel J.] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Battle, DJ (corresponding author), Dept Mol & Cellular Biochem, 383 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	battle.59@osu.edu			National Institutes of Health [R01NS077010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS077010 (to D. B.).	Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998; Arnold WD, 2013, ANN NEUROL, V74, P348, DOI 10.1002/ana.23995; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; BOELENS WC, 1993, CELL, V72, P881, DOI 10.1016/0092-8674(93)90577-D; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; DeMaria CT, 1996, J BIOL CHEM, V271, P12179, DOI 10.1074/jbc.271.21.12179; Dubowitz V, 1999, Eur J Paediatr Neurol, V3, P49; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Fischer U, 2011, WIRES RNA, V2, P718, DOI 10.1002/wrna.87; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Guan F, 2003, MOL CELL BIOL, V23, P3163, DOI 10.1128/MCB.23.9.3163-3172.2003; Guan F, 2007, RNA, V13, P2129, DOI 10.1261/rna.756707; Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X; Gunderson SI, 1997, GENE DEV, V11, P761, DOI 10.1101/gad.11.6.761; GUNDERSON SI, 1994, CELL, V76, P531, DOI 10.1016/0092-8674(94)90116-3; Gunnewiek JMTK, 2000, MOL CELL BIOL, V20, P2209, DOI 10.1128/MCB.20.6.2209-2217.2000; Hall-Pogar T, 2007, RNA, V13, P1103, DOI 10.1261/rna.577707; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183; Kambach C, 1999, CURR OPIN STRUC BIOL, V9, P222, DOI 10.1016/S0959-440X(99)80032-3; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liang SC, 2006, RNA, V12, P111, DOI 10.1261/rna.2213506; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lutz CS, 1998, RNA, V4, P1493, DOI 10.1017/S1355838298981183; LUTZFREYERMUTH C, 1990, P NATL ACAD SCI USA, V87, P6393, DOI 10.1073/pnas.87.16.6393; LUTZREYERMUTH C, 1989, MOL CELL BIOL, V9, P2975, DOI 10.1128/MCB.9.7.2975; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Macias S, 2008, MOL CELL, V30, P732, DOI 10.1016/j.molcel.2008.05.002; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Milcarek C, 2003, MOL IMMUNOL, V39, P809, DOI 10.1016/S0161-5890(02)00263-8; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Munsat TL., 1991, NEUROMUSCUL DISORD, V1, P81, DOI [10.1016/0960-8966(91)90052-t, DOI 10.1016/0960-8966(91)90052-T]; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Parsons DW, 1998, AM J HUM GENET, V63, P1712, DOI 10.1086/302160; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Phillips C, 2003, J BIOL CHEM, V278, P22102, DOI 10.1074/jbc.M301349200; Phillips C, 2001, EMBO J, V20, P6443, DOI 10.1093/emboj/20.22.6443; Phillips C, 2004, MOL CELL BIOL, V24, P6162, DOI 10.1128/MCB.24.14.6162-6171.2004; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; SCHERLY D, 1989, EMBO J, V8, P4163, DOI 10.1002/j.1460-2075.1989.tb08601.x; Simic G, 2008, ACTA NEUROPATHOL, V116, P223, DOI 10.1007/s00401-008-0411-1; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; TAKAGAKI Y, 1990, GENE DEV, V4, P2112, DOI 10.1101/gad.4.12a.2112; Tian B, 2012, WIRES RNA, V3, P385, DOI 10.1002/wrna.116; TSAI DE, 1991, NUCLEIC ACIDS RES, V19, P4931, DOI 10.1093/nar/19.18.4931; VANGELDER CWG, 1993, EMBO J, V12, P5191, DOI 10.1002/j.1460-2075.1993.tb06214.x; Varani L, 2000, NAT STRUCT BIOL, V7, P329; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wahle M., 1994, RNA PROCESSING PRACT, P1; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Workman E, 2012, BRAIN RES, V1462, P93, DOI 10.1016/j.brainres.2012.02.051; Workman E, 2009, HUM MOL GENET, V18, P2215, DOI 10.1093/hmg/ddp157; ZERRES K, 1995, LANCET, V346, P1162, DOI 10.1016/S0140-6736(95)91835-3; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; ZHOU Z, 2003, CURR PROTOC MOL BIOL, pCH27	70	19	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3703	3712		10.1074/jbc.M113.538264	http://dx.doi.org/10.1074/jbc.M113.538264			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362020	hybrid, Green Published			2022-12-28	WOS:000331368700051
J	Chaulk, SG; Lattanzi, VJ; Hiemer, SE; Fahlman, RP; Varelas, X				Chaulk, Steven G.; Lattanzi, Victoria J.; Hiemer, Samantha E.; Fahlman, Richard P.; Varelas, Xaralabos			The Hippo Pathway Effectors TAZ/YAP Regulate Dicer Expression and MicroRNA Biogenesis through Let-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell adhesion; Dicer; MicroRNA; RNA Processing; Signal Transduction; Hippo Pathway; Let-7; TAZ; YAP	CELL CONTACT INHIBITION; SIGNALING PATHWAY; STEM-CELLS; YAP; TAZ; PROLIFERATION; COACTIVATOR; PROTEIN; GROWTH; CANCER	MicroRNAs (miRNAs) are genome-encoded small double-stranded RNAs that have emerged as key regulators of gene expression and are implicated in most aspects of human development and disease. Canonical miRNA biogenesis involves processing of approximate to 70-nucleotide pre-miRNA hairpins by Dicer to generate mature approximate to 22-nucleotide miRNAs, which target complementary RNA sequences. Despite the importance of miRNA biogenesis, signaling mechanisms controlling this process are poorly defined. Here we demonstrate that the post-transcriptional regulation of Dicer is controlled by the cell density-mediated localization of the Hippo pathway effectors TAZ (transcriptional co-activator with PDZ-binding motif) and YAP (Yes-associated protein) (TAZ/YAP). We show that nuclear TAZ/YAP, which are abundant at low cell density, are required for efficient pre-miRNA processing. Knockdown of TAZ/YAP in low density cells, or density-mediated sequestration of TAZ/YAP into the cytoplasm, results in the defective processing of pre-miRNAs. Strikingly, one exception is Let-7, which accumulates upon loss of nuclear TAZ/YAP, leading to Let-7-dependent reduction in Dicer levels. Accordingly, inhibition of Let-7 rescues the miRNA biogenesis defects observed following TAZ/YAP knockdown. Thus, density-regulated TAZ/YAP localization defines a critical and previously unrecognized mechanism by which cells relay cell contact-induced cues to control miRNA biogenesis.	[Lattanzi, Victoria J.; Hiemer, Samantha E.; Varelas, Xaralabos] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Chaulk, Steven G.; Fahlman, Richard P.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Fahlman, Richard P.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2H7, Canada	Boston University; University of Alberta; University of Alberta	Fahlman, RP (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	rfahlman@ualberta.ca	Varelas, Xaralabos/ABB-9141-2020	Varelas, Xaralabos/0000-0002-2882-4541	Canadian Breast Cancer Foundation (CBCF); March of Dimes Foundation [5-FY11-578]; Concern Cancer Foundation	Canadian Breast Cancer Foundation (CBCF); March of Dimes Foundation(March of Dimes); Concern Cancer Foundation	Supported by a research grant from the Canadian Breast Cancer Foundation (CBCF). To whom correspondence may be addressed. Tel.: 780-492-9566; Fax: 780-492-0886; E-mail: rfahlman@ualberta.ca.; Supported in by Research Grant 5-FY11-578 from the March of Dimes Foundation and by funds from the Concern Cancer Foundation. To whom correspondence may be addressed: Dept. of Biochemistry, Boston University School of Medicine, Room K225, Boston, MA 02118. Tel.: 617-638-4182; Fax: 617-638-5339; E-mail: xvarelas@bu.edu.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hiemer SE, 2013, BBA-GEN SUBJECTS, V1830, P2323, DOI 10.1016/j.bbagen.2012.07.005; Hwang HW, 2009, P NATL ACAD SCI USA, V106, P7016, DOI 10.1073/pnas.0811523106; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Olive V, 2013, IMMUNOL REV, V253, P158, DOI 10.1111/imr.12054; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Varelas X, 2012, TRENDS CELL BIOL, V22, P88, DOI 10.1016/j.tcb.2011.10.002; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; WANG D, 2012, PLOS ONE, V7; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao D, 2012, CARCINOGENESIS, V33, P59, DOI 10.1093/carcin/bgr242	31	78	78	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1886	1891		10.1074/jbc.C113.529362	http://dx.doi.org/10.1074/jbc.C113.529362			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324261	Green Published, hybrid			2022-12-28	WOS:000331130200001
J	Naydenov, NG; Feygin, A; Wang, LF; Ivanov, AI				Naydenov, Nayden G.; Feygin, Alex; Wang, Lifu; Ivanov, Andrei I.			N-Ethylmaleimide-sensitive Factor Attachment Protein alpha (alpha SNAP) Regulates Matrix Adhesion and Integrin Processing in Human Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Cell Migration; Cell Motility; Snare Proteins; Trafficking	MEMBRANE TRAFFICKING; ENDOPLASMIC-RETICULUM; MEDIATED TRAFFICKING; APICAL JUNCTIONS; EXCHANGE FACTOR; DISTINCT ROLES; CANCER-CELLS; SYNTAXIN 6; MIGRATION; FUSION	Integrin-based adhesion to the extracellular matrix (ECM) plays critical roles in controlling differentiation, survival, and motility of epithelial cells. Cells attach to the ECM via dynamic structures called focal adhesions (FA). FA undergo constant remodeling mediated by vesicle trafficking and fusion. A soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein (SNAP) is an essential mediator of membrane fusion; however, its roles in regulating ECM adhesion and cell motility remain unexplored. In this study, we found that siRNA-mediated knockdown of SNAP induced detachment of intestinal epithelial cells, whereas overexpression of SNAP increased ECM adhesion and inhibited cell invasion. Loss of SNAP impaired Golgi-dependent glycosylation and trafficking of 1 integrin and decreased phosphorylation of focal adhesion kinase (FAK) and paxillin resulting in FA disassembly. These effects of SNAP depletion on ECM adhesion were independent of apoptosis and NSF. In agreement with our previous reports that Golgi fragmentation mediates cellular effects of SNAP knockdown, we found that either pharmacologic or genetic disruption of the Golgi recapitulated all the effects of SNAP depletion on ECM adhesion. Furthermore, our data implicates 1 integrin, FAK, and paxillin in mediating the observed pro-adhesive effects of SNAP. These results reveal novel roles for SNAP in regulating ECM adhesion and motility of epithelial cells.	[Naydenov, Nayden G.; Feygin, Alex; Ivanov, Andrei I.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Ivanov, Andrei I.] Virginia Commonwealth Univ, Virginia Inst Mol Med, Richmond, VA 23298 USA; [Ivanov, Andrei I.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Wang, Lifu] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Virginia	Ivanov, AI (corresponding author), VCU Massey Canc Ctr, Goodwin Lab, Dept Human & Mol Genet, 401 Coll St,Rm 223, Richmond, VA 23298 USA.	aivanov2@vcu.edu	Ivanov, Andrei/V-1672-2019		National Institutes of Health [RO1 DK083968, R01 DK084953]; Crohn's and Colitis Foundation of America [254881]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084953, R01DK083968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK083968 and R01 DK084953 (to A. I. I.) and Crohn's and Colitis Foundation of America Grant 254881 (to N. G. N.).	AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; AKIYAMA SK, 1987, J BIOL CHEM, V262, P17536; Andreeva AV, 2006, EXPERT OPIN THER TAR, V10, P723, DOI 10.1517/14728222.10.5.723; Aoki T, 2008, BIOCHEM J, V410, P93, DOI 10.1042/BJ20071304; Babbin BA, 2009, AM J PATHOL, V174, P436, DOI 10.2353/ajpath.2009.080171; Babcock M, 2004, J NEUROSCI, V24, P3964, DOI 10.1523/JNEUROSCI.5259-03.2004; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Batiz LF, 2006, NEUROBIOL DIS, V23, P152, DOI 10.1016/j.nbd.2006.02.009; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Burgoyne RD, 1998, BIOESSAYS, V20, P328, DOI 10.1002/(SICI)1521-1878(199804)20:4<328::AID-BIES9>3.0.CO;2-L; Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302; Chen PW, 2010, CELL ADHES MIGR, V4, P527, DOI 10.4161/cam.4.4.12399; CHRISPEELS MJ, 1982, J CELL BIOL, V93, P5, DOI 10.1083/jcb.93.1.5; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Day P, 2011, INT J ONCOL, V39, P863, DOI 10.3892/ijo.2011.1101; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377; Fletcher SJ, 2009, BIOCHEM SOC T, V37, P1072, DOI 10.1042/BST0371072; Grabowski P, 2002, VIRCHOWS ARCH, V441, P256, DOI 10.1007/s00428-002-0650-9; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Hendrix A, 2010, CANCER RES, V70, P9533, DOI 10.1158/0008-5472.CAN-10-3248; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Hong HK, 2004, P NATL ACAD SCI USA, V101, P1748, DOI 10.1073/pnas.0308268100; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; HOTCHIN NA, 1992, J BIOL CHEM, V267, P14852; Huttenlocher A., 2011, COLD SPRING HARBOR P, V3; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Jackson C L, 2000, Subcell Biochem, V34, P233; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jung JJ, 2012, BIOSCIENCE REP, V32, P383, DOI 10.1042/BSR20120006; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Luftman K, 2009, BIOCHEM BIOPH RES CO, V380, P65, DOI 10.1016/j.bbrc.2009.01.036; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Mammen JMV, 2003, CRIT CARE MED, V31, pS532, DOI 10.1097/01.CCM.0000081429.89277.AF; Manabe R, 2002, J CELL SCI, V115, P1497; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Morrell CN, 2005, J PHARMACOL EXP THER, V314, P155, DOI 10.1124/jpet.104.082529; Morton AJ, 2001, BRAIN RES BULL, V56, P111, DOI 10.1016/S0361-9230(01)00611-6; Naydenov NG, 2012, CELL CYCLE, V11, P4613, DOI 10.4161/cc.22885; Naydenov NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034320; Naydenov NG, 2012, J BIOL CHEM, V287, P5928, DOI 10.1074/jbc.M111.278358; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Naydenov NG, 2009, CELL CYCLE, V8, P2110, DOI 10.4161/cc.8.13.8928; Nishiwaki Y, 2013, DEV CELL, V25, P374, DOI 10.1016/j.devcel.2013.04.015; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Parvani JG, 2013, MOL BIOL CELL, V24, P3449, DOI 10.1091/mbc.E12-10-0776; Peter F, 1998, J CELL SCI, V111, P2625; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rankin CR, 2013, J BIOL CHEM, V288, P15229, DOI 10.1074/jbc.M112.440909; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riggs KA, 2012, J CELL SCI, V125, P3827, DOI 10.1242/jcs.102566; Roales-Bujan R, 2012, ACTA NEUROPATHOL, V124, P531, DOI 10.1007/s00401-012-0992-6; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; Shen X, 2007, P NATL ACAD SCI USA, V104, P1230, DOI 10.1073/pnas.0610535104; Sheppard D, 1996, BIOESSAYS, V18, P655, DOI 10.1002/bies.950180809; Skalski M, 2005, BIOCHEM BIOPH RES CO, V335, P1199, DOI 10.1016/j.bbrc.2005.07.195; Skalski M, 2011, BBA-MOL CELL RES, V1813, P148, DOI 10.1016/j.bbamcr.2010.09.008; Skalski M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-62; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Tiwari A, 2011, J BIOL CHEM, V286, P36749, DOI 10.1074/jbc.M111.260828; Tse KWK, 2009, J BIOL CHEM, V284, P22865, DOI 10.1074/jbc.M109.013169; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936; Valdembri D, 2012, CURR OPIN CELL BIOL, V24, P582, DOI 10.1016/j.ceb.2012.08.004; VEIGA SS, 1995, INT J CANCER, V61, P420, DOI 10.1002/ijc.2910610324; Wang LF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2565; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; WHITEHEART SW, 1992, J BIOL CHEM, V267, P12239; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012; Wu ZZ, 2011, BIOCHEM PHARMACOL, V82, P1860, DOI 10.1016/j.bcp.2011.09.010; Wu ZZ, 2010, BIOCHEM PHARMACOL, V80, P827, DOI 10.1016/j.bcp.2010.05.026; Zebda N, 2012, MICROVASC RES, V83, P71, DOI 10.1016/j.mvr.2011.06.007; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang YH, 2008, J BIOL CHEM, V283, P30689, DOI 10.1074/jbc.M801711200; Zhao CX, 2012, BBA-MOL CELL RES, V1823, P159, DOI 10.1016/j.bbamcr.2011.06.003; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001; Zou K, 2008, BIOCHEMISTRY-US, V47, P3370, DOI 10.1021/bi7014508	87	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2424	2439		10.1074/jbc.M113.498691	http://dx.doi.org/10.1074/jbc.M113.498691			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311785	Green Published, hybrid			2022-12-28	WOS:000331130200046
J	Park, SJ; Shin, JH; Jeong, JI; Song, JH; Jo, YK; Kim, ES; Lee, EH; Hwang, JJ; Lee, EK; Chung, SJ; Koh, JY; Jo, DG; Cho, DH				Park, So Jung; Shin, Ji Hyun; Jeong, Jae In; Song, Ji Hoon; Jo, Yoon Kyung; Kim, Eun Sung; Lee, Eunjoo H.; Hwang, Jung Jin; Lee, Eun Kyung; Chung, Sun Ju; Koh, Jae-Young; Jo, Dong-Gyu; Cho, Dong-Hyung			Down-regulation of Mortalin Exacerbates A beta-mediated Mitochondrial Fragmentation and Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimers Disease; Cell Death; Mitochondria; Mitochondrial Apoptosis; Neurodegenerative Diseases; Drp1; Amyloid-; Mitochondrial Fission; Mortalin	DYNAMIN-RELATED GTPASE; DEPENDENT PROTEIN-KINASE; HSP70 FAMILY; PROTEOMIC IDENTIFICATION; CANCER-CELLS; DRP1; FISSION; PHOSPHORYLATION; FUSION; DISEASE	Mitochondrial dynamics greatly influence the biogenesis and morphology of mitochondria. Mitochondria are particularly important in neurons, which have a high demand for energy. Therefore, mitochondrial dysfunction is strongly associated with neurodegenerative diseases. Until now various post-translational modifications for mitochondrial dynamic proteins and several regulatory proteins have explained complex mitochondrial dynamics. However, the precise mechanism that coordinates these complex processes remains unclear. To further understand the regulatory machinery of mitochondrial dynamics, we screened a mitochondrial siRNA library and identified mortalin as a potential regulatory protein. Both genetic and chemical inhibition of mortalin strongly induced mitochondrial fragmentation and synergistically increased A-mediated cytotoxicity as well as mitochondrial dysfunction. Importantly we determined that the expression of mortalin in Alzheimer disease (AD) patients and in the triple transgenic-AD mouse model was considerably decreased. In contrast, overexpression of mortalin significantly suppressed A-mediated mitochondrial fragmentation and cell death. Taken together, our results suggest that down-regulation of mortalin may potentiate A-mediated mitochondrial fragmentation and dysfunction in AD.	[Park, So Jung; Shin, Ji Hyun; Jo, Yoon Kyung; Kim, Eun Sung; Lee, Eunjoo H.; Cho, Dong-Hyung] Kyung Hee Univ, Grad Sch East West Med Sci, Dept East West Med Sci, Yongin 446701, South Korea; [Jeong, Jae In; Jo, Dong-Gyu] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, South Korea; [Chung, Sun Ju; Koh, Jae-Young] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul 138736, South Korea; [Song, Ji Hoon; Hwang, Jung Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci,Inst Innovat Canc Res, Seoul 138736, South Korea; [Lee, Eun Kyung] Catholic Univ Korea, Dept Biochem, Coll Med, Seoul 137701, South Korea	Kyung Hee University; Sungkyunkwan University (SKKU); University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Catholic University of Korea	Cho, DH (corresponding author), 1 Seocheon Dong, Yongin 446701, Gyeoggi Do, South Korea.	dhcho@khu.ac.kr	Jo, Dong-Gyu/AAN-9278-2021; Koh, Jae-Young/C-9014-2011; Hwang, Jung Jin/F-3424-2014	Jo, Dong-Gyu/0000-0003-2271-1076; Koh, Jae-Young/0000-0002-4318-495X; Lee, Eunjoo H./0000-0002-5569-0067	Korean Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea [A092042]; Korea-UK Collaborative Alzheimer's Disease Research Project, Ministry of Health & Welfare, Republic of Korea [A120196]	Korean Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea; Korea-UK Collaborative Alzheimer's Disease Research Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by Korean Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea Grant A092042 and the Korea-UK Collaborative Alzheimer's Disease Research Project, Ministry of Health & Welfare, Republic of Korea Grant A120196.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; BHATTACHARYYA T, 1995, J BIOL CHEM, V270, P1705, DOI 10.1074/jbc.270.4.1705; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Buizza L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029789; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chiasserini D, 2011, MOVEMENT DISORD, V26, P1639, DOI 10.1002/mds.23647; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Choi J, 2004, FREE RADICAL BIO MED, V36, P1155, DOI 10.1016/j.freeradbiomed.2004.02.002; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Deocaris CC, 2007, CANCER LETT, V252, P259, DOI 10.1016/j.canlet.2006.12.038; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; Eura Y, 2006, J CELL SCI, V119, P4913, DOI 10.1242/jcs.03253; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; Gawlowski T, 2012, J BIOL CHEM, V287, P30024, DOI 10.1074/jbc.M112.390682; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Hooper C, 2007, NEUROSCI LETT, V415, P135, DOI 10.1016/j.neulet.2007.01.049; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jin JH, 2006, MOL CELL PROTEOMICS, V5, P1193, DOI 10.1074/mcp.M500382-MCP200; Jo DG, 2010, NEUROBIOL AGING, V31, P917, DOI 10.1016/j.neurobiolaging.2008.07.003; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Kaul SC, 2003, EXP CELL RES, V286, P96, DOI 10.1016/S0014-4827(03)00101-0; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; Kawai A, 2001, J CELL SCI, V114, P3565; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Meuer K, 2007, CELL DEATH DIFFER, V14, P651, DOI 10.1038/sj.cdd.4402087; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Osorio C, 2007, NEUROBIOL AGING, V28, P1853, DOI 10.1016/j.neurobiolaging.2006.08.011; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Park J., 2010, PLOS ONE, V5; Park SJ, 2012, FEBS LETT, V586, P4303, DOI 10.1016/j.febslet.2012.10.035; Qu MY, 2012, NEUROSCI RES, V72, P94, DOI 10.1016/j.neures.2011.09.009; Qu MY, 2011, BRAIN RES, V1368, P336, DOI 10.1016/j.brainres.2010.10.068; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Shi M, 2008, J NEUROPATH EXP NEUR, V67, P117, DOI 10.1097/nen.0b013e318163354a; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Takano S, 1997, EXP CELL RES, V237, P38, DOI 10.1006/excr.1997.3754; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Tondera D, 2005, J CELL SCI, V118, P3049, DOI 10.1242/jcs.02415; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; WADHWA R, 1993, J BIOL CHEM, V268, P6615; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Wadhwa R, 2000, CANCER RES, V60, P6818; Walker C, 2006, AM J PATHOL, V168, P1526, DOI 10.2353/ajpath.2006.050603; Wang AM, 2013, NAT CHEM BIOL, V9, P112, DOI [10.1038/NCHEMBIO.1140, 10.1038/nchembio.1140]; Wang XW, 2008, NAT CELL BIOL, V10, P1090, DOI 10.1038/ncb1769; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yang H, 2011, BIOCHEM BIOPH RES CO, V410, P114, DOI 10.1016/j.bbrc.2011.05.116; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	72	51	51	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2195	2204		10.1074/jbc.M113.492587	http://dx.doi.org/10.1074/jbc.M113.492587			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324263	Green Published, hybrid			2022-12-28	WOS:000331130200027
J	Chen, YQ; Wei, HJ; Liu, F; Guan, JL				Chen, Yongqiang; Wei, Huijun; Liu, Fei; Guan, Jun-Lin			Hyperactivation of Mammalian Target of Rapamycin Complex 1 (mTORC1) Promotes Breast Cancer Progression through Enhancing Glucose Starvation-induced Autophagy and Akt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; TUBEROUS SCLEROSIS COMPLEX; CONDITIONAL KNOCKOUT; TUMORIGENESIS; ANGIOGENESIS; SUPPRESSION; SUFFICIENT; METABOLISM; ACTIVATION; MECHANISMS	The mammalian target of rapamycin complex 1 (mTORC1) is a master regulator of cell growth and proliferation. Recent studies have suggested that constitutive activation of mTORC1 in normal cells could lead to malignant tumor development in several tissues. However, the mechanisms of mTORC1 hyperactivation to promote the growth and metastasis of breast or other cancers are still not well characterized. Here, using a new inducible deletion system, we show that deletion of Tsc1 in mouse primary mammary tumor cells, either before or after their transplantation, significantly increased their growth in vivo. The increase in tumor growth was completely rescued by rapamycin treatment, suggesting a major contribution from mTORC1 hyperactivation. Interestingly, glucose starvation-induced autophagy, but not amino acid starvation-induced autophagy, was increased significantly in Tsc1-null tumor cells. Further analysis of these cells also showed an increased Akt activation but no significant changes in Erk signaling. Together, these results provide insights into the mechanism by which hyperactivation of mTORC1 promotes breast cancer progression through increasing autophagy and Akt activation in vivo.	[Chen, Yongqiang; Wei, Huijun; Guan, Jun-Lin] Univ Michigan, Sch Med, Div Mol Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Chen, Yongqiang; Wei, Huijun; Guan, Jun-Lin] Univ Michigan, Sch Med, Div Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Liu, Fei] Univ Michigan, Dept Biol & Mat Sci, Sch Dent, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Cincinnati, Dept Canc Biol, Coll Med, Cincinnati, OH 45267 USA.	guanjn@ucmail.uc.edu	Chen, Yongqiang/ABF-6081-2021	Chen, Yongqiang/0000-0003-2309-5674; , fei/0000-0002-2646-3009	National Institutes of Health [CA150926, CA163493]; NATIONAL CANCER INSTITUTE [R01CA150926, R01CA163493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported, in whole or in part, by National Institutes of Health Grants CA150926 and CA163493 (to J. L. G.).	Abbas HA, 2010, CELL STEM CELL, V7, P606, DOI 10.1016/j.stem.2010.09.013; Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Amaravadi RK, 2011, SCIENCE, V334, P1501, DOI 10.1126/science.1216428; Annibaldi A, 2010, CURR OPIN CLIN NUTR, V13, P466, DOI 10.1097/MCO.0b013e32833a5577; Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015; Chakraborty S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-163; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Fan HP, 2011, J BIOL CHEM, V286, P18573, DOI 10.1074/jbc.M110.200717; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoshii T, 2012, J CLIN INVEST, V122, P2114, DOI 10.1172/JCI62279; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Kladney RD, 2010, CANCER RES, V70, P8937, DOI 10.1158/0008-5472.CAN-10-1646; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Lu ZH, 2010, CANCER RES, V70, P3287, DOI 10.1158/0008-5472.CAN-09-3467; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Orlova KA, 2010, ANN NY ACAD SCI, V1184, P87, DOI 10.1111/j.1749-6632.2009.05117.x; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	43	29	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1164	1173		10.1074/jbc.M113.526335	http://dx.doi.org/10.1074/jbc.M113.526335			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275666	hybrid, Green Published			2022-12-28	WOS:000330541200047
J	Cherniavsky-Lev, M; Golani, O; Karlish, SJD; Garty, H				Cherniavsky-Lev, Marina; Golani, Ofra; Karlish, Steven J. D.; Garty, Haim			Ouabain-induced Internalization and Lysosomal Degradation of the Na+/K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-K-ATPASE; EXOGENOUS CARDIAC-GLYCOSIDES; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; FXYD PROTEINS; MUSCLE-CELLS; SODIUM-PUMP; NA,K-ATPASE; ENDOCYTOSIS; NA+,K+-ATPASE	Internalization of the Na+/K+-ATPase (the Na+ pump) has been studied in the human lung carcinoma cell line H1299 that expresses YFP-tagged alpha 1 from its normal genomic localization. Both real-time imaging and surface biotinylation have demonstrated internalization of alpha 1 induced by >= 100 nM ouabain which occurs in a time scale of hours. Unlike previous studies in other systems, the ouabain-induced internalization was insensitive to Src or PI3K inhibitors. Accumulation of alpha 1 in the cells could be augmented by inhibition of lysosomal degradation but not by proteosomal inhibitors. In agreement, the internalized alpha 1 could be colocalized with the lysosomal marker LAMP1 but not with Golgi or nuclear markers. In principle, internalization could be triggered by a conformational change of the ouabain-bound Na+/K+-ATPase molecule or more generally by the disruption of cation homeostasis (Na+, K+, Ca2+) due to the partial inhibition of active Na+ and K+ transport. Overexpression of ouabain-insensitive rat alpha 1 failed to inhibit internalization of human alpha 1 expressed in the same cells. In addition, incubating cells in a K+-free medium did not induce internalization of the pump or affect the response to ouabain. Thus, internalization is not the result of changes in the cellular cation balance but is likely to be triggered by a conformational change of the protein itself. In physiological conditions, internalization may serve to eliminate pumps that have been blocked by endogenous ouabain or other cardiac glycosides. This mechanism may be required due to the very slow dissociation of the ouabain.Na+/K+-ATPase complex.	[Cherniavsky-Lev, Marina; Golani, Ofra; Karlish, Steven J. D.; Garty, Haim] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Garty, H (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	h.garty@weizmann.ac.il						Akimova OA, 2008, PFLUG ARCH EUR J PHY, V455, P711, DOI 10.1007/s00424-007-0283-6; Berger G, 2011, AM J PHYSIOL-LUNG C, V301, pL23, DOI 10.1152/ajplung.00010.2010; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blaustein MP, 1996, KIDNEY INT, V49, P1748, DOI 10.1038/ki.1996.260; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; CASTRO J, 1979, J BIOL CHEM, V254, P2221; Chibalin AV, 1997, AM J PHYSIOL-CELL PH, V273, pC1458, DOI 10.1152/ajpcell.1997.273.5.C1458; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cornelius F, 2009, BIOCHEMISTRY-US, V48, P10056, DOI 10.1021/bi901212r; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; Feldmann T, 2007, AM J PHYSIOL-CELL PH, V293, pC885, DOI 10.1152/ajpcell.00602.2006; Ferrandi M, 2004, J BIOL CHEM, V279, P33306, DOI 10.1074/jbc.M402187200; Ferrandi M, 1999, AM J PHYSIOL-HEART C, V277, pH1338, DOI 10.1152/ajpheart.1999.277.4.H1338; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Gupta S, 2012, HYPERTENSION, V59, P665, DOI 10.1161/HYPERTENSIONAHA.111.176727; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Kotova O, 2006, J BIOL CHEM, V281, P20085, DOI 10.1074/jbc.M601577200; Lecuona E, 2009, AM J RESP CELL MOL, V41, P671, DOI 10.1165/rcmb.2008-0365OC; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Lindzen M, 2006, J BIOL CHEM, V281, P5947, DOI 10.1074/jbc.M512063200; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Liu Jiang, 2007, Pathophysiology, V14, P171, DOI 10.1016/j.pathophys.2007.09.008; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Liu LJ, 2004, AM J PHYSIOL-HEART C, V287, pH2173, DOI 10.1152/ajpheart.00352.2004; Moshitzky S, 2012, J BIOL CHEM, V287, P21130, DOI 10.1074/jbc.M112.347807; Schoner W, 2007, AM J CARDIOVASC DRUG, V7, P173, DOI 10.2165/00129784-200707030-00004; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Silva E, 2012, INT REV CEL MOL BIO, V294, P99, DOI 10.1016/B978-0-12-394305-7.00002-1; Taguchi T, 2013, J BIOCHEM, V153, P505, DOI 10.1093/jb/mvt034; Torielli L, 2008, AM J PHYSIOL-RENAL, V295, pF478, DOI 10.1152/ajprenal.90226.2008; WALLICK ET, 1988, METHOD ENZYMOL, V156, P201; Welch LC, 2010, FEBS LETT, V584, P3985, DOI 10.1016/j.febslet.2010.08.002; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Yan YL, 2012, MOL CELL BIOCHEM, V367, P175, DOI 10.1007/s11010-012-1331-x; Zhang LN, 2008, FUND CLIN PHARMACOL, V22, P615, DOI 10.1111/j.1472-8206.2008.00620.x; Zhang YB, 1999, AM J PHYSIOL-RENAL, V276, pF711, DOI 10.1152/ajprenal.1999.276.5.F711	40	24	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1049	1059		10.1074/jbc.M113.517003	http://dx.doi.org/10.1074/jbc.M113.517003			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275648	hybrid, Green Published			2022-12-28	WOS:000330541200037
J	Federici, M; Latagliata, EC; Ledonne, A; Rizzo, FR; Feligioni, M; Sulzer, D; Dunn, M; Sames, D; Gu, H; Nistico, R; Puglisi-Allegra, S; Mercuri, NB				Federici, Mauro; Latagliata, Emanuele Claudio; Ledonne, Ada; Rizzo, Francesca R.; Feligioni, Marco; Sulzer, Dave; Dunn, Matthew; Sames, Dalibor; Gu, Howard; Nistico, Robert; Puglisi-Allegra, Stefano; Mercuri, Nicola B.			Paradoxical Abatement of Striatal Dopaminergic Transmission by Cocaine and Methylphenidate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dopamine; Dopamine Transporters; Drug Action; Electrophysiology; Transgenic Mice; Amperometry; Cocaine; Microdialysis; Striatum	INDIVIDUAL-DIFFERENCES; MOLECULAR-MECHANISMS; MICE; SENSITIVITY; ADDICTION; RELEASE; RATS; AMPHETAMINE; TRANSPORTER; HYPOTHESIS	We combined in vitro amperometric, optical analysis of fluorescent false neurotransmitters and microdialysis techniques to unveil that cocaine and methylphenidate induced a marked depression of the synaptic release of dopamine (DA) in mouse striatum. In contrast to the classical dopamine transporter (DAT)-dependent enhancement of the dopaminergic signal observed at concentrations of cocaine lower than 3 m, the inhibitory effect of cocaine was found at concentrations higher than 3 m. The paradoxical inhibitory effect of cocaine and methylphenidate was associated with a decrease in synapsin phosphorylation. Interestingly, a cocaine-induced depression of DA release was only present in cocaine-insensitive animals (DAT-CI). Similar effects of cocaine were produced by methylphenidate in both wild-type and DAT-CI mice. On the other hand, nomifensine only enhanced the dopaminergic signal either in wild-type or in DAT-CI mice. Overall, these results indicate that cocaine and methylphenidate can increase or decrease DA neurotransmission by blocking reuptake and reducing the exocytotic release, respectively. The biphasic reshaping of DA neurotransmission could contribute to different behavioral effects of psychostimulants, including the calming ones, in attention deficit hyperactivity disorder.	[Federici, Mauro; Ledonne, Ada; Rizzo, Francesca R.; Nistico, Robert; Mercuri, Nicola B.] Ist Ricovero & Cura Carattere Sci IRCCS Fdn Santa, Lab Neurol Sperimentale, I-00143 Rome, Italy; [Latagliata, Emanuele Claudio; Puglisi-Allegra, Stefano] Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; [Latagliata, Emanuele Claudio; Puglisi-Allegra, Stefano] Univ Roma La Sapienza, Ctr Daniel Bovet, I-00185 Rome, Italy; [Nistico, Robert] Univ Roma La Sapienza, Dipartimento Fisiol & Farmacol, I-00185 Rome, Italy; [Latagliata, Emanuele Claudio; Puglisi-Allegra, Stefano] Fdn Santa Lucia, Lab Neurobiol Comportamento, I-00143 Rome, Italy; [Ledonne, Ada; Mercuri, Nicola B.] Univ Roma Tor Vergata, Dipartimento Med Sistemi, I-00133 Rome, Italy; [Sulzer, Dave] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Sulzer, Dave] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Sulzer, Dave] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Dunn, Matthew; Sames, Dalibor] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Feligioni, Marco] European Brain Res Inst, Pharmacol Synapt Plast Unit, I-00143 Rome, Italy; [Gu, Howard] Ohio State Univ, Coll Med, Dept Pharmacol, Columbus, OH 43210 USA	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; IRCCS Santa Lucia; University of Rome Tor Vergata; Columbia University; Columbia University; Columbia University; Columbia University; University System of Ohio; Ohio State University	Mercuri, NB (corresponding author), IRCCS Fdn Santa Lucia, Lab Neurol Sperimentale, Via Fosso di Fiorano 63, I-00143 Rome, Italy.	mercurin@med.uniroma2.it	Rizzo, Francesca Romana/AAC-1006-2019; Ledonne, Ada/K-9424-2016; Puglisi-Allegra, Stefano/ABI-7468-2020; FEDERICI, MAURO/AAB-9242-2019; Mercuri, Nicola Biagio/K-5348-2016	Rizzo, Francesca Romana/0000-0002-7682-5135; Puglisi-Allegra, Stefano/0000-0002-9433-2000; FEDERICI, MAURO/0000-0003-4563-1677; Mercuri, Nicola Biagio/0000-0001-6700-7491; Nistico, Robert/0000-0003-3433-9232; Ledonne, Ada/0000-0001-6302-207X; Emanuele Claudio, Latagliata/0000-0001-8402-2757	Progetto Finalizzato Strategico; National Institute of Mental Health [MH086545]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154, R01DA007418] Funding Source: NIH RePORTER	Progetto Finalizzato Strategico; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the Italian Minister of Health (Progetto Finalizzato Strategico), by National Institute of Mental Health Grant MH086545, and by the G. Harold and Leila Y. Mathers Charitable Foundation.	AMALRIC M, 1993, PROG BRAIN RES, V99, P209; Balcioglu A, 2009, NEUROPHARMACOLOGY, V57, P687, DOI 10.1016/j.neuropharm.2009.07.025; Bardo MT, 2013, PHARMACOL REV, V65, P255, DOI 10.1124/pr.111.005124; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bradberry CW, 2008, REV NEUROSCIENCE, V19, P113; Briegleb SK, 2004, NEUROPSYCHOPHARMACOL, V29, P2168, DOI 10.1038/sj.npp.1300536; Bystrowska B, 2012, PHARMACOL REP, V64, P1337, DOI 10.1016/S1734-1140(12)70931-3; Chen R, 2005, J NEUROCHEM, V94, P352, DOI 10.1111/j.1471-4159.2005.03199.x; Couper F. J., 2004, DRUGS HUMAN PERFORMA, P20; DACKIS CA, 1985, NEUROSCI BIOBEHAV R, V9, P469, DOI 10.1016/0149-7634(85)90022-3; Federici M, 2005, BIOL PSYCHIAT, V57, P361, DOI 10.1016/j.biopsych.2004.11.030; FLOOR E, 1990, J NEUROCHEM, V55, P1663, DOI 10.1111/j.1471-4159.1990.tb04954.x; GEORGE FR, 1990, PSYCHOPHARMACOLOGY, V101, P18, DOI 10.1007/BF02253711; Geracitano R, 2003, NEUROSCIENCE, V118, P399, DOI 10.1016/S0306-4522(02)00809-6; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GRACE AA, 1995, DRUG ALCOHOL DEPEN, V37, P111, DOI 10.1016/0376-8716(94)01066-T; Gulley JM, 2003, NEUROPSYCHOPHARMACOL, V28, P2089, DOI 10.1038/sj.npp.1300279; HUNT P, 1974, J PHARM PHARMACOL, V26, P370, DOI 10.1111/j.2042-7158.1974.tb09294.x; John CE, 2007, NEUROPHARMACOLOGY, V52, P1596, DOI 10.1016/j.neuropharm.2007.03.004; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; KUHAR MJ, 1991, TRENDS NEUROSCI, V14, P299, DOI 10.1016/0166-2236(91)90141-G; Marley RJ, 1998, PSYCHOPHARMACOLOGY, V140, P42, DOI 10.1007/s002130050737; Napolitano F, 2010, J NEUROSCI, V30, P11043, DOI 10.1523/JNEUROSCI.1682-10.2010; Parsons TD, 1995, COLD SPRING HARB SYM, V60, P389, DOI 10.1101/SQB.1995.060.01.043; Penberthy Jennifer K, 2010, Curr Drug Abuse Rev, V3, P49; Pittaluga A, 2006, NEUROPHARMACOLOGY, V50, P286, DOI 10.1016/j.neuropharm.2005.09.004; REFAHILYAMANI F, 1995, N-S ARCH PHARMACOL, V351, P136; Rocha BA, 1998, NATURE, V393, P175, DOI 10.1038/30259; Rodriguez PC, 2013, P NATL ACAD SCI USA, V110, P870, DOI 10.1073/pnas.1213569110; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Ruetsch Yvan A., 2001, Current Topics in Medicinal Chemistry, V1, P175, DOI 10.2174/1568026013395335; Sabeti J, 2002, J PHARMACOL EXP THER, V302, P1201, DOI 10.1124/jpet.102.035816; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Tella SR, 1997, J PHARMACOL EXP THER, V281, P508; Venton BJ, 2006, J NEUROSCI, V26, P3206, DOI 10.1523/JNEUROSCI.4901-04.2006; Ventura R, 2007, P NATL ACAD SCI USA, V104, P5181, DOI 10.1073/pnas.0610178104; Yorgason JT, 2011, J NEUROSCI METH, V202, P158, DOI 10.1016/j.jneumeth.2011.03.001; Zheng F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002610; Zimmer BA, 2011, NEUROPSYCHOPHARMACOL, V36, P2741, DOI 10.1038/npp.2011.165	40	19	19	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					264	274		10.1074/jbc.M113.495499	http://dx.doi.org/10.1074/jbc.M113.495499			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24280216	Green Published, hybrid			2022-12-28	WOS:000329370900023
J	Hasenour, CM; Ridley, DE; Hughey, CC; James, FD; Donahue, EP; Shearer, J; Viollet, B; Foretz, M; Wasserman, DH				Hasenour, Clinton M.; Ridley, D. Emerson; Hughey, Curtis C.; James, Freyja D.; Donahue, E. Patrick; Shearer, Jane; Viollet, Benoit; Foretz, Marc; Wasserman, David H.			5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) Effect on Glucose Production, but Not Energy Metabolism, Is Independent of Hepatic AMPK in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP; AMP Kinase; AMP-activated Kinase (AMPK); Energy Metabolism; Liver Metabolism; AICAR; Fat Metabolism; In Vivo	ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; ISOLATED RAT HEPATOCYTES; NUCLEAR RECEPTOR SHP; INSULIN-RESISTANCE; GLUCOKINASE TRANSLOCATION; GLUCAGON RECEPTOR; GENE-EXPRESSION; SHORT-TERM; COMPLEX I	Metabolic stress, as well as several antidiabetic agents, increases hepatic nucleotide monophosphate (NMP) levels, activates AMP-activated protein kinase (AMPK), and suppresses glucose production. We tested the necessity of hepatic AMPK for the in vivo effects of an acute elevation in NMP on metabolism. 5-Aminoimidazole-4-carboxamide 1-beta-d-ribofuranoside (AICAR; 8 mg center dot kg(-1)min(-1))-euglycemic clamps were performed to elicit an increase in NMP in wild type (alpha 1 alpha 2(lox/lox)) and liver-specific AMPK knock-out mice (alpha 1 alpha 2(lox/lox) + Albcre) in the presence of fixed glucose. Glucose kinetics were equivalent in 5-h fasted alpha 1 alpha 2(lox/lox) and alpha 1 alpha 2(lox/lox) + Albcre mice. AMPK was not required for AICAR-mediated suppression of glucose production and increased glucose disappearance. These results demonstrate that AMPK is unnecessary for normal 5-h fasting glucose kinetics and AICAR-mediated inhibition of glucose production. Moreover, plasma fatty acids and triglycerides also decreased independently of hepatic AMPK during AICAR administration. Although the glucoregulatory effects of AICAR were shown to be independent of AMPK, these studies provide in vivo support for the AMPK energy sensor paradigm. AICAR reduced hepatic energy charge by approximate to 20% in alpha 1 alpha 2(lox/lox), which was exacerbated by approximate to 2-fold in alpha 1 alpha 2(lox/lox) + Albcre. This corresponded to a approximate to 6-fold rise in AMP/ATP in alpha 1 alpha 2(lox/lox) + Albcre. Consistent with the effects on adenine nucleotides, maximal mitochondrial respiration was approximate to 30% lower in alpha 1 alpha 2(lox/lox) + Albcre than alpha 1 alpha 2(lox/lox) livers. Mitochondrial oxidative phosphorylation efficiency was reduced by 25%. In summary, these results demonstrate that the NMP capacity to inhibit glucose production in vivo is independent of liver AMPK. In contrast, AMPK promotes mitochondrial function and protects against a more precipitous fall in ATP during AICAR administration.	[Hasenour, Clinton M.; Ridley, D. Emerson; James, Freyja D.; Donahue, E. Patrick; Wasserman, David H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Wasserman, David H.] Vanderbilt Univ, Sch Med, Mouse Metab Phenotyping Ctr, Nashville, TN 37232 USA; [Viollet, Benoit; Foretz, Marc] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Viollet, Benoit; Foretz, Marc] CNRS, UMR 8104, F-75014 Paris, France; [Viollet, Benoit; Foretz, Marc] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Shearer, Jane] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada; [Hughey, Curtis C.; Shearer, Jane] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Calgary; University of Calgary	Hasenour, CM (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 823 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	clinton.m.hasenour@vanderbilt.edu	FORETZ, Marc/O-7334-2017; Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224	National Institutes of Health [U24 DK59637, R37 DK50277, DK20593]; Molecular Endocrinology Training Program at Vanderbilt; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, U24DK059637, P30DK020593, R37DK050277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Endocrinology Training Program at Vanderbilt; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants U24 DK59637 and R37 DK50277 (to D. H. W.) and DK20593 (the Diabetes Research and Training Center). This work was also supported by the Molecular Endocrinology Training Program at Vanderbilt.	Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Berglund ED, 2011, DIABETES, V60, P2720, DOI 10.2337/db11-0455; Berglund ED, 2009, J CLIN INVEST, V119, P2412, DOI 10.1172/JCI38650; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; Camacho RC, 2006, AM J PHYSIOL-ENDOC M, V290, pE405, DOI 10.1152/ajpendo.00385.2005; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Chanda D, 2008, AM J PHYSIOL-ENDOC M, V295, pE368, DOI 10.1152/ajpendo.00800.2007; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Garcia-Villafranca J, 2008, BIOCHIMIE, V90, P460, DOI 10.1016/j.biochi.2007.09.019; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hasenour CM, 2013, MOL CELL ENDOCRINOL, V366, P152, DOI 10.1016/j.mce.2012.06.018; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hughey CC, 2011, JOVE-J VIS EXP, V48, P2431, DOI DOI 10.3791/2431; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Iglesias MA, 2004, DIABETES, V53, P1649, DOI 10.2337/diabetes.53.7.1649; Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kang L, 2011, DIABETES, V60, P416, DOI 10.2337/db10-1116; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; KREBS H, 1964, PROC R SOC SER B-BIO, V159, P545, DOI 10.1098/rspb.1964.0019; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; MORGAN CR, 1965, DIABETES, V14, P669, DOI 10.2337/diab.14.10.669; Mukhtar MH, 2008, AM J PHYSIOL-REG I, V294, pR766, DOI 10.1152/ajpregu.00593.2007; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006; Pencek RR, 2005, DIABETES, V54, P355, DOI 10.2337/diabetes.54.2.355; Romestaing C, 2008, AM J PHYSIOL-ENDOC M, V294, pE110, DOI 10.1152/ajpendo.00407.2007; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shirai T, 2011, BIOCHEM BIOPH RES CO, V414, P287, DOI 10.1016/j.bbrc.2011.08.120; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; STEELE R, 1956, AM J PHYSIOL, V187, P15, DOI 10.1152/ajplegacy.1956.187.1.15; TAKETA K, 1965, J BIOL CHEM, V240, P651; Velasco G, 1997, ARCH BIOCHEM BIOPHYS, V337, P169, DOI 10.1006/abbi.1996.9784; Vincent MF, 1996, DIABETOLOGIA, V39, P1148, DOI 10.1007/BF02658500; VINCENT MF, 1991, DIABETES, V40, P1259, DOI 10.2337/diabetes.40.10.1259; VINCENT MF, 1992, BIOCHEM J, V281, P267, DOI 10.1042/bj2810267; Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008; WASSERMAN DH, 1991, AM J PHYSIOL, V260, pE811, DOI 10.1152/ajpendo.1991.260.6.E811; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	63	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5950	5959		10.1074/jbc.M113.528232	http://dx.doi.org/10.1074/jbc.M113.528232			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403081	Green Published, hybrid			2022-12-28	WOS:000332015500051
J	Shahani, N; Pryor, W; Swarnkar, S; Kholodilov, N; Thinakaran, G; Burke, RE; Subramaniam, S				Shahani, Neelam; Pryor, William; Swarnkar, Supriya; Kholodilov, Nikolai; Thinakaran, Gopal; Burke, Robert E.; Subramaniam, Srinivasa			Rheb GTPase Regulates beta-Secretase Levels and Amyloid beta Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aging; Amyloid; GTPase; Protein Stability; Secretases	PRECURSOR PROTEIN; MAMMALIAN TARGET; BACE1; DEGRADATION; LOCALIZATION; EXPRESSION; UBIQUITIN; MTOR; IDENTIFICATION; MYELINATION	Background: BACE1 (-secretase) is an important enzyme in Alzheimer disease pathology, but how it is regulated remains unclear. Results: Rheb GTPase binds and regulates BACE1 levels and its activity, in an mTOR independent manner. Conclusion: Rheb GTPase is a novel physiological regulator of BACE1 pathway. Significance: This study establishes a novel molecular link between Rheb and BACE1 that may have a role in age-related biology and disease. The -site amyloid precursor protein (APP)-cleaving enzyme 1 (-secretase, BACE1) initiates amyloidogenic processing of APP to generate amyloid (A), which is a hallmark of Alzheimer disease (AD) pathology. Cerebral levels of BACE1 are elevated in individuals with AD, but the molecular mechanisms are not completely understood. We demonstrate that Rheb GTPase (Ras homolog enriched in brain), which induces mammalian target of rapamycin (mTOR) activity, is a physiological regulator of BACE1 stability and activity. Rheb overexpression depletes BACE1 protein levels and reduces A generation, whereas the RNAi knockdown of endogenous Rheb promotes BACE1 accumulation, and this effect by Rheb is independent of its mTOR signaling. Moreover, GTP-bound Rheb interacts with BACE1 and degrades it through proteasomal and lysosomal pathways. Finally, we demonstrate that Rheb levels are down-regulated in the AD brain, which is consistent with an increased BACE1 expression. Altogether, our study defines Rheb as a novel physiological regulator of BACE1 levels and A generation, and the Rheb-BACE1 circuitry may have a role in brain biology and disease.	[Shahani, Neelam; Pryor, William; Swarnkar, Supriya; Subramaniam, Srinivasa] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Kholodilov, Nikolai; Burke, Robert E.] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Scripps Research Institute; Columbia University; University of Chicago	Subramaniam, S (corresponding author), 130 Scripps Way,3C1, Jupiter, FL 33458 USA.	ssubrama@scripps.edu	Swarnkar, Supriya/H-8054-2016; Swarnkar, Supriya/AAU-7752-2020; Burke, Robert/B-7226-2011; Core, Vector/CAF-4832-2022	Swarnkar, Supriya/0000-0001-7596-0215; Swarnkar, Supriya/0000-0001-7596-0215; Burke, Robert/0000-0002-4760-8553; 	Public Health Service Grant [R24 MH068855]; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER	Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Dr. Solomon H. Snyder of Johns Hopkins University for sharing reagents during the preliminary investigation of the study and to Dr. Louis Fernandes of The Harvard Brain Tissue Resource Center, which is supported in part by Public Health Service Grant R24 MH068855, for the generous sharing of human postmortem samples and Dr. Robert Vassar for the 3D5 BACE1 antibody. We are thankful to Natalie Defraene, Nancy Norton, and Trina Miles for the administrative support. We are grateful to the people in The Scripps Research Institute, Florida, especially in the Department of Neuroscience, for their continuous support for setting up the laboratory and providing technical support whenever needed.	Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Colombo A, 2013, NEUROBIOL DIS, V49, P137, DOI 10.1016/j.nbd.2012.08.011; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Dislich B, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00008; Efferson CL, 2010, CANCER RES, V70, P2476, DOI 10.1158/0008-5472.CAN-09-3114; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gong B, 2010, AGING CELL, V9, P1018, DOI 10.1111/j.1474-9726.2010.00632.x; Goorden SMI, 2011, MOL CELL BIOL, V31, P1672, DOI 10.1128/MCB.00985-10; Hanker AB, 2010, ONCOGENE, V29, P380, DOI 10.1038/onc.2009.336; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Hilgenberg Lutz G W, 2007, J Vis Exp, P562, DOI 10.3791/562; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jeppsson F, 2012, J BIOL CHEM, V287, P41245, DOI 10.1074/jbc.M112.409110; Kandalepas PC, 2012, J NEUROCHEM, V120, P55, DOI 10.1111/j.1471-4159.2011.07512.x; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Karbowniczek M, 2004, J BIOL CHEM, V279, P29930, DOI 10.1074/jbc.M402591200; Kim SR, 2012, MOL THER, V20, P275, DOI 10.1038/mt.2011.213; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Kuzuya A, 2007, J NEUROSCI RES, V85, P153, DOI 10.1002/jnr.21104; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Nawrot B, 2003, EUR J BIOCHEM, V270, P3962, DOI 10.1046/j.1432-1033.2003.03784.x; Neuman NA, 2011, EMBO MOL MED, V3, P189, DOI 10.1002/emmm.201100131; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Okada H, 2010, FASEB J, V24, P2783, DOI 10.1096/fj.09-146357; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Subramaniam S, 2012, NAT NEUROSCI, V15, P191, DOI 10.1038/nn.2994; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Takahashi K, 2005, J BIOL CHEM, V280, P32768, DOI 10.1074/jbc.M506280200; Vassar R, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt82; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020	55	39	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5799	5808		10.1074/jbc.M113.532713	http://dx.doi.org/10.1074/jbc.M113.532713			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24368770	Green Published, hybrid			2022-12-28	WOS:000332015500039
J	Li, M; Suzuki, K; Kim, NY; Liu, GH; Belmonte, JCI				Li, Mo; Suzuki, Keiichiro; Kim, Na Young; Liu, Guang-Hui; Belmonte, Juan Carlos Izpisua			A Cut above the Rest: Targeted Genome Editing Technologies in Human Pluripotent Stem Cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Embryonic Stem Cell; Gene Therapy; Induced Pluripotent Stem Cell (iPSC); Stem Cells; CRISPR; CAS9; HDAdV; TALEN; Genome Editing; ZFN	ZINC-FINGER-NUCLEASES; HOMOLOGOUS RECOMBINATION; GENE CORRECTION; DNA; DISEASE; GENERATION; MUTATIONS; PATIENT; ENDONUCLEASE; SPECIFICITY	Human pluripotent stem cells (hPSCs) offer unprecedented opportunities to study cellular differentiation and model human diseases. The ability to precisely modify any genomic sequence holds the key to realizing the full potential of hPSCs. Thanks to the rapid development of novel genome editing technologies driven by the enormous interest in the hPSC field, genome editing in hPSCs has evolved from being a daunting task a few years ago to a routine procedure in most laboratories. Here, we provide an overview of the mainstream genome editing tools, including zinc finger nucleases, transcription activator-like effector nucleases, clustered regularly interspaced short palindromic repeat/CAS9 RNA-guided nucleases, and helper-dependent adenoviral vectors. We discuss the features and limitations of these technologies, as well as how these factors influence the utility of these tools in basic research and therapies.	[Li, Mo; Suzuki, Keiichiro; Kim, Na Young; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Liu, Guang-Hui] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Salk Institute; Chinese Academy of Sciences; Institute of Biophysics, CAS	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Li, Mo/AAM-8266-2021; Li, Mo/J-2090-2014	Li, Mo/0000-0003-0827-8907; Suzuki, Keiichiro/0000-0001-5603-9105	G. Harold and Leila Y. Mathers Charitable Foundation; Ellison Medical Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Glenn Foundation for Medical Research; California Institute of Regenerative Medicine; "Thousand Young Talents" program of China; National Laboratory of Biomacromolecules; Strategic Priority Research Program of the Chinese Academy of Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107442] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Leona M. and Harry B. Helmsley Charitable Trust; Glenn Foundation for Medical Research; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); "Thousand Young Talents" program of China; National Laboratory of Biomacromolecules; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the G. Harold and Leila Y. Mathers Charitable Foundation, the Ellison Medical Foundation, the Leona M. and Harry B. Helmsley Charitable Trust, and the Glenn Foundation for Medical Research (to J. C. I. B.). This is the sixth article in the Thematic Mini-review Series "Development of Human Therapeutics Based on Induced Pluripotent Stem Cell (iPSC) Technology."; Supported by fellowships from the California Institute of Regenerative Medicine.; Supported by the "Thousand Young Talents" program of China, the National Laboratory of Biomacromolecules, and the Strategic Priority Research Program of the Chinese Academy of Sciences.	Alba R, 2005, GENE THER, V12, pS18, DOI 10.1038/sj.gt.3302612; Babinet C, 2001, AN ACAD BRAS CIENC, V73, P365, DOI 10.1590/S0001-37652001000300007; Banuelos CA, 2008, DNA REPAIR, V7, P1471, DOI 10.1016/j.dnarep.2008.05.005; Bhakta MS, 2013, GENOME RES, V23, P530, DOI 10.1101/gr.143693.112; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chang CJ, 2012, BLOOD, V120, P3906, DOI 10.1182/blood-2012-03-420703; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cherry ABC, 2013, ANNU REV MED, V64, P277, DOI 10.1146/annurev-med-050311-163324; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Collin J, 2011, STEM CELLS, V29, P1021, DOI 10.1002/stem.658; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Haruta M, 2013, GENE THER, V20, P504, DOI 10.1038/gt.2012.59; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Khan IF, 2010, MOL THER, V18, P1192, DOI 10.1038/mt.2010.55; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Li M, 2011, CELL RES, V21, P1740, DOI 10.1038/cr.2011.186; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; MELTON DW, 1994, BIOESSAYS, V16, P633, DOI 10.1002/bies.950160907; Mitsui K, 2009, BIOCHEM BIOPH RES CO, V388, P711, DOI 10.1016/j.bbrc.2009.08.075; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez-Pinera P, 2012, CURR OPIN CHEM BIOL, V16, P268, DOI 10.1016/j.cbpa.2012.06.007; Petek LM, 2010, MOL THER, V18, P983, DOI 10.1038/mt.2010.35; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Qu XY, 2013, NUCLEIC ACIDS RES, V41, P7771, DOI 10.1093/nar/gkt571; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; Sancho-Martinez I, 2011, CLIN PHARMACOL THER, V89, P746, DOI 10.1038/clpt.2010.341; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JB, 2012, GENOME RES, V22, P1316, DOI 10.1101/gr.122879.111; Wang YM, 2012, CIRC RES, V111, P1494, DOI 10.1161/CIRCRESAHA.112.274969; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	61	90	103	0	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4594	4599		10.1074/jbc.R113.488247	http://dx.doi.org/10.1074/jbc.R113.488247			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24362028	Green Published, hybrid			2022-12-28	WOS:000331607900008
J	Bacik, JP; Tavassoli, M; Patel, TR; McKenna, SA; Vocadlo, DJ; Khajehpour, M; Mark, BL				Bacik, John-Paul; Tavassoli, Marjan; Patel, Trushar R.; McKenna, Sean A.; Vocadlo, David J.; Khajehpour, Mazdak; Mark, Brian L.			Conformational Itinerary of Pseudomonas aeruginosa 1,6-Anhydro-N-acetylmuramic Acid Kinase during Its Catalytic Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme Mechanisms; Fluorescence; Peptidoglycan; Pseudomonas aeruginosa; 1,6-Anhydro-N-acetylmuramic Acid; AnmK; SAXS; Sugar Kinase	SUBSTRATE-SPECIFICITY; N-ACETYLGLUCOSAMINE; PROTEIN-STRUCTURE; ESCHERICHIA-COLI; YEAST HEXOKINASE; MECHANISM; MUREIN; GROWTH; INSIGHTS; BINDING	Anhydro-sugar kinases are unique from other sugar kinases in that they must cleave the 1,6-anhydro ring of their sugar substrate to phosphorylate it using ATP. Here we show that the peptidoglycan recycling enzyme 1,6-anhydro-N-acetylmuramic acid kinase (AnmK) from Pseudomonas aeruginosa undergoes large conformational changes during its catalytic cycle, with its two domains rotating apart by up to 32 degrees around two hinge regions to expose an active site cleft into which the substrates 1,6-anhydroMurNAc and ATP can bind. X-ray structures of the open state bound to a nonhydrolyzable ATP analog (AMPPCP) and 1,6-anhydroMurNAc provide detailed insight into a ternary complex that forms preceding an operative Michaelis complex. Structural analysis of the hinge regions demonstrates a role for nucleotide binding and possible cross-talk between the bound ligands to modulate the opening and closing of AnmK. Although AnmK was found to exhibit similar binding affinities for ATP, ADP, and AMPPCP according to fluorescence spectroscopy, small angle x-ray scattering analyses revealed that AnmK adopts an open conformation in solution in the absence of ligand and that it remains in this open state after binding AMPPCP, as we had observed for our crystal structure of this complex. In contrast, the enzyme favored a closed conformation when bound to ADP in solution, consistent with a previous crystal structure of this complex. Together, our findings show that the open conformation of AnmK facilitates binding of both the sugar and nucleotide substrates and that large structural rearrangements must occur upon closure of the enzyme to correctly align the substrates and residues of the enzyme for catalysis.	[Bacik, John-Paul; Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Tavassoli, Marjan; Patel, Trushar R.; McKenna, Sean A.; Khajehpour, Mazdak] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5S 1P6, Canada	University of Manitoba; University of Manitoba; Simon Fraser University	Mark, BL (corresponding author), Univ Manitoba, Winnipeg, MB R3T 2N2, Canada.	brian_mark@umanitoba.ca	Patel, Trushar R./AAB-6250-2020; Patel, Trushar R/F-2776-2011; Vocadlo, David J/E-5508-2014	Patel, Trushar R./0000-0003-0627-2923; Patel, Trushar R/0000-0003-0627-2923; Vocadlo, David J/0000-0001-6897-5558; Bacik, John-Paul/0000-0001-9315-5332; Mark, Brian/0000-0002-7344-1355; McKenna, Sean/0000-0002-9407-7257	Canadian Institutes of Health Research [MOP97818]; Cystic Fibrosis Canada; Natural Sciences and Engineering Research Council of Canada [314021-2012]; Natural Sciences and Engineering Research Council of Canada; National Research Council; Canadian Institutes of Health Research; University of Saskatchewan; Manitoba Health Research Council (MHRC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; Manitoba Health Research Council (MHRC)	This work was supported by Canadian Institutes of Health Research Grant MOP97818 and by the Cystic Fibrosis Canada and the Natural Sciences and Engineering Research Council of Canada (314021-2012). The Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, National Research Council, Canadian Institutes of Health Research, and the University of Saskatchewan.; Supported by a postdoctoral fellowship from the Manitoba Health Research Council (MHRC).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen FH, 2004, CHEM SOC REV, V33, P463, DOI 10.1039/b309040j; Bacik JP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198317; Cardenas ML, 1998, BBA-MOL CELL RES, V1401, P242, DOI 10.1016/S0167-4889(97)00150-X; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W.L, PYMOL MOL GRAPHICS S; Dzananovic E, 2013, RNA, V19, P333, DOI 10.1261/rna.035931.112; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GOODELL EW, 1985, J BACTERIOL, V163, P305, DOI 10.1128/JB.163.1.305-310.1985; Grueninger D, 2006, J MOL BIOL, V359, P787, DOI 10.1016/j.jmb.2006.04.013; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; Lee MJ, 2009, J AM CHEM SOC, V131, P8742, DOI 10.1021/ja9025566; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Nishimasu H, 2007, J BIOL CHEM, V282, P9923, DOI 10.1074/jbc.M610678200; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Patel TR, 2010, MATRIX BIOL, V29, P565, DOI 10.1016/j.matbio.2010.07.004; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; STEITZ TA, 1981, PHILOS T ROY SOC B, V293, P43, DOI 10.1098/rstb.1981.0058; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Uehara T, 2005, J BACTERIOL, V187, P3643, DOI 10.1128/JB.187.11.3643-3649.2005; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Weihofen WA, 2006, J MOL BIOL, V364, P388, DOI 10.1016/j.jmb.2006.08.085; Yeh JI, 2004, BIOCHEMISTRY-US, V43, P362, DOI 10.1021/bi034258o	35	7	7	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4504	4514		10.1074/jbc.M113.521633	http://dx.doi.org/10.1074/jbc.M113.521633			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362022	Green Published, hybrid			2022-12-28	WOS:000331403800058
J	Bashtrykov, P; Jankevicius, G; Jurkowska, RZ; Ragozin, S; Jeltsch, A				Bashtrykov, Pavel; Jankevicius, Gytis; Jurkowska, Renata Z.; Ragozin, Sergey; Jeltsch, Albert			The UHRF1 Protein Stimulates the Activity and Specificity of the Maintenance DNA Methyltransferase DNMT1 by an Allosteric Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Chromatin; DNA Methylation; DNA Methyltransferase; Enzyme Mechanisms	HEMI-METHYLATED DNA; HISTONE H3 TAIL; UBIQUITIN LIGASE ACTIVITY; HEMIMETHYLATED CPG SITES; RECOMBINANT HUMAN DNA; SRA DOMAIN; PHD FINGER; EPIGENETIC INHERITANCE; STRUCTURAL INSIGHT; CATALYTIC DOMAIN	The ubiquitin-like, containing PHD and RING finger domains protein 1 (UHRF1) is essential for maintenance DNA methylation by DNA methyltransferase 1 (DNMT1). UHRF1 has been shown to recruit DNMT1 to replicated DNA by the ability of its SET and RING-associated (SRA) domain to bind to hemimethylated DNA. Here, we demonstrate that UHRF1 also increases the activity of DNMT1 by almost 5-fold. This stimulation is mediated by a direct interaction of both proteins through the SRA domain of UHRF1 and the replication focus targeting sequence domain of DNMT1, and it does not require DNA binding by the SRA domain. Disruption of the interaction between DNMT1 and UHRF1 by replacement of key residues in the replication focus targeting sequence domain led to a strong reduction of DNMT1 stimulation. Additionally, the interaction with UHRF1 increased the specificity of DNMT1 for methylation of hemimethylated CpG sites. These findings show that apart from the targeting of DNMT1 to the replicated DNA UHRF1 increases the activity and specificity of DNMT1, thus exerting a multifaceted influence on the maintenance of DNA methylation.	[Bashtrykov, Pavel; Jurkowska, Renata Z.; Ragozin, Sergey; Jeltsch, Albert] Univ Stuttgart, Fac Chem, Inst Biochem, D-70569 Stuttgart, Germany; [Jankevicius, Gytis] Jacobs Univ Bremen, Sch Sci & Engn, MoLife Program, D-28759 Bremen, Germany	University of Stuttgart; Jacobs University	Jeltsch, A (corresponding author), Univ Stuttgart, Fac Chem, Inst Biochem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	albert.jeltsch@ibc.uni-stuttgart.de	Jeltsch, Albert/O-7404-2014; Jurkowska, Renata/AAE-2504-2020; Jankevicius, Gytis/C-7126-2015	Jeltsch, Albert/0000-0001-6113-9290; Jurkowska, Renata/0000-0002-4507-2222; Jankevicius, Gytis/0000-0002-0212-3923; Bashtrykov, Pavel/0000-0003-3838-2019	Deutsche Forschungsgemeinschaft DFG [JE 252/15-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft DFG Grant JE 252/15-1.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bacolla A, 1999, J BIOL CHEM, V274, P33011, DOI 10.1074/jbc.274.46.33011; Bashtrykov P, 2012, FEBS LETT, V586, P1821, DOI 10.1016/j.febslet.2012.05.026; Bashtrykov P, 2012, CHEM BIOL, V19, P572, DOI 10.1016/j.chembiol.2012.03.010; Berkyurek AC, 2014, J BIOL CHEM, V289, P379, DOI 10.1074/jbc.M113.523209; BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Cheng JD, 2013, J BIOL CHEM, V288, P1329, DOI 10.1074/jbc.M112.415398; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Flynn J, 1996, BIOCHEMISTRY-US, V35, P7308, DOI 10.1021/bi9600512; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Goyal R, 2006, NUCLEIC ACIDS RES, V34, P1182, DOI 10.1093/nar/gkl002; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Hu LL, 2011, CELL RES, V21, P1374, DOI 10.1038/cr.2011.124; Jeltsch A, 2008, NAT STRUCT MOL BIOL, V15, P1003, DOI 10.1038/nsmb1008-1003; Jeltsch A, 2006, EPIGENETICS-US, V1, P63, DOI 10.4161/epi.1.2.2767; Jeltsch Albert, 2002, Methods Mol Biol, V182, P85; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Jurkowska RZ, 2011, J BIOL CHEM, V286, P24200, DOI 10.1074/jbc.M111.254987; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Papait R, 2008, MOL BIOL CELL, V19, P3554, DOI 10.1091/mbc.E07-10-1059; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Qin WH, 2011, J CELL BIOCHEM, V112, P439, DOI 10.1002/jcb.22998; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rothbart SB, 2013, GENE DEV, V27, P1288, DOI 10.1101/gad.220467.113; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wang CK, 2011, CELL RES, V21, P1379, DOI 10.1038/cr.2011.123; Xie S, 2012, J MOL BIOL, V415, P318, DOI 10.1016/j.jmb.2011.11.012	55	79	81	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4106	4115		10.1074/jbc.M113.528893	http://dx.doi.org/10.1074/jbc.M113.528893			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24368767	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000331403800024
J	Huang, CH; Chu, YR; Ye, YH; Chen, X				Huang, Chih-Hsiang; Chu, Yue-Ru; Ye, Yihong; Chen, Xin			Role of HERP and a HERP-related Protein in HRD1-dependent Protein Degradation at the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; ER Quality Control; Protein Degradation; Protein Translocation; Ubiquitin Ligase	ER-ASSOCIATED DEGRADATION; UBIQUITIN-LIGASE; QUALITY-CONTROL; PATHWAY; COMPLEX; STRESS; HOMEOSTASIS; HRD1P	Misfolded proteins of the endoplasmic reticulum (ER) are retrotranslocated to the cytosol and degraded by the proteasome via a process termed ER-associated degradation (ERAD). The precise mechanism of retrotranslocation is unclear. Here, we use several lumenal ERAD substrates targeted for degradation by the ubiquitin ligase HRD1 including SHH (sonic hedgehog) and NHK (null Hong Kong 1-antitrypsin) to study the geometry, organization, and regulation of the HRD1-containing ERAD machinery. We report a new HRD1-associated membrane protein named HERP2, which is homologous to the previously identified HRD1 partner HERP1. Despite sequence homology, HERP2 is constitutively expressed in cells, whereas HERP1 is highly induced by ER stress. We find that these proteins are required for efficient degradation of both glycosylated and nonglycosylated SHH proteins as well as NHK. In cells depleted of HERPs, SHH proteins are largely trapped inside the ER with a fraction of the stabilized SHH protein bound to the HRD1-SEL1L ligase complex. Ubiquitination of SHH is significantly attenuated in the absence of HERPs, suggesting a defect in retrotranslocation. Both HERP proteins interact with HRD1 through a region located in the cytosol. However, unlike its homolog in Saccharomyces cerevisiae, HERPs do not regulate HRD1 stability or oligomerization status. Instead, they help recruit DERL2 to the HRD1-SEL1L complex. Additionally, the UBL domain of HERP1 also seems to have a function independent of DERL2 recruitment in ERAD. Our studies have revealed a critical scaffolding function for mammalian HERP proteins that is required for forming an active retrotranslocation complex containing HRD1, SEL1L, and DERL2.	[Huang, Chih-Hsiang; Chu, Yue-Ru; Chen, Xin] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli 35053, Taiwan; [Ye, Yihong] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Chen, Xin] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan	National Health Research Institutes - Taiwan; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); China Medical University Taiwan	Ye, YH (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	yihongy@niddk.nih.gov; xchen@nhri.org.tw			National Research Programs for Genomic Medicine (NRPGM), National Science Council; National Health Research Institutes, Taiwan, China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033008, ZIADK075044] Funding Source: NIH RePORTER	National Research Programs for Genomic Medicine (NRPGM), National Science Council; National Health Research Institutes, Taiwan, China(National Health Research Institutes - Taiwan); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Research Programs for Genomic Medicine (NRPGM), National Science Council, and National Health Research Institutes, Taiwan, China. This work was supported by the National Research Programs for Genomic Medicine (NRPGM), National Science Council and National Health Research Institutes, Taiwan, China.	Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Bernasconi R, 2013, MOL CELL, V52, P783, DOI 10.1016/j.molcel.2013.10.016; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Carroll SM, 2010, J BIOL CHEM, V285, P5146, DOI 10.1074/jbc.M109.067876; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Huang CH, 2013, J BIOL CHEM, V288, P25330, DOI 10.1074/jbc.M113.455212; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kny M, 2011, J BIOL CHEM, V286, P5151, DOI 10.1074/jbc.M110.134551; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038	28	27	27	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4444	4454		10.1074/jbc.M113.519561	http://dx.doi.org/10.1074/jbc.M113.519561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366871	hybrid, Green Published			2022-12-28	WOS:000331403800054
J	Moulton, VR; Gillooly, AR; Tsokos, GC				Moulton, Vaishali R.; Gillooly, Andrew R.; Tsokos, George C.			Ubiquitination Regulates Expression of the Serine/Arginine-rich Splicing Factor 1 (SRSF1) in Normal and Systemic Lupus Erythematosus (SLE) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmunity; Immunology; Proteasome; Protein Turnover; T Cell; T Cell Receptor; Ubiquitin	RECEPTOR ZETA-CHAIN; I-KAPPA-B; FACTOR SF2/ASF; FACTOR ASF/SF2; MESSENGER-RNA; DEGRADATION; PHOSPHORYLATION; ACTIVATION; MECHANISMS; SUBUNIT	Background: Mechanisms that control expression of the splicing factor SRSF1 in human T cells are unknown. Results: Ubiquitination and proteasome degradation of SRSF1 occur during T cell activation and in T cells from patients with systemic lupus erythematosus (SLE). Conclusion: Ubiquitin-proteasome degradation regulates SRSF1 expression in human T cells. Significance: Understanding how SRSF1 expression is regulated in SLE may enable new therapeutic approaches. T cells from patients with systemic lupus erythematosus (SLE) exhibit reduced expression of the critical T cell receptor (TCR)-associated CD3 signaling chain and are poor producers of the vital cytokine IL-2. By oligonucleotide pulldown and mass spectrometry discovery approaches, we identified the splicing regulator serine/arginine-rich splicing factor (SRSF) 1 or splicing factor 2/alternative splicing factor (SF2/ASF) to be important in the expression of CD3 chain. Importantly, increases in the expression of SRSF1 rescued IL-2 production in T cells from patients with SLE. In this study, we investigated the regulation of SRSF1 expression in resting and activated human T cells. We found that T cell stimulation induced a rapid and significant increase in mRNA expression of SRSF1; however, protein expression levels did not correlate with this increase. Co-engagement of CD28 induced a similar mRNA induction and reduction in protein levels. Proteasomal but not lysosomal degradation was involved in this down-regulation as evidenced by blocking with specific inhibitors MG132 and bafilomycin, respectively. Immunoprecipitation studies showed increased ubiquitination of SRSF1 in activated T cells. Interestingly, T cells from patients with SLE showed increased ubiquitination of SRSF1 when compared with those from healthy individuals. Our results demonstrate a novel mechanism of regulation of the splicing factor SRSF1 in human T cells and a potential molecular mechanism that controls its expression in SLE.	[Moulton, Vaishali R.; Gillooly, Andrew R.; Tsokos, George C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Rheumatol,Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Moulton, VR (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Rheumatol, 330 Brookline Ave,E CLS-928, Boston, MA 02215 USA.	vmoulton@bidmc.harvard.edu	tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360; Gillooly, Andrew/0000-0002-5798-4763	National Institutes of Health [R01 AI42269, K01 AR060781]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR060781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI42269 (to G. C. T.) and K01 AR060781 (to V. R. M.).	BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Breig O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059137; Bronevetsky Y, 2013, IMMUNOL REV, V253, P304, DOI 10.1111/imr.12059; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Brundula V, 1999, ARTHRITIS RHEUM-US, V42, P1908, DOI 10.1002/1529-0131(199909)42:9<1908::AID-ANR17>3.0.CO;2-7; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Dragone LL, 2009, IMMUNOL REV, V232, P218, DOI 10.1111/j.1600-065X.2009.00827.x; Feist E, 1996, J EXP MED, V184, P1313, DOI 10.1084/jem.184.4.1313; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Krishnan S, 2005, J IMMUNOL, V175, P3417, DOI 10.4049/jimmunol.175.5.3417; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Li DD, 2004, J IMMUNOL, V173, P7135, DOI 10.4049/jimmunol.173.12.7135; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; LINKERISRAELI M, 1983, J IMMUNOL, V130, P2651; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Martinez NM, 2013, IMMUNOL REV, V253, P216, DOI 10.1111/imr.12047; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Moulton VR, 2008, J BIOL CHEM, V283, P20037, DOI 10.1074/jbc.M710434200; Moulton VR, 2013, P NATL ACAD SCI USA, V110, P1845, DOI 10.1073/pnas.1214207110; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Moulton VR, 2010, J BIOL CHEM, V285, P12490, DOI 10.1074/jbc.M109.091660; Nambiar MP, 2003, LUPUS, V12, P46, DOI 10.1191/0961203303lu281oa; Nambiar MP, 2002, ARTHRITIS RHEUM-US, V46, P163, DOI 10.1002/1529-0131(200201)46:1<163::AID-ART10065>3.0.CO;2-J; Perl A, 2010, AUTOIMMUNITY, V43, P1, DOI 10.3109/08916930903374741; Scharschmidt E, 2004, MOL CELL BIOL, V24, P3860, DOI 10.1128/MCB.24.9.3860-3873.2004; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Sun SY, 2010, NAT STRUCT MOL BIOL, V17, P306, DOI 10.1038/nsmb.1750; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; Zhang J, 2004, CLIN IMMUNOL, V111, P234, DOI 10.1016/j.clim.2004.02.003	37	28	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4126	4134		10.1074/jbc.M113.518662	http://dx.doi.org/10.1074/jbc.M113.518662			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24368769	hybrid, Green Published			2022-12-28	WOS:000331403800026
J	Than, A; Zhang, XH; Leow, MKS; Poh, CL; Chong, SK; Chen, P				Aung Than; Zhang, Xiaohong; Leow, Melvin Khee-Shing; Poh, Chueh Loo; Chong, Seow Khoon; Chen, Peng			Apelin Attenuates Oxidative Stress in Human Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Adipokines; Antioxidants; Oxidative Stress; Reactive Oxygen Species (ROS)	INDUCED INSULIN-RESISTANCE; MITOCHONDRIAL DYSFUNCTION; ADIPOSE-TISSUE; GLUT4 TRANSLOCATION; GLUCOSE-TRANSPORT; PROMOTER ACTIVITY; BIOGENESIS; OBESITY; DIFFERENTIATION; ADIPOGENESIS	Background: Antioxidant effects of apelin on adipocytes are unknown. Results: Apelin not only suppresses production and release of reactive oxygen species, but also relieves oxidative-stress induced cellular dysfunctions in adipocytes. Conclusion: Apelin-APJ signaling acts as the negative autocrine feedbacks against oxidative stress in adipocytes. Significance: Apelin signaling may serve as a potential therapeutic target for metabolic disorders. It has been recently recognized that the increased oxidative stress (ROS overproduction) in obese condition is a key contributor to the pathogenesis of obesity-associated metabolic diseases. Apelin is an adipocytokine secreted by adipocytes, and known for its anti-obesity and anti-diabetic properties. In obesity, both oxidative stress and plasma level of apelin are increased. However, the regulatory roles of apelin on oxidative stress in adipocytes remain unknown. In the present study, we provide evidence that apelin, through its interaction with apelin receptor (APJ), suppresses production and release of reactive oxygen species (ROS) in adipocytes. This is further supported by the observations that apelin promotes the expression of anti-oxidant enzymes via MAPK kinase/ERK and AMPK pathways, and suppresses the expression of pro-oxidant enzyme via AMPK pathway. We further demonstrate that apelin is able to relieve oxidative stress-induced dysregulations of the expression of anti- and pro-oxidant enzymes, mitochondrial biogenesis and function, as well as release of pro- and anti-inflammatory adipocytokines. This study, for the first time, reveals the antioxidant properties of apelin in adipocytes, and suggests its potential as a novel therapeutic target for metabolic diseases.	[Aung Than; Zhang, Xiaohong; Poh, Chueh Loo; Chong, Seow Khoon; Chen, Peng] Nanyang Technol Univ, Div Bioengn, Singapore 637457, Singapore; [Leow, Melvin Khee-Shing] Brenner Ctr Mol Med, Singapore Inst Clin Sci, Singapore 117609, Singapore; [Leow, Melvin Khee-Shing] Tan Tock Seng Hosp, Singapore 308433, Singapore; [Leow, Melvin Khee-Shing] Duke NUS Grad Med Sch, Singapore 169857, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Tan Tock Seng Hospital; National University of Singapore	Chen, P (corresponding author), Nanyang Technol Univ, Div Bioengn, 70 Nanyang Dr, Singapore 637457, Singapore.	chenpeng@ntu.edu.sg	Poh, Chueh Loo/AAG-9907-2021; Leow, Melvin/H-3129-2019; Poh, Chueh Loo/G-6211-2010; Leow, Melvin/AAJ-1168-2020; Chen, Peng/G-6202-2010; Zhang, Xiaohong/A-3060-2015; Chong, Mark/D-2678-2013	Leow, Melvin/0000-0002-2837-5889; Chen, Peng/0000-0003-3730-1846; Chong, Mark/0000-0002-9586-6303; aung, than/0000-0003-1558-7310	Singapore Ministry of Health's National Medical Research Council under its EDG Grant [NMRC/EDG/1048/2011]; Singapore Ministry of Education [RGT7/13]	Singapore Ministry of Health's National Medical Research Council under its EDG Grant(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore)	This research was supported by the Singapore Ministry of Health's National Medical Research Council under its EDG Grant (NMRC/EDG/1048/2011) and Singapore Ministry of Education under its AcRF Tier 1 Grant (RGT7/13).	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Attane C, 2012, DIABETES, V61, P310, DOI 10.2337/db11-0100; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Beard KM, 2006, DIABETES, V55, P2678, DOI 10.2337/db05-1538; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; Castan-Laurell I, 2008, EUR J ENDOCRINOL, V158, P905, DOI 10.1530/EJE-08-0039; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Chen XH, 2010, MOL CELL ENDOCRINOL, V328, P63, DOI 10.1016/j.mce.2010.07.005; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Chu JYS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064859; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; Crujeiras AB, 2013, FREE RADICAL RES, V47, P243, DOI 10.3109/10715762.2013.772604; Dray C, 2008, CELL METAB, V8, P437, DOI 10.1016/j.cmet.2008.10.003; Evans J L, 2000, Diabetes Technol Ther, V2, P401, DOI 10.1089/15209150050194279; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Foussal C, 2010, FEBS LETT, V584, P2363, DOI 10.1016/j.febslet.2010.04.025; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gao CL, 2010, MOL CELL ENDOCRINOL, V320, P25, DOI 10.1016/j.mce.2010.01.039; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Hemmrich K, 2005, DIFFERENTIATION, V73, P28, DOI 10.1111/j.1432-0436.2005.07301003.x; Kanda Y, 2011, LIFE SCI, V89, P250, DOI 10.1016/j.lfs.2011.06.007; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Kobayashi H, 2009, AM J PHYSIOL-ENDOC M, V296, pE1326, DOI 10.1152/ajpendo.90921.2008; Krawczyk SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034904; Kumar S, 2008, AM J PHYSIOL-LUNG C, V295, pL370, DOI 10.1152/ajplung.90205.2008; Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Los M, 2009, BIOESSAYS, V31, P492, DOI 10.1002/bies.200900005; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Masri B, 2006, J BIOL CHEM, V281, P18317, DOI 10.1074/jbc.M600606200; Matsuoka T, 1997, J CLIN INVEST, V99, P144, DOI 10.1172/JCI119126; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Meigs JB, 2007, DIABETES CARE, V30, P2529, DOI 10.2337/dc07-0817; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Park J, 2006, DIABETES, V55, P2939, DOI 10.2337/db05-1570; Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354; Pitkin SL, 2010, PHARMACOL REV, V62, P331, DOI 10.1124/pr.110.002949; Prieto-Hontoria PL, 2009, J PHYSIOL BIOCHEM, V65, P43, DOI 10.1007/BF03165968; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Ray Gibanananda, 2002, Indian Journal of Experimental Biology, V40, P1213; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; Sankhla M, 2012, CLIN LAB, V58, P385; Shibata M, 2010, J BIOL CHEM, V285, P20915, DOI 10.1074/jbc.M110.126482; Soriguer F, 2009, OBES SURG, V19, P1574, DOI 10.1007/s11695-009-9955-y; Subauste AR, 2007, AM J PHYSIOL-ENDOC M, V293, pE159, DOI 10.1152/ajpendo.00629.2006; Tanaka T, 2003, EUR J ENDOCRINOL, V149, P61, DOI 10.1530/eje.0.1490061; Than A, 2013, J BIOL CHEM, V288, P15520, DOI 10.1074/jbc.M113.459792; Than A, 2012, MOL CELL ENDOCRINOL, V362, P227, DOI 10.1016/j.mce.2012.07.002; Than A, 2012, MOL CELL ENDOCRINOL, V351, P296, DOI 10.1016/j.mce.2012.01.005; Than A, 2011, MOL CELL ENDOCRINOL, V332, P261, DOI 10.1016/j.mce.2010.11.002; Tong WH, 2007, BIOMETALS, V20, P549, DOI 10.1007/s10534-006-9047-6; Trayhurn P, 2006, J NUTR, V136, p1935S, DOI 10.1093/jn/136.7.1935S; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang CH, 2013, FEBS J, V280, P1039, DOI 10.1111/febs.12096; Wenz T, 2013, MITOCHONDRION, V13, P134, DOI 10.1016/j.mito.2013.01.006; Whaley-Connell A, 2011, REV CARDIOVASC MED, V12, P21, DOI 10.3909/ricm0555; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Woo CH, 2000, J BIOL CHEM, V275, P32357, DOI 10.1074/jbc.M005638200; Xu S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.7; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Ye F, 2010, J ENDOCRINOL, V206, P27, DOI 10.1677/JOE-10-0090; Yue P, 2011, ENDOCRINOLOGY, V152, P59, DOI 10.1210/en.2010-0576; Zhang XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056346, 10.1371/journal.pone.0057885]; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zhen EY, 2013, ANAL BIOCHEM, V442, P1, DOI 10.1016/j.ab.2013.07.006; Zheng XT, 2013, ACS NANO, V7, P6278, DOI 10.1021/nn4023137; Zhu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041500; Zhu SM, 2011, MOL CELL BIOCHEM, V353, P305, DOI 10.1007/s11010-011-0799-0	82	69	69	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3763	3774		10.1074/jbc.M113.526210	http://dx.doi.org/10.1074/jbc.M113.526210			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362107	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000331368700056
J	Barbariga, M; Curnis, F; Spitaleri, A; Andolfo, A; Zucchelli, C; Lazzaro, M; Magnani, G; Musco, G; Corti, A; Alessio, M				Barbariga, Marco; Curnis, Flavio; Spitaleri, Andrea; Andolfo, Annapaola; Zucchelli, Chiara; Lazzaro, Massimo; Magnani, Giuseppe; Musco, Giovanna; Corti, Angelo; Alessio, Massimo			Oxidation-induced Structural Changes of Ceruloplasmin Foster NGR Motif Deamidation That Promotes Integrin Binding and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Integrins; Oxidative Stress; Protein Deamidation; Protein Misfolding; Structural Biology; Ceruloplasmin; NGR Motif; isoNGR Motif	ALZHEIMERS-DISEASE; ISOASPARTATE FORMATION; PARKINSONS-DISEASE; CHOROID-PLEXUS; COPPER; STRESS; BRAIN; IRON; NEURODEGENERATION; ISODGR	Background: Asparagine deamidation at Asn-Gly-Arg (NGR) sites leads to the isoAsp-Gly-Arg (isoDGR) integrin-binding motif formation. Results: Ceruloplasmin (Cp), which contains two NGR sites and is oxidized in cerebrospinal fluid (CSF) in neurodegenerative diseases, can, undergo oxidation-induced structural changes fostering NGR deamidation with gain of integrin binding and signaling properties, in vitro and ex vivo in pathological CSF. Conclusion: Cp NGR motifs can deamidate acquiring integrin-binding functions. Significance: Cp structural changes favor NGR deamidation. Asparagine deamidation occurs spontaneously in proteins during aging; deamidation of Asn-Gly-Arg (NGR) sites can lead to the formation of isoAsp-Gly-Arg (isoDGR), a motif that can recognize the RGD-binding site of integrins. Ceruloplasmin (Cp), a ferroxidase present in the cerebrospinal fluid (CSF), contains two NGR sites in its sequence: one exposed on the protein surface ((568)NGR) and the other buried in the tertiary structure ((962)NGR). Considering that Cp can undergo oxidative modifications in the CSF of neurodegenerative diseases, we investigated the effect of oxidation on the deamidation of both NGR motifs and, consequently, on the acquisition of integrin binding properties. We observed that the exposed (568)NGR site can deamidate under conditions mimicking accelerated Asn aging. In contrast, the hidden (962)NGR site can deamidate exclusively when aging occurs under oxidative conditions, suggesting that oxidation-induced structural changes foster deamidation at this site. NGR deamidation in Cp was associated with gain of integrin-binding function, intracellular signaling, and cell pro-adhesive activity. Finally, Cp aging in the CSF from Alzheimer disease patients, but not in control CSF, causes Cp deamidation with gain of integrin-binding function, suggesting that this transition might also occur in pathological conditions. In conclusion, both Cp NGR sites can deamidate during aging under oxidative conditions, likely as a consequence of oxidative-induced structural changes, thereby promoting a gain of function in integrin binding, signaling, and cell adhesion.	[Barbariga, Marco; Curnis, Flavio; Lazzaro, Massimo; Corti, Angelo; Alessio, Massimo] Ist Sci San Raffaele, I-20132 Milan, Italy; [Spitaleri, Andrea; Zucchelli, Chiara; Musco, Giovanna] Ist Sci San Raffaele, Dulbecco Telethon Inst, I-20132 Milan, Italy; [Spitaleri, Andrea; Zucchelli, Chiara; Musco, Giovanna] Ist Sci San Raffaele, Biomol NMR Spect, I-20132 Milan, Italy; [Andolfo, Annapaola] Ist Sci San Raffaele, Prote Serv, I-20132 Milan, Italy; [Magnani, Giuseppe] Ist Sci San Raffaele, INSPE Inst Expt Neurol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Alessio, M (corresponding author), Ist Sci San Raffaele, Via Olgettina 58, I-20132 Milan, Italy.	m.alessio@hsr.it	musco, giovanna/I-7122-2012; Curnis, Flavio/AAK-3542-2020; Alessio, Massimo/L-4518-2019; Corti, Angelo/F-7046-2012; Magnani, Giuseppe/AAN-2242-2020; Musco, Giovanna/Q-2756-2019; Zucchelli, Chiara/AAN-4832-2020; Spitaleri, Andrea/S-9368-2019; Alessio, Massimo/K-7028-2014	musco, giovanna/0000-0002-0469-2994; Curnis, Flavio/0000-0002-7231-9569; Corti, Angelo/0000-0002-0893-6191; Magnani, Giuseppe/0000-0001-8436-2903; Zucchelli, Chiara/0000-0003-2857-7170; Spitaleri, Andrea/0000-0003-3012-3557; Andolfo, Annapaola/0000-0002-0566-2391; Alessio, Massimo/0000-0002-4133-3472; Subba, Rajkrishna/0000-0003-0051-0062	Michael J. Fox Foundation for Parkinson's Research Grant [130-012/2310]; Fondazione Telethon Funding Source: Custom	Michael J. Fox Foundation for Parkinson's Research Grant; Fondazione Telethon(Fondazione Telethon)	Supported by Michael J. Fox Foundation for Parkinson's Research Grant 130-012/2310.	Arnal N, 2010, BRAIN RES, V1319, P118, DOI 10.1016/j.brainres.2009.11.085; Ayton S, 2013, ANN NEUROL, V73, P554, DOI 10.1002/ana.23817; Bento I, 2007, ACTA CRYSTALLOGR D, V63, P240, DOI 10.1107/S090744490604947X; Brewer GJ, 2010, AM J ALZHEIMERS DIS, V25, P490, DOI 10.1177/1533317510375083; Caltagarone J, 2007, BBA-MOL BASIS DIS, V1772, P438, DOI 10.1016/j.bbadis.2006.11.007; Capo CR, 2008, BIOMETALS, V21, P367, DOI 10.1007/s10534-007-9125-4; Corti A, 2011, J CELL SCI, V124, P515, DOI 10.1242/jcs.077172; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Curnis F, 2010, J BIOL CHEM, V285, P9114, DOI 10.1074/jbc.M109.044297; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dehart MP, 2012, J PHARM SCI-US, V101, P3096, DOI 10.1002/jps.23061; Eskici G, 2012, BIOCHEMISTRY-US, V51, P6289, DOI 10.1021/bi3006169; Frank AO, 2010, ANGEW CHEM INT EDIT, V49, P9278, DOI 10.1002/anie.201004363; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Grace EA, 2003, J NEUROSCI, V23, P493, DOI 10.1523/JNEUROSCI.23-02-00493.2003; Grimm S, 2011, FREE RADICAL RES, V45, P73, DOI 10.3109/10715762.2010.512040; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Ingrosso D, 2002, EUR J BIOCHEM, V269, P2032, DOI 10.1046/j.1432-1033.2002.02838.x; Ingrosso D, 2000, EUR J BIOCHEM, V267, P4397, DOI 10.1046/j.1432-1327.2000.01485.x; Kang JH, 2001, BBA-GEN SUBJECTS, V1568, P30, DOI 10.1016/S0304-4165(01)00198-2; Krzyzanowska A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00075; Lee KH, 2007, BRAIN RES, V1171, P1, DOI 10.1016/j.brainres.2007.07.053; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MUSCI G, 1993, J BIOL CHEM, V268, P13388; Olivieri S, 2011, J NEUROSCI, V31, P18568, DOI 10.1523/JNEUROSCI.3768-11.2011; Patel BN, 2002, J NEUROSCI, V22, P6578; Perez-Gracia E, 2009, ACTA NEUROPATHOL, V118, P497, DOI 10.1007/s00401-009-0574-4; Robinson NE, 2004, J PEPT RES, V63, P426, DOI 10.1111/j.1399-3011.2004.00151.x; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sedlak E, 2008, BIOPHYS J, V94, P1384, DOI 10.1529/biophysj.107.113696; Serot JM, 2012, J ALZHEIMERS DIS, V30, P17, DOI 10.3233/JAD-2012-111964; Shimizu T, 2000, ARCH BIOCHEM BIOPHYS, V381, P225, DOI 10.1006/abbi.2000.1955; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Spitaleri A, 2008, J BIOL CHEM, V283, P19757, DOI 10.1074/jbc.M710273200; Texel SJ, 2008, BIOCHEM SOC T, V36, P1277, DOI 10.1042/BST0361277; Vashchenko G, 2013, NUTRIENTS, V5, P2289, DOI 10.3390/nu5072289; Watanabe A, 1999, J BIOL CHEM, V274, P7368, DOI 10.1074/jbc.274.11.7368; Weintraub Steven J, 2007, Sci STKE, V2007, pre7, DOI 10.1126/stke.4092007re7; Wright S, 2007, NEUROBIOL AGING, V28, P226, DOI 10.1016/j.neurobiolaging.2005.12.002; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	47	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3736	3748		10.1074/jbc.M113.520981	http://dx.doi.org/10.1074/jbc.M113.520981			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24366863	Green Published, hybrid			2022-12-28	WOS:000331368700054
J	Huck, B; Duss, S; Hausser, A; Olayioye, MA				Huck, Bettina; Duss, Stephan; Hausser, Angelika; Olayioye, Monilola A.			Elevated Protein Kinase D3 (PKD3) Expression Supports Proliferation of Triple-negative Breast Cancer Cells and Contributes to mTORC1-S6K1 Pathway Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Breast Cancer; Endosomes; Golgi; Lysosomes; mTOR; Protein Kinase D (PKD); S6 Kinase	MAMMALIAN TARGET; PROSTATE-CANCER; S6 KINASE; ENDOPLASMIC-RETICULUM; AMINO-ACIDS; AUTOPHAGY; PHOSPHORYLATION; LOCALIZATION; RAPAMYCIN; GOLGI	Background: TNBC is an aggressive breast cancer subtype for which effective targeted therapies are still lacking. Results: PKD3 is increased in TNBC tissues and cells and contributes to mTORC1-S6K1 activation at endolysosomal membranes. Conclusion: PKD3 in TNBC cells is required for endolysosomal homeostasis and cell proliferation. Significance: PKD3 may represent a potential drug target in TNBC. Here, we show that the expression of the Golgi-localized serine-threonine kinase protein kinase D3 (PKD3) is elevated in triple-negative breast cancer (TNBC). Using an antibody array, we identified PKD3 to trigger the activation of S6 kinase 1 (S6K1), a main downstream target of the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway. Accordingly, PKD3 knockdown in TNBC cells led to reduced S6K1 phosphorylation, which was associated with impaired activation of mTORC1 at endolysosomal membranes, the accumulation of the mannose 6-phosphate receptor in and the recruitment of the autophagy marker light chain 3 to enlarged acidic vesicles. We further show that PKD3 depletion strongly inhibited cell spreading and proliferation of TNBC cells, identifying this kinase as a potential novel molecular therapeutic target in TNBC. Together, our data suggest that PKD3 in TNBC cells provides a molecular connection between the Golgi and endolysosomal compartments to enhance proliferative mTORC1-S6K1 signaling.	[Huck, Bettina; Hausser, Angelika; Olayioye, Monilola A.] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany; [Duss, Stephan] Friedrich Miescher Inst Med Res, CH-4058 Basel, Switzerland	University of Stuttgart; Friedrich Miescher Institute for Biomedical Research	Olayioye, MA (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.	monilola.olayioye@izi.uni-stuttgart.de	Hausser, Angelika/AAC-4531-2021		German Cancer Aid Grant [109583]; Landesgraduiertenforderung; Deutsche Forschungsgemeinschaft Heisenberg program	German Cancer Aid Grant; Landesgraduiertenforderung; Deutsche Forschungsgemeinschaft Heisenberg program(German Research Foundation (DFG))	This work was supported by German Cancer Aid Grant 109583 (to M. A. O.).; Supported by a fellowship from the Landesgraduiertenforderung.; Supported by the Deutsche Forschungsgemeinschaft Heisenberg program.	Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Crown J, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds196; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Eisenberg-Lerner A, 2012, CELL DEATH DIFFER, V19, P788, DOI 10.1038/cdd.2011.149; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Fraldi A, 2010, EMBO J, V29, P3607, DOI 10.1038/emboj.2010.237; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Huck B, 2012, J BIOL CHEM, V287, P34604, DOI 10.1074/jbc.M112.374652; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kim D, 2009, GROWTH FACTORS, V27, P12, DOI 10.1080/08977190802556986; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LaValle CR, 2012, MOL CANCER THER, V11, P1389, DOI 10.1158/1535-7163.MCT-11-0887; Lee AJX, 2012, J PATHOL, V226, P482, DOI 10.1002/path.2998; Liu XY, 2007, MOL BIOL CELL, V18, P1073, DOI 10.1091/mbc.E06-05-0406; Lu GW, 2007, CELL SIGNAL, V19, P867, DOI 10.1016/j.cellsig.2006.10.012; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Marks DL, 2012, TRAFFIC, V13, P565, DOI 10.1111/j.1600-0854.2012.01331.x; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Olayioye MA, 2013, CELL SIGNAL, V25, P1739, DOI 10.1016/j.cellsig.2013.04.010; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Tan AR, 2008, CANCER J, V14, P343, DOI 10.1097/PPO.0b013e31818d839b; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Ueng SH, 2012, INT J CLIN EXP PATHO, V5, P806; Vicent S, 2008, CANCER RES, V68, P2275, DOI 10.1158/0008-5472.CAN-07-6493; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Ziegler S, 2011, MOL BIOL CELL, V22, P570, DOI 10.1091/mbc.E10-05-0427; Zou ZP, 2012, J CELL SCI, V125, P4800, DOI 10.1242/jcs.106542	46	35	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3138	3147		10.1074/jbc.M113.502633	http://dx.doi.org/10.1074/jbc.M113.502633			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24337579	Green Published, hybrid			2022-12-28	WOS:000331368700004
J	Jamroze, A; Perugino, G; Valenti, A; Rashid, N; Rossi, M; Akhtar, M; Ciaramella, M				Jamroze, Anmbreen; Perugino, Giuseppe; Valenti, Anna; Rashid, Naeem; Rossi, Mose; Akhtar, Muhammad; Ciaramella, Maria			The Reverse Gyrase from Pyrobaculum calidifontis, a Novel Extremely Thermophilic DNA Topoisomerase Endowed with DNA Unwinding and Annealing Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Enzymes; DNA Helicase; DNA Recombination; DNA Repair; DNA Topoisomerase; Holliday Junction; Thermophiles	HELICASE-LIKE DOMAIN; SULFOLOBUS-SHIBATAE B12; ARCHAEON SULFOLOBUS; NUCLEOTIDE; SOLFATARICUS; MECHANISM; PROTEIN; ATP; BINDING; LATCH	Background: The thermophilic DNA topoisomerase reverse gyrase induces DNA-positive supercoiling. Results: The novel reverse gyrase, PcalRG, is presented. Conclusion:PcalRG is the most efficient and robust reverse gyrase known, and the first inducing ATP-dependent unwinding of Holliday junctions and annealing of single-stranded oligonucleotides. Significance:PcalRG shares structural and functional features with evolutionary conserved helicase-topoisomerase complexes involved in genome stability. Reverse gyrase is a DNA topoisomerase specific for hyperthermophilic bacteria and archaea. It catalyzes the peculiar ATP-dependent DNA-positive supercoiling reaction and might be involved in the physiological adaptation to high growth temperature. Reverse gyrase comprises an N-terminal ATPase and a C-terminal topoisomerase domain, which cooperate in enzyme activity, but details of its mechanism of action are still not clear. We present here a functional characterization of PcalRG, a novel reverse gyrase from the archaeon Pyrobaculum calidifontis. PcalRG is the most robust and processive reverse gyrase known to date; it is active over a wide range of conditions, including temperature, ionic strength, and ATP concentration. Moreover, it holds a strong ATP-inhibited DNA cleavage activity. Most important, PcalRG is able to induce ATP-dependent unwinding of synthetic Holliday junctions and ATP-stimulated annealing of unconstrained single-stranded oligonucleotides. Combined DNA unwinding and annealing activities are typical of certain helicases, but until now were shown for no other reverse gyrase. Our results suggest for the first time that a reverse gyrase shares not only structural but also functional features with evolutionary conserved helicase-topoisomerase complexes involved in genome stability.	[Jamroze, Anmbreen; Perugino, Giuseppe; Valenti, Anna; Rossi, Mose; Ciaramella, Maria] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Perugino, Giuseppe; Valenti, Anna; Rossi, Mose; Ciaramella, Maria] CNR, Inst Biosci & Bioresources, I-80131 Naples, Italy; [Jamroze, Anmbreen; Rashid, Naeem; Akhtar, Muhammad] Univ Punjab, Sch Biol Sci, Lahore 54590, Pakistan	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); University of Punjab	Ciaramella, M (corresponding author), CNR, Inst Biosci & Bioresources, Via P Castellino 111, I-80131 Naples, Italy.	maria.ciaramella@ibbr.cnr.it	Rashid, Naeem/AAD-7049-2021; Ciaramella, Maria/O-1152-2015; Perugino, Giuseppe/P-8147-2016	Ciaramella, Maria/0000-0003-1583-1694; Perugino, Giuseppe/0000-0003-3266-4744	Higher Education Commission of Pakistan; Ministero dell'Istruzione, Universita e Ricerca (FIRB-Merit) [RBNE08YFN3]; Ministero dell'Istruzione, Universita e Ricerca (FIRB-Futuro in Ricerca) [RBFR12OO1G_002]; Ministero degli Affari Esteri [L.401/1990]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Ministero dell'Istruzione, Universita e Ricerca (FIRB-Merit); Ministero dell'Istruzione, Universita e Ricerca (FIRB-Futuro in Ricerca); Ministero degli Affari Esteri(Ministry of Foreign Affairs and International Cooperation (Italy))	This work was supported in part by Ministero dell'Istruzione, Universita e Ricerca (FIRB-Merit RBNE08YFN3 and FIRB-Futuro in Ricerca RBFR12OO1G_002 "Nematic") and Ministero degli Affari Esteri (L.401/1990).; Recipient of a fellowship from the Higher Education Commission of Pakistan.	Amo Taku, 2002, Archaea, V1, P113, DOI 10.1155/2002/616075; Atomi H, 2004, J BACTERIOL, V186, P4829, DOI 10.1128/JB.186.14.4829-4833.2004; Bizard A, 2011, J MOL BIOL, V408, P839, DOI 10.1016/j.jmb.2011.03.030; Brochier-Armanet Celine, 2007, Archaea, V2, P83; Capp C, 2010, J BIOL CHEM, V285, P39637, DOI 10.1074/jbc.M110.173989; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Declais AC, 2000, J BIOL CHEM, V275, P19498, DOI 10.1074/jbc.M910091199; Duany YD, 2008, NUCLEIC ACIDS RES, V36, P5882, DOI 10.1093/nar/gkn587; Duany YD, 2011, BIOCHEMISTRY-US, V50, P5816, DOI 10.1021/bi200236a; Duany YD, 2011, PHYS CHEM CHEM PHYS, V13, P10009, DOI 10.1039/c0cp02859b; Ganguly A, 2013, J MOL BIOL, V425, P32, DOI 10.1016/j.jmb.2012.10.016; Ganguly A, 2011, NUCLEIC ACIDS RES, V39, P1789, DOI 10.1093/nar/gkq1048; Heine M, 2009, J MICROBIOL, V47, P229, DOI 10.1007/s12275-009-0019-8; Hsieh TS, 2006, J BIOL CHEM, V281, P5640, DOI 10.1074/jbc.M513252200; Hsieh TS, 2005, J BIOL CHEM, V280, P20467, DOI 10.1074/jbc.M502739200; JAXEL C, 1989, EMBO J, V8, P3135, DOI 10.1002/j.1460-2075.1989.tb08466.x; Jaxel C, 1996, NUCLEIC ACIDS RES, V24, P4668, DOI 10.1093/nar/24.23.4668; Jaxel C, 1999, EUR J BIOCHEM, V260, P103, DOI 10.1046/j.1432-1327.1999.00128.x; Jungblut SP, 2007, J MOL BIOL, V371, P197, DOI 10.1016/j.jmb.2007.05.031; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8; Li J, 2011, EXTREMOPHILES, V15, P281, DOI 10.1007/s00792-011-0356-5; Li Z, 2008, J BACTERIOL, V190, P3006, DOI 10.1128/JB.01662-07; NADAL M, 1994, J BIOL CHEM, V269, P5255; Nadal M, 2007, BIOCHIMIE, V89, P447, DOI 10.1016/j.biochi.2006.12.010; Napoli A, 2005, NUCLEIC ACIDS RES, V33, P564, DOI 10.1093/nar/gki202; Napoli A, 2004, J BIOL CHEM, V279, P33192, DOI 10.1074/jbc.M402619200; Napoli A, 2002, NUCLEIC ACIDS RES, V30, P2656, DOI 10.1093/nar/gkf377; Perugino G, 2009, BIOCHEM SOC T, V37, P69, DOI 10.1042/BST0370069; Rezazadeh S, 2012, MOL BIOL REP, V39, P4527, DOI 10.1007/s11033-011-1243-y; Rodriguez AC, 2003, BIOCHEMISTRY-US, V42, P5993, DOI 10.1021/bi034188l; Rodriguez AC, 2002, J BIOL CHEM, V277, P29865, DOI 10.1074/jbc.M202853200; Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418; Rudolph MG, 2013, NUCLEIC ACIDS RES, V41, P1058, DOI 10.1093/nar/gks1073; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Valenti A, 2008, NUCLEIC ACIDS RES, V36, P4587, DOI 10.1093/nar/gkn418; Valenti A, 2006, NUCLEIC ACIDS RES, V34, P2098, DOI 10.1093/nar/gkl115; Valenti A, 2012, J BIOL CHEM, V287, P30282, DOI 10.1074/jbc.M112.366377; Valenti A, 2010, J BIOL CHEM, V285, P36532, DOI 10.1074/jbc.M110.169029; Valenti A, 2009, NUCLEIC ACIDS RES, V37, P4287, DOI 10.1093/nar/gkp386; Woodman IL, 2009, BIOCHEM SOC T, V37, P74, DOI 10.1042/BST0370074; Zhang CY, 2013, BIOCHEM SOC T, V41, P405, DOI 10.1042/BST20120285	42	13	13	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3231	3243		10.1074/jbc.M113.517649	http://dx.doi.org/10.1074/jbc.M113.517649			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24347172	hybrid, Green Published			2022-12-28	WOS:000331368700012
J	Nguyen, N; Yi, JS; Park, H; Lee, JS; Ko, YG				Nga Nguyen; Yi, Jae-Sung; Park, Heonyong; Lee, Jae-Seon; Ko, Young-Gyu			Mitsugumin 53 (MG53) Ligase Ubiquitinates Focal Adhesion Kinase during Skeletal Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Focal Adhesion Kinase; Myogenesis; Skeletal Muscle; Ubiquitin-conjugating Enzyme (Ubc); Ubiquitin-dependent Protease	INSULIN-RECEPTOR SUBSTRATE-1; CELL-MEMBRANE REPAIR; PROTEIN-DEGRADATION; MUSCLE; EXPRESSION; PHOSPHORYLATION; DIFFERENTIATION; UBIQUITYLATION	Background: The FAK protein level decreases, but its mRNA level remains constant, during skeletal myogenesis, suggesting that an E3 ligase could induce FAK ubiquitination. Results: The E3 ligase MG53 induces FAK ubiquitination and degradation. Conclusion: MG53-mediated FAK ubiquitination and degradation is induced during myogenesis. Significance: This work provides a molecular mechanism for the negative feedback regulation of skeletal myogenesis. The striated muscle-specific mitsugumin 53 (MG53) is a novel E3 ligase that induces the ubiquitination of insulin receptor substrate 1 (IRS-1) during skeletal myogenesis, negatively regulating insulin-like growth factor and insulin signaling. Here we show that focal adhesion kinase (FAK) is the second target of MG53 during skeletal myogenesis. The FAK protein level gradually decreased, whereas its mRNA level was constant during myogenesis in C2C12 cells and MyoD-overexpressing mouse embryonic fibroblasts. The FAK protein was associated with the E2 enzyme UBE2H and the E3 enzyme MG53 in endogenous and exogenous immunoprecipitation experiments. FAK ubiquitination and degradation was induced by MG53 overexpression in myoblasts but abolished by MG53 or UBE2H knockdown in myotubes. Because RING-disrupted MG53 mutants (C14A and R) did not induce FAK ubiquitination and degradation, the RING domain was determined to be required for MG53-induced FAK ubiquitination. Taken together, these data indicate that MG53 induces FAK ubiquitination with the aid of UBE2H during skeletal myogenesis.	[Nga Nguyen; Yi, Jae-Sung; Ko, Young-Gyu] Korea Univ, Div Life Sci, Seoul 136701, South Korea; [Park, Heonyong] Dankook Univ, Dept Mol Biol, Yongin 448701, South Korea; [Lee, Jae-Seon] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea	Korea University; Dankook University; Korea Institute of Radiological & Medical Sciences	Ko, YG (corresponding author), Korea Univ, Div Life Sci, 145 Anam Ro, Seoul 136701, South Korea.	ygko@korea.ac.kr			National Research Foundation [2011-0030158, 2011-0017562]; Korea University	National Research Foundation; Korea University	This work was supported by National Research Foundation Grants 2011-0030158 and 2011-0017562 (to Y. G. K.). This work was also partially supported by a Korea University grant (to Y. G. K.).	Ahn S, 2012, BIOCHEM BIOPH RES CO, V419, P419, DOI 10.1016/j.bbrc.2012.02.037; Alloush J, 2013, JAMA NEUROL, V70, P928, DOI 10.1001/jamaneurol.2013.469; Bisht B, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-48; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chen C, 2006, MOL CANCER RES, V4, P695, DOI 10.1158/1541-7786.MCR-06-0182; Clemente CFMZ, 2005, AM J PHYSIOL-REG I, V289, pR862, DOI 10.1152/ajpregu.00348.2004; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Fluck M, 2002, J EXP BIOL, V205, P2337; Franchini KG, 2012, J MOL CELL CARDIOL, V52, P485, DOI 10.1016/j.yjmcc.2011.06.021; Gardrat F, 1997, MOL BIOL REP, V24, P77, DOI 10.1023/A:1006877214153; Hausenloy DJ, 2010, CIRCULATION, V121, P2547, DOI 10.1161/CIRCULATIONAHA.110.958462; Jung SY, 2010, BIOCHEM BIOPH RES CO, V396, P238, DOI 10.1016/j.bbrc.2010.04.072; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kim J, 2008, TRENDS CELL BIOL, V18, P264, DOI 10.1016/j.tcb.2008.03.007; Lee CS, 2010, CELL DEATH DIFFER, V17, P1254, DOI 10.1038/cdd.2010.1; Liu E, 2003, EMBO J, V22, P5036, DOI 10.1093/emboj/cdg503; Lundin VF, 2010, TRENDS BIOCHEM SCI, V35, P288, DOI 10.1016/j.tibs.2009.12.007; Luo SW, 2009, EMBO J, V28, P2568, DOI 10.1038/emboj.2009.178; Mao HP, 2003, J BIOL CHEM, V278, P18214, DOI 10.1074/jbc.M300126200; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Quach NL, 2009, MOL BIOL CELL, V20, P3422, DOI 10.1091/mbc.E09-02-0175; Rafiq K, 2012, J BIOL CHEM, V287, P5327, DOI 10.1074/jbc.M111.307009; Sekine Y, 2007, J IMMUNOL, V179, P2397, DOI 10.4049/jimmunol.179.4.2397; Shen Y, 1999, MOL BIOL CELL, V10, P2507, DOI 10.1091/mbc.10.8.2507; Shim EH, 2002, EMBO REP, V3, P857, DOI 10.1093/embo-reports/kvf175; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Yi JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3354	28	36	44	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3209	3216		10.1074/jbc.M113.525154	http://dx.doi.org/10.1074/jbc.M113.525154			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24344130	Green Published, hybrid			2022-12-28	WOS:000331368700010
J	Skorobogatko, Y; Landicho, A; Chalkley, RJ; Kossenkov, AV; Gallo, G; Vosseller, K				Skorobogatko, Yuliya; Landicho, Ashly; Chalkley, Robert J.; Kossenkov, Andrew V.; Gallo, Gianluca; Vosseller, Keith			O-Linked beta-N-Acetylglucosamine (O-GlcNAc) Site Thr-87 Regulates Synapsin I Localization to Synapses and Size of the Reserve Pool of Synaptic Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Neurobiology; O-GlcNAc; Signal Transduction; Synapses; Synaptic Plasticity	MASS-SPECTROMETRY; MEMBRANE CURVATURE; HIPPOCAMPAL-NEURONS; PHOSPHORYLATION; PROTEIN; TRANSFERASE; BRAIN; IDENTIFICATION; GLYCOSYLATION; GLCNACYLATION	Background: Synapsin I regulates synaptic plasticity and is modified by O-GlcNAc. Results: Mutation of O-GlcNAc site Thr-87 to alanine increases both localization of synapsin I to synapses and the reserve pool of synaptic vesicles. Conclusion:O-GlcNAcylation of Thr-87 may regulate synapsin I localization and function. Significance:O-GlcNAcylation of synapsin I may modulate synaptic plasticity. O-GlcNAc is a carbohydrate modification found on cytosolic and nuclear proteins. Our previous findings implicated O-GlcNAc in hippocampal presynaptic plasticity. An important mechanism in presynaptic plasticity is the establishment of the reserve pool of synaptic vesicles (RPSV). Dynamic association of synapsin I with synaptic vesicles (SVs) regulates the size and release of RPSV. Disruption of synapsin I function results in reduced size of the RPSV, increased synaptic depression, memory deficits, and epilepsy. Here, we investigate whether O-GlcNAc directly regulates synapsin I function in presynaptic plasticity. We found that synapsin I is modified by O-GlcNAc during hippocampal synaptogenesis in the rat. We identified three novel O-GlcNAc sites on synapsin I, two of which are known Ca2+/calmodulin-dependent protein kinase II phosphorylation sites. All O-GlcNAc sites mapped within the regulatory regions on synapsin I. Expression of synapsin I where a single O-GlcNAc site Thr-87 was mutated to alanine in primary hippocampal neurons dramatically increased localization of synapsin I to synapses, increased density of SV clusters along axons, and the size of the RPSV, suggesting that O-GlcNAcylation of synapsin I at Thr-87 may be a mechanism to modulate presynaptic plasticity. Thr-87 is located within an amphipathic lipid-packing sensor (ALPS) motif, which participates in targeting of synapsin I to synapses by contributing to the binding of synapsin I to SVs. We discuss the possibility that O-GlcNAcylation of Thr-87 interferes with folding of the ALPS motif, providing a means for regulating the association of synapsin I with SVs as a mechanism contributing to synapsin I localization and RPSV generation.	[Skorobogatko, Yuliya; Landicho, Ashly; Vosseller, Keith] Drexel Univ, Coll Med, Dept Biochem, Philadelphia, PA 19102 USA; [Chalkley, Robert J.] Univ Calif San Francisco, San Francisco, CA 94158 USA; [Kossenkov, Andrew V.] Wistar Inst Anat & Biol, Bioinformat Facil, Philadelphia, PA 19104 USA; [Gallo, Gianluca] Temple Univ, Dept Anat & Cell Biol, Shriners Hosp Pediat Res Ctr, Philadelphia, PA 19140 USA	Drexel University; University of California System; University of California San Francisco; The Wistar Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia	Vosseller, K (corresponding author), Drexel Univ, Coll Med, Dept Biochem, NCB, 245 N 15th St,Rm 10-112, Philadelphia, PA 19102 USA.	Keith.Vosseller@drexelmed.edu		Henderson, Ashley/0000-0002-4011-4323; Chalkley, Robert/0000-0002-9757-7302	National Institutes of Health from NIA [R21AG033226-02]; National Institutes of Health from NIGMS [8P41GM103481]; Mars Audrey Meyer Fellowship in Aging Research at Drexel University College of Medicine; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033226] Funding Source: NIH RePORTER	National Institutes of Health from NIA; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Mars Audrey Meyer Fellowship in Aging Research at Drexel University College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R21AG033226-02 from NIA (to K. V.) and Grant 8P41GM103481 from NIGMS (to R. J. C.). This work was also supported by Mars Audrey Meyer Fellowship in Aging Research at Drexel University College of Medicine.	Alfaro JF, 2012, P NATL ACAD SCI USA, V109, P7280, DOI 10.1073/pnas.1200425109; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bykhovskaia M, 2011, SEMIN CELL DEV BIOL, V22, P387, DOI 10.1016/j.semcdb.2011.07.003; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Chi P, 2003, NEURON, V38, P69, DOI 10.1016/S0896-6273(03)00151-X; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Cole RN, 1999, J NEUROCHEM, V73, P418, DOI 10.1046/j.1471-4159.1999.0730418.x; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Corradi A, 2008, J CELL SCI, V121, P3042, DOI 10.1242/jcs.035063; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Fassio A, 2011, HUM MOL GENET, V20, P2297, DOI 10.1093/hmg/ddr122; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Fulop N, 2008, BIOGERONTOLOGY, V9, P139, DOI 10.1007/s10522-007-9123-5; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; Gitler D, 2008, J NEUROSCI, V28, P10835, DOI 10.1523/JNEUROSCI.0924-08.2008; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Krabben L, 2011, J NEUROSCI, V31, P18149, DOI 10.1523/JNEUROSCI.4345-11.2011; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li L., 2012, PLOS ONE, V7; Newton J., 2006, J VIS EXP, V1, P117; Perlini LE, 2011, J CELL SCI, V124, P3643, DOI 10.1242/jcs.086223; Petersen K, 1999, NEUROSCIENCE, V91, P651, DOI 10.1016/S0306-4522(98)00596-X; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; SCHIEBLER W, 1986, J BIOL CHEM, V261, P8383; Schroder E, 2003, ANAL BIOCHEM, V313, P176, DOI 10.1016/S0003-2697(02)00567-5; Shupliakov O, 2011, SEMIN CELL DEV BIOL, V22, P393, DOI 10.1016/j.semcdb.2011.07.006; Skorobogatko YV, 2011, AMINO ACIDS, V40, P765, DOI 10.1007/s00726-010-0645-9; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Stefani G, 1997, J PHYSIOL-LONDON, V504, P501, DOI 10.1111/j.1469-7793.1997.501bd.x; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Zachara Natasha E., 2009, V534, P251, DOI 10.1007/978-1-59745-022-5_19; Zhong ZG, 1999, NEUROSCI LETT, V260, P93, DOI 10.1016/S0304-3940(98)00969-0	48	36	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3602	3612		10.1074/jbc.M113.512814	http://dx.doi.org/10.1074/jbc.M113.512814			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24280219	Green Published, hybrid			2022-12-28	WOS:000331368700043
J	Grillet, L; Ouerdane, L; Flis, P; Hoang, MTT; Isaure, MP; Lobinski, R; Curie, C; Mari, S				Grillet, Louis; Ouerdane, Laurent; Flis, Paulina; Minh Thi Thanh Hoang; Isaure, Marie-Pierre; Lobinski, Ryszard; Curie, Catherine; Mari, Stephane			Ascorbate Efflux as a New Strategy for Iron Reduction and Transport in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Ascorbic Acid; Iron; Membrane Transport; Reductase; Citrate; Malate; vtc2-4	TRANSFERRIN-BOUND IRON; METAL TRANSPORTER; DEVELOPING SEEDS; XYLEM SAP; DEFICIENCY RESPONSES; ARABIDOPSIS-THALIANA; ALUMINUM TOLERANCE; SEEDLING VIABILITY; MALATE TRANSPORTER; CHELATE REDUCTASE	Background: Iron long distance transport in plants is underdocumented. Results: Iron is delivered to embryos as ferric complexes with citrate/malate. An ascorbate-mediated reduction step is further required to acquire iron. Conclusion: Ascorbate plays a key role for the chemical reduction and transport of Fe2+. Significance: The identification of iron ligands and the transport process is crucial to further understand how iron is distributed within the plant. Iron (Fe) is essential for virtually all living organisms. The identification of the chemical forms of iron (the speciation) circulating in and between cells is crucial to further understand the mechanisms of iron delivery to its final targets. Here we analyzed how iron is transported to the seeds by the chemical identification of iron complexes that are delivered to embryos, followed by the biochemical characterization of the transport of these complexes by the embryo, using the pea (Pisum sativum) as a model species. We have found that iron circulates as ferric complexes with citrate and malate (Fe(III)(3)Cit(2)Mal(2), Fe(III)(3)Cit(3)Mal(1), Fe(III)Cit(2)). Because dicotyledonous plants only transport ferrous iron, we checked whether embryos were capable of reducing iron of these complexes. Indeed, embryos did express a constitutively high ferric reduction activity. Surprisingly, iron(III) reduction is not catalyzed by the expected membrane-bound ferric reductase. Instead, embryos efflux high amounts of ascorbate that chemically reduce iron(III) from citrate-malate complexes. In vitro transport experiments on isolated embryos using radiolabeled Fe-55 demonstrated that this ascorbate-mediated reduction is an obligatory step for the uptake of iron(II). Moreover, the ascorbate efflux activity was also measured in Arabidopsis embryos, suggesting that this new iron transport system may be generic to dicotyledonous plants. Finally, in embryos of the ascorbate-deficient mutants vtc2-4, vtc5-1, and vtc5-2, the reducing activity and the iron concentration were reduced significantly. Taken together, our results identified a new iron transport mechanism in plants that could play a major role to control iron loading in seeds.	[Grillet, Louis; Minh Thi Thanh Hoang; Curie, Catherine; Mari, Stephane] Univ Montpellier 2, Ecole Natl Super Agron, Inst Biol Integrat Plantes,Inst Natl Rech Agron, Lab Biochim & Physiol Mol Plantes,CNRS,UMR5004, F-34060 Montpellier 2, France; [Ouerdane, Laurent; Flis, Paulina; Isaure, Marie-Pierre; Lobinski, Ryszard] Univ Pau & Pays Adour, Inst Pluridisciplinaire Rech Environm & Mat, Lab Chim Analyt Bioinorgan & Environm, CNRS,UMR5254, F-64063 Pau 9, France	INRAE; Institut Agro; Agrocampus Ouest; Montpellier SupAgro; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour	Mari, S (corresponding author), Univ Montpellier 2, Ecole Natl Super Agron, Inst Biol Integrat Plantes,Inst Natl Rech Agron, Lab Biochim & Physiol Mol Plantes,CNRS,UMR5004, F-34060 Montpellier 2, France.	mari@supagro.inra.fr	Ouerdane, Laurent/A-8353-2015; Grillet, Louis/AFV-6693-2022	Ouerdane, Laurent/0000-0002-2752-3579; Grillet, Louis/0000-0002-2914-9023; Hoang, Minh/0000-0003-3296-5029; Flis, Paulina/0000-0002-5529-7599; ISAURE, Marie-Pierre/0000-0002-6557-5759; Lobinski, Ryszard/0000-0003-1908-2029	 [20110430]		We thank the Soleil Synchrotron (Gif sur Yvette, France) for the provision of beamtime (Project 20110430) and Nicolas Trcera from the LUCIA Beamline for help and advice during data collection. We also thank Nicholas Smirnoff for discussions regarding the vtc mutants.	Alves S, 2011, J PLANT PHYSIOL, V168, P1715, DOI 10.1016/j.jplph.2011.04.004; Bernal M, 2012, PLANT CELL, V24, P738, DOI 10.1105/tpc.111.090431; Bishop GM, 2011, NEUROTOX RES, V19, P443, DOI 10.1007/s12640-010-9195-x; Bradbury MWB, 1997, J NEUROCHEM, V69, P443; Delhaize E, 2004, P NATL ACAD SCI USA, V101, P15249, DOI 10.1073/pnas.0406258101; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Evans RW, 2008, J BIOL INORG CHEM, V13, P57, DOI 10.1007/s00775-007-0297-8; Flank AM, 2006, NUCL INSTRUM METH B, V246, P269, DOI 10.1016/j.nimb.2005.12.007; Fukushima T, 2012, P NATL ACAD SCI USA, V109, P16829, DOI 10.1073/pnas.1210131109; Green LS, 2004, PLANT PHYSIOL, V136, P2523, DOI 10.1104/pp.104.045633; Grusak MA, 1996, PLANT PHYSIOL, V110, P329, DOI 10.1104/pp.110.1.329; GUSTAFSSON JP, 2006, VISUAL MINTEQ VERSIO; Henriques R, 2002, PLANT MOL BIOL, V50, P587, DOI 10.1023/A:1019942200164; Hider RC, 2010, ANN NY ACAD SCI, V1202, P94, DOI 10.1111/j.1749-6632.2010.05573.x; Hoekenga OA, 2006, P NATL ACAD SCI USA, V103, P9738, DOI 10.1073/pnas.0602868103; Jeong J, 2008, P NATL ACAD SCI USA, V105, P10619, DOI 10.1073/pnas.0708367105; Jin CW, 2007, PLANT PHYSIOL, V144, P278, DOI 10.1104/pp.107.095794; Klatte M, 2009, PLANT PHYSIOL, V150, P257, DOI 10.1104/pp.109.136374; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Lane DJR, 2008, J BIOL CHEM, V283, P12701, DOI 10.1074/jbc.M800713200; Lane DJR, 2010, BIOCHEM J, V432, P123, DOI 10.1042/BJ20101317; Le Jean M, 2005, PLANT J, V44, P769, DOI 10.1111/j.1365-313X.2005.02569.x; Lopez-Millan AF, 2001, J EXP BOT, V52, P1489, DOI 10.1093/jexbot/52.360.1489; Mari S, 2006, J EXP BOT, V57, P4111, DOI 10.1093/jxb/erl184; Melkus G, 2009, PLANT PHYSIOL, V151, P1139, DOI 10.1104/pp.109.143974; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Ouerdane L, 2006, J ANAL ATOM SPECTROM, V21, P676, DOI 10.1039/b602689c; Patrick JW, 1997, ANNU REV PLANT PHYS, V48, P191, DOI 10.1146/annurev.arplant.48.1.191; Patrick JW, 2001, J EXP BOT, V52, P551, DOI 10.1093/jexbot/52.356.551; Pich A, 1996, J EXP BOT, V47, P41, DOI 10.1093/jxb/47.1.41; Rellan-Alvarez R, 2008, RAPID COMMUN MASS SP, V22, P1553, DOI 10.1002/rcm.3523; Rellan-Alvarez R, 2010, PLANT CELL PHYSIOL, V51, P91, DOI 10.1093/pcp/pcp170; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Roschzttardtz H, 2011, PLANT CELL, V23, P2725, DOI 10.1105/tpc.111.088088; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; Sarret G, 2009, NEW PHYTOL, V184, P581, DOI 10.1111/j.1469-8137.2009.02996.x; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Stacey MG, 2008, PLANT PHYSIOL, V146, P589, DOI 10.1104/pp.107.108183; Tegeder M, 2000, PLANT PHYSIOL, V122, P319, DOI 10.1104/pp.122.2.319; Tegeder M, 1999, PLANT J, V18, P151, DOI 10.1046/j.1365-313X.1999.00439.x; Terzano R, 2013, ANAL BIOANAL CHEM, V405, P5411, DOI 10.1007/s00216-013-6959-1; Trampczynska A, 2010, METALLOMICS, V2, P57, DOI 10.1039/b913299f; Urzica EI, 2012, PLANT CELL, V24, P3921, DOI 10.1105/tpc.112.102491; Van Dongen JT, 2003, ANN BOT-LONDON, V91, P729, DOI 10.1093/aob/mcg066; Varotto C, 2002, PLANT J, V31, P589, DOI 10.1046/j.1365-313X.2002.01381.x; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Walker EL, 2011, CURR OPIN PLANT BIOL, V14, P318, DOI 10.1016/j.pbi.2011.03.025; Waters BM, 2006, PLANT PHYSIOL, V141, P1446, DOI 10.1104/pp.106.082586; Wilke M, 2001, AM MINERAL, V86, P714; Zaharieva TB, 2003, PROTOPLASMA, V221, P269, DOI 10.1007/s00709-002-0051-6	53	107	114	2	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2515	2525		10.1074/jbc.M113.514828	http://dx.doi.org/10.1074/jbc.M113.514828			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24347170	hybrid, Green Published			2022-12-28	WOS:000333403000004
J	Ushijima, T; Okazaki, K; Tsushima, H; Iwamoto, Y				Ushijima, Takahiro; Okazaki, Ken; Tsushima, Hidetoshi; Iwamoto, Yukihide			CCAAT/Enhancer-binding Protein beta Regulates the Repression of Type II Collagen Expression during the Differentiation from Proliferative to Hypertrophic Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; EBP Transcription Factor; Chondrocytes; Collagen; Differentiation; Osteoarthritis	TRANSCRIPTION FACTOR SOX9; GENE-EXPRESSION; RETINOIC ACID; MESSENGER-RNA; C/EBP FAMILY; GROWTH-PLATE; X COLLAGEN; CELL-LINE; IN-VITRO; CARTILAGE	Background: CCAAT/enhancer-binding protein (C/EBP) promotes hypertrophic differentiation of chondrocytes. Results: C/EBP directly represses the expression of type II collagen by interacting with its intronic enhancer. Conclusion: C/EBP biphasically functions to repress genes characteristic of proliferative chondrocytes while stimulating genes expressed by hypertrophic chondrocytes. Significance: C/EBP is a key regulator to trigger phenotypic conversion from proliferative to hypertrophic chondrocytes. CCAAT/enhancer-binding protein (C/EBP) is a transcription factor that promotes hypertrophic differentiation by stimulating type X collagen and matrix metalloproteinase 13 during chondrocyte differentiation. However, the effect of C/EBP on proliferative chondrocytes is unclear. Here, we investigated whether C/EBP represses type II collagen (COL2A1) expression and is involved in the regulation of sex-determining region Y-type high mobility group box 9 (SOX9), a crucial factor for transactivation of Col2a1. Endogenous expression of C/EBP in the embryonic growth plate and differentiated ATDC5 cells were opposite to those of COL2A1 and SOX9. Overexpression of C/EBP by adenovirus vector in ATDC5 cells caused marked repression of Col2a1. The expression of Sox9 mRNA and nuclear protein was also repressed, resulting in decreased binding of SOX9 to the Col2a1 enhancer as shown by a ChIP assay. Knockdown of C/EBP by lentivirus expressing shRNA caused significant stimulation of these genes in ATDC5 cells. Reporter assays demonstrated that C/EBP repressed transcriptional activity of Col2a1. Deletion and mutation analysis showed that the C/EBP core responsive element was located between +2144 and +2152 bp within the Col2a1 enhancer. EMSA and ChIP assays also revealed that C/EBP directly bound to this region. Ex vivo organ cultures of mouse limbs transfected with C/EBP showed that the expression of COL2A1 and SOX9 was reduced upon ectopic C/EBP expression. Together, these results indicated that C/EBP represses the transcriptional activity of Col2a1 both directly and indirectly through modulation of Sox9 expression. This consequently promotes the phenotypic conversion from proliferative to hypertrophic chondrocytes during chondrocyte differentiation.	[Ushijima, Takahiro; Okazaki, Ken; Tsushima, Hidetoshi; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka 8128582, Japan	Kyushu University	Okazaki, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	okazaki@med.kyushu-u.ac.jp		Okazaki, Ken/0000-0003-1274-8406	Japan Society for the Promotion of Science [23592218]; Ministry of Health and Welfare of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant-in-Aid for Scientific Research Grant 23592218 from the Japan Society for the Promotion of Science and Research Grant for Intractable Disease from the Ministry of Health and Welfare of Japan.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Akiyama H, 2005, MATRIX BIOL, V23, P499, DOI 10.1016/j.matbio.2004.10.002; Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cheng AX, 2010, J BONE MINER RES, V25, P2404, DOI 10.1002/jbmr.174; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Furumatsu T, 2005, J BIOL CHEM, V280, P35203, DOI 10.1074/jbc.M502409200; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Haaijman A, 1997, J BONE MINER RES, V12, P1815, DOI 10.1359/jbmr.1997.12.11.1815; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Hayashida M, 2009, ARTHRITIS RHEUM-US, V60, P708, DOI 10.1002/art.24332; Higashikawa A, 2009, ARTHRITIS RHEUM-US, V60, P166, DOI 10.1002/art.24243; Hirata M, 2012, HUM MOL GENET, V21, P1111, DOI 10.1093/hmg/ddr540; Hirata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004543; Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998; Imamura T, 2005, J BIOL CHEM, V280, P16625, DOI 10.1074/jbc.M411469200; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Okazaki K, 2004, CLIN ORTHOP RELAT R, pS123, DOI 10.1097/01.blo.0000144478.51284.f3; Okazaki K, 2002, J BIOL CHEM, V277, P31526, DOI 10.1074/jbc.M202815200; Olive M, 1996, J BIOL CHEM, V271, P2040, DOI 10.1074/jbc.271.4.2040; Peng H, 2008, J CELL PHYSIOL, V215, P562, DOI 10.1002/jcp.21338; Sakaue H, 2002, GENE DEV, V16, P908, DOI 10.1101/gad.983202; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Tan LJ, 2003, J BIOL CHEM, V278, P17688, DOI 10.1074/jbc.M301676200; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Tsushima H, 2012, ANN RHEUM DIS, V71, P99, DOI 10.1136/annrheumdis-2011-200061; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; Zehentner BK, 1999, J BONE MINER RES, V14, P1734, DOI 10.1359/jbmr.1999.14.10.1734	42	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2852	2863		10.1074/jbc.M113.492843	http://dx.doi.org/10.1074/jbc.M113.492843			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24344131	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000333403000033
J	Brueggemann, LI; Mackie, AR; Cribbs, LL; Freda, J; Tripathi, A; Majetschak, M; Byron, KL				Brueggemann, Lioubov I.; Mackie, Alexander R.; Cribbs, Leanne L.; Freda, Jessica; Tripathi, Abhishek; Majetschak, Matthias; Byron, Kenneth L.			Differential Protein Kinase C-dependent Modulation of Kv7.4 and Kv7.5 Subunits of Vascular Kv7 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Patch Clamp Electrophysiology; Potassium Channels; Protein Phosphorylation; Signal Transduction; Vascular Smooth Muscle Cells; KCNQ Channel; Mesenteric Artery; Vasopressin	KCNQ POTASSIUM CHANNELS; SMOOTH-MUSCLE-CELLS; K+ CHANNELS; SIGNALING PATHWAYS; PROXIMITY LIGATION; K(V)7 CHANNELS; IN-VIVO; VASOPRESSIN; EPILEPSY; HYPERTENSION	The Kv7 family (Kv7.1-7.5) of voltage-activated potassium channels contributes to the maintenance of resting membrane potential in excitable cells. Previously, we provided pharmacological and electrophysiological evidence that Kv7.4 and Kv7.5 form predominantly heteromeric channels and that Kv7 activity is regulated by protein kinase C (PKC) in response to vasoconstrictors in vascular smooth muscle cells. Direct evidence for Kv7.4/7.5 heteromer formation, however, is lacking. Furthermore, it remains to be determined whether both subunits are regulated by PKC. Utilizing proximity ligation assays to visualize single molecule interactions, we now show that Kv7.4/Kv.7.5 heteromers are endogenously expressed in vascular smooth muscle cells. Introduction of dominant-negative Kv7.4 and Kv7.5 subunits in mesenteric artery myocytes reduced endogenous Kv7 currents by 84 and 76%, respectively. Expression of an inducible protein kinase C (PKC) translocation system revealed that PKC activation is sufficient to suppress endogenous Kv7 currents in A7r5 rat aortic and mesenteric artery smooth muscle cells. Arginine vasopressin (100 and 500 pm) and the PKC activator phorbol 12-myristate 13-acetate (1 nm) each inhibited human (h) Kv7.5 and hKv7.4/7.5, but not hKv7.4 channels expressed in A7r5 cells. A decrease in hKv7.5 and hKv7.4/7.5 current densities was associated with an increase in PKC-dependent phosphorylation of the channel proteins. These findings provide further evidence for a differential regulation of Kv7.4 and Kv7.5 channel subunits by PKC-dependent phosphorylation and new mechanistic insights into the role of heteromeric subunit assembly for regulation of vascular Kv7 channels.	[Brueggemann, Lioubov I.; Mackie, Alexander R.; Freda, Jessica; Majetschak, Matthias; Byron, Kenneth L.] Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Cribbs, Leanne L.] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Tripathi, Abhishek; Majetschak, Matthias; Byron, Kenneth L.] Loyola Univ Chicago, Stritch Sch Med, Dept Surg, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Byron, KL (corresponding author), 2160 S First Ave, Maywood, IL 60153 USA.	kbyron@lumc.edu		Byron, Kenneth/0000-0002-3875-9667	National Institutes of Health [R01 HL089564]; American Heart Association [0715618Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL089564 (to K. L. B.) and American Heart Association Pre-doctoral Fellowship 0715618Z (to A. R. M.).	Bal M, 2008, J BIOL CHEM, V283, P30668, DOI 10.1074/jbc.M805216200; Bal M, 2010, J NEUROSCI, V30, P2311, DOI 10.1523/JNEUROSCI.5175-09.2010; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Brueggemann LI, 2006, J PHARMACOL EXP THER, V317, P488, DOI 10.1124/jpet.105.095067; Brueggemann LI, 2007, AM J PHYSIOL-HEART C, V292, pH1352, DOI 10.1152/ajpheart.00065.2006; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; Brueggemann LI, 2009, MOL PHARMACOL, V76, P1053, DOI 10.1124/mol.109.057844; BYRON KL, 1993, J BIOL CHEM, V268, P6945; Chadha PS, 2012, HYPERTENSION, V59, P877, DOI 10.1161/HYPERTENSIONAHA.111.187427; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Fan JP, 2000, J PHYSIOL-LONDON, V524, P821, DOI 10.1111/j.1469-7793.2000.00821.x; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J NEUROSCI, V23, P84; Gratton JP, 2003, NAT MED, V9, P357, DOI 10.1038/nm835; Henderson KK, 2007, J APPL PHYSIOL, V102, P1402, DOI 10.1152/japplphysiol.00825.2006; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Jepps TA, 2011, CIRCULATION, V124, P602, DOI 10.1161/CIRCULATIONAHA.111.032136; Jepps TA, 2009, AM J PHYSIOL-GASTR L, V297, pG107, DOI 10.1152/ajpgi.00057.2009; Joshi S, 2009, J PHARMACOL EXP THER, V329, P368, DOI 10.1124/jpet.108.147785; Khanamiri S, 2013, HYPERTENSION, V62, P1090, DOI 10.1161/HYPERTENSIONAHA.113.01244; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Mackie AR, 2008, J PHARMACOL EXP THER, V325, P475, DOI 10.1124/jpet.107.135764; Mani BK, 2013, J CARDIOVASC PHARM, V61, P51, DOI 10.1097/FJC.0b013e3182771708; Mani BK, 2009, CELL CALCIUM, V45, P400, DOI 10.1016/j.ceca.2009.01.004; McCallum LA, 2011, J CELL MOL MED, V15, P577, DOI 10.1111/j.1582-4934.2010.01021.x; Nakajo K, 2005, J PHYSIOL-LONDON, V569, P59, DOI 10.1113/jphysiol.2005.094995; Navedo MF, 2010, CIRC RES, V106, P748, DOI 10.1161/CIRCRESAHA.109.213363; Ng FL, 2011, BRIT J PHARMACOL, V162, P42, DOI 10.1111/j.1476-5381.2010.01027.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spitzmaul G, 2013, J BIOL CHEM, V288, P9334, DOI 10.1074/jbc.M112.433383; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wickenden AD, 2001, BRIT J PHARMACOL, V132, P381, DOI 10.1038/sj.bjp.0703861; Yeung SYM, 2007, BRIT J PHARMACOL, V151, P758, DOI 10.1038/sj.bjp.0707284; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	48	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2099	2111		10.1074/jbc.M113.527820	http://dx.doi.org/10.1074/jbc.M113.527820			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24297175	Green Published, hybrid			2022-12-28	WOS:000331130200019
J	Hanna, J; Waterman, D; Isasa, M; Elsasser, S; Shi, Y; Gygi, S; Finley, D				Hanna, John; Waterman, David; Isasa, Marta; Elsasser, Suzanne; Shi, Yuan; Gygi, Steven; Finley, Daniel			Cuz1/Ynl155w, a Zinc-dependent Ubiquitin-binding Protein, Protects Cells from Metalloid-induced Proteotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Proteasome; Protein Degradation; Protein Misfolding; Stress Response; Ubiquitin	PROTEASOMAL DEGRADATION; TRANSCRIPTION FACTOR; 26S PROTEASOME; EXPRESSION; RESISTANCE; CDC48; IDENTIFICATION; SYSTEM; RPN1; UBP6	Background: Protein misfolding, a universal threat to cells, is dealt with by the ubiquitin-proteasome system. Results: Ynl155w is a zinc-dependent ubiquitin-binding protein, interacts with proteasome and Cdc48, and is essential for surviving metalloids. Conclusion: Ynl155w may protect cells from metalloid-induced proteotoxicity by delivering ubiquitinated proteins to Cdc48 and proteasome. Significance: Ynl155w represents a novel stress response factor for misfolded proteins. Protein misfolding is a universal threat to cells. The ubiquitin-proteasome system mediates a cellular stress response capable of eliminating misfolded proteins. Here we identify Cuz1/Ynl155w as a component of the ubiquitin system, capable of interacting with both the proteasome and Cdc48. Cuz1/Ynl155w is regulated by the transcription factor Rpn4, and is required for cells to survive exposure to the trivalent metalloids arsenic and antimony. A related protein, Yor052c, shows similar phenotypes, suggesting a multicomponent stress response pathway. Cuz1/Ynl155w functions as a zinc-dependent ubiquitin-binding protein. Thus, Cuz1/Ynl155w is proposed to protect cells from metalloid-induced proteotoxicity by delivering ubiquitinated substrates to Cdc48 and the proteasome for destruction.	[Hanna, John] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Waterman, David; Isasa, Marta; Elsasser, Suzanne; Shi, Yuan; Gygi, Steven; Finley, Daniel] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hanna, J (corresponding author), 75 Francis St, Boston, MA 02115 USA.	jwhanna@partners.org			National Institutes of Health [GM043601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122, R37GM043601, R01GM043601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM043601 (to D. F.).	Barthelme D, 2013, P NATL ACAD SCI USA, V110, P3327, DOI 10.1073/pnas.1300408110; Barthelme D, 2012, SCIENCE, V337, P843, DOI 10.1126/science.1224352; Buchberger Alexander, 2013, Subcell Biochem, V66, P195, DOI 10.1007/978-94-007-5940-4_8; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hanna J, 2012, J BIOL CHEM, V287, P34400, DOI 10.1074/jbc.M112.390294; Hwang GW, 2006, FEBS LETT, V580, P6813, DOI 10.1016/j.febslet.2006.11.045; Jacobson T, 2012, J CELL SCI, V125, P5073, DOI 10.1242/jcs.107029; Kirkpatrick DS, 2003, TOXICOL APPL PHARM, V186, P101, DOI 10.1016/S0041-008X(02)00019-4; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Matyskiela ME, 2013, J MOL BIOL, V425, P199, DOI 10.1016/j.jmb.2012.11.001; Owsianik G, 2002, MOL MICROBIOL, V43, P1295, DOI 10.1046/j.1365-2958.2002.02823.x; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Randles L, 2012, FRONT BIOSCI-LANDMRK, V17, P2140, DOI 10.2741/4042; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Sa-Moura B, 2013, J BIOL CHEM, V288, P33682, DOI 10.1074/jbc.M113.521088; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Wang XG, 2010, GENETICS, V184, P335, DOI 10.1534/genetics.109.112227; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	33	11	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1876	1885		10.1074/jbc.M113.534032	http://dx.doi.org/10.1074/jbc.M113.534032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297164	hybrid, Green Published			2022-12-28	WOS:000332401700056
J	Li, QL; Eades, G; Yao, Y; Zhang, YS; Zhou, Q				Li, Qinglin; Eades, Gabriel; Yao, Yuan; Zhang, Yongshu; Zhou, Qun			Characterization of a Stem-like Subpopulation in Basal-like Ductal Carcinoma in Situ (DCIS) Lesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Exosomes; MicroRNA; Breast Cancer; Cancer Stem Cells; Chemoprevention; Basal-like DCIS Stem Cell; Sulforaphane	INVASIVE BREAST-CANCER; CELLS; EXPRESSION; TRANSITION; EXOSOMES; WOMEN; SIDE	Background: Very little is known about cancer stem cells in ductal carcinoma in situ (DCIS). Results: Basal-like DCIS contain CD49f+/CD24- ALDH1+ stem-like subpopulations with enhanced migratory capacity, unique exosomal microRNA signature, and sulforaphane sensitivity. Conclusion: We characterized basal-like DCIS stem cells and demonstrate a potential chemopreventive strategy. Significance: DCIS stem cells are important therapeutic targets for preventing recurrence or progression to invasive disease. Previously, we found that basal-like ductal carcinoma in situ (DCIS) contains cancer stem-like cells. Here, we characterize stem-like subpopulations in a model of basal-like DCIS and identify subpopulations of CD49f+/CD24- stem-like cells that possess aldehyde dehydrogenase 1 activity. We found that these cells show enhanced migration potential compared with non-stem DCIS cells. We also found that the chemopreventive agent sulforaphane can target these DCIS stem-like cells, reduce aldehyde dehydrogenase 1 (ALDH1) expression, and decrease mammosphere and progenitor colony formation. Furthermore, we characterized exosomal trafficking of microRNAs in DCIS and found that several microRNAs (miRs) including miR-140, miR-29a, and miR-21 are differentially expressed in exosomes from DCIS stem-like cells. We found that SFN treatment could reprogram DCIS stem-like cells as evidenced by significant changes in exosomal secretion more closely resembling that of non-stem cancer cells. Finally, we demonstrated that exosomal secretion of miR-140 might impact signaling in nearby breast cancer cells.	[Li, Qinglin; Eades, Gabriel; Yao, Yuan; Zhang, Yongshu; Zhou, Qun] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Zhou, Q (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	qzhou@som.umaryland.edu	Li, Qinglin/K-2570-2015	Li, Qinglin/0000-0002-4125-1944	American Cancer Society; NCI, National Institutes of Health [R01 CA163820, R01 CA157779]; NATIONAL CANCER INSTITUTE [R01CA157779, P30CA134274, R01CA163820, T32CA154274] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by grants from American Cancer Society and NCI, National Institutes of Health R01 CA163820 and R01 CA157779 (to Q. Z.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; Espina V., 2010, PLOS ONE, V5; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Fisher B, 2001, SEMIN ONCOL, V28, P400, DOI 10.1053/sonc.2001.26151; Fowble B, 1997, INT J RADIAT ONCOL, V38, P949, DOI 10.1016/S0360-3016(97)00153-3; George WD, 2003, LANCET, V362, P95, DOI 10.1016/S0140-6736(03)13859-7; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Leonard GD, 2004, JNCI-J NATL CANCER I, V96, P906, DOI 10.1093/jnci/djh164; Li Q., 2013, ONCOGENE, V10, DOI 1038/onc.2013.226; Liu SL, 2012, J MAMMARY GLAND BIOL, V17, P15, DOI 10.1007/s10911-012-9242-8; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Nakanishi T, 2010, BRIT J CANCER, V102, P815, DOI 10.1038/sj.bjc.6605553; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Schnitt SJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2228; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130	22	60	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1303	1312		10.1074/jbc.M113.502278	http://dx.doi.org/10.1074/jbc.M113.502278			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297178	Green Published, hybrid			2022-12-28	WOS:000332401700010
J	Vogel, CFA; Khan, EM; Leung, PSC; Gershwin, ME; Chang, WLW; Wu, DL; Haarmann-Stemmann, T; Hoffmann, A; Denison, MS				Vogel, Christoph F. A.; Khan, Elaine M.; Leung, Patrick S. C.; Gershwin, M. Eric; Chang, W. L. William; Wu, Dalei; Haarmann-Stemmann, Thomas; Hoffmann, Alexander; Denison, Michael S.			Cross-talk between Aryl Hydrocarbon Receptor and the Inflammatory Response A ROLE FOR NUCLEAR FACTOR-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aryl Hydrocarbon Receptor; Dendritic Cells; Gene Regulation; Inflammation; NF-Kappa B (NF-KB)	TRANSFORMING GROWTH FACTOR-BETA(1); T-CELLS; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; TRANSCRIPTION FACTORS; RHEUMATOID-ARTHRITIS; DENDRITIC CELLS; IMMUNE-SYSTEM; MOUSE EMBRYO; AHR GENE; EXPRESSION	Background: Aryl hydrocarbon receptor (AhR) is a protein regulating differentiation and function of immune cells. Results: NF-B activates transcription of AhR and enhances activity of AhR-regulated genes. Conclusion: Activation of NF-B involves RelA-mediated expression of AhR. Significance: Inflammatory stimuli and cytokines that regulate NF-B induce AhR expression during activation and differentiation of immune cells. The aryl hydrocarbon receptor (AhR) is involved in the regulation of immune responses, T-cell differentiation, and immunity. Here, we show that inflammatory stimuli such as LPS induce the expression of AhR in human dendritic cells (DC) associated with an AhR-dependent increase of CYP1A1 (cytochrome P4501A1). In vivo data confirmed the elevated expression of AhR by LPS and the LPS-enhanced 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated induction of CYP1A1 in thymus of B6 mice. Inhibition of nuclear factor-B (NF-B) repressed both normal and LPS-enhanced, TCDD-inducible, AhR-dependent gene expression and canonical pathway control of RelA-regulated AhR-responsive gene expression. LPS-mediated induction of AhR was NF-B-dependent, as shown in mouse embryonic fibroblasts (MEFs) derived from Rel null mice. AhR expression and TCDD-mediated induction of CYP1A1 was significantly reduced in RelA-deficient MEF compared with wild type MEF cells and ectopic expression of RelA restored the expression of AhR and induction of CYP1A1 in MEF RelA null cells. Promoter analysis of the human AhR gene identified three putative NF-B-binding elements upstream of the transcription start site. Mutation analysis of the AhR promoter identified one NF-B site as responsible for mediating the induction of AhR expression by LPS and electrophoretic shift assays demonstrated that this NF-B motif is recognized by the RelA/p50 heterodimer. Our results show for the first time that NF-B RelA is a critical component regulating the expression of AhR and the induction of AhR-dependent gene expression in immune cells illustrating the interaction of AhR and NF-B signaling.	[Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Vogel, Christoph F. A.] Univ Calif Davis, Ctr Hlth & Environm, Davis, CA 95616 USA; [Leung, Patrick S. C.; Gershwin, M. Eric] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Chang, W. L. William] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Wu, Dalei] Sanford Burnham Med Res Inst, Orlando, FL 32827 USA; [Haarmann-Stemmann, Thomas] Leibniz Res Inst Environm Med, D-40225 Dusseldorf, Germany; [Hoffmann, Alexander] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90025 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Sanford Burnham Prebys Medical Discovery Institute; Leibniz Institut fur Umweltmedizinische Forschung (IUF); University of California System; University of California Los Angeles	Vogel, CFA (corresponding author), Univ Calif Davis, Dept Environm Toxicol, 1 Shields Ave, Davis, CA 95616 USA.	cfvogel@ucdavis.edu	Chang, W. L. William/AAX-1773-2021		NIEHS, National Institutes of Health [R01 ES019898-02, R01 ES007685]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007685, R01ES019898] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by NIEHS, National Institutes of Health Grants R01 ES019898-02 (to C. F. A. V.) and R01 ES007685 (to M. S. D.).	ABBOTT BD, 1995, DEV DYNAM, V204, P144, DOI 10.1002/aja.1002040205; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Allan LL, 2005, MOL PHARMACOL, V67, P1740, DOI 10.1124/mol.104.009100; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bankoti J, 2010, TOXICOL APPL PHARM, V246, P18, DOI 10.1016/j.taap.2010.03.013; CARRIER F, 1992, MOL CELL BIOL, V12, P1856, DOI 10.1128/MCB.12.4.1856; Chang WLW, 2004, J VIROL, V78, P8720, DOI 10.1128/JVI.78.16.8720-8731.2004; Chen YH, 1996, J BIOL CHEM, V271, P26261, DOI 10.1074/jbc.271.42.26261; Crawford RB, 1997, MOL PHARMACOL, V52, P921, DOI 10.1124/mol.52.6.921; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; FitzGerald CT, 1996, ARCH BIOCHEM BIOPHYS, V333, P170, DOI 10.1006/abbi.1996.0378; Fitzgerald CT, 1998, DNA CELL BIOL, V17, P811, DOI 10.1089/dna.1998.17.811; HAYASHI S, 1995, CARCINOGENESIS, V16, P1403, DOI 10.1093/carcin/16.6.1403; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Jin GB, 2010, TOXICOL SCI, V116, P514, DOI 10.1093/toxsci/kfq153; Kenyon NJ, 2008, TOXICOL APPL PHARM, V230, P269, DOI 10.1016/j.taap.2008.03.004; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Kobayashi S, 2008, RHEUMATOLOGY, V47, P1317, DOI 10.1093/rheumatology/ken259; Kostyuk VA, 2013, CURR MED CHEM, V20, P869; Lahoti TS, 2013, ANN RHEUM DIS, V72, P1708, DOI 10.1136/annrheumdis-2012-202639; Lawrence BP, 2012, NAT IMMUNOL, V13, P117, DOI 10.1038/ni.2213; Lawrence BP, 1996, TOXICOL APPL PHARM, V138, P275, DOI 10.1006/taap.1996.0126; Long WP, 1998, MOL PHARMACOL, V53, P691, DOI 10.1124/mol.53.4.691; Luecke S, 2010, CHEM-BIOL INTERACT, V184, P466, DOI 10.1016/j.cbi.2010.01.038; LUSTER MI, 1988, J IMMUNOL, V140, P928; Marshall NB, 2010, ANN NY ACAD SCI, V1183, P25, DOI 10.1111/j.1749-6632.2009.05125.x; MORRIS DL, 1993, IMMUNOPHARMACOLOGY, V26, P105, DOI 10.1016/0162-3109(93)90002-8; Nakahama T, 2011, P NATL ACAD SCI USA, V108, P14222, DOI 10.1073/pnas.1111786108; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Ruby CE, 2002, MOL PHARMACOL, V62, P722, DOI 10.1124/mol.62.3.722; SCHMIDT JV, 1993, J BIOL CHEM, V268, P22203; Shih VFS, 2012, NAT IMMUNOL, V13, P1162, DOI 10.1038/ni.2446; Sulentic CEW, 2011, TOXICOL SCI, V120, pS171, DOI 10.1093/toxsci/kfq324; Tian Y, 1999, J BIOL CHEM, V274, P510, DOI 10.1074/jbc.274.1.510; Tsuda M, 2011, HEPATOLOGY, V54, P1293, DOI 10.1002/hep.24526; TUCKER AN, 1986, MOL PHARMACOL, V29, P372; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; VOGEL C, 1994, ARCH TOXICOL, V68, P303, DOI 10.1007/s002040050073; Vogel CFA, 2003, BIOCHEM PHARMACOL, V66, P1231, DOI 10.1016/S0006-2952(03)00404-0; Vogel CFA, 2008, BIOCHEM BIOPH RES CO, V375, P331, DOI 10.1016/j.bbrc.2008.07.156; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; Vogel CFA, 2009, BIOCHEM PHARMACOL, V77, P734, DOI 10.1016/j.bcp.2008.09.036; Wolff S, 2001, MOL PHARMACOL, V59, P716, DOI 10.1124/mol.59.4.716; Wu DL, 2011, BIOCHEM BIOPH RES CO, V410, P358, DOI 10.1016/j.bbrc.2011.06.018	46	176	186	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1866	1875		10.1074/jbc.M113.505578	http://dx.doi.org/10.1074/jbc.M113.505578			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302727	Green Published, hybrid			2022-12-28	WOS:000332401700055
J	Lizak, C; Gerber, S; Zinne, D; Michaud, G; Schubert, M; Chen, F; Bucher, M; Darbre, T; Zenobi, R; Reymond, JL; Locher, KP				Lizak, Christian; Gerber, Sabina; Zinne, Daria; Michaud, Gaelle; Schubert, Mario; Chen, Fan; Bucher, Monika; Darbre, Tamis; Zenobi, Renato; Reymond, Jean-Louis; Locher, Kaspar P.			A Catalytically Essential Motif in External Loop 5 of the Bacterial Oligosaccharyltransferase PglB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED PROTEIN GLYCOSYLATION; X-RAY-STRUCTURE; SUBSTRATE-SPECIFICITY; N-GLYCOSYLATION; CAMPYLOBACTER-JEJUNI; MECHANISM; COMPLEX; STT3; GLYCANS; ROLES	Asparagine-linked glycosylation is a post-translational protein modification that is conserved in all domains of life. The initial transfer of a lipid-linked oligosaccharide (LLO) onto acceptor asparagines is catalyzed by the integral membrane protein oligosaccharyltransferase (OST). The previously reported structure of a single-subunit OST enzyme, the Campylobacter lari protein PglB, revealed a partially disordered external loop (EL5), whose role in catalysis was unclear. We identified a new and functionally important sequence motif in EL5 containing a conserved tyrosine residue (Tyr(293)) whose aromatic side chain is essential for catalysis. A synthetic peptide containing the conserved motif can partially but specifically rescue in vitro activity of mutated PglB lacking Tyr293. Using site-directed disulfide cross-linking, we show that disengagement of the structurally ordered part of EL5 is an essential step of the glycosylation reaction, probably by allowing sequon binding or glyco-product release. Our findings define two distinct mechanistic roles of EL5 in OST-catalyzed glycosylation. These functions, exerted by the two halves of EL5, are independent, because the loop can be cleaved by specific proteolysis with only slight reduction in activity.	[Lizak, Christian; Gerber, Sabina; Zinne, Daria; Schubert, Mario; Bucher, Monika; Locher, Kaspar P.] ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Michaud, Gaelle; Darbre, Tamis; Reymond, Jean-Louis] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Chen, Fan; Zenobi, Renato] ETH, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Dept Biol, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	locher@mol.biol.ethz.ch	Schubert, Mario/B-3972-2008	Schubert, Mario/0000-0003-0278-4091; Reymond, Jean-Louis/0000-0003-2724-2942	NCCR Structural Biology Zurich; Swiss National Science Foundation Grants [SNF 200020-125020, SNF 200020-124663, SNF 31003A-131075/1, SNF 31003A-146191/1]	NCCR Structural Biology Zurich; Swiss National Science Foundation Grants(Swiss National Science Foundation (SNSF))	This work was supported by a grant from NCCR Structural Biology Zurich (to K. P. L.) and Swiss National Science Foundation Grants SNF 200020-125020 (to J. L. R.), SNF 200020-124663 (to R. Z.), and SNF 31003A-131075/1 and SNF 31003A-146191/1 (to K. P. L.).	Abu-Qarn M, 2007, J MOL BIOL, V374, P1224, DOI 10.1016/j.jmb.2007.10.042; Baar C, 2003, P NATL ACAD SCI USA, V100, P11690, DOI 10.1073/pnas.1932838100; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Chen F, 2013, ANAL CHEM, V85, P3483, DOI 10.1021/ac4000943; Dell Anne, 2010, Int J Microbiol, V2010, P148178, DOI 10.1155/2010/148178; Eichler J, 2013, NAT REV MICROBIOL, V11, P151, DOI 10.1038/nrmicro2957; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Gerber S, 2013, J BIOL CHEM, V288, P8849, DOI 10.1074/jbc.M112.445940; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; Jervis AJ, 2012, J BACTERIOL, V194, P2355, DOI 10.1128/JB.00042-12; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; Lizak C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3627; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lizak C, 2011, BIOCONJUGATE CHEM, V22, P488, DOI 10.1021/bc100511k; Losfeld ME, 2012, FASEB J, V26, P4210, DOI 10.1096/fj.12-211656; Markley JL, 1998, PURE APPL CHEM, V70, P117, DOI 10.1351/pac199870010117; Matsumoto S, 2013, P NATL ACAD SCI USA, V110, P17868, DOI 10.1073/pnas.1309777110; Mattle D, 2010, J MOL BIOL, V404, P220, DOI 10.1016/j.jmb.2010.09.005; Morales JC, 2008, CHEM-EUR J, V14, P7828, DOI 10.1002/chem.200800335; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; Nothaft H, 2013, J BIOL CHEM, V288, P6912, DOI 10.1074/jbc.R112.417857; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Nyirenda J, 2013, STRUCTURE, V21, P32, DOI 10.1016/j.str.2012.10.011; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Schubert M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002706; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Tai VWF, 2001, BIOORGAN MED CHEM, V9, P1133, DOI 10.1016/S0968-0896(00)00334-5; Tai VWF, 2001, J ORG CHEM, V66, P6217, DOI 10.1021/jo0100345; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Woo JS, 2012, NAT STRUCT MOL BIOL, V19, P1310, DOI 10.1038/nsmb.2417; WRIGHT CS, 1990, J MOL BIOL, V215, P635, DOI 10.1016/S0022-2836(05)80174-3; WRIGHT CS, 1984, J MOL BIOL, V178, P91, DOI 10.1016/0022-2836(84)90232-8; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200	43	21	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					735	746		10.1074/jbc.M113.524751	http://dx.doi.org/10.1074/jbc.M113.524751			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275651	Green Published, hybrid			2022-12-28	WOS:000330541200013
J	Qian, YF; Kachroo, AH; Yellman, CM; Marcotte, EM; Johnson, KA				Qian, Yufeng; Kachroo, Aashiq H.; Yellman, Christopher M.; Marcotte, Edward M.; Johnson, Kenneth A.			Yeast Cells Expressing the Human Mitochondrial DNA Polymerase Reveal Correlations between Polymerase Fidelity and Human Disease Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Polymerase; DNA Replication; Mitochondrial DNA; Nucleic Acid Enzymology; Yeast; Human Mitochondria	SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; POLG MUTATIONS; MTDNA; GAMMA; DEFECTS; RECONSTITUTION; REPLICATION; MUTAGENESIS; GENES	Background: Mutations in the human mitochondrial DNA polymerase (Pol-) have been linked to diseases with varying severity and age of onset. Results: Yeast cells expressing human Pol- reveal a correlation of Pol- fidelity with human disease onset. Conclusion: Humanized yeast provides an efficient system to correlate biochemical defects in Pol- with physiological consequences. Significance: The Pol--associated diseases may be caused by the low accuracy of Pol- mutants, not low rates of replication. Mutations in the human mitochondrial polymerase (polymerase- (Pol-)) are associated with various mitochondrial disorders, including mitochondrial DNA (mtDNA) depletion syndrome, Alpers syndrome, and progressive external opthamalplegia. To correlate biochemically quantifiable defects resulting from point mutations in Pol- with their physiological consequences, we created humanized yeast, replacing the yeast mtDNA polymerase (MIP1) with human Pol-. Despite differences in the replication and repair mechanism, we show that the human polymerase efficiently complements the yeast mip1 knockouts, suggesting common fundamental mechanisms of replication and conserved interactions between the human polymerase and other components of the replisome. We also examined the effects of four disease-related point mutations (S305R, H932Y, Y951N, and Y955C) and an exonuclease-deficient mutant (D198A/E200A). In haploid cells, each mutant results in rapid mtDNA depletion, increased mutation frequency, and mitochondrial dysfunction. Mutation frequencies measured in vivo equal those measured with purified enzyme in vitro. In heterozygous diploid cells, wild-type Pol- suppresses mutation-associated growth defects, but continuous growth eventually leads to aerobic respiration defects, reduced mtDNA content, and depolarized mitochondrial membranes. The severity of the Pol- mutant phenotype in heterozygous diploid humanized yeast correlates with the approximate age of disease onset and the severity of symptoms observed in humans.	[Qian, Yufeng; Kachroo, Aashiq H.; Yellman, Christopher M.; Marcotte, Edward M.; Johnson, Kenneth A.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Kachroo, Aashiq H.; Yellman, Christopher M.; Marcotte, Edward M.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Marcotte, Edward M.; Johnson, Kenneth A.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Qian, YF (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, 2500 Speedway, Austin, TX 78712 USA.	yufengqian1005@gmail.com; kajohnson@mail.utexas.edu	Qian, Yufeng/F-3699-2012; Kachroo, Aashiq/Z-2505-2019	Qian, Yufeng/0000-0002-9901-6154; Kachroo, Aashiq/0000-0001-9770-778X; Marcotte, Edward/0000-0001-8808-180X	National Institutes of Health [GM044613]; National Institutes of Health, NIGMS; Welch Foundation [F-1604, F-1515]; National Science Foundation; Cancer Prevention Research Institute of Texas; United States Army [58343-MA]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076536, R01GM044613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); Cancer Prevention Research Institute of Texas; United States Army(United States Department of DefenseUnited States Army); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM044613 (to K. A. J.) and a grant from the National Institutes of Health, NIGMS (to E. M. M.). This work was also supported by Welch Foundation Grants F-1604 (to K. A. J.) and F-1515 (to E. M. M.), the National Science Foundation (to E. M. M.), the Cancer Prevention Research Institute of Texas (to E. M. M.), and United States Army Grant 58343-MA (to E. M. M.).	Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565; Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002; Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007; Batabyal D, 2010, J BIOL CHEM, V285, P34191, DOI 10.1074/jbc.M110.156182; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203; Dunham MJ, 2013, CURR OPIN GENET DEV, V23, P658, DOI 10.1016/j.gde.2013.10.001; Estep PA, 2011, BIOCHEMISTRY-US, V50, P6376, DOI 10.1021/bi200280r; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9; Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108; Foury F, 2002, CURR OPIN CHEM BIOL, V6, P106, DOI 10.1016/S1367-5931(01)00276-9; Franssens V, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/760629; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005; Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003; Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332; Kuusk S, 2005, J BIOL CHEM, V280, P24322, DOI 10.1074/jbc.M500354200; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; Lai CY, 2002, GENETICS, V162, P73; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Martinez MJ, 2004, MOL BIOL CELL, V15, P5295, DOI 10.1091/mbc.E03-11-0856; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Qian YF, 2013, BIOPHYS J, V104, p74A, DOI 10.1016/j.bpj.2012.11.448; Rinaldi T, 2010, FEMS YEAST RES, V10, P1006, DOI 10.1111/j.1567-1364.2010.00685.x; Shadel GS, 1999, AM J HUM GENET, V65, P1230, DOI 10.1086/302630; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Sohl CD, 2013, HUM MOL GENET, V22, P1074, DOI 10.1093/hmg/dds509; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454; Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4; Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089; Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267; Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Viikov K, 2011, MITOCHONDRION, V11, P119, DOI 10.1016/j.mito.2010.08.007; Vogelsang M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-382; Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598; Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634; Winderickx J, 2008, BBA-MOL CELL RES, V1783, P1381, DOI 10.1016/j.bbamcr.2008.01.020	56	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5970	5985		10.1074/jbc.M113.526418	http://dx.doi.org/10.1074/jbc.M113.526418			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398692	Green Published, hybrid			2022-12-28	WOS:000332015500053
J	Ruiz, R; Jideonwo, V; Ahn, M; Surendran, S; Tagliabracci, VS; Hou, YY; Gamble, A; Kerner, J; Irimia-Dominguez, JM; Puchowicz, MA; DePaoli-Roach, A; Hoppel, C; Roach, P; Morral, N				Ruiz, Rafaela; Jideonwo, Victoria; Ahn, Miwon; Surendran, Sneha; Tagliabracci, Vincent S.; Hou, Yongyong; Gamble, Aisha; Kerner, Janos; Irimia-Dominguez, Jose M.; Puchowicz, Michelle A.; DePaoli-Roach, Anna; Hoppel, Charles; Roach, Peter; Morral, Nuria			Sterol Regulatory Element-binding Protein-1 (SREBP-1) Is Required to Regulate Glycogen Synthesis and Gluconeogenic Gene Expression in Mouse Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Expression; Gluconeogenesis; Glucose Metabolism; Insulin Resistance; Liver Metabolism	DEPENDENT ADENOVIRAL VECTORS; HEPATIC STEATOSIS; INSULIN-RESISTANCE; FATTY LIVERS; MICE LACKING; OB/OB MICE; RAT-LIVER; IN-VIVO; GLUCOSE; OBESITY	Background: The role of SREBP-1 in regulating carbohydrate metabolism is unclear. Results: Silencing SREBP-1 reduced glycogen buildup and expression of genes involved in glycogen synthesis as well as gluconeogenesis. Conclusion: SREBP-1 is needed to regulate carbohydrate metabolism during the fed state. Thus, its depletion does not improve insulin resistance. Significance: This report provides a novel function for SREBP-1. Sterol regulatory element-binding protein-1 (SREBP-1) is a key transcription factor that regulates genes in the de novo lipogenesis and glycolysis pathways. The levels of SREBP-1 are significantly elevated in obese patients and in animal models of obesity and type 2 diabetes, and a vast number of studies have implicated this transcription factor as a contributor to hepatic lipid accumulation and insulin resistance. However, its role in regulating carbohydrate metabolism is poorly understood. Here we have addressed whether SREBP-1 is needed for regulating glucose homeostasis. Using RNAi and a new generation of adenoviral vector, we have silenced hepatic SREBP-1 in normal and obese mice. In normal animals, SREBP-1 deficiency increased Pck1 and reduced glycogen deposition during fed conditions, providing evidence that SREBP-1 is necessary to regulate carbohydrate metabolism during the fed state. Knocking SREBP-1 down in db/db mice resulted in a significant reduction in triglyceride accumulation, as anticipated. However, mice remained hyperglycemic, which was associated with up-regulation of gluconeogenesis gene expression as well as decreased glycolysis and glycogen synthesis gene expression. Furthermore, glycogen synthase activity and glycogen accumulation were significantly reduced. In conclusion, silencing both isoforms of SREBP-1 leads to significant changes in carbohydrate metabolism and does not improve insulin resistance despite reducing steatosis in an animal model of obesity and type 2 diabetes.	[Ruiz, Rafaela; Jideonwo, Victoria; Ahn, Miwon; Surendran, Sneha; Hou, Yongyong; Gamble, Aisha; Morral, Nuria] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Tagliabracci, Vincent S.; Irimia-Dominguez, Jose M.; DePaoli-Roach, Anna; Roach, Peter; Morral, Nuria] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Ruiz, Rafaela] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kerner, Janos; Hoppel, Charles] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Puchowicz, Michelle A.] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Case Western Reserve University; Case Western Reserve University	Morral, N (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, 975 W Walnut St,IB 130, Indianapolis, IN 46202 USA.	nmorralc@iu.edu	Morral, Nuria/AAC-7149-2020	Morral, Nuria/0000-0002-8932-2887	National Institutes of Health through the NIDDK [R01DK078595]; American Diabetes Association [1-08-RA-135]; National Institutes of Health [DK59637, U24-DK76174, R01DK078595-05S1]; T32-Diabetes and Obesity Research Training Program [DK064466]; DeVault diabetes and obesity program; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076174, U24DK059637, R01DK078595, U2CDK059637, T32DK064466, R37DK027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056454] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32-Diabetes and Obesity Research Training Program; DeVault diabetes and obesity program; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK078595 through the NIDDK. This work was also supported by American Diabetes Association Grant 1-08-RA-135. The Mouse Metabolic Phenotyping Centers at Vanderbilt University and Case Western Reserve University are supported by National Institutes of Health Grants DK59637 and U24-DK76174, respectively.; Supported by National Institutes of Health Grant R01DK078595-05S1.; Supported by the T32-Diabetes and Obesity Research Training Program Grant DK064466.; Supported by predoctoral fellowships from the DeVault diabetes and obesity program and the American Heart Association.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Becard D, 2001, DIABETES, V50, P2425, DOI 10.2337/diabetes.50.11.2425; Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunengraber DZ, 2003, AM J PHYSIOL-ENDOC M, V285, pE917, DOI 10.1152/ajpendo.00128.2003; Chakravarty K, 2004, J BIOL CHEM, V279, P15385, DOI 10.1074/jbc.M309905200; Deng S, 2009, J BIOL CHEM, V284, P27799, DOI 10.1074/jbc.M109.048744; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; GUINOVART JJ, 1979, FEBS LETT, V106, P284, DOI 10.1016/0014-5793(79)80515-3; Hansmannel F, 2006, BIOCHEM J, V399, P275, DOI 10.1042/BJ20060811; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; Harris SR, 2011, J BIOL CHEM, V286, P5895, DOI 10.1074/jbc.M110.196808; Hoppel CL, 1998, J BIOL CHEM, V273, P23495, DOI 10.1074/jbc.273.36.23495; Horton JD, 1999, J CLIN INVEST, V103, P1067, DOI 10.1172/JCI6246; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Li QL, 2012, FREE RADICAL BIO MED, V52, P1043, DOI 10.1016/j.freeradbiomed.2011.12.022; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Moore DD, 2012, CELL METAB, V15, P615, DOI 10.1016/j.cmet.2012.03.016; Morral N, 1998, HUM GENE THER, V9, P2709, DOI 10.1089/hum.1998.9.18-2709; Morral N, 1999, P NATL ACAD SCI USA, V96, P12816, DOI 10.1073/pnas.96.22.12816; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Pettinelli P, 2009, BBA-MOL BASIS DIS, V1792, P1080, DOI 10.1016/j.bbadis.2009.08.015; Richard J, 2011, EXPERT REV CARDIOVAS, V9, P321, DOI [10.1586/ERC.11.15, 10.1586/erc.11.15]; Ruiz R, 2009, HUM GENE THER, V20, P87, DOI 10.1089/hum.2008.081; Sandig V, 2000, P NATL ACAD SCI USA, V97, P1002, DOI 10.1073/pnas.97.3.1002; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Wendel AA, 2010, DIABETES, V59, P1321, DOI 10.2337/db09-1380; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200	40	83	84	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5510	5517		10.1074/jbc.M113.541110	http://dx.doi.org/10.1074/jbc.M113.541110			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398675	Green Published, hybrid			2022-12-28	WOS:000332015500015
J	Long, JM; Ray, B; Lahiri, DK				Long, Justin M.; Ray, Balmiki; Lahiri, Debomoy K.			MicroRNA-339-5p Down-regulates Protein Expression of beta-Site Amyloid Precursor Protein-Cleaving Enzyme 1 (BACE1) in Human Primary Brain Cultures and Is Reduced in Brain Tissue Specimens of Alzheimer Disease Subjects*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aging; Alzheimer Disease; Gene Regulation; MicroRNA; Secretases; -Peptide; Dementia; Human Brain Tissue; Human Neuron; Noncoding RNA	TRANSCRIPTIONAL REGULATION; SECRETASE; GENE; RNA; TARGETS; IDENTIFICATION; PROMOTER; CLEAVAGE; MIR-107; COMPLEX	Background: BACE1 is the rate-limiting enzyme in the synthesis of A from amyloid precursor protein. Results: Human miR-339-5p negatively regulates BACE1 and A in human brain cultures and is reduced in AD specimens. Conclusion: Human miR-339-5p physiologically regulates human BACE1 protein expression and A and is dysregulated in the AD brain. Significance: miR-339-5p represents a novel drug target in AD. Alzheimer disease (AD) results, in part, from the excess accumulation of the amyloid- (A) peptide as neuritic plaques in the brain. The short A peptide is derived from the large transmembrane A precursor protein (APP). The rate-limiting step in the production of A from APP is mediated by the -site APP-cleaving enzyme 1 (BACE1). Dysregulation of BACE1 levels leading to excess A deposition is implicated in sporadic AD. Thus, elucidating the full complement of regulatory pathways that control BACE1 expression is key to identifying novel drug targets central to the A-generating process. MicroRNAs (miRNAs) are expected to participate in this molecular network. Here, we identified a known miRNA, miR-339-5p, as a key contributor to this regulatory network. Two distinct miR-339-5p target sites were predicted in the BACE1 3-UTR by in silico analyses. Co-transfection of miR-339-5p with a BACE1 3-UTR reporter construct resulted in significant reduction in reporter expression. Mutation of both target sites eliminated this effect. Delivery of the miR-339-5p mimic also significantly inhibited expression of BACE1 protein in human glioblastoma cells and human primary brain cultures. Delivery of target protectors designed against the miR-339-5p BACE1 3-UTR target sites in primary human brain cultures significantly elevated BACE1 expression. Finally, miR-339-5p levels were found to be significantly reduced in brain specimens isolated from AD patients as compared with age-matched controls. Therefore, miR-339-5p regulates BACE1 expression in human brain cells and is most likely dysregulated in at least a subset of AD patients making this miRNA a novel drug target.	[Long, Justin M.; Ray, Balmiki; Lahiri, Debomoy K.] Indiana Univ Sch Med, Mol Neurogenet Lab, Inst Psychiat Res, Dept Psychiat, Indianapolis, IN 46202 USA; [Lahiri, Debomoy K.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Lahiri, DK (corresponding author), Indiana Univ Sch Med, Dept Psychiat, 791 Union Dr, Indianapolis, IN 46202 USA.	dlahiri@iupui.edu	Lahiri, Debomoy/AAZ-3322-2020	Long, Justin/0000-0003-0769-604X	National Institutes of Health [AG18379, AG18884, AG042804]; Alzheimer's Association Zenith award; Investigator Initiated Research Grant [IIRG-11-206418]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL107920, R01HL107920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018379, R21AG042804, R01AG018884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association Zenith award(Alzheimer's Association); Investigator Initiated Research Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG18379, AG18884, and AG042804 (to D. K. L.). This work was also supported by the Alzheimer's Association Zenith award and Investigator Initiated Research Grant IIRG-11-206418 (to D. K. L.).	Bailey JA, 2011, GENE, V488, P13, DOI 10.1016/j.gene.2011.06.017; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Barao S, 2013, CURR ALZHEIMER RES, V10, P671, DOI 10.2174/15672050113109990138; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Bruchova H, 2007, EXP HEMATOL, V35, P1657, DOI 10.1016/j.exphem.2007.08.021; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Delay C, 2012, NEUROBIOL DIS, V46, P285, DOI 10.1016/j.nbd.2012.01.003; Delay C, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-70; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Faghihi MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r56; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Fang MR, 2012, TOXICOL LETT, V209, P94, DOI 10.1016/j.toxlet.2011.11.032; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fleck D, 2012, CURR ALZHEIMER RES, V9, P178, DOI 10.2174/156720512799361637; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Ge YW, 2004, FASEB J, V18, P1037, DOI 10.1096/fj.03-1379fje; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2013, J ALZHEIMERS DIS, V35, P335, DOI 10.3233/JAD-122350; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Ichi S, 2010, J BIOL CHEM, V285, P36922, DOI 10.1074/jbc.M110.126714; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Ju XL, 2009, PEDIATR HEMAT ONCOL, V26, P1, DOI 10.1080/08880010802378338; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lahiri DK, 2009, MOL PSYCHIATR, V14, P992, DOI 10.1038/mp.2009.82; Lahiri DK, 2012, SCIENCE, V337, P1172, DOI 10.1126/science.337.6099.1172-a; Lahiri DK, 2006, J MOL NEUROSCI, V28, P193, DOI 10.1385/JMN:28:2:193; LAHIRI DK, 2014, ALZHEIMERS DEMENT; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Li Y, 2006, FASEB J, V20, P285, DOI 10.1096/fj.05-4986com; Liu W, 2012, NEUROBIOL AGING, V33, P522, DOI 10.1016/j.neurobiolaging.2010.04.034; Long JM, 2011, CURR MED CHEM, V18, P3314, DOI 10.2174/092986711796504592; Long JM, 2012, J BIOL CHEM, V287, P31298, DOI 10.1074/jbc.M112.366336; Long JM, 2012, EXP NEUROL, V235, P402, DOI 10.1016/j.expneurol.2011.12.043; Long JM, 2011, BIOCHEM BIOPH RES CO, V404, P889, DOI 10.1016/j.bbrc.2010.12.053; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Maloney B, 2011, GENE, V488, P1, DOI 10.1016/j.gene.2011.06.004; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2011, NUCLEIC ACIDS RES, V39, pW145, DOI 10.1093/nar/gkr294; Mihailovich M, 2007, NUCLEIC ACIDS RES, V35, P2975, DOI 10.1093/nar/gkm191; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nelson PT, 2010, J ALZHEIMERS DIS, V21, P75, DOI 10.3233/JAD-2010-091603; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Nowak K, 2006, J NEUROCHEM, V96, P1696, DOI 10.1111/j.1471-4159.2006.03692.x; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Okada H, 2010, INT J BIOCHEM CELL B, V42, P1256, DOI 10.1016/j.biocel.2010.02.002; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; Sambamurti K, 2004, FASEB J, V18, P1034, DOI 10.1096/fj.03-1378fje; Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Smith P, 2011, J NEUROCHEM, V116, P240, DOI 10.1111/j.1471-4159.2010.07097.x; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tonelli DD, 2004, NUCLEIC ACIDS RES, V32, P1808, DOI 10.1093/nar/gkh348; Ueda R, 2009, P NATL ACAD SCI USA, V106, P10746, DOI 10.1073/pnas.0811817106; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Wu ZS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-542; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zhou WH, 2006, MOL CELL BIOL, V26, P3353, DOI 10.1128/MCB.26.9.3353-3364.2006; Zong YY, 2011, BRAIN RES, V1395, P108, DOI 10.1016/j.brainres.2011.04.035	96	129	133	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5184	5198		10.1074/jbc.M113.518241	http://dx.doi.org/10.1074/jbc.M113.518241			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24352696	hybrid, Green Published			2022-12-28	WOS:000331607900060
J	Williams, CR; Gooch, JL				Williams, Clintoria R.; Gooch, Jennifer L.			Calcineurin A beta Regulates NADPH Oxidase ( Nox) Expression and Activity via Nuclear Factor of Activated T Cells ( NFAT) in Response to High Glucose*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Kidney; NADPH Oxidase; NFAT Transcription Factor; Oxidative Stress; Reactive Oxygen Species (ROS); High Glucose; Renal Hypertrophy	GROWTH-FACTOR-BETA; NAD(P)H OXIDASE; DIABETIC KIDNEY; RENAL INJURY; HYPERTROPHY; ALPHA; STREPTOZOTOCIN; NEPHROTOXICITY; ACCUMULATION; FIBRONECTIN	Background: Similar to its role in other organs, calcineurin is involved in kidney hypertrophy. However, downstream targets are not known. Results: The isoform of calcineurin (CnA) is required for hypertrophy and regulates Nox2 and Nox4 expression and function through NFAT. Conclusion: CnA and not CnA mediates hypertrophy in renal cells and is required for chronic ROS generation. Significance: Interaction of calcineurin and Nox signaling is essential for renal hypertrophy. Hypertrophy is an adaptive response that enables organs to appropriately meet increased functional demands. Previously, we reported that calcineurin (Cn) is required for glomerular and whole kidney hypertrophy in diabetic rodents (Gooch, J. L., Barnes, J. L., Garcia, S., and Abboud, H. E. (2003). Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation. Am. J. Physiol. Renal Physiol. 284, F144-F154; Reddy, R. N., Knotts, T. L., Roberts, B. R., Molkentin, J. D., Price, S. R., and Gooch, J. L. (2011). Calcineurin A is required for hypertrophy but not matrix expansion in the diabetic kidney. J. Cell Mol. Med. 15, 414-422). Because studies have also implicated the reactive oxygen species-generating enzymes NADPH oxidases (Nox) in diabetic kidney responses, we tested the hypothesis that Nox and Cn cooperate in a common signaling pathway. First, we examined the role of the two main isoforms of Cn in hypertrophic signaling. Using primary kidney cells lacking a catalytic subunit of Cn (CnA(-/-) or CnA(-/-)), we found that high glucose selectively activates CnA, whereas CnA is constitutively active. Furthermore, CnA but not CnA mediates hypertrophy. Next, we found that chronic reactive oxygen species generation in response to high glucose is attenuated in CnA(-/-) cells, suggesting that Cn is upstream of Nox. Consistent with this, loss of CnA reduces basal expression and blocks high glucose induction of Nox2 and Nox4. Inhibition of nuclear factor of activated T cells (NFAT), a CnA-regulated transcription factor, decreases Nox2 and Nox4 expression, whereas NFAT overexpression increases Nox2 and Nox4, indicating that the CnA/NFAT pathway modulates Nox. These data reveal that the CnA/NFAT pathway regulates Nox and plays an important role in high glucose-mediated hypertrophic responses in the kidney.	[Williams, Clintoria R.; Gooch, Jennifer L.] Atlanta Vet Adm Med Ctr, Atlanta, GA 30033 USA; [Williams, Clintoria R.; Gooch, Jennifer L.] Emory Univ, Sch Med, Dept Med, Div Nephrol, Atlanta, GA 30322 USA	Emory University	Williams, CR (corresponding author), Emory Univ, Sch Med, 101 Woodruff Circle,WMB 338, Atlanta, GA 30322 USA.	clricha@emory.edu			National Institutes of Health, NIDDK [T32 DK00756]; Department of Veterans Affairs MERIT award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007656] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Veterans Affairs MERIT award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant T32 DK00756 (to C. R. W.). This work was also supported by a Department of Veterans Affairs MERIT award (to J. L. G.).	Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Bhandarkar SS, 2009, J CLIN INVEST, V119, P2359, DOI 10.1172/JCI33877; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Cheng HF, 2002, KIDNEY INT, V62, P929, DOI 10.1046/j.1523-1755.2002.00520.x; Cobbs SL, 2007, BIOCHEM BIOPH RES CO, V362, P288, DOI 10.1016/j.bbrc.2007.07.186; Djamali A, 2012, AM J TRANSPLANT, V12, P1997, DOI 10.1111/j.1600-6143.2012.04081.x; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Etoh T, 2003, DIABETOLOGIA, V46, P1428, DOI 10.1007/s00125-003-1205-6; Fu YB, 2010, AM J NEPHROL, V32, P581, DOI 10.1159/000322105; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gooch JL, 2007, TRANSPLANTATION, V83, P439, DOI 10.1097/01.tp.0000251423.78124.51; Gooch JL, 2004, AM J PATHOL, V165, P1755, DOI 10.1016/S0002-9440(10)63430-X; Gooch JL, 2006, AM J PHYSIOL-RENAL, V290, pF769, DOI 10.1152/ajprenal.00281.2005; Gooch JL, 2004, J AM SOC NEPHROL, V15, P1421, DOI 10.1097/01.ASN.0000128076.91545.BB; Gooch JL, 2004, J BIOL CHEM, V279, P15561, DOI 10.1074/jbc.M308759200; Gooch JL, 2003, AM J PHYSIOL-RENAL, V284, pF144, DOI 10.1152/ajprenal.00158.2002; Gooch JL, 2001, J BIOL CHEM, V276, P42492, DOI 10.1074/jbc.M102994200; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maalouf RM, 2012, AM J PHYSIOL-CELL PH, V302, pC597, DOI 10.1152/ajpcell.00331.2011; Qi XM, 2011, INT IMMUNOPHARMACOL, V11, P1613, DOI 10.1016/j.intimp.2011.05.023; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reddy RN, 2011, J CELL MOL MED, V15, P414, DOI 10.1111/j.1582-4934.2009.00910.x; Roberts B, 2008, CELL CALCIUM, V43, P515, DOI 10.1016/j.ceca.2007.08.004; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Sedeek M, 2013, CLIN SCI, V124, P191, DOI 10.1042/CS20120330; SEYERHANSEN K, 1983, KIDNEY INT, V23, P643, DOI 10.1038/ki.1983.71; Wang LM, 2011, MOL ENDOCRINOL, V25, P1376, DOI 10.1210/me.2011-0029; Williams CR, 2012, AM J PHYSIOL-CELL PH, V303, pC213, DOI 10.1152/ajpcell.00227.2011; Zhang R, 2009, HYPERTENSION, V53, P556, DOI 10.1161/HYPERTENSIONAHA.108.124594	33	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4896	4905		10.1074/jbc.M113.514869	http://dx.doi.org/10.1074/jbc.M113.514869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24371139	Green Published, hybrid			2022-12-28	WOS:000331607900036
J	Zou, QJ; Yan, QM; Zhong, J; Wang, KP; Sun, HT; Yi, XL; Lai, LX				Zou, Qingjian; Yan, Quanmei; Zhong, Juan; Wang, Kepin; Sun, Haitao; Yi, Xiaoling; Lai, Liangxue			Direct Conversion of Human Fibroblasts into Neuronal Restricted Progenitors*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Induced Pluripotent Stem (iPS) Cell; Neural Stem Cell; Neurons; Reprogramming; Transcription Factors; Brn2; Brn4; Sox2; Induced Neuronal Restricted Progenitors; Trans-differentiation	NEURAL STEM-CELLS; DOPAMINERGIC-NEURONS; DERMAL FIBROBLASTS; BASAL PROGENITORS; RADIAL GLIA; MOUSE; DIFFERENTIATION; PRECURSORS; BRN-4; DOUBLECORTIN	Background: Neuronal restricted progenitors have not been generated from fibroblasts by transdifferentiation. Results: Human induced neuronal restricted progenitors (hiNRPs) were efficiently generated from fibroblasts by transfection of three defined factors: Sox2, c-Myc, and either Brn2 or Brn4. Conclusion: Unipotent neuronal restricted progenitors can be rapidly and efficiently produced from fibroblasts. Significance: This novel method will provide a new source of neurons for cellular replacement therapy of human neurodegenerative diseases. Neuronal restricted progenitors (NRPs) represent a type of transitional intermediate cells that lie between multipotent neural progenitors and terminal differentiated neurons during neurogenesis. These NRPs have the ability to self-renew and differentiate into neurons, but not into glial cells, which is considered an advantage for cellular therapy of human neurodegenerative diseases. However, difficulty in the extraction of highly purified NRPs from normal nervous tissue prevents further studies and applications. In this study, we report the conversion of human fetal fibroblasts into human induced NRPs (hiNRPs) in 11 days by using just three defined factors: Sox2, c-Myc, and either Brn2 or Brn4. The hiNRPs exhibited distinct neuronal characteristics, including cell morphology, multiple neuronal marker expression, self-renewal capacity, and a genome-wide transcriptional profile. Moreover, hiNRPs were able to differentiate into various terminal neurons with functional membrane properties but not glial cells. Direct generation of hiNRPs from somatic cells will provide a new source of cells for cellular replacement therapy of human neurodegenerative diseases.	[Zou, Qingjian; Yan, Quanmei; Zhong, Juan; Wang, Kepin; Yi, Xiaoling; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Zou, Qingjian] Univ Sci & Technol China, Sch Sci, Hefei 230027, Peoples R China; [Sun, Haitao] Southern Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou 510280, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Southern Medical University - China	Lai, LX (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China.	Lai_liangxue@gibh.ac.cn		/0000-0001-7925-9506	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA010201070]; Ministry of Science and Technology National Basic Research Program of China ( 973 Program) [2011CB944203, 2010CB945402]; National Natural Science Foundation of China [31071293]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology National Basic Research Program of China ( 973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA010201070, by Ministry of Science and Technology National Basic Research Program of China ( 973 Program) Grants 2011CB944203 and 2010CB945402, and by National Natural Science Foundation of China Grant 31071293.	Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; Azari H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020941; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Dominguez MH, 2013, CEREB CORTEX, V23, P2632, DOI 10.1093/cercor/bhs252; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fong CY, 2010, J CELL BIOCHEM, V111, P769, DOI 10.1002/jcb.22775; Giorgetti A, 2012, P NATL ACAD SCI USA, V109, P12556, DOI 10.1073/pnas.1209523109; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Holmin S, 1997, EUR J NEUROSCI, V9, P65, DOI 10.1111/j.1460-9568.1997.tb01354.x; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kalyani AJ, 1998, J NEUROSCI, V18, P7856; Karl C, 2005, J NEUROCHEM, V92, P264, DOI 10.1111/j.1471-4159.2004.02879.x; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kuwahara A, 2010, DEVELOPMENT, V137, P1035, DOI 10.1242/dev.046417; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Mo ZC, 2007, J NEUROSCI, V27, P4132, DOI 10.1523/JNEUROSCI.0111-07.2007; Moon JH, 2011, CELL RES, V21, P1305, DOI 10.1038/cr.2011.107; Mujtaba T, 1999, DEV BIOL, V214, P113, DOI 10.1006/dbio.1999.9418; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; Nistor G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020692; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rhee JM, 1998, J BIOL CHEM, V273, P34196, DOI 10.1074/jbc.273.51.34196; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rolfe KJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-124; Sheng C, 2012, CELL RES, V22, P208, DOI 10.1038/cr.2011.175; Shi JH, 2010, NEUROSCI RES, V67, P8, DOI 10.1016/j.neures.2010.01.007; Shimazaki T, 1999, EMBO J, V18, P444, DOI 10.1093/emboj/18.2.444; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Tan XF, 2011, CELL BIOL INT, V35, P1217, DOI 10.1042/CBI20110028; Tan XF, 2010, CELL BIOL INT, V34, P877, DOI 10.1042/CBI20100214; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Tian C, 2012, CURR MOL MED, V12, P126, DOI 10.2174/156652412798889018; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang LH, 2013, NAT METHODS, V10, P84, DOI [10.1038/NMETH.2283, 10.1038/nmeth.2283]; Yang H, 2000, P NATL ACAD SCI USA, V97, P13366, DOI 10.1073/pnas.97.24.13366; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323	45	45	51	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5250	5260		10.1074/jbc.M113.516112	http://dx.doi.org/10.1074/jbc.M113.516112			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24385434	Green Published, hybrid			2022-12-28	WOS:000331607900066
J	Ruggles, KV; Garbarino, J; Liu, Y; Moon, J; Schneider, K; Henneberry, A; Billheimer, J; Millar, JS; Marchadier, D; Valasek, MA; Joblin-Mills, A; Gulati, S; Munkacsi, AB; Repa, JJ; Rader, D; Sturley, SL				Ruggles, Kelly V.; Garbarino, Jeanne; Liu, Ying; Moon, James; Schneider, Kerry; Henneberry, Annette; Billheimer, Jeff; Millar, John S.; Marchadier, Dawn; Valasek, Mark A.; Joblin-Mills, Aidan; Gulati, Sonia; Munkacsi, Andrew B.; Repa, Joyce J.; Rader, Dan; Sturley, Stephen L.			A Functional, Genome-wide Evaluation of Liposensitive Yeast Identifies the "ARE2 Required for Viability" (ARV1) Gene Product as a Major Component of Eukaryotic Fatty Acid Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fatty Acid; Lipid Droplets; Lipid Metabolism; Lipotoxicity; Triglyceride; Yeast Genetics	PANCREATIC-BETA-CELLS; ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; INDUCED APOPTOSIS; COMPARATIVE TOXICITY; LIPID DROPLETS; LINOLEIC-ACID; HUMAN ISLETS; OLEIC-ACID; ER STRESS	The toxic subcellular accumulation of lipids predisposes several human metabolic syndromes, including obesity, type 2 diabetes, and some forms of neurodegeneration. To identify pathways that prevent lipid-induced cell death, we performed a genome-wide fatty acid sensitivity screen in Saccharomyces cerevisiae. We identified 167 yeast mutants as sensitive to 0.5 mm palmitoleate, 45% of which define pathways that were conserved in humans. 63 lesions also impacted the status of the lipid droplet; however, this was not correlated to the degree of fatty acid sensitivity. The most liposensitive yeast strain arose due to deletion of the ARE2 required for viability (ARV1) gene, encoding an evolutionarily conserved, potential lipid transporter that localizes to the endoplasmic reticulum membrane. Down-regulation of mammalian ARV1 in MIN6 pancreatic -cells or HEK293 cells resulted in decreased neutral lipid synthesis, increased fatty acid sensitivity, and lipoapoptosis. Conversely, elevated expression of human ARV1 in HEK293 cells or mouse liver significantly increased triglyceride mass and lipid droplet number. The ARV1-induced hepatic triglyceride accumulation was accompanied by up-regulation of DGAT1, a triglyceride synthesis gene, and the fatty acid transporter, CD36. Furthermore, ARV1 was identified as a transcriptional of the protein peroxisome proliferator-activated receptor (PPAR), a key regulator of lipid homeostasis whose transcriptional targets include DGAT1 and CD36. These results implicate ARV1 as a protective factor in lipotoxic diseases due to modulation of fatty acid metabolism. In conclusion, a lipotoxicity-based genetic screen in a model microorganism has identified 75 human genes that may play key roles in neutral lipid metabolism and disease.	[Ruggles, Kelly V.; Garbarino, Jeanne; Liu, Ying; Moon, James; Schneider, Kerry; Henneberry, Annette; Gulati, Sonia; Sturley, Stephen L.] Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10032 USA; [Sturley, Stephen L.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA; [Moon, James] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Moon, James] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Billheimer, Jeff; Millar, John S.; Marchadier, Dawn; Rader, Dan] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Valasek, Mark A.; Repa, Joyce J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Repa, Joyce J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Joblin-Mills, Aidan; Munkacsi, Andrew B.] Victoria Univ Wellington, Sch Biol Sci, Wellington 6012, New Zealand; [Joblin-Mills, Aidan; Munkacsi, Andrew B.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington 6012, New Zealand	Columbia University; Columbia University; Columbia University; Columbia University; University of Pennsylvania; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Victoria University Wellington; Victoria University Wellington	Sturley, SL (corresponding author), Columbia Univ, Dept Pediat, Med Ctr, 630 W 168th St, New York, NY 10032 USA.	sls37@columbia.edu	; moon, james/F-1031-2014	Repa, Joyce/0000-0001-5740-1954; Munkacsi, Andrew/0000-0003-3033-395X; Valasek, Mark/0000-0003-1721-3451; Ruggles, Kelly/0000-0002-0152-0863; moon, james/0000-0001-8071-1491	National Institutes of Health [DK54320, DK078592, 2 TL1 RR000082, 5 T32 DK007647]; American Diabetes Association; American Heart Association; Ara Parseghian Medical Research Foundation; National Niemann-Pick Disease Foundation; Wellington Medical Research Foundation; Neurological Foundation of New Zealand; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054320, R01DK078592, T32DK007647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Ara Parseghian Medical Research Foundation; National Niemann-Pick Disease Foundation; Wellington Medical Research Foundation; Neurological Foundation of New Zealand; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54320 (to S. L. S.) and DK078592 (to J. R.). This work was also supported by the American Diabetes Association, the American Heart Association, and the Ara Parseghian Medical Research Foundation.; Supported by National Institutes of Health Training Grants 2 TL1 RR000082 and 5 T32 DK007647. Present address: 227 E30th, 7-59F, New York University Medical Center, New York, NY 10016.; Supported by the National Niemann-Pick Disease Foundation, the Wellington Medical Research Foundation, and the Neurological Foundation of New Zealand.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Blakemore AIF, 2008, J CLIN ENDOCR METAB, V93, pS51, DOI 10.1210/jc.2008-1676; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Cauchi S, 2008, OBESITY, V16, P476, DOI 10.1038/oby.2007.77; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Cohen MH, 2002, AM J MED, V113, P91, DOI 10.1016/S0002-9343(02)01169-5; Cury-Boaventura MF, 2006, LIFE SCI, V78, P1448, DOI 10.1016/j.lfs.2005.07.038; Cury-Boaventura MF, 2004, CLIN NUTR, V23, P721, DOI 10.1016/j.clnu.2003.12.004; Cusi K, 2009, CURR DIABETES REP, V9, P200, DOI 10.1007/s11892-009-0033-6; De Gottardi A, 2007, LAB INVEST, V87, P792, DOI 10.1038/labinvest.3700590; Diakogiannaki E, 2008, J ENDOCRINOL, V197, P553, DOI 10.1677/JOE-08-0041; Duval C, 2007, BBA-MOL CELL BIOL L, V1771, P961, DOI 10.1016/j.bbalip.2007.05.003; Fei WH, 2008, EUKARYOT CELL, V7, P401, DOI 10.1128/EC.00386-07; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; Fores O, 2006, BBA-MOL CELL BIOL L, V1761, P725, DOI 10.1016/j.bbalip.2006.03.025; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Georgiev AG, 2013, TRAFFIC, V14, P912, DOI 10.1111/tra.12082; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Green CD, 2011, AM J PHYSIOL-ENDOC M, V300, pE640, DOI 10.1152/ajpendo.00544.2010; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Hatunic M, 2009, DIABETES RES CLIN PR, V83, P316, DOI 10.1016/j.diabres.2008.12.004; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurrasch DM, 2004, METHOD ENZYMOL, V389, P3; Kusminski CM, 2009, APOPTOSIS, V14, P1484, DOI 10.1007/s10495-009-0352-8; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Lim HY, 2011, FLY, V5, P234, DOI 10.4161/fly.5.3.15708; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Magre J, 1998, DIABETES, V47, P284, DOI 10.2337/diab.47.2.284; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Marchetti P, 2002, DIABETES, V51, P1419, DOI 10.2337/diabetes.51.5.1419; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Moffitt JH, 2005, DIABETOLOGIA, V48, P1819, DOI 10.1007/s00125-005-1861-9; Morcillo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021198; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Pineau L, 2009, TRAFFIC, V10, P673, DOI 10.1111/j.1600-0854.2009.00903.x; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Ruggles KV, 2013, ANNU REV NUTR, V33, P413, DOI 10.1146/annurev-nutr-071812-161254; Sargsyan E, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-115; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schrauwen P, 2010, BBA-MOL CELL BIOL L, V1801, P266, DOI 10.1016/j.bbalip.2009.09.011; Schwarz S, 2006, APOPTOSIS, V11, P1111, DOI 10.1007/s10495-006-6982-1; Seo T, 2001, BIOCHEMISTRY-US, V40, P4756, DOI 10.1021/bi0022947; Shechtman CF, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.215038; Smith JJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb1400157; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Swain E, 2002, J BIOL CHEM, V277, P36152, DOI 10.1074/jbc.M206624200; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Tinkelenberg AH, 2000, J BIOL CHEM, V275, P40667, DOI 10.1074/jbc.C000710200; Tong FM, 2010, J BIOL CHEM, V285, P33632, DOI 10.1074/jbc.M110.165761; Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007; Tsukamoto H, 2001, PRENATAL DIAG, V21, P55, DOI 10.1002/1097-0223(200101)21:1<55::AID-PD23>3.0.CO;2-M; Tsukamoto K, 2000, MOL THER, V1, P189, DOI 10.1006/mthe.2000.0028; Tsunoda K, 2001, DIABETOLOGIA, V44, P2092, DOI 10.1007/s001250100015; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Zhu Y, 2005, NEUROCHEM INT, V46, P127, DOI 10.1016/j.neuint.2004.08.003	85	27	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4417	4431		10.1074/jbc.M113.515197	http://dx.doi.org/10.1074/jbc.M113.515197			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24273168	Green Published, hybrid			2022-12-28	WOS:000331403800052
J	Balan, M; Pal, S				Balan, Murugabaskar; Pal, Soumitro			A Novel CXCR3-B Chemokine Receptor-induced Growth-inhibitory Signal in Cancer Cells Is Mediated through the Regulation of Bach-1 Protein and Nrf2 Protein Nuclear Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Chemokines; Heme Oxygenase; Nrf2; Nuclear Transport; Signal Transduction; Signaling	HEME OXYGENASE-1 GENE; HUMAN BREAST-CANCER; SPLICE VARIANT; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; CXC CHEMOKINES; MURINE MODEL; I-TAC; EXPRESSION; APOPTOSIS	Background: The chemokine receptor CXCR3-B initiates inhibitory signals. Results: CXCR3-B-mediated signal induced apoptosis and inhibited autophagy of breast cancer cells. It is associated with nuclear translocation of Bach-1, nuclear export of Nrf2, and down-regulation of HO-1. Conclusion: A CXCR3-B-mediated signal promotes apoptosis of breast cancer cells. Significance: Induction of CXCR3-B-mediated signaling can serve as a novel therapeutic approach for the treatment of breast cancer. Chemokines and their receptors play diverse roles in regulating cancer growth and progression. The receptor CXCR3 can have two splice variants with opposite functions. CXCR3-A promotes cell growth, whereas CXCR3-B mediates growth-inhibitory signals. However, the negative signals through CXCR3-B in cancer cells are not well characterized. In this study, we found that CXCR3-B-mediated signaling in MCF-7 and T47D breast cancer cells induced apoptotic cell death. Signals through CXCR3-B decreased the levels of the antiapoptotic proteins Bcl-2 and Bcl-xL and increased the expression of apoptotic cleaved poly(ADP-ribose) polymerase. Along with up-regulation in apoptosis, CXCR3-B signals were associated with a decrease in cellular autophagy with reduced levels of the autophagic markers Beclin-1 and LC3B. Notably, CXCR3-B down-regulated the expression of the cytoprotective and antiapoptotic molecule heme oxygenase-1 (HO-1) at the transcriptional level. There was an increased nuclear localization of Bach-1 and nuclear export of Nrf2, which are important negative and positive transcription factors, respectively, for HO-1 expression. We also observed that CXCR3-B promoted the activation of p38 MAPK and the inhibition of ERK-1/2. CXCR3-B could not induce cancer cell apoptosis at the optimal level when we either inhibited p38 activity or knocked down Bach-1. Further, CXCR3-B-induced apoptosis was down-regulated when we overexpressed HO-1. Together, our data suggest that CXCR3-B mediates a growth-inhibitory signal in breast cancer cells through the modulations of nuclear translocation of Bach-1 and Nrf2 and down-regulation of HO-1. We suggest that the induction of CXCR3-B-mediated signaling can serve as a novel therapeutic approach where the goal is to promote tumor cell apoptosis.	[Balan, Murugabaskar; Pal, Soumitro] Boston Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Balan, Murugabaskar; Pal, Soumitro] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Pal, S (corresponding author), Childrens Hosp, Div Nephrol, 300 Longwood Ave, Boston, MA 02115 USA.	soumitro.pal@childrens.harvard.edu			National Institutes of Health [R01 CA131145, R21 CA172946]; NATIONAL CANCER INSTITUTE [R01CA131145, R21CA172946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA131145 and R21 CA172946 (to S. P.).	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; Alam J, 2000, J BIOL CHEM, V275, P27694; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Banerjee P, 2012, J BIOL CHEM, V287, P32113, DOI 10.1074/jbc.M112.393140; Banerjee P, 2011, J BIOL CHEM, V286, P33580, DOI 10.1074/jbc.M111.248401; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Datta D, 2006, CANCER RES, V66, P9509, DOI 10.1158/0008-5472.CAN-05-4345; Datta D, 2010, J BIOL CHEM, V285, P36842, DOI 10.1074/jbc.M110.170324; Datta D, 2008, J AM SOC NEPHROL, V19, P2437, DOI 10.1681/ASN.2008040394; Deng YT, 2010, MOL CARCINOGEN, V49, P141, DOI 10.1002/mc.20583; Gacci M, 2009, J UROLOGY, V181, P843, DOI 10.1016/j.juro.2008.10.063; Grethe S, 2006, CELL SIGNAL, V18, P531, DOI 10.1016/j.cellsig.2005.05.023; Jain K, 2013, AM J CANCER RES, V3, P251; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Kelsen SG, 2004, AM J PHYSIOL-LUNG C, V287, pL584, DOI 10.1152/ajplung.00453.2003; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Ma XR, 2009, MOL CANCER THER, V8, P490, DOI 10.1158/1535-7163.MCT-08-0485; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Petrai I, 2008, INT J BIOCHEM CELL B, V40, P1764, DOI 10.1016/j.biocel.2008.01.008; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Shan Y, 2004, J BIOL CHEM, V279, P51769, DOI 10.1074/jbc.M409463200; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Suyama T, 2005, CANCER-AM CANCER SOC, V103, P258, DOI 10.1002/cncr.20747; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Walser TC, 2006, CANCER RES, V66, P7701, DOI 10.1158/0008-5472.CAN-06-0709; Wu Q, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-3; Xu K, 2013, INFLAMM RES, V62, P229, DOI 10.1007/s00011-012-0572-1; Zipin-Roitman A, 2007, CANCER RES, V67, P3396, DOI 10.1158/0008-5472.CAN-06-3087; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	39	39	45	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3126	3137		10.1074/jbc.M113.508044	http://dx.doi.org/10.1074/jbc.M113.508044			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24366869	Green Published, hybrid			2022-12-28	WOS:000331368700003
J	Huang, YL; Day, RN; Gunst, SJ				Huang, Youliang; Day, Richard N.; Gunst, Susan J.			Vinculin Phosphorylation at Tyr(1065) Regulates Vinculin Conformation and Tension Development in Airway Smooth Muscle Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytoskeleton; Excitation-Contraction Coupling; Fluorescence; Fluorescence Resonance Energy Transfer (FRET); Smooth Muscle	INDUCED ACTIN POLYMERIZATION; SMALL GTPASE RHOA; PROTEIN-KINASE-C; ALPHA-ACTININ; INTRAMOLECULAR ASSOCIATION; ACTIVATE VINCULIN; STRUCTURAL BASIS; FOCAL ADHESIONS; TALIN BINDING; CELL-ADHESION	Background: Vinculin assumes a closed inactive or an open talin/actin-binding conformation. During airway smooth muscle contraction, vinculin undergoes Tyr(1065) phosphorylation. Results: Tyr(1065) phosphorylation is required for vinculin conformation-sensitive FRET probes in smooth muscle to assume an open conformation and for tension generation. Conclusion: Tyr(1065) phosphorylation regulates the ligand-binding function of vinculin in airway smooth muscle. Significance: Tyr(1065) phosphorylation enables regulation of vinculin conformation by external stimuli. Vinculin localizes to membrane adhesion junctions in smooth muscle tissues, where its head domain binds to talin and its tail domain binds to filamentous actin, thus linking actin filaments to the extracellular matrix. Vinculin can assume a closed conformation, in which the head and tail domains bind to each other and mask the binding sites for actin and talin, and an open activated conformation that exposes the binding sites for talin and actin. Acetylcholine stimulation of tracheal smooth muscle tissues induces the recruitment of vinculin to the cell membrane and its interaction with talin and actin, which is required for active tension development. Vinculin phosphorylation at Tyr(1065) on its C terminus increases concurrently with tension development in tracheal smooth muscle tissues. In the present study, the role of vinculin phosphorylation at Tyr(1065) in regulating the conformation and function of vinculin during airway smooth muscle contraction was evaluated. Vinculin constructs with point mutations at Tyr(1065) (vinculin Y1065F and vinculin Y1065E) and vinculin conformation-sensitive FRET probes were expressed in smooth muscle tissues to determine how Tyr(1065) phosphorylation affects smooth muscle contraction and the conformation and cellular functions of vinculin. The results show that vinculin phosphorylation at tyrosine 1065 is required for normal tension generation in airway smooth muscle during contractile stimulation and that Tyr(1065) phosphorylation regulates the conformation and scaffolding activity of the vinculin molecule. We conclude that the phosphorylation of vinculin at tyrosine 1065 provides a mechanism for regulating the function of vinculin in airway smooth muscle in response to contractile stimulation.	[Huang, Youliang; Day, Richard N.; Gunst, Susan J.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Gunst, SJ (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	sgunst@iupui.edu		Gunst, Susan/0000-0001-9836-4782	National Institutes of Health [R01 HL29289, HL074099]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029289, R01HL074099, R01HL109629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL29289 and HL074099 (to S. J. G.).	Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Bass MD, 1999, BIOCHEM J, V341, P257, DOI 10.1042/0264-6021:3410257; Bois PRJ, 2005, MOL CELL BIOL, V25, P6112, DOI 10.1128/MCB.25.14.6112-6122.2005; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Bubeck P, 1997, J CELL SCI, V110, P1361; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Chen XS, 2006, AM J PHYSIOL-HEART C, V290, pH1915, DOI 10.1152/ajpheart.00643.2005; Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; Diez G, 2009, BIOPHYS J, V97, P3105, DOI 10.1016/j.bpj.2009.09.039; Dumbauld DW, 2013, P NATL ACAD SCI USA, V110, P9788, DOI 10.1073/pnas.1216209110; Eddinger TJ, 2005, AM J PHYSIOL-CELL PH, V289, pC1379, DOI 10.1152/ajpcell.00193.2005; GEIGER B, 1981, J CELL BIOL, V91, P614, DOI 10.1083/jcb.91.3.614; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Golji J, 2012, BIOPHYS J, V102, P2022, DOI 10.1016/j.bpj.2012.01.062; Golji J, 2011, BIOPHYS J, V100, P332, DOI 10.1016/j.bpj.2010.11.024; Golji J, 2010, BIOPHYS J, V99, P1073, DOI 10.1016/j.bpj.2010.05.024; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; HATHAWAY DR, 1985, AM J PHYSIOL, V249, pC345; Huang YL, 2011, J BIOL CHEM, V286, P3630, DOI 10.1074/jbc.M110.139923; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Kupper K, 2010, BIOCHEM BIOPH RES CO, V399, P560, DOI 10.1016/j.bbrc.2010.07.110; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Mohl CC, 2009, CELL MOTIL CYTOSKEL, V66, P350, DOI 10.1002/cm.20375; NORTH AJ, 1993, J CELL BIOL, V120, P1159, DOI 10.1083/jcb.120.5.1159; Palmer SM, 2009, J BIOL CHEM, V284, P7223, DOI 10.1074/jbc.M807842200; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Saez AO, 2004, AM J PHYSIOL-CELL PH, V286, pC433, DOI 10.1152/ajpcell.00030.2003; Saito Shin-Ya, 1996, Journal of Smooth Muscle Research, V32, P51; SEFTON BM, 1981, CELL, V24, P165, DOI 10.1016/0092-8674(81)90512-2; SMALL JV, 1985, EMBO J, V4, P45, DOI 10.1002/j.1460-2075.1985.tb02315.x; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tang DD, 2003, J PHYSIOL-LONDON, V553, P21, DOI 10.1113/jphysiol.2003.045047; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Zhang WW, 2006, J PHYSIOL-LONDON, V572, P659, DOI 10.1113/jphysiol.2006.106518; Zhang WW, 2012, J BIOL CHEM, V287, P33996, DOI 10.1074/jbc.M112.369603; Zhang WW, 2010, AM J PHYSIOL-CELL PH, V299, pC298, DOI 10.1152/ajpcell.00118.2010; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004; Zhang ZY, 2004, MOL BIOL CELL, V15, P4234, DOI 10.1091/mbc.E04-03-0264; Ziegler WH, 2002, J BIOL CHEM, V277, P7396, DOI 10.1074/jbc.M110008200; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	50	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3677	3688		10.1074/jbc.M113.508077	http://dx.doi.org/10.1074/jbc.M113.508077			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24338477	Green Published, hybrid			2022-12-28	WOS:000331368700049
J	Schwarz, J; Schmidt, S; Will, O; Koudelka, T; Kohler, K; Boss, M; Rabe, B; Tholey, A; Scheller, J; Schmidt-Arras, D; Schwake, M; Rose-John, S; Chalaris, A				Schwarz, Jeanette; Schmidt, Stefanie; Will, Olga; Koudelka, Tomas; Koehler, Kaja; Boss, Melanie; Rabe, Bjoern; Tholey, Andreas; Scheller, Juergen; Schmidt-Arras, Dirk; Schwake, Michael; Rose-John, Stefan; Chalaris, Athena			Polo-like Kinase 2, a Novel ADAM17 Signaling Component, Regulates Tumor Necrosis Factor similar to Ectodomain Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM ADAMTS; Metalloprotease; Phosphorylation; Shedding; Tumor Necrosis Factor (TNF); ADAM17; PLK2	ALPHA-CONVERTING-ENZYME; TNF-ALPHA; POTENTIAL ROLE; TACE; DISINTEGRIN; ACTIVATION; RECEPTOR; DOMAIN; PHOSPHORYLATION; PLK2	Background: The metalloprotease ADAM17 emerged as the main sheddase of several cytokines and cytokine receptors. Results: The acidophilic kinase PLK2 interacts with and phosphorylates ADAM17 in mammalian cells. Conclusion: PLK2 represents a novel cellular interaction partner of ADAM17 modulating its activity. Significance: Regulation of ADAM17 activity is essential for inflammatory responses. ADAM17 (a disintegrin and metalloprotease 17) controls pro- and anti-inflammatory signaling events by promoting ectodomain shedding of cytokine precursors and cytokine receptors. Despite the well documented substrate repertoire of ADAM17, little is known about regulatory mechanisms, leading to substrate recognition and catalytic activation. Here we report a direct interaction of the acidophilic kinase Polo-like kinase 2 (PLK2, also known as SNK) with the cytoplasmic portion of ADAM17 through the C-terminal noncatalytic region of PLK2 containing the Polo box domains. PLK2 activity leads to ADAM17 phosphorylation at serine 794, which represents a novel phosphorylation site. Activation of ADAM17 by PLK2 results in the release of pro-TNF and TNF receptors from the cell surface, and pharmacological inhibition of PLK2 leads to down-regulation of LPS-induced ADAM17-mediated shedding on primary macrophages and dendritic cells. Importantly, PLK2 expression is up-regulated during inflammatory conditions increasing ADAM17-mediated proteolytic events. Our findings suggest a new role for PLK2 in the regulation of inflammatory diseases by modulating ADAM17 activity.	[Schwarz, Jeanette; Schmidt, Stefanie; Koehler, Kaja; Boss, Melanie; Rabe, Bjoern; Scheller, Juergen; Schmidt-Arras, Dirk; Schwake, Michael; Rose-John, Stefan; Chalaris, Athena] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany; [Will, Olga] Univ Kiel, Mol Imaging North Competence Ctr, D-24118 Kiel, Germany; [Koudelka, Tomas; Tholey, Andreas] Univ Kiel, Inst Expt Med, AG Systemat Proteomforsch, D-24105 Kiel, Germany; [Scheller, Juergen] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany; [Schwake, Michael] Univ Bielefeld, Fac Chem Biochem 3, D-33615 Bielefeld, Germany	University of Kiel; University of Kiel; University of Kiel; Heinrich Heine University Dusseldorf; University of Bielefeld	Rose-John, S (corresponding author), Univ Kiel, Inst Biochem, Rudolf Hober Str 1, D-24118 Kiel, Germany.	rosejohn@biochem.uni-kiel.de	Tholey, Andreas/B-3407-2010; Schmidt-Arras, Dirk/ABB-6644-2020; Scheller, Jürgen/K-5290-2015; Schmidt-Arras, Dirk/J-6688-2014; Rose-John, Stefan/A-7998-2010	Tholey, Andreas/0000-0002-8687-6817; Schmidt-Arras, Dirk/0000-0002-1072-7495; Schmidt-Arras, Dirk/0000-0002-1072-7495; Rose-John, Stefan/0000-0002-7519-3279; Schwake, Michael/0000-0002-4173-2166	Deutsche Forschungsgemeinschaft [SFB 877, SFB 841, RA2404/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grant SFB 877 for Projects A1, B8, and Z2; Grant SFB 841 for Project C1; Seneszenz und Autoimmunitat Grant RA2404/1-1; and the Cluster of Excellence-"Inflammation at Interfaces").	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Burns TF, 2003, MOL CELL BIOL, V23, P5556, DOI 10.1128/MCB.23.16.5556-5571.2003; Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chanthaphavong RS, 2012, J BIOL CHEM, V287, P35887, DOI 10.1074/jbc.M112.365171; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; CLAY FJ, 1993, P NATL ACAD SCI USA, V90, P4882, DOI 10.1073/pnas.90.11.4882; Dang M, 2013, P NATL ACAD SCI USA, V110, P9776, DOI 10.1073/pnas.1307478110; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Evers DM, 2010, NAT NEUROSCI, V13, P1199, DOI 10.1038/nn.2624; Feldmann M, 2008, IMMUNOL REV, V223, P7, DOI 10.1111/j.1600-065X.2008.00626.x; Fong KP, 2011, BLOOD, V117, pE15, DOI 10.1182/blood-2010-05-283838; Garcia-Alvarez B, 2007, P NATL ACAD SCI USA, V104, P3107, DOI 10.1073/pnas.0609131104; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Hall KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031600; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Klug K, 2011, INNATE IMMUN-LONDON, V17, P470, DOI 10.1177/1753425910377799; Kothe M, 2007, BIOCHEMISTRY-US, V46, P5960, DOI 10.1021/bi602474j; La Marca R, 2011, NAT NEUROSCI, V14, P857, DOI 10.1038/nn.2849; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Lee KJ, 2011, NEURON, V69, P957, DOI 10.1016/j.neuron.2011.02.004; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Leonard JD, 2005, BIOCHEM J, V387, P797, DOI 10.1042/BJ20041727; Long CM, 2010, J LEUKOCYTE BIOL, V87, P1097, DOI 10.1189/jlb.1109763; Lorenzen I, 2012, FEBS LETT, V586, P1093, DOI 10.1016/j.febslet.2012.03.012; Lorenzen I, 2011, BIOCHEM BIOPH RES CO, V415, P330, DOI 10.1016/j.bbrc.2011.10.056; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; Maretzky T, 2011, ONCOGENE, V30, P611, DOI 10.1038/onc.2010.443; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mross K, 2008, J CLIN ONCOL, V26, P5511, DOI 10.1200/JCO.2008.16.1547; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rose-John S, 2013, PHARMACOL RES, V71, P19, DOI 10.1016/j.phrs.2013.01.012; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Salvi M, 2012, BBA-PROTEINS PROTEOM, V1824, P1366, DOI 10.1016/j.bbapap.2012.07.003; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schwarz J, 2013, BBA-MOL CELL RES, V1833, P3355, DOI 10.1016/j.bbamcr.2013.10.005; Scott AJ, 2011, J BIOL CHEM, V286, P35466, DOI 10.1074/jbc.M111.277434; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shimizu-Yoshida Y, 2001, BIOCHEM BIOPH RES CO, V289, P491, DOI 10.1006/bbrc.2001.5993; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; SUNKEL CE, 1988, J CELL SCI, V89, P25; Suthaus J, 2010, MOL BIOL CELL, V21, P2797, DOI 10.1091/mbc.E10-03-0240; van de Weerdt BCM, 2008, BBA-MOL CELL RES, V1783, P1015, DOI 10.1016/j.bbamcr.2008.02.019; Xu PL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002689; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Yoda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054412; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103	64	36	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					3080	3093		10.1074/jbc.M113.536847	http://dx.doi.org/10.1074/jbc.M113.536847			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338472	Green Published, hybrid			2022-12-28	WOS:000333403000054
J	Yip, YY; Yeap, YYC; Bogoyevitch, MA; Ng, DCH				Yip, Yan Y.; Yeap, Yvonne Y. C.; Bogoyevitch, Marie A.; Ng, Dominic C. H.			cAMP-dependent Protein Kinase and c-Jun N-terminal Kinase Mediate Stathmin Phosphorylation for the Maintenance of Interphase Microtubules during Osmotic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytoskeleton; Jun N-terminal Kinase (JNK); Protein Kinase A (PKA); Protein Phosphorylation; Signal Transduction; Osmotic Stress; Stathmin	ONCOPROTEIN 18; MULTISITE PHOSPHORYLATION; PHOSPHOPROTEIN STATHMIN; DESTABILIZING ACTIVITY; INHIBITOR SELECTIVITY; INDUCED APOPTOSIS; CYTOSOLIC TARGET; POTENTIAL TARGET; BINDING PROTEIN; T-LYMPHOCYTES	Dynamic microtubule changes after a cell stress challenge are required for cell survival and adaptation. Stathmin (STMN), a cytoplasmic microtubule-destabilizing phosphoprotein, regulates interphase microtubules during cell stress, but the signaling mechanisms involved are poorly defined. In this study ectopic expression of single alanine-substituted phospho-resistant mutants demonstrated that STMN Ser-38 and Ser-63 phosphorylation were specifically required to maintain interphase microtubules during hyperosmotic stress. STMN was phosphorylated on Ser-38 and Ser-63 in response to hyperosmolarity, heat shock, and arsenite treatment but rapidly dephosphorylated after oxidative stress treatment. Two-dimensional PAGE and Phos-tag gel analysis of stress-stimulated STMN phospho-isoforms revealed rapid STMN Ser-38 phosphorylation followed by subsequent Ser-25 and Ser-63 phosphorylation. Previously, we delineated stress-stimulated JNK targeting of STMN. Here, we identified cAMP-dependent protein kinase (PKA) signaling as responsible for stress-induced STMN Ser-63 phosphorylation. Increased cAMP levels induced by cholera toxin triggered potent STMN Ser-63 phosphorylation. Osmotic stress stimulated an increase in PKA activity and elevated STMN Ser-63 and CREB (cAMP-response element-binding protein) Ser-133 phosphorylation that was substantially attenuated by pretreatment with H-89, a PKA inhibitor. Interestingly, PKA activity and subsequent phosphorylation of STMN were augmented in the absence of JNK activation, indicating JNK and PKA pathway cross-talk during stress regulation of STMN. Taken together our study indicates that JNK- and PKA-mediated STMN Ser-38 and Ser-63 phosphorylation are required to preserve interphase microtubules in response to hyperosmotic stress.	Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne	Ng, DCH (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, 30 Flemington Rd, Parkville, Vic 3010, Australia.	ngd@unimelb.edu.au	Ng, Dominic/C-7291-2015	Ng, Dominic/0000-0003-4657-159X; Bogoyevitch, Marie/0000-0001-9745-3716	National Health and Medical Research Council of Australia [628335, 566804]; Australian Research Council [FT120100193]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was funded by National Health and Medical Research Council of Australia Grants 628335 (to D. C. H. N.) and 566804 (to M. A. B.).; Supported by an Australian Research Council Future Fellowship (FT120100193). To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, 30 Flemington Rd., Parkville, VIC, Australia 3010. Tel.: 61-3-8344-2543; Fax: 61-3-9348-1421; E-mail: ngd@unimelb.edu.au.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Belletti B, 2011, EXPERT OPIN THER TAR, V15, P1249, DOI 10.1517/14728222.2011.620951; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1995, EUR J BIOCHEM, V227, P388, DOI 10.1111/j.1432-1033.1995.tb20401.x; BERETTA L, 1993, J BIOL CHEM, V268, P20076; BRATTSAND G, 1994, EUR J BIOCHEM, V220, P359, DOI 10.1111/j.1432-1033.1994.tb18632.x; Byrne F. L., 2013, ONCOGENE, DOI 10.1038/onc.2013.11; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chae HJ, 2004, IMMUNOPHARM IMMUNOT, V26, P249, DOI 10.1081/IPH-120037722; Chen PW, 2010, J BIOL CHEM, V285, P10053, DOI 10.1074/jbc.M109.044420; CHNEIWEISS H, 1989, J NEUROCHEM, V53, P856, DOI 10.1111/j.1471-4159.1989.tb11783.x; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; DiPaolo G, 1996, J CELL BIOL, V133, P1383, DOI 10.1083/jcb.133.6.1383; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Gavet O, 1998, J CELL SCI, V111, P3333; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; Hayashi K, 2006, J NEUROCHEM, V99, P237, DOI 10.1111/j.1471-4159.2006.04113.x; Hewer RC, 2011, J MOL CELL CARDIOL, V50, P87, DOI 10.1016/j.yjmcc.2010.10.010; Holmfeldt P, 2007, MOL BIOL CELL, V18, P1909, DOI 10.1091/mbc.E07-01-0019; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Horwitz SB, 1997, J BIOL CHEM, V272, P8129, DOI 10.1074/jbc.272.13.8129; HSUEH YP, 1995, J BIOL CHEM, V270, P18094, DOI 10.1074/jbc.270.30.18094; Hu JY, 2010, CELL MOL LIFE SCI, V67, P321, DOI 10.1007/s00018-009-0187-z; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita-Kikuta E, 2012, ELECTROPHORESIS, V33, P849, DOI 10.1002/elps.201100518; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; le Gouvello S, 1998, J IMMUNOL, V161, P1113; Li N, 2011, P NATL ACAD SCI USA, V108, P12851, DOI 10.1073/pnas.1017372108; Liedtke W, 2002, AM J PATHOL, V160, P469, DOI 10.1016/S0002-9440(10)64866-3; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; MARKLUND U, 1993, J BIOL CHEM, V268, P15039; Mizumura K, 2006, J CELL PHYSIOL, V206, P363, DOI 10.1002/jcp.20465; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Ng DCH, 2011, J BIOL CHEM, V286, P1576, DOI 10.1074/jbc.M110.128157; Ng DCH, 2010, J BIOL CHEM, V285, P29001, DOI 10.1074/jbc.M110.128454; Santamaria E, 2009, PROTEOMICS, V9, P4495, DOI 10.1002/pmic.200900110; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; SOBEL A, 1989, J BIOL CHEM, V264, P3765; Togano T, 2005, J NEUROSCI RES, V80, P475, DOI 10.1002/jnr.20462; Torgersen KM, 2002, CELL SIGNAL, V14, P1, DOI 10.1016/S0898-6568(01)00214-5; Vancompernolle K, 2000, J BIOL CHEM, V275, P33876, DOI 10.1074/jbc.M004785200; Wang C, 2011, BIOCHEMISTRY-MOSCOW+, V76, P320, DOI 10.1134/S0006297911030047; Wen HL, 2010, HUM MOL GENET, V19, P1766, DOI 10.1093/hmg/ddq058; White E, 2011, PFLUG ARCH EUR J PHY, V462, P177, DOI 10.1007/s00424-011-0963-0; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Xu HF, 2008, BREAST CANCER RES TR, V107, P63, DOI 10.1007/s10549-007-9536-5; Zhang J, 2008, CELL DEATH DIFFER, V15, P1654, DOI 10.1038/cdd.2008.87	54	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2157	2169		10.1074/jbc.M113.470682	http://dx.doi.org/10.1074/jbc.M113.470682			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302736	hybrid, Green Published			2022-12-28	WOS:000331130200024
J	Bruntz, RC; Taylor, HE; Lindsley, CW; Brown, HA				Bruntz, Ronald C.; Taylor, Harry E.; Lindsley, Craig W.; Brown, H. Alex			Phospholipase D-2 Mediates Survival Signaling through Direct Regulation of Akt in Glioblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; PROTEIN-KINASE; PHOSPHATIDIC-ACID; INDUCED CYTOTOXICITY; BECLIN 1; AUTOPHAGY; GLIOMA; INHIBITION; EXPRESSION; AKT/PKB	The lack of innovative drug targets for glioblastoma multiforme (GBM) limits patient survival to approximately 1 year following diagnosis. The pro-survival kinase Akt provides an ideal target for the treatment of GBM as Akt signaling is frequently activated in this cancer type. However, the central role of Akt in physiological processes limits its potential as a therapeutic target. In this report, we show that the lipid-metabolizing enzyme phospholipase D (PLD) is a novel regulator of Akt in GBM. Studies using a combination of small molecule PLD inhibitors and siRNA knockdowns establish phosphatidic acid, the product of the PLD reaction, as an essential component for the membrane recruitment and activation of Akt. Inhibition of PLD enzymatic activity and subsequent Akt activation decreases GBM cell viability by specifically inhibiting autophagic flux. We propose a mechanism whereby phosphorylation of beclin1 by Akt prevents binding of Rubicon (RUN domain cysteine-rich domain containing beclin1-interacting protein), an interaction known to inhibit autophagic flux. These findings provide a novel framework through which Akt inhibition can be achieved without directly targeting the kinase.	[Bruntz, Ronald C.; Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Taylor, Harry E.] Vanderbilt Univ Sch Med, Dept Med, Nashville, TN 37232 USA; [Lindsley, Craig W.] Vanderbilt Univ Sch Med, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA; [Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Inst Chem Biol, Dept Chem, Nashville, TN 37232 USA; [Lindsley, Craig W.] Vanderbilt Specialized Chem Accelerated Probe Dev, Nashville, TN 37232 USA; [Brown, H. Alex] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Brown, H. Alex] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Brown, HA (corresponding author), Vanderbilt Univ Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Dept Pharmacol, 2220 Pierce Ave South, Nashville, TN 37232 USA.	alex.brown@vanderbilt.edu			National Institutes of Health from NIEHS [P01-ES013125]; McDonnell Foundation for Brain Cancer Research;  [U54 MH084659]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084659] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; McDonnell Foundation for Brain Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-ES013125 from NIEHS and Grant U54 MH084659. This work was also supported by the McDonnell Foundation for Brain Cancer Research, a Lai Sulin scholarship (to R. C. B.), and a Bixler-Johnson-Mayes Endowed Chair (to H. A. B.).	Ahn BH, 2003, MOL CELL BIOL, V23, P3103, DOI 10.1128/MCB.23.9.3103-3115.2003; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carlson R. H., 2013, ONCOLOGY TIMES, V35, P46; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Cheng CK, 2009, BRAIN PATHOL, V19, P112, DOI 10.1111/j.1750-3639.2008.00233.x; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Di Fulvio M, 2008, CELL SIGNAL, V20, P176, DOI 10.1016/j.cellsig.2007.10.009; Dowler S., 2002, SCI STKE, V2002, P16; Du KY, 2005, ONCOGENE, V24, P7401, DOI 10.1038/sj.onc.1209099; Edwards JL, 2006, CELL MICROBIOL, V8, P1253, DOI 10.1111/j.1462-5822.2006.00707.x; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Foster DA, 2003, MOL CANCER RES, V1, P789; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Giannone RJ, 2007, BIOTECHNIQUES, V43, P296, DOI 10.2144/000112550; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kumar CC, 2001, BBA-GEN SUBJECTS, V1526, P257, DOI 10.1016/S0304-4165(01)00143-X; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Lewis JA, 2009, BIOORG MED CHEM LETT, V19, P1916, DOI 10.1016/j.bmcl.2009.02.057; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Mahajan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009646; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Min DS, 2001, CARCINOGENESIS, V22, P1641, DOI 10.1093/carcin/22.10.1641; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Park MH, 2009, CARCINOGENESIS, V30, P356, DOI 10.1093/carcin/bgn287; Patel S, 2010, J BIOL CHEM, V285, P32055, DOI 10.1074/jbc.M110.171058; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scott SA, 2013, J BIOL CHEM, V288, P20477, DOI 10.1074/jbc.M113.451708; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	81	46	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					600	616		10.1074/jbc.M113.532978	http://dx.doi.org/10.1074/jbc.M113.532978			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24257753	Green Published, hybrid			2022-12-28	WOS:000330541200002
J	Crespillo, S; Casares, S; Mateo, PL; Conejero-Lara, F				Crespillo, Sara; Casares, Salvador; Mateo, Pedro L.; Conejero-Lara, Francisco			Thermodynamic Analysis of the Binding of 2F5 (Fab and Immunoglobulin G Forms) to Its gp41 Epitope Reveals a Strong Influence of the Immunoglobulin Fc Region on Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ISOTHERMAL TITRATION CALORIMETRY; HUMAN MONOCLONAL-ANTIBODY; CONSTANT-REGION; ANTIGEN-BINDING; CONFORMATIONAL-CHANGES; ECTODOMAIN REGION; HIV-1 VACCINE; MEMBRANE; NEUTRALIZATION	Immunotherapies and vaccines based on the induction of broadly neutralizing monoclonal antibodies (bNAbs) have become outstanding strategies against HIV-1. Diverse bNAbs recognizing different regions of the HIV-1 envelope have been identified and extensively studied. However, there is little information about the thermodynamics of binding of these bNAbs and their epitopes. We used isothermal titration calorimetry to characterize thermodynamically the interactions between bNAb 2F5 (in both the IgG and Fab forms) and its functional and core epitope peptides. We found that these interactions are enthalpically driven and opposed by a negative entropy change. The highest affinity was found for 2F5 IgG for its functional epitope, indicating that additional interactions involving residues flanking the core epitope contribute strongly to higher affinity. In addition, the strong influence of the Fc region on the binding affinity suggests long-range allosteric effects within IgG. Our results provide useful information for developing new therapeutics against HIV-1 and, in a broader scope, contribute to a better understanding of antigen-antibody recognition.	[Conejero-Lara, Francisco] Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain; Univ Granada, Fac Ciencias, Inst Biotecnol, E-18071 Granada, Spain	University of Granada; University of Granada	Conejero-Lara, F (corresponding author), Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain.	conejero@ugr.es	Lara, Francisco Conejero/F-2962-2016	Lara, Francisco Conejero/0000-0002-8282-2168	European Union [201038]	European Union(European Commission)	This work was supported by European Union Seventh Framework Programme (FP7/2007-2013) Grant 201038.	Biron Z, 2002, BIOCHEMISTRY-US, V41, P12687, DOI 10.1021/bi026261y; Bryson S, 2009, J VIROL, V83, P11862, DOI 10.1128/JVI.01604-09; Casadevall A, 2012, P NATL ACAD SCI USA, V109, P12272, DOI 10.1073/pnas.1209750109; CAVACINI LA, 1995, J IMMUNOL, V155, P3638; CONLEY AJ, 1994, P NATL ACAD SCI USA, V91, P3348, DOI 10.1073/pnas.91.8.3348; Dam TK, 2008, J BIOL CHEM, V283, P31366, DOI 10.1074/jbc.M806473200; Eryilmaz E, 2013, MOL IMMUNOL, V56, P588, DOI 10.1016/j.molimm.2013.06.006; Greenspan NS, 2010, TRENDS IMMUNOL, V31, P138, DOI 10.1016/j.it.2010.01.001; Guenaga J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002806; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; Huarte N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052740; Janda A, 2012, J BIOL CHEM, V287, P35409, DOI 10.1074/jbc.M112.404483; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kim M, 2013, J BIOL CHEM, V288, P31888, DOI 10.1074/jbc.M113.494609; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Liu J, 2009, BIOCHEMISTRY-US, V48, P2915, DOI 10.1021/bi802303b; Lu ZF, 2013, IMMUNOL LETT, V150, P152, DOI 10.1016/j.imlet.2013.01.011; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; Pritsch O, 1996, J CLIN INVEST, V98, P2235, DOI 10.1172/JCI119033; Purtscher M, 1996, AIDS, V10, P587, DOI 10.1097/00002030-199606000-00003; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sagawa T, 2005, MOL IMMUNOL, V42, P9, DOI 10.1016/j.molimm.2004.07.004; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Scharf O, 2001, J VIROL, V75, P6558, DOI 10.1128/JVI.75.14.6558-6565.2001; SCHWARZ FP, 1995, EUR J BIOCHEM, V228, P388; Sela-Culang I, 2012, J IMMUNOL, V189, P4890, DOI 10.4049/jimmunol.1201493; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; Tudor D, 2012, P NATL ACAD SCI USA, V109, P12680, DOI 10.1073/pnas.1200024109; Velazquez-Campoy A, 2006, NAT PROTOC, V1, P186, DOI 10.1038/nprot.2006.28; Welfle K, 2003, J MOL RECOGNIT, V16, P54, DOI 10.1002/jmr.607; Wibbenmeyer JA, 1999, BBA-PROTEIN STRUCT M, V1430, P191, DOI 10.1016/S0167-4838(98)00285-4; Xia YM, 2013, MOL IMMUNOL, V56, P28, DOI 10.1016/j.molimm.2013.04.004	42	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					594	599		10.1074/jbc.C113.524439	http://dx.doi.org/10.1074/jbc.C113.524439			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24302742	hybrid, Green Published			2022-12-28	WOS:000330541200001
J	Woodruff, ML; Rajala, A; Fain, GL; Rajala, RVS				Woodruff, Michael L.; Rajala, Ammaji; Fain, Gordon L.; Rajala, Raju V. S.			Modulation of Mouse Rod Photoreceptor Responses by Grb14 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic GMP (cGMP); Cyclic Nucleotides; Neurobiology; Photoreceptors; Receptor-tyrosine Kinase; Retina	RECEPTOR-BOUND PROTEIN-14; SINGLE-PHOTON RESPONSES; CGMP-PHOSPHODIESTERASE; GATED CHANNEL; LIGHT; INSULIN; SENSITIVITY; ACTIVATION; MICE; IDENTIFICATION	Previous experiments have indicated that growth factor receptor-bound protein 14 (Grb14) may modulate rod photoreceptor cGMP-gated channels by decreasing channel affinity for cGMP; however, the function of Grb14 in rod physiology is not known. In this study, we examined the role of Grb14 by recording electrical responses from rods in which the gene for the Grb14 protein had been deleted. Suction-electrode recordings from single mouse rods showed that responses of dark-adapted Grb14(-/-) mice to brief flashes decayed more rapidly than strain-controlled wild type (WT) rods, with decreased values of both integration time and the exponential time course of decay ((REC)). This result is consistent with an increase in channel affinity for cGMP produced by deletion of Grb14. However, Grb14(-/-) mouse rods also showed little change in dark current and a large and significant decrease in the limiting time constant (D), which are not consistent with an effect on channel affinity but seem rather to indicate modulation of the rate of inactivation of cyclic nucleotide phosphodiesterase 6 (PDE6). Grb14 has been reported to translocate from the inner to the outer segment in bright light, but we saw effects on response time course even in dark-adapted rods, although the effects were somewhat greater after rods had been adapted by exposure to bleaching illumination. Our results indicate that the mechanism of Grb14 action may be more complex than previously realized.	[Woodruff, Michael L.; Fain, Gordon L.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Rajala, Ammaji; Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Fain, Gordon L.] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Fain, Gordon L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Rajala, RVS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, 608 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	raju-rajala@ouhsc.edu		Fain, Gordon/0000-0002-9813-0342	National Institutes of Health/NEI [EY016507, EY00871, EY01844]; NATIONAL EYE INSTITUTE [R01EY001844, R01EY000871, R37EY001844, R01EY016507] Funding Source: NIH RePORTER	National Institutes of Health/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health/NEI Grants EY016507 and EY00871 (to R. V. S. R.) and EY01844 (to G. L. F.).	Basavarajappa DK, 2011, MOL CELL BIOL, V31, P3975, DOI 10.1128/MCB.05659-11; Cariou B, 2004, FRONT BIOSCI-LANDMRK, V9, P1626, DOI 10.2741/1228; Chen CK, 2010, J PHYSIOL-LONDON, V588, P3231, DOI 10.1113/jphysiol.2010.191221; Chen CK, 2012, J NEUROSCI, V32, P15998, DOI 10.1523/JNEUROSCI.1639-12.2012; Chen CK, 2010, J NEUROSCI, V30, P1213, DOI 10.1523/JNEUROSCI.4353-09.2010; Chen J, 2010, J NEUROSCI, V30, P16232, DOI 10.1523/JNEUROSCI.2868-10.2010; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Daly RJ, 1998, CELL SIGNAL, V10, P613, DOI 10.1016/S0898-6568(98)00022-9; Desbuquois B, 2013, FEBS J, V280, P794, DOI 10.1111/febs.12080; Fain GL, 2011, MOL NEUROBIOL, V44, P374, DOI 10.1007/s12035-011-8205-1; Field GD, 2002, NEURON, V35, P733, DOI 10.1016/S0896-6273(02)00822-X; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; Gross OP, 2012, NEURON, V76, P370, DOI 10.1016/j.neuron.2012.07.029; Gupta VK, 2010, EMBO REP, V11, P861, DOI 10.1038/embor.2010.142; HSU YT, 1993, NATURE, V365, P279, DOI 10.1038/365279c0; KOUTALOS Y, 1995, J GEN PHYSIOL, V106, P891, DOI 10.1085/jgp.106.5.891; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Li GY, 2007, J NEUROSCI, V27, P203, DOI 10.1523/JNEUROSCI.0445-06.2007; Lin RCY, 2010, ARTERIOSCL THROM VAS, V30, P724, DOI 10.1161/ATVBAHA.109.201988; Martemyanov KA, 2008, P NATL ACAD SCI USA, V105, P20988, DOI 10.1073/pnas.0808941106; NAKATANI K, 1995, J PHYSIOL-LONDON, V484, P69, DOI 10.1113/jphysiol.1995.sp020648; Nymark S, 2012, J PHYSIOL-LONDON, V590, P2353, DOI 10.1113/jphysiol.2012.228627; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Rajala A, 2009, BIOCHEMISTRY-US, V48, P5563, DOI 10.1021/bi9000062; Rajala R. V., 2013, INVEST OPHTHALMOL VI, V54; Rajala RVS, 2010, J BIOL CHEM, V285, P8894, DOI 10.1074/jbc.M109.070854; Rajala RVS, 2005, BIOCHEMISTRY-US, V44, P7929, DOI 10.1021/bi0500271; Tsang SH, 2006, J NEUROSCI, V26, P4472, DOI 10.1523/JNEUROSCI.4775-05.2006; Woodruff ML, 2008, J NEUROSCI, V28, P2064, DOI 10.1523/JNEUROSCI.2973-07.2008; Woodruff ML, 2004, J PHYSIOL-LONDON, V557, P821, DOI 10.1113/jphysiol.2004.064014	32	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					358	364		10.1074/jbc.M113.517045	http://dx.doi.org/10.1074/jbc.M113.517045			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24273167	Green Published, hybrid			2022-12-28	WOS:000329370900031
J	Rogacheva, MV; Manhart, CM; Chen, C; Guarne, A; Surtees, J; Alani, E				Rogacheva, Maria V.; Manhart, Carol M.; Chen, Cheng; Guarne, Alba; Surtees, Jennifer; Alani, Eric			Mlh1-Mlh3, a Meiotic Crossover and DNA Mismatch Repair Factor, Is a Msh2-Msh3-stimulated Endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Enzymes; DNA Mismatch Repair; DNA Recombination; DNA Repair; Meiosis; Mlh1-Mlh3; Crossing Over; Endonuclease	DOUBLE-STRAND BREAKS; MUTL-ALPHA; HOLLIDAY JUNCTIONS; YEAST MSH2-MSH6; CROSSING-OVER; MEIOSIS; RECOMBINATION; BINDING; PROTEIN; MLH1-PMS1	Background: Meiotic crossing over requires resolution of Holliday junctions through actions of the DNA mismatch repair factor Mlh1-Mlh3. Results: Mlh1-Mlh3 is a metal-dependent, Msh2-Msh3-stimulated endonuclease. Conclusion: Our observations support a direct role for Mlh1-Mlh3 endonuclease activity in recombination and repair. Significance: An enzymatic activity is identified for a key recombination and repair factor. Crossing over between homologous chromosomes is initiated in meiotic prophase in most sexually reproducing organisms by the appearance of programmed double strand breaks throughout the genome. In Saccharomyces cerevisiae the double-strand breaks are resected to form three prime single-strand tails that primarily invade complementary sequences in unbroken homologs. These invasion intermediates are converted into double Holliday junctions and then resolved into crossovers that facilitate homolog segregation during Meiosis I. Work in yeast suggests that Msh4-Msh5 stabilizes invasion intermediates and double Holliday junctions, which are resolved into crossovers in steps requiring Sgs1 helicase, Exo1, and a putative endonuclease activity encoded by the DNA mismatch repair factor Mlh1-Mlh3. We purified Mlh1-Mlh3 and showed that it is a metal-dependent and Msh2-Msh3-stimulated endonuclease that makes single-strand breaks in supercoiled DNA. These observations support a direct role for an Mlh1-Mlh3 endonuclease activity in resolving recombination intermediates and in DNA mismatch repair.	[Rogacheva, Maria V.; Manhart, Carol M.; Chen, Cheng; Alani, Eric] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Guarne, Alba] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Surtees, Jennifer] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	Cornell University; McMaster University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Alani, E (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 459 Biotechnol Bldg, Ithaca, NY 14853 USA.	eea3@cornell.edu	Manhart, Carol/AAQ-4938-2020		National Institutes of Health [GM53085, DG288295, GM087549]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM53085 (to M. V. R., C. M., C. C., and E. A.), DG288295 (Natural Science and Engineering Research Council; to A. G.), and GM087549 (to J. S.).	ALANI E, 1995, GENE DEV, V9, P234, DOI 10.1101/gad.9.2.234; Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown MS, 2013, G3-GENES GENOM GENET, V3, P9, DOI 10.1534/g3.112.004622; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; CHI NW, 1994, J BIOL CHEM, V269, P29984; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; Deschenes SM, 2007, CANCER LETT, V249, P148, DOI 10.1016/j.canlet.2006.08.008; Dixon F. J., 1969, INTRO STAT ANAL; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Drotschmann K, 2002, BIOL CHEM, V383, P969, DOI 10.1515/BC.2002.103; Duppatla V, 2009, BIOCHEM J, V423, P265, DOI 10.1042/BJ20090626; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GiraudPanis MJE, 1997, EMBO J, V16, P2528, DOI 10.1093/emboj/16.9.2528; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guarne A, 2012, PROG MOL BIOL TRANSL, V110, P41, DOI 10.1016/B978-0-12-387665-2.00003-1; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Habraken Y, 1996, CURR BIOL, V6, P1185, DOI 10.1016/S0960-9822(02)70686-6; Hall MC, 2002, J BIOL CHEM, V277, P3673, DOI 10.1074/jbc.M106120200; Hall MC, 2001, J MOL BIOL, V312, P637, DOI 10.1006/jmbi.2001.4958; Heck JA, 2006, P NATL ACAD SCI USA, V103, P3256, DOI 10.1073/pnas.0510998103; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N, 1997, GENE DEV, V11, P1573, DOI 10.1101/gad.11.12.1573; HUNTER N, 2007, TOPICS CURRENT GENET, V17, P381; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kijas AW, 2003, J MOL BIOL, V331, P123, DOI 10.1016/S0022-2836(03)00694-6; Kolas NK, 2005, J CELL BIOL, V171, P447, DOI 10.1083/jcb.200506170; Kosinski J, 2005, J MOL BIOL, V351, P895, DOI 10.1016/j.jmb.2005.06.044; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lenhart JS, 2013, MOL MICROBIOL, V90, P680, DOI 10.1111/mmi.12389; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Matos J, 2011, CELL, V147, P158, DOI 10.1016/j.cell.2011.08.032; Mauris J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007175; MCENTEE K, 1980, P NATL ACAD SCI-BIOL, V77, P857, DOI 10.1073/pnas.77.2.857; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Moens PB, 2002, J CELL SCI, V115, P1611; Nishant KT, 2008, GENETICS, V179, P747, DOI 10.1534/genetics.108.086645; Nishant KT, 2010, PLOS GENET, V6; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Plys AJ, 2012, J MOL BIOL, V422, P192, DOI 10.1016/j.jmb.2012.05.030; Rass U, 2006, METHOD ENZYMOL, V408, P485, DOI 10.1016/S0076-6879(06)08030-X; Robine N, 2007, MOL CELL BIOL, V27, P1868, DOI 10.1128/MCB.02063-06; Rose MD., 1990, METHODS YEAST GENETI; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Surtees JA, 2006, J MOL BIOL, V360, P523, DOI 10.1016/j.jmb.2006.05.032; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6	70	80	84	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5664	5673		10.1074/jbc.M113.534644	http://dx.doi.org/10.1074/jbc.M113.534644			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403070	hybrid, Green Published			2022-12-28	WOS:000332015500029
J	Acx, H; Chavez-Gutierrez, L; Serneels, L; Lismont, S; Benurwar, M; Elad, N; De Strooper, B				Acx, Hermien; Chavez-Gutierrez, Lucia; Serneels, Lutgarde; Lismont, Sam; Benurwar, Manasi; Elad, Nadav; De Strooper, Bart			Signature Amyloid beta Profiles Are Produced by Different gamma-Secretase Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid Precursor Protein; Enzyme Mechanisms; Neurobiology; Secretases; Amyloid Beta; Gamma-Secretase	CARBOXYL-TERMINAL FRAGMENT; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; INTRACELLULAR DOMAIN; PEPTIDE PRODUCTION; PRESENILIN; CLEAVAGE; RECONSTITUTION; DEFICIENCY; MUTATIONS	Background: -Secretase complexes generate amyloid- (A) in Alzheimer disease. Results: A profiles of the four -secretase complexes expressed in humans show that PSEN regulates total peptide levels and the A(38) pathway, whereas APH1 affects mainly the efficiency of the carboxypeptidase-like activity. Conclusion: -Secretase subunit composition regulates A generation. Significance: These intrinsic differences could be used to advance AD therapeutic development. -Secretase complexes are involved in the generation of amyloid- (A) in the brain. Therefore, -secretase has been proposed as a potential therapeutic target in Alzheimer disease (AD). Targeting -secretase activity in AD requires the pharmacological dissociation of the processing of physiological relevant substrates and the generation of toxic A. Previous reports suggest the differential targeting of -secretase complexes, based on their subunit composition, as a valid strategy. However, little is known about the biochemical properties of the different complexes, and key questions regarding their A product profiles should be first addressed. Here, we expressed, purified, and analyzed, under the same conditions, the endopeptidase and carboxypeptidase-like activities of the four -secretase complexes present in humans. We find that the nature of the catalytic subunit in the complex affects both activities. Interestingly, PSEN2 complexes discriminate between the A(40) and A(38) production lines, indicating that A generation in one or the other pathway can be dissociated. In contrast, the APH1 subunit mainly affects the carboxypeptidase-like activity, with APH1B complexes favoring the generation of longer A peptides. In addition, we determined that expression of a single human -secretase complex in cell lines retains the intrinsic attributes of the protease while present in the membrane, providing validation for the in vitro studies. In conclusion, our data show that each -secretase complex produces a characteristic A signature. The qualitative and quantitative differences between different -secretase complexes could be used to advance drug development in AD and other disorders.	[Acx, Hermien; Chavez-Gutierrez, Lucia; Serneels, Lutgarde; Lismont, Sam; Benurwar, Manasi; Elad, Nadav; De Strooper, Bart] VIB, Ctr Biol Dis, B-3000 Louvain, Belgium; [Acx, Hermien; Chavez-Gutierrez, Lucia; Serneels, Lutgarde; Lismont, Sam; Benurwar, Manasi; Elad, Nadav; De Strooper, Bart] Univ Louvain, Leuven Inst Neurodegenerat Disorders, Ctr Human Genet, B-3000 Louvain, Belgium; [Acx, Hermien; Chavez-Gutierrez, Lucia; Serneels, Lutgarde; Lismont, Sam; Benurwar, Manasi; Elad, Nadav; De Strooper, Bart] Univ Louvain, Univ Hosp Leuven, B-3000 Louvain, Belgium; [De Strooper, Bart] UCL, Inst Neurol, London WC1N 3BG, England	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; University of London; University College London	Chavez-Gutierrez, L (corresponding author), Katholieke Univ Leuven VIB, Ctr Biol Dis, Ctr Human Genet, O&N4 Herestr 49,Box 602, B-3000 Louvain, Belgium.	Lucia.ChavezGutierrez@cme.vib-kuleuven.be; Bart.DeStrooper@cme.vib-kuleuven.be	Chávez-Gutiérrez, Lucía/E-2657-2017; de+Strooper, Bart/Z-1638-2019	Serneels, Lutgarde/0000-0002-5463-4231; Elad, Nadav/0000-0001-6222-2280	Fonds voor Wetenschappelijk Onderzoek; University of Leuven; Flemish Institute for Biology; Stichting Alzheimer Onderzoek Grant [SAO-FRA P-12007]; Interuniversity Attraction Poles Program of the Belgian Federal Science, Policy Office [IUAP P6P7/1658]; Methusalem grant of the Flemish government; Arthur Bax-Anna Vanluffelen chair for Alzheimer research	Fonds voor Wetenschappelijk Onderzoek(FWO); University of Leuven(KU Leuven); Flemish Institute for Biology; Stichting Alzheimer Onderzoek Grant; Interuniversity Attraction Poles Program of the Belgian Federal Science, Policy Office; Methusalem grant of the Flemish government; Arthur Bax-Anna Vanluffelen chair for Alzheimer research	This work was supported by the Fonds voor Wetenschappelijk Onderzoek, the University of Leuven and the Flemish Institute for Biology, Stichting Alzheimer Onderzoek Grant SAO-FRA P-12007, the Interuniversity Attraction Poles Program IUAP P6P7/1658 of the Belgian Federal Science Policy Office, a Methusalem grant of the Flemish government, the University of Leuven (to B. D. S.), the Arthur Bax-Anna Vanluffelen chair for Alzheimer research (to. B. D. S.), and an anonymous foundation.	Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; BELYAEV AS, 1993, NUCLEIC ACIDS RES, V21, P1219, DOI 10.1093/nar/21.5.1219; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Borgegard T, 2012, J NEUROSCI, V32, P17297, DOI 10.1523/JNEUROSCI.1451-12.2012; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Franberg J, 2011, BIOCHEM BIOPH RES CO, V404, P564, DOI 10.1016/j.bbrc.2010.12.029; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Mastrangelo P, 2005, P NATL ACAD SCI USA, V102, P8972, DOI 10.1073/pnas.0500940102; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; MORI H, 1992, J BIOL CHEM, V267, P17082; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; WALKER PA, 1994, BIO-TECHNOL, V12, P601, DOI 10.1038/nbt0694-601; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wiltfang J, 2002, J NEUROCHEM, V81, P481, DOI 10.1046/j.1471-4159.2002.00818.x; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yagishita S, 2008, BIOCHEM BIOPH RES CO, V377, P141, DOI 10.1016/j.bbrc.2008.09.090; Yonemura Y, 2011, J BIOL CHEM, V286, P44569, DOI 10.1074/jbc.M111.270108; Yoshiike Y, 2003, J BIOL CHEM, V278, P23648, DOI 10.1074/jbc.M212785200	48	61	62	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4346	4355		10.1074/jbc.M113.530907	http://dx.doi.org/10.1074/jbc.M113.530907			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24338474	Green Published, hybrid			2022-12-28	WOS:000331403800045
J	Das, A; Durrant, D; Koka, S; Salloum, FN; Xi, L; Kukreja, RC				Das, Anindita; Durrant, David; Koka, Saisudha; Salloum, Fadi N.; Xi, Lei; Kukreja, Rakesh C.			Mammalian Target of Rapamycin (mTOR) Inhibition with Rapamycin Improves Cardiac Function in Type 2 Diabetic Mice POTENTIAL ROLE OF ATTENUATED OXIDATIVE STRESS AND ALTERED CONTRACTILE PROTEIN EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antioxidants; Cardiovascular Disease; Diabetes; mTOR; Oxidative Stress; Proteomics	CARBONIC-ANHYDRASE-II; ISCHEMIA-REPERFUSION INJURY; INDUCED INSULIN-RESISTANCE; SIROLIMUS-ELUTING STENTS; RENAL TUBULAR-ACIDOSIS; COENZYME-A SYNTHESIS; CARDIOMYOCYTE HYPERTROPHY; DILATED CARDIOMYOPATHY; MYOCARDIAL-ISCHEMIA; NEBULETTE MUTATIONS	Background: Elevated mammalian target of rapamycin (mTOR) signaling contributes to diabetic complications. Results: mTOR inhibitor, rapamycin, improves metabolic status and cardiac function, attenuates oxidative stress, and alters antioxidant and contractile protein expression in type 2 diabetic mice. Conclusion: Rapamycin may provide metabolic and cardiac benefits in diabetic mice. Significance: mTOR inhibition may be an attractive novel therapeutic strategy for diabetes-related complications. Elevated mammalian target of rapamycin (mTOR) signaling contributes to the pathogenesis of diabetes, with increased morbidity and mortality, mainly because of cardiovascular complications. Because mTOR inhibition with rapamycin protects against ischemia/reperfusion injury, we hypothesized that rapamycin would prevent cardiac dysfunction associated with type 2 diabetes (T2D). We also investigated the possible mechanisms and novel protein targets involved in rapamycin-induced preservation of cardiac function in T2D mice. Adult male leptin receptor null, homozygous db/db, or wild type mice were treated daily for 28 days with vehicle (5% DMSO) or rapamycin (0.25 mg/kg, intraperitoneally). Cardiac function was monitored by echocardiography, and protein targets were identified by proteomics analysis. Rapamycin treatment significantly reduced body weight, heart weight, plasma glucose, triglyceride, and insulin levels in db/db mice. Fractional shortening was improved by rapamycin treatment in db/db mice. Oxidative stress as measured by glutathione levels and lipid peroxidation was significantly reduced in rapamycin-treated db/db hearts. Rapamycin blocked the enhanced phosphorylation of mTOR and S6, but not AKT in db/db hearts. Proteomic (by two-dimensional gel and mass spectrometry) and Western blot analyses identified significant changes in several cytoskeletal/contractile proteins (myosin light chain MLY2, myosin heavy chain 6, myosin-binding protein C), glucose metabolism proteins (pyruvate dehydrogenase E1, PYGB, Pgm2), and antioxidant proteins (peroxiredoxin 5, ferritin heavy chain 1) following rapamycin treatment in db/db heart. These results show that chronic rapamycin treatment prevents cardiac dysfunction in T2D mice, possibly through attenuation of oxidative stress and alteration of antioxidants and contractile as well as glucose metabolic protein expression.	[Das, Anindita; Durrant, David; Koka, Saisudha; Salloum, Fadi N.; Xi, Lei; Kukreja, Rakesh C.] Virginia Commonwealth Univ, Pauley Heart Ctr, Div Cardiol, Richmond, VA 23298 USA	Virginia Commonwealth University	Das, A (corresponding author), Virginia Commonwealth Univ, Pauley Heart Ctr, Div Cardiol, 1101 East Marshall St,Sangar Hall,Rm 7020B, Richmond, VA 23298 USA.	adas2@vcu.edu	Das, Anindita/K-8003-2013; Salloum, Fadi N/C-2391-2008; Xi, Lei/A-3078-2008	Das, Anindita/0000-0003-4422-7277; Salloum, Fadi N/0000-0002-8947-9315; Xi, Lei/0000-0002-7569-3329	National Institutes of Health [RO1 HL51045, HL79424, HL93685, HL118808]; American Heart Association [10SDG3770011]; Virginia Commonwealth University [UL1RR031990]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031990] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118808, R01HL051045, R01HL093685, R01HL079424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Virginia Commonwealth University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL51045, HL79424, HL93685, and HL118808 (to R. C. K.). This work was also supported by American Heart Association National Scientist Development Grant 10SDG3770011 (to F. N. S.) and A. D. Williams' Fund of Virginia Commonwealth University Grant UL1RR031990 (to A. D.).	Adameova A, 2014, HEART FAIL REV, V19, P25, DOI 10.1007/s10741-013-9378-7; Alvarez BV, 2007, J PHYSIOL-LONDON, V579, P127, DOI 10.1113/jphysiol.2006.123638; Banmeyer I, 2005, FEBS LETT, V579, P2327, DOI 10.1016/j.febslet.2005.03.027; Baumgart D, 2007, J AM COLL CARDIOL, V50, P1627, DOI 10.1016/j.jacc.2007.07.035; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Brickson S, 2007, AM J PHYSIOL-HEART C, V292, pH1747, DOI 10.1152/ajpheart.01037.2006; Brown BF, 2012, CAN J PHYSIOL PHARM, V90, P1599, DOI 10.1139/y2012-142; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Chambers Kari T, 2011, J Biol Chem, V286, P11155, DOI 10.1074/jbc.M110.217349; Chong ZZ, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-45; Das A, 2012, J MOL CELL CARDIOL, V53, P858, DOI 10.1016/j.yjmcc.2012.09.007; de Waha A, 2011, CLIN RES CARDIOL, V100, P561, DOI 10.1007/s00392-010-0278-8; Deepa Sathyaseelan S, 2013, J Biochem Pharmacol Res, V1, P114; Dillmann W H, 1986, Adv Exp Med Biol, V194, P469; DILLMANN WH, 1980, DIABETES, V29, P579, DOI 10.2337/diab.29.7.579; Drake JC, 2010, AM J PHYSIOL-REG I, V299, pR1546, DOI 10.1152/ajpregu.00337.2010; Dutta D, 2013, AUTOPHAGY, V9, P328, DOI 10.4161/auto.22971; Ernande L, 2012, ARCH CARDIOVASC DIS, V105, P218, DOI 10.1016/j.acvd.2011.11.007; Essop MF, 2011, CARDIOVASC J AFR, V22, P175, DOI 10.5830/CVJA-2010-058; French CJ, 2011, CORONARY ARTERY DIS, V22, P479, DOI 10.1097/MCA.0b013e32834a3a71; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Gao G, 2011, AM J PHYSIOL-HEART C, V300, pH1583, DOI 10.1152/ajpheart.01084.2010; Gao XM, 2006, J HYPERTENS, V24, P1663, DOI 10.1097/01.hjh.0000239304.01496.83; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Howarth FC, 2011, EXP PHYSIOL, V96, P325, DOI 10.1113/expphysiol.2010.055574; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Jiang JH, 2013, INT J MOL MED, V31, P825, DOI 10.3892/ijmm.2013.1280; Jweied EE, 2005, AM J PHYSIOL-HEART C, V289, pH2478, DOI 10.1152/ajpheart.00638.2005; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Khan SA, 2006, J MOL CELL CARDIOL, V41, P256, DOI 10.1016/j.yjmcc.2006.04.014; Koka S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0249-5; KUKREJA RC, 1992, CARDIOVASC RES, V26, P641, DOI 10.1093/cvr/26.7.641; Lai LW, 1998, J CLIN INVEST, V101, P1320, DOI 10.1172/JCI1694; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Maiellaro-Rafferty K, 2013, J MOL CELL CARDIOL, V60, P151, DOI 10.1016/j.yjmcc.2013.04.021; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; Matsushima S, 2006, AM J PHYSIOL-HEART C, V291, pH2237, DOI 10.1152/ajpheart.00427.2006; Mellor KM, 2013, CLIN EXP PHARMACOL P, V40, P56, DOI 10.1111/j.1440-1681.2012.05738.x; Mellor KM, 2011, AUTOPHAGY, V7, P1263, DOI 10.4161/auto.7.10.17148; Mellor KM, 2011, J MOL CELL CARDIOL, V50, P1035, DOI 10.1016/j.yjmcc.2011.03.002; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Mori H, 2009, BIOCHEM BIOPH RES CO, V384, P471, DOI 10.1016/j.bbrc.2009.04.136; Omiya S, 2009, J MOL CELL CARDIOL, V46, P59, DOI 10.1016/j.yjmcc.2008.09.714; Pereira L, 2006, DIABETES, V55, P608, DOI 10.2337/diabetes.55.03.06.db05-1284; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Plutzky J, 2011, AM J CARDIOL, V108, p25B, DOI 10.1016/j.amjcard.2011.03.014; Pohlmann L, 2007, CIRC RES, V101, P928, DOI 10.1161/CIRCRESAHA.107.158774; Purevjav E, 2010, J AM COLL CARDIOL, V56, P1493, DOI 10.1016/j.jacc.2010.05.045; Rajapakse AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019237; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; REIBEL DK, 1981, AM J PHYSIOL, V240, pH606, DOI 10.1152/ajpheart.1981.240.4.H606; ROBISHAW JD, 1982, J BIOL CHEM, V257, P967; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schroeder MA, 2013, P NATL ACAD SCI USA, V110, pE958, DOI 10.1073/pnas.1213471110; Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039; Shin YJ, 2011, CURR EYE RES, V36, P1116, DOI 10.3109/02713683.2011.614372; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stohr A, 2013, J MOL CELL CARDIOL, V63, P189, DOI 10.1016/j.yjmcc.2013.07.011; Sung MMY, 2011, J MOL MED, V89, P459, DOI 10.1007/s00109-010-0720-4; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Turdi S, 2011, J MOL CELL CARDIOL, V50, P712, DOI 10.1016/j.yjmcc.2010.12.007; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vignier N, 2009, CIRC RES, V105, P239, DOI 10.1161/CIRCRESAHA.109.201251; Voelkers M, 2013, CIRCULATION, V128, P2132, DOI 10.1161/CIRCULATIONAHA.113.003638; Wang BT, 2011, P NATL ACAD SCI USA, V108, P15201, DOI 10.1073/pnas.1103746108; Xi L, 2011, J CELL MOL MED, V15, P2512, DOI 10.1111/j.1582-4934.2011.01257.x; Yang H, 2011, CLIN CHEM LAB MED, V49, P1773, DOI 10.1515/CCLM.2011.250	74	112	117	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4145	4160		10.1074/jbc.M113.521062	http://dx.doi.org/10.1074/jbc.M113.521062			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24371138	hybrid, Green Published			2022-12-28	WOS:000331403800028
J	Wondisford, AR; Xiong, LS; Chang, E; Meng, SM; Meyers, DJ; Li, MS; Cole, PA; He, L				Wondisford, Anne R.; Xiong, Lishou; Chang, Evan; Meng, Shumei; Meyers, David J.; Li, Mingsong; Cole, Philip A.; He, Ling			Control of Foxo1 Gene Expression by Co-activator P300	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CREB; Foxo; Gluconeogenesis; Histone Acetylase; P300	POSTTRANSLATIONAL MODIFICATION; HEPATIC GLUCONEOGENESIS; TRANSCRIPTION FACTORS; PROTEIN; PHOSPHORYLATION; ACETYLATION; DISEASE; SENSITIVITY; DEACETYLASE; REGULATOR	Background: The mechanism driving hepatic gene expression of Foxo1 in the fasted state remains unclear. Results: Activation of cAMP-PKA pathway induces Foxo1 gene expression through CREB and co-activator P300. Conclusion: P300 mediates Foxo1 gene expression by binding to Foxo1 proximal promoter. Significance: Induction of the Foxo1 gene by cAMP-PKA via P300 fully activates the gluconeogenic program during fasting to maintain euglycemia. FOXO1 is an important downstream mediator of the insulin signaling pathway. In the fed state, elevated insulin phosphorylates FOXO1 via AKT, leading to its nuclear exclusion and degradation. A reduction in nuclear FOXO1 levels then leads to suppression of hepatic glucose production. However, the mechanism leading to expression of Foxo1 gene in the fasted state is less clear. We found that Foxo1 mRNA and FOXO1 protein levels of Foxo1 were increased significantly in the liver of mice after 16 h of fasting. Furthermore, dibutyrl cAMP stimulated the expression of Foxo1 at both mRNA and protein level in hepatocytes. Because cAMP-PKA regulates hepatic glucose production through cAMP-response element-binding protein co-activators, we depleted these co-activators using adenoviral shRNAs. Interestingly, only depletion of co-activator P300 resulted in the decrease of Foxo1 mRNA and FOXO1 protein levels. In addition, inhibition of histone acetyltransferase activity of P300 significantly decreased hepatic Foxo1 mRNA and FOXO1 protein levels in fasted mice, as well as fasting blood glucose levels. By characterization of Foxo1 gene promoter, P300 regulates the Foxo1 gene expression through the binding to tandem cAMP-response element sites in the proximal promoter region of Foxo1 gene.	[He, Ling] Johns Hopkins Univ, Sch Med, Div Metab, Dept Pediat, Baltimore, MD 21287 USA; [Meyers, David J.; Cole, Philip A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA; [Li, Mingsong] Southern Med Univ, Nanfang Hosp, Digest Div, Guangzhou 510515, Guangdong, Peoples R China	Johns Hopkins University; Johns Hopkins University; Southern Medical University - China	He, L (corresponding author), Div Metab, 600 N Wolfe St, Baltimore, MD 21287 USA.	heling@jhmi.edu			NIDDK/National Institutes of Health [R00DK085142]; Johns Hopkins University-University of Maryland Diabetes Research Center [P60DK079637\, R37GM62437]; Flight Attendant Medical Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R00DK085142, R01DK063349, P60DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062437] Funding Source: NIH RePORTER	NIDDK/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Johns Hopkins University-University of Maryland Diabetes Research Center; Flight Attendant Medical Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIDDK/National Institutes of Health Grants R00DK085142 (to L. H.), and the Johns Hopkins University-University of Maryland Diabetes Research Center Grants P60DK079637, R37GM62437, and Flight Attendant Medical Research Institute (to P. A. C.).	Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Desouza C, 2003, DIABETES CARE, V26, P1485, DOI 10.2337/diacare.26.5.1485; Einarsdottir AB, 2009, LANCET, V373, P1316, DOI 10.1016/S0140-6736(09)60750-9; Fukuoka M, 2003, INT J MOL MED, V12, P503; Goodman RH, 2000, GENE DEV, V14, P1553; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; He L, 2013, MOL ENDOCRINOL, V27, P1322, DOI 10.1210/me.2012-1413; He L, 2012, J BIOL CHEM, V287, P32069, DOI 10.1074/jbc.M112.385864; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Higuchi M, 2013, STEM CELLS DEV, V22, P878, DOI 10.1089/scd.2012.0306; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; KREBS EG, 1989, JAMA-J AM MED ASSOC, V262, P1815, DOI 10.1001/jama.262.13.1815; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vannucci R C, 2001, Semin Neonatol, V6, P147, DOI 10.1053/siny.2001.0044; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570	30	38	37	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4326	4333		10.1074/jbc.M113.540500	http://dx.doi.org/10.1074/jbc.M113.540500			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24379407	Green Published, hybrid			2022-12-28	WOS:000331403800043
J	Discola, KF; Forster, A; Boulay, F; Simorre, JP; Attree, I; Dessen, A; Job, V				Discola, Karen F.; Foerster, Andreas; Boulay, Francois; Simorre, Jean-Pierre; Attree, Ina; Dessen, Andrea; Job, Viviana			Membrane and Chaperone Recognition by the Major Translocator Protein PopB of the Type III Secretion System of Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Host-Pathogen Interactions; Membrane Proteins; Pseudomonas aeruginosa; Type III Secretion System	PORE FORMATION; V-ANTIGEN; COMPLEX; BINDING; MODEL; DOMAINS; IPAB; ATPASE; PCRH; SIPB	Background: The type III secretion system allows bacteria to inject effectors directly into the host cytoplasm through a translocation pore. Results: Translocator proteins were characterized in lipid-bound and chaperone-associated forms. Conclusion:Pseudomonas translocators use different regions to recognize their common chaperone and the eukaryotic membrane. Significance: Mapping of key regions in translocators provides a starting point for the potential development of novel antibacterials. The type III secretion system is a widespread apparatus used by pathogenic bacteria to inject effectors directly into the cytoplasm of eukaryotic cells. A key component of this highly conserved system is the translocon, a pore formed in the host membrane that is essential for toxins to bypass this last physical barrier. In Pseudomonas aeruginosa the translocon is composed of PopB and PopD, both of which before secretion are stabilized within the bacterial cytoplasm by a common chaperone, PcrH. In this work we characterize PopB, the major translocator, in both membrane-associated and PcrH-bound forms. By combining sucrose gradient centrifugation experiments, limited proteolysis, one-dimensional NMR, and -lactamase reporter assays on eukaryotic cells, we show that PopB is stably inserted into bilayers with its flexible N-terminal domain and C-terminal tail exposed to the outside. In addition, we also report the crystal structure of the complex between PcrH and an N-terminal region of PopB (residues 51-59), which reveals that PopB lies within the concave face of PcrH, employing mostly backbone residues for contact. PcrH is thus the first chaperone whose structure has been solved in complex with both type III secretion systems translocators, revealing that both molecules employ the same surface for binding and excluding the possibility of formation of a ternary complex. The characterization of the major type III secretion system translocon component in both membrane-bound and chaperone-bound forms is a key step for the eventual development of antibacterials that block translocon assembly.	[Discola, Karen F.; Foerster, Andreas; Simorre, Jean-Pierre; Dessen, Andrea; Job, Viviana] Univ Grenoble Alpes, Inst Biol Struct, F-38000 Grenoble, France; [Discola, Karen F.; Foerster, Andreas; Boulay, Francois; Simorre, Jean-Pierre; Attree, Ina; Dessen, Andrea; Job, Viviana] Commissariat Energie Atom, Grenoble, France; [Discola, Karen F.; Foerster, Andreas; Boulay, Francois; Simorre, Jean-Pierre; Attree, Ina; Dessen, Andrea; Job, Viviana] CNRS, Grenoble, France; [Boulay, Francois; Attree, Ina] iRTSV, INSERM UMR1036, Grenoble, France; [Dessen, Andrea] CNPEM, Brazilian Natl Lab Biosci, BR-13083 Sao Paulo, Brazil	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm)	Job, V (corresponding author), Inst Biol Struct, 6 Rue Jules Horowitz, F-38000 Grenoble, France.	viviana.job@ibs.fr	Discola, Karen F/J-5025-2014	Forster, Andreas/0000-0003-1472-3990; Dessen, Andrea/0000-0001-6487-4020; simorre, jean-pierre/0000-0002-7943-1342; Attree, Ina/0000-0002-2580-764X; Job, Viviana/0000-0001-8421-5292	FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]	FRISBI; GRAL	We thank J. Marquez and the HTX Laboratory team for access to and help with high throughput crystallization, Eric Faudry and Francois Cretin for help with -Lac measurements, J.-P. Andrieu (Institut de Biologie Structurale-Grenoble Partnership for Structural Biology Platform) for N-terminal sequencing, and the European Synchrotron Radiation Facility for access to beamlines. This work used the platforms of the Grenoble Instruct center (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology.	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Allmond LR, 2003, INFECT IMMUN, V71, P2230, DOI 10.1128/IAI.71.4.2230-2233.2003; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Blocker AJ, 2008, P NATL ACAD SCI USA, V105, P6507, DOI 10.1073/pnas.0708344105; Chen L, 2013, MANAGE COMMUN Q, V27, P3, DOI 10.1177/0893318913475485; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Costa TRD, 2013, CELL MICROBIOL, V15, P1088, DOI 10.1111/cmi.12100; Costa TRD, 2010, J BIOL CHEM, V285, P25269, DOI 10.1074/jbc.M110.144311; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Damico RL, 1998, P NATL ACAD SCI USA, V95, P2580, DOI 10.1073/pnas.95.5.2580; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Galle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041547; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Hume PJ, 2003, MOL MICROBIOL, V49, P425, DOI 10.1046/j.1365-2958.2003.03559.x; Job V, 2010, J BIOL CHEM, V285, P23222, DOI 10.1074/jbc.M110.111278; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lokareddy RK, 2010, J BIOL CHEM, V285, P39965, DOI 10.1074/jbc.M110.135616; Loquet A, 2012, NATURE, V486, P276, DOI 10.1038/nature11079; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Mattei PJ, 2011, FEBS J, V278, P414, DOI 10.1111/j.1742-4658.2010.07974.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGhie EJ, 2002, MOL MICROBIOL, V44, P1309, DOI 10.1046/j.1365-2958.2002.02958.x; Miki T, 2010, MOL MICROBIOL, V77, P855, DOI 10.1111/j.1365-2958.2010.07248.x; Miki T, 2009, J BACTERIOL, V191, P6843, DOI 10.1128/JB.00863-09; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104; Romano FB, 2011, BIOCHEMISTRY-US, V50, P7117, DOI 10.1021/bi200905x; Ryndak MB, 2005, INFECT IMMUN, V73, P2433, DOI 10.1128/IAI.73.4.2433-2443.2005; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824; Schreiner M, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-13; Silver AC, 2007, P NATL ACAD SCI USA, V104, P9481, DOI 10.1073/pnas.0700286104; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101; Tomalka AG, 2013, J BACTERIOL, V195, P4836, DOI 10.1128/JB.00335-13; Travier L, 2008, INT J PARASITOL, V38, P757, DOI 10.1016/j.ijpara.2007.10.010; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Van QN, 1998, J MAGN RESON, V132, P154, DOI 10.1006/jmre.1998.1404; Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x; Verove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030488; Wagner S, 2010, P NATL ACAD SCI USA, V107, P17745, DOI 10.1073/pnas.1008053107; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	55	18	18	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3591	3601		10.1074/jbc.M113.517920	http://dx.doi.org/10.1074/jbc.M113.517920			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24297169	Green Published, hybrid			2022-12-28	WOS:000331368700042
J	Halabelian, L; Ricagno, S; Giorgetti, S; Santambrogio, C; Barbiroli, A; Pellegrino, S; Achour, A; Grandori, R; Marchese, L; Raimondi, S; Mangione, PP; Esposito, G; Al-Shawi, R; Simons, JP; Speck, I; Stoppini, M; Bolognesi, M; Bellotti, V				Halabelian, Levon; Ricagno, Stefano; Giorgetti, Sofia; Santambrogio, Carlo; Barbiroli, Alberto; Pellegrino, Sara; Achour, Adnane; Grandori, Rita; Marchese, Loredana; Raimondi, Sara; Mangione, P. Patrizia; Esposito, Gennaro; Al-Shawi, Raya; Simons, J. Paul; Speck, Ivana; Stoppini, Monica; Bolognesi, Martino; Bellotti, Vittorio			Class I Major Histocompatibility Complex, the Trojan Horse for Secretion of Amyloidogenic beta(2)-Microglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Major Histocompatibility Complex (MHC); Protein Aggregation; Protein Complexes; Protein Structure; Beta2 Microglobulin Amyloidosis; D76N Beta2-Microglobulin Variant	MASS-SPECTROMETRY; DYNAMICS; EXPRESSION; PROTEINS; EPITOPES; ANTIGEN; BINDING; DOMAIN	Background: Amyloidogenic D76N (2)m variant escapes the intracellular quality control despite its instability. Results: We show tridimensional structure and stability of D76N (2)m assembled within MHCI compared with the wild type protein. Conclusion: Assembly of D76N (2)m within the MHCI totally masks its misfolding propensity. Significance: The MHCI-mediated stabilization of amyloidogenic D76N (2)m explains the failure of quality control in preventing its secretion. To form extracellular aggregates, amyloidogenic proteins bypass the intracellular quality control, which normally targets unfolded/aggregated polypeptides. Human D76N (2)-microglobulin ((2)m) variant is the prototype of unstable and amyloidogenic protein that forms abundant extracellular fibrillar deposits. Here we focus on the role of the class I major histocompatibility complex (MHCI) in the intracellular stabilization of D76N (2)m. Using biophysical and structural approaches, we show that the MHCI containing D76N (2)m (MHCI76) displays stability, dissociation patterns, and crystal structure comparable with those of the MHCI with wild type (2)m. Conversely, limited proteolysis experiments show a reduced protease susceptibility for D76N (2)m within the MHCI76 as compared with the free variant, suggesting that the MHCI has a chaperone-like activity in preventing D76N (2)m degradation within the cell. Accordingly, D76N (2)m is normally assembled in the MHCI and circulates as free plasma species in a transgenic mouse model.	[Halabelian, Levon; Ricagno, Stefano; Bolognesi, Martino] Univ Milan, Dipartimento Biosci, I-20133 Milan, Italy; [Giorgetti, Sofia; Marchese, Loredana; Raimondi, Sara; Mangione, P. Patrizia; Stoppini, Monica; Bellotti, Vittorio] Inst Biochem A Castellani, Dept Mol Med, I-27100 Pavia, Italy; [Santambrogio, Carlo; Grandori, Rita] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy; [Barbiroli, Alberto] Univ Milan, Biochem Sect, Dipartimento Sci Mol Agroalimentari, I-20133 Milan, Italy; [Pellegrino, Sara] Univ Milan, Dipartimento Sci Farmaceut, Sez Chim Gen & Organ A Marchesini, I-20133 Milan, Italy; [Achour, Adnane] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, CIM, S-14186 Stockholm, Sweden; [Mangione, P. Patrizia; Simons, J. Paul; Speck, Ivana; Bellotti, Vittorio] UCL, Ctr Amyloidosis & Acute Phase Prot, Wolfson Drug Discovery Unit, London NW3 2PF, England; [Esposito, Gennaro] Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy; [Al-Shawi, Raya; Simons, J. Paul] UCL, Div Med, Ctr Biomed Sci, London NW3 2PF, England	University of Milan; University of Pavia; University of Milano-Bicocca; University of Milan; University of Milan; Karolinska Institutet; Karolinska University Hospital; University of London; University College London; University of Udine; University of London; University College London	Bolognesi, M (corresponding author), Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy.	martino.bolognesi@unimi.it; v.bellotti@ucl.ac.uk	Santambrogio, Carlo/W-6070-2019; Ricagno, Stefano/G-1456-2015; Pellegrino, Sara/C-4250-2011; Bolognesi, Martino/B-7924-2017; Simons, Paul/ABG-2628-2021; Giorgetti, Sofia/AAD-4341-2019; Simons, Paul/A-9960-2009; Ricagno, Stefano/AAH-9763-2020; Bellotti, Vittorio/A-6201-2014	Santambrogio, Carlo/0000-0003-3986-6971; Ricagno, Stefano/0000-0001-6678-5873; Pellegrino, Sara/0000-0002-2325-3583; Bolognesi, Martino/0000-0002-9253-5170; Simons, Paul/0000-0002-5007-6674; Giorgetti, Sofia/0000-0001-9438-6511; Simons, Paul/0000-0002-5007-6674; Ricagno, Stefano/0000-0001-6678-5873; BARBIROLI, ALBERTO GIUSEPPE/0000-0003-1678-5431; Mangione, Palma/0000-0003-0260-1400; Bellotti, Vittorio/0000-0001-8678-662X; Achour, Adnane/0000-0003-0432-710X	Italian Ministry of University and Research [FIRB RBFR109EOS]; Cariplo Foundation [2011-2096]; Regione Lombardia; Medical Research Council [MR/K000187/1]; MRC [MR/K000187/1] Funding Source: UKRI	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Cariplo Foundation(Fondazione Cariplo); Regione Lombardia(Regione Lombardia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Italian Ministry of University and Research Project FIRB RBFR109EOS (to S. G.); Cariplo Foundation Project 2011-2096) (to V. B.); the Regione Lombardia (to V. B.); and Medical Research Council Grant MR/K000187/1 (to V. B.).	Achour A, 1999, ACTA CRYSTALLOGR D, V55, P260, DOI 10.1107/S0907444998005265; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellotti V, 1999, CELL MOL LIFE SCI, V55, P977, DOI 10.1007/s000180050348; Benesch JL, 2006, CURR OPIN STRUC BIOL, V16, P245, DOI 10.1016/j.sbi.2006.03.009; Bjerager L, 1996, SCAND J IMMUNOL, V44, P615, DOI 10.1046/j.1365-3083.1996.d01-358.x; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Carey J, 2000, METHOD ENZYMOL, V328, P499, DOI 10.1016/S0076-6879(00)28415-2; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; Grandori Rita, 2009, Biotechnology Journal, V4, P73, DOI 10.1002/biot.200800250; Haass C., 2012, COLD SPRING HARB PER, V2; Invernizzi G, 2007, RAPID COMMUN MASS SP, V21, P1049, DOI 10.1002/rcm.2940; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Mangione PP, 2013, J BIOL CHEM, V288, P30917, DOI 10.1074/jbc.M113.498857; Massa M, 2000, CELL MOL LIFE SCI, V57, P675, DOI 10.1007/PL00000727; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Monti M, 2005, BBA-PROTEINS PROTEOM, V1753, P44, DOI 10.1016/j.bbapap.2005.09.004; Morgner N, 2012, CURR OPIN STRUC BIOL, V22, P44, DOI 10.1016/j.sbi.2011.12.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PEDERSEN LO, 1995, EUR J IMMUNOL, V25, P1609, DOI 10.1002/eji.1830250621; Pellegrino S, 2012, AMINO ACIDS, V43, P1995, DOI 10.1007/s00726-012-1274-2; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Santambrogio C, 2010, PROTEIN SCI, V19, P1386, DOI 10.1002/pro.419; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sroijak N, 2013, BIOCHEM CELL BIOL, V91, P102, DOI 10.1139/bcb-2012-0072; Steinberg MZ, 2007, PHYS CHEM CHEM PHYS, V9, P4690, DOI 10.1039/b705905a; Trojan A, 2000, NAT MED, V6, P667, DOI 10.1038/76243; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Webb AI, 2004, J BIOL CHEM, V279, P23438, DOI 10.1074/jbc.M314066200; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	40	21	21	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3318	3327		10.1074/jbc.M113.524157	http://dx.doi.org/10.1074/jbc.M113.524157			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24338476	Green Published, hybrid			2022-12-28	WOS:000331368700019
J	Lee, JG; Kim, W; Gygi, S; Ye, YH				Lee, Jin-Gu; Kim, Woong; Gygi, Steven; Ye, Yihong			Characterization of the Deubiquitinating Activity of USP19 and Its Role in Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Deubiquitination; ER-associated Degradation; Hsp90; Membrane Proteins; Ubiquitin; USP19; Tail-anchored Protein Biogenesis	UBIQUITIN LIGASE; CHAINS; MECHANISMS; INSERTION; PROTEINS; ENZYMES; ER	Background: The regulation and function of USP19 is unknown. Results: We identify Hsp90 as a USP19 interactor and regulator. USP19 is predominantly localized in the cytosol despite having a transmembrane domain. Conclusion: USP19 is a Hsp90-regulated deubiquitinase dispensable for ERAD. Significance: The study reveals a novel means of DUB regulation involving chaperone association and membrane integration. Deubiquitinating enzymes (DUBs) regulate various cellular processes ranging from protein degradation to cellular signaling. USP19, the only DUB containing a carboxyl-terminal transmembrane domain, was proposed to function in endoplasmic reticulum-associated degradation (ERAD). Here we characterize the function and regulation of USP19. We identify Hsp90 as a specific partner that binds the catalytic domain of USP19 to promote substrate association. Intriguingly, although overexpressed USP19 interacts with Derlin-1 and other ERAD machinery factors in the membrane, endogenous USP19 is mostly in the cytosol where it binds Hsp90. Accordingly, we detect neither interaction of endogenous USP19 with Derlin-1 nor significant effect on ERAD by USP19 depletion. The USP19 transmembrane domain appears to be partially stabilized in the cytosol by an interaction with its own catalytic domain, resulting in auto-inhibition of its deubiquitinating activity. These results clarify the role of USP19 in ERAD and suggest a novel DUB regulation that involves chaperone association and membrane integration. Moreover, our study indicates that the localization of tail-anchored membrane proteins can be subject to regulation in cells.	[Lee, Jin-Gu; Ye, Yihong] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Kim, Woong; Gygi, Steven] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Harvard Medical School	Ye, YH (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov		Lee, Jin-Gu/0000-0001-9477-6990	NIDDK of the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075044] Funding Source: NIH RePORTER	NIDDK of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the NIDDK of the National Institutes of Health.	Altun M, 2012, J BIOL CHEM, V287, P1962, DOI 10.1074/jbc.M111.305615; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee JG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2532; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Mei YD, 2011, J BIOL CHEM, V286, P35380, DOI 10.1074/jbc.M111.282020; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	20	34	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3510	3517		10.1074/jbc.M113.538934	http://dx.doi.org/10.1074/jbc.M113.538934			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24356957	Green Published, hybrid			2022-12-28	WOS:000331368700035
J	Moxley, MA; Sanyal, N; Krishnan, N; Tanner, JJ; Becker, DF				Moxley, Michael A.; Sanyal, Nikhilesh; Krishnan, Navasona; Tanner, John J.; Becker, Donald F.			Evidence for Hysteretic Substrate Channeling in the Proline Dehydrogenaseand Delta(1)-Pyrroline-5-carboxylate Dehydrogenase Coupled Reaction of Proline Utilization A (PutA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Enzyme Mechanisms; Enzyme Turnover; Flavin; Metabolism; Hysteresis; Proline; Substrate Channeling	DEPENDENT NAD(+) SYNTHETASE; FLAVIN REDOX STATE; ESCHERICHIA-COLI; CONFORMATIONAL-CHANGES; MULTIFUNCTIONAL PUTA; ANTHRANILATE SYNTHASE; GAMMA-SEMIALDEHYDE; KINETIC MECHANISM; STRUCTURAL BASIS; PROTEIN	Background: PutA from Escherichia coli is a bifunctional enzyme and transcriptional repressor in proline catabolism. Results: Steady-state and transient kinetic data revealed a mechanism in which the two enzymatic reactions are coupled by an activation step. Conclusion: Substrate channeling in PutA exhibits hysteretic behavior. Significance: This is the first kinetic model of bi-enzyme activity in PutA and reveals a novel mechanism of channeling activation. PutA (proline utilization A) is a large bifunctional flavoenzyme with proline dehydrogenase (PRODH) and (1)-pyrroline-5-carboxylate dehydrogenase (P5CDH) domains that catalyze the oxidation of l-proline to l-glutamate in two successive reactions. In the PRODH active site, proline undergoes a two-electron oxidation to (1)-pyrroline-5-carboxlylate, and the FAD cofactor is reduced. In the P5CDH active site, l-glutamate--semialdehyde (the hydrolyzed form of (1)-pyrroline-5-carboxylate) undergoes a two-electron oxidation in which a hydride is transferred to NAD(+)-producing NADH and glutamate. Here we report the first kinetic model for the overall PRODH-P5CDH reaction of a PutA enzyme. Global analysis of steady-state and transient kinetic data for the PRODH, P5CDH, and coupled PRODH-P5CDH reactions was used to test various models describing the conversion of proline to glutamate by Escherichia coli PutA. The coupled PRODH-P5CDH activity of PutA is best described by a mechanism in which the intermediate is not released into the bulk medium, i.e., substrate channeling. Unexpectedly, single-turnover kinetic experiments of the coupled PRODH-P5CDH reaction revealed that the rate of NADH formation is 20-fold slower than the steady-state turnover number for the overall reaction, implying that catalytic cycling speeds up throughput. We show that the limiting rate constant observed for NADH formation in the first turnover increases by almost 40-fold after multiple turnovers, achieving half of the steady-state value after 15 turnovers. These results suggest that EcPutA achieves an activated channeling state during the approach to steady state and is thus a new example of a hysteretic enzyme. Potential underlying causes of activation of channeling are discussed.	[Moxley, Michael A.; Sanyal, Nikhilesh; Krishnan, Navasona; Becker, Donald F.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA	University of Nebraska System; University of Nebraska Lincoln; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Becker, DF (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	dbecker3@unl.edu		Tanner, John/0000-0001-8314-113X	National Institutes of Health [GM065546, P20RR017675, P30GM103335]; Hatch Act of the University of Nebraska Agricultural Research Division; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335, R01GM065546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hatch Act of the University of Nebraska Agricultural Research Division; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM065546, P20RR017675, and P30GM103335. This work was also supported by funds provided through the Hatch Act as a contribution of the University of Nebraska Agricultural Research Division.	APPLEMAN JR, 1989, J BIOL CHEM, V264, P2625; Arentson BW, 2012, FRONT BIOSCI-LANDMRK, V17, P375, DOI 10.2741/3932; BEARNE SL, 1995, BIOCHEMISTRY-US, V34, P11515, DOI 10.1021/bi00036a026; Becker DF, 2001, BIOCHEMISTRY-US, V40, P4714, DOI 10.1021/bi0019491; Becker DF, 2011, ANTIOXID REDOX SIGN, V14, P1079, DOI 10.1089/ars.2010.3417; Chuenchor W, 2012, BIOCHEM J, V443, P417, DOI 10.1042/BJ20112210; Dexter JP, 2013, J BIOL CHEM, V288, P5770, DOI 10.1074/jbc.M112.339226; EASTERBY JS, 1973, BIOCHIM BIOPHYS ACTA, V293, P552, DOI 10.1016/0005-2744(73)90362-8; Fersht A., 1985, ENZYME STRUCTURE MEC; FORTEMCROBBIE C, 1989, BIOCHEM J, V261, P935, DOI 10.1042/bj2610935; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; FRIEDEN C, 1970, J BIOL CHEM, V245, P5788; Gutfreund H., 1995, KINETICS LIFE SCI RE; HOLMES WM, 1975, J BIOL CHEM, V250, P4462; Jimenez M, 1996, ARCH BIOCHEM BIOPHYS, V331, P15, DOI 10.1006/abbi.1996.0277; JOHNSON KA, 1986, METHOD ENZYMOL, V134, P677; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kadirvelraj R, 2013, BIOCHEMISTRY-US, V52, P1456, DOI 10.1021/bi301593c; KANE JF, 1973, J BACTERIOL, V113, P224, DOI 10.1128/JB.113.1.224-232.1973; LaRonde-LeBlanc N, 2009, NAT STRUCT MOL BIOL, V16, P421, DOI 10.1038/nsmb.1567; Lee YH, 2003, NAT STRUCT BIOL, V10, P109, DOI 10.1038/nsb885; Liang XW, 2013, ANTIOXID REDOX SIGN, V19, P998, DOI 10.1089/ars.2012.5074; LING MF, 1994, J MOL BIOL, V243, P950, DOI 10.1006/jmbi.1994.1696; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Luo M, 2012, BIOCHEMISTRY-US, V51, P10099, DOI 10.1021/bi301312f; MATHER MW, 1985, J BIOL CHEM, V260, P6148; Mouilleron S, 2007, CURR OPIN STRUC BIOL, V17, P653, DOI 10.1016/j.sbi.2007.09.003; Moxley MA, 2012, BIOCHEMISTRY-US, V51, P511, DOI 10.1021/bi201603f; Moxley MA, 2011, ARCH BIOCHEM BIOPHYS, V516, P113, DOI 10.1016/j.abb.2011.10.011; Natarajan SK, 2012, FREE RADICAL BIO MED, V53, P1181, DOI 10.1016/j.freeradbiomed.2012.07.002; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; POWLOWSKI JB, 1987, J BIOL CHEM, V262, P69; Roberts D. V., 1979, ENZYME KINETICS; Singh RK, 2011, J BIOL CHEM, V286, P43144, DOI 10.1074/jbc.M111.292474; Smith NE, 2013, INT J BIOCHEM CELL B, V45, P1878, DOI 10.1016/j.biocel.2013.05.028; Smith NE, 2012, BIOPHYS J, V102, P868, DOI 10.1016/j.bpj.2012.01.029; Srivastava D, 2012, J MOL BIOL, V420, P176, DOI 10.1016/j.jmb.2012.04.010; Srivastava D, 2010, P NATL ACAD SCI USA, V107, P2878, DOI 10.1073/pnas.0906101107; Srivastava D, 2010, BIOCHEMISTRY-US, V49, P560, DOI 10.1021/bi901717s; SUMEGI B, 1985, ARCH BIOCHEM BIOPHYS, V236, P741, DOI 10.1016/0003-9861(85)90680-0; Surber MW, 1998, ARCH BIOCHEM BIOPHYS, V354, P281, DOI 10.1006/abbi.1998.0697; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; Tanner JJ, 2013, HANDBOOK OF FLAVOPROTEINS, VOL 1: OXIDASES, DEHYDROGENASES AND RELATED SYSTEMS, P31; WILLIAMS I, 1975, ANAL BIOCHEM, V64, P85, DOI 10.1016/0003-2697(75)90408-X; Wu ZH, 2012, BIOPHYS J, V103, P1052, DOI 10.1016/j.bpj.2012.08.008; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhang WM, 2007, BIOCHEMISTRY-US, V46, P483, DOI 10.1021/bi061935g; Zhou YZ, 2008, AMINO ACIDS, V35, P711, DOI 10.1007/s00726-008-0053-6; Zhou YZ, 2008, J MOL BIOL, V381, P174, DOI 10.1016/j.jmb.2008.05.084; Zhu WD, 2005, BIOCHEMISTRY-US, V44, P12297, DOI 10.1021/bi051026b; Zhu WD, 2003, BIOCHEMISTRY-US, V42, P5469, DOI 10.1021/bi0272196; Zhu WD, 2013, BIOCHEMISTRY-US, V52, P4482, DOI 10.1021/bi400396g	55	25	25	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3639	3651		10.1074/jbc.M113.523704	http://dx.doi.org/10.1074/jbc.M113.523704			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24352662	hybrid, Green Published			2022-12-28	WOS:000331368700046
J	Parsons, MP; Kang, RJ; Buren, C; Dau, A; Southwell, AL; Doty, CN; Sanders, SS; Hayden, MR; Raymond, LA				Parsons, Matthew P.; Kang, Rujun; Buren, Caodu; Dau, Alejandro; Southwell, Amber L.; Doty, Crystal N.; Sanders, Shaun S.; Hayden, Michael R.; Raymond, Lynn A.			Bidirectional Control of Postsynaptic Density-95 (PSD-95) Clustering by Huntingtin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Culture; Huntington Disease; Patch Clamp Electrophysiology; Post-translational Modification; Protein Palmitoylation; Synapses	LONG-TERM POTENTIATION; MOUSE MODEL; EMBRYONIC LETHALITY; NEUROTROPHIC FACTOR; MUTANT HUNTINGTIN; SYNAPTIC STRENGTH; DISEASE; PALMITOYLATION; APOPTOSIS; TRANSPORT	Background: Wild-type huntingtin (HTT) interacts with synaptic proteins, yet its role in synaptic function is unclear. Results: HTT bidirectionally influences PSD-95 clustering in striatal spiny projection neurons. Conclusion: HTT plays a role in synaptic protein organization. Significance: HTT-reducing strategies are being tested as a treatment for Huntington disease. It is therefore critical to understand the role of HTT in cellular and synaptic function. Huntington disease is associated with early alterations in corticostriatal synaptic function that precede cell death, and it is postulated that ameliorating such changes may delay clinical onset and/or prevent neurodegeneration. Although many of these synaptic alterations are thought to be attributable to a toxic gain of function of the mutant huntingtin protein, the role that nonpathogenic huntingtin (HTT) plays in synaptic function is relatively unexplored. Here, we compare the immunocytochemical localization of a major postsynaptic scaffolding protein, PSD-95, in striatal neurons from WT mice and mice overexpressing HTT with 18 glutamine repeats (YAC18, nonpathogenic). We found that HTT overexpression resulted in a palmitoylation- and BDNF-dependent increase in PSD-95 clustering at synaptic sites in striatal spiny projection neurons (SPNs) co-cultured with cortical neurons. Surprisingly, the latter effect was mediated presynaptically, as HTT overexpression in cortical neurons alone was sufficient to increase PSD-95 clustering in the postsynaptic SPNs. In contrast, antisense oligonucleotide knockdown of HTT in WT co-cultures resulted in a significant reduction of PSD-95 clustering in SPNs. Notably, despite these bidirectional changes in PSD-95 clustering, we did not observe an alteration in basal electrophysiological measures of AMPA and NMDA receptors. Thus, unlike in previous studies in the hippocampus, enhanced or decreased PSD-95 clustering alone was insufficient to drive AMPA or NMDA receptors into or out of SPN synapses. In all, our results demonstrate that nonpathogenic HTT can indeed influence synaptic protein localization and uncover a novel role of HTT in PSD-95 distribution.	[Parsons, Matthew P.; Kang, Rujun; Buren, Caodu; Dau, Alejandro; Raymond, Lynn A.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; [Parsons, Matthew P.; Kang, Rujun; Buren, Caodu; Dau, Alejandro; Raymond, Lynn A.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Southwell, Amber L.; Doty, Crystal N.; Sanders, Shaun S.; Hayden, Michael R.] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada	University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia	Raymond, LA (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	lynn.raymond@ubc.ca	Raymond, Lynn A/A-6664-2010; Hayden, Michael R/D-8581-2011; Raymond, Lynn A./R-6707-2016	Raymond, Lynn A/0000-0002-8610-1042; Hayden, Michael R/0000-0001-5159-1419; Raymond, Lynn A./0000-0002-8610-1042; Southwell, Amber/0000-0002-6353-5008	Canadian Institutes of Health Research Emerging Team Grant [GPG-102165, MOP-102517]; Cure Huntington's Disease Initiative; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research Emerging Team Grant(Canadian Institutes of Health Research (CIHR)); Cure Huntington's Disease Initiative; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported in part by Canadian Institutes of Health Research Emerging Team Grant GPG-102165 and Grant MOP-102517 and the Cure Huntington's Disease Initiative.; Recipient of a Michael Smith Foundation for Health Research postdoctoral fellowship.	Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fan J, 2012, NEUROBIOL DIS, V45, P999, DOI 10.1016/j.nbd.2011.12.019; Fan J, 2009, J NEUROSCI, V29, P10928, DOI 10.1523/JNEUROSCI.2491-09.2009; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Grondin R, 2012, BRAIN, V135, P1197, DOI 10.1093/brain/awr333; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Hoffner G, 2002, J CELL SCI, V115, P941; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Leavitt BR, 2006, J NEUROCHEM, V96, P1121, DOI 10.1111/j.1471-4159.2005.03605.x; Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207; Milnerwood AJ, 2012, NEUROBIOL DIS, V48, P40, DOI 10.1016/j.nbd.2012.05.013; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010; Raymond LA, 2011, NEUROSCIENCE, V198, P252, DOI 10.1016/j.neuroscience.2011.08.052; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Stein V, 2003, J NEUROSCI, V23, P5503; Sun Q, 2011, J NEUROSCI, V31, P6800, DOI 10.1523/JNEUROSCI.5616-10.2011; Sun Y, 2001, J BIOL CHEM, V276, P24713, DOI 10.1074/jbc.M103501200; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Yoshii A, 2011, J NEUROSCI, V31, P11894, DOI 10.1523/JNEUROSCI.2190-11.2011; Yudowski GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053965; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zhang P, 2012, J NEUROPHYSIOL, V107, P1058, DOI 10.1152/jn.00526.2011; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	46	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3518	3528		10.1074/jbc.M113.513945	http://dx.doi.org/10.1074/jbc.M113.513945			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24347167	hybrid, Green Published			2022-12-28	WOS:000331368700036
J	Raynaud, F; Moutin, E; Schmidt, S; Dahl, J; Bertaso, F; Boeckers, TM; Homburger, V; Fagni, L				Raynaud, Fabrice; Moutin, Enora; Schmidt, Susanne; Dahl, Janine; Bertaso, Federica; Boeckers, Tobias M.; Homburger, Vincent; Fagni, Laurent			Rho-GTPase-activating Protein Interacting with Cdc-42-interacting Protein 4 Homolog 2 (Rich2) A NEW Ras-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1 (Rac1) GTPase-ACTIVATING PROTEIN THAT CONTROLS DENDRITIC SPINE MORPHOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutamate; Morphogenesis; Rac1; Rho GTPases; Synapses	LINKED MENTAL-RETARDATION; ACTIN CYTOSKELETON; GROWTH; OLIGOPHRENIN-1; ORGANIZATION; PLASTICITY; MORPHOLOGY; FAMILY; CELLS; CDC42	Background: Rich2 is a synaptic Rho-GAP (Rho-GTPase-activating protein) the target of which was unknown. Results: We found that Rich2 controls dendritic spine morphogenesis by inhibiting Rac1 activity. Conclusion: Rac1 is the target of Rich2 in spines. Significance: We identified for the first time Rich2 as a Rac1-GAP protein that plays an important role in spine formation. Development of dendritic spines is important for synaptic function, and alteration in spine morphogenesis is often associated with mental disorders. Rich2 was an uncharacterized Rho-GAP protein. Here we searched for a role of this protein in spine morphogenesis. We found that it is enriched in dendritic spines of cultured hippocampal pyramidal neurons during early stages of development. Rich2 specifically stimulated the Rac1 GTPase in these neurons. Inhibition of Rac1 by EHT 1864 increased the size and decreased the density of dendritic spines. Similarly, Rich2 overexpression increased the size and decreased the density of dendritic spines, whereas knock-down of the protein by specific si-RNA decreased both size and density of spines. The morphological changes were reflected by the increased amplitude and decreased frequency of miniature EPSCs induced by Rich2 overexpression, while si-RNA treatment decreased both amplitude and frequency of these events. Finally, treatment of neurons with EHT 1864 rescued the phenotype induced by Rich2 knock-down. These results suggested that Rich2 controls dendritic spine morphogenesis and function via inhibition of Rac1.	[Raynaud, Fabrice; Moutin, Enora; Bertaso, Federica; Homburger, Vincent; Fagni, Laurent] Inst Genom Fonct, CNRS, UMR 5203, F-34000 Montpellier, France; [Schmidt, Susanne] Ctr Rech Biochim Macromol, CNRS, UMR 5237, F-34000 Montpellier, France; [Raynaud, Fabrice; Moutin, Enora; Bertaso, Federica; Homburger, Vincent; Fagni, Laurent] INSERM, U661, F-34000 Montpellier, France; [Raynaud, Fabrice; Moutin, Enora; Schmidt, Susanne; Bertaso, Federica; Homburger, Vincent; Fagni, Laurent] Univ Montpellier I, F-34000 Montpellier, France; [Raynaud, Fabrice; Moutin, Enora; Schmidt, Susanne; Bertaso, Federica; Homburger, Vincent; Fagni, Laurent] Univ Montpellier 2, UMR 5203, F-34000 Montpellier, France; [Dahl, Janine; Boeckers, Tobias M.] Univ Ulm, Inst Anat & Cell Biol, D-89081 Ulm, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Ulm University	Fagni, L (corresponding author), Inst Genom Fonct, CNRS, UMR 5203, F-34000 Montpellier, France.	laurent.fagni@igf.cnrs.fr	Bertaso, Federica/C-9942-2019	Bertaso, Federica/0000-0003-3140-019X; Raynaud, Fabrice/0000-0003-3055-0524; Moutin, Enora/0000-0001-8250-703X	European Community [Health-F2-2008-222918 - REPLACES]; Deutsche Forschungsgemeinschaft DFG [SFB 497/B8]	European Community(European Commission); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by the European Community (Health-F2-2008-222918 - REPLACES), FUI DIATRAL, and FUI RHENEPI (to L. F.) and the Deutsche Forschungsgemeinschaft DFG (SFB 497/B8; to T. M. B.).	BENYAMIN Y, 1986, J IMMUNOL METHODS, V86, P21, DOI 10.1016/0022-1759(86)90260-7; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Buttery P, 2006, P NATL ACAD SCI USA, V103, P1924, DOI 10.1073/pnas.0510655103; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Khelfaoui M, 2007, J NEUROSCI, V27, P9439, DOI 10.1523/JNEUROSCI.2029-07.2007; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; LANCASTER CA, 1994, J BIOL CHEM, V269, P1137; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; Momboisse F, 2009, J CELL SCI, V122, P798, DOI 10.1242/jcs.038109; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Raynaud F, 2013, J NEUROSCI, V33, P9699, DOI 10.1523/JNEUROSCI.2725-12.2013; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Ven TJV, 2005, J NEUROSCI, V25, P9488, DOI 10.1523/JNEIROSCI.2450-05.2005; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002	28	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2600	2609		10.1074/jbc.M113.534636	http://dx.doi.org/10.1074/jbc.M113.534636			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24352656	Green Published, hybrid			2022-12-28	WOS:000333403000011
J	Chung, HH; Sze, SK; Tay, ASL; Lin, VCL				Chung, Hwa Hwa; Sze, Siu Kwan; Tay, Alvin Shun Long; Lin, Valerie C. -L.			Acetylation at Lysine 183 of Progesterone Receptor by p300 Accelerates DNA Binding Kinetics and Transactivation of Direct Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Histone Acetylase; Hormone Receptors; Nuclear Receptors; Post-translational Modification; Transcription	BREAST-CANCER CELLS; NF-KAPPA-B; TRANSCRIPTIONAL COACTIVATOR; ISOFORM-B; IN-VIVO; PHOSPHORYLATION; RECRUITMENT; P53; EXPRESSION; ACTIVATION	The identification of lysine acetylation of steroid hormone receptors has previously been based on the presence of consensus motif (K/R)XKK. This study reports the discovery by mass spectrometry of a novel progesterone receptor acetylation site at Lys-183 that is not in the consensus motif. In vivo acetylation and mutagenesis experiments revealed that Lys-183 is a primary site of progesterone receptor (PR) acetylation. Lys-183 acetylation is enhanced by p300 overexpression and abrogated by p300 gene silencing, suggesting that p300 is the major acetyltransferase for Lys-183 acetylation. Furthermore, p300-mediated Lys-183 acetylation is associated with heightened PR activity. Accordingly, the acetylation-mimicking mutant PRB-K183Q exhibited accelerated DNA binding kinetics and greater activity compared with the wild-type PRB on genes containing progesterone response element. In contrast, Lys-183 acetylation had no influence on PR tethering effect on the nuclear factor -light chain enhancer of activated B cells (NFB). Additionally, increases of Lys-183 acetylation by p300 overexpression or inhibition of deacetylation resulted in increases of Ser-294 phosphorylation levels. In conclusion, PR acetylation at Lys-183 by p300 potentiates PR activity through accelerated binding of its direct target genes without affecting PR tethering on other transcription factors. The effect may be mediated by enhancing Ser-294 phosphorylation.	[Chung, Hwa Hwa; Sze, Siu Kwan; Tay, Alvin Shun Long; Lin, Valerie C. -L.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lin, VCL (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	cllin@ntu.edu.sg	Sze, Siu Kwan/AAO-3342-2020; Chun Ling, Valerie Lin/A-2188-2011; Sze, Siu_kwan Newman/A-2199-2011	Sze, Siu Kwan/0000-0002-5652-1687; Sze, Siu_kwan Newman/0000-0002-5652-1687				Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Bannister AJ, 1995, ONCOGENE, V11, P2509; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Brayman MJ, 2006, MOL ENDOCRINOL, V20, P2278, DOI 10.1210/me.2005-0343; Cicatiello L, 2004, MOL CELL BIOL, V24, P7260, DOI 10.1128/MCB.24.16.7260-7274.2004; Daniel AR, 2007, MOL ENDOCRINOL, V21, P2890, DOI 10.1210/me.2007-0248; Daniel AR, 2007, STEROIDS, V72, P188, DOI 10.1016/j.steroids.2006.11.009; Daniel AR, 2010, MOL ENDOCRINOL, V24, P2126, DOI 10.1210/me.2010-0170; Daniel AR, 2009, MOL CELL ENDOCRINOL, V308, P47, DOI 10.1016/j.mce.2009.01.004; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; Davies S, 2004, GYNECOL ONCOL, V94, P463, DOI 10.1016/j.ygyno.2004.05.028; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dressing GE, 2009, STEROIDS, V74, P573, DOI 10.1016/j.steroids.2008.12.001; Duplessis TT, 2011, ENDOCRINOLOGY, V152, P2517, DOI 10.1210/en.2010-1281; Faivre EJ, 2008, MOL ENDOCRINOL, V22, P823, DOI 10.1210/me.2007-0437; Fan SJ, 2002, CANCER RES, V62, P141; Gan CS, 2008, J PROTEOME RES, V7, P4869, DOI 10.1021/pr800473j; Giangrande PH, 1999, RECENT PROG HORM RES, V54, P291; Grant PA, 2001, GENOME BIOL, V2; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; Hao PL, 2010, J PROTEOME RES, V9, P3520, DOI 10.1021/pr100037h; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Huang YH, 2002, ONCOGENE, V21, P6819, DOI 10.1038/sj.onc.1205854; Ianculescu I, 2012, J BIOL CHEM, V287, P4000, DOI 10.1074/jbc.M111.300194; Jacobsen BM, 2002, J BIOL CHEM, V277, P27793, DOI 10.1074/jbc.M202584200; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Lange CA, 1999, MOL ENDOCRINOL, V13, P829, DOI 10.1210/me.13.6.829; Li Y, 2013, MOL BIOL REP, V40, P1685, DOI 10.1007/s11033-012-2219-2; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lin VCL, 1999, CLIN CANCER RES, V5, P395; Liu L, 1999, MOL CELL BIOL, V19, P1202; Liu Z, 2001, P NATL ACAD SCI USA, V98, P12426, DOI 10.1073/pnas.231474798; Magklara A, 2009, MOL ENDOCRINOL, V23, P61, DOI 10.1210/me.2008-0028; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; MEYER ME, 1992, J BIOL CHEM, V267, P10882; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Oh SY, 2005, AM J OBSTET GYNECOL, V193, P1156, DOI 10.1016/j.ajog.2005.05.071; ONATE SA, 1995, SCIENCE, V270, P1354; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Polesskaya A, 2001, MOL CELL BIOL, V21, P5312, DOI 10.1128/MCB.21.16.5312-5320.2001; Qiu M, 2003, J STEROID BIOCHEM, V85, P147, DOI 10.1016/S0960-0760(03)00221-8; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Subtil-Rodriguez A, 2008, MOL CELL BIOL, V28, P3830, DOI 10.1128/MCB.01217-07; Telleria CM, 1998, ENDOCRINOLOGY, V139, P3597, DOI 10.1210/en.139.8.3597; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Wang CG, 2011, J STEROID BIOCHEM, V123, P91, DOI 10.1016/j.jsbmb.2010.12.003; Wong CW, 2001, BIOCHEMISTRY-US, V40, P6756, DOI 10.1021/bi010379h; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yin P, 2012, PLOS ONE, V7; Zheng ZY, 2008, BREAST CANCER RES TR, V110, P111, DOI 10.1007/s10549-007-9711-8	60	15	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2180	2194		10.1074/jbc.M113.517896	http://dx.doi.org/10.1074/jbc.M113.517896			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302725	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000331130200026
J	Dang, TTT; Facchini, PJ				Dang, Thu-Thuy T.; Facchini, Peter J.			CYP82Y1 Is N-Methylcanadine 1-Hydroxylase, a Key Noscapine Biosynthetic Enzyme in Opium Poppy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosynthesis; Cytochrome P-450; Enzyme Catalysis; Gene Silencing; Metabolism; Plant Biochemistry; Secondary Metabolism	COPTIS-JAPONICA CELLS; MOLECULAR-CLONING; PAPAVER-SOMNIFERUM; HETEROLOGOUS EXPRESSION; MORPHINE BIOSYNTHESIS; ALKALOID BIOSYNTHESIS; NEIGHBORING GENES; SYNTHASE; CYTOCHROME-P450; COEXPRESSION	Noscapine is a phthalideisoquinoline alkaloid investigated for its potent pharmacological properties. Although structurally elucidated more than a century ago, the biosynthesis of noscapine has not been established. Radiotracer studies have shown that noscapine is derived from the protoberberine alkaloid (S)-scoulerine and has been proposed to proceed through (S)-N-methylcanadine. However, pathway intermediates involved in the conversion of N-methylcanadine to noscapine have not been identified. We report the isolation and characterization of the cytochrome P-450 CYP82Y1, which catalyzes the 1-hydroxylation of N-methylcanadine to 1-hydroxy-N-methylcanadine. Comparison of transcript and metabolite profiles of eight opium poppy chemotypes revealed four cytochrome P-450s, three from the CYP82 and one from the CYP719 families, that were tightly correlated with noscapine accumulation. Recombinant CYP82Y1 was the only enzyme that accepted (R,S)-N-methylcanadine as a substrate with strict specificity and high affinity. As expected, CYP82Y1 was abundantly expressed in opium poppy stems where noscapine accumulation is highest among plant organs. Suppression of CYP82Y1 using virus-induced gene silencing caused a significant reduction in the levels of noscapine, narcotoline, and a putative downstream secoberbine intermediate and also resulted in increased accumulation of the upstream pathway intermediates scoulerine, tetrahydrocolum-bamine, canadine, and N-methylcanadine. The combined biochemical and physiological data support the 1-hydroxylation of (S)-N-methylcanadine catalyzed by CYP82Y1 as the first committed step in the formation of noscapine in opium poppy.	[Dang, Thu-Thuy T.; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Facchini, PJ (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca	DANG, THU-THUY/ADM-4345-2022	DANG, THU-THUY/0000-0002-6459-3664	Genome Canada; Genome Alberta; Government of Alberta; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation Leaders Opportunity Fund; Alberta Innovates Technology Futures Graduate Scholarship; Eyes High International Doctoral Scholarship from the University of Calgary	Genome Canada(Genome Canada); Genome Alberta; Government of Alberta; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Alberta Innovates Technology Futures Graduate Scholarship; Eyes High International Doctoral Scholarship from the University of Calgary	This work was supported through funding from Genome Canada, Genome Alberta, the Government of Alberta, the Natural Sciences and Engineering Research Council of Canada, and the Canada Foundation for Innovation Leaders Opportunity Fund.; Recipient of an Alberta Innovates Technology Futures Graduate Scholarship and an Eyes High International Doctoral Scholarship from the University of Calgary.	Anderson T, 1862, J CHEM SOC, V15, P446, DOI [10.1039/JS8621500446, DOI 10.1039/JS8621500446]; Battersby A. R., 1975, J CHEM SOC PERK T, V1, P1162; Battersby A. R., 1968, J CHEM SOC C, V17, P2163; Beaudoin GAW, 2013, BIOCHEM BIOPH RES CO, V431, P597, DOI 10.1016/j.bbrc.2012.12.129; Binutu OA, 2000, PHARM BIOL, V38, P210, DOI 10.1076/1388-0209(200007)3831-SFT210; Chavez MLD, 2011, ARCH BIOCHEM BIOPHYS, V507, P186, DOI 10.1016/j.abb.2010.11.016; Chen X., 2014, PLANT J, DOI 10.1111/tpj.12379; Dang TTT, 2014, FEBS LETT, V588, P198, DOI 10.1016/j.febslet.2013.11.037; Dang TTT, 2012, PLANT PHYSIOL, V159, P618, DOI 10.1104/pp.112.194886; Desgagne-Penix I, 2012, PLANT MOL BIOL, V79, P295, DOI 10.1007/s11103-012-9913-2; Desgagne-Penix I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-252; Dinesh-Kumar SP, 2003, METH MOL B, V236, P287; Facchini Peter J., 2007, Phytochemistry Reviews, V6, P97, DOI 10.1007/s11101-006-9042-0; Gesell A, 2009, J BIOL CHEM, V284, P24432, DOI 10.1074/jbc.M109.033373; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; Ikezawa N, 2003, J BIOL CHEM, V278, P38557, DOI 10.1074/jbc.M302470200; Ikezawa N, 2008, J BIOL CHEM, V283, P8810, DOI 10.1074/jbc.M705082200; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; KLEINSCHMIDT G, 1959, Z NATURFORSCH PT B, V14, P52, DOI 10.1515/znb-1959-0113; KRAUS PFX, 1995, P NATL ACAD SCI USA, V92, P2071, DOI 10.1073/pnas.92.6.2071; Kruse T, 2008, CHEM BIOL, V15, P149, DOI 10.1016/j.chembiol.2008.01.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JK, 2009, J KOREAN SOC APPL BI, V52, P646, DOI 10.3839/jksabc.2009.108; Lee S, 2010, P NATL ACAD SCI USA, V107, P21205, DOI 10.1073/pnas.1009975107; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Nguyen DT, 2010, J BIOL CHEM, V285, P16588, DOI 10.1074/jbc.M110.111757; Pauli HH, 1998, PLANT J, V13, P793, DOI 10.1046/j.1365-313X.1998.00085.x; Le PM, 2013, ANAL BIOANAL CHEM, V405, P4487, DOI 10.1007/s00216-012-6539-9; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Ro DK, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-83; SARIYAR G, 1977, PHYTOCHEMISTRY, V16, P2009, DOI 10.1016/0031-9422(77)80115-5; SARIYAR G, 1986, PHYTOCHEMISTRY, V25, P2403, DOI 10.1016/S0031-9422(00)81705-7; Sariyar G, 2002, PURE APPL CHEM, V74, P557, DOI 10.1351/pac200274040557; Takemura T, 2013, PHYTOCHEMISTRY, V91, P100, DOI 10.1016/j.phytochem.2012.02.013; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757	39	31	38	4	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2013	2026		10.1074/jbc.M113.505099	http://dx.doi.org/10.1074/jbc.M113.505099			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324259	Green Published, hybrid			2022-12-28	WOS:000331130200013
J	McKinlay, JB; Oda, Y; Ruhl, M; Posto, AL; Sauer, U; Harwood, CS				McKinlay, James B.; Oda, Yasuhiro; Ruehl, Martin; Posto, Amanda L.; Sauer, Uwe; Harwood, Caroline S.			Non-growing Rhodopseudomonas palustris Increases the Hydrogen Gas Yield from Acetate by Shifting from the Glyoxylate Shunt to the Tricarboxylic Acid Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Biofuel; Metabolic Engineering; Metabolic Regulation; Metabolic Tracers; Nitrogenase; Transcriptomics; Bacterial Starvation; Hydrogen Gas; Metabolic Flux Analysis	POLY-BETA-HYDROXYBUTYRATE; METABOLIC PATHWAYS; ESCHERICHIA-COLI; GENE-EXPRESSION; FLUX ANALYSIS; SEQUENCE; INSIGHTS; GROWTH; LIGHT; H-2	When starved for nitrogen, non-growing cells of the photosynthetic bacterium Rhodopseudomonas palustris continue to metabolize acetate and produce H-2, an important industrial chemical and potential biofuel. The enzyme nitrogenase catalyzes H-2 formation. The highest H-2 yields are obtained when cells are deprived of N-2 and thus use available electrons to synthesize H-2 as the exclusive product of nitrogenase. To understand how R. palustris responds metabolically to increase H-2 yields when it is starved for N-2, and thus not growing, we tracked changes in biomass composition and global transcript levels. In addition to a 3.5-fold higher H-2 yield by non-growing cells we also observed an accumulation of polyhydroxybutyrate to over 30% of the dry cell weight. The transcriptome of R. palustris showed down-regulation of biosynthetic processes and up-regulation of nitrogen scavenging mechanisms in response to N-2 starvation but gene expression changes did not point to metabolic activities that could generate the reductant necessary to explain the high H-2 yield. We therefore tracked C-13-labeled acetate through central metabolic pathways. We found that non-growing cells shifted their metabolism to use the tricarboxylic acid cycle to metabolize acetate in contrast to growing cells, which used the glyoxylate cycle exclusively. This shift enabled cells to more fully oxidize acetate, providing the necessary reducing power to explain the high H-2 yield.	[McKinlay, James B.; Posto, Amanda L.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Oda, Yasuhiro; Harwood, Caroline S.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Ruehl, Martin; Sauer, Uwe] Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	Indiana University System; Indiana University Bloomington; University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; ETH Zurich	McKinlay, JB (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jmckinla@indiana.edu	McKinlay, James B/N-1626-2019; Sauer, Uwe/Y-3556-2019	McKinlay, James B/0000-0003-2401-6229; 	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy (DOE) [DE-FG02-05ER15707]; Office of Science (BER), U.S. Department of Energy [DE-FG02-07ER64482, DE-SC0008131]; European Commission [LSHG-CT-2006-037469]; United States National Science Foundation [MCB-11457304]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); European Commission(European CommissionEuropean Commission Joint Research Centre); United States National Science Foundation(National Science Foundation (NSF))	Experimental aspects of this research were supported equally by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy (DOE), through Grant DE-FG02-05ER15707 and by the Office of Science (BER), U.S. Department of Energy, through Grant DE-FG02-07ER64482. Experimental work was also funded through the European Commission 7th Framework project BaSysBio (LSHG-CT-2006-037469). United States National Science Foundation Grant MCB-11457304 (to C. S. H.) and Office of Science (BER), U.S. Department of Energy Grant DE-SC0008131 (to J. B. M.) provided support for data analysis and manuscript preparation.	Adessi A, 2012, INT J HYDROGEN ENERG, V37, P15893, DOI 10.1016/j.ijhydene.2012.08.009; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Carlozzi P, 2001, J BIOTECHNOL, V88, P239, DOI 10.1016/S0168-1656(01)00280-2; Cronan JE, 2002, CURR OPIN MICROBIOL, V5, P202, DOI 10.1016/S1369-5274(02)00297-7; DEPHILIPPIS R, 1992, FEMS MICROBIOL LETT, V103, P187; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fischer E, 2003, J BIOL CHEM, V278, P46446, DOI 10.1074/jbc.M307968200; Gosse JL, 2010, BIOTECHNOL PROGR, V26, P907, DOI 10.1002/btpr.406; Hirakawa H, 2011, J BACTERIOL, V193, P2598, DOI 10.1128/JB.01479-10; Huang JJ, 2010, APPL ENVIRON MICROB, V76, P7717, DOI 10.1128/AEM.01143-10; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; KARR DB, 1983, APPL ENVIRON MICROB, V46, P1339, DOI 10.1128/AEM.46.6.1339-1344.1983; KIM MK, 1991, FEMS MICROBIOL LETT, V83, P199, DOI 10.1016/0378-1097(91)90354-D; Kranz RG, 1997, APPL ENVIRON MICROB, V63, P3003, DOI 10.1128/AEM.63.8.3003-3009.1997; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Lebedeva N. V., 2002, Mikrobiologiya, V71, P762; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; McKinlay JB, 2007, METAB ENG, V9, P177, DOI 10.1016/j.ymben.2006.10.006; McKinlay JB, 2011, MBIO, V2, DOI 10.1128/mBio.00323-10; McKinlay JB, 2010, P NATL ACAD SCI USA, V107, P11669, DOI 10.1073/pnas.1006175107; McKinlay JB, 2010, CURR OPIN BIOTECH, V21, P244, DOI 10.1016/j.copbio.2010.02.012; McKinlay JB, 2005, APPL ENVIRON MICROB, V71, P6651, DOI 10.1128/AEM.71.11.6651-6656.2005; Melnicki MR, 2009, INT J HYDROGEN ENERG, V34, P6157, DOI 10.1016/j.ijhydene.2009.05.115; Mukhopadhyay M, 2005, WORLD J MICROB BIOT, V21, P765, DOI 10.1007/s11274-004-5565-y; Nam TW, 2013, MBIO, V4, DOI 10.1128/mBio.00541-12; Oda Y, 2005, J BACTERIOL, V187, P7784, DOI 10.1128/JB.187.22.7784-7794.2005; Phattarasukol S, 2012, APPL ENVIRON MICROB, V78, P6812, DOI 10.1128/AEM.01418-12; Rey FE, 2007, APPL ENVIRON MICROB, V73, P1665, DOI 10.1128/AEM.02565-06; Rey FE, 2006, J BACTERIOL, V188, P6143, DOI 10.1128/JB.00381-06; Ruhl M, 2012, J BIOL CHEM, V287, P27959, DOI 10.1074/jbc.M112.366492; Ruhl M, 2012, BIOTECHNOL BIOENG, V109, P763, DOI 10.1002/bit.24344; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schwender J, 2006, J BIOL CHEM, V281, P34040, DOI 10.1074/jbc.M606266200; Singh SK, 2001, J BIOL CHEM, V276, P26154, DOI 10.1074/jbc.M101191200; TAHAMA H, 1990, AGR BIOL CHEM TOKYO, V54, P3177, DOI 10.1080/00021369.1990.10870489; Tang YJJ, 2007, APPL ENVIRON MICROB, V73, P3859, DOI 10.1128/AEM.02986-06; Vincenzini M, 1997, BIOTECHNOL LETT, V19, P759, DOI 10.1023/A:1018336209252; Weitzel M, 2013, BIOINFORMATICS, V29, P143, DOI 10.1093/bioinformatics/bts646; Wendisch VF, 2000, J BACTERIOL, V182, P3088, DOI 10.1128/JB.182.11.3088-3096.2000; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4	43	65	66	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1960	1970		10.1074/jbc.M113.527515	http://dx.doi.org/10.1074/jbc.M113.527515			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302724	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000331130200008
J	Tanaka, T; Nagashima, K; Inagaki, N; Kioka, H; Takashima, S; Fukuoka, H; Noji, H; Kakizuka, A; Imamura, H				Tanaka, Takashi; Nagashima, Kazuaki; Inagaki, Nobuya; Kioka, Hidetaka; Takashima, Seiji; Fukuoka, Hajime; Noji, Hiroyuki; Kakizuka, Akira; Imamura, Hiromi			Glucose-stimulated Single Pancreatic Islets Sustain Increased Cytosolic ATP Levels during Initial Ca2+ Influx and Subsequent Ca2+ Oscillations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; Calcium; Energy Metabolism; Imaging; Insulin; Pancreatic Islets	BETA-CELL LINE; INSULIN-SECRETION; GLUTAMATE-DEHYDROGENASE; CYTOPLASMIC CA2+; MEMBRANE; CALCIUM; METABOLISM; EXPRESSION; CHANNELS; RELEASE	In pancreatic islets, insulin secretion occurs via synchronous elevation of Ca2+ levels throughout the islets during high glucose conditions. This Ca2+ elevation has two phases: a quick increase, observed after the glucose stimulus, followed by prolonged oscillations. In these processes, the elevation of intracellular ATP levels generated from glucose is assumed to inhibit ATP-sensitive K+ channels, leading to the depolarization of membranes, which in turn induces Ca2+ elevation in the islets. However, little is known about the dynamics of intracellular ATP levels and their correlation with Ca2+ levels in the islets in response to changing glucose levels. In this study, a genetically encoded fluorescent biosensor for ATP and a fluorescent Ca2+ dye were employed to simultaneously monitor the dynamics of intracellular ATP and Ca2+ levels, respectively, inside single isolated islets. We observed rapid increases in cytosolic and mitochondrial ATP levels after stimulation with glucose, as well as with methyl pyruvate or leucine/glutamine. High ATP levels were sustained as long as high glucose levels persisted. Inhibition of ATP production suppressed the initial Ca2+ increase, suggesting that enhanced energy metabolism triggers the initial phase of Ca2+ influx. On the other hand, cytosolic ATP levels did not fluctuate significantly with the Ca2+ level in the subsequent oscillation phases. Importantly, Ca2+ oscillations stopped immediately before ATP levels decreased significantly. These results might explain how food or glucose intake evokes insulin secretion and how the resulting decrease in plasma glucose levels leads to cessation of secretion.	[Tanaka, Takashi; Kakizuka, Akira; Imamura, Hiromi] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Nagashima, Kazuaki; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan; [Imamura, Hiromi] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068501, Japan; [Kioka, Hidetaka; Takashima, Seiji] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Fukuoka, Hajime] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Noji, Hiroyuki] Univ Tokyo, Dept Appl Chem, Tokyo 1138656, Japan	Kyoto University; Kyoto University; Kyoto University; Osaka University; Tohoku University; University of Tokyo	Imamura, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan.	imamura@lif.kyoto-u.ac.jp	Imamura, Hiromi/AAD-5109-2019	Imamura, Hiromi/0000-0002-1896-0443; Inagaki, Nobuya/0000-0001-8261-2593; Fukuoka, Hajime/0000-0002-9060-4347	Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science, and Technology in Japan; Precursory Research for Embryonic Science from the Japan Science and Technology Agency; Japan Diabetes Foundation;  [22590977]; Grants-in-Aid for Scientific Research [24657101] Funding Source: KAKEN	Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science, and Technology in Japan; Precursory Research for Embryonic Science from the Japan Science and Technology Agency; Japan Diabetes Foundation; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research 22590977 (to K. N.) and by funds from the Platform for Dynamic Approaches to Living System (to T. T. and H. I.) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan, as well as by funds from Precursory Research for Embryonic Science (to H. I.) from the Japan Science and Technology Agency and by funds from the Japan Diabetes Foundation (to H. I.).	Ainscow EK, 2002, DIABETES, V51, pS162, DOI 10.2337/diabetes.51.2007.S162; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; ASHCROFT SJ, 1973, BIOCHEM J, V132, P223, DOI 10.1042/bj1320223; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Carobbio S, 2009, J BIOL CHEM, V284, P921, DOI 10.1074/jbc.M806295200; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dufer M, 2002, BIOCHEM J, V368, P817, DOI 10.1042/BJ20020657; Fahien LA, 2011, DIABETES, V60, P2450, DOI 10.2337/db10-1150; GHOSH A, 1991, J BIOL CHEM, V266, P22887; GILON P, 1993, J BIOL CHEM, V268, P22265; GILON P, 1992, J BIOL CHEM, V267, P20713; Goehring I, 2012, J BIOL CHEM, V287, P15706, DOI 10.1074/jbc.M111.314567; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; HELLMAN B, 1969, DIABETES, V18, P509, DOI 10.2337/diab.18.8.509; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1998, JPN J PHYSIOL, V48, P397, DOI 10.2170/jjphysiol.48.397; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Lembert N, 2001, BIOCHEM J, V354, P345, DOI 10.1042/0264-6021:3540345; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Li J, 2013, DIABETOLOGIA, V56, P1577, DOI 10.1007/s00125-013-2894-0; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Mertz RJ, 1996, J BIOL CHEM, V271, P4838, DOI 10.1074/jbc.271.9.4838; Miki T, 1997, P NATL ACAD SCI USA, V94, P11969, DOI 10.1073/pnas.94.22.11969; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakano M, 2011, ACS CHEM BIOL, V6, P709, DOI 10.1021/cb100313n; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Pratley RE, 2001, DIABETOLOGIA, V44, P929, DOI 10.1007/s001250100580; Pullen TJ, 2011, MOL CELL BIOL, V31, P3182, DOI 10.1128/MCB.01433-10; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; Terasawa S, 2011, BIOPHYS J, V100, P2193, DOI 10.1016/j.bpj.2011.03.030; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Yoshihara E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1127; Zawalich WS, 1997, J BIOL CHEM, V272, P3527, DOI 10.1074/jbc.272.6.3527	43	34	34	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2205	2216		10.1074/jbc.M113.499111	http://dx.doi.org/10.1074/jbc.M113.499111			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302735	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000331130200028
J	Sayed, A; Ghazy, MA; Ferreira, AJS; Setubal, JC; Chambergo, FS; Ouf, A; Adel, M; Dawe, AS; Archer, JAC; Bajic, VB; Siam, R; El-Dorry, H				Sayed, Ahmed; Ghazy, Mohamed A.; Ferreira, Ari J. S.; Setubal, Joao C.; Chambergo, Felipe S.; Ouf, Amged; Adel, Mustafa; Dawe, Adam S.; Archer, John A. C.; Bajic, Vladimir B.; Siam, Rania; El-Dorry, Hamza			A Novel Mercuric Reductase from the Unique Deep Brine Environment of Atlantis II in the Red Sea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Enzyme Mechanisms; Enzyme Structure; Metagenomics; Mutagenesis Site-specific; Atlantis II Brine Pool; Extreme Halophilic; Mercuric Reductase; Red Sea Atlantis II; Thermophilic	ION REDUCTASE; CRYSTAL-STRUCTURE; SWISS-MODEL; ACTIVE-SITE; GLUCOSE-DEHYDROGENASE; STRUCTURAL FEATURES; HALOPHILIC ARCHAEON; IN-VITRO; PROTEINS; ADAPTATION	Background: Molecular features underlying enzyme function in extreme environments are poorly understood. Results: Identification of the basis for thermostability, halophilicity, and detoxification activity in a mercuric reductase from hot deep-sea brine. Conclusion: A small number of structural modifications accounts for the enzyme's robustness. Significance: This work defines novel adaptations that enable enzymes to cope with multiple abiotic stressors simultaneously. A unique combination of physicochemical conditions prevails in the lower convective layer (LCL) of the brine pool at Atlantis II (ATII) Deep in the Red Sea. With a maximum depth of over 2000 m, the pool is characterized by acidic pH (5.3), high temperature (68 degrees C), salinity (26%), low light levels, anoxia, and high concentrations of heavy metals. We have established a metagenomic dataset derived from the microbial community in the LCL, and here we describe a gene for a novel mercuric reductase, a key component of the bacterial detoxification system for mercuric and organomercurial species. The metagenome-derived gene and an ortholog from an uncultured soil bacterium were synthesized and expressed in Escherichia coli. The properties of their products show that, in contrast to the soil enzyme, the ATII-LCL mercuric reductase is functional in high salt, stable at high temperatures, resistant to high concentrations of Hg2+, and efficiently detoxifies Hg(2+)in vivo. Interestingly, despite the marked functional differences between the orthologs, their amino acid sequences differ by less than 10%. Site-directed mutagenesis and kinetic analysis of the mutant enzymes, in conjunction with three-dimensional modeling, have identified distinct structural features that contribute to extreme halophilicity, thermostability, and high detoxification capacity, suggesting that these were acquired independently during the evolution of this enzyme. Thus, our work provides fundamental structural insights into a novel protein that has undergone multiple biochemical and biophysical adaptations to promote the survival of microorganisms that reside in the extremely demanding environment of the ATII-LCL.	[Sayed, Ahmed; Ghazy, Mohamed A.; Ferreira, Ari J. S.; Ouf, Amged; Adel, Mustafa; Siam, Rania; El-Dorry, Hamza] Amer Univ Cairo, Dept Biol, Sch Sci & Engn, New Cairo 11835, Egypt; [Sayed, Ahmed; Ghazy, Mohamed A.; Ferreira, Ari J. S.; Ouf, Amged; Adel, Mustafa; Siam, Rania; El-Dorry, Hamza] Amer Univ Cairo, Sci & Technol Res Ctr, Sch Sci & Engn, New Cairo 11835, Egypt; [Setubal, Joao C.] Univ Sao Paulo, Dept Bioquim, Inst Quim, BR-05508000 Sao Paulo, Brazil; [Chambergo, Felipe S.] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, BR-03828000 Sao Paulo, Brazil; [Dawe, Adam S.; Archer, John A. C.; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal 239556900, Saudi Arabia	Egyptian Knowledge Bank (EKB); American University Cairo; Egyptian Knowledge Bank (EKB); American University Cairo; Universidade de Sao Paulo; Universidade de Sao Paulo; King Abdullah University of Science & Technology	El-Dorry, H (corresponding author), Amer Univ Cairo, Dept Biol, Sch Sci & Engn, AUC Ave,POB 74, New Cairo 11835, Egypt.	dorry@aucegypt.edu	Ferreira, Ari J S/C-2266-2015; Archer, John/AAW-1990-2021; Setubal, Joao Carlos/C-7305-2012; Ghazy, Mohamed/ABD-6832-2020; Chambergo, Felipe S/B-8599-2012; Archer, John/D-5200-2012; Bajic, Vladimir/D-2810-2009	Ferreira, Ari J S/0000-0002-7526-5543; Archer, John/0000-0002-3302-3933; Setubal, Joao Carlos/0000-0001-9174-2816; Chambergo, Felipe S/0000-0001-7567-0656; Bajic, Vladimir/0000-0001-5435-4750				Antunes A, 2011, ENV MICROBIOL REP, V3, P416, DOI 10.1111/j.1758-2229.2011.00264.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BACKER H, 1972, NATURE-PHYS SCI, V240, P153, DOI 10.1038/physci240153a0; Barkay T, 2005, ADV APPL MICROBIOL, V57, P1, DOI 10.1016/S0065-2164(05)57001-1; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; Barkay T, 2010, ENVIRON MICROBIOL, V12, P2904, DOI 10.1111/j.1462-2920.2010.02260.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berezovsky IN, 2005, P NATL ACAD SCI USA, V102, P12742, DOI 10.1073/pnas.0503890102; Berezovsky IN, 1997, FEBS LETT, V418, P43, DOI 10.1016/S0014-5793(97)01346-X; Boyd ES, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00349; Britton KL, 2006, P NATL ACAD SCI USA, V103, P4846, DOI 10.1073/pnas.0508854103; BROWN NL, 1983, BIOCHEMISTRY-US, V22, P4089, DOI 10.1021/bi00286a015; CHRISTIAN JHB, 1962, BIOCHIM BIOPHYS ACTA, V65, P506, DOI 10.1016/0006-3002(62)90453-5; DeLong EF, 2009, NATURE, V459, P200, DOI 10.1038/nature08059; DISTEFANO MD, 1990, BIOCHEMISTRY-US, V29, P2703, DOI 10.1021/bi00463a013; DYM O, 1995, SCIENCE, V267, P1344, DOI 10.1126/science.267.5202.1344; EISENBERG H, 1992, ADV PROTEIN CHEM, V43, P1, DOI 10.1016/S0065-3233(08)60553-7; Engst S, 1999, BIOCHEMISTRY-US, V38, P3519, DOI 10.1021/bi982680c; Engst S, 1998, BIOCHEMISTRY-US, V37, P11496, DOI 10.1021/bi9808161; Esclapez J, 2007, FEBS LETT, V581, P837, DOI 10.1016/j.febslet.2007.01.054; FOX B, 1982, J BIOL CHEM, V257, P2498; Frolow F, 1996, NAT STRUCT BIOL, V3, P452, DOI 10.1038/nsb0596-452; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Goihberg E, 2007, PROTEINS, V66, P196, DOI 10.1002/prot.21170; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hennig M, 1997, BIOCHEMISTRY-US, V36, P6009, DOI 10.1021/bi962718q; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Jolley KA, 1997, EUR J BIOCHEM, V248, P362, DOI 10.1111/j.1432-1033.1997.00362.x; Kushner DJ., 1978, J BASIC MICROB, P317; LANYI JK, 1974, BACTERIOL REV, V38, P272, DOI 10.1128/MMBR.38.3.272-290.1974; Ledwidge R, 2005, BIOCHEMISTRY-US, V44, P11402, DOI 10.1021/bi050519d; Ledwidge R, 2010, BIOCHEMISTRY-US, V49, P8988, DOI 10.1021/bi100537f; LUND BO, 1993, BIOCHEM PHARMACOL, V45, P2017, DOI 10.1016/0006-2952(93)90012-L; Lutz RA, 2012, SCIENCE, V336, P301, DOI 10.1126/science.1222641; Madigan MT, 1999, CURR OPIN MICROBIOL, V2, P265, DOI 10.1016/S1369-5274(99)80046-0; MILLER AR, 1966, GEOCHIM COSMOCHIM AC, V30, P341, DOI 10.1016/0016-7037(66)90007-X; MILLER SM, 1989, BIOCHEMISTRY-US, V28, P1194, DOI 10.1021/bi00429a037; MOORE MJ, 1992, BIOCHEMISTRY-US, V31, P1677, DOI 10.1021/bi00121a015; MOORE MJ, 1989, BIOCHEMISTRY-US, V28, P1183, DOI 10.1021/bi00429a036; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; Ortega G, 2011, SCI REP-UK, V1, DOI 10.1038/srep00006; Paul S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r70; Pieper U, 1998, STRUCTURE, V6, P75, DOI 10.1016/S0969-2126(98)00009-4; Rossy E, 2004, J BIOL INORG CHEM, V9, P49, DOI 10.1007/s00775-003-0495-y; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SCHOTTEL JL, 1978, J BIOL CHEM, V253, P4341; SCHUMANN J, 1993, PROTEIN SCI, V2, P1612, DOI 10.1002/pro.5560021007; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sen D, 2011, APPL ENVIRON MICROB, V77, P7975, DOI 10.1128/AEM.05439-11; Siglioccolo A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-50; SUMMERS AO, 1986, ANNU REV MICROBIOL, V40, P607, DOI 10.1146/annurev.mi.40.100186.003135; Swift SA, 2012, DEEP-SEA RES PT I, V64, P118, DOI 10.1016/j.dsr.2012.02.006; Syud FA, 2003, J MOL BIOL, V326, P553, DOI 10.1016/S0022-2836(02)01304-9; Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257; Tokunaga H, 2008, PROTEIN SCI, V17, P1603, DOI 10.1110/ps.035725.108; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; WATANABE K, 1994, EUR J BIOCHEM, V226, P277, DOI 10.1111/j.1432-1033.1994.tb20051.x; Zhang YH, 1996, PROTEIN SCI, V5, P52	64	30	31	1	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1675	1687		10.1074/jbc.M113.493429	http://dx.doi.org/10.1074/jbc.M113.493429			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24280218	Green Published, hybrid			2022-12-28	WOS:000332401700040
J	Kriz, V; Pospichalova, V; Masek, J; Kilander, MBC; Slavik, J; Tanneberger, K; Schulte, G; Machala, M; Kozubik, A; Behrens, J; Bryja, V				Kriz, Vitezslav; Pospichalova, Vendula; Masek, Jan; Kilander, Michaela Brita Christina; Slavik, Josef; Tanneberger, Kristina; Schulte, Gunnar; Machala, Miroslav; Kozubik, Alois; Behrens, Juergen; Bryja, Vitezslav			beta-Arrestin Promotes Wnt-induced Low Density Lipoprotein Receptor-related Protein 6 (Lrp6) Phosphorylation via Increased Membrane Recruitment of Amer1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERGENT EXTENSION MOVEMENTS; SIGNALING PATHWAYS; IN-VIVO; CATENIN; ACTIVATION; BETA-ARRESTIN-2; DVL; APC; ENDOCYTOSIS; MECHANISM	beta-Arrestin is a scaffold protein that regulates signal transduction by seven transmembrane-spanning receptors. Among other functions it is also critically required for Wnt/beta-catenin signal transduction. In the present study we provide for the first time a mechanistic basis for the beta-arrestin function in Wnt/beta-catenin signaling. We demonstrate that beta-arrestin is required for efficient Wnt3a-induced Lrp6 phosphorylation, a key event in downstream signaling. beta-Arrestin regulates Lrp6 phosphorylation via a novel interaction with phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2)-binding protein Amer1/WTX/Fam123b. Amer1 has been shown very recently to bridge Wnt-induced and Dishevelled-associated PtdIns(4,5)P-2 production to the phosphorylation of Lrp6. Using fluorescence recovery after photobleaching we show here that beta-arrestin is required for the Wnt3a-induced Amer1 membrane dynamics and downstream signaling. Finally, we show that beta-arrestin interacts with PtdIns kinases PI4KII alpha and PIP5KI beta. Importantly, cells lacking beta-arrestin showed higher steady-state levels of the relevant PtdInsP and were unable to increase levels of these PtdInsP in response to Wnt3a. In summary, our data show that beta-arrestins regulate Wnt3a-induced Lrp6 phosphorylation by the regulation of the membrane dynamics of Amer1. We propose that beta-arrestins via their scaffolding function facilitate Amer1 interaction with PtdIns(4,5)P-2, which is produced locally upon Wnt3a stimulation by beta-arrestin- and Dishevelled-associated kinases.	[Kriz, Vitezslav; Pospichalova, Vendula; Masek, Jan; Schulte, Gunnar; Kozubik, Alois; Bryja, Vitezslav] Masaryk Univ, Inst Expt Biol, Fac Sci, CS-61137 Brno, Czech Republic; [Kriz, Vitezslav; Kozubik, Alois; Bryja, Vitezslav] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, CS-61265 Brno, Czech Republic; [Tanneberger, Kristina; Behrens, Juergen] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany; [Kilander, Michaela Brita Christina; Schulte, Gunnar] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Slavik, Josef; Machala, Miroslav] Vet Res Inst, Dept Toxicol Pharmacol & Immunotherapy, Brno 62100, Czech Republic; [Masek, Jan] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague, Czech Republic	Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Erlangen Nuremberg; Karolinska Institutet; Czech Veterinary Research Institute; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Bryja, V (corresponding author), Masaryk Univ, Inst Expt Biol, Fac Sci, Kotlarska 2, CS-61137 Brno, Czech Republic.	bryja@sci.muni.cz	Kozubík, Alois/H-1954-2014; Bryja, Vít?zslav/H-1925-2014; Masek, Jan/I-9029-2014; Bryja, Vítězslav/P-4217-2019; Mašek, Jan/N-3169-2019; Pospichalova, Vendula/C-6126-2015; Kriz, Vitezslav/G-6353-2014	Bryja, Vít?zslav/0000-0002-9136-5085; Bryja, Vítězslav/0000-0002-9136-5085; Mašek, Jan/0000-0003-2904-3808; Pospichalova, Vendula/0000-0002-5957-2156; Machala, Miroslav/0000-0001-6870-6542; Schulte, Gunnar/0000-0002-2700-7013; Kilander, Michaela/0000-0001-5166-4614	Czech Science Foundation [204/09/0498, 204/09/J030, GA13-32990S]; European Molecular Biology Organization (EMBO); Ministry of Education Youth and Sport of the Czech Republic [MSM0021622430]; Project KI-MU [CZ.1.07/2.3.00/20.0180]; European Social Fund; state budget of Czech Republic "Postdoc I" [CZ.1.07/2.3.00/30.0009]; Knut and Alice Wallenberg Foundation [KAW2008.0149]; Swedish Research Council [K2008-68P-20810-01-4, K2008-68K-20805-01-4]; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Deutsche Forschungsgemeinschaft [Be1550/6-1]	Czech Science Foundation(Grant Agency of the Czech Republic); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Ministry of Education Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Project KI-MU; European Social Fund(European Social Fund (ESF)); state budget of Czech Republic "Postdoc I"; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Czech Science Foundation Grants 204/09/0498, 204/09/J030, and GA13-32990S; a European Molecular Biology Organization (EMBO) installation grant; and Ministry of Education Youth and Sport of the Czech Republic Grant MSM0021622430. The collaboration between Masaryk University and Karolinska Institutet is supported by Project KI-MU Grant CZ.1.07/2.3.00/20.0180.; Supported by a project co-financed by the European Social Fund and the state budget of Czech Republic "Postdoc I," Grant CZ.1.07/2.3.00/30.0009.; Supported by Knut and Alice Wallenberg Foundation Grant KAW2008.0149, Swedish Research Council Grants K2008-68P-20810-01-4 and K2008-68K-20805-01-4, and The Swedish Foundation for International Cooperation in Research and Higher Education (STINT).; Supported by Deutsche Forschungsgemeinschaft Grant Be1550/6-1.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boutet A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-280; Bryja V, 2004, BBA-MOL CELL RES, V1691, P105, DOI 10.1016/j.bbamcr.2004.01.001; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Bryja V, 2008, EMBO REP, V9, P1244, DOI 10.1038/embor.2008.193; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Chen MY, 2009, J BIOL CHEM, V284, P35040, DOI 10.1074/jbc.M109.047456; Chen W, 2001, P NATL ACAD SCI USA, V98, P14889, DOI 10.1073/pnas.211572798; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kim GH, 2007, EMBO J, V26, P2513, DOI 10.1038/sj.emboj.7601688; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Nelson CD, 2008, J BIOL CHEM, V283, P21093, DOI 10.1074/jbc.M800431200; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Pfister AS, 2012, J BIOL CHEM, V287, P1734, DOI 10.1074/jbc.M111.308650; Qin YB, 2009, J BIOL CHEM, V284, P22544, DOI 10.1074/jbc.M109.014399; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schulte G, 2010, BRIT J PHARMACOL, V159, P1051, DOI 10.1111/j.1476-5381.2009.00466.x; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tanneberger K, 2011, J BIOL CHEM, V286, P19204, DOI 10.1074/jbc.M111.224881; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	44	10	10	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1128	1141		10.1074/jbc.M113.498444	http://dx.doi.org/10.1074/jbc.M113.498444			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265322	Green Published, hybrid			2022-12-28	WOS:000330541200044
J	Law, BMH; Spain, VA; Leinster, VHL; Chia, R; Beilina, A; Cho, HJ; Taymans, JM; Urban, MK; Sancho, RM; Ramirez, MB; Biskup, S; Baekelandt, V; Cai, HB; Cookson, MR; Berwick, DC; Harvey, K				Law, Bernard M. H.; Spain, Victoria A.; Leinster, Veronica H. L.; Chia, Ruth; Beilina, Alexandra; Cho, Hyun J.; Taymans, Jean-Marc; Urban, Mary K.; Sancho, Rosa M.; Ramirez, Marian Blanca; Biskup, Saskia; Baekelandt, Veerle; Cai, Huaibin; Cookson, Mark R.; Berwick, Daniel C.; Harvey, Kirsten			A Direct Interaction between Leucine-rich Repeat Kinase 2 and Specific beta-Tubulin Isoforms Regulates Tubulin Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; NEURONAL MIGRATION; 14-3-3 BINDING; ROC DOMAIN; LRRK2; PROTEIN; PHOSPHORYLATION; MICROTUBULES; GENE	Mutations in LRRK2, encoding the multifunctional protein leucine-rich repeat kinase 2 (LRRK2), are a common cause of Parkinson disease. LRRK2 has been suggested to influence the cytoskeleton as LRRK2 mutants reduce neurite outgrowth and cause an accumulation of hyperphosphorylated Tau. This might cause alterations in the dynamic instability of microtubules suggested to contribute to the pathogenesis of Parkinson disease. Here, we describe a direct interaction between LRRK2 and beta-tubulin. This interaction is conferred by the LRRK2 Roc domain and is disrupted by the familial R1441G mutation and artificial Roc domain mutations that mimic autophosphorylation. LRRK2 selectively interacts with three beta-tubulin isoforms: TUBB, TUBB4, and TUBB6, one of which (TUBB4) is mutated in the movement disorder dystonia type 4 (DYT4). Binding specificity is determined by lysine 362 and alanine 364 of beta-tubulin. Molecular modeling was used to map the interaction surface to the luminal face of microtubule protofibrils in close proximity to the lysine 40 acetylation site in beta-tubulin. This location is predicted to be poorly accessible within mature stabilized microtubules, but exposed in dynamic microtubule populations. Consistent with this finding, endogenous LRRK2 displays a preferential localization to dynamic microtubules within growth cones, rather than adjacent axonal microtubule bundles. This interaction is functionally relevant to microtubule dynamics, as mouse embryonic fibroblasts derived from LRRK2 knockout mice display increased microtubule acetylation. Taken together, our data shed light on the nature of the LRRK2-tubulin interaction, and indicate that alterations in microtubule stability caused by changes in LRRK2 might contribute to the pathogenesis of Parkinson disease.	[Law, Bernard M. H.; Spain, Victoria A.; Leinster, Veronica H. L.; Sancho, Rosa M.; Ramirez, Marian Blanca; Berwick, Daniel C.; Harvey, Kirsten] UCL, UCL Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Chia, Ruth; Beilina, Alexandra; Urban, Mary K.; Cookson, Mark R.] NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Cho, Hyun J.; Cai, Huaibin] NIA, Transgen Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Taymans, Jean-Marc; Baekelandt, Veerle] Katholieke Univ Leuven, Dept Neurosci, Lab Neurobiol & Gene Therapy, B-3000 Louvain, Belgium; [Taymans, Jean-Marc; Baekelandt, Veerle] Katholieke Univ Leuven, Leuven Res Inst Neurosci & Dis LIND, B-3000 Louvain, Belgium; [Biskup, Saskia] Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Biskup, Saskia] German Ctr Neurodegenerat Dis, D-72076 Tubingen, Germany	University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); KU Leuven; KU Leuven; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Harvey, K (corresponding author), UCL, UCL Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England.	kirsten.harvey@ucl.ac.uk	Berwick, Dan/J-2378-2012; Ramirez, Marian Blanca/AAN-7851-2020; Taymans, Jean-Marc/M-9175-2018; Baekelandt, Veerle/ABB-9736-2020; Cai, Huaibin/H-3359-2013; Chia, Ruth/AAF-4900-2021; Berwick, Dan/AAJ-7779-2021; Law, Bernard M. H./O-5098-2015; Cookson, Mark/AAW-2516-2021	Berwick, Dan/0000-0002-7144-7841; Taymans, Jean-Marc/0000-0001-5503-5524; Baekelandt, Veerle/0000-0001-8966-2921; Cai, Huaibin/0000-0002-8596-6108; Chia, Ruth/0000-0002-4709-7423; Berwick, Dan/0000-0002-7144-7841; Law, Bernard M. H./0000-0001-9571-6893; Cookson, Mark/0000-0002-1058-3831	National Institutes of Health Intramural Research Program of the National Institutes of Health, NIA; Wellcome Trust [WT088145AIA, WT095010MA]; Michael J. Fox Foundation; Vera Down British Medical Association; Ibercaja Obra Social award; Fund Druwe-Eerdekens; NATIONAL INSTITUTE ON AGING [ZIAAG000937, ZIAAG000928] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the National Institutes of Health, NIA; Wellcome Trust(Wellcome TrustEuropean Commission); Michael J. Fox Foundation; Vera Down British Medical Association; Ibercaja Obra Social award; Fund Druwe-Eerdekens; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the National Institutes of Health, NIA (to M. R. C. and H. C.), Wellcome Trust Grants WT088145AIA and WT095010MA (to K. H.), grants from the Michael J. Fox Foundation (to K. H., V. B., and J. M. T.), a Vera Down British Medical Association Research grant (to K. H.), an Ibercaja Obra Social award (to M. B. R.), and the Fund Druwe-Eerdekens managed by the King Baudouin Foundation (to J. M. T.).	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Berwick DC, 2012, HUM MOL GENET, V21, P4966, DOI 10.1093/hmg/dds342; Berwick DC, 2012, BIOCHEM SOC T, V40, P1123, DOI 10.1042/BST20120122; Berwick DC, 2011, TRENDS CELL BIOL, V21, P257, DOI 10.1016/j.tcb.2011.01.001; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Ciani L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-27; Civiero L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043472; Cueva JG, 2012, CURR BIOL, V22, P1066, DOI 10.1016/j.cub.2012.05.012; Daniels V, 2011, J NEUROCHEM, V116, P304, DOI 10.1111/j.1471-4159.2010.07105.x; Demer JL, 2010, INVEST OPHTH VIS SCI, V51, P4600, DOI 10.1167/iovs.10-5438; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Gillardon F, 2009, NEUROSCIENCE, V163, P533, DOI 10.1016/j.neuroscience.2009.06.051; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2010, J PROTEOME RES, V9, P1738, DOI 10.1021/pr9008578; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hersheson J, 2013, ANN NEUROL, V73, P546, DOI 10.1002/ana.23832; Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009; Hsu CH, 2010, NEURODEGENER DIS, V7, P68, DOI 10.1159/000285509; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kawakami F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030834; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526; Kumar RA, 2010, HUM MOL GENET, V19, P2817, DOI 10.1093/hmg/ddq182; Kumari U, 2009, FEBS J, V276, P6455, DOI 10.1111/j.1742-4658.2009.07344.x; Lin CH, 2010, J NEUROSCI, V30, P13138, DOI 10.1523/JNEUROSCI.1737-10.2010; Lohmann K, 2013, ANN NEUROL, V73, P537, DOI 10.1002/ana.23829; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou Loukia, 2010, Commun Integr Biol, V3, P396, DOI 10.4161/cib.3.5.12286; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; Sancho RM, 2009, HUM MOL GENET, V18, P3955, DOI 10.1093/hmg/ddp337; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Xiong YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000902; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	69	99	101	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					895	908		10.1074/jbc.M113.507913	http://dx.doi.org/10.1074/jbc.M113.507913			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275654	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000330541200025
J	Wang, SL; Horimoto, Y; Dee, DR; Yada, RY				Wang, Shenlin; Horimoto, Yasumi; Dee, Derek R.; Yada, Rickey Y.			Understanding the Mechanism of Prosegment-catalyzed Folding by Solution NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURE; KINETICALLY STABLE PROTEINS; ALPHA-LYTIC PROTEASE; ASPARTIC PROTEINASES; PORCINE PEPSIN; HEAT-CAPACITY; RELAXATION; IDENTIFICATION; DENATURATION; STABILITY	Multidomain protein folding is often more complex than a two-state process, which leads to the spontaneous folding of the native state. Pepsin, a zymogen-derived enzyme, without its prosegment (PS), is irreversibly denatured and folds to a thermodynamically stable, non-native conformation, termed refolded pepsin, which is separated from native pepsin by a large activation barrier. While it is known that PS binds refolded pepsin and catalyzes its conversion to the native form, little structural details are known regarding this conversion. In this study, solution NMR was used to elucidate the PS-catalyzed folding mechanism by examining the key equilibrium states, e. g. native and refolded pepsin, both in the free and PS-bound states, and pepsinogen, the zymogen form of pepsin. Refolded pepsin was found to be partially structured and lacked the correct domain-domain structure and active-site cleft formed in the native state. Analysis of chemical shift data revealed that upon PS binding refolded pepsin folds into a state more similar to that of pepsinogen than to native pepsin. Comparison of pepsin folding by wild-type and mutant PSs, including a double mutant PS, indicated that hydrophobic interactions between residues of prosegment and refolded pepsin lower the folding activation barrier. A mechanism is proposed for the binding of PS to refolded pepsin and how the formation of the native structure is mediated.	[Wang, Shenlin] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Horimoto, Yasumi; Yada, Rickey Y.] Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada; [Yada, Rickey Y.] Univ Guelph, Biophys Interdept Grp, Guelph, ON N1G 2W1, Canada; [Dee, Derek R.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada	University of Guelph; University of Guelph; University of Guelph; University of Alberta	Yada, RY (corresponding author), Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada.	ryada@uoguelph.ca	Dee, Derek/AAK-5892-2020; Yada, Rickey Y/A-8289-2013; wang, shenlin/B-6530-2016	wang, shenlin/0000-0002-0153-0578; Yada, Rickey/0000-0002-8648-2156	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs (CRC) Program; Canadian Institutes of Health Research (CIHR) Fellowship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs (CRC) Program(Canada Research Chairs); Canadian Institutes of Health Research (CIHR) Fellowship(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Research Chairs (CRC) Program.; Supported by the Canadian Institutes of Health Research (CIHR) Fellowship.	AHMAD F, 1978, BIOCHEMISTRY-US, V17, P241, DOI 10.1021/bi00595a008; AHMAD F, 1978, INT J PEPT PROT RES, V12, P155; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; Banci L, 2010, P NATL ACAD SCI USA, V107, P20190, DOI 10.1073/pnas.1010095107; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; COOPER JB, 1990, J MOL BIOL, V214, P199, DOI 10.1016/0022-2836(90)90156-G; Cooper JB, 2002, CURR DRUG TARGETS, V3, P155, DOI 10.2174/1389450024605382; Dee D. R., 2010, THESIS U GUELPH CANA; Dee D, 2006, BIOCHEMISTRY-US, V45, P13982, DOI 10.1021/bi061270i; Dee DR, 2010, BIOCHEMISTRY-US, V49, P365, DOI 10.1021/bi9014055; Dee DR, 2009, BBA-PROTEINS PROTEOM, V1794, P1795, DOI 10.1016/j.bbapap.2009.08.017; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; EDER J, 1993, BIOCHEMISTRY-US, V32, P18, DOI 10.1021/bi00052a004; Fuhrmann CN, 2004, J MOL BIOL, V338, P999, DOI 10.1016/j.jmb.2004.03.018; Gardner KH, 1997, BIOCHEMISTRY-US, V36, P1389, DOI 10.1021/bi9624806; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; HARTSUCK JA, 1992, PROTEINS, V13, P1, DOI 10.1002/prot.340130102; Horimoto Y, 2014, BIOMOL NMR ASSIGN, V8, P57, DOI 10.1007/s12104-012-9452-4; Horimoto Y, 2009, NEW BIOTECHNOL, V25, P318, DOI 10.1016/j.nbt.2009.03.010; Kamatari YO, 2003, PROTEIN SCI, V12, P717, DOI 10.1110/ps.0219903; Keller R., 2004, COMPUTER AIDED RESON, V1; Konno T, 2000, BIOCHEMISTRY-US, V39, P4182, DOI 10.1021/bi991923d; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Loladze VV, 2001, PROTEIN SCI, V10, P1343, DOI 10.1110/ps.370101; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; Meinhold DW, 2011, P NATL ACAD SCI USA, V108, P9078, DOI 10.1073/pnas.1105682108; Neudecker P, 2007, P NATL ACAD SCI USA, V104, P15717, DOI 10.1073/pnas.0705097104; Nguyen JT, 2008, ARCH PHARM, V341, P523, DOI 10.1002/ardp.200700267; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Shinde U, 2000, SEMIN CELL DEV BIOL, V11, P35, DOI 10.1006/scdb.1999.0349; SIELECKI AR, 1990, J MOL BIOL, V214, P143, DOI 10.1016/0022-2836(90)90153-D; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xia K, 2007, P NATL ACAD SCI USA, V104, P17329, DOI 10.1073/pnas.0705417104; Xia K, 2010, BIOCHEMISTRY-US, V49, P7239, DOI 10.1021/bi1010877	48	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					697	707		10.1074/jbc.M113.505891	http://dx.doi.org/10.1074/jbc.M113.505891			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265313	hybrid, Green Published			2022-12-28	WOS:000330541200010
J	Bronisz, A; Carey, HA; Godlewski, J; Sif, S; Ostrowski, MC; Sharma, SM				Bronisz, Agnieszka; Carey, Heather A.; Godlewski, Jakub; Sif, Said; Ostrowski, Michael C.; Sharma, Sudarshana M.			The Multifunctional Protein Fused in Sarcoma (FUS) Is a Coactivator of Microphthalmia-associated Transcription Factor (MITF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Osteoclast; Phosphorylation; Sumoylation; Transcription Coactivators	RNA-POLYMERASE-II; AMYOTROPHIC-LATERAL-SCLEROSIS; OSTEOCLAST DIFFERENTIATION; REPRESS TRANSCRIPTION; BINDING PROTEIN; FAMILY-MEMBERS; TET FAMILY; P38 MAPK; GENE; TLS	The microphthalmia-associated transcription factor (MITF) is required for terminal osteoclast differentiation and is a signaling effector engaged by macrophage colony-stimulating factor 1 (CSF-1) and receptor activator of nuclear factor-B ligand (RANKL). MITF exerts its regulatory functions through its association with cofactors. Discovering the identity of its various partners will provide insights into the mechanisms governing gene expression during osteoclastogenesis. Here, we demonstrate that the proto-oncogene fused in sarcoma (FUS), the chromatin remodeling ATPase BRG1, and MITF form a trimeric complex that is regulated by phosphorylation of MITF at Ser-307 by p38 MAPK during osteoclast differentiation. FUS was recruited to MITF target gene promoters Acp5 and Ctsk during osteoclast differentiation, and FUS knockdown abolished efficient transcription of Acp5 and Ctsk. Furthermore, sumoylation of MITF at Lys-316, known to negatively regulate MITF transcriptional activity, inhibited MITF interactions with FUS and BRG1 in a p38 MAPK phosphorylation-dependent manner. These results demonstrate that FUS is a coregulator of MITF activity and provide new insights into how the RANKL/p38 MAPK signaling nexus controls gene expression in osteoclasts.	[Bronisz, Agnieszka; Carey, Heather A.; Sif, Said; Ostrowski, Michael C.; Sharma, Sudarshana M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Godlewski, Jakub] Ohio State Univ, Dept Neurol Surg, Dardinger Family Lab Neurooncol & Neurosci, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ostrowski, MC (corresponding author), 598 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	michael.ostrowski@osumc.edu; Sudarshana.sharma@osumc.edu	Godlewski, Jakub/U-4700-2019; Bronisz, Agnieszka/G-5980-2019; Bronisz, Agnieszka/M-3485-2019; Sif, Said/AAE-5554-2019; Sharma, Sudarshana Mangalore/AAI-2475-2019; Ostrowski, Michael/H-3108-2011	Bronisz, Agnieszka/0000-0002-5841-1051; Bronisz, Agnieszka/0000-0002-5841-1051; Sif, Said/0000-0001-6268-1145; Ostrowski, Michael/0000-0003-2948-6297; Sharma, Sudarshana/0000-0002-9745-0061; Godlewski, Jakub/0000-0003-2122-9798	National Institutes of Health from NIAMS [R01-AR-0447129]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044719] Funding Source: NIH RePORTER	National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AR-0447129 from NIAMS (to M. C. O.).	Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; Bronisz A, 2006, MOL BIOL CELL, V17, P3897, DOI 10.1091/mbc.E06-05-0470; Gascoyne DM, 2004, ONCOGENE, V23, P3830, DOI 10.1038/sj.onc.1207497; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hallier M, 1998, J BIOL CHEM, V273, P4838, DOI 10.1074/jbc.273.9.4838; Harlow E, 2006, CSH PROTOC; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Kim J, 1999, PHYSIOL GENOMICS, V1, P127, DOI 10.1152/physiolgenomics.1999.1.3.127; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kurokawa R, 2011, ADV EXP MED BIOL, V722, P196, DOI 10.1007/978-1-4614-0332-6_12; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200; Powers CA, 1998, MOL ENDOCRINOL, V12, P4, DOI 10.1210/mend.12.1.0043; PRASAD DDK, 1994, ONCOGENE, V9, P3717; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; Schwartz JC, 2012, GENE DEV, V26, P2690, DOI 10.1101/gad.204602.112; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Tan AY, 2012, P NATL ACAD SCI USA, V109, P6030, DOI 10.1073/pnas.1203028109; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang L, 2005, MOL CELL BIOL, V25, P7953, DOI 10.1128/MCB.25.18.7953-7965.2005; Wei G, 2004, J IMMUNOL, V173, P1374, DOI 10.4049/jimmunol.173.2.1374; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	36	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					326	334		10.1074/jbc.M113.493874	http://dx.doi.org/10.1074/jbc.M113.493874			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24257758	hybrid, Green Published			2022-12-28	WOS:000329370900028
J	Fedyukina, DV; Jennaro, TS; Cavagnero, S				Fedyukina, Daria V.; Jennaro, Theodore S.; Cavagnero, Silvia			Charge Segregation and Low Hydrophobicity Are Key Features of Ribosomal Proteins from Different Organisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Bacteria; Protein Folding; Protein Stability; Ribosomes; Electrostatics; Hydrophobicity; Net Charge; Ribosomal Proteins	CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; EUKARYOTIC RIBOSOME; HALOPHILIC BACTERIA; ISOELECTRIC POINT; MESSENGER-RNA; SUBUNIT; SALT; STABILITY; IONS	Background: The ribosome is a highly charged complex comprising RNAs and proteins. Results: Ribosomal proteins exhibit low hydrophobicity and a significant degree of intramolecular charge segregation. Conclusion: The majority of ribosomal proteins from all organisms, particularly halophiles, use intramolecular charge segregation to minimize electrostatic repulsion with rRNA. Significance: The electrostatic properties of ribosomal proteins are important for ribosome stability, assembly, and interaction with translation factors and nascent proteins. Ribosomes are large and highly charged macromolecular complexes consisting of RNA and proteins. Here, we address the electrostatic and nonpolar properties of ribosomal proteins that are important for ribosome assembly and interaction with other cellular components and may influence protein folding on the ribosome. We examined 50 S ribosomal subunits from 10 species and found a clear distinction between the net charge of ribosomal proteins from halophilic and non-halophilic organisms. We found that approximate to 67% ribosomal proteins from halophiles are negatively charged, whereas only up to approximate to 15% of ribosomal proteins from non-halophiles share this property. Conversely, hydrophobicity tends to be lower for ribosomal proteins from halophiles than for the corresponding proteins from non-halophiles. Importantly, the surface electrostatic potential of ribosomal proteins from all organisms, especially halophiles, has distinct positive and negative regions across all the examined species. Positively and negatively charged residues of ribosomal proteins tend to be clustered in buried and solvent-exposed regions, respectively. Hence, the majority of ribosomal proteins is characterized by a significant degree of intramolecular charge segregation, regardless of the organism of origin. This key property enables the ribosome to accommodate proteins within its complex scaffold regardless of their overall net charge.	[Fedyukina, Daria V.; Jennaro, Theodore S.; Cavagnero, Silvia] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Cavagnero, S (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	cavagnero@chem.wisc.edu		Jennaro, Theodore/0000-0002-2496-6374	National Science Foundation [MCB 0951209]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by National Science Foundation Grant MCB 0951209 (to S. C.).	ABE Y, 1995, J BIOCHEM-TOKYO, V118, P946, DOI 10.1093/jb/118.5.946; ANDERSON CF, 1995, ANNU REV PHYS CHEM, V46, P657, DOI 10.1146/annurev.physchem.46.1.657; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bardavid RE, 2012, EXTREMOPHILES, V16, P787, DOI 10.1007/s00792-012-0476-6; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; Brodersen DE, 2005, FEBS J, V272, P2098, DOI 10.1111/j.1742-4658.2005.04651.x; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; DasSarma S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058587; Date MS, 2013, COMMUN COMPUT PHYS, V13, P90, DOI 10.4208/cicp.290711.121011s; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dill K., 2010, MOL DRIVING FORCES S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; DRAPER DE, 1995, ANNU REV BIOCHEM, V64, P593, DOI 10.1146/annurev.bi.64.070195.003113; Draper DE, 2004, RNA, V10, P335, DOI 10.1261/rna.5205404; Elcock AH, 1998, J MOL BIOL, V280, P731, DOI 10.1006/jmbi.1998.1904; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goo YA, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-3; Greber BJ, 2012, NAT STRUCT MOL BIOL, V19, P1228, DOI 10.1038/nsmb.2425; GUTTMAN HJ, 1995, BIOCHEMISTRY-US, V34, P1393, DOI 10.1021/bi00004a034; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; HOFFMAN DW, 1994, EMBO J, V13, P205, DOI 10.1002/j.1460-2075.1994.tb06250.x; Hubbard S. J., 1993, NACCESS; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Kavran JM, 2007, J MOL BIOL, V371, P1047, DOI 10.1016/j.jmb.2007.05.091; Kiraga J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-163; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Knight AM, 2013, ACS CHEM BIOL, V8, P1195, DOI 10.1021/cb400030n; Korobeinikova AV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P562, DOI 10.1134/S0006297912060028; KUNTZ ID, 1969, SCIENCE, V163, P1329, DOI 10.1126/science.163.3873.1329; KUNTZ ID, 1971, J AM CHEM SOC, V93, P514, DOI 10.1021/ja00731a036; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANYI JK, 1974, BACTERIOL REV, V38, P272, DOI 10.1128/MMBR.38.3.272-290.1974; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Leipply D, 2009, METHOD ENZYMOL, V469, P433, DOI 10.1016/S0076-6879(09)69021-2; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Ni HH, 1999, J PHYS CHEM B, V103, P3489, DOI 10.1021/jp984380a; Nozaki Y, 1967, METHOD ENZYMOL, V11, P715, DOI DOI 10.1016/S0076-6879(67)11088-4; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Ramakrishnan V, 2011, SCIENCE, V331, P681, DOI 10.1126/science.1202093; RAO JKM, 1981, BIOCHEMISTRY-US, V20, P6536, DOI 10.1021/bi00526a004; Record MT, 2013, FARADAY DISCUSS, V160, P9, DOI [10.1039/C2FD20128C, 10.1039/c2fd20128c]; Sayers EW, 2000, BIOCHEMISTRY-US, V39, P13602, DOI 10.1021/bi0013391; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257; Timsit Y, 2009, INT J MOL SCI, V10, P817, DOI 10.3390/ijms10030817; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Wahl MC, 2002, CURR PROTEIN PEPT SC, V3, P93, DOI 10.2174/1389203023380756; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; Woodson SA, 2011, ACCOUNTS CHEM RES, V44, P1312, DOI 10.1021/ar2000474; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	62	18	18	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6740	6750		10.1074/jbc.M113.507707	http://dx.doi.org/10.1074/jbc.M113.507707			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24398678	hybrid, Green Published			2022-12-28	WOS:000332389400035
J	Benbahouche, NE; Iliopoulos, I; Torok, I; Marhold, J; Henri, J; Kajava, AV; Farkas, R; Kempf, T; Schnolzer, M; Meyer, P; Kiss, I; Bertrand, E; Mechler, BM; Pradet-Balade, B				Benbahouche, Nour El Houda; Iliopoulos, Ioannis; Toeroek, Istvan; Marhold, Joachim; Henri, Julien; Kajava, Andrey V.; Farkas, Robert; Kempf, Tore; Schnoelzer, Martina; Meyer, Philippe; Kiss, Istvan; Bertrand, Edouard; Mechler, Bernard M.; Pradet-Balade, Berengere			Drosophila Spag Is the Homolog of RNA Polymerase II-associated Protein 3 (RPAP3) and Recruits the Heat Shock Proteins 70 and 90 (Hsp70 and Hsp90) during the Assembly of Cellular Machineries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hsp90; Protein Assembly; RNA Polymerase II; Small Nucleolar RNA (snoRNA); TOR Complex (TORC); Hsp70; R2TP Complex; RPAP3; Spaghetti Gene	HUMAN TRANSCRIPTION MACHINERY; INTERACTION NETWORK; BINDING-PROTEIN; 2ND CHROMOSOME; R2TP COMPLEX; CHAPERONE; GENE; MELANOGASTER; COCHAPERONE; REVEALS	Background: Mammalian RNA polymerase II-associated protein 3 (RPAP3) recruits heat shock protein 90 (Hsp90) to assemble cellular machineries such as RNA polymerases. Results:Spaghetti encodes the Drosophila homolog of RPAP3. Spaghetti is essential for development. Spag protein binds and stimulates Hsp90 and Hsp70. Conclusion: RPAP3 function is conserved among metazoans. Significance: Our data suggest that Hsp70 assists RPAP3 in complex assembly. The R2TP is a recently identified Hsp90 co-chaperone, composed of four proteins as follows: Pih1D1, RPAP3, and the AAA(+)-ATPases RUVBL1 and RUVBL2. In mammals, the R2TP is involved in the biogenesis of cellular machineries such as RNA polymerases, small nucleolar ribonucleoparticles and phosphatidylinositol 3-kinase-related kinases. Here, we characterize the spaghetti (spag) gene of Drosophila, the homolog of human RPAP3. This gene plays an essential function during Drosophila development. We show that Spag protein binds Drosophila orthologs of R2TP components and Hsp90, like its yeast counterpart. Unexpectedly, Spag also interacts and stimulates the chaperone activity of Hsp70. Using null mutants and flies with inducible RNAi, we show that spaghetti is necessary for the stabilization of snoRNP core proteins and target of rapamycin activity and likely the assembly of RNA polymerase II. This work highlights the strong conservation of both the HSP90/R2TP system and its clients and further shows that Spag, unlike Saccharomyces cerevisiae Tah1, performs essential functions in metazoans. Interaction of Spag with both Hsp70 and Hsp90 suggests a model whereby R2TP would accompany clients from Hsp70 to Hsp90 to facilitate their assembly into macromolecular complexes.	[Benbahouche, Nour El Houda; Bertrand, Edouard; Pradet-Balade, Berengere] CNRS, UMR 5535, Inst Genet Mol Montpellier, Equipe Labellisee Ligue Canc, F-34293 Montpellier 5, France; [Benbahouche, Nour El Houda; Bertrand, Edouard; Pradet-Balade, Berengere] Univ Montpellier 2, F-34095 Montpellier 5, France; [Benbahouche, Nour El Houda; Bertrand, Edouard; Pradet-Balade, Berengere] Univ Montpellier I, F-34967 Montpellier 2, France; [Iliopoulos, Ioannis; Toeroek, Istvan; Marhold, Joachim; Kiss, Istvan; Mechler, Bernard M.] German Canc Res Ctr, DKFZ ZMBH Alliance, Dept Dev Genet, D-69120 Heidelberg, Germany; [Henri, Julien; Meyer, Philippe] CNRS, FRE 3354, Lab Biol Mol & Cellulaire Eucaryotes, Inst Biol Phys Chim, F-75005 Paris, France; [Henri, Julien; Meyer, Philippe] Sorbonne Univ, Univ Paris 06, Inst Biol Phys Chim, Lab Biol Mol & Cellulaire Eucaryotes,FRE 3354, F-75005 Paris, France; [Kajava, Andrey V.] CNRS, UMR5237, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France; [Kajava, Andrey V.] Inst Biol Computat, F-34095 Montpellier, France; [Farkas, Robert] Slovak Acad Sci, Inst Expt Endocrinol, Lab Dev Genet, Bratislava 83306, Slovakia; [Kempf, Tore; Schnoelzer, Martina] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Mechler, Bernard M.] Charles Univ Prague, Fac Med 1, Inst Cellular Biol & Pathol, CZ-12801 Prague, Czech Republic; [Mechler, Bernard M.] VIT Univ, Vellore 632014, Tamil Nadu, India	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Helmholtz Association; German Cancer Research Center (DKFZ); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Slovak Academy of Sciences; Helmholtz Association; German Cancer Research Center (DKFZ); Charles University Prague; Vellore Institute of Technology	Bertrand, E (corresponding author), CNRS, UMR 5535, Inst Genet Mol Montpellier, Equipe Labellisee Ligue Canc, 1919 Route Mende, F-34293 Montpellier 5, France.	edouard.bertrand@igmm.cnrs.fr; mechler@bluewin.ch; pradet@igmm.cnrs.fr	Henri, Julien/AAB-3427-2020; Meyer, Philippe/AAC-6038-2019; Kajava, Andrey V/E-1107-2014; Farkas, Robert/ABB-1990-2021; Henri, Julien B/E-3340-2017	Henri, Julien/0000-0003-0772-8881; Meyer, Philippe/0000-0002-6220-0679; Kajava, Andrey V/0000-0002-2342-6886; Henri, Julien B/0000-0003-0772-8881; Farkas, Robert/0000-0002-9138-7567; bertrand, edouard/0000-0002-9642-7994	La Ligue Nationale Contre le Cancer; ANR; Czech Grant Foundation Grant [P302/11/1640]; Charles University Center [UNCE 204022]; First Faculty of Medicine [Prvouk/ILF/1]; Agence National de la Recherche Grant [ANR-11-BSV8-015-03]; LABEX DYNAMO Grant [ANR-11-LABX-0011]; Fondation Agence National de la Recherche pour la Recherche sur le Cancer Grant [SFI20101201793]	La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); ANR(French National Research Agency (ANR)); Czech Grant Foundation Grant; Charles University Center; First Faculty of Medicine; Agence National de la Recherche Grant(French National Research Agency (ANR)); LABEX DYNAMO Grant; Fondation Agence National de la Recherche pour la Recherche sur le Cancer Grant	This work was supported in part by La Ligue Nationale Contre le Cancer and ANR Grant Hsp90 Assembly.com (to E. B.); work in the laboratory of B. M. M. was supported by the Czech Grant Foundation Grant P302/11/1640, the Charles University Center UNCE 204022, and the First Faculty of Medicine Prvouk/ILF/1 (to B. M. M.); and work in the laboratory of P. M. was supported by Agence National de la Recherche Grant ANR-11-BSV8-015-03, the LABEX DYNAMO Grant ANR-11-LABX-0011, and the Fondation Agence National de la Recherche pour la Recherche sur le Cancer Grant SFI20101201793.	Back R, 2013, STRUCTURE, V21, P1834, DOI 10.1016/j.str.2013.07.024; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Boulon S, 2012, RNA BIOL, V9, DOI 10.4161/rna.9.2.18494; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Cloutier P, 2009, METHODS, V48, P381, DOI 10.1016/j.ymeth.2009.05.005; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Eckert K, 2010, J BIOL CHEM, V285, P31304, DOI 10.1074/jbc.M110.138263; Forget D, 2010, MOL CELL PROTEOMICS, V9, P2827, DOI 10.1074/mcp.M110.003616; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Glatter T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.79; Haslbeck V, 2013, J MOL BIOL, V425, P2922, DOI 10.1016/j.jmb.2013.05.019; HOHFELD J, 1995, CELL, V83, P589; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Iliopoulos I, 1997, BIOL CHEM, V378, P1177; Itsuki Y, 2008, FEBS LETT, V582, P2365, DOI 10.1016/j.febslet.2008.05.041; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jimenez B, 2012, J BIOL CHEM, V287, P5698, DOI 10.1074/jbc.M111.287458; Kirchner J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-36; Lee JS, 2012, PLOS ONE, V7; Makhnevych T, 2012, J CELL BIOL, V198, P623, DOI 10.1083/jcb.201111105; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Millson SH, 2008, BIOCHEM J, V413, P261, DOI 10.1042/BJ20080105; Minakhina S, 2006, GENETICS, V174, P253, DOI 10.1534/genetics.106.061978; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Pradet-Balade B, 2011, EMBO J, V30, P2205, DOI 10.1038/emboj.2011.128; Roch F, 1998, MOL GEN GENET, V257, P103, DOI 10.1007/PL00008620; Rodor J, 2011, PLANT J, V65, P807, DOI 10.1111/j.1365-313X.2010.04468.x; Rodor J, 2010, BIOCHEM SOC T, V38, P672, DOI 10.1042/BST0380672; Santos MG, 2007, CYTOTECHNOLOGY, V54, P15, DOI 10.1007/s10616-007-9060-9; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Torok I, 1999, MOL CELL BIOL, V19, P2308; TOROK I, 1995, J CELL BIOL, V129, P1473, DOI 10.1083/jcb.129.6.1473; TOROK T, 1993, GENETICS, V135, P71; Verheggen C, 2002, EMBO J, V21, P2736, DOI 10.1093/emboj/21.11.2736; Vorbruggen G, 2000, MECH DEVELOP, V90, P305, DOI 10.1016/S0925-4773(99)00249-X; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	42	34	34	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6236	6247		10.1074/jbc.M113.499608	http://dx.doi.org/10.1074/jbc.M113.499608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24394412	Green Published, hybrid			2022-12-28	WOS:000332015500076
J	Higman, VA; Briggs, DC; Mahoney, DJ; Blundell, CD; Sattelle, BM; Dyer, DP; Green, DE; DeAngelis, PL; Almond, A; Milner, CM; Day, AJ				Higman, Victoria A.; Briggs, David C.; Mahoney, David J.; Blundell, Charles D.; Sattelle, Benedict M.; Dyer, Douglas P.; Green, Dixy E.; DeAngelis, Paul L.; Almond, Andrew; Milner, Caroline M.; Day, Anthony J.			A Refined Model for the TSG-6 Link Module in Complex with Hyaluronan USE OF DEFINED OLIGOSACCHARIDES TO PROBE STRUCTURE AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondroitin; Hyaluronate; Isothermal Titration Calorimetry; Molecular Modeling; NMR; Defined Sugars; TSG-6	INTER-ALPHA-INHIBITOR; MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN TSG-6; BINDING DOMAIN; EXTRACELLULAR-MATRIX; STIMULATED GENE-6; TRYPSIN INHIBITOR; HEAVY-CHAINS; NMR; SURFACE	Background: The polysaccharide hyaluronan is organized through interactions with the protein TSG-6 during inflammation and ovulation. Results: NMR spectroscopy on TSG-6 in the presence of defined sugars provided restraints that allowed modeling of a refined hyaluronan/TSG-6 complex. Conclusion: TSG-6 binding causes bending of hyaluronan that explains its condensation of this polysaccharide. Significance: This provides novel structural insights into protein-hyaluronan interactions. Tumor necrosis factor-stimulated gene-6 (TSG-6) is an inflammation-associated hyaluronan (HA)-binding protein that contributes to remodeling of HA-rich extracellular matrices during inflammatory processes and ovulation. The HA-binding domain of TSG-6 consists solely of a Link module, making it a prototypical member of the superfamily of proteins that interacts with this high molecular weight polysaccharide composed of repeating disaccharides of d-glucuronic acid and N-acetyl-d-glucosamine (GlcNAc). Previously we modeled a complex of the TSG-6 Link module in association with an HA octasaccharide based on the structure of the domain in its HA-bound conformation. Here we have generated a refined model for a HA/Link module complex using novel restraints identified from NMR spectroscopy of the protein in the presence of 10 distinct HA oligosaccharides (from 4- to 8-mers); the model was then tested using unique sugar reagents, i.e. chondroitin/HA hybrid oligomers and an octasaccharide in which a single sugar ring was C-13-labeled. The HA chain was found to make more extensive contacts with the TSG-6 surface than thought previously, such that a d-glucuronic acid ring makes stacking and ionic interactions with a histidine and lysine, respectively. Importantly, this causes the HA to bend around two faces of the Link module (resembling the way that HA binds to CD44), potentially providing a mechanism for how TSG-6 can reorganize HA during inflammation. However, the HA-binding site defined here may not play a role in TSG-6-mediated transfer of heavy chains from inter--inhibitor onto HA, a process known to be essential for ovulation.	[Higman, Victoria A.; Mahoney, David J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Briggs, David C.; Dyer, Douglas P.; Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Briggs, David C.; Blundell, Charles D.; Sattelle, Benedict M.; Dyer, Douglas P.; Almond, Andrew; Milner, Caroline M.; Day, Anthony J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Green, Dixy E.; DeAngelis, Paul L.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oxford; University of Manchester; University of Manchester; University of Oklahoma System; University of Oklahoma Health Sciences Center	Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	anthony.day@manchester.ac.uk	Dyer, Douglas/L-9679-2019; Milner, Caroline M/P-5526-2015; Dyer, Douglas/J-2675-2015; Day, Anthony/O-1658-2015; Higman, Victoria/H-3795-2011	Dyer, Douglas/0000-0001-5567-6241; Milner, Caroline M/0000-0001-7355-9655; Dyer, Douglas/0000-0001-5567-6241; Day, Anthony/0000-0002-1415-3134; Higman, Victoria/0000-0002-3204-2665; Briggs, David/0000-0002-9793-7339; Blundell, Charles/0000-0002-1439-9126; Almond, Andrew/0000-0001-7471-6333	Arthritis Research UK [16539, 18472, 19489]; Medical Research Council [G0701180]; Biotechnology and Biological Sciences Research Council CASE studentship [BB/D526561/1]; Oklahoma Center for Advancement of Science and Technology; Medical Research Council [MC_U138274352] Funding Source: researchfish; Versus Arthritis [18472, 19489] Funding Source: researchfish; MRC [MC_U138274352, G0701180] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Oklahoma Center for Advancement of Science and Technology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Arthritis Research UK Grants 16539, 18472, and 19489 and Medical Research Council Grant G0701180.; Supported by Biotechnology and Biological Sciences Research Council CASE studentship (BB/D526561/1).; Recipient of an Oklahoma Center for Advancement of Science and Technology Health Research grant.	Almond A, 1998, GLYCOBIOLOGY, V8, P973, DOI 10.1093/glycob/8.10.973; Almond A, 1997, GLYCOBIOLOGY, V7, P597, DOI 10.1093/glycob/7.5.597; Almond A, 2000, J PHYS CHEM B, V104, P5634, DOI 10.1021/jp000402t; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Banerji S, 2010, J BIOL CHEM, V285, P10724, DOI 10.1074/jbc.M109.047647; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; BLOM A, 1995, J BIOL CHEM, V270, P9698, DOI 10.1074/jbc.270.17.9698; Blundell C. D., 2002, HYALURONAN, P161; Blundell CD, 2004, CHEMISTRY AND BIOLOGY OF HYALURONAN, P189; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Blundell CD, 2007, J BIOL CHEM, V282, P12976, DOI 10.1074/jbc.M611713200; Blundell CD, 2006, CARBOHYD RES, V341, P1985, DOI 10.1016/j.carres.2006.05.017; Blundell CD, 2006, ANAL BIOCHEM, V353, P236, DOI 10.1016/j.ab.2006.03.013; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Churchill CDM, 2009, J PHYS CHEM B, V113, P16046, DOI 10.1021/jp907887y; Day A. J., 2004, HYALURONAN STRUCTURE, VII, P675; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Day AJ, 2001, CURR OPIN STRUC BIOL, V11, P617, DOI 10.1016/S0959-440X(00)00256-6; Deangelis PL, 2003, J BIOL CHEM, V278, P35199, DOI 10.1074/jbc.M306431200; DeAngelis PL, 2002, CARBOHYD RES, V337, P1547, DOI 10.1016/S0008-6215(02)00219-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DOUGHERTY BA, 1993, J BIOL CHEM, V268, P7118; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Ievoli E, 2011, MATRIX BIOL, V30, P330, DOI 10.1016/j.matbio.2011.05.002; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inforzato A, 2010, J BIOL CHEM, V285, P17681, DOI 10.1074/jbc.M109.085639; Itano N, 2008, J BIOCHEM, V144, P131, DOI 10.1093/jb/mvn046; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Kahmann JD, 2000, STRUCTURE, V8, P763, DOI 10.1016/S0969-2126(00)00163-5; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2000, J BIOL CHEM, V275, P26967; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mahoney DJ, 2001, GLYCOBIOLOGY, V11, P1025, DOI 10.1093/glycob/11.12.1025; Mahoney DJ, 2001, J BIOL CHEM, V276, P22764, DOI 10.1074/jbc.M100666200; Matsumoto K, 2003, J BIOL CHEM, V278, P41205, DOI 10.1074/jbc.M305060200; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Nagyeri G, 2011, J BIOL CHEM, V286, P23559, DOI 10.1074/jbc.M111.222026; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Seyfried NT, 2005, J BIOL CHEM, V280, P5435, DOI 10.1074/jbc.M411297200; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Tracy BS, 2007, J BIOL CHEM, V282, P337, DOI 10.1074/jbc.M607569200; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Yamashita S, 2012, FEBS LETT, V586, P2404, DOI 10.1016/j.febslet.2012.05.055; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	78	35	36	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5619	5634		10.1074/jbc.M113.542357	http://dx.doi.org/10.1074/jbc.M113.542357			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403066	Green Published, hybrid			2022-12-28	WOS:000332015500026
J	Ishii, K; Adachi, T; Hamamoto, H; Sekimizu, K				Ishii, Kenichi; Adachi, Tatsuo; Hamamoto, Hiroshi; Sekimizu, Kazuhisa			Serratia marcescens Suppresses Host Cellular Immunity via the Production of an Adhesion-inhibitory Factor against Immunosurveillance Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Bacterial Toxins; Cellular Immune Response; Innate Immunity; Insect Immunity; Macrophages; Metalloprotease; Protein Purification; Silkworm	SILKWORM PARALYTIC PEPTIDE; INTENSIVE-CARE-UNIT; INNATE IMMUNITY; BOMBYX-MORI; PROTEUS-MIRABILIS; PHAGOCYTOSIS; CALRETICULIN; ACTIVATION; DROSOPHILA; METALLOPROTEASE	Background:Serratia marcescens induced an acute increase in immune cell numbers in silkworms. Results: Serralysin metalloprotease was identified as a factor that inhibited immune cell adhesion and bacterial clearance. Conclusion:S. marcescens suppresses cellular immunity by degrading adhesion molecules. Significance: A novel mode of immune evasion by S. marcescens is proposed. Injection of a culture supernatant of Serratia marcescens into the bloodstream of the silkworm Bombyx mori increased the number of freely circulating immunosurveillance cells (hemocytes). Using a bioassay with live silkworms, serralysin metalloprotease was purified from the culture supernatant and identified as the factor responsible for this activity. Serralysin inhibited the in vitro attachment of both silkworm hemocytes and murine peritoneal macrophages. Incubation of silkworm hemocytes or murine macrophages with serralysin resulted in degradation of the cellular immune factor BmSPH-1 or calreticulin, respectively. Furthermore, serralysin suppressed in vitro phagocytosis of bacteria by hemocytes and in vivo bacterial clearance in silkworms. Disruption of the ser gene in S. marcescens attenuated its host killing ability in silkworms and mice. These findings suggest that serralysin metalloprotease secreted by S. marcescens suppresses cellular immunity by decreasing the adhesive properties of immunosurveillance cells, thereby contributing to bacterial pathogenesis.	[Ishii, Kenichi; Adachi, Tatsuo; Hamamoto, Hiroshi; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo 1130033, Japan	University of Tokyo	Sekimizu, K (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Ishii, Kenichi/H-5469-2019; Hamamoto, Hiroshi/G-6397-2019	Hamamoto, Hiroshi/0000-0001-9315-7442	Japan Society for the Promotion of Science [21-10519, 24689008]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Japan Society of the Promotion of Science Fellows 21-10519 from the Japan Society for the Promotion of Science and in part by Japan Society for the Promotion of Science Grant-in-aid for Young Scientists (A) 24689008.	Belas R, 2004, INFECT IMMUN, V72, P5159, DOI 10.1128/IAI.72.9.5159-5167.2004; Bowen DJ, 2003, MICROBIOL-SGM, V149, P1581, DOI 10.1099/mic.0.26171-0; Castelli ME, 2008, J BACTERIOL, V190, P213, DOI 10.1128/JB.01348-07; Castelli ME, 2011, J BACTERIOL, V193, P63, DOI 10.1128/JB.00839-10; CHADWICK JS, 1990, J INVERTEBR PATHOL, V55, P133, DOI 10.1016/0022-2011(90)90044-7; Cho JH, 1999, EUR J BIOCHEM, V266, P878, DOI 10.1046/j.1432-1327.1999.00920.x; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; Fadel MP, 1999, J BIOL CHEM, V274, P15085, DOI 10.1074/jbc.274.21.15085; Gandhe AS, 2007, J IMMUNOL, V179, P6943, DOI 10.4049/jimmunol.179.10.6943; Ghiran I, 2003, J BIOL CHEM, V278, P21024, DOI 10.1074/jbc.M302306200; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; HOU RF, 1985, APPL ENTOMOL ZOOL, V20, P118, DOI 10.1303/aez.20.118; Imamura K, 2011, DRUG DISCOV THER, V5, P125, DOI 10.5582/ddt.2011.v5.3.125; Ishii K, 2008, J BIOL CHEM, V283, P2185, DOI 10.1074/jbc.M705480200; Ishii K, 2013, DEV COMP IMMUNOL, V39, P147, DOI 10.1016/j.dci.2012.10.014; Ishii K, 2012, J BIOL CHEM, V287, P36582, DOI 10.1074/jbc.M112.399667; Ishii K, 2010, J BIOL CHEM, V285, P33338, DOI 10.1074/jbc.M110.112987; Ishii K, 2010, J BIOL CHEM, V285, P28635, DOI 10.1074/jbc.M110.138446; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Kida Y, 2007, INFECT IMMUN, V75, P164, DOI 10.1128/IAI.01239-06; KOBAYASHI H, 1991, INSECT BIOCHEM, V21, P517, DOI 10.1016/0020-1790(91)90105-N; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Maragakis LL, 2008, INFECT CONT HOSP EP, V29, P418, DOI 10.1086/587969; McMahon KJ, 2012, J BACTERIOL, V194, P3241, DOI 10.1128/JB.00016-12; Means TK, 2010, VIRULENCE, V1, P37, DOI 10.4161/viru.1.1.10228; Nakahara Y, 2003, ARCH INSECT BIOCHEM, V52, P163, DOI 10.1002/arch.10080; Qi W, 2005, GUT, V54, P1091, DOI 10.1136/gut.2004.061887; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Rauch F, 2000, EXP CELL RES, V256, P105, DOI 10.1006/excr.2000.4818; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Sakamoto M, 2011, DEV COMP IMMUNOL, V35, P611, DOI 10.1016/j.dci.2011.01.003; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Toratani T, 2008, MICROBIOL-SGM, V154, P1326, DOI 10.1099/mic.0.2007/016246-0; Usui K, 2009, MICROB PATHOGENESIS, V46, P59, DOI 10.1016/j.micpath.2008.10.010; Villari P, 2001, INFECT CONT HOSP EP, V22, P630, DOI 10.1086/501834; Walker KE, 1999, MOL MICROBIOL, V32, P825, DOI 10.1046/j.1365-2958.1999.01401.x; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Watanabe T, 1997, J BACTERIOL, V179, P7111, DOI 10.1128/jb.179.22.7111-7117.1997; Zhuang SF, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700341200	43	47	50	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5876	5888		10.1074/jbc.M113.544536	http://dx.doi.org/10.1074/jbc.M113.544536			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398686	hybrid, Green Published			2022-12-28	WOS:000332015500045
J	Ohara-Nemoto, Y; Rouf, SMA; Naito, M; Yanase, A; Tetsuo, F; Ono, T; Kobayakawa, T; Shimoyama, Y; Kimura, S; Nakayama, K; Saiki, K; Konishi, K; Nemoto, TK				Ohara-Nemoto, Yuko; Rouf, Shakh M. A.; Naito, Mariko; Yanase, Amie; Tetsuo, Fumi; Ono, Toshio; Kobayakawa, Takeshi; Shimoyama, Yu; Kimura, Shigenobu; Nakayama, Koji; Saiki, Keitarou; Konishi, Kiyoshi; Nemoto, Takayuki K.			Identification and Characterization of Prokaryotic Dipeptidyl-peptidase 5 from Porphyromonas gingivalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Metabolism; Peptidases; Periodontal Disease; Subcellular Fractionation	SECRETED DIPEPTIDYL; GENOME SEQUENCE; OUTER-MEMBRANE; DPP 7; PURIFICATION; CHAIN; PROTEIN; SUBSTRATE; RESIDUES; COMPLEX	Background: Dipeptidyl-peptidases (DPPs) are key factors for amino acid metabolism and bacterial growth of asaccharolytic Porphyromonas gingivalis. Results: DPP5, which is specific for Ala and hydrophobic residues, is expressed in the periplasmic space of P. gingivalis.Conclusion: DPP5 was discovered in prokaryotes for the first time. Significance: The discovery of DPP5 expands understanding of amino acid and energy metabolism in prokaryotes. Porphyromonas gingivalis, a Gram-negative asaccharolytic anaerobe, is a major causative organism of chronic periodontitis. Because the bacterium utilizes amino acids as energy and carbon sources and incorporates them mainly as dipeptides, a wide variety of dipeptide production processes mediated by dipeptidyl-peptidases (DPPs) should be beneficial for the organism. In the present study, we identified the fourth P. gingivalis enzyme, DPP5. In a dpp4-7-11-disrupted P. gingivalis ATCC 33277, a DPP7-like activity still remained. PGN_0756 possessed an activity indistinguishable from that of the mutant, and was identified as a bacterial orthologue of fungal DPP5, because of its substrate specificity and 28.5% amino acid sequence identity with an Aspergillus fumigatus entity. P. gingivalis DPP5 was composed of 684 amino acids with a molecular mass of 77,453, and existed as a dimer while migrating at 66 kDa on SDS-PAGE. It preferred Ala and hydrophobic residues, had no activity toward Pro at the P1 position, and no preference for hydrophobic P2 residues, showed an optimal pH of 6.7 in the presence of NaCl, demonstrated K-m and k(cat)/K-m values for Lys-Ala-MCA of 688 m and 11.02 m(-1) s(-1), respectively, and was localized in the periplasm. DPP5 elaborately complemented DPP7 in liberation of dipeptides with hydrophobic P1 residues. Examinations of DPP- and gingipain gene-disrupted mutants indicated that DPP4, DPP5, DPP7, and DPP11 together with Arg- and Lys-gingipains cooperatively liberate most dipeptides from nutrient oligopeptides. This is the first study to report that DPP5 is expressed not only in eukaryotes, but also widely distributed in bacteria and archaea.	[Ohara-Nemoto, Yuko; Rouf, Shakh M. A.; Yanase, Amie; Tetsuo, Fumi; Ono, Toshio; Kobayakawa, Takeshi; Nemoto, Takayuki K.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Mol Biol, Course Med & Dent Sci, Nagasaki 8528588, Japan; [Naito, Mariko; Nakayama, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Microbiol & Oral Infect, Nagasaki 8528588, Japan; [Shimoyama, Yu; Kimura, Shigenobu] Iwate Med Univ, Div Mol Microbiol, Morioka, Iwate 0283694, Japan; [Saiki, Keitarou; Konishi, Kiyoshi] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Microbiol, Tokyo 1028159, Japan	Nagasaki University; Nagasaki University; Iwate Medical University; Nippon Dental University	Nemoto, TK (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Mol Biol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	tnemoto@nagasaki-u.ac.jp	Keitarou, Saiki/AAV-6909-2020	NAITO, Mariko/0000-0003-0769-7747; Nemoto, Takayuki K./0000-0002-5007-6260; Tetsuo, Fumi/0000-0002-6443-9827	Japan Society for the Promotion of Science; Institute for Fermentation, Osaka; Japanese Government (MEXT); Grants-in-Aid for Scientific Research [24592775] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Japanese Government (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (to Y. O.-N., T. K. N., T. K., and S. K.) and a grant from the Institute for Fermentation, Osaka (to T. K. N.).; Graduate student supported by a Japanese Government (MEXT) Scholarship. Present address: Laboratory of Biochemistry and Molecular Biology, Dept. of Applied Nutrition and Food Technology, Faculty of Applied Science and Technology, Islamic University, Kushtia-7003, Bangladesh.	Ahren B, 2004, J CLIN ENDOCR METAB, V89, P2078, DOI 10.1210/jc.2003-031907; Banbula A, 1999, J BIOL CHEM, V274, P9246, DOI 10.1074/jbc.274.14.9246; Banbula A, 2001, J BIOL CHEM, V276, P6299, DOI 10.1074/jbc.M008789200; Banbula A, 2000, INFECT IMMUN, V68, P1176, DOI 10.1128/IAI.68.3.1176-1182.2000; Beauvais A, 1997, J BIOL CHEM, V272, P6238, DOI 10.1074/jbc.272.10.6238; CHEN ZX, 1992, J BIOL CHEM, V267, P18896; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; ELLIS S, 1967, J BIOL CHEM, V242, P4623; FUJIMURA S, 1992, ORAL MICROBIOL IMMUN, V7, P212, DOI 10.1111/j.1399-302X.1992.tb00027.x; Herman GA, 2006, J CLIN PHARMACOL, V46, P876, DOI 10.1177/0091270006289850; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Hovik H, 2012, J BACTERIOL, V194, P100, DOI 10.1128/JB.06385-11; Iwai T, 2005, J VASC SURG, V42, P107, DOI 10.1016/j.jvs.2005.03.016; KADOWAKI T, 1994, J BIOL CHEM, V269, P21371; Kshirsagar AV, 2007, BLOOD PURIFICAT, V25, P125, DOI 10.1159/000096411; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Mazumdar V, 2009, J BACTERIOL, V191, P74, DOI 10.1128/JB.01123-08; Meuric V, 2010, FUTURE MICROBIOL, V5, P717, DOI 10.2217/FMB.10.32; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Monod M, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3392, DOI 10.1016/B978-0-12-382219-2.00749-3; Murakami Y, 2002, EUR J ORAL SCI, V110, P157, DOI 10.1034/j.1600-0722.2002.11171.x; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Nakajima Y, 2008, J BACTERIOL, V190, P7819, DOI 10.1128/JB.02010-07; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; Nguyen KA, 2009, MICROBIOL-SGM, V155, P328, DOI 10.1099/mic.0.024323-0; Niederman R, 1997, J DENT RES, V76, P575, DOI 10.1177/00220345970760010801; Oda H, 2009, J PERIODONTAL RES, V44, P362, DOI 10.1111/j.1600-0765.2008.01117.x; Ohara-Nemoto Y, 2011, J BIOL CHEM, V286, P38115, DOI 10.1074/jbc.M111.278572; Pederson RA, 1998, DIABETES, V47, P1253, DOI 10.2337/diabetes.47.8.1253; PIKE R, 1994, J BIOL CHEM, V269, P406; Pollanen MT, 2000, EUR J ORAL SCI, V108, P523, DOI 10.1034/j.1600-0722.2000.00881.x; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Rouf SMA, 2013, FEBS OPEN BIO, V3, P177, DOI 10.1016/j.fob.2013.03.004; Rouf SMA, 2013, BIOCHIMIE, V95, P824, DOI 10.1016/j.biochi.2012.11.019; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Shoji M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-152; SUIDO H, 1986, J DENT RES, V65, P1335, DOI 10.1177/00220345860650111101; Takahashi N, 2001, J DENT RES, V80, P1425, DOI 10.1177/00220345010800050801; Takahashi N, 2000, J BACTERIOL, V182, P4704, DOI 10.1128/JB.182.17.4704-4710.2000; Tsuda H, 2010, J PERIODONTAL RES, V45, P626, DOI 10.1111/j.1600-0765.2010.01277.x; Vermout S, 2008, FEMS IMMUNOL MED MIC, V54, P299, DOI 10.1111/j.1574-695X.2008.00479.x; Vukelic B, 2012, BIOL CHEM, V393, P37, DOI 10.1515/BC-2011-193	48	27	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5436	5448		10.1074/jbc.M113.527333	http://dx.doi.org/10.1074/jbc.M113.527333			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398682	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000332015500008
J	Toko, H; Hariharan, N; Konstandin, MH; Ormachea, L; McGregor, M; Gude, NA; Sundararaman, B; Joyo, E; Joyo, AY; Collins, B; Din, S; Mohsin, S; Uchida, T; Sussman, MA				Toko, Haruhiro; Hariharan, Nirmala; Konstandin, Mathias H.; Ormachea, Lucia; McGregor, Michael; Gude, Natalie A.; Sundararaman, Balaji; Joyo, Eri; Joyo, Anya Y.; Collins, Brett; Din, Shabana; Mohsin, Sadia; Uchida, Takafumi; Sussman, Mark A.			Differential Regulation of Cellular Senescence and Differentiation by Prolyl Isomerase Pin1 in Cardiac Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiovascular; Cellular Senescence; Differentiation; Molecular Cell Biology; Stem Cells; Pin1	STEM-CELLS; STABILITY; PROTEIN; P53; PHOSPHORYLATION; ACTIVATION; CHECKPOINTS; EXPRESSION; SUBSTRATE; DYNAMICS	Background: Pin1 is a prolyl isomerase that modulates the structure of phosphoproteins. Results: Loss of Pin1 causes cell cycle arrest and senescence, whereas Pin1 overexpression increases differentiation and inhibits senescence of cardiac progenitor cells (CPCs). Conclusion: Pin1 has pleiotropic roles in CPCs. Significance: Pin1 may be a molecular target to enhance repair, survival, and differentiation and antagonize senescence of CPCs. Autologous c-kit(+) cardiac progenitor cells (CPCs) are currently used in the clinic to treat heart disease. CPC-based regeneration may be further augmented by better understanding molecular mechanisms of endogenous cardiac repair and enhancement of pro-survival signaling pathways that antagonize senescence while also increasing differentiation. The prolyl isomerase Pin1 regulates multiple signaling cascades by modulating protein folding and thereby activity and stability of phosphoproteins. In this study, we examine the heretofore unexplored role of Pin1 in CPCs. Pin1 is expressed in CPCs in vitro and in vivo and is associated with increased proliferation. Pin1 is required for cell cycle progression and loss of Pin1 causes cell cycle arrest in the G(1) phase in CPCs, concomitantly associated with decreased expression of Cyclins D and B and increased expression of cell cycle inhibitors p53 and retinoblastoma (Rb). Pin1 deletion increases cellular senescence but not differentiation or cell death of CPCs. Pin1 is required for endogenous CPC response as Pin1 knock-out mice have a reduced number of proliferating CPCs after ischemic challenge. Pin1 overexpression also impairs proliferation and causes G(2)/M phase cell cycle arrest with concurrent down-regulation of Cyclin B, p53, and Rb. Additionally, Pin1 overexpression inhibits replicative senescence, increases differentiation, and inhibits cell death of CPCs, indicating that cell cycle arrest caused by Pin1 overexpression is a consequence of differentiation and not senescence or cell death. In conclusion, Pin1 has pleiotropic roles in CPCs and may be a molecular target to promote survival, enhance repair, improve differentiation, and antagonize senescence.	[Toko, Haruhiro; Hariharan, Nirmala; Konstandin, Mathias H.; Ormachea, Lucia; McGregor, Michael; Gude, Natalie A.; Sundararaman, Balaji; Joyo, Eri; Joyo, Anya Y.; Collins, Brett; Din, Shabana; Mohsin, Sadia; Sussman, Mark A.] San Diego State Univ, Inst Heart, San Diego, CA 92182 USA; [Toko, Haruhiro; Hariharan, Nirmala; Konstandin, Mathias H.; Ormachea, Lucia; McGregor, Michael; Gude, Natalie A.; Sundararaman, Balaji; Joyo, Eri; Joyo, Anya Y.; Collins, Brett; Din, Shabana; Mohsin, Sadia; Sussman, Mark A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Sci, Sendai, Miyagi 9818555, Japan	California State University System; San Diego State University; California State University System; San Diego State University; Tohoku University	Sussman, MA (corresponding author), San Diego State Univ, Dept Biol, North Life Sci Rm 426,5500 Campanile Dr, San Diego, CA 92182 USA.	heartman4ever@icloud.com	Sundararaman, Balaji/GWQ-5695-2022; Sussman, Mark/H-2284-2014	Sundararaman, Balaji/0000-0001-8559-1660; Sussman, Mark/0000-0002-0104-4799; Uchida, Takafumi/0000-0003-3665-4906	National Institutes of Health [1R37HL091102, 1R01HL105759, 5R01HL067245, 1R01HL113656, 1R01HL117163, 1R01HL113647]; American Heart Association [11POST7610164, 12POST12060191, 12PRE12060248]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation; Deutsche Forschungsgemeinschaft [DFG 3900/1-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL091102, P01HL085577, R01HL067245, R01HL105759, R01HL122525, R01HL113656, R01HL117163, R01HL113647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation(Uehara Memorial Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R37HL091102, 1R01HL105759, 5R01HL067245, 1R01HL113656, 1R01HL117163, and 1R01HL113647 (to M. A. S.), American Heart Association Grants 11POST7610164 (to H. T.), 12POST12060191 (to N. H.), and 12PRE12060248 (to S. D.), grants from the Mochida Memorial Foundation for Medical and Pharmaceutical Research and The Uehara Memorial Foundation (to H. T.), and Deutsche Forschungsgemeinschaft Grant DFG 3900/1-1 (to M. H. K.).	Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Becker EBE, 2007, CELL CYCLE, V6, P1332, DOI 10.4161/cc.6.11.4316; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bicknell K, 2005, BIOCHEM BIOPH RES CO, V332, P817, DOI 10.1016/j.bbrc.2005.05.022; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chandler H, 2013, CURR OPIN CELL BIOL, V25, P765, DOI 10.1016/j.ceb.2013.07.005; Chu KL, 2013, CELL CYCLE, V12, P944, DOI 10.4161/cc.23916; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; De Nicola F, 2007, J BIOL CHEM, V282, P19685, DOI 10.1074/jbc.M610282200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Driver Jane A, 2010, Curr Aging Sci, V3, P158; Farrell AS, 2013, MOL CELL BIOL, V33, P2930, DOI 10.1128/MCB.01455-12; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Gallo G, 2005, J CELL PHYSIOL, V205, P176, DOI 10.1002/jcp.20451; Gude N, 2006, CIRC RES, V99, P381, DOI 10.1161/01.RES.0000236754.21499.1c; Hutchins JRA, 2004, CELL CYCLE, V3, P41; Jentsch S, 2009, CELL CYCLE, V8, P3800, DOI 10.4161/cc.8.23.9971; Konstandin MH, 2013, CIRC RES, V113, P115, DOI 10.1161/CIRCRESAHA.113.301152; Lee TH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001906; Lee TH, 2009, NAT CELL BIOL, V11, P97, DOI 10.1038/ncb1818; Liao Y, 2009, ONCOGENE, V28, P2436, DOI 10.1038/onc.2009.98; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 1996, NATURE, V380, P544; Lufei CC, 2009, FEBS LETT, V583, P271, DOI 10.1016/j.febslet.2008.12.011; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Mantovani F, 2004, CELL CYCLE, V3, P905; Marques L, 2013, DIFFERENTIATION, V86, P48, DOI 10.1016/j.diff.2013.07.001; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Nakamura K, 2012, MOL CELL BIOL, V32, P2966, DOI 10.1128/MCB.05688-11; Namgoong GM, 2010, J BIOL CHEM, V285, P23829, DOI 10.1074/jbc.M109.092874; Nishi M, 2011, J BIOL CHEM, V286, P11593, DOI 10.1074/jbc.M110.187989; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Rizzolio F, 2012, CELL DEATH DIFFER, V19, P1152, DOI 10.1038/cdd.2011.202; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Siepe D, 2009, NAT CELL BIOL, V11, P967, DOI 10.1038/ncb1908; Sundararaman B, 2012, CIRC RES, V110, P1169, DOI 10.1161/CIRCRESAHA.112.267716; Thomas DM, 2003, CANCER BIOL THER, V2, P124, DOI 10.4161/cbt.2.2.235; Toko H, 2013, CIRC RES, V112, P1244, DOI 10.1161/CIRCRESAHA.113.301084; Uchida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031823; Wheaton K, 2010, AGING CELL, V9, P747, DOI 10.1111/j.1474-9726.2010.00601.x; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	50	26	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5348	5356		10.1074/jbc.M113.526442	http://dx.doi.org/10.1074/jbc.M113.526442			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24375406	hybrid, Green Published			2022-12-28	WOS:000332015500001
J	Ozturk, N; Selby, CP; Zhong, DP; Sancar, A				Ozturk, Nuri; Selby, Christopher P.; Zhong, Dongping; Sancar, Aziz			Mechanism of Photosignaling by Drosophila Cryptochrome ROLE OF THE REDOX STATUS OF THE FLAVIN CHROMOPHORE*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circadian Clock; Drosophila; Flavoproteins; Protein Conformation; Signal Transduction; Circadian Clock Resetting; Cryptochrome; Photoreceptor; Timeless Degradation	BLUE-LIGHT PHOTORECEPTORS; CIRCADIAN CLOCK; DNA PHOTOLYASE; COFACTOR; TIMELESS	Background: It is not known whether the redox status of cryptochrome affects circadian clock resetting. Results: Blocking cryptochrome photoreduction does not impair cryptochrome-mediated Timeless degradation and light can induce a conformational change in cryptochrome with oxidized flavin. Conclusion: Cryptochrome can mediate its function in either oxidized or reduced form. Significance: This study provides novel insight into cryptochrome photosignaling. Cryptochrome (CRY) is the primary circadian photoreceptor in Drosophila. Upon light absorption, dCRY undergoes a conformational change that enables it to bind to Timeless (dTIM), as well as to two different E3 ligases that ubiquitylate dTIM and dCRY, respectively, resulting in their proteolysis and resetting the phase of the circadian rhythm. Purified dCRY contains oxidized flavin (FAD(ox)), which is readily photoreduced to the anionic semiquinone through a set of 3 highly conserved Trp residues (Trp triad). The crystal structure of dCRY has revealed a fourth Trp (Trp-536) as a potential electron donor. Previously, we reported that the Trp triad played no role in photoinduced proteolysis of dCRY in Drosophila cells. Here we investigated the role of the Trp triad and Trp-536, and the redox status of the flavin on light-induced proteolysis of both dCRY and dTIM and resetting of the clock. We found that both oxidized (FAD(ox)) and reduced (FAD(?)) forms of dCRY undergo light-induced conformational change in vitro that enable dCRY to bind JET and that Trp triad and Trp-536 mutations that block known or presumed intraprotein electron transfer reactions do not affect dCRY phototransduction under bright or dim light in vivo as measured by light-induced proteolysis of dCRY and dTIM in Drosophila S2R+ cells. We conclude that both oxidized and reduced forms of dCRY are capable of photosignaling.	[Ozturk, Nuri; Selby, Christopher P.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Zhong, Dongping] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Zhong, Dongping] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Zhong, Dongping] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	Aziz_Sancar@med.unc.edu	Ozturk, Nuri/F-4140-2011	Ozturk, Nuri/0000-0001-5206-4127	National Institutes of Health [GM31082]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031082, R37GM031082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM31082 (to A. S.).	Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Czarna A, 2013, CELL, V153, P1394, DOI 10.1016/j.cell.2013.05.011; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Kao YT, 2008, J AM CHEM SOC, V130, P7695, DOI 10.1021/ja801152h; Kavakli IH, 2004, BIOCHEMISTRY-US, V43, P15103, DOI 10.1021/bi0478796; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Levy C, 2013, NATURE, V495, pE3, DOI 10.1038/nature11995; Li X, 2011, P NATL ACAD SCI USA, V108, P20844, DOI 10.1073/pnas.1114579108; Liu B, 2010, CURR OPIN PLANT BIOL, V13, P578, DOI 10.1016/j.pbi.2010.09.005; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Liu ZY, 2013, P NATL ACAD SCI USA, V110, P12972, DOI 10.1073/pnas.1311077110; Losi A, 2012, ANNU REV PLANT BIOL, V63, P49, DOI 10.1146/annurev-arplant-042811-105538; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Ozturk N, 2008, BIOCHEMISTRY-US, V47, P10255, DOI 10.1021/bi801085a; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Ozturk N, 2013, P NATL ACAD SCI USA, V110, P4980, DOI 10.1073/pnas.1303234110; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Ozturk N, 2009, BIOCHEMISTRY-US, V48, P8585, DOI 10.1021/bi901043s; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Partch CL, 2005, PHOTOCHEM PHOTOBIOL, V81, P1291, DOI 10.1562/2005-07-08-IR-607; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; Sancar A, 2004, J BIOL CHEM, V279, P34079, DOI 10.1074/jbc.R400016200; Song SH, 2007, J BIOL CHEM, V282, P17608, DOI 10.1074/jbc.M702874200; Vaidya AT, 2013, P NATL ACAD SCI USA, V110, P20455, DOI 10.1073/pnas.1313336110; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; Yu Xuhong, 2010, Arabidopsis Book, V8, pe0135, DOI 10.1199/tab.0135; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P4, DOI 10.1021/bi101665s	35	39	40	0	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4634	4642		10.1074/jbc.M113.542498	http://dx.doi.org/10.1074/jbc.M113.542498			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24379403	Green Published, hybrid			2022-12-28	WOS:000331607900011
J	Zanusso, G; Fiorini, M; Ferrari, S; Meade-White, K; Barbieri, I; Brocchi, E; Ghetti, B; Monaco, S				Zanusso, Gianluigi; Fiorini, Michele; Ferrari, Sergio; Meade-White, Kimberly; Barbieri, Ilaria; Brocchi, Emiliana; Ghetti, Bernardino; Monaco, Salvatore			Gerstmann-Str ussler-Scheinker Disease and "Anchorless Prion Protein" Mice Share Prion Conformational Properties Diverging from Sporadic Creutzfeldt-Jakob Disease*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Glycosyl Phosphatidylinositol Anchors; Neurodegenerative Diseases; Prions; Transgenic Mice	TRUNCATED FORMS; IDENTIFICATION; PHENOTYPE; AMYLOIDOSIS; ISOFORMS; VARIANT	Background: Prion strains exhibit distinct physical and biochemical repertoires, aggregation propensity, and biological properties. Results: A biochemical approach is developed for defining the conformational features of prions with or without glycosylphosphatidylinositol (GPI)-anchor. Conclusion: GPI anchorless prions are detected in human genetic prion diseases, but not in sporadic forms. Significance: Unveiling the structure of GPI anchorless prions to predict pathological properties. The role of the GPI-anchor in prion disease pathogenesis is still a challenging issue. In vitro studies have shown that anchorless cellular prion protein (PrPC) undergoes aberrant post-translational processing and metabolism. Moreover, transgenic (Tg) mice overexpressing anchorless PrPC develop a spontaneous neurological disease accompanied with widespread brain PrP amyloid deposition, in the absence of spongiform changes. Generation of PrP forms lacking the GPI and PrP amyloidosis are striking features of human stop codon mutations in the PrP gene (PRNP), associated with PrP cerebral amyloid angiopathy (PrP-CAA) and Gerstmann-Straussler-Scheinker (GSS) syndrome. More recently, the presence of anchorless PrP species has been also claimed in sporadic Creutzfeldt-Jakob disease (sCJD). Using a highly sensitive protein separation technique and taking advantage of reference maps of synthetic PrP peptides, we investigated brain tissues from scrapie-infected anchorless PrP Tg mice and wild type mice to determine the contribution of the GPI-anchor to the molecular mass and isoelectric point of PrP quasispecies under two-dimensional electrophoresis. We also assessed the conformational properties of anchorless and anchored prions under standard and inactivating conditions. These studies were extended to sCJD and GSS. At variance with GSS, characterization of PrP quasispecies in different sCJD subtypes ruled out the presence of anchorless prions. Moreover, under inactivating conditions, mice anchorless prions, but not sCJD prions, generated internal PrP fragments, cleaved at both N and C termini, similar to those found in PrP-CAA and GSS brain tissues. These findings show that anchorless PrPSc generates GSS-like PrP fragments, and suggest a major role for unanchored PrP in amyloidogenesis.	[Zanusso, Gianluigi; Fiorini, Michele; Ferrari, Sergio; Monaco, Salvatore] Univ Verona, Dept Neurol & Movement Sci, I-37134 Verona, Italy; [Meade-White, Kimberly] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, Hamilton, MT 59840 USA; [Barbieri, Ilaria; Brocchi, Emiliana] Ist Zooprofilatt Sperimentale Lombardia & Emilia, I-25124 Brescia, Italy; [Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	University of Verona; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); IZS Lombardia e Emilia; Indiana University System; Indiana University Bloomington	Zanusso, G (corresponding author), Univ Verona, Dept Neurol & Movement Sci, I-37134 Verona, Italy.	gianluigi.zanusso@univr.it; salvatore.monaco@univr.it	Monaco, Salvatore/K-4659-2018; Brocchi, Emiliana/G-1810-2019; Zanusso, Gianluigi/K-2823-2018; Ferrari, Sergio/AAE-5649-2019	Monaco, Salvatore/0000-0003-3191-8597; Brocchi, Emiliana/0000-0003-1864-080X; Zanusso, Gianluigi/0000-0001-5199-6264; ferrari, sergio/0000-0003-3855-5135; Fiorini, Michele/0000-0002-5339-8716	"Disabilita cognitiva e comportamentale nelle demenze e nelle psicosi" from Fondazione Cariverona;  [RF2009-1474758]	"Disabilita cognitiva e comportamentale nelle demenze e nelle psicosi" from Fondazione Cariverona; 	This work was supported in part by RF2009-1474758 (to G. Z.) and by "Disabilita cognitiva e comportamentale nelle demenze e nelle psicosi" from Fondazione Cariverona (to S. M.).	Campana V, 2007, J BIOL CHEM, V282, P22747, DOI 10.1074/jbc.M701468200; Castagna A, 2002, ELECTROPHORESIS, V23, P339, DOI 10.1002/1522-2683(200202)23:2<339::AID-ELPS339>3.0.CO;2-Y; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Dagdanova A, 2010, J BIOL CHEM, V285, P30489, DOI 10.1074/jbc.M110.161794; GHETTI B, 1995, BRAIN PATHOL, V5, P61, DOI 10.1111/j.1750-3639.1995.tb00578.x; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Jansen C, 2010, ACTA NEUROPATHOL, V119, P189, DOI 10.1007/s00401-009-0609-x; Jayadev S, 2011, ANN NEUROL, V69, P712, DOI 10.1002/ana.22264; Johnson RT, 2005, LANCET NEUROL, V4, P635, DOI 10.1016/S1474-4422(05)70192-7; Kim CL, 2004, VIROLOGY, V320, P40, DOI 10.1016/j.virol.2003.10.026; Nishina KA, 2007, ANAL BIOCHEM, V363, P318, DOI 10.1016/j.ab.2007.01.032; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Notari S, 2012, EMERG INFECT DIS, V18, P21, DOI 10.3201/eid1801.110589; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; STAHL N, 1990, BIOCHEMISTRY-US, V29, P8879, DOI 10.1021/bi00490a001; Stohr J, 2011, P NATL ACAD SCI USA, V108, P21223, DOI 10.1073/pnas.1117827108; Vazquez-Fernandez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050111; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Zanusso G, 2004, J BIOL CHEM, V279, P38936, DOI 10.1074/jbc.M405468200; Zanusso G, 2002, ELECTROPHORESIS, V23, P347, DOI 10.1002/1522-2683(200202)23:2<347::AID-ELPS347>3.0.CO;2-1; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	30	13	13	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4870	4881		10.1074/jbc.M113.531335	http://dx.doi.org/10.1074/jbc.M113.531335			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398683	Green Published, hybrid			2022-12-28	WOS:000331607900034
J	Byerly, MS; Petersen, PS; Ramamurthy, S; Seldin, MM; Lei, X; Provost, E; Wei, ZK; Ronnett, GV; Wong, GW				Byerly, Mardi S.; Petersen, Pia S.; Ramamurthy, Santosh; Seldin, Marcus M.; Lei, Xia; Provost, Elayne; Wei, Zhikui; Ronnett, Gabriele V.; Wong, G. William			C1q/TNF-related Protein 4 (CTRP4) Is a Unique Secreted Protein with Two Tandem C1q Domains That Functions in the Hypothalamus to Modulate Food Intake and Body Weight	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Energy Metabolism; Hormones; Hypothalamus; Metabolism; Neuropeptide; Obesity	SHORT-CHAIN COLLAGEN; NEUROTROPHIC FACTOR; CRYSTAL-STRUCTURE; NEUROPEPTIDE-Y; ENERGY-BALANCE; REGIONAL-DISTRIBUTION; SKELETAL-MUSCLE; ADIPOSE-TISSUE; FAMILY; BRAIN	CTRP4 is a unique member of the C1q family, possessing two tandem globular C1q domains. Its physiological function is poorly defined. Here, we show that CTRP4 is an evolutionarily conserved, approximate to 34-kDa secretory protein expressed in the brain. In human, mouse, and zebrafish brain, CTRP4 expression begins early in development and is widespread in the central nervous system. Neurons, but not astrocytes, express and secrete CTRP4, and secreted proteins form higher-order oligomeric complexes. CTRP4 is also produced by peripheral tissues and circulates in blood. Its serum levels are increased in leptin-deficient obese (ob/ob) mice. Functional studies suggest that CTRP4 acts centrally to modulate energy metabolism. Refeeding following an overnight fast induced the expression of CTRP4 in the hypothalamus. Central administration of recombinant protein suppressed food intake and altered the whole-body energy balance in both chow-fed and high-fat diet-fed mice. Suppression of food intake by CTRP4 is correlated with a decreased expression of orexigenic neuropeptide (Npy and Agrp) genes in the hypothalamus. These results establish CTRP4 as a novel nutrient-responsive central regulator of food intake and energy balance.	[Byerly, Mardi S.; Petersen, Pia S.; Seldin, Marcus M.; Lei, Xia; Wei, Zhikui; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Ramamurthy, Santosh; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Provost, Elayne] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Byerly, Mardi S.; Petersen, Pia S.; Ramamurthy, Santosh; Seldin, Marcus M.; Lei, Xia; Wei, Zhikui; Ronnett, Gabriele V.; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	gwwong@jhmi.edu		Wong, G. William/0000-0002-5286-6506; Wei, Zhikui/0000-0002-2311-9800	National Institutes of Health [DK084171]; American Heart Association [SDG2260721]; NIDDK/National Institutes of Health [T32DK007751]; Carlsberg Foundation of Denmark; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171, T32DK007751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIDDK/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Carlsberg Foundation of Denmark; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G. W. W.). This work was also supported by American Heart Association Grant SDG2260721 (to G. W. W.).; Supported by NIDDK/National Institutes of Health Training Grant T32DK007751 in cellular and molecular endocrinology.; Supported by a fellowship from the Carlsberg Foundation of Denmark.	Aerbajinai W, 2004, J BIOL CHEM, V279, P1916, DOI 10.1074/jbc.M305634200; Bariohay B, 2005, ENDOCRINOLOGY, V146, P5612, DOI 10.1210/en.2005-0419; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4; Byerly M. S., 2013, PLOS ONE, V8; Byerly MS, 2013, AM J PHYSIOL-REG I, V304, pR1085, DOI 10.1152/ajpregu.00368.2012; Byerly MS, 2013, EUR J NEUROSCI, V37, P1033, DOI 10.1111/ejn.12122; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Colombatti A, 2000, MATRIX BIOL, V19, P289, DOI 10.1016/S0945-053X(00)00074-3; Colombatti A, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00093; de Jonghe BC, 2009, PHYSIOL BEHAV, V97, P87, DOI 10.1016/j.physbeh.2009.02.009; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; Decressac M, 2012, EXP NEUROL, V238, P265, DOI 10.1016/j.expneurol.2012.09.004; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Grill HJ, 2009, INT J OBESITY, V33, pS11, DOI 10.1038/ijo.2009.10; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Hayes MR, 2011, CELL METAB, V13, P320, DOI 10.1016/j.cmet.2011.02.001; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ip NY, 1996, ANNU REV NEUROSCI, V19, P491; Ito-Ishida A, 2008, J NEUROSCI, V28, P5920, DOI 10.1523/JNEUROSCI.1030-08.2008; Jeimy SB, 2008, PLATELETS, V19, P83, DOI 10.1080/09537100701832157; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Kvansakul M, 2003, MATRIX BIOL, V22, P145, DOI 10.1016/S0945-053X(02)00119-1; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li Q, 2011, CANCER LETT, V308, P203, DOI 10.1016/j.canlet.2011.05.005; Lin JW, 2004, DEV BIOL, V274, P490, DOI 10.1016/j.ydbio.2004.07.002; Liu J, 2012, P NATL ACAD SCI USA, V109, P12248, DOI 10.1073/pnas.1202835109; Liu Li, 2008, J Vis Exp, DOI 10.3791/960; Lusk G, 1928, ELEMENTS SCI NUTR; MURAGAKI Y, 1991, J BIOL CHEM, V266, P7721; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Passini MA, 2001, J VIROL, V75, P12382, DOI 10.1128/JVI.75.24.12382-12392.2001; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Scott MM, 2011, J CLIN INVEST, V121, P2413, DOI 10.1172/JCI43703; Seldin MM, 2013, J BIOL CHEM, V288, P36073, DOI 10.1074/jbc.M113.500736; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; Tang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001; THOMAS JT, 1991, BIOCHEM J, V280, P617, DOI 10.1042/bj2800617; Tu XY, 2012, J STRUCT BIOL, V180, P439, DOI 10.1016/j.jsb.2012.07.011; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Wei ZK, 2012, J BIOL CHEM, V287, P35804, DOI 10.1074/jbc.M112.365965; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; YAMAGUCHI N, 1989, J BIOL CHEM, V264, P16022; Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3; Zhu J, 2012, J NEUROSCI RES, V90, P422, DOI 10.1002/jnr.22765	73	41	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4055	4069		10.1074/jbc.M113.506956	http://dx.doi.org/10.1074/jbc.M113.506956			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366864	hybrid, Green Published			2022-12-28	WOS:000331403800020
J	Jean-Alphonse, F; Bowersox, S; Chen, S; Beard, G; Puthenveedu, MA; Hanyaloglu, AC				Jean-Alphonse, Frederic; Bowersox, Shanna; Chen, Stanford; Beard, Gemma; Puthenveedu, Manojkumar A.; Hanyaloglu, Aylin C.			Spatially Restricted G Protein-coupled Receptor Activity via Divergent Endocytic Compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Endosomes; G Protein-coupled Receptor (GPCR); Receptor Recycling; Signaling; Sorting; GAIP-interacting Protein C Terminus (GIPC)	HUMAN LUTROPIN RECEPTOR; C-TERMINAL TAIL; HORMONE-RECEPTOR; EARLY ENDOSOME; PDZ-DOMAIN; BETA-2-ADRENERGIC RECEPTORS; BETA(1)-ADRENERGIC RECEPTOR; BINDING MOTIF; LH RECEPTOR; TRAFFICKING	Postendocytic sorting of G protein-coupled receptors (GPCRs) is driven by their interactions between highly diverse receptor sequence motifs with their interacting proteins, such as postsynaptic density protein (PSD95), Drosophila disc large tumor suppressor (Dlg1), zonula occludens-1 protein (zo-1) (PDZ) domain proteins. However, whether these diverse interactions provide an underlying functional specificity, in addition to driving sorting, is unknown. Here we identify GPCRs that recycle via distinct PDZ ligand/PDZ protein pairs that exploit their recycling machinery primarily for targeted endosomal localization and signaling specificity. The luteinizing hormone receptor (LHR) and 2-adrenergic receptor (B2AR), two GPCRs sorted to the regulated recycling pathway, underwent divergent trafficking to distinct endosomal compartments. Unlike B2AR, which traffics to early endosomes (EE), LHR internalizes to distinct pre-early endosomes (pre-EEs) for its recycling. Pre-EE localization required interactions of the LHR C-terminal tail with the PDZ protein GAIP-interacting protein C terminus, inhibiting its traffic to EEs. Rerouting the LHR to EEs, or EE-localized GPCRs to pre-EEs, spatially reprograms MAPK signaling. Furthermore, LHR-mediated activation of MAPK signaling requires internalization and is maintained upon loss of the EE compartment. We propose that combinatorial specificity between GPCR sorting sequences and interacting proteins dictates an unprecedented spatiotemporal control in GPCR signal activity.	[Jean-Alphonse, Frederic; Chen, Stanford; Beard, Gemma; Hanyaloglu, Aylin C.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Inst Reprod & Dev Biol, London W12 0NN, England; [Bowersox, Shanna; Puthenveedu, Manojkumar A.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Imperial College London; Carnegie Mellon University	Hanyaloglu, AC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Inst Reprod & Dev Biol, London W12 0NN, England.	a.hanyaloglu@imperial.ac.uk	; Puthenveedu, Manojkumar/A-3795-2016	JEAN-ALPHONSE, Frederic/0000-0002-7380-5825; /0000-0003-4206-737X; Puthenveedu, Manojkumar/0000-0002-3177-4231	Wellcome Trust Grant [WT085099MA]; Genesis Research Trust Grant; National Institutes of Health [R00 DA024698]; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA024698, R21DA036086] Funding Source: NIH RePORTER	Wellcome Trust Grant(Wellcome Trust); Genesis Research Trust Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by Wellcome Trust Grant WT085099MA and a Genesis Research Trust Grant (to A. C. H.). This work was also supported in part by National Institutes of Health Grant R00 DA024698 (to M. A. P.).	Alvarez CA, 1999, ENDOCRINOLOGY, V140, P1775, DOI 10.1210/en.140.4.1775; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; BOUVIER M, 1987, J BIOL CHEM, V262, P3106; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Cullen Peter J, 2012, Subcell Biochem, V59, P65, DOI 10.1007/978-94-007-3015-1_3; Danson C, 2013, J CELL SCI, V126, P4885, DOI 10.1242/jcs.125732; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Galet C, 2004, MOL ENDOCRINOL, V18, P434, DOI 10.1210/me.2003-0293; Galet C, 2003, MOL ENDOCRINOL, V17, P411, DOI 10.1210/me.2002-0161; Gan Z, 2009, TRAFFIC, V10, P600, DOI 10.1111/j.1600-0854.2009.00887.x; GHINEA N, 1992, J CELL BIOL, V118, P1347, DOI 10.1083/jcb.118.6.1347; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GUDERMANN T, 1992, J BIOL CHEM, V267, P4479; Gulappa T, 2011, CELL MOL LIFE SCI, V68, P2785, DOI 10.1007/s00018-010-0594-1; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Hirakawa T, 2003, J BIOL CHEM, V278, P49348, DOI 10.1074/jbc.M306557200; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Hunzicker-Dunn M, 2002, FEBS LETT, V521, P3, DOI 10.1016/S0014-5793(02)02822-3; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Innamorati G, 2001, J BIOL CHEM, V276, P13096, DOI 10.1074/jbc.M009780200; Innamorati G, 1998, P NATL ACAD SCI USA, V95, P2222, DOI 10.1073/pnas.95.5.2222; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jeanneteau F, 2004, MOL BIOL CELL, V15, P4926, DOI 10.1091/mbc.E04-04-0285; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Kishi M, 2001, MOL ENDOCRINOL, V15, P1624, DOI 10.1210/me.15.9.1624; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; MOORE RH, 1995, J CELL SCI, V108, P2983; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Odorizzi G, 1996, J CELL BIOL, V135, P139, DOI 10.1083/jcb.135.1.139; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Sandri C, 2012, CELL RES, V22, P1479, DOI 10.1038/cr.2012.110; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stallaert W, 2011, EXPERT OPIN DRUG DIS, V6, P811, DOI 10.1517/17460441.2011.586691; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Varsano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049227; Vistein R, 2013, P NATL ACAD SCI USA, V110, P15289, DOI 10.1073/pnas.1306340110; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Xiang Y, 2003, P NATL ACAD SCI USA, V100, P10776, DOI 10.1073/pnas.1831718100; Yi ZH, 2007, J NEUROSCI, V27, P11663, DOI 10.1523/JNEUROSCI.3252-07.2007; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	68	67	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3960	3977		10.1074/jbc.M113.526350	http://dx.doi.org/10.1074/jbc.M113.526350			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24375413	Green Published, hybrid			2022-12-28	WOS:000331403800012
J	Liu, Z; Gunasekaran, K; Wang, W; Razinkov, V; Sekirov, L; Leng, E; Sweet, H; Foltz, I; Howard, M; Rousseau, AM; Kozlosky, C; Fanslow, W; Yan, W				Liu, Zhi; Gunasekaran, Kannan; Wang, Wei; Razinkov, Vladimir; Sekirov, Laura; Leng, Esther; Sweet, Heather; Foltz, Ian; Howard, Monique; Rousseau, Anne-Marie; Kozlosky, Carl; Fanslow, William; Yan, Wei			Asymmetrical Fc Engineering Greatly Enhances Antibody-dependent Cellular Cytotoxicity (ADCC) Effector Function and Stability of the Modified Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; Cancer Therapy; Cell Death; FC Receptors; NK Cells	GAMMA RECEPTOR ENGAGEMENT; NATURAL-KILLER-CELLS; BISPECIFIC ANTIBODIES; HUMAN IGG1; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; BINDING-AFFINITY; IN-VIVO; CANCER; COMPLEX	Background: Co-crystal structure of Fc-FcRIII complex revealed that Fc binds to FcRIII asymmetrically. Results: We identified a panel of novel Fc heterodimers with enhanced ADCC activity. Conclusion: Asymmetrical Fc engineering is an efficient approach for enhancing ADCC activity and stability of engineered antibodies. Significance: The discovery could be applied in therapeutic antibodies for the treatment of cancers and infectious diseases. Antibody-dependent cellular cytotoxicity (ADCC) is mediated through the engagement of the Fc segment of antibodies with Fc receptors (FcRs) on immune cells upon binding of tumor or viral antigen. The co-crystal structure of FcRIII in complex with Fc revealed that Fc binds to FcRIII asymmetrically with two Fc chains contacting separate regions of the FcRIII by utilizing different residues. To fully explore this asymmetrical nature of the Fc-FcR interaction, we screened more than 9,000 individual clones in Fc heterodimer format in which different mutations were introduced at the same position of two Fc chains using a high throughput competition AlphaLISA (R) assay. To this end, we have identified a panel of novel Fc variants with significant binding improvement to FcRIIIA (both Phe-158 and Val-158 allotypes), increased ADCC activity in vitro, and strong tumor growth inhibition in mice xenograft human tumor models. Compared with previously identified Fc variants in conventional IgG format, Fc heterodimers with asymmetrical mutations can achieve similar or superior potency in ADCC-mediated tumor cell killing and demonstrate improved stability in the C(H)2 domain. Fc heterodimers also allow more selectivity toward activating FcRIIA than inhibitory FcRIIB. Afucosylation of Fc variants further increases the affinity of Fc to FcRIIIA, leading to much higher ADCC activity. The discovery of these Fc variants will potentially open up new opportunities of building the next generation of therapeutic antibodies with enhanced ADCC effector function for the treatment of cancers and infectious diseases.	[Liu, Zhi; Gunasekaran, Kannan; Wang, Wei; Sekirov, Laura; Leng, Esther; Sweet, Heather; Foltz, Ian; Howard, Monique; Yan, Wei] Amgen Inc, Dept Therapeut Discovery, Seattle, WA 98119 USA; [Razinkov, Vladimir] Amgen Inc, Dept Proc & Prod Dev, Seattle, WA 98119 USA; [Rousseau, Anne-Marie; Kozlosky, Carl; Fanslow, William] Amgen Inc, Therapeut Innovat Unit, Seattle, WA 98119 USA; [Liu, Zhi; Razinkov, Vladimir; Howard, Monique; Rousseau, Anne-Marie; Kozlosky, Carl; Fanslow, William; Yan, Wei] Amgen Inc, Seattle, WA 98119 USA; [Gunasekaran, Kannan; Wang, Wei] Amgen Inc, Thousand Oaks, CA 91320 USA; [Sekirov, Laura; Leng, Esther; Sweet, Heather; Foltz, Ian] Amgen Inc, Burnaby, BC V5A 1V7, Canada	Amgen; Amgen; Amgen; Amgen; Amgen	Liu, Z (corresponding author), Amgen Inc, Dept Therapeut Discovery, 1201 Amgen Court West, Seattle, WA 98119 USA.	liuz@amgen.com; ywei@amgen.com		Sweet, Heather/0000-0001-7478-0474				Albertsson PA, 2003, TRENDS IMMUNOL, V24, P603, DOI 10.1016/j.it.2003.09.007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Chames P, 2009, MABS-AUSTIN, V1, P539, DOI 10.4161/mabs.1.6.10015; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Esendagli G, 2008, LUNG CANCER, V59, P32, DOI 10.1016/j.lungcan.2007.07.022; Ferrara C, 2006, BIOTECHNOL BIOENG, V93, P851, DOI 10.1002/bit.20777; Gennari R, 2004, CLIN CANCER RES, V10, P5650, DOI 10.1158/1078-0432.CCR-04-0225; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Green SK, 2002, CANCER RES, V62, P6891; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Klein C, 2012, MABS-AUSTIN, V4, P653, DOI 10.4161/mabs.21379; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Li FB, 2012, P NATL ACAD SCI USA, V109, P10966, DOI 10.1073/pnas.1208698109; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Masuda K, 2007, MOL IMMUNOL, V44, P3122, DOI 10.1016/j.molimm.2007.02.005; Mimoto F, 2013, MABS-AUSTIN, V5, P229, DOI 10.4161/mabs.23452; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Pahl JHW, 2012, CLIN CANCER RES, V18, P432, DOI 10.1158/1078-0432.CCR-11-2277; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Repp R, 2011, J IMMUNOL METHODS, V373, P67, DOI 10.1016/j.jim.2011.08.003; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-5472.CAN-07-0696; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Zhang JB, 2009, PROTEIN EXPRES PURIF, V65, P77, DOI 10.1016/j.pep.2008.10.011	36	49	80	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3571	3590		10.1074/jbc.M113.513366	http://dx.doi.org/10.1074/jbc.M113.513366			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24311787	Green Published, hybrid			2022-12-28	WOS:000331368700041
J	Thomer, L; Becker, S; Emolo, C; Quach, A; Kim, HK; Rauch, S; Anderson, M; LeBlanc, JF; Schneewind, O; Faull, KF; Missiakas, D				Thomer, Lena; Becker, Samuel; Emolo, Carla; Quach, Austin; Kim, Hwan Keun; Rauch, Sabine; Anderson, Mark; LeBlanc, James F.; Schneewind, Olaf; Faull, Kym F.; Missiakas, Dominique			N-Acetylglucosaminylation of Serine-Aspartate Repeat Proteins Promotes Staphylococcus aureus Bloodstream Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Coagulation Factors; Fibrin; Glycosyltransferases; Infectious Diseases; Staphylococcus aureus; ClfA; Agglutination; Serine-Aspartate Repeat	FACTOR-BINDING-PROTEIN; CLUMPING FACTOR; MOLECULAR CHARACTERIZATION; FIBRINOGEN RECEPTOR; SURFACE-PROTEINS; FACTOR CLFA; FAMILY; GLYCOSYLATION; COAGULASE; NEWMAN	Background:Staphylococcus aureus agglutinates in plasma in a manner that requires host fibrinogen and clumping factor A, a bacterial surface protein with serine-aspartate (SD) repeats. Results: SdgB modifies serine residues in SD repeats with GlcNAc, and this glycosylation contributes to the pathogenesis of sepsis. Conclusion: Glycosylation of SD repeats aids bacterial escape from host defenses. Significance: Interference with glycosylation may alter staphylococcal infections. Staphylococcus aureus secretes products that convert host fibrinogen to fibrin and promote its agglutination with fibrin fibrils, thereby shielding bacteria from immune defenses. The agglutination reaction involves ClfA (clumping factor A), a surface protein with serine-aspartate (SD) repeats that captures fibrin fibrils and fibrinogen. Pathogenic staphylococci express several different SD proteins that are modified by two glycosyltransferases, SdgA and SdgB. Here, we characterized three genes of S. aureus, aggA, aggB (sdgA), and aggC (sdgB), and show that aggA and aggC contribute to staphylococcal agglutination with fibrin fibrils in human plasma. We demonstrate that aggB (sdgA) and aggC (sdgB) are involved in GlcNAc modification of the ClfA SD repeats. However, only sdgB is essential for GlcNAc modification, and an sdgB mutant is defective in the pathogenesis of sepsis in mice. Thus, GlcNAc modification of proteins promotes S. aureus replication in the bloodstream of mammalian hosts.	[Thomer, Lena; Becker, Samuel; Emolo, Carla; Kim, Hwan Keun; Rauch, Sabine; Anderson, Mark; Schneewind, Olaf; Missiakas, Dominique] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Quach, Austin; Faull, Kym F.] UCLA, David Geffen Sch Med, Pasarow Mass Spectrometry Lab, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Quach, Austin; Faull, Kym F.] UCLA, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [LeBlanc, James F.] UCLA, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA	University of Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Missiakas, D (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	dmissiak@bsd.uchicago.edu		Kim, Hwan Keun/0000-0003-2095-9705	National Institutes of Health from NIAID, Infectious Diseases Branch [AI38897, AI52474]; Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (National Institutes of Health) [1-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038897, R01AI052474] Funding Source: NIH RePORTER	National Institutes of Health from NIAID, Infectious Diseases Branch; Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI38897 and AI52474 from NIAID, Infectious Diseases Branch (to O. S.).; Members of and supported by the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (National Institutes of Health Award 1-U54-AI-057153).	Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Bensing BA, 2010, J BACTERIOL, V192, P4223, DOI 10.1128/JB.00373-10; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Drickamer K, 1998, TRENDS BIOCHEM SCI, V23, P321, DOI 10.1016/S0968-0004(98)01246-8; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Flick MJ, 2013, BLOOD, V121, P1783, DOI 10.1182/blood-2012-09-453894; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Ganesh VK, 2011, J BIOL CHEM, V286, P25963, DOI 10.1074/jbc.M110.217414; Geoghegan JA, 2010, J BIOL CHEM, V285, P6208, DOI 10.1074/jbc.M109.062208; Hazenbos WLW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003653; Iwashkiw JA, 2013, MOL MICROBIOL, V89, P14, DOI 10.1111/mmi.12265; Josefsson E, 1998, J BIOL CHEM, V273, P31145, DOI 10.1074/jbc.273.47.31145; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kroh HK, 2009, P NATL ACAD SCI USA, V106, P7786, DOI 10.1073/pnas.0811750106; Lessa FC, 2010, CLIN INFECT DIS, V51, P925, DOI 10.1086/656414; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McAdow M, 2012, J INNATE IMMUN, V4, P141, DOI 10.1159/000333447; McAdow M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002307; McCrea KW, 2000, MICROBIOL-SGM, V146, P1535, DOI 10.1099/00221287-146-7-1535; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; Palmqvist N, 2004, MICROBES INFECT, V6, P188, DOI 10.1016/j.micinf.2003.11.005; Panizzi P, 2011, NAT MED, V17, P1142, DOI 10.1038/nm.2423; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Sakinc T, 2006, INFECT IMMUN, V74, P4615, DOI 10.1128/IAI.01885-05; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Schwefel D, 2010, J AM CHEM SOC, V132, P8704, DOI 10.1021/ja101646k; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	42	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3478	3486		10.1074/jbc.M113.532655	http://dx.doi.org/10.1074/jbc.M113.532655			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24344128	Green Published, hybrid			2022-12-28	WOS:000331368700032
J	Liu, J; Ryabichko, S; Bogdanov, M; Fackelmayer, OJ; Dowhan, W; Krulwich, TA				Liu, Jun; Ryabichko, Sergey; Bogdanov, Mikhail; Fackelmayer, Oliver J.; Dowhan, William; Krulwich, Terry A.			Cardiolipin Is Dispensable for Oxidative Phosphorylation and Non-fermentative Growth of Alkaliphilic Bacillus pseudofirmus OF4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; Bacteria; Cardiolipin; Membrane; Phospholipid; Oxidative Phosphorylation	CYTOCHROME BC(1) COMPLEX; RESPIRATORY-CHAIN SUPERCOMPLEXES; ESCHERICHIA-COLI; ATP SYNTHASE; FIRMUS OF4; C-OXIDASE; STAPHYLOCOCCUS-AUREUS; GENE-EXPRESSION; MEMBRANE; MITOCHONDRIAL	Background: Fast cardiolipin-mediated proton translocation from pumps to ATP synthase has been hypothesized. Results: Mutational loss of membrane cardiolipin did not significantly affect alkaliphile ATP synthesis but other cardiolipin roles were observed. Conclusion: Cardiolipin contributes to respiratory complex stability, thus indirectly to oxidative phosphorylation, and to stationary phase survival. Significance: Clarification of cardiolipin roles in bacterial physiology can have pharmacological impact. Cardiolipin (CL), a membrane phospholipid in bacteria and mitochondria, has been hypothesized to facilitate movement of protons on the outer surface of membranes in support of respiration-dependent ATP synthesis, oxidative phosphorylation (OXPHOS). If so, the high levels of membrane CL found in alkaliphilic bacteria, such as Bacillus pseudofirmus OF4, might facilitate its robust OXPHOS at pH 10.5, where the bulk protonmotive (PMF) force is low. To address the role of CL in Bacillus pseudofirmus OF4, we studied strains in which genes (cls) potentially encoding a CL synthase (CLs) were deleted: three single (clsA, clsB, and clsC), one double (clsA/B), and one triple (clsA/B/C) mutant. Two-dimensional thin layer chromatography analyses of lipid extracts from P-32-labeled strains showed that the wild-type CL content was 15% of total phospholipids at pH 10.5 versus 3% at pH 7.5 during log phase. The % CL was higher (28-33%) at both pH values during stationary phase. The clsA gene plays a major role in CL biosynthesis as no detectable CL was found in clsA-containing mutants, whereas the CL precursor phosphatidylglycerol was elevated. The clsB mutant exhibited no significant reduction in CL, but clsB expression was up-regulated and appeared to support growth at pH 7.5. In the absence of detectable CL, the alkaliphile showed no significant deficits in non-fermentative growth, respiration-dependent ATP synthesis, or salt tolerance. Minor deficits in respiration and ATP synthase assembly were noted in individual mutants. In long term survival experiments, significant growth defects were found in clsA strains and the clsC strain at pH 10.5.	[Liu, Jun; Fackelmayer, Oliver J.; Krulwich, Terry A.] Mt Sinai, Icahn Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Bogdanov, Mikhail; Dowhan, William] Univ Texas Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ryabichko, Sergey] Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Dept Biochem, Kazan 420008, Russia	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Health Science Center Houston; Kazan Federal University	Krulwich, TA (corresponding author), Box 1603,1 Gustave Levy Pl, New York, NY 10029 USA.	terry.krulwich@mssm.edu	Bogdanov, Mikhail/J-3695-2017; Ryabichko, Sergey/N-7011-2013; Fackelmayer, Oliver/AAD-7638-2021	Ryabichko, Sergey/0000-0003-1309-9436; 	National Institutes of Health [R01 GM28454, R37 GM20478]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478, R01GM028454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM28454 (to T. A. K.) and R37 GM20478 (to W. D.).	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Bazan S, 2013, J BIOL CHEM, V288, P401, DOI 10.1074/jbc.M112.425876; Bogdanov Mikhail, 2008, V49, P197, DOI 10.1007/978-1-4020-8831-5_8; Branden M, 2006, P NATL ACAD SCI USA, V103, P19766, DOI 10.1073/pnas.0605909103; Chini V, 2007, LETT APPL MICROBIOL, V45, P479, DOI 10.1111/j.1472-765X.2007.02208.x; CLEJAN S, 1986, J BACTERIOL, V168, P334, DOI 10.1128/jb.168.1.334-340.1986; CLEJAN S, 1989, J BACTERIOL, V171, P1744, DOI 10.1128/jb.171.3.1744-1746.1989; FINE JB, 1982, J LIPID RES, V23, P660; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; GUIKEMA JA, 1981, BIOCHIM BIOPHYS ACTA, V637, P189, DOI 10.1016/0005-2728(81)90157-2; Guo DG, 1998, BBA-LIPID LIPID MET, V1389, P34, DOI 10.1016/S0005-2760(97)00086-6; Guo DG, 2000, BBA-MOL CELL BIOL L, V1483, P263, DOI 10.1016/S1388-1981(99)00193-6; Haiens TH, 2002, FEBS LETT, V528, P35, DOI 10.1016/S0014-5793(02)03292-1; HAINES TH, 1983, P NATL ACAD SCI-BIOL, V80, P160, DOI 10.1073/pnas.80.1.160; Haines TH, 2009, BBA-BIOMEMBRANES, V1788, P1997, DOI 10.1016/j.bbamem.2009.09.008; Hatefi Y, 1978, Methods Enzymol, V53, P27; Hicks DB, 2010, BBA-BIOENERGETICS, V1797, P1362, DOI 10.1016/j.bbabio.2010.02.028; HICKS DB, 1995, BBA-BIOENERGETICS, V1229, P303, DOI 10.1016/0005-2728(95)00024-D; HIRAOKA S, 1993, FEBS LETT, V336, P221, DOI 10.1016/0014-5793(93)80807-7; Hunte C, 2003, FEBS LETT, V545, P39, DOI 10.1016/S0014-5793(03)00391-0; Janto B, 2011, ENVIRON MICROBIOL, V13, P3289, DOI 10.1111/j.1462-2920.2011.02591.x; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Kikuchi S, 2000, J BACTERIOL, V182, P371, DOI 10.1128/JB.182.2.371-376.2000; Krulwich T.A., 2013, PROKARYOTES, P441, DOI DOI 10.1007/978-3-642-30123-0_58; Krulwich T.A., 2011, EXTREMOPHILES HDB, P120, DOI DOI 10.1007/978-4-431-53898-1_2.6; KRULWICH TA, 1995, MOL MICROBIOL, V15, P403, DOI 10.1111/j.1365-2958.1995.tb02253.x; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Liu J, 2008, BBA-BIOENERGETICS, V1777, P453, DOI 10.1016/j.bbabio.2008.02.004; Liu J, 2013, J BACTERIOL, V195, P220, DOI 10.1128/JB.01493-12; Liu J, 2009, J BIOL CHEM, V284, P8714, DOI 10.1074/jbc.M808738200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez CS, 2006, MICROBIOL-SGM, V152, P605, DOI 10.1099/mic.0.28345-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920; Mulkidjanian AY, 2006, BBA-BIOENERGETICS, V1757, P913, DOI 10.1016/j.bbabio.2006.02.015; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Preiss L, 2013, P NATL ACAD SCI USA, V110, P7874, DOI 10.1073/pnas.1303333110; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; QUIRK PG, 1991, BIOCHIM BIOPHYS ACTA, V1058, P131, DOI 10.1016/S0005-2728(05)80229-4; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Romantsov T, 2009, BBA-BIOMEMBRANES, V1788, P2092, DOI 10.1016/j.bbamem.2009.06.010; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakamoto J, 1996, FEMS MICROBIOL LETT, V143, P151, DOI 10.1016/0378-1097(96)00312-6; Salzberg LI, 2008, J BACTERIOL, V190, P7797, DOI 10.1128/JB.00720-08; Sanden T, 2010, P NATL ACAD SCI USA, V107, P4129, DOI 10.1073/pnas.0908671107; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Springer A, 2011, P NATL ACAD SCI USA, V108, P14461, DOI 10.1073/pnas.1107476108; STANLEY PE, 1969, ANAL BIOCHEM, V29, P381, DOI 10.1016/0003-2697(69)90323-6; Swartz TH, 2007, J BACTERIOL, V189, P3081, DOI 10.1128/JB.00021-07; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Tsai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-13; Vartak R, 2013, PROTEIN CELL, V4, P582, DOI 10.1007/s13238-013-3032-y; Wang ZX, 2004, J BIOL CHEM, V279, P26546, DOI 10.1074/jbc.M401206200; Wei Y, 2003, J BACTERIOL, V185, P5133, DOI 10.1128/JB.185.17.5133-5147.2003; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; WILLIAMS RJP, 1978, BIOCHIM BIOPHYS ACTA, V505, P1, DOI 10.1016/0304-4173(78)90007-1; WILLIAMS RJP, 1988, ANNU REV BIOPHYS BIO, V17, P71; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhang X, 2011, BIOCHEMISTRY-US, V50, P3891, DOI 10.1021/bi1017039	68	10	10	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2960	2971		10.1074/jbc.M113.536193	http://dx.doi.org/10.1074/jbc.M113.536193			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338478	Green Published, hybrid			2022-12-28	WOS:000333403000043
J	Lopez, M; Meier, D; Muller, A; Franken, P; Fujita, J; Fontana, A				Lopez, Martin; Meier, Daniel; Mueller, Andreas; Franken, Paul; Fujita, Jun; Fontana, Adriano			Tumor Necrosis Factor and Transforming Growth Factor beta Regulate Clock Genes by Controlling the Expression of the Cold Inducible RNA-binding Protein (CIRBP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circadian Rhythms; Cytokine; Gene Expression; Innate Immunity; Metabolism; Sickness Behavior; Sleep	MALE GERM-CELLS; CIRCADIAN CLOCK; TNF-ALPHA; IMMUNE-SYSTEM; HOST RESPONSE; METABOLISM; MICE; BRAIN; LIVER; SHOCK	Background: CIRBP facilitates expression of clock genes by stabilizing their transcripts. Results: Down-regulation of expression of clock genes by TNF and TGF is mediated by inhibition of CIRBP production. Conclusion: TNF and TGF impair the expression of Cirbp and thereby influence circadian gene expression. Significance: A novel regulatory pathway that links immune activation with circadian gene expression is identified. The circadian clock drives the rhythmic expression of a broad array of genes that orchestrate metabolism, sleep wake behavior, and the immune response. Clock genes are transcriptional regulators engaged in the generation of circadian rhythms. The cold inducible RNA-binding protein (CIRBP) guarantees high amplitude expression of clock. The cytokines TNF and TGF impair the expression of clock genes, namely the period genes and the proline- and acidic amino acid-rich basic leucine zipper (PAR-bZip) clock-controlled genes. Here, we show that TNF and TGF impair the expression of Cirbp in fibroblasts and neuronal cells. IL-1, IL-6, IFN, and IFN do not exert such effects. Depletion of Cirbp is found to increase the susceptibility of cells to the TNF-mediated inhibition of high amplitude expression of clock genes and modulates the TNF-induced cytokine response. Our findings reveal a new mechanism of cytokine-regulated expression of clock genes.	[Lopez, Martin; Meier, Daniel; Mueller, Andreas; Fontana, Adriano] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Franken, Paul] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Fujita, Jun] Kyoto Univ, Grad Sch Med, Dept Clin Mol Biol, Kyoto 6068501, Japan	University of Zurich; University of Lausanne; Kyoto University	Fontana, A (corresponding author), Univ Zurich, Inst Expt Immunol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	adriano.fontana@usz.ch	Franken, Paul/A-9633-2018	Franken, Paul/0000-0002-2500-2921; Lopez, Martin/0000-0002-6254-8915	Swiss National Science Foundation [310030_141055/1]; Velux Stiftung; Novartis Foundation; Cancer Foundation Zurich; Smoking Research Foundation Japan	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Stiftung; Novartis Foundation(Novartis); Cancer Foundation Zurich; Smoking Research Foundation Japan	This work was supported by the Swiss National Science Foundation Project 310030_141055/1 (to A. F.), the Velux Stiftung (to A. F.), the Novartis Foundation (to A. F.), the Cancer Foundation Zurich (to A. F.), and the Smoking Research Foundation Japan (to J. F.).	Al-Fageeh MB, 2009, RNA, V15, P1164, DOI 10.1261/rna.1179109; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P9897, DOI 10.1073/pnas.1120636110; Casalena G, 2012, SEMIN NEPHROL, V32, P295, DOI 10.1016/j.semnephrol.2012.04.009; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; DINARELLO CA, 1987, IMMUNOL LETT, V16, P227, DOI 10.1016/0165-2478(87)90151-9; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; Fujita Jun, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P243; Gast H, 2012, ANN NY ACAD SCI, V1261, P79, DOI 10.1111/j.1749-6632.2012.06640.x; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Gualerzi CO, 2003, J MOL BIOL, V331, P527, DOI 10.1016/S0022-2836(03)00732-0; Haimovich B, 2010, CRIT CARE MED, V38, P751, DOI 10.1097/CCM.0b013e3181cd131c; Hashiramoto A, 2009, MOD RHEUMATOL, V19, P637, DOI 10.1007/s10165-009-0205-x; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; Lamia KA, 2010, NATURE, V466, P571, DOI 10.1038/466571a; Li SC, 2012, BRAIN RES, V1441, P47, DOI 10.1016/j.brainres.2011.12.053; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; LLeonart ME, 2010, BBA-REV CANCER, V1805, P43, DOI 10.1016/j.bbcan.2009.11.001; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Masuda T, 2012, P NATL ACAD SCI USA, V109, P10885, DOI 10.1073/pnas.1121524109; Matsubara T, 2012, J LIPID RES, V53, P2698, DOI 10.1194/jlr.M031773; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Morrow JD, 2005, BRAIN BEHAV IMMUN, V19, P28, DOI 10.1016/j.bbi.2004.02.003; Nishiyama H, 1998, BIOCHEM BIOPH RES CO, V245, P534, DOI 10.1006/bbrc.1998.8482; Nishiyama H, 1998, AM J PATHOL, V152, P289; Ohdo S, 2001, NAT MED, V7, P356, DOI 10.1038/85507; Okada K, 2008, J SURG RES, V145, P5, DOI 10.1016/j.jss.2007.01.010; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Sakurai T, 2006, BBA-MOL CELL RES, V1763, P290, DOI 10.1016/j.bbamcr.2006.02.007; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Schmutz I, 2012, MOL CELL ENDOCRINOL, V349, P38, DOI 10.1016/j.mce.2011.05.007; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Stubblefield JJ, 2012, TRENDS ENDOCRIN MET, V23, P326, DOI 10.1016/j.tem.2012.03.007; Suzuki T, 2008, BIOMED RES-TOKYO, V29, P99, DOI 10.2220/biomedres.29.99; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Xia ZP, 2012, FEBS LETT, V586, P3299, DOI 10.1016/j.febslet.2012.07.004; Yamada H, 2012, J NUTR SCI VITAMINOL, V58, P88, DOI 10.3177/jnsv.58.88; Yamazaki H, 2002, AM J PHYSIOL-ENDOC M, V283, pE536, DOI 10.1152/ajpendo.00094.2001; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	49	19	21	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2736	2744		10.1074/jbc.M113.508200	http://dx.doi.org/10.1074/jbc.M113.508200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24337574	hybrid, Green Published			2022-12-28	WOS:000333403000023
J	Song, C; Psakis, G; Kopycki, J; Lang, C; Matysik, J; Hughes, J				Song, Chen; Psakis, Georgios; Kopycki, Jakub; Lang, Christina; Matysik, Jorg; Hughes, Jon			The D-ring, Not the A-ring, Rotates in Synechococcus OS-B ' Phytochrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; Cyanobacteria; Molecular Biology; NMR; Photoreceptors; Protein Structure; Structural Biology; Photoisomerization; Phytochrome	CHROMOPHORE-BINDING DOMAIN; ANGLE-SPINNING NMR; PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; SOLID-STATE NMR; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; CPH1 PHYTOCHROME; GROUND-STATE; CIRCULAR-DICHROISM; STRUCTURAL BASIS	Background: Phytochrome photoreceptors are activated by light-induced isomerization of the chromophore cofactor. Results: Photoactivation of Synechococcus OS-B phytochrome breaks an unusual chromophore D-ring hydrogen bond, whereas only subtle changes occur at the A-ring linkage to the protein. Conclusion: Activation arises from a photoflip of a strongly tilted D-ring. Significance: The hypothesis that the A-ring rotates upon photon absorption is wrong. Phytochrome photoreceptors in plants and microorganisms switch photochromically between two states, controlling numerous important biological processes. Although this phototransformation is generally considered to involve rotation of ring D of the tetrapyrrole chromophore, Ulijasz et al. (Ulijasz, A. T., Cornilescu, G., Cornilescu, C. C., Zhang, J., Rivera, M., Markley, J. L., and Vierstra, R. D. (2010) Nature 463, 250-254) proposed that the A-ring rotates instead. Here, we apply magic angle spinning NMR to the two parent states following studies of the 23-kDa GAF (cGMP phosphodiesterase/adenylyl cyclase/FhlA) domain fragment of phytochrome from Synechococcus OS-B. Major changes occur at the A-ring covalent linkage to the protein as well as at the protein residue contact of ring D. Conserved contacts associated with the A-ring nitrogen rule out an A-ring photoflip, whereas loss of contact of the D-ring nitrogen to the protein implies movement of ring D. Although none of the methine bridges showed a chemical shift change comparable with those characteristic of the D-ring photoflip in canonical phytochromes, denaturation experiments showed conclusively that the same occurs in Synechococcus OS-B phytochrome upon photoconversion. The results are consistent with the D-ring being strongly tilted in both states and the C15=C16 double bond undergoing a Z/E isomerization upon light absorption. More subtle changes are associated with the A-ring linkage to the protein. Our findings thus disprove A-ring rotation and are discussed in relation to the position of the D-ring, photoisomerization, and photochromicity in the phytochrome family.	[Song, Chen; Matysik, Jorg] Leiden Univ, Leids Inst Chem Onderzoek, NL-2300 RA Leiden, Netherlands; [Song, Chen; Matysik, Jorg] Univ Leipzig, Inst Analyt Chem, D-04103 Leipzig, Germany; [Psakis, Georgios; Kopycki, Jakub; Lang, Christina; Hughes, Jon] Univ Giessen, Inst Plant Physiol, D-35390 Giessen, Germany	Leiden University; Leiden University - Excl LUMC; Leipzig University; Justus Liebig University Giessen	Hughes, J (corresponding author), Univ Giessen, Inst Plant Physiol, Senckenbergstr 3, D-35390 Giessen, Germany.	jon.hughes@uni-giessen.de	Song, Chen/AAZ-5599-2021; Psakis, Georgios/ABK-6136-2022; Song, Chen/E-7483-2017	Song, Chen/0000-0003-1034-5881; Psakis, Georgios/0000-0003-3727-2694; Song, Chen/0000-0003-1034-5881; Psakis, Georgios/0000-0002-9594-3305	Deutsche Forschungsgemeinschaft [Hu702/8]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek [DN 89-190, ALW 822.02.007]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant Hu702/8 and Nederlandse Organisatie voor Wetenschappelijk Onderzoek Grants DN 89-190 and ALW 822.02.007.	Borucki B, 2003, BIOCHEMISTRY-US, V42, P13684, DOI 10.1021/bi035511n; Borucki B, 2009, BIOCHEMISTRY-US, V48, P6305, DOI 10.1021/bi900436v; Cornilescu G, 2008, J MOL BIOL, V383, P403, DOI 10.1016/j.jmb.2008.08.034; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; FALK H, 1978, MONATSH CHEM, V109, P1429, DOI 10.1007/BF00906056; Falk H., 1989, CHEM LINEAR OLIGOPYR; Goddard TD, 2008, SPARKY VERSION 3; Hahn J, 2006, FEBS J, V273, P1415, DOI 10.1111/j.1742-4658.2006.05164.x; Hahn J, 2008, J AM CHEM SOC, V130, P11170, DOI 10.1021/ja8031086; Hu FH, 2010, SCIENCE, V330, P505, DOI 10.1126/science.1191714; Hughes J, 2010, BIOCHEM SOC T, V38, P710, DOI 10.1042/BST0380710; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; Inomata K, 2009, BIOCHEMISTRY-US, V48, P2817, DOI 10.1021/bi802334u; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Lamparter T, 2001, EUR J BIOCHEM, V268, P4720, DOI 10.1046/j.1432-1327.2001.02395.x; Li SH, 2011, J AM CHEM SOC, V133, P1534, DOI 10.1021/ja108943n; Mailliet J, 2011, J MOL BIOL, V413, P115, DOI 10.1016/j.jmb.2011.08.023; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P3576, DOI 10.1021/bi300171s; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Roben M, 2010, CHEMPHYSCHEM, V11, P1248, DOI 10.1002/cphc.200900897; Rohmer T, 2008, P NATL ACAD SCI USA, V105, P15229, DOI 10.1073/pnas.0805696105; Rohmer T, 2006, J PHYS CHEM B, V110, P20580, DOI 10.1021/jp062454+; Rohmer T, 2010, J AM CHEM SOC, V132, P4431, DOI 10.1021/ja9108616; RUDIGER W, 1983, P NATL ACAD SCI-BIOL, V80, P6244, DOI 10.1073/pnas.80.20.6244; Schmidt M, 2007, BIOCHEMISTRY-US, V46, P416, DOI 10.1021/bi061844j; Song C, 2013, PHOTOCHEM PHOTOBIOL, V89, P259, DOI 10.1111/php.12029; Song C, 2011, BIOCHEMISTRY-US, V50, P10987, DOI 10.1021/bi201504a; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Strauss HM, 2005, BIOCHEMISTRY-US, V44, P8244, DOI 10.1021/bi050457r; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Thurber KR, 2009, J MAGN RESON, V196, P84, DOI 10.1016/j.jmr.2008.09.019; Ulijasz AT, 2008, J BIOL CHEM, V283, P21251, DOI 10.1074/jbc.M801592200; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; van Thor JJ, 2001, BIOCHEMISTRY-US, V40, P11460, DOI 10.1021/bi002651d; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; ZHAO KH, 1995, BBA-BIOENERGETICS, V1228, P244, DOI 10.1016/0005-2728(94)00180-D	41	37	38	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2552	2562		10.1074/jbc.M113.520031	http://dx.doi.org/10.1074/jbc.M113.520031			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24327657	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000333403000007
J	Brot, S; Auger, C; Bentata, R; Rogemond, V; Menigoz, S; Chounlamountri, N; Girard-Egrot, A; Honnorat, J; Moradi-Ameli, M				Brot, Sebastien; Auger, Carole; Bentata, Rabia; Rogemond, Veronique; Menigoz, Stephane; Chounlamountri, Naura; Girard-Egrot, Agnes; Honnorat, Jerome; Moradi-Ameli, Mahnaz			Collapsin Response Mediator Protein 5 (CRMP5) Induces Mitophagy, Thereby Regulating Mitochondrion Numbers in Dendrites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Cell Biology; Cell Culture; Dendrite; Mitochondria; Neurons	AUTOPHAGIC VACUOLES; NEURITE OUTGROWTH; EXPRESSION; INTERACTS; TUBULIN; PARKIN; PLASTICITY; MEMBRANES; DYNAMICS; PROMOTES	Degradation of damaged mitochondria by mitophagy is an essential process to ensure cell homeostasis. Because neurons, which have a high energy demand, are particularly dependent on the mitochondrial dynamics, mitophagy represents a key mechanism to ensure correct neuronal function. Collapsin response mediator proteins 5 (CRMP5) belongs to a family of cytosolic proteins involved in axon guidance and neurite outgrowth signaling during neural development. CRMP5, which is highly expressed during brain development, plays an important role in the regulation of neuronal polarity by inhibiting dendrite outgrowth at early developmental stages. Here, we demonstrated that CRMP5 was present in vivo in brain mitochondria and is targeted to the inner mitochondrial membrane. The mitochondrial localization of CRMP5 induced mitophagy. CRMP5 overexpression triggered a drastic change in mitochondrial morphology, increased the number of lysosomes and double membrane vesicles termed autophagosomes, and enhanced the occurrence of microtubule-associated protein 1 light chain 3 (LC3) at the mitochondrial level. Moreover, the lipidated form of LC3, LC3-II, which triggers autophagy by insertion into autophagosomes, enhanced mitophagy initiation. Lysosomal marker translocates at the mitochondrial level, suggesting autophagosome-lysosome fusion, and induced the reduction of mitochondrial content via lysosomal degradation. We show that during early developmental stages the strong expression of endogenous CRMP5, which inhibits dendrite growth, correlated with a decrease of mitochondrial content. In contrast, the knockdown or a decrease of CRMP5 expression at later stages enhanced mitochondrion numbers in cultured neurons, suggesting that CRMP5 modulated these numbers. Our study elucidates a novel regulatory mechanism that utilizes CRMP5-induced mitophagy to orchestrate proper dendrite outgrowth and neuronal function.	[Brot, Sebastien; Auger, Carole; Bentata, Rabia; Menigoz, Stephane; Chounlamountri, Naura; Honnorat, Jerome; Moradi-Ameli, Mahnaz] Fac Med Alexis Carrel, INSERM, UMR S1028, F-69372 Lyon, France; [Brot, Sebastien; Auger, Carole; Bentata, Rabia; Menigoz, Stephane; Chounlamountri, Naura; Honnorat, Jerome; Moradi-Ameli, Mahnaz] CNRS, UMR5292, F-69372 Lyon, France; [Brot, Sebastien; Auger, Carole; Bentata, Rabia; Menigoz, Stephane; Chounlamountri, Naura; Honnorat, Jerome; Moradi-Ameli, Mahnaz] Univ Lyon 1, Lyon Neurosci Res Ctr, F-69372 Lyon 08, France; [Rogemond, Veronique; Honnorat, Jerome] Hosp Civils Lyon, F-69677 Bron, France; [Menigoz, Stephane; Girard-Egrot, Agnes] Univ Lyon 1, Inst Chim & Biochim Mol & Supramol, CNRS UMR ICBMS 5246, F-69622 Villeurbanne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Moradi-Ameli, M (corresponding author), Univ Lyon 1, Fac Med Lyon Est, Lyon Neurosci Res Ctr, Rue Guillaume Paradin, F-69372 Lyon 08, France.	mahnaz.ameli-moradi@univ-lyon1.fr	Honnorat, jerome/G-6394-2017; Rogemond, Veronique/J-4824-2017; GIRARD-EGROT, Agnès/AAP-5586-2020	Honnorat, jerome/0000-0002-4721-5952; Rogemond, Veronique/0000-0003-2098-920X; GIRARD-EGROT, Agnès/0000-0003-2612-3124; BROT, Sebastien/0000-0002-4373-2135				Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Brot S, 2010, J NEUROSCI, V30, P10639, DOI 10.1523/JNEUROSCI.0059-10.2010; Burbulla LF, 2010, EUR J CLIN INVEST, V40, P1048, DOI 10.1111/j.1365-2362.2010.02354.x; Cherra SJ, 2013, AM J PATHOL, V182, P474, DOI 10.1016/j.ajpath.2012.10.027; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Guillemin Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009066; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Honnorat J, 2009, J NEUROL NEUROSUR PS, V80, P412, DOI 10.1136/jnnp.2007.138016; Hotta A, 2005, MOL BIOL CELL, V16, P32, DOI 10.1091/mbc.E04-08-0679; Inatome R, 2000, J BIOL CHEM, V275, P27291; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanki T, 2010, MOL MICROBIOL, V75, P795, DOI 10.1111/j.1365-2958.2009.07035.x; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Komatsu M, 2007, CELL DEATH DIFFER, V14, P887, DOI 10.1038/sj.cdd.4402120; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lajoie P, 2005, J CELL SCI, V118, P1991, DOI 10.1242/jcs.02324; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liu XY, 2010, MOL CELL BIOCHEM, V344, P277, DOI 10.1007/s11010-010-0552-0; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; MAGGIO B, 1994, PROG BIOPHYS MOL BIO, V62, P55, DOI 10.1016/0079-6107(94)90006-X; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ponnusamy R, 2013, J NEUROCHEM, V125, P855, DOI 10.1111/jnc.12188; Rembutsu M, 2008, BIOCHEMISTRY-US, V47, P2153, DOI 10.1021/bi702030w; Ricard D, 2001, J NEUROSCI, V21, P7203, DOI 10.1523/JNEUROSCI.21-18-07203.2001; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Rogemond V, 2008, J BIOL CHEM, V283, P14751, DOI 10.1074/jbc.M708480200; Takahashi S, 2003, GENES CELLS, V8, P81, DOI 10.1046/j.1365-2443.2003.00617.x; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Veyrac A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023721; Wang LH, 1997, J NEUROCHEM, V69, P2261; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yamashita N, 2011, J NEUROSCI, V31, P1773, DOI 10.1523/JNEUROSCI.5337-10.2011; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Young KW, 2010, J BIOCHEM MOL TOXIC, V24, P335, DOI 10.1002/jbt.20343	51	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2261	2276		10.1074/jbc.M113.490862	http://dx.doi.org/10.1074/jbc.M113.490862			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324268	Green Published, hybrid			2022-12-28	WOS:000331130200032
J	Hama, S; Kimura, Y; Mikami, A; Shiota, K; Toyoda, M; Tamura, A; Nagasaki, Y; Kanamura, K; Kajimoto, K; Kogure, K				Hama, Susumu; Kimura, Yuki; Mikami, Aya; Shiota, Kanako; Toyoda, Mao; Tamura, Atsushi; Nagasaki, Yukio; Kanamura, Kiyoshi; Kajimoto, Kazuaki; Kogure, Kentaro			Electric Stimulus Opens Intercellular Spaces in Skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Calcium; Cell Junctions; Cell Signaling; Connexin; Iontophoresis; Transdermal Delivery; Electric Stimulus	TIGHT JUNCTIONS; BARRIER FUNCTION; DRUG-DELIVERY; CONNEXIN PHOSPHORYLATION; TRANSDERMAL DELIVERY; IONTOPHORESIS; CYTOSKELETON; CELLS; COMBINATION; INVOLVEMENT	Iontophoresis is a technology for transdermal delivery of ionic small medicines by faint electricity. Since iontophoresis can noninvasively deliver charged molecules into the skin, this technology could be a useful administration method that may enhance patient comfort. Previously, we succeeded in the transdermal penetration of positively charged liposomes (diameters: 200-400 nm) encapsulating insulin by iontophoresis (Kajimoto, K., Yamamoto, M., Watanabe, M., Kigasawa, K., Kanamura, K., Harashima, H., and Kogure, K. (2011) Int. J. Pharm. 403, 57-65). However, the mechanism by which these liposomes penetrated the skin was difficult to define based on general knowledge of principles such as electro-repulsion and electro-osmosis. In the present study, we confirmed that rigid nanoparticles could penetrate into the epidermis by iontophoresis. We further found that levels of the gap junction protein connexin 43 protein significantly decreased after faint electric stimulus (ES) treatment, although occludin, CLD-4, and ZO-1 levels were unchanged. Moreover, connexin 43 phosphorylation and filamentous actin depolymerization in vivo and in vitro were observed when permeation of charged liposomes through intercellular spaces was induced by ES. Ca2+ inflow into cells was promoted by ES with charged liposomes, while a protein kinase C inhibitor prevented ES-induced permeation of macromolecules. Consequently, we demonstrate that ES treatment with charged liposomes induced dissociation of intercellular junctions via cell signaling pathways. These findings suggest that ES could be used to regulate skin physiology.	[Hama, Susumu; Kimura, Yuki; Mikami, Aya; Shiota, Kanako; Toyoda, Mao; Kogure, Kentaro] Kyoto Pharmaceut Univ, Dept Biophys Chem, Kyoto 6078414, Japan; [Tamura, Atsushi; Nagasaki, Yukio] Univ Tsukuba, Grad Sch Pure & Appl Sci, Ibaraki 3058573, Japan; [Kanamura, Kiyoshi] TTI Ellebeau Inc, Tokyo 1400002, Japan; [Kajimoto, Kazuaki] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan	Kyoto Pharmaceutical University; University of Tsukuba; Hokkaido University	Kogure, K (corresponding author), Kyoto Pharmaceut Univ, Dept Biophys Chem, Kyoto 6078414, Japan.	kogure@mb.kyoto-phu.ac.jp	Kajimoto, Kazuaki/L-6418-2018	Kajimoto, Kazuaki/0000-0002-1636-4154; Tamura, Atsushi/0000-0003-0235-7364; Hama, Susumu/0000-0002-2989-6168	Ministry of Education, Culture, Sports, Science, and Technology of Japan [2306]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Nanomedicine Molecular Science (No. 2306) from Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Abu Hashim II, 2010, INT J PHARMACEUT, V393, P127, DOI 10.1016/j.ijpharm.2010.04.020; Cazares-Delgadillo J, 2010, EUR J PHARM BIOPHARM, V75, P173, DOI 10.1016/j.ejpb.2010.03.011; De Vuyst E, 2009, CELL CALCIUM, V46, P176, DOI 10.1016/j.ceca.2009.07.002; Maghraby GM, 2008, EUR J PHARM SCI, V34, P203, DOI 10.1016/j.ejps.2008.05.002; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Inoue N, 2010, INT J PHARMACEUT, V391, P65, DOI 10.1016/j.ijpharm.2010.02.019; Kajimoto K, 2011, INT J PHARMACEUT, V403, P57, DOI 10.1016/j.ijpharm.2010.10.021; Kalia YN, 2004, ADV DRUG DELIVER REV, V56, P619, DOI 10.1016/j.addr.2003.10.026; Kigasawa K, 2010, INT J PHARMACEUT, V383, P157, DOI 10.1016/j.ijpharm.2009.08.036; Kigasawa K, 2012, BIOL PHARM BULL, V35, P781, DOI 10.1248/bpb.35.781; Kigasawa K, 2011, J CONTROL RELEASE, V150, P256, DOI 10.1016/j.jconrel.2011.01.018; Kigasawa K, 2009, BIOL PHARM BULL, V32, P684, DOI 10.1248/bpb.32.684; Kirn-Safran C, 2009, CELL MOL LIFE SCI, V66, P3421, DOI 10.1007/s00018-009-0096-1; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Li C, 2001, J MUSCLE RES CELL M, V22, P521, DOI 10.1023/A:1015026530258; Lurtz MM, 2003, AM J PHYSIOL-CELL PH, V285, pC1475, DOI 10.1152/ajpcell.00361.2002; Meidan VM, 2003, INT J PHARMACEUT, V264, P73, DOI 10.1016/S0378-5173(03)00390-9; Miyoshi J, 2008, BBA-BIOMEMBRANES, V1778, P670, DOI 10.1016/j.bbamem.2007.12.014; Nagasawa K, 2006, J CELL PHYSIOL, V208, P123, DOI 10.1002/jcp.20647; Ohtake K, 2003, PHARM RES, V20, P1838, DOI 10.1023/B:PHAM.0000003383.86238.d1; Park JH, 2008, CELL PROLIFERAT, V41, P786, DOI 10.1111/j.1365-2184.2008.00552.x; Peixoto EBMI, 2005, CELL STRUCT FUNCT, V29, P165, DOI 10.1247/csf.29.165; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sonaje K, 2012, MOL PHARMACEUT, V9, P1271, DOI 10.1021/mp200572t; Tamura A, 2009, BIOMACROMOLECULES, V10, P1818, DOI 10.1021/bm900252d; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Vemulapalli V, 2008, DRUG DELIV, V15, P437, DOI [10.1080/10717540802035145, 10.1080/10717540802035145 ]; Yamamoto T, 2008, ARCH DERMATOL RES, V300, P517, DOI 10.1007/s00403-008-0868-8	31	24	24	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2450	2456		10.1074/jbc.M113.514414	http://dx.doi.org/10.1074/jbc.M113.514414			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24318878	hybrid, Green Published			2022-12-28	WOS:000331130200048
J	Lee, J; Ozcan, U				Lee, Jaemin; Ozcan, Umut			Unfolded Protein Response Signaling and Metabolic Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Diabetes; ER Stress; Metabolic Diseases; Obesity; Unfolded Protein Response	ENDOPLASMIC-RETICULUM STRESS; NEURONAL CELL-DEATH; THIOREDOXIN-INTERACTING PROTEIN; TRANSCRIPTION FACTOR ATF6; ER STRESS; GLUCOSE-HOMEOSTASIS; TRANSMEMBRANE PROTEIN; TRANSLATIONAL CONTROL; INSULIN-RESISTANCE; HEPATIC STEATOSIS	The endoplasmic reticulum (ER) is a central organelle for protein biosynthesis, folding, and traffic. Perturbations in ER homeostasis create a condition termed ER stress and lead to activation of the complex signaling cascade called the unfolded protein response (UPR). Recent studies have documented that the UPR coordinates multiple signaling pathways and controls various physiologies in cells and the whole organism. Furthermore, unresolved ER stress has been implicated in a variety of metabolic disorders, such as obesity and type 2 diabetes. Therefore, intervening in ER stress and modulating signaling components of the UPR would provide promising therapeutics for the treatment of human metabolic diseases.	[Lee, Jaemin; Ozcan, Umut] Harvard Univ, Sch Med, Div Endocrinol, Boston Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Ozcan, U (corresponding author), Harvard Univ, Sch Med, Div Endocrinol, Boston Childrens Hosp, Boston, MA 02115 USA.	umut.ozcan@childrens.harvard.edu	Lee, Jaemin/AAP-4875-2021	Lee, Jaemin/0000-0002-0224-7141	National Institutes of Health [R01 DK081009, R01 DK098496]; American Diabetes Association Career Development Grant [7-09-CD-10]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098496, R01DK081009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Career Development Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	work was supported, in whole or in part, by National Institutes of Health Grants R01 DK081009 and R01 DK098496 (to U. O.). This work was also supported by American Diabetes Association Career Development Grant 7-09-CD-10 (to U. O.).	Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Bailly-Maitre B, 2010, J BIOL CHEM, V285, P6198, DOI 10.1074/jbc.M109.056648; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853; Clegg DJ, 2011, PHYSIOL BEHAV, V103, P10, DOI 10.1016/j.physbeh.2011.01.010; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Gao Y, 2012, MOL CELL BIOL, V32, P5129, DOI 10.1128/MCB.01009-12; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Glembotski CC, 2008, J MOL CELL CARDIOL, V44, P453, DOI 10.1016/j.yjmcc.2007.10.017; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 2012, J BIOL CHEM, V287, P44338, DOI 10.1074/jbc.M112.428987; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P949, DOI 10.1097/01.WCB.0000077641.41248.EA; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Ji C, 2005, ALCOHOL CLIN EXP RES, V29, P1496, DOI 10.1097/01.alc.0000174691.03751.11; Ji C, 2003, GASTROENTEROLOGY, V124, P1488, DOI 10.1016/S0016-5085(03)00276-2; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; LEE JHW, 2011, J HYDRO-ENVIRON RES, V5, P1, DOI DOI 10.1016/J.JHER.2011.02.001; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Li FM, 2008, ACTA BIOCH BIOPH SIN, V40, P226, DOI 10.1111/j.1745-7270.2008.00396.x; Liang CP, 2012, DIABETES, V61, P2609, DOI 10.2337/db11-1415; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Lu YX, 2013, LIFE SCI, V92, P1165, DOI 10.1016/j.lfs.2013.05.002; Luo DH, 2008, J BIOL CHEM, V283, P11905, DOI 10.1074/jbc.M710557200; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Martino MB, 2013, MUCOSAL IMMUNOL, V6, P639, DOI 10.1038/mi.2012.105; Masaki T, 1999, BIOCHEM BIOPH RES CO, V261, P350, DOI 10.1006/bbrc.1999.0972; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Park SW, 2013, SEMIN IMMUNOPATHOL, V35, P351, DOI 10.1007/s00281-013-0370-z; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Reimold AM, 2000, GENE DEV, V14, P152; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Thorp E, 2011, J LIPID RES, V52, P1033, DOI 10.1194/jlr.D012492; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Usui M, 2012, METABOLISM, V61, P1118, DOI 10.1016/j.metabol.2012.01.004; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Wang SY, 2012, CELL METAB, V16, P473, DOI 10.1016/j.cmet.2012.09.003; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Won JC, 2009, OBESITY, V17, P1861, DOI 10.1038/oby.2009.194; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zeng LF, 2004, EMBO J, V23, P950, DOI 10.1038/sj.emboj.7600106; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	100	200	209	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1203	1211		10.1074/jbc.R113.534743	http://dx.doi.org/10.1074/jbc.R113.534743			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24324257	Green Published, hybrid			2022-12-28	WOS:000332401700001
J	Drazic, A; Gebendorfer, KM; Mak, S; Steiner, A; Krause, M; Bepperling, A; Winter, J				Drazic, Adrian; Gebendorfer, Katharina M.; Mak, Stefanie; Steiner, Andrea; Krause, Maike; Bepperling, Alexander; Winter, Jeannette			Tetramers Are the Activation-competent Species of the HOCl-specific Transcription Factor HypT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; ESCHERICHIA-COLI; REDOX-SWITCH; REGULATED CHAPERONE; FIBRIL FORMATION; PRION PROTEIN; MECHANISM; STABILITY; ARGININE; OLIGOMERIZATION	Hypochlorous acid (HOCl) is an important component of the immune system and is produced by neutrophils to kill invading microorganisms. The transcription factor HypT is specifically activated by HOCl by methionine oxidation and protects Escherichia coli cells from the detrimental effects of HOCl. HypT forms dodecameric ring-like oligomers. Binding of HypT to DNA induces dissociation of the dodecamers into dimers and tetramers, thus forming the DNA-binding species. To dissect HypT dissociation, binding to DNA, and activation, we aimed to dissociate the dodecamers independently of DNA and to analyze HOCl-dependent activation in vitro. We found that HypT dodecamers dissociated into tetramers in the presence of L-arginine and NaCl, which was reversible upon dilution of the additive. Making use of the reversible dissociation, we generated mixed assemblies consisting of wild-type and mutant HypT subunits and determined that mutant subunits with reduced thermal stability were stabilized by wild-type HypT in the mixed assembly. HypT tetramers, as present at high NaCl concentrations, were stabilized against thermal unfolding and aggregation triggered by high HOCl concentrations. Importantly, in vitro activation by HOCl of HypT tetramers was completed within 1 min, whereas activation of dodecamers required 1 h for completion. Furthermore, activation of HypT tetramers required stoichiometric amounts of HOCl instead of an excess of HOCl, as observed for dodecamers. This supports the idea that small HypT oligomers are the activation-competent species, whereas the dodecamers are a storage form. Our study reveals the importance of the dynamic oligomeric state for HypT activation by HOCl.	[Drazic, Adrian; Gebendorfer, Katharina M.; Mak, Stefanie; Steiner, Andrea; Krause, Maike; Bepperling, Alexander; Winter, Jeannette] Tech Univ Munich, Dept Chem, CiPSM, D-85747 Garching, Germany	Technical University of Munich	Winter, J (corresponding author), Tech Univ Munich, Dept Chem, CiPSM, Lichtenbergstr 4, D-85747 Garching, Germany.	jeannette.winter@tum.de	Drazic, Adrian/AAC-6120-2019	Drazic, Adrian/0000-0001-9263-5502; Krause, Maike/0000-0003-4068-8172	Elitenetzwerk Bayern; Deutsche Forschungsgemeinschaft (DFG)	Elitenetzwerk Bayern; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Elitenetzwerk Bayern (to A. D. and K. M. G.) and the Emmy-Noether Program of the Deutsche Forschungsgemeinschaft (DFG; to J. W.).	Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Beauchamp DL, 2012, BIOPHYS CHEM, V161, P29, DOI 10.1016/j.bpc.2011.11.004; Bender RA, 2010, J BACTERIOL, V192, P4801, DOI 10.1128/JB.00266-10; Campioni S, 2012, J MOL BIOL, V424, P132, DOI 10.1016/j.jmb.2012.09.023; Chang DW, 2003, J BIOL CHEM, V278, P16466, DOI 10.1074/jbc.C300089200; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Cossins BP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002066; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Dominy BN, 2002, J MOL BIOL, V319, P541, DOI 10.1016/S0022-2836(02)00259-0; Drazic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075683; Drazic A, 2013, P NATL ACAD SCI USA, V110, P9493, DOI 10.1073/pnas.1300578110; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Franzmann TM, 2005, J MOL BIOL, V350, P1083, DOI 10.1016/j.jmb.2005.05.034; Gebendorfer KM, 2012, J BIOL CHEM, V287, P6892, DOI 10.1074/jbc.M111.287219; Gray MJ, 2013, ANNU REV MICROBIOL, V67, P141, DOI 10.1146/annurev-micro-102912-142520; Gray MJ, 2013, J BIOL CHEM, V288, P13789, DOI 10.1074/jbc.M113.454421; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Lange C, 2009, CURR PHARM BIOTECHNO, V10, P408, DOI 10.2174/138920109788488851; Lochowska A, 2001, J BIOL CHEM, V276, P2098, DOI 10.1074/jbc.M007192200; Lyutova EM, 2007, BIOTECHNOL PROGR, V23, P1411, DOI 10.1021/bp070209h; Mao Yong-Jin, 2007, BMC Biochemistry, V8, P28, DOI 10.1186/1471-2091-8-28; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Palm GJ, 2012, NUCLEIC ACIDS RES, V40, P4178, DOI 10.1093/nar/gkr1316; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; RICHEY B, 1987, J BIOL CHEM, V262, P7157; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; ROE JH, 1984, J MOL BIOL, V176, P495, DOI 10.1016/0022-2836(84)90174-8; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; Sainsbury S, 2009, NUCLEIC ACIDS RES, V37, P4545, DOI 10.1093/nar/gkp445; SCHULTZ SG, 1961, J GEN PHYSIOL, V45, P355, DOI 10.1085/jgp.45.2.355; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Srinivas V, 2003, PROTEIN SCI, V12, P1262, DOI 10.1110/ps.0302003; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; van Eunen K, 2010, FEBS J, V277, P749, DOI 10.1111/j.1742-4658.2009.07524.x; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winter J, 2004, CRIT REV BIOCHEM MOL, V39, P297, DOI 10.1080/10409230490900658; Winter J, 2002, ANAL BIOCHEM, V310, P148, DOI 10.1016/S0003-2697(02)00287-7; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Wolf SG, 1999, NATURE, V400, P83, DOI 10.1038/21918; Wright DB, 2002, J MOL BIOL, V323, P327, DOI 10.1016/S0022-2836(02)00916-6; Yeh V, 2010, PROTEIN SCI, V19, P47, DOI 10.1002/pro.281; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020	52	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					977	986		10.1074/jbc.M113.521401	http://dx.doi.org/10.1074/jbc.M113.521401			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275662	Green Published, hybrid			2022-12-28	WOS:000330541200032
J	Okamoto, H; Miyagawa, A; Shiota, T; Tamura, Y; Endo, T				Okamoto, Hiroaki; Miyagawa, Akiko; Shiota, Takuya; Tamura, Yasushi; Endo, Toshiya			Intramolecular Disulfide Bond of Tim22 Protein Maintains Integrity of the TIM22 Complex in the Mitochondrial Inner Membrane*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Disulfide; Membrane Proteins; Mitochondria; Protein Translocation; Yeast; Tim22	TWIN-PORE TRANSLOCASE; INTERMEMBRANE SPACE; SACCHAROMYCES-CEREVISIAE; MEDIATES INSERTION; CARRIER PROTEINS; STRUCTURAL BASIS; IMPORT; PATHWAY; MECHANISMS; COMPONENT	Background: Tim22 is a central component of the mitochondrial inner membrane protein insertion machinery TIM22 complex. Results: Lack of the disulfide bond of Tim22 destabilizes Tim22 and impairs substrate protein assembly. Conclusion: The disulfide bond of Tim22 has a role in stabilization of the TIM22 complex, which is important for the TIM22 protein assembly pathway. Significance: Tim40(Mia40)/Erv1-independent disulfide bond formation contributes to protein stability in mitochondria. Mitochondrial proteins require protein machineries called translocators in the outer and inner membranes for import into and sorting to their destination submitochondrial compartments. Among them, the TIM22 complex mediates insertion of polytopic membrane proteins into the inner membrane, and Tim22 constitutes its central insertion channel. Here we report that the conserved Cys residues of Tim22 form an intramolecular disulfide bond. By comparison of Tim22 Cys Ser mutants with wild-type Tim22, we show that the disulfide bond of Tim22 stabilizes Tim22 especially at elevated temperature through interactions with Tim18, which are also important for the stability of the TIM22 complex. We also show that lack of the disulfide bond in Tim22 impairs the assembly of TIM22 pathway substrate proteins into the inner membrane especially when the TIM22 complex handles excess amounts of substrate proteins. Our findings provide a new insight into the mechanism of the maintenance of the structural and functional integrity of the TIM22 complex.	[Okamoto, Hiroaki; Miyagawa, Akiko; Shiota, Takuya; Endo, Toshiya] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Tamura, Yasushi] Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Endo, Toshiya] Nagoya Univ, Struct Biol Res Ctr, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Endo, Toshiya] Nagoya Univ, Japan Sci & Technol Agcy JST, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Nagoya University; Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Endo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	endo@chem.nagoya-u.ac.jp	Yasushi, TAMURA/I-7122-2014; Tamura, Yasushi/H-8270-2017	Tamura, Yasushi/0000-0002-8462-0607	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); grant for CREST from the Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); grant for CREST from the Japan Science and Technology Agency (JST)	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (to T. E. and Y. T.) and a grant for CREST from the Japan Science and Technology Agency (JST) (to T. E.).	Adam A, 1999, EMBO J, V18, P313, DOI 10.1093/emboj/18.2.313; Becker T, 2009, CURR OPIN CELL BIOL, V21, P484, DOI 10.1016/j.ceb.2009.04.002; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Deponte M, 2009, J BIOCHEM, V146, P599, DOI 10.1093/jb/mvp133; Dimmer KS, 2012, BBA-BIOMEMBRANES, V1818, P1085, DOI 10.1016/j.bbamem.2011.08.027; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Endo T, 2010, ANTIOXID REDOX SIGN, V13, P1359, DOI 10.1089/ars.2010.3099; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; Gebert N, 2011, MOL CELL, V44, P811, DOI 10.1016/j.molcel.2011.09.025; Herrmann JM, 2012, J BIOL CHEM, V287, P4426, DOI 10.1074/jbc.R111.270678; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hwang DK, 2007, J CELL BIOL, V178, P1161, DOI 10.1083/jcb.200706195; Kawano S, 2009, P NATL ACAD SCI USA, V106, P14403, DOI 10.1073/pnas.0901793106; Kerscher O, 2000, MOL BIOL CELL, V11, P103, DOI 10.1091/mbc.11.1.103; Kerscher O, 1997, J CELL BIOL, V139, P1663, DOI 10.1083/jcb.139.7.1663; KITADA K, 1995, GENE, V165, P203, DOI 10.1016/0378-1119(95)00552-H; Koehler CM, 2000, MOL CELL BIOL, V20, P1187, DOI 10.1128/MCB.20.4.1187-1193.2000; Koehler CM, 1998, EMBO J, V17, P6477, DOI 10.1093/emboj/17.22.6477; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mihara K, 2000, BIOESSAYS, V22, P364, DOI 10.1002/(SICI)1521-1878(200004)22:4<364::AID-BIES6>3.0.CO;2-N; Mokranjac D, 2008, BBA-BIOENERGETICS, V1777, P758, DOI 10.1016/j.bbabio.2008.04.009; Mokranjac D, 2010, BBA-BIOENERGETICS, V1797, P1045, DOI 10.1016/j.bbabio.2010.01.026; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sideris DP, 2010, ANTIOXID REDOX SIGN, V13, P1189, DOI 10.1089/ars.2010.3157; Sirrenberg C, 1998, NATURE, V391, P912, DOI 10.1038/36136; Sirrenberg C, 1996, NATURE, V384, P582, DOI 10.1038/384582a0; Stojanovski D, 2012, BBA-MOL CELL RES, V1823, P1142, DOI 10.1016/j.bbamcr.2012.04.014; Tamura Y, 2010, EMBO J, V29, P2875, DOI 10.1038/emboj.2010.149; Wagner K, 2008, MOL CELL BIOL, V28, P4251, DOI 10.1128/MCB.02216-07; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Wrobel L, 2013, MOL BIOL CELL, V24, P543, DOI 10.1091/mbc.E12-09-0649	38	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4827	4838		10.1074/jbc.M113.543264	http://dx.doi.org/10.1074/jbc.M113.543264			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24385427	Green Published, hybrid			2022-12-28	WOS:000331607900030
J	Sahu, S; Philip, F; Scarlata, S				Sahu, Shriya; Philip, Finly; Scarlata, Suzanne			Hydrolysis Rates of Different Small Interfering RNAs ( siRNAs) by the RNA Silencing Promoter Complex, C3PO, Determines Their Regulation by Phospholipase C beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence Correlation Spectroscopy; Fluorescence Resonance Energy Transfer (FRET); Phospholipase C; Protein Assembly; siRNA; Enzymatic Rate	TRANSLIN; ASSOCIATION; G-ALPHA(Q); ACTIVATION; EXPRESSION; ROLES; TRAX	Background: PLC reverses siRNA down-regulation possibly by binding to the RNA silencing promoter C3PO. Results: PLC binds externally to C3PO to reduce rapid hydrolysis of specific siRNAs. Conclusion: A model for PLC effects on C3PO-mediated siRNA hydrolysis is presented. Significance: The studies provide a clue of the genes that may be regulated by cytosolic PLC. C3PO plays a key role in promoting RNA-induced gene silencing. C3PO consists of two subunits of the endonuclease translin-associated factor X (TRAX) and six subunits of the nucleotide-binding protein translin. We have found that TRAX binds strongly to phospholipase C (PLC), which transmits G protein signals from many hormones and sensory inputs. The association between PLC and TRAX is thought to underlie the ability of PLC to reverse gene silencing by small interfering RNAs. However, this reversal only occurs for some genes (e.g. GAPDH and LDH) but not others (e.g. Hsp90 and cyclophilin A). To understand this specificity, we carried out studies using fluorescence-based methods. In cells, we find that PLC, TRAX, and their complexes are identically distributed through the cytosol suggesting that selectivity is not due to large scale sequestration of either the free or complexed proteins. Using purified proteins, we find that PLC binds approximate to 5-fold more weakly to translin than to TRAX but approximate to 2-fold more strongly to C3PO. PLC does not alter TRAX-translin assembly to C3PO, and brightness studies suggest one PLC binds to one C3PO octamer without a change in the number of TRAX/translin molecules suggesting that PLC binds to an external site. Functionally, we find that C3PO hydrolyzes siRNA(GAPDH) at a faster rate than siRNA(Hsp90). However, when PLC is bound to C3PO, the hydrolysis rate of siRNA(GAPDH) becomes comparable with siRNA(Hsp90). Our results show that the selectivity of PLC toward certain genes lies in the rate at which the RNA is hydrolyzed by C3PO.	[Sahu, Shriya; Philip, Finly; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Scarlata, S (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	suzanne.scarlata@sunysb.edu			National Institutes of Health [GM053132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072853, R01GM053132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM053132.	Aisiku O, 2011, ARCH BIOCHEM BIOPHYS, V509, P186, DOI 10.1016/j.abb.2011.02.006; Aisiku OR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015001; Chennathukuzhi V, 2003, MOL CELL BIOL, V23, P6419, DOI 10.1128/MCB.23.18.6419-6434.2003; Dai RP, 2008, J BIOL CHEM, V283, P26894, DOI 10.1074/jbc.M804307200; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Filtz TM, 2009, FASEB J, V23, P3564, DOI 10.1096/fj.09-133983; Guo YJ, 2010, J BIOL CHEM, V285, P24999, DOI 10.1074/jbc.M110.132654; Gupta GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033035; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Jaendling A, 2010, BIOCHEM J, V429, P225, DOI 10.1042/BJ20100273; Lakowicz JR, 1999, PRINCIPLES FLUORESCE, P353; Li Z, 2008, BBA-GENE REGUL MECH, V1779, P479, DOI 10.1016/j.bbagrm.2008.03.008; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Lyon AM, 2011, NAT STRUCT MOL BIOL, V18, P999, DOI 10.1038/nsmb.2095; Parizotto EA, 2013, NAT STRUCT MOL BIOL, V20, P380, DOI 10.1038/nsmb.2487; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Perez-Cano L, 2013, NUCLEIC ACIDS RES, V41, P9956, DOI 10.1093/nar/gkt765; Philip F, 2012, FASEB J, V26, P4903, DOI 10.1096/fj.12-213934; Phillips F, 2006, SOCIAL CULTURE AND HIGH-TECH ECONOMIC DEVELOPMENT, P15; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Royer CA, 2008, METHOD ENZYMOL, V450, P79, DOI 10.1016/S0076-6879(08)03405-8; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; Scarlata S., 2004, REV FLUORESCENCE, P75; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Tian Y, 2011, NAT STRUCT MOL BIOL, V18, P658, DOI 10.1038/nsmb.2069; Wang JT, 2009, J BIOL CHEM, V284, P16906, DOI 10.1074/jbc.M109.006585; Wu PH, 2013, MOL CELL, V52, P113, DOI 10.1016/j.molcel.2013.08.023; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	31	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5134	5144		10.1074/jbc.M113.531467	http://dx.doi.org/10.1074/jbc.M113.531467			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24338081	Green Published, hybrid			2022-12-28	WOS:000331607900056
J	Allu, PKR; Chirasani, VR; Ghosh, D; Mani, A; Bera, AK; Maji, SK; Senapati, S; Mullasari, AS; Mahapatra, NR				Allu, Prasanna K. R.; Chirasani, Venkat R.; Ghosh, Dhiman; Mani, Anitha; Bera, Amal K.; Maji, Samir K.; Senapati, Sanjib; Mullasari, Ajit S.; Mahapatra, Nitish R.			Naturally Occurring Variants of the Dysglycemic Peptide Pancreastatin DIFFERENTIAL POTENCIES FOR MULTIPLE CELLULAR FUNCTIONS AND STRUCTURE-FUNCTION CORRELATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Genetic Polymorphism; Glucose Metabolism; Metabolic Diseases; Molecular Modeling; Nitric Oxide; Peptide Hormones; Glucose Uptake; Human Genetic Variation; Metabolic Disorder; Pancreastatin	A-DERIVED PEPTIDE; NITRIC-OXIDE SYNTHESIS; CHROMOGRANIN-A; L-ARGININE; MECHANISMS; CATESTATIN; DISEASE; MUSCLE; HYPERGLYCEMIA; HYPERTENSION	Pancreastatin (PST), a chromogranin A-derived peptide, is a potent physiological inhibitor of glucose-induced insulin secretion. PST also triggers glycogenolysis in liver and reduces glucose uptake in adipocytes and hepatocytes. Here, we probed for genetic variations in PST sequence and identified two variants within its functionally important carboxyl terminus domain: E287K and G297S. To understand functional implications of these amino acid substitutions, we tested the effects of wild-type (PST-WT), PST-287K, and PST-297S peptides on various cellular processes/events. The rank order of efficacy to inhibit insulin-stimulated glucose uptake was: PST-297S > PST-287K > PST-WT. The PST peptides also displayed the same order of efficacy for enhancing intracellular nitric oxide and Ca2+ levels in various cell types. In addition, PST peptides activated gluconeogenic genes in the following order: PST-297S approximate to PST-287K > PST-WT. Consistent with these in vitro results, the common PST variant allele Ser-297 was associated with significantly higher (by approximate to 17 mg/dl, as compared with the wild-type Gly-297 allele) plasma glucose level in our study population (n = 410). Molecular modeling and molecular dynamics simulations predicted the following rank order of -helical content: PST-297S > PST-287K > PST-WT. Corroboratively, circular dichroism analysis of PST peptides revealed significant differences in global structures (e.g. the order of propensity to form -helix was: PST-297S approximate to PST-287K > PST-WT). This study provides a molecular basis for enhanced potencies/efficacies of human PST variants (likely to occur in approximate to 300 million people worldwide) and has quantitative implications for inter-individual variations in glucose/insulin homeostasis.	[Allu, Prasanna K. R.; Chirasani, Venkat R.; Mani, Anitha; Bera, Amal K.; Senapati, Sanjib; Mahapatra, Nitish R.] Indian Inst Technol, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India; [Ghosh, Dhiman; Maji, Samir K.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Mullasari, Ajit S.] Madras Med Mission, Inst Cardiovasc Dis, Madras 600037, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Mahapatra, NR (corresponding author), Indian Inst Technol, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India.	nmahapatra@iitm.ac.in	Mahapatra, Nitish R/D-4123-2014; Chirasani, Venkata Reddy/ABB-4967-2021; Maji, Samir K. K./B-9640-2019; Chirasani, Venkata Reddy/AFN-6812-2022	Mahapatra, Nitish R/0000-0002-0695-3510; Chirasani, Venkata Reddy/0000-0003-1416-0438; Maji, Samir K. K./0000-0002-9110-1565; Chirasani, Venkata Reddy/0000-0003-1416-0438; Mani, Anitha/0000-0003-0163-1261; Bera, Amal Kanti/0000-0003-0362-5578	Department of Biotechnology and Science and Engineering Research Board, Government of India; University Grants Commission, Government of India	Department of Biotechnology and Science and Engineering Research Board, Government of India; University Grants Commission, Government of India(University Grants Commission, India)	This work was supported in part by the Department of Biotechnology and Science and Engineering Research Board, Government of India (to N. R. M.).; Supported by a University Grants Commission, Government of India research fellowship.	Acharya V, 2012, HUM MUTAT, V33, P332, DOI 10.1002/humu.21642; Bartolomucci A, 2011, ENDOCR REV, V32, P755, DOI 10.1210/er.2010-0027; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Cadman PE, 2002, ANN NY ACAD SCI, V971, P528, DOI 10.1111/j.1749-6632.2002.tb04518.x; DEFRONZO RA, 1989, METABOLISM, V38, P387, DOI 10.1016/0026-0495(89)90129-7; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Friese RS, 2010, PHYSIOL GENOMICS, V40, P195, DOI 10.1152/physiolgenomics.00164.2009; Gayen JR, 2009, J BIOL CHEM, V284, P28498, DOI 10.1074/jbc.M109.020636; Gonzalez-Yanes C, 2003, CELL MOL LIFE SCI, V60, P2749, DOI 10.1007/s00018-003-3346-7; Gonzalez-Yanes C, 2002, BIOCHEM BIOPH RES CO, V299, P525, DOI 10.1016/S0006-291X(02)02682-7; Gonzalez-Yanes C, 2000, DIABETES, V49, P1288, DOI 10.2337/diabetes.49.8.1288; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; HARUTA T, 1995, J BIOL CHEM, V270, P27991; Helle KB, 2010, CARDIOVASC RES, V85, P9, DOI 10.1093/cvr/cvp266; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HUTTNER WB, 1987, NATURE, V325, P305, DOI 10.1038/325305b0; Hutton JC, 2009, J BIOL CHEM, V284, P29241, DOI 10.1074/jbc.R109.025544; Kesavan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061393; KITAYAMA N, 1994, LIFE SCI, V54, P1571; KONECKI DS, 1987, J BIOL CHEM, V262, P17026; Larance M, 2008, MOL ENDOCRINOL, V22, P226, DOI 10.1210/me.2007-0282; Loh YP, 2012, J MOL NEUROSCI, V48, P347, DOI 10.1007/s12031-012-9728-2; Ludwig DS, 1996, J CLIN ENDOCR METAB, V81, P503, DOI 10.1210/jc.81.2.503; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Merry TL, 2009, IUBMB LIFE, V61, P479, DOI 10.1002/iub.179; O'Connor DT, 2005, J CLIN ENDOCR METAB, V90, P5414, DOI 10.1210/jc.2005-0408; PALMER RMJ, 1988, BIOCHEM BIOPH RES CO, V153, P1251, DOI 10.1016/S0006-291X(88)81362-7; Pfeiffer S, 1996, BRIT J PHARMACOL, V118, P1433, DOI 10.1111/j.1476-5381.1996.tb15557.x; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Sahu BS, 2012, J BIOL CHEM, V287, P43840, DOI 10.1074/jbc.M112.407916; Sahu BS, 2012, J CELL SCI, V125, P2323, DOI 10.1242/jcs.103176; SANCHEZ V, 1990, BIOSCIENCE REP, V10, P87, DOI 10.1007/BF01116856; Sanchez-Margalet V, 2000, ADV EXP MED BIOL, V482, P247; Sanchez-Margalet V, 2010, REGUL PEPTIDES, V161, P8, DOI 10.1016/j.regpep.2010.02.005; SANCHEZMARGALET V, 1992, MOL CELL ENDOCRINOL, V88, P129, DOI 10.1016/0303-7207(92)90017-Z; SanchezMargalet V, 1996, CELL SIGNAL, V8, P9, DOI 10.1016/0898-6568(95)02014-4; SCHMIDT WE, 1988, P NATL ACAD SCI USA, V85, P8231, DOI 10.1073/pnas.85.21.8231; SEKIYA K, 1988, FEBS LETT, V228, P153, DOI 10.1016/0014-5793(88)80606-9; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; TAMAMURA H, 1990, EUR J BIOCHEM, V191, P33, DOI 10.1111/j.1432-1033.1990.tb19090.x; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wen G, 2004, AM J HUM GENET, V74, P197, DOI 10.1086/381399; Zhang KX, 2006, DIABETES OBES METAB, V8, P621, DOI 10.1111/j.1463-1326.2006.00575.x; Zweier JL, 1999, BBA-BIOENERGETICS, V1411, P250, DOI 10.1016/S0005-2728(99)00018-3	50	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4455	4469		10.1074/jbc.M113.520916	http://dx.doi.org/10.1074/jbc.M113.520916			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24338022	Green Published, hybrid			2022-12-28	WOS:000331403800055
J	Buechner, CN; Heil, K; Michels, G; Carell, T; Kisker, C; Tessmer, I				Buechner, Claudia N.; Heil, Korbinian; Michels, Gudrun; Carell, Thomas; Kisker, Caroline; Tessmer, Ingrid			Strand-specific Recognition of DNA Damages by XPD Provides Insights into Nucleotide Excision Repair Substrate Versatility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atomic Force Microscopy; DNA Damage; DNA Helicase; DNA Repair; Single Molecule Biophysics; DNA Lesion Recognition; Protein-DNA Interactions	QUALITY-CONTROL; THYMINE DIMER; HELICASE; MECHANISM; PROTEIN; COMPLEX; TFIIH; TRANSLOCATION; MISMATCHES; DECAMER	Background: XPD is important for DNA lesion recognition by the nucleotide excision repair (NER) system. Results: Dependent on the lesion type, XPD recognizes lesions either on the protein-translocated or on the nontranslocated DNA strand. Conclusion: XPD employs different recognition strategies for different types of damage. Significance: Different lesion-specific recognition approaches may enhance the remarkably broad target spectrum of NER. Recognition and removal of DNA damages is essential for cellular and organismal viability. Nucleotide excision repair (NER) is the sole mechanism in humans for the repair of carcinogenic UV irradiation-induced photoproducts in the DNA, such as cyclobutane pyrimidine dimers. The broad substrate versatility of NER further includes, among others, various bulky DNA adducts. It has been proposed that the 5-3 helicase XPD (xeroderma pigmentosum group D) protein plays a decisive role in damage verification. However, despite recent advances such as the identification of a DNA-binding channel and central pore in the protein, through which the DNA is threaded, as well as a dedicated lesion recognition pocket near the pore, the exact process of target site recognition and verification in eukaryotic NER still remained elusive. Our single molecule analysis by atomic force microscopy reveals for the first time that XPD utilizes different recognition strategies to verify structurally diverse lesions. Bulky fluorescein damage is preferentially detected on the translocated strand, whereas the opposite strand preference is observed for a cyclobutane pyrimidine dimer lesion. Both states, however, lead to similar conformational changes in the resulting specific complexes, indicating a merge to a final verification state, which may then trigger the recruitment of further NER proteins.	[Buechner, Claudia N.; Michels, Gudrun; Kisker, Caroline; Tessmer, Ingrid] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2, D-97080 Wurzburg, Germany; [Heil, Korbinian; Carell, Thomas] Univ Munich, Dept Chem & Pharm, D-81377 Munich, Germany	University of Wurzburg; University of Munich	Tessmer, I (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	ingrid.tessmer@virchow.uni-wuerzburg.de	Kisker, Caroline/T-1724-2019; Carell, Thomas/G-4799-2012; Tessmer, Ingrid/O-2810-2013	Carell, Thomas/0000-0001-7898-2831; Tessmer, Ingrid/0000-0002-8353-6315; Kisker, Caroline/0000-0002-0216-6026; Heil, Korbinian/0000-0002-3454-8264	Deutsche Forschungsgemeinschaft Rudolf Virchow Center for Experimental Biomedicine [FZ 82, KI-562/2]	Deutsche Forschungsgemeinschaft Rudolf Virchow Center for Experimental Biomedicine(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Rudolf Virchow Center for Experimental Biomedicine Grants FZ 82 (to I. T. and C. K.) and KI-562/2 (to C. K.).	Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; Buechner CN, 2013, J MOL RECOGNIT, V26, P605, DOI 10.1002/jmr.2311; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; de Jesus BMB, 2008, MOL CELL BIOL, V28, P7225, DOI 10.1128/MCB.00781-08; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Ito S, 2007, MOL CELL, V26, P231, DOI 10.1016/j.molcel.2007.03.013; Jaciuk M, 2011, NAT STRUCT MOL BIOL, V18, P191, DOI 10.1038/nsmb.1973; Jain V, 2013, NUCLEIC ACIDS RES, V41, P869, DOI 10.1093/nar/gks1077; KIM ST, 1995, PHOTOCHEM PHOTOBIOL, V61, P171, DOI 10.1111/j.1751-1097.1995.tb03956.x; Kisker C., 2013, COLD SPRING HARB PER, V5; Krasikova YS, 2013, J BIOL CHEM, V288, P10936, DOI 10.1074/jbc.M112.444026; Kuper J, 2012, CURR OPIN STRUC BIOL, V22, P88, DOI 10.1016/j.sbi.2011.12.002; Kuper J, 2012, EMBO J, V31, P494, DOI 10.1038/emboj.2011.374; Lee JH, 2004, NUCLEIC ACIDS RES, V32, P2474, DOI 10.1093/nar/gkh568; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lukianova OA, 2005, CURR OPIN CHEM BIOL, V9, P145, DOI 10.1016/j.cbpa.2005.02.006; Mathieu N, 2013, CURR BIOL, V23, P204, DOI 10.1016/j.cub.2012.12.032; Mathieu N, 2010, P NATL ACAD SCI USA, V107, P17545, DOI 10.1073/pnas.1004339107; McAteer K, 1998, J MOL BIOL, V282, P1013, DOI 10.1006/jmbi.1998.2062; Moggs JG, 1996, J BIOL CHEM, V271, P7177, DOI 10.1074/jbc.271.12.7177; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; Mui TP, 2011, J AM CHEM SOC, V133, P16378, DOI 10.1021/ja207222t; NAEGELI H, 1992, J BIOL CHEM, V267, P392; Oksenych V, 2009, EMBO J, V28, P2971, DOI 10.1038/emboj.2009.230; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; Petit C, 1999, BIOCHIMIE, V81, P15, DOI 10.1016/S0300-9084(99)80034-0; Pugh RA, 2008, J MOL BIOL, V383, P982, DOI 10.1016/j.jmb.2008.09.001; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Ren B, 2009, J BIOL CHEM, V284, P4829, DOI 10.1074/jbc.M807943200; Rudolf J, 2010, NUCLEIC ACIDS RES, V38, P931, DOI 10.1093/nar/gkp1058; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Sugasawa K, 2009, MOL CELL, V36, P642, DOI 10.1016/j.molcel.2009.09.035; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; Tessmer I, 2012, NUCLEIC ACIDS RES, V40, P8296, DOI 10.1093/nar/gks574; Tessmer I, 2008, J BIOL CHEM, V283, P36646, DOI 10.1074/jbc.M805712200; Verhoeven EEA, 2002, EMBO J, V21, P4196, DOI 10.1093/emboj/cdf396; Verhoeven EEA, 2001, EMBO J, V20, P601, DOI 10.1093/emboj/20.3.601; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Yang Y, 2005, NUCLEIC ACIDS RES, V33, P4322, DOI 10.1093/nar/gki708	47	34	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3613	3624		10.1074/jbc.M113.523001	http://dx.doi.org/10.1074/jbc.M113.523001			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24338567	Green Published, hybrid			2022-12-28	WOS:000331368700044
J	Dikiy, I; Eliezer, D				Dikiy, Igor; Eliezer, David			N-terminal Acetylation Stabilizes N-terminal Helicity in Lipid- and Micelle-bound alpha-Synuclein and Increases Its Affinity for Physiological Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Synuclein; Lipid-binding Protein; Parkinson Disease; Post Translational Modification; Protein Aggregation; Synuclein; N-terminal Acetylation	PARKINSONS-DISEASE; PHOSPHOLIPID-BINDING; PACKING DEFECTS; EXTENDED-HELIX; PHOSPHORYLATION; CURVATURE; MUTATION; NMR; YEAST; AGGREGATION	Background: The functional effects of normal N-terminal acetylation of the Parkinson disease protein -synuclein are unknown. Results:N-Acetylation stabilizes helical structure at the N terminus of membrane-bound forms of synuclein, including a novel partly helical state. Conclusion: Stabilization of helicity increases affinity for membranes similar to synaptic vesicles. Significance:In vivo N-acetylation of -synuclein likely affects its physiological function and dysfunction. The Parkinson disease protein -synuclein is N-terminally acetylated, but most in vitro studies have been performed using unacetylated -synuclein. Binding to lipid membranes is considered key to the still poorly understood function of -synuclein. We report the effects of N-terminal acetylation on -synuclein binding to lipid vesicles of different composition and curvature and to micelles composed of the detergents -octyl-glucoside (BOG) and SDS. In the presence of SDS, N-terminal acetylation results in a slightly increased helicity for the N-terminal approximate to 10 residues of the protein, likely due to the stabilization of N-terminal fraying through the formation of a helix cap motif. In the presence of BOG, a detergent used in previous isolations of helical oligomeric forms of -synuclein, the N-terminally acetylated protein adopts a novel conformation in which the N-terminal approximate to 30 residues bind the detergent micelle in a partly helical conformation, whereas the remainder of the protein remains unbound and disordered. Binding of -synuclein to lipid vesicles with high negative charge content is essentially unaffected by N-terminal acetylation irrespective of curvature, but binding to vesicles of lower negative charge content is increased, with stronger binding observed for vesicles with higher curvature. Thus, the naturally occurring N-terminally acetylated form of -synuclein exhibits stabilized helicity at its N terminus and increased affinity for lipid vesicles similar to synaptic vesicles, a binding target of the protein in vivo. Furthermore, the novel BOG-bound state of N-terminally acetylated -synuclein may serve as a model of partly helical membrane-bound intermediates with a role in -synuclein function and dysfunction.	[Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; Weill Cornell Med Coll, Program Struct Biol, New York, NY 10065 USA	Cornell University; Cornell University	Eliezer, D (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA.	dae2005@med.cornell.edu	Dikiy, Igor/M-1031-2019	Dikiy, Igor/0000-0002-8155-7788	New York State Office of Science, Technology and Academic Research; Office of Research Infrastructure Programs (ORIP)/National Institutes of Health [CO6RR015495]; National Institutes of Health [P41GM066354]; Keck Foundation; New York State Assembly; United States Department of Defense; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG019391, R01AG025440] Funding Source: NIH RePORTER	New York State Office of Science, Technology and Academic Research; Office of Research Infrastructure Programs (ORIP)/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); New York State Assembly; United States Department of Defense(United States Department of Defense); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge Trudy Fiona Ramlall for significant help with protein production, David Snead and Shifeng Xiao for stimulating discussions, and Drs. Clay Bracken and Shibani Bhattacharya for help with NMR experiments. Data collection at New York Structural Biology Center was made possible by a grant from the New York State Office of Science, Technology and Academic Research and Office of Research Infrastructure Programs (ORIP)/National Institutes of Health facility improvement Grant CO6RR015495. The 900-MHz NMR spectrometers were purchased with funds from National Institutes of Health Grant P41GM066354, the Keck Foundation, New York State Assembly, and the United States Department of Defense.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Binolfi A, 2012, BIOCHEM SOC T, V40, P950, DOI 10.1042/BST20120096; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Borbat P, 2006, J AM CHEM SOC, V128, P10004, DOI 10.1021/ja063122l; Braun AR, 2012, J AM CHEM SOC, V134, P2613, DOI 10.1021/ja208316h; Burre J, 2013, NATURE, V498, pE4, DOI 10.1038/nature12125; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cabin DE, 2002, J NEUROSCI, V22, P8797; CHAKRABARTTY A, 1993, P NATL ACAD SCI USA, V90, P11332, DOI 10.1073/pnas.90.23.11332; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Devine MJ, 2011, MOVEMENT DISORD, V26, P2160, DOI 10.1002/mds.23948; Dikiy I, 2012, BBA-BIOMEMBRANES, V1818, P1013, DOI 10.1016/j.bbamem.2011.09.008; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Eliezer D, 2008, PARKINSON'S DISEASE: MOLECULAR AND THERAPEUTIC INSIGHTS FROM MODEL SYSTEMS, P575, DOI 10.1016/B978-0-12-374028-1.00042-7; EMSLEY L, 1992, J MAGN RESON, V97, P135, DOI 10.1016/0022-2364(92)90242-Y; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Hejjaoui M, 2012, J AM CHEM SOC, V134, P5196, DOI 10.1021/ja210866j; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; JARVIS JA, 1995, J BIOL CHEM, V270, P1323, DOI 10.1074/jbc.270.3.1323; Jensen MB, 2011, J BIOL CHEM, V286, P42603, DOI 10.1074/jbc.M111.271130; Jo E, 2004, EUR J BIOCHEM, V271, P3180, DOI 10.1111/j.1432-1033.2004.04250.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Junge F, 2008, CELL MOL LIFE SCI, V65, P1729, DOI 10.1007/s00018-008-8067-5; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Kang LJ, 2012, PROTEIN SCI, V21, P911, DOI 10.1002/pro.2088; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Kimura Y, 2000, J BIOL CHEM, V275, P4635, DOI 10.1074/jbc.275.7.4635; Kjaer L, 2009, BIOPHYS J, V96, P2857, DOI 10.1016/j.bpj.2008.12.3940; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Liu SM, 2004, EMBO J, V23, P4506, DOI 10.1038/sj.emboj.7600451; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; Maison W, 2001, J AM CHEM SOC, V123, P10245, DOI 10.1021/ja010812a; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Rohl CA, 1997, BIOCHEMISTRY-US, V36, P8435, DOI 10.1021/bi9706677; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Skoumpla K, 2007, J CELL SCI, V120, P1635, DOI 10.1242/jcs.001115; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Tulumello DV, 2012, BBA-BIOMEMBRANES, V1818, P1351, DOI 10.1016/j.bbamem.2012.01.013; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Varkey J, 2013, J BIOL CHEM, V288, P17620, DOI 10.1074/jbc.M113.476697; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Zabrocki P, 2008, BBA-MOL CELL RES, V1783, P1767, DOI 10.1016/j.bbamcr.2008.06.010; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	84	115	120	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3652	3665		10.1074/jbc.M113.512459	http://dx.doi.org/10.1074/jbc.M113.512459			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24338013	Green Published, hybrid			2022-12-28	WOS:000331368700047
J	Lai, AY; Lan, CP; Hasan, S; Brown, ME; McLaurin, J				Lai, Aaron Y.; Lan, Cynthia P.; Hasan, Salwa; Brown, Mary E.; McLaurin, JoAnne			scyllo-Inositol Promotes Robust Mutant Huntingtin Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Huntington Disease; Lysosomes; Neurodegenerative Diseases; Proteasome; huntingtin; scyllo-Inositol	UBIQUITIN-PROTEASOME SYSTEM; INCLUSION-BODY FORMATION; AMYLOID-BETA PEPTIDE; TRANSGENIC MODEL; NEURONAL CELLS; MOUSE MODEL; DISEASE; AGGREGATION; TOXICITY; STEREOISOMERS	Background: Effects of scyllo-inositol, a modulator of misfolded protein accumulation, were tested in a cellular model of Huntington disease. Results:scyllo-Inositol lowered mutant huntingtin aggregation and decreased protein abundance through proteasomal and lysosomal degradation. Conclusion:scyllo-Inositol promotes mutant huntingtin degradation in a model of Huntington disease. Significance: In contrast to other compounds targeting mutant huntingtin aggregation and accumulation, scyllo-inositol promotes effective degradation. Huntington disease is characterized by neuronal aggregates and inclusions containing polyglutamine-expanded huntingtin protein and peptide fragments (polyQ-Htt). We have used an established cell-based assay employing a PC12 cell line overexpressing truncated exon 1 of Htt with a 103-residue polyQ expansion that yields polyQ-Htt aggregates to investigate the fate of polyQ-Htt-drug complexes. scyllo-Inositol is an endogenous inositol stereoisomer known to inhibit accumulation and toxicity of the amyloid- peptide and -synuclein. In light of these properties, we investigated the effect of scyllo-inositol on polyQ-Htt accumulation. We show that scyllo-inositol lowered the number of visible polyQ-Htt aggregates and robustly decreased polyQ-Htt protein abundance without concomitant cellular toxicity. We found that scyllo-inositol-induced polyQ-Htt reduction was by rescue of degradation pathways mediated by the lysosome and by the proteasome but not autophagosomes. The rescue of degradation pathways was not a direct result of scyllo-inositol on the lysosome or proteasome but due to scyllo-inositol-induced reduction in mutant polyQ-Htt protein levels.	[Lai, Aaron Y.; Lan, Cynthia P.; Hasan, Salwa; Brown, Mary E.; McLaurin, JoAnne] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto	McLaurin, J (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	j.mclaurin@utoronto.ca			Canadian Institutes of Health Research [PRG37857, 120894]; Ontario postdoctoral scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario postdoctoral scholarship	This work was supported by Canadian Institutes of Health Research Grants PRG37857 (to J. M.) and 120894 (to A. L.) and an Ontario postdoctoral scholarship (to A. L.). J. M. declares a conflict of interest as a named inventor on patents and patent applications relating to scyllo-inositol and derivatives.	Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Aytan N, 2013, EXP NEUROL, V250, P228, DOI 10.1016/j.expneurol.2013.10.001; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bhutani N, 2012, J BIOL CHEM, V287, P17471, DOI 10.1074/jbc.M112.352781; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Butler DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029199; Cheung ZH, 2011, J NEUROCHEM, V118, P317, DOI 10.1111/j.1471-4159.2011.07314.x; Chopra V, 2007, P NATL ACAD SCI USA, V104, P16685, DOI 10.1073/pnas.0707842104; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Fenili D, 2007, J MOL MED, V85, P603, DOI 10.1007/s00109-007-0156-7; Fenili D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024032; Fuentealba RA, 2012, HUM MOL GENET, V21, P664, DOI 10.1093/hmg/ddr500; Gillis J, 2013, J BIOL CHEM, V288, P17225, DOI 10.1074/jbc.M112.421685; Hunter JM, 2007, J NEUROSCI RES, V85, P1774, DOI 10.1002/jnr.21287; Jana NR, 2010, FUTUR NEUROL, V5, P105, DOI 10.2217/FNL.09.69; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Karpuj MV, 1999, P NATL ACAD SCI USA, V96, P7388, DOI 10.1073/pnas.96.13.7388; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kazmi F, 2013, DRUG METAB DISPOS, V41, P897, DOI 10.1124/dmd.112.050054; Khandros E, 2012, BLOOD, V119, P5265, DOI 10.1182/blood-2011-12-397729; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lai AY, 2012, BBA-MOL BASIS DIS, V1822, P1629, DOI 10.1016/j.bbadis.2012.07.003; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Li G, 2013, J PHYS CHEM B, V117, P6603, DOI 10.1021/jp311350r; Li G, 2012, J PHYS CHEM B, V116, P1111, DOI 10.1021/jp208567n; Liang QL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-37; Lichtenberg M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.81; Lu BX, 2013, NAT NEUROSCI, V16, P562, DOI 10.1038/nn.3367; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Mitra S, 2009, J BIOL CHEM, V284, P4398, DOI 10.1074/jbc.M806269200; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ortega Z, 2010, J NEUROSCI, V30, P3675, DOI 10.1523/JNEUROSCI.5673-09.2010; Qi L, 2012, PLOS ONE, V7; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Sontag EM, 2013, P NATL ACAD SCI USA, V110, P3077, DOI 10.1073/pnas.1222663110; Sontag EM, 2012, J HUNTINGTONS DIS, V1, P119, DOI 10.3233/JHD-2012-129004; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Tashiro E, 2013, J BIOL CHEM, V288, P19958, DOI 10.1074/jbc.M113.477984; Torok B, 2013, CURR BIOACT COMPD, V9, P37; Townsend M, 2006, ANN NEUROL, V60, P668, DOI 10.1002/ana.21051; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; van Bebber F, 2010, NEUROBIOL DIS, V39, P265, DOI 10.1016/j.nbd.2010.03.023; Vekrellis K, 2009, J NEUROCHEM, V109, P1348, DOI 10.1111/j.1471-4159.2009.06054.x; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Wooten MW, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/62079; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6	57	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3666	3676		10.1074/jbc.M113.501635	http://dx.doi.org/10.1074/jbc.M113.501635			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24352657	hybrid, Green Published			2022-12-28	WOS:000331368700048
J	Cornilescu, CC; Cornilescu, G; Burgie, ES; Markley, JL; Ulijasz, AT; Vierstra, RD				Cornilescu, Claudia C.; Cornilescu, Gabriel; Burgie, E. Sethe; Markley, John L.; Ulijasz, Andrew T.; Vierstra, Richard D.			Dynamic Structural Changes Underpin Photoconversion of a Blue/Green Cyanobacteriochrome between Its Dark and Photoactivated States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyanobacteria; NMR; Phototransduction; Plant; Protein Structure; Bilin; Cyanobacteriochrome; Photoconversion; Photoreceptor; Phytochrome	PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; CHROMOPHORE-BINDING DOMAIN; GROUND-STATE; DXCF-CYANOBACTERIOCHROMES; CRYSTAL-STRUCTURE; PHYTOCHROME; LIGHT; NMR; PHOTOCHEMISTRY; PHOTOCYCLES	Background: Phytochromes are photochromic bili-proteins vital to microbial and plant photoperception. Results: NMR spectroscopy generated three-dimensional structures of the photosensing module from a cyanobacterial variant in the dark and photoactivated states. Conclusion: Photoconversion involves thioether bond rupture, bilin isomerization and sliding, and increased protein disorder. Significance: Combined with crystallographic models, these paired NMR structures provide an unprecedented view into photoconversion of a phytochrome-type photoreceptor. The phytochrome superfamily of photoreceptors exploits reversible light-driven changes in the bilin chromophore to initiate a variety of signaling cascades. The nature of these alterations and how they impact the protein moiety remain poorly resolved and might include several species-specific routes. Here, we provide a detailed picture of photoconversion for the photosensing cGMP phosphodiesterase/adenylyl cyclase/FhlA (GAF) domain from Thermosynechococcus elongatus (Te) PixJ, a member of the cyanobacteriochrome clade. Solution NMR structures of the blue light-absorbing dark state Pb and green light-absorbing photoactivated state Pg, combined with paired crystallographic models, revealed that the bilin and GAF domain dynamically transition via breakage of the C10/Cys-494 thioether bond, opposite rotations of the A and D pyrrole rings, sliding of the bilin in the GAF pocket, and the appearance of an extended region of disorder that includes Cys-494. Changes in GAF domain backbone dynamics were also observed that are likely important for inter-domain signal propagation. Taken together, photoconversion of T. elongatus PixJ from Pb to Pg involves complex structural changes within the GAF domain pocket that transduce light into a mechanical signal, many aspects of which should be relevant to others within the extended phytochrome superfamily.	[Cornilescu, Claudia C.; Cornilescu, Gabriel; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Dept Biochem, Madison, WI 53706 USA; [Burgie, E. Sethe; Ulijasz, Andrew T.; Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Ulijasz, Andrew T.] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Mol Bacteriol & Infect CMBI, London SW7 2AZ, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Imperial College London	Ulijasz, AT (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Ctr Mol Bacteriol & Infect, Flowers Bldg,Rm 2-20,Armstrong Rd, London SW7 2AZ, England.	a.ulijasz@imperial.ac.uk; vierstra@wisc.edu	Cornilescu, Claudia/K-1981-2015; Cornilescu, Gabriel/H-3113-2011	Cornilescu, Claudia/0000-0002-2401-7806; Cornilescu, Gabriel/0000-0002-1204-8904; Ulijasz, Andrew/0000-0003-0739-1297	National Institutes of Health [P41RR02301]; National Magnetic Resonance Facility at Madison, University of Wisconsin [P41GM66326]; United States National Science Foundation [MCB-07191530, MCB-1329956]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066326] Funding Source: NIH RePORTER; Direct For Biological Sciences [1329956] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1022010] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Magnetic Resonance Facility at Madison, University of Wisconsin; United States National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health Grants P41RR02301 and P41GM66326 (to the National Magnetic Resonance Facility at Madison, University of Wisconsin and to J. L. M.) and by United States National Science Foundation Grants MCB-07191530 and MCB-1329956 (to R. D. V.).	Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; Burgie ES, 2013, STRUCTURE, V21, P88, DOI 10.1016/j.str.2012.11.001; Chen Y, 2012, FEBS J, V279, P40, DOI 10.1111/j.1742-4658.2011.08397.x; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Cornilescu G, 2000, J AM CHEM SOC, V122, P10143, DOI 10.1021/ja0016194; Cornilescu G, 2008, J MOL BIOL, V383, P403, DOI 10.1016/j.jmb.2008.08.034; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Ferris HU, 2012, STRUCTURE, V20, P56, DOI 10.1016/j.str.2011.11.014; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Goto NK, 2001, J MOL BIOL, V308, P745, DOI 10.1006/jmbi.2001.4614; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Hirose Y, 2013, P NATL ACAD SCI USA, V110, P4974, DOI 10.1073/pnas.1302909110; Ishizuka T, 2011, BIOCHEMISTRY-US, V50, P953, DOI 10.1021/bi101626t; Narikawa R, 2013, P NATL ACAD SCI USA, V110, P918, DOI 10.1073/pnas.1212098110; Rockwell NC, 2013, P NATL ACAD SCI USA, V110, P806, DOI 10.1073/pnas.1220690110; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P3576, DOI 10.1021/bi300171s; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P1449, DOI 10.1021/bi201783j; Rockwell NC, 2011, P NATL ACAD SCI USA, V108, P11854, DOI 10.1073/pnas.1107844108; Schmidt M, 2007, BIOCHEMISTRY-US, V46, P416, DOI 10.1021/bi061844j; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; Ulijasz AT, 2009, J BIOL CHEM, V284, P29757, DOI 10.1074/jbc.M109.038513; Vierstra RD, 2011, TRENDS PLANT SCI, V16, P417, DOI 10.1016/j.tplants.2011.05.011; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wuthrich K., 1986, NMR PROTEINS NUCLEIC, P180; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Yoshihara S, 2006, BIOCHEMISTRY-US, V45, P3775, DOI 10.1021/bi051983l	37	47	48	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					3055	3065		10.1074/jbc.M113.531053	http://dx.doi.org/10.1074/jbc.M113.531053			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24337572	hybrid, Green Published			2022-12-28	WOS:000333403000051
J	Pfaff, C; Glindemann, N; Gruber, J; Frentzen, M; Sadre, R				Pfaff, Christian; Glindemann, Niels; Gruber, Jens; Frentzen, Margrit; Sadre, Radin			Chorismate Pyruvate-Lyase and 4-Hydroxy-3-solanesylbenzoate Decarboxylase Are Required for Plastoquinone Biosynthesis in the Cyanobacterium Synechocystis sp PCC6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyanobacteria; Isoprenoid; Mutant; Photosynthesis; Quinones; 4-Hydroxy-3-prenylbenzoate Decarboxylase; Chorismate Pyruvate-Lyase; Plastoquinone; Ubiquinone	ESCHERICHIA-COLI K-12; 4-HYDROXYBENZOATE DECARBOXYLASE; PHOTOSYSTEM-I; GENE; PHYLLOQUINONE; UBIQUINONE; UBIX; ACID; INACTIVATION; PURIFICATION	Background: Plastoquinone biosynthesis in cyanobacteria differs from that in plants. Results: Chorismate pyruvate-lyase and 4-hydroxy-3-solanesylbenzoate decarboxylase single-gene knock-out mutants are severely affected in plastoquinone synthesis, cell size/structure, and growth. Conclusion: The plastoquinone biosynthetic pathway likely evolved from a pre-existing ubiquinone pathway in cyanobacterial ancestors. Significance: Cyanobacterial mutants deficient in plastoquinone biosynthesis allow deeper understanding of processes related to energy transformation. Plastoquinone is a redox active lipid that serves as electron transporter in the bifunctional photosynthetic-respiratory transport chain of cyanobacteria. To examine the role of genes potentially involved in cyanobacterial plastoquinone biosynthesis, we have focused on three Synechocystis sp. PCC 6803 genes likely encoding a chorismate pyruvate-lyase (sll1797) and two 4-hydroxy-3-solanesylbenzoate decarboxylases (slr1099 and sll0936). The functions of the encoded proteins were investigated by complementation experiments with Escherichia coli mutants, by the in vitro enzyme assays with the recombinant proteins, and by the development of Synechocystis sp. single-gene knock-out mutants. Our results demonstrate that sll1797 encodes a chorismate pyruvate-lyase. In the respective knock-out mutant, plastoquinone was hardly detectable, and the mutant required 4-hydroxybenzoate for growth underlining the importance of chorismate pyruvate-lyase to initiate plastoquinone biosynthesis in cyanobacteria. The recombinant Slr1099 protein displayed decarboxylase activity and catalyzed in vitro the decarboxylation of 4-hydroxy-3-prenylbenzoate with different prenyl side chain lengths. In contrast to Slr1099, the recombinant Sll0936 protein did not show decarboxylase activity regardless of the conditions used. Inactivation of the sll0936 gene in Synechocystis sp., however, caused a drastic reduction in the plastoquinone content to levels very similar to those determined in the slr1099 knock-out mutant. This proves that not only slr1099 but also sll0936 is required for plastoquinone synthesis in the cyanobacterium. In summary, our data demonstrate that cyanobacteria produce plastoquinone exclusively via a pathway that is in the first reaction steps almost identical to ubiquinone biosynthesis in E. coli with conversion of chorismate to 4-hydroxybenzoate, which is then prenylated and decarboxylated.	[Pfaff, Christian; Glindemann, Niels; Gruber, Jens; Frentzen, Margrit] Rhein Westfal TH Aachen, Inst Biol 1, D-52056 Aachen, Germany; [Sadre, Radin] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	RWTH Aachen University; Michigan State University	Sadre, R (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	sadre@msu.edu		Sadre, Radin/0000-0002-8412-2579; Gruber, Jens/0000-0003-4474-1217				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2003, FEMS MICROBIOL LETT, V222, P17, DOI 10.1016/S0378-1097(03)00242-8; ASHBY MN, 1990, J BIOL CHEM, V265, P13157; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng ZG, 2003, PLANT CELL, V15, P2343, DOI 10.1105/tpc.013656; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; COX GB, 1969, J BACTERIOL, V99, P450, DOI 10.1128/JB.99.2.450-458.1969; Dahnhardt D, 2002, FEBS LETT, V523, P177, DOI 10.1016/S0014-5793(02)02978-2; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gulmezian M, 2007, ARCH BIOCHEM BIOPHYS, V467, P144, DOI 10.1016/j.abb.2007.08.009; Gulmezian M, 2006, J BACTERIOL, V188, P6435, DOI 10.1128/JB.00668-06; Johnson TW, 2000, J BIOL CHEM, V275, P8523, DOI 10.1074/jbc.275.12.8523; KNOELL HE, 1979, BIOCHEM BIOPH RES CO, V91, P919, DOI 10.1016/0006-291X(79)91967-3; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kruk J, 1997, CHEM PHYS LIPIDS, V87, P73, DOI 10.1016/S0009-3084(97)00027-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefebvre-Legendre L, 2007, J BIOL CHEM, V282, P13250, DOI 10.1074/jbc.M610249200; LEPPIK RA, 1976, BIOCHIM BIOPHYS ACTA, V428, P146, DOI 10.1016/0304-4165(76)90116-1; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Liu J, 2007, CURR MICROBIOL, V54, P102, DOI 10.1007/s00284-006-0153-z; Liu J, 2006, ACTA BIOCH BIOPH SIN, V38, P725, DOI 10.1111/j.1745-7270.2006.00214.x; Lupa B, 2005, GENOMICS, V86, P342, DOI 10.1016/j.ygeno.2005.05.002; Lupa B, 2008, CAN J MICROBIOL, V54, P75, DOI [10.1139/W07-113, 10.1139/w07-113]; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matsui T, 2006, ARCH MICROBIOL, V186, P21, DOI 10.1007/s00203-006-0117-5; MONOD J, 1951, BIOCHIM BIOPHYS ACTA, V7, P585, DOI 10.1016/0006-3002(51)90072-8; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Rangarajan ES, 2004, PROTEIN SCI, V13, P3006, DOI 10.1110/ps.04953004; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Sadre R, 2012, BIOCHEM J, V442, P621, DOI 10.1042/BJ20111796; Sadre R, 2010, J BIOL CHEM, V285, P18191, DOI 10.1074/jbc.M110.117929; Sakuragi Yumiko, 2006, V24, P205; SCHERER S, 1988, ARCH BIOCHEM BIOPHYS, V267, P228, DOI 10.1016/0003-9861(88)90027-6; Schultze M, 2009, BBA-BIOENERGETICS, V1787, P1479, DOI 10.1016/j.bbabio.2009.06.010; Shimada H, 2005, PLANT J, V41, P627, DOI 10.1111/j.1365-313X.2004.02326.x; SIEBERT M, 1994, MICROBIOL-SGM, V140, P897, DOI 10.1099/00221287-140-4-897; Smith N, 2006, ARCH BIOCHEM BIOPHYS, V445, P72, DOI 10.1016/j.abb.2005.10.026; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian L, 2007, PLANTA, V226, P1067, DOI 10.1007/s00425-007-0564-5; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766	45	17	18	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2675	2686		10.1074/jbc.M113.511709	http://dx.doi.org/10.1074/jbc.M113.511709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24337576	Green Published, hybrid			2022-12-28	WOS:000333403000018
J	Znameroski, EA; Li, X; Tsai, JC; Galazka, JM; Glass, NL; Cate, JHD				Znameroski, Elizabeth A.; Li, Xin; Tsai, Jordan C.; Galazka, Jonathan M.; Glass, N. Louise; Cate, Jamie H. D.			Evidence for Transceptor Function of Cellodextrin Transporters in Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergy; Biofuel; Cellulase; Fungi; Genetics; Cellodextrin Transporter; Neurospora crassa; Transceptor	MODEL FILAMENTOUS FUNGUS; KINASE-A PATHWAY; TRICHODERMA-REESEI; GLUCOSE; ENZYMES; ACTIVATION; EXPRESSION; GROWTH; DEGRADATION; INDUCTION	Background: Mechanisms filamentous fungi use to sense cellulose in the environment remain unclear. Results:Neurospora crassa cellodextrin transporters, CDT-1 and CDT-2, are required to induce the expression and secretion of cellulases, using a mechanism distinct from that in Trichoderma reesei. Conclusion: CDT-1 and/or CDT-2 may act as transporting receptors (transceptors). Significance: CDT-1- and/or CDT-2-mediated cellodextrin signaling may be conserved in industrially useful fungi. Neurospora crassa colonizes burnt grasslands and metabolizes both cellulose and hemicellulose from plant cell walls. When switched from a favored carbon source to cellulose, N. crassa dramatically up-regulates expression and secretion of genes encoding lignocellulolytic enzymes. However, the means by which N. crassa and other filamentous fungi sense the presence of cellulose in the environment remains unclear. Previously, we have shown that a N. crassa mutant carrying deletions of three -glucosidase enzymes (3G) lacks -glucosidase activity, but efficiently induces cellulase gene expression and cellulolytic activity in the presence of cellobiose as the sole carbon source. These observations indicate that cellobiose, or a modified version of cellobiose, functions as an inducer of lignocellulolytic gene expression and activity in N. crassa. Here, we show that in N. crassa, two cellodextrin transporters, CDT-1 and CDT-2, contribute to cellulose sensing. A N. crassa mutant carrying deletions for both transporters is unable to induce cellulase gene expression in response to crystalline cellulose. Furthermore, a mutant lacking genes encoding both the -glucosidase enzymes and cellodextrin transporters (3G2T) does not induce cellulase gene expression in response to cellobiose. Point mutations that severely reduce cellobiose transport by either CDT-1 or CDT-2 when expressed individually do not greatly impact cellobiose induction of cellulase gene expression. These data suggest that the N. crassa cellodextrin transporters act as transceptors with dual functions - cellodextrin transport and receptor signaling that results in downstream activation of cellulolytic gene expression. Similar mechanisms of transceptor activity likely occur in related ascomycetes used for industrial cellulase production.	[Znameroski, Elizabeth A.; Li, Xin; Tsai, Jordan C.; Galazka, Jonathan M.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Glass, N. Louise] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Glass, NL (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	Lglass@berkeley.edu; jcate@lbl.gov	Glass, N. Louise/ABA-7303-2021	Tsai, Jordan/0000-0001-5202-722X; Galazka, Jonathan/0000-0002-4153-0249	National Institutes of Health [P01 GM068087]; Energy Biosciences Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Energy Biosciences Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant P01 GM068087. This work was also supported by a grant from the Energy Biosciences Institute (to N. L. G. and J. H. D. C.).	Berka RM, 2011, NAT BIOTECHNOL, V29, P922, DOI 10.1038/nbt.1976; Biswas K, 2005, MOL MICROBIOL, V56, P649, DOI 10.1111/j.1365-2958.2005.04576.x; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Coradetti ST, 2013, MICROBIOLOGYOPEN, V2, P595, DOI 10.1002/mbo3.94; Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dementhon K, 2006, EUKARYOT CELL, V5, P2161, DOI 10.1128/EC.00253-06; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galazka J. M., 2011, CELLODEXTRIN TRANSPO; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Glass NL, 2013, ANNU REV MICROBIOL, V67, P477, DOI 10.1146/annurev-micro-092611-150044; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Honda S, 2009, GENETICS, V182, P11, DOI 10.1534/genetics.108.098707; Ivanova C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062631; Jacobson DJ, 2006, MYCOLOGIA, V98, P550, DOI 10.3852/mycologia.98.4.550; Jacobson DJ, 2004, MYCOLOGIA, V96, P66, DOI 10.2307/3761989; Kim H., 2013, APPL MICROBIOL BIOTE, DOI 10.1007/s00253-013-5339-2; Kraakman L, 1999, MOL MICROBIOL, V32, P1002, DOI 10.1046/j.1365-2958.1999.01413.x; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; KUBICEK CP, 1993, J BIOL CHEM, V268, P19364; Lee S.B., 1988, FUNGAL GENET REP, V35, P23, DOI [10.4148/1941-4765.1531, DOI 10.4148/1941-4765.1531]; Margolin B.S., 1997, FUNGAL GENET REP, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; PERKINS DD, 1976, EVOLUTION, V30, P281, DOI 10.1111/j.1558-5646.1976.tb00910.x; Porciuncula JD, 2013, BIOSCI BIOTECH BIOCH, V77, P1014, DOI 10.1271/bbb.120992; Rosgaard L, 2006, BIOTECHNOL PROGR, V22, P493, DOI 10.1021/bp050361o; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schwoppe C, 2003, EUR J BIOCHEM, V270, P1450, DOI 10.1046/j.1432-1033.2003.03507.x; Smith DG, 2003, MOL MICROBIOL, V50, P259, DOI 10.1046/j.1365-2958.2003.03680.x; Somerville C, 2007, CURR BIOL, V17, pR115, DOI 10.1016/j.cub.2007.01.010; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Thevelein JM, 2009, MOL BIOL EVOL, V26, P2407, DOI 10.1093/molbev/msp168; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Turner BC, 2001, FUNGAL GENET BIOL, V32, P67, DOI 10.1006/fgbi.2001.1247; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Vogel H.J., 1956, MICROB GENET B, V13, P42; Walch-Liu P, 2008, PLANT J, V54, P820, DOI 10.1111/j.1365-313X.2008.03443.x; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; WESTERGAARD M, 1947, AM J BOT, V34, P573, DOI 10.2307/2437339; Wu W., 2013, A VANLEEUW J MICROB, DOI 10.1007/s10482-013-9972-7; Wyman CE, 1999, ANNU REV ENERG ENV, V24, P189, DOI 10.1146/annurev.energy.24.1.189; Zhang WX, 2013, J BIOL CHEM, V288, P32861, DOI 10.1074/jbc.M113.505826; Znameroski EA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-6; Znameroski EA, 2012, P NATL ACAD SCI USA, V109, P6012, DOI 10.1073/pnas.1118440109	52	50	54	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2610	2619		10.1074/jbc.M113.533273	http://dx.doi.org/10.1074/jbc.M113.533273			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24344125	hybrid, Green Published			2022-12-28	WOS:000333403000012
J	Naegeli, A; Neupert, C; Fan, YY; Lin, CW; Poljak, K; Papini, AM; Schwarz, F; Aebi, M				Naegeli, Andreas; Neupert, Christine; Fan, Yao-Yun; Lin, Chia-Wei; Poljak, Kristina; Papini, Anna Maria; Schwarz, Flavio; Aebi, Markus			Molecular Analysis of an Alternative N-Glycosylation Machinery by Functional Transfer from Actinobacillus pleuropneumoniae to Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Glucose; Glycosylation; Glycosyltransferases; Post-translational Modification; Actinobacillus pleuropneumoniae	INFLUENZAE HMW1 ADHESIN; HAEMOPHILUS-INFLUENZAE; MECHANISM; PROTEINS; GLYCOSYLTRANSFERASE; GLYCOPROTEIN; ANTIBODIES; ANTIGENS; YERSINIA; SEQUENCE	N-Linked protein glycosylation is a frequent post-translational modification that can be found in all three domains of life. In a canonical, highly conserved pathway, an oligosaccharide is transferred by a membrane-bound oligosaccharyltransferase from a lipid donor to asparagines in the sequon NX(S/T) of secreted polypeptides. The -proteobacterium Actinobacillus pleuropneumoniae encodes an unusual pathway for N-linked protein glycosylation. This pathway takes place in the cytoplasm and is mediated by a soluble N-glycosyltransferase (NGT) that uses nucleotide-activated monosaccharides to glycosylate asparagine residues. To characterize the process of cytoplasmic N-glycosylation in more detail, we studied the glycosylation in A. pleuropneumoniae and functionally transferred the glycosylation system to Escherichia coli. N-Linked glucose specific human sera were used for the analysis of the glycosylation process. We identified autotransporter adhesins as the preferred protein substrate of NGT in vivo, and in depth analysis of the modified sites in E. coli revealed a surprisingly relaxed peptide substrate specificity. Although NX(S/T) is the preferred acceptor sequon, we detected glycosylation of alternative sequons, including modification of glutamine and serine residues. We also demonstrate the use of NGT to glycosylate heterologous proteins. Therefore, our study could provide the basis for a novel route for the engineering of N-glycoproteins in bacteria.	[Naegeli, Andreas; Neupert, Christine; Fan, Yao-Yun; Lin, Chia-Wei; Poljak, Kristina; Schwarz, Flavio; Aebi, Markus] Swiss Fed Inst Technol, Inst Microbiol, Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland; [Papini, Anna Maria] Univ Florence, Dipartimento Chim Ugo Schiff, Lab Peptide & Prot Chem & Biol, I-50019 Sesto Fiorentino, Italy	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Florence	Aebi, M (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch	Lin, Chia-wei/ABA-6065-2021; Papini, Anna Maria/AAZ-5204-2020; Fan, YaoYun/AAS-5920-2020	Lin, Chia-wei/0000-0003-4777-2916; Naegeli, Andreas/0000-0002-5938-9124; Schwarz, Flavio/0000-0002-1060-1585; Poljak, Kristina/0000-0002-0199-3812; Papini, Anna Maria/0000-0002-2947-7107	Swiss National Science Foundation [CRSII3_12733, 3100170-105541]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	The project was supported by Swiss National Science Foundation Grants CRSII3_12733 and 3100170-105541 (to M. A.) and by ETH Zurich. A patent application ("Pasteurellaceae vaccines," PCT/EP2012/065480) covering the use of N-glycosylated Pasteurellaceae autotransporter adhesins as vaccines has been filed by ETH Zurich on behalf of A. N., F. S., and M. A. and was licensed to Malcisbo AG.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; ARSCOTT P, 1992, J CLIN ENDOCR METAB, V75, P295, DOI 10.1210/jc.75.1.295; Benz I, 2001, MOL MICROBIOL, V40, P1403, DOI 10.1046/j.1365-2958.2001.02487.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charbonneau ME, 2012, MOL MICROBIOL, V83, P894, DOI 10.1111/j.1365-2958.2012.07973.x; Charbonneau ME, 2009, J BIOL CHEM, V284, P17340, DOI 10.1074/jbc.M109.010108; Choi KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015888; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeFrees S, 2006, GLYCOBIOLOGY, V16, P833, DOI 10.1093/glycob/cwl004; Effraimidis G, 2011, CLIN EXP IMMUNOL, V165, P38, DOI 10.1111/j.1365-2249.2011.04399.x; FADEN H, 1995, J INFECT DIS, V172, P132, DOI 10.1093/infdis/172.1.132; Gerber S, 2013, J BIOL CHEM, V288, P8849, DOI 10.1074/jbc.M112.445940; Grass S, 2003, MOL MICROBIOL, V48, P737, DOI 10.1046/j.1365-2958.2003.03450.x; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kawai F, 2011, J BIOL CHEM, V286, P38546, DOI 10.1074/jbc.M111.237602; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Lindenthal C, 1999, INFECT IMMUN, V67, P4084, DOI 10.1128/IAI.67.8.4084-4091.1999; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lolli F, 2005, J NEUROIMMUNOL, V167, P131, DOI 10.1016/j.jneuroim.2005.05.016; Lolli F, 2005, P NATL ACAD SCI USA, V102, P10273, DOI 10.1073/pnas.0503178102; Lomino JV, 2013, BIOORGAN MED CHEM, V21, P2262, DOI 10.1016/j.bmc.2013.02.007; Nita-Lazar M, 2005, GLYCOBIOLOGY, V15, P361, DOI 10.1093/glycob/cwi019; Racaityte K, 2005, J CHROMATOGR A, V1079, P354, DOI 10.1016/j.chroma.2005.03.080; RESETKOVA E, 1994, THYROID, V4, P269, DOI 10.1089/thy.1994.4.269; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Schwarz F, 2011, J BIOL CHEM, V286, P35267, DOI 10.1074/jbc.M111.277160; Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261; Sharon N, 1995, ESSAYS BIOCHEM, V30, P59; Sherlock O, 2006, J BACTERIOL, V188, P1798, DOI 10.1128/JB.188.5.1798-1807.2006; Thein M, 2010, J PROTEOME RES, V9, P6135, DOI 10.1021/pr1002438; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wang YJ, 2010, INT J PHARMACEUT, V386, P156, DOI 10.1016/j.ijpharm.2009.11.016; WENZEL BE, 1988, LANCET, V1, P56; WILCHEK M, 1987, METHOD ENZYMOL, V138, P429; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xiao LW, 2012, J BASIC MICROB, V52, P598, DOI 10.1002/jobm.201100365	43	57	60	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2170	2179		10.1074/jbc.M113.524462	http://dx.doi.org/10.1074/jbc.M113.524462			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24275653	Green Published, hybrid			2022-12-28	WOS:000331130200025
J	Tomioka, T; Shimazaki, T; Yamauchi, T; Oki, T; Ohgoh, M; Okano, H				Tomioka, Takeyasu; Shimazaki, Takuya; Yamauchi, Toshihiko; Oki, Toru; Ohgoh, Makoto; Okano, Hideyuki			LIM Homeobox 8 (Lhx8) Is a Key Regulator of the Cholinergic Neuronal Function via a Tropomyosin Receptor Kinase A (TrkA)-mediated Positive Feedback Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; SPATIAL MEMORY IMPAIRMENTS; APOPTOTIC CELL-DEATH; EMBRYONIC STEM-CELLS; RAT BASAL FOREBRAIN; ACETYLCHOLINE-RELEASE; NEUROTROPHIC FACTOR; TRANSCRIPTION FACTOR; SEPTAL CELLS; AGED RATS	Basal forebrain cholinergic neurons play an important role in cognitive functions such as learning and memory, and they are affected in several neurodegenerative diseases, including Alzheimer disease and Down syndrome. Despite their functional importance, the molecular mechanisms of functional maturation and maintenance of these cholinergic neurons after the differentiation stage have not been fully elucidated. This study demonstrates that the LIM homeobox 8 (Lhx8) transcription factor regulates cholinergic function in rat septal cholinergic neurons in primary cultures from E18.5 embryos and in the adult brain. Lhx8 expression modulated tropomyosin receptor kinase A (TrkA) expression in septal cholinergic neurons in vitro and in vivo, resulting in regulated acetylcholine release as an index of cholinergic function. In addition, Lhx8 expression and function were regulated by nerve growth factor (NGF), and the effect of NGF was potentiated by Lhx8-induced TrkA expression. Together, our findings suggest that positive feedback regulation between Lhx8, TrkA, and NGF is an important regulatory mechanism for cholinergic functions of the septum.	[Tomioka, Takeyasu; Shimazaki, Takuya; Okano, Hideyuki] Keio Univ, Dept Physiol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Tomioka, Takeyasu; Oki, Toru; Ohgoh, Makoto] Eisai & Co Ltd, Dept Biol Pharmacol, Discovery Res, Neurosci Prod Creat Unit, Tsukuba, Ibaraki 3002635, Japan; [Yamauchi, Toshihiko] Eisai & Co Ltd, Dept Biol, KAN Prod Creat Unit, Tsukuba, Ibaraki 3002635, Japan	Keio University; Eisai Co Ltd; Eisai Co Ltd	Okano, H (corresponding author), Keio Univ, Dept Physiol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan.	hidokano@a2.keio.jp	Shimazaki, Takuya/L-1159-2013; Okano, Hideyuki/I-7584-2019	Shimazaki, Takuya/0000-0002-3936-2098; 	Japanese Ministry of Education, Culture, Sports, Science and Technology; Eisai Co., Ltd.	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Eisai Co., Ltd.(Eisai Co Ltd)	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Funding Program for World-leading Innovative R&D on Science and Technology (to H. O.), and Eisai Co., Ltd.	Asbreuk CHJ, 2002, NEUROSCIENCE, V109, P287, DOI 10.1016/S0306-4522(01)00466-3; Auld DS, 2001, J NEUROSCI, V21, P3375, DOI 10.1523/JNEUROSCI.21-10-03375.2001; Auld DS, 2000, J PHARMACOL EXP THER, V292, P692; Backman C, 1996, J NEUROSCI, V16, P5437; Bridwell JL, 2001, GENE, V277, P239, DOI 10.1016/S0378-1119(01)00704-1; Casarosa S, 1999, DEVELOPMENT, V126, P525; Donello JE, 1996, J VIROL, V70, P4345, DOI 10.1128/JVI.70.7.4345-4351.1996; ElTamer A, 1996, NEUROSCI LETT, V203, P123, DOI 10.1016/0304-3940(95)12283-4; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fagan AM, 1997, J NEUROSCI, V17, P7644; FISCHER W, 1991, EXP NEUROL, V113, P93, DOI 10.1016/0014-4886(91)90167-B; FISCHER W, 1992, NEUROBIOL AGING, V13, P9, DOI 10.1016/0197-4580(92)90003-G; FISCHER W, 1994, P NATL ACAD SCI USA, V91, P8607, DOI 10.1073/pnas.91.18.8607; Fitzsimons HL, 2002, METHODS, V28, P227, DOI 10.1016/S1046-2023(02)00227-X; Fragkouli A, 2005, EUR J NEUROSCI, V21, P2923, DOI 10.1111/j.1460-9568.2005.04141.x; Goto M, 1996, MOL PHARMACOL, V49, P860; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Gustilo MC, 1999, J COMP NEUROL, V405, P491, DOI 10.1002/(SICI)1096-9861(19990322)405:4<491::AID-CNE4>3.0.CO;2-N; Ha DH, 1999, J COMP NEUROL, V406, P156; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; HEFTI F, 1986, J NEUROSCI, V6, P2155; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kosasa T, 1999, EUR J PHARMACOL, V380, P101, DOI 10.1016/S0014-2999(99)00545-2; Leanza G, 1996, EUR J NEUROSCI, V8, P1535, DOI 10.1111/j.1460-9568.1996.tb01616.x; LEANZA G, 1995, EUR J NEUROSCI, V7, P329, DOI 10.1111/j.1460-9568.1995.tb01068.x; Lopes R, 2012, P NATL ACAD SCI USA, V109, P3119, DOI 10.1073/pnas.1109251109; Ma L, 2000, DEVELOPMENT, V127, P3777; Ma L, 2003, DEVELOPMENT, V130, P3525, DOI 10.1242/dev.00582; Madziar B, 2005, J NEUROCHEM, V92, P767, DOI 10.1111/j.1471-4159.2004.02908.x; Manabe T, 2007, CELL DEATH DIFFER, V14, P1080, DOI 10.1038/sj.cdd.4402106; MartinezSerrano A, 1996, P NATL ACAD SCI USA, V93, P6355, DOI 10.1073/pnas.93.13.6355; MARTINEZSERRANO A, 1995, NEURON, V15, P473, DOI 10.1016/0896-6273(95)90051-9; MOBLEY WC, 1986, MOL BRAIN RES, V1, P53, DOI 10.1016/0169-328X(86)90020-3; Mori T, 2004, EUR J NEUROSCI, V19, P3129, DOI 10.1111/j.0953-816X.2004.03415.x; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohgoh M, 1998, EXP NEUROL, V149, P51, DOI 10.1006/exnr.1997.6719; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Oosawa H, 1999, J NEUROSCI RES, V57, P381, DOI 10.1002/(SICI)1097-4547(19990801)57:3<381::AID-JNR10>3.3.CO;2-3; Pongrac JL, 1996, J NEUROCHEM, V66, P804; Salehi A, 2003, TRENDS NEUROSCI, V26, P73, DOI 10.1016/S0166-2236(02)00038-3; Saragovi HU, 2005, J NEUROCHEM, V95, P1472, DOI 10.1111/j.1471-4159.2005.03479.x; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Sussel L, 1999, DEVELOPMENT, V126, P3359; SUZUKI T, 1994, BRAIN RES, V665, P311, DOI 10.1016/0006-8993(94)91353-6; Takahashi E, 1999, BIOCHEM BIOPH RES CO, V260, P54, DOI 10.1006/bbrc.1999.0857; TAKEI N, 1989, J NEUROCHEM, V53, P1405, DOI 10.1111/j.1471-4159.1989.tb08531.x; Toresson H, 2000, DEVELOPMENT, V127, P4361; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; WILCOX BJ, 1995, J COMP NEUROL, V359, P573, DOI 10.1002/cne.903590405; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yun K, 2001, DEVELOPMENT, V128, P193; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	59	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1000	1010		10.1074/jbc.M113.494385	http://dx.doi.org/10.1074/jbc.M113.494385			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265310	Green Published, hybrid			2022-12-28	WOS:000330541200034
J	Villarejo, A; Cortes-Cabrera, A; Molina-Ortiz, P; Portillo, F; Cano, A				Villarejo, Ana; Cortes-Cabrera, Alvaro; Molina-Ortiz, Patricia; Portillo, Francisco; Cano, Amparo			Differential Role of Snail1 and Snail2 Zinc Fingers in E-cadherin Repression and Epithelial to Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; TUMOR-GROWTH; SLUG; EXPRESSION; GENE; PHOSPHORYLATION; FAMILY; SUPERFAMILY; METASTASIS; REGULATORS	Snail1 (Snail) and Snail2 (Slug) are transcription factors that share a similar DNA binding structure of four and five C2H2 zinc finger motifs (ZF), respectively. Both factors bind specifically to a subset of E-box motifs (E2-box: CAGGTG/CACCTG) in target promoters like the E-cadherin promoter and are key mediators of epithelial-to-mesenchymal transition (EMT). However, there are differences in the biological actions, in binding affinities to E-cadherin promoter, and in the target genes of Snail1 and Snail2, although the molecular bases are presently unknown. In particular, the role of each Snail1 and Snail2 ZF in the binding to E-boxes and in EMT induction has not been previously explored. We have approached this question by modeling Snail1 and Snail2 protein-DNA interactions and through mutational and functional assays of different ZFs. Results show that Snail1 efficient repression and binding to human and mouse E-cadherin promoter as well as EMT-inducing ability require intact ZF1 and ZF2, while for Snail2, either ZF3 or ZF4 is essential for those functions. Furthermore, the differential distribution of E2-boxes in mouse and human E-cadherin promoters also contributes to the differential Snail factor activity. These data indicate a non-equivalent role of Snail1 and Snail2 ZFs in gene repression, contributing to the elucidation of the molecular differences between these important EMT regulators.	[Villarejo, Ana; Molina-Ortiz, Patricia; Portillo, Francisco; Cano, Amparo] Univ Autonoma Madrid, Dept Bioquim, Inst Invest Biomed Alberto Sols CSIC UAM, IdiPAZ, Madrid 28029, Spain; [Cortes-Cabrera, Alvaro] Ctr Biol Mol Severo Ochoa CSIC UAM, Unidad Bioinformat, Madrid 28049, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Portillo, F (corresponding author), Univ Autonoma Madrid, Dept Bioquim, Inst Invest Biomed Alberto Sols CSIC UAM, IdiPAZ, Arzobispo Morcillo 2, Madrid 28029, Spain.	fportillo@iib.uam.es; acano@iib.uam.es	; Cortes Cabrera, Alvaro/B-3748-2016	Portillo Perez, Francisco/0000-0003-4922-346X; Cortes Cabrera, Alvaro/0000-0003-4635-6267	Spanish Ministry of Economy and Competitiveness [SAF2010-21143, CSD2007-00017]; Comunidad de Madrid [S2010/BMD-2303]; Instituto de Salud Carlos III [RETIC-RD12/0036/0007]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the Spanish Ministry of Economy and Competitiveness (formerly Innovation and Sciences) [SAF2010-21143; Consolider-Ingenio CSD2007-00017]; Comunidad de Madrid [S2010/BMD-2303]; and the Instituto de Salud Carlos III [RETIC-RD12/0036/0007].	Alves CC, 2007, J PATHOL, V211, P507, DOI 10.1002/path.2138; Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Barrallo-Gimeno A, 2009, TRENDS GENET, V25, P248, DOI 10.1016/j.tig.2009.04.001; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Elloul S, 2006, VIRCHOWS ARCH, V449, P520, DOI 10.1007/s00428-006-0274-6; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hajra KM, 2002, CANCER RES, V62, P1613; Hemavathy K, 2000, GENE, V257, P1, DOI 10.1016/S0378-1119(00)00371-1; Hemavathy K, 2000, MOL CELL BIOL, V20, P5087, DOI 10.1128/MCB.20.14.5087-5095.2000; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manzanares M, 2001, TRENDS GENET, V17, P178, DOI 10.1016/S0168-9525(01)02232-6; Martinez-Alvarez C, 2004, DEV BIOL, V265, P207, DOI 10.1016/j.ydbio.2003.09.022; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Mingot JM, 2009, J CELL SCI, V122, P1452, DOI 10.1242/jcs.041749; Molina-Ortiz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036132; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Olmeda D, 2008, ONCOGENE, V27, P4690, DOI 10.1038/onc.2008.118; Olmeda D, 2007, CANCER RES, V67, P11721, DOI 10.1158/0008-5472.CAN-07-2318; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Peinado H, 2005, CELL CYCLE, V4, P1749, DOI 10.4161/cc.4.12.2224; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; MacPherson MR, 2010, MOL BIOL CELL, V21, P244, DOI 10.1091/mbc.E09-06-0504; Sefton M, 1998, DEVELOPMENT, V125, P3111; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Stanisavljevic J, 2011, J CELL SCI, V124, P4159, DOI 10.1242/jcs.078824; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Yamasaki H, 2005, GENES CELLS, V10, P455, DOI 10.1111/j.1365-2443.2005.00850.x; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	49	106	113	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					930	941		10.1074/jbc.M113.528026	http://dx.doi.org/10.1074/jbc.M113.528026			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24297167	Green Published, hybrid			2022-12-28	WOS:000330541200028
J	Rose, AE; Zhao, CG; Turner, EM; Steyer, AM; Schlieker, C				Rose, April E.; Zhao, Chenguang; Turner, Elizabeth M.; Steyer, Anna M.; Schlieker, Christian			Arresting a Torsin ATPase Reshapes the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Electron Microscopy (EM); Endoplasmic Reticulum(ER); Enzyme Mechanisms; Membrane Structure; AAA plus ATPase; Torsin	NUCLEAR-ENVELOPE; DYT1 DYSTONIA; MEMBRANE-PROTEINS; MUTANT TORSINA; CELLS; DOMAIN; PHOSPHORYLATION; INCLUSIONS; EXPRESSION; ORGANELLES	Torsins are membrane-tethered AAA+ ATPases residing in the nuclear envelope (NE) and endoplasmic reticulum (ER). Here, we show that the induction of a conditional, dominant-negative TorsinB variant provokes a profound reorganization of the endomembrane system into foci containing double membrane structures that are derived from the ER. These double-membrane sinusoidal structures are formed by compressing the ER lumen to a constant width of 15 nm, and are highly enriched in the ATPase activator LULL1. Further, we define an important role for a highly conserved aromatic motif at the C terminus of Torsins. Mutations in this motif perturb LULL1 binding, reduce ATPase activity, and profoundly limit the induction of sinusoidal structures.	[Rose, April E.; Zhao, Chenguang; Turner, Elizabeth M.; Steyer, Anna M.; Schlieker, Christian] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Schlieker, C (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave,POB 208114,Bass 236A, New Haven, CT 06520 USA.	christian.schlieker@yale.edu		Steyer, Anna/0000-0002-4814-7517	National Institutes of Health [DP2 OD008624-01]; Ellison Medical Foundation [AG-NS-0662-10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded, in whole or in part, by National Institutes of Health Grant DP2 OD008624-01 and Ellison Medical Foundation Grant AG-NS-0662-10.	ANDERSON RGW, 1983, J CELL SCI, V63, P1; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Bragg DC, 2004, MOL CELL NEUROSCI, V27, P417, DOI 10.1016/j.mcn.2004.07.009; Bragg DC, 2004, NEUROSCIENCE, V125, P651, DOI 10.1016/j.neuroscience.2004.01.053; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; Fukuda M, 2001, J BIOL CHEM, V276, P41112, DOI 10.1074/jbc.M106209200; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Hewett JW, 2004, J NEUROCHEM, V89, P1186, DOI 10.1111/j.1471-4159.2004.02404.x; Heyden ABV, 2011, EMBO J, V30, P3217, DOI 10.1038/emboj.2011.233; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jokhi V, 2013, CELL REP, V3, P988, DOI 10.1016/j.celrep.2013.03.015; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Jungwirth M, 2010, HUM MOL GENET, V19, P888, DOI 10.1093/hmg/ddp557; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; Lingwood D, 2009, J BIOL CHEM, V284, P12041, DOI 10.1074/jbc.M900220200; Mullins C., 2005, MOL BIOL INTELLIGENC; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Naismith TV, 2009, J BIOL CHEM, V284, P27866, DOI 10.1074/jbc.M109.020164; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Neuwald AF, 1999, GENOME RES, V9, P27; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; TAKEI K, 1994, NEURON, V12, P327, DOI 10.1016/0896-6273(94)90275-5; Vander Heyden AB, 2009, MOL BIOL CELL, V20, P2661, DOI 10.1091/mbc.E09-01-0094; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; Yamamoto A, 1996, J CELL SCI, V109, P1727; Zhao CG, 2013, P NATL ACAD SCI USA, V110, pE1545, DOI 10.1073/pnas.1300676110; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104	40	26	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					552	564		10.1074/jbc.M113.515791	http://dx.doi.org/10.1074/jbc.M113.515791			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24275647	hybrid, Green Published			2022-12-28	WOS:000329370900047
J	Shore, DM; Baillie, GL; Hurst, DH; Navas, F; Seltzman, HH; Marcu, JP; Abood, ME; Ross, RA; Reggio, PH				Shore, Derek M.; Baillie, Gemma L.; Hurst, Dow H.; Navas, Frank, III; Seltzman, Herbert H.; Marcu, Jahan P.; Abood, Mary E.; Ross, Ruth A.; Reggio, Patricia H.			Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor BINDING SITE ELUCIDATION AND RELATIONSHIP TO G PROTEIN SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Cannabinoid Receptors; Cannabinoids; G Protein-coupled Receptors (GPCR); Signaling	MUSCARINIC ACETYLCHOLINE-RECEPTORS; CB1 RECEPTOR; EXTRACELLULAR LOOP; STRUCTURAL BASIS; DRUG DISCOVERY; ACTIVATION; AGONISTS; INTERNALIZATION; CONSTRUCTION; RECOGNITION	Background: Cannabinoid-1 (CB1) receptor allosteric modulator ORG27569 increases CP55,940 binding, yet antagonizes G protein signaling. Results: ORG27569 binding sterically blocks movement in CB1 extracellular loops and transmembrane helix 6 (TMH6). Conclusion: ORG27569 increases CP55,940 binding by promoting an intermediate receptor conformation where changes important for signaling are blocked. Significance: This information may lead to the rational design of new allosteric modulators. The cannabinoid 1 (CB1) allosteric modulator, 5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide) (ORG27569), has the paradoxical effect of increasing the equilibrium binding of [H-3](-)-3-[2-hydroxyl-4-(1,1-dimethylheptyl)phenyl]-4-[3-hydroxylpropyl]cyclohexan-1-ol (CP55,940, an orthosteric agonist) while at the same time decreasing its efficacy (in G protein-mediated signaling). ORG27569 also decreases basal signaling, acting as an inverse agonist for the G protein-mediated signaling pathway. In ligand displacement assays, ORG27569 can displace the CB1 antagonist/inverse agonist, N-(piperidiny-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide(SR141716A). The goal of this work was to identify the binding site of ORG27569 at CB1. To this end, we used computation, synthesis, mutation, and functional studies to identify the ORG27569-binding site in the CB1 TMH3-6-7 region. This site is consistent with the results of K3.28(192)A, F3.36(200)A, W5.43(279)A, W6.48(356)A, and F3.25(189)A mutation studies, which revealed the ORG27569-binding site overlaps with our previously determined binding site of SR141716A but extends extracellularly. Additionally, we identified a key electrostatic interaction between the ORG27569 piperidine ring nitrogen and K3.28(192) that is important for ORG27569 to act as an inverse agonist. At this allosteric site, ORG27569 promotes an intermediate conformation of the CB1 receptor, explaining ORG27569's ability to increase equilibrium binding of CP55,940. This site also explains ORG27569's ability to antagonize the efficacy of CP55,940 in three complementary ways. 1) ORG27569 sterically blocks movements of the second extracellular loop that have been linked to receptor activation. 2) ORG27569 sterically blocks a key electrostatic interaction between the third extracellular loop residue Lys-373 and D2.63(176). 3) ORG27569 packs against TMH6, sterically hindering movements of this helix that have been shown to be important for receptor activation.	[Shore, Derek M.; Hurst, Dow H.; Reggio, Patricia H.] Univ N Carolina, Ctr Drug Discovery, Greensboro, NC 27402 USA; [Baillie, Gemma L.; Ross, Ruth A.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Baillie, Gemma L.; Ross, Ruth A.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada; [Navas, Frank, III; Seltzman, Herbert H.] Res Triangle Inst, Res Triangle Pk, NC 27709 USA; [Marcu, Jahan P.; Abood, Mary E.] Temple Univ, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Marcu, Jahan P.; Abood, Mary E.] Temple Univ, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA	University of North Carolina; University of North Carolina Greensboro; University of Aberdeen; University of Toronto; Research Triangle Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Reggio, PH (corresponding author), Univ N Carolina, Ctr Drug Discovery, Dept Chem & Biochem, Patricia A Sullivan Sci Bldg,POB 26170, Greensboro, NC 27402 USA.	phreggio@uncg.edu	Ross, R./AAG-7468-2019	Abood, Mary/0000-0002-1744-2820	National Institutes of Health [RO1 DA003934, KO5 DA021358]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003934, K05DA021358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DA003934 and KO5 DA021358 (to P. H. R.).	Ahn KH, 2013, J BIOL CHEM, V288, P9790, DOI 10.1074/jbc.M112.438804; Ahn KH, 2012, J BIOL CHEM, V287, P12070, DOI 10.1074/jbc.M111.316463; Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Ahn KH, 2009, BIOPOLYMERS, V91, P565, DOI 10.1002/bip.21179; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Al-awar R. S., 2003, [No title captured], Patent No. [2003/0229026 A1, 20030229026, US 2003/0229026]; Ambrosio C, 2000, MOL PHARMACOL, V57, P198; Baillie GL, 2013, MOL PHARMACOL, V83, P322, DOI 10.1124/mol.112.080879; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Bertalovitz AC, 2010, DRUG DEVELOP RES, V71, P404, DOI 10.1002/ddr.20388; Birdsall NJM, 1996, PROG BRAIN RES, V109, P147; BRAMBLETT RD, 1995, LIFE SCI, V56, P1971, DOI 10.1016/0024-3205(95)00178-9; Christopoulou FD, 2011, J CLIN PHARM THER, V36, P10, DOI 10.1111/j.1365-2710.2010.01164.x; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Decaillot FM, 2003, NAT STRUCT BIOL, V10, P629, DOI 10.1038/nsb950; Fay JF, 2012, J BIOL CHEM, V287, P33873, DOI 10.1074/jbc.M112.352328; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Huang XP, 2007, MOL PHARMACOL, V71, P759, DOI 10.1124/mol.106.028944; Hurst D, 2006, J MED CHEM, V49, P5969, DOI 10.1021/jm060446b; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Hurst DP, 2002, MOL PHARMACOL, V62, P1274, DOI 10.1124/mol.62.6.1274; Insel PA, 2007, BBA-BIOMEMBRANES, V1768, P994, DOI 10.1016/j.bbamem.2006.09.029; Kapur A, 2007, MOL PHARMACOL, V71, P1512, DOI 10.1124/mol.107.034645; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kotsikorou E, 2011, BIOCHEMISTRY-US, V50, P5633, DOI 10.1021/bi200010k; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; Marcu J, 2013, J PHARMACOL EXP THER, V345, P189, DOI 10.1124/jpet.112.201046; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; McAllister SD, 2004, J BIOL CHEM, V279, P48024, DOI 10.1074/jbc.M406648200; McAllister SD, 2003, J MED CHEM, V46, P5139, DOI 10.1021/jm0302647; McCusker EC, 2007, BIOTECHNOL PROGR, V23, P540, DOI 10.1021/bp060349b; Okazaki K, 2003, Patent, Patent No. [EP1331221A1, 1331221]; Peeters MC, 2012, BIOCHEM PHARMACOL, V84, P76, DOI 10.1016/j.bcp.2012.03.008; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Pelcman B, 2006, U. S. Patent Application, Patent No. [20120029016 A1, 20120029016]; Pertwee RG, 2009, BRIT J PHARMACOL, V156, P397, DOI 10.1111/j.1476-5381.2008.00048.x; Piscitelli F, 2012, J MED CHEM, V55, P5627, DOI 10.1021/jm201485c; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Rana S, 2010, J BIOL CHEM, V285, P31472, DOI 10.1074/jbc.M110.129213; Ripka A, 2010, U. S. Patent, Patent No. [WO2010/006130, 2010006130]; Ross RA, 2007, TRENDS PHARMACOL SCI, V28, P567, DOI 10.1016/j.tips.2007.10.006; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwartz TW, 2007, TRENDS PHARMACOL SCI, V28, P366, DOI 10.1016/j.tips.2007.06.008; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Song ZH, 1996, MOL PHARMACOL, V49, P891; Unal H, 2013, J BIOL CHEM, V288, P540, DOI 10.1074/jbc.M112.392514; Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870; Wang CIA, 2013, BIOCHEM PHARMACOL, V85, P153, DOI 10.1016/j.bcp.2012.09.001; Wess J, 2005, MOL PHARMACOL, V68, P1506, DOI 10.1124/mol.105.019141; WESS J, 1993, LIFE SCI, V53, P1447, DOI 10.1016/0024-3205(93)90618-D	56	60	62	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5828	5845		10.1074/jbc.M113.478495	http://dx.doi.org/10.1074/jbc.M113.478495			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24366865	Green Published, hybrid			2022-12-28	WOS:000332015500042
J	Lundius, EG; Vukojevic, V; Hertz, E; Stroth, N; Cederlund, A; Hiraiwa, M; Terenius, L; Svenningsson, P				Lundius, Ebba Gregorsson; Vukojevic, Vladana; Hertz, Ellen; Stroth, Nikolas; Cederlund, Andreas; Hiraiwa, Masao; Terenius, Lars; Svenningsson, Per			GPR37 Protein Trafficking to the Plasma Membrane Regulated by Prosaposin and GM1 Gangliosides Promotes Cell Viability*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence Correlation Spectroscopy; G Protein-coupled Receptors (GPCR); Ganglioside; Lipid Raft; Parkinson Disease; Pael-R	FLUORESCENCE CORRELATION SPECTROSCOPY; CROSS-CORRELATION SPECTROSCOPY; ENDOPLASMIC-RETICULUM STRESS; POLYMERASE-CHAIN-REACTION; DELTA-OPIOID RECEPTORS; CENTRAL-NERVOUS-SYSTEM; PARKINSONS-DISEASE; LIPID RAFTS; PAEL-R; NEUROTROPHIC FACTOR	Background: Intracellular GPR37 accumulation is neurotoxic and associated with parkinsonism, whereas plasma membrane association is protective. Results: The endogenous GPR37 ligand prosaposin promotes GPR37 surface density and association with GM1-enriched lipid rafts. Conclusion: GPR37, prosaposin, and GM1 constitute a pathway that improves cell viability through GPR37 trafficking to the plasma membrane. Significance: Targeting this pathway could reduce toxic intracellular GPR37 accumulation observed in parkinsonism. The subcellular distribution of the G protein-coupled receptor GPR37 affects cell viability and is implicated in the pathogenesis of parkinsonism. Intracellular accumulation and aggregation of GPR37 cause cell death, whereas GPR37 located in the plasma membrane provides cell protection. We define here a pathway through which the recently identified natural ligand, prosaposin, promotes plasma membrane association of GPR37. Immunoabsorption of extracellular prosaposin reduced GPR37(tGFP) surface density and decreased cell viability in catecholaminergic N2a cells. We found that GPR37(tGFP) partitioned in GM1 ganglioside-containing lipid rafts in the plasma membrane of live cells. This partitioning required extracellular prosaposin and was disrupted by lipid raft perturbation using methyl--cyclodextrin or cholesterol oxidase. Moreover, complex formation between GPR37(tGFP) and the GM1 marker cholera toxin was observed in the plasma membrane. These data show functional association between GPR37, prosaposin, and GM1 in the plasma membrane. These results thus tie together the three previously defined components of the cellular response to insult. Our findings identify a mechanism through which the receptor's natural ligand and GM1 may protect against toxic intracellular GPR37 aggregates observed in parkinsonism.	[Lundius, Ebba Gregorsson; Hertz, Ellen; Stroth, Nikolas; Cederlund, Andreas; Svenningsson, Per] Karolinska Univ Hosp, Ctr Mol Med L8 01, Dept Clin Neurosci, Lab Translat Neuropharmacol, S-17176 Stockholm, Sweden; [Vukojevic, Vladana; Terenius, Lars] Karolinska Univ Hosp, Ctr Mol Med L8 01, Dept Clin Neurosci, Lab Expt Alcohol & Drug Addict Res, S-17176 Stockholm, Sweden; [Hiraiwa, Masao] Vet Therapeut, San Diego, CA 92121 USA	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Svenningsson, P (corresponding author), Karolinska Univ Hosp, Ctr Mol Med L8 01, Dept Clin Neurosci, Lab Translat Neuropharmacol, S-17176 Stockholm, Sweden.	per.svenningsson@ki.se	Lundius, Ebba/J-6844-2014; Svenningsson, Per JL/K-5210-2014; Vukojevic, Vladana B/AAY-3144-2021	Lundius, Ebba/0000-0002-3616-9997; Vukojevic, Vladana/0000-0003-0873-5653	Swedish Research Council; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Research Council and Karolinska Institutet.	Achour L, 2008, TRENDS PHARMACOL SCI, V29, P528, DOI 10.1016/j.tips.2008.07.009; Bao L, 2003, NEURON, V37, P121, DOI 10.1016/S0896-6273(02)01103-0; Bjork K, 2011, ANNU REV PHARMACOL, V51, P211, DOI 10.1146/annurev-pharmtox-010510-100520; Bleicken S, 2011, CURR PROTEIN PEPT SC, V12, P691, DOI 10.2174/138920311798841744; Cahill CM, 2001, J COMP NEUROL, V440, P65, DOI 10.1002/cne.1370; Campana WM, 1998, FASEB J, V12, P307, DOI 10.1096/fasebj.12.3.307; Campana WM, 2000, J PERIPHER NERV SYST, V5, P126, DOI 10.1046/j.1529-8027.2000.00019.x; Castro BM, 2013, METHOD CELL BIOL, V117, P105, DOI 10.1016/B978-0-12-408143-7.00006-2; Coleman SK, 2009, J NEUROSCI, V29, P303, DOI 10.1523/JNEUROSCI.3953-08.2009; Dusonchet J, 2009, NEUROBIOL DIS, V35, P32, DOI 10.1016/j.nbd.2009.03.013; Elson EL, 2001, TRAFFIC, V2, P789, DOI 10.1034/j.1600-0854.2001.21107.x; Elson EL, 2013, METHOD ENZYMOL, V518, P11, DOI 10.1016/B978-0-12-388422-0.00002-9; Foldes-Papp Z, 2001, BIOL CHEM, V382, P473, DOI 10.1515/BC.2001.057; Foldes-Papp Z, 2001, J BIOTECHNOL, V86, P237, DOI 10.1016/S0168-1656(00)00416-8; Foo YH, 2012, BIOPHYS J, V102, P1174, DOI 10.1016/j.bpj.2012.01.040; Ganguly S, 2010, BIOPHYS J, V99, P1397, DOI 10.1016/j.bpj.2010.06.031; Gao HL, 2013, NEUROSCIENCE, V236, P373, DOI 10.1016/j.neuroscience.2013.01.007; Gray JA, 2001, BRAIN RES BULL, V56, P441, DOI 10.1016/S0361-9230(01)00623-2; Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933; Hiraiwa M, 1999, GLIA, V26, P353, DOI 10.1002/(SICI)1098-1136(199906)26:4<353::AID-GLIA9>3.0.CO;2-G; Hiraiwa M, 1997, BIOCHEM BIOPH RES CO, V240, P415, DOI 10.1006/bbrc.1997.7673; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; Kitao Y, 2007, HUM MOL GENET, V16, P50, DOI 10.1093/hmg/ddl439; Leng N, 1999, MOL BRAIN RES, V69, P73, DOI 10.1016/S0169-328X(99)00092-3; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lundius EG, 2013, J NEUROCHEM, V124, P410, DOI 10.1111/jnc.12081; Marazziti D, 1998, GENOMICS, V53, P315, DOI 10.1006/geno.1998.5433; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; Mimori S, 2012, BIOL PHARM BULL, V35, P84, DOI 10.1248/bpb.35.84; Misasi R, 1998, J NEUROCHEM, V71, P2313; Morita F, 2001, J CEREBR BLOOD F MET, V21, P1295, DOI 10.1097/00004647-200111000-00005; Morris MA, 2001, FASEB J, V15, pA1026, DOI 10.1096/fj.00-0603fje; Murakami T, 2004, ANN NEUROL, V55, P439, DOI 10.1002/ana.20064; Navarro A, 1999, BRAIN RES, V816, P47, DOI 10.1016/S0006-8993(98)01062-2; OBRIEN JS, 1995, FASEB J, V9, P681, DOI 10.1096/fasebj.9.8.7768361; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; Ochiai T, 2008, BBA-GEN SUBJECTS, V1780, P1441, DOI 10.1016/j.bbagen.2008.07.010; Pfeiffer R, 1998, EXP CELL RES, V244, P327, DOI 10.1006/excr.1998.4159; PICH EM, 1992, STROKE, V23, P234, DOI 10.1161/01.STR.23.2.234; Qi XY, 1999, BIOCHEMISTRY-US, V38, P6284, DOI 10.1021/bi990079o; Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097; Rigler R, 1998, J BIOTECHNOL, V63, P97, DOI 10.1016/S0168-1656(98)00079-0; Roettger BF, 1997, MOL PHARMACOL, V51, P357; Schneider JS, 2013, J NEUROL SCI, V324, P140, DOI 10.1016/j.jns.2012.10.024; SCHNEIDER JS, 1992, SCIENCE, V256, P843, DOI 10.1126/science.1350379; Sjogren B, 2006, EUR J PHARMACOL, V552, P1, DOI 10.1016/j.ejphar.2006.08.069; Sorice M, 2008, FEBS J, V275, P4903, DOI 10.1111/j.1742-4658.2008.06630.x; Ulrich M, 2006, BIOINFORMATICS, V22, P2709, DOI 10.1093/bioinformatics/btl456; Vukojevic V, 2005, CELL MOL LIFE SCI, V62, P535, DOI 10.1007/s00018-004-4305-7; Vukojevic V, 2010, P NATL ACAD SCI USA, V107, P4093, DOI 10.1073/pnas.0914612107; Vukojevic V, 2008, P NATL ACAD SCI USA, V105, P18176, DOI 10.1073/pnas.0809250105; Wang HQ, 2008, J NEUROCHEM, V107, P171, DOI 10.1111/j.1471-4159.2008.05607.x; Weidemann T, 2013, METHOD ENZYMOL, V518, P43, DOI 10.1016/B978-0-12-388422-0.00003-0; Weise K, 2010, BBA-BIOMEMBRANES, V1798, P1409, DOI 10.1016/j.bbamem.2009.12.006; Weisshart K, 2004, CURR PHARM BIOTECHNO, V5, P135, DOI 10.2174/1389201043376913; Yan LZ, 2000, NEUROSCI LETT, V278, P120, DOI 10.1016/S0304-3940(99)00902-7; Zeng ZZ, 1997, BIOCHEM BIOPH RES CO, V233, P559, DOI 10.1006/bbrc.1997.6408	58	31	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4660	4673		10.1074/jbc.M113.510883	http://dx.doi.org/10.1074/jbc.M113.510883			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24371137	Green Published, hybrid			2022-12-28	WOS:000331607900014
J	Wang, YZ; Xu, WP; Zhou, DJ; Neckers, L; Chen, SA				Wang, Yuanzhong; Xu, Wanping; Zhou, Dujin; Neckers, Len; Chen, Shiuan			Coordinated Regulation of Serum-andGlucocorticoid- inducible Kinase 3 by a C- terminal Hydrophobic Motif and Hsp90-Cdc37 Chaperone Complex*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hsp90; Molecular Chaperone; PI 3-Kinase (PI3K); Protein Stability; Ubiquitination; CHIP; Cdc37; SGK3; Hydrophobic Motif	GLUCOCORTICOID-INDUCED KINASE-1; BREAST-CANCER; LIGASE CHIP; DEGRADATION; HSP90; AKT; PATHWAY; CISK; PHOSPHORYLATION; IDENTIFICATION	Background: Serum- and glucocorticoid-inducible kinase 3 (SGK3) plays a pivotal role in Akt-independent oncogenic signaling. Results: Hsp90-Cdc37 chaperone complex acts in concert with the hydrophobic motif of SGK3 to regulate SGK3 stability and activation. Conclusion: Hsp90-Cdc37 complex is essential for SGK3 stability and activation. Significance: The involvement of Hsp90-Cdc37 in SGK3 regulation provides a rationale for Hsp90 inhibition in treating SGK3-dependent cancers. Serum- and glucocorticoid-inducible kinase 3 (SGK3) mediates a variety of cellular processes including membrane transport, cell proliferation, and survival, and it has been implicated in Akt-independent signaling downstream of oncogenic PIK3CA mutations (activating mutations in the catalytic subunit of PI3K) in human cancers. However, the regulation of SGK3 is poorly understood. Here we report that SGK3 stability and kinase activation are regulated by the Hsp90-Cdc37 chaperone complex. Hsp90-Cdc37 associates with the kinase domain of SGK3 and acts in concert with a C-terminal hydrophobic motif of SGK3 to prevent Hsp70 association and ubiquitin ligase CHIP (C terminus of Hsc70-interacting protein)-mediated degradation. Phosphorylation of hydrophobic motif triggers release of Cdc37 and concomitant association of 3-phosphoinositide dependent kinase 1 (PDK1) to activate SGK3. Our study provides new insights into regulation of SGK3 stability and activation and the rationale for application of Hsp90 inhibitors in treating SGK3-dependent cancers.	[Wang, Yuanzhong; Zhou, Dujin; Chen, Shiuan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Xu, Wanping; Neckers, Len] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	City of Hope; Beckman Research Institute of City of Hope; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chen, SA (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.	schen@coh.org	Wang, Yuanzhong/I-5963-2014	Wang, Yuanzhong/0000-0001-5739-9065	National Institutes of Health Grant [CA44735]; Carr Baird grant; Hope Idol; ThinkCure grant; NATIONAL CANCER INSTITUTE [ZIABC011032, R01CA044735, ZIASC010074] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carr Baird grant; Hope Idol; ThinkCure grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA44735 (to S. C.). This work was also supported by a Carr Baird grant (to Y. W.) and by Hope Idol 2012 (to S. C.) and a ThinkCure grant (to S. C.).	Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Bruhn Maressa A, 2013, Cancer Manag Res, V5, P281, DOI 10.2147/CMAR.S35178; Bruhn MA, 2010, GROWTH FACTORS, V28, P394, DOI 10.3109/08977194.2010.518616; Capra M, 2006, CANCER RES, V66, P8147, DOI 10.1158/0008-5472.CAN-05-3489; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dai FY, 2002, BIOCHEM BIOPH RES CO, V293, P1191, DOI 10.1016/S0006-291X(02)00349-2; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Jun X, 2001, J CELL BIOL, V154, P699; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Liu M, 2012, HEPATOLOGY, V55, P1754, DOI 10.1002/hep.25584; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Nilsen T, 2004, J BIOL CHEM, V279, P4794, DOI 10.1074/jbc.M309653200; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Speers C, 2009, CLIN CANCER RES, V15, P6327, DOI 10.1158/1078-0432.CCR-09-1107; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tessier M, 2006, J BIOL CHEM, V281, P23978, DOI 10.1074/jbc.M604333200; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Virbasius JV, 2001, P NATL ACAD SCI USA, V98, P12908, DOI 10.1073/pnas.221352898; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang YZ, 2011, BBA-MOL CELL RES, V1813, P109, DOI 10.1016/j.bbamcr.2010.09.017; Wang YZ, 2011, MOL ENDOCRINOL, V25, P72, DOI 10.1210/me.2010-0294; Xu J, 2012, BREAST CANCER RES TR, V134, P531, DOI 10.1007/s10549-012-2081-x; Xu J, 2009, J BIOL CHEM, V284, P14377, DOI 10.1074/jbc.M807770200; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Zhao Q, 2004, J BIOL CHEM, V279, P12560, DOI 10.1074/jbc.M308242200; Zhou D, 2008, J BIOL CHEM, V283, P541, DOI 10.1074/jbc.M703234200; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	34	13	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4815	4826		10.1074/jbc.M113.518480	http://dx.doi.org/10.1074/jbc.M113.518480			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24379398	Green Published, hybrid			2022-12-28	WOS:000331607900029
J	Cam, M; Bid, HK; Xiao, LL; Zambetti, GP; Houghton, PJ; Cam, H				Cam, Maren; Bid, Hemant K.; Xiao, Linlin; Zambetti, Gerard P.; Houghton, Peter J.; Cam, Hakan			p53/TAp63 and AKT Regulate Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling through Two Independent Parallel Pathways in the Presence of DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; DNA Damage Response; mTOR; mTOR Complex (mTORC); p53; p63; 4EBP1; REDD1; S6K1; Sestrin	PROTEIN-KINASE; S6 KINASE; IN-VIVO; P53; PHOSPHORYLATION; ACTIVATION; GROWTH; TSC2; STRESS; HYPOXIA	Under conditions of DNA damage, the mammalian target of rapamycin complex 1 (mTORC1) is inhibited, preventing cell cycle progression and conserving cellular energy by suppressing translation. We show that suppression of mTORC1 signaling to 4E-BP1 requires the coordinated activity of two tumor suppressors, p53 and p63. In contrast, suppression of S6K1 and ribosomal protein S6 phosphorylation by DNA damage is Akt-dependent. We find that loss of either p53, required for the induction of Sestrin 1/2, or p63, required for the induction of REDD1 and activation of the tuberous sclerosis complex, prevents the DNA damage-induced suppression of mTORC1 signaling. These data indicate that the negative regulation of cap-dependent translation by mTORC1 inhibition subsequent to DNA damage is abrogated in most human cancers.	[Cam, Maren; Bid, Hemant K.; Xiao, Linlin; Houghton, Peter J.; Cam, Hakan] Nationwide Childrens Hosp, Ctr Childhood Canc & Blood Dis, Columbus, OH 43205 USA; [Zambetti, Gerard P.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Houghton, Peter J.; Cam, Hakan] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; St Jude Children's Research Hospital; University System of Ohio; Ohio State University	Cam, H (corresponding author), Nationwide Childrens Hosp, Ctr Childhood Canc & Blood Dis, Columbus, OH 43205 USA.	hakan.cam@nationwidechildrens.org	Zambetti, Gerard/N-8093-2018	Zambetti, Gerard/0000-0002-0929-5007	National Cancer Institute/National Institutes of Health United States Public Health Service (USPHS) [CA77776]; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA077776] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health United States Public Health Service (USPHS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Cancer Institute/National Institutes of Health United States Public Health Service (USPHS) grant CA77776.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; Boehme KA, 2008, P NATL ACAD SCI USA, V105, P7785, DOI 10.1073/pnas.0703423105; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Dmitriev SE, 2003, MOL CELL BIOL, V23, P8925, DOI 10.1128/MCB.23.24.8925-8933.2003; Dotsch V., 2010, COLD SPRING HARB PER, V2; Edwards E, 2002, CANCER RES, V62, P4671; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Horton LE, 2002, ONCOGENE, V21, P5325, DOI 10.1038/sj.onc.1205662; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Matthew EM, 2009, CELL CYCLE, V8, P4168, DOI 10.4161/cc.8.24.10800; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Smith MA, 2012, PEDIATR BLOOD CANCER, V59, P329, DOI 10.1002/pbc.23319; Tee AR, 2000, ONCOGENE, V19, P3021, DOI 10.1038/sj.onc.1203622; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wanke V, 2005, EMBO J, V24, P4271, DOI 10.1038/sj.emboj.7600889; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu NH, 2012, J ONCOL, V2012, DOI 10.1155/2012/951724; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	42	45	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4083	4094		10.1074/jbc.M113.530303	http://dx.doi.org/10.1074/jbc.M113.530303			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366874	hybrid, Green Published			2022-12-28	WOS:000331403800022
J	Capdevila, JH; Pidkovka, N; Mei, SJ; Gong, Y; Falck, JR; Imig, JD; Harris, RC; Wang, WH				Capdevila, Jorge H.; Pidkovka, Nataliya; Mei, Shaojun; Gong, Yan; Falck, John R.; Imig, John D.; Harris, Raymond C.; Wang, Wenhui			The Cyp2c44 Epoxygenase Regulates Epithelial Sodium Channel Activity and the Blood Pressure Responses to Increased Dietary Salt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ENaC; Epoxygenase Pathway; ERK; Hypertension; Sodium Transport; EETs; Natriuresis	EPIDERMAL-GROWTH-FACTOR; COLLECTING DUCT CELLS; ARACHIDONIC-ACID; NA+ CHANNEL; RAT-KIDNEY; POTASSIUM INTAKE; LIDDLE-SYNDROME; ENAC; HYPERTENSION; PHOSPHORYLATION	Background: Epoxyeicosatrienoic acids (EETs) regulate sodium excretion in the distal nephron. Results: Lack of a Cyp2c44 epoxygenase blunts the ERK1/2-mediated inhibition of ENaC and causes salt-sensitive hypertension. Conclusion: Cyp2c44 is the epoxygenase responsible for the synthesis of natriuretic EETs during increased salt intake. Significance: Roles for the human CYP2C8 and CYP2C9 epoxygenases as antihypertensive therapeutic targets are proposed. Hypertension is a major risk factor for cerebral, cardiovascular, and renal disease, and its prevalence and devastating consequences raises a need for new strategies for its early diagnosis and treatment. We show here that lack of a Cyp2c44 epoxygenase causes dietary salt-sensitive hypertension, a common form of the human disease. Cyp2c44(-/-) mice on normal salt diets are normotensive but become hypertensive when fed high salt. Hypertensive Cyp2c44(-/-) mice show a hyperactive kidney epithelial sodium channel (ENaC) and reductions in ERK1/2 and ENaC subunit phosphorylation. The demonstration that amiloride, an ENaC inhibitor, lowers the blood pressure of hypertensive Cyp2c44(-/-) mice identifies a role for the channel in the hypertensive phenotype of the animals. These studies: (a) identify an antihypertensive role for the kidney Cyp2c44 epoxygenase and for its epoxyeicosatrienoic acid (EET) metabolites in the in vivo control of ENaC activity and the activation of mitogenic kinase pathways; (b) provide evidence for a Cyp2c44 epoxygenase, EET-mediated mechanism of ENaC regulation involving an ERK1/2-catalyzed threonine phosphorylation of the channel subunit: and (c) characterize a common scientific platform that could explain the seemingly unrelated biological activities attributed to the epoxygenase metabolites in cell proliferation, angiogenesis, channel activity, and blood pressure control. It is expected that these results will serve as a basis for the development of novel strategies for the early diagnosis and treatment of hypertension and of pathophysiologies associated with dysfunctional mitogenic signaling.	[Capdevila, Jorge H.; Pidkovka, Nataliya; Mei, Shaojun; Gong, Yan; Harris, Raymond C.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Imig, John D.] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA; [Wang, Wenhui] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA	Vanderbilt University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical College of Wisconsin; New York Medical College	Capdevila, JH (corresponding author), Vanderbilt Univ, Med Ctr North S3223, Sch Med, Nashville, TN 37232 USA.	jorge.capdevila@vanderbilt.edu		Imig, John/0000-0002-9668-2899	National Institutes of Health from the U.S. Public Health Service [DK038226, HL34300]; Robert A. Welch Foundation [GL625910]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER	National Institutes of Health from the U.S. Public Health Service; Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK038226 and HL34300 (to W.-H. W.) from the U.S. Public Health Service. This work was also supported by Robert A. Welch Foundation Grant GL625910 (to J. R. F.).	Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Butterworth MB, 2008, J BIOL CHEM, V283, P35305, DOI 10.1074/jbc.R800044200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CAPDEVILA JH, 1991, METHOD ENZYMOL, V206, P441; Capdevila JH, 2002, PROSTAG OTH LIPID M, V68-9, P325, DOI 10.1016/S0090-6980(02)00038-2; Capidevila JH, 2007, CURR OPIN NEPHROL HY, V16, P465, DOI 10.1097/MNH.0b013e32827ab48c; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chen JK, 1999, J BIOL CHEM, V274, P4764, DOI 10.1074/jbc.274.8.4764; Chen JK, 2002, P NATL ACAD SCI USA, V99, P6029, DOI 10.1073/pnas.092671899; Crews DC, 2010, HYPERTENSION, V55, P1102, DOI 10.1161/HYPERTENSIONAHA.110.150722; DeLozier TC, 2004, J PHARMACOL EXP THER, V310, P845, DOI 10.1124/jpet.104.067819; ELLIOTT P, 1988, BRIT MED J, V297, P319; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Falin RA, 2007, J GEN PHYSIOL, V130, P313, DOI 10.1085/jgp.200709775; Fejes-Toth G, 2008, AM J PHYSIOL-RENAL, V294, pF1298, DOI 10.1152/ajprenal.00579.2007; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Hamm LL, 2010, CURR OPIN NEPHROL HY, V19, P98, DOI 10.1097/MNH.0b013e328332bda4; HOLTHOFER H, 1987, CELL TISSUE RES, V249, P481; Hu JC, 2009, J BIOL CHEM, V284, P36334, DOI 10.1074/jbc.M109.032870; Imig JD, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00157; JACOBSON HR, 1984, PROSTAGLANDINS MEMBR, P311; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; MAKITA K, 1994, J CLIN INVEST, V94, P2414, DOI 10.1172/JCI117608; Manhiani M, 2009, AM J PHYSIOL-RENAL, V297, pF740, DOI 10.1152/ajprenal.00098.2009; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Mensah George A., 2002, Cardiology Clinics, V20, P225, DOI 10.1016/S0733-8651(02)00004-8; MOLLER B, 1995, ACTA PHYSIOL SCAND, V155, P165, DOI 10.1111/j.1748-1716.1995.tb09961.x; Munroe PB, 2013, CIRC RES, V112, P1365, DOI 10.1161/CIRCRESAHA.112.300387; Nakagawa K, 2006, J CLIN INVEST, V116, P1696, DOI 10.1172/JCI27546; Pavlov TS, 2011, AM J PHYSIOL-RENAL, V301, pF672, DOI 10.1152/ajprenal.00597.2010; Pidkovka N, 2013, J BIOL CHEM, V288, P5223, DOI 10.1074/jbc.M112.407981; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Pozzi A, 2010, J BIOL CHEM, V285, P12840, DOI 10.1074/jbc.M109.081554; Pratt JH, 2005, J AM SOC NEPHROL, V16, P3154, DOI 10.1681/ASN.2005050460; ROMAN RJ, 1987, AM J PHYSIOL, V252, pR833, DOI 10.1152/ajpregu.1987.252.5.R833; Rossier BC, 2008, HYPERTENSION, V52, P595, DOI 10.1161/HYPERTENSIONAHA.107.097147; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Schild L, 1996, NEPHROLOGIE, V17, P395; Shen JP, 2003, AM J PHYSIOL-RENAL, V284, pF57, DOI 10.1152/ajprenal.00028.2002; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Sun P, 2012, HYPERTENSION, V59, P339, DOI 10.1161/HYPERTENSIONAHA.111.178475; Sun P, 2010, J AM SOC NEPHROL, V21, P1667, DOI 10.1681/ASN.2009111110; Thomas CP, 2004, CURR OPIN NEPHROL HY, V13, P541, DOI 10.1097/00041552-200409000-00010; Tsao CC, 2001, J PHARMACOL EXP THER, V299, P39; VEHASKARI VM, 1989, AM J PHYSIOL, V256, pF803, DOI 10.1152/ajprenal.1989.256.5.F803; Warnock DG, 2001, AM J MED SCI, V322, P302, DOI 10.1097/00000441-200112000-00002; Wei Y, 2004, J GEN PHYSIOL, V124, P719, DOI 10.1085/jgp.200409140; Zhang YH, 2005, AM J PHYSIOL-CELL PH, V288, pC141, DOI 10.1152/ajpcell.00343.2004	51	44	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4377	4386		10.1074/jbc.M113.508416	http://dx.doi.org/10.1074/jbc.M113.508416			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24368771	hybrid, Green Published			2022-12-28	WOS:000331403800048
J	Feng, XH; Huang, Y; Lu, YG; Xiong, J; Wong, CO; Yang, P; Xia, JT; Chen, D; Du, GW; Venkatachalam, K; Xia, XF; Zhu, MX				Feng, Xinghua; Huang, Yu; Lu, Yungang; Xiong, Jian; Wong, Ching-On; Yang, Pu; Xia, Jintang; Chen, De; Du, Guangwei; Venkatachalam, Kartik; Xia, Xuefeng; Zhu, Michael X.			Drosophila TRPML Forms PI(3,5)P-2-activated Cation Channels in Both Endolysosomes and Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endosomes; Lysosomal Storage Disease; Lysosomes; Phosphoinositides; TRP Channels; Mucolipidosis; Mucolipin	MUCOLIPIDOSIS TYPE-IV; VARITINT-WADDLER PHENOTYPE; RECEPTOR POTENTIAL CHANNEL; CONSTITUTIVE ACTIVITY; CELL DEGENERATION; PROTEIN; MUTATION; GENE; TRAFFICKING; DEAFNESS	Background:Drosophila trpml mutants reproduced many defects associated with mucolipidosis type IV, but the fly TRPML channel remains uncharacterized. Results:Drosophila TRPML is a phosphoinositide-regulated cation channel on endolysosome and plasma membranes. Conclusion: Fly TRPML largely resembles mammalian TRPML1, but exhibits differences in subcellular localization and pH dependence. Significance: The data support using Drosophila for assessing TRPML1 function. Transient Receptor Potential mucolipin (TRPML) channels are implicated in endolysosomal trafficking, lysosomal Ca2+ and Fe2+ release, lysosomal biogenesis, and autophagy. Mutations in human TRPML1 cause the lysosome storage disease, mucolipidosis type IV (MLIV). Unlike vertebrates, which express three TRPML genes, TRPML1-3, the Drosophila genome encodes a single trpml gene. Although the trpml-deficient flies exhibit cellular defects similar to those in mammalian TRPML1 mutants, the biophysical properties of Drosophila TRPML channel remained uncharacterized. Here, we show that transgenic expression of human TRPML1 in the neurons of Drosophila trpml mutants partially suppressed the pupal lethality phenotype. When expressed in HEK293 cells, Drosophila TRPML was localized in both endolysosomes and plasma membrane and was activated by phosphatidylinositol 3,5-bisphosphate (PI(3,5)P-2) applied to the cytoplasmic side in whole lysosomes and inside-out patches excised from plasma membrane. The PI(3,5)P-2-evoked currents were blocked by phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2), but not other phosphoinositides. Using TRPML A487P, which mimics the varitint-waddler (Va) mutant of mouse TRPML3 with constitutive whole-cell currents, we show that TRPML is biphasically regulated by extracytosolic pH, with an optimal pH about 0.6 pH unit higher than that of human TRPML1. In addition to monovalent cations, TRPML exhibits high permeability to Ca2+, Mn2+, and Fe2+, but not Fe3+. The TRPML currents were inhibited by trivalent cations Fe3+, La3+, and Gd3+. These features resemble more closely to mammalian TRPML1 than TRPML2 and TRPML3, but with some obvious differences. Together, our data support the use of Drosophila for assessing functional significance of TRPML1 in cell physiology.	[Feng, Xinghua; Lu, Yungang; Xia, Jintang; Chen, De; Xia, Xuefeng] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China; [Feng, Xinghua; Huang, Yu; Lu, Yungang; Xiong, Jian; Wong, Ching-On; Yang, Pu; Du, Guangwei; Venkatachalam, Kartik; Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Huang, Yu; Xiong, Jian; Du, Guangwei; Venkatachalam, Kartik; Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Grad Program Cell & Regulatory Biol, Houston, TX 77030 USA; [Venkatachalam, Kartik] Univ Texas Hlth Sci Ctr Houston, Grad Program Neurosci, Houston, TX 77030 USA; [Xia, Xuefeng] Houston Methodist Res Inst, Ctr Genom Med, Houston, TX 77030 USA	Guangzhou Medical University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Xia, XF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China.	xuefengx@gmail.com; michael.x.zhu@uth.tmc.edu	Lu, yungang/N-1955-2015; Xiong, Jian/AAC-1836-2021; HUANG, YU/U-2835-2019	Lu, yungang/0000-0001-8949-661X; Xiong, Jian/0000-0001-9008-3134; Du, Guangwei/0000-0003-4193-6975; HUANG, YU/0000-0002-6982-8485	National Institutes of Health [R01 GM081658, GM092759]; Third Affiliated Hospital of Guangzhou Medical University; National Natural Science Foundation of China [81270868]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092759, R01GM081658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Third Affiliated Hospital of Guangzhou Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grants R01 GM081658 and GM092759 from the National Institutes of Health (to M. X. Z.), postdoctoral fellowships from the Third Affiliated Hospital of Guangzhou Medical University (to X. F. and Y. L.), and the National Natural Science Foundation of China (No. 81270868, to X. X.).	Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306; Bach G, 2005, PFLUG ARCH EUR J PHY, V451, P313, DOI 10.1007/s00424-004-1361-7; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Chandra M, 2011, GASTROENTEROLOGY, V140, P857, DOI 10.1053/j.gastro.2010.11.040; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dong XP, 2009, J BIOL CHEM, V284, P32040, DOI 10.1074/jbc.M109.037184; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Grimm C, 2012, J BIOL CHEM, V287, P22701, DOI 10.1074/jbc.M112.368876; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Lev S, 2010, J BIOL CHEM, V285, P2771, DOI 10.1074/jbc.M109.046508; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Micsenyi MC, 2009, J NEUROPATH EXP NEUR, V68, P125, DOI 10.1097/NEN.0b013e3181942cf0; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Sun T, 2011, AUTOPHAGY, V7, P1308, DOI 10.4161/auto.7.11.17759; Swetha MG, 2011, TRAFFIC, V12, P1037, DOI 10.1111/j.1600-0854.2011.01214.x; Thomas M, 2002, P NATL ACAD SCI USA, V99, P14640, DOI 10.1073/pnas.192581499; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; Venkatachalam K, 2013, AUTOPHAGY, V9, P98, DOI 10.4161/auto.22260; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Wong CO, 2012, CURR BIOL, V22, P1616, DOI 10.1016/j.cub.2012.06.055; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P11384, DOI 10.1073/pnas.1202194109; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	40	48	48	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4262	4272		10.1074/jbc.M113.506501	http://dx.doi.org/10.1074/jbc.M113.506501			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24375408	Green Published, hybrid			2022-12-28	WOS:000331403800037
J	Anderson, EL; Cole, JN; Olson, J; Ryba, B; Ghosh, P; Nizet, V				Anderson, Ericka L.; Cole, Jason N.; Olson, Joshua; Ryba, Bryan; Ghosh, Partho; Nizet, Victor			The Fibrinogen-binding M1 Protein Reduces Pharyngeal Cell Adherence and Colonization Phenotypes of M1T1 Group A Streptococcus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Adhesion; Bacterial Pathogenesis; Fibrinogen; Streptococcus pyogenes; Virulence Factors	EXTRACELLULAR CYSTEINE PROTEASE; COILED-COIL IRREGULARITIES; HYALURONIC-ACID CAPSULE; IN-VIVO; VIRULENCE; PYOGENES; PATHOGENESIS; ADHESION; PHAGOCYTOSIS; OPSONIZATION	Background: The group A Streptococcus (GAS) M1 protein binds fibrinogen (Fg) to block phagocytosis and to form a proinflammatory complex. Results: M1 and Fg limit GAS adherence and invasion of pharyngeal keratinocytes in vitro. Conclusion: Protease SpeB modulates M1 expression and GAS host cell interactions differentially during the course of infection. Significance: M1 protein is shown to impede pharyngeal colonization in vivo. Group A Streptococcus (GAS) is a leading human pathogen producing a diverse array of infections from simple pharyngitis (strep throat) to invasive conditions, including necrotizing fasciitis and toxic shock syndrome. The surface-anchored GAS M1 protein is a classical virulence factor that promotes phagocyte resistance and exaggerated inflammation by binding host fibrinogen (Fg) to form supramolecular networks. In this study, we used a virulent WT M1T1 GAS strain and its isogenic M1-deficient mutant to examine the role of M1-Fg binding in a proximal step in GAS infection-interaction with the pharyngeal epithelium. Expression of the M1 protein reduced GAS adherence to human pharyngeal keratinocytes by 2-fold, and this difference was increased to 4-fold in the presence of Fg. In stationary phase, surface M1 protein cleavage by the GAS cysteine protease SpeB eliminated Fg binding and relieved its inhibitory effect on GAS pharyngeal cell adherence. In a mouse model of GAS colonization of nasal-associated lymphoid tissue, M1 protein expression was associated with an average 6-fold decreased GAS recovery in isogenic strain competition assays. Thus, GAS M1 protein-Fg binding reduces GAS pharyngeal cell adherence and colonization in a fashion that is counterbalanced by SpeB. Inactivation of SpeB during the shift to invasive GAS disease allows M1-Fg binding, increasing pathogen phagocyte resistance and proinflammatory activities.	[Anderson, Ericka L.; Cole, Jason N.; Olson, Joshua; Ryba, Bryan; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Ghosh, Partho] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Cole, Jason N.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Cole, Jason N.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Queensland; University of Queensland	Nizet, V (corresponding author), Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr,Mail Code 0687, La Jolla, CA 92093 USA.	vnizet@ucsd.edu	Nizet, Victor/AAF-3190-2019	Nizet, Victor/0000-0003-3847-0422; Ryba, Bryan/0000-0002-2397-9245	National Institutes of Health [AI096837, AI077780]; UNCF/Merck; Australian National Health and Medical Research Council [APP1033258]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096837, R01AI077780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNCF/Merck(Merck & Company); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI096837 (to P. G. and V. N.) and AI077780 (to V. N.). This work was also supported by a UNCF/Merck postdoctoral fellowship (to E. L. A.) and Australian National Health and Medical Research Council Grant APP1033258 (to J. N. C.).	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; CHEN TR, 1988, CYTOGENET CELL GENET, V48, P19, DOI 10.1159/000132579; Cole JN, 2008, PROTEOM CLIN APPL, V2, P387, DOI 10.1002/prca.200780048; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Courtney HS, 2006, MOL MICROBIOL, V59, P936, DOI 10.1111/j.1365-2958.2005.04977.x; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dale JB, 1996, INFECT IMMUN, V64, P1495, DOI 10.1128/IAI.64.5.1495-1501.1996; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; FISCHETTI VA, 1991, SCI AM, V264, P58, DOI 10.1038/scientificamerican0691-58; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Hollands A, 2010, J INFECT DIS, V202, P11, DOI 10.1086/653124; Hyland KA, 2009, FEMS IMMUNOL MED MIC, V55, P422, DOI 10.1111/j.1574-695X.2009.00540.x; Jenkins HT, 2006, J BIOL CHEM, V281, P3690, DOI 10.1074/jbc.M511563200; Ji YD, 1997, INFECT IMMUN, V65, P2080, DOI 10.1128/IAI.65.6.2080-2087.1997; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kansal RG, 2003, J INFECT DIS, V187, P398, DOI 10.1086/368022; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Lauth X, 2009, J INNATE IMMUN, V1, P202, DOI 10.1159/000203645; Lefevre EA, 2007, J LEUKOCYTE BIOL, V82, P666, DOI 10.1189/jlb.0107050; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; Matsuka YV, 1999, INFECT IMMUN, V67, P4326, DOI 10.1128/IAI.67.9.4326-4333.1999; McArthur JD, 2006, MOL MICROBIOL, V59, P1, DOI 10.1111/j.1365-2958.2005.04967.x; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; Metzgar D, 2011, VIRULENCE, V2, P402, DOI 10.4161/viru.2.5.16342; Moses AE, 1997, INFECT IMMUN, V65, P64, DOI 10.1128/IAI.65.1.64-71.1997; Oehmcke S, 2010, CLIN CHIM ACTA, V411, P1172, DOI 10.1016/j.cca.2010.04.032; OGSTON CM, 1966, J CLIN PATHOL, V19, P352, DOI 10.1136/jcp.19.4.352; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; Park HS, 2003, J IMMUNOL, V171, P2532, DOI 10.4049/jimmunol.171.5.2532; Poon KWC, 2012, ANALYST, V137, P1807, DOI 10.1039/c2an35042d; Raeder R, 1998, RES MICROBIOL, V149, P539, DOI 10.1016/S0923-2508(99)80001-1; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Shulman ST, 2004, CLIN INFECT DIS, V39, P325, DOI 10.1086/421949; Steer AC, 2012, DRUGS, V72, P1213, DOI 10.2165/11634180-000000000-00000; Steer AC, 2009, CURR OPIN INFECT DIS, V22, P544, DOI 10.1097/QCO.0b013e328332bbfe; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; SUKHAREV AY, 1991, LAB DELO, P20; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Timmer AM, 2006, MOL MICROBIOL, V62, P15, DOI 10.1111/j.1365-2958.2006.05337.x; Uchiyama S, 2013, J MOL MED, V91, P861, DOI 10.1007/s00109-013-1012-6; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; WANG JR, 1994, INFECT IMMUN, V62, P442, DOI 10.1128/IAI.62.2.442-448.1994; WESSELS MR, 1994, P NATL ACAD SCI USA, V91, P12238, DOI 10.1073/pnas.91.25.12238; Yoshinaga Sumiko, 1998, Journal of Medical Investigation, V45, P77; Young Michael H, 2005, Expert Rev Anti Infect Ther, V3, P279, DOI 10.1586/14787210.3.2.279	59	18	18	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3539	3546		10.1074/jbc.M113.529537	http://dx.doi.org/10.1074/jbc.M113.529537			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24356958	Green Published, hybrid			2022-12-28	WOS:000331368700038
J	Fedosyuk, S; Grishkovskaya, I; Ribeiro, ED; Skern, T				Fedosyuk, Sofiya; Grishkovskaya, Irina; Ribeiro, Euripedes de Almeida, Jr.; Skern, Tim			Characterization and Structure of the Vaccinia Virus NF-kappa B Antagonist A46	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bcl-2 Family Proteins; Inflammation; MyD88; Protein-Protein Interactions; Viral Immunology	TIR-DOMAIN; INHIBITORY PEPTIDE; MOLECULAR-BASIS; PROTEIN A46; RECEPTOR; INNATE; SYSTEM; A52R; RECOGNITION; RECRUITMENT	Background: Vaccinia virus encodes several anti-inflammatory proteins that interfere with host signaling pathways. Results: The protein A46 has a similar fold to other vaccinia virus anti-inflammatory proteins but uses a different dimer interface. Conclusion: Variations in quaternary structure can affect the specificity of interactions of anti-inflammatory proteins. Significance: The structure illustrates how viruses can generate versatility of function from the same protein fold. Successful vaccinia virus (VACV) replication in the host requires expression of viral proteins that interfere with host immunity, such as antagonists of the activation of the proinflammatory transcription factor NF-B. Two such VACV proteins are A46 and A52. A46 interacts with the Toll-like receptor/interleukin-1R (TIR) domain of Toll-like receptors and intracellular adaptors such as MAL (MyD88 adapter-like), TRAM (TIR domain-containing adapter-inducing interferon- (TRIF)-related adaptor molecule), TRIF, and MyD88, whereas A52 binds to the downstream signaling components TRAF6 and IRAK2. Here, we characterize A46 biochemically, determine by microscale thermophoresis binding constants for the interaction of A46 with the TIR domains of MyD88 and MAL, and present the 2.0 resolution crystal structure of A46 residues 87-229. Full-length A46 behaves as a tetramer; variants lacking the N-terminal 80 residues are dimeric. Nevertheless, both bind to the Toll-like receptor domains of MAL and MyD88 with K-D values in the low m range. Like A52, A46 also shows a Bcl-2-like fold but with biologically relevant differences from that of A52. Thus, A46 uses helices 4 and 6 to dimerize, compared with the 1-6 face used by A52 and other Bcl-2 like VACV proteins. Furthermore, the loop between A46 helices 4-5 is flexible and shorter than in A52; there is also evidence for an intramolecular disulfide bridge between consecutive cysteine residues. We used molecular docking to propose how A46 interacts with the BB loop of the TRAM TIR domain. Comparisons of A46 and A52 exemplify how subtle changes in viral proteins with the same fold lead to crucial differences in biological activity.	[Fedosyuk, Sofiya; Skern, Tim] Med Univ Vienna, Max Perutz Labs, A-1030 Vienna, Austria; [Grishkovskaya, Irina; Ribeiro, Euripedes de Almeida, Jr.] Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Skern, T (corresponding author), Med Univ Vienna, Max Perutz Labs, Dr Bohr Gasse 9-3, A-1030 Vienna, Austria.	timothy.skern@meduniwien.ac.at	Skern, Tim/AAC-1732-2022	Skern, Tim/0000-0001-8865-5500; Grishkovskaya, Irina/0000-0003-0164-9373	Austrian Science Fund Grant [W1221]; Medical University of Vienna	Austrian Science Fund Grant; Medical University of Vienna	This work was supported by Austrian Science Fund Grant W1221, "DK: Structure and Interaction of Biological Macromolecules," and the Medical University of Vienna.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aoshi T, 2011, CURR OPIN VIROL, V1, P226, DOI 10.1016/j.coviro.2011.07.002; Bahar MW, 2011, J STRUCT BIOL, V175, P127, DOI 10.1016/j.jsb.2011.03.010; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; Bisht H, 2010, VIROLOGY, V398, P187, DOI 10.1016/j.virol.2009.11.026; Botos I., 2010, HDB CELL SIGNALLING, P139; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Franklin E, 2013, J STRUCT BIOL, V181, P1, DOI 10.1016/j.jsb.2012.10.015; Gonzalez JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-59; Graham S. C., 2008, PLOS PATHOG, V4; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kotwal GJ, 2012, ADV VIROL, V2012, DOI 10.1155/2012/131457; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lechauve C, 2009, J BIOL CHEM, V284, P36146, DOI 10.1074/jbc.M109.066811; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; McCoy SL, 2005, J IMMUNOL, V174, P3006, DOI 10.4049/jimmunol.174.5.3006; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Nickerson DP, 1997, PROTEIN ENG, V10, P1357, DOI 10.1093/protein/10.12.1357; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oda SI, 2011, MOL IMMUNOL, V48, P2144, DOI 10.1016/j.molimm.2011.07.014; Ohnishi H, 2010, BIOMOL NMR ASSIGN, V4, P123, DOI 10.1007/s12104-010-9222-0; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; Postigo A, 2012, J VIROL, V86, P203, DOI 10.1128/JVI.05817-11; Qin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034132; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Stack J, 2012, J BIOL CHEM, V287, P22672, DOI 10.1074/jbc.M112.349225; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tatematsu M, 2010, J BIOL CHEM, V285, P20128, DOI 10.1074/jbc.M109.099101; Tsung A, 2007, SHOCK, V27, P364, DOI 10.1097/01.shk.0000239773.95280.2c; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Vaux DL, 2012, NATURE, V492, P180, DOI 10.1038/492180a; Walsh SR, 2011, EXPERT REV VACCINES, V10, P1221, DOI [10.1586/ERV.11.79, 10.1586/erv.11.79]; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	63	25	25	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3749	3762		10.1074/jbc.M113.512756	http://dx.doi.org/10.1074/jbc.M113.512756			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24356965	hybrid, Green Published			2022-12-28	WOS:000331368700055
J	Koh, KH; Pan, X; Shen, HW; Arnold, SLM; Yu, AM; Gonzalez, FJ; Isoherranen, N; Jeong, H				Koh, Kwi Hye; Pan, Xian; Shen, Hong-Wu; Arnold, Samuel L. M.; Yu, Ai-Ming; Gonzalez, Frank J.; Isoherranen, Nina; Jeong, Hyunyoung			Altered Expression of Small Heterodimer Partner Governs Cytochrome P450 (CYP) 2D6 Induction during Pregnancy in CYP2D6-humanized Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Drug Metabolism; Pregnancy; Retinoid; Transgenic Mice; HNF4; SHP	NUCLEAR FACTOR 4-ALPHA; BILE-ACID CONCENTRATIONS; GENE-EXPRESSION; MOLECULAR-BASIS; X-RECEPTOR; TRANSCRIPTIONAL REGULATION; LIPID HOMEOSTASIS; DRUG-METABOLISM; HUMANIZED MOUSE; HEPATOCYTE-NUCLEAR-FACTOR-4-ALPHA	Background: CYP2D6-mediated drug metabolism is enhanced during pregnancy, but the underlying mechanisms remain unknown. Results: In CYP2D6-humanized mice, CYP2D6 induction during pregnancy was linked to decreased expression of SHP, a repressor of CYP2D6 expression. Conclusion: Decreased SHP expression may account for CYP2D6 induction during pregnancy. Significance: This may provide a mechanistic basis in designing optimal dosage regimens in pregnant women. Substrates of a major drug-metabolizing enzyme CYP2D6 display increased elimination during pregnancy, but the underlying mechanisms are unknown in part due to a lack of experimental models. Here, we introduce CYP2D6-humanized (Tg-CYP2D6) mice as an animal model where hepatic CYP2D6 expression is increased during pregnancy. In the mouse livers, expression of a known positive regulator of CYP2D6, hepatocyte nuclear factor 4 (HNF4), did not change during pregnancy. However, HNF4 recruitment to CYP2D6 promoter increased at term pregnancy, accompanied by repressed expression of small heterodimer partner (SHP). In HepG2 cells, SHP repressed HNF4 transactivation of CYP2D6 promoter. In transgenic (Tg)-CYP2D6 mice, SHP knockdown led to a significant increase in CYP2D6 expression. Retinoic acid, an endogenous compound that induces SHP, exhibited decreased hepatic levels during pregnancy in Tg-CYP2D6 mice. Administration of all-trans-retinoic acid led to a significant decrease in the expression and activity of hepatic CYP2D6 in Tg-CYP2D6 mice. This study provides key insights into mechanisms underlying altered CYP2D6-mediated drug metabolism during pregnancy, laying a foundation for improved drug therapy in pregnant women.	[Koh, Kwi Hye; Jeong, Hyunyoung] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60612 USA; [Pan, Xian; Jeong, Hyunyoung] Univ Illinois, Coll Pharm, Dept Biopharmaceut Sci, Chicago, IL 60612 USA; [Shen, Hong-Wu; Yu, Ai-Ming] Univ Calif Davis, Med Ctr, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Arnold, Samuel L. M.; Isoherranen, Nina] Univ Washington, Sch Pharm, Dept Pharmaceut, Seattle, WA 98195 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Davis; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jeong, H (corresponding author), Univ Illinois, Dept Pharm Practice MC 886, 833 S Wood St, Chicago, IL 60612 USA.	yjeong@uic.edu		Yu, Aiming/0000-0003-1441-4012	National Institutes of Health [HD065532, K12HK055892]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065532, K12HD055892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD065532 and Fellowship K12HK055892 (NICHD; to H. J.).	Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; Arnold SLM, 2012, J LIPID RES, V53, P587, DOI 10.1194/jlr.D019745; Bagamasbad P, 2012, ENDOCRINOLOGY, V153, P5334, DOI 10.1210/en.2012-1303; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Cai SY, 2010, J LIPID RES, V51, P2265, DOI 10.1194/jlr.M005546; Cairns W, 1996, J BIOL CHEM, V271, P25269, DOI 10.1074/jbc.271.41.25269; Carcillo JA, 2003, CLIN PHARMACOL THER, V73, P456, DOI 10.1016/S0009-9236(03)00055-9; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Choi SY, 2013, DRUG METAB DISPOS, V41, P263, DOI 10.1124/dmd.112.046276; Corchero J, 2001, MOL PHARMACOL, V60, P1260, DOI 10.1124/mol.60.6.1260; Dickmann LJ, 2008, BIOCHEM PHARMACOL, V75, P1677, DOI 10.1016/j.bcp.2008.01.012; Dickmann LJ, 2013, DRUG METAB DISPOS, V41, P270, DOI 10.1124/dmd.112.047118; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Felmlee MA, 2008, DRUG METAB DISPOS, V36, P435, DOI 10.1124/dmd.107.018838; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Glover DD, 2003, AM J OBSTET GYNECOL, V188, P1039, DOI 10.1067/mob.2003.223; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; HEIKKINEN J, 1981, BRIT J OBSTET GYNAEC, V88, P240, DOI 10.1111/j.1471-0528.1981.tb00975.x; HOGSTEDT S, 1985, CLIN PHARMACOL THER, V37, P688; Isoherranen N, 2013, DRUG METAB DISPOS, V41, P256, DOI 10.1124/dmd.112.050245; Jover R, 2009, CURR DRUG METAB, V10, P508, DOI 10.2174/138920009788898000; Koh KH, 2011, DRUG METAB DISPOS, V39, P165, DOI 10.1124/dmd.110.035790; KURTH MC, 1993, AM J MED GENET, V48, P166, DOI 10.1002/ajmg.1320480311; Lai KD, 2003, J BIOL CHEM, V278, P36418, DOI 10.1074/jbc.M303913200; Lee SS, 2008, HEPATOLOGY, V48, P635, DOI 10.1002/hep.22396; Lee YJ, 2012, EXP MOL MED, V44, P642, DOI 10.3858/emm.2012.44.11.073; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Malone CMP, 2011, EXP CELL RES, V317, P1590, DOI 10.1016/j.yexcr.2011.03.023; Milona A, 2010, HEPATOLOGY, V52, P1341, DOI 10.1002/hep.23849; Nelson BR, 2009, DEV DYNAM, V238, P2163, DOI 10.1002/dvdy.21848; Nikolaidou-Neokosmidou V, 2006, BIOCHEM J, V398, P439, DOI 10.1042/BJ20060169; Ohtsuki S, 2012, DRUG METAB DISPOS, V40, P83, DOI 10.1124/dmd.111.042259; Rizzo G, 2005, MOL PHARMACOL, V68, P551, DOI 10.1124/mol.105.012104; Shimamoto Y, 2004, J BIOL CHEM, V279, P7770, DOI 10.1074/jbc.M310577200; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Sit DK, 2008, J CLIN PSYCHIAT, V69, P652, DOI 10.4088/JCP.v69n0419; Sweeney TR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1313, DOI 10.1152/ajpendo.00071.2005; Temesvari M, 2012, J PHARMACOL EXP THER, V341, P294, DOI 10.1124/jpet.111.189597; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Topletz AR, 2013, DRUG METAB DISPOS, V41, P312, DOI 10.1124/dmd.112.049379; Tracy TS, 2005, AM J OBSTET GYNECOL, V192, P633, DOI 10.1016/j.ajog.2004.08.030; Wadelius M, 1997, CLIN PHARMACOL THER, V62, P400, DOI 10.1016/S0009-9236(97)90118-1; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Xie XF, 2009, MOL ENDOCRINOL, V23, P434, DOI 10.1210/me.2007-0531; Yu AM, 2004, DRUG METAB REV, V36, P243, DOI 10.1081/DMR-120034000; Yu AM, 2003, PHARMACOGENETICS, V13, P173, DOI 10.1097/00008571-200303000-00007; Zanger UM, 2004, N-S ARCH PHARMACOL, V369, P23, DOI 10.1007/s00210-003-0832-2; Zhang M, 2001, J BIOL CHEM, V276, P41690, DOI 10.1074/jbc.M105117200	51	35	36	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3105	3113		10.1074/jbc.M113.526798	http://dx.doi.org/10.1074/jbc.M113.526798			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24318876	hybrid, Green Published			2022-12-28	WOS:000331368700001
J	Koontz, J; Kontrogianni-Konstantopoulos, A				Koontz, Jason; Kontrogianni-Konstantopoulos, Aikaterini			Competition through Dimerization between Antiapoptotic and Proapoptotic HS-1-associated Protein X-1 (Hax-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bcl-2 Family Proteins; Cell Death; Oxidative Stress; Protein-Protein Interactions	CELL-DEATH; MITOCHONDRIAL PROTEIN; BCL-2 FAMILY; APOPTOSIS; OVEREXPRESSION; INTERACTS; INJURY; DOMAIN; PARL; IDENTIFICATION	Background: Hax-1 is a family of apoptotic regulators. The prototypical variant 1 has an antiapoptotic function. Results: Hax-1 variant 2 promotes cell death and can abrogate the protective effect of variant 1. Conclusion: The ratio of anti- and proapoptotic Hax-1 variants is likely to determine cell fate via sequestration or inactivation. Significance: Different splice variants of Hax-1 have opposing roles in regulating apoptosis. Studies on Hax-1 have mainly focused on variant (v) 1, demonstrating its antiapoptotic properties. However, HAX1 is heavily spliced, generating structurally distinct isoforms. We sought to characterize the Hax-1 isoforms expressed in rat heart before and after insult. We confirmed the presence of at least four Hax-1 transcripts in healthy rat cardiac muscle. These exhibited differential expression before and after induction of myocardial infarction, with v2 being up-regulated 12-fold at the transcript level and 1.5-fold at the protein level post-insult. Contrary to antiapoptotic rat and human v1, overexpression of rat v2 or human v4 (the human homologue of rat v2) in epithelial cells exacerbated cell death by 30% following H2O2 treatment compared with control vector. Coexpression of rat v1 and v2 or human v1 and v4 neutralized the protective effects of rat and human v1 and the proapoptotic effects of rat v2 and human v4 by modulating cytochrome c release. This is, at least partly, mediated by the ability of Hax-1 proteins to form homotypic and heterotypic dimers with binding affinities ranging from approximate to 3.8 nm for v1 dimers to approximate to 97 nm for v1/v2 dimers. The minimal binding region supporting these interactions lies between amino acids 97-278, which are shared by nearly all Hax-1 proteins, indicating that additional factors regulate the preferential formation of Hax-1 homo- or heterodimers. Our studies are the first to show that Hax-1 is a family of anti- and proapoptotic regulators that may modulate cell survival and death through homo- or heterodimerization.	[Koontz, Jason; Kontrogianni-Konstantopoulos, Aikaterini] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore		akons001@umaryland.edu			NHLBI, National Institutes of Health [1R21HL106197]; Science, Mathematics, and Research for Transformation (SMART) scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106197] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Science, Mathematics, and Research for Transformation (SMART) scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grant 1R21HL106197 to (A. K. K.). This work was also supported by a Science, Mathematics, and Research for Transformation (SMART) scholarship (to J. K.).	Aouacheria A, 2013, TRENDS CELL BIOL, V23, P103, DOI 10.1016/j.tcb.2012.10.010; Bowman AL, 2008, MOL BIOL CELL, V19, P3782, DOI 10.1091/mbc.E08-03-0237; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Esposti MD, 1999, J BIOL CHEM, V274, P29831, DOI 10.1074/jbc.274.42.29831; Fadeel B, 2009, BBA-GEN SUBJECTS, V1790, P1139, DOI 10.1016/j.bbagen.2009.06.004; Farrow SN, 1996, CURR OPIN GENET DEV, V6, P45, DOI 10.1016/S0959-437X(96)90009-X; Gallagher AR, 2000, P NATL ACAD SCI USA, V97, P4017, DOI 10.1073/pnas.97.8.4017; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Grzybowska EA, 2006, GENE, V371, P84, DOI 10.1016/j.gene.2005.11.035; Han YC, 2006, CIRC RES, V99, P415, DOI 10.1161/01.RES.0000237387.05259.a5; Jeyaraju DV, 2009, CELL DEATH DIFFER, V16, P1622, DOI 10.1038/cdd.2009.110; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; KULKARNI GV, 1994, J CELL SCI, V107, P1169; Lam AKM, 2013, FEBS LETT, V587, P3782, DOI 10.1016/j.febslet.2013.10.031; Lam CK, 2013, CIRC RES, V112, P79, DOI 10.1161/CIRCRESAHA.112.279935; Lees DM, 2008, J MOL BIOL, V379, P645, DOI 10.1016/j.jmb.2008.04.020; Lindenboim L, 2000, ONCOGENE, V19, P1783, DOI 10.1038/sj.onc.1203495; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Michels J., 2013, INT J CELL BIOL; Mirmohammadsadegh A, 2003, J INVEST DERMATOL, V120, P1045, DOI 10.1046/j.1523-1747.2003.12247.x; Morgan EE, 2006, EUR J HEART FAIL, V8, P687, DOI 10.1016/j.ejheart.2006.01.005; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; O'Shea KM, 2009, J MOL CELL CARDIOL, V47, P819, DOI 10.1016/j.yjmcc.2009.08.014; Ortiz DF, 2004, J BIOL CHEM, V279, P32761, DOI 10.1074/jbc.M404337200; Ouyang YB, 2002, FREE RADICAL BIO MED, V33, P544, DOI 10.1016/S0891-5849(02)00912-7; REED PW, 1972, J BIOL CHEM, V247, P6970; Sharp TV, 2002, J VIROL, V76, P802, DOI 10.1128/JVI.76.2.802-816.2002; Simmen T, 2011, EXPERT OPIN THER TAR, V15, P741, DOI 10.1517/14728222.2011.561787; Stridh H, 1998, FEBS LETT, V429, P351, DOI 10.1016/S0014-5793(98)00630-9; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Tao WK, 1998, J BIOL CHEM, V273, P23704, DOI 10.1074/jbc.273.37.23704; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Trebinska A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-76; Vafiadaki E, 2007, J MOL BIOL, V367, P65, DOI 10.1016/j.jmb.2006.10.057; Vafiadaki E, 2009, PFLUG ARCH EUR J PHY, V457, P687, DOI 10.1007/s00424-008-0506-5; Vafiadaki E, 2009, MOL BIOL CELL, V20, P306, DOI 10.1091/mbc.E08-06-0587; Willimott S, 2011, BIOCHEM BIOPH RES CO, V405, P480, DOI 10.1016/j.bbrc.2011.01.057; Yap SV, 2011, J CELL PHYSIOL, V226, P2752, DOI 10.1002/jcp.22638; Yap SV, 2010, J MOL CELL CARDIOL, V48, P1266, DOI 10.1016/j.yjmcc.2009.10.028; Yedavalli VSRK, 2005, J VIROL, V79, P13735, DOI 10.1128/JVI.79.21.13735-13746.2005; Yoshioka H, 2013, J CEREBR BLOOD F MET, V33, P1658, DOI 10.1038/jcbfm.2013.139; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao W, 2009, P NATL ACAD SCI USA, V106, P20776, DOI 10.1073/pnas.0906998106	45	19	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3468	3477		10.1074/jbc.M113.536151	http://dx.doi.org/10.1074/jbc.M113.536151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24347163	hybrid, Green Published			2022-12-28	WOS:000331368700031
J	Tian, WH; Wang, Y; Xu, Y; Guo, XP; Wang, B; Sun, L; Liu, LQ; Cui, FG; Zhuang, Q; Bao, XC; Schley, G; Chung, TL; Laslett, AL; Willam, C; Qin, BM; Maxwell, PH; Esteban, MA				Tian, Weihua; Wang, Yu; Xu, Yan; Guo, Xiangpeng; Wang, Bo; Sun, Li; Liu, Longqi; Cui, Fenggong; Zhuang, Qiang; Bao, Xichen; Schley, Gunnar; Chung, Tung-Liang; Laslett, Andrew L.; Willam, Carsten; Qin, Baoming; Maxwell, Patrick H.; Esteban, Miguel A.			The Hypoxia-inducible Factor Renders Cancer Cells More Sensitive to Vitamin C-induced Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; DNA Damage; Hypoxia-inducible Factor (HIF); Oxidative Stress; Vitamin C; Warburg Effect; Renal Cancer	ASCORBIC-ACID THERAPY; DEHYDROASCORBIC ACID; SUPPLEMENTAL ASCORBATE; SUPPORTIVE TREATMENT; HYDROGEN-PEROXIDE; SURVIVAL TIMES; VHL; TRANSPORTERS; CARCINOMA; EXPRESSION	Background: There is renewed interest in the possibility of using Vc as an anticancer agent. Results: Activation of HIF triggers a Warburg effect that renders cancer cells more sensitive to Vc-induced toxicity. Conclusion: These results provide a link between the metabolic state and the susceptibility to Vc. Significance: Our work helps to understand the preferential toxicity of Vc toward cancer cells. Megadose vitamin C (Vc) is one of the most enduring alternative treatments for diverse human diseases and is deeply engrafted in popular culture. Preliminary studies in the 1970s described potent effects of Vc on prolonging the survival of patients with terminal cancer, but these claims were later criticized. An improved knowledge of the pharmacokinetics of Vc and recent reports using cancer cell lines have renewed the interest in this subject. Despite these findings, using Vc as an adjuvant for anticancer therapy remains questionable, among other things because there is no proper mechanistic understanding. Here, we show that a Warburg effect triggered by activation of the hypoxia-inducible factor (HIF) pathway greatly enhances Vc-induced toxicity in multiple cancer cell lines, including von Hippel-Lindau (VHL)-defective renal cancer cells. HIF increases the intracellular uptake of oxidized Vc through its transcriptional target glucose transporter 1 (GLUT1), synergizing with the uptake of its reduced form through sodium-dependent Vc transporters. The resulting high levels of intracellular Vc induce oxidative stress and massive DNA damage, which then causes metabolic exhaustion by depleting cellular ATP reserves. HIF-positive cells are particularly sensitive to Vc-induced ATP reduction because they mostly rely on the rather inefficient glycolytic pathway for energy production. Thus, our experiments link Vc-induced toxicity and cancer metabolism, providing a new explanation for the preferential effect of Vc on cancer cells.	[Tian, Weihua; Wang, Yu; Xu, Yan; Guo, Xiangpeng; Wang, Bo; Sun, Li; Liu, Longqi; Cui, Fenggong; Zhuang, Qiang; Bao, Xichen; Qin, Baoming; Esteban, Miguel A.] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Tian, Weihua; Wang, Yu; Xu, Yan; Guo, Xiangpeng; Wang, Bo; Sun, Li; Liu, Longqi; Cui, Fenggong; Zhuang, Qiang; Bao, Xichen; Qin, Baoming; Esteban, Miguel A.] Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cells & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Tian, Weihua] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Schley, Gunnar; Willam, Carsten] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Chung, Tung-Liang; Laslett, Andrew L.] CSIRO, Mat Sci & Engn Div, Clayton, Vic 3168, Australia; [Chung, Tung-Liang; Laslett, Andrew L.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Maxwell, Patrick H.] Cambridge Inst Med Res, Cambridge CB20XY, England	Chinese Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Erlangen Nuremberg; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Regenerative Medicine Institute; Monash University	Esteban, MA (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	esteban@gibh.org	Tian, Weihua/AAC-8919-2022; Maxwell, Patrick H/C-5557-2008; Laslett, Andrew L/A-9760-2011	Maxwell, Patrick H/0000-0002-0338-2679; Laslett, Andrew L/0000-0003-4729-8193; Xu, Yan/0000-0001-5653-291X; Schley, Gunnar/0000-0001-9929-5854; Tian, Weihua/0000-0003-2357-3947	National Natural Science Foundation of China [31071309, 81202010]; Wellcome Trust [096956/Z/11/Z] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by National Natural Science Foundation of China Grants 31071309 and 81202010.	Abdel-Latif MMM, 2005, J CHEMOTHERAPY, V17, P539, DOI 10.1179/joc.2005.17.5.539; Alberghini A, 2005, J BIOL CHEM, V280, P30120, DOI 10.1074/jbc.M500971200; Alexander B, 2013, INTEGR CANCER THER, V12, P442, DOI 10.1177/1534735412473643; Bevan RJ, 2010, BRIT J NUTR, V103, P686, DOI 10.1017/S0007114509992285; CAMERON E, 1976, P NATL ACAD SCI USA, V73, P3685, DOI 10.1073/pnas.73.10.3685; CAMERON E, 1978, P NATL ACAD SCI USA, V75, P4538, DOI 10.1073/pnas.75.9.4538; CAMERON E, 1979, CANCER RES, V39, P663; Carosio R, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-55; Chen P, 2012, ANTI-CANCER DRUG, V23, P437, DOI 10.1097/CAD.0b013e32834fd01f; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; Cheng F, 2011, J BIOL CHEM, V286, P27559, DOI 10.1074/jbc.M111.243345; Corpe CP, 2013, J BIOL CHEM, V288, P9092, DOI 10.1074/jbc.M112.436790; CREAGAN ET, 1979, NEW ENGL J MED, V301, P687, DOI 10.1056/NEJM197909273011303; Du J, 2012, BBA-REV CANCER, V1826, P443, DOI 10.1016/j.bbcan.2012.06.003; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Esteban MA, 2012, NAT GENET, V44, P366, DOI 10.1038/ng.2222; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Frolova AI, 2011, REPRODUCTION, V142, P211, DOI 10.1530/REP-11-0114; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Gilkes DM, 2013, J BIOL CHEM, V288, P10819, DOI 10.1074/jbc.M112.442939; Graumlich JF, 1997, PHARMACEUT RES, V14, P1133, DOI 10.1023/A:1012186203165; Hao WS, 2010, J BIOL CHEM, V285, P12647, DOI 10.1074/jbc.M109.084194; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; Hong SW, 2013, ONCOGENE, V32, P1508, DOI 10.1038/onc.2012.176; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kim J, 2012, FREE RADICAL BIO MED, V53, P1607, DOI 10.1016/j.freeradbiomed.2012.07.079; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Knowles HJ, 2003, CANCER RES, V63, P1764; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kurbacher CM, 1996, CANCER LETT, V103, P183, DOI 10.1016/0304-3835(96)04212-7; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Lykkesfeldt J, 2000, ANAL BIOCHEM, V282, P89, DOI 10.1006/abio.2000.4592; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; May JM, 2011, BRIT J PHARMACOL, V164, P1793, DOI 10.1111/j.1476-5381.2011.01350.x; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Michels AJ, 2013, ANNU REV NUTR, V33, P45, DOI 10.1146/annurev-nutr-071812-161246; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; Montel-Hagen A, 2008, CELL, V132, P1039, DOI 10.1016/j.cell.2008.01.042; Ohno S, 2009, ANTICANCER RES, V29, P809; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; Parrow NL, 2013, ANTIOXID REDOX SIGN, V19, P2141, DOI 10.1089/ars.2013.5372; Pokorski M, 2003, J BIOMED SCI, V10, P193, DOI 10.1159/000068707; Riordan HD, 1990, J ORTHOMOL MED, V5, P5; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shimizu S, 1996, CANCER RES, V56, P2161; VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0; Verrax J, 2009, FREE RADICAL BIO MED, V47, P32, DOI 10.1016/j.freeradbiomed.2009.02.016; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Xu J, 2012, ONCOGENE, V31, P1065, DOI 10.1038/onc.2011.305; Xu JY, 2010, J AM SOC NEPHROL, V21, P2041, DOI 10.1681/ASN.2010040345; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	68	36	36	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3339	3351		10.1074/jbc.M113.538157	http://dx.doi.org/10.1074/jbc.M113.538157			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24371136	hybrid, Green Published			2022-12-28	WOS:000331368700021
J	Wang, WB; Chen, YF; Wang, SY; Hu, NG; Cao, ZY; Wang, WG; Tong, TJ; Zhang, XW				Wang, Weibin; Chen, Yifan; Wang, Shuya; Hu, Ningguang; Cao, Zhengyi; Wang, Wengong; Tong, Tanjun; Zhang, Xiaowei			PIASx alpha Ligase Enhances SUMO1 Modification of PTEN Protein as a SUMO E3 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						PI 3-Kinase (PI3K); PTEN; Sumoylation; Tumor; Ubiquitination; PIASx; SUMO E3 Ligase; Tumor Inhibition	TUMOR-SUPPRESSOR PTEN; RECEPTOR-INTERACTING PROTEIN-3; KAPPA-B ACTIVATION; CELL-SURVIVAL; UP-REGULATION; IN-VIVO; UBIQUITIN; P53; TRANSCRIPTION; CANCER	Background: The activity of PTEN tumor suppressor is tightly controlled. Results: SUMOylation of PTEN enhanced by PIASx regulates PTEN activity. Conclusion: PIASx is a novel SUMO E3 ligase to promote SUMOylation of PTEN. Significance: PIASx-mediated SUMOylation of PTEN has a central role in tumor inhibition. The tumor suppressor PTEN plays a critical role in the regulation of multiple cellular processes that include survival, cell cycle, proliferation, and apoptosis. PTEN is frequently mutated or deleted in various human cancer cells to promote tumorigenesis. PTEN is regulated by SUMOylation, but the SUMO E3 ligase involved in the SUMOylation of PTEN remains unclear. Here, we demonstrated that PIASx is a SUMO E3 ligase for PTEN. PIASx physically interacted with PTEN both in vitro and in vivo. Their interaction depended on the integrity of phosphatase and C2 domains of PTEN and the region of PIASx comprising residues 134-347. PIASx enhanced PTEN protein stability by reducing PTEN ubiquitination, whereas the mutation of PTEN SUMO1 conjugation sites neutralized the effect of PIASx on PTEN protein half-life. Functionally, PIASx, as a potential tumor suppressor, negatively regulated the PI3K-Akt pathway through stabilizing PTEN protein. Overexpression of PIASx led to G(0)/G(1) cell cycle arrest, thus triggering cell proliferation inhibition and tumor suppression, whereas PIASx knockdown or deficiency in catalytic activity abolished the inhibition. Together our studies suggest that PIASx is a novel SUMO E3 ligase for PTEN, and it positively regulates PTEN protein level in tumor suppression.	[Wang, Weibin; Chen, Yifan; Wang, Shuya; Hu, Ningguang; Cao, Zhengyi; Wang, Wengong; Tong, Tanjun; Zhang, Xiaowei] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China	Peking University	Zhang, XW (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Xueyuan Rd 38, Beijing 100191, Peoples R China.	xiaoweizhang@bjmu.edu.cn		, wei/0000-0002-5138-2892	National Natural Science Foundation of China [81170320, 81230008]; Beijing Natural Science Foundation [5122023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China Grants 81170320 and 81230008 and Beijing Natural Science Foundation Grant 5122023.	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Hettinger K, 2007, CELL DEATH DIFFER, V14, P218, DOI 10.1038/sj.cdd.4401946; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kakuguchi W, 2010, MOL CANCER RES, V8, P520, DOI 10.1158/1541-7786.MCR-09-0367; Kotaja N, 2000, MOL ENDOCRINOL, V14, P1986, DOI 10.1210/me.14.12.1986; Kotaja N, 2002, J BIOL CHEM, V277, P17781, DOI 10.1074/jbc.M106354200; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Ramakrishnan S, 1998, CANCER RES, V58, P622; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Sarge KD, 2009, METHODS MOL BIOL, V590, P265, DOI 10.1007/978-1-60327-378-7_17; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shen YH, 2006, J BIOL CHEM, V281, P7727, DOI 10.1074/jbc.M511105200; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sturm S, 2000, J MOL NEUROSCI, V14, P107, DOI 10.1385/JMN:14:1-2:107; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tamura M, 1999, CANCER RES, V59, P442; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Teng DHF, 1997, CANCER RES, V57, P5221; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Wu SY, 2009, EPIGENETICS-US, V4, P445, DOI 10.4161/epi.4.7.10030; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6	53	29	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3217	3230		10.1074/jbc.M113.508515	http://dx.doi.org/10.1074/jbc.M113.508515			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24344134	Green Published, hybrid			2022-12-28	WOS:000331368700011
J	Labourel, A; Jam, M; Jeudy, A; Hehemann, JH; Czjzek, M; Michel, G				Labourel, Aurore; Jam, Murielle; Jeudy, Alexandra; Hehemann, Jan-Hendrik; Czjzek, Mirjam; Michel, Gurvan			The beta-Glucanase ZgLamA from Zobellia galactanivorans Evolved a Bent Active Site Adapted for Efficient Degradation of Algal Laminarin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Algae; Carbohydrate Metabolism; Crystal Structure; Glycoside Hydrolases; Oligosaccharide; 1; 3-beta-glucan; Family GH16; Laminarinase; Marine Bacteria	MARINE BACTERIUM; STRUCTURAL-CHARACTERIZATION; RHODOTHERMUS-MARINUS; PHYTOPLANKTON BLOOM; KAPPA-CARRAGEENASE; CRYSTAL-STRUCTURES; STORAGE GLUCAN; EVOLUTION; METABOLISM; SEQUENCE	Laminarinase is commonly used to describe -1,3-glucanases widespread throughout Archaea, bacteria, and several eukaryotic lineages. Some -1,3-glucanases have already been structurally and biochemically characterized, but very few from organisms that are in contact with genuine laminarin, the storage polysaccharide of brown algae. Here we report the heterologous expression and subsequent biochemical and structural characterization of ZgLamA(GH16) from Zobellia galactanivorans, the first GH16 laminarinase from a marine bacterium associated with seaweeds. ZgLamA(GH16) contains a unique additional loop, compared with other GH16 laminarinases, which is composed of 17 amino acids and gives a bent shape to the active site cleft of the enzyme. This particular topology is perfectly adapted to the U-shaped conformation of laminarin chains in solution and thus explains the predominant specificity of ZgLamA(GH16) for this substrate. The three-dimensional structure of the enzyme and two enzyme-substrate complexes, one with laminaritetraose and the other with a trisaccharide of 1,3-1,4--d-glucan, have been determined at 1.5, 1.35, and 1.13 resolution, respectively. The structural comparison of substrate recognition pattern between these complexes allows the proposition that ZgLamA(GH16) likely diverged from an ancestral broad specificity GH16 -glucanase and evolved toward a bent active site topology adapted to efficient degradation of algal laminarin.	[Labourel, Aurore; Jam, Murielle; Jeudy, Alexandra; Hehemann, Jan-Hendrik; Czjzek, Mirjam; Michel, Gurvan] Univ Paris 06, Sorbonne Univ, UMR 7139, Stn Biol Roscoff, F-29682 Roscoff, Bretagne, France; [Labourel, Aurore; Jam, Murielle; Jeudy, Alexandra; Hehemann, Jan-Hendrik; Czjzek, Mirjam; Michel, Gurvan] CNRS, UMR Marine Plants & Biomolecules 7139, Stn Biol Roscoff, F-29682 Roscoff, Bretagne, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Michel, G (corresponding author), Stn Biol Roscoff, Pl Georges Teissier, F-29680 Roscoff, Brittany, France.	gurvan@sb-roscoff.fr		Hehemann, Jan-Hendrik/0000-0002-8700-2564; Labourel, Aurore/0000-0002-4762-5804; MICHEL, Gurvan/0000-0002-3009-6205	French National Research Agency [ANR-10-BTBR-04]; French Ministry of Higher Education and Research	French National Research Agency(French National Research Agency (ANR)); French Ministry of Higher Education and Research	This work was supported in part by the French National Research Agency with regards to the investment expenditure program IDEALG under Grant Agreement ANR-10-BTBR-04.; Supported by a Ph.D. fellowship from the French Ministry of Higher Education and Research.	Alderkamp AC, 2007, FEMS MICROBIOL ECOL, V59, P108, DOI 10.1111/j.1574-6941.2006.00219.x; [Anonymous], 1983, CARBOHYD POLYM, DOI 10.1016/0144-8617(83)90019-x; Arnosti C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00425; Barbeyron T, 1998, MOL BIOL EVOL, V15, P528, DOI 10.1093/oxfordjournals.molbev.a025952; Barbeyron T, 2001, INT J SYST EVOL MICR, V51, P985, DOI 10.1099/00207713-51-3-985; Barbeyron T, 2000, J BIOL CHEM, V275, P35499, DOI 10.1074/jbc.M003404200; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; BEATTIE A, 1961, BIOCHEM J, V79, P531, DOI 10.1042/bj0790531; Bleicher L, 2011, J PHYS CHEM B, V115, P7940, DOI 10.1021/jp200330z; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CLARKE AE, 1960, BIOCHIM BIOPHYS ACTA, V44, P161, DOI 10.1016/0006-3002(60)91534-1; Cloern JE, 1996, REV GEOPHYS, V34, P127, DOI 10.1029/96RG00986; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DiTullio GR, 2000, NATURE, V404, P595, DOI 10.1038/35007061; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Eklof JM, 2013, J BIOL CHEM, V288, P15786, DOI 10.1074/jbc.M113.462887; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Groisillier A, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-45; Hehemann JH, 2012, J BIOL CHEM, V287, P30571, DOI 10.1074/jbc.M112.377184; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hirokawa Y, 2008, PLANTA, V227, P589, DOI 10.1007/s00425-007-0641-9; JACKSON P, 1990, BIOCHEM J, V270, P705, DOI 10.1042/bj2700705; Janse I, 1996, J PHYCOL, V32, P382, DOI 10.1111/j.0022-3646.1996.00382.x; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawai R, 2006, APPL MICROBIOL BIOT, V71, P898, DOI 10.1007/s00253-005-0214-4; KEITEL T, 1994, EUR J BIOCHEM, V222, P203, DOI 10.1111/j.1432-1033.1994.tb18858.x; KIDBY DK, 1973, ANAL BIOCHEM, V55, P321, DOI 10.1016/0003-2697(73)90323-0; Krah M, 1998, EUR J BIOCHEM, V257, P101, DOI 10.1046/j.1432-1327.1998.2570101.x; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Michel G, 2010, NEW PHYTOL, V188, P67, DOI 10.1111/j.1469-8137.2010.03345.x; PERCIVAL EGV, 1951, J CHEM SOC, P720, DOI 10.1039/jr9510000720; Read SM, 1996, CARBOHYD RES, V281, P187, DOI 10.1016/0008-6215(95)00350-9; Rebuffet E, 2011, ENVIRON MICROBIOL, V13, P1253, DOI 10.1111/j.1462-2920.2011.02426.x; Rebuffet E, 2010, BIOCHEMISTRY-US, V49, P7590, DOI 10.1021/bi1003475; Siegel DA, 2002, SCIENCE, V296, P730, DOI 10.1126/science.1069174; SMITH SV, 1981, SCIENCE, V211, P838, DOI 10.1126/science.211.4484.838; Stone BA, 2009, CHEMISTRY, BIOCHEMISTRY, AND BIOLOGY OF (1-->3)-BETA-GLUCANS AND RELATED POLYSACCHARIDES, P5; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Thomas F, 2012, ENVIRON MICROBIOL, V14, P2379, DOI 10.1111/j.1462-2920.2012.02751.x; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Thomas F, 2013, J BIOL CHEM, V288, P23021, DOI 10.1074/jbc.M113.467217; Tsai LC, 2005, J MOL BIOL, V354, P642, DOI 10.1016/j.jmb.2005.09.041; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vasur J, 2009, FEBS J, V276, P4282, DOI 10.1111/j.1742-4658.2009.07099.x; Viladot JL, 1998, BIOCHEMISTRY-US, V37, P11332, DOI 10.1021/bi980586q; WANG MC, 1974, CARBOHYD RES, V37, P331, DOI 10.1016/S0008-6215(00)82922-5; Wang YK, 2010, J BIOL CHEM, V285, P14285, DOI 10.1074/jbc.M109.087023; Weiss MS, 2001, ACTA CRYSTALLOGR D, V57, P689, DOI 10.1107/S0907444901003572	57	50	51	4	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2027	2042		10.1074/jbc.M113.538843	http://dx.doi.org/10.1074/jbc.M113.538843			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24337571	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000331130200014
J	Park, M; Ohana, E; Choi, SY; Lee, MS; Park, JH; Muallem, S				Park, Meeyoung; Ohana, Ehud; Choi, Soo Young; Lee, Myeong-Sok; Park, Jong Hoon; Muallem, Shmuel			Multiple Roles of the SO42-/Cl-/OH- Exchanger Protein Slc26a2 in Chondrocyte Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anion Transport; Cellular Regulation; Chondrocytes; Insulin-like Growth Factor (IGF); Transporters	DYSPLASIA SULFATE TRANSPORTER; GROWTH-FACTOR-I; BONE-GROWTH; PROTEOGLYCAN SULFATION; SIGNALING PATHWAYS; CARTILAGE; FAMILY; DIFFERENTIATION; MUTATIONS; KINASE	Mutations in the SO42-/Cl-/OH- exchanger Slc26a2 cause the disease diastrophic dysplasia (DTD), resulting in aberrant bone development and, therefore, skeletal deformities. DTD is commonly attributed to a lack of chondrocyte SO42- uptake and proteoglycan sulfation. However, the skeletal phenotype of patients with DTD is typified by reduction in cartilage and osteoporosis of the long bones. Chondrocytes of patients with DTD are irregular in size and have a reduced capacity for proliferation and terminal differentiation. This raises the possibility of additional roles for Slc26a2 in chondrocyte function. Here, we examined the roles of Slc26a2 in chondrocyte biology using two distinct systems: mouse progenitor mesenchymal cells differentiated to chondrocytes and freshly isolated mouse articular chondrocytes differentiated into hypertrophic chondrocytes. Slc26a2 expression was manipulated acutely by delivery of Slc26a2 or shSlc26a2 with lentiviral vectors. We demonstrate that slc26a2 is essential for chondrocyte proliferation and differentiation and for proteoglycan synthesis. Slc26a2 also regulates the terminal stage of chondrocyte cell size expansion. These findings reveal multiple roles for Slc26a2 in chondrocyte biology and emphasize the importance of Slc26a2-mediated protein sulfation in cell signaling, which may account for the complex phenotype of DTD.	[Park, Meeyoung; Lee, Myeong-Sok; Park, Jong Hoon] Sookmyung Womens Univ, Res Ctr Womens Dis, Dept Biol Sci, Seoul 140742, South Korea; [Ohana, Ehud; Muallem, Shmuel] Natl Inst Dent & Craniofacial Res, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Choi, Soo Young] Hallym Univ, Inst Biosci & Biotechnol, Dept Biomed Sci & Res, Chunchon 200702, South Korea	Sookmyung Women's University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Hallym University	Park, JH (corresponding author), Sookmyung Womens Univ, Res Ctr Womens Dis, Dept Biol Sci, Seoul 140742, South Korea.	parkjh@sookmyung.ac.kr; shmuel.muallem@nih.gov	Ohana, Ehud/ABB-3060-2020	Ohana, Ehud/0000-0001-8598-4042	National Institutes of Health [ZIA DE000735]; National Research Foundation [NRF-2008-359-C00029, NRF-2009-0071060]; MSIP [2013R1A2A1A01011908]; Korean government; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation; MSIP; Korean government(Korean Government); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Intramural Grant ZIA DE000735. This work was also supported by National Research Foundation Grants NRF-2008-359-C00029 and NRF-2009-0071060] and MSIP Grant 2013R1A2A1A01011908 funded by the Korean government.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Beier F, 2010, J CELL BIOCHEM, V110, P573, DOI 10.1002/jcb.22604; Chapman JM, 2010, HISTOCHEM CELL BIOL, V133, P541, DOI 10.1007/s00418-010-0694-x; Cooper KL, 2013, NATURE, V495, P375, DOI 10.1038/nature11940; Cornaglia AI, 2009, CONNECT TISSUE RES, V50, P232, DOI 10.1080/03008200802684623; Danisovic L, 2012, TISSUE CELL, V44, P69, DOI 10.1016/j.tice.2011.11.005; de Andrea CE, 2012, J PATHOL, V226, P219, DOI 10.1002/path.3003; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007; Dwyer E, 2010, AM J MED GENET A, V152A, P3043, DOI 10.1002/ajmg.a.33736; Forlino A, 2005, HUM MOL GENET, V14, P859, DOI 10.1093/hmg/ddi079; Gualeni B, 2013, BONE, V54, P83, DOI 10.1016/j.bone.2013.01.036; Gualeni B, 2010, MATRIX BIOL, V29, P453, DOI 10.1016/j.matbio.2010.05.001; Guerit D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062582; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Haila S, 2001, J HISTOCHEM CYTOCHEM, V49, P973, DOI 10.1177/002215540104900805; Harrington EK, 2010, ANAT REC, V293, P225, DOI 10.1002/ar.21072; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; MacRae VE, 2007, GROWTH HORM IGF RES, V17, P435, DOI 10.1016/j.ghir.2007.05.002; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Markovich D, 2007, ANNU REV PHYSIOL, V69, P361, DOI 10.1146/annurev.physiol.69.040705.141319; Mertz EL, 2012, J BIOL CHEM, V287, P22030, DOI 10.1074/jbc.M110.116467; Mohan S, 2012, CURR OSTEOPOROS REP, V10, P178, DOI 10.1007/s11914-012-0100-9; Ohana E, 2012, J BIOL CHEM, V287, P5122, DOI 10.1074/jbc.M111.297192; Park S, 2013, GASTROENTEROLOGY, V145, P232, DOI 10.1053/j.gastro.2013.03.047; Patil AS, 2012, J CELL PHYSIOL, V227, P1796, DOI 10.1002/jcp.22905; Rokutanda S, 2009, DEV BIOL, V328, P78, DOI 10.1016/j.ydbio.2009.01.009; Rossi A, 1998, MATRIX BIOL, V17, P361, DOI 10.1016/S0945-053X(98)90088-9; Schonherr E, 2000, Dev Immunol, V7, P89, DOI 10.1155/2000/31748; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; Strott CA, 2003, J LIPID RES, V44, P1268, DOI 10.1194/jlr.R300005-JLR200; SupertiFurga A, 1996, AM J MED GENET, V63, P144, DOI 10.1002/(SICI)1096-8628(19960503)63:1<144::AID-AJMG25>3.0.CO;2-N; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; Wang F, 2011, J BIOCHEM, V150, P83, DOI 10.1093/jb/mvr037; Wang YM, 2006, ENDOCRINOLOGY, V147, P4753, DOI 10.1210/en.2006-0196; Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4; ZAPF J, 1986, HORM RES, V24, P160, DOI 10.1159/000180555; Zhang XP, 2004, BONE, V34, P809, DOI 10.1016/j.bone.2003.12.026	41	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1993	2001		10.1074/jbc.M113.503466	http://dx.doi.org/10.1074/jbc.M113.503466			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302720	Green Published, hybrid			2022-12-28	WOS:000331130200011
J	Podolnikova, NP; Yakovlev, S; Yakubenko, VP; Wang, X; Gorkun, OV; Ugarova, TP				Podolnikova, Nataly P.; Yakovlev, Sergiy; Yakubenko, Valentin P.; Wang, Xu; Gorkun, Oleg V.; Ugarova, Tatiana P.			The Interaction of Integrin alpha(IIb)beta(3) with Fibrin Occurs through Multiple Binding Sites in the alpha(IIb) beta-Propeller Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Fibrin; Fibrinogen; Integrin; Platelets; Clot Retraction	PLATELET GLYCOPROTEIN-IIB; AMINO-ACID-RESIDUES; GAMMA-C-DOMAIN; CLOT RETRACTION; MONOCLONAL-ANTIBODIES; THROMBUS FORMATION; STRUCTURAL BASIS; LIGAND-BINDING; IN-VIVO; AGGREGATION	The currently available antithrombotic agents target the interaction of platelet integrin (IIb3) (GPIIb-IIIa) with fibrinogen during platelet aggregation. Platelets also bind fibrin formed early during thrombus growth. It was proposed that inhibition of platelet-fibrin interactions may be a necessary and important property of (IIb3) antagonists; however, the mechanisms by which (IIb3) binds fibrin are uncertain. We have previously identified the 370-381 sequence (P3) in the C domain of fibrinogen as the fibrin-specific binding site for (IIb3) involved in platelet adhesion and platelet-mediated fibrin clot retraction. In the present study, we have demonstrated that P3 can bind to several discontinuous segments within the (IIb) -propeller domain of (IIb3) enriched with negatively charged and aromatic residues. By screening peptide libraries spanning the sequence of the (IIb) -propeller, several sequences were identified as candidate contact sites for P3. Synthetic peptides duplicating these segments inhibited platelet adhesion and clot retraction but not platelet aggregation, supporting the role of these regions in fibrin recognition. Mutant (IIb3) receptors in which residues identified as critical for P3 binding were substituted for homologous residues in the I-less integrin (M2) exhibited reduced cell adhesion and clot retraction. These residues are different from those that are involved in the coordination of the fibrinogen 404-411 sequence and from auxiliary sites implicated in binding of soluble fibrinogen. These results map the binding of fibrin to multiple sites in the (IIb) -propeller and further indicate that recognition specificity of (IIb3) for fibrin differs from that for soluble fibrinogen.	[Podolnikova, Nataly P.; Ugarova, Tatiana P.] Arizona State Univ, Ctr Metab & Vasc Biol, Tempe, AZ 85287 USA; [Wang, Xu] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Yakovlev, Sergiy] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Yakubenko, Valentin P.] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Gorkun, Oleg V.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University System of Maryland; University of Maryland Baltimore; Cleveland Clinic Foundation; University of North Carolina; University of North Carolina Chapel Hill	Podolnikova, NP (corresponding author), Arizona State Univ, Ctr Metab & Vasc Biol, POB 874501, Tempe, AZ 85287 USA.	Nataly.Podolnikova@asu.edu		Yakovlev, Sergiy/0000-0002-2078-5218	National Institutes of Health [HL63199, HL107539]; American Heart Association [0835257N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107539, R01HL063199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health grants HL63199 and HL107539 (to T. P. U.). This work was also supported by American Heart Association Grant 0835257N (to N. P.).	BEHNKE O, 1976, CONTRACTILE SYSTEMS, P105; Bennett JS, 2001, ANN NY ACAD SCI, V936, P340; COHEN I, 1989, BLOOD, V73, P1880; COHEN I, 1982, J CELL BIOL, V93, P775, DOI 10.1083/jcb.93.3.775; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; DEGAETANO G, 1971, THROMB DIATH HAEMOST, V26, P449, DOI 10.1055/s-0038-1653697; DSOUZA SE, 1991, NATURE, V350, P66, DOI 10.1038/350066a0; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; GANGULY P, 1982, BIOCHIM BIOPHYS ACTA, V714, P192, DOI 10.1016/0304-4165(82)90324-5; GULINO D, 1992, J BIOL CHEM, V267, P1001; Hantgan RR, 2010, BIOCHEMISTRY-US, V49, P9217, DOI 10.1021/bi1009858; HANTGAN RR, 1989, FIBRINOGEN, P203; Hayashi T, 2008, PFLUG ARCH EUR J PHY, V456, P1239, DOI 10.1007/s00424-008-0466-9; Hechler B, 2010, J THROMB HAEMOST, V8, P173, DOI 10.1111/j.1538-7836.2009.03666.x; Hogan KA, 2000, J BIOL CHEM, V275, P17778, DOI 10.1074/jbc.M001618200; Holmback K, 1996, EMBO J, V15, P5760, DOI 10.1002/j.1460-2075.1996.tb00962.x; HOUSTON DS, 1983, BIOCHIM BIOPHYS ACTA, V734, P267, DOI 10.1016/0005-2736(83)90124-4; HUBER W, 1995, EUR J BIOCHEM, V227, P647, DOI 10.1111/j.1432-1033.1995.tb20184.x; JENKINS CSP, 1971, BLOOD-J HEMATOL, V37, P395, DOI 10.1182/blood.V37.4.395.395; Kamata T, 1996, J BIOL CHEM, V271, P18610, DOI 10.1074/jbc.271.31.18610; Kamata T, 2001, J BIOL CHEM, V276, P44275, DOI 10.1074/jbc.M107021200; KATAGIRI Y, 1995, J BIOL CHEM, V270, P1785, DOI 10.1074/jbc.270.4.1785; KLOCZEWIAK M, 1989, BIOCHEMISTRY-US, V28, P2915, DOI 10.1021/bi00433a025; KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200; Lishko VK, 2002, BIOCHEMISTRY-US, V41, P12942, DOI 10.1021/bi026324c; MARGUERIE GA, 1980, J BIOL CHEM, V255, P154; MASUMOTO A, 1993, J CELL BIOL, V123, P245, DOI 10.1083/jcb.123.1.245; MORGENSTERN E, 1984, THROMB RES, V33, P617, DOI 10.1016/0049-3848(84)90116-6; Morgenstern E, 1984, Acta Histochem Suppl, V29, P183; Morrissey JH, 2012, J THROMB HAEMOST, V10, P2313, DOI 10.1111/jth.12001; MULLER B, 1993, J BIOL CHEM, V268, P6800; MUSTARD JF, 1978, BLOOD, V52, P453; Nurden Alan T, 2003, Semin Vasc Med, V3, P123; Osdoit S, 2001, J BIOL CHEM, V276, P6703, DOI 10.1074/jbc.M008945200; PARISE LV, 1993, BIOCHEM J, V289, P445, DOI 10.1042/bj2890445; PEERSCHKE EIB, 1985, AM J PHYSIOL, V248, pC466, DOI 10.1152/ajpcell.1985.248.5.C466; Podolnikova NP, 2005, BIOCHEMISTRY-US, V44, P16920, DOI 10.1021/bi051581d; Podolnikova NP, 2003, J BIOL CHEM, V278, P32251, DOI 10.1074/jbc.M300410200; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; Remijn JA, 2002, BRIT J HAEMATOL, V117, P650, DOI 10.1046/j.1365-2141.2002.03467.x; Rooney MM, 1998, BLOOD, V92, P2374, DOI 10.1182/blood.V92.7.2374.2374_2374_2381; Rooney MM, 1996, J BIOL CHEM, V271, P8553, DOI 10.1074/jbc.271.15.8553; SKAER RJ, 1979, J ULTRA MOL STRUCT R, V69, P28, DOI 10.1016/S0022-5320(79)80040-4; Soslau G, 2001, J BIOL CHEM, V276, P21173, DOI 10.1074/jbc.M008249200; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; UGAROVA TP, 1993, J BIOL CHEM, V268, P21080; White JG, 2000, PLATELETS, V11, P49, DOI 10.1080/09537100075805; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yakovlev S, 2000, BIOCHEMISTRY-US, V39, P15730, DOI 10.1021/bi001847a; Yalamanchili P, 2000, J BIOL CHEM, V275, P21877, DOI 10.1074/jbc.M908868199; Yang Z, 2000, P NATL ACAD SCI USA, V97, P14156, DOI 10.1073/pnas.97.26.14156; Yokoyama K, 1999, BIOCHEMISTRY-US, V38, P5872, DOI 10.1021/bi9827619; ZAMARRON C, 1990, THROMB HAEMOSTASIS, V64, P41; ZAMARRON C, 1991, J BIOL CHEM, V266, P16193; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702	59	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2371	2383		10.1074/jbc.M113.518126	http://dx.doi.org/10.1074/jbc.M113.518126			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24338009	hybrid, Green Published			2022-12-28	WOS:000331130200041
J	Jiang, JY; Nagaraju, M; Meyer, RC; Zhang, L; Hamelberg, D; Hall, RA; Brown, EM; Conn, PJ; Yang, JJ				Jiang, Jason Y.; Nagaraju, Mulpuri; Meyer, Rebecca C.; Zhang, Li; Hamelberg, Donald; Hall, Randy A.; Brown, Edward M.; Conn, P. Jeffrey; Yang, Jenny J.			Extracellular Calcium Modulates Actions of Orthosteric and Allosteric Ligands on Metabotropic Glutamate Receptor 1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calcium-binding Proteins; Drug Discovery; G Protein-coupled Receptors (GPCR); Glutamate Receptors Metabotropic; Allosteric Modulators; Orthosteric Agonist; Orthosteric Antagonist	BINDING-SITE; CA2+-BINDING SITES; STRUCTURAL BASIS; MOLECULAR-MECHANISM; DOMAIN; CA2+; ANTAGONIST; CPCCOET; IDENTIFICATION; ACTIVATION	Background: Extracellular Ca2+ alters mGluR1 activity but by an unknown mechanism. Results: Mutations in predicted Ca2+-binding sites modulated the potency of both orthosteric and allosteric modulators. Conclusion: Ca2+ binding exerts multiple types of effects on mGluR1. Significance: Improved knowledge of the mechanisms underlying the actions of Ca2+ on mGluR1 activity could facilitate development of isoform-selective drugs and/or suggest ways to tune the actions of available drugs. Metabotropic glutamate receptor 1 (mGluR1), a member of the family C G protein-coupled receptors, is emerging as a potential drug target for various disorders, including chronic neuronal degenerative diseases. In addition to being activated by glutamate, mGluR1 is also modulated by extracellular Ca2+. However, the underlying mechanism is unknown. Moreover, it has long been challenging to develop receptor-specific agonists due to homologies within the mGluR family, and the Ca2+-binding site(s) on mGluR1 may provide an opportunity for receptor-selective targeting by therapeutics. In the present study, we show that our previously predicted Ca2+-binding site in the hinge region of mGluR1 is adjacent to the site where orthosteric agonists and antagonists bind on the extracellular domain of the receptor. Moreover, we found that extracellular Ca2+ enhanced mGluR1-mediated intracellular Ca2+ responses evoked by the orthosteric agonist l-quisqualate. Conversely, extracellular Ca2+ diminished the inhibitory effect of the mGluR1 orthosteric antagonist (S)--methyl-4-carboxyphenylglycine. In addition, selective positive (Ro 67-4853) and negative (7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester) allosteric modulators of mGluR1 potentiated and inhibited responses to extracellular Ca2+, respectively, in a manner similar to their effects on the response of mGluR1 to glutamate. Mutations at residues predicted to be involved in Ca2+ binding, including E325I, had significant effects on the modulation of responses to the orthosteric agonist l-quisqualate and the allosteric modulator Ro 67-4853 by extracellular Ca2+. These studies reveal that binding of extracellular Ca2+ to the predicted Ca2+-binding site in the extracellular domain of mGluR1 modulates not only glutamate-evoked signaling but also the actions of both orthosteric ligands and allosteric modulators on mGluR1.	[Jiang, Jason Y.; Nagaraju, Mulpuri; Zhang, Li; Hamelberg, Donald; Yang, Jenny J.] Georgia State Univ, Dept Chem, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA; [Meyer, Rebecca C.; Hall, Randy A.] Emory Univ, Dept Pharmacol, Sch Med, Atlanta, GA 30322 USA; [Brown, Edward M.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Dept Med, Boston, MA 02115 USA; [Conn, P. Jeffrey] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	University System of Georgia; Georgia State University; Emory University; Harvard University; Brigham & Women's Hospital; Vanderbilt University	Yang, JJ (corresponding author), Georgia State Univ, Dept Chem, 552 Nat Sci Ctr, Atlanta, GA 30303 USA.	jenny@gsu.edu	Jiang, Yusheng/A-1087-2016	Hall, Randy/0000-0002-8318-8728	National Institutes of Health [GM081749-01, DK078331, NS055179]; Brains and Behavior fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055179, R37NS031373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brains and Behavior fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081749-01 (to J. J. Y.), DK078331 (to E. M. B.), and NS055179 (to R. A. H.). This work was also supported by a Brains and Behavior fellowship (to Y. J.).	Abe H, 2003, FEBS LETT, V545, P233, DOI 10.1016/S0014-5793(03)00569-6; Acher FC, 2011, NEUROPHARMACOLOGY, V60, P102, DOI 10.1016/j.neuropharm.2010.07.002; Babin V., 2008, AMBER; Brauner-Osborne H, 1999, NEUROREPORT, V10, P3923; Chen YY, 2011, BIOCHEM J, V435, P711, DOI 10.1042/BJ20101726; Conigrave AD, 2007, J NUTR, V137, p1524S, DOI 10.1093/jn/137.6.1524S; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Doshi U, 2009, J PHYS CHEM B, V113, P16590, DOI 10.1021/jp907388m; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Haas HS, 2007, ONCOL REP, V17, P1399; Harrington PE, 2007, CURR MED CHEM, V14, P3027, DOI 10.2174/092986707782794096; Hemstapat K, 2006, MOL PHARMACOL, V70, P616, DOI 10.1124/mol.105.021857; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Huang Y, 2007, J BIOL CHEM, V282, P19000, DOI 10.1074/jbc.M701096200; Huang Y, 2010, J BIOL CHEM, V285, P35919, DOI 10.1074/jbc.M110.147918; Huang Y, 2009, BIOCHEMISTRY-US, V48, P388, DOI 10.1021/bi8014604; Jiang YS, 2010, J BIOL CHEM, V285, P33463, DOI 10.1074/jbc.M110.147033; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lavreysen H, 2003, MOL PHARMACOL, V63, P1082, DOI 10.1124/mol.63.5.1082; LEVANT JA, 1973, NEW ENGL J MED, V289, P555, DOI 10.1056/NEJM197309132891104; Lindsley CW, 2004, J MED CHEM, V47, P5825, DOI 10.1021/jm049400d; Litschig S, 1999, MOL PHARMACOL, V55, P453; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nash MS, 2001, J BIOL CHEM, V276, P19286, DOI 10.1074/jbc.M007600200; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; Neyman S, 2008, EUR J NEUROSCI, V27, P1345, DOI 10.1111/j.1460-9568.2008.06109.x; Ogawa H, 2010, PROTEIN SCI, V19, P544, DOI 10.1002/pro.332; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Rodriguez AL, 2005, MOL PHARMACOL, V68, P1793, DOI 10.1124/mol.105.016139; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sato T, 2003, J BIOL CHEM, V278, P4314, DOI 10.1074/jbc.M210278200; Selkirk JV, 2001, NEUROPHARMACOLOGY, V40, P645, DOI 10.1016/S0028-3908(00)00208-2; Smith FL, 2004, EUR J PHARMACOL, V492, P137, DOI 10.1016/j.ejphar.2004.03.055; Suzuki Y, 2004, J BIOL CHEM, V279, P35526, DOI 10.1074/jbc.M404831200; Tabata T, 2002, MOL CELL NEUROSCI, V20, P56, DOI 10.1006/mcne.2002.1118; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Vassilev PM, 1997, BIOPHYS J, V72, P2103, DOI 10.1016/S0006-3495(97)78853-2; Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; Wang X, 2010, PROTEIN SCI, V19, P1180, DOI 10.1002/pro.394; Wang X, 2009, PROTEINS, V75, P787, DOI 10.1002/prot.22285; Whang PG, 2008, ORTHOPEDICS, V31, P1031; Yuan KY, 2011, J BIOL CHEM, V286, P24776, DOI 10.1074/jbc.M110.202804; Zhang F, 2010, P NATL ACAD SCI USA, V107, P4752, DOI 10.1073/pnas.0911660107; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106; Zhang ZX, 2002, J BIOL CHEM, V277, P33727, DOI 10.1074/jbc.M200976200	52	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1649	1661		10.1074/jbc.M113.507665	http://dx.doi.org/10.1074/jbc.M113.507665			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24280223	Green Published, hybrid			2022-12-28	WOS:000332401700038
J	Liberman, R; Bond, S; Shainheit, MG; Stadecker, MJ; Forgac, M				Liberman, Rachel; Bond, Sarah; Shainheit, Mara G.; Stadecker, Miguel J.; Forgac, Michael			Regulated Assembly of Vacuolar ATPase Is Increased during Cluster Disruption-induced Maturation of Dendritic Cells through a Phosphatidylinositol 3-Kinase/mTOR-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Dendritic Cells; Proton Pumps; Transport; Vacuolar Acidification; Vacuolar ATPase; Regulated V-ATPase Assembly	H+-ATPASE; E-CADHERIN; V-ATPASE; RECEPTOR; SUBUNIT; EXPRESSION; MOLECULES; ROTATION; IMMATURE; ALDOLASE	Background: The V-ATPase is induced to assemble during TLR-activated maturation of dendritic cells. Results: Cluster disruption of dendritic cells also induces V-ATPase assembly by a PI3K/mTOR-dependent mechanism. Conclusion: Semi-mature dendritic cells show increased V-ATPase assembly. Significance: Dendritic cell maturation associated with immune tolerance involves V-ATPase assembly. The vacuolar (H+)-ATPases (V-ATPases) are ATP-driven proton pumps composed of a peripheral V-1 domain and a membrane-embedded V-0 domain. Regulated assembly of V-1 and V-0 represents an important regulatory mechanism for controlling V-ATPase activity in vivo. Previous work has shown that V-ATPase assembly increases during maturation of bone marrow-derived dendritic cells induced by activation of Toll-like receptors. This increased assembly is essential for antigen processing, which is dependent upon an acidic lysosomal pH. Cluster disruption of dendritic cells induces a semi-mature phenotype associated with immune tolerance. Thus, semi-mature dendritic cells are able to process and present self-peptides to suppress autoimmune responses. We have investigated V-ATPase assembly in bone marrow-derived, murine dendritic cells and observed an increase in assembly following cluster disruption. This increased assembly is not dependent upon new protein synthesis and is associated with an increase in concanamycin A-sensitive proton transport in FITC-loaded lysosomes. Inhibition of phosphatidylinositol 3-kinase with wortmannin or mTORC1 with rapamycin effectively inhibits the increased assembly observed upon cluster disruption. These results suggest that the phosphatidylinositol 3-kinase/mTOR pathway is involved in controlling V-ATPase assembly during dendritic cell maturation.	[Liberman, Rachel; Bond, Sarah; Forgac, Michael] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Shainheit, Mara G.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Stadecker, Miguel J.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA; [Liberman, Rachel; Bond, Sarah; Forgac, Michael] Tufts Univ, Programs Cellular & Mol Physiol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Stadecker, Miguel J.] Tufts Univ, Sackler Sch Grad Biomed Sci, Programs Immunol, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University; Tufts University; Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			National Institutes of Health [GM34478]; NIAID [RO1 18919]; Sackler Dean's Fellow award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478, K12GM074869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sackler Dean's Fellow award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM34478 (to M. F.) and NIAID RO1 18919 (to M. J. S.). This work was also supported by a Sackler Dean's Fellow award (to R. L.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Granucci F, 1999, MICROBES INFECT, V1, P1079, DOI 10.1016/S1286-4579(99)00209-9; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lugt BV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020099; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Marshall FA, 2008, J IMMUNOL, V181, P7562, DOI 10.4049/jimmunol.181.11.7562; Nakamura I, 1997, J CELL PHYSIOL, V172, P230, DOI 10.1002/(SICI)1097-4652(199708)172:2<230::AID-JCP10>3.0.CO;2-D; Ocana-Morgner C, 2013, J IMMUNOL, V190, P5545, DOI 10.4049/jimmunol.1203095; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Riedl E, 2000, BLOOD, V96, P4276; Rivard N, 2009, FRONT BIOSCI-LANDMRK, V14, P510, DOI 10.2741/3259; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Schuler G, 2001, CURR PROTOC IMMUNOL; STEINMAN RM, 1974, J EXP MED, V139, P1431, DOI 10.1084/jem.139.6.1431; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Su Y, 2003, J BIOL CHEM, V278, P20013, DOI 10.1074/jbc.M210077200; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Watts C, 2010, CURR OPIN IMMUNOL, V22, P124, DOI 10.1016/j.coi.2009.12.005; WEBER K, 1969, J BIOL CHEM, V244, P4406; Xu YQ, 2012, J BIOL CHEM, V287, P26409, DOI 10.1074/jbc.M112.352229; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	48	50	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1355	1363		10.1074/jbc.M113.524561	http://dx.doi.org/10.1074/jbc.M113.524561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24273170	hybrid, Green Published			2022-12-28	WOS:000332401700014
J	Maalcke, WJ; Dietl, A; Marritt, SJ; Butt, JN; Jetten, MSM; Keltjens, JT; Barends, TRM; Kartal, B				Maalcke, Wouter J.; Dietl, Andreas; Marritt, Sophie J.; Butt, Julea N.; Jetten, Mike S. M.; Keltjens, Jan T.; Barends, Thomas R. M.; Kartal, Boran			Structural Basis of Biological NO Generation by Octaheme Oxidoreductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Enzyme Purification; Nitric Oxide; Nitrogen Metabolism; Protein Structure; Reactive Nitrogen Species; X-ray Crystallography; Anaerobic Ammonium Oxidation; Hydroxylamine; Octaheme Proteins	C NITRITE REDUCTASE; HYDROXYLAMINE OXIDOREDUCTASE; CYTOCHROME-C; OXIDE; AMMONIA; PROTEIN; MECHANISM; BACTERIUM; OXIDATION; QUANTITATION	Background: Multiheme proteins have crucial roles in diverse nitrogen cycle processes. Results: The kustc1061 octaheme protein from anaerobic ammonium-oxidizing (anammox) bacteria specifically oxidizes hydroxylamine to NO. Conclusion: Enzyme specificity derives from subtle amino acid changes near the P-460 catalytic heme. Significance: The presence of kustc1061 homologs in anammox and other bacteria enables the detoxification of hydroxylamine, thereby generating NO for respiratory purposes. Nitric oxide is an important molecule in all domains of life with significant biological functions in both pro- and eukaryotes. Anaerobic ammonium-oxidizing (anammox) bacteria that contribute substantially to the release of fixed nitrogen into the atmosphere use the oxidizing power of NO to activate inert ammonium into hydrazine (N2H4). Here, we describe an enzyme from the anammox bacterium Kuenenia stuttgartiensis that uses a novel pathway to make NO from hydroxylamine. This new enzyme is related to octaheme hydroxylamine oxidoreductase, a key protein in aerobic ammonium-oxidizing bacteria. By a multiphasic approach including the determination of the crystal structure of the K. stuttgartiensis enzyme at 1.8 resolution and refinement and reassessment of the hydroxylamine oxidoreductase structure from Nitrosomonas europaea, both in the presence and absence of their substrates, we propose a model for NO formation by the K. stuttgartiensis enzyme. Our results expand the understanding of the functions that the widespread family of octaheme proteins have.	[Maalcke, Wouter J.; Jetten, Mike S. M.; Keltjens, Jan T.; Kartal, Boran] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Microbiol, NL-6525 AJ Nijmegen, Netherlands; [Dietl, Andreas; Barends, Thomas R. M.] Max Planck Inst Med Res, Dept Biomol Mechanisms, D-69120 Heidelberg, Germany; [Marritt, Sophie J.; Butt, Julea N.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Marritt, Sophie J.; Butt, Julea N.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Jetten, Mike S. M.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands	Radboud University Nijmegen; Max Planck Society; University of East Anglia; University of East Anglia; Delft University of Technology	Barends, TRM (corresponding author), Max Planck Inst Med Res, Dept Biomol Mechanisms, Jahnstr 29, D-69120 Heidelberg, Germany.	Thomas.Barends@mpimf-heidelberg.mpg.de; kartal@science.ru.nl	Jetten, Mike/B-8834-2011; Kartal, Boran/ABD-5400-2021; Kartal, Boran/D-2488-2014; Butt, Julea/E-2133-2011; Keltjens, Jan/M-3002-2013	Jetten, Mike/0000-0002-4691-7039; Butt, Julea/0000-0002-9624-5226; Kartal, Boran/0000-0003-4199-952X	Netherlands Organization for Scientific Research [142.16.1201, VENI 863.11.003]; European Research Council [232937]; Max-Planck Society; UK Biotechnology and Biological Sciences Research Council [BB/G009228]; BBSRC [BB/G009228/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G009228/1] Funding Source: researchfish	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); Max-Planck Society(Max Planck SocietyFoundation CELLEX); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Netherlands Organization for Scientific Research Darwin Grants 142.16.1201 (to W. J. M.) and VENI 863.11.003 (to B. K.), by European Research Council Advanced Grant 232937 (to M. S. M. J), by the Max-Planck Society, and by UK Biotechnology and Biological Sciences Research Council Grant BB/G009228 (to S. J. M.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arp DJ, 2003, CRIT REV BIOCHEM MOL, V38, P471, DOI 10.1080/10409230390267446; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Astuti Y, 2004, J AM CHEM SOC, V126, P8001, DOI 10.1021/ja0496470; Atkinson SJ, 2007, FEBS LETT, V581, P3805, DOI 10.1016/j.febslet.2007.07.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruckdorfer Richard, 2005, Molecular Aspects of Medicine, V26, P3, DOI 10.1016/j.mam.2004.09.002; Campbell MA, 2011, FEMS MICROBIOL LETT, V322, P82, DOI 10.1111/j.1574-6968.2011.02340.x; Cedervall P, 2013, BIOCHEMISTRY-US, V52, P6211, DOI 10.1021/bi400960w; Cedervall PE, 2009, ACTA CRYSTALLOGR F, V65, P1296, DOI 10.1107/S1744309109046119; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clarke TA, 2008, METHOD ENZYMOL, V437, P63, DOI 10.1016/S0076-6879(07)37004-3; COLLINS MJ, 1993, J BIOL CHEM, V268, P14655; DeLano W.L, PYMOL MOL GRAPHICS S; Einsle O, 1999, NATURE, V400, P476, DOI 10.1038/22802; Einsle O, 2002, J AM CHEM SOC, V124, P11737, DOI 10.1021/ja0206487; Einsle O, 2004, BIOL CHEM, V385, P875, DOI 10.1515/BC.2004.115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farhoud MH, 2005, MOL CELL PROTEOMICS, V4, P1653, DOI 10.1074/mcp.M500171-MCP200; Fernandez ML, 2008, J INORG BIOCHEM, V102, P1523, DOI 10.1016/j.jinorgbio.2008.01.032; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Harp JM, 1999, ACTA CRYSTALLOGR D, V55, P1329, DOI 10.1107/S0907444999005442; Harp JM, 1998, ACTA CRYSTALLOGR D, V54, P622, DOI 10.1107/S0907444997019008; Hirst DG, 2011, METHODS MOL BIOL, V704, P1, DOI 10.1007/978-1-61737-964-2_1; Hooper AB, 1997, ANTON LEEUW INT J G, V71, P59, DOI 10.1023/A:1000133919203; HOOPER AB, 1979, BIOCHIM BIOPHYS ACTA, V571, P12, DOI 10.1016/0005-2744(79)90220-1; HOOPER AB, 1965, J BIOL CHEM, V240, P4044; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Igarashi N, 1997, NAT STRUCT BIOL, V4, P276, DOI 10.1038/nsb0497-276; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kartal B, 2011, NATURE, V479, P127, DOI 10.1038/nature10453; Kartal B, 2011, METHOD ENZYMOL, V486, P89, DOI [10.1016/S0076-6879(11)86004-0, 10.1016/B978-0-12-381294-0.00004-3]; Kartal B, 2010, APPL ENVIRON MICROB, V76, P6304, DOI 10.1128/AEM.00991-10; Klotz MG, 2008, ENVIRON MICROBIOL, V10, P3150, DOI 10.1111/j.1462-2920.2008.01733.x; Kostera J, 2010, BIOCHEMISTRY-US, V49, P8546, DOI 10.1021/bi1006783; Kurnikov IV, 2005, BIOCHEMISTRY-US, V44, P1856, DOI 10.1021/bi048060v; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lundberg JO, 2013, GUT, V62, P616, DOI 10.1136/gutjnl-2011-301649; Marritt SJ, 2008, J AM CHEM SOC, V130, P8588, DOI 10.1021/ja802641a; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McQuade LE, 2010, INORG CHEM, V49, P7464, DOI 10.1021/ic100802q; Mowat CG, 2004, NAT STRUCT MOL BIOL, V11, P1023, DOI 10.1038/nsmb827; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano T, 1999, LUMINESCENCE, V14, P283, DOI 10.1002/(SICI)1522-7243(199911/12)14:6<283::AID-BIO572>3.0.CO;2-G; Pacheco AA, 2011, METHOD ENZYMOL, V486, P447, DOI [10.1016/S0076-6879(11)86020-9, 10.1016/B978-0-12-381294-0.00020-1]; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Polyakov KM, 2009, J MOL BIOL, V389, P846, DOI 10.1016/j.jmb.2009.04.037; Poret-Peterson AT, 2008, ISME J, V2, P1213, DOI 10.1038/ismej.2008.71; Schalk J, 2000, BIOCHEMISTRY-US, V39, P5405, DOI 10.1021/bi992721k; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schreiber F, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00372; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shimamura M, 2008, J BIOSCI BIOENG, V105, P243, DOI 10.1263/jbb.105.243; TERRY KR, 1981, BIOCHEMISTRY-US, V20, P7026, DOI 10.1021/bi00527a039; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang YL, 2011, CELL MICROBIOL, V13, P518, DOI 10.1111/j.1462-5822.2011.01576.x; WATANABE T, 1982, J PHYS CHEM-US, V86, P2617, DOI 10.1021/j100211a014; YONETANI T, 1965, J BIOL CHEM, V240, P4509	62	68	71	4	92	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1228	1242		10.1074/jbc.M113.525147	http://dx.doi.org/10.1074/jbc.M113.525147			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302732	Green Published, hybrid			2022-12-28	WOS:000332401700004
J	Cui, HHL; Guo, B; Scicluna, B; Coleman, BM; Lawson, VA; Ellett, L; Meikle, PJ; Bukrinsky, M; Mukhamedova, N; Sviridov, D; Hill, AF				Cui, Huanhuan L.; Guo, Belinda; Scicluna, Benjamin; Coleman, Bradley M.; Lawson, Victoria A.; Ellett, Laura; Meikle, Peter J.; Bukrinsky, Michael; Mukhamedova, Nigora; Sviridov, Dmitri; Hill, Andrew F.			Prion Infection Impairs Cholesterol Metabolism in Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER A1; LIPID RAFTS; ALZHEIMERS-DISEASE; PROTEIN; MOUSE; ACCUMULATION; EFFLUX; EXPORT; ABCA1; CYCLODEXTRINS	Conversion of prion protein (PrPC) into a pathological isoform (PrPSc) during prion infection occurs in lipid rafts and is dependent on cholesterol. Here, we show that prion infection increases the abundance of cholesterol transporter, ATP-binding cassette transporter type A1 (ATP-binding cassette transporter type A1), but reduces cholesterol efflux from neuronal cells leading to the accumulation of cellular cholesterol. Increased abundance of ABCA1 in prion disease was confirmed in prion-infected mice. Mechanistically, conversion of PrPC to the pathological isoform led to PrPSc accumulation in rafts, displacement of ABCA1 from rafts and the cell surface, and enhanced internalization of ABCA1. These effects were abolished with reversal of prion infection or by loading cells with cholesterol. Stimulation of ABCA1 expression with liver X receptor agonist or overexpression of heterologous ABCA1 reduced the conversion of prion protein into the pathological form upon infection. These findings demonstrate a reciprocal connection between prion infection and cellular cholesterol metabolism, which plays an important role in the pathogenesis of prion infection in neuronal cells.	[Cui, Huanhuan L.; Meikle, Peter J.; Mukhamedova, Nigora; Sviridov, Dmitri] Baker Heart & Diabet Inst, Melbourne, Vic 8008, Australia; [Cui, Huanhuan L.; Guo, Belinda; Scicluna, Benjamin; Coleman, Bradley M.; Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Lawson, Victoria A.; Ellett, Laura] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Bukrinsky, Michael] George Washington Univ, Washington, DC 20554 USA; [Meikle, Peter J.; Sviridov, Dmitri] Hlth & Med Res Council Australia, Canberra, ACT, Australia; [Hill, Andrew F.] Australian Res Council, Sydney, NSW, Australia	Baker Heart and Diabetes Institute; University of Melbourne; University of Melbourne; George Washington University	Sviridov, D (corresponding author), Baker Heart & Diabet Inst, POB 6492, Melbourne, Vic 8008, Australia.	Dmitri.Sviridov@Bakeridi.edu.au	Hill, Andrew F./AAH-2854-2020; Sviridov, Dmitri/E-7943-2010; Hill, Andrew F./GZL-4124-2022; Hill, Andrew F/B-4527-2009; Lawson, Victoria/AAJ-7392-2021; Meikle, Peter J/B-4023-2009	Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Guo, Belinda/0000-0003-2146-8561; Lawson, Victoria/0000-0002-7362-7176; Meikle, Peter/0000-0002-2593-4665	National Institutes of Health [HL093818]; National Health and Medical Research Council of Australia [GNT1019847, GNT628946]; Victorian Government's OIS Program; May Stewart Bursary; Elizabeth Mary Sweet Scholarship, Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne; Australian postgraduate award; National Health and Medical Research Council of Australia Dora Lush Biomedical Postgraduate Scholarship [628959]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's OIS Program; May Stewart Bursary; Elizabeth Mary Sweet Scholarship, Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne; Australian postgraduate award(Australian Government); National Health and Medical Research Council of Australia Dora Lush Biomedical Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL093818. This work was also supported by National Health and Medical Research Council of Australia Grants GNT1019847 and GNT628946 and in part by the Victorian Government's OIS Program.; Supported by The May Stewart Bursary and The Elizabeth Mary Sweet Scholarship, Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne.; Supported by an Australian postgraduate award.; Supported by National Health and Medical Research Council of Australia Dora Lush Biomedical Postgraduate Scholarship 628959.	Bach C, 2009, J BIOL CHEM, V284, P31260, DOI 10.1074/jbc.M109.004382; Bories G, 2013, CIRC RES, V113, P1196, DOI 10.1161/CIRCRESAHA.113.301656; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Brazier MW, 2006, BRAIN RES BULL, V68, P346, DOI 10.1016/j.brainresbull.2005.09.010; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Christian AE, 1997, J LIPID RES, V38, P2264; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; Cui HL, 2012, J LIPID RES, V53, P696, DOI 10.1194/jlr.M023119; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Gaus K, 2004, FASEB J, V18, P574, DOI 10.1096/fj.03-0486fje; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; Haviv Y, 2008, ARCH NEUROL-CHICAGO, V65, P762, DOI 10.1001/archneur.65.6.762; Husemann J, 2001, AM J PATHOL, V158, P825, DOI 10.1016/S0002-9440(10)64030-8; Karten B, 2002, J NEUROCHEM, V83, P1154, DOI 10.1046/j.1471-4159.2002.01220.x; Kim WS, 2007, J BIOL CHEM, V282, P2851, DOI 10.1074/jbc.M607831200; Klappe K, 2009, CHEM PHYS LIPIDS, V161, P57, DOI 10.1016/j.chemphyslip.2009.07.004; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Kumar R, 2008, J GEN VIROL, V89, P1525, DOI 10.1099/vir.0.83358-0; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; Lewis V, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-18; Low H, 2012, JOVE-J VIS EXP, DOI 10.3791/3810; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Mange A, 2000, J VIROL, V74, P3135, DOI 10.1128/JVI.74.7.3135-3140.2000; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Mukhamedova N, 2008, J LIPID RES, V49, P2312, DOI 10.1194/jlr.M800095-JLR200; Pani A, 2010, CURR DRUG TARGETS, V11, P1018, DOI 10.2174/138945010791591386; Prior M, 2007, J VIROL, V81, P11195, DOI 10.1128/JVI.02559-06; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; Schatzl HM, 1997, J VIROL, V71, P8821; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Singaraja RR, 2009, CIRC RES, V105, P138, DOI 10.1161/CIRCRESAHA.108.193011; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Wang N, 2008, FASEB J, V22, P1073, DOI 10.1096/fj.07-9944com; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486	41	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					789	802		10.1074/jbc.M113.535807	http://dx.doi.org/10.1074/jbc.M113.535807			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24280226	Green Published, hybrid			2022-12-28	WOS:000330541200017
J	Frirdich, E; Vermeulen, J; Biboy, J; Soares, F; Taveirne, ME; Johnson, JG; DiRita, VJ; Girardin, SE; Vollmer, W; Gaynor, EC				Frirdich, Emilisa; Vermeulen, Jenny; Biboy, Jacob; Soares, Fraser; Taveirne, Michael E.; Johnson, Jeremiah G.; DiRita, Victor J.; Girardin, Stephen E.; Vollmer, Waldemar; Gaynor, Erin C.			Peptidoglycan LD-Carboxypeptidase Pgp2 Influences Campylobacter jejuni Helical Cell Shape and Pathogenic Properties and Provides the Substrate for the DL-Carboxypeptidase Pgp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Campylobacter; Carboxypeptidase; Host-Pathogen Interactions; Microbial Pathogenesis; Peptidoglycan; Bacterial Cell Shape	BACTERIAL MURAMYL DIPEPTIDE; BIOFILM FORMATION; HOST RECOGNITION; NOD1; MOTILITY; IDENTIFICATION; COLONIZATION; GENES; BIOSYNTHESIS; RESTORATION	Background:C. jejuni helical shape is important to pathogenesis. Results: Deletion of pgp2 results in loss of C. jejuni helical shape and change in peptidoglycan structure and pathogenic properties. Conclusion: Pgp2 is a ld-carboxypeptidase cleaving peptidoglycan tetrapeptides to tripeptides. Significance: Characterization of enzymes involved in C. jejuni peptidoglycan and cell shape maintenance is crucial to the understanding of fundamental properties of this organism. Despite the importance of Campylobacter jejuni as a pathogen, little is known about the fundamental aspects of its peptidoglycan (PG) structure and factors modulating its helical morphology. A PG dl-carboxypeptidase Pgp1 essential for maintenance of C. jejuni helical shape was recently identified. Bioinformatic analysis revealed the CJJ81176_0915 gene product as co-occurring with Pgp1 in several organisms. Deletion of cjj81176_0915 (renamed pgp2) resulted in straight morphology, representing the second C. jejuni gene affecting cell shape. The PG structure of a pgp2 mutant showed an increase in tetrapeptide-containing muropeptides and a complete absence of tripeptides, consistent with ld-carboxypeptidase activity, which was confirmed biochemically. PG analysis of a pgp1pgp2 double mutant demonstrated that Pgp2 activity is required to generate the tripeptide substrate for Pgp1. Loss of pgp2 affected several pathogenic properties; the deletion strain was defective for motility in semisolid agar, biofilm formation, and fluorescence on calcofluor white. pgp2 PG also caused decreased stimulation of the human nucleotide-binding oligomerization domain 1 (Nod1) proinflammatory mediator in comparison with wild type, as expected from the reduction in muropeptide tripeptides (the primary Nod1 agonist) in the mutant; however, these changes did not alter the ability of the pgp2 mutant strain to survive within human epithelial cells or to elicit secretion of IL-8 from epithelial cells after infection. The pgp2 mutant also showed significantly reduced fitness in a chick colonization model. Collectively, these analyses enhance our understanding of C. jejuni PG maturation and help to clarify how PG structure and cell shape impact pathogenic attributes.	[Frirdich, Emilisa; Vermeulen, Jenny; Gaynor, Erin C.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Biboy, Jacob; Vollmer, Waldemar] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Soares, Fraser; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Taveirne, Michael E.; Johnson, Jeremiah G.; DiRita, Victor J.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of British Columbia; Newcastle University - UK; University of Toronto; University of Michigan System; University of Michigan	Gaynor, EC (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 1365-2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	egaynor@mail.ubc.ca	Johnson, Jeremiah/AFL-6049-2022	Johnson, Jeremiah/0000-0001-5302-3247; Biboy, jacob/0000-0002-1286-6851; Soares, Fraser/0000-0002-3977-7939	Canadian Institutes for Health Research (CIHR) [MOP-68981]; Burroughs Wellcome Fund; Biotechnology and Biological Sciences Research Council [BB/I020012/1]; National Institutes of Health [R01 AI069383]; United States Department of Agriculture (USDA) [2012-67012-19704]; USDA [2013-67012-21136]; Canadian Institutes for Health Research (CIHR); Michael Smith Foundation for Health Research; Canada Research Chair award; Burroughs Wellcome Fund Career Development Award; BBSRC [BB/I020012/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007528, R01AI069383] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); USDA(United States Department of Agriculture (USDA)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Burroughs Wellcome Fund Career Development Award(Burroughs Wellcome Fund); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Canadian Institutes for Health Research (CIHR) Grant MOP-68981 and the Burroughs Wellcome Fund (to E. C. G.), Biotechnology and Biological Sciences Research Council Grant BB/I020012/1 (to W. V.), National Institutes of Health Grant R01 AI069383 (to V. J. D.), United States Department of Agriculture (USDA) Grant 2012-67012-19704 (to M. E. T.), and USDA Grant 2013-67012-21136 (to J. G. J.).; Supported by postdoctoral fellowships from the Canadian Institutes for Health Research (CIHR) and the Michael Smith Foundation for Health Research.; Supported by a Canada Research Chair award and a Burroughs Wellcome Fund Career Development Award. To whom correspondence should be addressed: Dept. of Microbiology and Immunology, University of British Columbia, 13652350 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada. Tel.: 604-822-2710; Fax: 604-822-6041; E-mail: egaynor@mail.ubc.ca.	Al-Sayeqh AF, 2010, MICROB PATHOGENESIS, V49, P294, DOI 10.1016/j.micpath.2010.06.011; Barendt SM, 2011, J BACTERIOL, V193, P2290, DOI 10.1128/JB.01555-10; Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; Blaser MJ, 2008, CAMPYLOBACTER, 3RD EDITION, P99; Bonis M, 2010, MOL MICROBIOL, V78, P809, DOI 10.1111/j.1365-2958.2010.07383.x; Boudreau MA, 2012, BIOCHEMISTRY-US, V51, P2974, DOI 10.1021/bi300174x; Bui NK, 2009, J BACTERIOL, V191, P494, DOI 10.1128/JB.00608-08; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Copass M, 1997, INFECT IMMUN, V65, P1949, DOI 10.1128/IAI.65.5.1949-1952.1997; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; DEMOT R, 1994, MOL MICROBIOL, V12, P333; Frirdich E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002602; Gallant CV, 2005, MOL MICROBIOL, V58, P1012, DOI 10.1111/j.1365-2958.2005.04892.x; Garrity GM, 2005, BERGEYS MANUAL SYST, P1145; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Hendrixson DR, 2008, MOL MICROBIOL, V70, P519, DOI 10.1111/j.1365-2958.2008.06428.x; Hendrixson DR, 2006, MOL MICROBIOL, V61, P1646, DOI 10.1111/j.1365-2958.2006.05336.x; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Hu L, 2008, CAMPYLOBACTER, 3RD EDITION, P297; Huber B, 2002, MOL MICROBIOL, V46, P411, DOI 10.1046/j.1365-2958.2002.03182.x; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Iovine NM, 2008, CAMPYLOBACTER, 3RD EDITION, P333; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Kalmokoff M, 2006, J BACTERIOL, V188, P4312, DOI 10.1128/JB.01975-05; KOEBNIK R, 1995, MOL MICROBIOL, V16, P1269, DOI 10.1111/j.1365-2958.1995.tb02348.x; Korza HJ, 2005, J BIOL CHEM, V280, P40802, DOI 10.1074/jbc.M506328200; Kumar A, 2012, RES MICROBIOL, V163, P254, DOI 10.1016/j.resmic.2012.01.006; Kumar S, 2013, CRIT REV MICROBIOL, V39, P229, DOI 10.3109/1040841X.2012.706249; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Lee MD, 2006, AVIAN DIS, V50, P1, DOI 10.1637/7474-111605R.1; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Mattei PJ, 2010, CURR OPIN STRUC BIOL, V20, P749, DOI 10.1016/j.sbi.2010.09.014; McLennan MK, 2008, J BACTERIOL, V190, P1097, DOI 10.1128/JB.00516-07; Mercier C, 2000, FEMS MICROBIOL LETT, V187, P47, DOI 10.1111/j.1574-6968.2000.tb09135.x; Moe KK, 2010, J VET MED SCI, V72, P411, DOI 10.1292/jvms.09-0339; Molbak K, 2008, CAMPYLOBACTER, 3RD EDITION, P151; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; NACHAMKIN I, 1993, APPL ENVIRON MICROB, V59, P1269, DOI 10.1128/AEM.59.5.1269-1273.1993; Naito M, 2010, J BACTERIOL, V192, P2182, DOI 10.1128/JB.01222-09; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Park SF, 2002, INT J FOOD MICROBIOL, V74, P177, DOI 10.1016/S0168-1605(01)00678-X; Rashid Y, 2011, PROTEIN J, V30, P558, DOI 10.1007/s10930-011-9364-7; RATTEE ID, 1974, PHYS CHEM DYE ABSORP, P180; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; Roure S, 2012, MOL MICROBIOL, V86, P845, DOI 10.1111/mmi.12019; Scheurwater EM, 2011, FEMS MICROBIOL LETT, V318, P1, DOI 10.1111/j.1574-6968.2011.02228.x; Svensson SL, 2009, MOL MICROBIOL, V71, P253, DOI 10.1111/j.1365-2958.2008.06534.x; Sycuro LK, 2013, MOL MICROBIOL, V90, P869, DOI 10.1111/mmi.12405; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; SZYMANSKI CM, 1995, INFECT IMMUN, V63, P4295, DOI 10.1128/IAI.63.11.4295-4300.1995; Templin MF, 1999, EMBO J, V18, P4108, DOI 10.1093/emboj/18.15.4108; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van Heijenoort J, 2011, MICROBIOL MOL BIOL R, V75, P636, DOI 10.1128/MMBR.00022-11; van Putten JPM, 2009, CURR TOP MICROBIOL, V337, P197, DOI 10.1007/978-3-642-01846-6_7; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; WASSENAAR TM, 1993, J GEN MICROBIOL, V139, P1171, DOI 10.1099/00221287-139-6-1171; WOOD PJ, 1980, CARBOHYD RES, V85, P271, DOI 10.1016/S0008-6215(00)84676-5; Wosten MMSM, 2004, J BIOL CHEM, V279, P16214, DOI 10.1074/jbc.M400357200; Young KD, 2007, CURR OPIN MICROBIOL, V10, P596, DOI 10.1016/j.mib.2007.09.009; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Zilbauer M, 2007, CELL MICROBIOL, V9, P2404, DOI 10.1111/j.1462-5822.2007.00969.x	73	54	56	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8007	8018		10.1074/jbc.M113.491829	http://dx.doi.org/10.1074/jbc.M113.491829			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24394413	Green Published, hybrid			2022-12-28	WOS:000333157500001
J	Zhao, P; Elks, CM; Stephens, JM				Zhao, Peng; Elks, Carrie M.; Stephens, Jacqueline M.			The Induction of Lipocalin-2 Protein Expression in Vivo and in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Adipose Tissue; ERK; Interferon; Tumor Necrosis Factor (TNF); NF-B; STAT	NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; INDUCED INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; TYROSINE PHOSPHORYLATION; SERINE PHOSPHORYLATION; INTERFERON-GAMMA; INNATE IMMUNITY; BINDING-PROTEIN	Background: Lipocalin-2 is induced in obesity/type 2 diabetes. Results: TNF and IFN induce LCN2 in vivo. STAT1 and NF-B are required for LCN2 induction and bind the human LCN2 promoter. Conclusion: An interplay between ERKs, STAT1, and NF-B signaling pathways mediates the IFN and TNF induction of LCN2. Significance: Cytokine modulation of LCN2 increases our understanding of gene regulation in obesity/type 2 diabetes. Lipocalin-2 (LCN2) is secreted from adipocytes, and its expression is up-regulated in obese and diabetic mice and humans. LCN2 expression and secretion have been shown to be induced by two proinflammatory cytokines, IFN and TNF, in cultured murine and human adipocytes. In these studies, we demonstrated that IFN and TNF induced LCN2 expression and secretion in vivo. Although we observed a strong induction of LCN2 expression and secretion from white adipose tissue (WAT) depots, the induction of LCN2 varied among different insulin-sensitive tissues. Knockdown experiments also demonstrated that STAT1 is required for IFN-induced lipocalin-2 expression in murine adipocytes. Similarly, knockdown of p65 in adipocytes demonstrated the necessity of the NF-B signaling pathway for TNF-mediated effects on LCN2. Activation of ERKs by IFN and TNF also affected STAT1 and NF-B signaling through modulation of serine phosphorylation. ERK activation-induced serine phosphorylation of both STAT1 and p65 mediated the additive effects of IFN and TNF on LCN2 expression. Our results suggest that these same mechanisms occur in humans as we observed STAT1 and NF-B binding to the human LCN2 promoter in chromatin immunoprecipitation assays performed in human fat cells. These studies substantially increase our knowledge regarding the requirements and mechanisms used by proinflammatory cytokines to induce LCN2 expression.	[Stephens, Jacqueline M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; Pennington Biomed Res Ctr, Adipocyte Biol Lab, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Stephens, JM (corresponding author), Louisiana State Univ, Dept Biol Sci, 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	jsteph1@lsu.edu	Stephens, Jacqueline M/R-5217-2018; Zhao, Peng/G-3562-2019; Elks, Carrie Marie/N-1961-2017		National Institutes of Health [R01DK052968-15]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052968, P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK052968-15 (to J. M. S.).	Catalan V, 2009, J MOL MED, V87, P803, DOI 10.1007/s00109-009-0486-8; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; GRANDALIANO G, 1994, J LAB CLIN MED, V123, P282; Guo H, 2013, ENDOCRINOLOGY, V154, P3525, DOI 10.1210/en.2013-1289; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Hu J, 2004, CARCINOGENESIS, V25, P1991, DOI 10.1093/carcin/bgh198; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; Jun LS, 2011, AM J PHYSIOL-ENDOC M, V301, pE825, DOI 10.1152/ajpendo.00147.2011; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; Nelson AL, 2005, CELL MICROBIOL, V7, P1404, DOI 10.1111/j.1462-5822.2005.00566.x; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; VIETOR I, 1993, J BIOL CHEM, V268, P18994; Waite KJ, 2001, J BIOL CHEM, V276, P7062, DOI 10.1074/jbc.M007894200; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhao P., 2013, JAKSTAT, V2; Zhao P, 2013, MOL METAB, V2, P161, DOI 10.1016/j.molmet.2013.04.003; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhu XJ, 1997, MOL CELL BIOL, V17, P6618, DOI 10.1128/MCB.17.11.6618	35	61	61	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5960	5969		10.1074/jbc.M113.532234	http://dx.doi.org/10.1074/jbc.M113.532234			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24391115	Green Published, hybrid			2022-12-28	WOS:000332015500052
J	Hugo, M; Van Laer, K; Reyes, AM; Vertommen, D; Messens, J; Radi, R; Trujillo, M				Hugo, Martin; Van Laer, Koen; Reyes, Anibal M.; Vertommen, Didier; Messens, Joris; Radi, Rafael; Trujillo, Madia			Mycothiol/Mycoredoxin 1-dependent Reduction of the Peroxiredoxin AhpE from Mycobacterium tuberculosis*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hydrogen Peroxide; Mycobacterium tuberculosis; Peroxiredoxin; Redox Signaling; Thiol; Mycoredoxin; Mycothiol	HYDROGEN-PEROXIDE; THIOREDOXIN REDUCTASE; BIOSYNTHESIS PATHWAY; 1-CYS PEROXIREDOXIN; DEPENDENT SYNTHESIS; REACTIVE OXYGEN; GLUTAREDOXIN; PROTEIN; MECHANISM; SMEGMATIS	Background: Mycothiol, the major low-molecular weight thiol of Mycobacterium tuberculosis, is important for peroxide detoxification and virulence. Results: Mycothiol, together with mycoredoxin-1, a glutaredoxin-like protein, reduces the one-cysteine peroxiredoxin AhpE from the bacterium. Conclusion:Mycobacterium tuberculosis AhpE is a mycothiol/mycoredoxin-1-dependent peroxidase. Significance: Our results provide the first molecular link between a thiol-dependent peroxidase and the mycothiol/mycoredoxin-1 pathway in Mycobacteria. Mycobacterium tuberculosis (M. tuberculosis), the pathogen responsible for tuberculosis, detoxifies cytotoxic peroxides produced by activated macrophages. M. tuberculosis expresses alkyl hydroxyperoxide reductase E (AhpE), among other peroxiredoxins. So far the system that reduces AhpE was not known. We identified M. tuberculosis mycoredoxin-1 (MtMrx1) acting in combination with mycothiol and mycothiol disulfide reductase (MR), as a biologically relevant reducing system for MtAhpE. MtMrx1, a glutaredoxin-like, mycothiol-dependent oxidoreductase, directly reduces the oxidized form of MtAhpE, through a protein mixed disulfide with the N-terminal cysteine of MtMrx1 and the sulfenic acid derivative of the peroxidatic cysteine of MtAhpE. This disulfide is then reduced by the C-terminal cysteine in MtMrx1. Accordingly, MtAhpE catalyzes the oxidation of wt MtMrx1 by hydrogen peroxide but not of MtMrx1 lacking the C-terminal cysteine, confirming a dithiolic mechanism. Alternatively, oxidized MtAhpE forms a mixed disulfide with mycothiol, which in turn is reduced by MtMrx1 using a monothiolic mechanism. We demonstrated the H2O2-dependent NADPH oxidation catalyzed by MtAhpE in the presence of MR, Mrx1, and mycothiol. Disulfide formation involving mycothiol probably competes with the direct reduction by MtMrx1 in aqueous intracellular media, where mycothiol is present at millimolar concentrations. However, MtAhpE was found to be associated with the membrane fraction, and since mycothiol is hydrophilic, direct reduction by MtMrx1 might be favored. The results reported herein allow the rationalization of peroxide detoxification actions inferred for mycothiol, and more recently, for Mrx1 in cellular systems. We report the first molecular link between a thiol-dependent peroxidase and the mycothiol/Mrx1 pathway in Mycobacteria.	[Hugo, Martin; Reyes, Anibal M.; Radi, Rafael; Trujillo, Madia] Univ Republica, Dept Bioquim, Montevideo 11800, Uruguay; [Hugo, Martin; Reyes, Anibal M.; Radi, Rafael; Trujillo, Madia] Univ Republica, Ctr Free Rad & Biomed Res, Montevideo 11800, Uruguay; [Van Laer, Koen; Messens, Joris] VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Van Laer, Koen; Messens, Joris] Brussels Ctr Redox Biol, B-1050 Brussels, Belgium; [Van Laer, Koen; Messens, Joris] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Vertommen, Didier] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Universite Catholique Louvain	Messens, J (corresponding author), Vrije Univ Brussel, VIB, Oxidat Stress Signaling Lab, Struct Biol Res Ctr, Pl Laan 2, B-1050 Brussels, Belgium.	joris.messens@vib-vub.be; madiat@fmed.edu.uy	Hugo, Martín/AAW-8351-2020; Messens, Joris/AAH-3008-2020	Hugo, Martín/0000-0003-3430-6457; Messens, Joris/0000-0002-2128-8264; Vertommen, Didier/0000-0001-7648-8282; Trujillo, Madia/0000-0003-2087-017X; Reyes, Anibal M./0000-0003-3911-4649	National Institutes of Health (NIH); Universidad de la Republica; agentschap voor innovatie door Wetenschap en technologie (IWT); Vlaams Instituut voor Biotechnologie (VIB); FWO [G.0305.12]; Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay) [FCE_2011_1_5706]; EMBO [439-2011]; ANII; IWT	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universidad de la Republica; agentschap voor innovatie door Wetenschap en technologie (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Vlaams Instituut voor Biotechnologie (VIB); FWO(FWO); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); EMBO(European Molecular Biology Organization (EMBO)); ANII; IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants from the National Institutes of Health (NIH) and Universidad de la Republica (to R. R.), agentschap voor innovatie door Wetenschap en technologie (IWT) (to K. V. L.), the Vlaams Instituut voor Biotechnologie (VIB) and the FWO (Project Grant G.0305.12) (to J. M.), Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay, FCE_2011_1_5706) (to M. T.). We thank EMBO for the Visiting Grant 439-2011 (to M. H.).; Supported in part by a PhD fellowship from ANII.; Recipient of an IWT PhD fellowship.	Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; CHI BK, 2013, ANTIOXID RE IN PRESS; Choi S, 2010, J PROTEOME RES, V9, P626, DOI 10.1021/pr900771r; Cole ST, 1998, NOVART FDN SYMP, V217, P160, DOI 10.1002/0470846526.ch12; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Pineyro MD, 2011, ARCH BIOCHEM BIOPHYS, V507, P287, DOI 10.1016/j.abb.2010.12.014; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Fomenko DE, 2011, P NATL ACAD SCI USA, V108, P2729, DOI 10.1073/pnas.1010721108; Gu S, 2003, MOL CELL PROTEOMICS, V2, P1284, DOI 10.1074/mcp.M300060-MCP200; Hanschmann EM, 2010, J BIOL CHEM, V285, P40699, DOI 10.1074/jbc.M110.185827; HILDEBRANDT AG, 1975, ARCH BIOCHEM BIOPHYS, V171, P385, DOI 10.1016/0003-9861(75)90047-8; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; Hugo M, 2012, UNDERSTANDING TUBERCULOSIS - DECIPHERING THE SECRET LIFE OF THE BACILLI, P293; Hugo M, 2009, BIOCHEMISTRY-US, V48, P9416, DOI 10.1021/bi901221s; Jaeger T, 2004, ARCH BIOCHEM BIOPHYS, V423, P182, DOI 10.1016/j.abb.2003.11.021; Li S, 2005, J MOL BIOL, V346, P1035, DOI 10.1016/j.jmb.2004.12.046; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C, 2009, CELL HOST MICROBE, V5, P220, DOI 10.1016/j.chom.2009.02.004; Newton GL, 2002, ARCH MICROBIOL, V178, P388, DOI 10.1007/s00203-002-0469-4; Alvarez MN, 2011, J BIOL CHEM, V286, P6627, DOI 10.1074/jbc.M110.167247; Oliva M, 2009, J EXP BOT, V60, P453, DOI 10.1093/jxb/ern317; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Patel MP, 1999, BIOCHEMISTRY-US, V38, P11827, DOI 10.1021/bi991025h; Pedrajas JR, 2010, ANTIOXID REDOX SIGN, V13, P249, DOI 10.1089/ars.2009.2950; Rawat M, 2003, MICROBIOL-SGM, V149, P1341, DOI 10.1099/mic.0.26084-0; Rawat M, 2002, ANTIMICROB AGENTS CH, V46, P3348, DOI 10.1128/AAC.46.11.3348-3355.2002; Rawat M, 2007, BIOCHEM BIOPH RES CO, V363, P71, DOI 10.1016/j.bbrc.2007.08.142; Reeves SA, 2011, BIOCHEMISTRY-US, V50, P8970, DOI 10.1021/bi200935d; Reyes AM, 2011, FREE RADICAL BIO MED, V51, P464, DOI 10.1016/j.freeradbiomed.2011.04.023; Reynolds CM, 2002, BIOCHEMISTRY-US, V41, P1990, DOI 10.1021/bi011802p; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Roos G, 2007, J MOL BIOL, V368, P800, DOI 10.1016/j.jmb.2007.02.045; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Ruys SPD, 2012, BIOCHEM J, V442, P681, DOI 10.1042/BJ20111530; SCHONBAUM GR, 1972, J BIOL CHEM, V247, P3353; Soito L, 2011, NUCLEIC ACIDS RES, V39, pD332, DOI 10.1093/nar/gkq1060; Ta P, 2011, J BACTERIOL, V193, P1981, DOI 10.1128/JB.01402-10; Trujillo M, 2006, J BIOL CHEM, V281, P20555, DOI 10.1074/jbc.M601008200; Van Laer K, 2013, ANTIOXID REDOX SIGN, V18, P1642, DOI 10.1089/ars.2012.4964; Van Laer K, 2013, J BIOL CHEM, V288, P7942, DOI 10.1074/jbc.M112.392688; Van Laer K, 2012, MOL MICROBIOL, V86, P787, DOI 10.1111/mmi.12030; Villadangos AF, 2011, MOL MICROBIOL, V82, P998, DOI 10.1111/j.1365-2958.2011.07882.x; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9	48	40	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5228	5239		10.1074/jbc.M113.510248	http://dx.doi.org/10.1074/jbc.M113.510248			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24379404	Green Published, hybrid			2022-12-28	WOS:000331607900064
J	Kojima, K; Imamoto, Y; Maeda, R; Yamashita, T; Shichida, Y				Kojima, Keiichi; Imamoto, Yasushi; Maeda, Ryo; Yamashita, Takahiro; Shichida, Yoshinori			Rod Visual Pigment Optimizes Active State to Achieve Efficient G Protein Activation as Compared with Cone Visual Pigments*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptors (GPCR); Membrane Bilayer; Membrane Proteins; Rhodopsin; UV Spectroscopy; Fluorescence Spectroscopy; G Protein Activation Efficiency	MONOMERIC RHODOPSIN; COUPLED RECEPTOR; TRANSDUCIN; LIGHT; PHOTOTRANSDUCTION; PHOSPHORYLATION; PHOTORECEPTORS; INTERMEDIATE; NANODISCS; MECHANISM	Background: The relationship between the properties of visual pigment and photoreceptor amplification efficiency is controversial. Results: Rhodopsin activates G protein more efficiently than cone pigments. Conclusion: Visual pigment properties are directly related to the photoreceptor sensitivity diversification. Significance: Amplification of cell responses is regulated by receptor molecules. Most vertebrate retinas contain two types of photoreceptor cells, rods and cones, which show different photoresponses to mediate scotopic and photopic vision, respectively. These cells contain different types of visual pigments, rhodopsin and cone visual pigments, respectively, but little is known about the molecular properties of cone visual pigments under physiological conditions, making it difficult to link the molecular properties of rhodopsin and cone visual pigments with the differences in photoresponse between rods and cones. Here we prepared bovine and mouse rhodopsin (bvRh and mRh) and chicken and mouse green-sensitive cone visual pigments (cG and mG) embedded in nanodiscs and applied time-resolved fluorescence spectroscopy to compare their G(t) activation efficiencies. Rhodopsin exhibited greater G(t) activation efficiencies than cone visual pigments. Especially, the G(t) activation efficiency of mRh was about 2.5-fold greater than that of mG at 37 degrees C, which is consistent with our previous electrophysiological data of knock-in mice. Although the active state (Meta-II) was in equilibrium with inactive states (Meta-I and Meta-III), quantitative determination of Meta-II in the equilibrium showed that the G(t) activation efficiency per Meta-II of bvRh was also greater than those of cG and mG. These results indicated that efficient G(t) activation by rhodopsin, resulting from an optimized active state of rhodopsin, is one of the causes of the high amplification efficiency of rods.	[Kojima, Keiichi; Imamoto, Yasushi; Maeda, Ryo; Yamashita, Takahiro; Shichida, Yoshinori] Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto 6068502, Japan	Kyoto University	Shichida, Y (corresponding author), Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto 6068502, Japan.	shichida@rh.biophys.kyoto-u.ac.jp	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526; Kojima, Keiichi/0000-0003-4729-0511	Japanese Ministry of Education, Culture, Sports, Science, and Technology [23370070, 25440167, 25251036]; Grants-in-Aid for Scientific Research [24121716, 25440167] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants-in-aid for Scientific Research 23370070 (to Y. I.), 25440167 (to T. Y.), and 25251036 (to Y. S.) and grants for excellent graduate schools.	Albert AD, 1998, BBA-BIOMEMBRANES, V1368, P52, DOI 10.1016/S0005-2736(97)00200-9; ANDERSON RE, 1970, BIOCHEMISTRY-US, V9, P3624, DOI 10.1021/bi00820a019; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Deng WT, 2009, P NATL ACAD SCI USA, V106, P17681, DOI 10.1073/pnas.0901382106; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; FUKADA Y, 1989, FEBS LETT, V246, P69, DOI 10.1016/0014-5793(89)80255-8; Gopalakrishna KN, 2012, BIOCHEMISTRY-US, V51, P1617, DOI 10.1021/bi3000935; Imai H, 1997, BIOCHEMISTRY-US, V36, P12773, DOI 10.1021/bi970809x; Imamoto Y, 2008, PHOTOCHEM PHOTOBIOL, V84, P941, DOI 10.1111/j.1751-1097.2008.00332.x; Imamoto Y, 2013, BIOCHEMISTRY-US, V52, P3010, DOI 10.1021/bi3015967; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Kuwayama S, 2005, BIOCHEMISTRY-US, V44, P2208, DOI 10.1021/bi047994g; Mao W, 2013, J BIOL CHEM, V288, P5257, DOI 10.1074/jbc.M112.430058; Matsuyama T, 2012, BIOCHEMISTRY-US, V51, P5454, DOI 10.1021/bi3004999; Morizumi T, 2005, BIOCHEMISTRY-US, V44, P9936, DOI 10.1021/bi0504512; Morizumi T, 2003, J BIOCHEM, V134, P259, DOI 10.1093/jb/mvg139; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Sakurai K, 2007, J GEN PHYSIOL, V130, P21, DOI 10.1085/jgp.200609729; Sato K, 2012, BIOCHEMISTRY-US, V51, P4300, DOI 10.1021/bi3000885; Sato K, 2010, BIOCHEMISTRY-US, V49, P736, DOI 10.1021/bi9018412; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Tachibanaki S, 1997, BIOCHEMISTRY-US, V36, P14173, DOI 10.1021/bi970932o; Tachibanaki S, 1998, FEBS LETT, V425, P126, DOI 10.1016/S0014-5793(98)00216-6; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Tachibanaki S, 2012, J BIOL CHEM, V287, P41186, DOI 10.1074/jbc.M112.403717; Tsukamoto H, 2011, BIOCHEMISTRY-US, V50, P5086, DOI 10.1021/bi200391a; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9; Yokoyama S, 2008, ANNU REV GENOM HUM G, V9, P259, DOI 10.1146/annurev.genom.9.081307.164228; Yuan C, 1998, COMP BIOCHEM PHYS B, V120, P785, DOI 10.1016/S0305-0491(98)10079-2	45	20	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5061	5073		10.1074/jbc.M113.508507	http://dx.doi.org/10.1074/jbc.M113.508507			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24375403	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000331607900050
J	Scheiner, ZS; Talib, S; Feigal, EG				Scheiner, Zachary S.; Talib, Sohel; Feigal, Ellen G.			The Potential for Immunogenicity of Autologous Induced Pluripotent Stem Cell-derived Therapies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Cell Therapy; Cellular Immune Response; Humoral Response; Induced Pluripotent Stem Cells; iPSC; Innate Immunity	IMMUNOSUPPRESSIVE THERAPY; HUMAN FIBROBLASTS; DOPAMINE NEURONS; CODING MUTATIONS; DIFFERENTIATION; TRANSPLANTATION; PATHOLOGY; ANTIGENS; DONOR; ASSAY	Induced pluripotent stem cell (iPSC) technology offers the promise of immune-matched cell therapies for a wide range of diseases and injuries. It is generally assumed that cells derived from autologous iPSCs will be immune-privileged. However, there are reasons to question this assumption, including recent studies that have tested iPSC immunogenicity in various ways with conflicting results. Understanding the risk of an immune response and developing strategies to minimize it will be important steps before clinical testing. Here, we review the evidence for autologous iPSC immunogenicity, its potential causes, and approaches for assessment and mitigation.	[Scheiner, Zachary S.; Talib, Sohel; Feigal, Ellen G.] Calif Inst Regenerat Med, San Francisco, CA 94107 USA		Feigal, EG (corresponding author), Calif Inst Regenerat Med, San Francisco, CA 94107 USA.	efeigal@cirm.ca.gov						Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Augustine JJ, 2012, CLIN CHIM ACTA, V413, P1359, DOI 10.1016/j.cca.2012.03.006; Baker M, 2011, NAT MED, V17, P241, DOI 10.1038/nm0311-241; Barrilleaux B, 2011, CELL STEM CELL, V9, P103, DOI 10.1016/j.stem.2011.07.006; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; Bruckner S, 2011, METHODS MOL BIOL, V699, P97, DOI 10.1007/978-1-61737-950-5_6; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Chung TL, 2010, STEM CELLS, V28, P1782, DOI 10.1002/stem.500; Cyranoski D, 2013, NAT BIOTECHNOL, V31, P272, DOI 10.1038/nbt0413-272c; Cyranoski D, 2013, NATURE, V494, P413, DOI 10.1038/494413a; Dhodapkar MV, 2002, BLOOD, V100, P174, DOI 10.1182/blood.V100.1.174; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Fairchild PJ, 2010, NAT REV IMMUNOL, V10, P868, DOI 10.1038/nri2878; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Garber K, 2013, NAT BIOTECHNOL, V31, P483, DOI 10.1038/nbt.2602; Gebauer BS, 2002, AM J TRANSPLANT, V2, P857, DOI 10.1034/j.1600-6143.2002.20908.x; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Gourraud PA, 2012, STEM CELLS, V30, P180, DOI 10.1002/stem.772; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Gutierrez-Dalmau A, 2007, DRUGS, V67, P1167, DOI 10.2165/00003495-200767080-00006; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hayashi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014099; Kadereit S, 2011, SEMIN IMMUNOPATHOL, V33, P551, DOI 10.1007/s00281-011-0265-9; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Mayhew CN, 2010, CURR OPIN ORGAN TRAN, V15, P54, DOI 10.1097/MOT.0b013e3283337e1c; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Morizane A, 2013, STEM CELL REP, V1, P283, DOI 10.1016/j.stemcr.2013.08.007; Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Okamura RM, 2007, J NEUROIMMUNOL, V192, P134, DOI 10.1016/j.jneuroim.2007.09.030; Okita K, 2011, CIRC RES, V109, P720, DOI 10.1161/RES.0b013e318232e187; Panopoulos AD, 2012, CURR OPIN HEMATOL, V19, P256, DOI 10.1097/MOH.0b013e328353c78f; Parent AV, 2013, CELL STEM CELL, V13, P219, DOI 10.1016/j.stem.2013.04.004; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Prokhorova TA, 2009, STEM CELLS DEV, V18, P47, DOI 10.1089/scd.2007.0266; Ravishankar B, 2012, P NATL ACAD SCI USA, V109, P3909, DOI 10.1073/pnas.1117736109; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Rodriguez-Piza I, 2010, STEM CELLS, V28, P36, DOI 10.1002/stem.248; Rountree CB, 2012, HEPATOLOGY, V55, P298, DOI 10.1002/hep.24762; Rozman P, 2002, TRANSPL IMMUNOL, V10, P165; Ruiz S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2381; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Sun XN, 2013, CELL STEM CELL, V13, P230, DOI 10.1016/j.stem.2013.06.014; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang C, 2011, SEMIN IMMUNOPATHOL, V33, P563, DOI 10.1007/s00281-011-0269-5; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Taylor CJ, 2012, CELL STEM CELL, V11, P147, DOI 10.1016/j.stem.2012.07.014; Tchabo Nana E, 2009, Cancer Immun, V9, P6; Wang JH, 2008, NAT BIOTECHNOL, V26, P901, DOI 10.1038/nbt.1484; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Zhao R, 2008, J CELL BIOCHEM, V105, P949, DOI 10.1002/jcb.21871; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	66	38	39	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4571	4577		10.1074/jbc.R113.509588	http://dx.doi.org/10.1074/jbc.R113.509588			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24362036	hybrid, Green Published			2022-12-28	WOS:000331607900005
J	Gohring, I; Sharoyko, VV; Malmgren, S; Andersson, LE; Spegel, P; Nicholls, DG; Mulder, H				Gohring, Isabel; Sharoyko, Vladimir V.; Malmgren, Siri; Andersson, Lotta E.; Spegel, Peter; Nicholls, David G.; Mulder, Hindrik			Chronic High Glucose and Pyruvate Levels Differentially Affect Mitochondrial Bioenergetics and Fuel-stimulated Insulin Secretion from Clonal INS-1832/13 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta Cell; Bioenergetics; Insulin Secretion; Metabolomics; Mitochondrial Metabolism; Uncoupling Proteins	PANCREATIC BETA-CELLS; UNCOUPLING PROTEIN-2; LACTATE-DEHYDROGENASE; OXIDATIVE STRESS; ISLETS; METABOLISM; RESPONSES; CHANNELS; RELEASE; OBESITY	Background: Elevated glucose may cause -cell dysfunction in type 2 diabetes, i.e., glucotoxicity. Results: Elevated glucose, but not pyruvate, perturbed insulin secretion and content, plasma and mitochondrial membrane potentials, and proton leak, while increasing glycolytic metabolites in -cells. Conclusion: Early metabolism of glucose exerts a toxic effect on clonal insulin-producing cells. Significance: Unraveling these mechanisms may provide protection of -cells in diabetes. Glucotoxicity in pancreatic -cells is a well established pathogenetic process in type 2 diabetes. It has been suggested that metabolism-derived reactive oxygen species perturb the -cell transcriptional machinery. Less is known about altered mitochondrial function in this condition. We used INS-1 832/13 cells cultured for 48 h in 2.8 mm glucose (low-G), 16.7 mm glucose (high-G), or 2.8 mm glucose plus 13.9 mm pyruvate (high-P) to identify metabolic perturbations. High-G cells showed decreased responsiveness, relative to low-G cells, with respect to mitochondrial membrane hyperpolarization, plasma membrane depolarization, and insulin secretion, when stimulated acutely with 16.7 mm glucose or 10 mm pyruvate. In contrast, high-P cells were functionally unimpaired, eliminating chronic provision of saturating mitochondrial substrate as a cause of glucotoxicity. Although cellular insulin content was depleted in high-G cells, relative to low-G and high-P cells, cellular functions were largely recovered following a further 24-h culture in low-G medium. After 2 h at 2.8 mm glucose, high-G cells did not retain increased levels of glycolytic or TCA cycle intermediates but nevertheless displayed increased glycolysis, increased respiration, and an increased mitochondrial proton leak relative to low-G and high-P cells. This notwithstanding, titration of low-G cells with low protonophore concentrations, monitoring respiration and insulin secretion in parallel, showed that the perturbed insulin secretion of high-G cells could not be accounted for by increased proton leak. The present study supports the idea that glucose-induced disturbances of stimulus-secretion coupling by extramitochondrial metabolism upstream of pyruvate, rather than exhaustion from metabolic overload, underlie glucotoxicity in insulin-producing cells.	[Gohring, Isabel; Sharoyko, Vladimir V.; Malmgren, Siri; Andersson, Lotta E.; Spegel, Peter; Nicholls, David G.; Mulder, Hindrik] Lund Univ, Ctr Diabet, CRC, Dept Clin Sci Malmo,Unit Mol Metab, S-20502 Malmo, Sweden; [Nicholls, David G.] Buck Inst Res Aging, Novato, CA 94945 USA	Lund University; Buck Institute for Research on Aging	Mulder, H (corresponding author), Lund Univ, Ctr Diabet, CRC Skane Univ Hosp, Dept Clin Sci Malmo,Unit Mol Metab, S-20502 Malmo, Sweden.	hindrik.mulder@med.lu.se	Sharoyko, Vladimir/J-3625-2014; Spégel, Peter/G-9947-2018	Sharoyko, Vladimir/0000-0002-3717-0471; Spégel, Peter/0000-0002-6092-2387; Mulder, Hindrik/0000-0002-6593-8417; Malmgren, Siri/0000-0002-4540-1102				Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Chan CB, 2004, DIABETES, V53, pS136, DOI 10.2337/diabetes.53.2007.S136; Collins S, 2012, BEST PRACT RES CL EN, V26, P753, DOI 10.1016/j.beem.2012.08.002; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Fridlyand LE, 2004, DIABETES, V53, P1942, DOI 10.2337/diabetes.53.8.1942; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; Goehring I, 2011, DIABETOLOGIA, V54, P2584, DOI 10.1007/s00125-011-2249-7; Goehring I, 2012, J BIOL CHEM, V287, P15706, DOI 10.1074/jbc.M111.314567; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; Jonas JC, 2009, DIABETES OBES METAB, V11, P65, DOI 10.1111/j.1463-1326.2009.01112.x; Jonas JC, 2001, J BIOL CHEM, V276, P35375, DOI 10.1074/jbc.M105020200; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; KOMATSU M, 1989, HORM METAB RES, V21, P405, DOI 10.1055/s-2007-1009249; Krus U, 2010, BIOCHEM J, V429, P205, DOI 10.1042/BJ20100142; LEAHY JL, 1986, J CLIN INVEST, V77, P908, DOI 10.1172/JCI112389; Malmgren S, 2013, J BIOL CHEM, V288, P11973, DOI 10.1074/jbc.M112.422527; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Nedergaard J, 2003, EXP PHYSIOL, V88, P65, DOI 10.1113/eph8802502; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; RIAL E, 1983, EUR J BIOCHEM, V137, P197, DOI 10.1111/j.1432-1033.1983.tb07815.x; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Rocheleau JV, 2002, J BIOL CHEM, V277, P30914, DOI 10.1074/jbc.M202314200; Sakai K, 2003, BIOCHEM BIOPH RES CO, V300, P216, DOI 10.1016/S0006-291X(02)02832-2; Segall L, 1999, AM J PHYSIOL-ENDOC M, V277, pE521, DOI 10.1152/ajpendo.1999.277.3.E521; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Spegel P, 2013, BIOCHEM J, V450, P595, DOI 10.1042/BJ20121349; Spegel P, 2011, BIOCHEM J, V435, P277, DOI 10.1042/BJ20100655; Thorrez L, 2011, GENOME RES, V21, P95, DOI 10.1101/gr.109173.110; Ward MW, 2000, J NEUROSCI, V20, P7208; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	38	34	34	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3786	3798		10.1074/jbc.M113.507335	http://dx.doi.org/10.1074/jbc.M113.507335			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24356960	Green Published, hybrid			2022-12-28	WOS:000331368700058
J	Aluvila, S; Mandal, T; Hustedt, E; Fajer, P; Choe, JY; Oh, KJ				Aluvila, Sreevidya; Mandal, Tirtha; Hustedt, Eric; Fajer, Peter; Choe, Jun Yong; Oh, Kyoung Joon			Organization of the Mitochondrial Apoptotic BAK Pore OLIGOMERIZATION OF THE BAK HOMODIMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bax; Bcl-2; Cell Death; Electron Paramagnetic Resonance (EPR); Mitochondria; Bak; Oligomerization Interface; Spin Labeling	ELECTRON-PARAMAGNETIC-RESONANCE; BCL-2 FAMILY-MEMBER; SPIN-LABELS; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURES; PROAPOPTOTIC BAX; GLOBAL ANALYSIS; BH3 DOMAINS; ACTIVATION; MEMBRANE	Background: BAK and BAX permeabilize the mitochondrial membrane during apoptosis. Results: Helices 2-5 of BAK form the BH3-in-groove homodimer in the membrane, which oligomerizes by juxtaposing the carboxyl termini of 3 and 5, respectively. Conclusion: A novel 3:3, 5:5 oligomerization interface exists in the BAK oligomeric pore. Significance: These results support a model for BAX/BAK pore formation, which constitutes a key regulatory step in mitochondrial apoptosis. The multidomain pro-apoptotic Bcl-2 family proteins BAK and BAX are believed to form large oligomeric pores in the mitochondrial outer membrane during apoptosis. Formation of these pores results in the release of apoptotic factors including cytochrome c from the intermembrane space into the cytoplasm, where they initiate the cascade of events that lead to cell death. Using the site-directed spin labeling method of electron paramagnetic resonance (EPR) spectroscopy, we have determined the conformational changes that occur in BAK when the protein targets to the membrane and forms pores. The data showed that helices 1 and 6 disengage from the rest of the domain, leaving helices 2-5 as a folded unit. Helices 2-5 were shown to form a dimeric structure, which is structurally homologous to the recently reported BAX BH3-in-groove homodimer. Furthermore, the EPR data and a chemical cross-linking study demonstrated the existence of a hitherto unknown interface between BAK BH3-in-groove homodimers in the oligomeric BAK. This novel interface involves the C termini of 3 and 5 helices. The results provide further insights into the organization of the BAK oligomeric pores by the BAK homodimers during mitochondrial apoptosis, enabling the proposal of a BAK-induced lipidic pore with the topography of a worm hole.	[Aluvila, Sreevidya; Mandal, Tirtha; Choe, Jun Yong; Oh, Kyoung Joon] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA; [Hustedt, Eric] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Fajer, Peter] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Vanderbilt University; State University System of Florida; Florida State University	Oh, KJ (corresponding author), 3333 Green Bay Rd, N Chicago, IL 60064 USA.	kyoung.oh@rosalindfranklin.edu		OH, KYOUNG JOON/0000-0002-4729-9674	National Institutes of Health [5 R01 GM097508]; American Heart Association [0835026G]; EPR Center at the Rosalind Franklin University of Medicine and Science (RFUMS); RFUMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EPR Center at the Rosalind Franklin University of Medicine and Science (RFUMS); RFUMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 R01 GM097508, Scientist Development Grant 0835026G from the American Heart Association, the EPR Center at the Rosalind Franklin University of Medicine and Science (RFUMS), and the Start-up fund from RFUMS.	Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Bottcher CJF, 1961, ANAL CHIM ACTA, V24, P203; Brandon S, 2012, J MAGN RESON, V218, P93, DOI 10.1016/j.jmr.2012.03.006; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeLano W.L, PYMOL MOL GRAPHICS S; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleissner MR, 2011, P NATL ACAD SCI USA, V108, P16241, DOI 10.1073/pnas.1111420108; Hubbell WL, 2013, CURR OPIN STRUC BIOL, V23, P725, DOI 10.1016/j.sbi.2013.06.008; Hustedt EJ, 1999, ANNU REV BIOPH BIOM, V28, P129, DOI 10.1146/annurev.biophys.28.1.129; Hustedt EJ, 1997, BIOPHYS J, V72, P1861, DOI 10.1016/S0006-3495(97)78832-5; Hustedt EJ, 2006, BIOPHYS J, V90, P340, DOI 10.1529/biophysj.105.068544; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Langen R, 2000, BIOCHEMISTRY-US, V39, P8396, DOI 10.1021/bi000604f; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Ma S, 2013, J BIOL CHEM, V288, P26027, DOI 10.1074/jbc.M113.490094; Martinez-Caballero S, 2009, J BIOL CHEM, V284, P12235, DOI 10.1074/jbc.M806610200; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Oh KJ, 2006, J BIOL CHEM, V281, P36999, DOI 10.1074/jbc.M602341200; Oh KJ, 2010, J BIOL CHEM, V285, P28924, DOI 10.1074/jbc.M110.135293; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Schafer B, 2009, MOL BIOL CELL, V20, P2276, DOI 10.1091/mbc.E08-10-1056; Sen KI, 2007, BIOCHEMISTRY-US, V46, P11639, DOI 10.1021/bi700859p; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281	42	58	60	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2537	2551		10.1074/jbc.M113.526806	http://dx.doi.org/10.1074/jbc.M113.526806			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24337568	Green Published, hybrid			2022-12-28	WOS:000333403000006
J	Rai, R; Tate, JJ; Georis, I; Dubois, E; Cooper, TG				Rai, Rajendra; Tate, Jennifer J.; Georis, Isabelle; Dubois, Evelyne; Cooper, Terrance G.			Constitutive and Nitrogen Catabolite Repression-sensitive Production of Gat1 Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gata; Glutamine; Nitrogen Metabolism; Protein Structure; TOR Complex (TORC); Transcription Initiation Factors; Gat1; Nitrogen Catabolite Repression; Rapamycin	METHIONINE SULFOXIMINE TREATMENT; TOR SIGNALING PATHWAY; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; REGULATED TRANSCRIPTION; GLN3 PHOSPHORYLATION; NUCLEAR-LOCALIZATION; RAPAMYCIN INHIBITION; CARBON STARVATION; FACTOR RESPONSES	Background:GAT1 transcription is nitrogen-responsive, whereas Gat1 isoforms (IsoA, IsoB) are produced constitutively. Results: IsoA/B initiate at different methionines. Gln3-dependent IsoA/B production is unresponsive to nitrogen, whereas Gat1(M1-S233) peptide production is nitrogen-responsive. Conclusion: Wild type and Gat1(M1-S233) protein production is nonparallel. Significance: This is the first instance of Gln3-dependent protein production failing to be nitrogen-responsive, suggesting additional level of Gat1 regulation. Nitrogen catabolite repression (NCR)-sensitive transcription is activated by Gln3 and Gat1. In nitrogen excess, Gln3 and Gat1 are cytoplasmic, and transcription is minimal. In poor nitrogen, Gln3 and Gat1 become nuclear and activate transcription. A long standing paradox has surrounded Gat1 production. Gat1 was first reported as an NCR-regulated activity mediating NCR-sensitive transcription in gln3 deletion strains. Upon cloning, GAT1 transcription was, as predicted, NCR-sensitive and Gln3- and Gat1-activated. In contrast, Western blots of Gat1-Myc(13) exhibited two constitutively produced species. Investigating this paradox, we demonstrate that wild type Gat1 isoforms (IsoA and IsoB) are initiated at Gat1 methionines 40, 95, and/or 102, but not at methionine 1. Their low level production is the same in rich and poor nitrogen conditions. When the Myc(13) tag is placed after Gat1 Ser-233, four N-terminal Gat1 isoforms (IsoC-F) are also initiated at methionines 40, 95, and/or 102. However, their production is highly NCR-sensitive, being greater in proline than glutamine medium. Surprisingly, all Gat1 isoforms produced in sufficient quantities to be confidently analyzed (IsoA, IsoC, and IsoD) require Gln3 and UAS(GATA) promoter elements, both requirements typical of NCR-sensitive transcription. These data demonstrate that regulated Gat1 production is more complex than previously recognized, with wild type versus truncated Gat1 proteins failing to be regulated in parallel. This is the first reported instance of Gln3 UAS(GATA)-dependent protein production failing to derepress in nitrogen poor conditions. A Gat1-lacZ ORF swap experiment indicated sequence(s) responsible for the nonparallel production are downstream of Gat1 leucine 61.	[Rai, Rajendra; Tate, Jennifer J.; Cooper, Terrance G.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Georis, Isabelle; Dubois, Evelyne] Univ Libre Brussels, Inst Rech Microbiol Jean Marie Wiame, B-1070 Brussels, Belgium	University of Tennessee System; University of Tennessee Health Science Center; Universite Libre de Bruxelles	Cooper, TG (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	tcooper@uthsc.edu		Cooper, Terrance G./0000-0002-7651-9963	National Institutes of Health [GM-35642]; Commission Communautaire Francaise; Fonds de la Recherche Fondamentale Collective Grant [2.4547.11]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commission Communautaire Francaise; Fonds de la Recherche Fondamentale Collective Grant(Fonds de la Recherche Scientifique - FNRS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35642 (to J. J. T., R. R., and T. G. C.). This work was also supported by the Commission Communautaire Francaise and Fonds de la Recherche Fondamentale Collective Grant 2.4547.11 (to I. G. and E. D.).	Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2002, MOL CELL BIOL, V22, P1246, DOI 10.1128/MCB.22.4.1246-1252.2002; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; Coffman J, 1996, FOLIA MICROBIOL, V41, P85, DOI 10.1007/BF02816348; Coffman JA, 1996, MOL CELL BIOL, V16, P847; Coffman JA, 1997, J BACTERIOL, V179, P3416, DOI 10.1128/jb.179.11.3416-3429.1997; COFFMAN JA, 1994, J BACTERIOL, V176, P7476, DOI 10.1128/JB.176.24.7476-7483.1994; COFFMAN JA, 1995, J BACTERIOL, V177, P6910, DOI 10.1128/jb.177.23.6910-6918.1995; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; CUNNINGHAM TS, 1993, J BACTERIOL, V175, P5851, DOI 10.1128/JB.175.18.5851-5861.1993; Cunningham TS, 1996, J BACTERIOL, V178, P3470, DOI 10.1128/jb.178.12.3470-3479.1996; DAUGHERTY JR, 1993, J BACTERIOL, V175, P64, DOI 10.1128/JB.175.1.64-73.1993; Feller A, 2013, J BIOL CHEM, V288, P1841, DOI 10.1074/jbc.M112.385054; Fournier CT, 2012, J PROTEOME RES, V11, P5712, DOI 10.1021/pr300538f; Frederiks F, 2009, NUCLEIC ACIDS RES, V37, P7047, DOI 10.1093/nar/gkp765; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Georis I, 2011, J BIOL CHEM, V286, P44897, DOI 10.1074/jbc.M111.290577; Georis I, 2011, MOL CELL BIOL, V31, P92, DOI 10.1128/MCB.00482-10; Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051; Georis I, 2009, MOL CELL BIOL, V29, P3803, DOI 10.1128/MCB.00399-09; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kulkarni A, 2006, FEMS YEAST RES, V6, P218, DOI 10.1111/j.1567-1364.2006.00031.x; Kuruvilla FG, 2001, P NATL ACAD SCI USA, V98, P7283, DOI 10.1073/pnas.121186898; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Mauro VR, 2007, METHOD ENZYMOL, V429, P323, DOI 10.1016/S0076-6879(07)29015-9; Miller JH, 1972, EXPT MOL GENETICS, P403; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; PARK HD, 1992, NUCLEIC ACIDS RES, V20, P1909, DOI 10.1093/nar/20.8.1909; Rai R, 2013, J BIOL CHEM, V288, P2789, DOI 10.1074/jbc.M112.421826; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Rowen DW, 1997, J BACTERIOL, V179, P3761, DOI 10.1128/jb.179.11.3761-3766.1997; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; SMITH CL, 1989, J VIROL, V63, P1569, DOI 10.1128/JVI.63.4.1569-1577.1989; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Soussi-Boudekou S, 1999, MOL MICROBIOL, V31, P753, DOI 10.1046/j.1365-2958.1999.01187.x; SoussiBoudekou S, 1997, MOL MICROBIOL, V23, P1157, DOI 10.1046/j.1365-2958.1997.3021665.x; STANBROUGH M, 1995, J BACTERIOL, V177, P94, DOI 10.1128/jb.177.1.94-102.1995; STANBROUGH M, 1995, P NATL ACAD SCI USA, V92, P9450, DOI 10.1073/pnas.92.21.9450; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2006, J BIOL CHEM, V281, P28460, DOI 10.1074/jbc.M604171200; Tate JJ, 2013, J BIOL CHEM, V288, P27243, DOI 10.1074/jbc.M113.484386; Tate JJ, 2010, J BIOL CHEM, V285, P17880, DOI 10.1074/jbc.M109.085712; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; Vilela C, 1998, NUCLEIC ACIDS RES, V26, P1150, DOI 10.1093/nar/26.5.1150; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072	64	8	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2918	2933		10.1074/jbc.M113.516740	http://dx.doi.org/10.1074/jbc.M113.516740			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24324255	Green Published, hybrid			2022-12-28	WOS:000333403000040
J	Sirisaengtaksin, N; Gireud, M; Yan, Q; Kubota, Y; Meza, D; Waymire, JC; Zage, PE; Bean, AJ				Sirisaengtaksin, Natalie; Gireud, Monica; Yan, Qing; Kubota, Yoshihisa; Meza, Denisse; Waymire, Jack C.; Zage, Peter E.; Bean, Andrew J.			UBE4B Protein Couples Ubiquitination and Sorting Machineries to Enable Epidermal Growth Factor Receptor (EGFR) Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Deubiquitination; E3 Ubiquitin Ligase; Endocytosis; Endosomes; Protein Sorting; Ubiquitination; ESCRT; USP8	MULTIVESICULAR BODY FORMATION; DOWN-REGULATION; ENDOSOMAL LOCALIZATION; COMPLEX; HRS; ENDOCYTOSIS; DEUBIQUITINATION; UBIQUITYLATION; BINDING; E3	Background: Membrane protein ubiquitination is required for endosomal sorting and degradation. Results: UBE4B binds endosomes and ubiquitinates the EGFR, enabling its degradation. Conclusion: UBE4B regulates EGF receptor sorting, degradation, expression, and signaling. Significance: UBE4B couples ubiquitination and sorting machineries on endosomes and establishes a role for an endosome-associated ubiquitin ligase as crucial mediator of sorting and degradation of a membrane protein. The signaling of plasma membrane proteins is tuned by internalization and sorting in the endocytic pathway prior to recycling or degradation in lysosomes. Ubiquitin modification allows recognition and association of cargo with endosomally associated protein complexes, enabling sorting of proteins to be degraded from those to be recycled. The mechanism that provides coordination between the cellular machineries that mediate ubiquitination and endosomal sorting is unknown. We report that the ubiquitin ligase UBE4B is recruited to endosomes in response to epidermal growth factor receptor (EGFR) activation by binding to Hrs, a key component of endosomal sorting complex required for transport (ESCRT) 0. We identify the EGFR as a substrate for UBE4B, establish UBE4B as a regulator of EGFR degradation, and describe a mechanism by which UBE4B regulates endosomal sorting, affecting cellular levels of the EGFR and its downstream signaling. We propose a model in which the coordinated action of UBE4B, ESCRT-0, and the deubiquitinating enzyme USP8 enable the endosomal sorting and lysosomal degradation of the EGFR.	[Sirisaengtaksin, Natalie; Gireud, Monica; Yan, Qing; Kubota, Yoshihisa; Meza, Denisse; Waymire, Jack C.; Bean, Andrew J.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Sirisaengtaksin, Natalie; Gireud, Monica; Yan, Qing; Kubota, Yoshihisa; Meza, Denisse; Waymire, Jack C.; Bean, Andrew J.] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Zage, Peter E.] Baylor Coll Med, Texas Childrens Canc Ctr, Sect Hematol Oncol, Dept Pediat, Houston, TX 77030 USA; [Zage, Peter E.] Baylor Coll Med, Texas Childrens Hematol Ctr, Sect Hematol Oncol, Dept Pediat, Houston, TX 77030 USA; [Zage, Peter E.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Bean, Andrew J.] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Bean, AJ (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, 6431 Fannin St,MSB 7-208, Houston, TX 77030 USA.	a.bean@uth.tmc.edu		Sirisaengtaksin, Natalie/0000-0002-8791-722X; Gireud-Goss, Monica/0000-0001-5172-2351	National Institutes of Health [MH58920, CA166749]; Discovery Fellowship from the Russell and Diana Hawkins Family Foundation; NATIONAL CANCER INSTITUTE [R01CA166749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Discovery Fellowship from the Russell and Diana Hawkins Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH58920 and CA166749. This work was also supported by a Discovery Fellowship from the Russell and Diana Hawkins Family Foundation.	Alexander A, 1998, Front Biosci, V3, pd729; Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Bean AJ, 2000, J BIOL CHEM, V275, P15271, DOI 10.1074/jbc.275.20.15271; Berlin I, 2010, J BIOL CHEM, V285, P34909, DOI 10.1074/jbc.M109.016287; Berruti G, 2010, BIOL REPROD, V82, P930, DOI 10.1095/biolreprod.109.081679; Bocock JP, 2010, TRAFFIC, V11, P756, DOI 10.1111/j.1600-0854.2010.01060.x; Eden ER, 2012, TRAFFIC, V13, P329, DOI 10.1111/j.1600-0854.2011.01305.x; Fukuda H, 2006, J BIOCHEM, V139, P137, DOI 10.1093/jb/mvj012; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hassink G, 2012, BIOL OPEN, V1, P607, DOI 10.1242/bio.2012778; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Krall JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015945; Krona C, 2003, ONCOGENE, V22, P2343, DOI 10.1038/sj.onc.1206324; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; MacDonald C, 2012, EMBO REP, V13, P331, DOI 10.1038/embor.2012.18; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2004, J BIOCHEM, V135, P385, DOI 10.1093/jb/mvh046; Nakamura N, 2005, MOL BIOL CELL, V16, P1696, DOI 10.1091/mbc.E04-03-0216; Nakayama K, 2004, J BIOCHEM, V136, P751, DOI 10.1093/jb/mvh183; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Rezvani K, 2007, J NEUROSCI, V27, P10508, DOI 10.1523/JNEUROSCI.3353-07.2007; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Row PE, 2007, J BIOL CHEM, V282, P30929, DOI 10.1074/jbc.M704009200; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Starita LM, 2013, P NATL ACAD SCI USA, V110, pE1263, DOI 10.1073/pnas.1303309110; Sun W, 2003, J CELL BIOL, V162, P125, DOI 10.1083/jcb.200302083; Sun W, 2010, TRAFFIC, V11, P867, DOI 10.1111/j.1600-0854.2010.01053.x; Tsujimoto S, 1999, EUR J NEUROSCI, V11, P3047, DOI 10.1046/j.1460-9568.1999.00716.x; Tsujimoto S, 2000, J BIOL CHEM, V275, P2938, DOI 10.1074/jbc.275.4.2938; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yan Q, 2005, MOL BIOL CELL, V16, P2470, DOI 10.1091/mbc.e04-11-1014; Zage PE, 2013, CANCER-AM CANCER SOC, V119, P915, DOI 10.1002/cncr.27785	54	30	31	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					3026	3039		10.1074/jbc.M113.495671	http://dx.doi.org/10.1074/jbc.M113.495671			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24344129	hybrid, Green Published			2022-12-28	WOS:000333403000049
J	Liu, D; Yang, C				Liu, Deng; Yang, Chen			The Nitrogen-regulated Response Regulator NrrA Controls Cyanophycin Synthesis and Glycogen Catabolism in the Cyanobacterium Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Cyanobacteria; Glycogen; Nitrogen Metabolism; Transcription Regulation; Cyanophycin Synthesis; NrrA; Sugar Catabolism; Nitrogen Limitation	SP STRAIN PCC-7120; HETEROCYST DIFFERENTIATION; GENOMIC RECONSTRUCTION; SP PCC-6803; PROTEIN; EXPRESSION; ANABAENA; SYNTHETASE; HETR; NTCA	The cellular metabolism in cyanobacteria is extensively regulated in response to changes of environmental nitrogen availability. Multiple regulators are involved in this process, including a nitrogen-regulated response regulator NrrA. However, the regulatory role of NrrA in most cyanobacteria remains to be elucidated. In this study, we combined a comparative genomic reconstruction of NrrA regulons in 15 diverse cyanobacterial species with detailed experimental characterization of NrrA-mediated regulation in Synechocystis sp. PCC 6803. The reconstructed NrrA regulons in most species included the genes involved in glycogen catabolism, central carbon metabolism, amino acid biosynthesis, and protein degradation. A predicted NrrA-binding motif consisting of two direct repeats of TG(T/A)CA separated by an 8-bp A/T-rich spacer was verified by in vitro binding assays with purified NrrA protein. The predicted target genes of NrrA in Synechocystis sp. PCC 6803 were experimentally validated by comparing the transcript levels and enzyme activities between the wild-type and nrrA-inactivated mutant strains. The effect of NrrA deficiency on intracellular contents of arginine, cyanophycin, and glycogen was studied. Severe impairments in arginine synthesis and cyanophycin accumulation were observed in the nrrA-inactivated mutant. The nrrA inactivation also resulted in a significantly decreased rate of glycogen degradation. Our results indicate that by directly up-regulating expression of the genes involved in arginine synthesis, glycogen degradation, and glycolysis, NrrA controls cyanophycin accumulation and glycogen catabolism in Synechocystis sp. PCC 6803. It is suggested that NrrA plays a role in coordinating the synthesis and degradation of nitrogen and carbon reserves in cyanobacteria.	[Liu, Deng; Yang, Chen] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yang, C (corresponding author), 300 Fenglin Rd, Shanghai, Peoples R China.	chenyang@sibs.ac.cn			National Basic Research Program of China [973:2012CB721101]; National Natural Science Foundation of China [31121001]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-G-5]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported in part by the National Basic Research Program of China Grant 973:2012CB721101, the National Natural Science Foundation of China Grant 31121001, and the Knowledge Innovation Program of the Chinese Academy of Sciences Grant KSCX2-EW-G-5.	Aboulmagd E, 2001, APPL ENVIRON MICROB, V67, P2176, DOI 10.1128/AEM.67.5.2176-2182.2001; ALLEN MM, 1984, ANNU REV MICROBIOL, V38, P1, DOI 10.1146/annurev.mi.38.100184.000245; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARNON DI, 1974, BIOCHIM BIOPHYS ACTA, V357, P231, DOI 10.1016/0005-2728(74)90063-2; Azuma M, 2011, PLANT CELL PHYSIOL, V52, P404, DOI 10.1093/pcp/pcq204; Baek JH, 2006, FEMS MICROBIOL LETT, V264, P104, DOI 10.1111/j.1574-6968.2006.00440.x; BEUF L, 1994, PLANT MOL BIOL, V25, P855, DOI 10.1007/BF00028880; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Ehira S, 2006, J BACTERIOL, V188, P8520, DOI 10.1128/JB.01314-06; Ehira S, 2011, J BIOL CHEM, V286, P38109, DOI 10.1074/jbc.M111.289124; El-Shehawy R, 2003, MICROBIOL-SGM, V149, P1139, DOI 10.1099/mic.0.26170-0; Espinosa J, 2006, MOL MICROBIOL, V61, P457, DOI 10.1111/j.1365-2958.2006.05231.x; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Fu J, 2006, FEMS MICROBIOL LETT, V260, P201, DOI 10.1111/j.1574-6968.2006.00312.x; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Grundel M, 2012, MICROBIOL-SGM, V158, P3032, DOI 10.1099/mic.0.062950-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haines Ricci J, 2011, Int J Biochem Mol Biol, V2, P8; Karradt A, 2008, J BIOL CHEM, V283, P32394, DOI 10.1074/jbc.M805823200; Krasikov V, 2012, PHYSIOL PLANTARUM, V145, P426, DOI 10.1111/j.1399-3054.2012.01585.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee S, 2007, PLANT PHYSIOL, V145, P1018, DOI 10.1104/pp.107.105023; Li H, 2001, ARCH MICROBIOL, V176, P9, DOI 10.1007/s002030100281; Maheswaran M, 2006, J BACTERIOL, V188, P2730, DOI 10.1128/JB.188.7.2730-2734.2006; Mao HM, 2010, CLIN BIOCHEM, V43, P1141, DOI 10.1016/j.clinbiochem.2010.05.017; Marin K, 2004, PLANT PHYSIOL, V136, P3290, DOI 10.1104/pp.104.045047; Mironov AA, 2000, MOL BIOL+, V34, P222, DOI 10.1007/BF02759643; Muro-Pastor AM, 2006, FEMS MICROBIOL LETT, V256, P171, DOI 10.1111/j.1574-6968.2006.00136.x; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Osanai T, 2011, J BIOL CHEM, V286, P30962, DOI 10.1074/jbc.M111.231183; Rajaram V, 2008, PROTEINS, V70, P429, DOI 10.1002/prot.21567; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; SCHUEGRAF A, 1960, J BIOL CHEM, V235, P3597; Schwarz R, 2005, MICROBIOL-SGM, V151, P2503, DOI 10.1099/mic.0.27883-0; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; TAYLOR LA, 1988, NUCLEIC ACIDS RES, V16, P358, DOI 10.1093/nar/16.1.358; VEGAPALAS MA, 1992, MOL MICROBIOL, V6, P1853, DOI 10.1111/j.1365-2958.1992.tb01357.x; VIOQUE A, 1992, NUCLEIC ACIDS RES, V20, P6331, DOI 10.1093/nar/20.23.6331; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Yang C, 2008, J BACTERIOL, V190, P1773, DOI 10.1128/JB.01469-07; Yoo SH, 2007, INT J BIOL MACROMOL, V40, P498, DOI 10.1016/j.ijbiomac.2006.11.009; Zhang CC, 2006, MOL MICROBIOL, V59, P367, DOI 10.1111/j.1365-2958.2005.04979.x; Ziegler K, 1998, EUR J BIOCHEM, V254, P154, DOI 10.1046/j.1432-1327.1998.2540154.x	48	20	21	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2055	2071		10.1074/jbc.M113.515270	http://dx.doi.org/10.1074/jbc.M113.515270			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24337581	Green Published, hybrid			2022-12-28	WOS:000331130200016
J	Murase, T; Eugenio, L; Schorr, M; Hussack, G; Tanha, J; Kitova, EN; Klassen, JS; Ng, KKS				Murase, Tomohiko; Eugenio, Luiz; Schorr, Melissa; Hussack, Greg; Tanha, Jamshid; Kitova, Elena N.; Klassen, John S.; Ng, Kenneth K. S.			Structural Basis for Antibody Recognition in the Receptor-binding Domains of Toxins A and B from Clostridium difficile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Bacterial Toxins; Mass Spectrometry (MS); Protein-Protein Interactions; X-ray Crystallography	MONOCLONAL-ANTIBODIES; MAXIMUM-LIKELIHOOD; INFECTION; MODEL; TCDA; REPEATS; DISEASE	Clostridium difficile infection is a serious and highly prevalent nosocomial disease in which the two large, Rho-glucosylating toxins TcdA and TcdB are the main virulence factors. We report for the first time crystal structures revealing how neutralizing and non-neutralizing single-domain antibodies (sdAbs) recognize the receptor-binding domains (RBDs) of TcdA and TcdB. Surprisingly, the complexes formed by two neutralizing antibodies recognizing TcdA do not show direct interference with the previously identified carbohydrate-binding sites, suggesting that neutralization of toxin activity may be mediated by mechanisms distinct from steric blockage of receptor binding. A camelid sdAb complex also reveals the molecular structure of the TcdB RBD for the first time, facilitating the crystallization of a strongly negatively charged protein fragment that has resisted previous attempts at crystallization and structure determination. Electrospray ionization mass spectrometry measurements confirm the stoichiometries of sdAbs observed in the crystal structures. These studies indicate how key epitopes in the RBDs from TcdA and TcdB are recognized by sdAbs, providing molecular insights into toxin structure and function and providing for the first time a basis for the design of highly specific toxin-specific therapeutic and diagnostic agents.	[Murase, Tomohiko; Eugenio, Luiz; Schorr, Melissa; Ng, Kenneth K. S.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Murase, Tomohiko; Eugenio, Luiz; Schorr, Melissa; Ng, Kenneth K. S.] Univ Calgary, Alberta Glyc Ctr, Calgary, AB T2N 1N4, Canada; [Hussack, Greg; Tanha, Jamshid] Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada; [Tanha, Jamshid] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Kitova, Elena N.; Klassen, John S.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Kitova, Elena N.; Klassen, John S.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada	University of Calgary; University of Calgary; National Research Council Canada; University of Ottawa; University of Alberta; University of Alberta	Ng, KKS (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	ngk@ucalgary.ca		Klassen, John/0000-0002-3389-7112; Ng, Kenneth K.S./0000-0001-7280-8445	National Institutes of Health [P41GM103393, P41RR001209]; Department of Energy Office of Biological and Environmental Research; Alberta Glycomics Centre; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); Alberta Glycomics Centre; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41GM103393 and P41RR001209 (to the Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program). This work was also supported by funds from Department of Energy Office of Biological and Environmental Research (to the Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program), the Alberta Glycomics Centre and Discovery grants from the Natural Sciences and Engineering Research Council of Canada (to K. K. S. N. and J. S. K.), and the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan (to Beamline 08-ID-1).	Albesa-Jove D, 2010, J MOL BIOL, V396, P1260, DOI 10.1016/j.jmb.2010.01.012; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Ballard JD, 2010, NATURE, V467, P665, DOI 10.1038/467665a; Carroll KC, 2011, ANNU REV MICROBIOL, V65, P501, DOI 10.1146/annurev-micro-090110-102824; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davies AH, 2011, BIOCHEM J, V436, P517, DOI 10.1042/BJ20110106; Davies NL, 2013, CLIN VACCINE IMMUNOL, V20, P377, DOI 10.1128/CVI.00625-12; DeLano W.L, PYMOL MOL GRAPHICS S; Demarest SJ, 2010, MABS-AUSTIN, V2, P190, DOI 10.4161/mabs.2.2.11220; Dingle T, 2008, GLYCOBIOLOGY, V18, P698, DOI 10.1093/glycob/cwn048; El-Hawiet A, 2011, GLYCOBIOLOGY, V21, P1217, DOI 10.1093/glycob/cwr055; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gardiner DF, 2009, VACCINE, V27, P3598, DOI 10.1016/j.vaccine.2009.03.058; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gerding DN, 2012, DISCOV MED, V13, P75; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hussack Greg, 2012, Methods Mol Biol, V911, P211, DOI 10.1007/978-1-61779-968-6_14; Hussack G, 2010, TOXINS, V2, P998, DOI 10.3390/toxins2050998; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Jank T, 2007, GLYCOBIOLOGY, V17, p15R, DOI 10.1093/glycob/cwm004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kink JA, 1998, INFECT IMMUN, V66, P2018, DOI 10.1128/IAI.66.5.2018-2025.1998; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee M, 2006, J ORG CHEM, V71, P5082, DOI 10.1021/jo052659z; Leuzzi R, 2013, INFECT IMMUN, V81, P2851, DOI 10.1128/IAI.01341-12; Lin H, 2012, J AM SOC MASS SPECTR, V23, P2122, DOI 10.1007/s13361-012-0483-y; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Permpoonpattana P, 2011, INFECT IMMUN, V79, P2295, DOI 10.1128/IAI.00130-11; Pruitt RN, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00028; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sauerborn M, 1997, FEMS MICROBIOL LETT, V155, P45, DOI 10.1016/S0378-1097(97)00365-0; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005	39	32	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2331	2343		10.1074/jbc.M113.505917	http://dx.doi.org/10.1074/jbc.M113.505917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311789	Green Published, hybrid			2022-12-28	WOS:000331130200037
J	Lee, P; Bax, DV; Bilek, MMM; Weiss, AS				Lee, Pearl; Bax, Daniel V.; Bilek, Marcela M. M.; Weiss, Anthony S.			A Novel Cell Adhesion Region in Tropoelastin Mediates Attachment to Integrin alpha(V)beta(5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Elastin; Extracellular Matrix; Fibroblast; Integrin; Dermal Fibroblast; Multiple Integrins; Tropoelastin	INCREASED EXPRESSION; ELASTIN; BINDING; PROTEIN; ALPHA-V-BETA-5; FIBROBLASTS; INHIBITION; MIGRATION	Background: Cellular integrin (V3) binds to RKRK at the C-terminal tail of tropoelastin. Results: Inhibition of integrin (V5) hinders cell adhesion to tropoelastin constructs comprising domains 17 and 18. Conclusion: Integrin (V5) mediates cell adhesion to tropoelastin through a central region. Significance: Understanding the cell adhesion activity of tropoelastin gives improved insight into the physiological and pathological cell responses to this protein. Tropoelastin protein monomers assemble to form elastin. Cellular integrin (V3) binds RKRK at the C-terminal tail of tropoelastin. We probed cell interactions with tropoelastin by deleting the RKRK sequence to identify other cell-binding interactions within tropoelastin. We found a novel human dermal fibroblast attachment and spreading site on tropoelastin that is located centrally in the molecule. Inhibition studies demonstrated that this cell adhesion was not mediated by either elastin-binding protein or glycosaminoglycans. Cell interactions were divalent cation-dependent, indicating integrin dependence. Function-blocking monoclonal antibodies revealed that (V) integrin(s) and integrin (V5) specifically were critical for cell adhesion to this part of tropoelastin. These data reveal a common (V) integrin-binding theme for tropoelastin: (V3) at the C terminus and (V5) at the central region of tropoelastin. Each (V) region contributes to fibroblast attachment and spreading, but they differ in their effects on cytoskeletal assembly.	[Lee, Pearl; Bax, Daniel V.; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Darlington, NSW 2006, Australia; [Bax, Daniel V.; Bilek, Marcela M. M.] Univ Sydney, Sch Phys, Darlington, NSW 2006, Australia; [Weiss, Anthony S.] Univ Sydney, Bosch Inst, Darlington, NSW 2006, Australia; [Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Darlington, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney	Weiss, AS (corresponding author), Univ Sydney, Sch Mol Biosci, Darlington, NSW 2006, Australia.	tony.weiss@sydney.edu.au	Weiss, Anthony S/F-8103-2010; Weiss, Anthony S/GYV-0157-2022	Weiss, Anthony S/0000-0002-8106-4836; Bilek, Marcela/0000-0003-3363-2664	National Institutes of Health [EB014283]; Australian Research Council; Australian Defense Health Foundation; National Health and Medical Research Council; Australian Postgraduate Research Award Ph.D. scholarship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); Australian Defense Health Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Research Award Ph.D. scholarship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant EB014283 (to A. S. W.). This work was also supported by the Australian Research Council, the Australian Defense Health Foundation, and the National Health and Medical Research Council (to A. S. W.) and by an Australian Postgraduate Research Award Ph.D. scholarship (to P. L.). A. S. W. is the scientific founder of Elastagen Pty. Ltd.	Akhtart K, 2011, J BIOL CHEM, V286, P13574, DOI 10.1074/jbc.M110.192088; Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p; AOTA S, 1994, J BIOL CHEM, V269, P24756; Asano Y, 2006, AM J PATHOL, V168, P499, DOI 10.2353/ajpath.2006.041306; Asano Y, 2004, AM J PATHOL, V164, P1275, DOI 10.1016/S0002-9440(10)63215-4; Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108; Bax DV, 2011, BIOMATERIALS, V32, P5100, DOI 10.1016/j.biomaterials.2011.03.079; Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; Caiado F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003752; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; Humphries MJ, 2001, SCIENCE, V294, P316, DOI 10.1126/science.1066240; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jung S, 1998, J NEUROPATH EXP NEUR, V57, P439, DOI 10.1097/00005072-199805000-00007; Karnik SK, 2003, MATRIX BIOL, V22, P409, DOI 10.1016/S0945-053X(03)00076-3; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Kielty CM, 2007, PHILOS T R SOC B, V362, P1293, DOI 10.1098/rstb.2007.2134; MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M; MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613; Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022; SENIOR RM, 1982, J CLIN INVEST, V70, P614, DOI 10.1172/JCI110654; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; Sinanan ACM, 2008, BIOL CELL, V100, P465, DOI 10.1042/BC20070115; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Trikha M, 2004, INT J CANCER, V110, P326, DOI 10.1002/ijc.20116; von Ballmoos MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014107; Wachi H, 2007, BIOCHEM J, V402, P63, DOI 10.1042/BJ20061145; Wang L., 2012, PLOS ONE, V7; Williamson MR, 2007, BIOMATERIALS, V28, P5307, DOI 10.1016/j.biomaterials.2007.08.019; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a	35	55	55	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1467	1477		10.1074/jbc.M113.518381	http://dx.doi.org/10.1074/jbc.M113.518381			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24293364	Green Published, hybrid			2022-12-28	WOS:000332401700023
J	Alaidarous, M; Ve, T; Casey, LW; Valkov, E; Ericsson, DJ; Ullah, MO; Schembri, MA; Mansell, A; Sweet, MJ; Kobe, B				Alaidarous, Mohammed; Ve, Thomas; Casey, Lachlan W.; Valkov, Eugene; Ericsson, Daniel J.; Ullah, M. Obayed; Schembri, Mark A.; Mansell, Ashley; Sweet, Matthew J.; Kobe, Bostjan			Mechanism of Bacterial Interference with TLR4 Signaling by Brucella Toll/Interleukin-1 Receptor Domain-containing Protein TcpB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIR-LIKE PROTEIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SCATTERING; ADAPTER; FAMILY; MYD88; SUBVERSION; REVEALS; SYSTEM	Upon activation of Toll-like receptors (TLRs), cytoplasmic Toll/interleukin-1 receptor (TIR) domains of the receptors undergo homo-or heterodimerization. This in turn leads to the recruitment of adaptor proteins, activation of transcription factors, and the secretion of pro-inflammatory cytokines. Recent studies have described the TIR domain-containing protein from Brucella melitensis, TcpB (BtpA/Btp1), to be involved in virulence and suppression of host innate immune responses. TcpB interferes with TLR4 and TLR2 signaling pathways by a mechanism that remains controversial. In this study, we show using co-immunoprecipitation analyses that TcpB interacts with MAL, MyD88, and TLR4 but interferes only with the MAL-TLR4 interaction. We present the crystal structure of the TcpB TIR domain, which reveals significant structural differences in the loop regions compared with other TIR domain structures. We demonstrate that TcpB forms a dimer in solution, and the crystal structure reveals the dimerization interface, which we validate by mutagenesis and biophysical studies. Our study advances the understanding of the molecular mechanisms of host immunosuppression by bacterial pathogens.	[Alaidarous, Mohammed; Ve, Thomas; Casey, Lachlan W.; Valkov, Eugene; Ericsson, Daniel J.; Ullah, M. Obayed; Schembri, Mark A.; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Alaidarous, Mohammed; Ve, Thomas; Casey, Lachlan W.; Valkov, Eugene; Ericsson, Daniel J.; Ullah, M. Obayed; Sweet, Matthew J.; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Alaidarous, Mohammed; Ve, Thomas; Casey, Lachlan W.; Valkov, Eugene; Ericsson, Daniel J.; Ullah, M. Obayed; Schembri, Mark A.; Sweet, Matthew J.; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Mansell, Ashley] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Melbourne, Vic 3168, Australia; [Valkov, Eugene] Med Res Council Lab Mol Biol, Cambridge CB2 0QH, England	University of Queensland; University of Queensland; University of Queensland; Monash University; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Kobe, B (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	b.kobe@uq.edu.au	Ericsson, Daniel/F-7458-2011; Ve, Thomas/AEK-1006-2022; Sweet, Matthew J/F-2229-2011; Schembri, Mark A/C-7262-2009; Alaidarous, Eman/D-9316-2012; Valkov, Eugene/AAA-1735-2020; Mansell, Ashley/B-9553-2008; Casey, Lachlan/N-3396-2015; Ullah, M Obayed/AAR-7211-2020; alaidarous, mohammed/ABE-9105-2020; Kobe, Bostjan/D-1292-2009	Ericsson, Daniel/0000-0001-5101-9244; Ve, Thomas/0000-0002-0113-1905; Sweet, Matthew J/0000-0002-0406-8139; Schembri, Mark A/0000-0003-4863-9260; Valkov, Eugene/0000-0002-3721-1739; Mansell, Ashley/0000-0002-6540-1281; Casey, Lachlan/0000-0002-4458-0137; Ullah, M Obayed/0000-0002-1175-3636; alaidarous, mohammed/0000-0002-6161-3834; Kobe, Bostjan/0000-0001-9413-9166	National Health and Medical Research Council Grant [APP1003326]; Ministry of Higher Education of Saudi Arabia; Majmaah University (Al Majmaah, Saudi Arabia); Australian Research Council [FT100100662, FT100100657]; National Health and Medical Research Council [APP1003470, APP1003325]	National Health and Medical Research Council Grant(National Health and Medical Research Council (NHMRC) of Australia); Ministry of Higher Education of Saudi Arabia; Majmaah University (Al Majmaah, Saudi Arabia); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council Grant APP1003326 (to B. K. and A. M.).; Supported by a Ph.D. scholarship from the Ministry of Higher Education of Saudi Arabia and the Majmaah University (Al Majmaah, Saudi Arabia).; Australian Research Council Future Fellow under Grant FT100100662.; Australian Research Council Future Fellow under Grant FT100100657 and Honorary National Health and Medical Research Council Research Fellow under Grant APP1003470.; National Health and Medical Research Council Senior Research Fellow under Grant APP1003325.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alaidarous M, 2013, ACTA CRYSTALLOGR F, V69, P1167, DOI 10.1107/S1744309113024408; Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Chan SL, 2010, PROTEIN SCI, V19, P155, DOI 10.1002/pro.275; Chan SL, 2009, J BIOL CHEM, V284, P21386, DOI 10.1074/jbc.C109.007591; Chang TH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003563; Chaudhary A, 2012, BIOCHEM BIOPH RES CO, V417, P299, DOI 10.1016/j.bbrc.2011.11.104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi YJ, 2013, FASEB J, V27, P243, DOI 10.1096/fj.12-217596; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Cirl C, 2010, INT J MED MICROBIOL, V300, P396, DOI 10.1016/j.ijmm.2010.04.001; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fekonja O, 2012, J BIOL CHEM, V287, P30993, DOI 10.1074/jbc.M112.376186; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaplan-Turkoz B, 2013, FEBS LETT, V587, P3412, DOI 10.1016/j.febslet.2013.09.007; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Low LY, 2007, BIOCHEM BIOPH RES CO, V356, P481, DOI 10.1016/j.bbrc.2007.03.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Ohnishi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038423; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Rana RR, 2013, MED MICROBIOL IMMUN, V202, P1, DOI 10.1007/s00430-012-0253-2; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Salcedo SP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00028; Sengupta D, 2010, J IMMUNOL, V184, P956, DOI 10.4049/jimmunol.0902008; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Snyder GA, 2013, P NATL ACAD SCI USA, V110, P6985, DOI 10.1073/pnas.1215770110; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; van Dijk JAPP, 2000, J CHROMATOGR A, V867, P105, DOI 10.1016/S0021-9673(99)01161-9; Ve T, 2012, CURR DRUG TARGETS, V13, P1360, DOI 10.2174/138945012803530260; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	61	53	56	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					654	668		10.1074/jbc.M113.523274	http://dx.doi.org/10.1074/jbc.M113.523274			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265315	Green Published, hybrid			2022-12-28	WOS:000330541200006
J	Hong, IH; Lewis, K; Iakova, P; Jin, JL; Sullivan, E; Jawanmardi, N; Timchenko, L; Timchenko, N				Hong, Il-Hwa; Lewis, Kyle; Iakova, Polina; Jin, Jingling; Sullivan, Emily; Jawanmardi, Nicole; Timchenko, Lubov; Timchenko, Nikolai			Age-associated Change of C/EBP Family Proteins Causes Severe Liver Injury and Acceleration of Liver Proliferation after CCl4 Treatments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIGENETIC REGULATION; MICE; INHIBITION; EXPRESSION; HEPATOCYTES; ALPHA; YOUNG; LEADS; RATS; BETA	The aged liver is more sensitive to the drug treatments and has a high probability of developing liver disorders such as fibrosis, cirrhosis, and cancer. Here we present mechanisms underlying age-associated severe liver injury and acceleration of liver proliferation after CCl4 treatments. We have examined liver response to CCl4 treatments using old WT mice and young C/EBP alpha-S193D knockin mice, which express an aged-like isoform of C/EBP alpha. Both animal models have altered chromatin structure as well as increased liver injury and proliferation after acute CCl4 treatments. We found that these age-related changes are associated with the repression of key regulators of liver biology: C/EBP alpha, Farnesoid X Receptor (FXR) and telomere reverse transcriptase (TERT). In quiescent livers of old WT and young S193D mice, the inhibition of TERT is mediated by HDAC1-C/EBP alpha complexes. After CCl4 treatments, TERT, C/EBP alpha and FXR are repressed by different mechanisms. These mechanisms include the increase of a dominant negative isoform, C/EBP beta-LIP, and subsequent repression of C/EBP alpha, FXR, and TERT promoters. C/EBP beta-LIP also disrupts Rb-E2F1 complexes in C/EBP alpha-S193D mice after CCl4 treatments. To examine if these alterations are involved in drug-mediated liver diseases, we performed chronic treatments of mice with CCl4. We found that C/EBP alpha-S193D mice developed fibrosis much more rapidly than WT mice. Thus, our data show that the age-associated alterations of C/EBP proteins create favorable conditions for the increased liver proliferation after CCl4 treatments and for development of drug-mediated liver diseases.	[Hong, Il-Hwa; Lewis, Kyle; Iakova, Polina; Jin, Jingling; Sullivan, Emily; Jawanmardi, Nicole; Timchenko, Nikolai] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Timchenko, Lubov] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Timchenko, Lubov] Baylor Coll Med, Dept Mol Physiol, Houston, TX 77030 USA; [Timchenko, Lubov] Baylor Coll Med, Dept Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Timchenko, N (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA.	nikolait@bcm.tmc.edu		Jin, Jingling/0000-0002-4365-1837	National Institutes of Health [GM551888, AG039885, AG028865, CA159942, R01AR044387, R01AR052791]; NATIONAL CANCER INSTITUTE [R01CA159942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052791, R01AR044387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028865, R21AG039885, T32AG000183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM551888, AG039885, AG028865, and CA159942 (to N. T.) and R01AR044387 and R01AR052791 (to L. T.).	Akiyama TE, 2003, BBA-GEN SUBJECTS, V1619, P223, DOI 10.1016/S0304-4165(02)00480-4; Aroor AR, 2010, ALCOHOL CLIN EXP RES, V34, P1543, DOI 10.1111/j.1530-0277.2010.01239.x; Cairo S, 2012, J HEPATOL, V57, P910, DOI 10.1016/j.jhep.2012.05.017; Fujii T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-79; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Iakova P, 2011, SEMIN CANCER BIOL, V21, P28, DOI 10.1016/j.semcancer.2010.09.001; Ibrahim ZS, 2008, JPN J VET RES, V56, P119; Jin JL, 2013, CELL REP, V3, P831, DOI 10.1016/j.celrep.2013.02.009; Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471; Jin JL, 2010, AGING CELL, V9, P895, DOI 10.1111/j.1474-9726.2010.00617.x; Jones K, 2012, AGEING RES REV, V11, P442, DOI 10.1016/j.arr.2012.02.007; Komatsu Y, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-5; Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007; Lopez-Diazguerrero NE, 2005, LIFE SCI, V77, P2840, DOI 10.1016/j.lfs.2005.05.034; Mandrekar P, 2011, WORLD J GASTROENTERO, V17, P2456, DOI 10.3748/wjg.v17.i20.2456; Meng FY, 2012, AM J PATHOL, V181, P804, DOI 10.1016/j.ajpath.2012.06.010; Meng ZP, 2010, MOL ENDOCRINOL, V24, P886, DOI 10.1210/me.2009-0286; Murali B, 2004, MECH AGEING DEV, V125, P421, DOI 10.1016/j.mad.2004.03.005; Orellana D, 2010, J BIOL CHEM, V285, P23442, DOI 10.1074/jbc.M110.129825; Park PH, 2005, AM J PHYSIOL-GASTR L, V289, pG1124, DOI 10.1152/ajpgi.00091.2005; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Schwabe RF, 2011, CANCER CELL, V20, P698, DOI 10.1016/j.ccr.2011.11.021; Sirma H, 2011, GASTROENTEROLOGY, V141, P326, DOI 10.1053/j.gastro.2011.03.047; Timchenko NA, 2011, MOL PATHOL LIB, V5, P279, DOI 10.1007/978-1-4419-7107-4_19; Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005; Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200; Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200; Wang GL, 2010, J CLIN INVEST, V120, P2549, DOI 10.1172/JCI41933; Wege H., 2007, COMP HEPATOLOGY, V6, P1037; Welm AL, 2000, J BIOL CHEM, V275, P27406; Zangar RC, 2000, CHEM-BIOL INTERACT, V125, P233, DOI 10.1016/S0009-2797(00)00149-6	31	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1106	1118		10.1074/jbc.M113.526780	http://dx.doi.org/10.1074/jbc.M113.526780			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24273171	hybrid, Green Published			2022-12-28	WOS:000330541200042
J	Nomura, T; Watanabe, S; Kaneko, K; Yamanaka, K; Nukina, N; Furukawa, Y				Nomura, Takao; Watanabe, Shoji; Kaneko, Kumi; Yamanaka, Koji; Nukina, Nobuyuki; Furukawa, Yoshiaki			Intranuclear Aggregation of Mutant FUS/TLS as a Molecular Pathomechanism of Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; CELL-FREE FORMATION; FUS PROTEINOPATHY; MUTATIONS; TLS; ALS; ACTIVATION; DOMAIN; GENE; INCLUSIONS	Dominant mutations in FUS/TLS cause a familial form of amyotrophic lateral sclerosis (fALS), where abnormal accumulation of mutant FUS proteins in cytoplasm has been observed as a major pathological change. Many of pathogenic mutations have been shown to deteriorate the nuclear localization signal in FUS and thereby facilitate cytoplasmic mislocalization of mutant proteins. Several other mutations, however, exhibit no effects on the nuclear localization of FUS in cultured cells, and their roles in the pathomechanism of fALS remain obscure. Here, we show that a pathogenic mutation, G156E, significantly increases the propensities for aggregation of FUS in vitro and in vivo. Spontaneous in vitro formation of amyloid-like fibrillar aggregates was observed in mutant but not wild-type FUS, and notably, those fibrils functioned as efficient seeds to trigger the aggregation of wild-type protein. In addition, the G156E mutation did not disturb the nuclear localization of FUS but facilitated the formation of intranuclear inclusions in rat hippocampal neurons with significant cytotoxicity. We thus propose that intranuclear aggregation of FUS triggered by a subset of pathogenic mutations is an alternative pathomechanism of FUS-related fALS diseases.	[Nomura, Takao; Furukawa, Yoshiaki] Keio Univ, Dept Chem, Lab Mechanist Chem Biomol, Yokohama, Kanagawa 2238522, Japan; [Watanabe, Shoji] Doshisha Univ, Grad Sch Brain Sci, Kyoto 6190225, Japan; [Kaneko, Kumi; Yamanaka, Koji] RIKEN Brain Sci Inst, Lab Motor Neuron Dis, Wako, Saitama 3510198, Japan; [Yamanaka, Koji] Nagoya Univ, Environm Med Res Inst, Dept Neurosci & Pathobiol, Nagoya, Aichi 4648601, Japan; [Nukina, Nobuyuki] Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Tokyo 1138421, Japan	Keio University; Doshisha University; RIKEN; Nagoya University; Juntendo University	Furukawa, Y (corresponding author), Keio Univ, Dept Chem, Lab Mechanist Chem Biomol, Yokohama, Kanagawa 2238522, Japan.	furukawa@chem.keio.ac.jp	Yamanaka, Koji/H-5806-2011; Nukina, Nobuyuki/GPP-6265-2022; Yamanaka, Koji/ABD-1034-2020; Furukawa, Yoshiaki/F-2871-2014	Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035; Furukawa, Yoshiaki/0000-0002-1918-372X	Ministry of Education, Culture, Sports, Science and Technology of Japan [24111542, 23111006, 22110004, 22240037, 25291028, 24657093, 24700391]; Research Committee of CNS Degenerative Diseases; Ministry of Health, Labour, and Welfare of Japan; CREST from Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Committee of CNS Degenerative Diseases(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); CREST from Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported by Grants-in-Aid 24111542 (to Y. F.), 23111006 (to K. Y.), 22110004 (to N. N.) for Scientific Research on Innovative Areas, 22240037 for Scientific Research (A) (to N. N.), 25291028 for Scientific Research (B) (to Y. F.), 24657093 for Challenging Exploratory Research (to Y. F.), and 24700391 for Young Scientists (B) (to S. W.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, grants-in-aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour, and Welfare of Japan (to K. Y.), and CREST from Japan Science and Technology Agency (to N. N.).	AVILA J, 1992, LIFE SCI, V50, P327, DOI 10.1016/0024-3205(92)90433-P; Baumer D, 2010, NEUROLOGY, V75, P611, DOI 10.1212/WNL.0b013e3181ed9cde; Bigio EH, 2013, ACTA NEUROPATHOL, V125, P463, DOI 10.1007/s00401-013-1089-6; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Corrado L, 2010, J MED GENET, V47, P190, DOI 10.1136/jmg.2009.071027; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; DeJesus-Hernandez M, 2010, HUM MUTAT, V31, pE1377, DOI 10.1002/humu.21241; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Fujioka Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02388; Gal J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.010; Groen EJN, 2010, ARCH NEUROL-CHICAGO, V67, P224, DOI 10.1001/archneurol.2009.329; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hewitt C, 2010, ARCH NEUROL-CHICAGO, V67, P455, DOI 10.1001/archneurol.2010.52; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Huang EJ, 2010, BRAIN PATHOL, V20, P1069, DOI 10.1111/j.1750-3639.2010.00413.x; Iko Y, 2004, J BIOL CHEM, V279, P44834, DOI 10.1074/jbc.M408552200; Ishigaki S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00529; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Misonou H, 2005, J NEUROSCI METH, V144, P165, DOI 10.1016/j.jneumeth.2004.11.007; Orozco D, 2012, EMBO REP, V13, P759, DOI 10.1038/embor.2012.90; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; PRASAD DDK, 1994, ONCOGENE, V9, P3717; Robertson J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.015; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Suzuki N, 2010, J HUM GENET, V55, P252, DOI 10.1038/jhg.2010.16; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Ticozzi N, 2009, NEUROLOGY, V73, P1180, DOI 10.1212/WNL.0b013e3181bbff05; Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200; Van Langenhove T, 2010, NEUROLOGY, V74, P366, DOI 10.1212/WNL.0b013e3181ccc732; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Waibel S, 2010, NEUROLOGY, V75, P815, DOI 10.1212/WNL.0b013e3181f07e26; Yan J, 2010, NEUROLOGY, V75, P807, DOI 10.1212/WNL.0b013e3181f07e0c; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761; Zhang ZC, 2012, P NATL ACAD SCI USA, V109, P12017, DOI 10.1073/pnas.1207247109; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513; Zinszner H, 1997, J CELL SCI, V110, P1741	47	85	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1192	1202		10.1074/jbc.M113.516492	http://dx.doi.org/10.1074/jbc.M113.516492			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24280224	Green Published, hybrid			2022-12-28	WOS:000330541200050
J	Cheng, W; Wang, L; Yang, BY; Zhang, R; Yao, C; He, LQ; Liu, ZX; Du, P; Hammache, K; Wen, J; Li, H; Xu, Q; Hua, ZC				Cheng, Wei; Wang, Lu; Yang, Bingya; Zhang, Rong; Yao, Chun; He, Liangqiang; Liu, Zexu; Du, Pan; Hammache, Kahina; Wen, Juan; Li, Huang; Xu, Qiang; Hua, Zichun			Self-renewal and Differentiation of Muscle Satellite Cells Are Regulated by the Fas-associated Death Domain*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Differentiation; Muscle; Notch Pathway; Stem Cells	TEMPLATE DNA STRANDS; STEM-CELLS; ASYMMETRIC DIVISION; CONTAINING PROTEIN; FADD; CYCLE; PHOSPHORYLATION; ACTIVATION; NOTCH; MECHANISMS	Background: The balance between self-renewal and differentiation in muscle stem cells is critical for tissue homeostasis. Results: Fas-associated death domain (FADD) phosphorylation mutation regulates muscle satellite cell cycle progression, inhibits muscle stem cell differentiation, and promotes muscle stem cell self-renewal. Conclusion: FADD regulates muscle stem cell fate decisions. Significance: The characterization of proteins involved in fate decisions in muscle stem cells is crucial for muscle stem cell biology. Making the decision between self-renewal and differentiation of adult stem cells is critical for tissue repair and homeostasis. Here we show that the apoptotic adaptor Fas-associated death domain (FADD) regulates the fate decisions of muscle satellite cells (SCs). FADD phosphorylation was specifically induced in cycling SCs, which was high in metaphase and declined in later anaphase. Furthermore, phosphorylated FADD at Ser-191 accumulated in the uncommitted cycling SCs and was asymmetrically localized in the self-renewing daughter SCs. SCs containing a phosphoryl-mimicking mutation at Ser-191 of FADD (FADD-D) expressed higher levels of stem-like markers and reduced commitment-associated markers. Moreover, a phosphoryl-mimicking mutation at Ser-191 of FADD suppressed SC activation and differentiation, which promoted the cycling SCs into a reversible quiescent state. Therefore, these data indicate that FADD regulates the fate determination of cycling SCs.	[Cheng, Wei; Wang, Lu; Yang, Bingya; Zhang, Rong; Yao, Chun; He, Liangqiang; Liu, Zexu; Du, Pan; Hammache, Kahina; Wen, Juan; Li, Huang; Xu, Qiang; Hua, Zichun] Nanjing Univ, Affiliated Stomatol Hosp, State Key Lab Pharmaceut Biotechnol, Coll Life Sci, Nanjing 210093, Jiangsu, Peoples R China; [Cheng, Wei; Wang, Lu; Yang, Bingya; Zhang, Rong; Yao, Chun; He, Liangqiang; Liu, Zexu; Du, Pan; Hammache, Kahina; Wen, Juan; Li, Huang; Xu, Qiang; Hua, Zichun] Nanjing Univ, Sch Stomatol, Affiliated Stomatol Hosp, Nanjing 210093, Jiangsu, Peoples R China; [Hua, Zichun] Nanjing Univ, Changzhou High Tech Res Inst, Changzhou 213164, Jiangsu, Peoples R China; [Hua, Zichun] Jiangsu TargetPharma Labs Inc, Changzhou 213164, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Hua, ZC (corresponding author), Nanjing Univ, Dept Biochem, Hankou Rd 22, Nanjing 210093, Jiangsu, Peoples R China.	zchua@nju.edu.cn		Wen, Juan/0000-0001-9832-2056	National Key Basic Research Program from Ministry of Science and Technology Grants [2012CB967004, 2014CB744501, 2011CB933502]; National Natural Science Foundation of China Grants [81121062, 30425009, 30330530, 30270291]; Jiangsu Provincial Nature Science Foundation Grants [BE2013630, BZ2012050, BK2011573]; Bureau of Science and Technology of Changzhou Grants [CM20122003, CZ20120004, CZ20130011, CE20135013, WF201207]	National Key Basic Research Program from Ministry of Science and Technology Grants; National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Nature Science Foundation Grants; Bureau of Science and Technology of Changzhou Grants	This work was supported by National Key Basic Research Program from Ministry of Science and Technology Grants 2012CB967004, 2014CB744501, and 2011CB933502; by National Natural Science Foundation of China Grants 81121062, 30425009, 30330530, and 30270291 by Jiangsu Provincial Nature Science Foundation Grants BE2013630, BZ2012050, and BK2011573; and by Bureau of Science and Technology of Changzhou Grants CM20122003, CZ20120004, CZ20130011, CE20135013, and WF201207.	Alappat EC, 2005, MOL CELL, V19, P321, DOI 10.1016/j.molcel.2005.06.024; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Cheng W, 2012, J BIOL CHEM, V287, P26126, DOI 10.1074/jbc.M112.342170; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Gemenetzidis E, 2010, CANCER RES, V70, P9515, DOI 10.1158/0008-5472.CAN-10-2173; Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Le Grand F, 2007, DEVELOPMENT, V134, P3953, DOI 10.1242/dev.005934; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; May P, 2002, J BIOL CHEM, V277, P18736, DOI 10.1074/jbc.M201979200; Mourkioti F, 2013, NAT CELL BIOL, V15, P895, DOI 10.1038/ncb2790; Osborn SL, 2007, J BIOL CHEM, V282, P22786, DOI 10.1074/jbc.M703163200; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Papoff G, 2010, BBA-MOL CELL RES, V1803, P898, DOI 10.1016/j.bbamcr.2010.04.006; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Shimada K, 2005, J PATHOL, V206, P423, DOI 10.1002/path.1791; Shimada K, 2004, CARCINOGENESIS, V25, P1089, DOI 10.1093/carcin/bgh130; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Steinhart R, 2007, GLIA, V55, P224, DOI 10.1002/glia.20454; Tajbakbsh S, 2009, ANNU REV CELL DEV BI, V25, P671, DOI 10.1146/annurev.cellbio.24.110707.175415; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; Ueno H, 2008, DEVELOPMENT, V135, P2023, DOI 10.1242/dev.019893; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yoshida N, 1998, J CELL SCI, V111, P769; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	54	6	6	1	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5040	5050		10.1074/jbc.M113.533448	http://dx.doi.org/10.1074/jbc.M113.533448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24375410	hybrid, Green Published			2022-12-28	WOS:000331607900048
J	Szabo, A; Radisky, ES; Sahin-Toth, M				Szabo, Andras; Radisky, Evette S.; Sahin-Toth, Miklos			Zymogen Activation Confers Thermodynamic Stability on a Key Peptide Bond and Protects Human Cationic Trypsin from Degradation*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium-binding Proteins; Pancreas; Protein Degradation; Proteolytic Enzymes; Serine Protease; Chymotrypsin C; Proteolytic Stability; Trypsin; Trypsinogen; Zymogen Activation	STRUCTURAL BASIS; REACTIVE-SITE; DETERMINANTS; ABSORPTION; MECHANISM; RESYNTHESIZE; HYDROLYSIS; EQUILIBRIA; INHIBITORS; DIGESTION	Background: Initial cleavage by chymotrypsin C regulates degradation of human cationic trypsin. Results: Cleavage is reversible and favors calcium-dependent bond formation in trypsin, but not in trypsinogen. Conclusion: Trypsin resistance to degradation derives from the regulated thermodynamic stability of a specific peptide bond that is responsive to physiological environment. Significance: This new paradigm explains the robustness of trypsin functioning in the protease-rich intestinal milieu. Human cationic trypsinogen, precursor of the digestive enzyme trypsin, can be rapidly degraded to protect the pancreas when pathological conditions threaten, while trypsin itself is impressively resistant to degradation. For either form, degradation is controlled by two necessary initial proteolytic events: cleavage of the Leu81-Glu82 peptide bond by chymotrypsin C (CTRC) and cleavage of the Arg122-Val123 peptide bond by trypsin. Here we demonstrate that the Leu81-Glu82 peptide bond of human cationic trypsin, but not trypsinogen, is thermodynamically stable, such that cleavage by CTRC leads to an equilibrium mixture containing 10% cleaved and 90% uncleaved trypsin. When cleaved trypsin was incubated with CTRC, the Leu81-Glu82 peptide bond was re-synthesized to establish the same equilibrium. The thermodynamic stability of the scissile peptide bond was not dependent on CTRC or Leu-81, as re-synthesis was also accomplished by other proteases acting on mutated cationic trypsin. The Leu81-Glu82 peptide bond is located within a calcium binding loop, and thermodynamic stability of the bond was strictly dependent on calcium and on the calcium-coordinated residue Glu-85. Trypsinolytic cleavage of the Arg122-Val123 site was also delayed in trypsin relative to trypsinogen in a calcium-dependent manner, but for this bond cleavage was modulated by kinetic rather than thermodynamic control. Our results reveal that the trypsinogen to trypsin conformational switch modulates cleavage susceptibility of nick sites by altering both the thermodynamics and kinetics of cleavage to protect human cationic trypsin from premature degradation.	[Szabo, Andras; Sahin-Toth, Miklos] Boston Univ, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA; [Radisky, Evette S.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Boston University; Mayo Clinic	Radisky, ES (corresponding author), 4500 San Pablo Rd,310 Griffin Bldg, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu; miklos@bu.edu	Radisky, Evette S/C-8526-2012	Radisky, Evette S/0000-0003-3121-109X; Sahin-Toth, Miklos/0000-0003-4513-9922; Szabo, Andras/0000-0001-8687-470X	National Institutes of Health [R01DK058088, R01DK082412, R01DK095753, R01CA154387]; NATIONAL CANCER INSTITUTE [R01CA154387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088, R01DK095753, R01DK082412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK058088, R01DK082412, and R01DK095753 (to M. S.-T.) and R01CA154387 (to E. S. R.).	Arolas JL, 2011, ANGEW CHEM INT EDIT, V50, P10357, DOI 10.1002/anie.201103262; BOHE M, 1986, DIGESTION, V34, P127, DOI 10.1159/000199321; BORGSTROM B, 1957, J CLIN INVEST, V36, P1521, DOI 10.1172/JCI103549; Bronner F, 2003, J CELL BIOCHEM, V88, P387, DOI 10.1002/jcb.10330; DELAAGE M, 1967, BIOCHEM BIOPH RES CO, V28, P390, DOI 10.1016/0006-291X(67)90323-3; DUFLOS C, 1995, J NUTR, V125, P2348, DOI 10.1093/jn/125.9.2348; Finkenstadt W. R., 1974, KINETICS THERMODYNAM, P389; FREEMAN HJ, 1978, ANNU REV MED, V29, P99, DOI 10.1146/annurev.me.29.020178.000531; HOMANDBERG GA, 1978, BIOCHEMISTRY-US, V17, P5220, DOI 10.1021/bi00617a023; HOMANDBERG GA, 1979, BIOCHEMISTRY-US, V18, P586, DOI 10.1021/bi00571a006; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Kiraly O, 2011, METHODS MOL BIOL, V705, P175, DOI 10.1007/978-1-61737-967-3_10; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LAYER P, 1986, AM J PHYSIOL, V251, pG475, DOI 10.1152/ajpgi.1986.251.4.G475; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; NIEKAMP CW, 1969, BIOCHEMISTRY-US, V8, P16, DOI 10.1021/bi00829a004; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 2006, ENDOCRIN METAB CLIN, V35, P303, DOI 10.1016/j.ecl.2006.02.002; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; SEALOCK RW, 1973, BIOCHEMISTRY-US, V12, P3139, DOI 10.1021/bi00741a001; Szabo A, 2012, FEBS J, V279, P4283, DOI 10.1111/febs.12018; Szabo A, 2012, J BIOL CHEM, V287, P20701, DOI 10.1074/jbc.M112.360065; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; TARLOW MJ, 1970, ARCH DIS CHILD, V45, P651, DOI 10.1136/adc.45.243.651; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106	34	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4753	4761		10.1074/jbc.M113.538884	http://dx.doi.org/10.1074/jbc.M113.538884			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403079	Green Published, hybrid			2022-12-28	WOS:000331607900022
J	Wegener, H; Paulsen, H; Seeger, K				Wegener, Henrik; Paulsen, Hauke; Seeger, Karsten			The Cysteine-rich Region of Type VII Collagen Is a Cystine Knot with a New Topology*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Cysteine-mediated Cross-linking; Extracellular Matrix; Molecular Modeling; NMR; Skin; Dystrophic Epidermolysis Bullosa	EPIDERMOLYSIS-BULLOSA-ACQUISITA; NC1 DOMAIN; CRYSTAL-STRUCTURE; TRIPLE-HELIX; GENE COL7A1; EXPRESSION; PEPTIDE; TRIMERIZATION; FIBRONECTIN; ANTIBODIES	Background: Type VII collagen is essential for skin stability as highlighted by related skin blistering diseases. Results: A fusion protein comprising the cysteine-rich region and parts of the flanking domains forms a trimer upon oxidization. Conclusion: The cysteine-rich region is an N-terminal cystine knot with novel topology. Significance: The cystine knot is also found in type IX collagen, indicating a general principle. Collagens are a group of extracellular matrix proteins with essential functions for skin integrity. Anchoring fibrils are made of type VII collagen (Col7) and link different skin layers together: the basal lamina and the underlying connective tissue. Col7 has a central collagenous domain and two noncollagenous domains located at the N and C terminus (NC1 and NC2), respectively. A cysteine-rich region of hitherto unknown function is located at the transition of the NC1 domain to the collagenous domain. A synthetic model peptide of this region was investigated by CD and NMR spectroscopy. The peptide folds into a collagen triple helix, and the cysteine residues form disulfide bridges between the different strands. The eight cystine knot topologies that are characterized by exclusively intermolecular disulfide bridges have been analyzed by molecular modeling. Two cystine knots are energetically preferred; however, all eight disulfide bridge arrangements are essentially possible. This novel cystine knot is present in type IX collagen, too. The conserved motif of the cystine knot is CX3CP. The cystine knot is N-terminal to the collagen triple helix in both collagens and therefore probably impedes unfolding of the collagen triple helix from the N terminus.	[Wegener, Henrik; Seeger, Karsten] Med Univ Lubeck, Inst Chem, D-23562 Lubeck, Germany; [Paulsen, Hauke] Med Univ Lubeck, Inst Phys, D-23562 Lubeck, Germany	University of Lubeck; University of Lubeck	Seeger, K (corresponding author), Med Univ Lubeck, Inst Chem, Ratzeburger Allee 160, D-23562 Lubeck, Germany.	karsten.seeger@chemie.uni-luebeck.de	Seeger, Karsten/D-4784-2011		Deutsche Forschungsgemeinschaft (DFG) Excellence Cluster "Inflammation at Interfaces" [DFG 306/1]	Deutsche Forschungsgemeinschaft (DFG) Excellence Cluster "Inflammation at Interfaces"(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Excellence Cluster "Inflammation at Interfaces" (DFG 306/1).	BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bella J, 2010, J STRUCT BIOL, V170, P377, DOI 10.1016/j.jsb.2010.02.003; Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200; Boudko SP, 2012, INT J BIOCHEM CELL B, V44, P21, DOI 10.1016/j.biocel.2011.09.009; Boudko SP, 2008, J BIOL CHEM, V283, P34345, DOI 10.1074/jbc.M806352200; Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054; Brinckmann J, 2010, LAB INVEST, V90, P739, DOI 10.1038/labinvest.2010.49; Brittingham R, 2006, BIOCHEM BIOPH RES CO, V343, P692, DOI 10.1016/j.bbrc.2006.03.034; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen M, 1997, J BIOL CHEM, V272, P14516, DOI 10.1074/jbc.272.23.14516; Chen M, 1999, J INVEST DERMATOL, V112, P177, DOI 10.1046/j.1523-1747.1999.00491.x; CHRISTIANO AM, 1992, HUM MOL GENET, V1, P475, DOI 10.1093/hmg/1.7.475; Colombo M, 2003, BIOCHEMISTRY-US, V42, P11434, DOI 10.1021/bi034925d; Dang NN, 2008, EXP DERMATOL, V17, P553, DOI 10.1111/j.1600-0625.2008.00723.x; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Diab M, 1996, BIOCHEM J, V314, P327, DOI 10.1042/bj3140327; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; GAMMON WR, 1988, J INVEST DERMATOL, V91, P228, DOI 10.1111/1523-1747.ep12470317; Gardella R, 2000, HUM MUTAT, V16, DOI 10.1002/1098-1004(200009)16:3<275::AID-HUMU22>3.0.CO;2-9; Gupta R, 2012, CLIN DERMATOL, V30, P60, DOI 10.1016/j.clindermatol.2011.03.011; Hansen CH, 2013, NAT METHODS, V10, P869, DOI [10.1038/NMETH.2601, 10.1038/nmeth.2601]; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Ishida Y, 2011, METHOD ENZYMOL, V499, P167, DOI 10.1016/B978-0-12-386471-0.00009-2; Iwata H, 2013, J IMMUNOL, V191, P2978, DOI 10.4049/jimmunol.1300310; KATZ BA, 1986, J BIOL CHEM, V261, P5480; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Leineweber S, 2011, FEBS LETT, V585, P1748, DOI 10.1016/j.febslet.2011.04.071; Levesque MJ, 2013, NAT METHODS, V10, P865, DOI [10.1038/NMETH.2589, 10.1038/nmeth.2589]; Ludwig RJ, 2011, J INVEST DERMATOL, V131, P167, DOI 10.1038/jid.2010.248; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; Pendaries V, 2012, J INVEST DERMATOL, V132, P1741, DOI 10.1038/jid.2012.11; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Ryoo YW, 2001, J DERMATOL SCI, V26, P125, DOI 10.1016/S0923-1811(00)00168-7; Schonig S, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-93; Sitaru C, 2005, J CLIN INVEST, V115, P870, DOI 10.1172/JCI200521386; VANDERREST M, 1985, J BIOL CHEM, V260, P220; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; Wegener H, 2013, BIOCHEM BIOPH RES CO, V430, P449, DOI 10.1016/j.bbrc.2012.11.119	42	15	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4861	4869		10.1074/jbc.M113.531327	http://dx.doi.org/10.1074/jbc.M113.531327			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24385431	Green Published, hybrid			2022-12-28	WOS:000331607900033
J	Leeb, C; Eresheim, C; Nimpf, J				Leeb, Christian; Eresheim, Christine; Nimpf, Johannes			Clusterin Is a Ligand for Apolipoprotein E Receptor 2 (ApoER2) and Very Low Density Lipoprotein Receptor (VLDLR) and Signals via the Reelin-signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apolipoproteins; Cell Proliferation; Cell Signaling; Lipoprotein Receptor; Neurogenesis; apoE Receptor 2; Clusterin; Reelin; Very Low Density Lipoprotein Receptor	POSTNATAL NEURONAL MIGRATION; CELL-DEATH; BRAIN-DEVELOPMENT; GENE FAMILY; PROTEIN; BINDING; DAB1; PHOSPHORYLATION; CHAPERONE; MOUSE	Background: Clusterin is a highly conserved glycoprotein with broad tissue distribution but enigmatic biological functions. Results: Clusterin signals via the lipoprotein receptors ApoER2 and VLDLR and stimulates cell proliferation in subventricular zone explants enabling neuronal outgrowth. Conclusion: Clusterin-mediated signaling is essential for neuronal chain formation in vitro. Significance: Discovery of a novel function of clusterin in neurogenesis. Clusterin, also known as apolipoprotein J, is a multifunctional glycoprotein with the capacity to interact with a wide range of molecules. Although clusterin has been implicated in a broad spectrum of physiological and pathological processes, such as Alzheimer disease or cancer, its precise functions remain elusive. Here we report, that clusterin binds to apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and is internalized by cells expressing either one of these receptors. Binding of clusterin to these receptors triggers a Reelin-like signal in cells expressing disabled-1 (Dab1). It induces phosphorylation of Dab1, which leads to activation of PI3K/Akt and n-cofilin. Cell proliferation and neuroblast chain formation in subventricular zone (SVZ) explants are compromised when clusterin, which is present in the subventricular zone, is blocked in vitro. These data suggest that in the subventricular zone where Reelin is not present but ApoER2, VLDLR, and Dab1, clusterin might be involved in maintaining neurogenesis in vivo.	[Leeb, Christian; Eresheim, Christine; Nimpf, Johannes] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Nimpf, J (corresponding author), Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Dr Bohr Gasse 9-2, A-1030 Vienna, Austria.	Johannes.Nimpf@meduniwien.ac.at		Nimpf, Johannes/0000-0002-9273-3492	Austrian Science Fund (FWF) [P24767-B21]; Austrian Science Fund (FWF) [P 24767] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF) Grant P24767-B21 (to J. N.).	Ammar H, 2008, J BIOL CHEM, V283, P12851, DOI 10.1074/jbc.M800403200; Andrade N, 2007, P NATL ACAD SCI USA, V104, P8508, DOI 10.1073/pnas.0611391104; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Bajari TM, 2003, FASEB J, V17, P1505, DOI 10.1096/fj.02-1106fje; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Brandes C, 2001, J BIOL CHEM, V276, P22160, DOI 10.1074/jbc.M102662200; BUJO H, 1995, P NATL ACAD SCI USA, V92, P9905, DOI 10.1073/pnas.92.21.9905; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Charnay Y, 2008, NEUROSCIENCE, V155, P714, DOI 10.1016/j.neuroscience.2008.06.022; Charnay Y, 2012, BRAIN RES BULL, V88, P434, DOI 10.1016/j.brainresbull.2012.05.006; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Curran T, 1998, BRAIN RES REV, V26, P285, DOI 10.1016/S0165-0173(97)00035-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Feng L, 2007, GENE DEV, V21, P2717, DOI 10.1101/gad.1604207; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; Gao ZH, 2013, CELL MOL LIFE SCI, V70, P2319, DOI 10.1007/s00018-012-1171-6; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Holtzman DM, 2001, NAT MED, V7, P977, DOI 10.1038/nm0901-977; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Imhof A, 2006, NEUROBIOL DIS, V22, P274, DOI 10.1016/j.nbd.2005.11.009; JACOBSEN L, 1995, J BIOL CHEM, V270, P6468, DOI 10.1074/jbc.270.12.6468; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Jossin Yves, 2011, Small GTPases, V2, P322; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Kim DH, 1997, J BIOL CHEM, V272, P8498, DOI 10.1074/jbc.272.13.8498; Klock G, 2009, ADV CANCER RES, V104, P115, DOI 10.1016/S0065-230X(09)04007-X; Koch S, 2002, EMBO J, V21, P5996, DOI 10.1093/emboj/cdf599; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; MACLACHLAN I, 1994, J BIOL CHEM, V269, P24127; Mahon MG, 1999, J BIOL CHEM, V274, P4036, DOI 10.1074/jbc.274.7.4036; Mayer H, 2006, MOL CELL BIOL, V26, P19, DOI 10.1128/MCB.26.1.19-27.2006; Miyake H, 2000, CANCER RES, V60, P170; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Nimpf J, 1998, ATHEROSCLEROSIS, V141, P191, DOI 10.1016/S0021-9150(98)00172-5; Nimpf J, 2000, BBA-MOL CELL BIOL L, V1529, P287, DOI 10.1016/S1388-1981(00)00155-4; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; Rice DS, 1998, DEVELOPMENT, V125, P3719; SCHNEIDER WJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P303, DOI 10.1016/0304-4157(89)90023-3; SENSIBAR JA, 1995, CANCER RES, V55, P2431; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; Trougakos IP, 2009, CANCER RES, V69, P403, DOI 10.1158/0008-5472.CAN-08-2912; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Willnow TE, 1998, BIOL CHEM, V379, P1025; Wilson MR, 2000, TRENDS BIOCHEM SCI, V25, P95, DOI 10.1016/S0968-0004(99)01534-0; Yang CR, 2000, P NATL ACAD SCI USA, V97, P5907, DOI 10.1073/pnas.97.11.5907; Yasui N, 2011, J BIOL CHEM, V286, P35247, DOI 10.1074/jbc.M111.242719	54	61	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4161	4172		10.1074/jbc.M113.529271	http://dx.doi.org/10.1074/jbc.M113.529271			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24381170	Green Published, hybrid			2022-12-28	WOS:000331403800029
J	Matsuda, I; Matsuo, K; Matsushita, Y; Haruna, Y; Niwa, M; Kataoka, T				Matsuda, Iyo; Matsuo, Kentaro; Matsushita, Yuka; Haruna, Yasushi; Niwa, Masamitsu; Kataoka, Takao			The C-terminal Domain of the Long Form of Cellular FLICE-inhibitory Protein (c-FLIPL) Inhibits the Interaction of the Caspase 8 Prodomain with the Receptor-interacting Protein 1 (RIP1) Death Domain and Regulates Caspase 8-dependent Nuclear Factor kappa B (NF-kappa B) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caspase; Death Domain; Fas; NF-B; RIP	SIGNALING COMPLEX; LYMPHOCYTE-PROLIFERATION; INTERLEUKIN-8 PRODUCTION; CFLIP ISOFORMS; IMMUNE-SYSTEM; APOPTOSIS; NECROSIS; LIFE; FAS; SURVIVAL	Caspase 8 plays an essential role in the regulation of apoptotic and non-apoptotic signaling pathways. The long form of cellular FLICE-inhibitory protein (c-FLIPL) has been shown previously to regulate caspase 8-dependent nuclear factor B (NF-B) activation by receptor-interacting protein 1 (RIP1) and TNF receptor-associated factor 2 (TRAF2). In this study, the molecular mechanism by which c-FLIPL regulates caspase 8-dependent NF-B activation was further explored in the human embryonic kidney cell line HEK 293 and variant cells barely expressing caspase 8. The caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone greatly diminished caspase 8-dependent NF-B activation induced by Fas ligand (FasL) when c-FLIPL, but not its N-terminal fragment c-FLIP(p43), was expressed. The prodomain of caspase 8 was found to interact with the RIP1 death domain and to be sufficient to mediate NF-B activation induced by FasL or c-FLIP(p43). The interaction of the RIP1 death domain with caspase 8 was inhibited by c-FLIPL but not c-FLIP(p43). Thus, these results reveal that the C-terminal domain of c-FLIPL specifically inhibits the interaction of the caspase 8 prodomain with the RIP1 death domain and, thereby, regulates caspase 8-dependent NF-B activation.	[Matsuda, Iyo; Matsuo, Kentaro; Matsushita, Yuka; Kataoka, Takao] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Haruna, Yasushi; Niwa, Masamitsu; Kataoka, Takao] Tokyo Inst Technol, Ctr Biol Resources & Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Kyoto Institute of Technology; Tokyo Institute of Technology	Kataoka, T (corresponding author), Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan.	takao.kataoka@kit.ac.jp			Japan Society for the Promotion of Science (JSPS) [19380057, 22380060, 25292061]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid for Scientific Research (KAKENHI) Grant numbers 19380057, 22380060, and 25292061 (to T. K.) from the Japan Society for the Promotion of Science (JSPS).	Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Dohrman A, 2005, J IMMUNOL, V174, P5270, DOI 10.4049/jimmunol.174.9.5270; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Fricker N, 2010, J CELL BIOL, V190, P377, DOI 10.1083/jcb.201002060; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Imamura R, 2004, J BIOL CHEM, V279, P46415, DOI 10.1074/jbc.M403226200; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kavuri SM, 2011, J BIOL CHEM, V286, P16631, DOI 10.1074/jbc.M110.148585; Kawadler H, 2008, MOL CELL, V31, P415, DOI 10.1016/j.molcel.2008.06.008; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Oberst A, 2011, NAT REV MOL CELL BIO, V12, P757, DOI 10.1038/nrm3214; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ozturk S, 2012, EXP CELL RES, V318, P1324, DOI 10.1016/j.yexcr.2012.01.019; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Shikama Y, 2003, EUR J IMMUNOL, V33, P1998, DOI 10.1002/eji.200324013; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Weinlich R, 2011, TRENDS CELL BIOL, V21, P630, DOI 10.1016/j.tcb.2011.09.002; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Yu JW, 2009, P NATL ACAD SCI USA, V106, P8169, DOI 10.1073/pnas.0812453106; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	54	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3876	3887		10.1074/jbc.M113.506485	http://dx.doi.org/10.1074/jbc.M113.506485			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24398693	hybrid, Green Published			2022-12-28	WOS:000331403800005
J	Weinreb, V; Li, L; Chandrasekaran, SN; Koehl, P; Delarue, M; Carter, CW				Weinreb, Violetta; Li, Li; Chandrasekaran, Srinivas Niranj; Koehl, Patrice; Delarue, Marc; Carter, Charles W., Jr.			Enhanced Amino Acid Selection in Fully Evolved Tryptophanyl-tRNA Synthetase, Relative to Its Urzyme, Requires Domain Motion Sensed by the D1 Switch, a Remote Dynamic Packing Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminoacyl tRNA Synthesis; Cooperativity; Enzyme Mechanisms; Mutagenesis Site Specific; Thermodynamics; Conformational Change; Minimum Action Path; Transition State; Allostery; Pocket Volume	GENETIC-CODE; CLASS-I; MG2+-ASSISTED CATALYSIS; ESCHERICHIA-COLI; BINDING; SPECIFICITY; TRPRS; RECOGNITION; ACTIVATION; GLUTAMINE	Background: Amino acid selection by tryptophanyl-tRNA synthetase (TrpRS) requires intermodular coupling. Results: Dynamic repacking of four side chains increases amino acid specificity 500-fold in contemporary TrpRS by reducing pocket size near the transition state. Conclusion: An ancient tertiary packing motif not only activates the catalytic Mg2+ ion during catalysis, but also determines cognate amino acid specificity. Significance: Allosteric enforcement of specificity increases robustness to mutation. We previously showed (Li, L., and Carter, C. W., Jr. (2013) J. Biol. Chem. 288, 34736-34745) that increased specificity for tryptophan versus tyrosine by contemporary Bacillus stearothermophilus tryptophanyl-tRNA synthetase (TrpRS) over that of TrpRS Urzyme results entirely from coupling between the anticodon-binding domain and an insertion into the Rossmann-fold known as Connecting Peptide 1. We show that this effect is closely related to a long range catalytic effect, in which side chain repacking in a region called the D1 Switch, accounts fully for the entire catalytic contribution of the catalytic Mg2+ ion. We report intrinsic and higher order interaction effects on the specificity ratio, (k(cat)/K-m)(Trp)/(k(cat)/K-m)(Tyr), of 15 combinatorial mutants from a previous study (Weinreb, V., Li, L., and Carter, C. W., Jr. (2012) Structure 20, 128-138) of the catalytic role of the D1 Switch. Unexpectedly, the same four-way interaction both activates catalytic assist by Mg2+ ion and contributes -4.4 kcal/mol to the free energy of the specificity ratio. A minimum action path computed for the induced-fit and catalytic conformation changes shows that repacking of the four residues precedes a decrease in the volume of the tryptophan-binding pocket. We suggest that previous efforts to alter amino acid specificities of TrpRS and glutaminyl-tRNA synthetase (GlnRS) by mutagenesis without extensive, modular substitution failed because mutations were incompatible with interdomain motions required for catalysis.	[Weinreb, Violetta; Li, Li; Chandrasekaran, Srinivas Niranj; Carter, Charles W., Jr.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Koehl, Patrice] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Delarue, Marc] Inst Pasteur, CNRS, Unite Mixte Rech 3528, F-75015 Paris, France	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Carter, CW (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	carter@med.unc.edu	Chandrasekaran, Srinivas Niranj/J-8262-2019	Chandrasekaran, Srinivas Niranj/0000-0001-8874-9988	National Institutes of Health from the NIGMS [40906]	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 40906 from the NIGMS.	Bullock TL, 2008, P NATL ACAD SCI USA, V105, P7428, DOI 10.1073/pnas.0711812105; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; Cammer S, 2010, BIOINFORMATICS, V26, P709, DOI 10.1093/bioinformatics/btq039; CARTER C W JR, 1990, Methods (Orlando), V1, P12, DOI 10.1016/S1046-2023(05)80142-2; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Corigliano EM, 2009, BIOCHEMISTRY-US, V48, P676, DOI 10.1021/bi801552y; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; EBEL JP, 1973, BIOCHIMIE, V55, P547, DOI 10.1016/S0300-9084(73)80415-8; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Franklin J, 2007, NUCLEIC ACIDS RES, V35, pW477, DOI 10.1093/nar/gkm342; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; IBBA M, 1994, BIOCHEMISTRY-US, V33, P7107, DOI 10.1021/bi00189a013; Kapustina M, 2007, STRUCTURE, V15, P1272, DOI 10.1016/j.str.2007.08.010; LAM SSM, 1975, BIOCHEMISTRY-US, V14, P2775, DOI 10.1021/bi00683a034; Laowanapiban P, 2009, P NATL ACAD SCI USA, V106, P1790, DOI 10.1073/pnas.0812752106; Li L, 2013, J BIOL CHEM, V288, P34736, DOI 10.1074/jbc.M113.510958; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Pham Y, 2007, MOL CELL, V25, P851, DOI 10.1016/j.molcel.2007.02.010; Pham Y, 2010, J BIOL CHEM, V285, P38590, DOI 10.1074/jbc.M110.136911; Praetorius-Ibba M, 2000, BIOCHEMISTRY-US, V39, P13136; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; ROGERS MJ, 1992, P NATL ACAD SCI USA, V89, P3463, DOI 10.1073/pnas.89.8.3463; ROGERS MJ, 1993, BIOCHIMIE, V75, P1083, DOI 10.1016/0300-9084(93)90007-F; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109; Weinreb V, 2008, J AM CHEM SOC, V130, P1488, DOI 10.1021/ja076557x; Weinreb V, 2012, STRUCTURE, V20, P128, DOI 10.1016/j.str.2011.10.020; Weinreb V, 2009, STRUCTURE, V17, P952, DOI 10.1016/j.str.2009.05.007	33	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4367	4376		10.1074/jbc.M113.538660	http://dx.doi.org/10.1074/jbc.M113.538660			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24394410	Green Published, hybrid			2022-12-28	WOS:000331403800047
J	Ran, Y; Cruz, PE; Ladd, TB; Fauq, AH; Jung, JI; Matthews, J; Felsenstein, KM; Golde, TE				Ran, Yong; Cruz, Pedro E.; Ladd, Thomas B.; Fauq, Abdul H.; Jung, Joo In; Matthews, Julian; Felsenstein, Kevin M.; Golde, Todd E.			gamma-Secretase Processing and Effects of gamma-Secretase Inhibitors and Modulators on Long A beta Peptides in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Amyloid Precursor Protein; Intramembrane Proteolysis; Protease	AMYLOID PRECURSOR PROTEIN; CARBOXYL-TERMINAL FRAGMENTS; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; INTRAMEMBRANE CLEAVAGE; ISOFORM PATTERN; SENILE PLAQUES; PRESENILIN; APP; DEPOSITION	Background: A peptides are generated by stepwise cleavage of the amyloid precursor protein. Results: As longer than A1-48 are efficiently cleaved by -secretase in cells with different response to inhibitors (GSIs) and modulators (GSMs). Conclusion: The initial -secretase cleavage does not precisely define subsequent product lines. Significance: Understanding how different species of A are generated and modulated by small molecules has broad therapeutic implications. Understanding how different species of A are generated by -secretase cleavage has broad therapeutic implications, because shifts in -secretase processing that increase the relative production of Ax-42/43 can initiate a pathological cascade, resulting in Alzheimer disease. We have explored the sequential stepwise -secretase cleavage model in cells. Eighteen BRI2-A fusion protein expression constructs designed to generate peptides from A1-38 to A1-55 and C99 (CTF) were transfected into cells, and A production was assessed. Secreted and cell-associated A were detected using ELISA and immunoprecipitation MALDI-TOF mass spectrometry. A peptides from 1-38 to 1-55 were readily detected in the cells and as soluble full-length A proteins in the media. A peptides longer than A1-48 were efficiently cleaved by -secretase and produced varying ratios of A1-40:A1-42. -Secretase cleavage of A1-51 resulted in much higher levels of A1-42 than any other long A peptides, but the processing of A1-51 was heterogeneous with significant amounts of shorter As, including A1-40, produced. Two PSEN1 variants altered A1-42 production from A1-51 but not A1-49. Unexpectedly, long A peptide substrates such as A1-49 showed reduced sensitivity to inhibition by -secretase inhibitors. In contrast, long A substrates showed little differential sensitivity to multiple -secretase modulators. Although these studies further support the sequential -secretase cleavage model, they confirm that in cells the initial -secretase cleavage does not precisely define subsequent product lines. These studies also raise interesting issues about the solubility and detection of long A, as well as the use of truncated substrates for assessing relative potency of -secretase inhibitors.	[Ran, Yong; Cruz, Pedro E.; Ladd, Thomas B.; Jung, Joo In; Matthews, Julian; Felsenstein, Kevin M.; Golde, Todd E.] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Dept Neurosci, Gainesville, FL 32610 USA; [Ran, Yong; Cruz, Pedro E.; Ladd, Thomas B.; Jung, Joo In; Matthews, Julian; Felsenstein, Kevin M.; Golde, Todd E.] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL 32610 USA; [Fauq, Abdul H.] Univ N Florida, Dept Chem & Phys, Jacksonville, FL 32224 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of North Florida	Ran, Y (corresponding author), 1275 Ctr Dr,BMS J-497, Gainesville, FL 32610 USA.	yran@ufl.edu; tgolde@ufl.edu			National Institutes of Health [P01 AG 020206, P01 AG025531]; NATIONAL CANCER INSTITUTE [P01CA166009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020206, P01AG025531] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AG 020206 and P01 AG025531 (to T. G.).	Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Best JD, 2007, J PHARMACOL EXP THER, V320, P552, DOI 10.1124/jpet.106.114330; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Crump CJ, 2012, BIOCHEMISTRY-US, V51, P7209, DOI 10.1021/bi301137h; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Esh C, 2005, BIOCHEMISTRY-US, V44, P13807, DOI 10.1021/bi051213+; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Fauq AH, 2007, BIOORG MED CHEM LETT, V17, P6392, DOI 10.1016/j.bmcl.2007.07.062; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Fukumori A, 2006, BIOCHEMISTRY-US, V45, P4907, DOI 10.1021/bi052412w; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Golde TE, 2013, BBA-BIOMEMBRANES, V1828, P2898, DOI 10.1016/j.bbamem.2013.06.005; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Holmes O, 2012, BIOCHEMISTRY-US, V51, P3565, DOI 10.1021/bi300303g; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jung JI, 2013, FASEB J, V27, P3775, DOI 10.1096/fj.12-225649; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Kukar TL, 2011, J BIOL CHEM, V286, P39804, DOI 10.1074/jbc.M111.274696; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; Lewis PA, 2001, BBA-MOL BASIS DIS, V1537, P58, DOI 10.1016/S0925-4439(01)00054-0; Maddalena AS, 2004, NEURODEGENER DIS, V1, P231, DOI 10.1159/000080991; Mayer SC, 2008, J MED CHEM, V51, P7348, DOI 10.1021/jm801252w; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Moore BD, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt121; Murphy MP, 2002, BBA-MOL BASIS DIS, V1586, P199, DOI 10.1016/S0925-4439(01)00098-9; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Pinnix I, 2013, AM J GERIAT PSYCHIAT, V21, P474, DOI 10.1016/j.jagp.2013.02.009; Portelius E, 2010, J ALZHEIMERS DIS, V21, P1005, DOI 10.3233/JAD-2010-100573; Portelius E, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt30; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; Raymond C, 2011, METHODS, V55, P44, DOI 10.1016/j.ymeth.2011.04.002; Sagi SA, 2011, J BIOL CHEM, V286, P39794, DOI 10.1074/jbc.M111.277228; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takami M., 2012, INT J ALZHEIMERS DIS, V2012; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200; Zou K, 2013, AM J PATHOL, V182, P2322, DOI 10.1016/j.ajpath.2013.01.053	60	19	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3276	3287		10.1074/jbc.M113.512921	http://dx.doi.org/10.1074/jbc.M113.512921			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24352661	hybrid, Green Published			2022-12-28	WOS:000331368700015
J	Ye, CQ; Lou, WJ; Li, YR; Chatzispyrou, IA; Huttemann, M; Lee, I; Houtkooper, RH; Vaz, FM; Chen, SL; Greenberg, ML				Ye, Cunqi; Lou, Wenjia; Li, Yiran; Chatzispyrou, Iliana A.; Huettemann, Maik; Lee, Icksoo; Houtkooper, Riekelt H.; Vaz, Frederic M.; Chen, Shuliang; Greenberg, Miriam L.			Deletion of the Cardiolipin-specific Phospholipase Cld1 Rescues Growth and Life Span Defects in the Tafazzin Mutant IMPLICATIONS FOR BARTH SYNDROME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiolipin; Mitochondria; Phospholipase; Phospholipid; Respiration; Barth Syndrome; Tafazzin	CYTOCHROME-C-OXIDASE; SUPPRESSES TEMPERATURE SENSITIVITY; LINKED CARDIOSKELETAL MYOPATHY; ADP/ATP CARRIER PROTEIN; RESPIRATORY-CHAIN; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL-DNA; MASS-SPECTROMETRY; BC(1) COMPLEX; UP-REGULATION	Background: Cardiolipin (CL) is deacylated by Cld1 to monolysocardiolipin, which is transacylated by tafazzin (Taz1) to form unsaturated CL. Results: Deletion of CLD1 rescues growth and respiration defects in taz1, whereas overexpression is deleterious to growth and respiration. Conclusion: Decreased CL/MLCL, not decreased unsaturated CL, causes defects in tafazzin-deficient cells. Significance: Attenuation of CL phospholipases may potentially treat Barth syndrome. Cardiolipin (CL) that is synthesized de novo is deacylated to monolysocardiolipin (MLCL), which is reacylated by tafazzin. Remodeled CL contains mostly unsaturated fatty acids. In eukaryotes, loss of tafazzin leads to growth and respiration defects, and in humans, this results in the life-threatening disorder Barth syndrome. Tafazzin deficiency causes a decrease in the CL/MLCL ratio and decreased unsaturated CL species. Which of these biochemical outcomes contributes to the physiological defects is not known. Yeast cells have a single CL-specific phospholipase, Cld1, that can be exploited to distinguish between these outcomes. The cld1 mutant has decreased unsaturated CL, but the CL/MLCL ratio is similar to that of wild type cells. We show that cld1 rescues growth, life span, and respiratory defects of the taz1 mutant. This suggests that defective growth and respiration in tafazzin-deficient cells are caused by the decreased CL/MLCL ratio and not by a deficiency in unsaturated CL. CLD1 expression is increased during respiratory growth and regulated by the heme activator protein transcriptional activation complex. Overexpression of CLD1 leads to decreased mitochondrial respiration and growth and instability of mitochondrial DNA. However, ATP concentrations are maintained by increasing glycolysis. We conclude that transcriptional regulation of Cld1-mediated deacylation of CL influences energy metabolism by modulating the relative contribution of glycolysis and respiration.	[Chen, Shuliang; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Huettemann, Maik] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Huettemann, Maik] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48201 USA; [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si 330714, Chungcheongnam, South Korea; [Chatzispyrou, Iliana A.; Houtkooper, Riekelt H.; Vaz, Frederic M.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	Wayne State University; Wayne State University; Wayne State University; Dankook University; University of Amsterdam; Academic Medical Center Amsterdam	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	mlgreen@sun.science.wayne.edu	lou, wenjia/I-7612-2019; Chen, Shuliang/N-9498-2013; Houtkooper, Riekelt/P-5001-2019	lou, wenjia/0000-0003-3772-4830; Chen, Shuliang/0000-0002-7175-7604; Vaz, Frederic/0000-0002-9048-1041; Houtkooper, Riekelt/0000-0001-9961-0842; Huttemann, Maik/0000-0001-6310-7081	Barth Syndrome Foundation; Barth Syndrome Foundation of Canada; Association Barth France; Wayne State University Thomas C. Rumble University Fellowship; Wayne State University Summer Dissertation Fellowship; Wayne State University; Academisch Medisch Centrum Ph.D. fellowship; ZonMw/Veni [91613050]; AMC	Barth Syndrome Foundation; Barth Syndrome Foundation of Canada; Association Barth France; Wayne State University Thomas C. Rumble University Fellowship; Wayne State University Summer Dissertation Fellowship; Wayne State University; Academisch Medisch Centrum Ph.D. fellowship; ZonMw/Veni; AMC	This work was supported by grants from the Barth Syndrome Foundation, Barth Syndrome Foundation of Canada, and Association Barth France (to M. L. G.), Wayne State University Thomas C. Rumble University Fellowship and Summer Dissertation Fellowship (to C. Y.), Wayne State University graduate enhancement research funds (to C. Y., W. L., and Y. L.), Academisch Medisch Centrum Ph.D. fellowship (to I. A. C.), and ZonMw/Veni Grant 91613050 and AMC postdoctoral fellowship (to R. H. H.).	Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; Baile MG, 2013, MOL BIOL CELL, V24, P2008, DOI 10.1091/mbc.E13-03-0121; Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Bu Y, 1998, NUCLEIC ACIDS RES, V26, P1002, DOI 10.1093/nar/26.4.1002; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Chen SL, 2010, J BIOL CHEM, V285, P10397, DOI 10.1074/jbc.M110.100784; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fontanesi F, 2008, HUM MOL GENET, V17, P775, DOI 10.1093/hmg/ddm349; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P507, DOI 10.1016/0005-2760(72)90065-3; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Hsu Y. H., 2013, PLOS ONE, V8; Hu Jia, 2013, Methods Mol Biol, V965, P463, DOI 10.1007/978-1-62703-239-1_30; Huttemann M, 2012, ADV EXP MED BIOL, V748, P237, DOI 10.1007/978-1-4614-3573-0_10; JAKOVCIC S, 1971, J CELL BIOL, V48, P490, DOI 10.1083/jcb.48.3.490; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; KELLY BL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P144, DOI 10.1016/0005-2760(90)90181-V; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Kwast KE, 1999, P NATL ACAD SCI USA, V96, P5446, DOI 10.1073/pnas.96.10.5446; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; LECOCQ J, 1964, BIOCHEMISTRY-US, V3, P976, DOI 10.1021/bi00895a023; Lee I, 2010, BBA-MOL BASIS DIS, V1802, P275, DOI 10.1016/j.bbadis.2009.10.005; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Ocampo A, 2012, CELL METAB, V16, P55, DOI 10.1016/j.cmet.2012.05.013; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200; PANGBORN MC, 1947, J BIOL CHEM, V168, P351; Paradies G, 2001, MITOCHONDRION, V1, P151, DOI 10.1016/S1567-7249(01)00011-3; Paradies G, 1998, FEBS LETT, V424, P155, DOI 10.1016/S0014-5793(98)00161-6; Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6; Petrosillo G, 2007, BBA-BIOENERGETICS, V1767, P1260, DOI 10.1016/j.bbabio.2007.07.011; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Su XF, 2006, MOL CELL BIOL, V26, P743, DOI 10.1128/MCB.26.3.743-753.2006; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; TAMAI KT, 1990, BIOCHIM BIOPHYS ACTA, V1046, P214, DOI 10.1016/0005-2760(90)90192-Z; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Valianpour F, 2003, J LIPID RES, V44, P560, DOI 10.1194/jlr.M200217-JLR200; Valianpour F, 2002, CLIN CHEM, V48, P1390; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wu JP, 1998, YEAST, V14, P985, DOI 10.1002/(SICI)1097-0061(199808)14:11<985::AID-YEA294>3.3.CO;2-3; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808; Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200; Zhou JM, 2009, J BIOL CHEM, V284, P18106, DOI 10.1074/jbc.M109.003236	87	41	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3114	3125		10.1074/jbc.M113.529487	http://dx.doi.org/10.1074/jbc.M113.529487			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24318983	Green Published, hybrid			2022-12-28	WOS:000331368700002
J	Premkumar, L; Kurth, F; Neyer, S; Schembri, MA; Martin, JL				Premkumar, Lakshmanane; Kurth, Fabian; Neyer, Simon; Schembri, Mark A.; Martin, Jennifer L.			The Multidrug Resistance IncA/C Transferable Plasmid Encodes a Novel Domain-swapped Dimeric Protein-disulfide Isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotic Resistance; Bacterial Conjugation; Crystal Structure; Disulfide; Enzyme Structure; DsbC; DsbG; Disulfide Isomerase; Domain Swapping; Horizontal Gene Transfer; Multidrug Resistance	ENTERICA SEROVAR TYPHIMURIUM; ACTIVE-SITE; IN-VIVO; CRYSTAL-STRUCTURE; BOND ISOMERASE; FUNCTIONAL-CHARACTERIZATION; DSBC; DIMERIZATION; MECHANISMS; EVOLUTION	Background: Bacterial IncA/C plasmids distribute antibiotic resistance genes and encode a conserved thioredoxin-fold protein (DsbP). Results: DsbP shuffles incorrect disulfide bonds in misfolded proteins, and its structure diverges from previously characterized disulfide isomerases. Conclusion: Plasmid-encoded DsbP is a novel domain-swapped protein-disulfide isomerase. Significance: IncA/C plasmids may encode this protein proofreading machinery to ensure horizontal gene transfer of antibiotic resistance genes. The multidrug resistance-encoding IncA/C conjugative plasmids disseminate antibiotic resistance genes among clinically relevant enteric bacteria. A plasmid-encoded disulfide isomerase is associated with conjugation. Sequence analysis of several IncA/C plasmids and IncA/C-related integrative and conjugative elements (ICE) from commensal and pathogenic bacteria identified a conserved DsbC/DsbG homolog (DsbP). The crystal structure of DsbP reveals an N-terminal domain, a linker region, and a C-terminal catalytic domain. A DsbP homodimer is formed through domain swapping of two DsbP N-terminal domains. The catalytic domain incorporates a thioredoxin-fold with characteristic CXXC and cis-Pro motifs. Overall, the structure and redox properties of DsbP diverge from the Escherichia coli DsbC and DsbG disulfide isomerases. Specifically, the V-shaped dimer of DsbP is inverted compared with EcDsbC and EcDsbG. In addition, the redox potential of DsbP (-161 mV) is more reducing than EcDsbC (-130 mV) and EcDsbG (-126 mV). Other catalytic properties of DsbP more closely resemble those of EcDsbG than EcDsbC. These catalytic differences are in part a consequence of the unusual active site motif of DsbP (CAVC); substitution to the EcDsbC-like (CGYC) motif converts the catalytic properties to those of EcDsbC. Structural comparison of the 12 independent subunit structures of DsbP that we determined revealed that conformational changes in the linker region contribute to mobility of the catalytic domain, providing mechanistic insight into DsbP function. In summary, our data reveal that the conserved plasmid-encoded DsbP protein is a bona fide disulfide isomerase and suggest that a dedicated oxidative folding enzyme is important for conjugative plasmid transfer.	[Premkumar, Lakshmanane; Kurth, Fabian; Neyer, Simon; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4067, Australia; [Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4067, Australia	University of Queensland; University of Queensland	Martin, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4067, Australia.	j.martin@imb.uq.edu.au	Schembri, Mark A/C-7262-2009; Martin, Jennifer L./A-6039-2010	Schembri, Mark A/0000-0003-4863-9260; Martin, Jennifer L./0000-0002-9225-8863	Australian Research Council (ARC) [FL0992138]; Australian Research Council [FT100100662]	Australian Research Council (ARC)(Australian Research Council); Australian Research Council(Australian Research Council)	This work was supported in part by Australian Research Council (ARC) Australian Laureate Fellowship FL0992138 (to J. L. M.).; Supported by Australian Research Council Future Fellow Grant FT100100662.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AOKI T, 1971, J GEN MICROBIOL, V65, P343, DOI 10.1099/00221287-65-3-343; Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x; Arredondo SA, 2009, J BIOL CHEM, V284, P23972, DOI 10.1074/jbc.M109.010199; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Bessette PH, 2001, J BACTERIOL, V183, P980, DOI 10.1128/JB.183.3.980-988.2001; Bouwman CW, 2003, J BACTERIOL, V185, P991, DOI 10.1128/JB.185.3.991-1000.2003; Carattoli A, 2012, ANTIMICROB AGENTS CH, V56, P783, DOI 10.1128/AAC.05116-11; Carlet J, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-11; Charbonnier JB, 1999, PROTEIN SCI, V8, P96; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dai SD, 1996, J MOL BIOL, V264, P1044, DOI 10.1006/jmbi.1996.0695; del Castillo CS, 2013, ANTIMICROB AGENTS CH, V57, P120, DOI 10.1128/AAC.01239-12; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Drieux L, 2013, J ANTIMICROB CHEMOTH, V68, P97, DOI 10.1093/jac/dks367; Elton TC, 2005, J BACTERIOL, V187, P8267, DOI 10.1128/JB.187.24.8267-8277.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Alarcon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023415; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Garriss G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000775; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; Hemmis CW, 2013, PLASMID, V70, P168, DOI 10.1016/j.plasmid.2013.05.004; Hemmis CW, 2011, J BACTERIOL, V193, P4588, DOI 10.1128/JB.00351-11; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2010, J BIOL CHEM, V285, P18423, DOI 10.1074/jbc.M110.101360; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Inaba K, 2009, J BIOCHEM, V146, P591, DOI 10.1093/jb/mvp102; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jiao L, 2013, J STRUCT BIOL, V183, P1, DOI 10.1016/j.jsb.2013.05.013; Johnson AP, 2013, J MED MICROBIOL, V62, P499, DOI 10.1099/jmm.0.052555-0; Johnson Timothy J, 2012, Mob Genet Elements, V2, P55; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kardas P, 2005, INT J ANTIMICROB AG, V26, P106, DOI 10.1016/j.ijantimicag.2005.04.017; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Levin BR, 2000, P NATL ACAD SCI USA, V97, P6981, DOI 10.1073/pnas.97.13.6981; Lewin A, 2008, BIOCHEM J, V414, P81, DOI 10.1042/BJ20080356; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mossner E, 1998, PROTEIN SCI, V7, P1233; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Sekizuka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025334; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Sykes R, 2010, J ANTIMICROB CHEMOTH, V65, P1842, DOI 10.1093/jac/dkq217; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vivian JP, 2009, J MOL BIOL, V394, P931, DOI 10.1016/j.jmb.2009.09.065; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Won SY, 2011, CLIN INFECT DIS, V53, P532, DOI 10.1093/cid/cir482; WOZNIAK R, 2009, PLOS GENET, V5; WU JH, 1987, PLASMID, V18, P54, DOI 10.1016/0147-619X(87)90078-3; WUNDERLICH M, 1993, J BIOL CHEM, V268, P24547; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yeh SM, 2007, ACTA CRYSTALLOGR D, V63, P465, DOI 10.1107/S0907444907003320; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207; Zhang M, 2004, ACTA CRYSTALLOGR D, V60, P1512, DOI 10.1107/S0907444904014S93; Zhao Z, 2003, J BIOL CHEM, V278, P43292, DOI 10.1074/jbc.M306945200	79	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2563	2576		10.1074/jbc.M113.516898	http://dx.doi.org/10.1074/jbc.M113.516898			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24311786	Green Published, hybrid			2022-12-28	WOS:000333403000008
J	Santos, E; Lazaro, JM; Perez-Arnaiz, P; Salas, M; de Vega, M				Santos, Eugenia; Lazaro, Jose M.; Perez-Arnaiz, Patricia; Salas, Margarita; de Vega, Miguel			Role of the LEXE Motif of Protein-primed DNA Polymerases in the Interaction with the Incoming Nucleotide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; DNA Polymerase; DNA Replication; Nucleic Acid Synthesis; Viral Polymerase	CRYSTAL-STRUCTURE; REPLICATION FIDELITY; EXONUCLEASE ACTIVITY; STRAND DISPLACEMENT; TERNARY COMPLEXES; TERMINAL PROTEIN; STRUCTURAL BASIS; RNA-POLYMERASES; T7 DNA; MECHANISM	Background: LEXE motif is conserved among the eukaryotic DNA polymerases. Results: Substitutions at LEXE residues decrease the replication and pyrophosphorolytic activities of 29 DNA polymerase and compromise nucleotide insertion fidelity. Conclusion: The results suggest a role for LEXE residues in making interactions with the incoming nucleotide. Significance: Results support the proposal of a third metal ion as a general feature of the two-metal ion mechanism. The LEXE motif, conserved in eukaryotic type DNA polymerases, is placed close to the polymerization active site. Previous studies suggested that the second Glu was involved in binding a third noncatalytic ion in bacteriophage RB69 DNA polymerase. In the protein-primed DNA polymerase subgroup, the LEXE motif lacks the first Glu in most cases, but it has a conserved Phe/Trp and a Gly preceding that position. To ascertain the role of those residues, we have analyzed the behavior of mutants at the corresponding phi 29 DNA polymerase residues Gly-481, Trp-483, Ala-484, and Glu-486. We show that mutations at Gly-481 and Trp-483 hamper insertion of the incoming dNTP in the presence of Mg2+ ions, a reaction highly improved when Mn2+ was used as metal activator. These results, together with previous crystallographic resolution of phi 29 DNA polymerase ternary complex, allow us to infer that Gly-481 and Trp-483 could form a pocket that orients Val-250 to interact with the dNTP. Mutants at Glu-486 are also defective in polymerization and, as mutants at Gly-481 and Trp-483, in the pyrophosphorolytic activity with Mg2+. Recovery of both reactions with Mn2+ supports a role for Glu-486 in the interaction with the pyrophosphate moiety of the dNTP.	[Santos, Eugenia; Lazaro, Jose M.; Perez-Arnaiz, Patricia; Salas, Margarita; de Vega, Miguel] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Inst Biol Mol Eladio Vinuela, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Salas, M (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Inst Biol Mol Eladio Vinuela, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	msalas@cbm.uam.es	Salas, Margarita/J-9873-2014; de Vega, Miguel/K-2878-2014; Arnaiz, Patricia Perez/AAH-3763-2019	Salas, Margarita/0000-0001-5939-3441; de Vega, Miguel/0000-0003-1285-7549; Arnaiz, Patricia Perez/0000-0001-9089-6223	Spanish Ministry of Economy and Competitiveness [BFU2011-23645]; Spanish Ministry of Science and Innovation [Consolider-Ingenio CSD2007-00015]; Autonomous Community of Madrid [S2009MAT-1507]; Fundacion Ramon Areces	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Autonomous Community of Madrid; Fundacion Ramon Areces	This work was supported by Spanish Ministry of Economy and Competitiveness Grant BFU2011-23645 (to M. S.), Spanish Ministry of Science and Innovation Grant Consolider-Ingenio CSD2007-00015 (to M. S.), Autonomous Community of Madrid Grant S2009MAT-1507 (to M. S.), and by an institutional grant from Fundacion Ramon Areces to the Centro de Biologia Molecular "Severo Ochoa."	ARNOLD E, 1995, CURR OPIN STRUC BIOL, V5, P27, DOI 10.1016/0959-440X(95)80006-M; Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BLANCO L, 1985, NUCLEIC ACIDS RES, V13, P1239, DOI 10.1093/nar/13.4.1239; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Blanco L, 1996, J BIOL CHEM, V271, P8509, DOI 10.1074/jbc.271.15.8509; BLASCO MA, 1991, J BIOL CHEM, V266, P7904; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Creighton S, 1995, METHOD ENZYMOL, V262, P232; de Vega M, 1998, J BIOL CHEM, V273, P28966, DOI 10.1074/jbc.273.44.28966; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; GARMENDIA C, 1992, J BIOL CHEM, V267, P2594; Hopfner KP, 1999, P NATL ACAD SCI USA, V96, P3600, DOI 10.1073/pnas.96.7.3600; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Jager Joachim, 1999, Current Opinion in Structural Biology, V9, P21, DOI 10.1016/S0959-440X(99)80004-9; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Lazaro JM, 1995, METHOD ENZYMOL, V262, P42; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Longas E, 2006, NUCLEIC ACIDS RES, V34, P6051, DOI 10.1093/nar/gkl769; MCDONELL MW, 1977, J MOL BIOL, V110, P119, DOI 10.1016/S0022-2836(77)80102-2; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; PENALVA MA, 1982, P NATL ACAD SCI-BIOL, V79, P5522, DOI 10.1073/pnas.79.18.5522; Perez-Arnaiz P, 2010, J MOL BIOL, V395, P223, DOI 10.1016/j.jmb.2009.10.061; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; Salas M, 1999, GENET ENG P, V21, P159; Salas M., 2008, ENCY VIROLOGY, P339; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Zakharova E, 2004, BIOCHEMISTRY-US, V43, P6587, DOI 10.1021/bi049615p	48	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2888	2898		10.1074/jbc.M113.530980	http://dx.doi.org/10.1074/jbc.M113.530980			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24324256	Green Published, hybrid			2022-12-28	WOS:000333403000037
J	Jacobs, JL; Zhu, JZ; Sarkar, SN; Coyne, CB				Jacobs, Jana L.; Zhu, Jianzhong; Sarkar, Saumendra N.; Coyne, Carolyn B.			Regulation of Mitochondrial Antiviral Signaling (MAVS) Expression and Signaling by the Mitochondria-associated Endoplasmic Reticulum Membrane (MAM) Protein Gp78	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ERad; Interferon; Mitochondria; Rig-like receptors (RLR); RNA Viruses; Gp78; MAM; MAVS; Antiviral Signaling	MOTILITY FACTOR-RECEPTOR; RIG-I; UBIQUITIN LIGASE; KAPPA-B; DEPENDENT PHOSPHORYLATION; ADAPTER PROTEIN; DEGRADATION; ACTIVATION; E3; ER	Background: Negative regulation of innate antiviral singling is crucial for preventing cell damage elicited by hyperinflammation. Results: Gp78 was identified as a negative regulator of innate antiviral signaling. Conclusion: Gp78 regulates MAVS by both decreasing protein levels and by inhibiting signaling via physical interactions. Significance: Gp78 regulation of innate antiviral signaling points to a novel and unexpected role for this protein. In a previous study, we identified the E3 ubiquitin ligase Gp78 by RNAi high-throughput screening as a gene whose depletion restricted enterovirus infection. In the current study, we show that Gp78, which localizes to the ER-mitochondria interface, is a regulator of RIG-I-like receptor (RLR) antiviral signaling. We show that depletion of Gp78 results in a robust decrease of vesicular stomatitis virus (VSV) infection and a corresponding enhancement of type I interferon (IFN) signaling. Mechanistically, we show that Gp78 modulates type I IFN induction by altering both the expression and signaling of the mitochondria-localized RLR adaptor mitochondrial antiviral signaling (MAVS). Expression of mutants of Gp78 that abolish its E3 ubiquitin ligase and its participation in ER-associated degradation (ERAD) lost their ability to degrade MAVS, but surprisingly maintained their ability to repress RLR signaling. In contrast, Gp78 lacking its entire C terminus lost both its ability to degrade MAVS and repress RLR signaling. We show that Gp78 interacts with both the N- and C-terminal domains of MAVS via its C-terminal RING domain, and that this interaction is required to abrogate Gp78-mediated attenuation of MAVS signaling. Our data thus implicate two parallel pathways by which Gp78 regulates MAVS signaling; one pathway requires its E3 ubiquitin ligase and ERAD activity to directly degrade MAVS, whereas the other pathway occurs independently of these activities, but requires the Gp78 RING domain and occurs via a direct association between this region and MAVS.	[Jacobs, Jana L.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Grad Sch Publ Hlth, Pittsburgh, PA 15219 USA; [Zhu, Jianzhong; Sarkar, Saumendra N.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15219 USA; [Sarkar, Saumendra N.; Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Coyne, CB (corresponding author), 427 Bridgeside Point 2,450 Technol Dr, Pittsburgh, PA 15219 USA.	coynec2@pitt.edu	Sarkar, Saumendra N/B-5038-2011	Sarkar, Saumendra N/0000-0002-2850-6121	National Institutes of Health [R01-AI081759]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI081759 (to C. B. C.).	Alexia C, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004496; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Belgnaoui SM, 2012, CELL HOST MICROBE, V12, P211, DOI 10.1016/j.chom.2012.06.009; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; BENLIMAME N, 1995, J CELL BIOL, V129, P459, DOI 10.1083/jcb.129.2.459; Bozym RA, 2012, CELL HOST MICROBE, V11, P153, DOI 10.1016/j.chom.2012.01.008; Castanier C, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-44; Castanier C, 2011, BBA-MOL CELL RES, V1813, P575, DOI 10.1016/j.bbamcr.2010.08.009; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Coyne CB, 2007, EMBO J, V26, P4016, DOI 10.1038/sj.emboj.7601831; Coyne CB, 2011, CELL HOST MICROBE, V9, P70, DOI 10.1016/j.chom.2011.01.001; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; DENNIS EA, 1972, J LIPID RES, V13, P263; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Fu M, 2013, MOL BIOL CELL, V24, P1153, DOI 10.1091/mbc.E12-08-0607; Goetz JG, 2007, J CELL SCI, V120, P3553, DOI 10.1242/jcs.03486; Goulet ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003298; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jabaut J, 2013, FREE RADICAL BIO MED, V60, P233, DOI 10.1016/j.freeradbiomed.2013.01.025; Jacobs JL, 2013, J MOL BIOL, V425, P5009, DOI 10.1016/j.jmb.2013.10.007; Jia YX, 2009, J IMMUNOL, V183, P4241, DOI 10.4049/jimmunol.0901646; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Lawlor K. E., 2013, BIOCH BIOPH IN PRESS; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Liang JS, 2003, J BIOL CHEM, V278, P23984, DOI 10.1074/jbc.M302683200; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; LIOTTA LA, 1986, P NATL ACAD SCI USA, V83, P3302, DOI 10.1073/pnas.83.10.3302; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Liu XY, 2010, CELL RES, V20, P994, DOI 10.1038/cr.2010.103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; NABI IR, 1990, CANCER RES, V50, P409; Nakhaei P, 2012, J VIROL, V86, P726, DOI 10.1128/JVI.05989-11; Paz S, 2011, CELL RES, V21, P895, DOI 10.1038/cr.2011.2; Pottekat A, 2004, J BIOL CHEM, V279, P15743, DOI 10.1074/jbc.M313537200; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; St-Pierre P, 2012, J CELL SCI, V125, P1727, DOI 10.1242/jcs.096396; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Wang HJ, 2000, J CELL BIOL, V150, P1489, DOI 10.1083/jcb.150.6.1489; Wang HJ, 1997, J CELL SCI, V110, P3043; Wang PH, 2013, CELL REP, V3, P1057, DOI 10.1016/j.celrep.2013.02.027; Wang YT, 2012, J IMMUNOL, V189, P5304, DOI 10.4049/jimmunol.1201445; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zhao YY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003086; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	70	29	32	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1604	1616		10.1074/jbc.M113.520254	http://dx.doi.org/10.1074/jbc.M113.520254			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24285545	Green Published, hybrid			2022-12-28	WOS:000332401700034
J	Kawai, M; Kinoshita, S; Shimba, S; Ozono, K; Michigami, T				Kawai, Masanobu; Kinoshita, Saori; Shimba, Shigeki; Ozono, Keiichi; Michigami, Toshimi			Sympathetic Activation Induces Skeletal Fgf23 Expression in a Circadian Rhythm-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Circadian Rhythms; Fibroblast Growth Factor (FGF); Nerve; Parathyroid Hormone; FGF23; Cryptochrome1; Phosphate Metabolism; Sympathetic Activity	GROWTH-FACTOR 23; GENE-EXPRESSION; NERVOUS-SYSTEM; PHOSPHATE; BONE; KLOTHO; METABOLISM; CLOCK; FIBROBLAST-GROWTH-FACTOR-23; HYPOPHOSPHATEMIA	Background: The mechanism whereby the circadian clock regulates phosphate metabolism remains elusive. Results:Fgf23 expression is regulated by the time of food intake which involves the alteration in circadian profile of sympathetic activity. Conclusion: The circadian network plays important roles in phosphate metabolism. Significance: The sympathetic regulation of Fgf23 expression may shed light on new regulatory networks that could be important for phosphate homeostasis. The circadian clock network is well known to link food intake and metabolic outputs. Phosphorus is a pivotal nutritional factor involved in energy and skeletal metabolisms and possesses a circadian profile in the circulation; however, the precise mechanisms whereby phosphate metabolism is regulated by the circadian clock network remain largely unknown. Because sympathetic tone, which displays a circadian profile, is activated by food intake, we tested the hypothesis that phosphate metabolism was regulated by the circadian clock network through the modification of food intake-associated sympathetic activation. Skeletal Fgf23 expression showed higher expression during the dark phase (DP) associated with elevated circulating FGF23 levels and enhanced phosphate excretion in the urine. The peaks in skeletal Fgf23 expression and urine epinephrine levels, a marker for sympathetic tone, shifted from DP to the light phase (LP) when mice were fed during LP. Interestingly, -adrenergic agonist, isoproterenol (ISO), induced skeletal Fgf23 expression when administered at ZT12, but this was not observed in Bmal1-deficient mice. In vitro reporter assays revealed that ISO trans-activated Fgf23 promoter through a cAMP responsive element in osteoblastic UMR-106 cells. The mechanism of circadian regulation of Fgf23 induction by ISO in vivo was partly explained by the suppressive effect of Cryptochrome1 (Cry1) on ISO signaling. These results indicate that the regulation of skeletal Fgf23 expression by sympathetic activity is dependent on the circadian clock system and may shed light on new regulatory networks of FGF23 that could be important for understanding the physiology of phosphate metabolism.	[Kawai, Masanobu; Kinoshita, Saori; Michigami, Toshimi] Osaka Med Ctr, Dept Bone & Mineral Res, Izumi Ku, Osaka 5941101, Japan; [Kawai, Masanobu; Kinoshita, Saori; Michigami, Toshimi] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka 5941101, Japan; [Shimba, Shigeki] Nihon Univ, Sch Pharm, Dept Hlth Sci, Funabashi, Chiba 2748555, Japan; [Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Nihon University; Osaka University	Kawai, M (corresponding author), Osaka Med Ctr, Dept Bone & Mineral Res, Izumi Ku, 840 Murodo Cho, Osaka 5941101, Japan.	kawaim@mch.pref.osaka.jp	Michigami, Toshimi/AAU-2326-2021		Sukoyaka Grant for Maternal and Child Health; Grants-in-Aid for Scientific Research [23591227] Funding Source: KAKEN	Sukoyaka Grant for Maternal and Child Health; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from Sukoyaka Grant for Maternal and Child Health (to M. K.).	Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Beret-Pages A, 2004, BONE, V35, P455, DOI 10.1016/j.bone.2004.04.002; Bergwitz C, 2011, ADV CHRONIC KIDNEY D, V18, P132, DOI 10.1053/j.ackd.2011.01.004; Brown WW, 2009, J CLIN ENDOCR METAB, V94, P17, DOI 10.1210/jc.2008-0220; Carpenter TO, 2010, J CLIN ENDOCR METAB, V95, pE352, DOI 10.1210/jc.2010-0589; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; FAGIUS J, 1994, CLIN SCI, V86, P159, DOI 10.1042/cs0860159; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Ito N, 2013, J STEROID BIOCHEM, V136, P183, DOI 10.1016/j.jsbmb.2012.09.029; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; NELSON W, 1964, AM J PHYSIOL, V206, P589, DOI 10.1152/ajplegacy.1964.206.3.589; Nishida Y, 2006, KIDNEY INT, V70, P2141, DOI 10.1038/sj.ki.5002000; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Razzaque MS, 2012, NAT REV ENDOCRINOL, V8, P579, DOI 10.1038/nrendo.2012.75; Saji F, 2010, AM J PHYSIOL-RENAL, V299, pF1212, DOI 10.1152/ajprenal.00169.2010; SAKAGUCHI T, 1988, AM J PHYSIOL, V255, pR284, DOI 10.1152/ajpregu.1988.255.2.R284; Samadfam R, 2009, ENDOCRINOLOGY, V150, P4835, DOI 10.1210/en.2009-0472; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Smith B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S15; Smith ER, 2012, J CLIN ENDOCR METAB, V97, P3357, DOI 10.1210/jc.2012-1811; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; TROISI RJ, 1991, HYPERTENSION, V17, P669, DOI 10.1161/01.HYP.17.5.669; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhang LY, 2012, P NATL ACAD SCI USA, V109, P20679, DOI 10.1073/pnas.1218699110	47	55	55	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1457	1466		10.1074/jbc.M113.500850	http://dx.doi.org/10.1074/jbc.M113.500850			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302726	hybrid, Green Published			2022-12-28	WOS:000332401700022
J	Okajima, K; Aihara, Y; Takayama, Y; Nakajima, M; Kashojiya, S; Hikima, T; Oroguchi, T; Kobayashi, A; Sekiguchi, Y; Yamamoto, M; Suzuki, T; Nagatani, A; Nakasako, M; Tokutomi, S				Okajima, Koji; Aihara, Yusuke; Takayama, Yuki; Nakajima, Mihoko; Kashojiya, Sachiko; Hikima, Takaaki; Oroguchi, Tomotaka; Kobayashi, Amane; Sekiguchi, Yuki; Yamamoto, Masaki; Suzuki, Tomomi; Nagatani, Akira; Nakasako, Masayoshi; Tokutomi, Satoru			Light-induced Conformational Changes of LOV1 (Light Oxygen Voltage-sensing Domain 1) and LOV2 Relative to the Kinase Domain and Regulation of Kinase Activity in Chlamydomonas Phototropin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Phosphorylation; Photoreceptors; Plant Biochemistry; Serine Threonine Protein Kinase; Spectroscopy; X-ray Scattering	BLUE-LIGHT; ARABIDOPSIS PHOTOTROPIN-1; FLAVIN MONONUCLEOTIDE; MUTATIONAL ANALYSIS; STRUCTURAL BASIS; BINDING DOMAINS; PHOTORECEPTOR; RECEPTOR; PHOT; NPH1	Phototropin (phot), a blue light (BL) receptor in plants, has two photoreceptive domains named LOV1 and LOV2 as well as a Ser/Thr kinase domain (KD) and acts as a BL-regulated protein kinase. A LOV domain harbors a flavin mononucleotide that undergoes a cyclic photoreaction upon BL excitation via a signaling state in which the inhibition of the kinase activity by LOV2 is negated. To understand the molecular mechanism underlying the BL-dependent activation of the kinase, the photochemistry, kinase activity, and molecular structure were studied with the phot of Chlamydomonas reinhardtii. Full-length and LOV2-KD samples of C. reinhardtii phot showed cyclic photoreaction characteristics with the activation of LOV- and BL-dependent kinase. Truncation of LOV1 decreased the photosensitivity of the kinase activation, which was well explained by the fact that the signaling state lasted for a shorter period of time compared with that of the phot. Small angle x-ray scattering revealed monomeric forms of the proteins in solution and detected BL-dependent conformational changes, suggesting an extension of the global molecular shapes of both samples. Constructed molecular model of full-length phot based on the small angle x-ray scattering data proved the arrangement of LOV1, LOV2, and KD for the first time that showed a tandem arrangement both in the dark and under BL irradiation. The models suggest that LOV1 alters its position relative to LOV2-KD under BL irradiation. This finding demonstrates that LOV1 may interact with LOV2 and modify the photosensitivity of the kinase activation through alteration of the duration of the signaling state in LOV2.	[Okajima, Koji; Nakajima, Mihoko; Kashojiya, Sachiko; Tokutomi, Satoru] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Naka Ku, Sakai, Osaka 5998531, Japan; [Okajima, Koji; Takayama, Yuki; Kashojiya, Sachiko; Hikima, Takaaki; Oroguchi, Tomotaka; Kobayashi, Amane; Sekiguchi, Yuki; Yamamoto, Masaki; Nakasako, Masayoshi] RIKEN, Harima Inst, Sayo, Hyogo 6795148, Japan; [Aihara, Yusuke; Suzuki, Tomomi; Nagatani, Akira] Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan; [Takayama, Yuki; Oroguchi, Tomotaka; Kobayashi, Amane; Sekiguchi, Yuki; Nakasako, Masayoshi] Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, Fujisawa, Kanagawa 2238522, Japan	Osaka Metropolitan University; RIKEN; Kyoto University; Keio University	Nakasako, M (corresponding author), RIKEN, Harima Inst, SPring 8,1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	nakasako@phys.keio.ac.jp; toxan@b.s.osakafu-u.ac.jp	Yamamoto, Masaki/B-7844-2015	Yamamoto, Masaki/0000-0002-1311-1768; Suzuki, Tomomi/0000-0003-0935-5505	Ministry of Education, Culture, Sports, Science, and Technology, Japan [22120002, 23120525, 22120005, 17084002, 17084008, 23657105, A06]; Grants-in-Aid for Scientific Research [22244054, 22120005] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research on Innovative Areas 22120002 (to A. N.), 23120525 (to M. Nakasako), and 22120005 (to S. T.), Grants-in-aid for Scientific Research on Priority Areas 17084002 (to A. N.) and 17084008 (to S. T.), Grant-in-aid for Exploratory Research 23657105 (to S. T.), and a Grant-in-aid for the Global COE Program "Formation of a strategic base for biodiversity and evolutionary research: from genome to ecosystem" (A06; to A. N.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Aihara Y, 2012, J BIOL CHEM, V287, P9901, DOI 10.1074/jbc.M111.324723; Cheng P, 2003, P NATL ACAD SCI USA, V100, P5938, DOI 10.1073/pnas.1031791100; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; de Carbonnel M, 2010, PLANT PHYSIOL, V152, P1391, DOI 10.1104/pp.109.150441; Demarsy E, 2012, EMBO J, V31, P3457, DOI 10.1038/emboj.2012.186; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Guinier A., 1955, SMALL ANGLE SCATTERI; Guo HM, 2005, BIOPHYS J, V89, P402, DOI 10.1529/biophysj.104.058230; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Holzer W, 2004, CHEM PHYS, V302, P105, DOI 10.1016/j.chemphys.2004.03.017; Huang KY, 2003, P NATL ACAD SCI USA, V100, P6269, DOI 10.1073/pnas.0931459100; Huang KY, 2002, PHYSIOL PLANTARUM, V115, P613, DOI 10.1034/j.1399-3054.2002.1150416.x; Im CS, 2006, PLANT J, V48, P1, DOI 10.1111/j.1365-313X.2006.02852.x; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kaiserli E, 2009, PLANT CELL, V21, P3226, DOI 10.1105/tpc.109.067876; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Katsura H, 2009, FEBS LETT, V583, P526, DOI 10.1016/j.febslet.2009.01.019; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Koyama T, 2009, BIOCHEMISTRY-US, V48, P7621, DOI 10.1021/bi9009192; Kozuka T, 2011, PLANT CELL, V23, P3684, DOI 10.1105/tpc.111.085852; Liu HY, 2011, NUCL ENG INT, V56, P16; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Matsuoka D, 2005, P NATL ACAD SCI USA, V102, P13337, DOI 10.1073/pnas.0506402102; Nakasako M, 2004, BIOCHEMISTRY-US, V43, P14881, DOI 10.1021/bi0485530; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Okajima K, 2012, J BIOL CHEM, V287, P40972, DOI 10.1074/jbc.M112.406512; Okajima K, 2011, FEBS LETT, V585, P3391, DOI 10.1016/j.febslet.2011.10.003; Onodera A, 2005, PLANT CELL PHYSIOL, V46, P367, DOI 10.1093/pcp/pci037; Pfeifer A, 2010, BIOCHEMISTRY-US, V49, P1024, DOI 10.1021/bi9016044; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Song SH, 2007, J PHOTOCH PHOTOBIO B, V87, P37, DOI 10.1016/j.jphotobiol.2006.12.007; Strickland D, 2010, NAT METHODS, V7, P623, DOI [10.1038/NMETH.1473, 10.1038/nmeth.1473]; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Swartz TE, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P305, DOI 10.1002/352760510X.ch14; Takayama Y, 2011, BIOCHEMISTRY-US, V50, P1174, DOI 10.1021/bi101689b; Takemiya A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3094; Trippens J, 2012, PLANT CELL, V24, P4687, DOI 10.1105/tpc.112.103523; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569	53	35	36	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					413	422		10.1074/jbc.M113.515403	http://dx.doi.org/10.1074/jbc.M113.515403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24285544	Green Published, hybrid			2022-12-28	WOS:000329370900036
J	Abuhusain, HJ; Matin, A; Qiao, Q; Shen, H; Kain, N; Day, BW; Stringer, BW; Daniels, B; Laaksonen, MA; Teo, C; McDonald, KL; Don, AS				Abuhusain, Hazem J.; Matin, Azadeh; Qiao, Qiao; Shen, Han; Kain, Nupur; Day, Bryan W.; Stringer, Brett W.; Daniels, Benjamin; Laaksonen, Maarit A.; Teo, Charlie; McDonald, Kerrie L.; Don, Anthony S.			A Metabolic Shift Favoring Sphingosine 1-Phosphate at the Expense of Ceramide Controls Glioblastoma Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Cancer; Ceramide; Glioblastoma; Sphingolipid; Sphingosine-1-Phosphate; glioma	KINASE-1 EXPRESSION; IN-VITRO; CELL; GROWTH; PROGRESSION; SURVIVAL; CANCER; SPHINGOLIPIDS; TEMOZOLOMIDE; INHIBITION	Studies in cell culture and mouse models of cancer have indicated that the soluble sphingolipid metabolite sphingosine 1-phosphate (S1P) promotes cancer cell proliferation, survival, invasiveness, and tumor angiogenesis. In contrast, its metabolic precursor ceramide is prodifferentiative and proapoptotic. To determine whether sphingolipid balance plays a significant role in glioma malignancy, we undertook a comprehensive analysis of sphingolipid metabolites in human glioma and normal gray matter tissue specimens. We demonstrate, for the first time, a systematic shift in sphingolipid metabolism favoring S1P over ceramide, which increases with increasing cancer grade. S1P content was, on average, 9-fold higher in glioblastoma tissues compared with normal gray matter, whereas the most abundant form of ceramide in the brain, C18 ceramide, was on average 5-fold lower. Increased S1P content in the tumors was significantly correlated with increased sphingosine kinase 1 (SPHK1) and decreased sphingosine phosphate phosphatase 2 (SGPP2) expression. Inhibition of S1P production by cultured glioblastoma cells, using a highly potent and selective SPHK1 inhibitor, blocked angiogenesis in cocultured endothelial cells without affecting VEGF secretion. Our findings validate the hypothesis that an altered ceramide/S1P balance is an important feature of human cancers and support the development of SPHK1 inhibitors as antiangiogenic agents for cancer therapy.	[Abuhusain, Hazem J.; Shen, Han; McDonald, Kerrie L.] Univ New S Wales, Fac Med, Prince Wales Clin Sch, Cure Life Neurooncol Grp, Sydney, NSW 2052, Australia; [Matin, Azadeh; Qiao, Qiao; Kain, Nupur; Daniels, Benjamin; Laaksonen, Maarit A.; Don, Anthony S.] Univ New S Wales, Fac Med, Prince Wales Clin Sch, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Day, Bryan W.; Stringer, Brett W.] Queensland Inst Med Res, Brain Canc Res Unit, Brisbane, Qld 4006, Australia; [Teo, Charlie] Prince Wales Private Hosp, Ctr Minimally Invas Neurosurg, Randwick, NSW 2033, Australia	University of New South Wales Sydney; University of New South Wales Sydney; QIMR Berghofer Medical Research Institute	Don, AS (corresponding author), Univ New S Wales, Lowy Canc Res Ctr C25, Level 2, Sydney, NSW 2052, Australia.	anthonyd@unsw.edu.au	Day, Bryan/AAV-6170-2020; Stringer, Brett/GZB-1390-2022; Don, Anthony Simon/AAE-9687-2021; Laaksonen, Maarit A/O-3467-2016	Don, Anthony Simon/0000-0003-1655-1184; Laaksonen, Maarit A/0000-0002-3676-0787; Day, Bryan/0000-0002-8948-9089; Daniels, Benjamin/0000-0001-8617-6055; Shen, Han/0000-0003-2435-2150; Stringer, Brett/0000-0003-4552-9736	National Health and Medical Research Council of Australia; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health [R24AA012725]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012725] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Sarita Tiwari and Dr. Russ Pickford for technical assistance and SphynKx Therapeutics LLC, University of Virginia, for the gift of the inhibitors SKI-1a and SKI-1b. We also thank the New South Wales Tissue Resource Centre at the University of Sydney, which is supported by the National Health and Medical Research Council of Australia, the Schizophrenia Research Institute, and National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health Grant R24AA012725 for control brain tissue samples, and acknowledge subsidized access to the Bioanalytical Mass Spectrometry Facility at the University of New South Wales, supported by the National Collaborative Research Infrastructure Scheme.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Anelli V, 2010, FASEB J, V24, P2727, DOI 10.1096/fj.09-150540; Bai RY, 2011, TRENDS MOL MED, V17, P301, DOI 10.1016/j.molmed.2011.01.011; Bieberich E, 2008, FUTURE LIPIDOL, V3, P273, DOI 10.2217/17460875.3.3.273; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Chae SS, 2004, J CLIN INVEST, V114, P1082, DOI 10.1172/JCI200422716; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Chen ZJ, 2009, J NEURO-ONCOL, V92, P121, DOI 10.1007/s11060-008-9742-y; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Day BW, 2013, CANCER CELL, V23, P238, DOI 10.1016/j.ccr.2013.01.007; ENDO K, 1991, CANCER RES, V51, P1613; French KJ, 2003, CANCER RES, V63, P5962; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Ginkel C, 2012, J BIOL CHEM, V287, P41888, DOI 10.1074/jbc.M112.413500; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hejazi L, 2011, BIOCHEM J, V438, P165, DOI 10.1042/BJ20110566; Jary E, 2010, MOL PHARMACOL, V78, P685, DOI 10.1124/mol.110.064873; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Karahatay S, 2007, CANCER LETT, V256, P101, DOI 10.1016/j.canlet.2007.06.003; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kharel Y, 2011, BIOCHEM J, V440, P345, DOI 10.1042/BJ20110817; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Le Stunff H, 2007, J BIOL CHEM, V282, P34372, DOI 10.1074/jbc.M703329200; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li J, 2008, CLIN CANCER RES, V14, P6996, DOI 10.1158/1078-0432.CCR-08-0754; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Nagahashi M, 2012, CANCER RES, V72, P726, DOI 10.1158/0008-5472.CAN-11-2167; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Rex K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068328; Riboni L, 2002, GLIA, V39, P105, DOI 10.1002/glia.10087; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sutphen R, 2004, CANCER EPIDEM BIOMAR, V13, P1185; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wong JWH, 2012, ANAL CHEM, V84, P470, DOI 10.1021/ac2026578; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Young N, 2007, EXP CELL RES, V313, P1615, DOI 10.1016/j.yexcr.2007.02.009; Young N, 2009, MOL CANCER RES, V7, P23, DOI 10.1158/1541-7786.MCR-08-0061; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	54	77	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37355	37364		10.1074/jbc.M113.494740	http://dx.doi.org/10.1074/jbc.M113.494740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24265321	Green Published, hybrid			2022-12-28	WOS:000329189700051
J	Lakshmi, SP; Reddy, AT; Zhang, YZ; Sciurba, FC; Mallampalli, RK; Duncan, SR; Reddy, RC				Lakshmi, Sowmya P.; Reddy, Aravind T.; Zhang, Yingze; Sciurba, Frank C.; Mallampalli, Rama K.; Duncan, Steven R.; Reddy, Raju C.			RETRACTED: Down-regulated Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) in Lung Epithelial Cells Promotes a PPAR gamma Agonist-reversible Proinflammatory Phenotype in Chronic Obstructive Pulmonary Disease (COPD) (Retracted article. See vol. 294, pg. 69, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication						Chromatin Histone Modification; Cigarette Smoke; Glucocorticoid Receptor; Histone Deacetylase; Inflammation; NF-kappa B (NF-KB); I-kappa-B Kinase; Human Bronchial Epithelial Cells; Oxidative Stress	KAPPA-B; GLUCOCORTICOID-RECEPTOR; PHOSPHORYLATION; EXPRESSION; DEGRADATION; RATS	Background: The mechanistic role of peroxisome proliferator-activated receptor (PPAR) in chronic obstructive pulmonary disease (COPD) is poorly understood. Results: COPD and cigarette smoke exposure down-regulated PPAR and produced inflammation that PPAR agonists reversed through multiple pathways. Conclusion: PPAR plays a pivotal role in COPD. Significance: PPAR agonists may be the first effective treatment for COPD. Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory condition and a leading cause of death, with no available cure. We assessed the actions in pulmonary epithelial cells of peroxisome proliferator-activated receptor (PPAR), a nuclear hormone receptor with anti-inflammatory effects, whose role in COPD is largely unknown. We found that PPAR was down-regulated in lung tissue and epithelial cells of COPD patients, via both reduced expression and phosphorylation-mediated inhibition, whereas pro-inflammatory nuclear factor-B (NF-B) activity was increased. Cigarette smoking is the main risk factor for COPD, and exposing airway epithelial cells to cigarette smoke extract (CSE) likewise down-regulated PPAR and activated NF-B. CSE also down-regulated and post-translationally inhibited the glucocorticoid receptor (GR-) and histone deacetylase 2 (HDAC2), a corepressor important for glucocorticoid action and whose down-regulation is thought to cause glucocorticoid insensitivity in COPD. Treating epithelial cells with synthetic (rosiglitazone) or endogenous (10-nitro-oleic acid) PPAR agonists strongly up-regulated PPAR expression and activity, suppressed CSE-induced production and secretion of inflammatory cytokines, and reversed its activation of NF-B by inhibiting the IB kinase pathway and by promoting direct inhibitory binding of PPAR to NF-B. In contrast, PPAR knockdown via siRNA augmented CSE-induced chemokine release and decreases in HDAC activity, suggesting a potential anti-inflammatory role of endogenous PPAR. The results imply that down-regulation of pulmonary epithelial PPAR by cigarette smoke promotes inflammatory pathways and diminishes glucocorticoid responsiveness, thereby contributing to COPD pathogenesis, and further suggest that PPAR agonists may be useful for COPD treatment.	[Lakshmi, Sowmya P.; Reddy, Aravind T.; Zhang, Yingze; Sciurba, Frank C.; Mallampalli, Rama K.; Duncan, Steven R.; Reddy, Raju C.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Sch Med, Pittsburgh, PA 15213 USA; [Lakshmi, Sowmya P.; Reddy, Aravind T.; Mallampalli, Rama K.; Reddy, Raju C.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Reddy, RC (corresponding author), Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Univ Dr C, Pittsburgh, PA 15240 USA.	reddyrc@upmc.edu	Reddy, Aravind/P-1847-2018; Lakshmi, Sowmya P./P-1851-2018; Sciurba, Frank/AAZ-9339-2021	Reddy, Aravind/0000-0001-8628-3467; Lakshmi, Sowmya P./0000-0003-1708-9462; Zhang, YIngze/0000-0001-8042-6105; sciurba, frank/0000-0001-7468-2225	United States Department of Veterans Affairs; National Institutes of Health [HL093196]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093196] Funding Source: NIH RePORTER	United States Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Merit Review award from the United States Department of Veterans Affairs and National Institutes of Health Grant HL093196 (to R. C. R).	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Barnes Peter J, 2009, Ther Adv Respir Dis, V3, P235, DOI 10.1177/1753465809348648; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Blanquicett C, 2010, FREE RADICAL BIO MED, V48, P1618, DOI 10.1016/j.freeradbiomed.2010.03.007; Caito S, 2008, ANTIOXID REDOX SIGN, V10, P253, DOI 10.1089/ars.2007.1889; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Camp HS, 1997, J BIOL CHEM, V272, P10811; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; Doyle K, 2010, J BIOL CHEM, V285, P17417, DOI 10.1074/jbc.M109.089250; Hou YZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2270; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Jeffery Peter K, 2004, Proc Am Thorac Soc, V1, P176, DOI 10.1513/pats.200402-009MS; Lahiri S, 2009, EUR J PHARMACOL, V609, P118, DOI 10.1016/j.ejphar.2009.03.005; Lea S., 2013, EUR RESP J, DOI 10.1183/09031936. 00187812; Lee SY, 2006, AM J PHYSIOL-LUNG C, V291, pL84, DOI 10.1152/ajplung.00388.2005; Li JE, 2010, ACTA BIOCH BIOPH SIN, V42, P603, DOI 10.1093/abbs/gmq071; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Martin A, 2012, J HYPERTENS, V30, P315, DOI 10.1097/HJH.0b013e32834f043b; Mercer Becky A, 2006, Int J Chron Obstruct Pulmon Dis, V1, P137, DOI 10.2147/copd.2006.1.2.137; Nencioni A, 2003, CRIT REV IMMUNOL, V23, P1, DOI 10.1615/CritRevImmunol.v23.i12.10; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Reddy AT, 2012, J IMMUNOL, V189, P5411, DOI 10.4049/jimmunol.1201487; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sharma R, 2009, PULM PHARMACOL THER, V22, P183, DOI 10.1016/j.pupt.2008.11.011; Wang XD, 2009, PULM PHARMACOL THER, V22, P318, DOI 10.1016/j.pupt.2009.01.004	33	57	60	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6383	6393		10.1074/jbc.M113.536805	http://dx.doi.org/10.1074/jbc.M113.536805			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24368768	Green Published, hybrid			2022-12-28	WOS:000332389400007
J	Pang, SS; Nguyen, STS; Perry, AJ; Day, CJ; Panjikar, S; Tiralongo, J; Whisstock, JC; Kwok, T				Pang, Siew Siew; Stanley Thai Son Nguyen; Perry, Andrew J.; Day, Christopher J.; Panjikar, Santosh; Tiralongo, Joe; Whisstock, James C.; Kwok, Terry			The Three-dimensional Structure of the Extracellular Adhesion Domain of the Sialic Acid-binding Adhesin SabA from Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Adhesion; Carbohydrate Binding Protein; Helicobacter pylori; Membrane Proteins; X-ray Crystallography; Outer Membrane Protein	DIFFRACTION DATA; REPLACEMENT; INSIGHTS	Background:Helicobacter pylori SabA outer membrane protein is crucial for the bacteria to adhere to host stomach surface during chronic infection. Results: The structure of the extracellular SabA adhesion region is determined by x-ray crystallography. Conclusion: SabA adhesion structure may provide insight into binding sites important for ligand receptor interactions. Significance: SabA is the first reported extracellular domain structure of the H. pylori outer membrane protein family. The gastric pathogen Helicobacter pylori is a major cause of acute chronic gastritis and the development of stomach and duodenal ulcers. Chronic infection furthermore predisposes to the development of gastric cancer. Crucial to H. pylori survival within the hostile environment of the digestive system are the adhesins SabA and BabA; these molecules belong to the same protein family and permit the bacteria to bind tightly to sugar moieties Lewis(B) and sialyl-Lewis(X), respectively, on the surface of epithelial cells lining the stomach and duodenum. To date, no representative SabA/BabA structure has been determined, hampering the development of strategies to eliminate persistent H. pylori infections that fail to respond to conventional therapy. Here, using x-ray crystallography, we show that the soluble extracellular adhesin domain of SabA shares distant similarity to the tetratricopeptide repeat fold family. The molecule broadly resembles a golf putter in shape, with the head region featuring a large cavity surrounded by loops that vary in sequence between different H. pylori strains. The N-terminal and C-terminal helices protrude at right angles from the head domain and together form a shaft that connects to a predicted outer membrane protein-like -barrel trans-membrane domain. Using surface plasmon resonance, we were able to detect binding of the SabA adhesin domain to sialyl-Lewis(X) and Lewis(X) but not to Lewis(A), Lewis(B), or Lewis(Y). Substitution of the highly conserved glutamine residue 159 in the predicted ligand-binding pocket abrogates the binding of the SabA adhesin domain to sialyl-Lewis(X) and Lewis(X). Taken together, these data suggest that the adhesin domain of SabA is sufficient in isolation for specific ligand binding.	[Pang, Siew Siew; Stanley Thai Son Nguyen; Perry, Andrew J.; Panjikar, Santosh; Whisstock, James C.; Kwok, Terry] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Stanley Thai Son Nguyen; Whisstock, James C.] Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Melbourne, Vic 3800, Australia; [Kwok, Terry] Monash Univ, Dept Microbiol, Melbourne, Vic 3800, Australia; [Day, Christopher J.; Tiralongo, Joe] Griffith Univ, Inst Glyc, Brisbane, Qld 4222, Australia; [Panjikar, Santosh] Australian Synchrotron, Melbourne, Vic 3168, Australia	Monash University; Monash University; Monash University; Griffith University	Whisstock, JC (corresponding author), Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol, Clayton Campus, Melbourne, Vic 3800, Australia.	james.whisstock@monash.edu; terry.kwok@monash.edu	Perry, Andrew/E-5607-2010; Panjikar, Santosh/D-2709-2012	Perry, Andrew/0000-0001-9256-6068; Panjikar, Santosh/0000-0001-7429-3879; Whisstock, James/0000-0003-4200-5611; Tiralongo, Joe/0000-0002-3529-6310; Day, Christopher/0000-0001-7953-4408; Kwok, Terry/0000-0002-5905-3233				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alm RA, 2000, INFECT IMMUN, V68, P4155, DOI 10.1128/IAI.68.7.4155-4168.2000; Aspholm M, 2006, METHOD ENZYMOL, V417, P293, DOI 10.1016/S0076-6879(06)17020-2; Aspholm M, 2006, PLOS PATHOG, V2, P989, DOI 10.1371/journal.ppat.0020110; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hothorn M, 2004, PLANT CELL, V16, P3437, DOI 10.1105/tpc.104.025684; Huergo LF, 2013, J BACTERIOL, V195, P1970, DOI 10.1128/JB.00059-13; Kim JK, 2003, BIOCHEMISTRY-US, V42, P4084, DOI 10.1021/bi027181x; Kuipers EJ, 2005, HELICOBACTER, V10, P66, DOI 10.1111/j.1523-5378.2005.00336.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Magalhaes A, 2010, BRAZ J MED BIOL RES, V43, P611, DOI 10.1590/S0100-879X2010007500049; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mu RL, 2012, STRUCTURE, V20, P887, DOI 10.1016/j.str.2012.03.001; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Pannu NS, 2003, ACTA CRYSTALLOGR D, V59, P1801, DOI 10.1107/S090744490301936X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheu BS, 2003, GUT, V52, P927, DOI 10.1136/gut.52.7.927; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; Unemo M, 2005, J BIOL CHEM, V280, P15390, DOI 10.1074/jbc.M412725200; Walz A, 2005, GLYCOBIOLOGY, V15, P700, DOI 10.1093/glycob/cwi049; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu J, 2010, BIOINFORMATICS, V26, P46, DOI 10.1093/bioinformatics/btp599	30	36	38	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6332	6340		10.1074/jbc.M113.513135	http://dx.doi.org/10.1074/jbc.M113.513135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24375407	Green Published, hybrid			2022-12-28	WOS:000332389400002
J	Coffman, K; Yang, B; Lu, J; Tetlow, AL; Pelliccio, E; Lu, S; Guo, DC; Tang, C; Dong, MQ; Tamanoi, F				Coffman, Kimberly; Yang, Bing; Lu, Jie; Tetlow, Ashley L.; Pelliccio, Emelia; Lu, Shan; Guo, Da-Chuan; Tang, Chun; Dong, Meng-Qiu; Tamanoi, Fuyuhiko			Characterization of the Raptor/ 4E-BP1 Interaction by Chemical Cross- linking Coupled with Mass Spectrometry Analysis*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mTOR; mTOR Complex (mTORC); Protein Cross-linking; Protein Kinases; Signaling; 4E-BP1; TOS Motif; Cross-linking Mass Spectrometry; Raptor	TRANSLATION FACTOR EIF4E; PROTEIN-STRUCTURE; STRUCTURAL BASIS; LINKED PEPTIDES; BINDING PARTNER; MTOR; PHOSPHORYLATION; ACTIVATION; COMPLEX; PATHWAY	Background: mTORC1 recruits its substrate 4E-BP1 via Raptor/4E-BP1 interaction. Chemical cross-linking/mass spectrometry permits characterization of protein-protein interactions. Results: Cross-linked peptides between Raptor and 4E-BP1 were identified. Raptor intramolecular cross-links were also identified. Conclusion: Raptor N-terminal region containing RNC1 is implicated in the interaction with the central region of 4E-BP1. Significance: Our study provides novel insight into how mTORC1 recognizes 4E-BP1. mTORC1 plays critical roles in the regulation of protein synthesis, growth, and proliferation in response to nutrients, growth factors, and energy conditions. One of the substrates of mTORC1 is 4E-BP1, whose phosphorylation by mTORC1 reverses its inhibitory action on eIF4E, resulting in the promotion of protein synthesis. Raptor in mTOR complex 1 is believed to recruit 4E-BP1, facilitating phosphorylation of 4E-BP1 by the kinase mTOR. We applied chemical cross-linking coupled with mass spectrometry analysis to gain insight into interactions between mTORC1 and 4E-BP1. Using the cross-linking reagent bis[sulfosuccinimidyl] suberate, we showed that Raptor can be cross-linked with 4E-BP1. Mass spectrometric analysis of cross-linked Raptor-4E-BP1 led to the identification of several cross-linked peptide pairs. Compilation of these peptides revealed that the most N-terminal Raptor N-terminal conserved domain (in particular residues from 89 to 180) of Raptor is the major site of interaction with 4E-BP1. On 4E-BP1, we found that cross-links with Raptor were clustered in the central region (amino acid residues 56-72) we call RCR (Raptor cross-linking region). Intramolecular cross-links of Raptor suggest the presence of two structured regions of Raptor: one in the N-terminal region and the other in the C-terminal region. In support of the idea that the Raptor N-terminal conserved domain and the 4E-BP1 central region are closely located, we found that peptides that encompass the RCR of 4E-BP1 inhibit cross-linking and interaction of 4E-BP1 with Raptor. Furthermore, mutations of residues in the RCR decrease the ability of 4E-BP1 to serve as a substrate for mTORC1 in vitro and in vivo.	[Coffman, Kimberly; Lu, Jie; Tetlow, Ashley L.; Pelliccio, Emelia; Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Inst Mol Biol, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Yang, Bing; Lu, Shan; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Guo, Da-Chuan; Tang, Chun] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan 430071, Hubei, Peoples R China	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Dong, MQ (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	dongmengqiu@nibs.ac.cn; fuyut@microbio.ucla.edu	Yang, Bing/L-2768-2015; Lu, Shan/ABI-5830-2020; Tang, Chun/P-4060-2019	Tang, Chun/0000-0001-6477-6500; Lu, Shan/0000-0003-4740-0610	National Institutes of Health [CA41996]; Ministry of Science and Technology of China [2010CB835203, 2013CB910200]; NATIONAL CANCER INSTITUTE [R01CA041996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA41996 (to F. T.). This work was also supported by Ministry of Science and Technology of China Grants 2010CB835203 (to M.-Q. D.) and 2013CB910200 (to C. T.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Assouline S, 2009, BLOOD, V114, P257, DOI 10.1182/blood-2009-02-205153; Bermejo GA, 2012, PROTEIN SCI, V21, P1824, DOI 10.1002/pro.2163; Brown CJ, 2007, J MOL BIOL, V372, P7, DOI 10.1016/j.jmb.2007.06.033; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Eguchi S, 2006, GENES CELLS, V11, P757, DOI 10.1111/j.1365-2443.2006.00977.x; Fletcher CM, 1998, BIOCHEMISTRY-US, V37, P9, DOI 10.1021/bi972494r; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Karbowniczek M, 2008, J INVEST DERMATOL, V128, P980, DOI 10.1038/sj.jid.5701074; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lee VHY, 2008, FEBS J, V275, P2185, DOI 10.1111/j.1742-4658.2008.06372.x; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Liu WZ, 2011, NUCLEIC ACIDS RES, V39, P8820, DOI 10.1093/nar/gkr650; Liu WZ, 2009, J BIOL CHEM, V284, P31336, DOI 10.1074/jbc.M109.049858; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Molinolo AA, 2007, CLIN CANCER RES, V13, P4964, DOI 10.1158/1078-0432.CCR-07-1041; Pandey A, 2000, Sci STKE, V2000, ppl1, DOI 10.1126/stke.2000.37.pl1; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Robb VA, 2007, J UROLOGY, V177, P346, DOI 10.1016/j.juro.2006.08.076; Rosettani P, 2007, J MOL BIOL, V368, P691, DOI 10.1016/j.jmb.2007.02.019; Rousseau D, 1996, ONCOGENE, V13, P2415; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Siddiqui N, 2012, J MOL BIOL, V415, P781, DOI 10.1016/j.jmb.2011.12.002; Singh P, 2010, ANAL CHEM, V82, P2636, DOI 10.1021/ac1000724; Sinz A, 2003, J MASS SPECTROM, V38, P1225, DOI 10.1002/JMS.559; Tabb DL, 2012, NAT METHODS, V9, P879, DOI 10.1038/nmeth.2139; Tamanoi F., 2010, STRUCTURE FUNCTION B, V28; Tang C, 2006, J BIOMOL NMR, V36, P37, DOI 10.1007/s10858-006-9065-2; Tomoo K, 2005, BBA-PROTEINS PROTEOM, V1753, P191, DOI 10.1016/j.bbapap.2005.07.023; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017	50	13	13	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4723	4734		10.1074/jbc.M113.482067	http://dx.doi.org/10.1074/jbc.M113.482067			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403073	Green Published, hybrid			2022-12-28	WOS:000331607900019
J	Hoffmann, G; Breitenbucher, F; Schuler, M; Ehrenhofer-Murray, AE				Hoffmann, Gesine; Breitenbuecher, Frank; Schuler, Martin; Ehrenhofer-Murray, Ann E.			A Novel Sirtuin 2 ( SIRT2) Inhibitor with p53-dependent Pro- apoptotic Activity in Non- small Cell Lung Cancer*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Histone Deacetylase Inhibitors; p53; SIRT; Sirt1; Sirtuins; Sirt2	NAD-DEPENDENT DEACETYLASE; PROTEIN DEACETYLASE; HISTONE DEACETYLASE; SIR2-LIKE PROTEINS; P53; DISEASE; ACETYLATION; ACTIVATION; FAMILY; YEAST	Background: Pharmacological inhibition of the NAD(+)-dependent deacetylase SIRT2 holds promise for cancer therapy by preventing deacetylation and inactivation of p53. Results: We identified two novel SIRT2 inhibitors that induce apoptosis in a p53-dependent fashion and activate three p53 target genes. Conclusion: Small-molecule inhibition of SIRT2 activates p53-dependent apoptosis in cancer cells. Significance: The compounds reported here are promising lead candidates for use in cancer treatment. Sirtuin 2 (SIRT2) is an NAD(+)-dependent protein deacetylase whose targets include histone H4 lysine 16, p53, and -tubulin. Because deacetylation of p53 regulates its effect on apoptosis, pharmacological inhibition of SIRT2-dependent p53 deacetylation is of great therapeutic interest for the treatment of cancer. Here, we have identified two structurally related compounds, AEM1 and AEM2, which are selective inhibitors of SIRT2 (IC50 values of 18.5 and 3.8 m, respectively), but show only weak effects on other sirtuins such as SIRT1, SIRT3, and yeast Sir2. Interestingly, both compounds sensitized non-small cell lung cancer cell lines toward the induction of apoptosis by the DNA-damaging agent etoposide. Importantly, this sensitization was dependent on the presence of functional p53, thus establishing a link between SIRT2 inhibition by these compounds and p53 activation. Further, treatment with AEM1 and AEM2 led to elevated levels of p53 acetylation and to increased expression of CDKN1A, which encodes the cell cycle regulator p21(WAF1), as well as the pro-apoptotic genes PUMA and NOXA, three transcriptional targets of p53. Altogether, our data suggest that inhibition of SIRT2 by these compounds causes increased activation of p53 by decreasing SIRT2-dependent p53 deacetylation. These compounds thus provide a good opportunity for lead optimization and drug development to target p53-proficient cancers.	[Hoffmann, Gesine; Ehrenhofer-Murray, Ann E.] Univ Duisburg Essen, Zentrum Med Biotechnol, D-45117 Essen, Germany; [Breitenbuecher, Frank; Schuler, Martin] Westdeutsches Tumorzentrum, Innere Klin Tumorforsch, D-45147 Essen, Germany; [Schuler, Martin] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Hoffmann, Gesine; Ehrenhofer-Murray, Ann E.] Humboldt Univ, Abt Mol Zellbiol, Inst Biol, D-10115 Berlin, Germany	University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Humboldt University of Berlin	Ehrenhofer-Murray, AE (corresponding author), Humboldt Univ, Abt Mol Zellbiol, Chausseestr 117, D-10115 Berlin, Germany.	ann.ehrenhofer-murray@hu-berlin.de			Deutsche Forschungsgemeinschaft [GRK1431, SCHU1541/5-1]; University of Duisburg-Essen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Duisburg-Essen	This work was supported by Deutsche Forschungsgemeinschaft Graduate Research Training Program Grants GRK1431 (to A.E.-M.) and SCHU1541/5-1 (to M. S.) and by the University of Duisburg-Essen.	Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bosch-Presegue Laia, 2011, Genes Cancer, V2, P648, DOI 10.1177/1947601911417862; Chopra V, 2012, CELL REP, V2, P1492, DOI 10.1016/j.celrep.2012.11.001; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; de Oliveira RM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00082; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Inoue T, 2007, CELL CYCLE, V6, P1011, DOI 10.4161/cc.6.9.4219; Jin YH, 2008, BIOCHEM BIOPH RES CO, V368, P690, DOI 10.1016/j.bbrc.2008.01.114; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Li YZ, 2011, GENES CELLS, V16, P34, DOI 10.1111/j.1365-2443.2010.01460.x; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Meiler J, 2012, J CANCER RES CLIN, V138, P1385, DOI 10.1007/s00432-012-1220-4; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; New M, 2012, MOL ONCOL, V6, P637, DOI 10.1016/j.molonc.2012.09.003; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ouaissi M, 2008, ANN SURG ONCOL, V15, P2318, DOI 10.1245/s10434-008-9940-z; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Pan M, 2012, J BIOL CHEM, V287, P2468, DOI 10.1074/jbc.M111.285031; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schuler M, 2003, CELL DEATH DIFFER, V10, P451, DOI 10.1038/sj.cdd.4401180; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Taylor DM, 2011, ACS CHEM BIOL, V6, P540, DOI 10.1021/cb100376q; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vater CA, 1996, ONCOGENE, V13, P739; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhang YJ, 2009, BIOCHEM BIOPH RES CO, V386, P729, DOI 10.1016/j.bbrc.2009.06.113; Zhao KH, 2003, STRUCTURE, V11, P1403, DOI 10.1016/j.str.2003.09.016	49	110	115	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5208	5216		10.1074/jbc.M113.487736	http://dx.doi.org/10.1074/jbc.M113.487736			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24379401	hybrid, Green Published			2022-12-28	WOS:000331607900062
J	Li, YH; Sun, XX; Elferich, J; Shinde, U; David, LL; Dai, MS				Li, Yuhuang; Sun, Xiao-Xin; Elferich, Johannes; Shinde, Ujwal; David, Larry L.; Dai, Mu-Shui			Monoubiquitination Is Critical for Ovarian Tumor Domain- containing Ubiquitin Aldehyde Binding Protein 1 ( Otub1) to Suppress UbcH5 Enzyme and Stabilize p53 Protein*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Deubiquitination; p53; Ubiquitin; Ubiquitin-conjugating Enzyme (Ubc); Ubiquitination; Deubiquitinating Enzymes; Otub1; UbcH5; Monoubiquitination	DEGRADATION SIGNAL; MDM2; DEUBIQUITINATION; HAUSP; INHIBITION; MECHANISM; SUBSTRATE; PATHWAY; COMPLEX; LIGASE	Background: Otub1 suppresses E2 UbcH5 to stabilize and activate p53. Results: UbcH5 monoubiquitinates Otub1, and monoubiquitination-defective Otub1 mutants fail to inhibit UbcH5 and induce p53. Conclusion: Monoubiquitination is critical for Otub1 to suppress UbcH5 and induce p53. Significance: We report the discovery of a novel molecular mechanism underlying Otub1 suppression of E2 and activation of p53. Ovarian tumor domain-containing ubiquitin (Ub) aldehyde binding protein 1 (Otub1) regulates p53 stability and activity via non-canonical inhibition of the MDM2 cognate Ub-conjugating enzyme (E2) UbcH5. However, it is not clear how this activity of Otub1 is regulated in cells. Here we report that Otub1 is monoubiquitinated by UbcH5 in cells and in vitro, primarily at the lysine 59 and 109 residues. This monoubiquitination, in turn, contributes to the activity of Otub1 to suppress UbcH5. The lysine-free Otub1 mutant (Otub1(K0)) fails to be monoubiquitinated and is unable to suppress the Ub-conjugating activity of UbcH5 in vitro and the MDM2-mediated p53 ubiquitination in cells. Consistently, this mutant is unable to stabilize p53, induce apoptosis, and suppress cell proliferation. Overexpression of Otub1(K0) inhibits DNA-damage induced apoptosis. Adding either Lys-59 or Lys-109 back to the Otub1(K0) mutant restores the monoubiquitination of Otub1 and its function to stabilize and activate p53. We further show that UbcH5 preferentially binds to the monoubiquitinated Otub1 via Ub interaction with its backside donor Ub-interacting surface, suggesting that this binding interferes with the self-assembly of Ub-charged UbcH5 (UbcH5 approximate to Ub) conjugates, which is critical for Ub transfer. Thus, our data reveal novel insights into the Otub1 inhibition of E2 wherein monoubiquitination promotes the interaction of Otub1 with UbcH5 and the function to suppress it.	[Li, Yuhuang; Sun, Xiao-Xin; Dai, Mu-Shui] Oregon Hlth & Sci Univ, Sch Med, Dept Mol & Med Genet, Portland, OR 97239 USA; [Elferich, Johannes; Shinde, Ujwal; David, Larry L.] Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Li, Yuhuang; Sun, Xiao-Xin; David, Larry L.; Dai, Mu-Shui] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Dai, MS (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	daim@ohsu.edu		Elferich, Johannes/0000-0002-9911-706X	NCI, National Institutes of Health [R00 CA127134, R01 CA160474]; Department of Defense [W81XWH-10-1029]; NATIONAL CANCER INSTITUTE [R01CA160474, R00CA127134, P30CA069533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020863] Funding Source: NIH RePORTER; Direct For Biological Sciences [0746589] Funding Source: National Science Foundation	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by NCI, National Institutes of Health grants R00 CA127134 and R01 CA160474 (to M. S. D.). This work was also supported by Department of Defense Grant W81XWH-10-1029 (to M. S. D.).	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; DeVine T, 2013, CURR PHARM DESIGN, V19, P3248, DOI 10.2174/1381612811319180009; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Goncharov T, 2013, EMBO J, V32, P1103, DOI 10.1038/emboj.2013.62; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Herhaus L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3519; Hock AK, 2011, EMBO J, V30, P4921, DOI 10.1038/emboj.2011.419; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Ju DH, 2006, J BIOL CHEM, V281, P10657, DOI 10.1074/jbc.M513790200; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Liu JH, 2011, EMBO J, V30, P846, DOI 10.1038/emboj.2011.11; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Stanisic V, 2009, J BIOL CHEM, V284, P16135, DOI 10.1074/jbc.M109.007484; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Sun XX, 2011, J BIOL CHEM, V286, P22730, DOI 10.1074/jbc.M111.223651; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Wilmarth Phillip A, 2009, J Ocul Biol Dis Infor, V2, P223; Yan FF, 2010, MOL BIOL CELL, V21, P1945, DOI 10.1091/mbc.E10-02-0116; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zulkifle N, 2013, INT J BIOL CHEM, V7, P1, DOI DOI 10.3923/ijbc.2013.1.14	42	37	38	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5097	5108		10.1074/jbc.M113.533109	http://dx.doi.org/10.1074/jbc.M113.533109			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403071	Green Published, hybrid			2022-12-28	WOS:000331607900053
J	van der Burgh, R; Nijhuis, L; Pervolaraki, K; Compeer, EB; Jongeneel, LH; van Gijn, M; Coffer, PJ; Murphy, MP; Mastroberardino, PG; Frenkel, J; Boes, M				van der Burgh, Robert; Nijhuis, Lotte; Pervolaraki, Kalliopi; Compeer, Ewoud B.; Jongeneel, Lieneke H.; van Gijn, Marielle; Coffer, Paul J.; Murphy, Michael P.; Mastroberardino, Pier G.; Frenkel, Joost; Boes, Marianne			Defects in Mitochondrial Clearance Predispose Human Monocytes to Interleukin-1 beta Hypersecretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Interleukin; Mitochondrial DNA; Monocytes; Redox Regulation; Autoinflammatory Disorder; Periodic Fever	GENOME-WIDE ASSOCIATION; INFLAMMASOME ACTIVATION; NLRP3 INFLAMMASOME; IL-1-BETA RELEASE; CROHN-DISEASE; AUTOPHAGY; CELLS; INHIBITION; CASPASE-1; APOPTOSIS	Background: Periodic fever syndromes are caused by deregulation of interleukin-1 release. Results: Defective autophagy leads to accumulation of damaged mitochondria in monocytes. Conclusion: Mitochondrial components in the cytosol cause priming of monocytes for interleukin-1 release. Significance: The molecular mechanism behind deregulated cytokine secretion provides new clues for intervention. Most hereditary periodic fever syndromes are mediated by deregulated IL-1 secretion. The generation of mature IL-1 requires two signals: one that induces synthesis of inflammasome components and substrates and a second that activates inflammasomes. The mechanisms that mediate autoinflammation in mevalonate kinase deficiency, a periodic fever disease characterized by a block in isoprenoid biosynthesis, are poorly understood. In studying the effects of isoprenoid shortage on IL-1 generation, we identified a new inflammasome activation signal that originates from defects in autophagy. We find that hypersecretion of IL-1 and IL-18 requires reactive oxygen species and is associated with an oxidized redox status of monocytes but not lymphocytes. IL-1 hypersecretion by monocytes involves decreased mitochondrial stability, release of mitochondrial content into the cytosol and attenuated autophagosomal degradation. Defective autophagy, as established by ATG7 knockdown, results in prolonged cytosolic retention of damaged mitochondria and increased IL-1 secretion. Finally, activation of autophagy in healthy but not mevalonate kinase deficiency patient cells reduces IL-1 secretion. Together, these results indicate that defective autophagy can prime monocytes for mitochondria-mediated NLRP3 inflammasome activation, thereby contributing to hypersecretion of IL-1 in mevalonate kinase deficiency.	[van der Burgh, Robert; Nijhuis, Lotte; Pervolaraki, Kalliopi; Compeer, Ewoud B.; Jongeneel, Lieneke H.; Coffer, Paul J.; Frenkel, Joost; Boes, Marianne] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, NL-3584 EA Utrecht, Netherlands; [Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 EA Utrecht, Netherlands; [van Gijn, Marielle] Univ Med Ctr Utrecht, Dept Genet, NL-3584 EA Utrecht, Netherlands; [Murphy, Michael P.] Wellcome Trust Res Labs, Mitochondrial Biol Unit, MRC, Cambridge CB2 0XY, England; [Mastroberardino, Pier G.] Erasmus MC, Dept Genet, NL-3015 GE Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wellcome Trust Sanger Institute; Erasmus University Rotterdam; Erasmus MC	Boes, M (corresponding author), Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Pediat Immunol, NL-3584 EA Utrecht, Netherlands.	mboes@umcutrecht.nl	Compeer, Ewoud Bernardus/E-8553-2015; Coffer, Paul/AAF-7970-2020; Murphy, Michael P/C-2120-2009	Compeer, Ewoud Bernardus/0000-0002-3050-7633; Murphy, Michael P/0000-0003-1115-9618; Boes, Marianne/0000-0003-2590-1692; MASTROBERARDINO, PIER GIORGIO/0000-0003-2364-4258	Netherlands Genomics Initiative [NGI/NWO 05040202]; Marie Curie Grant [IRG 247918]; WKZ-Fonds Foundation; Medical Research Council [MC_U105663142] Funding Source: researchfish; MRC [MC_U105663142] Funding Source: UKRI	Netherlands Genomics Initiative; Marie Curie Grant(European Commission); WKZ-Fonds Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by The Netherlands Genomics Initiative Grant NGI/NWO 05040202 and Marie Curie Grant IRG 247918.; Supported by a grant from the WKZ-Fonds Foundation.	Araki M, 2012, EUR J PHARMACOL, V674, P95, DOI 10.1016/j.ejphar.2011.10.044; Bachetti T, 2013, ANN RHEUM DIS, V72, P1044, DOI 10.1136/annrheumdis-2012-201952; Bodar EJ, 2011, ANN RHEUM DIS, V70, P2155, DOI 10.1136/ard.2011.149922; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Carta S, 2009, J LEUKOCYTE BIOL, V86, P549, DOI 10.1189/jlb.1008598; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Gomes LC, 2011, CELL CYCLE, V10, P2635, DOI 10.4161/cc.10.16.17002; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Henneman L, 2010, J INHERIT METAB DIS, V33, P625, DOI 10.1007/s10545-010-9173-8; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Kleinnijenhuis J, 2011, IMMUNOLOGY, V134, P341, DOI 10.1111/j.1365-2567.2011.03494.x; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667; Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008; Lee J, 2012, J BIOL CHEM, V287, P4033, DOI 10.1074/jbc.M111.280065; Li NY, 2003, FREE RADICAL BIO MED, V34, P465, DOI 10.1016/S0891-5849(02)01325-4; Liao YH, 2013, J LEUKOCYTE BIOL, V93, P289, DOI 10.1189/jlb.0812409; Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Parikh A, 2010, PROSTATE, V70, P971, DOI 10.1002/pros.21131; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Sane KM, 2010, J PHARMACOL EXP THER, V333, P23, DOI 10.1124/jpet.109.160192; SAULSON SS, 1992, AM J EMERG MED, V10, P97, DOI 10.1016/0735-6757(92)90139-O; Savic S, 2012, CURR OPIN RHEUMATOL, V24, P103, DOI 10.1097/BOR.0b013e32834dd2d5; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tassi S, 2010, P NATL ACAD SCI USA, V107, P9789, DOI 10.1073/pnas.1000779107; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Valdez LB, 2006, BBA-BIOENERGETICS, V1757, P166, DOI 10.1016/j.bbabio.2006.02.013; van Bruggen R, 2010, BLOOD, V115, P5398, DOI 10.1182/blood-2009-10-250803; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Woo IS, 2011, CANCER LETT, V309, P190, DOI 10.1016/j.canlet.2011.05.031; Yang PM, 2010, CANCER RES, V70, P7699, DOI 10.1158/0008-5472.CAN-10-1626; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	46	76	77	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5000	5012		10.1074/jbc.M113.536920	http://dx.doi.org/10.1074/jbc.M113.536920			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24356959	Green Published, hybrid			2022-12-28	WOS:000331607900045
J	Seifried, A; Knobloch, G; Duraphe, PS; Segerer, G; Manhard, J; Schindelin, H; Schultz, J; Gohla, A				Seifried, Annegrit; Knobloch, Gunnar; Duraphe, Prashant S.; Segerer, Gabriela; Manhard, Julia; Schindelin, Hermann; Schultz, Joerg; Gohla, Antje			Evolutionary and Structural Analyses of Mammalian Haloacid Dehalogenase-type Phosphatases AUM and Chronophin Provide Insight into the Basis of Their Different Substrate Specificities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Molecular Evolution; Pyridoxal Phosphate; Serine; Threonine Protein Phosphatase; Tyrosine-Protein Phosphatase (Tyrosine Phosphatase); X-ray Crystallography; Haloacid Dehalogenase Phosphatase; Phosphatase Substrate Specificity; Phosphoglycolate Phosphatase	PHOSPHOGLYCOLATE PHOSPHATASE; EYES ABSENT; PHYLOGENETIC ANALYSIS; PROTEIN PHOSPHATASES; GENETIC-POLYMORPHISM; CRYSTAL-STRUCTURES; HAD SUPERFAMILY; INFERENCE; MECHANISM; GENOMICS	Background: Substrate specificity determinants of mammalian haloacid dehalogenase (HAD) phosphatases are poorly understood. Results: AUM (aspartate-based, ubiquitous, Mg2+-dependent phosphatase) is a novel tyrosine phosphatase and paralog of the serine/threonine- and pyridoxal 5-phosphate phosphatase chronophin. Conclusion: Conserved cap residues in AUM or chronophin determine phosphatase substrate specificity. Significance: These findings provide a starting point for structure-based development of HAD phosphatase inhibitors. Mammalian haloacid dehalogenase (HAD)-type phosphatases are an emerging family of phosphatases with important functions in physiology and disease, yet little is known about the basis of their substrate specificity. Here, we characterize a previously unexplored HAD family member (gene annotation, phosphoglycolate phosphatase), which we termed AUM, for aspartate-based, ubiquitous, Mg2+-dependent phosphatase. AUM is a tyrosine-specific paralog of the serine/threonine-specific protein and pyridoxal 5-phosphate-directed HAD phosphatase chronophin. Comparative evolutionary and biochemical analyses reveal that a single, differently conserved residue in the cap domain of either AUM or chronophin is crucial for phosphatase specificity. We have solved the x-ray crystal structure of the AUM cap fused to the catalytic core of chronophin to 2.65 resolution and present a detailed view of the catalytic clefts of AUM and chronophin that explains their substrate preferences. Our findings identify a small number of cap domain residues that encode the different substrate specificities of AUM and chronophin.	[Seifried, Annegrit; Knobloch, Gunnar; Segerer, Gabriela; Manhard, Julia; Gohla, Antje] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97080 Wurzburg, Germany; [Seifried, Annegrit; Knobloch, Gunnar; Duraphe, Prashant S.; Schindelin, Hermann; Gohla, Antje] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Schultz, Joerg] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97074 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Gohla, A (corresponding author), Univ Wurzburg, Dept Pharmacol, Versbacher Str 9, D-97078 Wurzburg, Germany.	antje.gohla@virchow.uni-wuerzburg.de	Schindelin, Hermann/Q-2697-2019; Schultz, Joerg/B-9346-2008	Gohla, Antje/0000-0002-7442-1487; Knobloch, Gunnar/0000-0001-7356-9386	Deutsche Forschungsgemeinschaft [SFB688, FZ82]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grants SFB688 (to A. G.) and FZ82 (to A. G. and H. S.).	Afonine PV, 2007, ACTA CRYSTALLOGR D, V63, P1194, DOI 10.1107/S0907444907046148; Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; BARKER RF, 1978, ANN HUM GENET, V42, P143, DOI 10.1111/j.1469-1809.1978.tb00644.x; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Capra JA, 2013, TRENDS GENET, V29, P659, DOI 10.1016/j.tig.2013.07.001; Castri L, 1996, GENE GEOGR, V10, P37; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EIBERG H, 1993, CLIN GENET, V44, P254; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FONDA ML, 1992, J BIOL CHEM, V267, P15978; Galluzzi L, 2012, CELL REP, V2, P257, DOI 10.1016/j.celrep.2012.06.017; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HALASA J, 1988, ARCH IMMUNOL THER EX, V36, P695; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Huang YF, 2012, BIOINFORMATICS, V28, P176, DOI 10.1093/bioinformatics/btr635; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jang YM, 2003, J BIOL CHEM, V278, P50040, DOI 10.1074/jbc.M309619200; Kamenski T, 2004, MOL CELL, V15, P399, DOI 10.1016/j.molcel.2004.06.035; Kim YC, 2004, J BIOL CHEM, V279, P517, DOI 10.1074/jbc.M306054200; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lahiri SD, 2004, BIOCHEMISTRY-US, V43, P2812, DOI 10.1021/bi0356810; Lahiri SD, 2006, BIOORG CHEM, V34, P394, DOI 10.1016/j.bioorg.2006.09.007; Li CK, 2008, LINEAR MULTILINEAR A, V56, P1, DOI 10.1080/03081080701538074; Lu ZB, 2005, BIOCHEMISTRY-US, V44, P8684, DOI 10.1021/bi050009j; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mazin PV, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-29; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng EC, 2011, CURR OPIN STRUC BIOL, V21, P391, DOI 10.1016/j.sbi.2011.03.007; Mereniuk TR, 2012, CANCER RES, V72, P5934, DOI 10.1158/0008-5472.CAN-12-0939; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Peeraer Y, 2004, EUR J BIOCHEM, V271, P3421, DOI 10.1111/j.0014-2956.2004.04277.x; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; Rinaldo-Matthis A, 2002, NAT STRUCT BIOL, V9, P779, DOI 10.1038/nsb846; Roberts SJ, 2005, BBA-PROTEINS PROTEOM, V1752, P73, DOI 10.1016/j.bbapap.2005.06.009; SANTOLAMAZZA C, 1986, HUM HERED, V36, P281, DOI 10.1159/000153644; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seifried A, 2013, FEBS J, V280, P549, DOI 10.1111/j.1742-4658.2012.08633.x; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Stivala A, 2011, BIOINFORMATICS, V27, P3315, DOI 10.1093/bioinformatics/btr575; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Tremblay LW, 2006, BIOCHEMISTRY-US, V45, P1183, DOI 10.1021/bi051842j; TURNER VS, 1981, ANN HUM GENET, V45, P121, DOI 10.1111/j.1469-1809.1981.tb00313.x; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wallden K, 2007, BIOCHEMISTRY-US, V46, P13809, DOI 10.1021/bi7014794; Wallden K, 2011, J MOL BIOL, V408, P684, DOI 10.1016/j.jmb.2011.02.059; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200	73	21	23	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3416	3431		10.1074/jbc.M113.503359	http://dx.doi.org/10.1074/jbc.M113.503359			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24338473	Green Published, hybrid			2022-12-28	WOS:000331368700027
J	Kitamura, Y; Koide, M; Akakabe, Y; Matsuo, K; Shimoda, Y; Soma, Y; Ogata, T; Ueyama, T; Matoba, S; Yamada, H; Ikeda, K				Kitamura, Youhei; Koide, Masahiro; Akakabe, Yoshiki; Matsuo, Kiyonari; Shimoda, Yoshiaki; Soma, Yuka; Ogata, Takehiro; Ueyama, Tomomi; Matoba, Satoaki; Yamada, Hiroyuki; Ikeda, Koji			Manipulation of Cardiac Phosphatidylinositol 3-Kinase (PI3K)/Akt Signaling by Apoptosis Regulator through Modulating IAP Expression (ARIA) Regulates Cardiomyocyte Death during Doxorubicin-induced Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Apoptosis; Cardiomyopathy; Heart Failure; PI 3-Kinase (PI3K); ARIA (Apoptosis Regulator through Modulating IAP Expression); ECSCR (Endothelial Cell Surface-expressed Chemotaxis and Apoptosis Regulator); Cardiomyocyte Death	PHOSPHOINOSITIDE 3-KINASE; HEART-FAILURE; MYOCARDIAL-CONTRACTILITY; TRANSGENIC MICE; BINDING-PROTEIN; CELL-DEATH; AKT; PTEN; KINASE; PATHWAY	Background: The PI3K/Akt signaling regulates many aspects of cardiomyocyte homeostasis. Results: ARIA regulates cardiac PI3K/Akt signaling and modifies cardiomyocyte death and stress-induced cardiac dysfunction. Conclusion: ARIA is a novel factor involved in the regulation of cardiac PI3K/Akt signals. Significance: ARIA-mediated manipulation of cardiac PI3K/Akt signaling is an intriguing therapeutic target to treat cardiac dysfunction. PI3K/Akt signaling plays an important role in the regulation of cardiomyocyte death machinery, which can cause stress-induced cardiac dysfunction. Here, we report that apoptosis regulator through modulating IAP expression (ARIA), a recently identified transmembrane protein, regulates the cardiac PI3K/Akt signaling and thus modifies the progression of doxorubicin (DOX)-induced cardiomyopathy. ARIA is highly expressed in the mouse heart relative to other tissues, and it is also expressed in isolated rat cardiomyocytes. The stable expression of ARIA in H9c2 cardiac muscle cells increased the levels of membrane-associated PTEN and subsequently reduced the PI3K/Akt signaling and the downstream phosphorylation of Bad, a proapoptotic BH3-only protein. When challenged with DOX, ARIA-expressing H9c2 cells exhibited enhanced apoptosis, which was reversed by the siRNA-mediated silencing of Bad. ARIA-deficient mice exhibited normal heart morphology and function. However, DOX-induced cardiac dysfunction was significantly ameliorated in conjunction with reduced cardiomyocyte death and cardiac fibrosis in ARIA-deficient mice. Phosphorylation of Akt and Bad was substantially enhanced in the heart of ARIA-deficient mice even after treatment with DOX. Moreover, repressing the PI3K by cardiomyocyte-specific expression of dominant-negative PI3K (p110) abolished the cardioprotective effects of ARIA deletion. Notably, targeted activation of ARIA in cardiomyocytes but not in endothelial cells reduced the cardiac PI3K/Akt signaling and exacerbated the DOX-induced cardiac dysfunction. These studies, therefore, revealed a previously undescribed mode of manipulating cardiac PI3K/Akt signaling by ARIA, thus identifying ARIA as an attractive new target for the prevention of stress-induced myocardial dysfunction.	[Kitamura, Youhei; Koide, Masahiro; Akakabe, Yoshiki; Matsuo, Kiyonari; Shimoda, Yoshiaki; Soma, Yuka; Ogata, Takehiro; Ueyama, Tomomi; Matoba, Satoaki; Yamada, Hiroyuki; Ikeda, Koji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiol, Kyoto 6028566, Japan	Kyoto Prefectural University of Medicine	Ikeda, K (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiol, Kamigyo Ku, 465 Kajii,Kawaramachi Hirokoji, Kyoto 6028566, Japan.	ikedak@koto.kpu-m.ac.jp	koide, masahiro/AAZ-3823-2021	ikeda, Koji/0000-0002-9972-7255	Takeda Science Foundation [KAKENHI-23591107, KAKENHI-23659423]; Grants-in-Aid for Scientific Research [23591107] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research (C: KAKENHI-23591107) and for Challenging Exploratory Research (KAKENHI-23659423) and a research grant from Takeda Science Foundation.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; An T, 2013, PHYSIOL RES, V62, P379, DOI 10.33549/physiolres.932435; Armstrong LJ, 2008, ARTERIOSCL THROM VAS, V28, P1640, DOI 10.1161/ATVBAHA.108.162511; Chen B, 2007, CARDIOVASC TOXICOL, V7, P114, DOI 10.1007/s12012-007-0005-5; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Fan GC, 2008, CIRC RES, V103, P1270, DOI 10.1161/CIRCRESAHA.108.182832; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Ikeda K, 2009, P NATL ACAD SCI USA, V106, P8227, DOI 10.1073/pnas.0806780106; Katada T, 1999, CHEM PHYS LIPIDS, V98, P79, DOI 10.1016/S0009-3084(99)00020-1; Kishimoto H, 2003, CELL STRUCT FUNCT, V28, P11; Koide M, 2011, P NATL ACAD SCI USA, V108, P9472, DOI 10.1073/pnas.1101296108; Lin RCY, 2010, ARTERIOSCL THROM VAS, V30, P724, DOI 10.1161/ATVBAHA.109.201988; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Ma FX, 2009, GENES CELLS, V14, P281, DOI 10.1111/j.1365-2443.2008.01267.x; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; Morello F, 2009, CARDIOVASC RES, V82, P261, DOI 10.1093/cvr/cvn325; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Ruan HM, 2009, J MOL CELL CARDIOL, V46, P193, DOI 10.1016/j.yjmcc.2008.10.021; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schultz DR, 2003, SEMIN ARTHRITIS RHEU, V32, P345, DOI 10.1053/sarh.2003.50005; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Sprick MR, 2004, BBA-MOL CELL RES, V1644, P125, DOI 10.1016/j.bbamcr.2003.11.002; Taniyama Y, 2002, J MOL CELL CARDIOL, V34, P1241, DOI 10.1006/jmcc.2002.2068; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Wu WH, 2000, J BIOL CHEM, V275, P40113, DOI 10.1074/jbc.M004108200; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	41	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2788	2800		10.1074/jbc.M113.508143	http://dx.doi.org/10.1074/jbc.M113.508143			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338479	Green Published, hybrid			2022-12-28	WOS:000333403000028
J	Greenwald, EC; Redden, JM; Dodge-Kafka, KL; Saucerman, JJ				Greenwald, Eric C.; Redden, John M.; Dodge-Kafka, Kimberly L.; Saucerman, Jeffrey J.			Scaffold State Switching Amplifies, Accelerates, and Insulates Protein Kinase C Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AKAP; Cell Signaling; Enzyme Kinetics; Mathematical Modeling; Protein Kinase C (PKC); Scaffold Proteins; Anchoring	MAP KINASE; ANCHORING PROTEINS; AKAP79; ACTIVATION; PATHWAYS; CASCADES; MODELS; PKC	Scaffold proteins localize two or more signaling enzymes in close proximity to their downstream effectors. A-kinase-anchoring proteins (AKAPs) are a canonical family of scaffold proteins known to bind protein kinase A (PKA) and other enzymes. Several AKAPs have been shown to accelerate, amplify, and specify signal transduction to dynamically regulate numerous cellular processes. However, there is little theory available to mechanistically explain how signaling on protein scaffolds differs from solution biochemistry. In our present study, we propose a novel kinetic mechanism for enzymatic reactions on protein scaffolds to explain these phenomena, wherein the enzyme-substrate-scaffold complex undergoes stochastic state switching to reach an active state. This model predicted anchored enzymatic reactions to be accelerated, amplified, and insulated from inhibition compared with those occurring in solution. We exploited a direct interaction between protein kinase C (PKC) and AKAP7 as a model to validate these predictions experimentally. Using a genetically encoded PKC activity reporter, we found that both the strength and speed of substrate phosphorylation were enhanced by AKAP7. PKC tethered to AKAP7 was less susceptible to inhibition from the ATP-competitive inhibitor Go6976 and the substrate-competitive inhibitor PKC 20-28, but not the activation-competitive inhibitor calphostin C. Model predictions and experimental validation demonstrated that insulation is a general property of scaffold tethering. Sensitivity analysis indicated that these findings may be applicable to many other scaffolds as well. Collectively, our findings provide theoretical and experimental evidence that scaffold proteins can amplify, accelerate, and insulate signal transduction.	[Greenwald, Eric C.; Saucerman, Jeffrey J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Redden, John M.; Dodge-Kafka, Kimberly L.] Univ Connecticut, Ctr Hlth, Pat & Jim Calhoun Ctr Cardiol, Farmington, CT 06030 USA	University of Virginia; University of Connecticut	Dodge-Kafka, KL (corresponding author), Univ Connecticut, Ctr Hlth, Pat & Jim Calhoun Ctr Cardiol, Farmington, CT 06030 USA.	dodge@uchc.edu; jsaucerman@virginia.edu	Greenwald, Eric/B-9539-2011	Greenwald, Eric/0000-0003-3600-0750; Redden, John/0000-0003-4797-3267	National Institutes of Health [HL82705, HL094476]; State of Connecticut Department of Public Health [2011-0142]; American Heart Association [11PRE7830027]; National Institutes of Health Pharmacological Sciences Training Grant Predoctoral Fellowship at the University of Virginia [T32 GM007055]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082705, R01HL094476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Connecticut Department of Public Health; American Heart Association(American Heart Association); National Institutes of Health Pharmacological Sciences Training Grant Predoctoral Fellowship at the University of Virginia(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL82705 (to K. L. D.-K.), and HL094476 (to J. J. S.). This work was also supported by State of Connecticut Department of Public Health Grant 2011-0142 (to K. L. D.-K.), American Heart Association Predoctoral Fellowship 11PRE7830027 (to J. M. R.), and National Institutes of Health Pharmacological Sciences Training Grant Predoctoral Fellowship at the University of Virginia T32 GM007055 (to E. C. G.).	Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Greenwald EC, 2011, J CARDIOVASC PHARM, V58, P462, DOI 10.1097/FJC.0b013e31822001e3; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Locasale JW, 2007, P NATL ACAD SCI USA, V104, P13307, DOI 10.1073/pnas.0706311104; Malbon CC, 2004, BIOCHEM SOC T, V32, P861, DOI 10.1042/BST0320861; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Oliveira RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011725; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Patel HH, 2010, J BIOL CHEM, V285, P27632, DOI 10.1074/jbc.M110.146589; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Redden JM, 2012, BIOCHEM J, V446, P301, DOI 10.1042/BJ20120366; Sanderson JL, 2011, NEUROSCIENTIST, V17, P321, DOI 10.1177/1073858410384740; Saucerman JJ, 2004, CIRC RES, V95, P1216, DOI 10.1161/01.RES.0000150055.06226.4e; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	27	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2353	2360		10.1074/jbc.M113.497941	http://dx.doi.org/10.1074/jbc.M113.497941			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302730	Green Published, hybrid			2022-12-28	WOS:000331130200039
J	Hedrich, CM; Crispin, JC; Rauen, T; Ioannidis, C; Koga, T; Rodriguez, NR; Apostolidis, SA; Kyttaris, VC; Tsokos, GC				Hedrich, Christian M.; Crispin, Jose C.; Rauen, Thomas; Ioannidis, Christina; Koga, Tomohiro; Rodriguez, Noe Rodriguez; Apostolidis, Sokratis A.; Kyttaris, Vasileios C.; Tsokos, George C.			cAMP Responsive Element Modulator (CREM) alpha Mediates Chromatin Remodeling of CD8 during the Generation of CD3(+)CD4(-)CD8(-) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Chromatin Histone Modification; DNA Methylation; Epigenetics; Histone Methylation; Histone Modification; CD8; CREM; SLE; Double Negative T Cells	SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRANSGENIC MICE; THYMIC DIFFERENTIATION; THYMOCYTE DEVELOPMENT; CD8-ALPHA EXPRESSION; GENE-EXPRESSION; RUNX PROTEINS; ENHANCER; STAGE; SUBSET	TCR-(+)CD3(+)CD4(-)CD8(-) double negative T cells are expanded in the peripheral blood of patients with systemic lupus erythematosus (SLE) and lupus-prone mice. Double negative T cells have been claimed to derive from CD8(+) cells that down-regulate CD8 co-receptors and acquire a distinct effector phenotype that includes the expression of proinflammatory cytokines. This, along with the fact that double negative T cells have been documented in inflamed organs, suggests that they may contribute to disease expression and tissue damage. We recently linked the transcription factor cAMP responsive element modulator (CREM) , which is expressed at increased levels in T cells from SLE patients and lupus prone MRL/lpr mice, with trans-repression of a region syntenic to the murine CD8b promoter. However, the exact molecular mechanisms that result in a stable silencing of both CD8A and CD8B genes remain elusive. Here, we demonstrate that CREM orchestrates epigenetic remodeling of the CD8 cluster through the recruitment of DNA methyltransferase (DNMT) 3a and histone methyltransferase G9a. Thus, we propose that CREM is essential for the expansion of double negative T cells in SLE. CREM blockade may have therapeutic value in autoimmune disorders with DN T cell expansion.	[Hedrich, Christian M.; Crispin, Jose C.; Rauen, Thomas; Ioannidis, Christina; Koga, Tomohiro; Rodriguez, Noe Rodriguez; Apostolidis, Sokratis A.; Kyttaris, Vasileios C.; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Rheumatol, Boston, MA 02115 USA; [Hedrich, Christian M.] Univ Childrens Hosp Dresden, Dept Pediat Rheumatol & Immunol, D-01307 Dresden, Germany; [Rauen, Thomas] Rhein Westfal TH Aachen, Dept Nephrol & Clin Immunol, D-52074 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Technische Universitat Dresden; RWTH Aachen University	Hedrich, CM (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Rheumatol, Boston, MA 02115 USA.	chedrich@bidmc.harvard.edu; gtsokos@bidmc.harvard.edu	Hedrich, Christian/AAW-3958-2020; Rauen, Thomas/GLR-8682-2022; Koga, Tomohiro/AAU-9697-2020; tsokos, george C/O-3360-2013; Hedrich, Christian/AAD-6855-2019; Koga, Tomohiro/V-9397-2019; Crispín, José/I-4919-2019	tsokos, george C/0000-0001-9589-2360; Crispín, José/0000-0002-7590-3621; Rodriguez-Rodriguez, Noe/0000-0001-7825-5634; Hedrich, Christian/0000-0002-1295-6179; Koga, Tomohiro/0000-0003-2077-4428	National Institutes of Health [R01 AI42269, R01 AI49954, R01 AI85567]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI049954, R01AI085567, R01AI042269, R01AI049954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI42269, R01 AI49954, and R01 AI85567 (to G. C. T.).	Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Brenner C, 2007, DEV CELL, V12, P843, DOI 10.1016/j.devcel.2007.05.011; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Feik N, 2005, J IMMUNOL, V174, P1513, DOI 10.4049/jimmunol.174.3.1513; Garefalaki A, 2002, IMMUNITY, V16, P635, DOI 10.1016/S1074-7613(02)00308-4; Harker N, 2011, J IMMUNOL, V186, P6368, DOI 10.4049/jimmunol.1003567; Hassan H, 2011, P NATL ACAD SCI USA, V108, P18330, DOI 10.1073/pnas.1105835108; Hedrich CM, 2013, J BIOL CHEM, V288, P31880, DOI 10.1074/jbc.M113.508655; Hedrich CM, 2012, P NATL ACAD SCI USA, V109, P16606, DOI 10.1073/pnas.1210129109; Hedrich CM, 2011, J BIOL CHEM, V286, P43429, DOI 10.1074/jbc.M111.299339; Hedrich CM, 2011, TRENDS MOL MED, V17, P714, DOI 10.1016/j.molmed.2011.07.005; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Hostert A, 1997, J IMMUNOL, V158, P4270; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Kieffer LJ, 1996, INT IMMUNOL, V8, P1617, DOI 10.1093/intimm/8.10.1617; Kieffer LJ, 1997, J IMMUNOL, V159, P4907; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; LANDOLFI MMT, 1993, J IMMUNOL, V151, P1086; Lee JS, 1996, J BIOL CHEM, V271, P17666, DOI 10.1074/jbc.271.30.17666; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Rauen T, 2013, TRENDS MOL MED, V19, P262, DOI 10.1016/j.molmed.2013.02.001; Rauen T, 2011, J BIOL CHEM, V286, P43437, DOI 10.1074/jbc.M111.299313; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; WU L, 1990, INT IMMUNOL, V2, P51, DOI 10.1093/intimm/2.1.51; Zhang XL, 1998, J IMMUNOL, V161, P2254; Zhang XL, 2001, J EXP MED, V194, P685, DOI 10.1084/jem.194.5.685	31	50	52	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2361	2370		10.1074/jbc.M113.523605	http://dx.doi.org/10.1074/jbc.M113.523605			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24297179	Green Published, hybrid			2022-12-28	WOS:000331130200040
J	Zhou, Y; Waanders, LF; Holmseth, S; Guo, CY; Berger, UV; Li, YC; Lehre, AC; Lehre, KP; Danbolt, NC				Zhou, Yun; Waanders, Leonie F.; Holmseth, Silvia; Guo, Caiying; Berger, Urs V.; Li, Yuchuan; Lehre, Anne-Catherine; Lehre, Knut P.; Danbolt, Niels C.			Proteome Analysis and Conditional Deletion of the EAAT2 Glutamate Transporter Provide Evidence against a Role of EAAT2 in Pancreatic Insulin Secretion in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutamine Synthase; Immunohistochemistry; Insulin Secretion; Pancreatic Islets; Proteomics; Transgenic Mice; Excitatory Amino Acid Transporter; Glutamate Uptake; Slc1a2; VGLUT3	AMINO-ACID TRANSPORTERS; RAT-BRAIN; FUNCTIONAL-CHARACTERIZATION; DIFFERENTIAL EXPRESSION; BETA-CELLS; ISLETS; SPECIFICITY; GENE; CLONING; FAMILY	Background: EAAT2 glutamate transporter was suggested to modulate -cell function. Results: Conditional deletion of EAAT2 in pancreas was without consequences. Proteome analysis showed an abundance of neutral amino acid transporters and glutamate-metabolizing enzymes. No glutamate transporters were detected. Conclusion: EAAT2 plays its main role in the brain. Islet glutamate is predominantly intracellularly produced. Significance: Our work provides an overview of pancreas proteome, and conditional EAAT2 knock-out mice were generated. Islet function is incompletely understood in part because key steps in glutamate handling remain undetermined. The glutamate (excitatory amino acid) transporter 2 (EAAT2; Slc1a2) has been hypothesized to (a) provide islet cells with glutamate, (b) protect islet cells against high extracellular glutamate concentrations, (c) mediate glutamate release, or (d) control the pH inside insulin secretory granules. Here we floxed the EAAT2 gene to produce the first conditional EAAT2 knock-out mice. Crossing with Nestin-cyclization recombinase (Cre) eliminated EAAT2 from the brain, resulting in epilepsy and premature death, confirming the importance of EAAT2 for brain function and validating the genetic construction. Crossing with insulin-Cre lines (RIP-Cre and IPF1-Cre) to obtain pancreas-selective deletion did not appear to affect survival, growth, glucose tolerance, or -cell number. We found (using TaqMan RT-PCR, immunoblotting, immunocytochemistry, and proteome analysis) that the EAAT2 levels were too low to support any of the four hypothesized functions. The proteome analysis detected more than 7,000 islet proteins of which more than 100 were transporters. Although mitochondrial glutamate transporters and transporters for neutral amino acids were present at high levels, all other transporters with known ability to transport glutamate were strikingly absent. Glutamate-metabolizing enzymes were abundant. The level of glutamine synthetase was 2 orders of magnitude higher than that of glutaminase. Taken together this suggests that the uptake of glutamate by islets from the extracellular fluid is insignificant and that glutamate is intracellularly produced. Glutamine synthetase may be more important for islets than assumed previously.	[Zhou, Yun; Holmseth, Silvia; Li, Yuchuan; Lehre, Anne-Catherine; Lehre, Knut P.; Danbolt, Niels C.] Univ Oslo, Inst Basic Med Sci, Neurotransporter Grp, Dept Anat, N-0317 Oslo, Norway; [Waanders, Leonie F.] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Guo, Caiying] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Berger, Urs V.] UB In Situ, Natick, MA 01760 USA	University of Oslo; Max Planck Society; Howard Hughes Medical Institute	Danbolt, NC (corresponding author), Univ Oslo, Inst Basic Med Sci, Neurotransporter Grp, Dept Anat, POB 1105, N-0317 Oslo, Norway.	n.c.danbolt@medisin.uio.no	Danbolt, Niels Christian/A-1907-2014; Zhou, Yun/I-1840-2017; li, JACK/HHC-6755-2022	Danbolt, Niels Christian/0000-0003-4227-4520; Zhou, Yun/0000-0002-5682-0169; 	Norwegian Research Council (Centre of Excellence, Centre for Molecular Biology and Neuroscience); Norwegian Research Council [164297-V40, 183727-S10]; Norwegian Advanced Research Program (Toppforskningsprogrammet)	Norwegian Research Council (Centre of Excellence, Centre for Molecular Biology and Neuroscience); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Advanced Research Program (Toppforskningsprogrammet)	This work was supported by the Norwegian Research Council (Centre of Excellence, Centre for Molecular Biology and Neuroscience, and Grants 164297-V40 and 183727-S10) and by the Norwegian Advanced Research Program (Toppforskningsprogrammet).	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Avila JG, 2003, CELL TRANSPLANT, V12, P877, DOI 10.3727/000000003771000228; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Baglietto-Vargas D, 2004, BIOCHEM J, V381, P483, DOI 10.1042/BJ20040523; Bai LQ, 2003, AM J PHYSIOL-GASTR L, V284, pG808, DOI 10.1152/ajpgi.00333.2002; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Beckstrom H, 1999, J NEUROSCI RES, V55, P218, DOI 10.1002/(SICI)1097-4547(19990115)55:2<218::AID-JNR9>3.3.CO;2-C; Berger UV, 2006, ANAT EMBRYOL, V211, P595, DOI 10.1007/s00429-006-0109-x; Berger UV, 1998, ANAT EMBRYOL, V198, P13, DOI 10.1007/s004290050161; Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; BERTRAND G, 1995, AM J PHYSIOL-ENDOC M, V269, pE551, DOI 10.1152/ajpendo.1995.269.3.E551; BLISS CR, 1992, AM J PHYSIOL, V263, pE890, DOI 10.1152/ajpendo.1992.263.5.E890; Broer S, 2011, BIOCHEM J, V436, P193, DOI 10.1042/BJ20101912; Brosnan JT, 2000, J NUTR, V130, p988S, DOI 10.1093/jn/130.4.988S; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Chen XM, 1999, J CLIN INVEST, V103, P1159, DOI 10.1172/JCI5392; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Daigle ND, 2009, J CELL PHYSIOL, V220, P680, DOI 10.1002/jcp.21814; Danbolt NC, 1998, METHOD ENZYMOL, V296, P388; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; DANBOLT NC, 1990, BIOCHEMISTRY-US, V29, P6734, DOI 10.1021/bi00480a025; Danzer C, 2012, J PROTEOME RES, V11, P1598, DOI 10.1021/pr2007895; DEAN PM, 1973, DIABETOLOGIA, V9, P115, DOI 10.1007/BF01230690; Delacour A, 2004, MECH DEVELOP, V121, P3, DOI 10.1016/j.mod.2003.11.004; Di Cairano ES, 2011, J BIOL CHEM, V286, P14007, DOI 10.1074/jbc.M110.183517; Dixon G, 2003, J ENDOCRINOL, V179, P447, DOI 10.1677/joe.0.1790447; Eto K, 2003, AM J PHYSIOL-ENDOC M, V285, pE262, DOI 10.1152/ajpendo.00542.2002; Fahien LA, 2011, DIABETES, V60, P2450, DOI 10.2337/db10-1150; Fava E, 2012, DIABETOLOGIA, V55, P1013, DOI 10.1007/s00125-011-2438-4; Feldmann N, 2011, MOL CELL ENDOCRINOL, V338, P46, DOI 10.1016/j.mce.2011.02.019; Frigerio F, 2008, BBA-BIOENERGETICS, V1777, P965, DOI 10.1016/j.bbabio.2008.04.031; Fukushima D, 2010, J PHYSIOL PHARMACOL, V61, P265; Furness DN, 2008, NEUROSCIENCE, V157, P80, DOI 10.1016/j.neuroscience.2008.08.043; Gammelsaeter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022960; Graham TE, 2000, AM J PHYSIOL-ENDOC M, V278, pE83, DOI 10.1152/ajpendo.2000.278.1.E83; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Harada T, 2009, PANCREATOLOGY, V9, P13, DOI 10.1159/000178871; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; Holmseth S, 2006, ANAT EMBRYOL, V211, P257, DOI 10.1007/s00429-005-0077-6; Holmseth S, 2005, NEUROSCIENCE, V136, P649, DOI 10.1016/j.neuroscience.2005.07.022; Holmseth S, 2009, NEUROSCIENCE, V162, P1055, DOI 10.1016/j.neuroscience.2009.03.048; Holmseth S, 2012, J HISTOCHEM CYTOCHEM, V60, P174, DOI 10.1369/0022155411434828; In't Veld P, 2010, ADV EXP MED BIOL, V654, P1, DOI 10.1007/978-90-481-3271-3_1; Jermendy A, 2011, DIABETOLOGIA, V54, P594, DOI 10.1007/s00125-010-2036-x; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Julio-Pieper M, 2011, PHARMACOL REV, V63, P35, DOI 10.1124/pr.110.004036; Kambe T, 2011, BIOSCI BIOTECH BIOCH, V75, P1036, DOI 10.1271/bbb.110056; Kim SY, 2003, J NEUROCHEM, V86, P1458, DOI 10.1046/j.1471-4159.2003.01958.x; Kiryk A, 2008, NEUROTOX RES, V13, P19, DOI 10.1007/BF03033364; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Lehre AC, 2011, EPILEPSY RES, V95, P70, DOI 10.1016/j.eplepsyres.2011.02.014; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; LEVY LM, 1993, FEBS LETT, V317, P79, DOI 10.1016/0014-5793(93)81495-L; Li CH, 2004, J BIOL CHEM, V279, P13393, DOI 10.1074/jbc.M311502200; Li DD, 2013, J NEUROSCI, V33, P4434, DOI 10.1523/JNEUROSCI.3667-12.2013; Li YC, 2012, J HISTOCHEM CYTOCHEM, V60, P811, DOI 10.1369/0022155412458589; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LIU QR, 1992, P NATL ACAD SCI USA, V89, P12145, DOI 10.1073/pnas.89.24.12145; Lorincz A, 2008, J NEUROSCI, V28, P9083, DOI 10.1523/JNEUROSCI.2494-08.2008; MacDonald MJ, 2011, J BIOL CHEM, V286, P18383, DOI 10.1074/jbc.M111.241182; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Manfras BJ, 1995, EXP CLIN ENDOCR DIAB, V103, P95, DOI 10.1055/s-0029-1211402; Matsuo H, 2002, J BIOL CHEM, V277, P21017, DOI 10.1074/jbc.M200019200; Meabon JS, 2012, J HISTOCHEM CYTOCHEM, V60, P139, DOI 10.1369/0022155411430095; Milton ID, 1997, MOL BRAIN RES, V52, P17, DOI 10.1016/S0169-328X(97)00233-7; Montero F, 2007, BIOCHIMIE, V89, P1366, DOI 10.1016/j.biochi.2007.05.008; Moriyama Y, 2003, TRENDS PHARMACOL SCI, V24, P511, DOI 10.1016/j.tips.2003.08.002; Newsholme P, 2011, FRONT BIOSCI-LANDMRK, V16, P315, DOI 10.2741/3690; Nissim I, 1999, AM J PHYSIOL-RENAL, V277, pF493, DOI 10.1152/ajprenal.1999.277.4.F493; Palacin M, 2005, PHYSIOLOGY, V20, P112, DOI 10.1152/physiol.00051.2004; Parra LA, 2008, MOL PHARMACOL, V74, P1521, DOI 10.1124/mol.108.050005; Petyuk VA, 2008, J PROTEOME RES, V7, P3114, DOI 10.1021/pr800205b; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Pollard M, 2000, FEBS LETT, V484, P74, DOI 10.1016/S0014-5793(00)02114-1; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Svensson P, 2009, MOL CELL BIOL, V29, P2129, DOI 10.1128/MCB.01644-08; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Thwaites DT, 2011, BRIT J PHARMACOL, V164, P1802, DOI 10.1111/j.1476-5381.2011.01438.x; Tong QC, 2002, AM J PHYSIOL-ENDOC M, V282, pE1324, DOI 10.1152/ajpendo.00460.2001; Treutelaar MK, 2003, DIABETES, V52, P2503, DOI 10.2337/diabetes.52.10.2503; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Waanders LF, 2008, MOL CELL PROTEOMICS, V7, P1452, DOI 10.1074/mcp.M800141-MCP200; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; Yamada S, 2001, ENDOCR J, V48, P391, DOI 10.1507/endocrj.48.391; Zaia KA, 2009, J BIOL CHEM, V284, P8439, DOI 10.1074/jbc.M806407200; Zhou Y, 2012, AM J PHYSIOL-RENAL, V302, pF316, DOI 10.1152/ajprenal.00464.2011; Zlotnik A, 2011, J NEUROSURG ANESTH, V23, P45, DOI 10.1097/ANA.0b013e3181f82a8f	98	36	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1329	1344		10.1074/jbc.M113.529065	http://dx.doi.org/10.1074/jbc.M113.529065			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24280215	Green Published, hybrid			2022-12-28	WOS:000332401700012
J	DeSantis, ME; Sweeny, EA; Snead, D; Leung, EH; Go, MS; Gupta, K; Wendler, P; Shorter, J				DeSantis, Morgan E.; Sweeny, Elizabeth A.; Snead, David; Leung, Eunice H.; Go, Michelle S.; Gupta, Kushol; Wendler, Petra; Shorter, James			Conserved Distal Loop Residues in the Hsp104 and ClpB Middle Domain Contact Nucleotide-binding Domain 2 and Enable Hsp70-dependent Protein Disaggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL ATPASE DOMAIN; SACCHAROMYCES-CEREVISIAE; SUBSTRATE TRANSLOCATION; MASS-SPECTROMETRY; CHAPERONE SYSTEM; CENTRAL PORE; MECHANISM; DNAK; THERMOTOLERANCE; HSP70	The homologous hexameric AAA(+) proteins, Hsp104 from yeast and ClpB from bacteria, collaborate with Hsp70 to dissolve disordered protein aggregates but employ distinct mechanisms of intersubunit collaboration. How Hsp104 and ClpB coordinate polypeptide handover with Hsp70 is not understood. Here, we define conserved distal loop residues between middle domain (MD) helix 1 and 2 that are unexpectedly critical for Hsp104 and ClpB collaboration with Hsp70. Surprisingly, the Hsp104 and ClpB MD distal loop does not contact Hsp70 but makes intrasubunit contacts with nucleotide-binding domain 2 (NBD2). Thus, the MD does not invariably project out into solution as in one structural model of Hsp104 and ClpB hexamers. These intrasubunit contacts as well as those between MD helix 2 and NBD1 are different in Hsp104 and ClpB. NBD2-MD contacts dampen disaggregase activity and must separate for protein disaggregation. We demonstrate that ClpB requires DnaK more stringently than Hsp104 requires Hsp70 for protein disaggregation. Thus, we reveal key differences in how Hsp104 and ClpB coordinate polypeptide handover with Hsp70, which likely reflects differential tuning for yeast and bacterial proteostasis.	[DeSantis, Morgan E.; Sweeny, Elizabeth A.; Snead, David; Leung, Eunice H.; Go, Michelle S.; Gupta, Kushol; Shorter, James] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [DeSantis, Morgan E.; Sweeny, Elizabeth A.; Shorter, James] Univ Penn, Perelman Sch Med, Biochem & Mol Biophys Grad Grp, Philadelphia, PA 19104 USA; [Wendler, Petra] Univ Munich, Gene Ctr, Dept Biochem, D-81377 Munich, Germany	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Munich	Shorter, J (corresponding author), 805B Stellar Chance Labs, 422 Curie Blvd, Philadelphia, PA 19104 USA.	jshorter@mail.med.upenn.edu	Wendler, Petra/X-5799-2019; Gupta, Kushol/GOE-5620-2022; Wendler, Petra/C-9056-2014; Shorter, James/ABE-7307-2020	Gupta, Kushol/0000-0002-7006-2667; Wendler, Petra/0000-0002-8285-2199; Shorter, James/0000-0001-5269-8533; Sweeny, Elizabeth/0000-0001-7818-9112	National Institutes of Health (NIH) Training Grant [T32GM071339]; National Research Service Award Predoctoral Fellowship [F31NS079009]; NIH Training Grant [T32GM008275]; American Heart Association predoctoral fellowship; NIH Director's New Innovator Award [DP2OD002177]; Ellison Medical Foundation New Scholar in Aging Award; NIH Grant [R01GM099836]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071339, R01GM099836, T32GM008275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS079009] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002177] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Training Grant; National Research Service Award Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association predoctoral fellowship(American Heart Association); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation New Scholar in Aging Award(Lawrence Ellison Foundation); NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health (NIH) Training Grant T32GM071339 and National Research Service Award Predoctoral Fellowship F31NS079009 (to M. E. D.), NIH Training Grant T32GM008275 and an American Heart Association predoctoral fellowship (to E. A. S.), NIH Director's New Innovator Award DP2OD002177, Ellison Medical Foundation New Scholar in Aging Award, and NIH Grant R01GM099836 (to J. S.).	Barends TRM, 2010, CURR OPIN STRUC BIOL, V20, P46, DOI 10.1016/j.sbi.2009.12.014; Bohon J, 2008, STRUCTURE, V16, P1157, DOI 10.1016/j.str.2008.04.016; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; Coelho M, 2013, CURR BIOL, V23, P1844, DOI 10.1016/j.cub.2013.07.084; DeSantis ME, 2012, CHEM BIOL, V19, P1400, DOI 10.1016/j.chembiol.2012.09.013; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Doyle SM, 2007, P NATL ACAD SCI USA, V104, P11138, DOI 10.1073/pnas.0703980104; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Gupta S, 2007, J SYNCHROTRON RADIAT, V14, P233, DOI 10.1107/S0909049507013118; Haslberger T, 2008, NAT STRUCT MOL BIOL, V15, P641, DOI 10.1038/nsmb.1425; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hinault MP, 2010, J BIOL CHEM, V285, P38173, DOI 10.1074/jbc.M110.127753; Kaur P, 2009, ANAL CHEM, V81, P8141, DOI 10.1021/ac9013644; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krzewska J, 2001, FEBS LETT, V489, P92, DOI 10.1016/S0014-5793(00)02423-6; Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Mackay RG, 2008, BIOCHEMISTRY-US, V47, P1918, DOI 10.1021/bi701714s; Mayne L, 2011, J AM SOC MASS SPECTR, V22, P1898, DOI 10.1007/s13361-011-0235-4; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; Saibil HR, 2013, SCIENCE, V339, P1040, DOI 10.1126/science.1236012; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Senechal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006939; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Shorter J, 2005, NAT STRUCT MOL BIOL, V12, P4, DOI 10.1038/nsmb0105-4; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Sweeny EA, 2011, JOVE-J VIS EXP, DOI 10.3791/3190; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2010, BIOCHEM CELL BIOL, V88, P89, DOI [10.1139/O09-164, 10.1139/o09-164]; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Xu GZ, 2005, ANAL CHEM, V77, P3029, DOI 10.1021/ac048282z; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062454; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Zolkiewski M, 1999, PROTEIN SCI, V8, P1899, DOI 10.1110/ps.8.9.1899	69	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					848	867		10.1074/jbc.M113.520759	http://dx.doi.org/10.1074/jbc.M113.520759			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24280225	Green Published, hybrid			2022-12-28	WOS:000330541200022
J	Oger, F; Dubois-Chevalier, J; Gheeraert, C; Avner, S; Durand, E; Froguel, P; Salbert, G; Staels, B; Lefebvre, P; Eeckhoute, J				Oger, Frederik; Dubois-Chevalier, Julie; Gheeraert, Celine; Avner, Stephane; Durand, Emmanuelle; Froguel, Philippe; Salbert, Gilles; Staels, Bart; Lefebvre, Philippe; Eeckhoute, Jerome			Peroxisome Proliferator-activated Receptor gamma Regulates Genes Involved in Insulin/Insulin-like Growth Factor Signaling and Lipid Metabolism during Adipogenesis through Functionally Distinct Enhancer Classes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; DNA METHYLATION; ADIPOSE-TISSUE; CHROMATIN STATE; CELL; ADIPOCYTES; BINDING; FAT; DIFFERENTIATION; EXPLORATION	The nuclear receptor peroxisome proliferator-activated receptor (PPAR) gamma is a transcription factor whose expression is induced during adipogenesis and that is required for the acquisition and control of mature adipocyte functions. Indeed, PPAR gamma induces the expression of genes involved in lipid synthesis and storage through enhancers activated during adipocyte differentiation. Here, we show that PPAR gamma also binds to enhancers already active in preadipocytes as evidenced by an active chromatin state including lower DNA methylation levels despite higher CpG content. These constitutive enhancers are linked to genes involved in the insulin/insulin-like growth factor signaling pathway that are transcriptionally induced during adipogenesis but to a lower extent than lipid metabolism genes, because of stronger basal expression levels in preadipocytes. This is consistent with the sequential involvement of hormonal sensitivity and lipid handling during adipocyte maturation and correlates with the chromatin structure dynamics at constitutive and activated enhancers. Interestingly, constitutive enhancers are evolutionary conserved and can be activated in other tissues, in contrast to enhancers controlling lipid handling genes whose activation is more restricted to adipocytes. Thus, PPAR gamma utilizes both broadly active and cell type-specific enhancers to modulate the dynamic range of activation of genes involved in the adipogenic process.	[Oger, Frederik; Dubois-Chevalier, Julie; Gheeraert, Celine; Staels, Bart; Lefebvre, Philippe; Eeckhoute, Jerome] INSERM, UMR U1011, F-59000 Lille, France; [Oger, Frederik; Dubois-Chevalier, Julie; Gheeraert, Celine; Durand, Emmanuelle; Froguel, Philippe; Staels, Bart; Lefebvre, Philippe; Eeckhoute, Jerome] Univ Lille 2, F-59000 Lille, France; [Oger, Frederik; Dubois-Chevalier, Julie; Gheeraert, Celine; Staels, Bart; Lefebvre, Philippe; Eeckhoute, Jerome] Inst Pasteur, F-59019 Lille, France; [Oger, Frederik; Dubois-Chevalier, Julie; Gheeraert, Celine; Durand, Emmanuelle; Froguel, Philippe; Staels, Bart; Lefebvre, Philippe; Eeckhoute, Jerome] European Genom Inst Diabet, F-59000 Lille, France; [Avner, Stephane; Salbert, Gilles] Univ Rennes 1, F-35042 Rennes, France; [Avner, Stephane; Salbert, Gilles] CNRS, UMR6290, Team SP RTE, F-35042 Rennes, France; [Durand, Emmanuelle; Froguel, Philippe] CNRS, UMR 8199, F-59000 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Lefebvre, P (corresponding author), Univ Lille Nord France, Fac Med Lille Pole Rech, INSERM, UMR 1011, Batiment J&K,Blvd Prof Leclerc, F-59045 Lille, France.	philippe-claude.lefebvre@inserm.fr; jerome.eeckhoute@inserm.fr	Staels, Bart/N-9497-2016; Salbert, Gilles/W-9196-2019; Lefebvre, Philippe/F-2685-2010; Eeckhoute, Jerome/AAN-8219-2021; FROGUEL, Philippe/O-6799-2017	Staels, Bart/0000-0002-3784-1503; Salbert, Gilles/0000-0001-6115-4140; Lefebvre, Philippe/0000-0002-9366-5129; Eeckhoute, Jerome/0000-0002-7222-9264; FROGUEL, Philippe/0000-0003-2972-0784; Oger, Frederik/0000-0003-0006-5835; Dubois-Chevalier, Julie/0000-0003-0471-752X; Avner, Stephane/0000-0001-7413-1327	OSEO-ANVAR IT-DIAB; European Genomic Institute for Diabetes [ANR-10-LABX-46]; Medical Research Council [G1002084] Funding Source: researchfish; MRC [G1002084] Funding Source: UKRI	OSEO-ANVAR IT-DIAB; European Genomic Institute for Diabetes; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from OSEO-ANVAR IT-DIAB and European Genomic Institute for Diabetes Grant ANR-10-LABX-46.	Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Boucher J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1905; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; Eeckhoute J, 2012, PPAR RES, V2012, DOI 10.1155/2012/164140; Ernst J, 2013, GENOME RES, V23, P1142, DOI 10.1101/gr.144840.112; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henry SL, 2012, INT J BIOCHEM CELL B, V44, P435, DOI 10.1016/j.biocel.2011.12.011; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang YW, 2012, CELL, V150, P234, DOI 10.1016/j.cell.2012.06.022; Lefebvre B, 2010, J CLIN INVEST, V120, P1454, DOI 10.1172/JCI38606; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; MacIsaac KD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000773; Matsusue K, 2004, FASEB J, V18, P1477, DOI 10.1096/fj.04-1944fje; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Rigamonti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017637; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; Serandour AA, 2012, NUCLEIC ACIDS RES, V40, P8255, DOI 10.1093/nar/gks595; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siersbaek MS, 2012, MOL CELL BIOL, V32, P3452, DOI 10.1128/MCB.00526-12; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Smith U, 2001, FASEB J, V15, P215, DOI 10.1096/fj.00-0020com; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang W, 2011, CELL METAB, V14, P116, DOI 10.1016/j.cmet.2011.05.012; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Waki H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002311; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Wozniak SE, 2009, DIGEST DIS SCI, V54, P1847, DOI 10.1007/s10620-008-0585-3; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Wu DY, 2011, TRENDS ENDOCRIN MET, V22, P474, DOI 10.1016/j.tem.2011.07.006; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang ZZ, 2013, J COMPUT BIOL, V20, P237, DOI 10.1089/cmb.2012.0233; Zhou HY, 2013, ELIFE, V2, DOI 10.7554/eLife.00170	57	35	38	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					708	722		10.1074/jbc.M113.526996	http://dx.doi.org/10.1074/jbc.M113.526996			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24288131	Green Published, hybrid			2022-12-28	WOS:000330541200011
J	Blanco-Suarez, E; Hanley, JG				Blanco-Suarez, Elena; Hanley, Jonathan G.			Distinct Subunit-specific alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Trafficking Mechanisms in Cultured Cortical and Hippocampal Neurons in Response to Oxygen and Glucose Deprivation*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Excitotoxicity; Glutamate Receptors Ionotropic (AMPA; NMDA); Ischemia; Neurons; Receptor Endocytosis	LONG-TERM POTENTIATION; GLOBAL-ISCHEMIA; MOLECULAR-MECHANISMS; SYNAPTIC PLASTICITY; BRAIN ISCHEMIA; EXPRESSION; DEATH; ENDOCYTOSIS; SYNAPSES; PROTEINS	Background: Hippocampal CA1 neurons are more vulnerable to global ischemia than cortical neurons. Rapid internalization of GluA2 subunit contributes to OGD-induced hippocampal neuronal death. Results: GluA2 subunit is not internalized in response to OGD in cortical neurons. Conclusion: A crucial aspect of the mechanism leading to cell death is absent in cortical neurons. Significance: Differences in GluA2 trafficking may contribute to neuronal vulnerability to ischemia. Brain ischemia occurs when the blood supply to the brain is interrupted, leading to oxygen and glucose deprivation (OGD). This triggers a cascade of events causing a synaptic accumulation of glutamate. Excessive activation of glutamate receptors results in excitotoxicity and delayed cell death in vulnerable neurons. Following global cerebral ischemia, hippocampal CA1 pyramidal neurons are more vulnerable to injury than their cortical counterparts. The mechanisms that underlie this difference are unclear. Cultured hippocampal neurons respond to OGD with a rapid internalization of AMPA receptor (AMPAR) subunit GluA2, resulting in a switch from GluA2-containing Ca2+-impermeable receptors to GluA2-lacking Ca2+-permeable subtypes (CP-AMPARs). GluA2 internalization is a critical component of OGD-induced cell death in hippocampal neurons. It is unknown how AMPAR trafficking is affected in cortical neurons following OGD. Here, we show that cultured cortical neurons are resistant to an OGD insult that causes cell death in hippocampal neurons. GluA1 is inserted at the plasma membrane in both cortical and hippocampal neurons in response to OGD. In contrast, OGD causes a rapid endocytosis of GluA2 in hippocampal neurons, which is absent in cortical neurons. These data demonstrate that populations of neurons with different vulnerabilities to OGD recruit distinct cell biological mechanisms in response to insult, and that a crucial aspect of the mechanism leading to OGD-induced cell death is absent in cortical neurons. This strongly suggests that the absence of OGD-induced GluA2 trafficking contributes to the relatively low vulnerability of cortical neurons to ischemia.	[Blanco-Suarez, Elena; Hanley, Jonathan G.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	University of Bristol	Hanley, JG (corresponding author), Univ Bristol, Sch Biochem, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	jon.hanley@bristol.ac.uk		Hanley, Jonathan/0000-0003-1704-4707; Blanco-Suarez, Elena/0000-0002-2131-6376	SyMBaD-ITN ("Synapses: From Molecules to higher Brain Function and Diseases," Initial Training Network) Marie Curie Actions Grant [238608]; MRC [MR/L011131/1] Funding Source: UKRI; Medical Research Council [MR/L011131/1] Funding Source: researchfish	SyMBaD-ITN ("Synapses: From Molecules to higher Brain Function and Diseases," Initial Training Network) Marie Curie Actions Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by SyMBaD-ITN ("Synapses: From Molecules to higher Brain Function and Diseases," Initial Training Network) Marie Curie Actions Grant 238608.	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Ashby MC, 2004, TRENDS NEUROSCI, V27, P257, DOI 10.1016/j.tins.2004.03.010; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Cronberg T, 2005, EUR J NEUROSCI, V22, P310, DOI 10.1111/j.1460-9568.2005.04235.x; Dixon RM, 2009, J BIOL CHEM, V284, P14230, DOI 10.1074/jbc.M901203200; Forder JP, 2009, NEUROSCIENCE, V158, P293, DOI 10.1016/j.neuroscience.2008.10.021; Gorter JA, 1997, J NEUROSCI, V17, P6179; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jaafari N, 2012, J NEUROSCI, V32, P11618, DOI 10.1523/JNEUROSCI.5068-11.2012; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Man HY, 2011, CURR OPIN NEUROBIOL, V21, P291, DOI 10.1016/j.conb.2011.01.001; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Shepherd JD, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00049; Soundarapandian MM, 2005, MOL NEUROBIOL, V32, P145, DOI 10.1385/MN:32:2:145; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yang YL, 2010, P NATL ACAD SCI USA, V107, P11999, DOI 10.1073/pnas.0913004107	34	20	21	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4644	4651		10.1074/jbc.M113.533182	http://dx.doi.org/10.1074/jbc.M113.533182			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403083	Green Published, hybrid			2022-12-28	WOS:000331607900012
J	Engle, SJ; Vincent, F				Engle, Sandra J.; Vincent, Fabien			Small Molecule Screening in Human Induced Pluripotent Stem Cell-derived Terminal Cell Types	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Drug Action; Drug Development; Drug Discovery; Drug Screening; Stem Cells	EFFICIENT DIFFERENTIATION; DIRECTED DIFFERENTIATION; SCALABLE EXPANSION; KINASE INHIBITOR; PROGENITOR CELLS; MOTOR-NEURONS; SOMATIC-CELLS; DRUG; GENERATION; DISEASE	A need for better clinical outcomes has heightened interest in the use of physiologically relevant human cells in the drug discovery process. Patient-specific human induced pluripotent stem cells may offer a relevant, robust, scalable, and cost-effective model of human disease physiology. Small molecule high throughput screening in human induced pluripotent stem cell-derived cells with the intent of identifying novel therapeutic compounds is starting to influence the drug discovery process; however, the use of these cells presents many high throughput screening development challenges. This technology has the potential to transform the way drug discovery is performed.	[Engle, Sandra J.; Vincent, Fabien] Pfizer Inc, Dynam & Metab New Chem Ent, Pharmacokinet, Groton, CT 06340 USA	Pfizer	Engle, SJ (corresponding author), Pfizer Inc, Dynam & Metab New Chem Ent, Pharmacokinet, Groton, CT 06340 USA.	sandra.j.engle@pfizer.com						Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Almeida S, 2012, CELL REP, V2, P789, DOI 10.1016/j.celrep.2012.09.007; Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; An WF, 2010, MOL BIOTECHNOL, V45, P180, DOI 10.1007/s12033-010-9251-z; Andrews PD, 2010, BIOCHEM J, V432, P21, DOI 10.1042/BJ20101022; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Barbaric I, 2010, STEM CELL RES, V5, P104, DOI 10.1016/j.scr.2010.04.006; Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Blancas AA, 2011, STEM CELLS DEV, V20, P2153, DOI 10.1089/scd.2010.0432; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Brown ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011373; Burkhardt MF, 2013, MOL CELL NEUROSCI, V56, P355, DOI 10.1016/j.mcn.2013.07.007; Burridge Paul W, 2013, Methods Mol Biol, V997, P149, DOI 10.1007/978-1-62703-348-0_12; Cao N, 2013, CELL RES, V23, P1119, DOI 10.1038/cr.2013.102; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Charbord J, 2013, STEM CELLS, V31, P1816, DOI 10.1002/stem.1430; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Choi SM, 2013, HEPATOLOGY, V57, P2458, DOI 10.1002/hep.26237; Crompton LA, 2013, STEM CELL RES, V11, P1206, DOI 10.1016/j.scr.2013.08.002; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Desbordes SC, 2013, NAT PROTOC, V8, P111, DOI 10.1038/nprot.2012.139; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eggert US, 2013, NAT CHEM BIOL, V9, P206, DOI 10.1038/nchembio.1206; Eglen R, 2011, ASSAY DRUG DEV TECHN, V9, P108, DOI 10.1089/adt.2010.0305; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Goldbard S, 2006, CURR OPIN DRUG DISC, V9, P110; Guo L, 2011, TOXICOL SCI, V123, P281, DOI 10.1093/toxsci/kfr158; Haupt S, 2012, BIOTECHNOL APPL BIOC, V59, P77, DOI 10.1002/bab.1014; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Kang SJ, 2013, CELL BIOL TOXICOL, V29, P1, DOI 10.1007/s10565-012-9223-0; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Li ZH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2059; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Ma XC, 2013, STEM CELL TRANSL MED, V2, P409, DOI 10.5966/sctm.2012-0160; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Makhortova NR, 2011, NAT CHEM BIOL, V7, P544, DOI [10.1038/NCHEMBIO.595, 10.1038/nchembio.595]; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; McNeish J, 2010, J BIOL CHEM, V285, P17209, DOI 10.1074/jbc.M109.098814; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Minami I, 2012, CELL REP, V2, P1448, DOI 10.1016/j.celrep.2012.09.015; Muller LUW, 2012, BLOOD, V119, P5449, DOI 10.1182/blood-2012-02-408674; Nemes C., 2013, TISSUE ENG C, DOI 10.1089/ten.tec.2013.0026; Nolan GP, 2007, NAT CHEM BIOL, V3, P187, DOI 10.1038/nchembio0407-187; Oh SW, 2012, ARCH PHARM RES, V35, P1979, DOI 10.1007/s12272-012-1115-6; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; Panzica-Kelly JM, 2013, TOXICOL SCI, V131, P447, DOI 10.1093/toxsci/kfs293; Park TS, 2013, CYTOM PART A, V83A, P114, DOI 10.1002/cyto.a.22090; Peng J, 2013, J BIOMOL SCREEN, V18, P522, DOI 10.1177/1087057112474468; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Prescott C, 2011, PHILOS T R SOC B, V366, P2323, DOI 10.1098/rstb.2011.0047; Puttonen KA, 2013, CELL TRANSPLANT, V22, P1753, DOI 10.3727/096368912X658764; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Sams-Dodd F, 2013, DRUG DISCOV TODAY, V18, P211, DOI 10.1016/j.drudis.2012.10.010; Samuel R, 2013, P NATL ACAD SCI USA, V110, P12774, DOI 10.1073/pnas.1310675110; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Seki T, 2012, NAT PROTOC, V7, P718, DOI 10.1038/nprot.2012.015; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203; Sherman SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054948; Sherman SP, 2011, METHODS MOL BIOL, V767, P283, DOI 10.1007/978-1-61779-201-4_21; Sirenko O, 2013, J BIOMOL SCREEN, V18, P39, DOI 10.1177/1087057112457590; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takenaka T, 2001, BJU INT, V88, P7; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Wang Y, 2013, STEM CELL RES, V11, P1103, DOI 10.1016/j.scr.2013.07.011; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Xu T, 2013, STEM CELL TRANSL MED, V2, P355, DOI 10.5966/sctm.2012-0172; Xu XH, 2013, STEM CELL RES, V10, P213, DOI 10.1016/j.scr.2012.11.005; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yahata N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025788; Yang CS, 2011, STEM CELLS, V29, P1528, DOI 10.1002/stem.717; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003; Yoo CH, 2013, BIOMATERIALS, V34, P8149, DOI 10.1016/j.biomaterials.2013.07.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yung SK, 2013, STEM CELLS, V31, P1022, DOI 10.1002/stem.1308; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao WN, 2012, J BIOMOL SCREEN, V17, P1252, DOI 10.1177/1087057112456876; Zheng W, 2013, DRUG DISCOV TODAY, V18, P1067, DOI 10.1016/j.drudis.2013.07.001; Zweigerdt R, 2011, NAT PROTOC, V6, P689, DOI 10.1038/nprot.2011.318	98	34	35	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4562	4570		10.1074/jbc.R113.529156	http://dx.doi.org/10.1074/jbc.R113.529156			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24362033	Green Published, hybrid			2022-12-28	WOS:000331607900004
J	Iwai, K; Shibukawa, Y; Yamazaki, N; Wada, Y				Iwai, Kaori; Shibukawa, Yukinao; Yamazaki, Natsuko; Wada, Yoshinao			Transglutaminase 2-dependent Deamidation of Glyceraldehyde-3-phosphate Dehydrogenase Promotes Trophoblastic Cell Fusion*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Cytoskeleton; Protein Deamidation; Transglutaminases; Trophoblast; Cell Fusion; Glyceraldehyde-3-phosphate Dehydrogenase	TISSUE TRANSGLUTAMINASE; MULTIFUNCTIONAL PROTEIN; CELIAC-DISEASE; HUMAN PLACENTA; SYNCYTIN; EXPRESSION; ACTIN; GCMA; SYNCYTIOTROPHOBLAST; IDENTIFICATION	Background: This work explores proteins participating in trophoblastic cell fusion. Results: Gln-deamidated GAPDH accumulates at the plasma membrane and promotes cell fusion. Conclusion: Transglutaminase-2 regulates trophoblastic cell fusion through GAPDH deamidation. Significance: GAPDH and transglutaminase-2 have a novel function in cell fusion. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a multifunctional protein as well as a classic glycolytic enzyme, and its pleiotropic functions are achieved by various post-translational modifications and the resulting translocations to intracellular compartments. In the present study, GAPDH in the plasma membrane of BeWo choriocarcinoma cells displayed a striking acidic shift in two-dimensional electrophoresis after cell-cell fusion induction by forskolin. This post-translational modification was deamidation of multiple glutaminyl residues, as determined by molecular mass measurement and tandem mass spectrometry of acidic GAPDH isoforms. Transglutaminase (TG) inhibitors prevented this acidic shift and reduced cell fusion. Knockdown of the TG2 gene by short hairpin RNA reproduced these effects of TG inhibitors. Various GAPDH mutants with replacement of different numbers (one to seven) of Gln by Glu were expressed in BeWo cells. These deamidated mutants reversed the suppressive effect of wild-type GAPDH overexpression on cell fusion. Interestingly, the mutants accumulated in the plasma membrane, and this accumulation was increased according to the number of Gln/Glu substitutions. Considering that GAPDH binds F-actin via an electrostatic interaction and that the cytoskeleton is rearranged in trophoblastic cell fusion, TG2-dependent GAPDH deamidation was suggested to participate in actin cytoskeletal remodeling.	[Iwai, Kaori; Shibukawa, Yukinao; Yamazaki, Natsuko; Wada, Yoshinao] Osaka Med Ctr, Dept Mol Med, Izumi Ku, Osaka 5941101, Japan; [Iwai, Kaori; Shibukawa, Yukinao; Yamazaki, Natsuko; Wada, Yoshinao] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka 5941101, Japan; [Iwai, Kaori; Wada, Yoshinao] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University	Wada, Y (corresponding author), Osaka Med Ctr, Dept Mol Med, Izumi Ku, 840 Murodo Cho, Osaka 5941101, Japan.	waday@mch.pref.osaka.jp			Japan Society for the Promotion of Science [23390081, 24591618, 22-3627]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Scientific Research B (23390081) and C (24591618) and for JSPS Fellows (22-3627) from the Japan Society for the Promotion of Science.	Andrade J, 2004, BIOCHEM J, V384, P327, DOI 10.1042/BJ20040622; Anjum N, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-16; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; BIRCKBICHLER PJ, 1981, P NATL ACAD SCI-BIOL, V78, P5005, DOI 10.1073/pnas.78.8.5005; Boros S, 2008, EXP EYE RES, V86, P383, DOI 10.1016/j.exer.2007.11.011; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; CHANEY LK, 1983, J BIOL CHEM, V258, P62; Chang CW, 2011, MOL CELL BIOL, V31, P3820, DOI 10.1128/MCB.05582-11; COUTIFARIS C, 1991, DEVELOPMENT, V113, P767; Del Bello A, 2012, TRANSPLANTATION, V93, P936, DOI 10.1097/TP.0b013e31824b3720; Di Simone N, 2010, AM J GASTROENTEROL, V105, P2254, DOI 10.1038/ajg.2010.233; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; Forlemu NY, 2011, PROTEINS, V79, P2813, DOI 10.1002/prot.23107; Fornelli L, 2011, CHEM-EUR J, V17, P486, DOI 10.1002/chem.201002483; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Hager H, 1997, J PATHOL, V181, P106, DOI 10.1002/(SICI)1096-9896(199701)181:1<106::AID-PATH725>3.0.CO;2-K; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kiefte-de Jong JC, 2013, GASTROENTEROLOGY, V144, P726, DOI 10.1053/j.gastro.2013.01.003; Kiraly R, 2011, FEBS J, V278, P4717, DOI 10.1111/j.1742-4658.2011.08345.x; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Nurminskaya MV, 2012, INT REV CEL MOL BIO, V294, P1, DOI 10.1016/B978-0-12-394305-7.00001-X; Reiss N, 1996, BIOCHEM MOL BIOL INT, V40, P1191; Robinson NJ, 2007, BIOL REPROD, V77, P648, DOI 10.1095/biolreprod.107.061747; Ruebner M, 2012, J CELL BIOCHEM, V113, P2383, DOI 10.1002/jcb.24110; Schmid AW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176149; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shibukawa Y, 2010, MOL BIOL CELL, V21, P3973, DOI 10.1091/mbc.E10-03-0261; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200	39	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4989	4999		10.1074/jbc.M113.525568	http://dx.doi.org/10.1074/jbc.M113.525568			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24375405	hybrid, Green Published			2022-12-28	WOS:000331607900044
J	Nakamichi, Y; Mikami, B; Murata, K; Hashimoto, W				Nakamichi, Yusuke; Mikami, Bunzo; Murata, Kousaku; Hashimoto, Wataru			Crystal Structure of a Bacterial Unsaturated Glucuronyl Hydrolase with Specificity for Heparin*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondroitin; Enzyme Structure; Glycosaminoglycan; Glycoside Hydrolases; Heparan Sulfate; Heparin; Streptococcus; X-ray Crystallography	BACILLUS-SP GL1; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; EXPRESSION; DEGRADATION; CLONING; GLYCOSAMINOGLYCAN; BINDING; GLYCURONIDASE; PURIFICATION	Background: Bacterial unsaturated glucuronyl hydrolase (UGL) is essential for complete degradation of host glycosaminoglycans. Results: Crystal structure of Pedobacter heparinus UGL, Phep_2830 specific for heparin degradation, was determined. Conclusion: The pocket-like structure and lid loop of Phep_2830 are involved in heparin disaccharide recognition. Significance: This work contributes to understanding the bacterial degradation of host extracellular matrix components. Extracellular matrix molecules such as glycosaminoglycans (GAGs) are typical targets for some pathogenic bacteria, which allow adherence to host cells. Bacterial polysaccharide lyases depolymerize GAGs in -elimination reactions, and the resulting unsaturated disaccharides are subsequently degraded to constituent monosaccharides by unsaturated glucuronyl hydrolases (UGLs). UGL substrates are classified as 1,3- and 1,4-types based on the glycoside bonds. Unsaturated chondroitin and heparin disaccharides are typical members of 1,3- and 1,4-types, respectively. Here we show the reaction modes of bacterial UGLs with unsaturated heparin disaccharides by x-ray crystallography, docking simulation, and site-directed mutagenesis. Although streptococcal and Bacillus UGLs were active on unsaturated heparin disaccharides, those preferred 1,3- rather than 1,4-type substrates. The genome of GAG-degrading Pedobacter heparinus encodes 13 UGLs. Of these, Phep_2830 is known to be specific for unsaturated heparin disaccharides. The crystal structure of Phep_2830 was determined at 1.35- resolution. In comparison with structures of streptococcal and Bacillus UGLs, a pocket-like structure and lid loop at subsite +1 are characteristic of Phep_2830. Docking simulations of Phep_2830 with unsaturated heparin disaccharides demonstrated that the direction of substrate pyranose rings differs from that in unsaturated chondroitin disaccharides. Acetyl groups of unsaturated heparin disaccharides are well accommodated in the pocket at subsite +1, and aromatic residues of the lid loop are required for stacking interactions with substrates. Thus, site-directed mutations of the pocket and lid loop led to significantly reduced enzyme activity, suggesting that the pocket-like structure and lid loop are involved in the recognition of 1,4-type substrates by UGLs.	[Nakamichi, Yusuke; Murata, Kousaku; Hashimoto, Wataru] Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Appl Struct Biol, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Hashimoto, W (corresponding author), Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan.	whasimot@kais.kyoto-u.ac.jp	Nakamichi, Yusuke/H-1221-2018; Nakamichi, Yusuke/Y-2830-2019	Nakamichi, Yusuke/0000-0001-7089-663X; Nakamichi, Yusuke/0000-0001-7089-663X	Japan Society for the Promotion of Science; Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [23580112] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Japan Society for the Promotion of Science (to K. M. and W. H.), the Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and research fellowships from the Japan Society for the Promotion of Science for Young Scientists (to Y. N.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2005, CCP4 NEWSL, V42; Baron MJ, 2004, J BIOL CHEM, V279, P24714, DOI 10.1074/jbc.M402164200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Dong W, 2012, PROTEIN CELL, V3, P950, DOI 10.1007/s13238-012-2056-z; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; GU KN, 1995, BIOCHEM J, V312, P569, DOI 10.1042/bj3120569; Han C, 2009, STAND GENOMIC SCI, V1, P54, DOI 10.4056/sigs.22138; Hashimoto W, 1999, ARCH BIOCHEM BIOPHYS, V368, P367, DOI 10.1006/abbi.1999.1305; Hyun YJ, 2010, J APPL MICROBIOL, V108, P226, DOI 10.1111/j.1365-2672.2009.04418.x; Hyun YJ, 2010, APPL MICROBIOL BIOT, V86, P879, DOI 10.1007/s00253-009-2327-7; Itoh T, 2004, J BIOL CHEM, V279, P31804, DOI 10.1074/jbc.M403288200; Itoh T, 2006, J BIOL CHEM, V281, P29807, DOI 10.1074/jbc.M604975200; Jongkees SAK, 2011, J AM CHEM SOC, V133, P19334, DOI 10.1021/ja209067v; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Khan S, 2010, J MOL BIOL, V395, P504, DOI 10.1016/j.jmb.2009.10.064; Kim WS, 2004, J BIOCHEM MOL BIOL, V37, P684; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; Luo YD, 2007, ARCH BIOCHEM BIOPHYS, V460, P17, DOI 10.1016/j.abb.2007.01.029; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; Mori S, 2003, PROTEIN EXPRES PURIF, V29, P77, DOI 10.1016/S1046-5928(03)00019-6; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; Nakamichi Y, 2011, J BIOL CHEM, V286, P6262, DOI 10.1074/jbc.M110.182618; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASISEKHARAN R, 1993, P NATL ACAD SCI USA, V90, P3660, DOI 10.1073/pnas.90.8.3660; Sava IG, 2009, J BIOL CHEM, V284, P18194, DOI 10.1074/jbc.M901460200; Shim KW, 2008, PROTEIN EXPRES PURIF, V58, P222, DOI 10.1016/j.pep.2007.11.014; Su HS, 1996, APPL ENVIRON MICROB, V62, P2723, DOI 10.1128/AEM.62.8.2723-2734.1996; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	43	7	7	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4787	4797		10.1074/jbc.M113.522573	http://dx.doi.org/10.1074/jbc.M113.522573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403065	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000331607900025
J	Zhang, Z; Yu, HJ; Huang, JH; Faouzi, M; Schmitz, C; Penner, R; Fleig, A				Zhang, Zheng; Yu, Haijie; Huang, Junhao; Faouzi, Malika; Schmitz, Carsten; Penner, Reinhold; Fleig, Andrea			The TRPM6 Kinase Domain Determines the Mg center dot ATP Sensitivity of TRPM7/M6 Heteromeric Ion Channels*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Magnesium; Metabolic Regulation; Protein Complexes; Protein Kinases; TRP channels	SECONDARY HYPOCALCEMIA; HYPOMAGNESEMIA; MUTATION; PROTEIN; CATION; HOMEOSTASIS; CELLS; PLIK	Background: TRPM6 and TRPM7 combine ion channel and -kinase functions. Results: ATP inhibits TRPM7 but not TRPM6 or heteromeric TRPM6/M7 channels. Disruption of phosphorylation activity of TRPM6 kinase re-establishes ATP sensitivity to heteromeric channels. Conclusion: TRPM6 uncouples heteromeric channels from cellular energy levels. Significance: The altered characteristics of TRPM6/M7 compared with homomeric TRPM7 may enhance Ca2+ and Mg2+ transport in tissues co-expressing both proteins. The transient receptor potential melastatin member 7 (TRPM7) and member 6 (TRPM6) are divalent cation channel kinases essential for magnesium (Mg2+) homeostasis in vertebrates. It remains unclear how TRPM6 affects divalent cation transport and whether this involves functional homomeric TRPM6 plasma membrane channels or heteromeric channel assemblies with TRPM7. We show that homomeric TRPM6 is highly sensitive to intracellular free Mg2+ and therefore unlikely to be active at physiological levels of [Mg2+](i). Co-expression of TRPM7 and TRPM6 produces heteromeric TRPM7/M6 channels with altered pharmacology and sensitivity to intracellular MgATP compared with homomeric TRPM7. Strikingly, the activity of heteromeric TRPM7/M6 channels is independent of intracellular MgATP concentrations, essentially uncoupling channel activity from cellular energy status. Disruption of TRPM6 kinase phosphorylation activity re-introduces MgATP sensitivity to the heteromeric channel similar to that of TRPM7. Thus, TRPM6 modulates the functionality of TRPM7, and the TRPM6 kinase plays a critical role in tuning the phenotype of the TRPM7M6 channel complex.	[Zhang, Zheng; Yu, Haijie; Huang, Junhao; Faouzi, Malika; Penner, Reinhold; Fleig, Andrea] Univ Hawaii, Queens Med Ctr, Ctr Biomed Res, Lab Cell & Mol Signaling, Honolulu, HI 96813 USA; [Zhang, Zheng; Yu, Haijie; Huang, Junhao; Faouzi, Malika; Penner, Reinhold; Fleig, Andrea] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; [Schmitz, Carsten] Univ Colorado, Integrated Dept Immunol, Denver, CO 80206 USA; [Schmitz, Carsten] Natl Jewish Hlth, Denver, CO 80206 USA	The Queen's Medical Center; University of Hawaii System; University of Hawaii System; University of Colorado System; University of Colorado Denver; National Jewish Health	Penner, R (corresponding author), Queens Med Ctr, 1301 Punchbowl St, Honolulu, HI 96813 USA.	rpenner@hawaii.edu; afleig@hawaii.edu	Huang, Junhao/B-3607-2013	Huang, Junhao/0000-0001-9981-9558; Fleig, Andrea/0000-0001-8396-7249; Penner, Reinhold/0000-0002-5366-1537	National Institutes of Health [5R01GM090123, P01 GM078195]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM078195, R01GM090123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM090123 (to C. S.) and P01 GM078195 (to A. F.) This work was also supported by a private donation from Amy Chong (to A. F.).	Bessac BF, 2007, J PHYSIOL-LONDON, V582, P1073, DOI 10.1113/jphysiol.2007.130534; Chubanov V, 2005, N-S ARCH PHARMACOL, V371, P334, DOI 10.1007/s00210-005-1056-4; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Chubanov V, 2007, J BIOL CHEM, V282, P7656, DOI 10.1074/jbc.M611117200; Clark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001876; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Paravicini TM, 2012, INT J BIOCHEM CELL B, V44, P1381, DOI 10.1016/j.biocel.2012.05.010; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Penner R., 2007, V179, P313; Runnels LW, 2011, CURR PHARM BIOTECHNO, V12, P42; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanova LV, 2004, J BIOL CHEM, V279, P3708, DOI 10.1074/jbc.M308820200; Schlingmann KP, 2005, J PHYSIOL-LONDON, V566, P301, DOI 10.1113/jphysiol.2004.080200; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2005, J BIOL CHEM, V280, P37763, DOI 10.1074/jbc.M509175200; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Thebault S, 2008, J BIOL CHEM, V283, P19999, DOI 10.1074/jbc.M800167200; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Yu HJ, 2013, CELL MOL LIFE SCI, V70, P2757, DOI 10.1007/s00018-013-1284-6; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zierler S, 2011, J BIOL CHEM, V286, P39328, DOI 10.1074/jbc.M111.264341	32	60	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5217	5227		10.1074/jbc.M113.512285	http://dx.doi.org/10.1074/jbc.M113.512285			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24385424	Green Published, hybrid			2022-12-28	WOS:000331607900063
J	Yao, ST; Miao, C; Tian, H; Sang, H; Yang, NN; Jiao, P; Han, JJ; Zong, CL; Qin, SC				Yao, Shutong; Miao, Cheng; Tian, Hua; Sang, Hui; Yang, Nana; Jiao, Peng; Han, Jiju; Zong, Chuanlong; Qin, Shucun			Endoplasmic Reticulum Stress Promotes Macrophage-derived Foam Cell Formation by Up-regulating Cluster of Differentiation 36 (CD36) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atherosclerosis; Endoplasmic Reticulum Stress; Low Density Lipoprotein (LDL); Macrophages; Unfolded Protein Response; CD36; Foam Cell; Oxidized Low-density Lipoprotein	ATHEROSCLEROTIC LESION DEVELOPMENT; LOW-DENSITY LIPOPROTEINS; B SCAVENGER RECEPTOR; APOPTOSIS; LDL; ACTIVATION; PROTEIN; ACCUMULATION; MICE	Oxidized low-density lipoprotein (ox-LDL) up-regulates CD36, a scavenger receptor responsible for macrophage uptake of ox-LDL without limitation. However, the precise underlying mechanism is not completely understood. Our previous study has demonstrated that ox-LDL induces endoplasmic reticulum (ER) stress in macrophages. The goal of this study was to explore the exact relationship between ER stress and macrophage-derived foam cell formation and whether ER stress would be involved in ox-LDL-induced CD36 up-regulation. Our results showed that ox-LDL-induced lipid accumulation in macrophages was promoted synergistically by ER stress inducer tunicamycin (TM), while attenuated by ER stress inhibitor 4-phenylbutyric acid (PBA). Ox-LDL caused CD36 up-regulation with concomitant activation of ER stress as assessed by phosphorylation of inositol-requiring kinase/endonuclease-1 (IRE-1) and protein kinase-like ER kinase (PERK), up-regulation of X-box-binding protein 1 (XBP1) and glucose-regulated protein 78 (GRP 78), and nuclear translocation of activating transcription factor 6 (ATF6). TM not only up-regulated CD36 alone but also synergized with ox-LDL to increase CD36 expression. Alleviation of ER stress with PBA and siRNA against ATF6, IRE1, and GRP78 mitigated ox-LDL-induced CD36 protein up-regulation. Moreover, administration of apoE(-/-) mice with PBA suppressed the up-regulation of CD36, phospho-IRE1, and GRP78 in macrophage-dense atherosclerotic lesions and in peritoneal macrophages. Additionally, CD36 silencing attenuated ox-LDL-induced nuclear translocation of ATF6, phosphorylation of IRE1 and up-regulation of XBP1 and GRP78. These data indicate that CD36-mediated ox-LDL uptake in macrophages triggers ER stress response, which, in turn, plays a critical role in CD36 up-regulation, enhancing the foam cell formation by uptaking more ox-LDL.	[Yao, Shutong; Miao, Cheng; Tian, Hua; Sang, Hui; Yang, Nana; Jiao, Peng; Han, Jiju; Zong, Chuanlong; Qin, Shucun] Taishan Med Univ, Inst Atherosclerosis, Key Lab Atherosclerosis Univ Shandong, Tai An 271000, Shandong, Peoples R China; [Yao, Shutong; Sang, Hui] Taishan Med Univ, Coll Basic Med Sci, Tai An 271000, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Qin, SC (corresponding author), Taishan Med Univ, Inst Atherosclerosis, Tai An 271000, Shandong, Peoples R China.	shucunqin@hotmail.com			Taishan Scholars Foundation of the Shandong Province [zd056, zd057]; National Natural Science Foundation of China [81202949, 81370381, 81070247]	Taishan Scholars Foundation of the Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Taishan Scholars Foundation of the Shandong Province (zd056, zd057) and National Natural Science Foundation of China (81202949, 81370381, 81070247).	Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Cash JG, 2012, J BIOL CHEM, V287, P27876, DOI 10.1074/jbc.M112.377549; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gora S, 2010, FASEB J, V24, P3284, DOI 10.1096/fj.09-146852; Goyal T, 2012, CURR ATHEROSCLER REP, V14, P150, DOI 10.1007/s11883-012-0228-1; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hua YA, 2010, J CARDIOVASC PHARM, V55, P49, DOI 10.1097/FJC.0b013e3181c37d86; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Ishiyama J, 2011, J LIPID RES, V52, P299, DOI 10.1194/jlr.m007104; Jorgensen MM, 2000, J BIOL CHEM, V275, P33861, DOI 10.1074/jbc.M004663200; Kuchibhotla S, 2008, CARDIOVASC RES, V78, P185, DOI 10.1093/cvr/cvm093; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nakata A, 1999, ARTERIOSCL THROM VAS, V19, P1333, DOI 10.1161/01.ATV.19.5.1333; Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673; Pineau L, 2009, TRAFFIC, V10, P673, DOI 10.1111/j.1600-0854.2009.00903.x; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Tiwari RL, 2008, MED RES REV, V28, P483, DOI 10.1002/med.20118; Yao Shu-Tong, 2010, Shengli Xuebao, V62, P433; Yao ST, 2013, J ATHEROSCLER THROMB, V20, P94, DOI 10.5551/jat.13425; Yao ST, 2012, BBA-MOL CELL BIOL L, V1821, P954, DOI 10.1016/j.bbalip.2012.03.003; Yu XH, 2013, CLIN CHIM ACTA, V424, P245, DOI 10.1016/j.cca.2013.06.006; Zhou AX, 2013, SEMIN IMMUNOPATHOL, V35, P321, DOI 10.1007/s00281-013-0372-x; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1; Zhou MS, 2013, AM J PHYSIOL-HEART C, V305, pH563, DOI 10.1152/ajpheart.00042.2013	37	71	78	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4032	4042		10.1074/jbc.M113.524512	http://dx.doi.org/10.1074/jbc.M113.524512			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366867	hybrid, Green Published			2022-12-28	WOS:000331403800018
J	Spruiell, K; Richardson, RM; Cullen, JM; Awumey, EM; Gonzalez, FJ; Gyamfi, MA				Spruiell, Krisstonia; Richardson, Ricardo M.; Cullen, John M.; Awumey, Emmanuel M.; Gonzalez, Frank J.; Gyamfi, Maxwell A.			Role of Pregnane X Receptor in Obesity and Glucose Homeostasis in Male Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Metabolic Syndrome; Nuclear Receptors; Obesity; Peroxisome Proliferator-activated Receptor (PPAR)	ACTIVATED PROTEIN-KINASE; HIGH-FAT DIET; CONSTITUTIVE ANDROSTANE RECEPTOR; LOW PLASMA LEPTIN; NUCLEAR RECEPTOR; CROSS-TALK; INSULIN-RESISTANCE; INDUCED THERMOGENESIS; TARGETED DISRUPTION; HEPATIC STEATOSIS	Background: PXR is a xenobiotic nuclear receptor that defends against toxic agents. Results: In male mice fed a HFD, the mouse PXR gene promoted obesity, whereas mice lacking the PXR or possessing the human transgene were hyperglycemic. Conclusion: The impact of PXR on HFD-induced obesity and hyperglycemia is species-dependent. Significance: The current data provide in vivo significance of PXR in metabolic syndrome. Clinical obesity is a complex metabolic disorder affecting one in three adults. Recent reports suggest that pregnane X receptor (PXR), a xenobiotic nuclear receptor important for defense against toxic agents and for eliminating drugs and other xenobiotics, may be involved in obesity. Noting differences in ligand specificities between human and mouse PXRs, the role of PXR in high fat diet (HFD)-induced obesity was examined using male PXR-humanized (hPXR) transgenic and PXR-knock-out (PXR-KO) mice in comparison to wild-type (WT) mice. After 16 weeks on either a control diet or HFD, WT mice showed greater weight gain, whereas PXR-KO mice gained less weight due to their resistance to HFD-induced decreases in adipose tissue peroxisome proliferator-activated receptor and induction of hepatic carnitine palmitoyltransferase 1, suggesting increased energy metabolism. Interestingly, control-fed PXR-KO mice exhibited hepatomegaly, hyperinsulinemia, and hyperleptinemia but hypoadiponectinemia and lower adiponectin receptor R2 mRNA levels relative to WT mice. Evaluation of these biologic indicators in hPXR mice fed a control diet or HFD revealed further differences between the mouse and human receptors. Importantly, although HFD-fed hPXR mice were resistant to HFD-induced obesity, both PXR-KO and hPXR mice exhibited impaired induction of glucokinase involved in glucose utilization and displayed elevated fasting glucose levels and severely impaired glucose tolerance. Moreover, the basal hepatic levels of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase 1 were increased in hPXR mice compared with WT mice. Altogether, although the mouse PXR promotes HFD-induced obesity, the hPXR mouse carries a genetic predisposition for type 2 diabetes and thus provides a model for exploring the role of human PXR in the metabolic syndrome.	[Spruiell, Krisstonia; Richardson, Ricardo M.; Awumey, Emmanuel M.; Gyamfi, Maxwell A.] N Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; [Cullen, John M.] N Carolina State Univ, North Carolina Coll Vet Med, Raleigh, NC 27607 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA	University of North Carolina; North Carolina Central University; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gyamfi, MA (corresponding author), N Carolina Cent Univ, JLC Biomed Biotechnol Res Inst, Cardiovasc & Metab Dis Res Program, 700 George St, Durham, NC 27707 USA.	mgyamfi@nccu.edu	Cullen, John M/I-2051-2019		National Institutes of Health [U54 AA019765, SC1 HL099139, U54 CA156735, RO1 HL064761, R25HL059868, P20 MD000175]; National Cancer Institute Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC005562, ZIABC005708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants U54 AA019765, SC1 HL099139, U54 CA156735, RO1 HL064761, R25HL059868, and P20 MD000175, and the National Cancer Institute Intramural Research Program.	[Anonymous], [No title captured]; ASTRUP A, 1994, AM J CLIN NUTR, V59, P350, DOI 10.1093/ajcn/59.2.350; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Burt AD, 1998, SEMIN DIAGN PATHOL, V15, P246; BUTLER PC, 1990, DIABETES, V39, P217, DOI 10.2337/diabetes.39.2.217; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cheng J, 2012, TOXICOL SCI, V129, P456, DOI 10.1093/toxsci/kfs211; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Collins S, 1996, NATURE, V380, P677, DOI 10.1038/380677a0; Costa Angels, 2002, Treat Endocrinol, V1, P205; Dussault I, 2001, J BIOL CHEM, V276, P33309, DOI 10.1074/jbc.C100375200; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Fan CY, 1996, J BIOL CHEM, V271, P24698, DOI 10.1074/jbc.271.40.24698; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; FROMENTY B, 1995, GASTROENTEROLOGY, V108, P193, DOI 10.1016/0016-5085(95)90024-1; Gao J, 2010, DRUG METAB DISPOS, V38, P2091, DOI 10.1124/dmd.110.035568; George J, 2008, MOL PHARMACEUT, V5, P49, DOI 10.1021/mp700110z; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; Gyamfi MA, 2008, J PHARMACOL EXP THER, V324, P443, DOI 10.1124/jpet.107.132258; Gyamfi MA, 2006, J PHARMACOL EXP THER, V319, P360, DOI 10.1124/jpet.106.108175; Gyamfi MA, 2009, TOXICOL APPL PHARM, V234, P166, DOI 10.1016/j.taap.2008.09.022; Hashimoto T, 1999, J BIOL CHEM, V274, P19228, DOI 10.1074/jbc.274.27.19228; He JH, 2013, DIABETES, V62, P1876, DOI 10.2337/db12-1039; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; IYNEDJIAN PB, 1989, P NATL ACAD SCI USA, V86, P7838, DOI 10.1073/pnas.86.20.7838; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Kodama S, 2007, BIOCHEM J, V407, P373, DOI 10.1042/BJ20070481; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; Korach-Andre M, 2011, AM J PHYSIOL-ENDOC M, V301, pE210, DOI 10.1152/ajpendo.00541.2010; Kroetz DL, 1998, J BIOL CHEM, V273, P31581, DOI 10.1074/jbc.273.47.31581; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Ma X, 2007, DRUG METAB DISPOS, V35, P194, DOI 10.1124/dmd.106.012831; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MARETTE A, 1992, DIABETES, V41, P1562, DOI 10.2337/diabetes.41.12.1562; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Misra P, 2008, EXPERT OPIN THER TAR, V12, P91, DOI 10.1517/14728222.12.1.91; Misra P, 2007, INDIAN J MED RES, V125, P389; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Oleszczuk A, 2007, EXP TOXICOL PATHOL, V59, P205, DOI 10.1016/j.etp.2007.05.009; Parra P, 2008, J NUTR BIOCHEM, V19, P109, DOI 10.1016/j.jnutbio.2007.01.009; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Ravussin E, 1997, NAT MED, V3, P238, DOI 10.1038/nm0297-238; Roth A, 2008, MOL PHARMACOL, V73, P1282, DOI 10.1124/mol.107.041012; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Shemesh T, 2006, CLIN CHIM ACTA, V367, P69, DOI 10.1016/j.cca.2005.11.014; Sonoda J, 2005, P NATL ACAD SCI USA, V102, P2198, DOI 10.1073/pnas.0409481102; Sookoian S, 2010, PHARMACOGENET GENOM, V20, P1, DOI 10.1097/FPC.0b013e328333a1dd; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Surwit RS, 1997, DIABETES, V46, P1516, DOI 10.2337/diabetes.46.9.1516; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Valls C, 2006, EUR RADIOL, V16, P2292, DOI 10.1007/s00330-006-0146-0; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zammit VA, 1999, PROG LIPID RES, V38, P199, DOI 10.1016/S0163-7827(99)00002-8; Zhang H, 1999, ARCH BIOCHEM BIOPHYS, V368, P14, DOI 10.1006/abbi.1999.1307; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	71	60	63	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3244	3261		10.1074/jbc.M113.494575	http://dx.doi.org/10.1074/jbc.M113.494575			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362030	Green Published, hybrid			2022-12-28	WOS:000331368700013
J	Abendroth, J; Ollodart, A; Andrews, ESV; Myler, PJ; Staker, BL; Edwards, TE; Arcus, VL; Grundner, C				Abendroth, Jan; Ollodart, Anja; Andrews, Emma S. V.; Myler, Peter J.; Staker, Bart L.; Edwards, Thomas E.; Arcus, Vickery L.; Grundner, Christoph			Mycobacterium tuberculosis Rv2179c Protein Establishes a New Exoribonuclease Family with Broad Phylogenetic Distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Microbiology; Mycobacterium tuberculosis; Pseudomonas; Ribonuclease; Annotation	ADENOSINE NUCLEOTIDE-BINDING; RNASE-T; MATURATION; SEQUENCE	Ribonucleases (RNases) maintain the cellular RNA pool by RNA processing and degradation. In many bacteria, including the human pathogen Mycobacterium tuberculosis (Mtb), the enzymes mediating several central RNA processing functions are still unknown. Here, we identify the hypothetical Mtb protein Rv2179c as a highly divergent exoribonuclease. Although the primary sequence of Rv2179c has no detectable similarity to any known RNase, the Rv2179c crystal structure reveals an RNase fold. Active site residues are equivalent to those in the DEDD family of RNases, and Rv2179c has close structural homology to Escherichia coli RNase T. Consistent with the DEDD fold, Rv2179c has exoribonuclease activity, cleaving the 3 single-strand overhangs of duplex RNA. Functional orthologs of Rv2179c are prevalent in actinobacteria and found in bacteria as phylogenetically distant as proteobacteria. Thus, Rv2179c is the founding member of a new, large RNase family with hundreds of members across the bacterial kingdom.	[Abendroth, Jan; Staker, Bart L.; Edwards, Thomas E.] Emerald Bio, Bainbridge Isl, WA 98110 USA; [Ollodart, Anja; Myler, Peter J.; Grundner, Christoph] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Andrews, Emma S. V.; Arcus, Vickery L.] Univ Waikato, Dept Biol Sci, Hamilton 3240, New Zealand; [Myler, Peter J.; Grundner, Christoph] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Waikato; University of Washington; University of Washington Seattle	Grundner, C (corresponding author), Seattle Biomed Res Inst, 307 Westlake Ave N, Seattle, WA 98109 USA.	christoph.grundner@seattlebiomed.org	Myler, Peter John/AAR-9535-2021; Andrews, Emma/P-9877-2016	Andrews, Emma/0000-0003-2153-4346; Staker, Bart/0000-0001-9570-5086; Edwards, Thomas/0000-0002-0474-8003; Ollodart, Anja/0000-0002-6329-9463	National Institutes of Health from the NIAID [HHSN272200700057C, HHSN272201200025C]; Paul G. Allen Family Foundation [8999]; American Lung Association	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Paul G. Allen Family Foundation; American Lung Association	This work was supported, in whole or in part, by National Institutes of Health Federal Contracts HHSN272200700057C and HHSN272201200025C from the NIAID.; Supported by the Paul G. Allen Family Foundation Grant 8999 and the American Lung Association. To whom correspondence should be addressed: Seattle Biomedical Research Institute, 307 Westlake Ave. N., Seattle, WA 98109. Tel.: 206-256-7295; Fax: 206-256-7229; E-mail: christoph.grundner@seattlebiomed.org.	Abendroth Jan, 2011, Journal of Structural and Functional Genomics, V12, P83, DOI 10.1007/s10969-011-9101-7; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ansong C, 2013, CHEM BIOL, V20, P123, DOI 10.1016/j.chembiol.2012.11.008; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kwan AHY, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng124; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LI ZW, 1995, P NATL ACAD SCI USA, V92, P6883, DOI 10.1073/pnas.92.15.6883; Li ZW, 1996, J BIOL CHEM, V271, P1133, DOI 10.1074/jbc.271.2.1133; Li ZW, 1999, RNA, V5, P139, DOI 10.1017/S1355838299981669; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; McKenzie JL, 2012, RNA, V18, P1267, DOI 10.1261/rna.031229.111; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Qiu HB, 2007, ANAL CHEM, V79, P5547, DOI 10.1021/ac0622375; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zuo YH, 2007, STRUCTURE, V15, P417, DOI 10.1016/j.str.2007.02.004	24	9	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2139	2147		10.1074/jbc.M113.525683	http://dx.doi.org/10.1074/jbc.M113.525683			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311791	hybrid, Green Published			2022-12-28	WOS:000331130200022
J	Lai, L; Wang, M; Martin, OJ; Leone, TC; Vega, RB; Han, XL; Kelly, DP				Lai, Ling; Wang, Miao; Martin, Ola J.; Leone, Teresa C.; Vega, Rick B.; Han, Xianlin; Kelly, Daniel P.			A Role for Peroxisome Proliferator-activated Receptor gamma Coactivator 1 (PGC-1) in the Regulation of Cardiac Mitochondrial Phospholipid Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiac Metabolism; Cardiolipin; Gene Regulation; Heart; Mitochondria; Polyunsaturated Fatty Acids; Lipidomics; Phospholipids; Transcriptional Coregulators	MULTIDIMENSIONAL MASS-SPECTROMETRY; 3-HYDROXYACYL-COA DEHYDROGENASE-DEFICIENCY; SHOTGUN LIPIDOMICS; ERR-ALPHA; TRANSCRIPTIONAL CONTROL; ENERGY-METABOLISM; SKELETAL-MUSCLE; GENE-EXPRESSION; BARTH-SYNDROME; PPAR-ALPHA	The energy demands of the adult mammalian heart are met largely by ATP generated via oxidation of fatty acids in a high capacity mitochondrial system. Peroxisome proliferator-activated receptor coactivator 1 (PGC-1)- and - serve as inducible transcriptional coregulators of genes involved in mitochondrial biogenesis and metabolism. Whether PGC-1 plays a role in the regulation of mitochondrial structure is unknown. In this study, mice with combined deficiency of PGC-1 and PGC-1 (PGC-1(-/-)) in adult heart were analyzed. PGC-1(-/-) hearts exhibited a distinctive mitochondrial cristae-stacking abnormality suggestive of a phospholipid abnormality as has been described in humans with genetic defects in cardiolipin (CL) synthesis (Barth syndrome). A subset of molecular species, containing n-3 polyunsaturated species in the CL, phosphatidylcholine, and phosphatidylethanolamine profiles, was reduced in PGC-1-deficient hearts. Gene expression profiling of PGC-1(-/-) hearts revealed reduced expression of the gene encoding CDP-diacylglycerol synthase 1 (Cds1), an enzyme that catalyzes the proximal step in CL biosynthesis. Cds1 gene promoter-reporter cotransfection experiments and chromatin immunoprecipitation studies demonstrated that PGC-1 coregulates estrogen-related receptors to activate the transcription of the Cds1 gene. We conclude that the PGC-1/estrogen-related receptor axis coordinately regulates metabolic and membrane structural programs relevant to the maintenance of high capacity mitochondrial function in heart.	[Lai, Ling; Wang, Miao; Martin, Ola J.; Leone, Teresa C.; Vega, Rick B.; Han, Xianlin; Kelly, Daniel P.] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA	Sanford Burnham Prebys Medical Discovery Institute	Kelly, DP (corresponding author), Sanford Burnham Med Res Inst Lake Nona, 6400 Sanger Rd, Orlando, FL 32827 USA.	dkelly@sanfordburnham.org	Kelly, Daniel/ABG-2056-2021		National Institutes of Health [R01 DK045416, R01 HL58493, R01 HL101189]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101189, R01HL058493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, R01DK045416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK045416 (to D. P. K.), R01 HL58493 (to D. P. K.), and R01 HL101189 (to D. P. K.).	[Anonymous], 2010, LIPID ANAL ISOLATION; Bissler JJ, 2002, LAB INVEST, V82, P335, DOI 10.1038/labinvest.3780427; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gillingham M, 1999, J INHERIT METAB DIS, V22, P123, DOI 10.1023/A:1005437616934; HALLMAN M, 1971, BIOCHIM BIOPHYS ACTA, V253, P360, DOI 10.1016/0005-2728(71)90040-5; Han XL, 2008, RAPID COMMUN MASS SP, V22, P2115, DOI 10.1002/rcm.3595; Han XL, 2012, MASS SPECTROM REV, V31, P134, DOI 10.1002/mas.20342; Han XL, 2006, J LIPID RES, V47, P864, DOI 10.1194/jlr.D500044-JLR200; Harding CO, 1999, J INHERIT METAB DIS, V22, P276, DOI 10.1023/A:1005502626406; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Infante JP, 1997, MOL CELL BIOCHEM, V168, P101, DOI 10.1023/A:1006895209833; Infante JP, 2001, MOL GENET METAB, V72, P185, DOI 10.1006/mgme.2001.3148; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lu ZB, 2010, ANTIOXID REDOX SIGN, V13, P1011, DOI 10.1089/ars.2009.2940; Marin-Garcia J, 2000, MOL CELL BIOCHEM, V210, P47, DOI 10.1023/A:1007031919298; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Ovide-Bordeaux S, 2005, CLIN EXP PHARMACOL P, V32, P1061, DOI 10.1111/j.1440-1681.2005.04293.x; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Sihag S, 2009, J MOL CELL CARDIOL, V46, P201, DOI 10.1016/j.yjmcc.2008.10.025; SMOLICH JJ, 1989, AM J PHYSIOL, V257, pH1, DOI 10.1152/ajpheart.1989.257.1.H1; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; SUN DD, 1994, J NEUROCHEM, V62, P1929; Tamura Y, 2013, CELL METAB, V17, P709, DOI 10.1016/j.cmet.2013.03.018; van Werkhoven MA, 2006, J LIPID RES, V47, P2346, DOI 10.1194/jlr.D600024-JLR200; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang M, 2012, ANAL CHEM, V84, P4580, DOI 10.1021/ac300695p; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Yang J, 2009, MOL CELL BIOL, V29, P4091, DOI 10.1128/MCB.01669-08; Yang K, 2011, METABOLITES, V1, P21, DOI 10.3390/metabo1010021; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; ZAMBRANO F, 1975, BIOCHIM BIOPHYS ACTA, V380, P357, DOI 10.1016/0005-2760(75)90104-6	46	70	75	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2250	2259		10.1074/jbc.M113.523654	http://dx.doi.org/10.1074/jbc.M113.523654			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24337569	Green Published, hybrid			2022-12-28	WOS:000331130200031
J	Stachel, I; Geismann, C; Aden, K; Deisinger, F; Rosenstiel, P; Schreiber, S; Sebens, S; Arlt, A; Schafer, H				Stachel, Imke; Geismann, Claudia; Aden, Konrad; Deisinger, Florian; Rosenstiel, Philip; Schreiber, Stefan; Sebens, Susanne; Arlt, Alexander; Schaefer, Heiner			Modulation of Nuclear Factor E2-related Factor-2 (Nrf2) Activation by the Stress Response Gene Immediate Early Response-3 (IER3) in Colonic Epithelial Cells A NOVEL MECHANISM OF CELLULAR ADAPTION TO INFLAMMATORY STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Colitis; Colon Cancer; Nrf2; Oxidative Stress; Transcription Factors	NF-KAPPA-B; PANCREATIC-CANCER CELLS; PROTEASOME ACTIVITY; SIGNALING PATHWAY; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; COLORECTAL-CANCER; IEX-1 EXPRESSION; DRUG-RESISTANCE; KEAP1 GENE	Although nuclear factor E2-related factor-2 (Nrf2) protects from carcinogen-induced tumorigenesis, underlying the rationale for using Nrf2 inducers in chemoprevention, this antioxidative transcription factor may also act as a proto-oncogene. Thus, an enhanced Nrf2 activity promotes formation and chemoresistance of colon cancer. One mechanism causing persistent Nrf2 activation is the adaptation of epithelial cells to oxidative stress during chronic inflammation, e.g. colonocytes in inflammatory bowel diseases, and the multifunctional stress response gene immediate early response-3 (IER3) has a crucial role under these conditions. We now demonstrate that colonic tissue from Ier3(-/-) mice subject of dextran sodium sulfate colitis exhibit greater Nrf2 activity than Ier3(+/+) mice, manifesting as increased nuclear Nrf2 protein level and Nrf2 target gene expression. Likewise, human NCM460 colonocytes subjected to shRNA-mediated IER3 knockdown exhibit greater Nrf2 activity compared with control cells, whereas IER3 overexpression attenuated Nrf2 activation. IER3-deficient NCM460 cells exhibited reduced reactive oxygen species levels, indicating increased antioxidative protection, as well as lower sensitivity to TRAIL or anticancer drug-induced apoptosis and greater clonogenicity. Knockdown of Nrf2 expression reversed these IER3-dependent effects. Further, the enhancing effect of IER3 deficiency on Nrf2 activity relates to the control of the inhibitory tyrosine kinase Fyn by the PI3K/Akt pathway. Thus, the PI3K inhibitor LY294002 or knockdown of Akt or Fyn expression abrogated the impact of IER3 deficiency on Nrf2 activity. In conclusion, the interference of IER3 with the PI3K/Akt-Fyn pathway represents a novel mechanism of Nrf2 regulation that may get lost in tumors and by which IER3 exerts its stress-adaptive and tumor-suppressive activity.	[Stachel, Imke; Geismann, Claudia; Aden, Konrad; Deisinger, Florian; Schreiber, Stefan; Arlt, Alexander; Schaefer, Heiner] Dept Internal Med 1, Lab Mol Gastroenterol & Hepatol, D-24105 Kiel, Germany; [Sebens, Susanne] Inst Expt Med, D-24105 Kiel, Germany; [Rosenstiel, Philip] Inst Clin Mol Biol, D-24105 Kiel, Germany		Schafer, H (corresponding author), Dept Internal Med 1, UKSH Campus Kiel,Arnold Heller Str 3,Bldg 6, D-24105 Kiel, Germany.	hschaef@1med.uni-kiel.de	Aden, Konrad/H-1477-2014; Sebens, Susanne/C-1222-2010; Schäfer, Heiner/C-1055-2011; Geismann, Claudia/AAX-8158-2021; Aden, Konrad/AAG-3290-2020; Rosenstiel, Philip/A-5137-2009; Arlt, Alexander/G-7308-2019	Aden, Konrad/0000-0003-3482-7316; Geismann, Claudia/0000-0003-0640-9256; Rosenstiel, Philip/0000-0002-9692-8828; Arlt, Alexander/0000-0002-6160-1059; Schafer, Heiner/0000-0001-6936-9090	Medical Faculty of the University of Kiel; German Research Society Deutsche Forschungsgemeinschaft (DFG); DFG Cluster of Excellence Inflammation at Interfaces	Medical Faculty of the University of Kiel; German Research Society Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Cluster of Excellence Inflammation at Interfaces(German Research Foundation (DFG))	This work was supported by the Medical Faculty of the University of Kiel (to C. G., A. A., and H. S.), the German Research Society Deutsche Forschungsgemeinschaft (DFG) (to H. S. and A. A.), and the DFG Cluster of Excellence Inflammation at Interfaces.	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Akhdar H, 2009, EUR J CANCER, V45, P2219, DOI 10.1016/j.ejca.2009.05.017; Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Arlt A, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.35; Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; Arlt A, 2003, ONCOGENE, V22, P3343, DOI 10.1038/sj.onc.1206524; Arlt A, 2001, ONCOGENE, V20, P69, DOI 10.1038/sj.onc.1204061; Arlt A, 2008, BBA-MOL CELL RES, V1783, P941, DOI 10.1016/j.bbamcr.2007.12.010; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Billmann-Born S, 2011, J IMMUNOL, V186, P4027, DOI 10.4049/jimmunol.1000085; Chang LC, 2013, APPL IMMUNOHISTO M M, V21, P511, DOI 10.1097/PAI.0b013e318282ac20; Chang WCL, 2007, CARCINOGENESIS, V28, P2375, DOI 10.1093/carcin/bgm134; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Deng C, 2012, MOL MED REP, V5, P847, DOI 10.3892/mmr.2011.731; Eades G, 2011, J BIOL CHEM, V286, P40725, DOI 10.1074/jbc.M111.275495; Han LP, 2011, ULTRASTRUCT PATHOL, V35, P260, DOI 10.3109/01913123.2011.608916; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hong YB, 2010, PANCREAS, V39, P463, DOI 10.1097/MPA.0b013e3181c31314; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Kapoor S, 2012, ULTRASTRUCT PATHOL, V36, P285, DOI 10.3109/01913123.2012.697981; Kaspar JW, 2011, FASEB J, V25, P1076, DOI 10.1096/fj.10-171553; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kinch L, 2011, CANCER CELL, V20, P418, DOI 10.1016/j.ccr.2011.10.005; Kondratyev AD, 1996, CANCER RES, V56, P1498; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Leoncini E, 2011, J FOOD SCI, V76, pH175, DOI 10.1111/j.1750-3841.2011.02311.x; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Muerkoster S, 2005, CANCER RES, V65, P1316, DOI 10.1158/0008-5472.CAN-04-1626; Nambiar PR, 2004, CANCER RES, V64, P6394, DOI 10.1158/0008-5472.CAN-04-0933; Niture SK, 2013, FREE RADICAL BIO MED, V57, P119, DOI 10.1016/j.freeradbiomed.2012.12.014; O'Connor PM, 2010, INFLAMM BOWEL DIS, V16, P1411, DOI 10.1002/ibd.21217; Ooi A, 2011, CANCER CELL, V20, P511, DOI 10.1016/j.ccr.2011.08.024; Osawa Y, 2003, J IMMUNOL, V170, P4053, DOI 10.4049/jimmunol.170.8.4053; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rushworth SA, 2012, BLOOD, V120, P5188, DOI 10.1182/blood-2012-04-422121; Sasada T, 2008, ANN SURG ONCOL, V15, P609, DOI 10.1245/s10434-007-9669-0; Sebens S, 2011, J BIOL CHEM, V286, P40911, DOI 10.1074/jbc.M111.274902; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353; Shen L, 2009, CELL DEATH DIFFER, V16, P603, DOI 10.1038/cdd.2008.184; Sina C, 2010, INFLAMM BOWEL DIS, V16, P320, DOI 10.1002/ibd.21066; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Sommer SL, 2006, J APPL PHYSIOL, V100, P707, DOI 10.1152/japplphysiol.00306.2005; Ustyugova IV, 2012, INFLAMM BOWEL DIS, V18, P333, DOI 10.1002/ibd.21772; Wang R, 2008, BIOCHEM BIOPH RES CO, V373, P151, DOI 10.1016/j.bbrc.2008.06.004; Wu MX, 2013, EXPERT OPIN THER TAR, V17, P593, DOI 10.1517/14728222.2013.768234; Wu MX, 2003, APOPTOSIS, V8, P11, DOI 10.1023/A:1021688600370; Yoo NJ, 2012, HISTOPATHOLOGY, V60, P943, DOI 10.1111/j.1365-2559.2012.04178.x; Yu MA, 2011, CELL SIGNAL, V23, P883, DOI 10.1016/j.cellsig.2011.01.014; Zhang DD, 2010, ANTIOXID REDOX SIGN, V13, P1623, DOI 10.1089/ars.2010.3301; Zhi L, 2012, J IMMUNOL, V189, P1639, DOI 10.4049/jimmunol.1200528	59	34	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1917	1929		10.1074/jbc.M113.490920	http://dx.doi.org/10.1074/jbc.M113.490920			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311782	Green Published, hybrid			2022-12-28	WOS:000331130200004
J	Nguyen, A; Tao, H; Metrione, M; Hajri, T				Andrew Nguyen; Tao, Huan; Metrione, Michael; Hajri, Tahar			Very Low Density Lipoprotein Receptor (VLDLR) Expression Is a Determinant Factor in Adipose Tissue Inflammation and Adipocyte-Macrophage Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Adipose Tissue; Inflammation; Macrophages; Obesity; VLDLR	FATTY-ACID UPTAKE; NECROSIS-FACTOR-ALPHA; APOLIPOPROTEIN-E; ENDOPLASMIC-RETICULUM; OBESITY; MICE; APOE; METABOLISM; LIPASE; JNK	Background: Very low density lipoprotein receptor (VLDLR) is highly expressed in adipose tissue. Results: VLDLR deficiency attenuates inflammation in adipose tissue of mice fed a high fat diet and reduces adipocyte hypertrophy and inflammation in response to VLDL. Conclusion: VLDLR is a prominent player in adipose tissue inflammation in obesity. Significance: These studies provide a possible mechanism thorough which VLDL induces inflammation. Obesity is associated with adipose tissue remodeling, characterized by adipocyte hypertrophy and macrophage infiltration. Previously, we have shown that very low density lipoprotein receptor (VLDLR) is virtually absent in preadipocytes but is strongly induced during adipogenesis and actively participates in adipocyte hypertrophy. In this study, we investigated the role of VLDLR in adipose tissue inflammation and adipocyte-macrophage interactions in wild type and VLDLR-deficient mice fed a high fat diet. The results show that VLDLR deficiency reduced high fat diet-induced inflammation and endoplasmic reticulum (ER) stress in adipose tissue in conjunction with reduced macrophage infiltration, especially those expressing pro-inflammatory markers. In adipocyte culture, VLDLR deficiency prevented adipocyte hypertrophy and strongly reduced VLDL-induced ER stress and inflammation. Likewise, cultures of primary peritoneal macrophages show that VLDLR deficiency reduced lipid accumulation and inflammation but did not alter chemotactic response of macrophages to adipocyte signals. Moreover, VLDLR deficiency tempered the synergistic inflammatory interactions between adipocytes and macrophages in a co-culture system. Collectively, these results show that VLDLR contributes to adipose tissue inflammation and mediates VLDL-induced lipid accumulation and induction of inflammation and ER stress in adipocytes and macrophages.	[Andrew Nguyen; Metrione, Michael; Hajri, Tahar] Hackensack Univ, Dept Surg, Med Ctr, Hackensack, NJ 07601 USA; [Tao, Huan] Vanderbilt Univ, Atherosclerosis Res Unit, Div Cardiovasc Med, Nashville, TN 37212 USA	Hackensack University Medical Center; Vanderbilt University	Hajri, T (corresponding author), Dept Surg, Jurist Res Bldg,Rm 432,40 Prospect Ave, Hackensack, NJ 07601 USA.	thajri@hackensackumc.org	Hajri, Tahar/AAQ-6499-2020	Hajri, Tahar/0000-0003-3805-3717	Hackensack University Medical Center; American Heart Association [AHA0730356N]	Hackensack University Medical Center; American Heart Association(American Heart Association)	This work was supported by development grants from Hackensack University Medical Center and American Heart Association Award AHA0730356N.	Ahlin S, 2013, OBESITY, V21, pE571, DOI 10.1002/oby.20443; Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Bastie CC, 2004, DIABETES, V53, P2209, DOI 10.2337/diabetes.53.9.2209; Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400; Cai L., 2012, PLOS ONE, V7; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Chen XP, 2012, J BIOL CHEM, V287, P3751, DOI 10.1074/jbc.M111.310888; Chiba T, 2003, ARTERIOSCL THROM VAS, V23, P1423, DOI 10.1161/01.ATV.0000085040.58340.36; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Coenen KR, 2007, DIABETES, V56, P564, DOI 10.2337/db06-1375; Crawford DC, 2008, J LIPID RES, V49, P588, DOI 10.1194/jlr.M700409-JLR200; Du Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2011; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Gao JH, 2007, DIABETES, V56, P24, DOI 10.2337/db06-0144; Goudriaan JR, 2004, J LIPID RES, V45, P1475, DOI 10.1194/jlr.M400009-JLR200; Goudriaan JR, 2001, ARTERIOSCL THROM VAS, V21, P1488, DOI 10.1161/hq0901.095147; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Hajri T, 1998, J NUTR, V128, P477, DOI 10.1093/jn/128.3.477; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hajri T, 2001, J BIOL CHEM, V276, P23661, DOI 10.1074/jbc.M100942200; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Hajri T, 2011, AM J PHYSIOL-ENDOC M, V300, pE350, DOI 10.1152/ajpendo.00307.2010; He JY, 2011, ATHEROSCLEROSIS, V215, P243, DOI 10.1016/j.atherosclerosis.2010.12.018; Huang ZH, 2009, J BIOL CHEM, V284, P31512, DOI 10.1074/jbc.M109.004754; Huang ZH, 2009, AM J PHYSIOL-ENDOC M, V296, pE1110, DOI 10.1152/ajpendo.90964.2008; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Obunike JC, 2001, J BIOL CHEM, V276, P8934, DOI 10.1074/jbc.M008813200; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Patsouris D, 2009, J BIOL CHEM, V284, P31223, DOI 10.1074/jbc.M109.041665; Saraswathi V, 2006, J LIPID RES, V47, P1406, DOI 10.1194/jlr.M600159-JLR200; Satoh Noriko, 2010, Diabetes Care, V33, pe7, DOI 10.2337/dc09-1315; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shapiro H, 2013, J CLIN ENDOCR METAB, V98, P1173, DOI 10.1210/jc.2012-2745; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Takahashi K, 2008, AM J PHYSIOL-ENDOC M, V294, pE898, DOI 10.1152/ajpendo.00131.2007; TAKAHASHI S, 1995, J BIOL CHEM, V270, P15747, DOI 10.1074/jbc.270.26.15747; Tao H, 2011, BIOCHEM PHARMACOL, V82, P1950, DOI 10.1016/j.bcp.2011.09.003; Tao H, 2010, AM J PHYSIOL-ENDOC M, V298, pE68, DOI 10.1152/ajpendo.00367.2009; Ueda Y, 2011, OBESITY, V19, P1663, DOI 10.1038/oby.2011.58; Wang JL, 2012, ATHEROSCLEROSIS, V223, P342, DOI 10.1016/j.atherosclerosis.2012.06.003; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yagyu H, 2002, J BIOL CHEM, V277, P10037, DOI 10.1074/jbc.M109966200	50	41	41	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1688	1703		10.1074/jbc.M113.515320	http://dx.doi.org/10.1074/jbc.M113.515320			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24293365	Green Published, hybrid			2022-12-28	WOS:000332401700041
J	Cao, ZB; Subramaniam, S; Bulleid, NJ				Cao, Zhenbo; Subramaniam, Suraj; Bulleid, Neil J.			Lack of an Efficient Endoplasmic Reticulum-localized Recycling System Protects Peroxiredoxin IV from Hyperoxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Disulfide; Peroxiredoxin; Protein Isomerase; Thioredoxin; Thioredoxin Reductase	CYSTEINE-SULFINIC ACID; DISULFIDE BOND FORMATION; ACTIVE-SITE CYSTEINE; OXIDATIVE STRESS; 2-CYS PEROXIREDOXINS; SECRETORY PATHWAY; HYDROGEN-PEROXIDE; CELLS; INACTIVATION; REDUCTION	Background: Peroxiredoxin IV metabolizes endoplasmic reticulum-derived hydrogen peroxide. Results: In contrast to other peroxiredoxins, peroxiredoxin IV is insensitive to hyperoxidation within its cellular environment. Conclusion: There is a lack of a robust peroxiredoxin IV recycling system within the endoplasmic reticulum. Significance: Studying the reduction of peroxiredoxin IV highlights the different mechanisms for maintaining redox status within different cellular compartments. Typical 2-Cys peroxiredoxins are required to remove hydrogen peroxide from several different cellular compartments. Their activity can be regulated by hyperoxidation and consequent inactivation of the active-site peroxidatic cysteine. Here we developed a simple assay to quantify the hyperoxidation of peroxiredoxins. Hyperoxidation of peroxiredoxins can only occur efficiently in the presence of a recycling system, usually involving thioredoxin and thioredoxin reductase. We demonstrate that there is a marked difference in the sensitivity of the endoplasmic reticulum-localized peroxiredoxin to hyperoxidation compared with either the cytosolic or mitochondrial enzymes. Each enzyme is equally sensitive to hyperoxidation in the presence of a robust recycling system. Our results demonstrate that peroxiredoxin IV recycling in the endoplasmic reticulum is much less efficient than in the cytosol or mitochondria, leading to the protection of peroxiredoxin IV from hyperoxidation.	[Cao, Zhenbo; Subramaniam, Suraj; Bulleid, Neil J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Bulleid, NJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.	neil.bulleid@glasgow.ac.uk		Bulleid, Neil/0000-0002-9839-5279	Wellcome Trust [088053]; Scottish University Life Science Alliance (SULSA); BBSRC [BB/L00593X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L00593X/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Scottish University Life Science Alliance (SULSA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grant 088053 and by the Scottish University Life Science Alliance (SULSA).	Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; LODISH HF, 1993, J BIOL CHEM, V268, P20598; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Stacey MM, 2012, ANTIOXID REDOX SIGN, V17, P411, DOI 10.1089/ars.2011.4348; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; van Lith M, 2011, J CELL SCI, V124, P2349, DOI 10.1242/jcs.085530; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	28	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5490	5498		10.1074/jbc.M113.529305	http://dx.doi.org/10.1074/jbc.M113.529305			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403061	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000332015500013
J	Kocsis, ZS; Sarlos, K; Harami, GM; Martina, M; Kovacs, M				Kocsis, Zsuzsa S.; Sarlos, Kata; Harami, Gabor M.; Martina, Mate; Kovacs, Mihaly			A Nucleotide-dependent and HRDC Domain-dependent Structural Transition in DNA-bound RecQ Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; DNA Repair; DNA-Protein Interaction; Molecular Motors; Protein Conformation; Recombination; Structure	ESCHERICHIA-COLI RECQ; SINGLE-STRANDED-DNA; WERNER-SYNDROME PROTEIN; WINGED-HELIX DOMAIN; REP HELICASE; CONFORMATIONAL-CHANGES; KINETIC MECHANISM; ATP HYDROLYSIS; GENOME MAINTENANCE; CRYSTAL-STRUCTURES	Background: The mechanistic role of DNA-induced structural changes in RecQ helicases is largely unexplored. Results: DNA interaction of RecQ helicase depends on the nucleotide state of the enzyme and the presence of an intact HRDC domain. Conclusion: We identified a structural transition of the RecQ-DNA complex that is linked to the mechanoenzymatic cycle. Significance: This transition contributes to translocation along DNA and genome-maintaining activities. The allosteric communication between the ATP- and DNA-binding sites of RecQ helicases enables efficient coupling of ATP hydrolysis to translocation along single-stranded DNA (ssDNA) and, in turn, the restructuring of multistranded DNA substrates during genome maintenance processes. In this study, we used the tryptophan fluorescence signal of Escherichia coli RecQ helicase to decipher the kinetic mechanism of the interaction of the enzyme with ssDNA. Rapid kinetic experiments revealed that ssDNA binding occurs in a two-step mechanism in which the initial binding step is followed by a structural transition of the DNA-bound helicase. We found that the nucleotide state of RecQ greatly influences the kinetics of the detected structural transition, which leads to a high affinity DNA-clamped state in the presence of the nucleotide analog ADP-AlF4. The DNA binding mechanism is largely independent of ssDNA length, indicating the independent binding of RecQ molecules to ssDNA and the lack of significant DNA end effects. The structural transition of DNA-bound RecQ was not detected when the ssDNA binding capability of the helicase-RNase D C-terminal domain was abolished or the domain was deleted. The results shed light on the nature of conformational changes leading to processive ssDNA translocation and multistranded DNA processing by RecQ helicases.	[Kocsis, Zsuzsa S.; Sarlos, Kata; Harami, Gabor M.; Martina, Mate; Kovacs, Mihaly] Eotvos Lorand Univ, Dept Biochem, ELTE MTA Momentum Motor Enzymol Res Grp, H-1117 Budapest, Hungary	Eotvos Lorand University	Kovacs, M (corresponding author), Eotvos Lorand Univ, Dept Biochem, ELTE MTA Momentum Motor Enzymol Res Grp, Pazmany Ps 1-C, H-1117 Budapest, Hungary.	kovacsm@elte.hu	Kovacs, Mihaly/A-6841-2011; Harami, Gábor/I-2756-2017	Harami, Gábor/0000-0001-7234-2710; Horvath-Sarlos, Kata/0000-0003-3813-0209; Kocsis, Zsuzsa/0000-0002-4336-3325; Kovacs, Mihaly/0000-0002-1200-4741	Human Frontier Science Program Grant [RGY0072/2010]; "Momentum" Program of the Hungarian Academy of Sciences Grant [LP2011-006/2011]; European Union; European Social Fund [TAMOP 4.2.4.A/1-11-1-2012-0001]; State of Hungary	Human Frontier Science Program Grant(Human Frontier Science Program); "Momentum" Program of the Hungarian Academy of Sciences Grant; European Union(European Commission); European Social Fund(European Social Fund (ESF)); State of Hungary	This work was supported by Human Frontier Science Program Grant RGY0072/2010 (to M. K.) and "Momentum" Program of the Hungarian Academy of Sciences Grant LP2011-006/2011 (to M. K.). This work was also supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of the TAMOP 4.2.4.A/1-11-1-2012-0001 "National Excellence Program."	Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein DA, 2005, STRUCTURE, V13, P1173, DOI 10.1016/j.str.2005.04.018; Bjornson KP, 1998, BIOCHEMISTRY-US, V37, P891, DOI 10.1021/bi9719307; Bjornson KP, 1996, BIOCHEMISTRY-US, V35, P2268, DOI 10.1021/bi9522763; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Bujalowski W, 2000, J MOL BIOL, V295, P831, DOI 10.1006/jmbi.1999.3378; CHAO KL, 1990, J BIOL CHEM, V265, P1067; Courcelle J, 1999, MOL GEN GENET, V262, P543, DOI 10.1007/s004380051116; Dou SX, 2004, J BIOL CHEM, V279, P6354, DOI 10.1074/jbc.M311272200; Flowers S, 2003, BIOCHEMISTRY-US, V42, P1910, DOI 10.1021/bi025992v; Galletto R, 2004, BIOCHEMISTRY-US, V43, P11002, DOI 10.1021/bi049378q; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Gyimesi M, 2010, NUCLEIC ACIDS RES, V38, P4404, DOI 10.1093/nar/gkq145; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Harrigan JA, 2003, BIOCHIMIE, V85, P1185, DOI 10.1016/j.biochi.2003.10.006; Heilek GM, 1997, J VIROL, V71, P6264, DOI 10.1128/JVI.71.8.6264-6266.1997; Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046; Hu JS, 2005, P NATL ACAD SCI USA, V102, P18379, DOI 10.1073/pnas.0509380102; Jezewska MJ, 1996, J BIOL CHEM, V271, P4261; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2129, DOI 10.1021/bi952345d; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Khakhar RR, 2003, TRENDS CELL BIOL, V13, P493, DOI 10.1016/S0962-8924(03)00171-5; Kitano K, 2010, STRUCTURE, V18, P177, DOI 10.1016/j.str.2009.12.011; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P6032, DOI 10.1021/bi020122z; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Li N, 2010, J BIOL CHEM, V285, P6922, DOI 10.1074/jbc.M109.069286; Liu JL, 2004, J BIOL CHEM, V279, P42794, DOI 10.1074/jbc.M405008200; Liu SS, 2013, FEBS LETT, V587, P2635, DOI 10.1016/j.febslet.2013.06.048; LOHMAN TM, 1981, J MOL BIOL, V152, P67, DOI 10.1016/0022-2836(81)90096-6; Lucic B, 2011, NUCLEIC ACIDS RES, V39, P1703, DOI 10.1093/nar/gkq1031; Lucius AL, 2006, BIOCHEMISTRY-US, V45, P7237, DOI 10.1021/bi0518287; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Pan BY, 2010, J BIOL CHEM, V285, P15884, DOI 10.1074/jbc.M110.104299; Pandey N, 2011, BIOINFORMATION, V7, P371; Pike ACW, 2009, P NATL ACAD SCI USA, V106, P1039, DOI 10.1073/pnas.0806908106; Rad B, 2012, BIOCHEMISTRY-US, V51, P2921, DOI 10.1021/bi3000676; Rad B, 2012, P NATL ACAD SCI USA, V109, P1443, DOI 10.1073/pnas.1119952109; Ren H, 2007, NUCLEIC ACIDS RES, V35, P6029, DOI 10.1093/nar/gkm544; Sarlos K, 2012, P NATL ACAD SCI USA, V109, P9804, DOI 10.1073/pnas.1114468109; Sato A, 2010, J BIOCHEM, V148, P517, DOI 10.1093/jb/mvq097; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; Stole E, 1997, BIOCHEMISTRY-US, V36, P3483, DOI 10.1021/bi962881l; Tadokoro T, 2012, AGING-US, V4, P418, DOI 10.18632/aging.100463; Toseland CP, 2013, J BIOL CHEM, V288, P25183, DOI 10.1074/jbc.M113.484667; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Kobbe C, 2003, J BIOL CHEM, V278, P52997, DOI 10.1074/jbc.M308338200; WONG I, 1992, SCIENCE, V256, P350, DOI 10.1126/science.256.5055.350; Wu L, 2005, EMBO J, V24, P2679, DOI 10.1038/sj.emboj.7600740; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Xu HQ, 2003, J BIOL CHEM, V278, P34925, DOI 10.1074/jbc.M303581200; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200; Zittel MC, 2005, NUCLEIC ACIDS RES, V33, P6982, DOI 10.1093/nar/gki999	59	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5938	5949		10.1074/jbc.M113.530741	http://dx.doi.org/10.1074/jbc.M113.530741			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403069	Green Published, hybrid			2022-12-28	WOS:000332015500050
J	Nabokina, SM; Inoue, K; Subramanian, VS; Valle, JE; Yuasa, H; Said, HM				Nabokina, Svetlana M.; Inoue, Katsuhisa; Subramanian, Veedamali S.; Valle, Judith E.; Yuasa, Hiroaki; Said, Hamid M.			Molecular Identification and Functional Characterization of the Human Colonic Thiamine Pyrophosphate Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Intestinal Epithelium; Membrane Transport; Thiamine; Transfection; Transporters	WATER-SOLUBLE VITAMINS; CHOLINE TRANSPORT; EPITHELIAL-CELLS; MECHANISM; PROTEINS; FAMILY; BIOSYNTHESIS; COLONOCYTES; SYSTEM	Colonic microbiota synthesize a considerable amount of thiamine in the form of thiamine pyrophosphate (TPP). Recent functional studies from our laboratory have shown the existence of a specific, high-affinity, and regulated carrier-mediated uptake system for TPP in human colonocytes. Nothing, however, is known about the molecular identity of this system. Here we report on the molecular identification of the colonic TPP uptake system as the product of the SLC44A4 gene. We cloned the cDNA of SLC44A4 from human colonic epithelial NCM460 cells, which, upon expression in ARPE19 cells, led to a significant (p < 0.01, >5-fold) induction in [H-3]TPP uptake. Uptake by the induced system was also found to be temperature- and energy-dependent; Na+-independent, slightly higher at acidic buffer pH, and highly sensitive to protonophores; saturable as a function of TPP concentration, with an apparent K-m of 0.17 +/- 0.064 m; and highly specific for TPP and not affected by free thiamine, thiamine monophosphate, or choline. Expression of the human TPP transporter was found to be high in the colon and negligible in the small intestine. A cell surface biotinylation assay and live cell confocal imaging studies showed the human TPP transporter protein to be expressed at the apical membrane domain of polarized epithelia. These results show, for the first time, the molecular identification and characterization of a specific and high-affinity TPP uptake system in human colonocytes. The findings further support the hypothesis that the microbiota-generated TPP is absorbable and could contribute toward host thiamine homeostasis, especially toward cellular nutrition of colonocytes.	[Nabokina, Svetlana M.; Subramanian, Veedamali S.; Valle, Judith E.; Said, Hamid M.] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA; [Nabokina, Svetlana M.; Subramanian, Veedamali S.; Valle, Judith E.; Said, Hamid M.] Univ Calif Irvine, Dept Physiol Biophys, Irvine, CA 92697 USA; [Nabokina, Svetlana M.; Subramanian, Veedamali S.; Valle, Judith E.] Dept Vet Affairs Med Ctr, Long Beach, CA 90822 USA; [Inoue, Katsuhisa; Said, Hamid M.] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Biopharmaceut, Tokyo 1920392, Japan; [Yuasa, Hiroaki] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Nagoya, Aichi 4678603, Japan	University of California System; University of California Irvine; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; Tokyo University of Pharmacy & Life Sciences; Nagoya City University	Said, HM (corresponding author), Vet Affairs Med Ctr 151, Long Beach, CA 90822 USA.	hmsaid@uci.edu	Yuasa, Hiroaki/AGW-4587-2022	Yuasa, Hiroaki/0000-0001-8349-6694	National Institutes of Health [DK 56061-15]; Department of Veteran Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK056061, R01DK056061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 56061-15 (to H. M. S.). This work was also supported by the Department of Veteran Affairs (to H. M. S.).	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; BARROW BJ, 1989, HISTOCHEM J, V21, P289, DOI 10.1007/BF01757182; Berdanier C.D., 2018, ADV NUTR MACRONUTRIE; Bettendorff L, 2009, FEBS J, V276, P2917, DOI 10.1111/j.1742-4658.2009.07019.x; Bian J, 2011, J BACTERIOL, V193, P3912, DOI 10.1128/JB.00386-11; BRASITUS TA, 1984, BIOCHIM BIOPHYS ACTA, V773, P290, DOI 10.1016/0005-2736(84)90093-2; CZERNOBI.B, 1968, CANCER, V21, P165, DOI 10.1002/1097-0142(196802)21:2<165::AID-CNCR2820210202>3.0.CO;2-E; DAWSON I, 1963, GASTROENTEROLOGY, V44, P745; Dudeja PK, 2001, AM J PHYSIOL-CELL PH, V281, pC786, DOI 10.1152/ajpcell.2001.281.3.C786; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; GUERRANT N. B., 1932, Journal of Biological Chemistry, V98, P225; Gurerrant NB, 1937, J NUTR, V13, P305; Mullen GP, 2007, GENETICS, V177, P195, DOI 10.1534/genetics.107.074120; Nabokina SM, 2012, AM J PHYSIOL-GASTR L, V303, pG389, DOI 10.1152/ajpgi.00151.2012; Najjar VA, 1943, J AMER MED ASSOC, V123, P683, DOI 10.1001/jama.1943.02840460017005; O'Regan S, 2000, P NATL ACAD SCI USA, V97, P1835, DOI 10.1073/pnas.030339697; Reidling JC, 2007, AM J PHYSIOL-GASTR L, V292, pG275, DOI 10.1152/ajpgi.00327.2006; Rindi G, 2000, P SOC EXP BIOL MED, V224, P246, DOI 10.1046/j.1525-1373.2000.22428.x; Said HM, 2013, AM J PHYSIOL-GASTR L, V305, pG601, DOI 10.1152/ajpgi.00231.2013; Said HM, 2011, BIOCHEM J, V437, P357, DOI 10.1042/BJ20110326; Said HM, 1999, AM J PHYSIOL-CELL PH, V277, pC645, DOI 10.1152/ajpcell.1999.277.4.C645; Said HM, 2001, AM J PHYSIOL-GASTR L, V281, pG144, DOI 10.1152/ajpgi.2001.281.1.G144; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Subramanian VS, 2008, BIOCHEM BIOPH RES CO, V374, P123, DOI 10.1016/j.bbrc.2008.06.120; Subramanian VS, 2009, AM J PHYSIOL-CELL PH, V296, pC663, DOI 10.1152/ajpcell.00396.2008; TALLAKSEN CME, 1992, ALCOHOL CLIN EXP RES, V16, P320, DOI 10.1111/j.1530-0277.1992.tb01384.x; Tanphaichirt V., 1994, MODERN NUTR HLTH DIS; Traiffort E, 2005, J NEUROCHEM, V92, P1116, DOI 10.1111/j.1471-4159.2004.02962.x; Traiffort E, 2013, MOL ASPECTS MED, V34, P646, DOI 10.1016/j.mam.2012.10.011; Victor M., 1989, WERNICKE KORSAKOFF S, V2nd; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; Zhao RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1512, DOI 10.1152/ajpcell.00547.2001; Zufferey R, 2004, NEUROCHEM RES, V29, P461, DOI 10.1023/B:NERE.0000013752.43906.e5	33	49	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4405	4416		10.1074/jbc.M113.528257	http://dx.doi.org/10.1074/jbc.M113.528257			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24379411	hybrid, Green Published			2022-12-28	WOS:000331403800051
J	Zhao, PW; Lane, TR; Gao, HGL; Hurst, DP; Kotsikorou, E; Le, L; Brailoiu, E; Reggio, PH; Abood, ME				Zhao, Pingwei; Lane, Tom R.; Gao, Helen G. L.; Hurst, Dow P.; Kotsikorou, Evangelia; Le, Long; Brailoiu, Eugen; Reggio, Patricia H.; Abood, Mary E.			Crucial Positively Charged Residues for Ligand Activation of the GPR35 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; G Protein-coupled Receptors (GPCR); MAP Kinases (MAPKs); Molecular Modeling; Trafficking	PROTEIN-COUPLED RECEPTOR; INDUCED CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; TRANSMEMBRANE DOMAIN; ORPHAN RECEPTOR; KYNURENIC ACID; RHODOPSIN; AGONIST; BINDING; MEMORIES	Background: The structure and function of GPR35 are not understood. Results: Using a GPR35 activated state molecular model, we identified crucial amino acid residues required for ligand activation using -arrestin trafficking, ERK1/2 activation, and calcium imaging. Conclusion: Arginines in TMH3-4-5-6 affected agonist signaling. Significance: Identification of residues for GPR35 agonist signaling is critical for the design of ligands with improved potency. GPR35 is a G protein-coupled receptor expressed in the immune, gastrointestinal, and nervous systems in gastric carcinomas and is implicated in heart failure and pain perception. We investigated residues in GPR35 responsible for ligand activation and the receptor structure in the active state. GPR35 contains numerous positively charged amino acids that face into the binding pocket that cluster in two distinct receptor regions, TMH3-4-5-6 and TMH1-2-7. Computer modeling implicated TMH3-4-5-6 for activation by the GPR35 agonists zaprinast and pamoic acid. Mutation results for the TMH1-2-7 region of GPR35 showed no change in ligand efficacies at the K1.32A, R2.65A, R7.33A, and K7.40A mutants. However, mutation of arginine residues in the TMH3-4-5-6 region (R4.60, R6.58, R3.36, R(164), and R(167) in the EC2 loop) had effects on signaling for one or both agonists tested. R4.60A resulted in a total ablation of agonist-induced activation in both the -arrestin trafficking and ERK1/2 activation assays. R6.58A increased the potency of zaprinast 30-fold in the pERK assay. The R(167)A mutant decreased the potency of pamoic acid in the -arrestin trafficking assay. The R(164)A and R(164)L mutants decreased potencies of both agonists. Similar trends for R6.58A and R(167)A were observed in calcium responses. Computer modeling showed that the R6.58A mutant has additional interactions with zaprinast. R3.36A did not express on the cell surface but was trapped in the cytoplasm. The lack of surface expression of R3.36A was rescued by a GPR35 antagonist, CID2745687. These results clearly show that R4.60, R(164), R(167), and R6.58 play crucial roles in the agonist initiated activation of GPR35.	[Zhao, Pingwei; Gao, Helen G. L.; Abood, Mary E.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Zhao, Pingwei; Le, Long; Abood, Mary E.] Temple Univ, Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA; [Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Brailoiu, Eugen] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA; [Lane, Tom R.; Hurst, Dow P.; Kotsikorou, Evangelia; Reggio, Patricia H.] Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27402 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of North Carolina; University of North Carolina Greensboro	Reggio, PH (corresponding author), Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27402 USA.	phreggio@uncg.edu; mabood@temple.edu		Kotsikorou, Evangelia/0000-0002-8398-2139; Abood, Mary/0000-0002-1744-2820	National Institutes of Health [RO1 DA023204, KO5 DA021358, P30 DA013429]; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA021358, P30DA013429, R01DA023204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DA023204 (to M. E. A.), KO5 DA021358 (to P. H. R.), and P30 DA013429.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; Barth MC, 2009, J BIOL CHEM, V284, P19189, DOI 10.1074/jbc.M109.024042; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Cosi C, 2011, NEUROPHARMACOLOGY, V60, P1227, DOI 10.1016/j.neuropharm.2010.11.014; Fallarini S, 2010, BIOCHEM BIOPH RES CO, V398, P420, DOI 10.1016/j.bbrc.2010.06.091; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Greco K., 2003, ARIPIPRAZOLE OLANZAP; Guarnieri F, 1996, J AM CHEM SOC, V118, P5580, DOI 10.1021/ja952745o; Guo JA, 2008, J PHARMACOL EXP THER, V324, P342, DOI 10.1124/jpet.107.127266; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Javitch JA, 1997, J BIOL CHEM, V272, P18546, DOI 10.1074/jbc.272.30.18546; Jenkins L, 2011, BRIT J PHARMACOL, V162, P733, DOI 10.1111/j.1476-5381.2010.01082.x; Jenkins L, 2010, BIOCHEM J, V432, P451, DOI 10.1042/BJ20101287; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; MacKenzie AE, 2014, MOL PHARMACOL, V85, P91, DOI 10.1124/mol.113.089482; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; McAllister SD, 2003, J MED CHEM, V46, P5139, DOI 10.1021/jm0302647; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Nakanishi J, 2006, BIOCHEM BIOPH RES CO, V343, P1191, DOI 10.1016/j.bbrc.2006.03.064; Neubig RR, 2010, MOL PHARMACOL, V78, P558, DOI 10.1124/mol.110.067645; O'Dowd BF, 1998, GENOMICS, V47, P310, DOI 10.1006/geno.1998.5095; Ohshiro H, 2008, BIOCHEM BIOPH RES CO, V365, P344, DOI 10.1016/j.bbrc.2007.10.197; Oka S, 2010, BIOCHEM BIOPH RES CO, V395, P232, DOI 10.1016/j.bbrc.2010.03.169; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Okumura S, 2004, CANCER SCI, V95, P131, DOI 10.1111/j.1349-7006.2004.tb03193.x; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shrimpton AE, 2004, CLIN GENET, V66, P537, DOI 10.1111/j.1399-0004.2004.00363.x; Stahl Heinrich P., 2011, HDB PHARM SALTS PROP; Taniguchi Y, 2008, PHARMACOLOGY, V82, P245, DOI 10.1159/000157625; Taniguchi Y, 2006, FEBS LETT, V580, P5003, DOI 10.1016/j.febslet.2006.08.015; Tao Q, 1999, MOL PHARMACOL, V55, P605; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Whitnell RM, 2008, J COMPUT CHEM, V29, P741, DOI 10.1002/jcc.20822; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yang YH, 2010, PHARMACOLOGY, V86, P1, DOI 10.1159/000314164; Zhang RD, 2005, MOL PHARMACOL, V68, P69, DOI 10.1124/mol.104.007823; Zhao PW, 2010, MOL PHARMACOL, V78, P560, DOI 10.1124/mol.110.066746	55	15	15	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3625	3638		10.1074/jbc.M113.508382	http://dx.doi.org/10.1074/jbc.M113.508382			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24347166	Green Published, hybrid			2022-12-28	WOS:000331368700045
J	Desai, R; Kilburn, D; Lee, HT; Woodson, SA				Desai, Ravi; Kilburn, Duncan; Lee, Hui-Ting; Woodson, Sarah A.			Increased Ribozyme Activity in Crowded Solutions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Macromolecular Crowding; Ribozyme; RNA Catalysis; RNA Folding; X-ray Scattering; PEG	GROUP-I INTRON; POLYETHYLENE-GLYCOL; AQUEOUS-SOLUTIONS; CRYSTAL-STRUCTURE; EXCLUDED-VOLUME; CORE HELICES; TRANSFER-RNA; AZOARCUS; CATALYSIS; BINDING	Background: RNAs have evolved to function in the crowded environment of the cell. Results: Large crowder molecules increase the catalytic activity of a group I ribozyme at physiological Mg2+, whereas small neutral molecules do not. Conclusion: Excluded volume due to crowding stabilizes the native active state of RNAs. Significance: Crowding significantly improves RNA folding and function. Noncoding RNAs must function in the crowded environment of the cell. Previous small-angle x-ray scattering experiments showed that molecular crowders stabilize the structure of the Azoarcus group I ribozyme, allowing the ribozyme to fold at low physiological Mg2+ concentrations. Here, we used an RNA cleavage assay to show that the PEG and Ficoll crowder molecules increased the biochemical activity of the ribozyme, whereas sucrose did not. Crowding lowered the Mg2+ threshold at which activity was detected and increased total RNA cleavage at high Mg2+ concentrations sufficient to fold the RNA in crowded or dilute solution. After correcting for solution viscosity, the observed reaction rate was proportional to the fraction of active ribozyme. We conclude that molecular crowders stabilize the native ribozyme and favor the active structure relative to compact inactive folding intermediates.	[Desai, Ravi; Kilburn, Duncan; Lee, Hui-Ting; Woodson, Sarah A.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA	Johns Hopkins University	Woodson, SA (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA.	swoodson@jhu.edu		Woodson, Sarah/0000-0003-0170-1987	National Institute of Standards and Technology; National Institutes of Health [GM60819]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060819] Funding Source: NIH RePORTER	National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institute of Standards and Technology and by National Institutes of Health Grant GM60819.	Adams PL, 2004, RNA, V10, P1867, DOI 10.1261/rna.7140504; Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Behrouzi R., 2012, THESIS J HOPKINS U; Behrouzi R, 2012, CELL, V149, P348, DOI 10.1016/j.cell.2012.01.057; Buscaglia R, 2013, NUCLEIC ACIDS RES, V41, P7934, DOI 10.1093/nar/gkt440; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Chauhan S, 2005, J MOL BIOL, V353, P1199, DOI 10.1016/j.jmb.2005.09.015; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; GONZALEZTELLO P, 1994, J CHEM ENG DATA, V39, P611, DOI 10.1021/je00015a050; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; Kilburn D, 2013, J AM CHEM SOC, V135, P10055, DOI 10.1021/ja4030098; Kilburn D, 2010, J AM CHEM SOC, V132, P8690, DOI 10.1021/ja101500g; Kirincic S, 1999, FLUID PHASE EQUILIBR, V155, P311, DOI 10.1016/S0378-3812(99)00005-9; Kuo LY, 1999, BBA-GENE STRUCT EXPR, V1489, P281, DOI 10.1016/S0167-4781(99)00200-6; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; MINTON AP, 1981, BIOPOLYMERS, V20, P2093, DOI 10.1002/bip.1981.360201006; Moghaddam S, 2009, J MOL BIOL, V393, P753, DOI 10.1016/j.jmb.2009.08.044; Nakano S, 2009, J AM CHEM SOC, V131, P16881, DOI 10.1021/ja9066628; Perez-Salas UA, 2004, BIOCHEMISTRY-US, V43, P1746, DOI 10.1021/bi035642o; Rangan P, 2004, J MOL BIOL, V339, P41, DOI 10.1016/j.jmb.2004.03.059; Rangan P, 2003, J MOL BIOL, V329, P229, DOI 10.1016/S0022-2836(03)00430-3; Rangan P, 2003, P NATL ACAD SCI USA, V100, P1574, DOI 10.1073/pnas.0337743100; REINHOLDHUREK B, 1992, NATURE, V357, P173, DOI 10.1038/357173a0; Sinan S, 2011, J BIOL CHEM, V286, P37304, DOI 10.1074/jbc.M111.287706; Solomatin SV, 2010, NATURE, V463, P681, DOI 10.1038/nature08717; Stahley MR, 2006, CURR OPIN STRUC BIOL, V16, P319, DOI 10.1016/j.sbi.2006.04.005; Strulson CA, 2012, NAT CHEM, V4, P941, DOI [10.1038/NCHEM.1466, 10.1038/nchem.1466]; Tanner MA, 1996, RNA, V2, P74; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	29	40	40	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2972	2977		10.1074/jbc.M113.527861	http://dx.doi.org/10.1074/jbc.M113.527861			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24337582	Green Published, hybrid			2022-12-28	WOS:000333403000044
J	Scott, I; Webster, BR; Chan, CK; Okonkwo, JU; Han, K; Sack, MN				Scott, Iain; Webster, Bradley R.; Chan, Carmen K.; Okonkwo, Joshua U.; Han, Kim; Sack, Michael N.			GCN5-like Protein 1 (GCN5L1) Controls Mitochondrial Content through Coordinated Regulation of Mitochondrial Biogenesis and Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Autophagy; Lysosomes; Mitochondria; Subcellular Organelles; GCN5L1; PGC1; Acetylation; Mitophagy	SELECTIVE AUTOPHAGY; LIPID-METABOLISM; PARKIN; HOMEOSTASIS; CLEARANCE; DISEASE	Background: The balance between mitochondrial biogenesis and autophagy controls cellular mitochondrial content. Results: Mitochondrial deacetylation-induced mitophagy evokes concurrent and interdependent up-regulation of TFEB and PGC-1 to sustain cellular mitochondrial content. Conclusion: Mitochondrial content is coordinately regulated by the mitochondrial and lysosome biogenesis programs under GCN5L1 control. Significance: Counter-regulatory interdependent programs function to sustain mitochondrial content/homeostasis in a nutrient-sensing, acetylation-dependent manner. Cellular mitochondrial content is governed by the competing processes of organelle biogenesis and degradation. It is proposed that these programs are tightly regulated to ensure that the cell maintains sufficient organelles to meet its biosynthetic, energetic, and other homeostatic requirements. We recently reported that GCN5L1, a putative nutrient-sensing regulator, controls mitochondrial removal by autophagy. Here we show that genetic deletion of GCN5L1 has a direct positive effect on the expression and activity of Transcriptional Factor EB (TFEB), which acts as a master regulator of autophagy. Surprisingly, the induction of TFEB-mediated autophagy pathways does not diminish cellular mitochondrial content, as its activity is countered by induction of the mitochondrial biogenesis transcriptional co-activator PPAR coactivator 1 (PGC-1). Concurrent induction of the TFEB and PGC-1 pathways results in an increased mitochondrial turnover rate in GCN5L1(-/-) cells. Finally, we show that genetic knockdown of either TFEB or PGC-1 leads to a corresponding decrease in the expression of the other gene, indicating that these proteins act coordinately, and in opposition, to maintain cellular mitochondrial content in response to the modulation of nutrient-sensing signatures.	[Scott, Iain; Webster, Bradley R.; Chan, Carmen K.; Okonkwo, Joshua U.; Han, Kim; Sack, Michael N.] NHLBI, Lab Mitochondrial Biol & Metab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sack, MN (corresponding author), NHLBI, Bldg 10 CRC,Room 5-3216E,9000 Rockville Pike, Bethesda, MD 20892 USA.	sackm@nhlbi.nih.gov	Sack, Michael/AAG-1000-2020		NHLBI Intramural Research Program [HL006047-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL116728, ZIAHL006047, ZIGHL006020] Funding Source: NIH RePORTER	NHLBI Intramural Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the NHLBI Intramural Research Program (HL006047-01).	Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Glick D, 2012, MOL CELL BIOL, V32, P2570, DOI 10.1128/MCB.00167-12; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Hubbard VM, 2012, BIOGERONTOLOGY, V13, P21, DOI 10.1007/s10522-011-9331-x; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; McLeod CJ, 2005, TRENDS CARDIOVAS MED, V15, P118, DOI 10.1016/j.tcm.2005.05.001; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Scott I., 2012, BIOCHEM J, V443, P627; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Tsunemi T., 2012, SCI TRANSL MED, V4; Webster BR, 2013, J CELL SCI, V126, P4843, DOI 10.1242/jcs.131300; Wild P, 2010, NAT CELL BIOL, V12, P104, DOI 10.1038/ncb0210-104; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	27	87	89	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2864	2872		10.1074/jbc.M113.521641	http://dx.doi.org/10.1074/jbc.M113.521641			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24356961	Green Published, hybrid			2022-12-28	WOS:000333403000034
J	Nguyen, T; Chen, CJ; Shively, JE				Tung Nguyen; Chen, Charng-Jui; Shively, John E.			Phosphorylation of CEACAM1 Molecule by Calmodulin Kinase IID in a Three-dimensional Model of Mammary Gland Lumen Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Breast Cancer; Calmodulin; CaMKII; Cell Adhesion; RNA Interference (RNAi)	DEPENDENT PROTEIN-KINASE; SHORT CYTOPLASMIC DOMAIN; BILIARY GLYCOPROTEIN CD66A; CELL ADHESION MOLECULE; APOPTOSIS; ACTIN; IDENTIFICATION; MORPHOGENESIS; SEQUENCES; ISOFORMS	Background: CEACAM1, a cell-cell adhesion molecule that induces lumen formation, requires phosphorylation on Thr-457 for its function. Results: Biochemical and RNAi approaches identified that CaMKIID was responsible for phosphorylation of Thr-457 and lumen formation. Conclusion: CaMKIID, up-regulated during lumen formation, is associated with CEACAM1-mediated apoptosis, a key feature of lumen formation. Significance: Lumen formation, a hallmark of epithelial cells, is lost upon malignant transformation. Carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1), a transmembrane protein, expressed on normal breast epithelial cells is down-regulated in breast cancer. Phosphorylation of Thr-457 on the short cytoplasmic domain isoform (CEACAM1-SF) that is predominant in normal epithelial cells is required for lumen formation in a three-dimensional model that involves apoptosis of the central acinar cells. Calmodulin kinase IID (CaMKIID) was selected as a candidate for the kinase required for Thr-457 phosphorylation from a gene chip analysis comparing genes up-regulated in MCF7 cells expressing wild type CEACAM1-SF compared with the T457A-mutated gene (Chen, C. J., Kirshner, J., Sherman, M. A., Hu, W., Nguyen, T., and Shively, J. E. (2007) J. Biol. Chem. 282, 5749-5760). Up-regulation of CaMKIID during lumen formation was confirmed by analysis of mRNA and protein levels. CaMKIID was able to phosphorylate a synthetic peptide corresponding to the cytoplasmic domain of CEACAM1-SF and was covalently bound to biotinylated and T457C-modified peptide in the presence of a kinase trap previously described by Shokat and co-workers (Maly, D. J., Allen, J. A., and Shokat, K. M. (2004) J. Am. Chem. Soc. 126, 9160-9161). When cell lysates from wild type-transfected MCF7 cells undergoing lumen formation were incubated with the peptide and kinase trap, a cross-linked band corresponding to CaMKIID was observed. When these cells were treated with an RNAi that inhibits CaMKIID expression, lumen formation was blocked by over 90%. We conclude that CaMKIID specifically phosphorylates Thr-457 on CEACAM1-SF, which in turn regulates the process of lumen formation via apoptosis of the central acinar cells.	[Tung Nguyen; Chen, Charng-Jui; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, 1450 East Duarte Rd, Duarte, CA 91010 USA.	jshively@coh.org			National Institutes of Health [CA84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA84202.	BARNETT TR, 1993, MOL CELL BIOL, V13, P1273, DOI 10.1128/MCB.13.2.1273; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen CJ, 2010, EXP CELL RES, V316, P638, DOI 10.1016/j.yexcr.2009.11.001; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dery KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.204057; Edlund M, 1998, FEBS LETT, V425, P166, DOI 10.1016/S0014-5793(98)00222-1; Edlund M, 1996, J BIOL CHEM, V271, P1393, DOI 10.1074/jbc.271.3.1393; Gaur S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-46; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hoffman L, 2013, BIOCHEMISTRY-US, V52, P1198, DOI 10.1021/bi3016586; Huang J, 1998, ANTICANCER RES, V18, P3203; Huang J, 1999, J CELL SCI, V112, P4193; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Krutchinsky AN, 2001, ANAL CHEM, V73, P5066, DOI 10.1021/ac010682o; Lu RZ, 2011, J BIOL CHEM, V286, P27528, DOI 10.1074/jbc.M111.235762; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Maly DJ, 2004, J AM CHEM SOC, V126, P9160, DOI 10.1021/ja048659i; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Patel PC, 2013, J BIOL CHEM, V288, P29654, DOI 10.1074/jbc.M113.504639; Salas MA, 2010, J MOL CELL CARDIOL, V48, P1298, DOI 10.1016/j.yjmcc.2009.12.015; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; Tombes RM, 1999, BBA-MOL CELL RES, V1452, P1, DOI 10.1016/S0167-4889(99)00113-5; TURBIDE C, 1991, J BIOL CHEM, V266, P309; Yamauchi T, 2005, BIOL PHARM BULL, V28, P1342, DOI 10.1248/bpb.28.1342; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200	31	12	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2934	2945		10.1074/jbc.M113.496992	http://dx.doi.org/10.1074/jbc.M113.496992			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24302721	Green Published, hybrid			2022-12-28	WOS:000333403000041
J	Velisetty, P; Chalamalasetti, SV; Chakrapani, S				Velisetty, Phanindra; Chalamalasetti, Sreevatsa V.; Chakrapani, Sudha			Structural Basis for Allosteric Coupling at the Membrane-Protein Interface in Gloeobacter violaceus Ligand-gated Ion Channel (GLIC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cys-loop Receptors; Gating; Ion Channels; Membrane Reconstitution; Spectroscopy	NICOTINIC ACETYLCHOLINE-RECEPTOR; CYS-LOOP RECEPTOR; X-RAY-STRUCTURE; GABA(A) RECEPTOR; GLYCINE RECEPTOR; AGONIST BINDING; SIDE-CHAINS; CONFORMATIONAL-CHANGES; TRANSMEMBRANE DOMAINS; EXTRACELLULAR DOMAIN	Background: Allosteric mechanisms in ligand-gated ion-channels (pLGIC) that couple neurotransmitter binding to channel opening are poorly understood. GLIC is an important prokaryotic surrogate. Results: EPR studies at the junctional interface of GLIC reveal structural changes during desensitization. Conclusion: The closed conformation is characterized by extensive intrasubunit interactions at the junctional interface that weaken during desensitization. Significance: These studies elucidate the role of structural dynamics in pLGIC function. Ligand binding at the extracellular domain of pentameric ligand-gated ion channels initiates a relay of conformational changes that culminates at the gate within the transmembrane domain. The interface between the two domains is a key structural entity that governs gating. Molecular events in signal transduction at the interface are poorly defined because of its intrinsically dynamic nature combined with functional modulation by membrane lipid and water vestibules. Here we used electron paramagnetic resonance spectroscopy to delineate protein motions underlying Gloeobacter violaceus ligand-gated ion channel gating in a membrane environment and report the interface conformation in the closed and the desensitized states. Extensive intrasubunit interactions were observed in the closed state that are weakened upon desensitization and replaced by newer intersubunit contacts. Gating involves major rearrangements of the interfacial loops, accompanied by reorganization of the protein-lipid-water interface. These structural changes may serve as targets for modulation of gating by lipids, alcohols, and amphipathic drug molecules.	[Velisetty, Phanindra; Chalamalasetti, Sreevatsa V.; Chakrapani, Sudha] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Chakrapani, S (corresponding author), 10900 Euclid Ave,Robbins Bldg,E620, Cleveland, OH 44106 USA.	sudha.chakrapani@case.edu		chakrapani, sudha/0000-0003-0722-2338	American Heart Association Scientist Development Grant [12SDG12070069]	American Heart Association Scientist Development Grant(American Heart Association)	This work was supported by American Heart Association Scientist Development Grant 12SDG12070069 (to S. C.).	Absalom NL, 2003, J BIOL CHEM, V278, P50151, DOI 10.1074/jbc.M305357200; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; Amadi ST, 2010, J BIOL CHEM, V285, P26710, DOI 10.1074/jbc.M110.132621; Baier CJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00069; Barrantes FJ, 2002, MOL MEMBR BIOL, V19, P277, DOI 10.1080/09687680210166226; Bartos M, 2009, MOL NEUROBIOL, V40, P236, DOI 10.1007/s12035-009-8084-x; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Boileau AJ, 2002, J BIOL CHEM, V277, P2931, DOI 10.1074/jbc.M109334200; Borghese CM, 2003, J PHARMACOL EXP THER, V307, P42, DOI 10.1124/jpet.102.053710; Bouzat C, 1998, MOL PHARMACOL, V54, P146, DOI 10.1124/mol.54.1.146; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; CamposCaro A, 1996, P NATL ACAD SCI USA, V93, P6118, DOI 10.1073/pnas.93.12.6118; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; FARAHBAKHSH ZT, 1992, PHOTOCHEM PHOTOBIOL, V56, P1019, DOI 10.1111/j.1751-1097.1992.tb09725.x; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Galzi JL, 1996, EMBO J, V15, P5824, DOI 10.1002/j.1460-2075.1996.tb00969.x; GALZI JL, 1990, J BIOL CHEM, V265, P10430; Gonzalez-Gutierrez G, 2013, P NATL ACAD SCI USA, V110, P18716, DOI 10.1073/pnas.1313156110; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; Goyal R, 2011, J BIOL CHEM, V286, P34635, DOI 10.1074/jbc.M111.269647; Green WN, 1997, J BIOL CHEM, V272, P20945, DOI 10.1074/jbc.272.33.20945; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Gross A, 2002, BIOCHEMISTRY-US, V41, P1123, DOI 10.1021/bi015828s; Grutter T, 2005, CR BIOL, V328, P223, DOI 10.1016/j.crvi.2004.11.004; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; HEIDMANN T, 1980, EUR J BIOCHEM, V110, P35, DOI 10.1111/j.1432-1033.1980.tb04839.x; Hibbs RE, 2006, J MOL NEUROSCI, V30, P73, DOI 10.1385/JMN:30:1:73; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Hu XQ, 2003, J BIOL CHEM, V278, P46583, DOI 10.1074/jbc.M308974200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Labriola JM, 2013, J BIOL CHEM, V288, P11294, DOI 10.1074/jbc.M113.458133; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mowrey DD, 2013, STRUCTURE, V21, P1897, DOI 10.1016/j.str.2013.07.014; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Thompson AJ, 2006, J BIOL CHEM, V281, P16576, DOI 10.1074/jbc.M601265200; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Velisetty P, 2012, J BIOL CHEM, V287, P36864, DOI 10.1074/jbc.M112.401067; Velisetty P, 2012, J BIOL CHEM, V287, P18467, DOI 10.1074/jbc.M112.348045; Wang QA, 2010, J BIOL CHEM, V285, P40373, DOI 10.1074/jbc.M110.161513; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Zhang H, 1997, BIOCHEMISTRY-US, V36, P15856, DOI 10.1021/bi972357u	69	32	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					3013	3025		10.1074/jbc.M113.523050	http://dx.doi.org/10.1074/jbc.M113.523050			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338475	hybrid, Green Published			2022-12-28	WOS:000333403000048
J	Bruck, I; Kaplan, DL				Bruck, Irina; Kaplan, Daniel L.			The Replication Initiation Protein Sld2 Regulates Helicase Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDK (Cyclin-dependent Kinase); Cell Cycle; DNA-binding Protein; DNA Helicase; DNA Replication	EUKARYOTIC DNA-REPLICATION; SINGLE-STRANDED-DNA; MCM2-7 HELICASE; BUDDING YEAST; ORIGIN DNA; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; COMPLEX; GINS; CDC45	Assembly of the Cdc45-Mcm2-7-GINS (CMG) replicative helicase complex must be regulated to ensure that DNA unwinding is coupled with DNA synthesis. Sld2 is required for the initiation of DNA replication in budding yeast. We identified a mutant of Sld2, Sld2-m1,4, that is specifically defective in Mcm2-7 binding. When this sld2-m1,4 mutant is expressed, cells exhibit severe inhibition of DNA replication. Furthermore, the CMG complex assembles prematurely in G(1) in mutant cells, but not wild-type cells. These data suggest that Sld2 binding to Mcm2-7 is essential to block the inappropriate formation of a CMG helicase complex in G(1). We also study a mutant of Sld2 that is defective in binding DNA, sld2-DNA, and find that sld2-DNA cells exhibit no GINS-Mcm2-7 interaction. These data suggest that Sld2 association with DNA is required for CMG assembly in S phase.	[Bruck, Irina; Kaplan, Daniel L.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32312 USA	State University System of Florida; Florida State University	Kaplan, DL (corresponding author), Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32312 USA.	Daniel.Kaplan@med.fsu.edu		Kaplan, Daniel/0000-0003-2760-7745	National Science Foundation [1265431]; Div Of Molecular and Cellular Bioscience [1265431] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant 1265431 (to D. L. K.).	Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2010, NUCLEIC ACIDS RES, V38, P6078, DOI 10.1093/nar/gkq422; Bruck I, 2013, J BIOL CHEM, V288, P7550, DOI 10.1074/jbc.M112.440941; Bruck I, 2011, J BIOL CHEM, V286, P36414, DOI 10.1074/jbc.M111.282822; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fernandez-Cid A, 2013, MOL CELL, V50, P577, DOI 10.1016/j.molcel.2013.03.026; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kanke M, 2012, EMBO J, V31, P2182, DOI 10.1038/emboj.2012.68; Kanter DM, 2011, NUCLEIC ACIDS RES, V39, P2580, DOI 10.1093/nar/gkq1222; Marino F, 2013, BIOPHYS CHEM, V177, P34, DOI 10.1016/j.bpc.2013.02.009; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Ohlenschlager O, 2012, NUCLEIC ACIDS RES, V40, P8309, DOI 10.1093/nar/gks591; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	36	16	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1948	1959		10.1074/jbc.M113.532085	http://dx.doi.org/10.1074/jbc.M113.532085			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24307213	hybrid, Green Published			2022-12-28	WOS:000331130200007
J	Wang, XW; Zhao, XF; Wang, JX				Wang, Xian-Wei; Zhao, Xiao-Fan; Wang, Jin-Xing			C-type Lectin Binds to beta-Integrin to Promote Hemocytic Phagocytosis in an Invertebrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Integrin; Invertebrates; Phagocytosis; Protein-Protein Interactions; RNA Interference (RNAi); C-type Lectin; Opsonin	PATTERN-RECOGNITION RECEPTOR; PROTEIN; LIGAND; DOMAIN; CELLS; SHRIMP; IDENTIFICATION; COLLECTINS; PATHOGENS; DEFENSE	Phagocytosis is a conserved cellular response among metazoans. Opsonins are some molecules that label targets to increase their susceptibility to phagocytosis. Opsonins are usually captured by receptors on the surface of phagocytes. Our previous study found the C-type lectin FcLec4 from Chinese white shrimp Fenneropenaeus chinensis might function as an opsonin to facilitate bacterial clearance. In the present study we purified the native FcLec4 protein and confirmed its opsonic activity in the near relation, kuruma shrimp Marsupenaeus japonicus. The possible receptor of FcLec4 was identified as -integrin by panning a T7 phage display library of shrimp hemocytes and then confirmed by co-immunoprecipitation assay. We further proved that the interaction between FcLec4 and -integrin did not rely on the carbohydrate recognition domain but on the N terminus of FcLec4. In addition, inhibition of FcLec4 expression using RNAi delayed bacterial clearance, and -integrin knockdown suppressed the opsonic activity of FcLec4. This study is the first to show the direct interaction between an opsonin and its receptor in crustaceans. Our study provides new insights into invertebrate phagocytosis and the functions of C-type lectins.	[Wang, Xian-Wei; Zhao, Xiao-Fan; Wang, Jin-Xing] Shandong Univ, Shandong Prov Key Lab Anim Cells & Dev Biol, Key Lab Plant Cell Engn & Germplasm Innovat, Sch Life Sci,Minist Educ, Jinan 250100, Shandong, Peoples R China	Shandong University	Wang, JX (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	jxwang@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021; Zhao, Xiao-Fan/AGW-9886-2022	Zhao, Xiao-Fan/0000-0003-1809-4730; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31130056, 31302217]; National Basic Research Program of China (973 Program) [2012CB114405]; Ph.D. Programs Foundation of the Ministry of Education of China [20110131130003]; Provincial Natural Science Foundation of Shandong, China [ZR2011CM014]; China Postdoctoral Science Foundation [2013M540553]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Provincial Natural Science Foundation of Shandong, China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported financially by National Natural Science Foundation of China Grants 31130056 and 31302217 (to J.-X. W. and X.-W. W.), National Basic Research Program of China (973 Program, 2012CB114405 (to J.-X. W.), the Ph.D. Programs Foundation of the Ministry of Education of China (Grant 20110131130003 to J.-X. W.), the Provincial Natural Science Foundation of Shandong, China (Grant ZR2011CM014 to J.-X. W.), and the China Postdoctoral Science Foundation (Grant 2013M540553 to X.-W. W.).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Arlinghaus FT, 2013, J BIOL CHEM, V288, P947, DOI 10.1074/jbc.M112.399618; Arlinghaus FT, 2012, TOXICON, V60, P512, DOI 10.1016/j.toxicon.2012.03.001; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Chiba H, 2001, INFECT IMMUN, V69, P1587, DOI 10.1128/IAI.69.3.1587-1592.2001; Cohen ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020597; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Ghiran I, 2000, J EXP MED, V192, P1797, DOI 10.1084/jem.192.12.1797; Goh YS, 2011, IMMUNOLOGY, V133, P74, DOI 10.1111/j.1365-2567.2011.03411.x; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Jia W, 2005, BLOOD, V106, P3854, DOI 10.1182/blood-2005-04-1658; Kamiguti AS, 2003, FEBS LETT, V549, P129, DOI 10.1016/S0014-5793(03)00799-3; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Koizumi N, 1999, J INSECT PHYSIOL, V45, P853, DOI 10.1016/S0022-1910(99)00069-4; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; Lee SY, 2001, J IMMUNOL, V166, P7319, DOI 10.4049/jimmunol.166.12.7319; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Litvack ML, 2010, INNATE IMMUN-LONDON, V16, P191, DOI 10.1177/1753425910369271; Liu WF, 2009, J PROTEOME RES, V8, P1198, DOI 10.1021/pr800840x; Ma THT, 2008, J INVERTEBR PATHOL, V99, P332, DOI 10.1016/j.jip.2008.08.003; MALHOTRA R, 1990, J EXP MED, V172, P955, DOI 10.1084/jem.172.3.955; Mamali I, 2009, DEV COMP IMMUNOL, V33, P858, DOI 10.1016/j.dci.2009.02.004; May RC, 2001, J CELL SCI, V114, P1061; Nagaosa K, 2011, J BIOL CHEM, V286, P25770, DOI 10.1074/jbc.M110.204503; PASQUALINI R, 1995, J CELL BIOL, V130, P1189, DOI 10.1083/jcb.130.5.1189; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Shiratsuchi A, 2012, J BIOL CHEM, V287, P21663, DOI 10.1074/jbc.M111.333807; Takagi J, 2004, BIOCHEM SOC T, V32, P403, DOI 10.1042/BST0320403; Takagi J, 2002, BIOCHEMISTRY-US, V41, P4339, DOI 10.1021/bi016047u; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; THORNQVIST PO, 1994, DEV COMP IMMUNOL, V18, P3, DOI 10.1016/0145-305X(94)90247-X; Tian YY, 2009, DEV COMP IMMUNOL, V33, P772, DOI 10.1016/j.dci.2009.01.002; Tozer EC, 1996, J BIOL CHEM, V271, P21978, DOI 10.1074/jbc.271.36.21978; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; van de Wetering JK, 2004, EUR J BIOCHEM, V271, P1229, DOI 10.1111/j.1432-1033.2004.04040.x; Wang SA, 2009, J IMMUNOL, V182, P5250, DOI 10.4049/jimmunol.0802970; Wang XW, 2011, FISH SHELLFISH IMMUN, V30, P241, DOI 10.1016/j.fsi.2010.10.012; Wang XW, 2009, DEV COMP IMMUNOL, V33, P1039, DOI 10.1016/j.dci.2009.05.004; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; Wu CL, 2011, PROTEOMICS, V11, P2249, DOI 10.1002/pmic.201000728; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Ye T, 2012, J PROTEOME RES, V11, P4834, DOI 10.1021/pr300274k; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	49	98	104	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2405	2414		10.1074/jbc.M113.528885	http://dx.doi.org/10.1074/jbc.M113.528885			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324258	hybrid, Green Published			2022-12-28	WOS:000331130200044
J	Antony, ML; Lee, J; Hahm, ER; Kim, SH; Marcus, AI; Kumari, V; Ji, XH; Yang, Z; Vowell, CL; Wipf, P; Uechi, GT; Yates, NA; Romero, G; Sarkar, SN; Singh, SV				Antony, Marie L.; Lee, Joomin; Hahm, Eun-Ryeong; Kim, Su-Hyeong; Marcus, Adam I.; Kumari, Vandana; Ji, Xinhua; Yang, Zhen; Vowell, Courtney L.; Wipf, Peter; Uechi, Guy T.; Yates, Nathan A.; Romero, Guillermo; Sarkar, Saumendra N.; Singh, Shivendra V.			Growth Arrest by the Antitumor Steroidal Lactone Withaferin A in Human Breast Cancer Cells Is Associated with Down-regulation and Covalent Binding at Cysteine 303 of beta-Tubulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cancer Chemoprevention; Cell Cycle; Natural Products; Tubulin; Withaferin A	ALLYL ISOTHIOCYANATE; COMPOUND WITHAFERIN; AYURVEDIC MEDICINE; MICHAEL ACCEPTORS; INDUCED APOPTOSIS; MITOTIC ARREST; ACTIVATION; PREVENTION; TARGET; PHOSPHORYLATION	Background: The tubulin microtubule network remains an attractive anticancer target. Results: The antitumor steroidal lactone withaferin A (WA) down-regulates tubulin and binds to Cys(303) of -tubulin. Conclusion: Tubulin is a novel target of WA-mediated growth arrest in human breast cancer cells. Significance: Favorable safety and pharmacokinetic profiles merit clinical investigation of WA for prevention and/or treatment of breast cancer. Withaferin A (WA), a C-5,C-6-epoxy steroidal lactone derived from a medicinal plant (Withania somnifera), inhibits growth of human breast cancer cells in vitro and in vivo and prevents mammary cancer development in a transgenic mouse model. However, the mechanisms underlying the anticancer effect of WA are not fully understood. Herein, we report that tubulin is a novel target of WA-mediated growth arrest in human breast cancer cells. The G(2) and mitotic arrest resulting from WA exposure in MCF-7, SUM159, and SK-BR-3 cells was associated with a marked decrease in protein levels of -tubulin. These effects were not observed with the naturally occurring C-6,C-7-epoxy analogs of WA (withanone and withanolide A). A non-tumorigenic normal mammary epithelial cell line (MCF-10A) was markedly more resistant to mitotic arrest by WA compared with breast cancer cells. Vehicle-treated control cells exhibited a normal bipolar spindle with chromosomes aligned along the metaphase plate. In contrast, WA treatment led to a severe disruption of normal spindle morphology. NMR analyses revealed that the A-ring enone in WA, but not in withanone or withanolide A, was highly reactive with cysteamine and rapidly succumbed to irreversible nucleophilic addition. Mass spectrometry demonstrated direct covalent binding of WA to Cys(303) of -tubulin in MCF-7 cells. Molecular docking indicated that the WA-binding pocket is located on the surface of -tubulin and characterized by a hydrophobic floor, a hydrophobic wall, and a charge-balanced hydrophilic entrance. These results provide novel insights into the mechanism of growth arrest by WA in breast cancer cells.	[Antony, Marie L.; Lee, Joomin; Hahm, Eun-Ryeong; Kim, Su-Hyeong; Romero, Guillermo; Singh, Shivendra V.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15260 USA; [Sarkar, Saumendra N.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15260 USA; [Vowell, Courtney L.; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Marcus, Adam I.; Yang, Zhen] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Kumari, Vandana; Ji, Xinhua] NCI, Biomol Struct Sect, Ctr Canc Res, Frederick, MD 21702 USA; [Uechi, Guy T.; Yates, Nathan A.] Univ Pittsburgh, Sch Med, Biomed Mass Spectrometry Ctr, Pittsburgh, PA 15213 USA; [Uechi, Guy T.; Yates, Nathan A.; Sarkar, Saumendra N.; Singh, Shivendra V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, SV (corresponding author), Univ Pittsburgh, Hillman Canc Ctr 2 32A, Inst Canc, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	singhs@upmc.edu	Sarkar, Saumendra N/B-5038-2011; Ji, Xinhua/C-9664-2012; Wipf, Peter/AAG-1771-2021; Antony, Marie Lue/AAB-3952-2019	Sarkar, Saumendra N/0000-0002-2850-6121; Ji, Xinhua/0000-0001-6942-1514; Wipf, Peter/0000-0001-7693-5863; 	National Institutes of Health from NCI [R01 CA142604-04, R01 CA129347-07]; Center for Cancer Research, NCI, National Institutes of Health; National Institutes of Health Cancer Center from NCI [P30CA047904]; NATIONAL CANCER INSTITUTE [R01CA129347, ZIABC010326, R01CA142604, P30CA047904] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Cancer Center from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA142604-04 and R01 CA129347-07 from NCI (to S. V. S.) and by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health (to X. J.). The work performed in the University of Pittsburgh Cancer Institute Flow Cytometry Facility and Cancer Biomarkers Facility was supported in part by National Institutes of Health Cancer Center Support Grant P30CA047904 from NCI.	Aggarwal BB, 2011, CURR DRUG TARGETS, V12, P1595; Amslinger S, 2010, CHEMMEDCHEM, V5, P351, DOI 10.1002/cmdc.200900499; Avonto C, 2011, ANGEW CHEM INT EDIT, V50, P467, DOI 10.1002/anie.201005959; Bayraktar S, 2013, BREAST CANCER RES TR, V138, P21, DOI 10.1007/s10549-013-2421-5; Castelli VV, 1999, J ORG CHEM, V64, P8122; Chen JG, 2002, CANCER RES, V62, P1935; Devi PU, 1996, INT J RADIAT BIOL, V69, P193, DOI 10.1080/095530096146020; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Geng F, 2011, J BIOL CHEM, V286, P32259, DOI 10.1074/jbc.M111.278127; Hahm ER, 2013, JNCI-J NATL CANCER I, V105, P1111, DOI 10.1093/jnci/djt153; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hahm ER, 2011, MOL CARCINOGEN, V50, P614, DOI 10.1002/mc.20760; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hosono T, 2005, J BIOL CHEM, V280, P41487, DOI 10.1074/jbc.M507127200; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krenske EH, 2011, J ORG CHEM, V76, P5074, DOI 10.1021/jo200761w; Lee J, 2012, BREAST CANCER RES TR, V136, P45, DOI 10.1007/s10549-012-2239-6; Lee J, 2010, CARCINOGENESIS, V31, P1991, DOI 10.1093/carcin/bgq175; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDUENA RF, 1991, PHARMACOL THERAPEUT, V49, P133, DOI 10.1016/0163-7258(91)90027-J; Manoharan S, 2009, INDIAN J EXP BIOL, V47, P16; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P1499, DOI 10.1016/S0968-0896(01)00024-4; Mishra L C, 2000, Altern Med Rev, V5, P334; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Padmavathi B, 2005, EVID-BASED COMPL ALT, V2, P99, DOI 10.1093/ecam/neh064; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; Rosenker CJ, 2013, ORG LETT, V15, P1076, DOI 10.1021/ol400094k; Serafimova IM, 2012, NAT CHEM BIOL, V8, P471, DOI [10.1038/NCHEMBIO.925, 10.1038/nchembio.925]; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SHOHAT B, 1971, INT J CANCER, V8, P487, DOI 10.1002/ijc.2910080317; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Vyas A. R., 2013, AAPS J, DOI 10.1208/s12248-013-9531-1; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xiao D, 2004, ONCOGENE, V23, P5594, DOI 10.1038/sj.onc.1207747; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Zheng SQ, 2012, J MED CHEM, V55, P4837, DOI 10.1021/jm3003922	50	76	77	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1852	1865		10.1074/jbc.M113.496844	http://dx.doi.org/10.1074/jbc.M113.496844			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297176	Green Published, hybrid			2022-12-28	WOS:000332401700054
J	Le, HT; Sin, WC; Lozinsky, S; Bechberger, J; Vega, JL; Guo, XQ; Saez, JC; Naus, CC				Le, Hoa T.; Sin, Wun Chey; Lozinsky, Shannon; Bechberger, John; Luis Vega, Jose; Guo, Xu Qiu; Saez, Juan C.; Naus, Christian C.			Gap Junction Intercellular Communication Mediated by Connexin43 in Astrocytes Is Essential for Their Resistance to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Astrocytes; Connexin; Gap Junctions; Hydrogen Peroxide; Hypoxia; Hemichannels; Hypoxia; Reoxygenation	CULTURED ASTROCYTES; LIFE-CYCLE; CELL-DEATH; FUNCTIONAL HEMICHANNELS; METABOLIC INHIBITION; CORTICAL ASTROCYTES; PROTEIN CONNEXIN43; PLASMA-MEMBRANE; CHANNELS; PHOSPHORYLATION	Background: The gap junction protein Cx43 is implicated in maintaining anti-oxidative defense in astrocytes. Results: In contrast to hypoxia/reoxygenation, oxidative stress induced by H2O2 triggers more astrocytic death in the absence of Cx43 channels. Conclusion: Gap junction intercellular communication is required for Cx43-mediated resistance to H2O2. Significance: An altered Cx43 phosphorylation state in response to cellular stress may be critical for Cx43-mediated cell death or recovery. Oxidative stress induced by reactive oxygen species (ROS) is associated with various neurological disorders including aging, neurodegenerative diseases, as well as traumatic and ischemic insults. Astrocytes have an important role in the anti-oxidative defense in the brain. The gap junction protein connexin43 (Cx43) forms intercellular channels as well as hemichannels in astrocytes. In the present study, we investigated the contribution of Cx43 to astrocytic death induced by the ROS hydrogen peroxide (H2O2) and the mechanism by which Cx43 exerts its effects. Lack of Cx43 expression or blockage of Cx43 channels resulted in increased ROS-induced astrocytic death, supporting a cell protective effect of functional Cx43 channels. H2O2 transiently increased hemichannel activity, but reduced gap junction intercellular communication (GJIC). GJIC in wild-type astrocytes recovered after 7 h, but was absent in Cx43 knock-out astrocytes. Blockage of Cx43 hemichannels incompletely inhibited H2O2-induced hemichannel activity, indicating the presence of other hemichannel proteins. Panx1, which is predicted to be a major hemichannel contributor in astrocytes, did not appear to have any cell protective effect from H2O2 insults. Our data suggest that GJIC is important for Cx43-mediated ROS resistance. In contrast to hypoxia/reoxygenation, H2O2 treatment decreased the ratio of the hypophosphorylated isoform to total Cx43 level. Cx43 has been reported to promote astrocytic death induced by hypoxia/reoxygenation. We therefore speculate the increase in Cx43 dephosphorylation may account for the facilitation of astrocytic death. Our findings suggest that the role of Cx43 in response to cellular stress is dependent on the activation of signaling pathways leading to alteration of Cx43 phosphorylation states.	[Le, Hoa T.; Sin, Wun Chey; Lozinsky, Shannon; Bechberger, John; Luis Vega, Jose; Guo, Xu Qiu; Naus, Christian C.] Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Luis Vega, Jose; Saez, Juan C.] Pontificia Univ Catolica Chile, Dept Fisiol, Santiago 8330025, Chile; [Luis Vega, Jose] Univ Antofagasta, Lab Fisiol Expt, Inst Antofagasta, Antofagasta 1270300, Chile; [Saez, Juan C.] Ctr Interdisciplinario Neurociencias Valparaiso, Valparaiso 2340000, Chile	University of British Columbia; Pontificia Universidad Catolica de Chile; Universidad de Antofagasta	Naus, CC (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	christian.naus@ubc.ca	Vega, Jose Luis/AAE-3131-2019; Vega, José Luis/AAT-4119-2021	Vega, Jose Luis/0000-0001-9333-8729; 	Heart and Stroke Foundation of Canada; Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile [FONDECYT 3120006]; CIHR	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant-in-aid from the Heart and Stroke Foundation of Canada (to C. C. N.) and the Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant FONDECYT 3120006 (to J. L. V.) of Chile. Funding was partly provided through the CIHR Team Grant on "Vascular Cognitive Impairment: Animal Models of Co-morbidity."	Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; ARMSTEAD WM, 1988, AM J PHYSIOL, V255, pH401, DOI 10.1152/ajpheart.1988.255.2.H401; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bruzzone S, 2001, FASEB J, V15, P10; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Chen YM, 2001, GLIA, V33, P343, DOI 10.1002/1098-1136(20010315)33:4<343::AID-GLIA1033>3.0.CO;2-H; Choi JH, 2007, EUR J PHARMACOL, V571, P106, DOI 10.1016/j.ejphar.2007.06.042; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Dahl G, 2006, IUBMB LIFE, V58, P409, DOI 10.1080/15216540600794526; Danilov CA, 2008, GLIA, V56, P801, DOI 10.1002/glia.20655; DERMIETZEL R, 1991, J NEUROSCI, V11, P1421; DERMIETZEL R, 1993, TRENDS NEUROSCI, V16, P186, DOI 10.1016/0166-2236(93)90151-B; Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024; FLAMM ES, 1978, STROKE, V9, P445, DOI 10.1161/01.STR.9.5.445; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; Giardina SF, 2007, BIOCHEM BIOPH RES CO, V362, P747, DOI 10.1016/j.bbrc.2007.08.066; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; HU J, 1995, CHEM-BIOL INTERACT, V95, P291, DOI 10.1016/0009-2797(94)03568-S; Hutnik CML, 2008, INVEST OPHTH VIS SCI, V49, P800, DOI 10.1167/iovs.07-0717; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Kang KS, 2000, CANCER LETT, V152, P97, DOI 10.1016/S0304-3835(99)00438-3; Kar R, 2013, J BONE MINER RES, V28, P1611, DOI 10.1002/jbmr.1917; Kozoriz MG, 2013, NEUROPHARMACOLOGY, V75, P549, DOI 10.1016/j.neuropharm.2013.05.003; Kuo ML, 1998, MUTAT RES-GEN TOX EN, V413, P143, DOI 10.1016/S1383-5718(98)00020-5; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lee DE, 2010, J NUTR BIOCHEM, V21, P680, DOI 10.1016/j.jnutbio.2009.03.014; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Li W, 2005, J BIOL CHEM, V280, P7941, DOI 10.1074/jbc.M410548200; Li WEI, 2000, EUR J NEUROSCI, V12, P2644, DOI 10.1046/j.1460-9568.2000.00162.x; Lin JHC, 2008, J NEUROSCI, V28, P681, DOI 10.1523/JNEUROSCI.3827-07.2008; Liu SS, 2006, DEVELOPMENT, V133, P2063, DOI 10.1242/dev.02374; Maragakis NJ, 2001, ARCH NEUROL-CHICAGO, V58, P365, DOI 10.1001/archneur.58.3.365; Martinez AD, 2000, BRAIN RES REV, V32, P250, DOI 10.1016/S0165-0173(99)00086-7; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; Nagy JI, 2000, BRAIN RES REV, V32, P29, DOI 10.1016/S0165-0173(99)00066-1; Orellana JA, 2010, GLIA, V58, P329, DOI 10.1002/glia.20926; Ozog MA, 2002, CANCER RES, V62, P3544; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Quist AP, 2000, J CELL BIOL, V148, P1063, DOI 10.1083/jcb.148.5.1063; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Rouach N, 2004, GLIA, V45, P28, DOI 10.1002/glia.10300; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Salameh A, 2006, ADV CARDIOL, V42, P57, DOI 10.1159/000092562; Scemes E, 2012, BBA-BIOMEMBRANES, V1818, P1880, DOI 10.1016/j.bbamem.2011.06.005; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Todt I, 2001, J MEMBRANE BIOL, V181, P107, DOI 10.1007/s00232001-0014-4; TOWER DB, 1973, J NEUROCHEM, V20, P269, DOI 10.1111/j.1471-4159.1973.tb12126.x; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Upham BL, 1997, CARCINOGENESIS, V18, P37, DOI 10.1093/carcin/18.1.37; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003	66	79	83	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1345	1354		10.1074/jbc.M113.508390	http://dx.doi.org/10.1074/jbc.M113.508390			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24302722	hybrid, Green Published			2022-12-28	WOS:000332401700013
J	Okon, IS; Coughlan, KA; Zou, MH				Okon, Imoh S.; Coughlan, Kathleen A.; Zou, Ming-Hui			Liver Kinase B1 Expression Promotes Phosphatase Activity and Abrogation of Receptor Tyrosine Kinase Phosphorylation in Human Cancer Cells (Publication with Expression of Concern. See vol. 294, pg. 10022, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Publication with Expression of Concern						Epidermal Growth Factor Receptor (EGFR); Growth Factors; LKB; Lung Cancer; Receptor Tyrosine Kinase; LKB1	ACTIVATED PROTEIN-KINASE; LUNG-CANCER; MOLECULAR-MECHANISMS; IGF-I; LKB1; MUTATIONS; GENE; AMPK; PREVALENCE; SURVIVAL	Background: Frequent loss of liver kinase B1 (LKB1) has been reported in human neoplasm. Results: LKB1 depletion correlated with enhanced RTK phosphorylation in human lung cancer cell line. Ectopic LKB1 expression in deficient lung and cervical cancer cell lines abrogated a repertoire of phospho-RTKs associated with tumor development and progression. Conclusion: LKB1 promotes protein tyrosine phosphatase activity and inhibition of RTK-activated pathways. Significance: LKB1 protects against RTK-driven tumors. Aberrant receptor tyrosine kinase phosphorylation (pRTK) has been associated with diverse pathological conditions, including human neoplasms. In lung cancer, frequent liver kinase B1 (LKB1) mutations correlate with tumor progression, but potential links with pRTK remain unknown. Heightened and sustained receptor activation was demonstrated by LKB1-deficient A549 (lung) and HeLaS3 (cervical) cancer cell lines. Depletion (siRNA) of endogenous LKB1 expression in H1792 lung cancer cells also correlated with increased pRTK. However, ectopic LKB1 expression in A549 and HeLaS3 cell lines, as well as H1975 activating-EGF receptor mutant lung cancer cell resulted in dephosphorylation of several tumor-enhancing RTKs, including EGF receptor, ErbB2, hepatocyte growth factor receptor (c-Met), EphA2, rearranged during transfection (RET), and insulin-like growth factor I receptor. Receptor abrogation correlated with attenuation of phospho-Akt and increased apoptosis. Global phosphatase inhibition by orthovanadate or depletion of protein tyrosine phosphatases (PTPs) resulted in the recovery of receptor phosphorylation. Specifically, the activity of SHP-2, PTP-1, and PTP-PEST was enhanced by LKB1-expressing cells. Our findings provide novel insight on how LKB1 loss of expression or function promotes aberrant RTK signaling and rapid growth of cancer cells.	[Okon, Imoh S.; Coughlan, Kathleen A.; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Sect Mol Med, Oklahoma City, OK 73104 USA; [Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, BSEB 306A,941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu			National Institutes of Health [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089920, R01HL096032, R01HL080499, R01HL105157, R01HL110488, R01HL074399, R01HL079584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, and HL110488 (to M.-H.Z.).	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Fan DH, 2009, ACTA BIOCH BIOPH SIN, V41, P97, DOI 10.1093/abbs/gmn011; Faoro L, 2010, J BIOL CHEM, V285, P18575, DOI 10.1074/jbc.M109.075085; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Finn AJ, 2003, NAT NEUROSCI, V6, P717, DOI 10.1038/nn1071; GULLICK WJ, 1991, BRIT MED BULL, V47, P87, DOI 10.1093/oxfordjournals.bmb.a072464; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Kinch MS, 2003, CLIN CANCER RES, V9, P613; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mahoney CL, 2009, BRIT J CANCER, V100, P370, DOI 10.1038/sj.bjc.6604886; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Meng T.- C., 2006, J CANC MOL, V2, P9; Nitert MD, 2005, MOL CELL ENDOCRINOL, V229, P31, DOI 10.1016/j.mce.2004.10.003; Nony P, 2003, ONCOGENE, V22, P9165, DOI 10.1038/sj.onc.1207179; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Piantadosi CA, 2012, BBA-GEN SUBJECTS, V1820, P712, DOI 10.1016/j.bbagen.2011.03.008; Poels J, 2009, BIOESSAYS, V31, P944, DOI 10.1002/bies.200900003; Puri Neelu, 2008, J Carcinog, V7, P9; Rodriguez-Nieto S, 2009, CARCINOGENESIS, V30, P547, DOI 10.1093/carcin/bgp035; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V319, P1, DOI 10.1016/j.bbrc.2004.04.150; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Shah U, 2008, CANCER RES, V68, P3562, DOI 10.1158/0008-5472.CAN-07-6620; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sorenson CM, 2002, AM J PHYSIOL-RENAL, V282, pF442, DOI 10.1152/ajprenal.00184.2001; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tiganis T, 2002, IUBMB LIFE, V53, P3, DOI 10.1080/15216540210811; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Varewijck AJ, 2013, DIABETES, V62, P2539, DOI 10.2337/db12-1773; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zhang SM, 2008, CANCER RES, V68, P740, DOI 10.1158/0008-5472.CAN-07-2989; Zhuang ZG, 2006, MOL CANCER RES, V4, P843, DOI 10.1158/1541-7786.MCR-06-0118	45	8	8	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1639	1648		10.1074/jbc.M113.500934	http://dx.doi.org/10.1074/jbc.M113.500934			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24285539	hybrid, Green Published			2022-12-28	WOS:000332401700037
J	Van Acker, T; Eyckerman, S; Vande Walle, L; Gerlo, S; Goethals, M; Lamkanfi, M; Bovijn, C; Tavernier, J; Peelman, F				Van Acker, Tim; Eyckerman, Sven; Vande Walle, Lieselotte; Gerlo, Sarah; Goethals, Marc; Lamkanfi, Mohamed; Bovijn, Celia; Tavernier, Jan; Peelman, Frank			The Small GTPase Arf6 Is Essential for the Tram/Trif Pathway in TLR4 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokines; Interferon; Endocytosis; Innate Immunity; Lipopolysaccharide (LPS); Mal TIRAP; MyD88; Toll-like Receptors (TLR); TRIF; Arf6	INTERFERON REGULATORY FACTOR-3; RECEPTOR-MEDIATED PHAGOCYTOSIS; RIBOSYLATION FACTOR 6; MYD88 ADAPTER-LIKE; NF-KAPPA-B; PLASMA-MEMBRANE; ACTIVATING PROTEIN; IKK-EPSILON; MOLECULE; REQUIREMENT	Background: The small GTPase Arf6 affects LPS-induced cytokine secretion. Results: Arf6 regulates transport of the TLR4 adaptor protein Tram and internalization of LPS. Conclusion: Arf6 plays an essential role in regulating the Tram/Trif-dependent TLR4 pathway. Significance: Knowing how TLR4 is modulated is crucial for understanding innate immunity. Recognition of lipopolysaccharides (LPS) by Toll-like receptor 4 (TLR4) at the plasma membrane triggers NF-B activation through recruitment of the adaptor proteins Mal and MyD88. Endocytosis of the activated TLR4 allows recruitment of the adaptors Tram and Trif, leading to activation of the transcription factor IRF3 and interferon production. The small GTPase ADP-ribosylation factor 6 (Arf6) was shown to regulate the plasma membrane association of Mal. Here we demonstrate that inhibition of Arf6 also markedly reduced LPS-induced cytokine production in Mal(-/-) mouse macrophages. In this article, we focus on a novel role for Arf6 in the MyD88-independent TLR4 pathway. MyD88-independent IRF3 activation and IRF3-dependent gene transcription were strictly dependent on Arf6. Arf6 was involved in transport of Tram to the endocytic recycling compartment and internalization of LPS, possibly explaining its requirement for LPS-induced IRF3 activation. Together, these results show a critical role for Arf6 in regulating Tram/Trif-dependent TLR4 signaling.	[Van Acker, Tim; Eyckerman, Sven; Gerlo, Sarah; Bovijn, Celia; Tavernier, Jan; Peelman, Frank] VIB, Cytokine Receptor Lab, Dept Med Prot Res, B-9000 Ghent, Belgium; [Van Acker, Tim; Eyckerman, Sven; Vande Walle, Lieselotte; Gerlo, Sarah; Goethals, Marc; Lamkanfi, Mohamed; Bovijn, Celia; Tavernier, Jan; Peelman, Frank] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Van Acker, Tim; Eyckerman, Sven; Vande Walle, Lieselotte; Gerlo, Sarah; Goethals, Marc; Lamkanfi, Mohamed; Bovijn, Celia; Tavernier, Jan; Peelman, Frank] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Ghent University	Peelman, F (corresponding author), Univ Ghent VIB, Dept Med Prot Res, Cytokine Receptor Lab, Dept Biochem, B-9000 Ghent, Belgium.	frank.peelman@vib-ugent.be	Tavernier, Jan/AAG-3636-2019		Ghent University; Belgian Government [P7/13]; Instituut voor de Aanmoediging van Innovatie door Wetenshap en Technologie in Vlaanderen (IWT, Flanders)	Ghent University(Ghent University); Belgian Government; Instituut voor de Aanmoediging van Innovatie door Wetenshap en Technologie in Vlaanderen (IWT, Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was supported using grants from Ghent University (Group-ID Multidisciplinary Research Partnerships) and the Belgian Government (Interuniversitary Attraction Poles P7/13).; Supported by the Instituut voor de Aanmoediging van Innovatie door Wetenshap en Technologie in Vlaanderen (IWT, Flanders).	Balana ME, 2005, J CELL SCI, V118, P2201, DOI 10.1242/jcs.02351; Bovijn C, 2013, J BIOL CHEM, V288, P12054, DOI 10.1074/jbc.M112.415810; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Fielding AB, 2005, EMBO J, V24, P3389, DOI 10.1038/sj.emboj.7600803; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Furman C, 2002, J BIOL CHEM, V277, P7962, DOI 10.1074/jbc.M109149200; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Gould GW, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002186; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Icardi L, 2012, FASEB J, V26, P240, DOI 10.1096/fj.11-191122; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jia T, 2012, MOL MED REP, V6, P167, DOI 10.3892/mmr.2012.877; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Klein S, 2006, J BIOL CHEM, V281, P12352, DOI 10.1074/jbc.M601021200; Lin RT, 1999, MOL CELL BIOL, V19, P959; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Niedergang F, 2003, J CELL BIOL, V161, P1143, DOI 10.1083/jcb.200210069; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Otani T, 2011, DEV CELL, V20, P219, DOI 10.1016/j.devcel.2011.02.001; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Radhakrishna H, 1999, J CELL SCI, V112, P855; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Rizzo A, 2013, INT IMMUNOPHARMACOL, V17, P453, DOI 10.1016/j.intimp.2013.07.005; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Svensson HG, 2008, EUR J IMMUNOL, V38, P818, DOI 10.1002/eji.200737331; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Uchida H, 2001, J EXP MED, V193, P955, DOI 10.1084/jem.193.8.955; Ulrichts P, 2007, FEBS LETT, V581, P629, DOI 10.1016/j.febslet.2007.01.026; Ulrichts P, 2010, J CELL SCI, V123, P256, DOI 10.1242/jcs.056002; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Wan T, 2010, J BIOL CHEM, V285, P3750, DOI 10.1074/jbc.M109.069385; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wong KW, 2003, J EXP MED, V198, P603, DOI 10.1084/jem.20021363; Wu Jing-Yiing, 2012, Commun Integr Biol, V5, P316, DOI 10.4161/cib.20182; Wu JY, 2012, J BIOL CHEM, V287, P4323, DOI 10.1074/jbc.M111.295113; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	62	21	21	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1364	1376		10.1074/jbc.M113.499194	http://dx.doi.org/10.1074/jbc.M113.499194			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297182	hybrid, Green Published			2022-12-28	WOS:000332401700015
J	Loo, TW; Clarke, DM				Loo, Tip W.; Clarke, David M.			Locking Intracellular Helices 2 and 3 Together Inactivates Human P-glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Drug Resistance; Membrane Proteins; Protein Folding; Protein Misfolding; P-glycoprotein	DRUG-BINDING POCKET; NUCLEOTIDE-BINDING; TRANSMEMBRANE SEGMENT-11; MULTIDRUG TRANSPORTER; PROMOTE MATURATION; ABC TRANSPORTERS; ATPASE ACTIVITY; MUTANTS; SITES; RESISTANCE	The P-glycoprotein (P-gp) drug pump (ABCB1) has two transmembrane domains and two nucleotide-binding domains (NBDs). Coupling of the drug-binding sites in the transmembrane domains to the NBDs occurs through interaction of the intracellular helices (IHs) with residues in the NBDs (IH1/IH4/NBD1 and IH2/IH3/NBD2). We showed previously that cross-linking of cysteines in IH3 and IH1 with a short cross-linker mimicked drug binding as it activated P-gp ATPase activity. Here we show that residue A259C(IH2) could be directly cross-linked to W803C(IH3). Cross-linking was inhibited by the presence of ATP and adenosine 5-(,-imino)triphosphate but not by ADP. Cross-linking of mutant A259C/W803C inhibited its verapamil-stimulated ATPase activity mutant, but activity was restored after addition of dithiothreitol. Because these residues are close to the ball-and-socket joint A266C(IH2)/Phe(1086)(NBD2), we mutated the adjacent Tyr(1087)(NBD2) close to IH3. Mutants Y1087A and Y1087L, but not Y1087F, were misprocessed, and all inhibited ATPase activity. Mutation of hydrophobic residues (F793A, L797A, L814A, and L818A) flanking IH3 also inhibited maturation. The results suggest that these residues, together with Trp(803) and Phe(804), form a large hydrophobic pocket. The results show that there is an important hydrophobic network at the IH2/IH3/NBD2 transmission interface that is critical for folding and activity of P-gp.	[Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (to D. M. C.).	Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Globisch C, 2008, CHEMMEDCHEM, V3, P280, DOI 10.1002/cmdc.200700249; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kapoor K, 2013, J BIOL CHEM, V288, P32622, DOI 10.1074/jbc.M113.498980; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Loo TW, 2008, J BIOL CHEM, V283, P24860, DOI 10.1074/jbc.M803351200; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2013, BIOCHEMISTRY-US, V52, P7167, DOI 10.1021/bi401269m; Loo TW, 2013, BIOCHEMISTRY-US, V52, P3194, DOI 10.1021/bi400425k; Loo TW, 2013, J BIOL CHEM, V288, P20326, DOI 10.1074/jbc.M113.484550; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Loo TW, 2012, BIOCHEM PHARMACOL, V83, P345, DOI 10.1016/j.bcp.2011.11.014; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2004, J BIOL CHEM, V279, P18232, DOI 10.1074/jbc.M400229200; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; LOO TW, 1994, J BIOL CHEM, V269, P7243; Loo TW, 1999, BIOCHEMISTRY-US, V38, P5124, DOI 10.1021/bi982525y; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200; Pajeva IK, 2013, CHEMMEDCHEM, V8, P748, DOI 10.1002/cmdc.201200491; Ravna AW, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-33; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; Wise JG, 2012, BIOCHEMISTRY-US, V51, P5125, DOI 10.1021/bi300299z	49	16	16	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					229	236		10.1074/jbc.M113.527804	http://dx.doi.org/10.1074/jbc.M113.527804			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24275649	Green Published, hybrid			2022-12-28	WOS:000329370900020
J	Thakur, HC; Singh, M; Nagel-Steger, L; Kremer, J; Prumbaum, D; Fansa, EK; Ezzahoini, H; Nouri, K; Gremer, L; Abts, A; Schmitt, L; Raunser, S; Ahmadian, MR; Piekorz, RP				Thakur, Harish C.; Singh, Madhurendra; Nagel-Steger, Luitgard; Kremer, Jana; Prumbaum, Daniel; Fansa, Eyad Kalawy; Ezzahoini, Hakima; Nouri, Kazem; Gremer, Lothar; Abts, Andre; Schmitt, Lutz; Raunser, Stefan; Ahmadian, Mohammad R.; Piekorz, Roland P.			The Centrosomal Adaptor TACC3 and the Microtubule Polymerase chTOG Interact via Defined C-terminal Subdomains in an Aurora-A Kinase-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Centrosome; Microtubules; Mitosis; Mitotic Spindle; Protein Domains; Aurora-A; Coiled-Coil; Protein Interaction; TACC3; chTOG	INTERKINETIC NUCLEAR MIGRATION; SPINDLE POLE ORGANIZATION; COILED-COIL; PROTEIN COMPLEXES; LOCALIZATION; CANCER; PHOSPHORYLATION; AMPLIFICATION; DYNAMICS; FAMILY	The cancer-associated, centrosomal adaptor protein TACC3 (transforming acidic coiled-coil 3) and its direct effector, the microtubule polymerase chTOG (colonic and hepatic tumor overexpressed gene), play a crucial function in centrosome-driven mitotic spindle assembly. It is unclear how TACC3 interacts with chTOG. Here, we show that the C-terminal TACC domain of TACC3 and a C-terminal fragment adjacent to the TOG domains of chTOG mediate the interaction between these two proteins. Interestingly, the TACC domain consists of two functionally distinct subdomains, CC1 (amino acids (aa) 414-530) and CC2 (aa 530-630). Whereas CC1 is responsible for the interaction with chTOG, CC2 performs an intradomain interaction with the central repeat region of TACC3, thereby masking the TACC domain before effector binding. Contrary to previous findings, our data clearly demonstrate that Aurora-A kinase does not regulate TACC3-chTOG complex formation, indicating that Aurora-A solely functions as a recruitment factor for the TACC3-chTOG complex to centrosomes and proximal mitotic spindles. We identified with CC1 and CC2, two functionally diverse modules within the TACC domain of TACC3 that modulate and mediate, respectively, TACC3 interaction with chTOG required for spindle assembly and microtubule dynamics during mitotic cell division.	[Thakur, Harish C.; Singh, Madhurendra; Kremer, Jana; Fansa, Eyad Kalawy; Ezzahoini, Hakima; Nouri, Kazem; Ahmadian, Mohammad R.; Piekorz, Roland P.] Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Nagel-Steger, Luitgard; Gremer, Lothar] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Nagel-Steger, Luitgard; Gremer, Lothar] Forschungszentrum Julich, ICS 6, D-52425 Julich, Germany; [Abts, Andre; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Prumbaum, Daniel; Raunser, Stefan] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Max Planck Society	Piekorz, RP (corresponding author), Univ Dusseldorf, Univ Klinikum, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany.	Roland.Piekorz@uni-duesseldorf.de	Gremer, Lothar/H-9128-2013; Raunser, Stefan/AHE-1573-2022; Nagel-Steger, Luitgard/H-6415-2013	Gremer, Lothar/0000-0001-7065-5027; Nagel-Steger, Luitgard/0000-0001-5232-2149; Singh, Madhurendra/0000-0001-9935-5706; Thakur, Harish/0000-0001-6996-2046; Nouri, Kazem/0000-0001-7787-1304; Raunser, Stefan/0000-0001-9373-3016	NRW (North Rhine-Westphalia) graduate school "BioStruct; Biological Structures in Molecular Medicine and Biotechnology"; Deutsche Forschungsgemeinschaft [SFB 728/TP A5]; research commission of the medical faculty of the Heinrich-Heine-University; strategic research fund of the Heinrich-Heine-University; International Graduate School of Protein Science and Technology (iGRASP); Bundesministerium fur Bildung und Forschung (NGFNplus program) [01GS08100]	NRW (North Rhine-Westphalia) graduate school "BioStruct; Biological Structures in Molecular Medicine and Biotechnology"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); research commission of the medical faculty of the Heinrich-Heine-University; strategic research fund of the Heinrich-Heine-University; International Graduate School of Protein Science and Technology (iGRASP); Bundesministerium fur Bildung und Forschung (NGFNplus program)(Federal Ministry of Education & Research (BMBF))	This work was supported by a fellowship of the NRW (North Rhine-Westphalia) graduate school "BioStruct; Biological Structures in Molecular Medicine and Biotechnology" (to H. C. T.), the Deutsche Forschungsgemeinschaft (SFB 728/TP A5;to R. P. P.), the research commission of the medical faculty of the Heinrich-Heine-University (grants to R. P. P. and M. R. A.), the strategic research fund of the Heinrich-Heine-University (grants to R. P. P. and M. R. A.), and the International Graduate School of Protein Science and Technology (iGRASP; to K. N. and M. R. A.).; Supported by Bundesministerium fur Bildung und Forschung (NGFNplus program Grant 01GS08100).	Albee AJ, 2008, MOL BIOL CELL, V19, P3347, DOI 10.1091/mbc.E07-11-1204; Albee AJ, 2006, J BIOL CHEM, V281, P38293, DOI 10.1074/jbc.M607203200; Anderhub SJ, 2012, CANCER LETT, V322, P8, DOI 10.1016/j.canlet.2012.02.006; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Angrisano T, 2006, NUCLEIC ACIDS RES, V34, P364, DOI 10.1093/nar/gkj400; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Booth DG, 2011, EMBO J, V30, P906, DOI 10.1038/emboj.2011.15; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Cunha-Ferreira I, 2009, TRAFFIC, V10, P482, DOI 10.1111/j.1600-0854.2009.00905.x; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535; Fielding AB, 2011, ONCOGENE, V30, P521, DOI 10.1038/onc.2010.431; Fu WX, 2013, P NATL ACAD SCI USA, V110, P15295, DOI 10.1073/pnas.1312382110; Fu WX, 2011, CELL RES, V21, P1655, DOI 10.1038/cr.2011.106; Garriga-Canut M, 2004, J BIOL CHEM, V279, P23597, DOI 10.1074/jbc.M313987200; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gergely F, 2002, BIOESSAYS, V24, P915, DOI 10.1002/bies.10162; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Gomez-Baldo L, 2010, CELL CYCLE, V9, P1143, DOI 10.4161/cc.9.6.11018; Guo YR, 2013, ACS CHEM BIOL, V8, P626, DOI 10.1021/cb300604u; Hao ZL, 2002, MOL REPROD DEV, V63, P291, DOI 10.1002/mrd.90012; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Hood FE, 2013, J CELL BIOL, V202, P463, DOI 10.1083/jcb.201211127; Hood Fiona E, 2011, Bioarchitecture, V1, P105; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Jeng JC, 2009, CELL CYCLE, V8, P3537, DOI 10.4161/cc.8.21.9935; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kramer A, 2011, MOL ONCOL, V5, P324, DOI 10.1016/j.molonc.2011.05.003; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lauffart B, 2002, BIOCHEM J, V363, P195, DOI 10.1042/0264-6021:3630195; Lauffart Brenda, 2005, BMC Womens Health, V5, P8, DOI 10.1186/1472-6874-5-8; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Lioutas A, 2013, EMBO REP, V14, P829, DOI 10.1038/embor.2013.109; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mardin BR, 2012, J CELL BIOL, V197, P11, DOI 10.1083/jcb.201108006; Marthiens V, 2012, J CELL SCI, V125, P3281, DOI 10.1242/jcs.094797; Mattison C., 2006, CENTROSOME CYCLE CEL, P925; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; NIGG EA, 2004, CENTROSOMES DEV DIS; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Partch CL, 2011, P NATL ACAD SCI USA, V108, P7739, DOI 10.1073/pnas.1101357108; Peset I, 2005, J CELL BIOL, V170, P1057, DOI 10.1083/jcb.200504037; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Piekorz RP, 2002, EMBO J, V21, P653, DOI 10.1093/emboj/21.4.653; Popov AV, 2001, EMBO J, V20, P397, DOI 10.1093/emboj/20.3.397; Raab MS, 2012, CANCER RES, V72, P5374, DOI 10.1158/0008-5472.CAN-12-2026; Raff JW, 2002, TRENDS CELL BIOL, V12, P222, DOI 10.1016/S0962-8924(02)02268-7; Risse SL, 2013, BIOL CHEM, V394, P421, DOI 10.1515/hsz-2012-0246; Royle SJ, 2012, J CELL SCI, V125, P19, DOI 10.1242/jcs.094607; Sadek CM, 2003, GENE EXPR PATTERNS, V3, P203, DOI 10.1016/S1567-133X(02)00066-2; Sardon T, 2010, EMBO REP, V11, P977, DOI 10.1038/embor.2010.171; Sato M, 2004, MOL BIOL CELL, V15, P1609, DOI 10.1091/mbc.e03-11-0837; Schmidt S, 2010, ONCOGENE, V29, P6184, DOI 10.1038/onc.2010.354; Schmidt S, 2010, CELL CYCLE, V9, P4469, DOI 10.4161/cc.9.22.13684; Schneider L, 2008, ONCOGENE, V27, P116, DOI 10.1038/sj.onc.1210628; Schneider L, 2007, J BIOL CHEM, V282, P29273, DOI 10.1074/jbc.M704151200; Schuendeln MM, 2004, MOL CELL BIOL, V24, P6403, DOI 10.1128/MCB.24.14.6403-6409.2004; Shi YH, 2012, PROTEIN SCI, V21, P1197, DOI 10.1002/pro.2107; Simpson RJY, 2004, J BIOL CHEM, V279, P39789, DOI 10.1074/jbc.M404130200; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Still IH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-16; Thakur H.C., 2012, THESIS H HEINE U DUS; Thakur HC, 2013, BIOL CHEM, V394, P1411, DOI 10.1515/hsz-2013-0184; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vitre BD, 2012, CURR OPIN CELL BIOL, V24, P809, DOI 10.1016/j.ceb.2012.10.006; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Wurdak H, 2010, P NATL ACAD SCI USA, V107, P16542, DOI 10.1073/pnas.1010300107; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Yang YT, 2012, NAT NEUROSCI, V15, P1201, DOI 10.1038/nn.3171; Yao R, 2012, ONCOGENE, V31, P135, DOI 10.1038/onc.2011.235; Yao R., 2013, ONCOGENE, DOI 10.1038/onc.2013.382; Yao R, 2007, CANCER SCI, V98, P555, DOI 10.1111/j.1349-7006.2007.00433.x; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	84	33	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					74	88		10.1074/jbc.M113.532333	http://dx.doi.org/10.1074/jbc.M113.532333			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24273164	hybrid, Green Published			2022-12-28	WOS:000329370900007
J	Bies, J; Sramko, M; Wolff, L				Bies, Juraj; Sramko, Marek; Wolff, Linda			Stress-induced Phosphorylation of Thr(486) in c-Myb by p38 Mitogen-activated Protein Kinases Attenuates Conjugation of SUMO-2/3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; p38 MAPK; Phosphorylation; Protein Degradation; Protein Stability; Stress; Sumoylation; Transcription; Myb	NEGATIVE REGULATORY DOMAIN; INDUCED TRANSCRIPTION ACTIVATION; T-CELL DEVELOPMENT; V-MYB; LEUKEMIA; PROLIFERATION; DEGRADATION; GENE; DIFFERENTIATION; INTEGRATION	c-Myb plays an essential role in regulation of properly balanced hematopoiesis through transcriptional regulation of genes directly controlling cellular processes such as proliferation, differentiation, and apoptosis. The transcriptional activity and protein levels of c-Myb are strictly controlled through post-translational modifications such as phosphorylation, acetylation, ubiquitination, and SUMOylation. Conjugation of small ubiquitin-like modifier (SUMO) proteins has been shown to suppress the transcriptional activity of c-Myb. SUMO-1 modifies c-Myb under physiological conditions, whereas SUMO-2/3 conjugation was reported in cells under stress. Because stress also activates several cellular protein kinases, we investigated whether phosphorylation of c-Myb changes in stressed cells and whether a mutual interplay exists between phosphorylation and SUMOylation of c-Myb. Here we show that several types of environmental stress induce a rapid change in c-Myb phosphorylation. Interestingly, the phosphorylation of Thr(486), located in close proximity to SUMOylation site Lys(499) of c-Myb, is detected preferentially in nonSUMOylated protein and has a negative effect on stress-induced SUMOylation of c-Myb. Stress-activated p38 MAPKs phosphorylate Thr(486) in c-Myb, attenuate its SUMOylation, and increase its proteolytic turnover. Stressed cells expressing a phosphorylation-deficient T486A mutant demonstrate decreased expression of c-Myb target genes Bcl-2 and Bcl-xL and accelerated apoptosis because of increased SUMOylation of the mutant protein. These results suggest that phosphorylation-dependent modulation of c-Myb SUMOylation may be important for proper response of cells to stress. In summary, we have identified a novel regulatory interplay between phosphorylation and SUMOylation of c-Myb that regulates its activity in stressed cells.	[Bies, Juraj; Sramko, Marek; Wolff, Linda] NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bies, J (corresponding author), NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bldg 37-4124,37 Convent Dr,MSC 4263, Bethesda, MD 20892 USA.	biesj@mail.nih.gov			Intramural Research Program of the National Cancer Institute, Center for Cancer Research, National Institutes of Health	Intramural Research Program of the National Cancer Institute, Center for Cancer Research, National Institutes of Health	This work was supported, in whole or in part, by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, National Institutes of Health.	Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; AZIZ N, 1995, P NATL ACAD SCI USA, V92, P6429, DOI 10.1073/pnas.92.14.6429; BARLETTA C, 1987, SCIENCE, V235, P1064, DOI 10.1126/science.3469751; Belloni E, 2011, LEUKEMIA, V25, P733, DOI 10.1038/leu.2010.317; Bies J, 2000, ONCOGENE, V19, P2846, DOI 10.1038/sj.onc.1203613; Bies J, 1999, J VIROL, V73, P2038, DOI 10.1128/JVI.73.3.2038-2044.1999; Bies J, 2001, BLOOD CELL MOL DIS, V27, P422, DOI 10.1006/bcmd.2001.0400; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Bies J, 1997, ONCOGENE, V14, P203, DOI 10.1038/sj.onc.1200828; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; CALABRETTA B, 1991, P NATL ACAD SCI USA, V88, P2351, DOI 10.1073/pnas.88.6.2351; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Corradini F, 2005, J BIOL CHEM, V280, P30254, DOI 10.1074/jbc.M504703200; Dahle O, 2003, EUR J BIOCHEM, V270, P1338, DOI 10.1046/j.1432-1033.2003.03504.x; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Frampton J, 1996, GENE DEV, V10, P2720, DOI 10.1101/gad.10.21.2720; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kitagawa K, 2009, ONCOGENE, V28, P2393, DOI 10.1038/onc.2009.111; Kitagawa K, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-27; Koller R, 1996, VIROLOGY, V224, P224, DOI 10.1006/viro.1996.0524; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Lieu YK, 2009, P NATL ACAD SCI USA, V106, P21689, DOI 10.1073/pnas.0907623106; Lieu YK, 2004, P NATL ACAD SCI USA, V101, P14853, DOI 10.1073/pnas.0405338101; Lipsick JS, 1999, ONCOGENE, V18, P3047, DOI 10.1038/sj.onc.1202745; Miglarese MR, 1996, J BIOL CHEM, V271, P22697, DOI 10.1074/jbc.271.37.22697; Molvaersmyr AK, 2010, NUCLEIC ACIDS RES, V38, P4970, DOI 10.1093/nar/gkq245; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Murati A, 2009, LEUKEMIA, V23, P85, DOI 10.1038/leu.2008.257; O'Neil J, 2007, J EXP MED, V204, P3059, DOI 10.1084/jem.20071637; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Ouyang J, 2009, EPIGENETICS-US, V4, P440, DOI 10.4161/epi.4.7.9807; Pani E, 2008, BLOOD CELL MOL DIS, V40, P388, DOI 10.1016/j.bcmd.2007.09.010; Pearson R, 2000, EMBO J, V19, P6112, DOI 10.1093/emboj/19.22.6112; PELICCI PG, 1984, SCIENCE, V224, P1117, DOI 10.1126/science.6585957; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Sakamoto H, 2006, BLOOD, V108, P896, DOI 10.1182/blood-2005-09-3846; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Sramko M, 2006, J BIOL CHEM, V281, P40065, DOI 10.1074/jbc.M609404200; Sumner R, 2000, ONCOGENE, V19, P3335, DOI 10.1038/sj.onc.1203660; Taylor D, 1996, GENE DEV, V10, P2732, DOI 10.1101/gad.10.21.2732; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Tomita A, 1998, LEUKEMIA, V12, P1422, DOI 10.1038/sj.leu.2401113; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; Wolff L, 1996, CRIT REV ONCOGENESIS, V7, P245, DOI 10.1615/CritRevOncog.v7.i3-4.60; Yang SH, 2003, CELL CYCLE, V2, P528, DOI 10.4161/cc.2.6.597; Yuan J, 2010, J IMMUNOL, V184, P2793, DOI 10.4049/jimmunol.0902846; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhang JF, 2012, J VIROL, V86, P10524, DOI 10.1128/JVI.01077-12; Zhou FF, 2011, MOL BIOL CELL, V22, P3533, DOI 10.1091/mbc.E11-06-0483; Zhou Y, 2011, FRONT BIOSCI-LANDMRK, V16, P1109, DOI 10.2741/3738	54	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36983	36993		10.1074/jbc.M113.500264	http://dx.doi.org/10.1074/jbc.M113.500264			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24257756	hybrid, Green Published			2022-12-28	WOS:000329189700020
J	Gan, HC; Wang, GB; Hao, Q; Wang, QJ; Tang, H				Gan, Huachen; Wang, Guibo; Hao, Qin; Wang, Q. Jane; Tang, Hua			Protein Kinase D Promotes Airway Epithelial Barrier Dysfunction and Permeability through Down-regulation of Claudin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Junctions; Epithelial Cell; Permeability; Protein Kinase D (PKD); Tight Junctions; Claudin-1	APICAL JUNCTIONAL COMPLEX; TIGHT JUNCTIONS; INTRACELLULAR REDISTRIBUTION; ALTERED EXPRESSION; OCCLUDIN; GROWTH; PHOSPHORYLATION; DIFFERENTIATION; ACTIVATION; VEGF	At the interface between host and external environment, the airway epithelium serves as a major protective barrier. In the present study we show that protein kinase D (PKD) plays an important role in the formation and integrity of the airway epithelial barrier. Either inhibition of PKD activity or silencing of PKD increased transepithelial electrical resistance (TEER), resulting in a tighter epithelial barrier. Among the three PKD isoforms, PKD3 knockdown was the most efficient one to increase TEER in polarized airway epithelial monolayers. In contrast, overexpression of PKD3 wild type, but not PKD3 kinase-inactive mutant, disrupted the formation of apical intercellular junctions and their reassembly, impaired the development of TEER, and increased paracellular permeability to sodium fluorescein in airway epithelial monolayers. We further found that overexpression of PKD, in particular PKD3, markedly suppressed the mRNA and protein levels of claudin-1 but had only minor effects on the expression of other tight junctional proteins (claudin-3, claudin-4, claudin-5, occludin, and ZO-1) and adherent junctional proteins (E-cadherin and -catenin). Immunofluorescence study revealed that claudin-1 level was markedly reduced and almost disappeared from intercellular contacts in PKD3-overexpressed epithelial monolayers and that claudin-4 was also restricted from intercellular contacts and tended to accumulate in the cell cytosolic compartments. Last, we found that claudin-1 knockdown prevented TEER elevation by PKD inhibition or silencing in airway epithelial monolayers. These novel findings indicate that PKD negatively regulates human airway epithelial barrier formation and integrity through down-regulation of claudin-1, which is a key component of tight junctions.	[Gan, Huachen; Wang, Guibo; Hao, Qin; Tang, Hua] Univ Texas Hlth Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA; [Wang, Q. Jane] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tang, H (corresponding author), Univ Texas Hlth Ctr Tyler, Dept Cellular & Mol Biol, 11937 US Highway 271, Tyler, TX 75708 USA.	hua.tang@uthct.edu	Wang, Qiming Jane/B-6064-2012; Gan, Huachen/AAE-5925-2021	Wang, Qiming Jane/0000-0002-9502-4851; 	NHLBI, National Institutes of Health [R21-HL097216]; NATIONAL CANCER INSTITUTE [R01CA142580] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097216] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	work was supported, in whole or in part, by NHLBI, National Institutes of Health Grant R21-HL097216 (to H. T.).	Auer A, 2005, MOL BIOL CELL, V16, P4375, DOI 10.1091/mbc.E05-03-0251; Banan A, 2005, J PHARMACOL EXP THER, V313, P962, DOI 10.1124/jpet.104.083428; Bastea LI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030459; Bhat AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037174; Chen J, 2005, MOL PHARMACOL, V67, P152, DOI 10.1124/mol.104.004200; Cording J, 2013, J CELL SCI, V126, P554, DOI 10.1242/jcs.114306; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; Deissler HL, 2013, EXP EYE RES, V115, P162, DOI 10.1016/j.exer.2013.07.018; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Ha CH, 2008, ARTERIOSCL THROM VAS, V28, P1782, DOI 10.1161/ATVBAHA.108.172528; Hackett NR, 2011, PLOS ONE, V6; Hao Q, 2013, ANTICANCER RES, V33, P393; Hao Q, 2009, AM J PHYSIOL-CELL PH, V296, pC821, DOI 10.1152/ajpcell.00504.2008; Hao Q, 2009, J BIOL CHEM, V284, P799, DOI 10.1074/jbc.M807546200; Harten SK, 2009, MOL BIOL CELL, V20, P1089, DOI 10.1091/mbc.E08-06-0566; Hirota JA, 2012, CURR OPIN IMMUNOL, V24, P740, DOI 10.1016/j.coi.2012.08.012; Inai T, 1999, EUR J CELL BIOL, V78, P849, DOI 10.1016/S0171-9335(99)80086-7; Kluger MS, 2013, ARTERIOSCL THROM VAS, V33, P489, DOI 10.1161/ATVBAHA.112.300893; Komiya S, 2005, GENES CELLS, V10, P1065, DOI 10.1111/j.1365-2443.2005.00899.x; Koval M, 2009, AM J PHYSIOL-LUNG C, V297, pL217, DOI 10.1152/ajplung.00196.2009; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Mitchell LA, 2011, AM J PHYSIOL-LUNG C, V301, pL40, DOI 10.1152/ajplung.00299.2010; Miwa D, 2013, ANGIOGENESIS, V16, P675, DOI 10.1007/s10456-013-9345-x; Ngok SP, 2012, J CELL BIOL, V199, P1103, DOI 10.1083/jcb.201207009; Ogasawara N, 2010, PHARMACOL RES, V61, P489, DOI 10.1016/j.phrs.2010.03.002; Ohta H, 2012, AM J PHYSIOL-LUNG C, V302, pL193, DOI 10.1152/ajplung.00349.2010; Olayioye MA, 2013, CELL SIGNAL, V25, P1739, DOI 10.1016/j.cellsig.2013.04.010; Park JE, 2008, J IMMUNOL, V181, P2044, DOI 10.4049/jimmunol.181.3.2044; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Rey O, 2003, BIOCHEM BIOPH RES CO, V302, P817, DOI 10.1016/S0006-291X(03)00269-9; Rezaee F, 2013, J VIROL, V87, P11088, DOI 10.1128/JVI.01573-13; Rezaee F, 2011, J ALLERGY CLIN IMMUN, V128, P1216, DOI 10.1016/j.jaci.2011.08.035; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Schulzke JD, 2012, ANN NY ACAD SCI, V1257, P1, DOI 10.1111/j.1749-6632.2012.06485.x; Shaykhiev R, 2011, CELL MOL LIFE SCI, V68, P877, DOI 10.1007/s00018-010-0500-x; Sheth B, 2000, MECH DEVELOP, V97, P93, DOI 10.1016/S0925-4773(00)00416-0; Soini Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-70; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Tang H, 2000, J BIOL CHEM, V275, P8389, DOI 10.1074/jbc.275.12.8389; Tinsley JH, 2004, AM J PHYSIOL-CELL PH, V286, pC105, DOI 10.1152/ajpcell.00340.2003; Tobey NA, 2004, AM J PHYSIOL-GASTR L, V286, pG1042, DOI 10.1152/ajpgi.00387.2003; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wan R, 2013, J CELL PHYSIOL, V228, P1295, DOI 10.1002/jcp.24286; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038	59	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37343	37354		10.1074/jbc.M113.511527	http://dx.doi.org/10.1074/jbc.M113.511527			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24265314	Green Published, hybrid			2022-12-28	WOS:000329189700050
J	Grin, I; Hartmann, MD; Sauer, G; Hernandez Alvarez, B; Schutz, M; Wagner, S; Madlung, J; Macek, B; Felipe-Lopez, A; Hensel, M; Lupas, A; Linke, D				Grin, Iwan; Hartmann, Marcus D.; Sauer, Guido; Hernandez Alvarez, Birte; Schuetz, Monika; Wagner, Samuel; Madlung, Johannes; Macek, Boris; Felipe-Lopez, Alfonso; Hensel, Michael; Lupas, Andrei; Linke, Dirk			A Trimeric Lipoprotein Assists in Trimeric Autotransporter Biogenesis in Enterobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Adhesion; Bacterial Pathogenesis; Crystal Structure; Lipoprotein; Membrane Trafficking; Enterobacteria; Gram-negative Bacteria; Membrane Insertion; Autotransport	ENTERICA SEROVAR TYPHIMURIUM; GRAM-NEGATIVE BACTERIA; COILED-COIL; PROTEIN; ADHESINS; IDENTIFICATION; EXPRESSION; PREDICTION; SYSTEM; SERVER	Background: Autotransporter adhesins reach the bacterial cell surface by a complex mechanism. Results: In the case of the autotransporter SadA from Salmonella, a lipoprotein assists in surface display. Conclusion: The similarity to eukaryotic MATH domains suggests that the lipoprotein assists in trimerization of SadA. Significance: Understanding the similarities between autotransport systems might lead to new ways of inhibiting bacterial adhesion. Trimeric autotransporter adhesins (TAAs) are important virulence factors of many Gram-negative bacterial pathogens. TAAs form fibrous, adhesive structures on the bacterial cell surface. Their N-terminal extracellular domains are exported through a C-terminal membrane pore; the insertion of the pore domain into the bacterial outer membrane follows the rules of -barrel transmembrane protein biogenesis and is dependent on the essential Bam complex. We have recently described the full fiber structure of SadA, a TAA of unknown function in Salmonella and other enterobacteria. In this work, we describe the structure and function of SadB, a small inner membrane lipoprotein. The sadB gene is located in an operon with sadA; orthologous operons are only found in enterobacteria, whereas other TAAs are not typically associated with lipoproteins. Strikingly, SadB is also a trimer, and its co-expression with SadA has a direct influence on SadA structural integrity. This is the first report of a specific export factor of a TAA, suggesting that at least in some cases TAA autotransport is assisted by additional periplasmic proteins.	[Grin, Iwan; Hartmann, Marcus D.; Sauer, Guido; Hernandez Alvarez, Birte; Lupas, Andrei; Linke, Dirk] Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany; [Grin, Iwan; Schuetz, Monika; Wagner, Samuel] Univ Tubingen, Inst Med Mikrobiol & Hyg, D-72076 Tubingen, Germany; [Madlung, Johannes; Macek, Boris] Univ Tubingen, Proteome Ctr Tubingen, D-72076 Tubingen, Germany; [Felipe-Lopez, Alfonso; Hensel, Michael] Univ Osnabruck, Fachbereich Biol Chem, Abt Mikrobiol, D-49076 Osnabruck, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University Osnabruck	Linke, D (corresponding author), Univ Oslo, Dept Biosci, N-0316 Oslo, Norway.	dirk.linke@ibv.uio.no	Linke, Dirk/F-9147-2010; Hartmann, Marcus/L-8759-2019; Macek, Boris/N-1442-2015	Linke, Dirk/0000-0003-3150-6752; Hartmann, Marcus/0000-0001-6937-5677; Macek, Boris/0000-0002-1206-2458; Hensel, Michael/0000-0001-6604-6253; Hernandez Alvarez, Birte/0000-0003-0635-8698	Collaborative Research Center Grant (German Science Foundation) [SFB766]; Max Planck Society; Collaborative Research Center Grant from the German Science Foundation [SFB944]; Alexander von Humboldt Foundation; Deutscher Akademischer Austauschdienst fellowship	Collaborative Research Center Grant (German Science Foundation); Max Planck Society(Max Planck Society); Collaborative Research Center Grant from the German Science Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutscher Akademischer Austauschdienst fellowship(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported in part by Collaborative Research Center Grant SFB766 (German Science Foundation) (to D. L.) and by institutional funds from the Max Planck Society.; Supported by Collaborative Research Center Grant SFB944 from the German Science Foundation.; Supported by the Alexander von Humboldt Foundation through a Sofja Kovalevskaja Award.; Supported by a Deutscher Akademischer Austauschdienst fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez BH, 2008, PROTEIN ENG DES SEL, V21, P11, DOI 10.1093/protein/gzm071; Arnold T, 2007, J MOL BIOL, V366, P1174, DOI 10.1016/j.jmb.2006.12.029; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dautin N, 2010, TOXINS, V2, P1179, DOI 10.3390/toxins2061179; Eckert DM, 1998, J MOL BIOL, V284, P859, DOI 10.1006/jmbi.1998.2214; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerlach RG, 2007, APPL ENVIRON MICROB, V73, P4234, DOI 10.1128/AEM.00509-07; Grin I, 2011, NUCLEIC ACIDS RES, V39, pW353, DOI 10.1093/nar/gkr364; Hartmann MD, 2012, P NATL ACAD SCI USA, V109, P20907, DOI 10.1073/pnas.1211872110; Hartmann MD, 2009, P NATL ACAD SCI USA, V106, P16950, DOI 10.1073/pnas.0907256106; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hiss JA, 2009, BRIEF BIOINFORM, V10, P569, DOI 10.1093/bib/bbp030; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Husseiny MI, 2005, INFECT IMMUN, V73, P1598, DOI 10.1128/IAI.73.3.1598-1605.2005; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Paramasivam N, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00218; Raghunathan D, 2011, INFECT IMMUN, V79, P4342, DOI 10.1128/IAI.05592-11; Rahman O, 2008, WORLD J MICROB BIOT, V24, P2377, DOI 10.1007/s11274-008-9795-2; Remmert M, 2010, MOL BIOL EVOL, V27, P1348, DOI 10.1093/molbev/msq017; Schulz GE, 2003, ADV PROTEIN CHEM, V63, P47; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Szabady RL, 2005, P NATL ACAD SCI USA, V102, P221, DOI 10.1073/pnas.0406055102; Szczesny P, 2008, BIOINFORMATICS, V24, P1251, DOI 10.1093/bioinformatics/btn118; Thein M, 2010, J PROTEOME RES, V9, P6135, DOI 10.1021/pr1002438	40	19	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7388	7398		10.1074/jbc.M113.513275	http://dx.doi.org/10.1074/jbc.M113.513275			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24369174	Green Published, hybrid			2022-12-28	WOS:000332761500011
J	Banerjee, P; Bandyopadhyay, A				Banerjee, Priyam; Bandyopadhyay, Arun			Cytosolic Dynamics of Annexin A6 Trigger Feedback Regulation of Hypertrophy via Atrial Natriuretic Peptide in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Annexin; Cardiac Hypertrophy; Cell Biology; Microscopy; Natriuretic Peptides; Protein Dynamics; Signaling; Trafficking	CARDIAC-HYPERTROPHY; PHOSPHOLIPID-BINDING; SECRETORY VESICLES; MEMBRANE-BINDING; VI; HEART; PROTEIN; MECHANISMS; CELL; AGGREGATION	Background: Altered annexin A6 expression is associated with several cardiovascular disorders, including myocyte hypertrophy, but precise functions of the protein remain elusive. Results: Dynamic association of annexin A6 with intracellular atrial natriuretic peptide precursor protects against adrenergic stimulation-induced hypertrophy of H9c2 cardiomyocytes. Conclusion: Annexin A6 negatively regulates hypertrophic progression of cardiomyocytes. Significance: Annexin A6 exhibits potential for antihypertrophic therapeutics. Malfunctions in regulatory pathways that control cell size are prominent in pathological cardiac hypertrophy. Here, we show annexin A6 (Anxa6) to be a crucial regulator of atrial natriuretic peptide (ANP)-mediated counterhypertrophic responses in cardiomyocytes. Adrenergic stimulation of H9c2 cardiomyocytes by phenylephrine (PE) increased the cell size with enhanced expression of biochemical markers of hypertrophy, concomitant with elevated expression and subcellular redistribution of Anxa6. Stable cell lines with controlled increase in Anxa6 levels were protected against PE-induced adverse changes, whereas Anxa6 knockdown augmented the hypertrophic responses. Strikingly, Anxa6 knockdown also abrogated PE-induced juxtanuclear accumulation of secretory granules (SG) containing ANP propeptides (pro-ANP), a signature of maladaptive hypertrophy having counteractive functions. Mechanistically, PE treatment prompted a dynamic association of Anxa6 with pro-ANP-SG, parallel to their participation in anterograde traffic, in an isoform-specific fashion. Moreover, Anxa6 mutants that failed to associate with pro-ANP hindered ANP-mediated protection against hypertrophy, which was rescued, at least partially, by WT Anxa6. Additionally, elevated intracellular calcium (Ca2+) stimulated Anxa6-pro-ANP colocalization and membrane association. It also rescued pro-ANP translocation in cells expressing an Anxa6 mutant (Anxa6(C)). Furthermore, stable overexpression of Anxa6(T356D), a mutant with superior flexibility, provided enhanced protection against PE, compared with WT, presumably due to enhanced membrane-binding capacity. Together, the present study delivers a cooperative mechanism where Anxa6 potentiates ANP-dependent counterhypertrophic responses in cardiomyocytes by facilitating regulated traffic of pro-ANP.	[Banerjee, Priyam; Bandyopadhyay, Arun] CSIR, Indian Inst Chem Biol, Cell Biol & Physiol Div, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bandyopadhyay, A (corresponding author), CSIR, Indian Inst Chem Biol, Cell Biol & Physiol Div, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	arunb@iicb.res.in	Banerjee, Priyam/D-2363-2011	Banerjee, Priyam/0000-0001-9398-9345	CSIR; Wellcome Trust	CSIR(Council of Scientific & Industrial Research (CSIR) - India); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Professor Anna Huttenlocher (University of Wisconsin, Madison, WI) for the tol2-mpx-Dendra2 construct, Swapan Mondal for laboratory assistance, and Thangamuniyadi Muruganandan and Diptadeep Sarkar for technical support with AFM and spinning disc microscopy, respectively. A. B. gratefully acknowledges the Central Confocal and Atomic Force Microscopy Facility at IICB (funded by CSIR) and the CSIR-IICB Live Cell Imaging Facility (co-funded by the Wellcome Trust and CSIR) for the imaging experiments.	Ayala-Sanmartin J, 2001, BIOCHEM BIOPH RES CO, V283, P72, DOI 10.1006/bbrc.2001.4748; Baertschi AJ, 2001, CIRC RES, V89, pE23, DOI 10.1161/hh1501.095715; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Bubikat A, 2005, J BIOL CHEM, V280, P21594, DOI 10.1074/jbc.m501103200; Calvieri C, 2012, J MOL MED, V90, P5, DOI 10.1007/s00109-011-0801-z; Camors E, 2005, CARDIOVASC RES, V65, P793, DOI 10.1016/j.cardiores.2004.11.010; Canaff L, 1996, P NATL ACAD SCI USA, V93, P9483, DOI 10.1073/pnas.93.18.9483; Chen MZ, 2012, MOL CELL BIOCHEM, V371, P77, DOI 10.1007/s11010-012-1424-6; Chlystun M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053774; Chudakov DM, 2007, BIOTECHNIQUES, V42, P553, DOI 10.2144/000112470; Creutz CE, 2005, BIOCHEMISTRY-US, V44, P13795, DOI 10.1021/bi051160w; CREUTZ CE, 1992, BIOCHEM BIOPH RES CO, V184, P347, DOI 10.1016/0006-291X(92)91199-Z; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; De K, 2004, J ENDOCRINOL, V182, P303, DOI 10.1677/joe.0.1820303; Donnelly SR, 1997, CELL MOL LIFE SCI, V53, P533, DOI 10.1007/s000180050068; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; DOUBELL AF, 1991, HYPERTENSION, V18, P648, DOI 10.1161/01.HYP.18.5.648; Enrich C, 2011, BBA-MOL CELL RES, V1813, P935, DOI 10.1016/j.bbamcr.2010.09.015; Frentzou GA, 2010, MOL CELL BIOCHEM, V345, P119, DOI 10.1007/s11010-010-0565-8; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Freye-Minks C, 2003, BIOCHEMISTRY-US, V42, P620, DOI 10.1021/bi026742h; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; GOLDBERG M, 1991, CELL TISSUE RES, V263, P81, DOI 10.1007/BF00318402; Grewal T, 2000, J BIOL CHEM, V275, P33806, DOI 10.1074/jbc.M002662200; GunteskiHamblin AM, 1996, AM J PHYSIOL-HEART C, V270, pH1091, DOI 10.1152/ajpheart.1996.270.3.H1091; Hawkins TE, 1999, MOL CELL BIOL, V19, P8028; HAZARIKA P, 1991, J CELL BIOCHEM, V46, P78, DOI 10.1002/jcb.240460112; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; JACKLE S, 1994, J BIOL CHEM, V269, P1026; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; KAETZEL MA, 1994, BBA-MOL CELL RES, V1223, P368, DOI 10.1016/0167-4889(94)90097-3; Klaiber M, 2010, BASIC RES CARDIOL, V105, P583, DOI 10.1007/s00395-010-0098-z; Koese M, 2013, ONCOGENE, V32, P2858, DOI 10.1038/onc.2012.303; Locate S, 2008, CELL BIOL INT, V32, P1388, DOI 10.1016/j.cellbi.2008.08.009; Ma HL, 2012, J VIROL, V86, P1789, DOI 10.1128/JVI.06003-11; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Masedunskas A, 2012, TRAFFIC, V13, P627, DOI 10.1111/j.1600-0854.2012.01328.x; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mishra S, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-7; Molkentin JD, 2003, J CLIN INVEST, V111, P1275, DOI 10.1172/JCI200318389; Monastyrskaya K, 2009, CELL MOL LIFE SCI, V66, P2623, DOI 10.1007/s00018-009-0027-1; O'Donnell PJ, 2003, J MOL CELL CARDIOL, V35, P915, DOI 10.1016/S0022-2828(03)00171-8; Planavila A, 2005, J BIOL CHEM, V280, P17464, DOI 10.1074/jbc.M414220200; Podszywalow-Bartnicka P, 2010, J CELL BIOCHEM, V111, P168, DOI 10.1002/jcb.22685; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Roostalu U, 2012, DEV CELL, V22, P515, DOI 10.1016/j.devcel.2011.12.008; Rosenkranz AC, 2003, CARDIOVASC RES, V57, P515, DOI 10.1016/S0008-6363(02)00667-3; Rybkin II, 2007, J CELL BIOL, V179, P527, DOI 10.1083/jcb.200707101; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Song GJ, 1998, J MOL CELL CARDIOL, V30, P443, DOI 10.1006/jmcc.1997.0608; Song GJ, 2002, FASEB J, V16, P622, DOI 10.1096/fj.01-0892fje; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Sztolsztener ME, 2010, ARCH BIOCHEM BIOPHYS, V493, P221, DOI 10.1016/j.abb.2009.11.001; THIBAULT G, 1992, AM J PHYSIOL, V262, pC907, DOI 10.1152/ajpcell.1992.262.4.C907; Trouve P, 1999, AM J PHYSIOL-HEART C, V276, pH1159, DOI 10.1152/ajpheart.1999.276.4.H1159; Watkins SJ, 2011, IN VITRO CELL DEV-AN, V47, P125, DOI 10.1007/s11626-010-9368-1; Yoo SK, 2011, J LEUKOCYTE BIOL, V89, P661, DOI 10.1189/jlb.1010567	60	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5371	5385		10.1074/jbc.M113.514810	http://dx.doi.org/10.1074/jbc.M113.514810			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403064	Green Published, hybrid			2022-12-28	WOS:000332015500003
J	Dey, M; Mann, BR; Anshu, A; Amin-ul Mannan, M				Dey, Madhusudan; Mann, Brian Rick; Anshu, Ashish; Amin-ul Mannan, M.			Activation of Protein Kinase PKR Requires Dimerization-induced cis-Phosphorylation within the Activation Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Phosphorylation; Protein Kinase RNA (PKR); Protein Kinases; Protein Phosphorylation; Stress Response; Activation Loop; eIF2	DOUBLE-STRANDED-RNA; INITIATION-FACTOR 2-ALPHA; TRANSLATIONAL REGULATION; SUBSTRATE RECOGNITION; CATALYTIC DOMAIN; BINDING DOMAINS; IN-VIVO; MECHANISM; GCN2; AUTOPHOSPHORYLATION	Background: PKR regulates many biological processes including stress response. Results: An activation-loop-phosphorylation bypass mutant of PKR functions without a key dimer-interface residue. The PKR kinase domain together with a kinase-dead partner, but not alone, activates the catalytic function. Conclusion: Activation loop phosphorylation occurs in cis following dimerization. Significance: PKR autophosphorylates in the activation loop in cis to initiate the antiviral signaling cascade. Protein kinase R (PKR) functions in a plethora of cellular processes, including viral and cellular stress responses, by phosphorylating the translation initiation factor eIF2. The minimum requirements for PKR function are homodimerization of its kinase and RNA-binding domains, and autophosphorylation at the residue Thr-446 in a flexible loop called the activation loop. We investigated the interdependence between dimerization and Thr-446 autophosphorylation using the yeast Saccharomyces cerevisiae model system. We showed that an engineered PKR that bypassed the need for Thr-446 autophosphorylation (PKRT446 approximate to P-bypass mutant) could function without a key residue (Asp-266 or Tyr-323) that is essential for PKR dimerization, suggesting that dimerization precedes and stimulates activation loop autophosphorylation. We also showed that the PKRT446 approximate to P-bypass mutant was able to phosphorylate eIF2 even without its RNA-binding domains. These two significant findings reveal that PKR dimerization and activation loop autophosphorylation are mutually exclusive yet interdependent processes. Also, we provide evidence that Thr-446 autophosphorylation during PKR activation occurs in a cis mechanism following dimerization.	[Dey, Madhusudan; Mann, Brian Rick; Anshu, Ashish; Amin-ul Mannan, M.] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53211 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Dey, M (corresponding author), Univ Wisconsin, Dept Biol Sci, Rm 460,Lapham Hall,3209 N Maryland Ave, Milwaukee, WI 53211 USA.	deym@uwm.edu	Mannan, Mohammad Amin-ul/AAT-6203-2021	Mannan, Mohammad Amin-ul/0000-0001-7484-6736	National Institutes of Health [1R15GM101575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM101575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant 1R15GM101575 (to M. D.).	Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Carpick BW, 1997, J BIOL CHEM, V272, P9510, DOI 10.1074/jbc.272.14.9510; CHEN JJ, 1991, P NATL ACAD SCI USA, V88, P7729, DOI 10.1073/pnas.88.17.7729; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Cui WJ, 2011, ACTA CRYSTALLOGR D, V67, P423, DOI 10.1107/S0907444911006445; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Dey M, 2005, MOL CELL BIOL, V25, P3063, DOI 10.1128/MCB.25.8.3063-3075.2005; Dey M, 2007, J BIOL CHEM, V282, P6653, DOI 10.1074/jbc.M607897200; Dey M, 2011, P NATL ACAD SCI USA, V108, P4316, DOI 10.1073/pnas.1014872108; Dong BH, 2001, RNA, V7, P361, DOI 10.1017/S1355838201002230; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; FENG GS, 1992, P NATL ACAD SCI USA, V89, P5447, DOI 10.1073/pnas.89.12.5447; Gelev V, 2006, J MOL BIOL, V364, P352, DOI 10.1016/j.jmb.2006.08.077; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harashima A, 2010, GENE DEV, V24, P2640, DOI 10.1101/gad.1965010; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2009, STRUCTURE, V17, P5, DOI 10.1016/j.str.2008.12.005; KOSTURA M, 1989, MOL CELL BIOL, V9, P1576, DOI 10.1128/MCB.9.4.1576; Kronfeld-Kinar Y, 1999, CELL GROWTH DIFFER, V10, P201; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; LANGLAND JO, 1992, J BIOL CHEM, V267, P10729; Lemaire PA, 2005, J MOL BIOL, V345, P81, DOI 10.1016/j.jmb.2004.10.031; Lemaire PA, 2008, J MOL BIOL, V381, P351, DOI 10.1016/j.jmb.2008.05.056; Li SD, 2006, P NATL ACAD SCI USA, V103, P10005, DOI 10.1073/pnas.0602317103; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; PATEL RC, 1995, P NATL ACAD SCI USA, V92, P8283, DOI 10.1073/pnas.92.18.8283; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Ung TL, 2001, EMBO J, V20, P3728, DOI 10.1093/emboj/20.14.3728; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; Vattem KM, 2001, EUR J BIOCHEM, V268, P3674, DOI 10.1046/j.1432-1327.2001.02273.x; Vattem KM, 2001, EUR J BIOCHEM, V268, P1143, DOI 10.1046/j.1432-1327.2001.01979.x; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wu SY, 1997, J BIOL CHEM, V272, P1291, DOI 10.1074/jbc.272.2.1291; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200	54	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5747	5757		10.1074/jbc.M113.527796	http://dx.doi.org/10.1074/jbc.M113.527796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24338483	Green Published, hybrid			2022-12-28	WOS:000332015500035
J	Noam, Y; Ehrengruber, MU; Koh, A; Feyen, P; Manders, EMM; Abbott, GW; Wadman, WJ; Baram, TZ				Noam, Yoav; Ehrengruber, Markus U.; Koh, Annie; Feyen, Paul; Manders, Erik M. M.; Abbott, Geoffrey W.; Wadman, Wytse J.; Baram, Tallie Z.			Filamin A Promotes Dynamin-dependent Internalization of Hyperpolarization-activated Cyclic Nucleotide-gated Type 1 (HCN1) Channels and Restricts I-h in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Endocytosis; Ion Channels; Neurons; Trafficking; HCN; Ih; Filamin A	BINDING PROTEIN FILAMIN; SURFACE EXPRESSION; ALZHEIMERS-DISEASE; INTRACELLULAR TRAFFICKING; POTASSIUM CHANNEL; PYRAMIDAL NEURONS; EXCITABILITY; LOCALIZATION; TRIP8B; COLOCALIZATION	Background: HCN channels influence neuronal excitability. Results: Filamin-A (FLNa) facilitated selective, reversible dynamin-dependent internalization of HCN1 and reduced I-h. In hippocampal neurons, dominant-negative FLNa enhanced native HCN1, and decoy peptides disrupting HCN1-FLNa binding reduced channel clustering and augmented endogenous I-h. Conclusion: FLNa modulates neuronal excitability via dynamin-mediated HCN1 endocytosis. Significance: Novel roles for FLNa in mature neuronal function are presented. The actin-binding protein filamin A (FLNa) regulates neuronal migration during development, yet its roles in the mature brain remain largely obscure. Here, we probed the effects of FLNa on the regulation of ion channels that influence neuronal properties. We focused on the HCN1 channels that conduct I-h, a hyperpolarization-activated current crucial for shaping intrinsic neuronal properties. Whereas regulation of HCN1 channels by FLNa has been observed in melanoma cell lines, its physiological relevance to neuronal function and the underlying cellular pathways that govern this regulation remain unknown. Using a combination of mutational, pharmacological, and imaging approaches, we find here that FLNa facilitates a selective and reversible dynamin-dependent internalization of HCN1 channels in HEK293 cells. This internalization is accompanied by a redistribution of HCN1 channels on the cell surface, by accumulation of the channels in endosomal compartments, and by reduced I-h density. In hippocampal neurons, expression of a truncated dominant-negative FLNa enhances the expression of native HCN1. Furthermore, acute abrogation of HCN1-FLNa interaction in neurons, with the use of decoy peptides that mimic the FLNa-binding domain of HCN1, abolishes the punctate distribution of HCN1 channels in neuronal cell bodies, augments endogenous I-h, and enhances the rebound-response (voltage-sag) of the neuronal membrane to transient hyperpolarizing events. Together, these results support a major function of FLNa in modulating ion channel abundance and membrane trafficking in neurons, thereby shaping their biophysical properties and function.	[Noam, Yoav; Ehrengruber, Markus U.; Koh, Annie; Baram, Tallie Z.] Univ Calif Irvine, Dept Anat Neurobiol & Pediat, Irvine, CA 92697 USA; [Abbott, Geoffrey W.] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; [Feyen, Paul; Wadman, Wytse J.] Univ Amsterdam, SILS Ctr Neurosci, NL-1098 XH Amsterdam, Netherlands; [Manders, Erik M. M.] Univ Amsterdam, van Leeuwenhoek Ctr Adv Microscopy, NL-1098 XH Amsterdam, Netherlands	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Amsterdam; University of Amsterdam	Baram, TZ (corresponding author), Univ Calif Irvine, Med Sci 1,ZOT 4475, Irvine, CA 92697 USA.	tallie@uci.edu	Baram, Tallie Z/J-6447-2014		National Institutes of Health [R37 NS35439, T32 NS45540]; Netherlands Organization for Scientific Research; Dutch National Epilepsy Fund Grant [NEF 08-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035439, T32NS045540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch National Epilepsy Fund Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 NS35439 and T32 NS45540 (to T. Z. B. and Y. N.). This work was also supported by a Rubicon grant from the Netherlands Organization for Scientific Research (to Y. N.) and Dutch National Epilepsy Fund Grant NEF 08-01 (to W. J. W.).	Amendola J, 2012, J NEUROSCI, V32, P2166, DOI 10.1523/JNEUROSCI.5297-11.2012; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Campanac E, 2008, J NEUROSCI, V28, P8635, DOI 10.1523/JNEUROSCI.1411-08.2008; Cho EY, 2007, MOL ENDOCRINOL, V21, P2242, DOI 10.1210/me.2007-0202; D'Amelio M, 2012, PROG NEUROBIOL, V99, P42, DOI 10.1016/j.pneurobio.2012.07.001; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Han Y, 2011, J BIOL CHEM, V286, P20823, DOI 10.1074/jbc.M111.236125; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Huang Z, 2011, NAT NEUROSCI, V14, P478, DOI 10.1038/nn.2757; Jaiswal JK, 2007, NAT CHEM BIOL, V3, P92, DOI 10.1038/nchembio855; Jung S, 2011, J NEUROSCI, V31, P14291, DOI 10.1523/JNEUROSCI.1148-11.2011; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim CS, 2012, NEURON, V75, P503, DOI 10.1016/j.neuron.2012.05.027; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim EY, 2007, MOL PHARMACOL, V72, P622, DOI 10.1124/mol.107.038026; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Lewis AS, 2010, CHANNELS, V4, P215, DOI 10.4161/chan.4.3.11630; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Liao ZD, 2011, CHANNELS, V5, P115, DOI 10.4161/chan.5.2.14195; Lin RW, 2002, PHARMACOLOGY, V66, P173, DOI 10.1159/000065531; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Lu Q, 2010, J ALZHEIMERS DIS, V22, P235, DOI 10.3233/JAD-2010-100585; MACCAFERRI G, 1993, J NEUROPHYSIOL, V69, P2129, DOI 10.1152/jn.1993.69.6.2129; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Minsaas L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012212; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Narayanan R, 2010, NEURON, V68, P921, DOI 10.1016/j.neuron.2010.11.033; Noam Y, 2012, J COMP NEUROL, V520, P3013, DOI 10.1002/cne.23106; Noam Y, 2011, CURR OPIN NEUROBIOL, V21, P873, DOI 10.1016/j.conb.2011.06.013; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Onoprishvili I, 2003, MOL PHARMACOL, V64, P1092, DOI 10.1124/mol.64.5.1092; Petrecca K, 2000, J NEUROSCI, V20, P8736; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Postea O, 2011, NAT REV DRUG DISCOV, V10, P903, DOI 10.1038/nrd3576; Ramakrishnan NA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375832; Saito Y, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-50; Sampson LJ, 2003, J BIOL CHEM, V278, P41988, DOI 10.1074/jbc.M307479200; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Sarkisian MR, 2008, TRENDS NEUROSCI, V31, P54, DOI 10.1016/j.tins.2007.11.009; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Shin M, 2007, J BIOL CHEM, V282, P33168, DOI 10.1074/jbc.M703736200; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Suphamungmee W, 2012, J MOL BIOL, V424, P248, DOI 10.1016/j.jmb.2012.09.025; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Tsang SY, 2004, J BIOL CHEM, V279, P43752, DOI 10.1074/jbc.M408747200; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; vanSteensel B, 1996, J CELL SCI, V109, P787; Wang HY, 2012, J NEUROSCI, V32, P9773, DOI 10.1523/JNEUROSCI.0354-12.2012; Zhang WJ, 1998, J NEUROSCI, V18, P914	68	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5889	5903		10.1074/jbc.M113.522060	http://dx.doi.org/10.1074/jbc.M113.522060			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403084	hybrid, Green Published			2022-12-28	WOS:000332015500046
J	Singh, V; Lin, R; Yang, JB; Cha, B; Sarker, R; Tse, CM; Donowitz, M				Singh, Varsha; Lin, Rong; Yang, Jianbo; Cha, Boyoung; Sarker, Rafiquel; Tse, Chung Ming; Donowitz, Mark			AKT and GSK-3 Are Necessary for Direct Ezrin Binding to NHE3 as Part of a C-terminal Stimulatory Complex ROLE OF A NOVEL SER-RICH NHE3 C-TERMINAL MOTIF IN NHE3 ACTIVITY AND TRAFFICKING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Ezrin; Membrane; Phosphorylation; Trafficking; Na+; H+ Exchanger; Absorption; Alpha Helix	BORDER NA+/H+ EXCHANGER; GLYCOGEN-SYNTHASE KINASE-3; ISOFORM 3; MOLECULAR PHYSIOLOGY; BASAL ACTIVITY; ERM PROTEINS; INHIBITION; DOMAIN; PHOSPHORYLATION; ACTIVATION	Background: Phosphoinositides and ezrin form a complex with NHE3, which stimulates basal transport activity. How this complex is regulated is unknown. Results: GSK-3 and Akt stimulate NHE3 activity by changing ezrin binding. Conclusion: Sequential effects of two kinase regulate the association of NHE3 with ezrin to affect basal activity. Significance: A novel Ser cluster in the NHE3 C-terminal domain regulates its ezrin binding. Basal activity of the BB Na+/H+ exchanger NHE3 requires multiprotein complexes that form on its C terminus. One complex stimulates basal NHE3 activity and contains ezrin and phosphoinositides as major components; how it stimulates NHE3 activity is not known. This study tested the hypothesis that ezrin dynamically associates with this complex, which sets ezrin binding. NHE3 activity was reduced by an Akt(i). This effect was eliminated if ezrin binding to NHE3 was inhibited by a point mutant. Recombinant AKT phosphorylated NHE3 C terminus in the domain ezrin directly binds. This domain (amino acids 475-589) is predicted to be -helical and contains a conserved cluster of three serines (Ser(515), Ser(522), and Ser(526)). Point mutations of two of these (S515A, S515D, or S526A) reduced basal NHE3 activity and surface expression and had no Akt(i) inhibition. S526D had NHE3 activity equal to wild type with normal Akt(i) inhibition. Ezrin binding to NHE3 was regulated by Akt, being eliminated by Akt(i). NHE3-S515A and -S526D did not bind ezrin; NHE3-S515D had reduced ezrin binding; NHE3-S526D bound ezrin normally. NHE3-Ser(526) is predicted to be a GSK-3 kinase phosphorylation site. A GSK-3 inhibitor reduced basal NHE3 activity as well as ezrin-NHE3 binding, and this effect was eliminated in NHE3-S526A and -S526D mutants. The conclusions were: 1) NHE3 basal activity is regulated by a signaling complex that is controlled by sequential effects of two kinases, Akt and GSK-3, which act on a Ser cluster in the same NHE3 C-terminal domain that binds ezrin; and 2) these kinases regulate the dynamic association of ezrin with NHE3 to affect basal NHE3 activity.	[Singh, Varsha; Lin, Rong; Yang, Jianbo; Cha, Boyoung; Sarker, Rafiquel; Tse, Chung Ming; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Singh, Varsha; Lin, Rong; Yang, Jianbo; Cha, Boyoung; Sarker, Rafiquel; Tse, Chung Ming; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; [Lin, Rong] Huazhong Univ Sci & Technol, Tongji Med Sch, Union Hosp, Tongji Med Coll,Div Gastroenterol, Wuhan 430074, Peoples R China	Johns Hopkins University; Johns Hopkins University; Huazhong University of Science & Technology	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Ross 925,720 Rutland Ave, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Yang, Jianbo/G-1254-2013		National Institutes of Health [R01DK26523, R01DK61765, P01DK072084, K08DK088950]; Conte Hopkins Digestive Diseases Basic and Translational Research Core Center from NIDDK, National Institutes of Health [P30DK089502]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502, R01DK026523, P01DK072084, K08DK088950, R01DK061765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conte Hopkins Digestive Diseases Basic and Translational Research Core Center from NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK26523, R01DK61765, P01DK072084, and K08DK088950. This work was also supported by Conte Hopkins Digestive Diseases Basic and Translational Research Core Center Grant P30DK089502 from NIDDK, National Institutes of Health.	Adachi A, 2010, J CELL SCI, V123, P3215, DOI 10.1242/jcs.063941; Akhter S, 2000, BIOCHEMISTRY-US, V39, P1990, DOI 10.1021/bi991739s; Akhter S, 2002, AM J PHYSIOL-CELL PH, V283, pC927, DOI 10.1152/ajpcell.00613.2001; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Cha B, 2008, CLIN EXP PHARMACOL P, V35, P863, DOI 10.1111/j.1440-1681.2008.04931.x; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Colosimo PF, 2010, DEV DYNAM, V239, P115, DOI 10.1002/dvdy.21963; Donowitz M, 2000, ANN NY ACAD SCI, V915, P30; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Hayashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055623; He PJ, 2011, MOL BIOL CELL, V22, P3812, DOI 10.1091/mbc.E11-04-0328; Kim M, 2007, J CELL SCI, V120, P2309, DOI 10.1242/jcs.007443; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Lee-Kwon W, 2001, J BIOL CHEM, V276, P31296, DOI 10.1074/jbc.M103900200; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; Mohan S, 2010, J BIOL CHEM, V285, P34566, DOI 10.1074/jbc.M110.165712; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Murtazina R, 2011, AM J PHYSIOL-CELL PH, V301, pC126, DOI 10.1152/ajpcell.00311.2010; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Noel J, 1996, J CELL SCI, V109, P929; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Sandu C, 2006, AM J PHYSIOL-GASTR L, V291, pG868, DOI 10.1152/ajpgi.00023.2006; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Serrador JM, 2002, J BIOL CHEM, V277, P10400, DOI 10.1074/jbc.M110694200; Shiue H, 2005, J BIOL CHEM, V280, P1688, DOI 10.1074/jbc.M409471200; Singh V, 2014, CLIN GASTROENTEROL H, V12, P27, DOI 10.1016/j.cgh.2013.10.020; Wagner U, 1996, J CELL SCI, V109, P1537; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; WELSH GI, 1994, BIOCHEM J, V303, P15, DOI 10.1042/bj3030015; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; YUN CHC, 1995, P NATL ACAD SCI USA, V92, P10723, DOI 10.1073/pnas.92.23.10723; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; Zachos NC, 2009, J BIOL CHEM, V284, P23708, DOI 10.1074/jbc.M109.012641; Zachos NC, 2008, CELL PHYSIOL BIOCHEM, V22, P693, DOI 10.1159/000185553; Zhao HR, 2004, P NATL ACAD SCI USA, V101, P9485, DOI 10.1073/pnas.0308400101; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753; Zizak M, 2012, J BIOL CHEM, V287, P13442, DOI 10.1074/jbc.M111.307256	50	14	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5449	5461		10.1074/jbc.M113.521336	http://dx.doi.org/10.1074/jbc.M113.521336			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398676	hybrid, Green Published			2022-12-28	WOS:000332015500009
J	Kline, CF; Scott, J; Curran, J; Hund, TJ; Mohler, PJ				Kline, Crystal F.; Scott, John; Curran, Jerry; Hund, Thomas J.; Mohler, Peter J.			Ankyrin-B Regulates Ca(v)2.1 and Ca(v)2.2 Channel Expression and Targeting*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Proteins; Cytoskeleton; Ion Channels; Membrane Trafficking; Protein Sorting; Protein Targeting	GATED CALCIUM-CHANNELS; AXON INITIAL SEGMENT; G-PROTEIN MODULATION; BETA-GAMMA-SUBUNITS; CA2+ CHANNELS; N-TYPE; SYNAPTIC-TRANSMISSION; PURKINJE-CELLS; CARDIAC DEATH; MICE LACKING	Background: Calcium channels control membrane excitability. The mechanisms underlying Ca(v)2.1/Ca(v)2.2 targeting are not well understood. Results: Ankyrin-B associates with Ca(v)2.1/Ca(v)2.2. Loss of ankyrin-B results in reduced expression of Ca(v)2.1/Ca(v)2.2 in select brain regions. Conclusion: Ankyrin-B plays a role in the expression of Ca(v)2.1/Ca(v)2.2. Significance: Results identify pathway for membrane targeting of calcium channels and regulation of membrane excitability. N-type and P/Q-type calcium channels are documented players in the regulation of synaptic function; however, the mechanisms underlying their expression and cellular targeting are poorly understood. Ankyrin polypeptides are essential for normal integral membrane protein expression in a number of cell types, including neurons, cardiomyocytes, epithelia, secretory cells, and erythrocytes. Ankyrin dysfunction has been linked to defects in integral protein expression, abnormal cellular function, and disease. Here, we demonstrate that ankyrin-B associates with Ca(v)2.1 and Ca(v)2.2 in cortex, cerebellum, and brain stem. Additionally, using in vitro and in vivo techniques, we demonstrate that ankyrin-B, via its membrane-binding domain, associates with a highly conserved motif in the DII/III loop domain of Ca(v)2.1 and Ca(v)2.2. Further, we demonstrate that this domain is necessary for proper targeting of Ca(v)2.1 and Ca(v)2.2 in a heterologous system. Finally, we demonstrate that mutation of a single conserved tyrosine residue in the ankyrin-binding motif of both Ca(v)2.1 (Y797E) and Ca(v)2.2 (Y788E) results in loss of association with ankyrin-B in vitro and in vivo. Collectively, our findings identify an interaction between ankyrin-B and both Ca(v)2.1 and Ca(v)2.2 at the amino acid level that is necessary for proper Ca(v)2.1 and Ca(v)2.2 targeting in vivo.	[Kline, Crystal F.; Scott, John; Curran, Jerry; Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Hund, Thomas J.] Ohio State Univ, Dept Biomed Engn, Coll Engn, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kline, CF (corresponding author), Dorothy M Davis Heart & Lung Res Inst, 473 W 12th Ave,DHLRI 110G, Columbus, OH 43210 USA.	faith.kline@osumc.edu	Curran, Jerry W/B-9762-2012		National Institutes of Health [HL084583, HL083422, HL114383, HL096805, HL114893]; American Heart Association; Saving Tiny Hearts Society; Ohio State University William D. and Jacquelyn L. Wells Fund for Cardiovascular Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114383, R01HL084583, R00HL096805, R01HL114893, K99HL096805, R01HL083422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Saving Tiny Hearts Society; Ohio State University William D. and Jacquelyn L. Wells Fund for Cardiovascular Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084583, HL083422, and HL114383 (to P. J. M.) and HL096805 and HL114893 (to T. J. H.). This work was also supported by the American Heart Association (to P. J. M.), the Saving Tiny Hearts Society (to P. J. M.), and The Ohio State University William D. and Jacquelyn L. Wells Fund for Cardiovascular Research (to P. J. M.).	Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cheever TR, 2013, INT REV CEL MOL BIO, V301, P157, DOI 10.1016/B978-0-12-407704-1.00004-X; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Cunha SR, 2008, J BIOL CHEM, V283, P31968, DOI 10.1074/jbc.M806050200; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Cunha SR, 2011, CIRCULATION, V124, P1212, DOI 10.1161/CIRCULATIONAHA.111.023986; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; DELCOUR AH, 1993, SCIENCE, V259, P980, DOI 10.1126/science.8094902; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; ELLINOR PT, 1993, NATURE, V363, P455, DOI 10.1038/363455a0; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Fransen E, 1997, HUM MOL GENET, V6, P1625, DOI 10.1093/hmg/6.10.1625; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Indriati DW, 2013, J NEUROSCI, V33, P3668, DOI 10.1523/JNEUROSCI.2921-12.2013; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Kim C, 2001, MOL CELL NEUROSCI, V18, P235, DOI 10.1006/mcne.2001.1013; Kim C, 2009, J BIOL CHEM, V284, P2738, DOI 10.1074/jbc.M807179200; KORDELI E, 1990, J CELL BIOL, V110, P1341, DOI 10.1083/jcb.110.4.1341; Le Scouarnec S, 2008, P NATL ACAD SCI USA, V105, P15617, DOI 10.1073/pnas.0805500105; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Luvisetto S, 2006, NEUROSCIENCE, V142, P823, DOI 10.1016/j.neuroscience.2006.06.049; Miller RJ, 1997, TRENDS NEUROSCI, V20, P189, DOI 10.1016/S0166-2236(96)01037-5; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Mohler PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001051; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2011, J MOL CELL CARDIOL, V50, P939, DOI 10.1016/j.yjmcc.2011.04.003; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Needham LK, 2001, J NEUROSCI, V21, P1490, DOI 10.1523/JNEUROSCI.21-05-01490.2001; Nooney JM, 1996, EUR J PHARMACOL, V306, P41, DOI 10.1016/0014-2999(96)00195-1; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Patil PG, 1996, BIOPHYS J, V71, P2509, DOI 10.1016/S0006-3495(96)79444-4; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sedlacek K, 2008, CIRC-CARDIOVASC GENE, V1, P93, DOI 10.1161/CIRCGENETICS.108.792192; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; YUE DT, 1990, SCIENCE, V250, P1735, DOI 10.1126/science.2176745; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	52	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5285	5295		10.1074/jbc.M113.523639	http://dx.doi.org/10.1074/jbc.M113.523639			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24394417	Green Published, hybrid			2022-12-28	WOS:000331607900069
J	Rao, M; Gottesfeld, JM				Rao, Mahendra; Gottesfeld, Joel M.			Introduction to Thematic Minireview Series: Development of Human Therapeutics Based on Induced Pluripotent Stem Cell (iPSC) Technology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Genomic Instability; Induced Pluripotent Stem Cells; Regenerative Medicine; Stem Cells; Toxicology; Gene Correction; Immunogenicity		With the advent of human induced pluripotent stem cell (hiPSC) technology, it is now possible to derive patient-specific cell lines that are of great potential in both basic research and the development of new therapeutics for human diseases. Not only do hiPSCs offer unprecedented opportunities to study cellular differentiation and model human diseases, but the differentiated cell types obtained from iPSCs may become therapeutics themselves. These cells can also be used in the screening of therapeutics and in toxicology assays for potential liabilities of therapeutic agents. The remarkable achievement of transcription factor reprogramming to generate iPSCs was recognized by the award of the Nobel Prize in Medicine to Shinya Yamanaka in 2012, just 6 years after the first publication of reprogramming methods to generate hiPSCs (Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007) Cell 131, 861-872). This minireview series highlights both the promises and challenges of using iPSC technology for disease modeling, drug screening, and the development of stem cell therapeutics.	[Rao, Mahendra] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA; [Gottesfeld, Joel M.] Scripps Res Inst, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; Scripps Research Institute	Gottesfeld, JM (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	joelg@scripps.edu		Gottesfeld, Joel/0000-0002-4643-5777				Engle SJ, 2014, J BIOL CHEM, V289, P4562, DOI 10.1074/jbc.R113.529156; Harding J, 2014, J BIOL CHEM, V289, P4585, DOI 10.1074/jbc.R113.463737; Kolaja K, 2014, J BIOL CHEM, V289, P4555, DOI 10.1074/jbc.R113.481028; Li M., 2014, J BIOL CHEM, V289; Peterson SE, 2014, J BIOL CHEM, V289, P4578, DOI 10.1074/jbc.R113.516419; Scheiner ZS, 2014, J BIOL CHEM, V289, P4571, DOI 10.1074/jbc.R113.509588	6	6	7	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4553	4554		10.1074/jbc.R113.543652	http://dx.doi.org/10.1074/jbc.R113.543652			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24362035	Green Published, hybrid			2022-12-28	WOS:000331607900002
J	Zamiri, B; Reddy, K; Macgregor, RB; Pearson, CE				Zamiri, Bita; Reddy, Kaalak; Macgregor, Robert B., Jr.; Pearson, Christopher E.			TMPyP4 Porphyrin Distorts RNA G- quadruplex Structures of the Disease- associated r( GGGGCC) n Repeat of the C9orf72 Gene and Blocks Interaction of RNAbinding Proteins*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyotrophic Lateral Sclerosis (Lou Gehrig Disease); RNA; RNA-binding Protein; RNA Structure; RNA-Protein Interaction; ASF; SF2; C9orf72; G-quadruplex; TMPyP4; hnRNPA1	MENTAL-RETARDATION PROTEIN; FRAGILE-X; HEXANUCLEOTIDE REPEAT; MESSENGER-RNA; ANTISENSE TRANSCRIPTS; TRANSLATION; FOCI; FORM; DNA; EXPANSION	Background: Amyotrophic lateral sclerosis and frontotemporal dementia are caused by expansion of the C9orf72 (GGGGCC)n repeat, whose RNA can form G-quadruplexes. Results: r(GGGGCC)n G-quadruplex distortion by TMPyP4 ablates interaction of the hnRNPA1 and ASF/SF2 proteins. Conclusion: G-quadruplexes can be modulated by TMPyP4, which can ablate protein interactions. Significance: Disruption of secondary structures in the C9orf72 RNA repeats may be a potential therapeutic avenue. Certain DNA and RNA sequences can form G-quadruplexes, which can affect genetic instability, promoter activity, RNA splicing, RNA stability, and neurite mRNA localization. Amyotrophic lateral sclerosis and frontotemporal dementia can be caused by expansion of a (GGGGCC)n repeat in the C9orf72 gene. Mutant r(GGGGCC)n- and r(GGCCCC)n-containing transcripts aggregate in nuclear foci, possibly sequestering repeat-binding proteins such as ASF/SF2 and hnRNPA1, suggesting a toxic RNA pathogenesis, as occurs in myotonic dystrophy. Furthermore, the C9orf72 repeat RNA was recently demonstrated to undergo the noncanonical repeat-associated non-AUG translation (RAN translation) into pathologic dipeptide repeats in patient brains, a process that is thought to depend upon RNA structure. We previously demonstrated that the r(GGGGCC)n RNA forms repeat tract length-dependent G-quadruplex structures that bind the ASF/SF2 protein. Here we show that the cationic porphyrin (5,10,15,20-tetra(N-methyl-4-pyridyl) porphyrin (TMPyP4)), which can bind some G-quadruplex-forming sequences, can bind and distort the G-quadruplex formed by r(GGGGCC)8, and this ablates the interaction of either hnRNPA1 or ASF/SF2 with the repeat. These findings provide proof of concept that nucleic acid binding small molecules, such as TMPyP4, can distort the secondary structure of the C9orf72 repeat, which may beneficially disrupt protein interactions, which may ablate either protein sequestration and/or RAN translation into potentially toxic dipeptides. Disruption of secondary structure formation of the C9orf72 RNA repeats may be a viable therapeutic avenue, as well as a means to test the role of RNA structure upon RAN translation.	[Zamiri, Bita; Macgregor, Robert B., Jr.] Univ Toronto, Leslie Dan Fac Pharm, Grad Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada; [Reddy, Kaalak; Pearson, Christopher E.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Reddy, Kaalak; Pearson, Christopher E.] Univ Toronto, Program Mol Genet, Toronto, ON M5S 1A1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Pearson, CE (corresponding author), Hosp Sick Children, Program Genet & Genome Biol, 101 Coll St East Tower,15-312 TMDT, Toronto, ON M5G 1L7, Canada.	cepearson.sickkids@gmail.com		Pearson, Christopher/0000-0001-9545-4205	Amyotrophic Lateral Sclerosis Association of America; Canadian Institutes of Health Research (CIHR); Natural Science and Engineering Research Council of Canada	Amyotrophic Lateral Sclerosis Association of America; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Amyotrophic Lateral Sclerosis Association of America (to C. E. P.), the Canadian Institutes of Health Research (CIHR) (to C. E. P.), and the Natural Science and Engineering Research Council of Canada (to R. B. M.).	Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; CANTOR CR, 1970, BIOPOLYMERS, V9, P1059, DOI 10.1002/bip.1970.360090909; Darnell JC, 2004, MENT RETARD DEV D R, V10, P49, DOI 10.1002/mrdd.20008; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Duchler M, 2012, J DRUG TARGET, V20, P389, DOI 10.3109/1061186X.2012.669384; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Gomez-Tortosa E, 2013, NEUROLOGY, V80, P366, DOI 10.1212/WNL.0b013e31827f08ea; Keating LR, 2004, BIOCHEMISTRY-US, V43, P15891, DOI 10.1021/bi0483209; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Martino L, 2009, J PHYS CHEM B, V113, P14779, DOI 10.1021/jp9066394; Melko M, 2010, BIOCHIMIE, V92, P919, DOI 10.1016/j.biochi.2010.05.018; MIURA T, 1995, J MOL BIOL, V248, P233, DOI 10.1006/jmbi.1995.0217; Mori K, 2013, ACTA NEUROPATHOL, V126, P881, DOI 10.1007/s00401-013-1189-3; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Morris MJ, 2012, NUCLEIC ACIDS RES, V40, P4137, DOI 10.1093/nar/gkr1308; Nakagama H, 2006, MUTAT RES-FUND MOL M, V598, P120, DOI 10.1016/j.mrfmmm.2006.01.014; Ofer N, 2009, NUCLEIC ACIDS RES, V37, P2712, DOI 10.1093/nar/gkp130; Oostra BA, 2009, BBA-GEN SUBJECTS, V1790, P467, DOI 10.1016/j.bbagen.2009.02.007; Pearson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002018; Phan AT, 2006, CURR OPIN STRUC BIOL, V16, P288, DOI 10.1016/j.sbi.2006.05.011; Reddy K, 2013, NEURON, V78, P405, DOI 10.1016/j.neuron.2013.04.034; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; Shin J, 2009, NEUROSCI LETT, V466, P99, DOI 10.1016/j.neulet.2009.07.079; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Wei CY, 2009, BIOPHYS CHEM, V143, P79, DOI 10.1016/j.bpc.2009.04.005; Weisman-Shomer P, 2003, NUCLEIC ACIDS RES, V31, P3963, DOI 10.1093/nar/gkg453; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Xu Y, 2013, CHEMBIOCHEM, V14, P927, DOI 10.1002/cbic.201300157; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	51	145	148	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4653	4659		10.1074/jbc.C113.502336	http://dx.doi.org/10.1074/jbc.C113.502336			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24371143	Green Published, hybrid			2022-12-28	WOS:000331607900013
J	Sydor, AM; Lebrette, H; Ariyakumaran, R; Cavazza, C; Zamble, DB				Sydor, Andrew M.; Lebrette, Hugo; Ariyakumaran, Rishikesh; Cavazza, Christine; Zamble, Deborah B.			Relationship between Ni(II) and Zn(II) Coordination and Nucleotide Binding by the Helicobacter pylori [NiFe]-Hydrogenase and Urease Maturation Factor HypB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hydrogenase; Metal Homeostasis; Metalloproteins; Nickel; Protein-Metal Ion Interaction; Metalloezyme Biosynthesis	METAL-BINDING; ACCESSORY PROTEINS; BRADYRHIZOBIUM-JAPONICUM; GTPASE ACTIVITY; HYDROGENASE; CHAPERONE; SEQUENCE; ZINC; UREG; PH	The pathogen Helicobacter pylori requires two nickel-containing enzymes, urease and [NiFe]-hydrogenase, for efficient colonization of the human gastric mucosa. These enzymes possess complex metallocenters that are assembled by teams of proteins in multistep pathways. One essential accessory protein is the GTPase HypB, which is required for Ni(II) delivery to [NiFe]-hydrogenase and participates in urease maturation. Ni(II) or Zn(II) binding to a site embedded in the GTPase domain of HypB modulates the enzymatic activity, suggesting a mechanism of regulation. In this study, biochemical and structural analyses of H. pylori HypB (HpHypB) revealed an intricate link between nucleotide and metal binding. HpHypB nickel coordination, stoichiometry, and affinity were modulated by GTP and GDP, an effect not observed for zinc, and biochemical evidence suggests that His-107 coordination to nickel toggles on and off in a nucleotide-dependent manner. These results are consistent with the crystal structure of HpHypB loaded with Ni(II), GDP, and P-i, which reveals a nickel site distinct from that of zinc-loaded Methanocaldococcus jannaschii HypB as well as subtle changes to the protein structure. Furthermore, Cys-142, a metal ligand from the Switch II GTPase motif, was identified as a key component of the signal transduction between metal binding and the enzymatic activity. Finally, potassium accelerated the enzymatic activity of HpHypB but had no effect on the other biochemical properties of the protein. Altogether, this molecular level information about HpHypB provides insight into its cellular function and illuminates a possible mechanism of metal ion discrimination.	[Sydor, Andrew M.; Ariyakumaran, Rishikesh; Zamble, Deborah B.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Lebrette, Hugo; Cavazza, Christine] Univ Grenoble Alpes, IBS, CEA, DSV,IBS, F-38000 Grenoble, France; [Lebrette, Hugo; Cavazza, Christine] CNRS, IBS, F-38000 Grenoble, France	University of Toronto; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Zamble, DB (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.	dzamble@chem.utoronto.ca	Cavazza, Christine/AAL-5795-2020	Sydor, Andrew/0000-0003-3585-0446; Zamble, Deborah/0000-0002-8976-3375; Lebrette, Hugo/0000-0002-8081-181X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; University Joseph Fourier for Ph.D	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University Joseph Fourier for Ph.D	This work was supported by funding from the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, Commissariat a l'Energie Atomique for institutional support, and University Joseph Fourier for Ph.D. funding (to H. L.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anand B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009944; Ash MR, 2010, J BIOL CHEM, V285, P14594, DOI 10.1074/jbc.M110.111914; Atanassova A, 2005, J BACTERIOL, V187, P4689, DOI 10.1128/JB.187.14.4689-4697.2005; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Blaby-Haas CE, 2012, METALLOMICS, V4, P488, DOI 10.1039/c2mt20012k; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Chan Chung K. C., 2011, J BIOL CHEM, V286, P43081, DOI DOI 10.1074/JBC.M111.290726; Chan K.-H., 2012, PLOS ONE, V7; Chung KCC, 2011, FEBS LETT, V585, P291, DOI 10.1016/j.febslet.2010.12.024; Dias AV, 2008, BIOCHEMISTRY-US, V47, P11981, DOI 10.1021/bi801337x; Douglas CD, 2013, BIOCHEMISTRY-US, V52, P6030, DOI 10.1021/bi400812r; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; EATON KA, 1994, INFECT IMMUN, V62, P3604, DOI 10.1128/IAI.62.9.3604-3607.1994; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fong YH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001678; FU CL, 1995, P NATL ACAD SCI USA, V92, P2333, DOI 10.1073/pnas.92.6.2333; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Hauryliuk V, 2008, BIOPHYS J, V95, P1704, DOI 10.1529/biophysj.107.127290; Herbst RW, 2010, J AM CHEM SOC, V132, P10338, DOI 10.1021/ja1005724; Herrera V, 2009, CLIN MICROBIOL INFEC, V15, P971, DOI 10.1111/j.1469-0691.2009.03031.x; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaluarachchi H, 2011, BIOCHEMISTRY-US, V50, P10761, DOI 10.1021/bi201590d; Kaluarachchi H, 2010, NAT PROD REP, V27, P681, DOI 10.1039/b906688h; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Leach MR, 2007, CURR OPIN CHEM BIOL, V11, P159, DOI 10.1016/j.cbpa.2007.01.011; Leach MR, 2005, BIOCHEMISTRY-US, V44, P12229, DOI 10.1021/bi050993j; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Li YJ, 2009, CHEM REV, V109, P4617, DOI 10.1021/cr900010n; Maier RJ, 1996, FEMS MICROBIOL LETT, V141, P71; Maier RJ, 2007, BIOMETALS, V20, P655, DOI 10.1007/s10534-006-9061-8; MAIER T, 1993, J BACTERIOL, V175, P630, DOI 10.1128/JB.175.3.630-635.1993; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehta N, 2003, J BACTERIOL, V185, P726, DOI 10.1128/JB.185.3.726-734.2003; Mehta N, 2003, MICROB PATHOGENESIS, V35, P229, DOI 10.1016/S0882-4010(03)00151-7; Mendieta J, 2009, J MOL BIOL, V390, P17, DOI 10.1016/j.jmb.2009.05.018; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Mobley HLT, 2001, HELICOBACTER PYLORI: MOLECULAR AND CELLULAR BIOLOGY, P155; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; Olson JW, 2001, MOL MICROBIOL, V39, P176, DOI 10.1046/j.1365-2958.2001.02244.x; Olson JW, 2000, J BACTERIOL, V182, P1702, DOI 10.1128/JB.182.6.1702-1705.2000; Sadek F.S., 1959, TALANTA, V2, P38, DOI [10.1016/0039-9140(59)80028-X, DOI 10.1016/0039-9140(59)80028-X]; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Scott DR, 1998, GASTROENTEROLOGY, V114, P58, DOI 10.1016/S0016-5085(98)70633-X; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107; SIMONS TJB, 1993, J BIOCHEM BIOPH METH, V27, P25, DOI 10.1016/0165-022X(93)90065-V; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stingl K, 2007, EMBO J, V26, P232, DOI 10.1038/sj.emboj.7601471; Sydor AM, 2013, METAL IONS LIFE SCI, V12, P375, DOI 10.1007/978-94-007-5561-1_11; Sydor AM, 2013, BIOCHEMISTRY-US, V52, P1788, DOI 10.1021/bi301600z; Sydor AM, 2011, J BACTERIOL, V193, P1359, DOI 10.1128/JB.01333-10; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Tougu V, 2008, J NEUROCHEM, V104, P1249, DOI 10.1111/j.1471-4159.2007.05061.x; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Xia W, 2012, J BIOL CHEM, V287, P6753, DOI 10.1074/jbc.M111.287581; Yamanaka K, 2000, J BACTERIOL, V182, P7078, DOI 10.1128/JB.182.24.7078-7082.2000; Zambelli B, 2005, J BIOL CHEM, V280, P4684, DOI 10.1074/jbc.M408483200; Zambelli B, 2009, PROTEINS, V74, P222, DOI 10.1002/prot.22205	68	45	46	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3828	3841		10.1074/jbc.M113.502781	http://dx.doi.org/10.1074/jbc.M113.502781			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24338018	Green Published, hybrid			2022-12-28	WOS:000331403800001
J	Fujiwara, T; Saburi, W; Matsui, H; Mori, H; Yao, M				Fujiwara, Takaaki; Saburi, Wataru; Matsui, Hirokazu; Mori, Haruhide; Yao, Min			Structural Insights into the Epimerization of beta-1,4-Linked Oligosaccharides Catalyzed by Cellobiose 2-Epimerase, the Sole Enzyme Epimerizing Non-anomeric Hydroxyl Groups of Unmodified Sugars	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Carbohydrate-binding Protein; Crystal Structure; Enzyme Mechanisms; Glycobiology; AGE Superfamily; Cellobiitol; Cellobiose 2-Epimerase; Epimerization	CRYSTAL-STRUCTURE; RUMINOCOCCUS-ALBUS; X-RAY; MECHANISM; COMPLEX; THERMOSTABILITY; ABSORPTION; EPILACTOSE; BACTERIUM; ISOMERASE	Background: The details of the catalytic mechanism of cellobiose 2-epimerase (CE) remains unclear. Results: The crystal structures of Rhodothermus marinus CE in the apo form and complexes with its substrates/products 4-O--d-glucopyranosyl-d-mannnose, epilactose, or cellobiitol (reaction intermediate analog) were elucidated. Conclusion: Epimerization catalyzed by CE proceeds through ring opening, deprotonation/reprotonation, carbon-carbon bond rotation, and ring closure. Significance: This study yielded structural insights into epimerization catalyzed by CE. Cellobiose 2-epimerase (CE) reversibly converts d-glucose residues into d-mannose residues at the reducing end of unmodified 1,4-linked oligosaccharides, including -1,4-mannobiose, cellobiose, and lactose. CE is responsible for conversion of 1,4-mannobiose to 4-O--d-mannosyl-d-glucose in mannan metabolism. However, the detailed catalytic mechanism of CE is unclear due to the lack of structural data in complex with ligands. We determined the crystal structures of halothermophile Rhodothermus marinus CE (RmCE) in complex with substrates/products or intermediate analogs, and its apo form. The structures in complex with the substrates/products indicated that the residues in the 5-6 loop as well as those in the inner six helices form the catalytic site. Trp-322 and Trp-385 interact with reducing and non-reducing end parts of these ligands, respectively, by stacking interactions. The architecture of the catalytic site also provided insights into the mechanism of reversible epimerization. His-259 abstracts the H2 proton of the d-mannose residue at the reducing end, and consistently forms the cis-enediol intermediate by facilitated depolarization of the 2-OH group mediated by hydrogen bonding interaction with His-200. His-390 subsequently donates the proton to the C2 atom of the intermediate to form a d-glucose residue. The reverse reaction is mediated by these three histidines with the inverse roles of acid/base catalysts. The conformation of cellobiitol demonstrated that the deprotonation/reprotonation step is coupled with rotation of the C2-C3 bond of the open form of the ligand. Moreover, it is postulated that His-390 is closely related to ring opening/closure by transferring a proton between the O5 and O1 atoms of the ligand.	[Fujiwara, Takaaki; Yao, Min] Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Saburi, Wataru; Matsui, Hirokazu; Mori, Haruhide] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University	Yao, M (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido 0600810, Japan.	yao@castor.sci.hokudai.ac.jp	Saburi, Wataru/A-4271-2012; Mori, Haruhide/AAV-6374-2021; yao, min/F-5287-2011	Saburi, Wataru/0000-0002-2015-7086; Mori, Haruhide/0000-0001-7346-9131; yao, min/0000-0003-1687-5904	Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [26660081] Funding Source: KAKEN	Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMEIN M, 1969, BIOCHEM BIOPH RES CO, V36, P223, DOI 10.1016/0006-291X(69)90318-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujiwara T, 2013, FEBS LETT, V587, P840, DOI 10.1016/j.febslet.2013.02.007; Ito S, 2008, APPL MICROBIOL BIOT, V79, P433, DOI 10.1007/s00253-008-1449-7; Ito S, 2009, BIOTECHNOL LETT, V31, P1065, DOI 10.1007/s10529-009-9979-3; Itoh T, 2000, J MOL BIOL, V303, P733, DOI 10.1006/jmbi.2000.4188; Itoh T, 2008, J MOL BIOL, V377, P1443, DOI 10.1016/j.jmb.2008.01.090; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kawahara R, 2012, J BIOL CHEM, V287, P42389, DOI 10.1074/jbc.M112.390336; KELLIS JT, 1988, NATURE, V333, P784, DOI 10.1038/333784a0; Kovalevsky AY, 2010, STRUCTURE, V18, P688, DOI 10.1016/j.str.2010.03.011; Lee YC, 2007, J MOL BIOL, V367, P895, DOI 10.1016/j.jmb.2006.11.001; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Mozzarelli A, 1996, ANNU REV BIOPH BIOM, V25, P343; Nishimukai M, 2008, J AGR FOOD CHEM, V56, P10340, DOI 10.1021/jf801556m; Ojima T, 2013, BIOSCI BIOTECH BIOCH, V77, P189, DOI 10.1271/bbb.120742; Ojima T, 2011, BIOSCI BIOTECH BIOCH, V75, P2162, DOI 10.1271/bbb.110456; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pack SP, 2004, J BIOTECHNOL, V111, P269, DOI 10.1016/j.jbiotec.2004.01.018; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Solomons JTG, 2004, J MOL BIOL, V342, P847, DOI 10.1016/j.jmb.2004.07.085; Suzuki T, 2010, J AGR FOOD CHEM, V58, P1927, DOI 10.1021/jf9035063; Takano K, 2009, J BIOCHEM, V145, P79, DOI 10.1093/jb/mvn144; Thoden JB, 2003, PROTEIN SCI, V12, P1051, DOI 10.1110/ps.0243203; TYLER TR, 1967, ARCH BIOCHEM BIOPHYS, V119, P363, DOI 10.1016/0003-9861(67)90466-3; Watanabe J, 2008, J DAIRY SCI, V91, P4518, DOI 10.3168/jds.2008-1367; Yamane J, 2010, J APPL CRYSTALLOGR, V43, P1329, DOI 10.1107/S0021889810037222; Yoshida H, 2013, FEBS OPEN BIO, V3, P35, DOI 10.1016/j.fob.2012.11.008	31	34	38	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3405	3415		10.1074/jbc.M113.531251	http://dx.doi.org/10.1074/jbc.M113.531251			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24362032	Green Published, hybrid			2022-12-28	WOS:000331368700026
J	Joshi, A; Lee, RTC; Mohl, J; Sedano, M; Khong, WX; Ng, OT; Maurer-Stroh, S; Garg, H				Joshi, Anjali; Lee, Raphael T. C.; Mohl, Jonathan; Sedano, Melina; Khong, Wei Xin; Ng, Oon Tek; Maurer-Stroh, Sebastian; Garg, Himanshu			Genetic Signatures of HIV-1 Envelope-mediated Bystander Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AIDS; Apoptosis; Genetics; HIV; Infectious Diseases; Retrovirus; Virology	IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD MONONUCLEAR-CELLS; T-CELLS; CORECEPTOR USAGE; ANTIBODY NEUTRALIZATION; INFECTED INDIVIDUALS; GLYCOSYLATION SITES; MACROPHAGE TROPISM; ENV CLONES; SUBTYPE	Background: Determinants of HIV-1 Env-mediated apoptosis remain poorly understood. Results: We studied the bystander apoptosis-inducing activity of a panel of primary HIV Envs. Conclusion: Residues Arg-476 and Asn-425 are associated with differences in HIV-1 Env-mediated bystander apoptosis induction. Significance: We identified specific genetic signatures within the HIV-1 Env that are associated with the bystander apoptosis-inducing phenotype. The envelope (Env) glycoprotein of HIV is an important determinant of viral pathogenesis. Several lines of evidence support the role of HIV-1 Env in inducing bystander apoptosis that may be a contributing factor in CD4(+) T cell loss. However, most of the studies testing this phenomenon have been conducted with laboratory-adapted HIV-1 isolates. This raises the question of whether primary Envs derived from HIV-infected patients are capable of inducing bystander apoptosis and whether specific Env signatures are associated with this phenomenon. We developed a high throughput assay to determine the bystander apoptosis inducing activity of a panel of primary Envs. We tested 38 different Envs for bystander apoptosis, virion infectivity, neutralizing antibody sensitivity, and putative N-linked glycosylation sites along with a comprehensive sequence analysis to determine if specific sequence signatures within the viral Env are associated with bystander apoptosis. Our studies show that primary Envs vary considerably in their bystander apoptosis-inducing potential, a phenomenon that correlates inversely with putative N-linked glycosylation sites and positively with virion infectivity. By use of a novel phylogenetic analysis that avoids subtype bias coupled with structural considerations, we found specific residues like Arg-476 and Asn-425 that were associated with differences in bystander apoptosis induction. A specific role of these residues was also confirmed experimentally. These data demonstrate for the first time the potential of primary R5 Envs to mediate bystander apoptosis in CD4(+) T cells. Furthermore, we identify specific genetic signatures within the Env that may be associated with the bystander apoptosis-inducing phenotype.	[Joshi, Anjali; Mohl, Jonathan; Sedano, Melina; Garg, Himanshu] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Ctr Excellence Infect Dis, El Paso, TX 79905 USA; [Lee, Raphael T. C.; Maurer-Stroh, Sebastian] Agcy Sci Technol & Res, Bioinformat Inst, Singapore 138671, Singapore; [Lee, Raphael T. C.; Khong, Wei Xin; Ng, Oon Tek] Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore; [Maurer-Stroh, Sebastian] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Texas Tech University System; Texas Tech University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Garg, H (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, 5001 El Paso Dr, El Paso, TX 79905 USA.	himanshu.garg@ttuhsc.edu	Maurer-Stroh, Sebastian/Q-9476-2019; Mohl, Jonathon/ABA-7868-2021; Lee, Raphael Tze Chuen/GYU-4585-2022	Maurer-Stroh, Sebastian/0000-0003-0813-9640; Lee, Raphael Tze Chuen/0000-0001-5634-9154; Mohl, Jonathon/0000-0003-4440-4608				Ahr Barbara, 2004, Retrovirology, V1, P12, DOI 10.1186/1742-4690-1-12; Biard-Piechaczyk M, 2000, VIROLOGY, V268, P329, DOI 10.1006/viro.1999.0151; Bjorndal A, 1999, AIDS RES HUM RETROV, V15, P647, DOI 10.1089/088922299310944; Blanco J, 2003, VIROLOGY, V305, P318, DOI 10.1006/viro.2002.1764; Borggren M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020135; Bunnik EM, 2010, VIROLOGY, V397, P224, DOI 10.1016/j.virol.2009.11.009; Castedo M, 2003, ANN NY ACAD SCI, V1010, P19, DOI 10.1196/annals.1299.004; Cayabyab M, 1999, J VIROL, V73, P976, DOI 10.1128/JVI.73.2.976-984.1999; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; de Mendoza C, 2008, JAIDS-J ACQ IMM DEF, V48, P241, DOI 10.1097/QAI.0b013e3181734f0e; Denizot M, 2008, AUTOPHAGY, V4, P998, DOI 10.4161/auto.6880; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Douek Daniel, 2007, Top HIV Med, V15, P114; Edo-Matas D, 2012, VIROLOGY, V422, P70, DOI 10.1016/j.virol.2011.10.005; Edo-Matas D, 2011, VIROLOGY, V412, P269, DOI 10.1016/j.virol.2011.01.010; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; Espert L, 2007, AUTOPHAGY, V3, P32, DOI 10.4161/auto.3275; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Etemad-Moghadam B, 2000, J VIROL, V74, P4433, DOI 10.1128/JVI.74.9.4433-4440.2000; Etemad-Moghadam B, 2001, J VIROL, V75, P5646, DOI 10.1128/JVI.75.12.5646-5655.2001; FINKEL TH, 1994, CURR OPIN IMMUNOL, V6, P605, DOI 10.1016/0952-7915(94)90149-X; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Gandhi RT, 1998, J EXP MED, V187, P1113, DOI 10.1084/jem.187.7.1113; Garg H, 2008, CELL MOL LIFE SCI, V65, P3134, DOI 10.1007/s00018-008-8147-6; Garg H, 2007, J BIOL CHEM, V282, P16899, DOI 10.1074/jbc.M701701200; Garg H, 2012, VIRUSES-BASEL, V4, P3020, DOI 10.3390/v4113020; Garg H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-34; Garg H, 2009, AIDS RES HUM RETROV, V25, P811, DOI 10.1089/aid.2009.0010; Garg H, 2006, J LEUKOCYTE BIOL, V79, P351, DOI 10.1189/jlb.0805430; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Gordon SN, 2008, J VIROL, V82, P3725, DOI 10.1128/JVI.02408-07; GOUGEON ML, 1993, AIDS RES HUM RETROV, V9, P287, DOI 10.1089/aid.1993.9.287; GOUGEON ML, 1993, SCIENCE, V260, P1269, DOI 10.1126/science.8098552; Gray L, 2005, VIROLOGY, V337, P384, DOI 10.1016/j.virol.2005.04.034; Gray L, 2009, J VIROL, V83, P5430, DOI 10.1128/JVI.02648-08; HAHN BH, 1985, P NATL ACAD SCI USA, V82, P4813, DOI 10.1073/pnas.82.14.4813; Holm GH, 2004, J VIROL, V78, P4541, DOI 10.1128/JVI.78.9.4541-4551.2004; Holman AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049538; Holman AG, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-43; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Hunt PW, 2013, BLOOD, V121, P4635, DOI 10.1182/blood-2012-06-436345; Jansson M, 1999, J HUMAN VIROL, V2, P325; Joshi A, 2011, J BIOL CHEM, V286, P36404, DOI 10.1074/jbc.M111.281659; KANESHIMA H, 1994, J VIROL, V68, P8188, DOI 10.1128/JVI.68.12.8188-8192.1994; Karlsson GB, 1998, J EXP MED, V188, P1159, DOI 10.1084/jem.188.6.1159; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Koot M, 1996, J INFECT DIS, V173, P349, DOI 10.1093/infdis/173.2.349; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kulkarni SS, 2009, VIROLOGY, V385, P505, DOI 10.1016/j.virol.2008.12.032; Labonte JA, 2000, J VIROL, V74, P10690, DOI 10.1128/JVI.74.22.10690-10698.2000; LAURENTCRAWFORD AG, 1995, RES VIROLOGY, V146, P5, DOI 10.1016/0923-2516(96)80585-1; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li S, 1999, J VIROL, V73, P9741, DOI 10.1128/JVI.73.12.9741-9755.1999; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Meissner EG, 2005, VIROLOGY, V336, P184, DOI 10.1016/j.virol.2005.03.032; Meissner EG, 2004, VIROLOGY, V328, P74, DOI 10.1016/j.virol.2004.07.019; Meissner EG, 2006, J VIROL, V80, P11019, DOI 10.1128/JVI.01382-06; Meythaler M, 2008, J MED PRIMATOL, V37, P33, DOI 10.1111/j.1600-0684.2008.00323.x; Meythaler M, 2009, J VIROL, V83, P572, DOI 10.1128/JVI.01715-08; Mosier D. E., 2005, Current Drug Targets - Infectious Disorders, V5, P171, DOI 10.2174/1568005054201553; Navis M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002422; Olivieri K, 2007, VIROLOGY, V358, P23, DOI 10.1016/j.virol.2006.08.027; OYAIZU N, 1995, ADV EXP MED BIOL, V374, P101; OYAIZU N, 1993, BLOOD, V82, P3392; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Pirovano W, 2006, NUCLEIC ACIDS RES, V34, P6540, DOI 10.1093/nar/gkl901; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Shankarappa R, 1998, VIROLOGY, V241, P251, DOI 10.1006/viro.1997.8996; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Spijkerman I, 1998, J INFECT DIS, V178, P397, DOI 10.1086/515627; Sterjovski J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-89; Sterjovski J, 2011, VIROLOGY, V410, P418, DOI 10.1016/j.virol.2010.12.010; Streeck H, 2010, J INFECT DIS, V202, pS302, DOI 10.1086/655652; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas ER, 2007, VIROLOGY, V360, P105, DOI 10.1016/j.virol.2006.09.036; van Gils MJ, 2011, J VIROL, V85, P8443, DOI 10.1128/JVI.05214-11; van Gils MJ, 2011, J VIROL, V85, P6986, DOI 10.1128/JVI.00268-11; van Rij RP, 2000, J CLIN INVEST, V106, P1569, DOI 10.1172/JCI7953C1; Varbanov M, 2006, AIDS REV, V8, P221; Wade J, 2010, VIROLOGY, V396, P246, DOI 10.1016/j.virol.2009.10.029; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649; Xu SG, 2007, J MICROBIOL, V45, P441	91	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2497	2514		10.1074/jbc.M113.514018	http://dx.doi.org/10.1074/jbc.M113.514018			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24265318	hybrid, Green Published			2022-12-28	WOS:000333403000003
J	Shrive, AK; Moeller, JB; Burns, I; Paterson, JM; Shaw, AJ; Schlosser, A; Sorensen, GL; Greenhough, TJ; Holmskov, U				Shrive, Annette K.; Moeller, Jesper B.; Burns, Ian; Paterson, Jenny M.; Shaw, Amy J.; Schlosser, Anders; Sorensen, Grith L.; Greenhough, Trevor J.; Holmskov, Uffe			Crystal Structure of the Tetrameric Fibrinogen-like Recognition Domain of Fibrinogen C Domain Containing 1 (FIBCD1) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Ligand-binding Protein; Pattern Recognition Receptor; Receptor Structure-Function; Structural Biology; FIBCD1; Acetyl Binding; Chitin Receptor; Fibrinogen-like Domain	MOLECULAR REPLACEMENT; L-FICOLIN; GEOMETRY; LECTIN	Background: FIBCD1 is a tetrameric plasma membrane protein that uses a fibrinogen-like recognition domain (FReD) for pattern recognition of acetyl groups on chitin. Results: The x-ray structure of the FIBCD1 FReD reveals how FIBCD1 binds acetylated and sulfated molecules. Conclusion: FReD domains combine versatility with conservation to recognize their targets. Significance: The structure suggests how FIBCD1 binds acetylated pathogen-associated molecular patterns (PAMPS) and endogenous glycosaminoglycans. The high resolution crystal structures of a recombinant fragment of the C-terminal fibrinogen-like recognition domain of FIBCD1, a vertebrate receptor that binds chitin, have been determined. The overall tetrameric structure shows similarity in structure and aggregation to the horseshoe crab innate immune protein tachylectin 5A. The high affinity ligand N-acetylmannosamine (ManNAc) binds in the S1 site, predominantly via the acetyl group with the oxygen and acetamide nitrogen hydrogen-bonded to the protein and the methyl group inserted into a hydrophobic pocket. The binding of the ManNAc pyranose ring differs markedly between the two independent subunits, but in all structures the binding of the N-acetyl group is conserved. In the native structure, a crystal contact results in one of the independent protomers binding the first GlcNAc of the Asn(340)N-linked glycan on the other independent protomer. In the ligand-bound structure this GlcNAc is replaced by the higher affinity ligand ManNAc. In addition, a sulfate ion has been modeled into the electron density at a location similar to the S3 binding site in L-ficolin, whereas in the native structure an acetate ion has been placed in the S1 N-acetyl binding site, and a sulfate ion has been placed adjacent to this site. These ion binding sites are ideally placed to receive the N-acetyl and sulfate groups of sulfated GalNAc residues of glycosaminoglycans such as chondroitin and dermatan sulfate. Together, these structures give insight into important determinants of ligand selectivity, demonstrating versatility in recognition and binding while maintaining conservation in N-acetyl and calcium binding.	[Shrive, Annette K.; Burns, Ian; Paterson, Jenny M.; Shaw, Amy J.; Greenhough, Trevor J.] Keele Univ, Sch Life Sci, Res Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England; [Moeller, Jesper B.; Schlosser, Anders; Sorensen, Grith L.; Holmskov, Uffe] Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, DK-5000 Odense, Denmark	Keele University; University of Southern Denmark	Shrive, AK (corresponding author), Keele Univ, Sch Life Sci, Res Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England.	a.k.shrive@keele.ac.uk	Holmskov, Uffe/AAA-3056-2022; Moeller, Jesper B/E-6377-2015	Holmskov, Uffe/0000-0002-2391-9445; Moeller, Jesper B/0000-0001-8786-8037; Sorensen, Grith Lykke/0000-0002-5273-1097	Medical Research Council; Central Laboratory of the Research Councils (CLRC) Daresbury Laboratory; Diamond Light Source [Midlands BAG MX310]; Danish Medical Research Council; NOVO Nordic Foundation; Lundbeck Foundation; Fonden til Laegevidenskabens Fremme; Medical Research Council [G0400743] Funding Source: researchfish; MRC [G0400743] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Central Laboratory of the Research Councils (CLRC) Daresbury Laboratory; Diamond Light Source; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NOVO Nordic Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Fonden til Laegevidenskabens Fremme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (to A. K. S., T. J. G., and I. B.), Central Laboratory of the Research Councils (CLRC) Daresbury Laboratory, the Diamond Light Source (Midlands BAG MX310), the Danish Medical Research Council (to U. H.), the NOVO Nordic Foundation (to U. H.), the Lundbeck Foundation (U. H.), and Fonden til Laegevidenskabens Fremme (to U. H.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Garlatti V, 2007, J BIOL CHEM, V282, P35814, DOI 10.1074/jbc.M705741200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Garlatti V, 2010, J INNATE IMMUN, V2, P17, DOI 10.1159/000233475; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Inamori K, 1999, J BIOL CHEM, V274, P3272, DOI 10.1074/jbc.274.6.3272; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kairies N, 2001, P NATL ACAD SCI USA, V98, P13519, DOI 10.1073/pnas.201523798; Kleywegt GJ, 2003, STRUCTURE, V11, P1051, DOI 10.1016/S0969-2126(03)00186-2; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Rossi V, 1998, J BIOL CHEM, V273, P1232, DOI 10.1074/jbc.273.2.1232; Schlosser A, 2009, J IMMUNOL, V183, P3800, DOI 10.4049/jimmunol.0901526; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Shrive AK, 1996, ACTA CRYSTALLOGR D, V52, P1049, DOI 10.1107/S0907444996008311; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Thomsen T, 2010, J BIOL CHEM, V285, P1229, DOI 10.1074/jbc.M109.061523	22	19	19	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2880	2887		10.1074/jbc.M113.520577	http://dx.doi.org/10.1074/jbc.M113.520577			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24293368	Green Published, hybrid			2022-12-28	WOS:000333403000036
J	Huang, L; Huang, QY; Huang, HQ				Huang, Lin; Huang, Qing-Yu; Huang, He-Qing			The Evidence of HeLa Cell Apoptosis Induced with Tetraethylammonium Using Proteomics and Various Analytical Methods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bioinformatics; Flow Cytometry; Pharmacology; Proteomics; Western Blotting; HeLa Cell Line; Patch Clamp Technology; RT-qPCR; Tetraethylammonium	PROTEIN-DISULFIDE ISOMERASE; ENOYL-COA HYDRATASE; POTASSIUM CHANNEL; UP-REGULATION; CANCER-CELLS; K+ CHANNEL; EXPRESSION; SORCIN; CISPLATIN; 4-AMINOPYRIDINE	Tetraethylammonium (TEA) is a potassium channel (KCh) blocker applied in the functional and pharmacological studies of the KChs. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, a colorimetric assay to quantitatively measure living cells, demonstrated that TEA reduced the HeLa cell viability dose-dependently. Flow cytometry analysis indicated an increased apoptosis rate of the HeLa cell after exposing to TEA. The patch clamp technique revealed that the K+ current of the HeLa cell was inhibited up to 80% when exposed to TEA. In addition, quantitative real-time PCR approach set up cross-talk among the cytotoxicity of TEA, 4-aminopyridine, and anti-cancer drug such as cisplatin. Using comparative proteomics combined with MALDI-TOF MS/MS, 33 significantly changed proteins were found from TEA treatment group; among these proteins, 12 were up-regulated, and 21 were down-regulated. Here we indicated that these proteins were closely connected with many biological functions such as oxidative stress response, signal transduction, metabolism, protein synthesis, and degradation. Both Western blotting and quantitative real-time PCR approaches further verified these differential proteins. Ingenuity Pathways Analysis software, a tool to analyze omics data and model biological system, was applied to analyze the interaction pathways of these proteins. The subcellular locations of the differential proteins are also predicted from Uniprot. All results above can help in our understanding of the mechanism of TEA-induced cytotoxicity and provide potential cancer biomarkers. Various experimental results in this study (like those for cisplatin) indicated that TEA is not only a KCh blocker but also a potential anti-cancer drug.	[Huang, Lin; Huang, Qing-Yu; Huang, He-Qing] Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, State Key Lab Cellular Stress Biol, Xiamen 361005, Peoples R China; [Huang, Lin] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA	Xiamen University; Oregon State University	Huang, HQ (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, State Key Lab Cellular Stress Biol, Xiamen 361005, Peoples R China.	hqhuang@xmu.edu.cn	Huang, Qingyu/O-1662-2014	Huang, Qingyu/0000-0002-5076-2084	State Natural Science Fund [30870515]; PCSIRT (Program for Changjiang Scholars and Innovative Research Team in University), China [IRT0941]	State Natural Science Fund(National Natural Science Foundation of China (NSFC)); PCSIRT (Program for Changjiang Scholars and Innovative Research Team in University), China	This work was supported by State Natural Science Fund 30870515 and by PCSIRT (Program for Changjiang Scholars and Innovative Research Team in University) Project IRT0941, China.	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Agnihotri G, 2003, BIOORGAN MED CHEM, V11, P9, DOI 10.1016/S0968-0896(02)00333-4; BARDWELL JCA, 1994, MOL MICROBIOL, V14, P199, DOI 10.1111/j.1365-2958.1994.tb01281.x; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capozzi F, 2007, J PROTEOME RES, V6, P4245, DOI 10.1021/pr070314m; Chavez JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019892; Checinska A, 2009, J PROTEOMICS, V72, P575, DOI 10.1016/j.jprot.2008.11.016; Chen DS, 2009, AQUAT TOXICOL, V94, P163, DOI 10.1016/j.aquatox.2009.06.014; CHEN L, 2011, PLOS ONE, V6; Chin LS, 1997, J NEUROSCI RES, V48, P122, DOI 10.1002/(SICI)1097-4547(19970415)48:2<122::AID-JNR4>3.0.CO;2-E; Cho YE, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010884; Cui JW, 2005, MOL CELL PROTEOMICS, V4, P1718, DOI 10.1074/mcp.M400165-MCP200; Dilly S, 2013, BIOCHEM PHARMACOL, V85, P560, DOI 10.1016/j.bcp.2012.12.015; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Fanarraga Monica Lopez, 2010, Commun Integr Biol, V3, P306; Fowler MR, 2009, PFLUG ARCH EUR J PHY, V457, P1049, DOI 10.1007/s00424-008-0575-5; Guidoni L, 2002, J RECEPT SIGNAL TR R, V22, P315, DOI 10.1081/RRS-120014604; Han XB, 2007, APOPTOSIS, V12, P1837, DOI 10.1007/s10495-007-0101-9; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Huang QY, 2011, PROTEOMICS, V11, P3743, DOI 10.1002/pmic.201100084; Huang QY, 2011, COMP BIOCHEM PHYS C, V153, P67, DOI 10.1016/j.cbpc.2010.08.009; Ji XT, 2012, J PROTEOMICS, V75, P3145, DOI 10.1016/j.jprot.2012.03.013; Kawakami M, 2007, BIOL PHARM BULL, V30, P1065, DOI 10.1248/bpb.30.1065; Kim JA, 2000, PHARMACOLOGY, V60, P74, DOI 10.1159/000028350; Ko HS, 2002, J BIOL CHEM, V277, P35386, DOI 10.1074/jbc.M203412200; Leanza L, 2012, EMBO MOL MED, V4, P577, DOI 10.1002/emmm.201200235; Lee GW, 2012, ACTA PHYSIOL, V204, P513, DOI 10.1111/j.1748-1716.2011.02359.x; Lei YL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005397; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Liu XA, 2010, FEBS LETT, V584, P3185, DOI 10.1016/j.febslet.2010.06.002; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Luo LZ, 2012, J PROTEOMICS, V77, P237, DOI 10.1016/j.jprot.2012.08.023; Matsumoto T, 2005, BASIC RES CARDIOL, V100, P250, DOI 10.1007/s00395-005-0518-7; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nonn L, 2003, MOL CANCER RES, V1, P682; Park KS, 2008, PHYSIOLOGY, V23, P49, DOI 10.1152/physiol.00031.2007; Patel SK, 2013, J CELL MOL MED, V17, P134, DOI 10.1111/j.1582-4934.2012.01656.x; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Qi J, 2006, BIOCHEM BIOPH RES CO, V349, P303, DOI 10.1016/j.bbrc.2006.08.042; Salerno DM, 2012, J CELL PHYSIOL, V227, P3613, DOI 10.1002/jcp.24067; Saraste A, 1997, CIRCULATION, V95, P320; Satou M, 2010, ENDOCRINOLOGY, V151, P4765, DOI 10.1210/en.2010-0412; Shen QJ, 2009, J NEUROSCI RES, V87, P3153, DOI 10.1002/jnr.22136; Song IS, 2011, INT J MOL SCI, V12, P7163, DOI 10.3390/ijms12107163; Sun H, 2008, TOXICOL APPL PHARM, V232, P25, DOI 10.1016/j.taap.2008.05.024; Tan QL, 2012, J GEN PHYSIOL, V139, P295, DOI 10.1085/jgp.201110725; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Thevenin AF, 2011, BIOCHEMISTRY-US, V50, P8417, DOI 10.1021/bi200802w; Valencia-Cruz G, 2009, AM J PHYSIOL-CELL PH, V297, pC1544, DOI 10.1152/ajpcell.00064.2009; Wallace JL, 2011, J MEMBRANE BIOL, V242, P53, DOI 10.1007/s00232-011-9376-4; Wang G, 2008, BIOCHEM BIOPH RES CO, V374, P204, DOI 10.1016/j.bbrc.2008.07.003; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wible BA, 2002, J BIOL CHEM, V277, P17852, DOI 10.1074/jbc.M201689200; Xu Y, 2010, MICROBES INFECT, V12, P683, DOI 10.1016/j.micinf.2010.04.002; Yang KB, 2009, CHEMOTHERAPY, V55, P372, DOI 10.1159/000235730; Zeng HZ, 2011, INT J MOL SCI, V12, P3489, DOI 10.3390/ijms12063489; Zhan QM, 2005, MUTAT RES-FUND MOL M, V569, P133, DOI 10.1016/j.mrfmmm.2004.06.055; Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175; Zhang J, 2011, BIOMED PHARMACOTHER, V65, P157, DOI 10.1016/j.biopha.2011.02.010; Zhang Y, 2008, J BIOL CHEM, V283, P10632, DOI 10.1074/jbc.M800253200	63	7	8	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2217	2229		10.1074/jbc.M113.515932	http://dx.doi.org/10.1074/jbc.M113.515932			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24297172	hybrid, Green Published			2022-12-28	WOS:000331130200029
J	Wang, JL; Park, JW; Drissi, H; Wang, XF; Xu, RH				Wang, Jianle; Park, Jung W.; Drissi, Hicham; Wang, Xiaofang; Xu, Ren-He			Epigenetic Regulation of miR-302 by JMJD1C Inhibits Neural Differentiation of Human Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Embryonic Stem Cell; Epigenetics; Histone Methylation; MicroRNA; Neurodifferentiation	HISTONE METHYLATION; ES CELLS; PLURIPOTENCY; TARGETS; GROWTH; IDENTIFICATION; EXPRESSION; MOUSE	It has been recently reported that the regulatory circuitry formed by OCT4, miR-302, and NR2F2 controls both pluripotency and neural differentiation of human embryonic stem cells (hESCs). We show here that JMJD1C, a histone 3 lysine 9 (H3K9) demethylase expressed in hESCs, directly interacts with this circuitry. hESCs with stable knockdown of JMJD1C remain pluripotent while having reduced miR-302 expression, decreased BMP signaling, and enhanced TGF signaling. JMJD1C binds to the miR-302 promoter and reduces H3K9 methylation. Withdrawal of basic fibroblast growth factor (bFGF) from the culture induces neural differentiation of the knockdown, but not the control, cells within 3 days, accompanied by elevated NR2F2 expression. This can be attenuated with miR-302 mimics or an H3K9 methytransferase inhibitor. Together, our findings suggest that JMJD1C represses neural differentiation of hESCs at least partially by epigenetically sustaining miR-302 expression and that JMJD1C knockdown is sufficient to trigger neural differentiation upon withdrawal of exogenous bFGF.	[Wang, Jianle; Park, Jung W.; Wang, Xiaofang; Xu, Ren-He] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Drissi, Hicham] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Wang, XF (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA.	xiaofangwang@uchc.edu; renhexu@uchc.edu	Xu, Ren-He/M-3125-2016; wang, xiaofang/A-9967-2015; Xu, Ren-He/AAK-7392-2021; Park, Jung Woo/R-6263-2019	wang, xiaofang/0000-0002-2911-0161; Park, Jung Woo/0000-0003-0657-7401; drissi, hicham/0000-0002-3322-281X	Connecticut Stem Cell Research Grants [06SCB14, 09SCD01, 10SCA21, 11SCB08]	Connecticut Stem Cell Research Grants	This work was supported by Connecticut Stem Cell Research Grants 06SCB14 and 09SCD01 (to R. X.), 10SCA21 (to X. W.), and 11SCB08 (to H. D.).	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Barroso-delJesus A, 2011, FASEB J, V25, P1497, DOI 10.1096/fj.10-172221; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Castermans D, 2007, EUR J HUM GENET, V15, P422, DOI 10.1038/sj.ejhg.5201785; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Coskun V, 2012, CURR OPIN NEUROBIOL, V22, P762, DOI 10.1016/j.conb.2012.07.001; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Katoh M, 2006, INT J MOL MED, V17, P795; Katoh M, 2007, INT J ONCOL, V31, P219; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Kim SM, 2010, NUCLEIC ACIDS RES, V38, P6389, DOI 10.1093/nar/gkq491; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Lin G, 2010, METHODS MOL BIOL, V636, P1, DOI 10.1007/978-1-60761-691-7_1; Lipchina I, 2012, CELL CYCLE, V11, P1517, DOI 10.4161/cc.19846; Lipchina I, 2011, GENE DEV, V25, P2173, DOI 10.1101/gad.17221311; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Miyazono K, 2000, J CELL SCI, V113, P1101; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang JL, 2010, BIOL REPROD, V82, P105, DOI 10.1095/biolreprod.109.078055; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Wen S, 2009, PROG NEUROBIOL, V87, P98, DOI 10.1016/j.pneurobio.2008.10.002; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	38	34	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2384	2395		10.1074/jbc.M113.535799	http://dx.doi.org/10.1074/jbc.M113.535799			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24318875	Green Published, hybrid			2022-12-28	WOS:000331130200042
J	Jiang, WR; Cady, G; Hossain, MM; Huang, QQ; Wang, X; Jin, JP				Jiang, Wen-rui; Cady, Geoffrey; Hossain, M. Moazzem; Huang, Qi-Quan; Wang, Xin; Jin, J. -P.			Mechanoregulation of h2-Calponin Gene Expression and the Role of Notch Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Biology; Gene Transcription; Mechanotransduction; Transcription Promoter	VASCULAR SMOOTH-MUSCLE; CELLS IN-VITRO; EXTRACELLULAR-MATRIX; SENSORY TRANSDUCTION; MOLECULAR-CLONING; CULTURED-CELLS; CALPONIN; MYOSIN; ACTIN; CYTOSKELETAL	Background: Mechanical forces regulate gene expression. The mechanisms are not well understood. Results: A HES-1 site in the promoter of h2-calponin gene is a tension-regulated repressor responsive to Notch signaling. Conclusion: Notch regulation plays a role in the mechanoregulation of h2-calponin. Significance: The findings demonstrated a novel mechanism in the mechanoregulation of h2-calponin gene expression. The essential role of mechanical signals in regulating the function of living cells is universally observed. However, how mechanical signals are transduced in cells to regulate gene expression is largely unknown. We previously demonstrated that the gene encoding h2-calponin (Cnn2) is sensitively regulated by mechanical tension. In the present study, mouse genomic DNA containing the Cnn2 promoter was cloned, and a nested set of 5 truncations was studied. Transcriptional activity of the Cnn2 promoter-reporter constructs was examined in transfected NIH/3T3, HEK293, and C2C12 cells for their responses to the stiffness of culture substrate. The results showed significant transcriptional activities of the -1.00- and -1.24-kb promoter constructs, whereas the -0.61-kb construct was inactive. The -1.38-, -1.57-, and -2.12-kb constructs showed higher transcriptional activity, whereas only the -1.57- and -2.12-kb constructs exhibited repression of expression when the host cells were cultured on low stiffness substrate. Internal deletion of the segment between -1.57 and -1.38 kb in the -2.12-kb promoter construct abolished the low substrate stiffness-induced repression. Site-specific deletion or mutation of an HES-1 transcription factor binding site in this region also abolished this repression effect. The level of HES-1 increased in cells cultured under a low tension condition, corresponding to the down-regulation of h2-calponin. h2-Calponin gene expression is further affected by the treatment of cells with Notch inhibitor and activator, suggesting an upstream signaling mechanism.	[Jiang, Wen-rui; Cady, Geoffrey; Hossain, M. Moazzem; Huang, Qi-Quan; Wang, Xin; Jin, J. -P.] Wayne State Univ, Dept Physiol, Sch Med, Detroit, MI 48201 USA	Wayne State University	Jin, JP (corresponding author), Wayne State Univ, Dept Physiol, Sch Med, Detroit, MI 48201 USA.	jjin@med.wayne.edu	Jin, Jian-Ping/AAD-1149-2020	Jin, JP/0000-0001-9932-1063	National Institutes of Health [HL-086720]; China Scholarship Council [2008659010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-086720 ( to J. P. J.).; Recipient of a scholarship from the China Scholarship Council under File 2008659010. Ph.D. candidate at Tangdu Hospital, Fourth Military Medical University, China.	ABE M, 1990, J BIOCHEM-TOKYO, V108, P835, DOI 10.1093/oxfordjournals.jbchem.a123289; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; APPLEGATE D, 1994, J BIOL CHEM, V269, P10683; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen J., 2011, ULTR S, V1, P1; Chow EK, 2006, J EXP MED, V203, P2589, DOI 10.1084/jem.20060929; Corey D, 2003, J CELL SCI, V116, P1, DOI 10.1242/jcs.00101; de Cavanagh EMV, 2009, AM J PHYSIOL-HEART C, V296, pH550, DOI 10.1152/ajpheart.01176.2008; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; HAEBERLE JR, 1994, J BIOL CHEM, V269, P12424; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; HORIUCHI KY, 1991, BIOCHEM BIOPH RES CO, V176, P1487, DOI 10.1016/0006-291X(91)90455-G; Hossain MM, 2006, BIOCHEMISTRY-US, V45, P15670, DOI 10.1021/bi061718f; Hossain MM, 2005, J BIOL CHEM, V280, P42442, DOI 10.1074/jbc.M509952200; Hossain MM, 2003, AM J PHYSIOL-CELL PH, V284, pC156, DOI 10.1152/ajpcell.00233.2002; Huang QQ, 2008, J BIOL CHEM, V283, P25887, DOI 10.1074/jbc.M801163200; Huang QQ, 1999, J MOL EVOL, V49, P780, DOI 10.1007/PL00006600; Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382; Kageyama R, 1997, INT J BIOCHEM CELL B, V29, P1389, DOI 10.1016/S1357-2725(97)89968-2; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kang J, 2011, J THEOR BIOL, V274, P109, DOI 10.1016/j.jtbi.2011.01.011; Kuromitsu J, 1997, MOL CELL BIOL, V17, P707, DOI 10.1128/MCB.17.2.707; Li J, 2008, MOL CELL BIOCHEM, V309, P41, DOI 10.1007/s11010-007-9641-0; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Masuda H, 1996, J BIOCHEM-TOKYO, V120, P415; Mikhailenko SV, 2010, J R SOC INTERFACE, V7, pS295, DOI 10.1098/rsif.2010.0107.focus; Morrow D, 2005, CIRC RES, V96, P567, DOI 10.1161/01.RES.0000159182.98874.43; Morrow D, 2007, AM J PHYSIOL-CELL PH, V292, pC488, DOI 10.1152/ajpcell.00337.2005; NISHIDA W, 1993, GENE, V130, P297, DOI 10.1016/0378-1119(93)90435-6; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rayment I, 1996, STRUCTURE, V4, P501, DOI 10.1016/S0969-2126(96)00055-X; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; SHIRINSKY VP, 1992, J BIOL CHEM, V267, P15886; Shivashankar GV, 2011, ANNU REV BIOPHYS, V40, P361, DOI 10.1146/annurev-biophys-042910-155319; STRASSER P, 1993, FEBS LETT, V330, P13, DOI 10.1016/0014-5793(93)80909-E; TAKAHASHI K, 1986, BIOCHEM BIOPH RES CO, V141, P20, DOI 10.1016/S0006-291X(86)80328-X; TAKAHASHI K, 1991, J BIOL CHEM, V266, P13284; Tang J, 2006, J BIOL CHEM, V281, P6664, DOI 10.1074/jbc.M506991200; Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013; TRABELSITERZIDIS H, 1995, BIOCHEM J, V306, P211, DOI 10.1042/bj3060211; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; WINDER SJ, 1993, BIOCHEM J, V296, P827, DOI 10.1042/bj2960827; WINDER SJ, 1990, J BIOL CHEM, V265, P10148; WINDER SJ, 1991, ADV EXP MED BIOL, V304, P37; Wu KC, 2008, CELL BIOCHEM BIOPHYS, V52, P139, DOI 10.1007/s12013-008-9031-6; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	51	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1617	1628		10.1074/jbc.M113.498147	http://dx.doi.org/10.1074/jbc.M113.498147			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24285540	Green Published, hybrid			2022-12-28	WOS:000332401700035
J	Rauch, JN; Gestwicki, JE				Rauch, Jennifer N.; Gestwicki, Jason E.			Binding of Human Nucleotide Exchange Factors to Heat Shock Protein 70 (Hsp70) Generates Functionally Distinct Complexes in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Isothermal Titration Calorimetry; Molecular Chaperone; Protein Complexes; Protein Folding; Protein Misfolding; Protein-Protein Interactions; Hsp40; Cochaperones	HEAT-SHOCK-PROTEIN; HIGH-THROUGHPUT SCREEN; MOLECULAR CHAPERONES; STRUCTURAL BASIS; NEGATIVE REGULATOR; HSP110 CHAPERONES; HSC70 CHAPERONE; QUALITY-CONTROL; ATP HYDROLYSIS; J-DOMAIN	Background: There has been an expansion of the number of Hsp70 cochaperones in mammals, providing the opportunity for combinatorial assembly of permutations with specialized functions. Results: We studied the chaperone activity of Hsp70 combined with four different NEFs and four J proteins. Conclusion: Some combinations were active, whereas others were inactive. Significance: Cochaperones appear to expand the functional diversity of Hsp70. Proteins with Bcl2-associated anthanogene (BAG) domains act as nucleotide exchange factors (NEFs) for the molecular chaperone heat shock protein 70 (Hsp70). There are six BAG family NEFs in humans, and each is thought to link Hsp70 to a distinct cellular pathway. However, little is known about how the NEFs compete for binding to Hsp70 or how they might differentially shape its biochemical activities. Toward these questions, we measured the binding of human Hsp72 (HSPA1A) to BAG1, BAG2, BAG3, and the unrelated NEF Hsp105. These studies revealed a clear hierarchy of affinities: BAG3 > BAG1 > Hsp105 >> BAG2. All of the NEFs competed for binding to Hsp70, and their relative affinity values predicted their potency in nucleotide and peptide release assays. Finally, we combined the Hsp70-NEF pairs with cochaperones of the J protein family (DnaJA1, DnaJA2, DnaJB1, and DnaJB4) to generate 16 permutations. The activity of the combinations in ATPase and luciferase refolding assays were dependent on the identity and stoichiometry of both the J protein and NEF so that some combinations were potent chaperones, whereas others were inactive. Given the number and diversity of cochaperones in mammals, it is likely that combinatorial assembly could generate a large number of distinct permutations.	[Rauch, Jennifer N.; Gestwicki, Jason E.] Univ Michigan, Dept Biochem, Ann Arbor, MI 48109 USA; [Rauch, Jennifer N.; Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Rauch, Jennifer N.; Gestwicki, Jason E.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Gestwicki, Jason E.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Gestwicki, Jason E.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94158 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gestwicki, JE (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Inst Neurodegenerat Dis, 675 Nelson Rising Ln, San Francisco, CA 94158 USA.	jason.gestwicki@ucsf.edu	Rauch, Jennifer/AGI-2683-2022	Rauch, Jennifer/0000-0001-6853-5915	National Institutes of Health [NS059690]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS059690.	Ahmad A, 2011, P NATL ACAD SCI USA, V108, P18966, DOI 10.1073/pnas.1111220108; Alberti S, 2003, CELL STRESS CHAPERON, V8, P225, DOI 10.1379/1466-1268(2003)008<0225:BNEFOH>2.0.CO;2; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; Blazer Levi L, 2010, Curr Protoc Cytom, VChapter 13, DOI 10.1002/0471142956.cy1311s51; Brehmer D, 2004, J BIOL CHEM, V279, P27957, DOI 10.1074/jbc.M403558200; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Brive L, 2001, BIOCHEM BIOPH RES CO, V289, P1099, DOI 10.1006/bbrc.2001.6087; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Carrettiero DC, 2009, J NEUROSCI, V29, P2151, DOI 10.1523/JNEUROSCI.4660-08.2009; Cesa LC, 2013, ACS CHEM BIOL, V8, P1988, DOI 10.1021/cb400356m; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chang L, 2011, CHEM BIOL, V18, P210, DOI 10.1016/j.chembiol.2010.12.010; Chang L, 2010, J BIOL CHEM, V285, P21282, DOI 10.1074/jbc.M110.124149; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Erbse A, 2004, BIOCHEM SOC T, V32, P617, DOI 10.1042/BST0320617; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Finka A, 2013, CELL STRESS CHAPERON, V18, P591, DOI 10.1007/s12192-013-0413-3; Franceschelli S, 2008, J CELL PHYSIOL, V215, P575, DOI 10.1002/jcp.21397; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gassler CS, 2001, J BIOL CHEM, V276, P32538, DOI 10.1074/jbc.M105328200; Gillies AT, 2012, MOL BIOSYST, V8, P2901, DOI 10.1039/c2mb25248a; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Li Z, 2013, NAT STRUCT MOL BIOL, V20, P929, DOI 10.1038/nsmb.2608; Liu Y., 2010, PLOS COMPUT BIOL, V6; Luders J, 2000, J BIOL CHEM, V275, P14817, DOI 10.1074/jbc.275.20.14817; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Miyata Y, 2010, J BIOMOL SCREEN, V15, P1211, DOI 10.1177/1087057110380571; Nollen EAA, 2000, MOL CELL BIOL, V20, P1083, DOI 10.1128/MCB.20.3.1083-1088.2000; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rerole AL, 2011, METHODS MOL BIOL, V787, P205, DOI 10.1007/978-1-61779-295-3_16; Ricci Laura, 2008, Curr Chem Genomics, V2, P90, DOI 10.2174/1875397300802010090; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Saxena A, 2012, J BIOL CHEM, V287, P19158, DOI 10.1074/jbc.M111.297580; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Smith MC, 2013, BIOCHEMISTRY-US, V52, P5354, DOI 10.1021/bi4009209; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; Srinivasan SR, 2012, MOL BIOSYST, V8, P2323, DOI 10.1039/c2mb25145k; Stuart JK, 1998, J BIOL CHEM, V273, P22506, DOI 10.1074/jbc.273.35.22506; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Thompson AD, 2012, ACS CHEM BIOL, V7, P1677, DOI 10.1021/cb3002599; Tsukahara F, 2010, BLOOD, V116, P3582, DOI 10.1182/blood-2009-10-249623; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Vembar SS, 2010, J BIOL CHEM, V285, P22484, DOI 10.1074/jbc.M110.102186; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Williamson DS, 2009, J MED CHEM, V52, P1510, DOI 10.1021/jm801627a; Wisen S, 2008, ANAL BIOCHEM, V374, P371, DOI 10.1016/j.ab.2007.12.009; Wittung-Stafshede P, 2003, BIOCHEMISTRY-US, V42, P4937, DOI 10.1021/bi027333o; Xu XP, 2012, J BIOL CHEM, V287, P5661, DOI 10.1074/jbc.M111.275057; Xu Z, 2013, J CELL SCI, V126, P4173, DOI 10.1242/jcs.126102; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518; Yamagishi N, 2000, BIOCHEM BIOPH RES CO, V272, P850, DOI 10.1006/bbrc.2000.2864; ZEINER M, 1995, P NATL ACAD SCI USA, V92, P11465, DOI 10.1073/pnas.92.25.11465; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	86	107	117	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1402	1414		10.1074/jbc.M113.521997	http://dx.doi.org/10.1074/jbc.M113.521997			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24318877	hybrid, Green Published			2022-12-28	WOS:000332401700018
J	Crain, AV; Broderick, JB				Crain, Adam V.; Broderick, Joan B.			Pyruvate Formate-lyase and Its Activation by Pyruvate Formate-lyase Activating Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circular Dichroism (CD); Electron Paramagnetic Resonance (EPR); Radicals; S-Adenosylmethionine (AdoMet); Surface Plasmon Resonance (SPR)	GLYCYL RADICAL ENZYME; UNIQUE IRON SITE; ESCHERICHIA-COLI; S-ADENOSYLMETHIONINE; MOLECULAR-PROPERTIES; INACTIVE FORM; ACTIVE ENZYME; FLAVODOXIN; PROTEIN; CLUSTER	Background: PFL is a glycyl radical enzyme (GRE) activated by a radical AdoMet-activating enzyme (PFL-AE). Results: Equilibrium constants for PFL-AE binding to PFL and AdoMet are determined, and the effects of substrates on activation are quantified. Conclusion:In vivo, PFL-AE exists largely in complex with PFL and AdoMet. Significance: GREs play key roles in anaerobic metabolism, but their activation is poorly understood. The activation of pyruvate formate-lyase (PFL) by pyruvate formate-lyase activating enzyme (PFL-AE) involves formation of a specific glycyl radical on PFL by the PFL-AE in a reaction requiring S-adenosylmethionine (AdoMet). Surface plasmon resonance experiments were performed under anaerobic conditions on the oxygen-sensitive PFL-AE to determine the kinetics and equilibrium constant for its interaction with PFL. These experiments show that the interaction is very slow and rate-limited by large conformational changes. A novel AdoMet binding assay was used to accurately determine the equilibrium constants for AdoMet binding to PFL-AE alone and in complex with PFL. The PFL-AE bound AdoMet with the same affinity (approximate to 6 m) regardless of the presence or absence of PFL. Activation of PFL in the presence of its substrate pyruvate or the analog oxamate resulted in stoichiometric conversion of the [4Fe-4S](1+) cluster to the glycyl radical on PFL; however, 3.7-fold less activation was achieved in the absence of these small molecules, demonstrating that pyruvate or oxamate are required for optimal activation. Finally, in vivo concentrations of the entire PFL system were calculated to estimate the amount of bound protein in the cell. PFL, PFL-AE, and AdoMet are essentially fully bound in vivo, whereas electron donor proteins are partially bound.	[Broderick, Joan B.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; Montana State Univ, Astrobiol Biogeocatalysis Res Ctr, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Broderick, JB (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	jbroderick@chemistry.montana.edu		Broderick, Joan/0000-0001-7057-9124	National Institutes of Health [2R01GM054608-14]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01GM054608-14.	AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; Becker A, 2002, J BIOL CHEM, V277, P40036, DOI 10.1074/jbc.M205821200; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Beinert H, 1978, Methods Enzymol, V54, P435; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BIANCHI V, 1993, BIOCHEM BIOPH RES CO, V197, P792, DOI 10.1006/bbrc.1993.2548; BLASCHKOWSKI HP, 1982, EUR J BIOCHEM, V123, P563; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broderick JB, 1997, J AM CHEM SOC, V119, P7396, DOI 10.1021/ja9711425; Broderick JB, 2000, BIOCHEM BIOPH RES CO, V269, P451, DOI 10.1006/bbrc.2000.2313; Buckel W, 2006, ANNU REV MICROBIOL, V60, P27, DOI 10.1146/annurev.micro.60.080805.142216; CONRADT H, 1984, ARCH BIOCHEM BIOPHYS, V228, P133, DOI 10.1016/0003-9861(84)90054-7; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Crain AV, 2013, BBA-PROTEINS PROTEOM, V1834, P2512, DOI 10.1016/j.bbapap.2013.08.014; FREY M, 1994, J BIOL CHEM, V269, P12432; Hall DA, 2001, P NATL ACAD SCI USA, V98, P9521, DOI 10.1073/pnas.171168898; Halliday NM, 2010, ANAL BIOCHEM, V403, P20, DOI 10.1016/j.ab.2010.04.021; Henshaw TF, 2000, J AM CHEM SOC, V122, P8331, DOI 10.1021/ja002012q; IFUKU O, 1994, EUR J BIOCHEM, V224, P173, DOI 10.1111/j.1432-1033.1994.tb20009.x; KNAPPE J, 1990, FEMS MICROBIOL LETT, V75, P383, DOI 10.1111/j.1574-6968.1990.tb04108.x; KNAPPE J, 1969, EUR J BIOCHEM, V11, P316, DOI 10.1111/j.1432-1033.1969.tb00775.x; KNAPPE J, 1974, EUR J BIOCHEM, V50, P253, DOI 10.1111/j.1432-1033.1974.tb03894.x; KNAPPE J, 1984, P NATL ACAD SCI-BIOL, V81, P1332, DOI 10.1073/pnas.81.5.1332; KNAPPE J, 1993, BIOCHEM SOC T, V21, P731, DOI 10.1042/bst0210731; Knappe J, 1975, Methods Enzymol, V41, P508; Krebs C, 2002, J AM CHEM SOC, V124, P912, DOI 10.1021/ja017562i; Kulzer R, 1998, J BIOL CHEM, V273, P4897, DOI 10.1074/jbc.273.9.4897; Leuthner B, 1998, MOL MICROBIOL, V28, P615, DOI 10.1046/j.1365-2958.1998.00826.x; LOFAS S, 1995, BIOSENS BIOELECTRON, V10, P813, DOI 10.1016/0956-5663(95)99220-F; Nnyepi MR, 2007, ARCH BIOCHEM BIOPHYS, V459, P1, DOI 10.1016/j.abb.2006.12.024; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; PECHER A, 1982, ARCH MICROBIOL, V132, P365, DOI 10.1007/BF00413390; Peng Y, 2010, J BIOL CHEM, V285, P27224, DOI 10.1074/jbc.M109.096875; PLAGA W, 1988, EUR J BIOCHEM, V178, P445, DOI 10.1111/j.1432-1033.1988.tb14468.x; RODEL W, 1988, EUR J BIOCHEM, V177, P153, DOI 10.1111/j.1432-1033.1988.tb14356.x; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Sekowska A, 2000, J MOL MICROB BIOTECH, V2, P145; UNKRIG V, 1989, EUR J BIOCHEM, V184, P723, DOI 10.1111/j.1432-1033.1989.tb15072.x; Val DL, 1998, J BACTERIOL, V180, P2644, DOI 10.1128/JB.180.10.2644-2651.1998; VETTER H, 1971, H-S Z PHYSIOL CHEM, V352, P433, DOI 10.1515/bchm2.1971.352.1.433; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; Walsby CJ, 2002, J AM CHEM SOC, V124, P11270, DOI 10.1021/ja027078v; Walsby CJ, 2005, INORG CHEM, V44, P727, DOI 10.1021/ic0484811; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s; WONG KK, 1993, BIOCHEMISTRY-US, V32, P14102, DOI 10.1021/bi00214a005; Yang YT, 2001, METAB ENG, V3, P115, DOI 10.1006/mben.2000.0166	48	28	27	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5723	5729		10.1074/jbc.M113.496877	http://dx.doi.org/10.1074/jbc.M113.496877			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24338017	hybrid, Green Published			2022-12-28	WOS:000332015500033
J	Cho, KI; Patil, H; Senda, E; Wang, J; Yi, HQ; Qiu, S; Yoon, D; Yu, MZ; Orry, A; Peachey, NS; Ferreira, PA				Cho, Kyoung-in; Patil, Hemangi; Senda, Eugene; Wang, Jessica; Yi, Haiqing; Qiu, Sunny; Yoon, Dosuk; Yu, Minzhong; Orry, Andrew; Peachey, Neal S.; Ferreira, Paulo A.			Differential Loss of Prolyl Isomerase or Chaperone Activity of Ran- binding Protein 2 ( Ranbp2) Unveils Distinct Physiological Roles of Its Cyclophilin Domain in Proteostasis*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Chaperone Chaperonin; Enzymes; Proteasome; Protein Misfolding; Ubiquitination	CIS-TRANS ISOMERASE; CYCLOSPORINE-A-BINDING; HEPATITIS-C VIRUS; UBIQUITIN-PROTEASOME SYSTEM; NUCLEAR-PORE COMPLEX; PROLINE ISOMERIZATION; HOMOLOG NINAA; IN-VIVO; GENE ENCODES; DROSOPHILA	Background: Cyclophilins harbor ill-defined chaperone and prolyl isomerase activities toward physiological substrates. Results: Nonoverlapping chaperone or prolyl isomerase activity loss of Ran-binding protein 2 (Ranbp2) cyclophilin domain triggers unique impairments of proteostasis in distinct cell types and ubiquitin-proteasome system. Conclusion: Ranbp2 cyclophilin subdomains present discriminating physiological activities toward substrates or regulation of ubiquitin-proteasome system. Significance: Ranbp2-mediated mechanistic links in proteostasis with physiological and therapeutic relevance are uncovered. The immunophilins, cyclophilins, catalyze peptidyl cis-trans prolyl-isomerization (PPIase), a rate-limiting step in protein folding and a conformational switch in protein function. Cyclophilins are also chaperones. Noncatalytic mutations affecting the only cyclophilins with known but distinct physiological substrates, the Drosophila NinaA and its mammalian homolog, cyclophilin-B, impair opsin biogenesis and cause osteogenesis imperfecta, respectively. However, the physiological roles and substrates of most cyclophilins remain unknown. It is also unclear if PPIase and chaperone activities reflect distinct cyclophilin properties. To elucidate the physiological idiosyncrasy stemming from potential cyclophilin functions, we generated mice lacking endogenous Ran-binding protein-2 (Ranbp2) and expressing bacterial artificial chromosomes of Ranbp2 with impaired C-terminal chaperone and with (Tg-Ranbp2(WT-HA)) or without PPIase activities (Tg-Ranbp2(R2944A-HA)). The transgenic lines exhibit unique effects in proteostasis. Either line presents selective deficits in M-opsin biogenesis with its accumulation and aggregation in cone photoreceptors but without proteostatic impairment of two novel Ranbp2 cyclophilin partners, the cytokine-responsive effectors, STAT3/STAT5. Stress-induced STAT3 activation is also unaffected in Tg-Ranbp2(R2944A-HA)::Ranbp2(-/-). Conversely, proteomic analyses found that the multisystem proteinopathy/amyotrophic lateral sclerosis proteins, heterogeneous nuclear ribonucleoproteins A2/B1, are down-regulated post-transcriptionally only in Tg-Ranbp2(R2944A-HA)::Ranbp2(-/-). This is accompanied by the age- and tissue-dependent reductions of diubiquitin and ubiquitylated proteins, increased deubiquitylation activity, and accumulation of the 26 S proteasome subunits S1 and S5b. These manifestations are absent in another line, Tg-Ranbp2(CLDm-HA)::Ranbp2(-/-), harboring SUMO-1 and S1-binding mutations in the Ranbp2 cyclophilin-like domain. These results unveil distinct mechanistic and biological links between PPIase and chaperone activities of Ranbp2 cyclophilin toward proteostasis of selective substrates and with novel therapeutic potential.	[Cho, Kyoung-in; Patil, Hemangi; Senda, Eugene; Wang, Jessica; Yi, Haiqing; Qiu, Sunny; Yoon, Dosuk; Ferreira, Paulo A.] Duke Univ, Dept Ophthalmol, Med Ctr, Durham, NC 27710 USA; [Cho, Kyoung-in; Patil, Hemangi; Senda, Eugene; Wang, Jessica; Yi, Haiqing; Qiu, Sunny; Yoon, Dosuk; Ferreira, Paulo A.] Duke Univ, Dept Pathol, Med Ctr, Durham, NC 27710 USA; [Yu, Minzhong; Peachey, Neal S.] Cleveland Clin Fdn, Dept Ophthalm Res, Cole Eye Inst, Cleveland, OH 44195 USA; [Orry, Andrew] MolSoft LLC, San Diego, CA 92121 USA; [Peachey, Neal S.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Peachey, Neal S.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Ophthalmol, Cleveland, OH 44195 USA	Duke University; Duke University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Ferreira, PA (corresponding author), Duke Univ, Med Ctr, DUEC 3802,2351 Erwin Rd, Durham, NC 27710 USA.	paulo.ferreira@duke.edu	Peachey, Neal/G-5533-2010; Ferreira, Paulo A/S-4209-2016	Peachey, Neal/0000-0002-4419-7226; Ferreira, Paulo A/0000-0003-4585-1717	National Institutes of Health [EY019492, GM083165, GM083165-03S1, 2P30-EY005722, 5P30NS061789]; Foundation Fighting Blindness; Department of Veterans Affairs; Research to Prevent Blindness to Cleveland Clinic; Duke University; NATIONAL EYE INSTITUTE [R01EY019492, P30EY005722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Department of Veterans Affairs(US Department of Veterans Affairs); Research to Prevent Blindness to Cleveland Clinic(Research to Prevent Blindness (RPB)); Duke University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019492, GM083165, and GM083165-03S1 (to P. A. F.), 2P30-EY005722 (to Duke University Eye Center), and 5P30NS061789 (to Duke Neurotransgenic Laboratory). This work was also supported by the Foundation Fighting Blindness, the Department of Veterans Affairs, and an unrestricted award from Research to Prevent Blindness to Cleveland Clinic.; Supported by Deans' Summer Undergraduate Research Fellowships at Duke University.	Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Aslanukov A, 2006, PLOS GENET, V2, P1653, DOI 10.1371/journal.pgen.0020177; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; Bauer K, 2009, ONCOGENE, V28, P2784, DOI 10.1038/onc.2009.142; Baugh J, 2012, BIOL CHEM, V393, P579, DOI 10.1515/hsz-2012-0151; Ben-Gedalya T, 2011, J CELL SCI, V124, P1891, DOI 10.1242/jcs.077693; Bernasconi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013008; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Braslavsky CIV, 2000, BIOCHEMISTRY-US, V39, P11629, DOI 10.1021/bi001010f; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Castagnet P, 2003, HUM MOL GENET, V12, P1847, DOI 10.1093/hmg/ddg202; Chatterji U, 2010, J GEN VIROL, V91, P1189, DOI 10.1099/vir.0.018531-0; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Cho KI, 2009, CELL DEATH DIFFER, V16, P287, DOI 10.1038/cdd.2008.153; Cho KI, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003555; Cho KI, 2010, DIS MODEL MECH, V3, P595, DOI 10.1242/dmm.004648; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Colgan J, 2005, J IMMUNOL, V174, P6030, DOI 10.4049/jimmunol.174.10.6030; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COOK KH, 1979, P NATL ACAD SCI USA, V76, P6157, DOI 10.1073/pnas.76.12.6157; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Culjkovic-Kraljacic B, 2012, CELL REP, V2, P207, DOI 10.1016/j.celrep.2012.07.007; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; Dennissen FJA, 2012, PROG NEUROBIOL, V96, P190, DOI 10.1016/j.pneurobio.2012.01.003; Di Nunzio F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046037; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Fan SL, 2011, MOL BIOL CELL, V22, P4539, DOI 10.1091/mbc.E11-03-0267; Fauser S, 2001, MAMM GENOME, V12, P406, DOI 10.1007/s003350010291; FERREIRA PA, 1995, J BIOL CHEM, V270, P23179, DOI 10.1074/jbc.270.39.23179; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Ferreira PA, 1998, J BIOL CHEM, V273, P24676, DOI 10.1074/jbc.273.38.24676; Ferreira PA, 1997, P NATL ACAD SCI USA, V94, P1556, DOI 10.1073/pnas.94.4.1556; Ferreira PA, 2000, METHOD ENZYMOL, V315, P455; Ferreira PA, 2012, J NEUROGENET, V26, P132, DOI 10.3109/01677063.2011.647143; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; FRESKGARD PO, 1992, SCIENCE, V258, P466, DOI 10.1126/science.1357751; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; Galat A, 2010, CELL MOL LIFE SCI, V67, P3467, DOI 10.1007/s00018-010-0437-0; Gemmill TR, 2005, J BIOL CHEM, V280, P15510, DOI 10.1074/jbc.M412172200; Hamada M, 2011, J CELL BIOL, V194, P597, DOI 10.1083/jcb.201102018; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haruta M, 2009, P NATL ACAD SCI USA, V106, P9397, DOI 10.1073/pnas.0808940106; He J, 2012, STRUCTURE, V20, P513, DOI 10.1016/j.str.2011.12.015; Heiduschka P, 2010, INVEST OPHTH VIS SCI, V51, P1424, DOI 10.1167/iovs.09-3606; Helekar SA, 1997, P NATL ACAD SCI USA, V94, P5432, DOI 10.1073/pnas.94.10.5432; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hopkins S, 2012, J HEPATOL, V57, P47, DOI 10.1016/j.jhep.2012.02.024; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ingelfinger D, 2003, NUCLEIC ACIDS RES, V31, P4791, DOI 10.1093/nar/gkg660; Ishikawa Y, 2012, J BIOL CHEM, V287, P22253, DOI 10.1074/jbc.M111.333336; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Jackson SE, 2013, TOP CURR CHEM, V328, P35, DOI 10.1007/128_2011_151; Kassube SA, 2012, J MOL BIOL, V423, P752, DOI 10.1016/j.jmb.2012.08.026; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Kubicek K, 2012, GENE DEV, V26, P1891, DOI 10.1101/gad.192781.112; Langer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017011; Lee JP, 1999, P NATL ACAD SCI USA, V96, P3251, DOI 10.1073/pnas.96.6.3251; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Mahadevan K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001545; Mandel Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2980; Mavlyutov TA, 2002, TRAFFIC, V3, P630, DOI 10.1034/j.1600-0854.2002.30905.x; Moparthi SB, 2010, BIOCHEMISTRY-US, V49, P1137, DOI 10.1021/bi901997q; Munte TF, 1998, J NEUROL, V245, P206, DOI 10.1007/s004150050206; NAIR APK, 1994, NATURE, V369, P239, DOI 10.1038/369239a0; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; ONDEK B, 1992, J BIOL CHEM, V267, P16460; Pan H, 2008, J BIOL CHEM, V283, P623, DOI 10.1074/jbc.M704934200; Park JM, 2013, CELL, V154, P637, DOI 10.1016/j.cell.2013.07.001; Patil H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.96; Patil H, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120183; Patil H, 2012, BIOL OPEN, V1, P140, DOI 10.1242/bio.2011489; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Ramanathan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015827; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; REGAN D, 1976, BRAIN, V99, P43, DOI 10.1093/brain/99.1.43; Rycyzyn MA, 2002, P NATL ACAD SCI USA, V99, P6790, DOI 10.1073/pnas.092160699; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Samardzija M, 2006, FASEB J, V20, P2411, DOI 10.1096/fj.06-5895fje; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Sano Y, 2006, AM J PATHOL, V169, P132, DOI 10.2353/ajpath.2006.060085; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; Scognamiglio A, 2008, BBA-MOL CELL RES, V1783, P2030, DOI 10.1016/j.bbamcr.2008.07.007; Setsuie R, 2009, NEUROCHEM INT, V54, P314, DOI 10.1016/j.neuint.2008.12.013; Shen Z., 2013, PLOS ONE, V8; Sherry B, 1998, P NATL ACAD SCI USA, V95, P1758, DOI 10.1073/pnas.95.4.1758; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; Smajlovic A, 2009, FEBS LETT, V583, P1114, DOI 10.1016/j.febslet.2009.02.037; Snyder SH, 1998, TRENDS PHARMACOL SCI, V19, P21, DOI 10.1016/S0165-6147(97)01146-2; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; Strunze S, 2011, CELL HOST MICROBE, V10, P210, DOI 10.1016/j.chom.2011.08.010; Sune G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013930; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Tian XF, 2011, ASSAY DRUG DEV TECHN, V9, P165, DOI 10.1089/adt.2010.0317; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Weininger U, 2009, P NATL ACAD SCI USA, V106, P12335, DOI 10.1073/pnas.0902102106; Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yang DS, 1999, J BIOL CHEM, V274, P32970, DOI 10.1074/jbc.274.46.32970; Yi HQ, 2007, J BIOL CHEM, V282, P34770, DOI 10.1074/jbc.M706903200; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Yu MZ, 2012, EXP EYE RES, V96, P124, DOI 10.1016/j.exer.2011.12.011; Zhang R., 2010, PLOS ONE, V5; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	136	11	11	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4600	4625		10.1074/jbc.M113.538215	http://dx.doi.org/10.1074/jbc.M113.538215			26	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403063	Green Published, hybrid			2022-12-28	WOS:000331607900009
J	Anderluh, A; Klotzsch, E; Reismann, AWAF; Brameshuber, M; Kudlacek, O; Newman, AH; Sitte, HH; Schutz, GJ				Anderluh, Andreas; Klotzsch, Enrico; Reismann, Alexander W. A. F.; Brameshuber, Mario; Kudlacek, Oliver; Newman, Amy Hauck; Sitte, Harald H.; Schuetz, Gerhard J.			Single Molecule Analysis Reveals Coexistence of Stable Serotonin Transporter Monomers and Oligomers in the Live Cell Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Membrane Proteins; Protein Dynamics; Protein-Protein Interactions; Serotonin Transporters; Single Molecule Biophysics; Oligomerization	HUMAN DOPAMINE TRANSPORTER; ENERGY-TRANSFER MICROSCOPY; RAT GABA TRANSPORTER-1; NEUROTRANSMITTER TRANSPORTERS; LIVING CELLS; TRANSMEMBRANE SEGMENT; COCAINE ANALOGS; CROSS-LINKING; PROTEIN; TRAFFICKING	Background: The serotonin transporter (SERT) terminates synaptic signaling by reuptake of the neurotransmitter serotonin. Results: Interaction kinetics and number of subunits are elucidated by single molecule brightness analysis of SERT complexes. Conclusion: The oligomeric state of SERT complexes is stably determined before being integrated into the plasma membrane. Significance: The results reveal the first evidence for kinetic trapping of preformed neurotransmitter transporter oligomers. The human serotonin transporter (hSERT) is responsible for the termination of synaptic serotonergic signaling. Although there is solid evidence that SERT forms oligomeric complexes, the exact stoichiometry of the complexes and the fractions of different coexisting oligomeric states still remain enigmatic. Here we used single molecule fluorescence microscopy to obtain the oligomerization state of the SERT via brightness analysis of single diffraction-limited fluorescent spots. Heterologously expressed SERT was labeled either with the fluorescent inhibitor JHC 1-64 or via fusion to monomeric GFP. We found a variety of oligomerization states of membrane-associated transporters, revealing molecular associations larger than dimers and demonstrating the coexistence of different degrees of oligomerization in a single cell; the data are in agreement with a linear aggregation model. Furthermore, oligomerization was found to be independent of SERT surface density, and oligomers remained stable over several minutes in the live cell plasma membrane. Together, the results indicate kinetic trapping of preformed SERT oligomers at the plasma membrane.	[Anderluh, Andreas; Klotzsch, Enrico; Reismann, Alexander W. A. F.; Brameshuber, Mario; Schuetz, Gerhard J.] Vienna Univ Technol, Inst Appl Phys, A-1060 Vienna, Austria; [Kudlacek, Oliver; Sitte, Harald H.] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Newman, Amy Hauck] NIDA, Med Chem Sect, Mol Targets & Medicat Discovery Branch, Intramural Res Program, Baltimore, MD 21224 USA	Technische Universitat Wien; Medical University of Vienna; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Klotzsch, E (corresponding author), Vienna Univ Technol, Inst Appl Phys, Getreidemarkt 9, A-1060 Vienna, Austria.	enricoklotzsch@gmail.com; schuetz@iap.tuwien.ac.at	Klotzsch, Enrico/J-8831-2012; Sitte, Harald/N-2681-2013; Schuetz, Gerhard/B-1243-2008	Klotzsch, Enrico/0000-0002-7577-9042; Brameshuber, Mario/0000-0001-8672-2255; Kudlacek, Oliver/0000-0002-3086-8551; Sitte, Harald/0000-0002-1339-7444; Schuetz, Gerhard/0000-0003-1542-1089	Austrian Science Fund/FWF Projects [F3506-B20, F3519-B20]; National Institute on Drug Abuse-Intramural Research Program; Federation of European Biochemical Societies; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000389] Funding Source: NIH RePORTER	Austrian Science Fund/FWF Projects(Austrian Science Fund (FWF)); National Institute on Drug Abuse-Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Federation of European Biochemical Societies; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Austrian Science Fund/FWF Projects F3506-B20 (to H. H. S.) and F3519-B20 (to G. J. S.) and by the National Institute on Drug Abuse-Intramural Research Program (to A. H. N.).; Supported by a long term fellowship from the Federation of European Biochemical Societies. To whom correspondence may be addressed. Tel.: 43-01-58801134884; E-mail: enricoklotzsch@gmail.com.	AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Brameshuber M, 2010, J BIOL CHEM, V285, P41765, DOI 10.1074/jbc.M110.182121; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Cha JH, 2005, J MED CHEM, V48, P7513, DOI 10.1021/jm050431y; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Fjorback AW, 2009, BIOCHEM BIOPH RES CO, V380, P724, DOI 10.1016/j.bbrc.2009.01.128; Gao YX, 2009, OPT EXPRESS, V17, P4685, DOI 10.1364/OE.17.004685; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hilber B, 2005, NEUROPHARMACOLOGY, V49, P811, DOI 10.1016/j.neuropharm.2005.08.008; Jess U, 1996, FEBS LETT, V394, P44, DOI 10.1016/0014-5793(96)00916-7; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Kohler K, 2000, J BIOL CHEM, V275, P26113, DOI 10.1074/jbc.M003564200; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Madl J, 2010, J BIOL CHEM, V285, P41135, DOI 10.1074/jbc.M110.177881; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Masson J, 1999, PHARMACOL REV, V51, P439; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; Molnar E, 2012, J BIOL CHEM, V287, P42664, DOI 10.1074/jbc.M112.386045; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; SAHINTOTH M, 1994, P NATL ACAD SCI USA, V91, P5421, DOI 10.1073/pnas.91.12.5421; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Schmidt T, 1996, ANAL CHEM, V68, P4397, DOI 10.1021/ac960710g; Schoen I, 2011, NANO LETT, V11, P4008, DOI 10.1021/nl2025954; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Schwarzenbacher M, 2008, NAT METHODS, V5, P1053, DOI 10.1038/nmeth.1268; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sitte HH, 2003, EUR J PHARMACOL, V479, P229, DOI 10.1016/j.ejphar.2003.08.072; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sucic S, 2013, J BIOL CHEM, V288, P5330, DOI 10.1074/jbc.M112.408237; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Suzuki KGN, 2012, NAT CHEM BIOL, V8, P774, DOI [10.1038/nchembio.1028, 10.1038/NCHEMBIO.1028]; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Ulbrich M, 2011, COUNTING MOL QUANTIT, P1; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Vogelsang J, 2010, CHEMPHYSCHEM, V11, P2475, DOI 10.1002/cphc.201000189; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	50	44	44	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4387	4394		10.1074/jbc.M113.531632	http://dx.doi.org/10.1074/jbc.M113.531632			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24394416	Green Published, hybrid			2022-12-28	WOS:000331403800049
J	Piepenbrink, KH; Maldarelli, GA; de la Pena, CFM; Mulvey, GL; Snyder, GA; De Masi, L; von Rosenvinge, EC; Gunther, S; Armstrong, GD; Donnenberg, MS; Sundberg, EJ				Piepenbrink, Kurt H.; Maldarelli, Grace A.; de la Pena, Claudia F. Martinez; Mulvey, George L.; Snyder, Greg A.; De Masi, Leon; von Rosenvinge, Erik C.; Guenther, Sebastian; Armstrong, Glen D.; Donnenberg, Michael S.; Sundberg, Eric J.			Structure of Clostridium difficile PilJ Exhibits Unprecedented Divergence from Known Type IV Pilins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Adhesion; Microbiology; Microfilaments; Protein Assembly; Protein Structure	ENTEROTOXIGENIC ESCHERICHIA-COLI; TOXIN-COREGULATED PILUS; X-RAY; PATHOGENESIS; COMPUTATION; BIOGENESIS; SCATTERING; SOFTWARE; PROTEINS; MOTILITY	Background: Type IV pili are non-covalently assembled appendages, characterized now in both Gram-negative and Gram-positive bacteria. Results:Clostridium difficile produces Type IV pili containing PilJ, a pilin with a novel dual-pilin fold. Conclusion: Models suggest that the C-terminal pilin domain is exposed in pili, providing a unique interaction surface. Significance: The novel fold of PilJ suggests a new mode for Type IV pilus function. Type IV pili are produced by many pathogenic Gram-negative bacteria and are important for processes as diverse as twitching motility, cellular adhesion, and colonization. Recently, there has been an increased appreciation of the ability of Gram-positive species, including Clostridium difficile, to produce Type IV pili. Here we report the first three-dimensional structure of a Gram-positive Type IV pilin, PilJ, demonstrate its incorporation into Type IV pili, and offer insights into how the Type IV pili of C. difficile may assemble and function. PilJ has several unique structural features, including a dual-pilin fold and the incorporation of a structural zinc ion. We show that PilJ is incorporated into Type IV pili in C. difficile and present a model in which the incorporation of PilJ into pili exposes the C-terminal domain of PilJ to create a novel interaction surface.	[Piepenbrink, Kurt H.; Snyder, Greg A.; Guenther, Sebastian; Sundberg, Eric J.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Maldarelli, Grace A.; Snyder, Greg A.; De Masi, Leon; von Rosenvinge, Erik C.; Donnenberg, Michael S.; Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Donnenberg, Michael S.; Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [de la Pena, Claudia F. Martinez; Mulvey, George L.; Armstrong, Glen D.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada; [de la Pena, Claudia F. Martinez; Mulvey, George L.; Armstrong, Glen D.] Univ Calgary, Alberta Glycom Ctr, Calgary, AB T2N 1N4, Canada	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Calgary; University of Calgary	Sundberg, EJ (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	esundberg@ihv.umaryland.edu	Guenther, Sebastian/GON-7207-2022	Guenther, Sebastian/0000-0002-7329-6653; Donnenberg, Michael/0000-0002-8818-3184; von Rosenvinge, Erik C./0000-0002-1862-7288; Martinez de la Pena, Claudia Fabiola/0000-0003-4516-3404; Piepenbrink, Kurt/0000-0002-2527-0301; Sundberg, Eric/0000-0003-0478-3033	National Institutes of Health [T32 AI095190, R21 AI105881]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI110045, T32AI095190, R21AI105881, R01AI114902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK067872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 AI095190 and R21 AI105881.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhuptani P, 2012, CRIT CARE MED, V40, pU105; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; BORRIELLO SP, 1988, FEMS MICROBIOL LETT, V49, P65, DOI 10.1111/j.1574-6968.1988.tb02683.x; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forgetta V, 2011, J CLIN MICROBIOL, V49, P2230, DOI 10.1128/JCM.00391-11; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; Goulding D, 2009, INFECT IMMUN, V77, P5478, DOI 10.1128/IAI.00551-09; HENRICHSEN J, 1983, ANNU REV MICROBIOL, V37, P81, DOI 10.1146/annurev.mi.37.100183.000501; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Lammie D, 2007, ACTA CRYSTALLOGR D, V63, P1022, DOI 10.1107/S0907444907032933; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; LEE KK, 1994, MOL MICROBIOL, V11, P705, DOI 10.1111/j.1365-2958.1994.tb00348.x; Li J, 2008, STRUCTURE, V16, P137, DOI 10.1016/j.str.2007.10.027; Li J, 2012, J MOL BIOL, V418, P47, DOI 10.1016/j.jmb.2012.02.017; Liu HG, 2012, ACTA CRYSTALLOGR A, V68, P278, DOI 10.1107/S010876731104788X; Lu J, 2008, BIOCHEM SOC T, V36, P1317, DOI 10.1042/BST0361317; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rakotoarivonina H, 2002, MICROBIOL-SGM, V148, P1871, DOI 10.1099/00221287-148-6-1871; Ramboarina S, 1999, BIOCHEMISTRY-US, V38, P9600, DOI 10.1021/bi9905258; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; Stone BJ, 1998, INFECT IMMUN, V66, P1768, DOI 10.1128/IAI.66.4.1768-1775.1998; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tacket CO, 1998, INFECT IMMUN, V66, P692, DOI 10.1128/IAI.66.2.692-695.1998; TANIGUCHI T, 1995, INFECT IMMUN, V63, P724, DOI 10.1128/IAI.63.2.724-728.1995; Varga JJ, 2006, MOL MICROBIOL, V62, P680, DOI 10.1111/j.1365-2958.2006.05414.x; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350; Yoshida T, 1999, J BACTERIOL, V181, P2038, DOI 10.1128/JB.181.7.2038-2043.1999; Zhang XL, 2000, INFECT IMMUN, V68, P3067, DOI 10.1128/IAI.68.6.3067-3073.2000	52	29	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4334	4345		10.1074/jbc.M113.534404	http://dx.doi.org/10.1074/jbc.M113.534404			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362261	Green Published, hybrid			2022-12-28	WOS:000331403800044
J	Yamashita, T; Ono, K; Ohuchi, H; Yumoto, A; Gotoh, H; Tomonari, S; Sakai, K; Fujita, H; Imamoto, Y; Noji, S; Nakamura, K; Shichida, Y				Yamashita, Takahiro; Ono, Katsuhiko; Ohuchi, Hideyo; Yumoto, Akane; Gotoh, Hitoshi; Tomonari, Sayuri; Sakai, Kazumi; Fujita, Hirofumi; Imamoto, Yasushi; Noji, Sumihare; Nakamura, Katsuki; Shichida, Yoshinori			Evolution of Mammalian Opn5 as a Specialized UV-absorbing Pigment by a Single Amino Acid Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Proteins; Molecular Evolution; Photoreceptors; Rhodopsin; Signal Transduction; Nonvisual Photoreception	VISUAL PIGMENT; DEEP BRAIN; OPSIN; MELANOPSIN; GENE; PHOTORECEPTORS; ISOMERIZATION	Opn5 is one of the recently identified opsin groups that is responsible for nonvisual photoreception in animals. We previously showed that a chicken homolog of mammalian Opn5 (Opn5m) is a G(i)-coupled UV sensor having molecular properties typical of bistable pigments. Here we demonstrated that mammalian Opn5m evolved to be a more specialized photosensor by losing one of the characteristics of bistable pigments, direct binding of all-trans-retinal. We first confirmed that Opn5m proteins in zebrafish, Xenopus tropicalis, mouse, and human are also UV-sensitive pigments. Then we found that only mammalian Opn5m proteins lack the ability to directly bind all-trans-retinal. Mutational analysis showed that these characteristics were acquired by a single amino acid replacement at position 168. By comparing the expression patterns of Opn5m between mammals and chicken, we found that, like chicken Opn5m, mammalian Opn5m was localized in the ganglion cell layer and inner nuclear layer of the retina. However, the mouse and primate (common marmoset) opsins were distributed not in the posterior hypothalamus (including the region along the third ventricle) where chicken Opn5m is localized, but in the preoptic hypothalamus. Interestingly, RPE65, an essential enzyme for forming 11-cis-retinal in the visual cycle is expressed near the preoptic hypothalamus of the mouse and common marmoset brain but not near the region of the chicken brain where chicken Opn5m is expressed. Therefore, mammalian Opn5m may work exclusively as a short wavelength sensor in the brain as well as in the retina with the assistance of an 11-cis-retinal-supplying system.	[Yamashita, Takahiro; Yumoto, Akane; Sakai, Kazumi; Imamoto, Yasushi; Shichida, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; [Ono, Katsuhiko; Gotoh, Hitoshi] Kyoto Prefectural Univ Med, Dept Biol, Kyoto 6038334, Japan; [Ohuchi, Hideyo; Fujita, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cytol & Histol, Okayama 7008558, Japan; [Tomonari, Sayuri; Noji, Sumihare] Univ Tokushima, Grad Sch, Inst Sci & Technol, Dept Life Syst, Tokushima 7708506, Japan; [Nakamura, Katsuki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan	Kyoto University; Kyoto Prefectural University of Medicine; Okayama University; Tokushima University; Kyoto University	Shichida, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan.	shichida@rh.biophys.kyoto-u.ac.jp		Imamoto, Yasushi/0000-0002-0803-4163	Cooperation Research Program of Primate Research Institute, Kyoto University; Global Center of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology (Japan); Grants-in-Aid for Scientific Research [25440167] Funding Source: KAKEN	Cooperation Research Program of Primate Research Institute, Kyoto University; Global Center of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology (Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Cooperation Research Program of Primate Research Institute, Kyoto University. This work was also supported in part by Grants-in-Aid for Scientific Research (to T. Y., K. O., H. O., S. N., K. N., and Y. S.) and the Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: From Genome to Ecosystem" of the Ministry of Education, Culture, Sports, Science and Technology (Japan).	Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Cai X, 2009, OPHTHALMIC GENET, V30, P57, DOI 10.1080/13816810802626399; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Forger NG, 2009, J NEUROENDOCRINOL, V21, P393, DOI 10.1111/j.1365-2826.2009.01825.x; Franklin K., 2007, MOUSE BRAIN STEREOTA; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; HOFFMAN RA, 1965, SCIENCE, V148, P1609, DOI 10.1126/science.148.3677.1609; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Kim JE, 2001, BIOCHEMISTRY-US, V40, P13774, DOI 10.1021/bi0116137; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Kojima D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026388; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Kuraku S, 2011, GENOME BIOL EVOL, V3, P1449, DOI 10.1093/gbe/evr120; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Nieto PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026417; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohuchi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031534; OISHI T, 1993, ZOOL SCI, V10, P757; Oishi T, 2001, MICROSC RES TECHNIQ, V53, P43, DOI 10.1002/jemt.1067; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Tang PH, 2011, J NEUROSCI, V31, P10403, DOI 10.1523/JNEUROSCI.0182-11.2011; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Tomonari S, 2008, DEV DYNAM, V237, P1910, DOI 10.1002/dvdy.21611; Tsutsui K, 2007, BIOCHEMISTRY-US, V46, P6437, DOI 10.1021/bi7003763; Vigh B, 2002, HISTOL HISTOPATHOL, V17, P555, DOI 10.14670/HH-17.555; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; WADE PD, 1988, P NATL ACAD SCI USA, V85, P9322, DOI 10.1073/pnas.85.23.9322; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107; Yuasa S., 2010, STEREOTAXIC ATLAS MA	41	40	41	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3991	4000		10.1074/jbc.M113.514075	http://dx.doi.org/10.1074/jbc.M113.514075			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24403072	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000331403800014
J	Kikuchi, R; Ohata, H; Ohoka, N; Kawabata, A; Naito, M				Kikuchi, Ryo; Ohata, Hirokazu; Ohoka, Nobumichi; Kawabata, Atsushi; Naito, Mikihiko			APOLLON Protein Promotes Early Mitotic CYCLIN A Degradation Independent of the Spindle Assembly Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Cyclins; Mitosis; Protein Degradation; Ubiquitin; APC; C; APPOLON; Cyclin A; Spindle Assembly Checkpoint	E2/E3 UBIQUITIN LIGASE; CELL-CYCLE; DESTRUCTION BOX; EARLY MITOSIS; COMPLEX; APC/C; ANAPHASE; CDC20; BINDING; INHIBITION	Background: CYCLIN A is degraded in early mitosis independent of spindle assembly checkpoint. Results: APOLLON interacts with CYCLIN A and promotes its degradation in mitosis. Conclusion: APOLLON is a novel regulator of CYCLIN A degradation in early mitosis. Significance: This study expands our knowledge on the huge APOLLON protein known to regulate apoptosis and cytokinesis. In the mammalian cell cycle, both CYCLIN A and CYCLIN B are required for entry into mitosis, and their elimination is also essential to complete the process. During mitosis, CYCLIN A and CYCLIN B are ubiquitylated by the anaphase-promoting complex/cyclosome (APC/C) and then subjected to proteasomal degradation. However, CYCLIN A, but not CYCLIN B, begins to be degraded in the prometaphase when APC/C is inactivated by the spindle assembly checkpoint (SAC). Here, we show that APOLLON (also known as BRUCE or BIRC6) plays a role in SAC-independent degradation of CYCLIN A in early mitosis. APPOLON interacts with CYCLIN A that is not associated with cyclin-dependent kinases. APPOLON also interacts with APC/C, and it facilitates CYCLIN A ubiquitylation. In APPOLON-deficient cells, mitotic degradation of CYCLIN A is delayed, and the total, but not the cyclin-dependent kinase-bound, CYCLIN A level was increased. We propose APPOLON to be a novel regulator of mitotic CYCLIN A degradation independent of SAC.	[Kikuchi, Ryo; Ohata, Hirokazu; Kawabata, Atsushi; Naito, Mikihiko] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Kikuchi, Ryo; Kawabata, Atsushi; Naito, Mikihiko] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Ohata, Hirokazu; Naito, Mikihiko] Univ Tokyo, Grad Sch Frontier Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Ohoka, Nobumichi; Naito, Mikihiko] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan	University of Tokyo; University of Tokyo; University of Tokyo; National Institute of Health Sciences - Japan	Naito, M (corresponding author), Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan.	miki-naito@nihs.go.jp			Ministry of Education, Science, Sports and Culture, Japan; NOVARTIS Foundation (Japan) for the Promotion of Science; Cosmetology Research Foundation; Grants-in-Aid for Scientific Research [23790117] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Cosmetology Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Science, Sports and Culture, Japan (grants-in-aid for cancer research and scientific research), the NOVARTIS Foundation (Japan) for the Promotion of Science, and the Cosmetology Research Foundation.	Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Chen ZH, 1999, BIOCHEM BIOPH RES CO, V264, P847, DOI 10.1006/bbrc.1999.1585; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Di Fiore B, 2010, J CELL BIOL, V190, P501, DOI 10.1083/jcb.201001083; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fry AM, 2006, CELL CYCLE, V5, P1487, DOI 10.4161/cc.5.14.3003; Fung TK, 2005, CELL CYCLE, V4, P1411, DOI 10.4161/cc.4.10.2046; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Hitz C, 2005, GENESIS, V42, P91, DOI 10.1002/gene.20128; Ishioka T, 2007, GENES CELLS, V12, P735, DOI 10.1111/j.1365-2443.2007.01087.x; Jacobs HW, 2001, EMBO J, V20, P2376, DOI 10.1093/emboj/20.10.2376; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kaspar M, 2001, CURR BIOL, V11, P685, DOI 10.1016/S0960-9822(01)00205-6; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Klotzbucher A, 1996, EMBO J, V15, P3053, DOI 10.1002/j.1460-2075.1996.tb00668.x; Kops GJPL, 2008, FRONT BIOSCI-LANDMRK, V13, P3606, DOI 10.2741/2953; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Lotz K, 2004, MOL CELL BIOL, V24, P9339, DOI 10.1128/MCB.24.21.9339-9350.2004; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Merrick KA, 2008, MOL CELL, V32, P662, DOI 10.1016/j.molcel.2008.10.022; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Naito M, 2004, MOL CELL BIOL, V24, P8418, DOI 10.1128/MCB.24.19.8418-8427.2004; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Raff JW, 2002, J CELL BIOL, V157, P1139, DOI 10.1083/jcb.200203035; Ramachandran V, 2007, CELL CYCLE, V6, P171, DOI 10.4161/cc.6.2.3716; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Sczaniecka Matylda M, 2008, SEB Exp Biol Ser, V59, P243; Sedgwick GG, 2013, EMBO J, V32, P303, DOI 10.1038/emboj.2012.335; Sekine K, 2005, BIOCHEM BIOPH RES CO, V330, P279, DOI 10.1016/j.bbrc.2005.02.165; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; van Zon W, 2010, J CELL BIOL, V190, P587, DOI 10.1083/jcb.200912084; Vanoosthuyse V, 2005, TRENDS CELL BIOL, V15, P231, DOI 10.1016/j.tcb.2005.03.003; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vernooy SY, 2002, CURR BIOL, V12, P1164, DOI 10.1016/S0960-9822(02)00935-1; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452	64	11	11	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3457	3467		10.1074/jbc.M113.514430	http://dx.doi.org/10.1074/jbc.M113.514430			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24302728	hybrid, Green Published			2022-12-28	WOS:000331368700030
J	Qi, YT; Zuo, Y; Yeh, ETH; Cheng, JK				Qi, Yitao; Zuo, Yong; Yeh, Edward T. H.; Cheng, Jinke			An Essential Role of Small Ubiquitin-like Modifier (SUMO)-specific Protease 2 in Myostatin Expression and Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Gene Transcription; Myogenesis; SUMOylation; Transforming Growth Factor (TGF)	MUSCLE SATELLITE CELL; STEM-CELL; SUMO PROTEASES; PROTEINS; GENE; ADIPOGENESIS; SUMOYLATION; PROMOTER; SENP2; MASS	Background: It is unknown whether SUMOylation regulates myogenesis in skeletal muscle. Results: SENP2 de-SUMOylates MEF2A, promoting myostatin expression and suppressing myogenesis in skeletal muscle. Conclusion: SENP2 plays a critical role in the regulation of myostatin-induced inhibition of myogenesis. Significance: SENP2 is a potential therapeutic target in skeletal muscle regeneration. Sentrin/small ubiquitin-like modifier (SUMO)-specific protease 2 (SENP2) has broad de-SUMOylation activities in vitro, which is essential for embryonic heart development. Here, we show that myostatin, a key factor in skeletal muscle development, is markedly reduced in Senp2(-/-) mouse embryonic fibroblast cells and embryos. SENP2 regulates the transcription of myostatin mainly through de-SUMOylation of MEF2A. Silencing SENP2 can reduce myostatin expression and, therefore, promote myogenesis of skeletal muscle. These results reveal the important role of SENP2 in the regulation of myostatin expression and myogenesis.	[Qi, Yitao; Zuo, Yong; Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200025, Peoples R China; [Qi, Yitao; Yeh, Edward T. H.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA; [Zuo, Yong; Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200438, Peoples R China; [Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA	Shanghai Jiao Tong University; Saint Lukes Episcopal Hospital; Texas Heart Institute; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center	Cheng, JK (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, 280 Chongqing South Rd, Shanghai 200025, Peoples R China.	jkcheng@shsmu.edu.cn	Qi, Yitao/B-4220-2014	Qi, Yitao/0000-0003-4820-2659	National Basic Research Program of China (973 Program) [2010CB912104, 2012CB910102]; National Natural Science Foundation of China [91019021]; Shanghai Committee of Science and Technology [11XD1403200, 1DZ2260200]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by National Basic Research Program of China (973 Program) Grants 2010CB912104 (to J. C.) and 2012CB910102 (to Y. Z.), by National Natural Science Foundation of China Grant 91019021 (to J. C.), and by Shanghai Committee of Science and Technology Grants 11XD1403200 (to J. C.) and 1DZ2260200.	Artaza JN, 2005, ENDOCRINOLOGY, V146, P3547, DOI 10.1210/en.2005-0362; Artaza JN, 2007, J ENDOCRINOL, V194, P63, DOI 10.1677/JOE-07-0072; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chiu SY, 2008, PLOS BIOL, V6, P2801, DOI 10.1371/journal.pbio.0060310; Chow KH, 2012, NUCLEUS-PHILA, V3, P349, DOI 10.4161/nucl.20822; Deng B, 2012, MOL CELL BIOCHEM, V363, P291, DOI 10.1007/s11010-011-1181-y; Du R, 2007, J BIOCHEM MOL BIOL, V40, P547; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Itahana Y, 2006, MOL CELL BIOL, V26, P4675, DOI 10.1128/MCB.01830-05; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Qin J, 2013, RES VET SCI, V94, P84, DOI 10.1016/j.rvsc.2012.07.018; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Schwienhorst I, 2000, MOL GEN GENET, V263, P771, DOI 10.1007/s004380000254; Walsh FS, 2005, BIOCHEM SOC T, V33, P1513, DOI 10.1042/BST0331513; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	33	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3288	3293		10.1074/jbc.M113.518282	http://dx.doi.org/10.1074/jbc.M113.518282			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24344126	Green Published, hybrid			2022-12-28	WOS:000331368700016
J	Schwartze, JT; Becker, S; Sakkas, E; Wujak, LA; Niess, G; Usemann, J; Reichenberger, F; Herold, S; Vadasz, I; Mayer, K; Seeger, W; Morty, RE				Schwartze, Julian T.; Becker, Simone; Sakkas, Elpidoforos; Wujak, Lukasz A.; Niess, Gero; Usemann, Jakob; Reichenberger, Frank; Herold, Susanne; Vadasz, Istvan; Mayer, Konstantin; Seeger, Werner; Morty, Rory E.			Glucocorticoids Recruit Tgfbr3 and Smad1 to Shift Transforming Growth Factor-beta Signaling from the Tgfbr1/Smad2/3 Axis to the Acvrl1/Smad1 Axis in Lung Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibroblast; Glucocorticoids; Lung; SMAD Transcription Factor; Transforming Growth Factor Beta (TGFbeta)	BONE MORPHOGENETIC PROTEIN; PULMONARY ARTERIAL-HYPERTENSION; CELL PROLIFERATION; EXPRESSION; CORTICOSTEROIDS; DEXAMETHASONE; MECHANISMS; BALANCE; GROWTH-FACTOR-BETA-1; PHARMACOKINETICS	Background: TGF- is a mediator of lung diseases treated with glucocorticoids, but TGF-/glucocorticoid interactions in the lung have not been studied. Results: Glucocorticoids drive Smad1 and inhibit Smad3 TGF- signaling in lung cells. Conclusion: Glucocorticoids modulate pulmonary TGF- signaling in vitro and in vivo. Significance: Glucocorticoid effects on TGF- signaling are relevant drug/cell interactions and may be relevant drug/disease interactions. Glucocorticoids represent the mainstay therapy for many lung diseases, providing outstanding management of asthma but performing surprisingly poorly in patients with acute respiratory distress syndrome, chronic obstructive pulmonary disease, lung fibrosis, and blunted lung development associated with bronchopulmonary dysplasia in preterm infants. TGF- is a pathogenic mediator of all four of these diseases, prompting us to explore glucocorticoid/TGF- signaling cross-talk. Glucocorticoids, including dexamethasone, methylprednisolone, budesonide, and fluticasone, potentiated TGF- signaling by the Acvrl1/Smad1/5/8 signaling axis and blunted signaling by the Tgfbr1/Smad2/3 axis in NIH/3T3 cells, as well as primary lung fibroblasts, smooth muscle cells, and endothelial cells. Dexamethasone drove expression of the accessory type III TGF- receptor Tgfbr3, also called betaglycan. Tgfbr3 was demonstrated to be a switch that blunted Tgfbr1/Smad2/3 and potentiated Acvrl1/Smad1 signaling in lung fibroblasts. The Acvrl1/Smad1 axis, which was stimulated by dexamethasone, was active in lung fibroblasts and antagonized Tgfbr1/Smad2/3 signaling. Dexamethasone acted synergistically with TGF- to drive differentiation of primary lung fibroblasts to myofibroblasts, revealed by acquisition of smooth muscle actin and smooth muscle myosin, which are exclusively Smad1-dependent processes in fibroblasts. Administration of dexamethasone to live mice recapitulated these observations and revealed a lung-specific impact of dexamethasone on lung Tgfbr3 expression and phospho-Smad1 levels in vivo. These data point to an interesting and hitherto unknown impact of glucocorticoids on TGF- signaling in lung fibroblasts and other constituent cell types of the lung that may be relevant to lung physiology, as well as lung pathophysiology, in terms of drug/disease interactions.	[Schwartze, Julian T.; Becker, Simone; Sakkas, Elpidoforos; Wujak, Lukasz A.; Niess, Gero; Usemann, Jakob; Seeger, Werner; Morty, Rory E.] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodelling, D-61231 Bad Nauheim, Germany; [Schwartze, Julian T.; Becker, Simone; Sakkas, Elpidoforos; Wujak, Lukasz A.; Niess, Gero; Usemann, Jakob; Reichenberger, Frank; Herold, Susanne; Vadasz, Istvan; Mayer, Konstantin; Seeger, Werner; Morty, Rory E.] Univ Giessen, Dept Internal Med Pulmonol, D-35392 Giessen, Germany; [Schwartze, Julian T.; Becker, Simone; Sakkas, Elpidoforos; Wujak, Lukasz A.; Niess, Gero; Usemann, Jakob; Reichenberger, Frank; Herold, Susanne; Vadasz, Istvan; Mayer, Konstantin; Seeger, Werner; Morty, Rory E.] German Ctr Lung Res, Marburg Lung Ctr, D-35392 Giessen, Germany; [Reichenberger, Frank] Asklepios Lung Ctr Munich Gauting, Div Pulmonol, D-82131 Gauting, Germany	Max Planck Society; Justus Liebig University Giessen	Morty, RE (corresponding author), Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodelling, Pk Str 1, D-61231 Bad Nauheim, Germany.	rory.morty@mpi-bn.mpg.de	usemann, jakob/ABH-3129-2020; Reichenberger, Frank/AAJ-7232-2020; Vadasz, Istvan/AAO-8288-2021	Reichenberger, Frank/0000-0003-1136-4769; Schwartze, Julian Tristan/0000-0003-3829-8693; Vadasz, Istvan/0000-0003-1370-9783; Herold, Susanne/0000-0001-6343-0911; Usemann, Jakob/0000-0002-9987-2866; Seeger, Werner/0000-0003-1946-0894	Max Planck Society; German Research Foundation [Mo1789/1-1]; German Research Foundation through Excellence Cluster 147 "Cardio-Pulmonary System"; Federal Ministry of Higher Education, Research and the Arts of the State of Hessen LOEWE-Programme; German Center for Lung Research (Deutsches Zentrum fur Lungenforschung)	Max Planck Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG)); German Research Foundation through Excellence Cluster 147 "Cardio-Pulmonary System"(German Research Foundation (DFG)); Federal Ministry of Higher Education, Research and the Arts of the State of Hessen LOEWE-Programme; German Center for Lung Research (Deutsches Zentrum fur Lungenforschung)	This work was supported by the Max Planck Society; the German Research Foundation through Individual Grant Mo1789/1-1 (to R. E. M.) and Excellence Cluster 147 "Cardio-Pulmonary System" (to K. M., S. H., I. V., W. S., and R. E. M.); the Federal Ministry of Higher Education, Research and the Arts of the State of Hessen LOEWE-Programme (to K. M., S. H., I. V., W. S., and R. E. M.); and the German Center for Lung Research (Deutsches Zentrum fur Lungenforschung).	Abe H, 2012, J BIOL CHEM, V287, P20430, DOI 10.1074/jbc.M111.275610; Alejandre-Alcazar MA, 2008, DEV DYNAM, V237, P259, DOI 10.1002/dvdy.21403; Alejandre-Alcazar MA, 2007, AM J PHYSIOL-LUNG C, V292, pL537, DOI 10.1152/ajplung.00050.2006; Althaus M, 2011, AM J RESP CELL MOL, V44, P53, DOI 10.1165/2009-0335OC; Araoka T, 2010, MOL CELLS, V30, P209, DOI 10.1007/s10059-010-0109-9; Barnes PJ, 2011, J BIOL CHEM, V286, P32899, DOI 10.1074/jbc.R110.206466; Barnes PJ, 2011, IMMUNOL REV, V242, P31, DOI 10.1111/j.1600-065X.2011.01020.x; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Barnes PJ, 2010, RESPIRATION, V80, P89, DOI 10.1159/000315416; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Chen WQ, 2013, ARTERIOSCL THROM VAS, V33, P305, DOI 10.1161/ATVBAHA.112.300485; Collins JJP, 2013, AM J PHYSIOL-LUNG C, V304, pL438, DOI 10.1152/ajplung.00251.2012; Collins JJP, 2012, AM J PHYSIOL-LUNG C, V303, pL778, DOI 10.1152/ajplung.00280.2011; Czock D, 2005, CLIN PHARMACOKINET, V44, P61, DOI 10.2165/00003088-200544010-00003; Davidson ENB, 2009, J IMMUNOL, V182, P7937, DOI 10.4049/jimmunol.0803991; de Benedictis FM, 2012, AM J RESP CRIT CARE, V185, P12, DOI 10.1164/rccm.201107-1174CI; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Doyle LW, 2010, NEONATOLOGY, V98, P217, DOI 10.1159/000286210; Eickelberg O, 2007, TRENDS CARDIOVAS MED, V17, P263, DOI 10.1016/j.tcm.2007.09.003; Farkas L, 2011, AM J PHYSIOL-LUNG C, V301, pL391, DOI 10.1152/ajplung.00369.2010; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Geraci MW, 2001, CIRC RES, V88, P555, DOI 10.1161/01.RES.88.6.555; Girerd B, 2010, AM J RESP CRIT CARE, V181, P851, DOI 10.1164/rccm.200908-1284OC; Gordon KJ, 2008, CARCINOGENESIS, V29, P252, DOI 10.1093/carcin/bgm249; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Gu L, 2004, ACTA PHARMACOL SIN, V25, P1479; Hubner M, 2005, IMMUNOL ALLERGY CLIN, V25, P469, DOI 10.1016/j.iac.2005.05.004; Islam SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061340; Jain M, 2011, AM J RESP CRIT CARE, V183, P1490, DOI 10.1164/rccm.201009-1409OC; Jeffery TK, 2005, AM J PHYSIOL-LUNG C, V288, pL370, DOI 10.1152/ajplung.00242.2004; Josephson MB, 2012, AM J PHYSIOL-LUNG C, V303, pL382, DOI 10.1152/ajplung.00125.2012; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kumarasamy A, 2009, AM J RESP CRIT CARE, V180, P1239, DOI 10.1164/rccm.200902-0215OC; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Long L, 2009, CIRCULATION, V119, P566, DOI 10.1161/CIRCULATIONAHA.108.821504; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; Madurga A, 2013, AM J PHYSIOL-LUNG C, V305, pL893, DOI 10.1152/ajplung.00267.2013; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsubara T, 2006, LAB INVEST, V86, P357, DOI 10.1038/labinvest.3700400; McDevitt TM, 2007, AM J PHYSIOL-LUNG C, V292, pL249, DOI 10.1152/ajplung.00088.2006; Mima A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017929; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Morris E, 2011, J CELL PHYSIOL, V226, P3340, DOI 10.1002/jcp.22690; Morty RE, 2007, ARTERIOSCL THROM VAS, V27, P1072, DOI 10.1161/ATVBAHA.107.141200; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Phan Sem H, 2012, Proc Am Thorac Soc, V9, P148, DOI 10.1513/pats.201201-011AW; Ponce-Castaneda MV, 1998, BBA-PROTEIN STRUCT M, V1384, P189, DOI 10.1016/S0167-4838(98)00033-8; Price LC, 2011, EUR RESPIR J, V37, P813, DOI 10.1183/09031936.00028310; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rosendahl A, 2002, AM J RESP CELL MOL, V27, P160, DOI 10.1165/ajrcmb.27.2.4779; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Scharpfenecker M, 2009, INT J RADIAT ONCOL, V73, P506, DOI 10.1016/j.ijrobp.2008.09.052; Southwood M, 2008, J PATHOL, V214, P85, DOI 10.1002/path.2261; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Tarantal AF, 2010, EUR RESPIR J, V36, P907, DOI 10.1183/09031936.00011810; Thompson BT, 2010, MINERVA ANESTESIOL, V76, P441; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Walter Nicholas, 2006, Proc Am Thorac Soc, V3, P330, DOI 10.1513/pats.200602-016TK; Wapner R, 2011, CLIN PERINATOL, V38, P529, DOI 10.1016/j.clp.2011.06.013; Warburton D, 2013, AM J PHYSIOL-LUNG C, V304, pL83, DOI 10.1152/ajplung.00258.2012; Watterberg K, 2012, CLIN PERINATOL, V39, P47, DOI 10.1016/j.clp.2011.12.017; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xu B, 2012, AM J PHYSIOL-LUNG C, V303, pL89, DOI 10.1152/ajplung.00060.2012; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yao HW, 2012, AM J PHYSIOL-LUNG C, V303, pL557, DOI 10.1152/ajplung.00175.2012; Zakrzewicz A, 2007, EUR RESPIR J, V29, P1094, DOI 10.1183/09031936.00138206	70	42	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3262	3275		10.1074/jbc.M113.541052	http://dx.doi.org/10.1074/jbc.M113.541052			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24347165	hybrid, Green Published			2022-12-28	WOS:000331368700014
J	Spomer, L; Gertzen, CGW; Schmitz, B; Haussinger, D; Gohlke, H; Keitel, V				Spomer, Lina; Gertzen, Christoph G. W.; Schmitz, Birte; Haeussinger, Dieter; Gohlke, Holger; Keitel, Verena			A Membrane-proximal, C-terminal alpha-Helix Is Required for Plasma Membrane Localization and Function of the G Protein-coupled Receptor (GPCR) TGR5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-Helix Receptor; Bile Acid; Cyclic AMP (cAMP); Molecular Dynamics; Trafficking	BILE-ACID RECEPTOR; CARBOXYL-TERMINUS; CRYSTAL-STRUCTURE; ENDOPLASMIC-RETICULUM; SECONDARY STRUCTURE; GPBAR1 TGR5; TRANSPORT; EXPRESSION; ACTIVATION; SIMULATION	Background: TGR5 is a G protein-coupled bile acid receptor that modulates the immune response, glucose homeostasis, and liver regeneration. Results: Secondary structure of the receptor C terminus determines plasma membrane trafficking. Conclusion: TGR5 plasma membrane content and responsiveness to extracellular ligands depends on C-terminal -helix formation. Significance: This provides insights into the structure-function relationship of TGR5, which is a potential drug target for metabolic diseases. The C terminus of G protein-coupled receptors (GPCRs) is important for G protein-coupling and activation; in addition, sorting motifs have been identified in the C termini of several GPCRs that facilitate correct trafficking from the endoplasmic reticulum to the plasma membrane. The C terminus of the GPCR TGR5 lacks any known sorting motif such that other factors must determine its trafficking. Here, we investigate deletion and substitution variants of the membrane-proximal C terminus of TGR5 with respect to plasma membrane localization and function using immunofluorescence staining, flow cytometry, and luciferase assays. Peptides of the membrane-proximal C-terminal variants are subjected to molecular dynamics simulations and analyzed with respect to their secondary structure. Our results reveal that TGR5 plasma membrane localization and responsiveness to extracellular ligands is fostered by a long ( 9 residues) -helical stretch at the C terminus, whereas the presence of -strands or only a short -helical stretch leads to retention in the endoplasmic reticulum and a loss of function. As a proof-of-principle, chimeras of TGR5 containing the membrane-proximal amino acids of the (2) adrenergic receptor ((2)AR), the sphingosine 1-phosphate receptor-1 (S1P1), or the -type opioid receptor (OR) were generated. These TGR5(2)AR, TGR5S1P1, or TGR5OR chimeras were correctly sorted to the plasma membrane. As the exchanged amino acids of the (2)AR, the S1P1, or the OR form -helices in crystal structures but lack significant sequence identity to the respective TGR5 sequence, we conclude that the secondary structure of the TGR5 membrane-proximal C terminus is the determining factor for plasma membrane localization and responsiveness towards extracellular ligands.	[Spomer, Lina; Haeussinger, Dieter; Keitel, Verena] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany; [Gertzen, Christoph G. W.; Schmitz, Birte; Gohlke, Holger] Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Keitel, V (corresponding author), Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany.	verena.keitel@med.uni-duesseldorf.de	Keitel, Verena/AAF-3471-2019; Keitel, Verena/AAH-9016-2021	Keitel, Verena/0000-0003-1383-7662	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 974 Dusseldorf]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 974 Dusseldorf "Kommunikation und Systemrelevanz bei Leberschadigung und Regeneration."	Ahn KH, 2010, BIOCHEMISTRY-US, V49, P502, DOI 10.1021/bi901619r; Ahn KH, 2009, BIOPOLYMERS, V91, P565, DOI 10.1002/bip.21179; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHAKRABARTTY A, 1991, NATURE, V351, P586, DOI 10.1038/351586a0; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Sancho D, 2011, J AM CHEM SOC, V133, P6809, DOI 10.1021/ja200834s; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Gnanakaran S, 2003, CURR OPIN STRUC BIOL, V13, P168, DOI 10.1016/S0959-440X(03)00040-X; Golovin A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-312; Hammad MM, 2012, BIOL CHEM, V393, P541, DOI 10.1515/hsz-2011-0284; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hov JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012403; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Keitel V, 2012, CLIN RES HEPATOL GAS, V36, P412, DOI 10.1016/j.clinre.2012.03.008; Keitel V, 2010, GLIA, V58, P1794, DOI 10.1002/glia.21049; Keitel V, 2010, BIOL CHEM, V391, P785, DOI 10.1515/BC.2010.077; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lavoie B, 2010, J PHYSIOL-LONDON, V588, P3295, DOI 10.1113/jphysiol.2010.192146; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Lin MM, 2011, P NATL ACAD SCI USA, V108, P16622, DOI 10.1073/pnas.1113649108; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; Oksche A, 1998, FEBS LETT, V424, P57, DOI 10.1016/S0014-5793(98)00140-9; Orel M, 2012, FEBS J, V279, P2357, DOI 10.1111/j.1742-4658.2012.08614.x; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Poole DP, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01487.x; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RODRIGUEZ MC, 1992, MOL ENDOCRINOL, V6, P327, DOI 10.1210/me.6.3.327; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sato H, 2008, J MED CHEM, V51, P1831, DOI 10.1021/jm7015864; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stadel R, 2011, J NEUROCHEM, V117, P1, DOI 10.1111/j.1471-4159.2011.07186.x; Team RC., 2022, LANG ENV STAT COMP; Thielen A, 2005, FEBS LETT, V579, P5227, DOI 10.1016/j.febslet.2005.08.043; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034	56	12	12	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3689	3702		10.1074/jbc.M113.502344	http://dx.doi.org/10.1074/jbc.M113.502344			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24338481	Green Published, hybrid			2022-12-28	WOS:000331368700050
J	Brookheart, RT; Lee, CYS; Espenshade, PJ				Brookheart, Rita T.; Lee, Chih-Yung S.; Espenshade, Peter J.			Casein Kinase 1 Regulates Sterol Regulatory Element-binding Protein (SREBP) to Control Sterol Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein Stability; Serine; Threonine Protein Kinase; Sterol; Transcription Factors; Yeast; CK1; Casein Kinase 1; SREBP	FISSION YEAST SREBP; DSC E3 LIGASE; SCHIZOSACCHAROMYCES-POMBE; CIRCADIAN CLOCK; DNA-BINDING; TRANSCRIPTION FACTORS; MOLECULAR-CLONING; CKI-EPSILON; OXYGEN; DEGRADATION	Background: SREBP transcription factor controls sterol homeostasis. Results: Fission yeast casein kinase 1 (CK1) binds and accelerates degradation of active SREBP, inhibiting expression of target genes and decreasing ergosterol. Conclusion: CK1 controls nuclear SREBP stability to regulate sterol homeostasis in fission yeast. Significance: CK1 is the first kinase shown to regulate fungal SREBP and functions in the control of SREBP and sterol homeostasis. Sterol homeostasis is tightly controlled by the sterol regulatory element-binding protein (SREBP) transcription factor that is highly conserved from fungi to mammals. In fission yeast, SREBP functions in an oxygen-sensing pathway to promote adaptation to decreased oxygen supply that limits oxygen-dependent sterol synthesis. Low oxygen stimulates proteolytic cleavage of the SREBP homolog Sre1, generating the active transcription factor Sre1N that drives expression of sterol biosynthetic enzymes. In addition, low oxygen increases the stability and DNA binding activity of Sre1N. To identify additional signals controlling Sre1 activity, we conducted a genetic overexpression screen. Here, we describe our isolation and characterization of the casein kinase 1 family member Hhp2 as a novel regulator of Sre1N. Deletion of Hhp2 increases Sre1N protein stability and ergosterol levels in the presence of oxygen. Hhp2-dependent Sre1N degradation by the proteasome requires Hhp2 kinase activity, and Hhp2 binds and phosphorylates Sre1N at specific residues. Our results describe a role for casein kinase 1 as a direct regulator of sterol homeostasis. Given the role of mammalian Hhp2 homologs, casein kinase 1 and 1E, in regulation of the circadian clock, these findings may provide a mechanism for coordinating circadian rhythm and lipid metabolism.	[Brookheart, Rita T.; Lee, Chih-Yung S.; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu			National Institutes of Health [HL077588, HL106971]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL106971, R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077588 (to P. J. E.) and HL106971 (to R. T. B.).	Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BURKE JD, 1994, MOL GEN GENET, V242, P169, DOI 10.1007/BF00391010; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; DHILLON N, 1994, EMBO J, V13, P2777, DOI 10.1002/j.1460-2075.1994.tb06571.x; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Grietzen KF, 1999, J BIOL CHEM, V274, P32063, DOI 10.1074/jbc.274.45.32063; Hatori M, 2011, P NATL ACAD SCI USA, V108, P4864, DOI 10.1073/pnas.1015959108; HAYLES J, 1992, ANNU REV GENET, V26, P373, DOI 10.1146/annurev.ge.26.120192.002105; HOEKSTRA MF, 1994, MOL BIOL CELL, V5, P877, DOI 10.1091/mbc.5.8.877; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hughes AL, 2007, J BIOL CHEM, V282, P24388, DOI 10.1074/jbc.M701326200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ishiguro T, 2010, NAT CELL BIOL, V12, P500, DOI 10.1038/ncb2052; Janoo RTK, 2001, GENETICS, V157, P1205; Kalousi A, 2010, J CELL SCI, V123, P2976, DOI 10.1242/jcs.068122; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; KEARNEY PH, 1994, BIOCHEM BIOPH RES CO, V203, P231, DOI 10.1006/bbrc.1994.2172; Kotzka J, 2004, J BIOL CHEM, V279, P22404, DOI 10.1074/jbc.M401198200; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee CYS, 2011, MOL CELL, V44, P225, DOI 10.1016/j.molcel.2011.08.031; Lee CYS, 2009, EMBO J, V28, P135, DOI 10.1038/emboj.2008.271; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Li SM, 2011, MOL ENDOCRINOL, V25, P2084, DOI 10.1210/me.2011-1227; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Matsumoto E, 2010, J BIOL CHEM, V285, P33028, DOI 10.1074/jbc.M109.089391; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porter JR, 2012, MOL BIOL CELL, V23, P3764, DOI 10.1091/mbc.E12-06-0451; Porter JR, 2010, J BIOL CHEM, V285, P41051, DOI 10.1074/jbc.M110.144337; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; Rosenfeld E, 2003, YEAST, V20, P1115, DOI 10.1002/yea.1026; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rumpf C, 2010, CELL CYCLE, V9, P2657, DOI 10.4161/cc.9.13.12146; Sehgal A, 2007, PLOS GENET, V3, P1389, DOI 10.1371/journal.pgen.0030131; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462	64	11	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2725	2735		10.1074/jbc.M113.511899	http://dx.doi.org/10.1074/jbc.M113.511899			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24327658	Green Published, hybrid			2022-12-28	WOS:000333403000022
J	Li, XM; Xu, M; Wang, F; Kohan, AB; Haas, MK; Yang, Q; Lou, DW; Obici, S; Davidson, WS; Tso, P				Li, Xiaoming; Xu, Min; Wang, Fei; Kohan, Alison B.; Haas, Michael K.; Yang, Qing; Lou, Danwen; Obici, Silvana; Davidson, W. Sean; Tso, Patrick			Apolipoprotein A-IV Reduces Hepatic Gluconeogenesis through Nuclear Receptor NR1D1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apolipoproteins; Diabetes; Gluconeogenesis; Nuclear Receptors; Phosphoenolpyruvate Carboxykinase; Apolipoprotein A-IV; NR1D1	REV-ERB-ALPHA; FREE HORMONE HYPOTHESIS; PLASMA APOLIPOPROTEINS; BINDING PROTEINS; CELLULAR UPTAKE; AIV; METABOLISM; SECRETION; INTESTINE; CELLS	We showed recently that apoA-IV improves glucose homeostasis by enhancing pancreatic insulin secretion in the presence of elevated levels of glucose. Therefore, examined whether apolipoprotein A-IV (apoA-IV) also regulates glucose metabolism through the suppression of hepatic gluconeogenesis. The ability of apoA-IV to lower gluconeogenic gene expression and glucose production was measured in apoA-IV-/- and wild-type mice and primary mouse hepatocytes. The transcriptional regulation of Glc-6-Pase and phosphoenolpyruvate carboxykinase (PEPCK) by apoA-IV was determined by luciferase activity assay. Using bacterial two-hybrid library screening, NR1D1 was identified as a putative apoA-IV-binding protein. The colocalization and interaction between apoA-IV and NR1D1 were confirmed by immunofluorescence, in situ proximity ligation assay, and coimmunoprecipitation. Enhanced recruitment of NR1D1 and activity by apoA-IV to Glc-6-Pase promoter was verified with ChIP and a luciferase assay. Down-regulation of apoA-IV on gluconeogenic genes is mediated through NR1D1, as illustrated in cells with NR1D1 knockdown by siRNA. We found that apoA-IV suppresses the expression of PEPCK and Glc-6-Pase in hepatocytes; decreases hepatic glucose production; binds and activates nuclear receptor NR1D1 and stimulates NR1D1 expression; in cells lacking NR1D1, fails to inhibit PEPCK and Glc-6-Pase gene expression; and stimulates higher hepatic glucose production and higher gluconeogenic gene expression in apoA-IV-/- mice. We conclude that apoA-IV inhibits hepatic gluconeogenesis by decreasing Glc-6-Pase and PEPCK gene expression through NR1D1. This novel regulatory pathway connects an influx of energy as fat from the gut (and subsequent apoA-IV secretion) with inhibition of hepatic glucose production.	[Li, Xiaoming; Xu, Min; Wang, Fei; Kohan, Alison B.; Haas, Michael K.; Yang, Qing; Lou, Danwen; Obici, Silvana; Davidson, W. Sean; Tso, Patrick] Univ Cincinnati, Metab Dis Inst, Cincinnati Obes Res Ctr, Cincinnati, OH 45237 USA; [Li, Xiaoming; Xu, Min; Wang, Fei; Kohan, Alison B.; Yang, Qing; Lou, Danwen; Davidson, W. Sean; Tso, Patrick] Univ Cincinnati, Metab Dis Inst, Dept Pathol & Lab Med, Coll Med, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Tso, P (corresponding author), Univ Cincinnati, Metab Dis Inst, Dept Pathol & Lab Med, 2120 E Galbraith Rd, Cincinnati, OH 45237 USA.	tsopp@ucmail.uc.edu		Davidson, William/0000-0003-2756-2989; Kohan, Alison/0000-0003-3127-7283	National Institutes of Health [DK 59630, DK 92138, DK 76928, F32-091173-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059630, U24DK059630, R01DK092138, R01DK076928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 59630, DK 92138, and DK 76928 (to P. T.) and F32-091173-01 (to A. B. K.).	Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Andreassen TK, 2006, HORM METAB RES, V38, P279, DOI 10.1055/s-2006-925348; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bajzer M, 2011, DIABETOLOGIA, V54, P3121, DOI 10.1007/s00125-011-2302-6; BISGAIER CL, 1985, J LIPID RES, V26, P11; Bottermann K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066045; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; De Wolf FA, 2000, PHARMACOL REV, V52, P207; Duez H, 2008, DIABETES VASC DIS RE, V5, P82, DOI 10.3132/dvdr.2008.0014; EMMANUEL F, 1994, J BIOL CHEM, V269, P29883; Ferretti G, 2002, CHEM PHYS LIPIDS, V114, P45, DOI 10.1016/S0009-3084(01)00201-8; GHISELLI G, 1989, BIOCHIM BIOPHYS ACTA, V1006, P26, DOI 10.1016/0005-2760(89)90319-6; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Hall Robert K., 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P119; Hammes A, 2005, CELL, V122, P751, DOI 10.1016/j.cell.2005.06.032; Hammond GL, 2002, OBSTET GYN CLIN N AM, V29, P411, DOI 10.1016/S0889-8545(02)00008-6; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; IWATSUKA H, 1970, ENDOCRINOL JAPON, V17, P23; KALOGERIS TJ, 1994, J LIPID RES, V35, P1141; Kalogeris TJ, 2001, AM J PHYSIOL-REG I, V280, pR1155, DOI 10.1152/ajpregu.2001.280.4.R1155; Laitinen S, 2005, BIOCHIMIE, V87, P21, DOI 10.1016/j.biochi.2004.12.006; Liu M, 2001, AM J PHYSIOL-REG I, V280, pR1382, DOI 10.1152/ajpregu.2001.280.5.R1382; Lo CM, 2011, DIABETES, V60, P2000, DOI 10.2337/db10-0789; Lu S, 2006, J BIOL CHEM, V281, P3473, DOI 10.1074/jbc.M502501200; Main LA, 1996, BBA-LIPID LIPID MET, V1300, P17, DOI 10.1016/0005-2760(95)00228-6; MENDEL CM, 1989, ENDOCRINOLOGY, V124, P468, DOI 10.1210/endo-124-1-468; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; Pan XY, 2013, J BIOL CHEM, V288, P20464, DOI 10.1074/jbc.M113.473454; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Thorngate FE, 2003, J LIPID RES, V44, P2331, DOI 10.1194/jlr.M300224-JLR200; UNGER RH, 1985, DIABETOLOGIA, V28, P574, DOI 10.1007/BF00281991; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Watson CS, 2003, EXP BIOL MED, V228, P1272, DOI 10.1177/153537020322801106; Weinberg RB, 2002, CURR OPIN LIPIDOL, V13, P125, DOI 10.1097/00041433-200204000-00003; WINDMUELLER HG, 1981, J BIOL CHEM, V256, P3012; WU AL, 1979, J BIOL CHEM, V254, P7316; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	43	33	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2396	2404		10.1074/jbc.M113.511766	http://dx.doi.org/10.1074/jbc.M113.511766			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24311788	Green Published, hybrid			2022-12-28	WOS:000331130200043
J	El Hachmane, MF; Rees, KA; Veale, EL; Sumbayev, VV; Mathie, A				El Hachmane, Mickael-F; Rees, Kathryn A.; Veale, Emma L.; Sumbayev, Vadim V.; Mathie, Alistair			Enhancement of TWIK-related Acid-sensitive Potassium Channel 3 (TASK3) Two-pore Domain Potassium Channel Activity by Tumor Necrosis Factor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Ion Channels; Jun N-terminal Kinase (JNK); p38; Patch Clamp Electrophysiology; Potassium Channels; Tumor Necrosis Factor (TNF)	CEREBELLAR GRANULE NEURONS; K+ CHANNELS; CELL-DEATH; TNF-ALPHA; VOLUME REGULATION; APOPTOTIC SURGE; UP-REGULATION; K2P CHANNELS; NITRIC-OXIDE; ACTIVATION	Background: TASK3 potassium channels regulate cellular excitability and intracellular potassium homeostasis. Results: TNF enhances current through TASK3 channels by modulating channel gating. Conclusion: TNF treatment, together with an increase of potassium efflux through TASK3 channels, promotes apoptosis. Significance: A novel mechanism for TNF-mediated changes in cellular homeostasis is described. TASK3 two-pore domain potassium (K2P) channels are responsible for native leak K channels in many cell types which regulate cell resting membrane potential and excitability. In addition, TASK3 channels contribute to the regulation of cellular potassium homeostasis. Because TASK3 channels are important for cell viability, having putative roles in both neuronal apoptosis and oncogenesis, we sought to determine their behavior under inflammatory conditions by investigating the effect of TNF on TASK3 channel current. TASK3 channels were expressed in tsA-201 cells, and the current through them was measured using whole cell voltage clamp recordings. We show that THP-1 human myeloid leukemia monocytes, co-cultured with hTASK3-transfected tsA-201 cells, can be activated by the specific Toll-like receptor 7/8 activator, R848, to release TNF that subsequently enhances hTASK3 current. Both hTASK3 and mTASK3 channel activity is increased by incubation with recombinant TNF (10 ng/ml for 2-15 h), but other K2P channels (hTASK1, hTASK2, hTREK1, and hTRESK) are unaffected. This enhancement by TNF is not due to alterations in levels of channel expression at the membrane but rather to an alteration in channel gating. The enhancement by TNF can be blocked by extracellular acidification but persists for mutated TASK3 (H98A) channels that are no longer acid-sensitive even in an acidic extracellular environment. TNF action on TASK3 channels is mediated through the intracellular C terminus of the channel. Furthermore, it occurs through the ASK1 pathway and is JNK- and p38-dependent. In combination, TNF activation and TASK3 channel activity can promote cellular apoptosis.	[El Hachmane, Mickael-F; Rees, Kathryn A.; Veale, Emma L.; Sumbayev, Vadim V.; Mathie, Alistair] Univ Kent, Medway Sch Pharm, Chatham ME4 4TB, Kent, England	University of Greenwich; University of Kent	Mathie, A (corresponding author), Univ Kent, Medway Sch Pharm, Cent Ave, Chatham ME4 4TB, Kent, England.	a.a.mathie@kent.ac.uk	Mathie, Alistair/K-7198-2019; Veale, Emma/AAA-5022-2022; Sumbayev, Vadim/HCH-7696-2022	Mathie, Alistair/0000-0001-6094-2890; Veale, Emma/0000-0002-6778-9929; 	BBSRC; BBSRC [BB/J000930/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J000930/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Royal Society Industry Fellow, supported by the BBSRC. To whom correspondence should be addressed. Tel.: 01634-202955; Fax: 01634-883927; E-mail: a.a.mathie@kent.ac.uk.	Aimond F, 2000, J BIOL CHEM, V275, P39110, DOI 10.1074/jbc.M008192200; Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Aras MA, 2005, NEUROSCI LETT, V387, P136, DOI 10.1016/j.neulet.2005.06.024; Bagriantsev SN, 2012, EMBO J, V31, P3297, DOI 10.1038/emboj.2012.171; Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Barone FC, 2001, MED RES REV, V21, P129, DOI 10.1002/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO;2-H; Bittner S, 2010, BRAIN PATHOL, V20, P999, DOI 10.1111/j.1750-3639.2010.00407.x; Bittner S, 2009, BRAIN, V132, P2501, DOI 10.1093/brain/awp163; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Brickley SG, 2007, J NEUROSCI, V27, P9329, DOI 10.1523/JNEUROSCI.1427-07.2007; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Clarke CE, 2008, J BIOL CHEM, V283, P16985, DOI 10.1074/jbc.M801368200; Clarke CE, 2004, J PHYSIOL-LONDON, V560, P51, DOI 10.1113/jphysiol.2004.070292; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Czeschik JC, 2008, NEUROSCI LETT, V434, P293, DOI 10.1016/j.neulet.2008.01.070; Czirjak G, 2003, MOL PHARMACOL, V63, P646, DOI 10.1124/mol.63.3.646; Defer N, 2007, J BIOL CHEM, V282, P35564, DOI 10.1074/jbc.M704003200; Dolga AM, 2008, J NEUROCHEM, V107, P1158, DOI 10.1111/j.1471-4159.2008.05701.x; Duprat F, 2005, J PHYSIOL-LONDON, V562, P235, DOI 10.1113/jphysiol.2004.071266; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Goetz FW, 2004, DEV COMP IMMUNOL, V28, P487, DOI 10.1016/j.dci.2003.09.008; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Houzen H, 1997, J NEUROSCI RES, V50, P990, DOI 10.1002/(SICI)1097-4547(19971215)50:6<990::AID-JNR9>3.3.CO;2-8; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Kapiszewska M, 2007, TOXICOL IN VITRO, V21, P1020, DOI 10.1016/j.tiv.2007.03.005; Knoch ME, 2008, GLIA, V56, P89, DOI 10.1002/glia.20592; Lauritzen I, 2003, J BIOL CHEM, V278, P32068, DOI 10.1074/jbc.M302631200; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Marsh B, 2012, MOL CELL NEUROSCI, V49, P375, DOI 10.1016/j.mcn.2012.01.002; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; Mathie A, 2010, J PHYSIOL-LONDON, V588, P3149, DOI 10.1113/jphysiol.2010.192344; McLaughlin B, 2001, J NEUROSCI, V21, P3303, DOI 10.1523/JNEUROSCI.21-10-03303.2001; Meuth SG, 2008, J NEURO-ONCOL, V87, P263, DOI 10.1007/s11060-008-9517-5; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Montague JW, 1999, STEROIDS, V64, P563, DOI 10.1016/S0039-128X(99)00034-3; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; Nam JH, 2011, AM J PHYSIOL-CELL PH, V300, pC1013, DOI 10.1152/ajpcell.00475.2010; Nicholas SA, 2009, CELL RES, V19, P973, DOI 10.1038/cr.2009.44; Niemeyer MI, 2000, J PHYSIOL-LONDON, V524, P757, DOI 10.1111/j.1469-7793.2000.00757.x; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Patel AJ, 2004, PFLUG ARCH EUR J PHY, V448, P261, DOI 10.1007/s00424-004-1255-8; Pei L, 2003, P NATL ACAD SCI USA, V100, P7803, DOI 10.1073/pnas.1232448100; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Redman PT, 2009, J PHYSIOL-LONDON, V587, P4393, DOI 10.1113/jphysiol.2009.176321; Seguin DG, 1997, AM J PHYSIOL-CELL PH, V272, pC1854, DOI 10.1152/ajpcell.1997.272.6.C1854; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Sumbayev VV, 2008, FEBS LETT, V582, P319, DOI 10.1016/j.febslet.2007.12.024; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Trimarchi JR, 2000, BIOL REPROD, V63, P851, DOI 10.1095/biolreprod63.3.851; Veale EL, 2007, MOL PHARMACOL, V71, P1666, DOI 10.1124/mol.106.033241; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Watkins CS, 1996, J PHYSIOL-LONDON, V491, P401, DOI 10.1113/jphysiol.1996.sp021224; Yi BA, 2001, P NATL ACAD SCI USA, V98, P11016, DOI 10.1073/pnas.191351798; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X	60	11	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1388	1401		10.1074/jbc.M113.500033	http://dx.doi.org/10.1074/jbc.M113.500033			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24307172	hybrid, Green Published			2022-12-28	WOS:000332401700017
J	Martinez-Sernandez, V; Mezo, M; Gonzalez-Warleta, M; Perteguer, MJ; Muino, L; Guitian, E; Garate, T; Ubeira, FM				Martinez-Sernandez, Victoria; Mezo, Mercedes; Gonzalez-Warleta, Marta; Perteguer, Maria J.; Muino, Laura; Guitian, Esteban; Garate, Teresa; Ubeira, Florencio M.			The MF6p/FhHDM-1 Major Antigen Secreted by the Trematode Parasite Fasciola hepatica Is a Heme-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heme; Iron; Parasite; Trafficking; Transporters	CATTLE TICK; CELLS; PEROXIDASE; TRAFFICKING; DEGRADATION; ADAPTATIONS; FAMILY; SHEEP	Background: The mechanisms involved in heme handling in trematodes are poorly understood. Results: The biochemical and functional characteristics of a new family of small proteins (MF6p/FhHDM-1) secreted by Fasciola and other trematodes are reported. Conclusion: The Fasciola MF6p/FhHDM-1 major antigen is a heme-binding protein. Significance: Our results provide new insights into the biology of hematophagous trematodes. Blood-feeding parasites have developed biochemical mechanisms to control heme intake and detoxification. Here we show that a major antigen secreted by Fasciola hepatica, previously reported as MF6p, of unknown function (gb|CCA61804.1), and as FhHDM-1, considered to be a helminth defense molecule belonging to the family of cathelicidin-like proteins (gb|ADZ24001.1), is in fact a heme-binding protein. The heme-binding nature of the MF6p/FhHDM-1 protein was revealed in two independent experiments: (i) immunopurification of the secreted proteinheme complexes with mAb MF6 and subsequent analysis by C8 reversed-phase HPLC and MS/MS spectrometry and (ii) analysis of the binding ability of the synthetic protein to hemin in vitro. By immunohistochemistry analysis, we have observed that MF6p/FhHDM-1 is produced by parenchymal cells and transported to other tissues (e.g. vitellaria and testis). Interestingly, MF6p/FhHDM-1 is absent both in the intestinal cells and in the lumen of cecum, but it can be released through the tegumental surface to the external medium, where it binds to free heme molecules regurgitated by the parasite after hemoglobin digestion. Proteins that are close analogs of the Fasciola MF6p/FhHDM-1 are present in other trematodes, including Clonorchis, Opistorchis, Paragonimus, Schistosoma, and Dicrocoelium. Using UV-visible spectroscopy and immunoprecipitation techniques, we observed that synthetic MF6p/FhHDM-1 binds to hemin with 1:1 stoichiometry and an apparent K-d of 1.14 x 10(-6) m(-1). We also demonstrated that formation of synthetic MF6p/FhHDM-1hemin complexes inhibited hemin degradation by hydrogen peroxide and hemin peroxidase-like activity in vitro. Our results suggest that MF6p/FhHDM-1 may be involved in heme homeostasis in trematodes.	[Martinez-Sernandez, Victoria; Muino, Laura; Ubeira, Florencio M.] Univ Santiago de Compostela, Fac Farm, Lab Parasitol, Santiago De Compostela 15782, Spain; [Mezo, Mercedes; Gonzalez-Warleta, Marta] INGACAL, Ctr Invest Agr Mabegondo, Lab Parasitol, Abegondo 15318, A Coruna, Spain; [Perteguer, Maria J.; Garate, Teresa] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid 28220, Spain; [Muino, Laura] Univ Autonoma Chile, Santiago, Chile; [Guitian, Esteban] Univ Santiago de Compostela, Unidad Espectrometria Masas & Prote, Santiago De Compostela 15782, Spain	Universidade de Santiago de Compostela; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidad Autonoma de Chile; Universidade de Santiago de Compostela	Ubeira, FM (corresponding author), Univ Santiago de Compostela, Fac Farm, Lab Parasitol, Santiago De Compostela 15782, Spain.	fm.ubeira@usc.es	González-Warleta, Marta/R-5124-2019; Mezo, Mercedes/R-4703-2019; PERTEGUER, MARIA J/T-1266-2018	González-Warleta, Marta/0000-0003-3315-5757; Mezo, Mercedes/0000-0001-8819-453X; PERTEGUER, MARIA J/0000-0002-7533-5134; Ubeira, Florencio/0000-0001-7312-2752; Guitian Fernandez, Esteban/0000-0002-7749-1149; Muino, Laura/0000-0002-6198-5304	Ministerio de Ciencia e Innovacion, Spain [AGL2010-22290-C02, AGL2011-30563-C03]; Xunta de Galicia, Spain [CN 2012/155]; European Fund for Regional Development (FEDER); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario)	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia, Spain(Xunta de Galicia); European Fund for Regional Development (FEDER)(European Commission); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario)	This work was supported in part by Ministerio de Ciencia e Innovacion, Spain, Grants AGL2010-22290-C02 and AGL2011-30563-C03; Xunta de Galicia, Spain, Grant CN 2012/155; and the European Fund for Regional Development (FEDER).; Recipient of a predoctoral fellowship from the Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario).	AFT RL, 1984, J BIOL CHEM, V259, P301; Ahmad E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026186; Andrews SJ, 1999, FASCIOLOSIS, P1; Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; BALLA G, 1991, LAB INVEST, V64, P648; Cervi Laura, 2009, Current Immunology Reviews, V5, P277; Chen CY, 2011, CELL, V145, P720, DOI 10.1016/j.cell.2011.04.025; Dewilde S, 2008, PROTEIN SCI, V17, P1653, DOI 10.1110/ps.036558.108; Dowling DJ, 2010, INFECT IMMUN, V78, P793, DOI 10.1128/IAI.00573-09; Drevet JR, 2006, MOL CELL ENDOCRINOL, V250, P70, DOI 10.1016/j.mce.2005.12.027; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Fairweather I, 1999, FASCIOLOSIS, P47; Giuliani A, 2010, METHODS MOL BIOL, V618, P137, DOI 10.1007/978-1-60761-594-1_10; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Grinberg LN, 1999, FREE RADICAL BIO MED, V27, P214, DOI 10.1016/S0891-5849(99)00082-9; Halton DW, 1997, INT J PARASITOL, V27, P693, DOI 10.1016/S0020-7519(97)00011-8; Hamilton CM, 2009, INFECT IMMUN, V77, P2488, DOI 10.1128/IAI.00919-08; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; HOPKINS DR, 1992, AM J TROP MED HYG, V46, P626, DOI 10.4269/ajtmh.1992.46.626; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Kotpal R. L., 2012, MODERN TXB ZOOLOGY I, P335; Kumar S, 2008, ANTIMICROB AGENTS CH, V52, P705, DOI 10.1128/AAC.00898-07; Kumar V., 1999, TREMATODE INFECT DIS, P19; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lara FA, 2005, J EXP BIOL, V208, P3093, DOI 10.1242/jeb.01749; Lechardeur D, 2010, J BIOL CHEM, V285, P16032, DOI 10.1074/jbc.M109.024505; Lee KS, 2007, J BIOL CHEM, V282, P36525, DOI 10.1074/jbc.M705620200; Li BL, 2009, ANAL CHIM ACTA, V651, P234, DOI 10.1016/j.aca.2009.09.009; Li T, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-13; Logullo C, 2002, INSECT BIOCHEM MOLEC, V32, P1805, DOI 10.1016/S0965-1748(02)00162-5; Lowther J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000369; Martinez-Ibeas AM, 2013, EXP PARASITOL, V135, P287, DOI 10.1016/j.exppara.2013.07.005; Mas-Coma S, 2009, ADV PARASIT, V69, P41, DOI 10.1016/S0065-308X(09)69002-3; Maya-Monteiro CM, 2004, INSECT BIOCHEM MOLEC, V34, P81, DOI 10.1016/j.ibmb.2003.09.005; MCGONIGLE S, 1995, PARASITOLOGY, V111, P209, DOI 10.1017/S0031182000064969; Mehlhorn H., 2008, ENCY PARASITOLOGY, P137; Mezo M, 2004, J PARASITOL, V90, P845, DOI 10.1645/GE-192R; Mezo M, 2003, J PARASITOL, V89, P843, DOI 10.1645/GE-74RI.1; Mezo M, 2011, VET PARASITOL, V180, P237, DOI 10.1016/j.vetpar.2011.03.009; Muino L, 2011, MOL BIOCHEM PARASIT, V179, P80, DOI 10.1016/j.molbiopara.2011.06.003; OLIVEIRA PL, 1995, J BIOL CHEM, V270, P10897, DOI 10.1074/jbc.270.18.10897; Pankao V, 2006, VET PARASITOL, V142, P281, DOI 10.1016/j.vetpar.2006.07.009; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Reedy CJ, 2008, NUCLEIC ACIDS RES, V36, pD307, DOI 10.1093/nar/gkm814; RIM HJ, 1994, PARASITOL TODAY, V10, P207, DOI 10.1016/0169-4758(94)90111-2; Robinson MW, 2012, FASEB J, V26, P4614, DOI 10.1096/fj.12-213876; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; SANMARTIN ML, 1991, PARASITOL RES, V77, P301, DOI 10.1007/BF00930905; Stiebler R, 2011, J BIOENERG BIOMEMBR, V43, P93, DOI 10.1007/s10863-011-9335-x; Tielens AGM, 1999, FASCIOLOSIS, P277; Toh SQ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-108; Toledo R, 2011, J PROTEOMICS, V74, P1485, DOI 10.1016/j.jprot.2011.03.029; Torgerson P, 1999, FASCIOLOSIS, P113; Travascio P, 1998, CHEM BIOL, V5, P505, DOI 10.1016/S1074-5521(98)90006-0; Udipi S.A., 2012, OXIDATIVE STRESS MOL, P73; Wilks A., 2002, HEME CHLOROPHYLL BIL, P157	59	24	24	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1441	1456		10.1074/jbc.M113.499517	http://dx.doi.org/10.1074/jbc.M113.499517			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24280214	Green Published, hybrid			2022-12-28	WOS:000332401700021
J	Sedek, M; van der Velden, LM; Strous, GJ				Sedek, Magdalena; van der Velden, Lieke M.; Strous, Ger J.			Multimeric Growth Hormone Receptor Complexes Serve as Signaling Platforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Cell Surface Receptor; Cytokine Action; Growth Hormone; JAK Kinase; JAK2; SCFTrCP2; Blue Native Electrophoresis; Cytokine Receptor; Hexamers	LIGAND-INDUCED INTERNALIZATION; BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; DEGRADATION; PATHWAY; SYSTEM; IDENTIFICATION; DIMERIZATION; ENDOCYTOSIS; LINKAGE	Growth hormone (GH) signaling is required for promoting longitudinal body growth, stem cell activation, differentiation, and survival and for regulation of metabolism. Failure to adequately regulate GH signaling leads to disease: excessive GH signaling has been connected to cancer, and GH insensitivity has been reported in cachexia patients. Since its discovery in 1989, the receptor has served a pivotal role as the prototype cytokine receptor both structurally and functionally. Phosphorylation and ubiquitylation regulate the GH receptor (GHR) at the cell surface: two ubiquitin ligases (SCFTrCP2 and CHIP) determine the GH responsiveness of cells by controlling its endocytosis, whereas JAK2 initiates the JAK/STAT pathway. We used blue native electrophoresis to identify phosphorylated and ubiquitylated receptor intermediates. We show that GHRs occur as approximate to 500-kDa complexes that dimerize into active approximate to 900-kDa complexes upon GH binding. The dimerized complexes act as platforms for transient interaction with JAK2 and ubiquitin ligases. If GH and receptors are made in the same cell (autocrine mode), only limited numbers of approximate to 900-kDa complexes are formed. The experiments reveal the dynamic changes in post-translational modifications during GH-induced signaling events and show that relatively simple cytokine receptors like GHRs are able to form higher order protein complexes. Insight in the complex formation of cytokine receptors is crucially important for engineering cytokines that control ligand-induced cell responses and for generating a new class of therapeutic agents for a wide range of diseases.	[Strous, Ger J.] UMC Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; Univ Med Ctr Utrecht, Inst Biomembranes, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Strous, GJ (corresponding author), UMC Utrecht, Dept Cell Biol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	gstrous@umcutrecht.nl			Marie Curie Network Grant [MRTN-CT-2006-034555]; RUBICON European Network of Excellence Grant [LSHG-CT-2005-018683]	Marie Curie Network Grant; RUBICON European Network of Excellence Grant	The work was supported by Marie Curie Network Grant MRTN-CT-2006-034555 ("UbiRegulators") and RUBICON European Network of Excellence Grant LSHG-CT-2005-018683.	Almeida ACD, 2012, MOL ENDOCRINOL, V26, P165, DOI 10.1210/me.2011-1211; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Brunet-Dunand SE, 2009, ENDOCRINOLOGY, V150, P1341, DOI 10.1210/en.2008-0608; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; FRANK SJ, 1994, ENDOCRINOLOGY, V135, P148, DOI 10.1210/en.135.1.148; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Govers R, 1997, EMBO J, V16, P4851, DOI 10.1093/emboj/16.16.4851; Putters J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014676; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sedek M, 2013, BIOCHEM J, V453, P231, DOI 10.1042/BJ20121375; Slotman JA, 2012, J BIOL CHEM, V287, P15533, DOI 10.1074/jbc.M111.302521; Stroud R. M., 2004, SCI STKE, V2004, pre7; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; van den Eijnden MJ, 2007, MOL ENDOCRINOL, V21, P2832, DOI 10.1210/me.2007-0092; van den Eijnden MJM, 2006, J CELL SCI, V119, P3078, DOI 10.1242/jcs.03036; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; van Kerkhof P, 2002, ENDOCRINOLOGY, V143, P1243, DOI 10.1210/en.143.4.1243; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; van Kerkhof P, 2001, BIOCHEM SOC T, V29, P488, DOI 10.1042/BST0290488; van Kerkhof P, 2001, J BIOL CHEM, V276, P3778, DOI 10.1074/jbc.M007326200; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200	27	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					65	73		10.1074/jbc.M113.523373	http://dx.doi.org/10.1074/jbc.M113.523373			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24280222	Green Published, hybrid			2022-12-28	WOS:000329370900006
J	Kirwan, JP; Hodges, RS				Kirwan, J. Paul; Hodges, Robert S.			Transmission of Stability Information through the N-domain of Tropomyosin Is Interrupted by a Stabilizing Mutation (A109L) in the Hydrophobic Core of the Stability Control Region (Residues 97-118)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circular Dichroism (CD); Contractile Protein; Protein Stability; Recombinant Protein Expression; Tropomyosin; Stability Control Region; Tropomyosin N-domain 1-131; Differential Scanning Calorimetry (DSC); Stability Signal Transmission; Two-stranded Coiled-coils	HELICAL COILED-COILS; GCN4 LEUCINE-ZIPPER; DE-NOVO DESIGN; PERFORMANCE LIQUID-CHROMATOGRAPHY; AMINO-ACID SUBSTITUTIONS; AMPHIPATHIC ALPHA-HELIX; OLIGOMERIZATION-STATE; PROTEIN STABILITY; MUSCLE REGULATION; CRYSTAL-STRUCTURE	Background: A stability control region (SCR) (residues 97-118) is conserved in vertebrate tropomyosins and controls overall stability. Results: An A109L mutation interrupts the transmission of stability information along the coiled-coil, inducing two domains. Conclusion: The optimum stability provided by the SCR is critical for transmission of the stability signal. Significance: Learning how stability information is transmitted along tropomyosin is crucial to understanding function and signaling. Tropomyosin (Tm) is an actin-binding, thin filament, two-stranded -helical coiled-coil critical for muscle contraction and cytoskeletal function. We made the first identification of a stability control region (SCR), residues 97-118, in the Tm sequence that controls overall protein stability but is not required for folding. We also showed that the individual -helical strands of the coiled-coil are stabilized by Leu-110, whereas the hydrophobic core is destabilized in the SCR by Ala residues at three consecutive d positions. Our hypothesis is that the stabilization of the individual -helices provides an optimum stability and allows functionally beneficial dynamic motion between the -helices that is critical for the transmission of stabilizing information along the coiled-coil from the SCR. We prepared three recombinant (rat) Tm(1-131) proteins, including the wild type sequence, a destabilizing mutation L110A, and a stabilizing mutation A109L. These proteins were evaluated by circular dichroism (CD) and differential scanning calorimetry. The single mutation L110A destabilizes the entire Tm(1-131) molecule, showing that the effect of this mutation is transmitted 165 along the coiled-coil in the N-terminal direction. The single mutation A109L prevents the SCR from transmitting stabilizing information and separates the coiled-coil into two domains, one that is approximate to 9 degrees C more stable than wild type and one that is approximate to 16 degrees C less stable. We know of no other example of the substitution of a stabilizing Leu residue in a coiled-coil hydrophobic core position d that causes this dramatic effect. We demonstrate the importance of the SCR in controlling and transmitting the stability signal along this rodlike molecule.	[Kirwan, J. Paul; Hodges, Robert S.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Program Struct Biol & Biophys, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Hodges, RS (corresponding author), Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, L18-9118,MS 8101,12801 E 17th Ave, Aurora, CO 80045 USA.	Robert.Hodges@ucdenver.edu	Kirwan, John P/G-6942-2012					Acharya A, 2006, BIOCHEMISTRY-US, V45, P11324, DOI 10.1021/bi060822u; Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w; Bai F, 2011, BIOPHYS J, V100, P1014, DOI 10.1016/j.bpj.2011.01.001; BAILEY K, 1948, BIOCHEM J, V43, P271, DOI 10.1042/bj0430271; BAILEY K, 1946, NATURE, V157, P368, DOI 10.1038/157368b0; Brown JH, 2013, PROTEINS, V81, P635, DOI 10.1002/prot.24218; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; Ciani B, 2010, P NATL ACAD SCI USA, V107, P19850, DOI 10.1073/pnas.1008502107; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4; Cooper A, 1999, CURR OPIN CHEM BIOL, V3, P557, DOI 10.1016/S1367-5931(99)00008-3; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Freire E, 1999, P NATL ACAD SCI USA, V96, P10118, DOI 10.1073/pnas.96.18.10118; Freire E, 2001, Methods Mol Biol, V168, P37; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Greenfield NJ, 2006, J MOL BIOL, V364, P80, DOI 10.1016/j.jmb.2006.08.033; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Gunning P. W., 2008, TROPOMYOSIN; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HEELEY DH, 1987, J BIOL CHEM, V262, P9971; Helfman DM, 2008, ADV EXP MED BIOL, V644, P124; HITCHCOCK SE, 1973, J MOL BIOL, V80, P825, DOI 10.1016/0022-2836(73)90212-X; Hitchcock-DeGregori SE, 2002, BIOCHEMISTRY-US, V41, P15036, DOI 10.1021/bi026519k; HODGES R S, 1992, Current Biology, V2, P122, DOI 10.1016/0960-9822(92)90241-2; Hodges R. S., 1972, COLD SPRING HARB SYM, V37, P299; Hodges RS, 2009, J MOL BIOL, V392, P747, DOI 10.1016/j.jmb.2009.07.039; Hodges RS, 1996, BIOCHEM CELL BIOL, V74, P133, DOI 10.1139/o96-015; HODGES RS, 1981, J BIOL CHEM, V256, P1214; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; HUYGHUESDESPOINTES BMP, 1993, PROTEIN SCI, V2, P80; Karibe A, 2001, CIRCULATION, V103, P65; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kawai M., 2009, J BIOPHYS, V2009; Kimura-Sakiyama C, 2008, J MOL BIOL, V376, P80, DOI 10.1016/j.jmb.2007.10.078; Kirwan JP, 2010, J STRUCT BIOL, V170, P294, DOI 10.1016/j.jsb.2010.01.020; Kohn WD, 1998, TRENDS BIOTECHNOL, V16, P379, DOI 10.1016/S0167-7799(98)01212-8; Kohn WD, 1997, J MOL BIOL, V267, P1039, DOI 10.1006/jmbi.1997.0930; Kohn WD, 1998, J MOL BIOL, V283, P993, DOI 10.1006/jmbi.1998.2125; Kovacs JM, 2006, BIOPOLYMERS, V84, P283, DOI 10.1002/bip.20417; Kremneva E, 2004, BIOPHYS J, V87, P3922, DOI 10.1529/biophysj.104.048793; KRYLOV D, 1994, EMBO J, V13, P2849, DOI 10.1002/j.1460-2075.1994.tb06579.x; Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200; Kwok SC, 2003, J BIOL CHEM, V278, P35248, DOI 10.1074/jbc.M305306200; Landis C, 1999, J BIOL CHEM, V274, P31279, DOI 10.1074/jbc.274.44.31279; Landis CA, 1997, J BIOL CHEM, V272, P14051, DOI 10.1074/jbc.272.22.14051; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Lee DL, 2003, PROTEIN SCI, V12, P1395, DOI 10.1110/ps.0241403; Lehman W, 2008, ADV EXP MED BIOL, V644, P95; LEHRER SS, 1982, J BIOL CHEM, V257, P8073; Li XC, 2010, J STRUCT BIOL, V170, P307, DOI 10.1016/j.jsb.2009.12.017; Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060; Lin JJC, 2008, ADV EXP MED BIOL, V644, P201; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Lu SM, 2004, PROTEIN SCI, V13, P714, DOI 10.1110/ps.03443204; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mathur MC, 2011, BIOCHEM BIOPH RES CO, V406, P74, DOI 10.1016/j.bbrc.2011.01.112; Matousek WM, 2007, J MOL BIOL, V374, P206, DOI 10.1016/j.jmb.2007.09.007; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; Mills JB, 2006, J CHROMATOGR A, V1133, P248, DOI 10.1016/j.chroma.2006.08.042; Monera OD, 1996, PROTEIN ENG, V9, P353, DOI 10.1093/protein/9.4.353; MONERA OD, 1993, J BIOL CHEM, V268, P19218; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Oakley MG, 2001, CURR OPIN STRUC BIOL, V11, P450, DOI 10.1016/S0959-440X(00)00232-3; OBrien R, 1996, BIOPHYS J, V70, P2403, DOI 10.1016/S0006-3495(96)79808-9; Olson TM, 2001, J MOL CELL CARDIOL, V33, P723, DOI 10.1006/jmcc.2000.1339; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; PATO MD, 1981, J BIOL CHEM, V256, P593; Paulucci AA, 2002, J BIOL CHEM, V277, P39574, DOI 10.1074/jbc.M204749200; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; POTTER JD, 1974, BIOCHEMISTRY-US, V13, P2697, DOI 10.1021/bi00710a007; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; SCHOLTZ JM, 1993, BIOCHEMISTRY-US, V32, P9668, DOI 10.1021/bi00088a019; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; Singh A, 2007, BIOCHEMISTRY-US, V46, P14917, DOI 10.1021/bi701570b; Siththanandan VB, 2009, PFLUG ARCH EUR J PHY, V458, P761, DOI 10.1007/s00424-009-0653-3; SODEK J, 1972, P NATL ACAD SCI USA, V69, P3800, DOI 10.1073/pnas.69.12.3800; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Stewart V, 2010, J BACTERIOL, V192, P734, DOI 10.1128/JB.00172-09; STURTEVANT JM, 1991, BIOPOLYMERS, V31, P489, DOI 10.1002/bip.360310504; SUEKI M, 1984, MACROMOLECULES, V17, P148, DOI 10.1021/ma00132a006; TALBOT JA, 1981, J BIOL CHEM, V256, P2374; THOMPSON KS, 1993, BIOCHEMISTRY-US, V32, P5491, DOI 10.1021/bi00072a001; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Wagschal K, 1999, J MOL BIOL, V285, P785, DOI 10.1006/jmbi.1998.2284; Wagschal K, 1999, PROTEIN SCI, V8, P2312; Wang F, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/435271; WHITE SP, 1987, NATURE, V325, P826, DOI 10.1038/325826a0; Wieczorek DF, 2008, ADV EXP MED BIOL, V644, P132; WILLIAMS RW, 1987, BIOCHIM BIOPHYS ACTA, V916, P200, DOI 10.1016/0167-4838(87)90109-9; Woods E. F., 1977, AUST J BIOL SCI, V6, P527; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; WRABL J, 1994, BIOPOLYMERS, V34, P1659, DOI 10.1002/bip.360341210; ZHOU NE, 1992, BIOPOLYMERS, V32, P419, DOI 10.1002/bip.360320419; ZHOU NE, 1992, BIOCHEMISTRY-US, V31, P5739, DOI 10.1021/bi00140a008; ZHOU NE, 1994, J MOL BIOL, V237, P500, DOI 10.1006/jmbi.1994.1250; ZHOU NE, 1994, PROTEIN ENG, V7, P1365, DOI 10.1093/protein/7.11.1365; ZHOU NE, 1994, PROTEIN PEPTIDE LETT, V1, P114; Zoetewey DL, 2003, J MOL BIOL, V334, P1063, DOI 10.1016/j.jmb.2003.10.020	120	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4356	4366		10.1074/jbc.M113.507236	http://dx.doi.org/10.1074/jbc.M113.507236			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362038	hybrid, Green Published			2022-12-28	WOS:000331403800046
J	Toustrup-Jensen, MS; Einholm, AP; Schack, VR; Nielsen, HN; Holm, R; Sobrido, MJ; Andersen, JP; Clausen, T; Vilsen, B				Toustrup-Jensen, Mads S.; Einholm, Anja P.; Schack, Vivien R.; Nielsen, Hang N.; Holm, Rikke; Sobrido, Maria-Jesus; Andersen, Jens P.; Clausen, Torben; Vilsen, Bente			Relationship between Intracellular Na+ Concentration and Reduced Na+ Affinity in Na+,K+-ATPase Mutants Causing Neurological Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mutation; Membrane Transport; Na; K-ATPase; Neurological Diseases; Sodium Transport; Familial Hemiplegic Migraine; Intracellular Sodium; Rapid-onset Dystonia Parkinsonism	FAMILIAL HEMIPLEGIC MIGRAINE; ONSET DYSTONIA-PARKINSONISM; DE-NOVO MUTATIONS; ALTERNATING HEMIPLEGIA; ALPHA-SUBUNIT; TRANSMEMBRANE SEGMENT; TERMINAL TYROSINES; CRYSTAL-STRUCTURE; SODIUM-PUMP; K+-ATPASE	Background: Na+,K+-ATPase mutations extending the C terminus cause neurological disease. Results: C-terminal extension reduces Na+ affinity. Analysis of several mutants establishes a relationship between change in Na+ affinity and change of intracellular Na+ and K+ concentrations. Conclusion: The Na+ affinity of the Na+,K+-ATPase is a major in vivo determinant of the intracellular Na+ concentration. Significance: Insight in pathophysiology and regulation of the Na+,K+-ATPase is obtained. The neurological disorders familial hemiplegic migraine type 2 (FHM2), alternating hemiplegia of childhood (AHC), and rapid-onset dystonia parkinsonism (RDP) are caused by mutations of Na+,K+-ATPase (2) and (3) isoforms, expressed in glial and neuronal cells, respectively. Although these disorders are distinct, they overlap in phenotypical presentation. Two Na+,K+-ATPase mutations, extending the C terminus by either 28 residues (+28 mutation) or an extra tyrosine (+Y), are associated with FHM2 and RDP, respectively. We describe here functional consequences of these and other neurological disease mutations as well as an extension of the C terminus only by a single alanine. The dependence of the mutational effects on the specific isoform in which the mutation is introduced was furthermore studied. At the cellular level we have characterized the C-terminal extension mutants and other mutants, addressing the question to what extent they cause a change of the intracellular Na+ and K+ concentrations ([Na+](i) and [K+](i)) in COS cells. C-terminal extension mutants generally showed dramatically reduced Na+ affinity without disturbance of K+ binding, as did other RDP mutants. No phosphorylation from ATP was observed for the +28 mutation of (2) despite a high expression level. A significant rise of [Na+](i) and reduction of [K+](i) was detected in cells expressing mutants with reduced Na+ affinity and did not require a concomitant reduction of the maximal catalytic turnover rate or expression level. Moreover, two mutations that increase Na+ affinity were found to reduce [Na+](i). It is concluded that the Na+ affinity of the Na+,K+-ATPase is an important determinant of [Na+](i).	[Toustrup-Jensen, Mads S.; Einholm, Anja P.; Schack, Vivien R.; Nielsen, Hang N.; Holm, Rikke; Andersen, Jens P.; Clausen, Torben; Vilsen, Bente] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Sobrido, Maria-Jesus] Fdn Publ Galega Med Xen, Inst Invest Sanitaria Santiago de Compostela IDIS, Santiago De Compostela 15706, Spain; [Sobrido, Maria-Jesus] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Santiago De Compostela 15706, Spain	Aarhus University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Vilsen, B (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark.	bv@fi.au.dk		Andersen, Jens Peter/0000-0003-0654-4300; Vilsen, Bente/0000-0002-4727-9382; Toustrup-Jensen, Mads Schak/0000-0003-2064-5861; Schack, Vivien/0000-0002-1365-3938	Danish Medical Research Council; Novo Nordisk Foundation (Vilhelm Pedersen og Hustrus Legat); Lundbeck Foundation; L'Oreal Denmark; Institute of Health Carlos III (Spain); Lundbeck Foundation [R118-2012-11726, R93-2011-8682, R48-2009-4638] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation (Vilhelm Pedersen og Hustrus Legat); Lundbeck Foundation(Lundbeckfonden); L'Oreal Denmark; Institute of Health Carlos III (Spain)(Instituto de Salud Carlos III); Lundbeck Foundation(Lundbeckfonden)	This work was supported in part by grants from the Danish Medical Research Council, the Novo Nordisk Foundation (Vilhelm Pedersen og Hustrus Legat), the Lundbeck Foundation, L'Oreal Denmark, and by the Miguel Servet program of the Institute of Health Carlos III (Spain).	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Azarias G, 2013, J BIOL CHEM, V288, P2734, DOI 10.1074/jbc.M112.425785; Bassi MT, 2004, J MED GENET, V41, P621, DOI 10.1136/jmg.2003.017863; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; Brashear A, 2012, DEV MED CHILD NEUROL, V54, P1065, DOI 10.1111/j.1469-8749.2012.04421.x; Buchanan R, 2002, J PHYSIOL-LONDON, V545, P229, DOI 10.1113/jphysiol.2002.023325; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; CLAUSEN T, 1987, J PHYSIOL-LONDON, V388, P163, DOI 10.1113/jphysiol.1987.sp016608; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Deprez L, 2008, EPILEPSIA, V49, P500, DOI 10.1111/j.1528-1167.2007.01415.x; Despa S, 2012, CARDIOVASC RES, V95, P480, DOI 10.1093/cvr/cvs213; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; EVERTS ME, 1992, ACTA PHYSIOL SCAND, V145, P353, DOI 10.1111/j.1748-1716.1992.tb09375.x; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Jen JC, 2007, J NEUROL NEUROSUR PS, V78, P523, DOI 10.1136/jnnp.2006.103267; Jurkat-Rott K, 2004, NEUROLOGY, V62, P1857, DOI 10.1212/01.WNL.0000127310.11526.FD; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; KAPLAN JH, 1980, NATURE, V288, P587, DOI 10.1038/288587a0; Kirshenbaum GS, 2011, GENES BRAIN BEHAV, V10, P542, DOI 10.1111/j.1601-183X.2011.00691.x; KJELDSEN K, 1984, ACTA PHYSIOL SCAND, V122, P103, DOI 10.1111/j.1748-1716.1984.tb07488.x; LEE KH, 1980, NATURE, V285, P338, DOI 10.1038/285338a0; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Meier S, 2010, J GEN PHYSIOL, V135, P115, DOI 10.1085/jgp.200910301; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; Rose CR, 2001, J NEUROSCI, V21, P4207, DOI 10.1523/JNEUROSCI.21-12-04207.2001; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Schack VR, 2012, J BIOL CHEM, V287, P2191, DOI 10.1074/jbc.M111.323022; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Tavraz NN, 2008, J BIOL CHEM, V283, P31097, DOI 10.1074/jbc.M802771200; Thompson CB, 1999, AM J PHYSIOL-CELL PH, V276, pC1411, DOI 10.1152/ajpcell.1999.276.6.C1411; Toustrup-Jensen M, 2003, J BIOL CHEM, V278, P11402, DOI 10.1074/jbc.M212136200; Toustrup-Jensen M, 2002, J BIOL CHEM, V277, P38607, DOI 10.1074/jbc.M203665200; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Vedovato N, 2010, J GEN PHYSIOL, V136, P63, DOI 10.1085/jgp.201010407; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106	45	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3186	3197		10.1074/jbc.M113.543272	http://dx.doi.org/10.1074/jbc.M113.543272			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24356962	hybrid, Green Published			2022-12-28	WOS:000331368700008
J	Pan, C; Fang, D; Xu, GR; Liang, J; Zhang, GY; Wang, HZ; Xie, LP; Zhang, RQ				Pan, Cong; Fang, Dong; Xu, Guangrui; Liang, Jian; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing			A Novel Acidic Matrix Protein, PfN44, Stabilizes Magnesium Calcite to Inhibit the Crystallization of Aragonite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biomaterials; Biomineralization; Cloning; Extracellular Matrix Proteins; Protein Chemistry	NACREOUS LAYER FORMATION; SOLUBLE ORGANIC MATRIX; PEARL OYSTER; PINCTADA-MAXIMA; FRAMEWORK FORMATION; CARBONIC-ANHYDRASE; EXTRAPALLIAL FLUID; KEY MACROMOLECULE; PRISMATIC LAYER; SHELL MATRIX	Background: Thermodynamically unstable magnesium calcite is deposited in the shell of pearl oysters at ambient pressure. Results: The novel acidic matrix protein PfN44 interacts with magnesium to inhibit the deposition of aragonite. Conclusion: PfN44 participates in shell formation by inhibiting aragonite formation. Significance: Results of this study suggest a connection between the matrix protein and magnesium. Magnesium is widely used to control calcium carbonate deposition in the shell of pearl oysters. Matrix proteins in the shell are responsible for nucleation and growth of calcium carbonate crystals. However, there is no direct evidence supporting a connection between matrix proteins and magnesium. Here, we identified a novel acidic matrix protein named PfN44 that affected aragonite formation in the shell of the pearl oyster Pinctada fucata. Using immunogold labeling assays, we found PfN44 in both the nacreous and prismatic layers. In shell repair, PfN44 was repressed, whereas other matrix proteins were up-regulated. Disturbing the function of PfN44 by RNAi led to the deposition of porous nacreous tablets with overgrowth of crystals in the nacreous layer. By in vitro circular dichroism spectra and fluorescence quenching, we found that PfN44 bound to both calcium and magnesium with a stronger affinity for magnesium. During in vitro calcium carbonate crystallization and calcification of amorphous calcium carbonate, PfN44 regulated the magnesium content of crystalline carbonate polymorphs and stabilized magnesium calcite to inhibit aragonite deposition. Taken together, our results suggested that by stabilizing magnesium calcite to inhibit aragonite deposition, PfN44 participated in P. fucata shell formation. These observations extend our understanding of the connections between matrix proteins and magnesium.	[Pan, Cong; Fang, Dong; Xu, Guangrui; Liang, Jian; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Xie, LP (corresponding author), Tsinghua Univ, Rm 206,Old Bldg Sch Life Sci, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Basic Research Program of China [2010CB126405]; National High Technology Research and Development Program of China [2010AA09Z405]; National Natural Science Foundation of China [31172382, U0831001]; Independent Research Projects of Tsinghua University [20111080964]; Ministry of Agriculture [2011ZX08011-006]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Research Projects of Tsinghua University; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This work was supported by National Basic Research Program of China Grant 2010CB126405, National High Technology Research and Development Program of China Grant 2010AA09Z405, National Natural Science Foundation of China Grants 31172382 and U0831001 (Joint Fund with Guangdong), and Independent Research Projects of Tsinghua University Grant 20111080964. Grant 2011ZX08011-006 is a Major Project of Ministry of Agriculture.	Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010; Aizenberg J, 1996, ADV MATER, V8, P222, DOI 10.1002/adma.19960080307; Albeck S, 1996, CHEM-EUR J, V2, P278, DOI 10.1002/chem.19960020308; Almeida MJ, 2000, J EXP ZOOL, V288, P327, DOI 10.1002/1097-010X(20001215)288:4<327::AID-JEZ5>3.0.CO;2-#; BISCHOFF WD, 1987, GEOCHIM COSMOCHIM AC, V51, P1413, DOI 10.1016/0016-7037(87)90325-5; Bonucci E, 2009, J BONE MINER METAB, V27, P255, DOI 10.1007/s00774-009-0061-y; BORBAS JE, 1991, J EXP ZOOL, V258, P1, DOI 10.1002/jez.1402580102; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; Fu G, 2005, BIOMACROMOLECULES, V6, P1289, DOI 10.1021/bm049314v; Fujimura Takuya, 1995, Venus the Japanese Journal of Malacology, V54, P25; Furuhashi T, 2009, COMP BIOCHEM PHYS B, V154, P351, DOI 10.1016/j.cbpb.2009.07.011; Glazer L, 2010, J BIOL CHEM, V285, P12831, DOI 10.1074/jbc.M109.071068; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; Liu XJ, 2012, P ROY SOC B-BIOL SCI, V279, P1000, DOI 10.1098/rspb.2011.1661; Long X, 2011, CRYST GROWTH DES, V11, P2866, DOI 10.1021/cg200028x; LOWENSTAM HA, 1975, SCIENCE, V188, P363, DOI 10.1126/science.1118730; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Marie B, 2007, FEBS J, V274, P2933, DOI 10.1111/j.1742-4658.2007.05825.x; Marie B, 2009, CHEMBIOCHEM, V10, P1495, DOI 10.1002/cbic.200900009; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marin F, 2007, BIOMATERIALS, V28, P2368, DOI 10.1016/j.biomaterials.2007.01.029; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Michenfelder M, 2003, BIOPOLYMERS, V70, P522, DOI 10.1002/bip.10536; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyazaki Y, 2010, COMP BIOCHEM PHYS B, V155, P241, DOI 10.1016/j.cbpb.2009.11.009; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217; MURAMOTO K, 1994, COMP BIOCHEM PHYS B, V107, P401, DOI 10.1016/0305-0491(94)90204-6; Nudelman F, 2008, J STRUCT BIOL, V162, P290, DOI 10.1016/j.jsb.2008.01.008; Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6; Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x; Radha AV, 2010, P NATL ACAD SCI USA, V107, P16438, DOI 10.1073/pnas.1009959107; Raz S, 2000, ADV MATER, V12, P38, DOI 10.1002/(SICI)1521-4095(200001)12:1<38::AID-ADMA38>3.0.CO;2-I; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; SIMKISS K, 1977, CALC TISS RES, V24, P199, DOI 10.1007/BF02223316; Sud D, 2001, TISSUE CELL, V33, P154, DOI 10.1054/tice.2000.0166; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; UENO M, 1980, J EXP ZOOL, V213, P161, DOI 10.1002/jez.1402130202; Wang DB, 2009, P NATL ACAD SCI USA, V106, P21511, DOI 10.1073/pnas.0906741106; WEINER S, 1979, CALCIFIED TISSUE INT, V29, P163, DOI 10.1007/BF02408072; Weiner S, 2005, SCIENCE, V309, P1027, DOI 10.1126/science.1114920; Weiner S, 2003, CONNECT TISSUE RES, V44, P214, DOI 10.1080/713713619; Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; WILBUR KM, 1984, BIOL BULL, V166, P251, DOI 10.2307/1541446; WILKINSON BH, 1979, GEOLOGY, V7, P524, DOI 10.1130/0091-7613(1979)7<524:BPATEO>2.0.CO;2; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6; Zhou YJ, 2010, COMP BIOCHEM PHYS B, V156, P158, DOI 10.1016/j.cbpb.2010.02.012	58	52	52	2	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2776	2787		10.1074/jbc.M113.504027	http://dx.doi.org/10.1074/jbc.M113.504027			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24302723	Green Published, hybrid			2022-12-28	WOS:000333403000027
J	Andresen, CA; Smedegaard, S; Sylvestersen, KB; Svensson, C; Iglesias-Gato, D; Cazzamali, G; Nielsen, TK; Nielsen, ML; Flores-Morales, A				Andresen, Christina Aaen; Smedegaard, Stine; Sylvestersen, Kathrine Beck; Svensson, Charlotte; Iglesias-Gato, Diego; Cazzamali, Giuseppe; Nielsen, Tine Kragh; Nielsen, Michael Lund; Flores-Morales, Amilcar			Protein Interaction Screening for the Ankyrin Repeats and Suppressor of Cytokine Signaling (SOCS) Box (ASB) Family Identify Asb11 as a Novel Endoplasmic Reticulum Resident Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Glycation; Mass Spectrometry (MS); Proteomics; Ubiquitin Ligase; Ubiquitylation	STRUCTURAL BASIS; CREATINE-KINASE; DEGRADATION; BINDING; REGULATOR; INSIGHTS; PATHWAY	The ankyrin and SOCS (suppressor of cytokine signaling) box (ASB) family of proteins function as the substrate recognition subunit in a subset of Elongin-Cullin-SOCS (ECS) E3 ubiquitin ligases. Despite counting 18 members in humans, the identity of the physiological targets of the Asb proteins remains largely unexplored. To increase our understanding of the function of ASB proteins, we conducted a family-wide SILAC (stable isotope labeling by amino acids in cell culture)-based protein/protein interaction analysis. This investigation led to the identification of novel as well as known ASB-associated proteins like Cullin 5 and Elongins B/C. We observed that several proteins can be bound by more than one Asb protein. The additional exploration of this phenomenon demonstrated that ASB-Cullin 5 complexes can oligomerize and provides evidence that Cullin 5 forms heterodimeric complexes with the Cullin 4a-DDB1 complex. We also demonstrated that ASB11 is a novel endoplasmic reticulum-associated ubiquitin ligase with the ability to interact and promote the ubiquitination of Ribophorin 1, an integral protein of the oligosaccharyltransferase (OST) glycosylation complex. Moreover, expression of ASB11 can increase Ribophorin 1 protein turnover in vivo. In summary, we provide a comprehensive protein/protein interaction data resource that can aid the biological and functional characterization of ASB ubiquitin ligases.	[Andresen, Christina Aaen; Smedegaard, Stine; Svensson, Charlotte; Iglesias-Gato, Diego; Flores-Morales, Amilcar] Univ Copenhagen, Fac Hlth Sci, Dept Dis Biol, DK-2200 Copenhagen, Denmark; [Sylvestersen, Kathrine Beck; Nielsen, Michael Lund] Univ Copenhagen, Fac Hlth Sci, Dept Prote, DK-2200 Copenhagen, Denmark; [Cazzamali, Giuseppe] Univ Copenhagen, Fac Hlth Sci, Prot Struct Novo Nordisk Res Fdn, Ctr Prot Res, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Flores-Morales, A (corresponding author), Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn, Ctr Prot Res, Blegdamsvej 3b,Bldg 6-1, DK-2200 Copenhagen, Denmark.	amilcar.flores@cpr.ku.dk	Iglesias-Gato, Diego/R-1794-2016	Iglesias-Gato, Diego/0000-0002-8982-9936; Beck Sylvestersen, Kathrine/0000-0002-8201-4769; Nielsen, Michael/0000-0002-0067-9039	Danish Research Council; Novo Nordisk research foundation; Novo Nordisk Fonden [NNF12OC0002286, NNF13OC0006477] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Michael Lund Nielsen] Funding Source: researchfish	Danish Research Council(Det Frie Forskningsrad (DFF)); Novo Nordisk research foundation(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); Novo Nordisk Foundation Center for Protein Research	This work was supported by grant from the Danish Research Council and the Novo Nordisk research foundation (to A. F.-M.).	Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Chung AS, 2005, MOL CELL BIOL, V25, P4716, DOI 10.1128/MCB.25.11.4716-4726.2005; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Debrincat MA, 2007, J BIOL CHEM, V282, P4728, DOI 10.1074/jbc.M609164200; Diks SH, 2006, J CELL BIOL, V174, P581, DOI 10.1083/jcb.200601081; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Hansen CA, 2008, CELL CYCLE, V7, P325, DOI 10.4161/cc.7.3.5354; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kile BT, 2001, MOL CELL BIOL, V21, P6189, DOI 10.1128/MCB.21.18.6189-6197.2001; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Kwon S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-23; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; Nie L, 2011, CELL RES, V21, P754, DOI 10.1038/cr.2010.165; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Tee JM, 2012, STEM CELLS DEV, V21, P3091, DOI 10.1089/scd.2012.0123; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Vesterlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025358; Wimuttisuk W, 2007, MOL BIOL CELL, V18, P899, DOI 10.1091/mbc.E06-06-0542; Wu W, 2011, J BIOL CHEM, V286, P41153, DOI 10.1074/jbc.M111.273755; Zadjali F, 2011, J BIOL CHEM, V286, P480, DOI 10.1074/jbc.M110.173526; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	44	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2043	2054		10.1074/jbc.M113.534602	http://dx.doi.org/10.1074/jbc.M113.534602			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24337577	hybrid, Green Published			2022-12-28	WOS:000331130200015
J	Christensen, CE; Karlsson, M; Winther, JR; Jensen, PR; Lerche, MH				Christensen, Caspar Elo; Karlsson, Magnus; Winther, Jakob R.; Jensen, Pernille Rose; Lerche, Mathilde H.			Non-invasive In-cell Determination of Free Cytosolic [NAD(+)]/[NADH] Ratios Using Hyperpolarized Glucose Show Large Variations in Metabolic Phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Glucose; NAD; NADH; Prostate Cancer; Hyperpolarization; Metabolic Phenotype	NICOTINAMIDE-ADENINE DINUCLEOTIDE; POSITRON-EMISSION-TOMOGRAPHY; REDOX STATE; NAD(+) METABOLISM; PROSTATE-CANCER; BLOOD-FLOW; NADH; PATHWAY; DISEASE; INHIBITION	Accumulating evidence suggest that the pyridine nucleotide NAD has far wider biological functions than its classical role in energy metabolism. NAD is used by hundreds of enzymes that catalyze substrate oxidation and, as such, it plays a key role in various biological processes such as aging, cell death, and oxidative stress. It has been suggested that changes in the ratio of free cytosolic [NAD(+)]/[NADH] reflects metabolic alterations leading to, or correlating with, pathological states. We have designed an isotopically labeled metabolic bioprobe of free cytosolic [NAD(+)]/[NADH] by combining a magnetic enhancement technique (hyperpolarization) with cellular glycolytic activity. The bioprobe reports free cytosolic [NAD(+)]/[NADH] ratios based on dynamically measured in-cell [pyruvate]/[lactate] ratios. We demonstrate its utility in breast and prostate cancer cells. The free cytosolic [NAD(+)]/[NADH] ratio determined in prostate cancer cells was 4 times higher than in breast cancer cells. This higher ratio reflects a distinct metabolic phenotype of prostate cancer cells consistent with previously reported alterations in the energy metabolism of these cells. As a reporter on free cytosolic [NAD(+)]/[NADH] ratio, the bioprobe will enable better understanding of the origin of diverse pathological states of the cell as well as monitor cellular consequences of diseases and/or treatments.	[Karlsson, Magnus; Jensen, Pernille Rose; Lerche, Mathilde H.] Albeda Res Aps, DK-1799 Copenhagen, Denmark; [Christensen, Caspar Elo] Albeda Innovat Aps, DK-1799 Copenhagen, Denmark; [Christensen, Caspar Elo; Winther, Jakob R.] Univ Copenhagen, Dept Biol, Copenhagen Bioctr, DK-2200 Copenhagen N, Denmark	University of Copenhagen	Lerche, MH (corresponding author), Albeda Res Aps, Gamle Carlsberg Vej 10, DK-1799 Copenhagen, Denmark.	Mathilde.lerche@albeda.dk	Winther, Jakob R./K-4451-2014; Jensen, Pernille Rose/GQQ-6261-2022; Jensen, Pernille Rose/AAX-5696-2020; Jensen, Pernille Rose/J-8648-2016; Karlsson, Magnus/AAZ-1768-2021; Christensen, Caspar Elo/K-2753-2014; Lerche, Mathilde Hauge/J-5487-2017	Winther, Jakob R./0000-0001-6995-9154; Jensen, Pernille Rose/0000-0003-4359-848X; Jensen, Pernille Rose/0000-0003-4359-848X; Jensen, Pernille Rose/0000-0003-4359-848X; Christensen, Caspar Elo/0000-0002-0214-8477; Karlsson, Magnus/0000-0001-7738-1700; Lerche, Mathilde Hauge/0000-0002-5899-2781	Danish National Advanced Technology Foundation (Hojteknologifonden)	Danish National Advanced Technology Foundation (Hojteknologifonden)	This work was supported by the Danish National Advanced Technology Foundation (Hojteknologifonden).	ABRAGAM A, 1978, REP PROG PHYS, V41, P395, DOI 10.1088/0034-4885/41/3/002; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Barron JT, 2000, AM J PHYSIOL-HEART C, V279, pH2872, DOI 10.1152/ajpheart.2000.279.6.H2872; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; BOARD M, 1990, BIOCHEM J, V265, P503, DOI 10.1042/bj2650503; Bonda DJ, 2011, LANCET NEUROL, V10, P275, DOI 10.1016/S1474-4422(11)70013-8; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Burgess SC, 2008, J BIOL CHEM, V283, P1670, DOI 10.1074/jbc.M706540200; Cai H, 2012, CURR ALZHEIMER RES, V9, P5, DOI 10.2174/156720512799015064; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Costello LC, 1997, J BIOL CHEM, V272, P28875, DOI 10.1074/jbc.272.46.28875; Costello LC, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-17; Effert PJ, 1996, J UROLOGY, V155, P994, DOI 10.1016/S0022-5347(01)66366-3; Gaikwad A, 2001, J BIOL CHEM, V276, P22559, DOI 10.1074/jbc.M101053200; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Hochachka PW, 2002, BIOESSAYS, V24, P749, DOI 10.1002/bies.10131; Hofer C, 1999, EUR UROL, V36, P31, DOI 10.1159/000019923; Ido Y, 2004, P NATL ACAD SCI USA, V101, P653, DOI 10.1073/pnas.0307458100; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Lin CC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00785; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Ma YX, 2012, CURR DRUG TARGETS, V13, P222, DOI 10.2174/138945012799201711; Medina-Cleghorn D, 2013, PFLUG ARCH EUR J PHY, V465, P427, DOI 10.1007/s00424-012-1201-0; Meier S, 2011, MOL BIOSYST, V7, P2834, DOI 10.1039/c1mb05202k; Mycielska ME, 2009, BIOESSAYS, V31, P10, DOI 10.1002/bies.080137; Sanni LA, 2001, AM J PATHOL, V159, P1105, DOI 10.1016/S0002-9440(10)61786-5; Schwab M., 2011, ENCY CANC, V2; Teodoro JS, 2013, TOXICOL MECH METHOD, V23, P297, DOI 10.3109/15376516.2012.759305; Veech RL, 2006, BIOCHEM MOL BIOL EDU, V34, P168, DOI 10.1002/bmb.2006.49403403168; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Vlassenko AG, 2006, P NATL ACAD SCI USA, V103, P1964, DOI 10.1073/pnas.0510632103; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Ying WH, 2007, FRONT BIOSCI-LANDMRK, V12, P1863, DOI 10.2741/2194; Ying WH, 2006, FRONT BIOSCI-LANDMRK, V11, P3129, DOI 10.2741/2038; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zhao YZ, 2011, CELL METAB, V14, P555, DOI 10.1016/j.cmet.2011.09.004	42	88	88	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2344	2352		10.1074/jbc.M113.498626	http://dx.doi.org/10.1074/jbc.M113.498626			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302737	Green Published, hybrid			2022-12-28	WOS:000331130200038
J	Shulman, E; Belakhov, V; Wei, G; Kendall, A; Meyron-Holtz, EG; Ben-Shachar, D; Schacht, J; Baasov, T				Shulman, Eli; Belakhov, Valery; Wei, Gao; Kendall, Ann; Meyron-Holtz, Esther G.; Ben-Shachar, Dorit; Schacht, Jochen; Baasov, Timor			Designer Aminoglycosides That Selectively Inhibit Cytoplasmic Rather than Mitochondrial Ribosomes Show Decreased Ototoxicity A STRATEGY FOR THE TREATMENT OF GENETIC DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics Action; Genetic Diseases; Mitochondrial Apoptosis; Oxidative Stress; Ribosome Function; Aminoglycosides; Cytoplasmic Protein Synthesis Inhibition; Mitochondrial Protein Synthesis Inhibition; Ototoxicity	PREMATURE TERMINATION CODONS; SUPEROXIDE-PRODUCTION; PROTEIN-SYNTHESIS; SYNTHETIC AMINOGLYCOSIDES; NONSENSE MUTATION; FENTON REACTION; READ-THROUGH; ANTIBIOTICS; IRON; SUPPRESSION	There is compelling evidence that aminoglycoside (AG) antibiotics can induce the mammalian ribosome to suppress disease-causing nonsense mutations and partially restore the expression of functional proteins. However, prolonged AG treatment can cause detrimental side effects in patients, including most prominently, ototoxicity. Recent mechanistic discussions have considered the relative contributions of mitochondrial and cytoplasmic protein synthesis inhibition to AG-induced ototoxicity. We show that AGs inhibit mitochondrial protein synthesis in mammalian cells and perturb cell respiration, leading to a time- and dose-dependent increase in superoxide overproduction and accumulation of free ferrous iron in mitochondria caused by oxidative damage of mitochondrial aconitase, ultimately leading to cell apoptosis via the Fenton reaction. These deleterious effects increase with the increased potency of AG to inhibit the mitochondrial rather than cytoplasmic protein synthesis, which in turn correlates with their ototoxic potential in both murine cochlear explants and the guinea pig in vivo. The deleterious effects of AGs were alleviated in synthetic derivatives specially designed for the treatment of genetic diseases caused by nonsense mutations and possessing low affinity toward mitochondrial ribosomes. This work highlights the benefit of a mechanism-based drug redesign strategy that can maximize the translational value of readthrough therapy while mitigating drug-induced side effects. This approach holds promise for patients suffering from genetic diseases caused by nonsense mutations.	[Shulman, Eli; Belakhov, Valery; Baasov, Timor] Technion IIT, Schulich Fac Chem, Edith & Joseph Fischer Enzyme Inhibitors Lab, IL-32000 Haifa, Israel; [Meyron-Holtz, Esther G.] Technion IIT, Fac Biotechnol & Food Engn, Lab Mol Nutr, IL-32000 Haifa, Israel; [Wei, Gao; Kendall, Ann; Schacht, Jochen] Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA; [Ben-Shachar, Dorit] Technion IIT, Dept Psychiat, Rambam Med Ctr, Psychobiol Lab, IL-31096 Haifa, Israel; [Ben-Shachar, Dorit] Technion IIT, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Michigan System; University of Michigan; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Baasov, T (corresponding author), Technion IIT, Schulich Fac Chem, IL-32000 Haifa, Israel.	chtimor@techunix.technion.ac.il	Baasov, Timor/L-5173-2019; Ben-Shachar, Dorit/D-4703-2015	Baasov, Timor/0000-0002-1427-2619; Ben-Shachar, Dorit/0000-0003-2317-1489; Belakhov, Valery/0000-0003-1918-974X	National Institutes of Health [1 R01 GM094792-01 A1]; German-Israeli Foundation [G-1048-95.5/2009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R01 GM094792-01 A1 (to T. B. and J. S.). This work was also supported by German-Israeli Foundation Grant G-1048-95.5/2009 (to T. B.).	Bindokas VP, 1996, J NEUROSCI, V16, P1324; Bottger EC, 2013, HEARING RES, V303, P12, DOI 10.1016/j.heares.2013.01.006; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Brendel C, 2011, J MOL MED, V89, P389, DOI 10.1007/s00109-010-0704-4; BURKE JF, 1985, NUCLEIC ACIDS RES, V13, P6265, DOI 10.1093/nar/13.17.6265; Cantu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007095; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chernikov VG, 2003, B EXP BIOL MED+, V135, P103, DOI 10.1023/A:1023474719042; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; Clerici WJ, 1996, HEARING RES, V101, P14, DOI 10.1016/S0378-5955(96)00126-8; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; EUSTICE DC, 1984, BIOCHEMISTRY-US, V23, P1462, DOI 10.1021/bi00302a019; Feldman L, 2007, KIDNEY INT, V72, P359, DOI 10.1038/sj.ki.5002295; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Francis SP, 2013, J NEUROSCI, V33, P3079, DOI 10.1523/JNEUROSCI.3430-12.2013; Goldmann T, 2012, EMBO MOL MED, V4, P1186, DOI 10.1002/emmm.201201438; Goldmann T, 2010, INVEST OPHTH VIS SCI, V51, P6671, DOI 10.1167/iovs.10-5741; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hainrichson M, 2008, ORG BIOMOL CHEM, V6, P227, DOI 10.1039/b712690p; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P3244, DOI 10.1073/pnas.0707265105; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P20888, DOI 10.1073/pnas.0811258106; HUTCHIN T, 1994, ANTIMICROB AGENTS CH, V38, P2517, DOI 10.1128/AAC.38.11.2517; Huth M, 2011, INT J OTOLARYNGOL, V2011; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Kalghatgi S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006055; Kandasamy J, 2012, J MED CHEM, V55, P10630, DOI 10.1021/jm3012992; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Keeling KM, 2012, CRIT REV BIOCHEM MOL, V47, P444, DOI 10.3109/10409238.2012.694846; Kondo J, 2007, CHEMBIOCHEM, V8, P1700, DOI 10.1002/cbic.200700271; KURTZ DI, 1974, BIOCHEMISTRY-US, V13, P572, DOI 10.1021/bi00700a026; LAUTERMANN J, 1995, HEARING RES, V86, P15, DOI 10.1016/0378-5955(95)00049-A; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Malik V, 2010, ANN NEUROL, V67, P771, DOI 10.1002/ana.22024; Matt T, 2012, P NATL ACAD SCI USA, V109, P10984, DOI 10.1073/pnas.1204073109; McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Nudelman I, 2010, BIOORGAN MED CHEM, V18, P3735, DOI 10.1016/j.bmc.2010.03.060; Nudelman I, 2009, J MED CHEM, V52, P2836, DOI 10.1021/jm801640k; Petrat F, 2002, BIOCHEM J, V362, P137, DOI 10.1042/0264-6021:3620137; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Rowe SM, 2011, J MOL MED, V89, P1149, DOI 10.1007/s00109-011-0787-6; Sha SH, 2006, NEW ENGL J MED, V354, P1856, DOI 10.1056/NEJMc053428; Shalev M, 2013, J PHARMACEUT BIOMED, V75, P33, DOI 10.1016/j.jpba.2012.11.014; Thomas C, 2009, REDOX REP, V14, P102, DOI 10.1179/135100009X392566; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vecsler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020733; Wang D, 2012, MOL GENET METAB, V105, P116, DOI 10.1016/j.ymgme.2011.10.005; Woodmansee AN, 2002, METHOD ENZYMOL, V349, P3, DOI 10.1016/S0076-6879(02)49316-0; Xie J, 2011, HEARING RES, V281, P28, DOI 10.1016/j.heares.2011.05.008	53	78	83	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2318	2330		10.1074/jbc.M113.533588	http://dx.doi.org/10.1074/jbc.M113.533588			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302717	hybrid, Green Published			2022-12-28	WOS:000331130200036
J	Chen, BX; Siderovski, DP; Neubig, RR; Lawson, MA; Trejo, J				Chen, Buxin; Siderovski, David P.; Neubig, Richard R.; Lawson, Mark A.; Trejo, JoAnn			Regulation of Protease-activated Receptor 1 Signaling by the Adaptor Protein Complex 2 and R4 Subfamily of Regulator of G Protein Signaling Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Proteins; G Protein-coupled Receptors (GPCR); G Proteins; Intracellular Trafficking; Thrombin	THROMBIN RECEPTOR; BETA-ARRESTINS; PLATELET ACTIVATION; INTERNALIZATION; CLATHRIN; TRAFFICKING; KINASE; ALPHA; TRANSACTIVATION; DEGRADATION	Background: The function of the clathrin adaptor AP-2 in the regulation of GPCR coupling to G protein signaling is not known. Results: AP-2 controls GPCR signaling by modulating receptor surface expression and, unexpectedly, through RGS protein recruitment to G proteins. Conclusion: AP-2 has diverse functions in the regulation of GPCR signaling. Significance: AP-2 provides a new mode of GPCR signal regulation. The G protein-coupled protease-activated receptor 1 (PAR1) is irreversibly proteolytically activated by thrombin. Hence, the precise regulation of PAR1 signaling is important for proper cellular responses. In addition to desensitization, internalization and lysosomal sorting of activated PAR1 are critical for the termination of signaling. Unlike most G protein-coupled receptors, PAR1 internalization is mediated by the clathrin adaptor protein complex 2 (AP-2) and epsin-1, rather than -arrestins. However, the function of AP-2 and epsin-1 in the regulation of PAR1 signaling is not known. Here, we report that AP-2, and not epsin-1, regulates activated PAR1-stimulated phosphoinositide hydrolysis via two different mechanisms that involve, in part, a subset of R4 subfamily of regulator of G protein signaling (RGS) proteins. A significantly greater increase in activated PAR1 signaling was observed in cells depleted of AP-2 using siRNA or in cells expressing a PAR1 (420)AKKAA(424) mutant with defective AP-2 binding. This effect was attributed to AP-2 modulation of PAR1 surface expression and efficiency of G protein coupling. We further found that ectopic expression of R4 subfamily members RGS2, RGS3, RGS4, and RGS5 reduced activated PAR1 wild-type signaling, whereas signaling by the PAR1 AKKAA mutant was minimally affected. Intriguingly, siRNA-mediated depletion analysis revealed a function for RGS5 in the regulation of signaling by the PAR1 wild type but not the AKKAA mutant. Moreover, activation of the PAR1 wild type, and not the AKKAA mutant, induced G(q) association with RGS3 via an AP-2-dependent mechanism. Thus, AP-2 regulates activated PAR1 signaling by altering receptor surface expression and through recruitment of RGS proteins.	[Chen, Buxin; Trejo, JoAnn] Univ Calif San Diego, Dept Pharmacol, Sch Med, La Jolla, CA 92093 USA; [Lawson, Mark A.] Univ Calif San Diego, Dept Reprod Med, Sch Med, La Jolla, CA 92093 USA; [Siderovski, David P.] W Virginia Univ, Dept Physiol & Pharmacol, Sch Med, Morgantown, WV 26506 USA; [Neubig, Richard R.] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; West Virginia University; Michigan State University	Trejo, J (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr,BSB Rm 3044A, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu	Lawson, Mark/ABH-2007-2020; Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; Neubig, Richard/0000-0003-0501-0008; TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [R01 GM090689]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037568, P50HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM090689 (to J. T.).	Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; BENKA ML, 1995, FEBS LETT, V363, P49, DOI 10.1016/0014-5793(95)00278-H; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Gegenbauer K, 2012, BLOOD, V119, P3799, DOI 10.1182/blood-2011-11-390369; Hains MD, 2004, METHOD ENZYMOL, V389, P71; ISHII K, 1994, J BIOL CHEM, V269, P1125; Kim I, 2013, J CELL BIOL, V200, P419, DOI 10.1083/jcb.201206096; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Laroche G, 2010, AM J PHYSIOL-CELL PH, V299, pC654, DOI 10.1152/ajpcell.00441.2009; Lin HL, 2013, J BIOL CHEM, V288, P11203, DOI 10.1074/jbc.M112.439950; Ma PS, 2012, BLOOD, V119, P1935, DOI 10.1182/blood-2011-10-387910; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2004, J BIOL CHEM, V279, P21938, DOI 10.1074/jbc.M401672200; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tian Y, 2013, P NATL ACAD SCI USA, V110, P17071, DOI 10.1073/pnas.1315110110; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wagener BM, 2009, TRAFFIC, V10, P1286, DOI 10.1111/j.1600-0854.2009.00957.x; Wang Q, 2002, J BIOL CHEM, V277, P24949, DOI 10.1074/jbc.M203802200; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x	39	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1580	1591		10.1074/jbc.M113.528273	http://dx.doi.org/10.1074/jbc.M113.528273			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297163	hybrid, Green Published			2022-12-28	WOS:000332401700032
J	Zhuang, XL; Semenova, E; Maric, D; Craigie, R				Zhuang, Xiaolei; Semenova, Elena; Maric, Dragan; Craigie, Robert			Dephosphorylation of Barrier-to-autointegration Factor by Protein Phosphatase 4 and Its Role in Cell Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-ENVELOPE; STRUCTURAL BASIS; RETROVIRAL DNA; IN-VITRO; BAF; EMERIN; COMPLEX; LOCALIZATION; CHROMATIN; BINDING	Barrier-to-autointegration factor (BAF or BANF1) is highly conserved in multicellular eukaryotes and was first identified for its role in retroviral DNA integration. Homozygous BAF mutants are lethal and depletion of BAF results in defects in chromatin segregation during mitosis and subsequent nuclear envelope assembly. BAF exists both in phosphorylated and unphosphorylated forms with phosphorylation sites Thr-2, Thr-3, and Ser-4, near the N terminus. Vaccinia-related kinase 1 is the major kinase responsible for phosphorylation of BAF. We have identified the major phosphatase responsible for dephosphorylation of Ser-4 to be protein phosphatase 4 catalytic subunit. By examining the cellular distribution of phosphorylated BAF (pBAF) and total BAF (tBAF) through the cell cycle, we found that pBAF is associated with the core region of telophase chromosomes. Depletion of BAF or perturbing its phosphorylation state results not only in nuclear envelope defects, including mislocalization of LEM domain proteins and extensive invaginations into the nuclear interior, but also impaired cell cycle progression. This phenotype is strikingly similar to that seen in cells from patients with progeroid syndrome resulting from a point mutation in BAF.	[Zhuang, Xiaolei; Semenova, Elena; Craigie, Robert] NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA; [Maric, Dragan] NINDS, Flow Cytometry Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Craigie, R (corresponding author), NIDDK, NIH, Bldg 5,Rm 301, Bethesda, MD 20892 USA.	bobc@helix.nih.gov			National Institutes of Health [DK036171]; NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Project DK036171. This work was supported by the Intramural Research Program of NIDDK, National Institutes of Health.	Asencio C, 2012, CELL, V150, P122, DOI 10.1016/j.cell.2012.04.043; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Bengtsson L, 2006, MOL BIOL CELL, V17, P1154, DOI 10.1091/mbc.E05-04-0356; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Bradley CM, 2005, NAT STRUCT MOL BIOL, V12, P935, DOI 10.1038/nsmb989; Brandt A, 2006, CURR BIOL, V16, P543, DOI 10.1016/j.cub.2006.01.051; Cai M, 1998, NAT STRUCT BIOL, V5, P903, DOI 10.1038/2345; Cai ML, 2007, J BIOL CHEM, V282, P14525, DOI 10.1074/jbc.M700576200; Carnegie GK, 2003, J CELL SCI, V116, P1905, DOI 10.1242/jcs.00409; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Cohen PT, 2005, FEBS J, V272, P303; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; COZZONE AJ, 1988, ANNU REV MICROBIOL, V42, P97, DOI 10.1146/annurev.mi.42.100188.000525; de Oca RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007050; Dechat T, 2004, J CELL SCI, V117, P6117, DOI 10.1242/jcs.01529; Furukawa K, 2003, J CELL SCI, V116, P3811, DOI 10.1242/jcs.00682; Furukawa K, 1999, J CELL SCI, V112, P2485; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gupton SL, 2006, PLANT PHYSIOL BIOCH, V44, P95, DOI 10.1016/j.plaphy.2006.03.003; Haraguchi T, 2000, J CELL SCI, V113, P779; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Haraguchi T, 2007, J CELL SCI, V120, P1967, DOI 10.1242/jcs.03461; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Huang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025123; Lee KK, 2001, J CELL SCI, V114, P4567; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Mansharamani M, 2005, J BIOL CHEM, V280, P13863, DOI 10.1074/jbc.M413020200; Margalit A, 2005, P NATL ACAD SCI USA, V102, P3290, DOI 10.1073/pnas.0408364102; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Puente XS, 2011, AM J HUM GENET, V88, P650, DOI 10.1016/j.ajhg.2011.04.010; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Shumaker DK, 2001, EMBO J, V20, P1754, DOI 10.1093/emboj/20.7.1754; Skoko D, 2009, P NATL ACAD SCI USA, V106, P16610, DOI 10.1073/pnas.0909077106; Umland TC, 2000, BIOCHEMISTRY-US, V39, P9130, DOI 10.1021/bi000572w; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197	39	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1119	1127		10.1074/jbc.M113.492777	http://dx.doi.org/10.1074/jbc.M113.492777			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265311	Green Published, hybrid			2022-12-28	WOS:000330541200043
J	Li, Q; Hakimi, P; Liu, X; Yu, WM; Ye, F; Fujioka, H; Raza, S; Shankar, E; Tang, FQ; Dunwoodie, SL; Danielpour, D; Hoppel, CL; Ramirez-Bergeron, DL; Qu, CK; Hanson, RW; Yang, YC				Li, Qiang; Hakimi, Parvin; Liu, Xia; Yu, Wen-Mei; Ye, Fang; Fujioka, Hisashi; Raza, Syed; Shankar, Eswar; Tang, Fangqiang; Dunwoodie, Sally L.; Danielpour, David; Hoppel, Charles L.; Ramirez-Bergeron, Diana L.; Qu, Cheng-Kui; Hanson, Richard W.; Yang, Yu-Chung			Cited2, a Transcriptional Modulator Protein, Regulates Metabolism in Murine Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CBP; Differentiation; Embryonic Stem Cell; Glucose Metabolism; Glycolysis	ACTIVATED RECEPTOR-GAMMA; PARTIALLY RESCUES; BINDING-PROTEIN; GENE-EXPRESSION; DIFFERENTIATION; HIF-1-ALPHA; MOUSE; GLYCOLYSIS; PLURIPOTENCY; DEFECTS	CREB-binding protein (CBP)/p300 interacting transactivator with glutamic acid (Glu) and aspartic acid (Asp)-tail 2 (Cited2) was recently shown to be essential for gluconeogenesis in the adult mouse. The metabolic function of Cited2 in mouse embryonic stem cells (mESCs) remains elusive. In the current study, the metabolism of glucose was investigated in mESCs, which contained a deletion in the gene for Cited2 (Cited2(/-)). Compared with its parental wild type counterpart, Cited2(/-) ESCs have enhanced glycolysis, alternations in mitochondria morphology, reduced glucose oxidation, and decreased ATP content. Cited2 is recruited to the hexokinase 1 (HK1) gene promoter to regulate transcription of HK1, which coordinates glucose metabolism in wild type ESCs. Reduced glucose oxidation and enhanced glycolytic activity in Cited2(/-) ESCs correlates with defective differentiation during hypoxia, which is reflected in an increased expression of pluripotency marker (Oct4) and epiblast marker (Fgf5) and decreased expression of lineage specification markers (T, Gata-6, and Cdx2). Knockdown of hypoxia inducible factor-1 in Cited2(/-) ESCs re-initiates the expression of differentiation markers T and Gata-6. Taken together, a deletion of Cited2 in mESCs results in abnormal mitochondrial morphology and impaired glucose metabolism, which correlates with a defective cell fate decision.	[Li, Qiang; Hakimi, Parvin; Raza, Syed; Tang, Fangqiang; Hanson, Richard W.; Yang, Yu-Chung] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Liu, Xia; Yu, Wen-Mei; Hoppel, Charles L.; Qu, Cheng-Kui] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Ye, Fang; Fujioka, Hisashi; Shankar, Eswar; Danielpour, David] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Ramirez-Bergeron, Diana L.] Case Western Reserve Univ, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Danielpour, David; Ramirez-Bergeron, Diana L.; Qu, Cheng-Kui; Yang, Yu-Chung] Case Western Reserve Univ, Ctr Canc, Cleveland, OH 44106 USA; [Ye, Fang; Hoppel, Charles L.] Case Western Reserve Univ, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Dunwoodie, Sally L.] Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Div, Darlinghurst, NSW 2010, Australia; [Dunwoodie, Sally L.] Univ New S Wales, St Vincents Clin Sch, Kensington, NSW 2010, Australia; [Dunwoodie, Sally L.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Kensington, NSW 2010, Australia	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of New South Wales Sydney	Yang, YC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, 10900 Euclid Ave,W444, Cleveland, OH 44106 USA.	yu-chung.yang@case.edu	Dunwoodie, Sally L/M-4019-2018; Hakimi, Parvin/AAB-1643-2021; Li, Qiang/O-8055-2014; Shankar, Eswar/E-5139-2015	Dunwoodie, Sally L/0000-0002-2069-7349; Li, Qiang/0000-0002-1779-0737; Shankar, Eswar/0000-0001-8968-838X	National Institutes of Health [R01HL091896, R01HL096597]; Ellison Medical Foundation [AG-SS 2420-10]; National Health and Medical Research Council (NHMRC) [1042002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096597, R01HL091896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL091896 (to Y-C. Y) and R01HL096597 (to D. R. B.), Grant AG-SS 2420-10 from the Ellison Medical Foundation (to R. W. H.), and National Health and Medical Research Council (NHMRC) Senior Research Fellowship 1042002 (to S. L. D).	AKUNDI RS, 2012, NEURODEGENE IN PRESS; Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; BALLARD FJ, 1969, BIOCHEM J, V112, P195, DOI 10.1042/bj1120195; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Chen Y, 2008, DEVELOPMENT, V135, P2939, DOI 10.1242/dev.021097; Cheung KF, 2013, CANCER-AM CANCER SOC, V119, P1217, DOI 10.1002/cncr.27865; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Coletta DK, 2008, AM J PHYSIOL-ENDOC M, V294, pE910, DOI 10.1152/ajpendo.00607.2007; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Du JW, 2012, BLOOD, V119, P2789, DOI 10.1182/blood-2011-10-387902; Duggirala R, 2001, AM J HUM GENET, V68, P1149, DOI 10.1086/320100; Fan YJ, 2010, J BIOL CHEM, V285, P7324, DOI 10.1074/jbc.M109.035584; Folmes CDL, 2013, J CARDIOVASC TRANSL, V6, P10, DOI 10.1007/s12265-012-9431-2; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; GNAIGER E, 2000, MITOCHONDRIA COLD; Han Y, 2010, STEM CELLS, V28, P799, DOI 10.1002/stem.316; Hohorst H. J., 1965, METHODS ENZYMATIC AN, V2nd; Huang TQ, 2012, MOL VIS, V18, P1260; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Johnson MT, 2003, J BIOL CHEM, V278, P31457, DOI 10.1074/jbc.R300002200; JOMAIN M, 1969, J LIPID RES, V10, P674; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; Khatri S, 2010, J BIOL CHEM, V285, P15960, DOI 10.1074/jbc.M110.121871; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li Q, 2012, J BIOL CHEM, V287, P29088, DOI 10.1074/jbc.M112.378034; Luo FM, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-26; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; McCleland ML, 2012, CANCER RES, V72, P5812, DOI 10.1158/0008-5472.CAN-12-1098; Nekanti U, 2010, INT J BIOL SCI, V6, P499; Nemetski SM, 2007, J BIOL CHEM, V282, P240, DOI 10.1074/jbc.M607275200; Ou XA, 2011, BLOOD, V117, P440, DOI 10.1182/blood-2010-03-273011; Papanicolaou KN, 2012, CIRC RES, V111, P1012, DOI 10.1161/CIRCRESAHA.112.274142; Peng TI, 2004, ANN NY ACAD SCI, V1011, P112, DOI 10.1196/annals.1293.012; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sakai M, 2012, NAT MED, V18, P612, DOI 10.1038/nm.2691; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Shen JH, 2011, MOL CELL BIOL, V31, P4902, DOI 10.1128/MCB.05629-11; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; SLEIN MW, 1965, METHODS ENZYMATIC AN; Song J, 2012, MOL CELL PROTEOMICS, V11, P1036, DOI 10.1074/mcp.M111.011114; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Weninger WJ, 2005, DEVELOPMENT, V132, P1337, DOI 10.1242/dev.01696; Wilkerson DC, 2011, INT J BIOCHEM CELL B, V43, P1252, DOI 10.1016/j.biocel.2011.05.005; Xu B, 2007, DEV BIOL, V301, P130, DOI 10.1016/j.ydbio.2006.08.072; Yang SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003112; Ye F, 2011, J BIOL CHEM, V286, P40013, DOI 10.1074/jbc.M111.292029; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Zha XJ, 2011, CANCER RES, V71, P13, DOI 10.1158/0008-5472.CAN-10-1668; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhong XM, 2009, J BIOL CHEM, V284, P9168, DOI 10.1074/jbc.M805562200; ZHOU J, 2013, J CLIN INVE IN PRESS; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	65	16	17	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					251	263		10.1074/jbc.M113.497594	http://dx.doi.org/10.1074/jbc.M113.497594			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24265312	Green Published, hybrid			2022-12-28	WOS:000329370900022
J	Schmid, S; Sachs, D; tenOever, BR				Schmid, Sonja; Sachs, David; tenOever, Benjamin R.			Mitogen-activated Protein Kinase-mediated Licensing of Interferon Regulatory Factor 3/7 Reinforces the Cell Response to Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellular Immune Response; MAP Kinases (MAPKs); Protein Phosphorylation; Transcriptomics; Virus; Dimer Formation; IRF3; IRF7; PML Nuclear Bodies; SP100	PROMYELOCYTIC LEUKEMIA PROTEIN; NF-KAPPA-B; FACTOR-I IRF-1; CRYSTAL-STRUCTURE; TRANSCRIPTION FACTORS; DNA-BINDING; RIG-I; GENE-EXPRESSION; BETA-INTERFERON; NUCLEAR-BODIES	The induction of the intrinsic antiviral defense in mammals relies on the accumulation of foreign genetic material. As such, complete engagement of this response is limited to replication-competent viruses. Interferon regulatory factors (IRFs) are mediators of this defense with shared enhancer elements but display a spectrum of transcriptional potential. Here we describe a mechanism designed to enhance this response should a pathogen not be successfully inhibited. We find that activation of IRF7 results in the induction of MAP3K8 and restructuring of the antiviral transcriptome. MAP3K8 mediates the phosphorylation and repression of IRF3 homodimers to promote greater transcriptional activity through utilization of IRF3:IRF7 heterodimers. Among the genes influenced by the MAP3K8/IRF7 signaling axis are members of the SP100 gene family that serve as general transcriptional enhancers of the antiviral defense. We propose that this feed forward loop serves to reinforce the cellular response and is reserved for imminent threats to the host.	[Schmid, Sonja; tenOever, Benjamin R.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Sachs, David] Icahn Sch Med Mt Sinai, Dept Genom, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	tenOever, BR (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	benjamin.tenoever@mssm.edu		Schmid, Sonja/0000-0002-1946-5970; tenOever, Benjamin/0000-0003-0324-3078; Sachs, David/0000-0002-4445-2055	National Institutes of Health from NIAID [A1080624]	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant A1080624 from the NIAID.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Au WC, 2001, VIROLOGY, V280, P273, DOI 10.1006/viro.2000.0782; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Blondel D, 2010, J VIROL, V84, P10719, DOI 10.1128/JVI.01286-10; Bonilla WV, 2002, J VIROL, V76, P3810, DOI 10.1128/JVI.76.8.3810-3818.2002; Borden KLB, 2008, BBA-MOL CELL RES, V1783, P2145, DOI 10.1016/j.bbamcr.2008.06.005; Chattopadhyay S, 2013, J VIROL, V87, P16, DOI 10.1128/JVI.01853-12; Chelbi-Alix MK, 1998, J VIROL, V72, P1043, DOI 10.1128/JVI.72.2.1043-1051.1998; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Doody GM, 2010, NUCLEIC ACIDS RES, V38, P5336, DOI 10.1093/nar/gkq268; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Farlik M, 2012, MOL CELL BIOL, V32, P1032, DOI 10.1128/MCB.06021-11; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Genin P, 2009, MOL CELL BIOL, V29, P3435, DOI 10.1128/MCB.01805-08; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Grotzinger T, 1996, J BIOL CHEM, V271, P25253, DOI 10.1074/jbc.271.41.25253; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Iki S, 2005, VIROLOGY, V343, P106, DOI 10.1016/j.virol.2005.08.010; Ireton RC, 2011, VIRUSES-BASEL, V3, P906, DOI 10.3390/v3060906; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Lallemand-Breitenbach V., 2010, COLD SPRING HARB PER, V2; Langlois RA, 2012, P NATL ACAD SCI USA, V109, P12117, DOI 10.1073/pnas.1206039109; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; Li J., 2013, MBIO, V4; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Morin P, 2002, J MOL BIOL, V316, P1009, DOI 10.1006/jmbi.2001.5401; Newhart A, 2013, MOL BIOL CELL, V24, P1454, DOI 10.1091/mbc.E12-09-0669; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schmid S, 2010, J BIOL CHEM, V285, P42013, DOI 10.1074/jbc.M110.165936; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tavalai N, 2008, BBA-MOL CELL RES, V1783, P2207, DOI 10.1016/j.bbamcr.2008.08.004; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Thakar J, 2013, J INTERF CYTOK RES, V33, P700, DOI 10.1089/jir.2012.0113; Tsatsanis C, 1998, P NATL ACAD SCI USA, V95, P3827, DOI 10.1073/pnas.95.7.3827; Ulbricht T, 2012, J CELL BIOL, V199, P49, DOI 10.1083/jcb.201112015; Varble A, 2013, CELL HOST MICROBE, V14, P346, DOI 10.1016/j.chom.2013.08.007; VEALS SA, 1993, MOL CELL BIOL, V13, P196, DOI 10.1128/MCB.13.1.196; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; Vougioukalaki M, 2011, CANCER LETT, V304, P80, DOI 10.1016/j.canlet.2011.02.004; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Wang JT, 2009, J VIROL, V83, P1856, DOI 10.1128/JVI.01099-08; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Xiao NM, 2009, J IMMUNOL, V183, P7975, DOI 10.4049/jimmunol.0902718; Xu J, 2013, P NATL ACAD SCI USA, V110, P15025, DOI 10.1073/pnas.1303193110; Yang HM, 2002, EUR J BIOCHEM, V269, P6142, DOI 10.1046/j.1432-1033.2002.03330.x; Yang HT, 2011, J IMMUNOL, V186, P1989, DOI 10.4049/jimmunol.1001003; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	91	20	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					299	311		10.1074/jbc.M113.519934	http://dx.doi.org/10.1074/jbc.M113.519934			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24275658	Green Published, hybrid			2022-12-28	WOS:000329370900026
J	Matsumura, N; Takami, M; Okochi, M; Wada-Kakuda, S; Fujiwara, H; Tagami, S; Funamoto, S; Ihara, Y; Morishima-Kawashima, M				Matsumura, Nobutaka; Takami, Mako; Okochi, Masayasu; Wada-Kakuda, Satoko; Fujiwara, Hitomi; Tagami, Shinji; Funamoto, Satoru; Ihara, Yasuo; Morishima-Kawashima, Maho			gamma Secretase Associated with Lipid Rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid Precursor Protein; Lipid Raft; Membrane; Secretases; Amyloid -Protein; -Secretase	AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMER-DISEASE; CARBOXYL-TERMINAL FRAGMENT; INTRAMEMBRANE CLEAVAGE; BETA-PROTEIN; PRESENILIN ENDOPROTEOLYSIS; TRANSMEMBRANE DOMAIN; MECHANISM; A-BETA-42; BETA-PROTEIN-42	Background: Intramembranous cleavages of -carboxyl-terminal fragment (CTF) by -secretase generate amyloid -protein (A). Results: Three- to six-residue peptides are released successively along with A generation by lipid raft-associated -secretase. Conclusion: -Secretase cleaves CTF through multiple interactive pathways for stepwise successive processing to generate A. Significance: This cleavage model provides insights into the precise molecular mechanism of A generation. -Secretase generates amyloid -protein (A), a pathogenic molecule in Alzheimer disease, through the intramembrane cleavage of the -carboxyl-terminal fragment (CTF) of -amyloid precursor protein. We previously showed the framework of the -secretase cleavage, i.e. the stepwise successive processing of CTF at every three (or four) amino acids. However, the membrane integrity of -secretase was not taken into consideration because of the use of the 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonic acid-solubilized reconstituted -secretase system. Here, we sought to address how the membrane-integrated -secretase cleaves CTF by using -secretase associated with lipid rafts. Quantitative analyses using liquid chromatography-tandem mass spectrometry of the CTF transmembrane domain-derived peptides released along with A generation revealed that the raft-associated -secretase cleaves CTF in a stepwise sequential manner, but novel penta- and hexapeptides as well as tri- and tetrapeptides are released. The cropping of these peptides links the two major tripeptide-cleaving pathways generating A40 and A42 at several points, implying that there are multiple interactive pathways for the stepwise cleavages of CTF. It should be noted that A38 and A43 are generated through three routes, and -secretase modulator 1 enhances all the three routes generating A38, which results in decreases in A42 and A43 and an increase in A38. These observations indicate that multiple interactive pathways for stepwise successive processing by -secretase define the species and quantity of A produced.	[Matsumura, Nobutaka; Morishima-Kawashima, Maho] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Mol Neuropathol, Sapporo, Hokkaido 0600812, Japan; [Takami, Mako; Wada-Kakuda, Satoko; Fujiwara, Hitomi; Funamoto, Satoru; Ihara, Yasuo] Doshisha Univ, Fac Life & Med Sci, Dept Neuropathol, Kizugawa 6190225, Japan; [Okochi, Masayasu; Tagami, Shinji] Osaka Univ, Grad Sch Med, Dept Integrated Med, Osaka 5650871, Japan; [Funamoto, Satoru; Ihara, Yasuo] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020076, Japan	Hokkaido University; Doshisha University; Osaka University; Japan Science & Technology Agency (JST)	Morishima-Kawashima, M (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Mol Neuropathol, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	maho@pharm.hokudai.ac.jp		Okochi, Masayasu/0000-0002-2318-7651	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research (C) from the Japan Society for the Promotion of Science (to M. M.-K.) and by a Ministry of Education, Culture, Sports, Science and Technology-supported program for the Strategic Research Foundation at Private Universities, 2012-2017 (to Y. I.).	Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Bhattacharyya R, 2013, J NEUROSCI, V33, P11169, DOI 10.1523/JNEUROSCI.4704-12.2013; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; De Strooper B., 2012, COLD SPRING HARBOR P, V2; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Li HL, 2009, STRUCTURE, V17, P326, DOI 10.1016/j.str.2009.01.007; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Pester O, 2013, J AM CHEM SOC, V135, P1317, DOI 10.1021/ja3112093; Portelius E, 2006, J PROTEOME RES, V5, P1010, DOI 10.1021/pr050475v; Portelius E, 2009, NEURODEGENER DIS, V6, P258, DOI 10.1159/000264639; Portelius E, 2011, NEUROBIOL AGING, V32, P1090, DOI 10.1016/j.neurobiolaging.2009.06.002; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yagishita S, 2008, J BIOL CHEM, V283, P733, DOI 10.1074/jbc.M707103200	36	67	70	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5109	5121		10.1074/jbc.M113.510131	http://dx.doi.org/10.1074/jbc.M113.510131			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24375443	Green Published, hybrid			2022-12-28	WOS:000331607900054
J	Niegowski, D; Kleinschmidt, T; Olsson, U; Ahmad, S; Rinaldo-Matthis, A; Haeggstrom, JZ				Niegowski, Damian; Kleinschmidt, Thea; Olsson, Ulrika; Ahmad, Shabbir; Rinaldo-Matthis, Agnes; Haeggstrom, Jesper Z.			Crystal Structures of Leukotriene C-4 Synthase in Complex with Product Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Asthma; Glutathion; Leukotriene; Lipid-binding Protein; Membrane Proteins; LTA4; LTC4; LTC4 Synthase	MEMBRANE-ASSOCIATED PROTEINS; MAPEG; TRANSFERASES; SUPERFAMILY; ASTHMA; MODEL	Background: Leukotriene (LT) C-4 synthase (LTC4S) is a membrane protein catalyzing the formation of pathogenic mediators of asthma. Results: Crystal structures of complexes of WT and mutated LTC4S with three product analogs. Conclusion: Evidence for the binding mode of LTA(4) and LTC4 at the active site of LTC4S and a mechanistic model. Significance: New insights into the molecular mechanism of LTC4S. Leukotriene (LT) C-4 synthase (LTC4S) catalyzes the conjugation of the fatty acid LTA(4) with the tripeptide GSH to produce LTC4, the parent compound of the cysteinyl leukotrienes, important mediators of asthma. Here we mutated Trp-116 in human LTC4S, a residue proposed to play a key role in substrate binding, into an Ala or Phe. Biochemical and structural characterization of these mutants along with crystal structures of the wild type and mutated enzymes in complex with three product analogs, viz. S-hexyl-, 4-phenyl-butyl-, and 2-hydroxy-4-phenyl-butyl-glutathione, provide new insights to binding of substrates and product, identify a new conformation of the GSH moiety at the active site, and suggest a route for product release, aided by Trp-116.	[Niegowski, Damian; Kleinschmidt, Thea; Olsson, Ulrika; Ahmad, Shabbir; Rinaldo-Matthis, Agnes; Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, S-10777 Stockholm, Sweden	Karolinska Institutet	Rinaldo-Matthis, A (corresponding author), Karolinska Insitutet, Dept Med Biochem & Biophys, Div Chem 2, S-10777 Stockholm, Sweden.	agnes.rinaldo-matthis@ki.se; jesper.haeggstrom@ki.se		Ahmad, Shabbir/0000-0003-2374-1197	Swedish Research Council [621-2011-5003, 10350, 20854]; Vinnova Foundation; Stockholm County Council; FP7 [201668]; Karolinska Institutet; CERIC Linneus grant	Swedish Research Council(Swedish Research CouncilEuropean Commission); Vinnova Foundation(Vinnova); Stockholm County Council(Stockholm County Council); FP7; Karolinska Institutet(Karolinska Institutet); CERIC Linneus grant	This work was supported by The Swedish Research Council Grants 621-2011-5003, 10350, 20854, and CERIC Linneus grant), the Vinnova Foundation (CIDaT project), Dr. Hans Kroner Graduiertenkolleg, the Stockholm County Council (Cardiovascular Program, Thematic Center of Inflammation), and FP7 (201668).; Recipient of a Distinguished Professor Award from Karolinska Institutet. To whom correspondence may be addressed: Div. of Chemistry II, Dept. of Medical Biochemistry and Biophysics, Karolinska Insitutet, S-107 77 Stockholm, Sweden. Tel.: 46-8-524-87612 or 46-8-524-87648; Fax: 46-8-736-0439; E-mail: jesper.haeggstrom@ki.se.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bisgaard H, 2001, PEDIATRICS, V107, P381, DOI 10.1542/peds.107.2.381; Cao J, 2013, J BIOL CHEM, V288, P1806, DOI 10.1074/jbc.R112.421909; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Jakobsson PJ, 2000, AM J RESP CRIT CARE, V161, pS20, DOI 10.1164/ajrccm.161.supplement_1.ltta-5; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Lundstrom K, 2004, COMB CHEM HIGH T SCR, V7, P431, DOI 10.2174/1386207043328634; Lynch KR, 1999, NATURE, V399, P789; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Muller G, 2000, CURR MED CHEM, V7, P861, DOI 10.2174/0929867003374534; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Rinaldo-Matthis A, 2010, J BIOL CHEM, V285, P40771, DOI 10.1074/jbc.M110.105940; Saino H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.150177; Salinas AE, 1999, CURR MED CHEM, V6, P279; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sjogren T, 2013, P NATL ACAD SCI USA, V110, P3806, DOI 10.1073/pnas.1218504110; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145	29	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5199	5207		10.1074/jbc.M113.534628	http://dx.doi.org/10.1074/jbc.M113.534628			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24366866	hybrid, Green Published			2022-12-28	WOS:000331607900061
J	Sasikumar, AN; Kinzy, TG				Sasikumar, Arjun N.; Kinzy, Terri Goss			Mutations in the Chromodomain-like Insertion of Translation Elongation Factor 3 Compromise Protein Synthesis through Reduced ATPase Activity*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Ribosomes; Translation; Translation Elongation Factors; Yeast; Chromodomain	FACTOR-I; YEAST; BINDING; MECHANISM; RIBOSOMES; SITE; RNA	Background: Eukaryotic translation elongation factor 3 (eEF3) is a ribosome binding ATPase essential for fungal protein synthesis. Results: Mutations in the chromodomain-like insertion in an ATPase domain of eEF3 reduce ATPase activity but not ribosome binding. Conclusion: The chromodomain-like insertion affects the ATPase activity of eEF3 and translation. Significance: The chromodomain-like insertion of eEF3 may be targeted to develop new antifungal compounds. Translation elongation is mediated by ribosomes and multiple soluble factors, many of which are conserved across bacteria and eukaryotes. During elongation, eukaryotic elongation factor 1A (eEF1A; EF-Tu in bacteria) delivers aminoacylated-tRNA to the A-site of the ribosome, whereas eEF2 (EF-G in bacteria) translocates the ribosome along the mRNA. Fungal translation elongation is striking in its absolute requirement for a third factor, the ATPase eEF3. eEF3 binds close to the E-site of the ribosome and has been proposed to facilitate the removal of deacylated tRNA from the E-site. eEF3 has two ATP binding cassette (ABC) domains, the second of which carries a unique chromodomain-like insertion hypothesized to play a significant role in its binding to the ribosome. This model was tested in the current study using a mutational analysis of the Sac7d region of the chromodomain-like insertion. Specific mutations in this domain result in reduced growth rate as well as slower translation elongation. In vitro analysis demonstrates that these mutations do not affect the ability of eEF3 to interact with the ribosome. Kinetic analysis revealed a larger turnover number for ribosomes in comparison to eEF3, indicating that the partial reactions involving the ribosome are significantly faster than that of eEF3. Mutations in the chromodomain-like insertion severely compromise the ribosome stimulated ATPase of eEF3, strongly suggesting that it exerts an allosteric effect on the hydrolytic activity of eEF3. The chromodomain-like insertion is, therefore, vital to eEF3 function and may be targeted for developing novel antifungal drugs.	[Sasikumar, Arjun N.; Kinzy, Terri Goss] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kinzy, TG (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	kinzytg@rutgers.edu		Kinzy, Terri/0000-0003-1394-9226	National Institutes of Health Grant [RO1 GM57483]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM57483.	Anand M, 2003, J BIOL CHEM, V278, P6985, DOI 10.1074/jbc.M209224200; Anand M, 2006, J BIOL CHEM, V281, P32318, DOI 10.1074/jbc.M601899200; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Burke D., 2000, METHODS YEAST GENETI; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; CARVALHO MDD, 1984, ARCH BIOCHEM BIOPHYS, V234, P603, DOI 10.1016/0003-9861(84)90310-2; DASMAHAPATRA B, 1981, J BIOL CHEM, V256, P5; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Esposito AM, 2010, J VIS EXP; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hinnebusch A.G., 2007, TRANSLATIONAL CONTRO, P225; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Leshin JA, 2011, RNA BIOL, V8, P478, DOI 10.4161/rna.8.3.14453; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; MIYAZAKI M, 1988, J BIOCHEM-TOKYO, V104, P445, DOI 10.1093/oxfordjournals.jbchem.a122487; Moreno JMP, 1998, BIOCHEM BIOPH RES CO, V252, P465, DOI 10.1006/bbrc.1998.9664; QIN SL, 1990, J BIOL CHEM, V265, P1903; Shin BS, 2007, METHOD ENZYMOL, V429, P185, DOI 10.1016/S0076-6879(07)29009-3; SKOGERSON L, 1968, J BIOL CHEM, V243, P5354; Smith MW, 2001, MOL CELL BIOL, V21, P8264, DOI 10.1128/MCB.21.24.8264-8275.2001; Sturtevant Joy, 2002, Expert Opin Ther Targets, V6, P545, DOI 10.1517/14728222.6.5.545; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; URITANI M, 1988, J BIOCHEM-TOKYO, V103, P522, DOI 10.1093/oxfordjournals.jbchem.a122302; Valente L, 2003, CELL MOL LIFE SCI, V60, P2115, DOI 10.1007/s00018-003-2334-2; Yang HM, 1996, BBA-MOL CELL RES, V1310, P303, DOI 10.1016/0167-4889(95)00179-4	31	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4853	4860		10.1074/jbc.M113.536201	http://dx.doi.org/10.1074/jbc.M113.536201			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24379402	Green Published, hybrid			2022-12-28	WOS:000331607900032
J	Zhang, C; Huang, Y; Jiang, YS; Mulpuri, N; Wei, L; Hamelberg, D; Brown, EM; Yang, JJ				Zhang, Chen; Huang, Yun; Jiang, Yusheng; Mulpuri, Nagaraju; Wei, Ling; Hamelberg, Donald; Brown, Edward M.; Yang, Jenny J.			Identification of an L-Phenylalanine Binding Site Enhancing the Cooperative Responses of the Calcium-sensing Receptor to Calcium*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Calcium Imaging; Calcium Signaling; Cooperativity; G Protein-coupled Receptors (GPCR); Calcium-sensing Receptor; Calcium Oscillation	EXTRACELLULAR CA2+-SENSING RECEPTOR; MOLECULAR-DYNAMICS; CA2+-BINDING SITES; AMINO-ACIDS; PROTEIN; DOMAIN; OSCILLATIONS; MECHANISM; SPECIFICITY; ACTIVATION	Background: The calcium-sensing receptor (CaSR) is a key mediator of Ca2+ homeostasis in vivo. Results: An l-Phe binding site at the CaSR hinge region globally enhances its cooperative activation by Ca2+. Conclusion: Communication between the binding sites for Ca2+ and l-Phe is crucial for functional cooperativity of CaSR-mediated signaling. Significance: The results provide important insights into the molecular basis of Ca2+ sensing by the CaSR. Functional positive cooperative activation of the extracellular calcium ([Ca2+](o))-sensing receptor (CaSR), a member of the family C G protein-coupled receptors, by [Ca2+](o) or amino acids elicits intracellular Ca2+ ([Ca2+](i)) oscillations. Here, we report the central role of predicted Ca2+-binding site 1 within the hinge region of the extracellular domain (ECD) of CaSR and its interaction with other Ca2+-binding sites within the ECD in tuning functional positive homotropic cooperativity caused by changes in [Ca2+](o). Next, we identify an adjacent l-Phe-binding pocket that is responsible for positive heterotropic cooperativity between [Ca2+](o) and l-Phe in eliciting CaSR-mediated [Ca2+](i) oscillations. The heterocommunication between Ca2+ and an amino acid globally enhances functional positive homotropic cooperative activation of CaSR in response to [Ca2+](o) signaling by positively impacting multiple [Ca2+](o)-binding sites within the ECD. Elucidation of the underlying mechanism provides important insights into the longstanding question of how the receptor transduces signals initiated by [Ca2+](o) and amino acids into intracellular signaling events.	[Zhang, Chen; Huang, Yun; Jiang, Yusheng; Mulpuri, Nagaraju; Wei, Ling; Hamelberg, Donald; Yang, Jenny J.] Georgia State Univ, Dept Chem, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA; [Brown, Edward M.] Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	University System of Georgia; Georgia State University; Harvard University; Brigham & Women's Hospital	Yang, JJ (corresponding author), Georgia State Univ, Dept Chem, Univ Plaza, Atlanta, GA 30303 USA.	jenny@gsu.edu	Jiang, Yusheng/A-1087-2016	Huang, Yun/0000-0001-5950-9168	National Institutes of Health [GM081749, EB007268]; National Science Foundation [MCB-0953061]; Center for Diagnostics and Therapeutics (CDT) fellowship; Georgia Research Alliance; Direct For Biological Sciences [0953061] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Center for Diagnostics and Therapeutics (CDT) fellowship; Georgia Research Alliance; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081749 and EB007268 (to J. J. Y.). This work was also supported by National Science Foundation Grant MCB-0953061 (to D. H.), a Center for Diagnostics and Therapeutics (CDT) fellowship (to C. Z.), and funds from the Georgia Research Alliance.	Ackers GK, 1998, ADV PROTEIN CHEM, V51, P185; Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; [Anonymous], 2008, AMBER 10; Anthis NJ, 2011, J AM CHEM SOC, V133, P18966, DOI 10.1021/ja2082813; Bai M, 2004, CELL CALCIUM, V35, P197, DOI 10.1016/j.ceca.2003.10.018; Brauner-Osborne H, 1999, J BIOL CHEM, V274, P18382, DOI 10.1074/jbc.274.26.18382; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Breitwieser GE, 2006, CURR TOP DEV BIOL, V73, P85, DOI 10.1016/S0070-2153(05)73003-9; Breitwieser GE, 2012, MOL ENDOCRINOL, V26, P1482, DOI 10.1210/me.2011-1370; BRINGHURST FR, 1993, ENDOCRINOLOGY, V132, P2090, DOI 10.1210/en.132.5.2090; Broadhead GK, 2011, J BIOL CHEM, V286, P8786, DOI 10.1074/jbc.M110.149724; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Buchan AMJ, 2001, GASTROENTEROLOGY, V120, P1128, DOI 10.1053/gast.2001.23246; Bugaj V, 2005, J BIOL CHEM, V280, P16790, DOI 10.1074/jbc.M500192200; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Cheng SX, 2004, GASTROENTEROLOGY, V126, P148, DOI 10.1053/j.gastro.2003.10.064; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conigrave AD, 2002, EUR J CLIN NUTR, V56, P1072, DOI 10.1038/sj.ejcn.1601463; Conigrave AD, 2007, J NUTR, V137, p1524S, DOI 10.1093/jn/137.6.1524S; Conigrave AD, 2006, AM J PHYSIOL-GASTR L, V291, pG753, DOI 10.1152/ajpgi.00189.2006; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Doshi U, 2012, J CHEM THEORY COMPUT, V8, P4004, DOI 10.1021/ct3004194; Doshi U, 2009, J PHYS CHEM B, V113, P16590, DOI 10.1021/jp907388m; Francesconi A, 2004, J NEUROSCI RES, V75, P472, DOI 10.1002/jnr.10853; Galvez T, 2000, MOL PHARMACOL, V57, P419, DOI 10.1124/mol.57.3.419; Gama L, 2001, J BIOL CHEM, V276, P39053, DOI 10.1074/jbc.M105662200; Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017; Hamelberg D, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2789432; Hammerland LG, 1999, MOL PHARMACOL, V55, P642; Hannan FM, 2012, HUM MOL GENET, V21, P2768, DOI 10.1093/hmg/dds105; Hendy GN, 2009, PROG MOL BIOL TRANSL, V89, P31, DOI 10.1016/S1877-1173(09)89003-0; Hinson TK, 1997, GENOMICS, V45, P279, DOI 10.1006/geno.1997.4943; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hu JX, 2003, TRENDS ENDOCRIN MET, V14, P282, DOI 10.1016/S1043-2760(03)00104-8; Huang C, 2007, J CELL MOL MED, V11, P923, DOI 10.1111/j.1582-4934.2007.00114.x; Huang Y, 2007, J BIOL CHEM, V282, P19000, DOI 10.1074/jbc.M701096200; Huang Y, 2010, J BIOL CHEM, V285, P35919, DOI 10.1074/jbc.M110.147918; Huang Y, 2009, BIOCHEMISTRY-US, V48, P388, DOI 10.1021/bi8014604; Jiang YS, 2010, J BIOL CHEM, V285, P33463, DOI 10.1074/jbc.M110.147033; Jolliffe I. T., 2002, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; LEVY RM, 1984, BIOPOLYMERS, V23, P1099, DOI 10.1002/bip.360230610; Liou AP, 2011, AM J PHYSIOL-GASTR L, V300, pG538, DOI 10.1152/ajpgi.00342.2010; Mathias RS, 2001, J BONE MINER RES, V16, P2238, DOI 10.1359/jbmr.2001.16.12.2238; Miedlich S, 2002, J BIOL CHEM, V277, P49691, DOI 10.1074/jbc.M205578200; Mongan J, 2004, J COMPUT AID MOL DES, V18, P433, DOI 10.1007/s10822-004-4121-z; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mun HC, 2005, J BIOL CHEM, V280, P29067, DOI 10.1074/jbc.M500002200; Mun HC, 2004, J BIOL CHEM, V279, P51739, DOI 10.1074/jbc.M406164/200; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Silve C, 2005, J BIOL CHEM, V280, P37917, DOI 10.1074/jbc.M506263200; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Thakker RV, 2004, CELL CALCIUM, V35, P275, DOI 10.1016/j.ceca.2003.10.010; Tordoff MG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00496; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tu CL, 2004, CELL CALCIUM, V35, P265, DOI 10.1016/j.ceca.2003.10.019; Wang MH, 2006, J BIOL CHEM, V281, P8864, DOI 10.1074/jbc.M512865200; Wang X, 2009, PROTEINS, V75, P787, DOI 10.1002/prot.22285; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Wise A, 1999, NEUROPHARMACOLOGY, V38, P1647, DOI 10.1016/S0028-3908(99)00119-7; Young SH, 2002, AM J PHYSIOL-CELL PH, V282, pC1414, DOI 10.1152/ajpcell.00432.2001; Zhang ZX, 2002, J BIOL CHEM, V277, P33727, DOI 10.1074/jbc.M200976200	70	23	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5296	5309		10.1074/jbc.M113.537357	http://dx.doi.org/10.1074/jbc.M113.537357			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24394414	Green Published, hybrid			2022-12-28	WOS:000331607900070
J	Eitas, TK; Chou, WC; Wen, HT; Gris, D; Robbins, GR; Brickey, J; Oyama, Y; Ting, JPY				Eitas, Timothy K.; Chou, Wei-Chun; Wen, Haitao; Gris, Denis; Robbins, Gregory R.; Brickey, June; Oyama, Yoshitaka; Ting, Jenny P. -Y.			The Nucleotide-binding Leucine-rich Repeat (NLR) Family Member NLRX1 Mediates Protection against Experimental Autoimmune Encephalomyelitis and Represses Macrophage/Microglia-induced Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Immunology; Innate immunity; Interleukin; Neuroimmunology	ALZHEIMERS-DISEASE; CNS; DEATH; MICROGLIA; RESPONSES; TH1	Background: The nucleotide-binding leucine-rich repeat (NLR) family of innate immune genes are important regulators of inflammatory responses in mammals. Results: The NLR gene, Nlrx1, suppresses neuroinflammation in vivo and inhibits microglial (Mg) activation. Conclusion: NLRX1 immunosuppressive function in Mg correlates with suppression of neuroinflammation during mouse models of Multiple Sclerosis (MS). Significance: NLR genes can have protective roles during neuroinflammation. The nucleotide binding domain and leucine-rich repeat-containing (NLR) family of proteins is known to activate innate immunity, and the inflammasome-associated NLRs are prime examples. In contrast, the concept that NLRs can inhibit innate immunity is still debated, and the impact of such inhibitory NLRs in diseases shaped by adaptive immune responses is entirely unexplored. This study demonstrates that, in contrast to other NLRs that activate immunity, NLRX1 plays a protective role in experimental autoimmune encephalomyelitis (EAE), a mouse model for multiple sclerosis. When compared with wild-type controls, Nlrx1(-/-) mice have significantly worsened clinical scores and heightened CNS tissue damage during EAE. NLRX1 does not alter the production of encephalitogenic T cells in the peripheral lymphatic tissue, but Nlrx1(-/-) mice are more susceptible to adoptively transferred myelin-reactive T cells. Analysis of the macrophage and microglial populations indicates that NLRX1 reduces activation during both active and passive EAE models. This work represents the first case of an NLR that attenuates microglia inflammatory activities and protects against a neurodegenerative disease model caused by autoreactive T cells.	[Eitas, Timothy K.; Chou, Wei-Chun; Wen, Haitao; Robbins, Gregory R.; Brickey, June; Oyama, Yoshitaka; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Canc Res Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Canc Res Ctr, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Gris, Denis] Univ Sherbrooke, Ctr Rech Clin Etienne Le Bel, Sherbrooke, PQ J1H 5N4, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Sherbrooke	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Canc Res Ctr, Dept Microbiol & Immunol, Curriculum Genet & Mol Biol, Campus Box 7295, Chapel Hill, NC 27599 USA.	jpyting@gmail.com	Gris, Denis/ABE-5229-2021; Gris, Denis/AGA-1192-2022; Wen, Haitao/AAJ-7621-2020; Chou, Wei-Chun/AAO-6532-2020	Gris, Denis/0000-0003-1215-2434; Gris, Denis/0000-0003-1215-2434; Chou, Wei-Chun/0000-0003-3355-6921	National Multiple Sclerosis Society (NMSS) [CA-10530A-8, RG-1785G9/2]; Cancer Research Institute; NMSS; Canadian Institutes of Health and Research; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER	National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Cancer Research Institute; NMSS(National Multiple Sclerosis Society); Canadian Institutes of Health and Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Multiple Sclerosis Society (NMSS) Grants CA-10530A-8 and RG-1785G9/2 (to J. P. Y. T.).; Supported by the Irvington Fellowship Program of the Cancer Research Institute.; Supported by a postdoctoral fellowship from NMSS.; Supported by a fellowship from the Canadian Institutes of Health and Research.	Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brini E, 2009, J NEUROIMMUNOL, V209, P33, DOI 10.1016/j.jneuroim.2009.01.022; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Dann A, 2012, NAT NEUROSCI, V15, P98, DOI 10.1038/nn.2964; Dienz O., 2006, CLIN IMMUNOL, V30, P27; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Inoue M, 2012, P NATL ACAD SCI USA, V109, P10480, DOI 10.1073/pnas.1201836109; Inoue M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002767; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Locatelli G, 2012, NAT NEUROSCI, V15, P543, DOI 10.1038/nn.3062; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Polazzi E, 2010, PROG NEUROBIOL, V92, P293, DOI 10.1016/j.pneurobio.2010.06.009; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Popovic N, 2002, ANN NEUROL, V51, P215, DOI 10.1002/ana.10092; Ramaglia V, 2012, P NATL ACAD SCI USA, V109, P965, DOI 10.1073/pnas.1111924109; Schreiner B, 2008, EUR J IMMUNOL, V38, P2706, DOI 10.1002/eji.200838137; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296	33	38	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4173	4179		10.1074/jbc.M113.533034	http://dx.doi.org/10.1074/jbc.M113.533034			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24366868	Green Published, hybrid			2022-12-28	WOS:000331403800030
J	Dong, YS; Zhang, LJ; Bai, YP; Zhou, HM; Campbell, AM; Chen, HY; Yong, WD; Zhang, WJ; Zeng, Q; Shou, WN; Zhang, ZY				Dong, Yuanshu; Zhang, Lujuan; Bai, Yunpeng; Zhou, Hong-Ming; Campbell, Amanda M.; Chen, Hanying; Yong, Weidong; Zhang, Wenjun; Zeng, Qi; Shou, Weinian; Zhang, Zhong-Yin			Phosphatase of Regenerating Liver 2 (PRL2) Deficiency Impairs Kit Signaling and Spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein Phosphatase; Pten; Signal Transduction; Spermatogenesis; Testis	RECEPTOR TYROSINE KINASE; HUMAN COLORECTAL-CANCER; GENE-EXPRESSION; C-KIT; GERM-CELLS; IN-VITRO; PROTEIN; METASTASIS; INVASION; MOUSE	Background: The PRLs are oncogenic when overexpressed but their physiological function is not well defined. Results: PRL2-deficient mice exhibit testis hypotrophy, decreased sperm production, and impaired reproductive potential. Conclusion: PRL2 promotes Kit signaling and germ cell survival by down-regulating PTEN. Significance: The study reveals the biological importance of PRL2 in spermatogenesis and identifies PRL2 as a novel target for cancer and male contraception. The Phosphatase of Regenerating Liver (PRL) proteins promote cell signaling and are oncogenic when overexpressed. However, our understanding of PRL function came primarily from studies with cultured cell lines aberrantly or ectopically expressing PRLs. To define the physiological roles of the PRLs, we generated PRL2 knock-out mice to study the effects of PRL deletion in a genetically controlled, organismal model. PRL2-deficient male mice exhibit testicular hypotrophy and impaired spermatogenesis, leading to decreased reproductive capacity. Mechanistically, PRL2 deficiency results in elevated PTEN level in the testis, which attenuates the Kit-PI3K-Akt pathway, resulting in increased germ cell apoptosis. Conversely, increased PRL2 expression in GC-1 cells reduces PTEN level and promotes Akt activation. Our analyses of PRL2-deficient animals suggest that PRL2 is required for spermatogenesis during testis development. The study also reveals that PRL2 promotes Kit-mediated PI3K/Akt signaling by reducing the level of PTEN that normally antagonizes the pathway. Given the strong cancer susceptibility to subtle variations in PTEN level, the ability of PRL2 to repress PTEN expression qualifies it as an oncogene and a novel target for developing anti-cancer agents.	[Dong, Yuanshu; Zhang, Lujuan; Bai, Yunpeng; Zhou, Hong-Ming; Campbell, Amanda M.; Shou, Weinian; Zhang, Zhong-Yin] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Chen, Hanying; Yong, Weidong; Zhang, Wenjun; Shou, Weinian] Indiana Univ Sch Med, Dept Pediat, Riley Heart Res Ctr, Indianapolis, IN 46202 USA; [Zeng, Qi] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Zhang, ZY (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	zyzhang@iu.edu	Bai, Yunpeng/M-8396-2014		National Institutes of Health [CA69202, HL85098, HD42024]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042024] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants CA69202, HL85098, and HD42024.	Achiwa H, 2007, CANCER RES, V67, P643, DOI 10.1158/0008-5472.CAN-06-2436; Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Anai S, 2006, HUM GENE THER, V17, P975, DOI 10.1089/hum.2006.17.975; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Ciraolo E, 2010, MOL BIOL CELL, V21, P704, DOI 10.1091/mbc.E09-08-0744; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Dong YS, 2012, J BIOL CHEM, V287, P32172, DOI 10.1074/jbc.M112.393462; Dumaual CM, 2006, J HISTOCHEM CYTOCHEM, V54, P1401, DOI 10.1369/jhc.6A7019.2006; Fagerli UM, 2008, BLOOD, V111, P806, DOI 10.1182/blood-2007-07-101139; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Gilbert D, 2011, NAT REV CANCER, V11, P278, DOI 10.1038/nrc3021; Guerif F, 2002, BIOL REPROD, V67, P70, DOI 10.1095/biolreprod67.1.70; Hardy S, 2010, CANCER RES, V70, P8959, DOI 10.1158/0008-5472.CAN-10-2041; HOFMANN MC, 1992, EXP CELL RES, V201, P417, DOI 10.1016/0014-4827(92)90291-F; Kato H, 2004, CLIN CANCER RES, V10, P7318, DOI 10.1158/1078-0432.CCR-04-0485; Kim ST, 2012, REPROD SCI, V19, P31, DOI 10.1177/1933719111424449; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; Li J, 2005, CLIN CANCER RES, V11, P2195, DOI 10.1158/1078-0432.CCR-04-1984; Li ZR, 2007, SURG TODAY, V37, P646, DOI 10.1007/s00595-006-3437-9; Li ZR, 2006, BIOCHEM BIOPH RES CO, V348, P229, DOI 10.1016/j.bbrc.2006.07.043; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Liu ZB, 2012, INT J NANOMED, V7, P5039, DOI 10.2147/IJN.S34022; Matter WF, 2001, BIOCHEM BIOPH RES CO, V283, P1061, DOI 10.1006/bbrc.2001.4881; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Miskad UA, 2004, PATHOBIOLOGY, V71, P176, DOI 10.1159/000078671; Peng LR, 2004, J CANCER RES CLIN, V130, P521, DOI 10.1007/s00432-004-0563-x; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Qian F, 2007, MOL MED, V13, P151, DOI 10.2119/2006-00076.Qian; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Rasoulpour T, 2006, ENDOCRINOLOGY, V147, P4213, DOI 10.1210/en.2006-0174; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Ruwanpura SM, 2010, J ENDOCRINOL, V205, P117, DOI 10.1677/JOE-10-0025; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Saito Y, 2003, GENE THER, V10, P1961, DOI 10.1038/sj.gt.3302100; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Stephens B, 2008, MOL CANCER THER, V7, P202, DOI 10.1158/1535-7163.MCT-07-0542; Stewart AL, 2002, MOL MED, V8, P451, DOI 10.1007/BF03402025; Subauste MC, 2005, J BIOL CHEM, V280, P5676, DOI 10.1074/jbc.M405561200; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Vincent S, 1998, DEVELOPMENT, V125, P4585; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang Q, 2002, CANCER LETT, V175, P63, DOI 10.1016/S0304-3835(01)00703-0; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Yagi T, 2003, BLOOD, V102, P1849, DOI 10.1182/blood-2003-02-0578; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689; Zeng Q, 2003, CANCER RES, V63, P2716; Zeng Q, 1998, BIOCHEM BIOPH RES CO, V244, P421, DOI 10.1006/bbrc.1998.8291; Zhang Lei, 2011, Spermatogenesis, V1, P186; Zhao ZY, 1996, GENOMICS, V35, P172, DOI 10.1006/geno.1996.0336; Zhou JX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019798, 10.1371/journal.pone.0014752, 10.1371/journal.pone.0024340]	64	23	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3799	3810		10.1074/jbc.M113.512079	http://dx.doi.org/10.1074/jbc.M113.512079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24371141	Green Published, hybrid			2022-12-28	WOS:000331368700059
J	Cattaneo, M; Baronchelli, S; Schiffer, D; Mellai, M; Caldera, V; Saccani, GJ; Dalpra, L; Daga, A; Orlandi, R; DeBlasio, P; Biunno, I				Cattaneo, Monica; Baronchelli, Simona; Schiffer, Davide; Mellai, Marta; Caldera, Valentina; Saccani, Gloria Jotti; Dalpra, Leda; Daga, Antonio; Orlandi, Rosaria; DeBlasio, Pasquale; Biunno, Ida			Down-modulation of SEL1L, an Unfolded Protein Response and Endoplasmic Reticulum-associated Degradation Protein, Sensitizes Glioma Stem Cells to the Cytotoxic Effect of Valproic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain Tumors; Cancer Stem Cells; Cell Proliferation; Drug Resistance; Histone Deacetylase	HISTONE DEACETYLASE INHIBITORS; IN-VITRO; EXPRESSION PROFILES; CANCER; GENE; GROWTH; PATHWAY; LINES; VIVO; DIFFERENTIATION	Background: Valproic acid is considered as a promising anti-cancer therapeutic agent acting on unfolded protein response. SEL1L is an UPR-responsive gene. Results: SEL1L interference synergy enhances VPA cytotoxic effects on glioma stem cells. Conclusion: VPA treatment combined with SEL1L depletion may influence GSC pharmacological response. Significance: Targeting SEL1L in association with valproic acid treatment may improve glioma treatment. Valproic acid (VPA), an histone deacetylase inhibitor, is emerging as a promising therapeutic agent for the treatments of gliomas by virtue of its ability to reactivate the expression of epigenetically silenced genes. VPA induces the unfolded protein response (UPR), an adaptive pathway displaying a dichotomic yin yang characteristic; it initially contributes in safeguarding the malignant cell survival, whereas long-lasting activation favors a proapoptotic response. By triggering UPR, VPA might tip the balance between cellular adaptation and programmed cell death via the deregulation of protein homeostasis and induction of proteotoxicity. Here we aimed to investigate the impact of proteostasis on glioma stem cells (GSC) using VPA treatment combined with subversion of SEL1L, a crucial protein involved in homeostatic pathways, cancer aggressiveness, and stem cell state maintenance. We investigated the global expression of GSC lines untreated and treated with VPA, SEL1L interference, and GSC line response to VPA treatment by analyzing cell viability via MTT assay, neurosphere formation, and endoplasmic reticulum stress/UPR-responsive proteins. Moreover, SEL1L immunohistochemistry was performed on primary glial tumors. The results show that (i) VPA affects GSC lines viability and anchorage-dependent growth by inducing differentiative programs and cell cycle progression, (ii) SEL1L down-modulation synergy enhances VPA cytotoxic effects by influencing GSCs proliferation and self-renewal properties, and (iii) SEL1L expression is indicative of glioma proliferation rate, malignancy, and endoplasmic reticulum stress statuses. Targeting the proteostasis network in association to VPA treatment may provide an alternative approach to deplete GSC and improve glioma treatments.	[Cattaneo, Monica; Baronchelli, Simona; Biunno, Ida] Ist Ricovero & Cura Carattere Sci IRCCS MultiMed, I-20138 Milan, Italy; [Schiffer, Davide; Mellai, Marta; Caldera, Valentina] Policlin Monza Fdn, Neurobiooncol Ctr, I-13100 Vercelli, Italy; [Saccani, Gloria Jotti] Univ Parma, Dept Biomed Biotechnol & Translat Sci, I-19138 Parma, Italy; [Dalpra, Leda] Univ Milano Bicocca, Dept Surg & Translat Med, I-20900 Monza, Italy; [Dalpra, Leda] S Gerardo Hosp, Dept Surg Pathol, I-20900 Monza, Italy; [Daga, Antonio] IRCCS Azienda Osped Univ San Martino, Ist Sci Tumori, Ist Nazl Ric Canc, Dept Hematol Oncol, I-16132 Genoa, Italy; [Orlandi, Rosaria] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Mol Targeting Unit, I-20133 Milan, Italy; [DeBlasio, Pasquale] ISENET, I-20138 Milan, Italy; [Cattaneo, Monica; Baronchelli, Simona; Biunno, Ida] CNR, Inst Genet & Biomed Res, I-20138 Milan, Italy	University of Parma; University of Milano-Bicocca; University of Genoa; IRCCS AOU San Martino IST; Fondazione IRCCS Istituto Nazionale Tumori Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR)	Biunno, I (corresponding author), CNR, Inst Genet & Biomed Res, Via Fantoli 16-15, I-20138 Milan, Italy.	ida.biunno@irgb.cnr.it	Baronchelli, Simona/G-6771-2016; Orlandi, Rosaria/C-1182-2017; Daga, Antonio/Z-2417-2019	Baronchelli, Simona/0000-0002-1857-1472; Orlandi, Rosaria/0000-0002-0533-9041; Daga, Antonio/0000-0001-5845-8530; De Blasio, Pasquale/0000-0003-1698-1221; /0000-0002-1866-5866; , IDA_2/0000-0002-1068-4763	Ministero della Salute [RF-MUL-2008-1248034]; Compagnia di San Paolo, Turin [2011.0438]	Ministero della Salute(Ministry of Health, Italy); Compagnia di San Paolo, Turin(Compagnia di San Paolo)	This work was supported by grants from Ministero della Salute (RF-MUL-2008-1248034) and Compagnia di San Paolo, Turin (2011.0438).	Adler JT, 2008, SURGERY, V144, P956, DOI 10.1016/j.surg.2008.08.027; Ashktorab H, 2012, DIGEST DIS SCI, V57, P905, DOI 10.1007/s10620-011-2026-y; Barberis MCP, 2006, HISTOPATHOLOGY, V48, P614, DOI 10.1111/j.1365-2559.2005.02274.x; Baronchelli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057462; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; BOWDEN CL, 1994, JAMA-J AM MED ASSOC, V271, P918, DOI 10.1001/jama.271.12.918; Cardano M, 2011, J BIOL CHEM, V286, P18708, DOI 10.1074/jbc.M110.210740; Cattaneo M, 2003, ONCOGENE, V22, P6359, DOI 10.1038/sj.onc.1206665; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen Y, 2012, J NEURO-ONCOL, V109, P23, DOI 10.1007/s11060-012-0871-y; Choi MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011885; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Das CM, 2007, J NEURO-ONCOL, V85, P159, DOI 10.1007/s11060-007-9402-7; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Ferrero S, 2006, HUM PATHOL, V37, P505, DOI 10.1016/j.humpath.2005.12.012; Francisco AB, 2010, J BIOL CHEM, V285, P13694, DOI 10.1074/jbc.M109.085340; Galanis E, 2009, J CLIN ONCOL, V27, P2052, DOI 10.1200/JCO.2008.19.0694; Granelli P, 2004, CLIN CANCER RES, V10, P5857, DOI 10.1158/1078-0432.CCR-04-0075; Grant B, 1996, GENETICS, V143, P237; Griffero F, 2009, J BIOL CHEM, V284, P7138, DOI 10.1074/jbc.M807111200; Kahali S, 2010, NEOPLASIA, V12, P80, DOI 10.1593/neo.91422; Li SA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-19; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Liu Q., 2013, MOL CARCINOG, DOI 10.1002/mc.22023; Lu Y, 2009, TOHOKU J EXP MED, V219, P17, DOI 10.1620/tjem.219.17; Machado Marcel Cerqueira Cesar, 2011, J Exp Ther Oncol, V9, P85; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Masoudi A, 2008, ANTICANCER RES, V28, P2437; Mottet D, 2008, CLIN EXP METASTAS, V25, P183, DOI 10.1007/s10585-007-9131-5; Natsume A, 2011, BRAIN TUMOR PATHOL, V28, P1, DOI 10.1007/s10014-010-0011-3; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Olzmann J. A, 2013, COLD SPRING HARB PER, V5; Orlandi R, 2002, CANCER RES, V62, P567; Orlandi R, 2002, INT J BIOL MARKER, V17, P104, DOI 10.1177/172460080201700205; Osuka S, 2012, NEUROL MED-CHIR, V52, P186, DOI 10.2176/nmc.52.186; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Ryu CH, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/987495; Schonthal AH, 2013, BIOCHEM PHARMACOL, V85, P653, DOI 10.1016/j.bcp.2012.09.012; Shabason JE, 2011, J CELL MOL MED, V15, P2735, DOI 10.1111/j.1582-4934.2011.01296.x; Shankar S, 2008, ADV EXP MED BIOL, V615, P261, DOI 10.1007/978-1-4020-6554-5_13; Shao CJ, 2012, CHINESE MED J-PEKING, V125, P4338, DOI 10.3760/cma.j.issn.0366-6999.2012.24.004; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Stockhausen MT, 2005, BRIT J CANCER, V92, P751, DOI 10.1038/sj.bjc.6602309; Su JM, 2011, CLIN CANCER RES, V17, P589, DOI 10.1158/1078-0432.CCR-10-0738; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun P, 2009, STEM CELLS, V27, P1473, DOI 10.1002/stem.89; Takezaki T, 2011, CANCER SCI, V102, P1306, DOI 10.1111/j.1349-7006.2011.01943.x; The WHO, 2020, CLASSIFICATION TUMOU; Thomas RP, 2013, CLIN PHARMACOL-ADV A, V5, P1, DOI 10.2147/CPAA.S26586; Walkinshaw DR, 2008, CURR ONCOL, V15, P237	52	20	21	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2826	2838		10.1074/jbc.M113.527754	http://dx.doi.org/10.1074/jbc.M113.527754			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24311781	Green Published, hybrid			2022-12-28	WOS:000333403000031
J	Singha, B; Gatla, HR; Manna, S; Chang, TP; Sanacora, S; Poltoratsky, V; Vancura, A; Vancurova, I				Singha, Bipradeb; Gatla, Himavanth Reddy; Manna, Subrata; Chang, Tzu-Pei; Sanacora, Shannon; Poltoratsky, Vladimir; Vancura, Ales; Vancurova, Ivana			Proteasome Inhibition Increases Recruitment of I kappa B Kinase beta (IKK beta), S536P-p65, and Transcription Factor EGR1 to Interleukin-8 (IL-8) Promoter, Resulting in Increased IL-8 Production in Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemokines; Chromatin Immunoprecipitation (ChIP); Egr-1; Immunology; NF-B (NF-KB); Ovarian Cancer; Proteasome; Transcription Regulation; Interleukin-8	INDEPENDENT PROSTATE-CANCER; NUCLEAR TRANSLOCATION; DRUG-RESISTANCE; GENE-EXPRESSION; GROWTH-FACTOR; P65 SUBUNIT; PHOSPHORYLATION; ALPHA; BORTEZOMIB; PROTEIN	Background: IL-8 promotes angiogenesis and metastasis in ovarian cancer. Results: Proteasome inhibition induces specific recruitment of IKK, EGR-1, and S536P-p65 to the IL-8 promoter. Conclusion: The increased IKK, EGR-1, and S536P-p65 recruitment results in the increased IL-8 expression and release in ovarian cancer cells. Significance: The BZ-increased IL-8 release may be responsible for the BZ-limited effectiveness in ovarian cancer treatment. Proinflammatory and pro-angiogenic chemokine interleukin-8 (IL-8, CXCL8) contributes to ovarian cancer progression through its induction of tumor cell proliferation, survival, angiogenesis, and metastasis. Proteasome inhibition by bortezomib, which has been used as a frontline therapy in multiple myeloma, has shown only limited effectiveness in ovarian cancer and other solid tumors. However, the responsible mechanisms remain elusive. Here, we show that proteasome inhibition dramatically increases the IL-8 expression and release in ovarian cancer cells. The responsible mechanism involves an increased nuclear accumulation of IB kinase (IKK) and an increased recruitment of the nuclear IKK, p65-phosphorylated at Ser-536, and the transcription factor early growth response-1 (EGR-1) to the endogenous IL-8 promoter. Coimmunoprecipitation studies identified the nuclear EGR-1 associated with IKK and with p65, with preferential binding to S536P-p65. Both IKK activity and EGR-1 expression are required for the increased IL-8 expression induced by proteasome inhibition in ovarian cancer cells. Interestingly, in multiple myeloma cells the IL-8 release is not increased by bortezomib. Together, these data indicate that the increased IL-8 release may represent one of the underlying mechanisms responsible for the decreased effectiveness of proteasome inhibition in ovarian cancer treatment and identify IKK and EGR-1 as potential new targets in ovarian cancer combination therapies.	[Singha, Bipradeb; Gatla, Himavanth Reddy; Manna, Subrata; Chang, Tzu-Pei; Sanacora, Shannon; Vancura, Ales; Vancurova, Ivana] St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA; [Poltoratsky, Vladimir] St Johns Univ, Dept Pharmaceut Sci, Queens, NY 11439 USA	Saint John's University; Saint John's University	Vancurova, I (corresponding author), St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA.	vancuroi@stjohns.edu	Gatla, Himavanth/AAP-7955-2021	Vancura, Ales/0000-0002-5895-1218	National Institutes of Health [AI085497, CA173452]; NATIONAL CANCER INSTITUTE [R15CA173452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI085497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI085497 and CA173452 (to I. V.).	Aghajanian C, 2005, J CLIN ONCOL, V23, P5943, DOI 10.1200/JCO.2005.16.006; Aghajanian C, 2009, GYNECOL ONCOL, V115, P215, DOI 10.1016/j.ygyno.2009.07.023; Aguilera C, 2004, P NATL ACAD SCI USA, V101, P16537, DOI 10.1073/pnas.0404429101; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Annunziata CM, 2010, CANCER-AM CANCER SOC, V116, P3276, DOI 10.1002/cncr.25190; Barbolina MV, 2007, J BIOL CHEM, V282, P4924, DOI 10.1074/jbc.M608428200; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Domingo-Domenech J, 2006, CLIN CANCER RES, V12, P5578, DOI 10.1158/1078-0432.CCR-05-2767; Ear T, 2005, J IMMUNOL, V175, P1834, DOI 10.4049/jimmunol.175.3.1834; Espinosa L, 2011, AM J CANCER RES, V1, P446; Frankel A, 2000, CLIN CANCER RES, V6, P3719; Furuya M, 2007, HUM PATHOL, V38, P1676, DOI 10.1016/j.humpath.2007.03.023; Gasparian AV, 2009, CELL CYCLE, V8, P1559, DOI 10.4161/cc.8.10.8415; Ghosh CC, 2010, J IMMUNOL, V185, P3685, DOI 10.4049/jimmunol.0902230; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hernandez L, 2010, CANCER RES, V70, P4005, DOI 10.1158/0008-5472.CAN-09-3912; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Hochrainer K, 2013, J BIOL CHEM, V288, P285, DOI 10.1074/jbc.M112.385625; Hoffmann E, 2008, J BIOL CHEM, V283, P12120, DOI 10.1074/jbc.M800583200; Howell SB, 2010, MOL PHARMACOL, V77, P887, DOI 10.1124/mol.109.063172; Hsu S, 2012, CANCER RES, V72, P5494, DOI 10.1158/0008-5472.CAN-11-3993; Huang RP, 1998, CELL DEATH DIFFER, V5, P96, DOI 10.1038/sj.cdd.4400322; Huang S, 2000, CANCER RES, V60, P5334; Jain N, 1996, J BIOL CHEM, V271, P13530, DOI 10.1074/jbc.271.23.13530; Jandial DD, 2009, CLIN CANCER RES, V15, P553, DOI 10.1158/1078-0432.CCR-08-2081; Juvekar A, 2011, MOL CANCER RES, V9, P183, DOI 10.1158/1541-7786.MCR-10-0368; Kuhn DJ, 2012, SEMIN HEMATOL, V49, P258, DOI 10.1053/j.seminhematol.2012.04.003; KUNKEL SL, 1990, PROG CLIN BIOL RES, V349, P433; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Lee CM, 2010, DRUG METAB DISPOS, V38, P2166, DOI 10.1124/dmd.110.035501; Leizer AL, 2011, AM J REPROD IMMUNOL, V65, P438, DOI 10.1111/j.1600-0897.2010.00914.x; LEONARD EJ, 1990, IMMUNOL TODAY, V11, P97, DOI 10.1016/0167-5699(90)90035-8; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Leveque D, 2007, IN VIVO, V21, P273; Li CY, 2010, J BIOL CHEM, V285, P16096, DOI 10.1074/jbc.M109.072694; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Ma JJ, 2009, J BIOL CHEM, V284, P34600, DOI 10.1074/jbc.M109.016246; Mabuchi S, 2004, CLIN CANCER RES, V10, P7645, DOI 10.1158/1078-0432.CCR-04-0958; Mabuchi S, 2004, J BIOL CHEM, V279, P23477, DOI 10.1074/jbc.M313709200; Manna S, 2013, J IMMUNOL, V191, P2837, DOI 10.4049/jimmunol.1300895; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; Milliken D, 2002, CLIN CANCER RES, V8, P1108; Moreno R, 2010, NUCLEIC ACIDS RES, V38, P6029, DOI 10.1093/nar/gkq439; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Murphy MA, 2012, CANCER CAUSE CONTROL, V23, P1839, DOI 10.1007/s10552-012-0063-2; Natoli G, 2006, FEBS LETT, V580, P2843, DOI 10.1016/j.febslet.2006.02.072; Natoli G, 2012, IMMUNOL REV, V246, P183, DOI 10.1111/j.1600-065X.2012.01103.x; Negus RPM, 1997, AM J PATHOL, V150, P1723; Penson RT, 2000, INT J GYNECOL CANCER, V10, P33, DOI 10.1046/j.1525-1438.2000.00003.x; Powers GL, 2010, ONCOGENE, V29, P1509, DOI 10.1038/onc.2009.434; Ramaswami S, 2012, METHODS MOL BIOL, V809, P121, DOI 10.1007/978-1-61779-376-9_8; Ramirez PT, 2008, GYNECOL ONCOL, V108, P68, DOI 10.1016/j.ygyno.2007.08.071; Richardson PG, 2005, CELL CYCLE, V4, P290; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Sakamoto K, 2013, ONCOGENE, V32, P1854, DOI 10.1038/onc.2012.192; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Shah JJ, 2009, LEUKEMIA, V23, P1964, DOI 10.1038/leu.2009.173; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Tsuchiya Y, 2010, MOL CELL, V39, P570, DOI 10.1016/j.molcel.2010.07.030; Valle BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061836; Vu HY, 2008, ARCH BIOCHEM BIOPHYS, V475, P156, DOI 10.1016/j.abb.2008.04.026; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wier EM, 2012, J BIOL CHEM, V287, P43019, DOI 10.1074/jbc.M112.388694; Xu L, 2000, ONCOL RES, V12, P97, DOI 10.3727/096504001108747567; Yemelyanov A, 2006, ONCOGENE, V25, P387, DOI 10.1038/sj.onc.1209066; Zerbini LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024285	73	50	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2687	2700		10.1074/jbc.M113.502641	http://dx.doi.org/10.1074/jbc.M113.502641			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24337575	hybrid, Green Published			2022-12-28	WOS:000333403000019
J	He, HQ; Troksa, EL; Caltabiano, G; Pardo, L; Ye, RD				He, Hui-Qiong; Troksa, Erica L.; Caltabiano, Gianluigi; Pardo, Leonardo; Ye, Richard D.			Structural Determinants for the Interaction of Formyl Peptide Receptor 2 with Peptide Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemokines; Computer Modeling; G Protein-coupled Receptors (GPCR); Peptides; Receptor Structure-Function	PROTEIN-COUPLED RECEPTORS; N-FORMYLPEPTIDE RECEPTOR; LISTERIA-MONOCYTOGENES; HUMAN-NEUTROPHILS; SMALL-MOLECULE; BINDING-SITE; IDENTIFICATION; CHEMOATTRACTANTS; ACTIVATION; RESPONSES	Unlike formyl peptide receptor 1 (FPR1), FPR2/ALX (FPR2) interacts with peptides of diverse sequences but has low affinity for the Escherichia coli-derived chemotactic peptide fMet-Leu-Phe (fMLF). Using computer modeling and site-directed mutagenesis, we investigated the structural requirements for FPR2 to interact with formyl peptides of different length and composition. In calcium flux assay, the N-formyl group of these peptides is necessary for activation of both FPR2 and FPR1, whereas the composition of the C-terminal amino acids appears more important for FPR2 than FPR1. FPR2 interacts better with pentapeptides (fMLFII, fMLFIK) than tetrapeptides (fMLFK, fMLFW) and tripeptide (fMLF) but only weakly with peptides carrying negative charges at the C terminus (e.g. fMLFE). In contrast, FPR1 is less sensitive to negative charges at the C terminus. A CXCR4-based homology model of FPR1 and FPR2 suggested that Asp-281(7.32) is crucial for the interaction of FPR2 with certain formyl peptides as its negative charge may be repulsive with the terminal COO- group of fMLF and negatively charged Glu in fMLFE. Asp-281(7.32) might also form a stable interaction with the positively charged Lys in fMLFK. Site-directed mutagenesis was performed to remove the negative charge at position 281 in FPR2. The D281(7.32)G mutant showed improved affinity for fMLFE and fMLF and reduced affinity for fMLFK compared with wild type FPR2. These results indicate that different structural determinants are used by FPR1 and FPR2 to interact with formyl peptides.	[He, Hui-Qiong; Ye, Richard D.] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China; [Troksa, Erica L.; Ye, Richard D.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Caltabiano, Gianluigi; Pardo, Leonardo] Univ Autonoma Madrid, Fac Med, Lab Med Computac, Unitat Bioestadist, Bellaterra 08193, Spain	Shanghai Jiao Tong University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Autonomous University of Madrid	Ye, RD (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China.	ye.richard@outlook.com	Ye, Richard/O-5223-2016; Caltabiano, Gianluigi/F-4654-2010; Ye, Richard/ABF-2413-2020	Ye, Richard/0000-0002-2164-5620; Caltabiano, Gianluigi/0000-0002-2929-7069; Ye, Richard/0000-0002-2164-5620; Pardo, Leonardo/0000-0003-1778-7420	National Basic Research Program of China (973 Program) [2012CB518000]; National Natural Science Foundation of China [31270941]; National Institutes of Health [R01 AI033503, P01 HL077806]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120073110069]; Ministerio de Ciencia e Innovacion [SAF2010-22198-C02-02]; Instituto de Salud Carlos III of Spain [RD07/0067/0008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033503] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III of Spain(Instituto de Salud Carlos III); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Basic Research Program of China (973 Program Grant 2012CB518000) and National Natural Science Foundation of China (Grant 31270941). This work was also supported by National Institutes of Health Grants R01 AI033503 and P01 HL077806, and by Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant 20120073110069), the Ministerio de Ciencia e Innovacion (SAF2010-22198-C02-02) and the Instituto de Salud Carlos III (RD07/0067/0008) of Spain.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; Case D. A., 2006, AMBER9; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; FREER RJ, 1982, BIOCHEMISTRY-US, V21, P257, DOI 10.1021/bi00531a009; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gonzalez A, 2012, CHEMBIOCHEM, V13, P1393, DOI 10.1002/cbic.201200189; Govaerts C, 2001, J BIOL CHEM, V276, P13217, DOI 10.1074/jbc.M011670200; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; He R, 2000, J IMMUNOL, V165, P4598, DOI 10.4049/jimmunol.165.8.4598; Jongejan A, 2005, NAT CHEM BIOL, V1, P98, DOI 10.1038/nchembio714; Kirpotina LN, 2010, MOL PHARMACOL, V77, P159, DOI 10.1124/mol.109.060673; Lala A, 1999, EUR J BIOCHEM, V264, P495, DOI 10.1046/j.1432-1327.1999.00647.x; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Mills JS, 1998, J BIOL CHEM, V273, P10428, DOI 10.1074/jbc.273.17.10428; Mills JS, 2000, J BIOL CHEM, V275, P39012, DOI 10.1074/jbc.M003081200; MURPHY PM, 1992, J BIOL CHEM, V267, P7637; Nanamori M, 2004, MOL PHARMACOL, V66, P1213, DOI 10.1124/mol.104.004309; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; NIEDEL JE, 1979, SCIENCE, V205, P1412, DOI 10.1126/science.472759; QUEHENBERGER O, 1993, J BIOL CHEM, V268, P18167; Quehenberger O, 1997, BIOCHEM BIOPH RES CO, V238, P377, DOI 10.1006/bbrc.1997.7298; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; ROT A, 1987, P NATL ACAD SCI USA, V84, P7967, DOI 10.1073/pnas.84.22.7967; SCHIFFMANN E, 1975, P NATL ACAD SCI USA, V72, P1059, DOI 10.1073/pnas.72.3.1059; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; SKLAR LA, 1990, BIOCHEMISTRY-US, V29, P313, DOI 10.1021/bi00454a002; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; YE RD, 1992, BIOCHEM BIOPH RES CO, V184, P582, DOI 10.1016/0006-291X(92)90629-Y; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	37	47	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2295	2306		10.1074/jbc.M113.509216	http://dx.doi.org/10.1074/jbc.M113.509216			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24285541	Green Published, hybrid			2022-12-28	WOS:000331130200034
J	Heckmann, BL; Zhang, XD; Xie, XT; Saarinen, A; Lu, X; Yang, XY; Liu, J				Heckmann, Bradlee L.; Zhang, Xiaodong; Xie, Xitao; Saarinen, Alicia; Lu, Xin; Yang, Xingyuan; Liu, Jun			Defective Adipose Lipolysis and Altered Global Energy Metabolism in Mice with Adipose Overexpression of the Lipolytic Inhibitor G(0)/G(1) Switch Gene 2 (G0S2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue; Adipose Tissue Metabolism; Adipose Triglyceride Lipase; Energy Metabolism; Fatty Acid; Fatty Acid Metabolism; Fatty Acid Oxidation; Lipolysis; Metabolism; G0S2	HORMONE-SENSITIVE LIPASE; TRIGLYCERIDE LIPASE; PROTEIN; TISSUE; OBESITY; CGI-58	Biochemical and cell-based studies have identified the G0S2 (G(0)/G(1) switch gene 2) as a selective inhibitor of the key intracellular triacylglycerol hydrolase, adipose triglyceride lipase. To better understand the physiological role of G0S2, we constructed an adipose tissue-specific G0S2 transgenic mouse model. In comparison with wild type animals, the transgenic mice exhibited a significant increase in overall fat mass and a decrease in peripheral triglyceride accumulation. Basal and adrenergically stimulated lipolysis was attenuated in adipose explants isolated from the transgenic mice. Following fasting or injection of a 3-adrenergic agonist, in vivo lipolysis and ketogenesis were decreased in G0S2 transgenic mice when compared with wild type animals. Consequently, adipose overexpression of G0S2 prevented the switch of energy substrate from carbohydrates to fatty acids during fasting. Moreover, G0S2 overexpression promoted accumulation of more and larger lipid droplets in brown adipocytes without impacting either mitochondrial morphology or expression of oxidative genes. This phenotypic change was accompanied by defective cold adaptation. Furthermore, feeding with a high fat diet caused a greater gain of both body weight and adiposity in the transgenic mice. The transgenic mice also displayed a decrease in fasting plasma levels of free fatty acid, triglyceride, and insulin as well as improved glucose and insulin tolerance. Cumulatively, these results indicate that fat-specific G0S2 overexpression uncouples adiposity from insulin sensitivity and overall metabolic health through inhibiting adipose lipolysis and decreasing circulating fatty acids.	[Heckmann, Bradlee L.; Zhang, Xiaodong; Xie, Xitao; Saarinen, Alicia; Liu, Jun] Mayo Clin, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA; [Heckmann, Bradlee L.; Zhang, Xiaodong; Xie, Xitao; Saarinen, Alicia; Liu, Jun] Mayo Clin, Metab Hlth Program, Scottsdale, AZ 85259 USA; [Heckmann, Bradlee L.] Mayo Grad Sch, Rochester, MN 55905 USA; [Lu, Xin] Univ Kentucky, Transgen Anim Facil, Lexington, KY 40508 USA; [Yang, Xingyuan] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45267 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; University of Kentucky; University System of Ohio; University of Cincinnati	Liu, J (corresponding author), Mayo Clin Arizona, Dept Biochem & Mol Biol, Hlth Program, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	liu.jun@mayo.edu		Heckmann, Bradlee/0000-0002-3271-7183	National Institutes of Health [DK089178]; American Diabetes Association [1-10-JF-30]; Mayo Foundation for Medical Research and Education; Mayo Clinic College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089178, R56DK089178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Mayo Foundation for Medical Research and Education; Mayo Clinic College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the National Institutes of Health (DK089178) and The American Diabetes Association (1-10-JF-30) (to J. L.).; Supported by predoctoral funding from The Mayo Foundation for Medical Research and Education and the Mayo Clinic College of Medicine.	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Ahn J, 2013, LIPIDS, V48, P209, DOI 10.1007/s11745-013-3756-8; Bachner D, 1998, DEV DYNAM, V213, P398; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hoy AJ, 2011, ENDOCRINOLOGY, V152, P48, DOI 10.1210/en.2010-0661; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Mi J, 2010, J OBES, V2010, DOI 10.1155/2010/892081; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2010, J LIPID RES, V51, P975, DOI 10.1194/jlr.M002352; Morak M, 2012, MOL CELL PROTEOMICS, V11, P1777, DOI 10.1074/mcp.M111.015743; Moran O, 2003, Pediatr Diabetes, V4, P101, DOI 10.1034/j.1399-5448.2003.00017.x; Perkins GA, 1998, J BIOENERG BIOMEMBR, V30, P431, DOI 10.1023/A:1020586012561; Ramos-Jimenez Arnulfo, 2008, Clin Med Circ Respirat Pulm Med, V2, P1; RUSSELL L, 1991, DNA CELL BIOL, V10, P581, DOI 10.1089/dna.1991.10.581; Sawada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014006; Schrammel A, 2013, BBA-MOL CELL BIOL L, V1831, P1600, DOI 10.1016/j.bbalip.2013.07.004; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; SIDEROVSKI DP, 1990, DNA CELL BIOL, V9, P579, DOI 10.1089/dna.1990.9.579; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; VATNICK I, 1987, AM J PHYSIOL, V252, pE391, DOI 10.1152/ajpendo.1987.252.3.E391; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wu JW, 2012, ENDOCRINOLOGY, V153, P2198, DOI 10.1210/en.2011-1518; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	37	42	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1905	1916		10.1074/jbc.M113.522011	http://dx.doi.org/10.1074/jbc.M113.522011			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302733	hybrid, Green Published			2022-12-28	WOS:000331130200003
J	Nooh, MM; Chumpia, MM; Hamilton, TB; Bahouth, SW				Nooh, Mohammed M.; Chumpia, Maryanne M.; Hamilton, Thomas B.; Bahouth, Suleiman W.			Sorting of beta(1)-Adrenergic Receptors Is Mediated by Pathways That Are Either Dependent on or Independent of Type I PDZ, Protein Kinase A (PKA), and SAP97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adrenergic Receptor; Confocal Microscopy; G Protein-coupled Receptor (GPCR); Protein Kinase A (PKA); Trafficking	ENDOCYTIC RECYCLING SIGNAL; COUPLED RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; MEMBRANE TRAFFICKING; BETA-ARRESTIN; PHOSPHORYLATION SITES; ANCHORING PROTEINS; CRYSTAL-STRUCTURE; AMPA RECEPTORS; BINDING	The (1)-adrenergic receptor ((1)-AR) is a target for treatment of major cardiovascular diseases, such as heart failure and hypertension. Recycling of agonist-internalized (1)-AR is dependent on type I PSD-95/DLG/ZO1 (PDZ) in the C-tail of the (1)-AR and on protein kinase A (PKA) activity (Gardner, L. A., Naren, A. P., and Bahouth, S. W. (2007) J. Biol. Chem. 282, 5085-5099). We explored the effects of point mutations in the PDZ and in the activity of PKA on recycling of the (1)-AR and its binding to the PDZ-binding protein SAP97. These studies indicated that (1)-AR recycling was inhibited by PKA inhibitors and by mutations in the PDZ that interfered with SAP97 binding. The trafficking effects of short sequences differing in PDZ and SAP97 binding were examined using chimeric mutant (1)-AR. (1)-AR chimera containing the type I PDZ of the (2)-adrenergic receptor that does not bind to SAP97 failed to recycle except when serine 312 was mutated to aspartic acid. (1)-AR chimera with type I PDZ sequences from the C-tails of aquaporin-2 or GluR1 recycled in a SAP97- and PKA-dependent manner. Non-PDZ (1)-AR chimera derived from -opioid, dopamine 1, or GluR2 receptors promoted rapid recycling of chimeric (1)-AR in a SAP97- and PKA-independent manner. Moreover, the nature of the residue at position -3 in the PDZ regulated whether the (1)-AR was internalized alone or in complex with SAP97. These results indicate that divergent pathways were involved in trafficking the (1)-AR and provide a roadmap for its trafficking via type I PDZs versus non-PDZs.	[Nooh, Mohammed M.; Chumpia, Maryanne M.; Hamilton, Thomas B.; Bahouth, Suleiman W.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Nooh, Mohammed M.] Cairo Univ, Dept Biochem, Fac Pharm, Cairo 11562, Egypt	University of Tennessee System; University of Tennessee Health Science Center; Egyptian Knowledge Bank (EKB); Cairo University	Bahouth, SW (corresponding author), Univ Tennessee HSC, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	sbahouth@uthsc.edu		Nooh, Mohammed/0000-0001-9794-4099	confocal microscopy unit at the NEI Vision Core (NEI, National Institutes of Health) [5P30EY13080-10]; NATIONAL EYE INSTITUTE [P30EY013080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085848] Funding Source: NIH RePORTER	confocal microscopy unit at the NEI Vision Core (NEI, National Institutes of Health); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the confocal microscopy unit at the NEI Vision Core (NEI, National Institutes of Health, Grant 5P30EY13080-10, D. Johnson, principal investigator), the Molecular Resources Center for DNA sequencing, and Daniel Morse for figure preparation.	Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chu P, 1997, J BIOL CHEM, V272, P27124, DOI 10.1074/jbc.272.43.27124; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dunn HA, 2013, J BIOL CHEM, V288, P15023, DOI 10.1074/jbc.M113.473660; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gardner LA, 2004, J BIOL CHEM, V279, P21135, DOI 10.1074/jbc.M313652200; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Gardner LA, 2011, CELL SIGNAL, V23, P46, DOI 10.1016/j.cellsig.2010.07.020; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Hu LA, 2002, J BIOL CHEM, V277, P1607, DOI 10.1074/jbc.M107297200; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Katsura T, 1997, AM J PHYSIOL-RENAL, V272, pF816; Klussmann E, 1999, J BIOL CHEM, V274, P4934, DOI 10.1074/jbc.274.8.4934; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li X, 2013, J BIOL CHEM, V288, P33797, DOI 10.1074/jbc.M113.470559; Liu Y, 2007, BIOCHEMISTRY-US, V46, P10864, DOI 10.1021/bi700879k; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; MARSH EW, 1995, J CELL BIOL, V129, P1509, DOI 10.1083/jcb.129.6.1509; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Naim E, 2005, KIDNEY INT, V68, P955, DOI 10.1111/j.1523-1755.2005.00489.x; Nisar SP, 2012, J BIOL CHEM, V287, P24505, DOI 10.1074/jbc.M112.347104; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nooh MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063379; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Penn RB, 1999, J PHARMACOL EXP THER, V288, P428; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Seibold A, 2000, MOL PHARMACOL, V58, P1162, DOI 10.1124/mol.58.5.1162; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Tran TM, 2007, BIOCHEMISTRY-US, V46, P14438, DOI 10.1021/bi700922h; Valentine CD, 2011, MOL BIOL CELL, V22, P2970, DOI 10.1091/mbc.E11-01-0034; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; Zhou WG, 2008, J NEUROSCI, V28, P10220, DOI 10.1523/JNEUROSCI.3434-08.2008	52	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2277	2294		10.1074/jbc.M113.513481	http://dx.doi.org/10.1074/jbc.M113.513481			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324269	hybrid, Green Published			2022-12-28	WOS:000331130200033
J	Koenig, A; Buskiewicz, IA; Fortner, KA; Russell, JQ; Asaoka, T; He, YW; Hakem, R; Eriksson, JE; Budd, RC				Koenig, Andreas; Buskiewicz, Iwona A.; Fortner, Karen A.; Russell, Jennifer Q.; Asaoka, Tomoko; He, You-Wen; Hakem, Razqallah; Eriksson, John E.; Budd, Ralph C.			The c-FLIPL Cleavage Product p43FLIP Promotes Activation of Extracellular Signal-regulated Kinase (ERK), Nuclear Factor kappa B (NF-kappa B), and Caspase-8 and T Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG FORM; INHIBITORY PROTEIN; DEATH; FAS; APOPTOSIS; COMPLEX; RECEPTORS; RIPOPTOSOME; LYMPHOCYTES; IMMUNITY	Caspase-8 is now appreciated to govern both apoptosis following death receptor ligation and cell survival and growth via inhibition of the Ripoptosome. Cells must therefore carefully regulate the high level of caspase-8 activity during apoptosis versus the modest levels observed during cell growth. The caspase-8 paralogue c-FLIP is a good candidate for a molecular rheostat of caspase-8 activity. c-FLIP can inhibit death receptor-mediated apoptosis by competing with caspase-8 for recruitment to FADD. However, full-length c-FLIPL can also heterodimerize with caspase-8 independent of death receptor ligation and activate caspase-8 via an activation loop in the C terminus of c-FLIPL. This triggers cleavage of c-FLIPL at Asp-376 by caspase-8 to produce p43FLIP. The continued function of p43FLIP has, however, not been determined. We demonstrate that acute deletion of endogenous c-FLIP in murine effector T cells results in loss of caspase-8 activity and cell death. The lethality and caspase-8 activity can both be rescued by the transgenic expression of p43FLIP. Furthermore, p43FLIP associates with Raf1, TRAF2, and RIPK1, which augments ERK and NF-kappa B activation, IL-2 production, and T cell proliferation. Thus, not only is c-FLIP the initiator of caspase-8 activity during T cell activation, it is also an initial caspase-8 substrate, with cleaved p43FLIP serving to both stabilize caspase-8 activity and promote activation of pathways involved with T cell growth.	[Koenig, Andreas; Buskiewicz, Iwona A.; Fortner, Karen A.; Russell, Jennifer Q.; Budd, Ralph C.] Univ Vermont, Coll Med, Vermont Ctr Immunol & Infect Dis, Burlington, VT 05405 USA; [Koenig, Andreas; Fortner, Karen A.; Russell, Jennifer Q.; Budd, Ralph C.] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; [Buskiewicz, Iwona A.] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Asaoka, Tomoko; Eriksson, John E.] Univ Turku, Turku Ctr Biotechnol, FIN-20521 Turku, Finland; [Asaoka, Tomoko; Eriksson, John E.] Abo Akad Univ, BioCity, FIN-20521 Turku, Finland; [Asaoka, Tomoko; Eriksson, John E.] Abo Akad Univ, Dept Biol Sci, BioCity, FIN-20520 Turku, Finland; [He, You-Wen] Duke Univ, Dept Immunol, Med Ctr, Durham, NC 27710 USA; [Hakem, Razqallah] Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2C1, Canada	University of Vermont; University of Vermont; University of Vermont; University of Turku; Abo Akademi University; Abo Akademi University; Duke University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Koenig, A (corresponding author), Univ Vermont, Coll Med, Immunobiol Program, Given Med Bldg,C-344,89 Beaumont Ave, Burlington, VT 05405 USA.	akoenig@uvm.edu		Hakem, Razqallah/0000-0001-5948-7931; Asaoka, Tomoko/0000-0001-5141-2353	National Institutes of Health [GM103496, AI36333, AI45666]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036333, P01AI045666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM103496, AI36333, and AI45666.	AGGARWAL BB, 1995, FEBS LETT, V364, P5, DOI 10.1016/0014-5793(95)00339-B; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Chau H, 2005, J EXP MED, V202, P405, DOI 10.1084/jem.20050118; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Collins C, 2005, J IMMUNOL, V175, P5656, DOI 10.4049/jimmunol.175.9.5656; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Dohrman A, 2005, J IMMUNOL, V175, P311, DOI 10.4049/jimmunol.175.1.311; Dohrman A, 2005, J IMMUNOL, V174, P5270, DOI 10.4049/jimmunol.174.9.5270; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Hinshaw-Makepeace J, 2008, EUR J IMMUNOL, V38, P54, DOI 10.1002/eji.200636956; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; OWENSCHAUB LB, 1994, CANCER RES, V54, P1580; Perlman H, 2001, ARTHRITIS RHEUM, V44, P21, DOI 10.1002/1529-0131(200101)44:1<21::AID-ANR4>3.0.CO;2-8; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Rincon M, 1997, MOL CELL BIOL, V17, P1522, DOI 10.1128/MCB.17.3.1522; Salmena L, 2005, J EXP MED, V202, P727, DOI 10.1084/jem.20050683; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang N, 2005, J EXP MED, V202, P395, DOI 10.1084/jem.20050117	40	33	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1183	1191		10.1074/jbc.M113.506428	http://dx.doi.org/10.1074/jbc.M113.506428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275659	hybrid, Green Published			2022-12-28	WOS:000330541200049
J	Kook, S; Zhan, XZ; Kaoud, TS; Dalby, KN; Gurevich, VV; Gurevich, EV				Kook, Seunghyi; Zhan, Xuanzhi; Kaoud, Tamer S.; Dalby, Kevin N.; Gurevich, Vsevolod V.; Gurevich, Eugenia V.			Arrestin-3 Binds c-Jun N-terminal Kinase 1 (JNK1) and JNK2 and Facilitates the Activation of These Ubiquitous JNK Isoforms in Cells via Scaffolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Jun N-terminal Kinase (JNK); MAP Kinases (MAPKs); Protein Phosphorylation; Scaffold Proteins; Signal Transduction	PROTEIN-COUPLED RECEPTORS; MAP-KINASE; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; BETA-ARRESTINS; INOSITOL HEXAKISPHOSPHATE; NONVISUAL ARRESTINS; CORTICAL-NEURONS; PATHWAY; DEATH	Non-visual arrestins scaffold mitogen-activated protein kinase (MAPK) cascades. The c-Jun N-terminal kinases (JNKs) are members of MAPK family. Arrestin-3 has been shown to enhance the activation of JNK3, which is expressed mainly in neurons, heart, and testes, in contrast to ubiquitous JNK1 and JNK2. Although all JNKs are activated by MKK4 and MKK7, both of which bind arrestin-3, the ability of arrestin-3 to facilitate the activation of JNK1 and JNK2 has never been reported. Using purified proteins we found that arrestin-3 directly binds JNK11 and JNK22, interacting with the latter comparably to JNK32. Phosphorylation of purified JNK11 and JNK22 by MKK4 or MKK7 is increased by arrestin-3. Endogenous arrestin-3 interacted with endogenous JNK1/2 in different cell types. Arrestin-3 also enhanced phosphorylation of endogenous JNK1/2 in intact cells upon expression of upstream kinases ASK1, MKK4, or MKK7. We observed a biphasic effect of arrestin-3 concentrations on phosphorylation of JNK11 and JNK22 both in vitro and in vivo. Thus, arrestin-3 acts as a scaffold, facilitating JNK11 and JNK22 phosphorylation by MKK4 and MKK7 via bringing JNKs and their activators together. The data suggest that arrestin-3 modulates the activity of ubiquitous JNK1 and JNK2 in non-neuronal cells, impacting the signaling pathway that regulates their proliferation and survival.	[Kook, Seunghyi; Zhan, Xuanzhi; Gurevich, Vsevolod V.; Gurevich, Eugenia V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Kaoud, Tamer S.] Menia Univ, Fac Pharm, Al Minya 61519, Egypt; [Kaoud, Tamer S.; Dalby, Kevin N.] Univ Texas Austin, Div Med Chem, Austin, TX 78712 USA	Vanderbilt University; Egyptian Knowledge Bank (EKB); Minia University; University of Texas System; University of Texas Austin	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu; Eugenia.gurevich@vanderbilt.edu	Zhan, Xuanzhi/N-4644-2013; Gurevich, Vsevolod/A-3236-2008; Dalby, Kevin N/A-1905-2013; Kaoud, Tamer S/C-3618-2019	Gurevich, Vsevolod/0000-0002-3950-5351; Dalby, Kevin N/0000-0001-9272-5129; Kaoud, Tamer S/0000-0003-1298-8725	National Institutes of Health [NS065868, DA030103, GM077561, GM081756, EY011500, GM059802]; Welch Foundation [F-1390]; Cancer Prevention Research Institute of Texas (CPRIT); NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077561, R01GM081756, R01GM059802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Cancer Prevention Research Institute of Texas (CPRIT); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS065868 and DA030103 (to E. V. G.), GM077561, GM081756, and EY011500 (to V. V. G.), and GM059802 (to K. N. D.). This work was also supported by the Welch Foundation (F-1390) (to K. N. D.).; Supported by a postdoctoral trainee fellowship from Cancer Prevention Research Institute of Texas (CPRIT).	ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; DONOSO LA, 1990, CURR EYE RES, V9, P343, DOI 10.3109/02713689008999622; Engstrom W, 2010, CELL PROLIFERAT, V43, P56, DOI 10.1111/j.1365-2184.2009.00654.x; Fogarty MP, 2003, BIOCHEM J, V371, P789, DOI 10.1042/BJ20021660; Gao YQ, 2005, J CEREBR BLOOD F MET, V25, P694, DOI 10.1038/sj.jcbfm.9600062; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Hanson SM, 2008, BIOCHEMISTRY-US, V47, P1070, DOI 10.1021/bi7021359; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Johnson GL, 2011, ACS CHEM BIOL, V6, P18, DOI 10.1021/cb100384z; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kaoud TS, 2012, ACS CHEM BIOL, V7, P1873, DOI 10.1021/cb300261e; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Levchenko A., 2004, Systems Biology, V1, P139, DOI 10.1049/sb:20045014; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Madsen JA, 2011, PROTEOMICS, V11, P1329, DOI 10.1002/pmic.201000565; Matsuura H, 2002, J BIOL CHEM, V277, P40703, DOI 10.1074/jbc.M202004200; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Namgung U, 2000, J NEUROSCI, V20, P6442, DOI 10.1523/JNEUROSCI.20-17-06442.2000; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pullikuth A, 2005, MOL CELL BIOL, V25, P5119, DOI 10.1128/MCB.25.12.5119-5133.2005; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Seo J, 2011, J BIOL CHEM, V286, P27894, DOI 10.1074/jbc.M111.260448; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Storez H, 2005, J BIOL CHEM, V280, P40210, DOI 10.1074/jbc.M508001200; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; WACKER WB, 1977, J IMMUNOL, V119, P1949; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Willoughby EA, 2003, J BIOL CHEM, V278, P10731, DOI 10.1074/jbc.M207324200; Yan CL, 2011, J PHYS CHEM B, V115, P1491, DOI 10.1021/jp1073522; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X; Zhan XZ, 2013, J BIOL CHEM, V288, P28535, DOI 10.1074/jbc.M113.508085; Zhan XZ, 2011, BIOCHEMISTRY-US, V50, P10520, DOI 10.1021/bi201506g	70	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37332	37342		10.1074/jbc.M113.510412	http://dx.doi.org/10.1074/jbc.M113.510412			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24257757	hybrid, Green Published			2022-12-28	WOS:000329189700049
J	Lin, QQ; London, E				Lin, Qingqing; London, Erwin			The Influence of Natural Lipid Asymmetry upon the Conformation of a Membrane-inserted Protein (Perfringolysin O)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Toxins; Cholesterol; Cholesterol-binding Protein; Membrane Bilayer; Membrane Biophysics; Membrane Proteins	CHOLESTEROL-DEPENDENT CYTOLYSIN; TOXIN T-DOMAIN; CLOSTRIDIUM-PERFRINGENS; PORE FORMATION; TRANSMEMBRANE DOMAINS; PREPORE COMPLEX; LOW PH; PHOSPHATIDYLSERINE; OLIGOMERIZATION; TOPOGRAPHY	Background: Lipid asymmetry is an important property of eukaryotic plasma membranes not present in commonly used model membrane vesicles. Results: PFO insertion in asymmetric model membrane vesicles was distinct from that in symmetric vesicles. A novel transmembrane insertion intermediate was identified. Conclusion: Lipid asymmetry can strongly influence protein behavior. Significance: This report illustrates a new approach to study proteins in membranes with natural lipid asymmetry. Eukaryotic membrane proteins generally reside in membrane bilayers that have lipid asymmetry. However, in vitro studies of the impact of lipids upon membrane proteins are generally carried out in model membrane vesicles that lack lipid asymmetry. Our recently developed method to prepare lipid vesicles with asymmetry similar to that in plasma membranes and with controlled amounts of cholesterol was used to investigate the influence of lipid composition and lipid asymmetry upon the conformational behavior of the pore-forming, cholesterol-dependent cytolysin perfringolysin O (PFO). PFO conformational behavior in asymmetric vesicles was found to be distinct both from that in symmetric vesicles with the same lipid composition as the asymmetric vesicles and from that in vesicles containing either only the inner leaflet lipids from the asymmetric vesicles or only the outer leaflet lipids from the asymmetric vesicles. The presence of phosphatidylcholine in the outer leaflet increased the cholesterol concentration required to induce PFO binding, whereas phosphatidylethanolamine and phosphatidylserine in the inner leaflet of asymmetric vesicles stabilized the formation of a novel deeply inserted conformation that does not form pores, even though it contains transmembrane segments. This conformation may represent an important intermediate stage in PFO pore formation. These studies show that lipid asymmetry can strongly influence the behavior of membrane-inserted proteins.	[Lin, Qingqing; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Erwin.London@stonybrook.edu			National Science Foundation [DMR 1104367, MCB 1019986]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grants DMR 1104367 and MCB 1019986.	Braun JS, 2007, INFECT IMMUN, V75, P4245, DOI 10.1128/IAI.00031-07; BRETSCHER MS, 1972, NATURE-NEW BIOL, V236, P11, DOI 10.1038/newbio236011a0; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3265, DOI 10.1021/bi026696l; Cheng HT, 2011, BIOPHYS J, V100, P2671, DOI 10.1016/j.bpj.2011.04.048; Cheng HT, 2009, J BIOL CHEM, V284, P6079, DOI 10.1074/jbc.M806077200; Cockeran Riana, 2003, Expert Rev Anti Infect Ther, V1, P231, DOI 10.1586/14787210.1.2.231; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Dowd KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002787; Flanagan JJ, 2009, BIOCHEMISTRY-US, V48, P3977, DOI 10.1021/bi9002309; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Heuck AP, 2007, J BIOL CHEM, V282, P22629, DOI 10.1074/jbc.M703207200; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Lin Q., 2014, PLOS ONE INE PRESS; Lin QQ, 2013, J BIOL CHEM, V288, P1340, DOI 10.1074/jbc.M112.415596; MARINETTI GV, 1976, CHEM PHYS LIPIDS, V16, P239, DOI 10.1016/0009-3084(76)90019-0; Martin G, 2005, HUM REPROD, V20, P3459, DOI 10.1093/humrep/dei245; Moe PC, 2010, BIOCHEMISTRY-US, V49, P9498, DOI 10.1021/bi1013886; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; NAKAMURA M, 1995, BIOCHEMISTRY-US, V34, P6513, DOI 10.1021/bi00019a032; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; Nicol F, 1999, BIOPHYS J, V76, P2121, DOI 10.1016/S0006-3495(99)77368-6; Nir S, 1999, MOL MEMBR BIOL, V16, P95, DOI 10.1080/096876899294814; O'Brien DK, 2004, INFECT IMMUN, V72, P5204, DOI 10.1128/IAI.72.9.5204-5215.2004; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Paidassi H, 2011, J MOL BIOL, V408, P277, DOI 10.1016/j.jmb.2011.02.029; PORTNOY DA, 1992, INFECT IMMUN, V60, P2710, DOI 10.1128/IAI.60.7.2710-2717.1992; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramachandran R, 2005, P NATL ACAD SCI USA, V102, P7139, DOI 10.1073/pnas.0500556102; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosconi MP, 2004, BIOCHEMISTRY-US, V43, P9127, DOI 10.1021/bi049354j; SCHICK PK, 1976, J CLIN INVEST, V57, P1221, DOI 10.1172/JCI108390; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Shahidullah K, 2010, J MOL BIOL, V396, P209, DOI 10.1016/j.jmb.2009.11.037; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Solovyova AS, 2004, BIOPHYS J, V87, P540, DOI 10.1529/biophysj.104.039974; Tweten RK, 2001, CURR TOP MICROBIOL, V257, P15; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Wang J, 2006, BIOCHEMISTRY-US, V45, P8124, DOI 10.1021/bi060587f	45	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5467	5478		10.1074/jbc.M113.533943	http://dx.doi.org/10.1074/jbc.M113.533943			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398685	hybrid, Green Published			2022-12-28	WOS:000332015500011
J	Bloemink, M; Deacon, J; Langer, S; Vera, C; Combs, A; Leinwand, L; Geeves, MA				Bloemink, Marieke; Deacon, John; Langer, Stephen; Vera, Carlos; Combs, Ariana; Leinwand, Leslie; Geeves, Michael A.			The Hypertrophic Cardiomyopathy Myosin Mutation R453C Alters ATP Binding and Hydrolysis of Human Cardiac beta- Myosin*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cardiac Muscle; Cardiomyopathy; Fluorescence; Kinetics; Myosin; Homology Models; Protein Structure-Function; Sequence Alignment	HEAVY-CHAIN; DILATED CARDIOMYOPATHY; R403Q MUTATION; SWISS-MODEL; MUSCLE; ACTIN; ISOFORM; PROTEIN; MOTOR; SUBFRAGMENT-1	Background: R453C is a mutation in human cardiac myosin and is associated with a high incidence of sudden cardiac death. Results: R453C alters few kinetic parameters, except for the conformational changes associated with ATP binding and hydrolysis. Conclusion: The closure of switch-2 on ATP is disrupted by R453C. Significance: This is the first detailed kinetic analysis of the motor domain of the human -cardiac myosin carrying the R453C mutation. The human hypertrophic cardiomyopathy mutation R453C results in one of the more severe forms of the myopathy. Arg-453 is found in a conserved surface loop of the upper 50-kDa domain of the myosin motor domain and lies between the nucleotide binding pocket and the actin binding site. It connects to the cardiomyopathy loop via a long -helix, helix O, and to Switch-2 via the fifth strand of the central -sheet. The mutation is, therefore, in a position to perturb a wide range of myosin molecular activities. We report here the first detailed biochemical kinetic analysis of the motor domain of the human -cardiac myosin carrying the R453C mutation. A recent report of the same mutation (Sommese, R. F., Sung, J., Nag, S., Sutton, S., Deacon, J. C., Choe, E., Leinwand, L. A., Ruppel, K., and Spudich, J. A. (2013) Proc. Natl. Acad. Sci. U.S.A. 110, 12607-12612) found reduced ATPase and in vitro motility but increased force production using an optical trap. Surprisingly, our results show that the mutation alters few biochemical kinetic parameters significantly. The exceptions are the rate constants for ATP binding to the motor domain (reduced by 35%) and the ATP hydrolysis step/recovery stroke (slowed 3-fold), which could be the rate-limiting step for the ATPase cycle. Effects of the mutation on the recovery stroke are consistent with a perturbation of Switch-2 closure, which is required for the recovery stroke and the subsequent ATP hydrolysis.	[Bloemink, Marieke; Geeves, Michael A.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Deacon, John; Langer, Stephen; Vera, Carlos; Combs, Ariana; Leinwand, Leslie] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Kent; University of Colorado System; University of Colorado Boulder	Leinwand, L (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	leslie.leinwand@colorado.edu; m.a.geeves@kent.ac.uk	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; Vera, Carlos/0000-0003-1207-4878; Bloemink, Marieke Johanna/0000-0001-9441-2783; LEINWAND, LESLIE/0000-0003-1470-4810	National Institutes of Health (University of Colorado Molecular Biophysics) [T32 GM65013, GM29090]; Wellcome Trust [085309]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029090, F32GM065013, T32GM065103] Funding Source: NIH RePORTER	National Institutes of Health (University of Colorado Molecular Biophysics)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM65013 (University of Colorado Molecular Biophysics Training Grant; to J. D.) and GM29090 (to L. A. L.). This work was also supported by Wellcome Trust Program Grant 085309 (to M. A. G.).	Ackerman MJ, 2002, J AM COLL CARDIOL, V39, P2042, DOI 10.1016/S0735-1097(02)01900-9; Adamek N, 2011, CELL MOL LIFE SCI, V68, P139, DOI 10.1007/s00018-010-0448-x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; Bloemink MJ, 2007, J MOL BIOL, V373, P1184, DOI 10.1016/j.jmb.2007.08.050; Buvoli M, 2008, TRENDS CARDIOVAS MED, V18, P141, DOI 10.1016/j.tcm.2008.04.001; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P4239, DOI 10.1007/s00018-012-1111-5; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Frazier A, 2008, PEDIATR CARDIOL, V29, P846, DOI 10.1007/s00246-007-9177-9; Fujita H, 1997, J CLIN INVEST, V99, P1010, DOI 10.1172/JCI119228; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Greber-Platzer S, 2001, J MOL CELL CARDIOL, V33, P141, DOI 10.1006/jmcc.2000.1287; Iorga B, 2007, J BIOL CHEM, V282, P3559, DOI 10.1074/jbc.M608191200; JOHNSON KA, 1978, BIOCHEMISTRY-US, V17, P3432, DOI 10.1021/bi00610a002; Koester Michael C., 2001, J Athl Train, V36, P197; Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061; Lakdawala NK, 2010, J AM COLL CARDIOL, V55, P320, DOI 10.1016/j.jacc.2009.11.017; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Lowey S, 2008, J BIOL CHEM, V283, P20579, DOI 10.1074/jbc.M800554200; Lowey S, 2013, J BIOL CHEM, V288, P14780, DOI 10.1074/jbc.M113.450668; MARIAN AJ, 1994, TEX HEART I J, V21, P6; Maron BJ, 2002, CIRCULATION, V106, P2419, DOI 10.1161/01.CIR.0000034170.83171.0B; MILLAR NC, 1983, FEBS LETT, V160, P141, DOI 10.1016/0014-5793(83)80954-5; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Preller M, 2013, CYTOSKELETON, V70, P651, DOI 10.1002/cm.21125; Ramaraj R, 2008, CARDIOL REV, V16, P172, DOI 10.1097/CRD.0b013e318178e525; Redwood CS, 1999, CARDIOVASC RES, V44, P20, DOI 10.1016/S0008-6363(99)00213-8; Resnicow DI, 2010, P NATL ACAD SCI USA, V107, P1053, DOI 10.1073/pnas.0913527107; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SIEMANKOWSKI RF, 1984, J BIOL CHEM, V259, P5045; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; Yamashita H, 2000, J BIOL CHEM, V275, P28045; Zadro C, 2009, BBA-MOL BASIS DIS, V1792, P27, DOI 10.1016/j.bbadis.2008.10.017	38	38	38	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5158	5167		10.1074/jbc.M113.511204	http://dx.doi.org/10.1074/jbc.M113.511204			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24344137	hybrid, Green Published			2022-12-28	WOS:000331607900058
J	Gong, WB; Wang, JF; Perrett, S; Feng, YG				Gong, Weibin; Wang, Jinfeng; Perrett, Sarah; Feng, Yingang			Retinoblastoma-binding Protein 1 Has an Interdigitated Double Tudor Domain with DNA Binding Activity*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; Epigenetics; Nuclear Magnetic Resonance; Protein Structure; Tumor Suppressor Gene	DEACETYLASE COMPLEX; STRUCTURAL BASIS; RBP1; IDENTIFICATION; METHYLATION; RECOGNITION; FAMILY; SYSTEM; COACTIVATOR; REPRESSION	Background: Retinoblastoma-binding protein 1 (RBBP1), a tumor suppressor, has a Tudor domain with unknown function. Results: The Tudor domain adopts an interdigitated double Tudor structure with DNA binding activity. Conclusion: The Tudor domain of the RBBP1 family is a DNA binding module. Significance: Our research provides further structural insights into RBBP1 function and the diversity of Tudor domains. Retinoblastoma-binding protein 1 (RBBP1) is a tumor and leukemia suppressor that binds both methylated histone tails and DNA. Our previous studies indicated that RBBP1 possesses a Tudor domain, which cannot bind histone marks. In order to clarify the function of the Tudor domain, the solution structure of the RBBP1 Tudor domain was determined by NMR and is presented here. Although the proteins are unrelated, the RBBP1 Tudor domain forms an interdigitated double Tudor structure similar to the Tudor domain of JMJD2A, which is an epigenetic mark reader. This indicates the functional diversity of Tudor domains. The RBBP1 Tudor domain structure has a significant area of positively charged surface, which reveals a capability of the RBBP1 Tudor domain to bind nucleic acids. NMR titration and isothermal titration calorimetry experiments indicate that the RBBP1 Tudor domain binds both double- and single-stranded DNA with an affinity of 10-100 m; no apparent DNA sequence specificity was detected. The DNA binding mode and key interaction residues were analyzed in detail based on a model structure of the Tudor domain-dsDNA complex, built by HADDOCK docking using the NMR data. Electrostatic interactions mediate the binding of the Tudor domain with DNA, which is consistent with NMR experiments performed at high salt concentration. The DNA-binding residues are conserved in Tudor domains of the RBBP1 protein family, resulting in conservation of the DNA-binding function in the RBBP1 Tudor domains. Our results provide further insights into the structure and function of RBBP1.	[Gong, Weibin; Wang, Jinfeng; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Feng, Yingang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Energy Genet, Qingdao 266101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Perrett, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	sarah.perrett@cantab.net; fengyg@qibebt.ac.cn	Feng, Yingang/B-6304-2008; Perrett, Sarah/AAS-9483-2020	Feng, Yingang/0000-0002-0879-1316; Perrett, Sarah/0000-0003-0137-0997	Chinese Ministry of Science and Technology 973 Program Grants [2012CB911000, 2013CB910700]; National Natural Science Foundation of China Grants [30970571, 31110103914, 31200578, 30770434]	Chinese Ministry of Science and Technology 973 Program Grants; National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Ministry of Science and Technology 973 Program Grants 2012CB911000 and 2013CB910700 (to S. P.) and National Natural Science Foundation of China Grants 30970571 (to Y. F.), 31110103914 (to S. P.), 31200578 (to W. G.), and 30770434 (to J. W.).	Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Callebaut I, 1997, BIOCHEM J, V321, P125, DOI 10.1042/bj3210125; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cao JN, 2001, J NATL CANCER I, V93, P1159, DOI 10.1093/jnci/93.15.1159; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; Cui DX, 2004, CANCER EPIDEM BIOMAR, V13, P1136; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2002, PYMOL USERS MANUAL; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FATTAEY AR, 1993, ONCOGENE, V8, P3149; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Gong WB, 2012, J BIOL CHEM, V287, P8531, DOI 10.1074/jbc.M111.299149; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kim D, 2010, NAT STRUCT MOL BIOL, V17, P1027, DOI 10.1038/nsmb.1856; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Lai A, 1999, ONCOGENE, V18, P2091, DOI 10.1038/sj.onc.1202520; Lancelot N, 2007, NUCLEIC ACIDS RES, V35, P5898, DOI 10.1093/nar/gkm607; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Monroe DG, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-104; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Pek JW, 2012, DEVELOPMENT, V139, P2255, DOI 10.1242/dev.073304; Ponting CP, 1997, TRENDS BIOCHEM SCI, V22, P51, DOI 10.1016/S0968-0004(96)30049-2; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shimojo H, 2008, J MOL BIOL, V378, P987, DOI 10.1016/j.jmb.2008.03.021; Takahashi T, 1999, BRIT J CANCER, V81, P342, DOI 10.1038/sj.bjc.6690698; Tripsianes K, 2011, NAT STRUCT MOL BIOL, V18, P1414, DOI 10.1038/nsmb.2185; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; Winter SF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002735; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wu MY, 2008, JNCI-J NATL CANCER I, V100, P1247, DOI 10.1093/jnci/djn253; Wu MY, 2006, GENE DEV, V20, P2859, DOI 10.1101/gad.1452206; Wu RC, 2013, P NATL ACAD SCI USA, V110, P4616, DOI 10.1073/pnas.1218318110; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	53	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4882	4895		10.1074/jbc.M113.501940	http://dx.doi.org/10.1074/jbc.M113.501940			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24379399	Green Published, hybrid			2022-12-28	WOS:000331607900035
J	Harding, J; Mirochnitchenko, O				Harding, John; Mirochnitchenko, Oleg			Preclinical Studies for Induced Pluripotent Stem Cell-based Therapeutics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Animal Models; Differentiation; Induced Pluripotent Stem Cell (iPSC); Regenerative Medicine; Stem Cells	HEPATOCYTE-LIKE CELLS; HUMAN IPS CELLS; MYOCARDIAL-INFARCTION; SOMATIC-CELLS; FUNCTIONAL RECOVERY; DNA METHYLATION; DIFFERENTIATION; GENERATION; MOUSE; TRANSPLANTATION	Induced pluripotent stem cells (iPSCs) and their differentiated derivatives can potentially be applied to cell-based therapy for human diseases. The properties of iPSCs are being studied intensively both to understand the basic biology of pluripotency and cellular differentiation and to solve problems associated with therapeutic applications. Examples of specific preclinical applications summarized briefly in this minireview include the use of iPSCs to treat diseases of the liver, nervous system, eye, and heart and metabolic conditions such as diabetes. Early stage studies illustrate the potential of iPSC-derived cells and have identified several challenges that must be addressed before moving to clinical trials. These include rigorous quality control and efficient production of required cell populations, improvement of cell survival and engraftment, and development of technologies to monitor transplanted cell behavior for extended periods of time. Problems related to immune rejection, genetic instability, and tumorigenicity must be solved. Testing the efficacy of iPSC-based therapies requires further improvement of animal models precisely recapitulating human disease conditions.	[Harding, John; Mirochnitchenko, Oleg] NIH, Div Comparat Med, Off Res Infrastruct Programs,Off Director, Div Program Coordinat Planning & Strateg Initiat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Mirochnitchenko, O (corresponding author), NIH, Div Comparat Med, Off Res Infrastruct Programs,Off Director, Div Program Coordinat Planning & Strateg Initiat, Bethesda, MD 20892 USA.	oleg.mirochnitchenko@nih.gov						Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Ben-David U, 2012, STEM CELLS, V30, P612, DOI 10.1002/stem.1057; Cai WB, 2011, AM J NUCL MED MOLEC, V1, P18; Carpenter L, 2012, STEM CELLS DEV, V21, P977, DOI 10.1089/scd.2011.0075; Chen F, 2013, BIOMATERIALS, V34, P1701, DOI 10.1016/j.biomaterials.2012.11.018; Chen Q, 2011, CHROMOSOME RES, V19, P857, DOI 10.1007/s10577-011-9239-y; Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790; Cheng FY, 2012, BIOMATERIALS, V33, P3195, DOI 10.1016/j.biomaterials.2012.01.023; de Almeida PE, 2013, CIRC RES, V112, P549, DOI 10.1161/CIRCRESAHA.111.249243; Emborg ME, 2013, CELL REP, V3, P646, DOI 10.1016/j.celrep.2013.02.016; Ezashi T, 2012, REPROD DOMEST ANIM, V47, P92, DOI 10.1111/j.1439-0531.2012.02061.x; Ghosh Z, 2011, CANCER RES, V71, P5030, DOI 10.1158/0008-5472.CAN-10-4402; Gomi M, 2012, BRAIN RES, V1459, P52, DOI 10.1016/j.brainres.2012.03.049; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Gu E, 2012, THERANOSTICS, V2, P335, DOI 10.7150/thno.3666; Gu MX, 2012, CIRC RES, V111, P882, DOI 10.1161/CIRCRESAHA.112.269001; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Hibino N, 2012, J THORAC CARDIOV SUR, V143, P696, DOI 10.1016/j.jtcvs.2011.06.046; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Hong SG, 2013, MOL THER, V21, P272, DOI 10.1038/mt.2012.255; Hussein SMI, 2012, CURR OPIN GENET DEV, V22, P435, DOI 10.1016/j.gde.2012.08.007; Jensen MB, 2013, J STROKE CEREBROVASC, V22, P304, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.008; Jeon K, 2012, STEM CELLS DEV, V21, P2642, DOI 10.1089/scd.2011.0665; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Jiao QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027646; Joven J, 2013, HIV MED, V14, P233, DOI 10.1111/hiv.12000; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kawai H, 2010, J CEREBR BLOOD F MET, V30, P1487, DOI 10.1038/jcbfm.2010.32; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Knoepfler PS, 2012, REGEN MED, V7, P713, DOI [10.2217/RME.12.51, 10.2217/rme.12.51]; Kobayashi Y., 2012, PLOS ONE, V7; Koh S, 2013, STEM CELLS DEV, V22, P951, DOI 10.1089/scd.2012.0393; Kuroda T, 2013, BIOL PHARM BULL, V36, P189, DOI 10.1248/bpb.b12-00970; Kuroda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037342; Lee AS, 2011, J BIOL CHEM, V286, P32697, DOI 10.1074/jbc.M111.235739; Li M, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt46; Li Y, 2012, MOL MED, V18, P1312, DOI 10.2119/molmed.2012.00242; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376; Lund RJ, 2012, NAT REV GENET, V13, P732, DOI 10.1038/nrg3271; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Martinez-Fernandez A, 2009, CIRC RES, V105, P648, DOI 10.1161/CIRCRESAHA.109.203109; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Mashimo T, 2012, CELL REP, V2, P685, DOI 10.1016/j.celrep.2012.08.009; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Menendez S, 2012, AGING CELL, V11, P41, DOI 10.1111/j.1474-9726.2011.00754.x; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Morris SA, 2013, CELL RES, V23, P33, DOI 10.1038/cr.2013.1; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; Pouya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027925; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Ronen D, 2012, CURR OPIN GENET DEV, V22, P444, DOI 10.1016/j.gde.2012.09.003; Ruggiero A, 2012, EUR RADIOL, V22, P189, DOI 10.1007/s00330-011-2190-7; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Sancho-Martinez I, 2012, NAT CELL BIOL, V14, P892, DOI 10.1038/ncb2567; Semi K, 2013, INT J CANCER, V132, P1240, DOI 10.1002/ijc.27963; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Sohn YD, 2012, PROG MOL BIOL TRANSL, V111, P1, DOI 10.1016/B978-0-12-398459-3.00001-0; Soto-Gutierrez A, 2010, CELL TRANSPLANT, V19, P655, DOI 10.3727/096368910X508753; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Suzuki S, 2012, CELL STEM CELL, V10, P753, DOI 10.1016/j.stem.2012.04.021; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Templin C, 2012, CIRCULATION, V126, P430, DOI 10.1161/CIRCULATIONAHA.111.087684; Thatava T, 2011, GENE THER, V18, P283, DOI 10.1038/gt.2010.145; Tong M, 2011, CELL RES, V21, P1634, DOI 10.1038/cr.2011.143; Tucker BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018992; van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480; Varela C, 2012, J CLIN INVEST, V122, P569, DOI 10.1172/JCI46268; Wu YM, 2008, HEPATOLOGY, V47, P279, DOI 10.1002/hep.21937; Wu YH, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/767195; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yamashita T, 2011, CELL TRANSPLANT, V20, P883, DOI 10.3727/096368910X539092; Yang J. J., 2012, J TISSUE ENG REGEN M, DOI 10.1002/term.1640; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhang GC, 2012, STEM CELLS DEV, V21, P955, DOI 10.1089/scd.2011.0649; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhang YM, 2012, CELL CYCLE, V11, P4536, DOI 10.4161/cc.22575; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhong BN, 2011, MOL THER, V19, P1667, DOI 10.1038/mt.2011.51; Zhou L, 2011, STEM CELLS, V29, P972, DOI 10.1002/stem.637; Zhu FF, 2011, DIABETOLOGIA, V54, P2325, DOI 10.1007/s00125-011-2246-x; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	99	40	40	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4585	4593		10.1074/jbc.R113.463737	http://dx.doi.org/10.1074/jbc.R113.463737			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24362021	Green Published, hybrid			2022-12-28	WOS:000331607900007
J	Siguier, B; Haon, M; Nahoum, V; Marcellin, M; Burlet-Schiltz, O; Coutinho, PM; Henrissat, B; Mourey, L; O'Donohue, MJ; Berrin, JG; Tranier, S; Dumon, C				Siguier, Beatrice; Haon, Mireille; Nahoum, Virginie; Marcellin, Marlene; Burlet-Schiltz, Odile; Coutinho, Pedro M.; Henrissat, Bernard; Mourey, Lionel; O'Donohue, Michael J.; Berrin, Jean-Guy; Tranier, Samuel; Dumon, Claire			First Structural Insights into alpha-L-Arabinofuranosidases from the Two GH62 Glycoside Hydrolase Subfamilies*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biofuel; Biotechnology; Enzyme Structure; Fungi; Glycoside Hydrolases; Oligosaccharide; Arabinofuranosidase; CAZyme; GH62; Hemicellulase	SEQUENCE; SACCHARIFICATION; SECRETOME; COMPLEX; ENZYMES	Background: -l-Arabinofuranosidases hydrolyze arabinofuranosyl side chains from xylans. Results: The first crystal structures of two fungal -l-arabinofuranosidases representing two distinct subfamilies from the glycoside hydrolase GH62 family are presented. The examination of these unveils specificity determinants. Conclusion: The structures of complexes with arabinose and cellotriose provide preliminary insight into substrate recognition and catalysis. Significance: This work provides the first structural description members of the GH62 family. -l-Arabinofuranosidases are glycoside hydrolases that specifically hydrolyze non-reducing residues from arabinose-containing polysaccharides. In the case of arabinoxylans, which are the main components of hemicellulose, they are part of microbial xylanolytic systems and are necessary for complete breakdown of arabinoxylans. Glycoside hydrolase family 62 (GH62) is currently a small family of -l-arabinofuranosidases that contains only bacterial and fungal members. Little is known about the GH62 mechanism of action, because only a few members have been biochemically characterized and no three-dimensional structure is available. Here, we present the first crystal structures of two fungal GH62 -l-arabinofuranosidases from the basidiomycete Ustilago maydis (UmAbf62A) and ascomycete Podospora anserina (PaAbf62A). Both enzymes are able to efficiently remove the -l-arabinosyl substituents from arabinoxylan. The overall three-dimensional structure of UmAbf62A and PaAbf62A reveals a five-bladed -propeller fold that confirms their predicted classification into clan GH-F together with GH43 -l-arabinofuranosidases. Crystallographic structures of the complexes with arabinose and cellotriose reveal the important role of subsites +1 and +2 for sugar binding. Intriguingly, we observed that PaAbf62A was inhibited by cello-oligosaccharides and displayed binding affinity to cellulose although no activity was observed on a range of cellulosic substrates. Bioinformatic analyses showed that UmAbf62A and PaAbf62A belong to two distinct subfamilies within the GH62 family. The results presented here provide a framework to better investigate the structure-function relationships within the GH62 family.	[Siguier, Beatrice; O'Donohue, Michael J.; Dumon, Claire] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Siguier, Beatrice; O'Donohue, Michael J.; Dumon, Claire] INRA, Natl Inst Agr Res, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Siguier, Beatrice; O'Donohue, Michael J.; Dumon, Claire] CNRS, UMR5504, F-31400 Toulouse, France; [Siguier, Beatrice; Nahoum, Virginie; Marcellin, Marlene; Burlet-Schiltz, Odile; Mourey, Lionel; Tranier, Samuel] CNRS, IPBS, F-31077 Toulouse, France; [Siguier, Beatrice; Nahoum, Virginie; Marcellin, Marlene; Burlet-Schiltz, Odile; Mourey, Lionel; Tranier, Samuel] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [Haon, Mireille; Berrin, Jean-Guy] Natl Inst Agr Res, Biotechnol Champignons Filamenteux UMR1163, F-13288 Marseille, France; [Haon, Mireille; Berrin, Jean-Guy] Aix Marseille Univ, Polytech Marseille, F-13288 Marseille, France; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille, CNRS, UMR7257, F-13288 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Berrin, JG (corresponding author), INRA, Lab Biotechnol Champignons Filamente, Marseille, France.	jean-guy.berrin@univ-amu.fr; samuel.tranier@ipbs.fr; claire.dumon@insa-toulouse.fr	Henrissat, Bernard/J-2475-2012; O'Donohue, Michael J/E-9183-2013; BERRIN, Jean-Guy/AAF-3107-2021; O'Donohue, Michael/ABD-9239-2021; Claire, Dumon/AAI-2553-2021; BERRIN, Jean-Guy/E-1460-2014; Mourey, Lionel/B-5662-2009; Tranier, Samuel/C-6059-2011	Henrissat, Bernard/0000-0002-3434-8588; O'Donohue, Michael J/0000-0003-4246-3938; O'Donohue, Michael/0000-0003-4246-3938; Claire, Dumon/0000-0003-4925-7336; BERRIN, Jean-Guy/0000-0001-7570-3745; Mourey, Lionel/0000-0002-8259-1259; Schiltz, Odile/0000-0002-3606-2356; Tranier, Samuel/0000-0001-9751-163X; Nahoum, Virginie/0000-0003-3125-6618	region Midi-Pyrenees; National Institute of Agricultural Research (INRA) CEPIA research department; European funds (FEDER)	region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); National Institute of Agricultural Research (INRA) CEPIA research department; European funds (FEDER)(European Commission)	This work was supported in part by grants from the region Midi-Pyrenees (to B. S.) and the National Institute of Agricultural Research (INRA) CEPIA research department.; Supported by Region Midi-Pyrenees and European funds (FEDER).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen B., 2013, PLOS ONE, V8; Couturier M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-57; Couturier M, 2011, APPL ENVIRON MICROB, V77, P237, DOI 10.1128/AEM.01761-10; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; De La Mare M, 2013, ENZYME MICROB TECH, V53, P351, DOI 10.1016/j.enzmictec.2013.07.008; Dumon C, 2012, PROCESS BIOCHEM, V47, P346, DOI 10.1016/j.procbio.2011.06.017; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Faraco V, 2013, LIGNOCELLULOSE CONVE, P93; Faure R, 2009, AUST J CHEM, V62, P533, DOI 10.1071/CH08458; Gautier V, 2012, MOL CELL PROTEOMICS, V11, P527, DOI 10.1074/mcp.M111.015230; Gilbert H. J., 2013, GLYCOSIDE HYDROLASE, V62; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hashimoto K, 2011, BIOSCI BIOTECH BIOCH, V75, P342, DOI 10.1271/bbb.100434; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KELLETT LE, 1990, BIOCHEM J, V272, P369, DOI 10.1042/bj2720369; KORMELINK FJM, 1993, CARBOHYD RES, V249, P355, DOI 10.1016/0008-6215(93)84100-K; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leijdekkers AGM, 2013, BIORESOURCE TECHNOL, V128, P518, DOI 10.1016/j.biortech.2012.10.126; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neer EJ, 1996, CELL, V84, P175, DOI 10.1016/S0092-8674(00)80969-1; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; Paes G, 2008, BIOCHEMISTRY-US, V47, P7441, DOI 10.1021/bi800424e; Paoli M, 2001, NAT STRUCT BIOL, V8, P744, DOI 10.1038/nsb0901-744; Pons T, 2004, PROTEINS, V54, P424, DOI 10.1002/prot.10604; Ravalason H, 2012, BIORESOURCE TECHNOL, V114, P589, DOI 10.1016/j.biortech.2012.03.009; Ribeiro DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050571; Sakamoto T, 2011, APPL MICROBIOL BIOT, V90, P137, DOI 10.1007/s00253-010-2988-2; Saulnier L, 2007, J CEREAL SCI, V46, P261, DOI 10.1016/j.jcs.2007.06.014; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Vincent P, 1997, BIOCHEM J, V322, P845, DOI 10.1042/bj3220845; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	45	33	33	4	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5261	5273		10.1074/jbc.M113.528133	http://dx.doi.org/10.1074/jbc.M113.528133			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24394409	Green Published, hybrid			2022-12-28	WOS:000331607900067
J	Banerjee, B; Goss, DJ				Banerjee, Bidisha; Goss, Dixie J.			Eukaryotic Initiation Factor (eIF) 4F Binding to Barley Yellow Dwarf Virus (BYDV) 3 '-Untranslated Region Correlates with Translation Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence; Plant Viruses; Protein Synthesis; Protein-Nucleic Acid Interaction; RNA Viruses; eIF4F	CAP-INDEPENDENT TRANSLATION; MESSENGER-RNA; POLY(A)-BINDING PROTEIN; POLY(A) TAIL; MECHANISM; ELEMENT	Background: Little is known about BYDV protein synthesis initiation mechanisms. Results: eIF4F binding correlates with 3 BTE translation efficiency and is enthalpically and entropically favorable. Conclusion: Binding of eIF4F to the 3 BTE is important for efficient BYDV translation. Significance: Binding of eIF4F to the 3-UTR to initiate assembly of the protein synthesis initiation complex is a novel mechanism that may be used by other viruses containing a 3 BTE. Eukaryotic initiation factor (eIF) 4F binding to mRNA is the first committed step in cap-dependent protein synthesis. Barley yellow dwarf virus (BYDV) employs a cap-independent mechanism of translation initiation that is mediated by a structural BYDV translation element (BTE) located in the 3-UTR of its mRNA. eIF4F bound the BTE and a translationally inactive mutant with high affinity, thus questioning the role of eIF4F in translation of BYDV. To examine the effects of eIF4F in BYDV translation initiation, BTE mutants with widely different in vitro translation efficiencies ranging from 5 to 164% compared with WT were studied. Using fluorescence anisotropy to obtain quantitative data, we show 1) the equilibrium binding affinity (complex stability) correlated well with translation efficiency, whereas the on rate of binding did not; 2) other unidentified proteins or small molecules in wheat germ extract prevented eIF4F binding to mutant BTE but not WT BTE; 3) BTE mutant-eIF4F interactions were found to be both enthalpically and entropically favorable with an enthalpic contribution of 52-90% to G degrees at 25 degrees C, suggesting that hydrogen bonding contributes to stability; and 4) in contrast to cap-dependent and tobacco etch virus internal ribosome entry site interaction with eIF4F, poly(A)-binding protein did not increase eIF4F binding. Further, the eIF4F bound to the 3 BTE with higher affinity than for either m(7)G cap or tobacco etch virus internal ribosome entry site, suggesting that the 3 BTE may play a role in sequestering host cell initiation factors and possibly regulating the switch from replication to translation.	[Goss, Dixie J.] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA; [Goss, Dixie J.] CUNY, Grad Ctr, New York, NY 10065 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System	Goss, DJ (corresponding author), CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA.	dgoss@hunter.cuny.edu			National Science Foundation [MCB1157632]; Div Of Molecular and Cellular Bioscience [1157632] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB1157632 (to D. J. G.).	BALASTA ML, 1993, J BIOL CHEM, V268, P18599; BERNSTEIN P, 1989, TRENDS BIOCHEM SCI, V14, P373, DOI 10.1016/0968-0004(89)90011-X; Bi XP, 2000, J BIOL CHEM, V275, P17740, DOI 10.1074/jbc.M909464199; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P1624, DOI 10.1021/bi00220a026; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Filbin ME, 2009, CURR OPIN STRUC BIOL, V19, P267, DOI 10.1016/j.sbi.2009.03.005; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; GARLAND DL, 1978, BIOCHEMISTRY-US, V17, P4266, DOI 10.1021/bi00613a024; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Guo L, 2001, MOL CELL, V7, P1103, DOI 10.1016/S1097-2765(01)00252-0; Guo L, 2000, RNA, V6, P1808, DOI 10.1017/S1355838200001539; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; Khan MA, 2005, BIOCHEMISTRY-US, V44, P4510, DOI 10.1021/bi047298g; Khan MA, 2008, BBA-GENE REGUL MECH, V1779, P622, DOI 10.1016/j.bbagrm.2008.07.004; Khan MA, 2008, J BIOL CHEM, V283, P1340, DOI 10.1074/jbc.M703356200; Kohler JJ, 2001, BIOCHEMISTRY-US, V40, P130, DOI 10.1021/bi001881p; Kraft JJ, 2013, NUCLEIC ACIDS RES, V41, P3398, DOI 10.1093/nar/gkt026; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Mayberry LK, 2007, METHOD ENZYMOL, V430, P397, DOI 10.1016/S0076-6879(07)30015-3; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; Miller WA, 1997, ANNU REV PHYTOPATHOL, V35, P167, DOI 10.1146/annurev.phyto.35.1.167; Morley SJ, 2001, PROG MOLEC, V27, P1; MUNROE D, 1990, MOL CELL BIOL, V10, P3441, DOI 10.1128/MCB.10.7.3441; MUNROE D, 1990, GENE, V91, P151, DOI 10.1016/0378-1119(90)90082-3; OLSEN K, 1993, BIOCHEMISTRY-US, V32, P9686, DOI 10.1021/bi00088a021; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Kneller ELP, 2006, VIRUS RES, V119, P63, DOI 10.1016/j.virusres.2005.10.010; Prevot D, 2003, EMBO J, V22, P1909, DOI 10.1093/emboj/cdg175; Rakotondrafara AM, 2006, RNA, V12, P1893, DOI 10.1261/rna.115606; Ray S, 2006, J BIOL CHEM, V281, P35826, DOI 10.1074/jbc.M605762200; SONENBERG N, 1988, PROG NUCLEIC ACID RE, V35, P173, DOI 10.1016/S0079-6603(08)60614-5; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Treder K, 2008, RNA, V14, P134, DOI 10.1261/rna.777308; Wang ZH, 2010, VIROLOGY, V402, P177, DOI 10.1016/j.virol.2010.03.025; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Yanagiya A, 2009, MOL CELL BIOL, V29, P1661, DOI 10.1128/MCB.01187-08	41	9	10	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4286	4294		10.1074/jbc.M113.530329	http://dx.doi.org/10.1074/jbc.M113.530329			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24379412	Green Published, hybrid			2022-12-28	WOS:000331403800039
J	Basu, S; Rajakaruna, S; De Arcangelis, A; Zhang, LP; Georges-Labouesse, E; Menko, AS				Basu, Subhasree; Rajakaruna, Suren; De Arcangelis, Adele; Zhang, Liping; Georges-Labouesse, Elisabeth; Menko, A. Sue			alpha 6 Integrin Transactivates Insulin-like Growth Factor Receptor-1 (IGF-1R) to Regulate Caspase-3-mediated Lens Epithelial Cell Differentiation Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Development; Integrins; Lens; Signal Transduction	FACTOR-I RECEPTOR; SRC-FAMILY KINASES; NF-KAPPA-B; FIBER CELL; SIGNALING PATHWAY; 3 BETA-1-INTEGRIN; CARCINOMA-CELLS; EGF RECEPTOR; C-SRC; ACTIVATION	The canonical mitochondrial death pathway was first discovered for its role in signaling apoptosis. It has since been found to have a requisite function in differentiation initiation in many cell types including the lens through low level activation of the caspase-3 protease. The ability of this pathway to function as a molecular switch in lens differentiation depends on the concurrent induction of survival molecules in the Bcl-2 and IAP families, induced downstream of an IGF-1R/NFB coordinate survival signal, to regulate caspase-3 activity. Here we investigated whether 6 integrin signals upstream to this IGF-1R-mediated survival-linked differentiation signal. Our findings show that IGF-1R is recruited to and activated specifically in 6 integrin receptor signaling complexes in the lens equatorial region, where lens epithelial cells initiate their differentiation program. In studies with both 6 integrin knock-out mice lenses and primary lens cell cultures following 6 integrin siRNA knockdown, we show that IGF-1R activation is dependent on 6 integrin and that this transactivation requires Src kinase activity. In addition, without 6 integrin, activation and expression of NFB was diminished, and expression of Bcl-2 and IAP family members were down-regulated, resulting in high levels of caspase-3 activation. As a result, a number of hallmarks of lens differentiation failed to be induced; including nuclear translocation of Prox1 in the differentiation initiation zone and apoptosis was promoted. We conclude that 6 integrin is an essential upstream regulator of the IGF-1R survival pathway that regulates the activity level of caspase-3 for it to signal differentiation initiation of lens epithelial cells.	[Basu, Subhasree; Rajakaruna, Suren; Zhang, Liping; Menko, A. Sue] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [De Arcangelis, Adele; Georges-Labouesse, Elisabeth] Univ Strasbourg, CNRS UMR7104, Inserm U964, Inst Genet & Biol Mol & Cellulaire,Dept Dev & Ste, Illkirch Graffenstaden, France	Jefferson University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Menko, AS (corresponding author), 564 Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.	sue.menko@jefferson.edu	De Arcangelis, Adèle/M-5101-2016	De Arcangelis, Adèle/0000-0003-1114-8441; Menko, A. Sue/0000-0002-7514-4696	National Institutes of Health [EY10577]; NATIONAL EYE INSTITUTE [R01EY010577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY10577 (to A. S. M.).	Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; Alizadeh A, 2004, INVEST OPHTH VIS SCI, V45, P884, DOI 10.1167/iovs.03-0677; Alizadeh A, 2003, INVEST OPHTH VIS SCI, V44, P5252, DOI 10.1167/iovs.03-0224; Baron W, 2005, GLIA, V49, P467, DOI 10.1002/glia.20132; Baron W, 2003, CURR BIOL, V13, P151, DOI 10.1016/S0960-9822(02)01437-9; Baron W, 2002, EMBO J, V21, P1957, DOI 10.1093/emboj/21.8.1957; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Basu S, 2012, J BIOL CHEM, V287, P8384, DOI 10.1074/jbc.M112.341586; Belmokhtar CA, 2000, EXP CELL RES, V254, P99, DOI 10.1006/excr.1999.4737; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Bernal-Mizrachi L, 2006, P NATL ACAD SCI USA, V103, P9220, DOI 10.1073/pnas.0507809103; Bonfoco E, 2000, NEUROSCIENCE, V101, P1145, DOI 10.1016/S0306-4522(00)00429-2; Chen XR, 2008, MOL VIS, V14, P2076; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Dayyani F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051189; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Duncan MK, 2002, MECH DEVELOP, V112, P195, DOI 10.1016/S0925-4773(01)00645-1; Epaud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048071; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Friedland JC, 2007, J CELL SCI, V120, P3700, DOI 10.1242/jcs.03484; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; HERNANDEZSANCHEZ C, 1995, J BIOL CHEM, V270, P29176, DOI 10.1074/jbc.270.49.29176; Hierck BP, 1996, DEV DYNAM, V206, P100, DOI 10.1002/(SICI)1097-0177(199605)206:1<100::AID-AJA9>3.0.CO;2-M; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jameson MJ, 2011, MOL CANCER THER, V10, P2124, DOI 10.1158/1535-7163.MCT-11-0294; Keramaris E, 2000, MOL CELL NEUROSCI, V15, P368, DOI 10.1006/mcne.2000.0838; Kiely P., 2005, CELL ENG, P49; Koyama N, 2009, J MED INVESTIG, V56, P247, DOI 10.2152/jmi.56.247; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lallier TE, 1996, DEVELOPMENT, V122, P2539; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Leonard M, 2013, DEV DYNAM, V242, P469, DOI 10.1002/dvdy.23935; Levy L, 2000, MOL BIOL CELL, V11, P453, DOI 10.1091/mbc.11.2.453; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Lygoe KA, 2004, WOUND REPAIR REGEN, V12, P461, DOI 10.1111/j.1067-1927.2004.12402.x; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; Menko AS, 2010, EXP EYE RES, V91, P640, DOI 10.1016/j.exer.2010.08.006; MENKO AS, 1984, DEV BIOL, V103, P129, DOI 10.1016/0012-1606(84)90014-9; MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2; Menko KS, 2001, DEV DYNAM, V220, P337, DOI 10.1002/dvdy.1114; MERDES A, 1991, J CELL BIOL, V115, P397, DOI 10.1083/jcb.115.2.397; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200; MORI C, 1995, ANAT REC, V242, P103, DOI 10.1002/ar.1092420114; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Morozov V, 2006, DEVELOPMENT, V133, P813, DOI 10.1242/dev.02262; Sasaoka T, 2001, ENDOCRINOLOGY, V142, P5226, DOI 10.1210/en.142.12.5226; Sastry SK, 1996, J CELL BIOL, V133, P169, DOI 10.1083/jcb.133.1.169; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; Schreiber TD, 2009, HAEMATOL-HEMATOL J, V94, P1493, DOI 10.3324/haematol.2009.006072; Simirskii VN, 2007, DEV BIOL, V306, P658, DOI 10.1016/j.ydbio.2007.04.004; Son AI, 2013, MOL VIS, V19, P254; Sorokina EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021122; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Walker J., 2004, ROLE MATRIX CELL ADH, P245; Walker J, 2009, EXP EYE RES, V88, P216, DOI 10.1016/j.exer.2008.06.020; Walker JL, 1999, DEV BIOL, V210, P497, DOI 10.1006/dbio.1999.9277; Walker JL, 2002, DEV BIOL, V251, P195, DOI 10.1006/dbio.2002.0823; Walker JL, 2002, DEV DYNAM, V223, P273, DOI 10.1002/dvdy.10050; Weber GF, 2005, J BIOL CHEM, V280, P22135, DOI 10.1074/jbc.M414270200; Weil M, 1999, CURR BIOL, V9, P361, DOI 10.1016/S0960-9822(99)80162-6; Wewer UM, 1997, AM J PATHOL, V151, P1191; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Wilschut KJ, 2011, STEM CELL RES, V7, P112, DOI 10.1016/j.scr.2011.05.001; Xu L, 2002, EXP EYE RES, V74, P753, DOI 10.1006/exer.2002.1175; Yang SY, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-17; Zeiss CJ, 2004, INVEST OPHTH VIS SCI, V45, P964, DOI 10.1167/iovs.03-0439; Zhao HT, 2008, DEV BIOL, V318, P276, DOI 10.1016/j.ydbio.2008.03.028; Zheng B, 1998, P NATL ACAD SCI USA, V95, P11217, DOI 10.1073/pnas.95.19.11217; Zou L, 2012, J BIOL CHEM, V287, P7190, DOI 10.1074/jbc.M111.304972	81	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3842	3855		10.1074/jbc.M113.515254	http://dx.doi.org/10.1074/jbc.M113.515254			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24381169	hybrid, Green Published			2022-12-28	WOS:000331403800002
J	Martin-Esteban, A; Gomez-Molina, P; Sanz-Bravo, A; de Castro, JAL				Martin-Esteban, Adrian; Gomez-Molina, Patricia; Sanz-Bravo, Alejandro; Lopez de Castro, Jose A.			Combined Effects of Ankylosing Spondylitis-associated ERAP1 Polymorphisms Outside the Catalytic and Peptide-binding Sites on the Processing of Natural HLA-B27 Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminopeptidase; Antigen Processing; Arthritis; Major Histocompatibility Complex (MHC); Pathogenesis; Peptides	CLASS-I MOLECULES; ER AMINOPEPTIDASE; TRIMS PRECURSORS; SUSCEPTIBILITY; HAPLOTYPES; SEVERITY; EPITOPES; ALLELES; ANTIGEN	ERAP1 polymorphism involving residues 528 and 575/725 is associated with ankylosing spondylitis among HLA-B27-positive individuals. We used four recombinant variants to address the combined effects of the K528R and D575N polymorphism on the processing of HLA-B27 ligands. The hydrolysis of a fluorogenic substrate, Arg-528/Asp-575 < Lys-528/Asp-575 < Arg-528/Asn-575 < Lys-528/Asn-575, indicated that the relative activity of variants carrying Arg-528 or Lys-528 depends on residue 575. Asp-575 conferred lower activity than Asn-575, but the difference depended on residue 528. The same hierarchy was observed with synthetic precursors of HLA-B27 ligands, but the effects were peptide-dependent. Sometimes the epitope yields were variant-specific at all times. For other peptides, concomitant generation and destruction led to similar epitope amounts with all the variants at long, but not at short, digestion times. The generation/destruction balance of two related HLA-B27 ligands was analyzed in vitro and in live cells. Their relative yields at long digestion times were comparable with those from HLA-B27-positive cells, suggesting that ERAP1 was a major determinant of the abundance of these peptides in vivo. The hydrolysis of fluorogenic and peptide substrates by an HLA-B27 ligand or a shorter peptide, respectively, was increasingly inhibited as a function of ERAP1 activity, indicating that residues 528 and 575 affect substrate inhibition of ERAP1 trimming. The significant and complex effects of co-occurring ERAP1 polymorphisms on multiple HLA-B27 ligands, and their potential to alter the immunological and pathogenetic features of HLA-B27 as a function of the ERAP1 context, explain the epistatic association of both molecules in ankylosing spondylitis.	CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; Univ Autonoma Madrid, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	de Castro, JAL (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1, E-28049 Madrid, Spain.	aldecastro@cbm.uam.es	Molina, Carmen Patricia Gómez/AAC-6194-2020; Sanz, Alejandro/AAA-4646-2019	Molina, Carmen Patricia Gómez/0000-0001-6135-0694; Sanz-Bravo, Alejandro/0000-0002-1821-1127	Plan Nacional de I + D + i [SAF2011/25681]; Fundacion Ramon Areces	Plan Nacional de I + D + i; Fundacion Ramon Areces	This work was supported by Grant SAF2011/25681 (Plan Nacional de I + D + i) (to J. A. L. C.) and an institutional grant from the Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa.	Bird LA, 2003, EUR J IMMUNOL, V33, P748, DOI 10.1002/eji.200323678; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; BREWERTON DA, 1973, LANCET, V1, P904; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Choi CB, 2010, ANN RHEUM DIS, V69, P582, DOI 10.1136/ard.2008.105296; Cragnolini JJ, 2009, MOL CELL PROTEOMICS, V8, P1850, DOI 10.1074/mcp.M900107-MCP200; de Castro JAL, 2004, TISSUE ANTIGENS, V63, P424, DOI 10.1111/j.0001-2815.2004.00220.x; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Evnouchidou I, 2011, J IMMUNOL, V186, P1909, DOI 10.4049/jimmunol.1003337; Evnouchidou I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003658; Garcia-Medel N, 2012, MOL CELL PROTEOMICS, V11, P1416, DOI 10.1074/mcp.M112.019588; Goto Y, 2006, FEBS LETT, V580, P1833, DOI 10.1016/j.febslet.2006.02.041; Harvey D, 2009, HUM MOL GENET, V18, P4204, DOI 10.1093/hmg/ddp371; Hearn A, 2009, J IMMUNOL, V183, P5526, DOI 10.4049/jimmunol.0803663; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Maksymowych WP, 2009, ARTHRITIS RHEUM, V60, P1317, DOI 10.1002/art.24467; Marcilla M, 2008, TISSUE ANTIGENS, V71, P495, DOI 10.1111/j.1399-0039.2008.01051.x; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nguyen TT, 2011, NAT STRUCT MOL BIOL, V18, P604, DOI 10.1038/nsmb.2021; Reeves E, 2013, J IMMUNOL, V191, P35, DOI 10.4049/jimmunol.1300598; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Seregin SS, 2013, AUTOIMMUNITY, V46, P497, DOI 10.3109/08916934.2013.819855; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Szczypiorska M, 2011, RHEUMATOLOGY, V50, P1969, DOI 10.1093/rheumatology/ker229; Wang CM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3855; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	30	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3978	3990		10.1074/jbc.M113.529610	http://dx.doi.org/10.1074/jbc.M113.529610			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24352655	Green Published, hybrid			2022-12-28	WOS:000331403800013
J	Roth-Johnson, EA; Vizcarra, CL; Bois, JS; Quinlan, ME				Roth-Johnson, Elizabeth A.; Vizcarra, Christina L.; Bois, Justin S.; Quinlan, Margot E.			Interaction between Microtubules and the Drosophila Formin Cappuccino and Its Effect on Actin Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Polarity; Cytoskeleton; Formin; Microtubules; Oocyte; Capu; TIRF	HOMOLOGY-2 DOMAIN; MOUSE OOCYTES; SPIRE; NUCLEATORS; MDIA1; COORDINATION; ASSOCIATION; ALIGNMENT; FILAMENTS; PROFILIN	Background: Cappuccino is a formin actin nucleator that regulates cytoskeletal organization during Drosophila oogenesis. Results: Cappuccino binds microtubules through two domains and cannot nucleate actin filaments when bound to microtubules. Conclusion: Actin filament assembly and microtubule binding are mutually exclusive activities of Cappuccino. Significance: We provide mechanistic insight into the role of formins as coordinators of the actin and microtubule cytoskeletons. Formin family actin nucleators are potential coordinators of the actin and microtubule cytoskeletons, as they can both nucleate actin filaments and bind microtubules in vitro. To gain a more detailed mechanistic understanding of formin-microtubule interactions and formin-mediated actin-microtubule cross-talk, we studied microtubule binding by Cappuccino (Capu), a formin involved in regulating actin and microtubule organization during Drosophila oogenesis. We found that two distinct domains within Capu, FH2 and tail, work together to promote high-affinity microtubule binding. The tail domain appears to bind microtubules through nonspecific charge-based interactions. In contrast, distinct residues within the FH2 domain are important for microtubule binding. We also report the first visualization of a formin polymerizing actin filaments in the presence of microtubules. Interestingly, microtubules are potent inhibitors of the actin nucleation activity of Capu but appear to have little effect on Capu once it is bound to the barbed end of an elongating filament. Because Capu does not simultaneously bind microtubules and assemble actin filaments in vitro, its actin assembly and microtubule binding activities likely require spatial and/or temporal regulation within the Drosophila oocyte.	[Roth-Johnson, Elizabeth A.] Univ Calif Los Angeles, Mol Biol Interdept PhD Program, Los Angeles, CA 90095 USA; [Vizcarra, Christina L.; Bois, Justin S.; Quinlan, Margot E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Quinlan, Margot E.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Quinlan, ME (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles E Young Dr East, Los Angeles, CA 90095 USA.	margot@chem.ucla.edu		Bois, Justin/0000-0001-7137-8746	National Institutes of Health Ruth L. Kirschstein National Research Service Award [GM007185]; National Institutes of Health-National Research Service Award Fellowship [F32GM087857]; National Institutes of Health, NIGMS [R01 GM096133]; Burroughs Welcome Fund Career Award in the Biomedical Sciences; March of Dimes Foundation [5-FY10-81]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, F32GM087857, R01GM096133] Funding Source: NIH RePORTER	National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health-National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Burroughs Welcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Ruth L. Kirschstein National Research Service Award GM007185 (to E. A. R.-J.), National Institutes of Health-National Research Service Award Fellowship F32GM087857 (to C. L. V.), National Institutes of Health, NIGMS Grant R01 GM096133, a Burroughs Welcome Fund Career Award in the Biomedical Sciences, and March of Dimes Foundation Grant 5-FY10-81 (to M. E. Q.).	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Bor B, 2012, MOL BIOL CELL, V23, P3801, DOI 10.1091/mbc.E12-04-0288; Cheng LN, 2011, DEV CELL, V20, P342, DOI 10.1016/j.devcel.2011.01.008; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Dehmelt L, 2005, GENOME BIOL, V6; Dettenhofer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002497; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Gasteier JE, 2005, EXP CELL RES, V306, P192, DOI 10.1016/j.yexcr.2005.02.006; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewkowicz E, 2008, J CELL BIOL, V183, P1287, DOI 10.1083/jcb.200807023; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Luschnig S, 2004, GENETICS, V167, P325, DOI 10.1534/genetics.167.1.325; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Parton RM, 2011, J CELL BIOL, V194, P121, DOI 10.1083/jcb.201103160; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2013, DEVELOPMENT, V140, P4417, DOI 10.1242/dev.097337; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; SINGLETON K, 1994, DEV BIOL, V161, P154, DOI 10.1006/dbio.1994.1017; Tanaka T, 2011, DEVELOPMENT, V138, P2523, DOI 10.1242/dev.062208; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Wen YD, 2004, KENYON REV, V26, P1; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zhou F, 2006, EXP CELL RES, V312, P1119, DOI 10.1016/j.yexcr.2005.12.035; Zhou F, 2009, HUM MOL GENET, V18, P2472, DOI 10.1093/hmg/ddp185	43	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4395	4404		10.1074/jbc.M113.499921	http://dx.doi.org/10.1074/jbc.M113.499921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362037	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000331403800050
J	Ahn, BJ; Le, H; Shin, MW; Bae, SJ; Lee, EJ; Wee, HJ; Cha, JH; Lee, HJ; Lee, HS; Kim, JH; Kim, CY; Seo, JH; Lo, EH; Jeon, S; Lee, MN; Oh, GT; Yin, GN; Ryu, JK; Suh, JK; Kim, KW				Ahn, Bum Ju; Le, Hoang; Shin, Min Wook; Bae, Sung-Jin; Lee, Eun Ji; Wee, Hee-Jun; Cha, Jong-Ho; Lee, Hyo-Jong; Lee, Hye Shin; Kim, Jeong Hun; Kim, Chang-Yeon; Seo, Ji Hae; Lo, Eng H.; Jeon, Sejin; Lee, Mi-Ni; Oh, Goo Taeg; Yin, Guo Nan; Ryu, Ji-Kan; Suh, Jun-Kyu; Kim, Kyu-Won			Ninjurin1 Deficiency Attenuates Susceptibility of Experimental Autoimmune Encephalomyelitis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmune Diseases; Autoimmunity; Inflammation; Leukocyte; Multiple Sclerosis; EAE; Ninjurin1; Leukocyte Trafficking; Transendothelial Migration	CENTRAL-NERVOUS-SYSTEM; TRANSENDOTHELIAL MIGRATION; LEUKOCYTE ADHESION; MYELOID CELLS; RESPONSES; DISEASE; TRANSMIGRATION; INFLAMMATION; DIAPEDESIS; CHEMOKINES	Background: Effect of Ninjurin1 deletion in the experimental autoimmune encephalomyelitis (EAE) mice has not been examined. Results: Ninjurin1 knock-out (KO) mice are resistance to EAE due to a defect of leukocyte recruitment into lesion sites. Conclusion: Ninjurin1 is a potent target molecule for treating inflammatory diseases such as multiple sclerosis. Significance: Our study proved contribution of Ninjurin1 in EAE pathogenesis in vivo and supports the importance of its targeting strategies. Ninjurin1 is a homotypic adhesion molecule that contributes to leukocyte trafficking in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. However, in vivo gene deficiency animal studies have not yet been done. Here, we constructed Ninjurin1 knock-out (KO) mice and investigated the role of Ninjurin1 on leukocyte trafficking under inflammation conditions such as EAE and endotoxin-induced uveitis. Ninjurin1 KO mice attenuated EAE susceptibility by reducing leukocyte recruitment into the injury regions of the spinal cord and showed less adhesion of leukocytes on inflamed retinal vessels in endotoxin-induced uveitis mice. Moreover, the administration of a custom-made antibody (Ab(26-37)) targeting the Ninjurin1 binding domain ameliorated the EAE symptoms, showing the contribution of its adhesion activity to leukocyte trafficking. In addition, we addressed the transendothelial migration (TEM) activity of bone marrow-derived macrophages and Raw264.7 cells according to the expression level of Ninjurin1. TEM activity was decreased in Ninjurin1 KO bone marrow-derived macrophages and siNinj1 Raw264.7 cells. Consistent with this, GFP-tagged mNinj1-overexpressing Raw264.7 cells increased their TEM activity. Taken together, we have clarified the contribution of Ninjurin1 to leukocyte trafficking in vivo and delineated its direct functions to TEM, emphasizing Ninjurin1 as a beneficial therapeutic target against inflammatory diseases such as multiple sclerosis.	[Ahn, Bum Ju; Le, Hoang; Shin, Min Wook; Bae, Sung-Jin; Lee, Eun Ji; Wee, Hee-Jun; Cha, Jong-Ho; Seo, Ji Hae; Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, SNU Harvard NeuroVasc Protect Res Ctr, Seoul 151742, South Korea; [Ahn, Bum Ju; Le, Hoang; Shin, Min Wook; Bae, Sung-Jin; Lee, Eun Ji; Wee, Hee-Jun; Cha, Jong-Ho; Seo, Ji Hae; Kim, Kyu-Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea; [Lee, Hyo-Jong] Inje Univ, Coll Pharm, Gimhae 621749, South Korea; [Lee, Hye Shin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Kim, Jeong Hun] Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness Lab, Seoul 110744, South Korea; [Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul 110744, South Korea; [Kim, Chang-Yeon] Yale Univ, Sch Med, New Haven, CT 06510 USA; [Seo, Ji Hae; Lo, Eng H.] Massachusettes Gen Hosp, Neuroprotect Res Lab, Dept Radiol, Boston, MA 02114 USA; [Seo, Ji Hae; Lo, Eng H.] Massachusettes Gen Hosp, Neuroprotect Res Lab, Dept Neurol, Boston, MA 02114 USA; [Seo, Ji Hae; Lo, Eng H.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Jeon, Sejin; Lee, Mi-Ni; Oh, Goo Taeg] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Jeon, Sejin; Lee, Mi-Ni; Oh, Goo Taeg] Ewha Womans Univ, Program GT5, Seoul 120750, South Korea; [Yin, Guo Nan; Ryu, Ji-Kan; Suh, Jun-Kyu] Inha Univ, Sch Med, Natl Res Ctr Sexual Med, Inchon 402751, South Korea; [Yin, Guo Nan; Ryu, Ji-Kan; Suh, Jun-Kyu] Inha Univ, Sch Med, Dept Urol, Inchon 402751, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Inje University; University of Texas System; UTMD Anderson Cancer Center; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Ewha Womans University; Ewha Womans University; Inha University; Inha University	Kim, KW (corresponding author), Seoul Natl Univ, Coll Pharm, SNU Harvard NeuroVasc Protect Res Ctr, Seoul 151742, South Korea.	qwonkim@snu.ac.kr	shin, minwook/HGA-4297-2022; Kim, Kyu Won/AAJ-7213-2020; Jeon, Sejin/GWU-7864-2022; Oh, Goo Taeg/AAQ-9995-2021; Jeon, Sejin/GRJ-6826-2022; Bae, Sung-Jin/AAX-9144-2021	Kim, Jeong Hun/0000-0003-2957-1766; Bae, Sung-Jin/0000-0001-8975-0876; Lee, Hyo-Jong/0000-0003-4826-7954; Le, Hoang/0000-0001-8427-3230; yin, guonan/0000-0002-2512-7337	National Research Foundation of Korea; Ministry of Education, Science, and Technology through the Global Research Laboratory Program [2011-0021874]; Brain Korea 21 Program [2013-036038]; Global Core Research Center Program [2012-0001187]; National Institutes of Health [R37-NS37074, R01-76694, P01-NS55104]; Korea government (Ministry of Education, Science, and Technology) [2013003407]; Ministry for Health, Welfare, and Family Affairs [A110076]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037074, P01NS055104] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology through the Global Research Laboratory Program; Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Global Core Research Center Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea government (Ministry of Education, Science, and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry for Health, Welfare, and Family Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from a National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology through the Global Research Laboratory Program (2011-0021874), Brain Korea 21 Program (2013-036038), and the Global Core Research Center Program (2012-0001187). This work was also supported by National Institutes of Health Grants R37-NS37074, R01-76694, and P01-NS55104.; Supported by the National Research Foundation of Korea grant funded by the Korea government (Ministry of Education, Science, and Technology) 2013003407.; Supported by Korea Healthcare technology R&D Project, Ministry for Health, Welfare, and Family Affairs Grant A110076.	Ahn BJ, 2012, BIOCHEM BIOPH RES CO, V428, P438, DOI 10.1016/j.bbrc.2012.10.099; Ahn BJ, 2009, BIOCHEM BIOPH RES CO, V387, P321, DOI 10.1016/j.bbrc.2009.07.019; Araki T, 1997, J BIOL CHEM, V272, P21373, DOI 10.1074/jbc.272.34.21373; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Cho SJ, 2013, P NATL ACAD SCI USA, V110, P9362, DOI 10.1073/pnas.1221242110; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Ifergan I, 2011, ANN NEUROL, V70, P751, DOI 10.1002/ana.22519; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Ishida S, 2003, NAT MED, V9, P781, DOI 10.1038/nm877; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Lee HJ, 2009, CELL DEATH DIFFER, V16, P1395, DOI 10.1038/cdd.2009.78; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lo EH, 2010, NAT MED, V16, P1205, DOI 10.1038/nm.2226; Lo EH, 2009, NAT MED, V15, P844, DOI 10.1038/nm0809-844; Lopez-Diego RS, 2008, NAT REV DRUG DISCOV, V7, P909, DOI 10.1038/nrd2358; Mamdouh Z, 2008, J EXP MED, V205, P951, DOI 10.1084/jem.20072328; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; O'Brien CD, 2003, BLOOD, V101, P2816, DOI 10.1182/blood-2002-08-2396; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Ousman SS, 2012, NAT NEUROSCI, V15, P1096, DOI 10.1038/nn.3161; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0	36	32	33	4	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3328	3338		10.1074/jbc.M113.498212	http://dx.doi.org/10.1074/jbc.M113.498212			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24347169	hybrid, Green Published			2022-12-28	WOS:000331368700020
J	Butera, D; Wind, T; Lay, AJ; Beck, J; Castellino, FJ; Hogg, PJ				Butera, Diego; Wind, Troels; Lay, Angelina J.; Beck, Julia; Castellino, Francis J.; Hogg, Philip J.			Characterization of a Reduced Form of Plasma Plasminogen as the Precursor for Angiostatin Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Angiogenesis; Disulfide; Plasmin; Plasminogen	ALLOSTERIC DISULFIDE BONDS; GROWTH-FACTOR-D; PHOSPHOGLYCERATE KINASE; ANTIPHOSPHOLIPID SYNDROME; CYTOKINE RECEPTOR; BETA(2)-GLYCOPROTEIN I; CHEMICAL CLEAVAGE; CRYSTAL-STRUCTURE; PROTEIN FUNCTION; PROSTATE-CANCER	Background: The angiogenesis inhibitor, angiostatin, is an internal fragment of the blood zymogen, plasminogen. Results: A fraction of plasminogen contains a reduced Cys(462)-Cys-(541) disulfide bond. Conclusion: Reduced plasminogen is the precursor for angiostatin. Significance: The plasminogen disulfide bonds reduced during angiostatin formation are examples of allosteric disulfides, and their structures help define new allosteric disulfide bond configurations. Plasma plasminogen is the precursor of the tumor angiogenesis inhibitor, angiostatin. Generation of angiostatin in blood involves activation of plasminogen to the serine protease plasmin and facilitated cleavage of two disulfide bonds and up to three peptide bonds in the kringle 5 domain of the protein. The mechanism of reduction of the two allosteric disulfides has been explored in this study. Using thiol-alkylating agents, mass spectrometry, and an assay for angiostatin formation, we show that the Cys(462)-Cys(541) disulfide bond is already cleaved in a fraction of plasma plasminogen and that this reduced plasminogen is the precursor for angiostatin formation. From the crystal structure of plasminogen, we propose that plasmin ligands such as phosphoglycerate kinase induce a conformational change in reduced kringle 5 that leads to attack by the Cys(541) thiolate anion on the Cys(536) sulfur atom of the Cys(512)-Cys(536) disulfide bond, resulting in reduction of the bond by thiol/disulfide exchange. Cleavage of the Cys(512)-Cys(536) allosteric disulfide allows further conformational change and exposure of the peptide backbone to proteolysis and angiostatin release. The Cys(462)-Cys(541) and Cys(512)-Cys(536) disulfides have -/+RHHook and -LHHook configurations, respectively, which are two of the 20 different measures of the geometry of a disulfide bond. Analysis of the structures of the known allosteric disulfide bonds identified six other bonds that have these configurations, and they share some functional similarities with the plasminogen disulfides. This suggests that the -/+RHHook and -LHHook disulfides, along with the -RHStaple bond, are potential allosteric configurations.	[Butera, Diego; Wind, Troels; Lay, Angelina J.; Hogg, Philip J.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Butera, Diego; Wind, Troels; Lay, Angelina J.; Hogg, Philip J.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia; [Beck, Julia; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Beck, Julia; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of New South Wales Sydney; University of New South Wales Sydney; University of Notre Dame; University of Notre Dame	Hogg, PJ (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Level 2, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au		Hogg, Philip/0000-0001-6486-2863	National Health and Medical Research Council; Cancer Council New South Wales	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales(Cancer Council New South Wales)	This work was supported by grants from the National Health and Medical Research Council and the Cancer Council New South Wales.	CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Chiu J., 2013, BIOCHEMISTRY, DOI 10.1021/bi401518b; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; Crowley SD, 2012, EXP CELL RES, V318, P1049, DOI 10.1016/j.yexcr.2012.02.023; Cuneo MJ, 2010, P NATL ACAD SCI USA, V107, P6805, DOI 10.1073/pnas.0914077107; Daly EB, 2004, BBA-MOL CELL RES, V1691, P17, DOI 10.1016/j.bbamcr.2003.11.004; Davydova N, 2012, PROTEIN EXPRES PURIF, V82, P232, DOI 10.1016/j.pep.2012.01.001; Ganderton T, 2011, BLOOD, V118, P5312, DOI 10.1182/blood-2011-06-360297; Giannakopoulos B, 2013, NEW ENGL J MED, V368, P1033, DOI 10.1056/NEJMra1112830; Giannakopoulos B, 2012, J AUTOIMMUN, V39, P121, DOI 10.1016/j.jaut.2012.05.005; Hansen RE, 2005, BIOCHEMISTRY-US, V44, P5899, DOI 10.1021/bi0500372; Hogg PJ, 2013, NAT REV CANCER, V13, P425, DOI 10.1038/nrc3519; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Ioannou Y, 2011, ARTHRITIS RHEUM-US, V63, P2774, DOI 10.1002/art.30383; Ioannou Y, 2010, BLOOD, V116, P1961, DOI 10.1182/blood-2009-04-215335; JACOBSON GR, 1973, J BIOL CHEM, V248, P6583; Kassam G, 2001, J BIOL CHEM, V276, P8924, DOI 10.1074/jbc.M009071200; Kwon M, 2002, J BIOL CHEM, V277, P10903, DOI 10.1074/jbc.M111219200; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lay AJ, 2000, NATURE, V408, P869, DOI 10.1038/35048596; Lay AJ, 2002, METHOD ENZYMOL, V348, P87, DOI 10.1016/S0076-6879(02)48629-6; Lay AJ, 2002, J BIOL CHEM, V277, P9062, DOI 10.1074/jbc.M111531200; Leppanen VM, 2011, BLOOD, V117, P1507, DOI 10.1182/blood-2010-08-301549; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Lijnen HR, 2001, ANN NY ACAD SCI, V936, P226; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Metcalfe C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110036; Mulligan-Kehoe MJ, 2001, J BIOL CHEM, V276, P8588, DOI 10.1074/jbc.M006434200; Nakamura H, 2005, ANTIOXID REDOX SIGN, V7, P823, DOI 10.1089/ars.2005.7.823; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Passam FH, 2010, J THROMB HAEMOST, V8, P1754, DOI 10.1111/j.1538-7836.2010.03944.x; Passam FH, 2010, BLOOD, V116, P1995, DOI 10.1182/blood-2010-02-271494; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; Stathakis P, 1997, J BIOL CHEM, V272, P20641, DOI 10.1074/jbc.272.33.20641; Stathakis P, 1999, J BIOL CHEM, V274, P8910, DOI 10.1074/jbc.274.13.8910; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Toivanen PI, 2009, J BIOL CHEM, V284, P16037, DOI 10.1074/jbc.M109.001123; Torchinski Y. M., 1974, THIOL DISULFIDE GROU, P24; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang H, 2004, CANCER RES, V64, P162, DOI 10.1158/0008-5472.CAN-03-1862; Wang JH, 2007, CANCER RES, V67, P149, DOI 10.1158/0008-5472.CAN-06-2971; Wang JH, 2010, CANCER RES, V70, P471, DOI 10.1158/0008-5472.CAN-09-2863; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]; WU HL, 1987, P NATL ACAD SCI USA, V84, P8292, DOI 10.1073/pnas.84.23.8292; WU HL, 1987, P NATL ACAD SCI USA, V84, P8793, DOI 10.1073/pnas.84.24.8793; Wu J, 1996, ANAL BIOCHEM, V235, P161, DOI 10.1006/abio.1996.0108; Yamada Y, 2003, IMMUNOL LETT, V86, P199, DOI 10.1016/S0165-2478(03)00006-3; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505; Zieker D, 2010, INT J CANCER, V126, P1513, DOI 10.1002/ijc.24835	57	16	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2992	3000		10.1074/jbc.M113.539924	http://dx.doi.org/10.1074/jbc.M113.539924			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338014	hybrid, Green Published			2022-12-28	WOS:000333403000046
J	Concha-Marambio, L; Diaz-Espinoza, R; Soto, C				Concha-Marambio, Luis; Diaz-Espinoza, Rodrigo; Soto, Claudio			The Extent of Protease Resistance of Misfolded Prion Protein Is Highly Dependent on the Salt Concentration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Neurodegenerative Diseases; Prions; Protein Degradation; Protein Misfolding; Protease Resistance; Transmissible Spongiform Encephalopathies	CYCLIC AMPLIFICATION; INFECTIOUS PRIONS; SCRAPIE PRIONS; IN-VITRO; REPLICATION; CONVERSION; TRANSMISSION; PROPAGATION; STRAINS; FORM	Background: A hallmark property of infectious prion protein (PrPSc) is its resistance to proteases. Results: We show that the extent of PrPSc proteolytic resistance can be reversibly altered by changing salt concentration. Conclusion: Thus, protease resistance is not an intrinsic property of the infectious agent, but it depends upon the environmental conditions. Significance: These findings have practical and conceptual implications for understanding the mechanism of prion formation and clearance. Transmissible spongiform encephalopathies are neurodegenerative diseases caused by prions in mammals. An aberrantly folded protein (PrPSc) is the main component of these proteinaceous infectious particles. Prions exhibit strong resistance to protease digestion, which is typically exploited for biochemical discrimination from its native cellular form (PrPC). This classical feature has been partially challenged by the isolation of sizeable amounts of protease-sensitive PrPSc isoforms that self-propagate in vivo. Here, we report that the degree of PrPSc protease resistance is highly dependent on the concentration of salt in the solution. Similar changes were observed in PrPSc obtained from different strains and species. Strikingly, the effect of salt is reversible and is associated with changes on the size of PrPSc particles, but surprisingly, the more protease-sensitive species consists of a larger size. These findings shed light on the mechanistic aspects of prion proteolysis and should be considered when assessing samples of biomedical relevance.	[Concha-Marambio, Luis; Diaz-Espinoza, Rodrigo; Soto, Claudio] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA; [Concha-Marambio, Luis] Univ Los Andes, Fac Med, Santiago 7620001, Chile	University of Texas System; University of Texas Health Science Center Houston; Universidad de los Andes - Chile	Soto, C (corresponding author), 6431 Fannin St,MSE R462, Houston, TX 77030 USA.	claudio.soto@uth.tmc.edu	Concha-Marambio, Luis/V-3247-2019; Diaz-Espinoza, Rodrigo/HDM-8819-2022	Concha-Marambio, Luis/0000-0002-9454-8389; 	National Institutes of Health [R01NS049173, P01AI077774]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS049173 and P01AI077774 (to C. S.).	BAJORATH J, 1988, EUR J BIOCHEM, V176, P441, DOI 10.1111/j.1432-1033.1988.tb14301.x; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Diaz-Espinoza R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031678; Diaz-Espinoza R, 2012, NAT STRUCT MOL BIOL, V19, P370, DOI 10.1038/nsmb.2266; Diaz-Espinoza R, 2010, PRION, V4, P1, DOI 10.4161/pri.4.2.11960; Gonzalez-Montalban N, 2013, FASEB J, V27, P3702, DOI 10.1096/fj.13-230466; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; Kocisko DA, 1996, BIOCHEMISTRY-US, V35, P13434, DOI 10.1021/bi9610562; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Nishina K, 2004, J BIOL CHEM, V279, P40788, DOI 10.1074/jbc.M406548200; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Prior F, 2004, J HOSP INFECT, V58, P78, DOI 10.1016/j.jhin.2004.04.020; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; PRUSINER SB, 1987, ACTA NEUROPATHOL, V72, P299, DOI 10.1007/BF00687261; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saa P, 2012, J VIROL, V86, P10494, DOI 10.1128/JVI.01286-12; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220; Sajnani G, 2012, PRION, V6, DOI 10.4161/pri.22309; Sajnani G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002547; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Soto C, 2001, TRENDS MOL MED, V7, P109, DOI 10.1016/S1471-4914(01)01931-1; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Zomosa-Signoret V, 2008, VET RES, V39, DOI 10.1051/vetres:2007048	34	6	6	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					3073	3079		10.1074/jbc.M113.513267	http://dx.doi.org/10.1074/jbc.M113.513267			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338008	Green Published, hybrid			2022-12-28	WOS:000333403000053
J	D'Lima, NG; Teschke, CM				D'Lima, Nadia G.; Teschke, Carolyn M.			ADP-dependent Conformational Changes Distinguish Mycobacterium tuberculosis SecA2 from SecA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; FRET; Protein Export; Secretion; Tuberculosis	ATP-BINDING-SITE; NUCLEOTIDE EXCHANGE; TRANSLOCATION; SECRETION; PROTEINS; COMPLEX; SYSTEM; EXPORT; CYCLE	In bacteria, most secreted proteins are exported through the SecYEG translocon by the SecA ATPase motor via the general secretion or Sec pathway. The identification of an additional SecA protein, particularly in Gram-positive pathogens, has raised important questions about the role of SecA2 in both protein export and establishment of virulence. We previously showed in Mycobacterium tuberculosis, the causative agent of tuberculosis, the accessory SecA2 protein possesses ATPase activity that is required for bacterial survival in host macrophages, highlighting its importance in virulence. Here, we show that SecA2 binds ADP with much higher affinity than SecA1 and releases the nucleotide more slowly. Nucleotide binding also regulates movement of the precursor-binding domain in SecA2, unlike in SecA1 or conventional SecA proteins. This conformational change involving closure of the clamp in SecA2 may provide a mechanism for the cell to direct protein export through the conventional SecA1 pathway under normal growth conditions while preventing ordinary precursor proteins from interacting with the specialized SecA2 ATPase.	[D'Lima, Nadia G.; Teschke, Carolyn M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Teschke, Carolyn M.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Teschke, CM (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	teschke@uconn.edu			University of Connecticut Research Foundation Large Faculty grant program	University of Connecticut Research Foundation Large Faculty grant program	This work was supported by University of Connecticut Research Foundation Large Faculty grant program.	Bates PA, 2001, PROTEINS, P39; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001; Burkholder KM, 2009, MICROBES INFECT, V11, P859, DOI 10.1016/j.micinf.2009.05.006; Caspers M, 2008, ARCH MICROBIOL, V189, P605, DOI 10.1007/s00203-008-0351-0; de Keyzer J, 2002, J BIOL CHEM, V277, P46059, DOI 10.1074/jbc.M208449200; Doyle SM, 2000, BIOCHEMISTRY-US, V39, P11667, DOI 10.1021/bi000299y; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Fak JJ, 2004, BIOCHEMISTRY-US, V43, P7307, DOI 10.1021/BI0357208; Feltcher ME, 2010, FUTURE MICROBIOL, V5, P1581, DOI [10.2217/fmb.10.112, 10.2217/FMB.10.112]; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Gold VAM, 2013, BIOCHEM J, V449, P695, DOI 10.1042/BJ20121314; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hinchey J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015857; Hou JM, 2008, J BACTERIOL, V190, P4880, DOI 10.1128/JB.00412-08; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Kusters I, 2011, CELL MOL LIFE SCI, V68, P2053, DOI 10.1007/s00018-011-0681-y; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Lingappa V R, 1980, Recent Prog Horm Res, V36, P451; Natale P, 2004, J BIOL CHEM, V279, P13769, DOI 10.1074/jbc.M312892200; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Owens MU, 2002, FEMS MICROBIOL LETT, V211, P133, DOI 10.1016/S0378-1097(02)00708-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Randall LL, 2005, J MOL BIOL, V348, P479, DOI 10.1016/j.jmb.2005.02.036; RANDALL LL, 1995, TRENDS BIOCHEM SCI, V20, P65, DOI 10.1016/S0968-0004(00)88959-8; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Rigel NW, 2009, J BIOL CHEM, V284, P9927, DOI 10.1074/jbc.M900325200; Robson A, 2007, J MOL BIOL, V374, P965, DOI 10.1016/j.jmb.2007.09.086; Robson A, 2009, P NATL ACAD SCI USA, V106, P5111, DOI 10.1073/pnas.0809592106; Sardis MF, 2010, MOL MICROBIOL, V76, P1070, DOI 10.1111/j.1365-2958.2010.07176.x; Scopes R. K., 1993, PROTEIN PURIFICATION, P210; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; Sullivan JT, 2012, INFECT IMMUN, V80, P996, DOI 10.1128/IAI.05987-11; Tomkiewicz D, 2006, J BIOL CHEM, V281, P15709, DOI 10.1074/jbc.M600205200; Vrontou E, 2004, BBA-MOL CELL RES, V1694, P67, DOI 10.1016/j.bbamcr.2004.06.003; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Wowor AJ, 2011, J MOL BIOL, V408, P87, DOI 10.1016/j.jmb.2011.02.006; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmer J, 2009, J MOL BIOL, V394, P606, DOI 10.1016/j.jmb.2009.10.024	43	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2307	2317		10.1074/jbc.M113.533323	http://dx.doi.org/10.1074/jbc.M113.533323			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24297168	Green Published, hybrid			2022-12-28	WOS:000331130200035
J	Tanno, H; Shigematsu, T; Nishikawa, S; Hayakawa, A; Denda, K; Tanaka, T; Komada, M				Tanno, Hidetaka; Shigematsu, Takeshi; Nishikawa, Shuhei; Hayakawa, Akira; Denda, Kimitoshi; Tanaka, Toshiaki; Komada, Masayuki			Ubiquitin-interacting Motifs Confer Full Catalytic Activity, but Not Ubiquitin Chain Substrate Specificity, to Deubiquitinating Enzyme USP37	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Deubiquitination; Protease; Protein Degradation; Ubiquitin; Ubiquitination	POLYUBIQUITIN; PROTEIN; RECOGNITION; FAMILY	Ubiquitin-specific proteases (USPs) consist of a family of deubiquitinating enzymes with more than 50 members in humans. Three of them, including USP37, contain ubiquitin-interacting motifs (UIMs), an approximate to 20-amino acid -helical stretch that binds to ubiquitin. However, the roles of the UIMs in these USP enzymes remain unknown. USP37 has three UIMs, designated here as UIMs 1, 2, and 3 from the N-terminal side, between the Cys and His boxes comprising the catalytic core. Here, we examined the role of the UIMs in USP37 using its mutants that harbor mutations in the UIMs. The nuclear localization of USP37 was not affected by the UIM mutations. However, mutations in UIM2 or UIM3, but not UIM1, resulted in a significant decrease in USP37 binding to ubiquitinated proteins in the cell. In vitro, a region of USP37 harboring the three UIMs also bound to both Lys(48)-linked and Lys(63)-linked ubiquitin chains in a UIM2- and UIM3-dependent manner. The level of USP37 ubiquitination was also reduced by mutations in UIM2 or UIM3, suggesting their role in ubiquitination of USP37 itself. Finally, mutants lacking functional UIM2 or UIM3 exhibited a reduced isopeptidase activity toward ubiquitinated proteins in the cell and both Lys(48)-linked and Lys(63)-linked ubiquitin chains. These results suggested that the UIMs in USP37 contribute to the full enzymatic activity, but not ubiquitin chain substrate specificity, of USP37 possibly by holding the ubiquitin chain substrate in the proximity of the catalytic core.	[Tanno, Hidetaka; Shigematsu, Takeshi; Nishikawa, Shuhei; Hayakawa, Akira; Denda, Kimitoshi; Tanaka, Toshiaki; Komada, Masayuki] Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Komada, M (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259-B16 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	makomada@bio.titech.ac.jp	Tanaka, Toshiaki/C-5567-2013	Tanaka, Toshiaki/0000-0002-9448-1452; Tanno, Hidetaka/0000-0001-6749-0938	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22370068, 24112003]; Grants-in-Aid for Scientific Research [26440048] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 22370068 and 24112003 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. K.).	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Burrows AC, 2012, J BIOL CHEM, V287, P39021, DOI 10.1074/jbc.M112.390328; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Das CM, 2013, ONCOGENE, V32, P1691, DOI 10.1038/onc.2012.182; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Eletr ZM, 2014, BBA-MOL CELL RES, V1843, P114, DOI 10.1016/j.bbamcr.2013.06.027; Fujimuro M, 2005, METHOD ENZYMOL, V399, P75, DOI 10.1016/S0076-6879(05)99006-X; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Song AX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013202; Tanno H, 2012, MOL BIOL CELL, V23, P1343, DOI 10.1091/mbc.E11-09-0817; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Yang WC, 2013, ONCOGENE, V32, P5167, DOI 10.1038/onc.2012.537	28	21	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2415	2423		10.1074/jbc.M113.528372	http://dx.doi.org/10.1074/jbc.M113.528372			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324262	Green Published, hybrid			2022-12-28	WOS:000331130200045
J	Dockal, M; Hartmann, R; Fries, M; Thomassen, MCLGD; Heinzmann, A; Ehrlich, H; Rosing, J; Osterkamp, F; Polakowski, T; Reineke, U; Griessner, A; Brandstetter, H; Scheiflinger, F				Dockal, Michael; Hartmann, Rudolf; Fries, Markus; Thomassen, M. Christella L. G. D.; Heinzmann, Alexandra; Ehrlich, Hartmut; Rosing, Jan; Osterkamp, Frank; Polakowski, Thomas; Reineke, Ulrich; Griessner, Andreas; Brandstetter, Hans; Scheiflinger, Friedrich			Small Peptides Blocking Inhibition of Factor Xa and Tissue Factor-Factor VIIa by Tissue Factor Pathway Inhibitor (TFPI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Coagulation Factors; Crystal Structure; Enzyme Inhibitors; Hemostasis; Peptide Interactions; Peptides; Protein Domains	PROTEIN-S; COAGULATION INHIBITOR; MACROMOLECULAR STRUCTURES; THROMBIN GENERATION; KUNITZ DOMAIN; HEMOPHILIA-A; PLASMA; MAINTENANCE; REFINEMENT; DISORDERS	Background: Tissue factor pathway inhibitor (TFPI) inhibits coagulation factors Xa and VIIa. Results: A de novo synthesized 20-mer peptide that binds to TFPI was structurally and functionally characterized. Conclusion: The peptide binds to the Kunitz domain 1 of TFPI and blocks inhibition of factor Xa and factor VIIa by TFPI. Significance: The peptide can potentially prevent bleeding in hemophilia patients. Tissue factor pathway inhibitor (TFPI) is a Kunitz-type protease inhibitor that inhibits activated factor X (FXa) via a slow-tight binding mechanism and tissue factor-activated FVII (TF-FVIIa) via formation of a quaternary FXa-TFPI-TF-FVIIa complex. Inhibition of TFPI enhances coagulation in hemophilia models. Using a library approach, we selected and subsequently optimized peptides that bind TFPI and block its anticoagulant activity. One peptide (termed compound 3), bound with high affinity to the Kunitz-1 (K1) domain of TFPI (K-d approximate to 1 nm). We solved the crystal structure of this peptide in complex with the K1 of TFPI at 2.55- resolution. The structure of compound 3 can be segmented into a N-terminal anchor; an -shaped loop; an intermediate segment; a tight glycine-loop; and a C-terminal -helix that is anchored to K1 at its reactive center loop and two-stranded -sheet. The contact surface has an overall hydrophobic character with some charged hot spots. In a model system, compound 3 blocked FXa inhibition by TFPI (EC50 = 11 nm) and inhibition of TF-FVIIa-catalyzed FX activation by TFPI (EC50 = 2 nm). The peptide prevented transition from the loose to the tight FXa-TFPI complex, but did not affect formation of the loose FXa-TFPI complex. The K1 domain of TFPI binds and inhibits FVIIa and the K2 domain similarly inhibits FXa. Because compound 3 binds to K1, our data show that K1 is not only important for FVIIa inhibition but also for FXa inhibition, i.e. for the transition of the loose to the tight FXa-TFPI complex. This mode of action translates into normalization of coagulation of hemophilia plasmas. Compound 3 thus bears potential to prevent bleeding in hemophilia patients.	[Dockal, Michael; Hartmann, Rudolf; Fries, Markus; Ehrlich, Hartmut; Scheiflinger, Friedrich] Baxter Innovat GmbH, A-2304 Orth, Austria; [Thomassen, M. Christella L. G. D.; Heinzmann, Alexandra; Rosing, Jan] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6229 ER Maastricht, Netherlands; [Osterkamp, Frank; Polakowski, Thomas; Reineke, Ulrich] 3B Pharmaceut GmbH, D-12489 Berlin, Germany; [Griessner, Andreas; Brandstetter, Hans] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Baxter International Inc; Baxter Innovations GmbH; Maastricht University; Salzburg University	Dockal, M (corresponding author), Baxter Innovat GmbH, Uferstr 15, A-2304 Orth, Austria.	Michael_dockal@baxter.com	Scheiflinger, Friedrich/AAO-6307-2020; Brandstetter, Hans/E-6754-2011	Brandstetter, Hans/0000-0002-6089-3045; Thomassen, Stella/0000-0002-9686-6364				Andrejasic M, 2008, ACTA CRYSTALLOGR D, V64, P1093, DOI 10.1107/S0907444908027388; Ariens RAS, 1999, THROMB HAEMOSTASIS, V81, P203; BROZE GJ, 1988, BLOOD, V71, P335; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burgering MJM, 1997, J MOL BIOL, V269, P395, DOI 10.1006/jmbi.1997.1029; Chan WC, 2000, FMOC SOLID PHASE PEP; Dahm A, 2003, BLOOD, V101, P4387, DOI 10.1182/blood-2002-10-3188; Duckers C, 2008, BLOOD, V112, P3615, DOI 10.1182/blood-2008-06-162453; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERHARDTSEN E, 1995, BLOOD COAGUL FIBRIN, V6, P388, DOI 10.1097/00001721-199507000-00004; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GIRARD TJ, 1993, METHOD ENZYMOL, V222, P195; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; Hedner U, 2008, ANNU REV MED, V59, P29, DOI 10.1146/annurev.med.59.061606.095605; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HIGUCHI DA, 1992, BLOOD, V79, P1712; Hilden I, 2012, BLOOD, V119, P5871, DOI 10.1182/blood-2012-01-401620; HUANG ZF, 1993, J BIOL CHEM, V268, P26950; JESTY J, 1973, BIOCHEM J, V131, P791, DOI 10.1042/bj1310791; Knappe S, 2013, THROMB HAEMOSTASIS, V109, P450, DOI 10.1160/TH12-07-0529; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LINDHOUT T, 1994, BIOCHEM J, V297, P131, DOI 10.1042/bj2970131; Liu TY, 2006, THROMB HAEMOSTASIS, V95, P68, DOI 10.1160/TH05-05-0361; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mine S, 2002, BIOCHEMISTRY-US, V41, P78, DOI 10.1021/bi011299g; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ndonwi M, 2008, J THROMB HAEMOST, V6, P1044, DOI 10.1111/j.1538-7836.2008.02980.x; Ndonwi M, 2010, BLOOD, V116, P1344, DOI 10.1182/blood-2009-10-246686; Palige M, 2010, BLOOD, V116, P4417; Peraramelli S, 2012, THROMB HAEMOSTASIS, V108, P266, DOI 10.1160/TH11-12-0902; Petersen LC, 1996, EUR J BIOCHEM, V235, P310, DOI 10.1111/j.1432-1033.1996.0310f.x; Prasad S, 2008, BLOOD, V111, P672, DOI 10.1182/blood-2007-07-098913; Sere KM, 2004, BLOOD, V104, P3624, DOI 10.1182/blood-2004-03-1146; Sichler K, 2002, FEBS LETT, V530, P220, DOI 10.1016/S0014-5793(02)03495-6; VALENTIN S, 1993, BLOOD COAGUL FIBRIN, V4, P713, DOI 10.1097/00001721-199304050-00007; Waters EK, 2013, J THROMB HAEMOST, V11, P1137, DOI 10.1111/jth.12201; Waters EK, 2011, BLOOD, V117, P5514, DOI 10.1182/blood-2010-10-311936; WESSELSCHMIDT R, 1992, BLOOD, V79, P2004; WUN TC, 1988, J BIOL CHEM, V263, P6001; Zhang Z., 2013, THROMB HAEMOST, DOI 10.1160/TH13-08-0635; Zogg T, 2011, PROG MOL BIOL TRANSL, V99, P51, DOI 10.1016/B978-0-12-385504-6.00002-6	43	37	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1732	1741		10.1074/jbc.M113.533836	http://dx.doi.org/10.1074/jbc.M113.533836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24275667	Green Published, hybrid			2022-12-28	WOS:000332401700044
J	Schneider, N; Cordeiro, S; Machtens, JP; Braams, S; Rauen, T; Fahlke, C				Schneider, Nicole; Cordeiro, Soenke; Machtens, Jan-Philipp; Braams, Simona; Rauen, Thomas; Fahlke, Christoph			Functional Properties of the Retinal Glutamate Transporters GLT-1c and EAAT5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutamate; Ion Channels; Neurotransmitter Transport; Patch Clamp; Retina; Excitatory Amino Acid Transporter	AMINO-ACID TRANSPORTER; RAT RETINA; TRANSMITTER CLEARANCE; TIGER SALAMANDER; CHLORIDE CHANNEL; ANION CHANNELS; BIPOLAR CELLS; LOCALIZATION; EXPRESSION; CURRENTS	Background: GLT-1c and EAAT5 are two excitatory amino acid transporters co-expressed in retinal neurons. Results: GLT-1c and EAAT5 differ in glutamate and Na+ affinity, individual transport rates as well as in unitary anion current amplitudes. Conclusion: GLT-1c and EAAT5 are optimized to fulfill different physiological tasks. Significance: Identification of unitary channel properties underlying separate anion conductances associated with GLT-1c and EAAT5. In the mammalian retina, glutamate uptake is mediated by members of a family of glutamate transporters known as excitatory amino acid transporters (EAATs). Here we cloned and functionally characterized two retinal EAATs from mouse, the GLT-1/EAAT2 splice variant GLT-1c, and EAAT5. EAATs are glutamate transporters and anion-selective ion channels, and we used heterologous expression in mammalian cells, patch-clamp recordings and noise analysis to study and compare glutamate transport and anion channel properties of both EAAT isoforms. We found GLT-1c to be an effective glutamate transporter with high affinity for Na+ and glutamate that resembles original GLT-1/EAAT2 in all tested functional aspects. EAAT5 exhibits glutamate transport rates too low to be accurately measured in our experimental system, with significantly lower affinities for Na+ and glutamate than GLT-1c. Non-stationary noise analysis demonstrated that GLT-1c and EAAT5 also differ in single-channel current amplitudes of associated anion channels. Unitary current amplitudes of EAAT5 anion channels turned out to be approximately twice as high as single-channel amplitudes of GLT-1c. Moreover, at negative potentials open probabilities of EAAT5 anion channels were much larger than for GLT-1c. Our data illustrate unique functional properties of EAAT5, being a low-affinity and low-capacity glutamate transport system, with an anion channel optimized for anion conduction in the negative voltage range.	[Schneider, Nicole; Machtens, Jan-Philipp; Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst, D-52428 Julich, Germany; [Schneider, Nicole; Cordeiro, Soenke; Machtens, Jan-Philipp; Fahlke, Christoph] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Schneider, Nicole; Fahlke, Christoph] Zentrum Syst Neurowissensch, D-30559 Hannover, Germany; [Cordeiro, Soenke] Inst Physiol, D-24118 Kiel, Germany; [Braams, Simona; Rauen, Thomas] Univ Osnabruck, FB Biol Chem, D-49076 Osnabruck, Germany	Helmholtz Association; Research Center Julich; Hannover Medical School; University Osnabruck	Fahlke, C (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Leo Brandt Str, D-52428 Julich, Germany.	c.fahlke@fz-juelich.de	Fahlke, Christoph/G-3635-2013; Cordeiro, Soenke/A-1782-2012; Machtens, Jan-Philipp/M-8659-2013	Fahlke, Christoph/0000-0001-8602-9952; Machtens, Jan-Philipp/0000-0003-1673-8571; Rauen, Thomas/0000-0001-9699-182X	Deutsche Forschungs-gemeinschaft [FA301/9]	Deutsche Forschungs-gemeinschaft(German Research Foundation (DFG))	These studies were supported by the Deutsche Forschungs-gemeinschaft FA301/9 (to Ch. F.).	Alekov AK, 2009, J GEN PHYSIOL, V133, P485, DOI 10.1085/jgp.200810155; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bergles DE, 2002, J NEUROSCI, V22, P10153; Coco S, 1997, EUR J NEUROSCI, V9, P1902, DOI 10.1111/j.1460-9568.1997.tb00757.x; DACHEUX RF, 1976, SCIENCE, V191, P963, DOI 10.1126/science.175443; DEROUICHE A, 1995, J NEUROSCI RES, V42, P131, DOI 10.1002/jnr.490420115; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Efron B., 1994, MONOGRAPHS STAT APPL; Eliasof S, 1998, J NEUROSCI, V18, P698; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fyk-Kolodziej B, 2004, VISUAL NEUROSCI, V21, P551, DOI 10.1017/S0952523804214067; Gameiro A, 2011, BIOPHYS J, V100, P2623, DOI 10.1016/j.bpj.2011.04.034; Hebeisen S, 2005, BIOPHYS J, V89, P1710, DOI 10.1529/biophysj.104.056093; HILLE B, 2002, IONIC CHANNELS EXCIT; Hotzy J, 2013, J BIOL CHEM, V288, P36492, DOI 10.1074/jbc.M113.489385; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Kugler P, 2003, HISTOCHEM CELL BIOL, V120, P199, DOI 10.1007/s00418-003-0555-y; Larsson HP, 1996, BIOPHYS J, V70, P733, DOI 10.1016/S0006-3495(96)79613-3; LASANSKY A, 1981, J PHYSIOL-LONDON, V310, P205, DOI 10.1113/jphysiol.1981.sp013544; Lehre KP, 1997, BRAIN RES, V744, P129, DOI 10.1016/S0006-8993(96)01022-0; Leinenweber A, 2011, J BIOL CHEM, V286, P1927, DOI 10.1074/jbc.M110.153486; Maenpaa H, 2004, CURR EYE RES, V28, P159, DOI 10.1076/ceyr.28.3.159.26244; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Palmer MJ, 2003, J NEUROSCI, V23, P4831; PICAUD S, 1995, P NATL ACAD SCI USA, V92, P9417, DOI 10.1073/pnas.92.20.9417; Pow DV, 2000, NEUROSCI LETT, V280, P21, DOI 10.1016/S0304-3940(99)00988-X; Pow DV, 1999, CELL TISSUE RES, V297, P57, DOI 10.1007/s004410051333; Pow DV, 2000, NEUROCHEM INT, V37, P191, DOI 10.1016/S0197-0186(00)00022-X; Rabl K, 2003, VISUAL NEUROSCI, V20, P557, DOI 10.1017/S0952523803205095; Rauen T, 2004, NEUROCHEM INT, V45, P1095, DOI 10.1016/j.neuint.2004.04.006; Rauen T, 1998, CELL TISSUE RES, V291, P19; Rauen T, 1996, CELL TISSUE RES, V286, P325, DOI 10.1007/s004410050702; Schulz K, 1996, NEUROSCI LETT, V211, P191, DOI 10.1016/0304-3940(96)12762-2; SIGWORTH FJ, 1992, METHOD ENZYMOL, V207, P746; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Ward MM, 2004, CELL TISSUE RES, V315, P305, DOI 10.1007/s00441-003-0849-3; Wersinger E, 2006, J PHYSIOL-LONDON, V577, P221, DOI 10.1113/jphysiol.2006.118281; Wiessner M, 2002, CELL TISSUE RES, V310, P31, DOI 10.1007/s00441-002-0612-1; Winter N, 2012, BRAIN, V135, P3416, DOI 10.1093/brain/aws255	45	45	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1815	1824		10.1074/jbc.M113.517177	http://dx.doi.org/10.1074/jbc.M113.517177			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24307171	Green Published, hybrid			2022-12-28	WOS:000332401700051
J	Yates, CJ; Masuyer, G; Schwager, SLU; Akif, M; Sturrock, ED; Acharya, KR				Yates, Christopher J.; Masuyer, Geoffrey; Schwager, Sylva L. U.; Akif, Mohd; Sturrock, Edward D.; Acharya, K. Ravi			Molecular and Thermodynamic Mechanisms of the Chloride-dependent Human Angiotensin-I-converting Enzyme (ACE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; Crystallography; Hypertension; Protein Structure; Thermodynamics; Angiotensin-1-converting Enzyme; Chloride Ion Activation; Enzymology	CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVE-SITE; N-DOMAIN; IDENTIFICATION; RESIDUES; SPECIFICITY; ACTIVATION; REACTIVITY; BINDING	Background: The angiotensin-1-converting enzyme (ACE) is a zinc protease unique in its chloride ion dependence. Results: Key substrate interactions with the catalytic site affect the structure and thermodynamics of ACE, which modulate chloride ion-dependent hydrolysis. Conclusion: Substrate composition influences chloride affinity in ACE. Significance: The interdependence of ACE substrate composition, structure, and thermodynamics influence its chloride ion activation in biology. Somatic angiotensin-converting enzyme (sACE), a key regulator of blood pressure and electrolyte fluid homeostasis, cleaves the vasoactive angiotensin-I, bradykinin, and a number of other physiologically relevant peptides. sACE consists of two homologous and catalytically active N- and C-domains, which display marked differences in substrate specificities and chloride activation. A series of single substitution mutants were generated and evaluated under varying chloride concentrations using isothermal titration calorimetry. The x-ray crystal structures of the mutants provided details on the chloride-dependent interactions with ACE. Chloride binding in the chloride 1 pocket of C-domain ACE was found to affect positioning of residues from the active site. Analysis of the chloride 2 pocket R522Q and R522K mutations revealed the key interactions with the catalytic site that are stabilized via chloride coordination of Arg(522). Substrate interactions in the S2 subsite were shown to affect chloride affinity in the chloride 2 pocket. The Glu(403)-Lys(118) salt bridge in C-domain ACE was shown to stabilize the hinge-bending region and reduce chloride affinity by constraining the chloride 2 pocket. This work demonstrated that substrate composition to the C-terminal side of the scissile bond as well as interactions of larger substrates in the S2 subsite moderate chloride affinity in the chloride 2 pocket of the ACE C-domain, providing a rationale for the substrate-selective nature of chloride dependence in ACE and how this varies between the N- and C-domains.	[Yates, Christopher J.; Schwager, Sylva L. U.; Sturrock, Edward D.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7935 Observatory, South Africa; [Yates, Christopher J.; Schwager, Sylva L. U.; Sturrock, Edward D.] Univ Cape Town, Div Med Biochem, ZA-7935 Observatory, South Africa; [Masuyer, Geoffrey; Akif, Mohd; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Cape Town; University of Cape Town; University of Bath	Sturrock, ED (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7935 Observatory, South Africa.	Edward.Sturrock@uct.ac.za; K.R.Acharya@bath.ac.uk	Masuyer, Geoffrey/AAO-5977-2021	Masuyer, Geoffrey/0000-0002-9527-2310; Acharya, K. Ravi/0000-0002-3009-4058	Medical Research Council [G1001685]; Wellcome Trust [088464]; University of Cape Town; South African National Research Foundation; MRC [G1001685] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); University of Cape Town; South African National Research Foundation(National Research Foundation - South Africa); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Project Grant G1001685 and Wellcome Trust Equipment Grant 088464 (to K. R. A.). This work was also supported by the University of Cape Town and the South African National Research Foundation (to E. D. S. and C. J. Y.).	Abadir PM, 2011, P NATL ACAD SCI USA, V108, P14849, DOI 10.1073/pnas.1101507108; Acharya KR, 2003, NAT REV DRUG DISCOV, V2, P891, DOI 10.1038/nrd1227; Anthony CS, 2012, CURR MED CHEM, V19, P845; Anthony CS, 2010, J BIOL CHEM, V285, P35685, DOI 10.1074/jbc.M110.167866; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balyasnikova IV, 2003, TISSUE ANTIGENS, V61, P49, DOI 10.1034/j.1399-0039.2003.610104.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CHEN YNP, 1990, BIOCHEMISTRY-US, V29, P10493, DOI 10.1021/bi00498a011; Corless RM, 1996, ADV COMPUT MATH, V5, P329, DOI 10.1007/BF02124750; Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048; CORVOL P, 2004, HDB PROTEOLYTIC ENZY, P332; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez M, 2001, J BIOL CHEM, V276, P4998, DOI 10.1074/jbc.M009009200; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; Golicnik M, 2010, ANAL BIOCHEM, V406, P94, DOI 10.1016/j.ab.2010.06.041; Gordon K, 2003, BIOCHEM J, V371, P437, DOI 10.1042/BJ20021842; Guy JL, 2003, BIOCHEMISTRY-US, V42, P13185, DOI 10.1021/bi035268s; HUBERT C, 1991, J BIOL CHEM, V266, P15377; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Liu XF, 2001, J BIOL CHEM, V276, P33518, DOI 10.1074/jbc.M101495200; Lodish H., 1999, MOL CELL BIOL; Masuyer G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00717; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moiseeva NA, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1167, DOI 10.1007/s10541-005-0242-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Rushworth CA, 2008, FEBS J, V275, P6033, DOI 10.1111/j.1742-4658.2008.06733.x; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SEN I, 1993, J BIOL CHEM, V268, P25748; SHAPIRO R, 1983, BIOCHEMISTRY-US, V22, P3850, DOI 10.1021/bi00285a021; Stockbridge RB, 2009, J BIOL CHEM, V284, P22747, DOI 10.1074/jbc.M109.017806; Sturrock ED, 2004, CELL MOL LIFE SCI, V61, P2677, DOI 10.1007/s00018-004-4239-0; Tzakos AG, 2003, PROTEIN ENG, V16, P993, DOI 10.1093/protein/gzg122; Watermeyer J. M., 2009, CURRENT ENZYME INHIB, V5, P134, DOI DOI 10.2174/157340809789071155; Watermeyer JM, 2006, BIOCHEMISTRY-US, V45, P12654, DOI 10.1021/bi061146z; WEI L, 1992, J BIOL CHEM, V267, P13398; Yu XC, 1997, J BIOL CHEM, V272, P3511, DOI 10.1074/jbc.272.6.3511	42	22	22	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1798	1814		10.1074/jbc.M113.512335	http://dx.doi.org/10.1074/jbc.M113.512335			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24297181	Green Published, hybrid			2022-12-28	WOS:000332401700050
J	Lee, JM; Gang, GT; Kim, DK; Kim, YD; Koo, SH; Lee, CH; Choi, HS				Lee, Ji-Min; Gang, Gil-Tae; Kim, Don-Kyu; Kim, Yong Deuk; Koo, Seung-Hoi; Lee, Chul-Ho; Choi, Hueng-Sik			Ursodeoxycholic Acid Inhibits Liver X Receptor alpha-mediated Hepatic Lipogenesis via Induction of the Nuclear Corepressor SMILE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACIDS; LXR-ALPHA; CHENODEOXYCHOLIC ACID; BINDING PROTEIN; ACTIVATION; TRANSCRIPTION; HETERODIMER; INTERACTS; PATHWAY; ELEMENT	Small heterodimer partner interacting leucine zipper protein (SMILE) has been identified as a nuclear corepressor of the nuclear receptor (NRs) family. Here, we examined the role of SMILE in the regulation of nuclear receptor liver X receptor (LXR alpha)-mediated sterol regulatory element binding protein-1c (SREBP-1c) gene expression. We found that SMILE inhibited T0901317 (T7)-induced transcriptional activity of LXR alpha, which functions as a major regulator of lipid metabolism by inducing SREBP-1c, fatty acid synthase (FAS), and acetyl-CoA carboxylase (ACC) gene expression. Moreover, we demonstrated that SMILE physically interacts with LXR alpha and represses T7-induced LXR alpha transcriptional activity by competing with coactivator SRC-1. Adenoviral overexpression of SMILE (Ad-SMILE) attenuated fat accumulation and lipogenic gene induction in the liver of T7 administered or of high fat diet (HFD)-fed mice. Furthermore, we investigated the mechanism by which ursodeoxycholic acid (UDCA) inhibits LXR alpha-induced lipogenic gene expression. Interestingly, UDCA treatment significantly increased SMILE promoter activity and gene expression in an adenosine monophosphate-activated kinase-dependent manner. Furthermore, UDCA treatment repressed T7-induced SREBP-1c, FAS, and ACC protein levels, whereas knockdown of endogenous SMILE gene expression by adenovirus SMILE shRNA (Ad-shSMILE) significantly reversed UDCA-mediated repression of SREBP-1c, FAS, and ACC protein levels. Collectively, these results demonstrate that UDCA activates SMILE gene expression through adenosine monophosphate-activated kinase phosphorylation, which leads to repression of LXR alpha-mediated hepatic lipogenic enzyme gene expression.	[Lee, Ji-Min; Kim, Don-Kyu; Kim, Yong Deuk; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju 500757, South Korea; [Lee, Ji-Min; Kim, Don-Kyu; Kim, Yong Deuk; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Gang, Gil-Tae; Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Koo, Seung-Hoi] Korea Univ, Div Life Sci, Coll Life Sci & Biotechnol, Seoul 136713, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Res Inst Med Sci, Dept Biomed Sci, Sch Med, Kwangju 501746, South Korea	Chonnam National University; Chonnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea University; Chonnam National University	Choi, HS (corresponding author), Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Koo, Seung-Hoi/E-2763-2015	Koo, Seung-Hoi/0000-0001-8769-2879	National Creative Research Initiatives through the National Research Foundation of Korea (NRF) [20110018305]; Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea (NRF) [20100019512]; Korean government (Ministry of Science, ICT & Future Planning); National Research Foundation of Korea [NRF-2012M3A9B6055345, NRF-2010-0019513]; Ministry of Science, ICT & Future Planning, Republic of Korea	National Creative Research Initiatives through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (Ministry of Science, ICT & Future Planning)(Ministry of Science, ICT & Future Planning, Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning, Republic of Korea(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported in part by National Creative Research Initiatives Grant 20110018305 and Future-based Technology Development Program (BIO Fields) Grant 20100019512 through the National Research Foundation of Korea (NRF) funded by the Korean government (Ministry of Science, ICT & Future Planning).; Supported by National Research Foundation of Korea Grants NRF-2012M3A9B6055345 and NRF-2010-0019513 and the Ministry of Science, ICT & Future Planning, Republic of Korea.	Angulo Paul, 2002, Curr Gastroenterol Rep, V4, P37, DOI 10.1007/s11894-002-0036-9; Arisawa S, 2009, BIOCHEM PHARMACOL, V77, P858, DOI 10.1016/j.bcp.2008.11.012; Auboeuf D, 1997, DIABETES, V46, P1319, DOI 10.2337/diabetes.46.8.1319; Beuers U, 1998, HEPATOLOGY, V28, P1449, DOI 10.1002/hep.510280601; Brendel C, 2002, MOL ENDOCRINOL, V16, P2065, DOI 10.1210/me.2001-0194; Copaci Ionel, 2005, Rom J Gastroenterol, V14, P259; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Gbaguidi GF, 2004, NUCLEIC ACIDS RES, V32, P1113, DOI 10.1093/nar/gkh260; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Heery DM, 2001, J BIOL CHEM, V276, P6695, DOI 10.1074/jbc.M009404200; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Hogan MR, 2006, FEBS LETT, V580, P58, DOI 10.1016/j.febslet.2005.11.046; Huuskonen J, 2004, ARTERIOSCL THROM VAS, V24, P703, DOI 10.1161/01.ATV.0000121202.72593.da; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Kay HY, 2011, ANTIOXID REDOX SIGN, V15, P2135, DOI 10.1089/ars.2010.3834; Lee JH, 2012, MOL CELL BIOCHEM, V368, P147, DOI 10.1007/s11010-012-1353-4; Lepage G, 1997, J PEDIATR-US, V130, P52, DOI 10.1016/S0022-3476(97)70310-X; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Li Y, 2002, MOL ENDOCRINOL, V16, P506, DOI 10.1210/me.16.3.506; Lopez-Mateo I, 2012, CELL CYCLE, V11, P3887, DOI 10.4161/cc.22133; Lu R, 2000, NUCLEIC ACIDS RES, V28, P2446, DOI 10.1093/nar/28.12.2446; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Misra J, 2011, J BIOL CHEM, V286, P41972, DOI 10.1074/jbc.M111.274514; Nedumaran B, 2010, J BIOL CHEM, V285, P9221, DOI 10.1074/jbc.M109.073650; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Omata M, 2007, GUT, V56, P1747, DOI 10.1136/gut.2007.120956; POUPON R, 1995, PHARMACOL THERAPEUT, V66, P1, DOI 10.1016/0163-7258(94)00073-C; Ratziu V, 2011, J HEPATOL, V54, P1011, DOI 10.1016/j.jhep.2010.08.030; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; SCHOENFIELD LJ, 1981, ANN INTERN MED, V95, P257, DOI 10.7326/0003-4819-95-3-257; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Talukdar S, 2007, J LIPID RES, V48, P2647, DOI 10.1194/jlr.M700189-JLR200; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006; Trauner M, 2010, DIGEST DIS, V28, P220, DOI 10.1159/000282091; Uzun MA, 2009, HEPATOL RES, V39, P814, DOI 10.1111/j.1872-034X.2009.00511.x; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Xie YB, 2008, BIOCHEM J, V416, P463, DOI 10.1042/BJ20080782	43	35	36	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1079	1091		10.1074/jbc.M113.491522	http://dx.doi.org/10.1074/jbc.M113.491522			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265317	Green Published, hybrid			2022-12-28	WOS:000330541200040
J	Squeglia, F; Bachert, B; De Simone, A; Lukomski, S; Berisio, R				Squeglia, Flavia; Bachert, Beth; De Simone, Alfonso; Lukomski, Slawomir; Berisio, Rita			The Crystal Structure of the Streptococcal Collagen- like Protein 2 Globular Domain from Invasive M3-type Group A Streptococcus Shows Significant Similarity to Immunomodulatory HIV Protein gp41*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Crystal Structure; Molecular Dynamics; Protein Folding; Streptococcus	TRIPLE-HELIX; SURFACE PROTEIN; GENOME SEQUENCE; CELLULAR FIBRONECTIN; TRIMERIZATION DOMAIN; MOLECULAR-DYNAMICS; BIOFILM FORMATION; NC1 DOMAIN; M3 STRAIN; FACTOR-H	Background: Streptococcal collagen-like proteins play crucial roles in host adhesion, host cell entry, and immunomodulation of host defenses. Results: This study provides the first three-dimensional structural description of a streptococcal collagen-like protein. Conclusion: The crystal structure evidences a six-helical bundle fold, which is unusual in bacterial proteins and characteristic of viral fusion proteins. Significance: The high resolution structure provides a structural basis for the design of inhibitors of streptococcal invasion. The arsenal of virulence factors deployed by streptococci includes streptococcal collagen-like (Scl) proteins. These proteins, which are characterized by a globular domain and a collagen-like domain, play key roles in host adhesion, host immune defense evasion, and biofilm formation. In this work, we demonstrate that the Scl2.3 protein is expressed on the surface of invasive M3-type strain MGAS315 of Streptococcus pyogenes. We report the crystal structure of Scl2.3 globular domain, the first of any Scl. This structure shows a novel fold among collagen trimerization domains of either bacterial or human origin. Despite there being low sequence identity, we observed that Scl2.3 globular domain structurally resembles the gp41 subunit of the envelope glycoprotein from human immunodeficiency virus type 1, an essential subunit for viral fusion to human T cells. We combined crystallographic data with modeling and molecular dynamics techniques to gather information on the entire lollipop-like Scl2.3 structure. Molecular dynamics data evidence a high flexibility of Scl2.3 with remarkable interdomain motions that are likely instrumental to the protein biological function in mediating adhesive or immune-modulatory functions in host-pathogen interactions. Altogether, our results provide molecular tools for the understanding of Scl-mediated streptococcal pathogenesis and important structural insights for the future design of small molecular inhibitors of streptococcal invasion.	[Squeglia, Flavia; Berisio, Rita] CNR, Inst Biostruct & Bioimaging, I-80134 Naples, Italy; [Bachert, Beth; Lukomski, Slawomir] W Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; [De Simone, Alfonso] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); West Virginia University; Imperial College London	Berisio, R (corresponding author), CNR, Inst Biostruct & Bioimaging, Via Mezzocannone 16, I-80134 Naples, Italy.	rita.berisio@cnr.it	Squeglia, Flavia/AAA-8152-2019; Squeglia, Flavia/ABC-6150-2020	Squeglia, Flavia/0000-0001-9142-3313; Berisio, Rita/0000-0001-5025-6483	National Institutes of Health [AI50666]; public service grant; Ministero Italiano dell'Istruzione, dell'Universita e della Ricerca [200993WWF9, BM1003-00772]; Mizutani Foundation for glycoscience; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); public service grant; Ministero Italiano dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Mizutani Foundation for glycoscience; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI50666, a public service grant (to S. L.). This work was also supported by the Ministero Italiano dell'Istruzione, dell'Universita e della Ricerca (Grant PRIN 2009-protocol 200993WWF9 and COST Action BM1003 Grant BM1003-00772) and the Mizutani Foundation for glycoscience (to R. B.).	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Beres SB, 2004, P NATL ACAD SCI USA, V101, P11833, DOI 10.1073/pnas.0404163101; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Beres SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003026; Beres SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/pnas.0911295107; Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602; Berisio R, 2012, CURR PROTEIN PEPT SC, V13, P855, DOI 10.2174/138920312804871157; Berisio R, 2009, J PEPT SCI, V15, P131, DOI 10.1002/psc.1082; Bisno AL, 2005, CLIN INFECT DIS, V41, P1150, DOI 10.1086/444505; Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4; Boudko SP, 2012, INT J BIOCHEM CELL B, V44, P21, DOI 10.1016/j.biocel.2011.09.009; Boudko SP, 2009, J MOL BIOL, V392, P787, DOI 10.1016/j.jmb.2009.07.057; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Cantisani M., 2013, J MED CHEM, DOI 10. 1021/jm400771k; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Caswell CC, 2008, MOL MICROBIOL, V67, P584, DOI 10.1111/j.1365-2958.2007.06067.x; Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x; Caswell CC, 2010, FEMS MICROBIOL LETT, V303, P61, DOI 10.1111/j.1574-6968.2009.01864.x; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Cheng TJR, 2008, P NATL ACAD SCI USA, V105, P431, DOI 10.1073/pnas.0710868105; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; De Simone A, 2008, BIOCHEM BIOPH RES CO, V372, P121, DOI 10.1016/j.bbrc.2008.04.190; Gao YM, 2010, FEMS MICROBIOL LETT, V309, P55, DOI 10.1111/j.1574-6968.2010.02013.x; Han RL, 2006, MOL MICROBIOL, V61, P351, DOI 10.1111/j.1365-2958.2006.05237.x; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Horn HW, 2004, J CHEM PHYS, V120, P9665, DOI 10.1063/1.1683075; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Improta R, 2008, PROTEIN SCI, V17, P955, DOI 10.1110/ps.073301908; Karlstrom A, 2004, VET MICROBIOL, V104, P179, DOI 10.1016/j.vetmic.2004.09.014; Kaul R, 1997, AM J MED, V103, P18, DOI 10.1016/S0002-9343(97)00160-5; Koellhoffer JF, 2012, BIOCHEMISTRY-US, V51, P7665, DOI 10.1021/bi300976m; Kvansakul M, 2003, MATRIX BIOL, V22, P145, DOI 10.1016/S0945-053X(02)00119-1; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Lukomski S, 2000, INFECT IMMUN, V68, P6542, DOI 10.1128/IAI.68.12.6542-6553.2000; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Oliver-Kozup H, 2013, MOL MICROBIOL, V87, P672, DOI 10.1111/mmi.12125; Oliver-Kozup HA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-262; Olsen RJ, 2010, ANNU REV PATHOL-MECH, V5, P1, DOI 10.1146/annurev-pathol-121808-102135; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pahlman LI, 2007, J BIOL CHEM, V282, P24873, DOI 10.1074/jbc.M610015200; Paterson GK, 2008, FEMS MICROBIOL LETT, V285, P170, DOI 10.1111/j.1574-6968.2008.01217.x; Pawlowski M., 2013, 7 INT C GRAM POS MIC, P12; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Raman SS, 2006, J PHYS CHEM B, V110, P20678, DOI 10.1021/jp0625715; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x; Rety S, 2005, J BIOL CHEM, V280, P43073, DOI 10.1074/jbc.M510087200; Reuter M, 2010, J BIOL CHEM, V285, P38473, DOI 10.1074/jbc.M110.143727; Ruggiero A, 2011, BIOCHEM J, V435, P33, DOI 10.1042/BJ20101643; Sharkawy A, 2002, CLIN INFECT DIS, V34, P454, DOI 10.1086/338466; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Shulman ST, 2006, CLIN INFECT DIS, V42, P441, DOI 10.1086/499812; Squeglia F, 2013, ACTA CRYSTALLOGR F, V69, P1023, DOI 10.1107/S174430911302068X; Stetefeld J, 2003, STRUCTURE, V11, P339, DOI 10.1016/S0969-2126(03)00025-X; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Vitagliano L, 2011, BIOPHYS J, V100, P2253, DOI 10.1016/j.bpj.2011.03.033; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Whatmore AM, 2001, MICROBIOL-UK, V147, P419, DOI 10.1099/00221287-147-2-419; Wirz JA, 2011, MATRIX BIOL, V30, P9, DOI 10.1016/j.matbio.2010.09.005; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yu ZX, 2011, J BIOL CHEM, V286, P18960, DOI 10.1074/jbc.M110.217422; Yu ZX, 2010, PROTEIN SCI, V19, P775, DOI 10.1002/pro.356	73	21	21	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5122	5133		10.1074/jbc.M113.523597	http://dx.doi.org/10.1074/jbc.M113.523597			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24356966	hybrid, Green Published			2022-12-28	WOS:000331607900055
J	Dougherty, JD; Reineke, LC; Lloyd, RE				Dougherty, Jonathan D.; Reineke, Lucas C.; Lloyd, Richard E.			mRNA Decapping Enzyme 1a (Dcp1a)-induced Translational Arrest through Protein Kinase R (PKR) Activation Requires the N-terminal Enabled Vasodilator-stimulated Protein Homology 1 (EVH1) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MRNA Decay; P-body; Positive-strand RNA Viruses; Protein Kinase R (PKR); Translation Regulation; Poliovirus	STRESS GRANULE FORMATION; P-BODY FORMATION; CELLULAR ACTIVATOR; BINDING; DECAY; PHOSPHORYLATION; EIF2-ALPHA; COMPLEX; SITES; XRN1	We have shown previously that poliovirus infection disrupts cytoplasmic P-bodies in infected mammalian cells. During the infectious cycle, poliovirus causes the directed cleavage of Dcp1a and Pan3, coincident with the dispersion of P-bodies. We now show that expression of Dcp1a prior to infection, surprisingly, restricts poliovirus infection. This inhibition of infection was independent of P-body formation because expression of GFP-Dcp1a mutants that cannot enter P-bodies restricted poliovirus infection similar to wild-type GFP-Dcp1a. Expression of wild-type or mutant GFP-Dcp1a induced phosphorylation of eIF2 through the eIF2 kinase protein kinase R (PKR). Activation of PKR required the amino-terminal EVH1 domain of Dcp1a. This PKR-induced translational inhibition appears to be specific to Dcp1a because the expression of other P-body components, Pan2, Pan3, Ccr4, or Caf1, did not result in the inhibition of poliovirus gene expression or induce eIF2 phosphorylation. The translation blockade induced by Dcp1a expression suggests novel signaling linking RNA degradation/decapping and regulation of translation.	[Dougherty, Jonathan D.; Reineke, Lucas C.; Lloyd, Richard E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine	Lloyd, RE (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.	rlloyd@bcm.edu			National Institutes of Health Public Health Service [AI50237]; NCI, National Institutes of Health Cancer Center [P30CA1251230]; National Institutes of Health [HD007495, DK56338, CA125123]; Dan L. Duncan Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD007495, T32HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050237, R56AI050237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dan L. Duncan Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant AI50237; by NCI, National Institutes of Health Cancer Center Support Grant P30CA1251230; and by National Institutes of Health Grants HD007495, DK56338, and CA125123 (to the Integrated Microscopy Core at Baylor College of Medicine). This work was also supported by the Dan L. Duncan Cancer Center and the John S. Dunn Gulf Coast Consortium for Chemical Genomics.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Aizer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049783; Aizer A, 2008, PRION, V2, P131, DOI 10.4161/pri.2.4.7773; Anderson E, 2011, J MOL BIOL, V413, P973, DOI 10.1016/j.jmb.2011.09.025; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10; Arribere JA, 2011, MOL CELL, V44, P745, DOI 10.1016/j.molcel.2011.09.019; Bail S, 2006, NAT STRUCT MOL BIOL, V13, P7, DOI 10.1038/nsmb0106-7; Ball LJ, 2002, FEBS LETT, V513, P45, DOI 10.1016/S0014-5793(01)03291-4; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Bennett RL, 2006, BLOOD, V108, P821, DOI 10.1182/blood-2005-11-006817; Boeda B, 2007, MOL CELL, V28, P1071, DOI 10.1016/j.molcel.2007.10.033; Borja MS, 2011, RNA, V17, P278, DOI 10.1261/rna.2382011; Braun JE, 2012, NAT STRUCT MOL BIOL, V19, P1324, DOI 10.1038/nsmb.2413; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Callebaut I, 2002, FEBS LETT, V519, P178, DOI 10.1016/S0014-5793(02)02751-5; Chahar HS, 2013, VIROLOGY, V436, P1, DOI 10.1016/j.virol.2012.09.041; Chang TC, 2004, GENE DEV, V18, P2010, DOI 10.1101/gad.1219104; Chiang P. Y., 2013, PLOS ONE, V8; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; David A, 2011, J BIOL CHEM, V286, P20688, DOI 10.1074/jbc.M110.209452; Deshmukh MV, 2008, MOL CELL, V29, P324, DOI 10.1016/j.molcel.2007.11.027; Dougherty JD, 2011, J VIROL, V85, P64, DOI 10.1128/JVI.01657-10; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Erickson SL, 2011, J CELL SCI, V124, P293, DOI 10.1242/jcs.072140; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; George CX, 1996, VIROLOGY, V221, P180, DOI 10.1006/viro.1996.0364; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobson A, 2004, MOL CELL, V15, P1, DOI 10.1016/j.molcel.2004.06.031; JONES CL, 1983, VIROLOGY, V129, P415, DOI 10.1016/0042-6822(83)90180-0; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Lloyd RE, 2006, VIRUS RES, V119, P76, DOI 10.1016/j.virusres.2005.10.016; Long RM, 2003, MOL CELL, V11, P1126, DOI 10.1016/S1097-2765(03)00198-9; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Okumura F, 2013, J BIOL CHEM, V288, P2839, DOI 10.1074/jbc.M112.401851; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017; Reineke LC, 2012, MOL BIOL CELL, V23, P3499, DOI 10.1091/mbc.E12-05-0385; Rzeczkowski K, 2011, J CELL BIOL, V194, P581, DOI 10.1083/jcb.201006089; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; She M, 2008, MOL CELL, V29, P337, DOI 10.1016/j.molcel.2008.01.002; She MP, 2004, NAT STRUCT MOL BIOL, V11, P249, DOI 10.1038/nsmb730; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Simon E, 2006, TRENDS BIOCHEM SCI, V31, P241, DOI 10.1016/j.tibs.2006.03.001; Singh M, 2011, BIOCHEMISTRY-US, V50, P4550, DOI 10.1021/bi200104h; Singh M, 2009, J MOL BIOL, V385, P457, DOI 10.1016/j.jmb.2008.10.068; STEVENS A, 1987, ARCH BIOCHEM BIOPHYS, V252, P339, DOI 10.1016/0003-9861(87)90040-3; Stevens A, 2001, METHOD ENZYMOL, V342, P251, DOI 10.1016/S0076-6879(01)42549-3; Sudhakar A, 2000, BIOCHEMISTRY-US, V39, P12929, DOI 10.1021/bi0008682; THIMMAPPAYA B, 1982, CELL, V31, P543, DOI 10.1016/0092-8674(82)90310-5; THOMIS DC, 1992, P NATL ACAD SCI USA, V89, P10837, DOI 10.1073/pnas.89.22.10837; Tritschler F, 2009, P NATL ACAD SCI USA, V106, P21591, DOI 10.1073/pnas.0909871106; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836; White JP, 2011, J VIROL, V85, P8884, DOI 10.1128/JVI.00792-11; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196	68	19	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3936	3949		10.1074/jbc.M113.518191	http://dx.doi.org/10.1074/jbc.M113.518191			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24382890	Green Published, hybrid			2022-12-28	WOS:000331403800010
J	Kowalczyk-Quintas, C; Willen, L; Dang, AT; Sarrasin, H; Tardivel, A; Hermes, K; Schneider, H; Gaide, O; Donze, O; Kirby, N; Headon, DJ; Schneider, P				Kowalczyk-Quintas, Christine; Willen, Laure; Anh Thu Dang; Sarrasin, Heidi; Tardivel, Aubry; Hermes, Katharina; Schneider, Holm; Gaide, Olivier; Donze, Olivier; Kirby, Neil; Headon, Denis J.; Schneider, Pascal			Generation and Characterization of Function-blocking Anti-ectodysplasin A (EDA) Monoclonal Antibodies That Induce Ectodermal Dysplasia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Embryo; Receptors; Tooth; Tumor Necrosis Factor (TNF)	HAIR FOLLICLE INDUCTION; KAPPA-B; SIGNALING PATHWAYS; SHH EXPRESSION; FEATHER TRACT; GENE; RECEPTOR; MOUSE; MUTATIONS; HOMOLOG	Background: The TNF family ligand EDA1 is required for development of hair, teeth, and many glands. Results: Mouse fetuses exposed to anti-EDA antibodies develop a permanent ectodermal dysplasia. Conclusion: Monoclonal anti-EDA antibodies block EDA at stoichiometric ratio in vitro and in vivo. Significance: Down-modulation of EDA has useful research and potentially therapeutic applications. Development of ectodermal appendages, such as hair, teeth, sweat glands, sebaceous glands, and mammary glands, requires the action of the TNF family ligand ectodysplasin A (EDA). Mutations of the X-linked EDA gene cause reduction or absence of many ectodermal appendages and have been identified as a cause of ectodermal dysplasia in humans, mice, dogs, and cattle. We have generated blocking antibodies, raised in Eda-deficient mice, against the conserved, receptor-binding domain of EDA. These antibodies recognize epitopes overlapping the receptor-binding site and prevent EDA from binding and activating EDAR at close to stoichiometric ratios in in vitro binding and activity assays. The antibodies block EDA1 and EDA2 of both mammalian and avian origin and, in vivo, suppress the ability of recombinant Fc-EDA1 to rescue ectodermal dysplasia in Eda-deficient Tabby mice. Moreover, administration of EDA blocking antibodies to pregnant wild type mice induced in developing wild type fetuses a marked and permanent ectodermal dysplasia. These function-blocking anti-EDA antibodies with wide cross-species reactivity will enable study of the developmental and postdevelopmental roles of EDA in a variety of organisms and open the route to therapeutic intervention in conditions in which EDA may be implicated.	[Kowalczyk-Quintas, Christine; Willen, Laure; Anh Thu Dang; Sarrasin, Heidi; Tardivel, Aubry; Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Hermes, Katharina; Schneider, Holm] Univ Hosp Erlangen, Dept Pediat, D-91054 Erlangen, Germany; [Gaide, Olivier] Univ Lausanne, Dept Dermatol, CH-1011 Lausanne, Switzerland; [Donze, Olivier] Adipogen, CH-1066 Epalinges, Switzerland; [Kirby, Neil] Edimer Pharmaceut, Cambridge, MA 02142 USA; [Headon, Denis J.] Univ Edinburgh, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland; [Headon, Denis J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9RG, Midlothian, Scotland	University of Lausanne; University of Erlangen Nuremberg; University of Lausanne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Schneider, P (corresponding author), Univ Lausanne, Dept Biochem, Boveresses 155, CH-1066 Epalinges, Switzerland.	pascal.schneider@unil.ch		Schneider, Pascal/0000-0003-0677-9409	Swiss National Science Foundation; Edimer Pharmaceuticals; Biotechnology and Biological Sciences Research Council [BBS/E/D/20221657, BB/J017183/1] Funding Source: researchfish; BBSRC [BBS/E/D/20221657, BB/J017183/1] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Edimer Pharmaceuticals; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Swiss National Science Foundation (to P. S.) and by project funding from Edimer Pharmaceuticals (to O. G., H. S., D. H., and P. S.). O. G. and P. S. are shareholders of Edimer Pharmaceuticals. N. K. is shareholder, director, and employee of Edimer Pharmaceuticals. H. S. is a member of the clinical advisory board of Edimer Pharmaceuticals.	Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Casal ML, 2007, AM J HUM GENET, V81, P1050, DOI 10.1086/521988; Chen YW, 2001, P NATL ACAD SCI USA, V98, P7218, DOI 10.1073/pnas.131076098; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cui CY, 2003, HUM MOL GENET, V12, P2931, DOI 10.1093/hmg/ddg325; Ferguson BM, 1997, HUM MOL GENET, V6, P1589, DOI 10.1093/hmg/6.9.1589; Fessing MY, 2006, AM J PATHOL, V169, P2075, DOI 10.2353/ajpath.2006.060227; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; Hammerschmidt B, 2007, DEV BIOL, V305, P246, DOI 10.1016/j.ydbio.2007.02.010; Hashimoto T, 2008, CELL CYCLE, V7, P106, DOI 10.4161/cc.7.1.5135; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Heath J, 2009, J INVEST DERMATOL, V129, P2358, DOI 10.1038/jid.2009.102; Hill NL, 2002, J COMP PATHOL, V126, P220, DOI 10.1053/jcpa.2001.0531; Houghton L, 2005, DEVELOPMENT, V132, P863, DOI 10.1242/dev.01651; Houghton L, 2007, DEV DYNAM, V236, P3020, DOI 10.1002/dvdy.21337; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Hymowitz SG, 2003, STRUCTURE, V11, P1513, DOI 10.1016/j.str.2003.11.009; Israel EJ, 1997, IMMUNOLOGY, V92, P69, DOI 10.1046/j.1365-2567.1997.00326.x; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kowalczyk C, 2011, J BIOL CHEM, V286, P30769, DOI 10.1074/jbc.M111.267997; KRAEHENBUHL JP, 1969, J CELL BIOL, V42, P345, DOI 10.1083/jcb.42.2.345; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Morrison S. L., 2002, CURRENT PROTOCOLS IM, V47; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Mues G, 2010, EUR J HUM GENET, V18, P19, DOI 10.1038/ejhg.2009.127; NAKATA M, 1980, AM J HUM GENET, V32, P908; Newton K, 2004, MOL CELL BIOL, V24, P1608, DOI 10.1128/MCB.24.4.1608-1613.2004; Pantalacci S, 2008, MOL BIOL EVOL, V25, P912, DOI 10.1093/molbev/msn038; PINHEIRO M, 1979, AM J MED GENET, V4, P113, DOI 10.1002/ajmg.1320040202; Pispa J, 1999, DEV BIOL, V216, P521, DOI 10.1006/dbio.1999.9514; Pispa J, 2008, HUM MOL GENET, V17, P3380, DOI 10.1093/hmg/ddn232; Pummila M, 2007, DEVELOPMENT, V134, P117, DOI 10.1242/dev.02708; Rawlins EL, 2005, DEV DYNAM, V233, P1378, DOI 10.1002/dvdy.20461; Schmidt-Ullrich R, 2006, DEVELOPMENT, V133, P1045, DOI 10.1242/dev.02278; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Swee LK, 2009, J BIOL CHEM, V284, P27567, DOI 10.1074/jbc.M109.042259; Tucker AS, 2000, DEVELOPMENT, V127, P4691; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Zankl A, 2001, EUR J PEDIATR, V160, P296, DOI 10.1007/s004310100738; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011	45	23	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4273	4285		10.1074/jbc.M113.535740	http://dx.doi.org/10.1074/jbc.M113.535740			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24391090	Green Published, hybrid			2022-12-28	WOS:000331403800038
J	Papke, RL; Horenstein, NA; Kulkarni, AR; Stokes, C; Corrie, LW; Maeng, CY; Thakur, GA				Papke, Roger L.; Horenstein, Nicole A.; Kulkarni, Abhijit R.; Stokes, Clare; Corrie, Lu W.; Maeng, Cheol-Young; Thakur, Ganesh A.			The Activity of GAT107, an Allosteric Activator and Positive Modulator of alpha 7 Nicotinic Acetylcholine Receptors (nAChR), Is Regulated by Aromatic Amino Acids That Span the Subunit Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Electrophysiology; Mutagenesis Site-specific; Nicotinic Acetylcholine Receptors; Structural Biology; Voltage Clamp	LIGAND-BINDING DOMAIN; AGONIST BINDING; PNU-120596; SITE; SELECTIVITY; DIVERSITY; AUGMENTS; RELEASE; RAT	GAT107, the (+)-enantiomer of racemic 4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide, is a strong positive allosteric modulator (PAM) of 7 nicotinic acetylcholine receptor (nAChR) activation by orthosteric agonists with intrinsic allosteric agonist activities. The direct activation produced by GAT107 in electrophysiological studies is observed only as long as GAT107 is freely diffusible in solution, although the potentiating activity primed by GAT107 can persist for over 30 min after drug washout. Direct activation is sensitive to 7 nAChR antagonist methyllycaconitine, although the primed potentiation is not. The data are consistent with GAT107 activity arising from two different sites. We show that the coupling between PAMs and the binding of orthosteric ligands requires tryptophan 55 (Trp-55), which is located at the subunit interface on the complementary surface of the orthosteric binding site. Mutations of Trp-55 increase the direct activation produced by GAT107 and reduce or prevent the synergy between allosteric and orthosteric binding sites, so that these mutants can also be directly activated by other PAMs such as PNU-120596 and TQS, which do not activate wild-type 7 in the absence of orthosteric agonists. We identify Tyr-93 as an essential element for orthosteric activation, because Y93C mutants are insensitive to orthosteric agonists but respond to GAT107. Our data show that both orthosteric and allosteric activation of 7 nAChR require cooperative activity at the interface between the subunits in the extracellular domain. These cooperative effects rely on key aromatic residues, and although mutations of Trp-55 reduce the restraints placed on the requirement for orthosteric agonists, Tyr-93 can conduct both orthosteric activation and desensitization among the subunits.	[Papke, Roger L.; Stokes, Clare; Corrie, Lu W.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Horenstein, Nicole A.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Kulkarni, Abhijit R.; Thakur, Ganesh A.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Kulkarni, Abhijit R.; Thakur, Ganesh A.] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Maeng, Cheol-Young] SK Biopharmaceut, Taejon 305712, South Korea	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Northeastern University; Northeastern University; SK Group	Papke, RL (corresponding author), Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Acad Res Bldg,Rm R5-234,POB 100267,1200 Newell Dr, Gainesville, FL 32610 USA.	rlpapke@ufl.edu; g.thakur@neu.edu			National Institutes of Health [GM57481, DA027113]; NATIONAL EYE INSTITUTE [R01EY024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM57481 (to R. L. P.) and DA027113 (to G. A. T.).	Akk G, 2001, J PHYSIOL-LONDON, V535, P729, DOI 10.1111/j.1469-7793.2001.00729.x; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; Bertrand D, 2008, MOL PHARMACOL, V74, P1407, DOI 10.1124/mol.107.042820; Brejc K, 2002, NOVART FDN SYMP, V245, P22; Briggs CA, 2009, BRIT J PHARMACOL, V158, P1486, DOI 10.1111/j.1476-5381.2009.00426.x; Callahan PM, 2013, NEUROPHARMACOLOGY, V67, P201, DOI 10.1016/j.neuropharm.2012.10.019; Corringer PJ, 1998, J NEUROSCI, V18, P648; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Freitas K, 2013, J PHARMACOL EXP THER, V344, P264, DOI 10.1124/jpet.112.197871; Gay EA, 2008, J PHYSIOL-LONDON, V586, P1105, DOI 10.1113/jphysiol.2007.149492; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Hajos M, 2010, CURR PHARM DESIGN, V16, P538, DOI 10.2174/138161210790361434; Halevi S, 2003, J BIOL CHEM, V278, P34411, DOI 10.1074/jbc.M300170200; Horenstein NA, 2007, J BIOL CHEM, V282, P5899, DOI 10.1074/jbc.M609202200; Kalappa BI, 2013, BRIT J PHARMACOL, V169, P1862, DOI 10.1111/bph.12247; Kulkarni AR, 2013, TETRAHEDRON LETT, V54, P6592, DOI 10.1016/j.tetlet.2013.09.107; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Leiser SC, 2009, PHARMACOL THERAPEUT, V122, P302, DOI 10.1016/j.pharmthera.2009.03.009; Munro G, 2012, BRIT J PHARMACOL, V167, P421, DOI 10.1111/j.1476-5381.2012.02003.x; Papke RL, 1996, NEUROSCI LETT, V213, P201; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Papke RL, 2011, NEUROPHARMACOLOGY, V60, P159, DOI 10.1016/j.neuropharm.2010.07.014; Papke RL, 2010, METHODS, V51, P121, DOI 10.1016/j.ymeth.2010.01.012; Peng C, 2013, MOL PHARMACOL, V84, P459, DOI 10.1124/mol.113.086462; Sitzia F, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00081; Stewart DS, 2006, BIOCHEMISTRY-US, V45, P10641, DOI 10.1021/bi060686t; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Thakur GA, 2013, J MED CHEM, V56, P8943, DOI 10.1021/jm401267t; Thomsen MS, 2012, J NEUROIMMUNOL, V251, P65, DOI 10.1016/j.jneuroim.2012.07.006; Thomsen MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027014; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang JY, 2010, MOL PHARMACOL, V78, P1012, DOI 10.1124/mol.110.066662; Williams DK, 2012, MOL PHARMACOL, V82, P746, DOI 10.1124/mol.112.080317; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Williams DK, 2011, J GEN PHYSIOL, V137, P369, DOI 10.1085/jgp.201010587; Williams DK, 2009, J PHARMACOL EXP THER, V330, P40, DOI 10.1124/jpet.109.151225; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	39	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4515	4531		10.1074/jbc.M113.524603	http://dx.doi.org/10.1074/jbc.M113.524603			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24362025	Green Published, hybrid			2022-12-28	WOS:000331403800059
J	Tracy, CM; Gray, AJ; Cuellar, J; Shaw, TS; Howlett, AC; Taylor, RM; Prince, JT; Ahn, NG; Valpuesta, JM; Willardson, BM				Tracy, Christopher M.; Gray, Amy J.; Cuellar, Jorge; Shaw, Tanner S.; Howlett, Alyson C.; Taylor, Ryan M.; Prince, John T.; Ahn, Natalie G.; Valpuesta, Jose M.; Willardson, Barry M.			Programmed Cell Death Protein 5 Interacts with the Cytosolic Chaperonin Containing Tailless Complex Polypeptide 1 (CCT) to Regulate beta-Tubulin Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Chaperone Chaperonin; Electron Microscopy (EM); Protein Folding; Tubulin; Programmed Cell Death Protein 5	PHOSDUCIN-LIKE PROTEIN; GROUP-II CHAPERONIN; GAMMA-DIMER; LID CLOSURE; MOLECULAR CHAPERONES; ELECTRON-MICROSCOPY; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; ATP HYDROLYSIS; MECHANISM	Programmed cell death protein 5 (PDCD5) has been proposed to act as a pro-apoptotic factor and tumor suppressor. However, the mechanisms underlying its apoptotic function are largely unknown. A proteomics search for binding partners of phosducin-like protein, a co-chaperone for the cytosolic chaperonin containing tailless complex polypeptide 1 (CCT), revealed a robust interaction between PDCD5 and CCT. PDCD5 formed a complex with CCT and -tubulin, a key CCT-folding substrate, and specifically inhibited -tubulin folding. Cryo-electron microscopy studies of the PDCD5CCT complex suggested a possible mechanism of inhibition of -tubulin folding. PDCD5 bound the apical domain of the CCT subunit, projecting above the folding cavity without entering it. Like PDCD5, -tubulin also interacts with the CCT apical domain, but a second site is found at the sensor loop deep within the folding cavity. These orientations of PDCD5 and -tubulin suggest that PDCD5 sterically interferes with -tubulin binding to the CCT apical domain and inhibits -tubulin folding. Given the importance of tubulins in cell division and proliferation, PDCD5 might exert its apoptotic function at least in part through inhibition of -tubulin folding.	[Tracy, Christopher M.; Gray, Amy J.; Shaw, Tanner S.; Howlett, Alyson C.; Taylor, Ryan M.; Prince, John T.; Willardson, Barry M.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; [Cuellar, Jorge; Valpuesta, Jose M.] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Ahn, Natalie G.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	Brigham Young University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Colorado System; University of Colorado Boulder	Willardson, BM (corresponding author), Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA.	bmwillardson@chem.byu.edu	Valpuesta, Jose M/AAA-6002-2019; Valpuesta, José M/T-1977-2017; Cuéllar, Jorge/GOH-3100-2022; Cuéllar, Jorge/S-4269-2017	Valpuesta, José M/0000-0001-7468-8053; Cuéllar, Jorge/0000-0002-7789-807X; Cuéllar, Jorge/0000-0002-7789-807X; Willardson, Barry/0000-0002-8503-2268	National Institutes of Health [GM078550]; MINECO Grant [BFU2010-15703]; Madrid Regional Government Grant [S2009MAT-1507]; NATIONAL EYE INSTITUTE [R01EY012287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MINECO Grant(Spanish Government); Madrid Regional Government Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078550 (to B. M. W.). This work was also supported by MINECO Grant BFU2010-15703 (to J. M. V.) and Madrid Regional Government Grant S2009MAT-1507 (to J. M. V.).	Booth CR, 2008, NAT STRUCT MOL BIOL, V15, P746, DOI 10.1038/nsmb.1436; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; Cuellar J, 2008, NAT STRUCT MOL BIOL, V15, P858, DOI 10.1038/nsmb.1464; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Douglas NR, 2011, CELL, V144, P240, DOI 10.1016/j.cell.2010.12.017; Grunbeck A, 2012, ACS CHEM BIOL, V7, P967, DOI 10.1021/cb300059z; Han XR, 2012, CELL SIGNAL, V24, P1713, DOI 10.1016/j.cellsig.2012.04.011; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Howlett AC, 2009, J BIOL CHEM, V284, P16386, DOI 10.1074/jbc.M900800200; Humrich J, 2005, J BIOL CHEM, V280, P20042, DOI 10.1074/jbc.M409233200; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Knol JC, 2005, MOL CELL BIOL, V25, P8393, DOI 10.1128/MCB.25.18.8393-8400.2005; Lai CWJ, 2013, J NEUROSCI, V33, P7941, DOI 10.1523/JNEUROSCI.5001-12.2013; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Li HY, 2008, ONCOL REP, V20, P573, DOI 10.3892/or_00000044; Liu HT, 1999, BIOCHEM BIOPH RES CO, V254, P203, DOI 10.1006/bbrc.1998.9893; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; Lukov GL, 2005, EMBO J, V24, P1965, DOI 10.1038/sj.emboj.7600673; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Matson DR, 2011, MOL INTERV, V11, P141, DOI 10.1124/mi.11.2.12; McLaughlin JN, 2002, P NATL ACAD SCI USA, V99, P7962, DOI 10.1073/pnas.112075699; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prince JT, 2008, BIOINFORMATICS, V24, P2796, DOI 10.1093/bioinformatics/btn513; Russmann F, 2012, P NATL ACAD SCI USA, V109, P21208, DOI 10.1073/pnas.1218836109; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Savage JR, 2000, J BIOL CHEM, V275, P30399, DOI 10.1074/jbc.M005120200; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2009, J STRUCT BIOL, V166, P234, DOI 10.1016/j.jsb.2009.02.007; Shen PS, 2012, J VIROL, V86, P7907, DOI 10.1128/JVI.00407-12; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Spinola M, 2006, J CLIN ONCOL, V24, P1672, DOI 10.1200/JCO.2005.04.4339; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Xu LJ, 2012, APOPTOSIS, V17, P1235, DOI 10.1007/s10495-012-0754-x; Xu LJ, 2009, NEOPLASIA, V11, P345, DOI 10.1593/neo.81524; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Yao HW, 2009, ARCH BIOCHEM BIOPHYS, V486, P141, DOI 10.1016/j.abb.2009.03.018; Yebenes H, 2011, TRENDS BIOCHEM SCI, V36, P424, DOI 10.1016/j.tibs.2011.05.003; Zhang JJ, 2011, STRUCTURE, V19, P633, DOI 10.1016/j.str.2011.03.005; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701	52	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4490	4502		10.1074/jbc.M113.542159	http://dx.doi.org/10.1074/jbc.M113.542159			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24375412	hybrid, Green Published			2022-12-28	WOS:000331403800057
J	Graindorge, M; Giustini, C; Kraut, A; Moyet, L; Curien, G; Matringe, M				Graindorge, Matthieu; Giustini, Cecile; Kraut, Alexandra; Moyet, Lucas; Curien, Gilles; Matringe, Michel			Three Different Classes of Aminotransferases Evolved Prephenate Aminotransferase Functionality in Arogenate-competent Microorganisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amination; Amino Acid; Bacterial Metabolism; Enzymes; Tyrosine	L-TYROSINE BIOSYNTHESIS; AROMATIC-AMINO-ACIDS; L-PHENYLALANINE; ARABIDOPSIS-THALIANA; LYSINE BIOSYNTHESIS; BIOCHEMICAL-CHARACTERIZATION; REGULATORY PROPERTIES; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; DEHYDROGENASE	Background: The genes encoding prephenate aminotransferase in arogenate-competent microorganisms for tyrosine synthesis are still unknown. Results: Three different classes of aminotransferase use prephenate as an amino acceptor. Conclusion: Prephenate aminotransferase functionality has arisen more than once during evolution. Significance: This first identification of prephenate aminotransferases in arogenate competent microorganisms affords a better understanding of the origin and fixation of the arogenate route during evolution. The aromatic amino acids phenylalanine and tyrosine represent essential sources of high value natural aromatic compounds for human health and industry. Depending on the organism, alternative routes exist for their synthesis. Phenylalanine and tyrosine are synthesized either via phenylpyruvate/4-hydroxyphenylpyruvate or via arogenate. In arogenate-competent microorganisms, an aminotransferase is required for the transamination of prephenate into arogenate, but the identity of the genes is still unknown. We present here the first identification of prephenate aminotransferases (PATs) in seven arogenate-competent microorganisms and the discovery that PAT activity is provided by three different classes of aminotransferase, which belong to two different fold types of pyridoxal phosphate enzymes: an aspartate aminotransferase subgroup 1 in tested - and -proteobacteria, a branched-chain aminotransferase in tested cyanobacteria, and an N-succinyldiaminopimelate aminotransferase in tested actinobacteria and in the -proteobacterium Nitrosomonas europaea. Recombinant PAT enzymes exhibit high activity toward prephenate, indicating that the corresponding genes encode bona fide PAT. PAT functionality was acquired without other modification of substrate specificity and is not a general catalytic property of the three classes of aminotransferases.	[Graindorge, Matthieu; Giustini, Cecile; Moyet, Lucas; Curien, Gilles; Matringe, Michel] CEA, Direct Sci Vivant, Inst Rech Technol & Sci Vivant, Lab Physiol Cellulaire & Vegetale, F-38054 Grenoble, France; [Graindorge, Matthieu] Univ Grenoble Alpes, F-38054 Grenoble, France; [Giustini, Cecile; Matringe, Michel] INRA, USC1359, F-38054 Grenoble, France; [Kraut, Alexandra] INSERM, Lab Etud Dynam Proteomes, U880, F-38054 Grenoble, France; [Moyet, Lucas; Curien, Gilles] CNRS, UMR 5168, F-38054 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Curien, G (corresponding author), CNRS, CEA iRTSV, Lab Physiol Cellulaire & Vegetale, UMR 5168, 17 Rue Martyrs, F-38054 Grenoble, France.	gilles.curien@cea.fr; michel.matringe@cea.fr			French National Institute for Agricultural Research (INRA); CNRS; Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA); University of Grenoble Alpes; GRAL Labex (Grenoble Alliance for Integrated Structural Cell Biology) [ANR-10-LABEX-04]	French National Institute for Agricultural Research (INRA); CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)(French Atomic Energy Commission); University of Grenoble Alpes; GRAL Labex (Grenoble Alliance for Integrated Structural Cell Biology)	This work was supported in part by the French National Institute for Agricultural Research (INRA), CNRS, and the Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA).; Supported by a Ph.D. fellowship from the University of Grenoble Alpes.; Supported by a grant from the GRAL Labex (Grenoble Alliance for Integrated Structural Cell Biology: ANR-10-LABEX-04).	ABOUZEID A, 1995, APPL ENVIRON MICROB, V61, P1298, DOI 10.1128/AEM.61.4.1298-1302.1995; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; Berger BJ, 2003, J BACTERIOL, V185, P2418, DOI 10.1128/JB.185.8.2418-2431.2003; Bernay B, 2009, MOL CELL PROTEOMICS, V8, P946, DOI 10.1074/mcp.M800501-MCP200; Bonner CA, 2008, MICROBIOL MOL BIOL R, V72, P13, DOI 10.1128/MMBR.00026-07; BYNG G, 1981, PHYTOCHEMISTRY, V20, P1289, DOI 10.1016/0031-9422(81)80023-4; CHAMPNEY WS, 1970, J BIOL CHEM, V245, P3763; Cho MH, 2007, J BIOL CHEM, V282, P30827, DOI 10.1074/jbc.M702662200; Christendat D, 1999, BIOCHEMISTRY-US, V38, P4782, DOI 10.1021/bi982673o; CONNELLY JA, 1986, Z NATURFORSCH C, V41, P69; Dewick PM, 1998, NAT PROD REP, V15, P17; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; FAZEL AM, 1979, J BACTERIOL, V138, P805, DOI 10.1128/JB.138.3.805-815.1979; Fuchs TM, 2000, J BACTERIOL, V182, P3626, DOI 10.1128/JB.182.13.3626-3631.2000; Garcia I, 1997, BIOCHEM J, V325, P761, DOI 10.1042/bj3250761; Graindorge M, 2010, FEBS LETT, V584, P4357, DOI 10.1016/j.febslet.2010.09.037; HALL GC, 1982, J BACTERIOL, V149, P65, DOI 10.1128/JB.149.1.65-78.1982; Hartmann M, 2003, J BIOTECHNOL, V104, P199, DOI 10.1016/S0168-1656(03)00156-1; Haslam E., 1993, SHIKIMIC ACID METABO; Hudson AO, 2006, PLANT PHYSIOL, V140, P292, DOI 10.1104/pp.105.072629; JENSEN RA, 1975, NATURE, V254, P667, DOI 10.1038/254667a0; Jensen RA, 1996, J BACTERIOL, V178, P2161, DOI 10.1128/jb.178.8.2161-2171.1996; JUNG E, 1986, P NATL ACAD SCI USA, V83, P7231, DOI 10.1073/pnas.83.19.7231; KOCH GLE, 1971, BIOCHIM BIOPHYS ACTA, V229, P795, DOI 10.1016/0005-2795(71)90298-4; Kraut A, 2009, J PROTEOME RES, V8, P3778, DOI 10.1021/pr900095u; Large P. J., 1986, YEAST, V2, P1; Legrand P, 2006, STRUCTURE, V14, P767, DOI 10.1016/j.str.2006.01.006; LINDSTEDT S, 1977, BIOCHEMISTRY-US, V16, P3369, DOI 10.1021/bi00634a013; Maeda H, 2011, NAT CHEM BIOL, V7, P19, DOI [10.1038/nchembio.485, 10.1038/NCHEMBIO.485]; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; PATEL N, 1977, J BIOL CHEM, V252, P5839; Razal RA, 1996, PHYTOCHEMISTRY, V41, P31, DOI 10.1016/0031-9422(95)00628-1; Rippert P, 2002, PLANT MOL BIOL, V48, P361, DOI 10.1023/A:1014018926676; Rippert P, 2002, EUR J BIOCHEM, V269, P4753, DOI 10.1046/j.1432-1033.2002.03172.x; Rippert P, 2009, PLANT PHYSIOL, V149, P1251, DOI 10.1104/pp.108.130070; Scapin G, 1998, ADV ENZYMOL RAMB, V72, P279; SIEHL DL, 1986, Z NATURFORSCH C, V41, P79; SIEHL DL, 1988, ARCH BIOCHEM BIOPHYS, V260, P822, DOI 10.1016/0003-9861(88)90513-9; Song J, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-13; STENMARK SL, 1974, NATURE, V247, P290, DOI 10.1038/247290a0; SUBRAMANIAM P, 1994, MICROBIOL-SGM, V140, P3431, DOI 10.1099/13500872-140-12-3431; TURNBULL J, 1990, BIOCHEMISTRY-US, V29, P10255, DOI 10.1021/bi00496a015; ZHAO G, 1993, EUR J BIOCHEM, V212, P157, DOI 10.1111/j.1432-1033.1993.tb17646.x	43	13	16	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3198	3208		10.1074/jbc.M113.486480	http://dx.doi.org/10.1074/jbc.M113.486480			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24302739	Green Published, hybrid			2022-12-28	WOS:000331368700009
J	Chopra, A; Anderson, A; Giardina, C				Chopra, Avijeet; Anderson, Amy; Giardina, Charles			Novel Piperazine-based Compounds Inhibit Microtubule Dynamics and Sensitize Colon Cancer Cells to Tumor Necrosis Factor-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Colon Cancer; Inflammation; Mitosis; Molecular Docking; Small Molecules; Microtubule Inhibitors	SPINDLE-ASSEMBLY CHECKPOINT; CHROMOSOME SEGREGATION; CYCLE CHECKPOINTS; VINCA ALKALOIDS; CHFR; MITOSIS; TUBULIN; PROTEIN; DOCKING; DOMAIN	Background: Mitotic spindles are important targets of cancer chemotherapeutic agents. Results: A new class of tubulin-targeting agents is identified that effectively sensitizes colon cancer cells to ligand-induced apoptosis. Conclusion: AK301 is a novel, piperazine-based compound that induces mitotic arrest and increases ligand-dependent apoptosis. Significance: Mitotically active compounds that stimulate ligand-induced apoptotic signaling might be useful for augmenting immune-based cancer therapies. We recently identified a series of mitotically acting piperazine-based compounds that potently increase the sensitivity of colon cancer cells to apoptotic ligands. Here we describe a structure-activity relationship study on this compound class and identify a highly active derivative ((4-(3-chlorophenyl)piperazin-1-yl)(2-ethoxyphenyl)methanone), referred to as AK301, the activity of which is governed by the positioning of functional groups on the phenyl and benzoyl rings. AK301 induced mitotic arrest in HT29 human colon cancer cells with an ED50 of approximate to 115 nm. Although AK301 inhibited growth of normal lung fibroblast cells, mitotic arrest was more pronounced in the colon cancer cells (50% versus 10%). Cells arrested by AK301 showed the formation of multiple microtubule organizing centers with Aurora kinase A and -tubulin. Employing in vitro and in vivo assays, tubulin polymerization was found to be slowed (but not abolished) by AK301. In silico molecular docking suggests that AK301 binds to the colchicine-binding domain on -tubulin, but in a novel orientation. Cells arrested by AK301 expressed elevated levels of TNFR1 on their surface and more readily activated caspases-8, -9, and -3 in the presence of TNF. Relative to other microtubule destabilizers, AK301 was the most active TNF-sensitizing agent and also stimulated Fas- and TRAIL-induced apoptosis. In summary, we report a new class of mitosis-targeting agents that effectively sensitizes cancer cells to apoptotic ligands. These compounds should help illuminate the role of microtubules in regulating apoptotic ligand sensitivity and may ultimately be useful for developing agents that augment the anti-cancer activities of the immune response.	[Chopra, Avijeet; Giardina, Charles] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Anderson, Amy] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Chopra, A (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, 91 N Eagleville Rd, Storrs, CT 06269 USA.	avijeet.chopra@uconn.edu	Chopra, Avijeet/H-5611-2013	Chopra, Avijeet/0000-0001-6020-488X	National Institutes of Health [R21CA125592]; NATIONAL CANCER INSTITUTE [R21CA125592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant R21CA125592 (to C. G.).	Barton NR, 1996, P NATL ACAD SCI USA, V93, P1735, DOI 10.1073/pnas.93.5.1735; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BUDMAN DR, 1992, SEMIN ONCOL, V19, P639; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Chaturvedi P, 2002, CANCER RES, V62, P1797; CHEUNG HT, 1980, CELL BIOL INT REP, V4, P1125, DOI 10.1016/0309-1651(80)90050-8; Chopra AS, 2013, CANCER BIOL THER, V14, P436, DOI 10.4161/cbt.23787; Cooper G. M., 2000, CELL MOL APPROACH, P569; Dujardin D, 1998, J CELL BIOL, V141, P849, DOI 10.1083/jcb.141.4.849; Eum HA, 2011, AM J PATHOL, V179, P1221, DOI 10.1016/j.ajpath.2011.05.046; Flatt PM, 2000, DRUG METAB REV, V32, P283, DOI 10.1081/DMR-100102335; Franco D, 2002, CELL DEATH DIFFER, V9, P1090, DOI 10.1038/sj.cdd.4401074; Gergely F, 2008, GENE DEV, V22, P2291, DOI 10.1101/gad.1715208; Godman CA, 2008, CANCER BIOL THER, V7, P1570, DOI 10.4161/cbt.7.10.6561; Goncalves A, 2000, BIOCHEM PHARMACOL, V60, P1579, DOI 10.1016/S0006-2952(00)00481-0; HIMES RH, 1991, PHARMACOL THERAPEUT, V51, P257, DOI 10.1016/0163-7258(91)90081-V; Inan MS, 2000, GASTROENTEROLOGY, V118, P724, DOI 10.1016/S0016-5085(00)70142-9; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Kramer A, 2002, LEUKEMIA, V16, P767, DOI 10.1038/sj.leu.2402454; Kuratnik A, 2012, BIOCHEM PHARMACOL, V83, P1217, DOI 10.1016/j.bcp.2012.01.024; Lodish H., 2000, MOL CELL BIOL, P838; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Morrison KC, 2012, ANAL BIOCHEM, V420, P26, DOI 10.1016/j.ab.2011.08.020; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Pellegrini F, 2005, CANCER INVEST, V23, P264, DOI 10.1081/CNV-200055970; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Privette LM, 2008, TRANSL ONCOL, V1, P57, DOI 10.1593/tlo.08109; Ranaivoson FM, 2012, ACTA CRYSTALLOGR D, V68, P927, DOI 10.1107/S0907444912017143; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rigatti MJ, 2012, MOL CARCINOGEN, V51, P363, DOI 10.1002/mc.20795; Saunders W, 2005, SEMIN CANCER BIOL, V15, P25, DOI 10.1016/j.semcancer.2004.09.003; Schmit TL, 2007, MOL CANCER THER, V6, P1920, DOI 10.1158/1535-7163.MCT-06-0781; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Summers MK, 2005, ONCOGENE, V24, P2589, DOI 10.1038/sj.onc.1208428; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TAYLOR EW, 1965, J CELL BIOL, V25, P145, DOI 10.1083/jcb.25.1.145; Taylor RD, 2002, J COMPUT AID MOL DES, V16, P151, DOI 10.1023/A:1020155510718; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Verma R, 2010, BIOCHEM PHARMACOL, V79, P565, DOI 10.1016/j.bcp.2009.09.020; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wang TH, 1998, J BIOL CHEM, V273, P4928, DOI 10.1074/jbc.273.9.4928	52	31	31	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2978	2991		10.1074/jbc.M113.499319	http://dx.doi.org/10.1074/jbc.M113.499319			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338023	Green Published, hybrid			2022-12-28	WOS:000333403000045
J	Du, YQ; Teng, XY; Wang, N; Zhang, X; Chen, JF; Ding, PP; Qiao, Q; Wang, QK; Zhang, L; Yang, CQ; Yang, ZM; Chu, YW; Du, X; Zhou, XH; Hu, WG				Du, Yiqun; Teng, Xiaoyan; Wang, Na; Zhang, Xin; Chen, Jianfeng; Ding, Peipei; Qiao, Qian; Wang, Qingkai; Zhang, Long; Yang, Chaoqun; Yang, Zhangmin; Chu, Yiwei; Du, Xiang; Zhou, Xuhui; Hu, Weiguo			NF-kappa B and Enhancer-binding CREB Protein Scaffolded by CREB-binding Protein (CBP)/p300 Proteins Regulate CD59 Protein Expression to Protect Cells from Complement Attack	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CBP; Complement System; CREB; NF-B (NF-KB); p300	REACTIVE LYSIS CD59; BREAST-CANCER CELLS; ALZHEIMERS-DISEASE; MEMBRANE INHIBITOR; GENE-TRANSCRIPTION; INNATE IMMUNITY; MEDIATED LYSIS; ACTIVATION; TARGET; PHOSPHORYLATION	Background: CD59 is the sole membrane complement regulatory protein in restricting membrane attack complex assembly. Results:CD59 gene produces eight transcripts that share three transcriptional initiation sites but the same open reading frame. Conclusion: NF-B and CREB (as an enhancer-binding protein) bridged by CBP/p300 are responsible for the inducible expression of CD59. Significance:CD59 regulation mechanism suggests potential drug targets for controlling various complement-related human diseases. The complement system can be activated spontaneously for immune surveillance or induced to clear invading pathogens, in which the membrane attack complex (MAC, C5b-9) plays a critical role. CD59 is the sole membrane complement regulatory protein (mCRP) that restricts MAC assembly. CD59, therefore, protects innocent host cells from attacks by the complement system, and host cells require the constitutive and inducible expression of CD59 to protect themselves from deleterious destruction by complement. However, the mechanisms that underlie CD59 regulation remain largely unknown. In this study we demonstrate that the widely expressed transcription factor Sp1 may regulate the constitutive expression of CD59, whereas CREB-binding protein (CBP)/p300 bridge NF-B and CREB, which surprisingly functions as an enhancer-binding protein to induce the up-regulation of CD59 during in lipopolysaccharide (LPS)-triggered complement activation, thus conferring host defense against further MAC-mediated destruction. Moreover, individual treatment with LPS, TNF-, and the complement activation products (sublytic MAC (SC5b-9) and C5a) could increase the expression of CD59 mainly by activating NF-B and CREB signaling pathways. Together, our findings identify a novel gene regulation mechanism involving CBP/p300, NF-B, and CREB; this mechanism suggests potential drug targets for controlling various complement-related human diseases.	[Du, Yiqun; Teng, Xiaoyan; Wang, Na; Zhang, Xin; Chen, Jianfeng; Ding, Peipei; Qiao, Qian; Wang, Qingkai; Zhang, Long; Hu, Weiguo] Fudan Univ, Shanghai Canc Ctr, Collaborat Innovat Ctr Canc Med, Inst Canc, Shanghai 200032, Peoples R China; [Du, Yiqun; Teng, Xiaoyan; Wang, Na; Zhang, Xin; Chen, Jianfeng; Ding, Peipei; Qiao, Qian; Wang, Qingkai; Zhang, Long; Hu, Weiguo] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Teng, Xiaoyan; Zhang, Xin; Chen, Jianfeng; Ding, Peipei; Qiao, Qian; Wang, Qingkai; Zhang, Long; Hu, Weiguo] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Teng, Xiaoyan; Yang, Zhangmin] Shaanxi Normal Univ, Coll Life Sci, Dept Biochem & Mol Biol, Xian 710062, Shaanxi, Peoples R China; [Yang, Chaoqun; Zhou, Xuhui] Second Mil Med Univ, Changzheng Hosp, Shanghai 200003, Peoples R China; [Chu, Yiwei; Hu, Weiguo] Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai 200032, Peoples R China; [Du, Xiang] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Pathol,Dept Oncol, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University; Shaanxi Normal University; Naval Medical University; Fudan University; Fudan University	Zhou, XH (corresponding author), Second Mil Med Univ, Changzheng Hosp, Shanghai 200003, Peoples R China.	xuhuizhou0522@163.com; weiguohu@fudan.edu.cn	Zhang, Long/HCI-5197-2022; Hu, Weiguo/AAP-2239-2021	Hu, Weiguo/0000-0002-7397-6800; Chen, Jianfeng/0000-0002-4182-145X	National Natural Science Foundation of China [91029726, 81171910]; Major State Basic Research Development Program of China [2013CB910802]; Program for New Century Excellent Talents in University, Ministry of Education of China [NCET-11-0107]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Program for Shanghai Pujiang Talent [11PJ1400500]; Shanghai Committee of Science and Technology [12DZ2260100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University, Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)Ministry of Education, China); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Program for Shanghai Pujiang Talent; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by the National Natural Science Foundation of China (91029726, 81171910), the Major State Basic Research Development Program of China (2013CB910802), the Program for New Century Excellent Talents in University (NCET-11-0107), Ministry of Education of China, the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, the Program for Shanghai Pujiang Talent (11PJ1400500), and the Shanghai Committee of Science and Technology (12DZ2260100) (to W. H.).	Aiyaz M, 2012, IMMUNOBIOLOGY, V217, P204, DOI 10.1016/j.imbio.2011.07.023; Amet T, 2012, HEPATOLOGY, V55, P354, DOI 10.1002/hep.24686; Attali G, 2004, EUR J IMMUNOL, V34, P3236, DOI 10.1002/eji.200425011; Barros MMO, 2009, TRANSFUSION, V49, P154, DOI 10.1111/j.1537-2995.2008.01936.x; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Chan HM, 2001, J CELL SCI, V114, P2363; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; Cui WJ, 2012, FEBS LETT, V586, P766, DOI 10.1016/j.febslet.2012.01.039; Dale E, 2006, ADV PHYSIOL EDUC, V30, P152, DOI 10.1152/advan.00065.2006; Donev RM, 2006, CANCER RES, V66, P2451, DOI 10.1158/0008-5472.CAN-05-3191; Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3; Gemei M, 2013, INT J BIOL MARKER, V28, P267, DOI 10.5301/JBM.5000020; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Goodman RH, 2000, GENE DEV, V14, P1553; Holguin MH, 1996, J IMMUNOL, V157, P1659; Koch N, 2009, J LEUKOCYTE BIOL, V86, P155, DOI [10.1189/jlb.0708443, 10.1189/JLB.0708443]; Langer HF, 2010, BLOOD, V116, P4395, DOI 10.1182/blood-2010-01-261503; Li B, 2011, CELL IMMUNOL, V272, P61, DOI 10.1016/j.cellimm.2011.09.006; Manderson AP, 2001, J EXP MED, V194, P747, DOI 10.1084/jem.194.6.747; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MCGEER PL, 1991, BRAIN RES, V544, P315, DOI 10.1016/0006-8993(91)90071-3; MERI S, 1991, LAB INVEST, V65, P532; Morgan BP, 2005, IMMUNOL LETT, V97, P171, DOI 10.1016/j.imlet.2004.11.010; Nevo Y, 2013, BLOOD, V121, P129, DOI 10.1182/blood-2012-07-441857; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Ruiz-Arguelles A, 2007, AUTOIMMUN REV, V6, P155, DOI 10.1016/j.autrev.2006.09.008; Rus HG, 2001, IMMUNOL REV, V180, P49, DOI 10.1034/j.1600-065X.2001.1800104.x; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Sampaziotis F, 2002, MED HYPOTHESES, V58, P136, DOI 10.1054/mehy.2001.1476; Saura CA, 2011, REV NEUROSCIENCE, V22, P153, DOI 10.1515/RNS.2011.018; SCHMITZ J, 1995, J CLIN INVEST, V96, P1520, DOI 10.1172/JCI118190; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Siu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x; Song WC, 2006, AUTOIMMUNITY, V39, P403, DOI 10.1080/08916930600739647; Spiller OB, 2000, CLIN EXP IMMUNOL, V121, P234, DOI 10.1046/j.1365-2249.2000.01305.x; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tone M, 1999, J BIOL CHEM, V274, P710, DOI 10.1074/jbc.274.2.710; Wesche-Soldato DE, 2007, CURR DRUG TARGETS, V8, P493, DOI 10.2174/138945007780362764; Wu GX, 2009, CIRC RES, V104, P550, DOI 10.1161/CIRCRESAHA.108.191361; Yang LB, 2000, J NEUROSCI, V20, P7505; Zanjani H, 2005, ALZ DIS ASSOC DIS, V19, P55, DOI 10.1097/01.wad.0000165506.60370.94; Zhu JH, 2013, J PROTEOME RES, V12, P2791, DOI 10.1021/pr400139c	48	27	29	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2711	2724		10.1074/jbc.M113.525501	http://dx.doi.org/10.1074/jbc.M113.525501			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338025	hybrid, Green Published			2022-12-28	WOS:000333403000021
J	Sampath, H; Ntambi, JM				Sampath, Harini; Ntambi, James M.			Role of Stearoyl-CoA Desaturase-1 in Skin Integrity and Whole Body Energy Balance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Energy Metabolism; Fatty Acid Metabolism; Lipids; Obesity; Skin; Energy Metabolism; Skin	ACTIVATED RECEPTOR-ALPHA; HUMAN APOLIPOPROTEIN C1; INSULIN-RESISTANCE; PROTECTS MICE; TARGETED DISRUPTION; LIPID-METABOLISM; GENE-EXPRESSION; ASEBIA MOUSE; FATTY-ACIDS; OBESITY	The skin is the single largest organ in humans, serving as a major barrier to infection, water loss, and abrasion. The functional diversity of skin requires the synthesis of large amounts of lipids, such as triglycerides, wax esters, squalene, ceramides, free cholesterol, free fatty acids, and cholesterol and retinyl esters. Some of these lipids are used as cell membrane components, signaling molecules, and a source of energy. An important class of lipid metabolism enzymes expressed in skin is the (9)-desaturases, which catalyze the synthesis in (9)-monounsaturated lipids, primarily oleoyl-CoA (18:1n-9) and palmitoyl-CoA (16:1n-7), the major monounsaturated fatty acids in cutaneous lipids. Mice with a deletion of the (9)-desaturase-1 isoform (SCD1) either globally (Scd1(-/-)) or specifically in the skin (skin-specific Scd1-knockout; SKO) present with marked changes in cutaneous lipids and skin integrity. Interestingly, these mice also exhibit increased whole body energy expenditure, protection against diet-induced adiposity, hepatic steatosis, and glucose intolerance. The increased energy expenditure in skin-specific Scd1-knockout (SKO) mice is a surprising phenotype, as it links cutaneous lipid homeostasis with whole body energy balance. This minireview summarizes the role of skin SCD1 in regulating skin integrity and whole body energy homeostasis and offers a discussion of potential pathways that may connect these seemingly disparate phenotypes.	[Sampath, Harini] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA; [Ntambi, James M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Ntambi, James M.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	Oregon Health & Science University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sampath, H (corresponding author), Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA.	sampath@ohsu.edu; ntambi@biochem.wisc.edu			American Heart Association [11POST7480004]; National Institutes of Health from NIDDK [R01162388]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK100640] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by American Heart Association Grant 11POST7480004. To whom correspondence may be addressed. E-mail: sampath@ohsu.edu.; Supported by National Institutes of Health Grant R01162388 from NIDDK. To whom correspondence may be addressed. E-mail: ntambi@biochem.wisc.edu.	Beiraghi S, 2003, GENE, V309, P11, DOI 10.1016/S0378-1119(03)00461-x; Bene H, 2001, BIOCHEM BIOPH RES CO, V284, P1194, DOI 10.1006/bbrc.2001.5102; Berry DC, 2007, PPAR RES, V2007, DOI 10.1155/2007/73256; Binczek E, 2007, BIOL CHEM, V388, P405, DOI 10.1515/BC.2007.046; Carter EA, 2011, INT J MOL MED, V28, P589, DOI 10.3892/ijmm.2011.752; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Demling RH., 2009, EPLASTY, V9, P9; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Dobrzyn P, 2008, AM J PHYSIOL-ENDOC M, V294, pE357, DOI 10.1152/ajpendo.00471.2007; ELIAS PM, 1992, SEMIN DERMATOL, V11, P176; Feingold KR, 2009, J LIPID RES, V50, pS417, DOI 10.1194/jlr.R800039-JLR200; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Flowers MT, 2012, J LIPID RES, V53, P1646, DOI 10.1194/jlr.M027508; Flowers MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019734; Fluhr JW, 2003, J INVEST DERMATOL, V120, P728, DOI 10.1046/j.1523-1747.2003.12134.x; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hart DW, 2002, ANN SURG, V235, P152, DOI 10.1097/00000658-200201000-00020; Heinemann FS, 1998, MOL BIOL CELL, V9, P3445, DOI 10.1091/mbc.9.12.3445; Heinemann FS, 2003, J BIOL CHEM, V278, P42966, DOI 10.1074/jbc.M306240200; Heinemann FS, 2003, BIOCHEMISTRY-US, V42, P6929, DOI 10.1021/bi034071x; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Hyun CK, 2010, BIOCHEM BIOPH RES CO, V399, P480, DOI 10.1016/j.bbrc.2010.07.072; Jong MC, 2001, DIABETES, V50, P2779, DOI 10.2337/diabetes.50.12.2779; Jong MC, 1998, J CLIN INVEST, V101, P145, DOI 10.1172/JCI791; Kato H, 2006, J CELL SCI, V119, P2342, DOI 10.1242/jcs.02951; Lee SH, 2004, J LIPID RES, V45, P1674, DOI 10.1194/jlr.M400039-JLR200; Liu XQ, 2011, ADV NUTR, V2, P15, DOI 10.3945/an.110.000125; Lodhi IJ, 2009, CELL METAB, V9, P111, DOI 10.1016/j.cmet.2009.01.004; Lotti T, 2010, DERMATOL THER, V23, P119, DOI 10.1111/j.1529-8019.2010.01305.x; Man WC, 2006, J BIOL CHEM, V281, P1251, DOI 10.1074/jbc.M508733200; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Miyazaki M, 2006, J LIPID RES, V47, P700, DOI 10.1194/jlr.C500025-JLR200; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Miyazaki M, 2005, P NATL ACAD SCI USA, V102, P12501, DOI 10.1073/pnas.0503132102; Miyazaki M, 2003, J BIOL CHEM, V278, P33904, DOI 10.1074/jbc.M304724200; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Miyazaki M, 2001, J LIPID RES, V42, P1018; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Miyazaki M, 2009, BIOCHEM BIOPH RES CO, V380, P818, DOI 10.1016/j.bbrc.2009.01.183; Naldi L, 2010, DERMATOL THER, V23, P114, DOI 10.1111/j.1529-8019.2010.01304.x; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Overton JM, 2004, PHYSIOL BEHAV, V81, P749, DOI 10.1016/j.physbeh.2004.04.025; Padhi Tanmay, 2013, Indian J Dermatol, V58, P299, DOI 10.4103/0019-5154.113950; Parimoo S, 1999, J INVEST DERM SYMP P, V4, P320, DOI 10.1038/sj.jidsp.5640238; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Romanowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009701; Sampath H, 2006, CURR OPIN CLIN NUTR, V9, P84, DOI 10.1097/01.mco.0000214564.59815.af; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Sampath H, 2008, FUTURE LIPIDOL, V3, P163, DOI 10.2217/17460875.3.2.163; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Sampath H, 2011, DERM-ENDOCRINOL, V3, P62, DOI 10.4161/derm.3.2.14832; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Sampath H, 2009, J BIOL CHEM, V284, P19961, DOI 10.1074/jbc.M109.014225; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Stenn KS, 2001, J CUTAN PATHOL, V28, P445, DOI 10.1034/j.1600-0560.2001.028009445.x; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; WILMORE DW, 1975, J APPL PHYSIOL, V38, P593, DOI 10.1152/jappl.1975.38.4.593; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Zhang L, 2001, BIOCHEM J, V357, P183, DOI 10.1042/0264-6021:3570183; Zhang SB, 2005, BIOCHEM J, V388, P135, DOI 10.1042/BJ20041554; Zheng Y, 1999, NAT GENET, V23, P268, DOI 10.1038/15446; Zheng Y, 2001, GENOMICS, V71, P182, DOI 10.1006/geno.2000.6429	67	48	50	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2482	2488		10.1074/jbc.R113.516716	http://dx.doi.org/10.1074/jbc.R113.516716			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24356954	hybrid, Green Published			2022-12-28	WOS:000333403000001
J	Valderrama, JA; Shingler, V; Carmona, M; Diaz, E				Andres Valderrama, J.; Shingler, Victoria; Carmona, Manuel; Diaz, Eduardo			AccR Is a Master Regulator Involved in Carbon Catabolite Repression of the Anaerobic Catabolism of Aromatic Compounds in Azoarcus sp CIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Transcription; Gene Regulation; Microbiology; Protein-DNA Interaction; Signal Transduction; Transcription Regulation; Anaerobic Degradation; Azoarcus; Carbon Catabolite Repression	CRC GLOBAL REGULATOR; GRAM-NEGATIVE BACTERIA; SP STRAIN CIB; PSEUDOMONAS-PUTIDA; RESPONSE REGULATOR; ESCHERICHIA-COLI; CENTRAL PATHWAY; SUICIDE VECTOR; EXPRESSION; BENZOATE	Here we characterized the first known transcriptional regulator that accounts for carbon catabolite repression (CCR) control of the anaerobic catabolism of aromatic compounds in bacteria. The AccR response regulator of Azoarcus sp. CIB controls succinate-responsive CCR of the central pathways for the anaerobic catabolism of aromatics by this strain. Phosphorylation of AccR to AccR-P triggers a monomer-to-dimer transition as well as the ability to bind to the target promoter and causes repression both in vivo and in vitro. Substitution of the Asp(60) phosphorylation target residue of the N-terminal receiver motif of AccR to a phosphomimic Glu residue generates a constitutively active derivative that behaves as a superrepressor of the target genes. AccR-P binds in vitro to a conserved inverted repeat (ATGCA-N-6-TGCAT) present at two different locations within the P-N promoter of the bzd genes for anaerobic benzoate degradation. Because the DNA binding-proficient C-terminal domain of AccR is monomeric, we propose an activation mechanism in which phosphorylation of Asp(60) of AccR alleviates interdomain repression mediated by the N-terminal domain. The presence of AccR-like proteins encoded in the genomes of other -proteobacteria of the Azoarcus/Thauera group further suggests that AccR constitutes a master regulator that controls anaerobic CCR in these bacteria.	[Andres Valderrama, J.; Carmona, Manuel; Diaz, Eduardo] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid 28040, Spain; [Shingler, Victoria] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Umea University	Diaz, E (corresponding author), CSIC, Ctr Invest Biol, Dept Environm Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	ediaz@cib.csic.es	Valderrama, Jonathan Andres/AAC-1098-2021; Diaz, Eduardo/F-8605-2016	Diaz, Eduardo/0000-0002-9731-6524; Shingler, Victoria/0000-0002-7349-1678; Valderrama Traslavina, J. Andres/0000-0001-7440-4225; Carmona, Manuel/0000-0002-1591-7618	Ministry of Economy and Competitiveness of Spain [BIO2009-10438, CSD2007-00005, BIO2012-39501]; European Union [311815]; Swedish Research Council [621-2011-4791]; Ministry of Economy and Competitiveness of Spain	Ministry of Economy and Competitiveness of Spain(Spanish Government); European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ministry of Economy and Competitiveness of Spain(Spanish Government)	This work was supported by Ministry of Economy and Competitiveness of Spain Grants BIO2009-10438, CSD2007-00005, and BIO2012-39501), European Union FP7 Grant 311815, and Swedish Research Council Grant 621-2011-4791.	Valderrama JA, 2012, J BIOL CHEM, V287, P10494, DOI 10.1074/jbc.M111.309005; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Barragan MJL, 2005, J BIOL CHEM, V280, P10683, DOI 10.1074/jbc.M412259200; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Collier DN, 1996, RES MICROBIOL, V147, P551, DOI 10.1016/0923-2508(96)84011-3; Da Re S, 1999, MOL MICROBIOL, V34, P504, DOI 10.1046/j.1365-2958.1999.01614.x; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Durante-Rodriguez G, 2006, J BACTERIOL, V188, P2343, DOI 10.1128/JB.188.7.2343-2354.2006; Durante-Rodriguez G, 2008, MICROBIOL-SGM, V154, P306, DOI 10.1099/mic.0.2007/011361-0; Durante-Rodriguez G, 2010, J BIOL CHEM, V285, P35694, DOI 10.1074/jbc.M110.143503; Felsenstein J., 1993, PHYLYP PHYLOGENETIC; Fonseca P, 2013, ENVIRON MICROBIOL, V15, P24, DOI 10.1111/j.1462-2920.2012.02708.x; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Heider J, 1998, ARCH MICROBIOL, V170, P120, DOI 10.1007/s002030050623; Hernandez-Arranz S, 2013, ENVIRON MICROBIOL, V15, P227, DOI 10.1111/j.1462-2920.2012.02863.x; Hester KL, 2000, J BACTERIOL, V182, P1150, DOI 10.1128/JB.182.4.1150-1153.2000; Juarez JF, 2013, ENVIRON MICROBIOL, V15, P148, DOI 10.1111/j.1462-2920.2012.02818.x; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KILEY PJ, 1991, J BACTERIOL, V173, P16, DOI 10.1128/jb.173.1.16-22.1991; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KLOSE KE, 1993, J MOL BIOL, V232, P67, DOI 10.1006/jmbi.1993.1370; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurashima-Ito K, 2005, BIOCHEMISTRY-US, V44, P14835, DOI 10.1021/bi0509043; Lan CY, 1998, J BACTERIOL, V180, P171, DOI 10.1128/JB.180.1.171-174.1998; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Leoni L, 2003, BIOCHEM BIOPH RES CO, V303, P926, DOI 10.1016/S0006-291X(03)00450-9; MACGREGOR CH, 1991, J BACTERIOL, V173, P7204, DOI 10.1128/jb.173.22.7204-7212.1991; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Marques S, 2006, CURR OPIN BIOTECH, V17, P50, DOI 10.1016/j.copbio.2005.12.001; Mattison K, 2002, J BIOL CHEM, V277, P32714, DOI 10.1074/jbc.M204122200; Maxam A M, 1980, Methods Enzymol, V65, P499; Milani M, 2005, STRUCTURE, V13, P1289, DOI 10.1016/j.str.2005.05.014; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Milojevic T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064609; Morales G, 2004, J BACTERIOL, V186, P1337, DOI 10.1128/JB.186.5.1337-1344.2004; Morales G, 2006, ENVIRON MICROBIOL, V8, P1764, DOI 10.1111/j.1462-2920.2006.01061.x; Moreno R, 2012, MOL MICROBIOL, V83, P24, DOI 10.1111/j.1365-2958.2011.07912.x; Moreno R, 2010, J BIOL CHEM, V285, P24412, DOI 10.1074/jbc.M110.126615; Moreno R, 2009, PROTEOMICS, V9, P2910, DOI 10.1002/pmic.200800918; Moreno-Ruiz E, 2003, J BACTERIOL, V185, P2026, DOI 10.1128/JB.185.6.2026-2030.2003; Ohtsubo Y, 2006, MOL MICROBIOL, V60, P1563, DOI 10.1111/j.1365-2958.2006.05197.x; Petruschka L, 2001, MOL GENET GENOMICS, V266, P199, DOI 10.1007/s004380100539; Pfluger K, 2008, J BACTERIOL, V190, P3374, DOI 10.1128/JB.02002-07; Prieto MA, 2004, FEMS MICROBIOL REV, V28, P503, DOI 10.1016/j.femsre.2004.04.004; Rojo F, 2010, FEMS MICROBIOL REV, V34, P658, DOI 10.1111/j.1574-6976.2010.00218.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shingler V, 2003, ENVIRON MICROBIOL, V5, P1226, DOI 10.1111/j.1462-2920.2003.00472.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trautwein K, 2012, J BACTERIOL, V194, P518, DOI 10.1128/JB.05072-11; Valentini M, 2013, ENVIRON MICROBIOL, V15, P1707, DOI 10.1111/1462-2920.12056	57	14	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1892	1904		10.1074/jbc.M113.517714	http://dx.doi.org/10.1074/jbc.M113.517714			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24302740	Green Published, hybrid			2022-12-28	WOS:000331130200002
J	Tamai, S; Imaizumi, K; Kurabayashi, N; Nguyen, MD; Abe, T; Inoue, M; Fukada, Y; Sanada, K				Tamai, So-ichi; Imaizumi, Keisuke; Kurabayashi, Nobuhiro; Minh Dang Nguyen; Abe, Takaya; Inoue, Masatoshi; Fukada, Yoshitaka; Sanada, Kamon			Neuroprotective Role of the Basic Leucine Zipper Transcription Factor NFIL3 in Models of Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyotrophic Lateral Sclerosis (Lou Gehrig Disease); Clock Genes; Neurodegeneration; Neurodegenerative Diseases; Neuroprotection; NFIL3	MOTOR-NEURON DEGENERATION; GENE-EXPRESSION; DISEASE PROGRESSION; MOLECULAR PATHWAYS; CIRCADIAN CLOCK; E4BP4; INDUCTION; REGULATOR	Background: ALS is a motor neuron disease characterized by the loss of axons and neurons. Results: NFIL3 protects neurons in cellular and animal models of ALS. Conclusion: NFIL3 is a neuroprotective molecule intrinsic to neurons. Significance: NFIL3 is a potential therapeutic target for the treatment of ALS and related neurodegenerative diseases. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the loss of motor neurons. Here we show that the basic leucine zipper transcription factor NFIL3 (also called E4BP4) confers neuroprotection in models of ALS. NFIL3 is up-regulated in primary neurons challenged with neurotoxic insults and in a mouse model of ALS. Overexpression of NFIL3 attenuates excitotoxic neuronal damage and protects neurons against neurodegeneration in a cell-based ALS model. Conversely, reduction of NFIL3 exacerbates neuronal demise in adverse conditions. Transgenic neuronal expression of NFIL3 in ALS mice delays disease onset and attenuates motor axon and neuron degeneration. These results suggest that NFIL3 plays a neuroprotective role in neurons and constitutes a potential therapeutic target for neurodegeneration.	[Tamai, So-ichi; Imaizumi, Keisuke; Kurabayashi, Nobuhiro; Sanada, Kamon] Univ Tokyo, Mol Genet Res Lab, Grad Sch Sci, Tokyo 1130033, Japan; [Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Abe, Takaya] RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan; [Inoue, Masatoshi; Fukada, Yoshitaka] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Tokyo 1130033, Japan	University of Tokyo; University of Calgary; University of Calgary; University of Calgary; RIKEN; University of Tokyo	Fukada, Y (corresponding author), Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	sfukada@mail.ecc.u-tokyo.ac.jp; kamon_sanada@gen.s.u-tokyo.ac.jp	KURABAYASHI, NOBUHIRO/G-4891-2014; 吉孝, 深田/G-5090-2014; SANADA, YOSHIKADO/G-5014-2014	Sanada, Kamon/0000-0002-0280-8957; Inoue, Masatoshi/0000-0001-5077-0052; Kurabayashi, Nobuhiro/0000-0003-3097-8539	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Canadian Institutes of Health Research; Grants-in-Aid for Scientific Research [24650161, 26640005] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. K., Y. F., and K. S.) and by an operating grant from the Canadian Institutes of Health Research (to M. D. N).	Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; COWELL IG, 1992, MOL CELL BIOL, V12, P3070, DOI 10.1128/MCB.12.7.3070; Doi M, 2004, CURR BIOL, V14, P975, DOI 10.1016/j.cub.2004.05.043; Doi M, 2001, P NATL ACAD SCI USA, V98, P8089, DOI 10.1073/pnas.141090998; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hua H, 2006, CANCER SCI, V97, P589, DOI 10.1111/j.1349-7006.2006.00225.x; Inoue H, 2003, EMBO J, V22, P6665, DOI 10.1093/emboj/cdg634; Junghans D, 2004, DEVELOPMENT, V131, P4425, DOI 10.1242/dev.01313; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Krestel HE, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e39; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; MacGillavry HD, 2009, J NEUROSCI, V29, P15542, DOI 10.1523/JNEUROSCI.3938-09.2009; Male V, 2012, TRENDS IMMUNOL, V33, P98, DOI 10.1016/j.it.2011.10.002; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Nishimura Y, 2001, J BIOL CHEM, V276, P19921, DOI 10.1074/jbc.M010332200; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Takeuchi S, 2010, J NEUROPATH EXP NEUR, V69, P1044, DOI 10.1097/NEN.0b013e3181f4a90a; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; ZHANG W, 1995, MOL CELL BIOL, V15, P6055	28	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1629	1638		10.1074/jbc.M113.524389	http://dx.doi.org/10.1074/jbc.M113.524389			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24280221	Green Published, hybrid			2022-12-28	WOS:000332401700036
J	Wang, L; Uhlig, PC; Eikenberry, EF; Robenek, H; Bruckner, P; Hansen, U				Wang, Lei; Uhlig, Philipp C.; Eikenberry, Eric F.; Robenek, Horst; Bruckner, Peter; Hansen, Uwe			Lateral Growth Limitation of Corneal Fibrils and Their Lamellar Stacking Depend on Covalent Collagen Cross-linking by Transglutaminase-2 and Lysyl Oxidases, Respectively	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GELS; SKIN FRAGILITY; FILM DETECTION; STROMA; DECORIN; FIBRILLOGENESIS; ULTRASTRUCTURE; ORGANIZATION; FIBROBLASTS; EXPRESSION	Corneal stroma contains an extracellular matrix of orthogonal lamellae formed by parallel and equidistant fibrils with a homogeneous diameter of similar to 35 nm. This is indispensable for corneal transparency and mechanical functions. However, the mechanisms controlling corneal fibrillogenesis are incompletely understood and the conditions required for lamellar stacking are essentially unknown. Under appropriate conditions, chick embryo corneal fibroblasts can produce an extracellular matrix in vitro resembling primary corneal stroma during embryonic development. Among other requirements, cross-links between fibrillar collagens, introduced by tissue transglutaminase-2, are necessary for the self-assembly of uniform, small diameter fibrils but not their lamellar stacking. By contrast, the subsequent lamellar organization into plywood-like stacks depends on lysyl aldehyde-derived cross-links introduced by lysyl oxidase activity, which, in turn, only weakly influences fibril diameters. These cross-links are introduced at early stages of fibrillogenesis. The enzymes are likely to be important for a correct matrix deposition also during repair of the cornea.	[Wang, Lei; Uhlig, Philipp C.; Bruckner, Peter; Hansen, Uwe] Univ Hosp Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Robenek, Horst] Leibniz Inst Arteriosclerosis Res, D-48149 Munster, Germany	University of Munster	Hansen, U (corresponding author), Univ Hosp Munster, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.	peter.bruckner@uni-muenster.de	Bruckner, Peter/F-4817-2019	Bruckner, Peter/0000-0002-5566-5611	Deutsche Forschungsgemeinschaft [SFB 492]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant SFB 492 and Projects A2 and B3.	BARD JBL, 1993, J CELL SCI, V105, P1045; BARD JBL, 1977, J CELL BIOL, V74, P816, DOI 10.1083/jcb.74.3.816; Birk DE, 2011, BIOL EXTRACELL MATR, P77, DOI 10.1007/978-3-642-16555-9_3; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BIRK DE, 1984, J CELL BIOL, V99, P2024, DOI 10.1083/jcb.99.6.2024; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BRUNS RR, 1987, INVEST OPHTH VIS SCI, V28, P1939; Chakravarti S, 2003, INVEST OPHTH VIS SCI, V44, P2422, DOI 10.1167/iovs.02-0783; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen SJ, 2010, DEV DYNAM, V239, P844, DOI 10.1002/dvdy.22216; CRAIG AS, 1981, J ULTRA MOL STRUCT R, V74, P232, DOI 10.1016/S0022-5320(81)80081-0; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; GELMAN RA, 1979, J BIOL CHEM, V254, P180; Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216; Hansen U, 2006, MATRIX BIOL, V25, P252, DOI 10.1016/j.matbio.2006.01.005; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Hay E D, 1969, Monogr Dev Biol, V1, P1; HUNZIKER EB, 1984, J CELL BIOL, V98, P267, DOI 10.1083/jcb.98.1.267; KEENE DR, 1987, J CELL BIOL, V105, P2393, DOI 10.1083/jcb.105.5.2393; Koch M, 2003, J BIOL CHEM, V278, P43236, DOI 10.1074/jbc.M302112200; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; Linsenmayer TF, 1998, PROG RETIN EYE RES, V17, P231; LINSENMAYER TF, 1983, J CELL BIOL, V96, P124, DOI 10.1083/jcb.96.1.124; Meek KM, 2001, MICRON, V32, P261, DOI 10.1016/S0968-4328(00)00041-X; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; PROCKOP DJ, 1982, METHOD ENZYMOL, V82, P305; Raghunath M, 1999, INVEST OPHTH VIS SCI, V40, P2780; Ruberti JW, 2008, PROG RETIN EYE RES, V27, P549, DOI 10.1016/j.preteyeres.2008.08.001; SCOTT JE, 1991, BIOCHEM SOC T, V19, P877, DOI 10.1042/bst0190877; Tsukahara N, 2010, J VET MED SCI, V72, P1137, DOI 10.1292/jvms.09-0470; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; Yamauchi M, 1996, BIOCHEM BIOPH RES CO, V219, P311, DOI 10.1006/bbrc.1996.0229; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhang W, 2004, CURR EYE RES, V28, P37, DOI 10.1076/ceyr.28.1.37.23493	38	13	13	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					921	929		10.1074/jbc.M113.496364	http://dx.doi.org/10.1074/jbc.M113.496364			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265319	Green Published, hybrid			2022-12-28	WOS:000330541200027
J	Blenner, MA; Dong, XC; Springer, TA				Blenner, Mark A.; Dong, Xianchi; Springer, Timothy A.			Structural Basis of Regulation of von Willebrand Factor Binding to Glycoprotein Ib	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Directed Evolution; Immunology; Protein Folding; Structural Biology; von Willebrand Factor; Glycoprotein Ib; Yeast Display	FACTOR A1 DOMAIN; LEUCINE-RICH REPEATS; IX-V COMPLEX; CRYSTAL-STRUCTURE; ALPHA-THROMBIN; SNAKE-VENOM; DISEASE; RECEPTOR; ADHESION; REVEALS	Background: Force in fluid flow regulates von Willebrand factor (VWF) A1 domain binding to glycoprotein Ib (GPIb). Results: X-ray crystal structures of high affinity A1-GPIb complexes and mutations reveal interactions involving central leucine-rich repeats of GPIb. Conclusion: Structural changes are on a pathway to a force-induced super high affinity state. Significance: A1-GPIb complexes provide insight into mechanochemistry of bleeding disorders. Activation by elongational flow of von Willebrand factor (VWF) is critical for primary hemostasis. Mutations causing type 2B von Willebrand disease (VWD), platelet-type VWD (PT-VWD), and tensile force each increase affinity of the VWF A1 domain and platelet glycoprotein Ib (GPIb) for one another; however, the structural basis for these observations remains elusive. Directed evolution was used to discover a further gain-of-function mutation in A1 that shifts the long range disulfide bond by one residue. We solved multiple crystal structures of this mutant A1 and A1 containing two VWD mutations complexed with GPIb containing two PT-VWD mutations. We observed a gained interaction between A1 and the central leucine-rich repeats (LRRs) of GPIb, previously shown to be important at high shear stress, and verified its importance mutationally. These findings suggest that structural changes, including central GPIb LRR-A1 contact, contribute to VWF affinity regulation. Among the mutant complexes, variation in contacts and poor complementarity between the GPIb -finger and the region of A1 harboring VWD mutations lead us to hypothesize that the structures are on a pathway to, but have not yet reached, a force-induced super high affinity state.	[Springer, Timothy A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Springer, Timothy A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, 3 Blackfan Circle, Boston, MA 02115 USA.	timothy.springer@childrens.harvard.edu	Blenner, Mark/AAP-9422-2021; Dong, Xianchi/C-1393-2015	Dong, Xianchi/0000-0001-5121-1236	National Institutes of Health [HL-103526, NIH-1F32HL-099167]; American Heart Association [AHA-10POST4170043]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL099167, R01HL108248, P01HL103526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-103526 and Postdoctoral Fellowship NIH-1F32HL-099167 (to M. A. B.). This work was also supported by American Heart Association Postdoctoral Fellowship AHA-10POST4170043 (to M. A. B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Cauwenberghs N, 2001, BLOOD, V98, P652, DOI 10.1182/blood.V98.3.652; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Celikel R, 2003, SCIENCE, V301, P218, DOI 10.1126/science.1084183; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Luca M, 2000, BLOOD, V95, P164; Dong JF, 2001, BLOOD, V97, P162, DOI 10.1182/blood.V97.1.162; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Dumas JJ, 2003, SCIENCE, V301, P222, DOI 10.1126/science.1083917; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Flood VH, 2009, J THROMB HAEMOST, V7, P1832, DOI 10.1111/j.1538-7836.2009.03594.x; Flood VH, 2010, BLOOD, V116, P280, DOI 10.1182/blood-2009-10-249102; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6; GINSBURG D, 1993, THROMB HAEMOSTASIS, V69, P177; Huang RH, 2009, STRUCTURE, V17, P1476, DOI 10.1016/j.str.2009.09.011; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim J, 2010, NATURE, V466, P992, DOI 10.1038/nature09295; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Maita N, 2003, J BIOL CHEM, V278, P37777, DOI 10.1074/jbc.M305566200; McEwan PA, 2009, BLOOD, V114, P4883, DOI 10.1182/blood-2009-05-224170; Mi LZ, 2008, BIOCHEMISTRY-US, V47, P10314, DOI 10.1021/bi801006s; Miura S, 2000, J BIOL CHEM, V275, P7539, DOI 10.1074/jbc.275.11.7539; Othman M, 2013, SEMIN THROMB HEMOST, V39, P663, DOI 10.1055/s-0033-1353442; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; Shen Y, 2006, J BIOL CHEM, V281, P26419, DOI 10.1074/jbc.M604296200; Song GJ, 2012, P NATL ACAD SCI USA, V109, P21420, DOI 10.1073/pnas.1218581109; Springer TA, 2011, J THROMB HAEMOST, V9, P130, DOI 10.1111/j.1538-7836.2011.04320.x; Tait AS, 2001, BLOOD, V98, P1812, DOI 10.1182/blood.V98.6.1812; Uff S, 2002, J BIOL CHEM, V277, P35657, DOI 10.1074/jbc.M205271200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Varughese KI, 2004, ACTA CRYSTALLOGR D, V60, P405, DOI 10.1107/S0907444903026805; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049; Zarpellon A, 2011, P NATL ACAD SCI USA, V108, P8628, DOI 10.1073/pnas.1017042108; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zhou YF, 2011, EMBO J, V30, P4098, DOI 10.1038/emboj.2011.297	51	47	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5565	5579		10.1074/jbc.M113.511220	http://dx.doi.org/10.1074/jbc.M113.511220			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24391089	hybrid, Green Published			2022-12-28	WOS:000332015500022
J	Wang, J; Song, JL; An, C; Dong, WJ; Zhang, JX; Yin, CC; Hale, J; Baines, AJ; Mohandas, N; An, XL				Wang, Jie; Song, Jinlei; An, Chao; Dong, Wenji; Zhang, Jingxin; Yin, Changcheng; Hale, John; Baines, Anthony J.; Mohandas, Narla; An, Xiuli			A 130-kDa Protein 4.1B Regulates Cell Adhesion, Spreading, and Migration of Mouse Embryo Fibroblasts by Influencing Actin Cytoskeleton Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Adhesion; Cytoskeleton; Membrane; Migration	C-TERMINAL-DOMAIN; TUMOR-SUPPRESSOR; FUNCTIONAL-CHARACTERIZATION; HEREDITARY ELLIPTOCYTOSIS; MEMBRANE-PROTEINS; MYELINATED AXONS; LUNG-CANCER; FERM DOMAIN; BAND 4.1B; FAMILY	Background: The function of protein 4.1B in behaviors of motile cells remains poorly understood. Results: Deficiency of 130-kDa 4.1B resulted in impaired cell adhesion, spreading, migration, and stress fiber formation. Conclusion: Protein 4.1B plays an important role in modulating cell adhesion and motility. Significance: Our results identify a novel function for protein 4.1B and have implications for understanding the mechanisms of 4.1 function. Protein 4.1B is a member of protein 4.1 family, adaptor proteins at the interface of membranes and the cytoskeleton. It is expressed in most mammalian tissues and is known to be required in formation of nervous and cardiac systems; it is also a tumor suppressor with a role in metastasis. Here, we explore functions of 4.1B using primary mouse embryonic fibroblasts (MEF) derived from wild type and 4.1B knock-out mice. MEF cells express two 4.1B isoforms: 130 and 60-kDa. 130-kDa 4.1B was absent from 4.1B knock-out MEF cells, but 60-kDa 4.1B remained, suggesting incomplete knock-out. Although the 130-kDa isoform was predominantly located at the plasma membrane, the 60-kDa isoform was enriched in nuclei. 130-kDa-deficient 4.1B MEF cells exhibited impaired cell adhesion, spreading, and migration; they also failed to form actin stress fibers. Impaired cell spreading and stress fiber formation were rescued by re-expression of the 130-kDa 4.1B but not the 60-kDa 4.1B. Our findings document novel, isoform-selective roles for 130-kDa 4.1B in adhesion, spreading, and migration of MEF cells by affecting actin organization, giving new insight into 4.1B functions in normal tissues as well as its role in cancer.	[Wang, Jie; Song, Jinlei; Zhang, Jingxin; Yin, Changcheng] Peking Univ, Hlth Sci Ctr, Dept Biophys, Beijing 100191, Peoples R China; [Wang, Jie; An, Xiuli] New York Blood Ctr, Membrane Biol Lab, New York, NY 10065 USA; [An, Chao; Hale, John; Mohandas, Narla] New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10065 USA; [Dong, Wenji] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Cell Biol, Beijing 100005, Peoples R China; [Dong, Wenji] Peking Union Med Coll, Beijing 100005, Peoples R China; [Baines, Anthony J.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [An, Xiuli] Zhengzhou Univ, Coll Life Sci, Zhengzhou 450051, Peoples R China	Peking University; New York Blood Center; New York Blood Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Kent; Zhengzhou University	Yin, CC (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biophys, Xueyuan Rd, Beijing 100191, Peoples R China.	ccyin@bjmu.edu.cn; xan@nybloodcenter.org		Hale, John/0000-0001-8624-584X; Baines, Anthony/0000-0003-3068-7811; Yin, Chang-Cheng/0000-0001-7748-3205	National Institutes of Health [DK 26263, DK 32094]; Natural Science Foundation of China [81171905, 81272187]; American Society of Hematology (ASH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263, R01DK026263, P01DK032094] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Society of Hematology (ASH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 26263 and DK 32094. This work was also supported by Natural Science Foundation of China Grants 81171905 and 81272187 and by an American Society of Hematology (ASH) bridge grant (to X. A.).	An XL, 2006, BIOCHEMISTRY-US, V45, P5725, DOI 10.1021/bi060015v; An XL, 2001, J BIOL CHEM, V276, P35778, DOI 10.1074/jbc.M101364200; Baines AJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-85; Baines AJ, 2014, BBA-BIOMEMBRANES, V1838, P605, DOI 10.1016/j.bbamem.2013.05.030; Baines AJ, 2010, PROTOPLASMA, V244, P99, DOI 10.1007/s00709-010-0181-1; Bridgewater RE, 2012, J CELL SCI, V125, P3695, DOI 10.1242/jcs.095810; Busam RD, 2011, J BIOL CHEM, V286, P4511, DOI 10.1074/jbc.M110.174011; Buttermore ED, 2011, J NEUROSCI, V31, P8013, DOI 10.1523/JNEUROSCI.1015-11.2011; Cavanna T, 2007, J CELL SCI, V120, P606, DOI 10.1242/jcs.000273; Chen LX, 2011, J CELL SCI, V124, P2478, DOI 10.1242/jcs.078170; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Cifuentes-Diaz C, 2011, PLOS ONE, V6; Conboy J, 1999, P SOC EXP BIOL MED, V220, P73, DOI 10.1046/j.1525-1373.1999.d01-12.x; CORREAS I, 1986, J BIOL CHEM, V261, P3362; Denisenko-Nehrbass N, 2003, EUR J NEUROSCI, V17, P411, DOI 10.1046/j.1460-9568.2003.02441.x; Einheber S, 2013, GLIA, V61, P240, DOI 10.1002/glia.22430; Gascard P, 2004, BBA-GENE STRUCT EXPR, V1680, P71, DOI 10.1016/j.bbaexp.2004.08.006; Gascard P, 1999, MOL BIOL CELL, V10, P1783, DOI 10.1091/mbc.10.6.1783; Gimm JA, 2002, BIOCHEMISTRY-US, V41, P7275, DOI 10.1021/bi0256330; Gutmann DH, 2001, NEUROBIOL DIS, V8, P266, DOI 10.1006/nbdi.2000.0376; Gutmann DH, 2000, HUM MOL GENET, V9, P1495, DOI 10.1093/hmg/9.10.1495; Han BG, 2000, NAT STRUCT BIOL, V7, P871; Jung Y, 2012, BIOCHEM BIOPH RES CO, V426, P578, DOI 10.1016/j.bbrc.2012.08.129; Jung YS, 2011, DEV DYNAM, V240, P271, DOI 10.1002/dvdy.22513; Kang QZ, 2009, BLOOD, V113, P6128, DOI 10.1182/blood-2008-10-182329; Kang QZ, 2009, J CELL SCI, V122, P1091, DOI 10.1242/jcs.039644; Liu CR, 2013, J BIOL CHEM, V288, P11407, DOI 10.1074/jbc.M112.436659; Luque CM, 1998, J BIOL CHEM, V273, P11643, DOI 10.1074/jbc.273.19.11643; Luque CM, 2000, J CELL SCI, V113, P2485; McCarty JH, 2005, P NATL ACAD SCI USA, V102, P13479, DOI 10.1073/pnas.0506068102; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Moleirinho S, 2013, BIOCHEM J, V452, P183, DOI 10.1042/BJ20121642; Nunomura W., 2011, INT J CELL BIOL, V2011; Nunomura W, 2012, BIOCHEM J, V446, P427, DOI 10.1042/BJ20120535; Nunomura W, 2009, BIOCHEM J, V417, P141, DOI 10.1042/BJ20081372; Parra M, 2004, GENOMICS, V84, P637, DOI 10.1016/j.ygeno.2004.06.004; Parra M, 2000, J BIOL CHEM, V275, P3247, DOI 10.1074/jbc.275.5.3247; Parra MK, 2008, EMBO J, V27, P122, DOI 10.1038/sj.emboj.7601957; Peters LL, 1998, GENOMICS, V54, P348, DOI 10.1006/geno.1998.5537; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Ralston KJ, 2004, J BIOL CHEM, V279, P33816, DOI 10.1074/jbc.M401040200; Ruiz-Saenz A, 2011, J CELL SCI, V124, P2529, DOI 10.1242/jcs.083634; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Salomao M, 2010, BLOOD, V116, P267, DOI 10.1182/blood-2010-02-264127; Scott C, 2001, EUR J BIOCHEM, V268, P3709, DOI 10.1046/j.1432-1327.2001.02276.x; Stagg MA, 2008, CIRC RES, V103, P855, DOI 10.1161/CIRCRESAHA.108.176461; Sun CX, 2002, J CELL SCI, V115, P3991, DOI 10.1242/jcs.00094; TCHERNIA G, 1981, J CLIN INVEST, V68, P454, DOI 10.1172/JCI110275; Tran YK, 1999, CANCER RES, V59, P35; Xu J., 2005, CURR PROTOC MOL BIOL; Yageta M, 2002, CANCER RES, V62, P5129; Yang SM, 2009, BBA-BIOMEMBRANES, V1788, P1458, DOI 10.1016/j.bbamem.2009.03.022; Yi CL, 2005, MOL CELL BIOL, V25, P10052, DOI 10.1128/MCB.25.22.10052-10059.2005; Yu HF, 2011, FRONT BIOSCI-LANDMRK, V16, P1536, DOI 10.2741/3803; Yu TX, 2002, BIOCHEM J, V365, P783, DOI 10.1042/BJ20020060; Zhang YJ, 2012, TUMOR BIOL, V33, P1915, DOI 10.1007/s13277-012-0452-x	56	11	12	5	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5925	5937		10.1074/jbc.M113.516617	http://dx.doi.org/10.1074/jbc.M113.516617			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24381168	hybrid, Green Published			2022-12-28	WOS:000332015500049
J	Hughan, SC; Spring, CM; Schoenwaelder, SM; Sturgeon, S; Alwis, I; Yuan, YP; McFadyen, JD; Westein, E; Goddard, D; Ono, A; Yamanashi, Y; Nesbitt, WS; Jackson, SP				Hughan, Sascha C.; Spring, Christopher M.; Schoenwaelder, Simone M.; Sturgeon, Sharelle; Alwis, Imala; Yuan, Yuping; McFadyen, James D.; Westein, Erik; Goddard, Duncan; Ono, Akiko; Yamanashi, Yuji; Nesbitt, Warwick S.; Jackson, Shaun P.			Dok-2 Adaptor Protein Regulates the Shear- dependent Adhesive Function of Platelet Integrin alpha(II)beta(3) in Mice*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Proteins; Integrins; Mechanotransduction; Platelets; Shear Stress	VON-WILLEBRAND-FACTOR; RASGAP-BINDING PROTEINS; T-CELL-RECEPTOR; NEGATIVE REGULATION; THROMBUS FORMATION; TYROSINE PHOSPHORYLATION; ANTIPLATELET THERAPY; MURINE PLATELETS; CALCIUM SIGNALS; FAMILY-MEMBERS	Background: Dok proteins are negative regulators of immunoreceptor signaling and, potentially, integrin adhesion receptors. Results: Deficiency of Dok-2 results in enhanced shear-dependent integrin adhesion in platelets, leading to accelerated platelet thrombus growth. Conclusion: Dok-2 is a shear-specific negative regulator of blood clot formation. Significance: Dok-2 regulates biomechanical platelet adhesion, and targeting this molecule may provide new avenues to regulate thrombosis. The Dok proteins are a family of adaptor molecules that have a well defined role in regulating cellular migration, immune responses, and tumor progression. Previous studies have demonstrated that Doks-1 to 3 are expressed in platelets and that Dok-2 is tyrosine-phosphorylated downstream of integrin (IIb3), raising the possibility that it participates in integrin (IIb3) outside-in signaling. We demonstrate that Dok-2 in platelets is primarily phosphorylated by Lyn kinase. Moreover, deficiency of Dok-2 leads to dysregulated integrin (IIb3)-dependent cytosolic calcium flux and phosphatidylinositol(3,4)P-2 accumulation. Although agonist-induced integrin (IIb3) affinity regulation was unaltered in Dok-2(-/-) platelets, Dok-2 deficiency was associated with a shear-dependent increase in integrin (IIb3) adhesive function, resulting in enhanced platelet-fibrinogen and platelet-platelet adhesive interactions under flow. This increase in adhesion was restricted to discoid platelets and involved the shear-dependent regulation of membrane tethers. Dok-2 deficiency was associated with an increased rate of platelet aggregate formation on thrombogenic surfaces, leading to accelerated thrombus growth in vivo. Overall, this study defines an important role for Dok-2 in regulating biomechanical adhesive function of discoid platelets. Moreover, they define a previously unrecognized prothrombotic mechanism that is not detected by conventional platelet function assays.	[Hughan, Sascha C.; Spring, Christopher M.; Schoenwaelder, Simone M.; Sturgeon, Sharelle; Alwis, Imala; Yuan, Yuping; McFadyen, James D.; Westein, Erik; Goddard, Duncan; Ono, Akiko; Nesbitt, Warwick S.; Jackson, Shaun P.] Monash Univ, Australian Ctr Blood Dis, Fac Med Nursing & Hlth Sci, Alfred Med Res & Educ Precinct, Melbourne, Vic 3004, Australia; [Jackson, Shaun P.] Univ Sydney, Heart Res Inst, Sydney, NSW 2006, Australia; [Jackson, Shaun P.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Yamanashi, Yuji] Univ Tokyo, Inst Med Sci, Div Genet, Tokyo 1088639, Japan	Monash University; University of Sydney; Heart Research Institute; University of Sydney; University of Tokyo	Jackson, SP (corresponding author), Monash Univ, Australian Ctr Blood Dis, AMREP, 89 Commercial Rd, Melbourne, Vic 3004, Australia.	shaun.jackson@monash.edu		Nesbitt, Warwick/0000-0001-5644-7053; Schoenwaelder, Simone/0000-0003-0465-5840; Jackson, Shaun/0000-0002-4750-1991	National Health and Medical Research Council Australia project grant; C. J. Martin fellowship; career development award (biomedical); Australia fellowship	National Health and Medical Research Council Australia project grant(National Health and Medical Research Council (NHMRC) of Australia); C. J. Martin fellowship(National Health and Medical Research Council (NHMRC) of Australia); career development award (biomedical); Australia fellowship	This work was supported by a National Health and Medical Research Council Australia project grant (to S. C. H. and W. S. N.), by a C. J. Martin fellowship (to S. C. H.), by a career development award (biomedical) (to S. C. H.), and by an Australia fellowship (to S. P. J.).	Abramson J, 2003, EUR J IMMUNOL, V33, P85, DOI 10.1002/immu.200390011; Bedirian A, 2004, J BIOL CHEM, V279, P19335, DOI 10.1074/jbc.M310689200; Bhatt DL, 2003, NAT REV DRUG DISCOV, V2, P15, DOI 10.1038/nrd985; Cai DS, 2003, J BIOL CHEM, V278, P25323, DOI 10.1074/jbc.M212430200; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; De Meyer SF, 2008, BRIT J HAEMATOL, V142, P515, DOI 10.1111/j.1365-2141.2008.07233.x; Di Cristofano A, 1998, J BIOL CHEM, V273, P4827, DOI 10.1074/jbc.273.9.4827; Dong S, 2006, J EXP MED, V203, P2509, DOI 10.1084/jem.20060650; Dopheide SM, 2002, BLOOD, V99, P159, DOI 10.1182/blood.V99.1.159; Garcia A, 2004, BLOOD, V103, P2088, DOI 10.1182/blood-2003-07-2392; Gerard A, 2004, ONCOGENE, V23, P1594, DOI 10.1038/sj.onc.1207283; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Grimm J, 2001, J CELL BIOL, V154, P345, DOI 10.1083/jcb.200102032; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Huang CL, 2004, J BIOL CHEM, V279, P42279, DOI 10.1074/jbc.M402540200; Hughan SC, 2007, J THROMB HAEMOST, V5, P387, DOI 10.1111/j.1538-7836.2007.02307.x; Jackson SP, 2009, J THROMB HAEMOST, V7, P17, DOI 10.1111/j.1538-7836.2009.03401.x; Jackson SP, 2003, NAT REV DRUG DISCOV, V2, P775, DOI 10.1038/nrd1198; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Kasirer-Friede A, 2007, IMMUNOL REV, V218, P247, DOI 10.1111/j.1600-065X.2007.00532.x; Kasirer-Friede A, 2010, BLOOD, V115, P2274, DOI 10.1182/blood-2009-08-238238; Kulkarni S, 2000, J CLIN INVEST, V105, P783, DOI 10.1172/JCI7569; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Lemay S, 2000, MOL CELL BIOL, V20, P2743, DOI 10.1128/MCB.20.8.2743-2754.2000; Lock P, 1999, J BIOL CHEM, V274, P22775, DOI 10.1074/jbc.274.32.22775; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Maxwell MJ, 2007, BLOOD, V109, P566, DOI 10.1182/blood-2006-07-028282; Maxwell MJ, 2004, J BIOL CHEM, V279, P32196, DOI 10.1074/jbc.M400746200; Mazzucato M, 2002, BLOOD, V100, P2793, DOI 10.1182/blood-2002-02-0514; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Ng CH, 2007, BLOOD, V110, P259, DOI 10.1182/blood-2006-10-055194; Niki M, 2004, J EXP MED, V200, P1689, DOI 10.1084/jem.20041306; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Phillips DR, 2001, THROMB HAEMOSTASIS, V86, P246; Quek LS, 2000, BLOOD, V96, P4246; Rathore V, 2003, BLOOD, V102, P3658, DOI 10.1182/blood-2003-06-1888; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Schoenwaelder SM, 2007, J BIOL CHEM, V282, P28648, DOI 10.1074/jbc.M704358200; Senis YA, 2009, J THROMB HAEMOST, V7, P1718, DOI 10.1111/j.1538-7836.2009.03565.x; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shinohara H, 2005, J EXP MED, V201, P333, DOI 10.1084/jem.20041817; Stork B, 2007, EMBO J, V26, P1140, DOI 10.1038/sj.emboj.7601557; Sturgeon Sharelle A., 2006, Journal of Pharmacological and Toxicological Methods, V53, P20, DOI 10.1016/j.vascn.2005.06.006; Tsiara S, 2003, CLIN APPL THROMB-HEM, V9, P177, DOI 10.1177/107602960300900301; Waterman PM, 2012, IMMUNOL LETT, V143, P122, DOI 10.1016/j.imlet.2012.02.009; Yamanashi Y, 2000, GENE DEV, V14, P11; Yasuda T, 2004, J EXP MED, V200, P1681, DOI 10.1084/jem.20041247; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015; Yuan YP, 1999, J BIOL CHEM, V274, P36241, DOI 10.1074/jbc.274.51.36241; Zhao MM, 2006, MOL CELL BIOL, V26, P2479, DOI 10.1128/MCB.26.7.2479-2489.2006	54	8	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5051	5060		10.1074/jbc.M113.520148	http://dx.doi.org/10.1074/jbc.M113.520148			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24385425	Green Published, hybrid			2022-12-28	WOS:000331607900049
J	Ganguly, S; Mukherjee, A; Mazumdar, B; Ghosh, AN; Banerjee, KK				Ganguly, Sreerupa; Mukherjee, Amarshi; Mazumdar, Budhaditya; Ghosh, Amar N.; Banerjee, Kalyan K.			The beta-Prism Lectin Domain of Vibrio cholerae Hemolysin Promotes Self-assembly of the beta-Pore-forming Toxin by a Carbohydrate-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Glycoprotein; Lectin; Lipid-binding Protein; Liposomes; Protein Assembly; Pore-forming Toxins; Vibrio cholerae Hemolysin	EL-TOR; CRYSTAL-STRUCTURE; ALPHA-HEMOLYSIN; CYTOLYSIN VCC; CHOLESTEROL; SPECIFICITY; ACTIVATION; PROTEINS; MODE; OLIGOMERIZATION	Vibrio cholerae cytolysin/hemolysin (VCC) is an amphipathic 65-kDa -pore-forming toxin with a C-terminal -prism lectin domain. Because deletion or point mutation of the lectin domain seriously compromises hemolytic activity, it is thought that carbohydrate-dependent interactions play a critical role in membrane targeting of VCC. To delineate the contributions of the cytolysin and lectin domains in pore formation, we used wild-type VCC, 50-kDa VCC (VCC50) without the lectin domain, and mutant VCCD617A with no carbohydrate-binding activity. VCC and its two variants with no carbohydrate-binding activity moved to the erythrocyte stroma with apparent association constants on the order of 10(7) m(-1). However, loss of the lectin domain severely reduced the efficiency of self-association of the VCC monomer with the -barrel heptamer in the synthetic lipid bilayer from approximate to 83 to 27%. Notably, inactivation of the carbohydrate-binding activity by the D617A mutation marginally reduced oligomerization to approximate to 77%. Oligomerization of VCC50 was temperature-insensitive; by contrast, VCC self-assembly increased with increasing temperature, suggesting that the process is driven by entropy and opposed by enthalpy. Asialofetuin, the (1)-galactosyl-terminated glycoprotein inhibitor of VCC-induced hemolysis, promoted oligomerization of 65-kDa VCC to a species that resembled the membrane-inserted heptamer in stoichiometry and morphology but had reduced global amphipathicity. In conclusion, we propose (i) that the -prism lectin domain facilitated toxin assembly by producing entropy during relocation in the heptamer and (ii) that glycoconjugates inhibited VCC by promoting its assembly to a water-soluble, less amphipathic oligomer variant with reduced ability to penetrate the bilayer.	[Ganguly, Sreerupa; Mukherjee, Amarshi; Mazumdar, Budhaditya; Banerjee, Kalyan K.] Natl Inst Cholera & Enter Dis, Div Biochem, Kolkata 700010, India; [Ghosh, Amar N.] Natl Inst Cholera & Enter Dis, Div Electron Microscopy, Kolkata 700010, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Banerjee, KK (corresponding author), Natl Inst Cholera & Enter Dis, Div Biochem, P-33,CIT Rd, Kolkata 700010, India.	kalyanbanerjee1061@rediffmail.com	Mukherjee, Amarshi/AFY-4069-2022	Mukherjee, Amarshi/0000-0002-4458-3901	Council of Scientific and Industrial Research (New Delhi, India) [9/482(0048)/2009EMR-1]; University Grants Commission (New Delhi)	Council of Scientific and Industrial Research (New Delhi, India)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (New Delhi)(University Grants Commission, India)	This work was supported by Senior Research Fellowship 9/482(0048)/2009EMR-1 (to S. G.) from the Council of Scientific and Industrial Research (New Delhi, India) and a senior research fellowship (to A. M.) from the University Grants Commission (New Delhi).	Abrami L, 2000, TRENDS MICROBIOL, V8, P168, DOI 10.1016/S0966-842X(00)01722-4; Saka HA, 2008, MICROB PATHOGENESIS, V44, P118, DOI 10.1016/j.micpath.2007.08.013; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bourne Y, 2002, BIOCHEM J, V364, P173, DOI 10.1042/bj3640173; Chakraborty DC, 2011, J BIOL CHEM, V286, P34542, DOI 10.1074/jbc.M111.241851; Chattopadhyay K, 2003, J BIOL CHEM, V278, P38470, DOI 10.1074/jbc.M305965200; Chattopadhyay K, 2002, EUR J BIOCHEM, V269, P4351, DOI 10.1046/j.1432-1033.2002.03137.x; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Dutta S, 2010, J BACTERIOL, V192, P169, DOI 10.1128/JB.00930-09; Figueroa-Arredondo P, 2001, INFECT IMMUN, V69, P1613, DOI 10.1128/IAI.69.3.1613-1624.2001; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Fullner KJ, 2002, J EXP MED, V195, P1455, DOI 10.1084/jem.20020318; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Gilbert RJC, 2002, CELL MOL LIFE SCI, V59, P832, DOI 10.1007/s00018-002-8471-1; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Harris JR, 2002, J STRUCT BIOL, V139, P122; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; KRASILNIKOV OV, 1992, BIOCHIM BIOPHYS ACTA, V1111, P7, DOI 10.1016/0005-2736(92)90268-Q; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levan S, 2013, J MOL BIOL, V425, P944, DOI 10.1016/j.jmb.2012.12.016; Lohner S, 2009, FASEB J, V23, P2521, DOI 10.1096/fj.08-127688; Mazumdar B, 2011, INDIAN J MED RES, V133, P131; Mukherjee G, 2008, MOL IMMUNOL, V45, P266, DOI 10.1016/j.molimm.2007.04.024; Nagamune K, 1996, INFECT IMMUN, V64, P4655, DOI 10.1128/IAI.64.11.4655-4658.1996; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Rai AK, 2013, J BIOL CHEM, V288, P1665, DOI 10.1074/jbc.M112.430181; Saha N, 1997, J BIOL CHEM, V272, P162, DOI 10.1074/jbc.272.1.162; Sankaranarayanan R, 1996, NAT STRUCT BIOL, V3, P596, DOI 10.1038/nsb0796-596; Sharma A, 2007, J BIOSCIENCES, V32, P1089, DOI 10.1007/s12038-007-0111-3; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; SPIRO RG, 1974, J BIOL CHEM, V249, P5704; SPIRO RG, 1960, J BIOL CHEM, V235, P2860; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; YAMAMOTO K, 1990, INFECT IMMUN, V58, P4106, DOI 10.1128/IAI.58.12.4106-4116.1990; Zitzer A, 1999, J BIOL CHEM, V274, P1375, DOI 10.1074/jbc.274.3.1375; ZITZER A, 1995, MED MICROBIOL IMMUN, V184, P37, DOI 10.1007/BF00216788	42	5	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4001	4008		10.1074/jbc.M113.522284	http://dx.doi.org/10.1074/jbc.M113.522284			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24356964	Green Published, hybrid			2022-12-28	WOS:000331403800015
J	Albright, RA; Ornstein, DL; Cao, WX; Chang, WC; Robert, D; Tehan, M; Hoyer, D; Liu, L; Stabach, P; Yang, GX; De La Cruz, EM; Braddock, DT				Albright, Ronald A.; Ornstein, Deborah L.; Cao, Wenxiang; Chang, William C.; Robert, Donna; Tehan, Martin; Hoyer, Denton; Liu, Lynn; Stabach, Paul; Yang, Guangxiao; De La Cruz, Enrique M.; Braddock, Demetrios T.			Molecular Basis of Purinergic Signal Metabolism by Ectonucleotide Pyrophosphatase/Phosphodiesterases 4 and 1 and Implications in Stroke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Enzyme Catalysis; Platelets; Stroke; X-ray Crystallography; Purinergic Metabolism	POSTERIOR LONGITUDINAL LIGAMENT; DIADENOSINE TETRAPHOSPHATE AP4A; LYSOPHOSPHATIDIC ACID RECEPTOR; ALKALINE-PHOSPHATASE; LYSOPHOSPHOLIPASE-D; NUCLEOTIDE PYROPHOSPHATASES/PHOSPHODIESTERASES; TARGETED DISRUPTION; TRIPHOSPHATE AP3A; PLATELET-FUNCTION; AUTOTAXIN	Background: Nucleotide pyrophosphatase/phosphodiesterases (NPPs) metabolize extracellular purinergic signals. Results: NPP4 and NPP1 exhibit nearly identical active site geometry but distinct substrate specificity. Conclusion: A tripartite lysine claw in NPP1 stabilizes ATP in the catalytic pocket. NPP4 lacks this motif and is unable to hydrolyze ATP effectively. Significance: Understanding NPP4 and NPP1 catalysis enables insight into the pathogenesis of stroke and ectopic bone mineralization. NPP4 is a type I extracellular membrane protein on brain vascular endothelium inducing platelet aggregation via the hydrolysis of Ap3A, whereas NPP1 is a type II extracellular membrane protein principally present on the surface of chondrocytes that regulates tissue mineralization. To understand the metabolism of purinergic signals resulting in the physiologic activities of the two enzymes, we report the high resolution crystal structure of human NPP4 and explore the molecular basis of its substrate specificity with NPP1. Both enzymes cleave Ap3A, but only NPP1 can hydrolyze ATP. Comparative structural analysis reveals a tripartite lysine claw in NPP1 that stabilizes the terminal phosphate of ATP, whereas the corresponding region of NPP4 contains features that hinder this binding orientation, thereby inhibiting ATP hydrolysis. Furthermore, we show that NPP1 is unable to induce platelet aggregation at physiologic concentrations reported in human blood, but it could stimulate platelet aggregation if localized at low nanomolar concentrations on vascular endothelium. The combined studies expand our understanding of NPP1 and NPP4 substrate specificity and range and provide a rational mechanism by which polymorphisms in NPP1 confer stroke resistance.	[Albright, Ronald A.; Chang, William C.; Tehan, Martin; Stabach, Paul; Yang, Guangxiao; Braddock, Demetrios T.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Ornstein, Deborah L.; Robert, Donna] Dartmouth Coll, Geisel Sch Med, Dept Pathol, Hanover, NH 03755 USA; [Cao, Wenxiang; Chang, William C.; Liu, Lynn; De La Cruz, Enrique M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hoyer, Denton] Yale Univ, Yale Ctr Mol Discovery, West Haven, CT 06516 USA	Yale University; Dartmouth College; Yale University; Yale University	Braddock, DT (corresponding author), Yale Univ, Sch Med, Dept Pathol, 310 Cedar St, New Haven, CT 06510 USA.	demetrios.braddock@yale.edu	hoyer, daniel/L-3647-2019	hoyer, daniel/0000-0002-1405-7089	Connecticut Department of Public Health [RFP 2013-0913]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, R25GM096161] Funding Source: NIH RePORTER	Connecticut Department of Public Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by Connecticut Department of Public Health Grant RFP 2013-0913 (to D. T. B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Albright RA, 2012, BLOOD, V120, P4432, DOI 10.1182/blood-2012-04-425215; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertrand J, 2012, ANN RHEUM DIS, V71, P1249, DOI 10.1136/annrheumdis-2011-200892; Birk AV, 2002, J LAB CLIN MED, V139, P116, DOI 10.1067/mlc.2002.121334; Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Duan RD, 2003, J BIOL CHEM, V278, P38528, DOI 10.1074/jbc.M305437200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Flanagan JM, 2013, BLOOD, V121, P3237, DOI 10.1182/blood-2012-10-464156; Gachet C, 2012, PURINERG SIGNAL, V8, P609, DOI 10.1007/s11302-012-9303-x; Gijsbers R, 2001, J BIOL CHEM, V276, P1361, DOI 10.1074/jbc.M007552200; GOLDMAN SJ, 1986, CIRC RES, V59, P362, DOI 10.1161/01.RES.59.3.362; HARAHAP AR, 1988, J IMMUNOL, V141, P2317; Hirakawa H, 2004, J ORTHOP SCI, V9, P591, DOI 10.1007/s00776-004-0823-2; Jankowski J, 1999, ANAL BIOCHEM, V269, P72, DOI 10.1006/abio.1999.3097; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Jansen S, 2012, STRUCTURE, V20, P1948, DOI 10.1016/j.str.2012.09.001; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Kalya S, 2005, CURR OPIN RHEUMATOL, V17, P325, DOI 10.1097/01.bor.0000160783.14798.10; Kato K, 2012, P NATL ACAD SCI USA, V109, P16876, DOI 10.1073/pnas.1208017109; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Knowles AF, 2011, PURINERG SIGNAL, V7, P21, DOI 10.1007/s11302-010-9214-7; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Levy-Litan V, 2010, AM J HUM GENET, V86, P273, DOI 10.1016/j.ajhg.2010.01.010; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; LUTHJE J, 1987, BLUT, V54, P193, DOI 10.1007/BF00594193; LUTHJE J, 1983, BIOCHEM BIOPH RES CO, V115, P253, DOI 10.1016/0006-291X(83)90997-X; LUTHJE J, 1985, BLUT, V51, P405, DOI 10.1007/BF00320727; Mackenzie NCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032177; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Nikolic-Hughes I, 2005, J AM CHEM SOC, V127, P9314, DOI 10.1021/ja051603j; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; OGILVIE A, 1989, BIOCHEM J, V259, P97, DOI 10.1042/bj2590097; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Olgilvie A., 1992, AP4A OTHER DINUCLEOT, P357; Omatsu-Kanbe M, 2002, EXP PHYSIOL, V87, P643, DOI 10.1113/eph8702455; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEARSON JD, 1985, ANNU REV PHYSIOL, V47, P617, DOI 10.1146/annurev.ph.47.030185.003153; Pizzuti A, 1999, DIABETES, V48, P1881, DOI 10.2337/diabetes.48.9.1881; Raj GV, 2004, PROSTATE, V61, P105, DOI 10.1002/pros.20083; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Sakagami H, 2005, J BIOL CHEM, V280, P23084, DOI 10.1074/jbc.M413438200; Saunders LP, 2008, MOL CANCER THER, V7, P3352, DOI 10.1158/1535-7163.MCT-08-0463; Saunders LP, 2011, J BIOL CHEM, V286, P30130, DOI 10.1074/jbc.M111.246884; Schodel J, 2004, BIOCHEM BIOPH RES CO, V321, P767, DOI 10.1016/j.bbrc.2004.06.179; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Terkeltaub Robert, 2006, Purinergic Signal, V2, P371, DOI 10.1007/s11302-005-5304-3; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Vollmayer P, 2003, EUR J BIOCHEM, V270, P2971, DOI 10.1046/j.1432-1033.2003.03674.x; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Zalatan JG, 2006, BIOCHEMISTRY-US, V45, P9788, DOI 10.1021/bi060847t; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	64	28	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3294	3306		10.1074/jbc.M113.505867	http://dx.doi.org/10.1074/jbc.M113.505867			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24338010	Green Published, hybrid			2022-12-28	WOS:000331368700017
J	Chattopadhyay, R; Dyukova, E; Singh, NK; Ohba, M; Mobley, JA; Rao, GN				Chattopadhyay, Rima; Dyukova, Elena; Singh, Nikhlesh K.; Ohba, Motoi; Mobley, James A.; Rao, Gadiparthi N.			Vascular Endothelial Tight Junctions and Barrier Function Are Disrupted by 15(S)-Hydroxyeicosatetraenoic Acid Partly via Protein Kinase C epsilon-mediated Zona Occludens-1 Phosphorylation at Threonine 770/772	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Eicosanoid; Endothelial Cell; Lipoxygenase Pathway; Signal Transduction; Tight Junctions	LOW-DENSITY-LIPOPROTEIN; CELL JUNCTIONS; ATHEROSCLEROSIS; ZO-1; 15-LIPOXYGENASE; OCCLUDIN; INFLAMMATION; ACTIVATION; LIPOXYGENASE; OXIDATION	Background: Tight junctions play an essential role in the maintenance of endothelial barrier function. Results: 15(S)-HETE stimulated ZO-1 phosphorylation at Thr-770/772 residues in PKCE-dependent MEK1-ERK1/2 activation disrupting endothelial tight junctions and barrier function. Conclusion: PKCE by interrupting ZO-1 and occludin interactions plays a role in 15(S)-HETE-induced endothelial TJ disruption. Significance: 12/15-Lipoxygenase appears to be a crucial player in the modulation of endothelial barrier permeability. Disruption of tight junctions (TJs) perturbs endothelial barrier function and promotes inflammation. Previously, we have shown that 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE), the major 15-lipoxygenase 1 (15-LO1) metabolite of arachidonic acid, by stimulating zona occludens (ZO)-2 tyrosine phosphorylation and its dissociation from claudins 1/5, induces endothelial TJ disruption and its barrier dysfunction. Here, we have studied the role of serine/threonine phosphorylation of TJ proteins in 15(S)-HETE-induced endothelial TJ disruption and its barrier dysfunction. We found that 15(S)-HETE enhances ZO-1 phosphorylation at Thr-770/772 residues via PKCE-mediated MEK1-ERK1/2 activation, causing ZO-1 dissociation from occludin, disrupting endothelial TJs and its barrier function, and promoting monocyte transmigration; these effects were reversed by T770A/T772A mutations. In the arteries of WT mice ex vivo, 15(S)-HETE also induced ZO-1 phosphorylation and endothelial TJ disruption in a PKCE and MEK1-ERK1/2-dependent manner. In line with these observations, in WT mice high fat diet feeding induced 12/15-lipoxygenase (12/15-LO) expression in the endothelium and caused disruption of its TJs and barrier function. However, in 12/15-LO-/- mice, high fat diet feeding did not cause disruption of endothelial TJs and barrier function. These observations suggest that the 12/15-LO-12/15(S)-HETE axis, in addition to tyrosine phosphorylation of ZO-2, also stimulates threonine phosphorylation of ZO-1 in the mediation of endothelial TJ disruption and its barrier dysfunction.	[Chattopadhyay, Rima; Dyukova, Elena; Singh, Nikhlesh K.; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Ohba, Motoi] Showa Univ, Inst Mol Oncol, Shinagawa Ku, Tokyo 1428555, Japan; [Mobley, James A.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35291 USA	University of Tennessee System; University of Tennessee Health Science Center; Showa University; University of Alabama System; University of Alabama Birmingham	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Singh, Nikhlesh/AAA-4253-2020	Singh, Nikhlesh/0000-0002-3665-6023	National Institutes of Health from NHLBI [HL074860]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074860] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL074860 from NHLBI (to G. N. R.).	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BAILEY JM, 1995, ATHEROSCLEROSIS, V113, P247, DOI 10.1016/0021-9150(94)05452-O; BAILEY JM, 1983, J LIPID RES, V24, P1419; Bajpai AK, 2007, INVEST OPHTH VIS SCI, V48, P4930, DOI 10.1167/iovs.07-0617; Balda MS, 1996, FEBS LETT, V399, P326, DOI 10.1016/S0014-5793(96)01352-X; Bardin N, 2009, ARTERIOSCL THROM VAS, V29, P746, DOI 10.1161/ATVBAHA.108.183251; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; CATHCART MK, 1991, J LIPID RES, V32, P63; Chakrabarti SK, 2009, OBESITY, V17, P1657, DOI 10.1038/oby.2009.192; Chamorro D, 2009, MOL BIOL CELL, V20, P4120, DOI 10.1091/mbc.E08-11-1129; Chang MS, 2005, INVEST OPHTH VIS SCI, V46, P849, DOI 10.1167/iovs.04-1166; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Chen SA, 2010, J IMMUNOL, V185, P5619, DOI 10.4049/jimmunol.1001879; Chen YH, 2000, MOL BIOL CELL, V11, P849, DOI 10.1091/mbc.11.3.849; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Cines DB, 1998, BLOOD, V91, P3527; Collins NT, 2006, ARTERIOSCL THROM VAS, V26, P62, DOI 10.1161/01.ATV.0000194097.92824.b3; Cyrus T, 2001, CIRCULATION, V103, P2277; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Guo YD, 2011, J BIOL CHEM, V286, P33832, DOI 10.1074/jbc.M110.216564; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Hatley ME, 2003, J BIOL CHEM, V278, P25369, DOI 10.1074/jbc.M301175200; HENRIKSSON P, 1985, BIOCHIM BIOPHYS ACTA, V834, P272, DOI 10.1016/0005-2760(85)90166-3; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Iden S, 2012, J CELL BIOL, V196, P623, DOI 10.1083/jcb.201104143; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; Kim JH, 2010, AM J PATHOL, V176, P1517, DOI 10.2353/ajpath.2010.090398; Kotla S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004214; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kundumani-Sridharan V, 2013, J BIOL CHEM, V288, P15830, DOI 10.1074/jbc.M113.453290; Leopold JA, 2009, FREE RADICAL BIO MED, V47, P1673, DOI 10.1016/j.freeradbiomed.2009.09.009; Li J, 2013, ARTERIOSCL THROM VAS, V33, P971, DOI 10.1161/ATVBAHA.113.301335; Liu Y, 2012, INT J BIOCHEM CELL B, V44, P1184, DOI 10.1016/j.biocel.2012.04.009; Matsumura M, 2003, BIOCHEM BIOPH RES CO, V303, P350, DOI 10.1016/S0006-291X(03)00345-0; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Natarajan R, 2002, DIABETOLOGIA, V45, P125, DOI 10.1007/s125-002-8253-x; Nishio E, 1997, BRIT J PHARMACOL, V122, P1516, DOI 10.1038/sj.bjp.0701529; Nomme J, 2011, J BIOL CHEM, V286, P43352, DOI 10.1074/jbc.M111.304089; Othman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057254; Petecchia L, 2012, LAB INVEST, V92, P1140, DOI 10.1038/labinvest.2012.67; Phinikaridou A, 2012, CIRCULATION, V126, P707, DOI 10.1161/CIRCULATIONAHA.112.092098; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; RAO GN, 1994, J BIOL CHEM, V269, P32586; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; ROSS R, 1976, SCIENCE, V193, P1094, DOI 10.1126/science.822515; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; SIMON TC, 1989, ATHEROSCLEROSIS, V75, P31, DOI 10.1016/0021-9150(89)90204-9; Sonobe Y, 2009, J BIOL CHEM, V284, P31834, DOI 10.1074/jbc.M109.025940; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; STEVENSON BR, 1989, BIOCHEM J, V263, P597, DOI 10.1042/bj2630597; STUART RO, 1995, P NATL ACAD SCI USA, V92, P6072, DOI 10.1073/pnas.92.13.6072; Tash BR, 2012, P NATL ACAD SCI USA, V109, P10855, DOI 10.1073/pnas.1121390109; VONAKIS BM, 1992, J BIOL CHEM, V267, P23625; YLAHERTTUALA S, 1995, J CLIN INVEST, V95, P2692, DOI 10.1172/JCI117971; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Yoshida H, 2004, CLIN CHIM ACTA, V345, P161, DOI 10.1016/j.cccn.2004.03.018; Zarbock A, 2009, J IMMUNOL, V183, P4715, DOI 10.4049/jimmunol.0802592; Zhao TQ, 2009, J LIPID RES, V50, P521, DOI 10.1194/jlr.M800388-JLR200	66	44	44	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3148	3163		10.1074/jbc.M113.528190	http://dx.doi.org/10.1074/jbc.M113.528190			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24338688	Green Published, hybrid			2022-12-28	WOS:000331368700005
J	Gozdziewicz, TK; Lugowski, C; Lukasiewicz, J				Gozdziewicz, Tomasz K.; Lugowski, Czeslaw; Lukasiewicz, Jolanta			First Evidence for a Covalent Linkage between Enterobacterial Common Antigen and Lipopolysaccharide in Shigella sonnei Phase II ECALPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Endotoxin; Lipopolysaccharide (LPS); Mass Spectrometry (MS); NMR; ECA; Shigella; Enterobacterial Common Antigen	TETANUS TOXOID CONJUGATE; O-SPECIFIC POLYSACCHARIDE; ESCHERICHIA-COLI; CHEMICAL CHARACTERIZATION; SERRATIA-MARCESCENS; R-MUTANTS; IMMUNOGENICITY; BIOSYNTHESIS; IDENTIFICATION; ANTIBODIES	Background: Enterobacterial common antigen (ECA) is a surface antigen of all enteric bacteria. Results: ECA polysaccharide substitutes the outer core region of Shigella sonnei lipopolysaccharide (LPS). Conclusion: First structural evidence for the existence of ECA covalently associated with LPS (ECA(LPS)). Significance: ECA(LPS) is the only immunogenic form of ECA and could be a target for therapeutic strategies against nosocomial infections. Enterobacterial common antigen (ECA) is expressed by Gram-negative bacteria belonging to Enterobacteriaceae, including emerging drug-resistant pathogens such as Escherichia coli, Klebsiella pneumoniae, and Proteus spp. Recent studies have indicated the importance of ECA for cell envelope integrity, flagellum expression, and resistance of enteric bacteria to acetic acid and bile salts. ECA, a heteropolysaccharide built from the trisaccharide repeating unit, 3)--d-Fucp4NAc-(14)--d-ManpNAcA-(14)--d-GlcpNAc-(1, occurs as a cyclic form (ECA(CYC)), a phosphatidylglycerol (PG)-linked form (ECA(PG)), and an endotoxin/lipopolysaccharide (LPS)-associated form (ECA(LPS)). Since the discovery of ECA in 1962, the structures of ECA(PG) and ECA(CYC) have been completely elucidated. However, no direct evidence has been presented to support a covalent linkage between ECA and LPS; only serological indications of co-association have been reported. This is paradoxical, given that ECA was first identified based on the capacity of immunogenic ECA(LPS) to elicit antibodies cross-reactive with enterobacteria. Using a simple isolation protocol supported by serological tracking of ECA epitopes and NMR spectroscopy and mass spectrometry, we have succeeded in the first detection, isolation, and complete structural analysis of poly- and oligosaccharides of Shigella sonnei phase II ECA(LPS). ECA(LPS) consists of the core oligosaccharide substituted with one to four repeating units of ECA at the position occupied by the O-antigen in the case of smooth S. sonnei phase I. These data represent the first structural evidence for the existence of ECA(LPS) in the half-century since it was first discovered and provide insights that could prove helpful in further structural analyses and screening of ECA(LPS) among Enterobacteriaceae species.	[Gozdziewicz, Tomasz K.; Lugowski, Czeslaw; Lukasiewicz, Jolanta] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, PL-53114 Wroclaw, Poland; [Lugowski, Czeslaw] Univ Opole, Dept Biotechnol & Mol Biol, PL-45035 Opole, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; University of Opole	Lukasiewicz, J (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, R Weigla 12, PL-53114 Wroclaw, Poland.	czaja@iitd.pan.wroc.pl		Lugowski, Czeslaw/0000-0002-2336-0530; Lukasiewicz, Jolanta/0000-0001-8081-7261	Wroclaw Research Centre EIT+ within the project "Biotechnologies and Advanced Medical Technologies"-BioMed [POIG.01.01.02-02-003/08]; European Regional Development Fund (Operational Programme Innovative Economy) [1.1.2]	Wroclaw Research Centre EIT+ within the project "Biotechnologies and Advanced Medical Technologies"-BioMed; European Regional Development Fund (Operational Programme Innovative Economy)(European Commission)	This work was supported by Wroclaw Research Centre EIT+ within the project "Biotechnologies and Advanced Medical Technologies"-BioMed (POIG.01.01.02-02-003/08) co-financed by the European Regional Development Fund (Operational Programme Innovative Economy, 1.1.2).	Barua S, 2002, MOL MICROBIOL, V43, P629, DOI 10.1046/j.1365-2958.2002.02768.x; BASU S, 1987, EUR J BIOCHEM, V162, P75, DOI 10.1111/j.1432-1033.1987.tb10544.x; Castelli ME, 2008, J BACTERIOL, V190, P213, DOI 10.1128/JB.01348-07; Castelli ME, 2011, J BACTERIOL, V193, P63, DOI 10.1128/JB.00839-10; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DELL A, 1984, CARBOHYD RES, V133, P95, DOI 10.1016/0008-6215(84)85186-1; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Duda KA, 2009, ARCH IMMUNOL THER EX, V57, P147, DOI 10.1007/s00005-009-0018-9; Erbel PJA, 2003, J BACTERIOL, V185, P1995, DOI 10.1128/JB.185.6.1995-2004.2003; Fregolino E, 2012, CARBOHYD RES, V363, P29, DOI 10.1016/j.carres.2012.09.017; GAMIAN A, 1982, EUR J BIOCHEM, V129, P105, DOI 10.1111/j.1432-1033.1982.tb07027.x; Goddard T., 2001, SPARKY; Kajimura J, 2005, J BACTERIOL, V187, P6917, DOI 10.1128/JB.187.20.6917-6927.2005; KISS P, 1978, EUR J BIOCHEM, V88, P211, DOI 10.1111/j.1432-1033.1978.tb12440.x; KUHN HM, 1988, FEMS MICROBIOL LETT, V54, P195, DOI 10.1111/j.1574-6968.1988.tb02743.x; KUHN HM, 1983, INFECT IMMUN, V40, P696, DOI 10.1128/IAI.40.2.696-700.1983; KUNIN CM, 1963, J EXP MED, V118, P565, DOI 10.1084/jem.118.4.565; KUNIN CM, 1962, P SOC EXP BIOL MED, V111, P160, DOI 10.3181/00379727-111-27734; KUNIN CM, 1963, J BACTERIOL, V85, P541, DOI 10.1128/JB.85.3.541-548.1963; Lehrer J, 2007, J BACTERIOL, V189, P2618, DOI 10.1128/JB.01905-06; LUGOWSKI C, 1983, INFECT IMMUN, V42, P1086, DOI 10.1128/IAI.42.3.1086-1091.1983; Lugowski C, 1996, FEMS IMMUNOL MED MIC, V16, P21, DOI 10.1016/S0928-8244(96)00065-X; LUGOWSKI C, 1983, CARBOHYD RES, V118, P173, DOI 10.1016/0008-6215(83)88045-8; LUGOWSKI C, 1987, Postepy Higieny i Medycyny Doswiadczalnej, V41, P384; LUGOWSKI C, 1978, EUR J BIOCHEM, V91, P89, DOI 10.1111/j.1432-1033.1978.tb20941.x; LUGOWSKI C, 1991, FEMS MICROBIOL LETT, V77, P315, DOI 10.1016/0378-1097(91)90572-R; MAKELA PH, 1976, BACTERIOL REV, V40, P591; MANNEL D, 1978, EUR J BIOCHEM, V86, P361, DOI 10.1111/j.1432-1033.1978.tb12318.x; MAYER H, 1972, INFECT IMMUN, V6, P540, DOI 10.1128/IAI.6.4.540-544.1972; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Muller-Loennies S, 2007, INT J MED MICROBIOL, V297, P321, DOI 10.1016/j.ijmm.2007.04.002; Muszynski A, 2013, MICROBIOL-SGM, V159, P1782, DOI 10.1099/mic.0.066662-0; Rabsztyn K, 2011, BIOCHEMISTRY-MOSCOW+, V76, P832, DOI 10.1134/S0006297911070145; Radziejewska-Lebrecht J, 2003, ADV EXP MED BIOL, V529, P215; Radziejewska-Lebrecht J, 1998, ACTA BIOCHIM POL, V45, P1011, DOI 10.18388/abp.1998_4358; Ramos-Morales F, 2003, J BACTERIOL, V185, P5328, DOI 10.1128/JB.185.17.5328-5332.2003; Richmond P, 1999, VACCINE, V18, P641, DOI 10.1016/S0264-410X(99)00276-5; Richmond P, 2001, J INFECT DIS, V183, P160, DOI 10.1086/317646; Richmond P, 2001, INFECT IMMUN, V69, P2378, DOI 10.1128/IAI.69.4.2378-2382.2001; Rick PD, 1998, GLYCOBIOLOGY, V8, P557, DOI 10.1093/glycob/8.6.557; RICK PD, 1985, J BACTERIOL, V162, P494, DOI 10.1128/JB.162.2.494-503.1985; Snape MD, 2005, LANCET INFECT DIS, V5, P21, DOI 10.1016/S1473-3099(04)01251-4; Vinogradov EV, 1999, EUR J BIOCHEM, V261, P629, DOI 10.1046/j.1432-1327.1999.00280.x; VINOGRADOV EV, 1994, CARBOHYD RES, V258, P223, DOI 10.1016/0008-6215(94)84088-1; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83	46	20	21	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2745	2754		10.1074/jbc.M113.512749	http://dx.doi.org/10.1074/jbc.M113.512749			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24324266	Green Published, hybrid			2022-12-28	WOS:000333403000024
J	Ishikawa, M; Iwamoto, T; Fukumoto, S; Yamada, Y				Ishikawa, Masaki; Iwamoto, Tsutomu; Fukumoto, Satoshi; Yamada, Yoshihiko			Pannexin 3 Inhibits Proliferation of Osteoprogenitor Cells by Regulating Wnt and p21 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; Calcium Intracellular Release; Cell Proliferation; Pannexin; Wnt Signaling; Hemichannel and ER Ca2+Channel; Intracellular ATP and Ca2+levels; Pannexin 3; Wnt; -Catenin Signaling; p21	GAP-JUNCTION PROTEINS; TRANSCRIPTION FACTOR LEF-1; RECEPTOR-RELATED PROTEIN-5; DUAL-KINASE MECHANISM; BETA-CATENIN; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; EXPRESSION; PHOSPHORYLATION; PATHWAY	Background: The mechanism of the transition from osteoprogenitor cell proliferation to differentiation is unclear. Results: Panx3 inhibits osteoprogenitor proliferation by blocking canonical Wnt signaling and promoting p21 activation. Conclusion: A Panx3 hemichannel induces multiple Panx3 signaling pathways critical for the cell cycle exit. Significance: Our findings reveal that Panx3 is a new regulator to switch the stage from proliferation to differentiation in osteoprogenitor cells. Canonical Wnt signaling and BMP promote the proliferation and differentiation of osteoprogenitors, respectively. However, the regulatory mechanism involved in the transition from proliferation to differentiation is unclear. Here, we show that Panx3 (pannexin 3) plays a key role in this transition by inhibiting the proliferation and promoting the cell cycle exit. Using primary calvarial cells and explants, C3H10T1/2 cells, and C2C12 cells, we found that Panx3 expression inhibited cell growth, whereas the inhibition of endogenous Panx3 expression increased it. We also found that the Panx3 hemichannel inhibited cell growth by promoting -catenin degradation through GSK3 activation. Additionally, the Panx3 hemichannel inhibited cyclin D1 transcription and Rb phosphorylation through reduced cAMP/PKA/CREB signaling. Furthermore, the Panx3 endoplasmic reticulum Ca2+ channel induced the transcription and phosphorylation of p21, through the calmodulin/Smad pathway, and resulted in the cell cycle exit. Our results reveal that Panx3 is a new regulator that promotes the switch from proliferation to differentiation of osteoprogenitors via multiple Panx3 signaling pathways.	[Ishikawa, Masaki; Yamada, Yoshihiko] NIDCR, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Iwamoto, Tsutomu] Univ Tokushima, Grad Sch, Dept Pediat Dent, Tokushima 7708504, Japan; [Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Pediat Dent, Sendai, Miyagi 9808576, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tokushima University; Tohoku University	Yamada, Y (corresponding author), NIDCR, NIH, 30 Convent Dr,MSC 4370,Bldg 30,Rm 407, Bethesda, MD 20892 USA.	yoshi.yamada@nih.gov	Iwamoto, Tsutomu/AAA-6597-2019; Iwamoto, Tsutomu/AAI-8952-2021	Iwamoto, Tsutomu/0000-0001-8472-605X; Fukumoto, Satoshi/0000-0002-5046-6891	National Institutes of Health Intramural Research Program at the NIDCR; Ministry of Education, Science, and Culture of Japan [20679006]; NEXT program [LS010]; Japan Society for the Promotion of Science for Young Scientists; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000483] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program at the NIDCR; Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program at the NIDCR. This work was also supported by Grant-in-Aid 20679006 from the Ministry of Education, Science, and Culture of Japan (to S. F.) and NEXT program Grant LS010 (to S. F.).; Supported in part by the Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists.	Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Beier F, 2002, MOL ENDOCRINOL, V16, P2163, DOI 10.1210/me.2001-0103; Bellosta P, 2003, J BONE MINER RES, V18, P818, DOI 10.1359/jbmr.2003.18.5.818; Bellows CG, 2001, J BONE MINER RES, V16, P1983, DOI 10.1359/jbmr.2001.16.11.1983; Bernardi H, 2011, AM J PHYSIOL-CELL PH, V300, pC1122, DOI 10.1152/ajpcell.00214.2010; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DUMONT JE, 1989, TRENDS BIOCHEM SCI, V14, P67, DOI 10.1016/0968-0004(89)90046-7; ECAROTCHARRIER B, 1983, J CELL BIOL, V96, P639, DOI 10.1083/jcb.96.3.639; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; FARR A, 1992, NUCLEIC ACIDS RES, V20, P920, DOI 10.1093/nar/20.4.920; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hay E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008284; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Ishikawa M, 2011, J CELL BIOL, V193, P1257, DOI 10.1083/jcb.201101050; Iwamoto T, 2010, J BIOL CHEM, V285, P18948, DOI 10.1074/jbc.M110.127027; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kubota T, 2009, J BONE MINER METAB, V27, P265, DOI 10.1007/s00774-009-0064-8; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lohman AW, 2012, J VASC RES, V49, P405, DOI 10.1159/000338758; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Matsunobu T, 2009, DEV BIOL, V332, P325, DOI 10.1016/j.ydbio.2009.06.002; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Mohammad Khalid S., 2008, V455, P37, DOI 10.1007/978-1-59745-104-8_3; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nakashima A, 2005, J BIOL CHEM, V280, P37660, DOI 10.1074/jbc.M504612200; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pardali K, 2005, J CELL PHYSIOL, V204, P260, DOI 10.1002/jcp.20304; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Raucci A, 2008, J CELL PHYSIOL, V215, P442, DOI 10.1002/jcp.21323; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Ray A, 2006, CEREBELLUM, V5, P189, DOI 10.1080/14734220500530082; Ryten M, 2002, J CELL BIOL, V158, P345, DOI 10.1083/jcb.200202025; Seo JH, 2009, BIOCHEM BIOPH RES CO, V384, P100, DOI 10.1016/j.bbrc.2009.04.082; Sun L, 2005, P NATL ACAD SCI USA, V102, P17130, DOI 10.1073/pnas.0508480102; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Urano Tomohiko, 2007, Nihon Rinsho, V65 Suppl 9, P95; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Wang A, 2000, J BIOL CHEM, V275, P4532, DOI 10.1074/jbc.275.6.4532; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wu XH, 2010, MICROSC RES TECHNIQ, V73, P540, DOI 10.1002/jemt.20792; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang L, 2012, BIOCHEM BIOPH RES CO, V419, P83, DOI 10.1016/j.bbrc.2012.01.132	64	37	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2839	2851		10.1074/jbc.M113.523241	http://dx.doi.org/10.1074/jbc.M113.523241			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24338011	Green Published, hybrid			2022-12-28	WOS:000333403000032
J	Guijarro-Munoz, I; Compte, M; Alvarez-Cienfuegos, A; Alvarez-Vallina, L; Sanz, L				Guijarro-Munoz, Irene; Compte, Marta; Alvarez-Cienfuegos, Ana; Alvarez-Vallina, Luis; Sanz, Laura			Lipopolysaccharide Activates Toll-like Receptor 4 (TLR4)-mediated NF-kappa B Signaling Pathway and Proinflammatory Response in Human Pericytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Chemokines; Cytokine; Inflammation; Lipopolysaccharide (LPS); HMGB1; NF-B; TLR4; Pericyte	MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; GENE-EXPRESSION; CYTOKINE; ARRAY; RECOGNITION; PROTEIN; INNATE; HMGB1	Pericytes and mesenchymal stem cells (MSCs) are ontogenically related, and in fact, no significant phenotypic differences could be observed by flow cytometry. Transcriptome analysis of human pericytes and MSCs revealed that 43 genes were up-regulated more than 10-fold in pericytes compared with MSCs. Identification of Toll-like receptor 4 (TLR4) as one of the most abundant RNA species in pericytes with respect to MSCs and confirmation of TLR4 expression on the cell surface led us to obtain a comprehensive overview of the expression program of lipopolysaccharide (LPS)-stimulated pericytes. Transcriptional profiling of LPS-treated cells revealed that 22 genes were up-regulated more than 5-fold. Of them, 10 genes encoded chemokines and cytokines (CXCL10, CCL20, IL8, CXCL1, IL6, CCL2, IL1B, CXCL2, IL1A, and CXCL6), and three genes encoded adhesion molecules (ICAM1, VCAM1, and SELE). LPS induced nuclear translocation of the transcription factor NF-B in stimulated pericytes. Moreover, inhibition of NF-B activation by SC-514 blocked LPS-induced up-regulation of a subset of chemokine genes, confirming the key role of NF-B in LPS signaling in pericytes. At the protein level, we assessed the secretion of the proinflammatory cytokines and chemokines IL-6, IL-8, CXCL1, CXCL2, CXCL3, and CCL2 not only after LPS treatment but also in HMGB1-stimulated pericytes. Up-regulation of the adhesion molecules ICAM-1 and VCAM-1 resulted in an increased adhesion of peripheral blood leukocytes to an LPS-treated pericyte monolayer. The role of pericytes in the inflammatory context has been scarcely addressed; according to these results, pericytes should be considered as active players in the inflammatory cascade with potential physiopathological implications.	[Guijarro-Munoz, Irene; Compte, Marta; Alvarez-Cienfuegos, Ana; Alvarez-Vallina, Luis; Sanz, Laura] Hosp Univ Puerta Hierro Majadahonda, Mol Immunol Unit, Madrid 28222, Spain	Hospital Puerta de Hierro-Majadahonda	Sanz, L (corresponding author), Hosp Univ Puerta Hierro Majadahonda, Mol Immunol Unit, Madrid 28222, Spain.	lsalcober@salud.madrid.org	Sanz, Laura/F-8542-2010; Alvarez-Vallina, Luis/ABD-2431-2020	Sanz, Laura/0000-0002-3119-3218; Alvarez-Vallina, Luis/0000-0003-3053-6757; Compte Grau, Marta/0000-0002-7138-9266	Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III [PI08/90856, PS09/00227]; Fundacion Investigacion Biomedica Hospital Puerta de Hierro; Ministerio de Economia y Competitividad [BIO2011-22738]; Comunidad de Madrid [S2010/BMD-2312]	Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fundacion Investigacion Biomedica Hospital Puerta de Hierro; Ministerio de Economia y Competitividad(Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III Grants PI08/90856 and PS09/00227 and Fundacion Investigacion Biomedica Hospital Puerta de Hierro (to L. S.) and by Ministerio de Economia y Competitividad Grant BIO2011-22738 and Comunidad de Madrid Grant S2010/BMD-2312 (to L. A.-V.).	Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Barlow KD, 2013, CANCER MICROENVIRON, V6, P1, DOI 10.1007/s12307-012-0102-2; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Bose A, 2013, J IMMUNOL, V191, P971, DOI 10.4049/jimmunol.1300280; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Covas DT, 2003, BRAZ J MED BIOL RES, V36, P1179, DOI 10.1590/S0100-879X2003000900006; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; Dellavalle A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1508; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Edelman DA, 2007, J TRAUMA, V62, P89, DOI 10.1097/TA.0b013e31802dd712; Edelman DA, 2007, AM J SURG, V193, P730, DOI 10.1016/j.amjsurg.2006.08.086; Edelman DA, 2006, J SURG RES, V134, P22, DOI 10.1016/j.jss.2006.03.007; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Guijarro-Munoz I, 2012, EXP CELL RES, V318, P371, DOI 10.1016/j.yexcr.2011.12.005; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Keeley EC, 2011, EXP CELL RES, V317, P685, DOI 10.1016/j.yexcr.2010.10.020; Kim S, 2013, MOL MED, V19, P88, DOI 10.2119/molmed.2012.00306; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; Li AH, 2002, MICROVASC RES, V64, P476, DOI 10.1006/mvre.2002.2442; Mai JT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-61; Maier CL, 2011, ARTERIOSCL THROM VAS, V31, P183, DOI 10.1161/ATVBAHA.110.217117; Matthay MA, 2010, CHEST, V138, P965, DOI 10.1378/chest.10-0518; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nemeth K, 2010, J MOL MED, V88, P5, DOI 10.1007/s00109-009-0523-7; Paquet-Fifield S, 2009, J CLIN INVEST, V119, P2795, DOI 10.1172/JCI38535; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Perros F, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-125; Pober JS, 2012, TRENDS IMMUNOL, V33, P49, DOI 10.1016/j.it.2011.09.006; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Rajeevan MS, 2001, METHODS, V25, P443, DOI 10.1006/meth.2001.1266; Rossini A, 2008, J MOL CELL CARDIOL, V44, P683, DOI 10.1016/j.yjmcc.2008.01.009; Samaniego R, 2013, J INVEST DERMATOL, V133, P2255, DOI 10.1038/jid.2013.88; Sanz L, 2008, MICROVASC RES, V75, P308, DOI 10.1016/j.mvr.2007.11.007; Singh S, 2011, MICROVASC RES, V82, P318, DOI 10.1016/j.mvr.2011.06.011; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Starkie RL, 2001, J PHYSIOL-LONDON, V533, P585, DOI 10.1111/j.1469-7793.2001.0585a.x; Treutiger CJ, 2003, J INTERN MED, V254, P375, DOI 10.1046/j.1365-2796.2003.01204.x; Tu ZD, 2011, INVEST OPHTH VIS SCI, V52, P9005, DOI 10.1167/iovs.11-8008; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; VERBEEK MM, 1995, J IMMUNOL, V154, P5876; Xu JG, 2007, AM J PHYSIOL-LUNG C, V293, pL131, DOI 10.1152/ajplung.00431.2006; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038701; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Zeuke S, 2002, CARDIOVASC RES, V56, P126, DOI 10.1016/S0008-6363(02)00512-6	60	179	188	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2457	2468		10.1074/jbc.M113.521161	http://dx.doi.org/10.1074/jbc.M113.521161			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24307174	hybrid, Green Published			2022-12-28	WOS:000331130200049
J	Candasamy, AJ; Haworth, RS; Cuello, F; Ibrahim, M; Aravamudhan, S; Kruger, M; Holt, MR; Terracciano, CMN; Mayr, M; Gautel, M; Avkiran, M				Candasamy, Alexandra J.; Haworth, Robert S.; Cuello, Friederike; Ibrahim, Michael; Aravamudhan, Sriram; Krueger, Marcus; Holt, Mark R.; Terracciano, Cesare M. N.; Mayr, Manuel; Gautel, Mathias; Avkiran, Metin			Phosphoregulation of the Titin-cap Protein Telethonin in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CaMKII; Cardiac Muscle; Cardiomyopathy; Excitation-Contraction Coupling; Protein Kinase D (PKD); Protein Phosphorylation	SARCOMERIC PROTEIN; KINASE-D; Z-DISC; DILATED CARDIOMYOPATHY; MUSCULAR-DYSTROPHY; TUBULE STRUCTURE; MAMMALIAN HEART; TROPONIN-I; T-CAP; PHOSPHORYLATION	Background: Telethonin mutations are associated with cardiomyopathy through unknown mechanisms. Results: Telethonin is a substrate for CaMK family kinases and exists in a bis-phosphorylated state in cardiomyocytes, in which non-phosphorylated telethonin disrupts transverse tubule organization and intracellular calcium transients. Conclusion: Telethonin phosphorylation is critical for the maintenance of normal cardiomyocyte morphology and calcium handling. Significance: Disruption of phospho-telethonin functions may contribute to pathogenesis in cardiomyopathy. Telethonin (also known as titin-cap or t-cap) is a muscle-specific protein whose mutation is associated with cardiac and skeletal myopathies through unknown mechanisms. Our previous work identified cardiac telethonin as an interaction partner for the protein kinase D catalytic domain. In this study, kinase assays used in conjunction with MS and site-directed mutagenesis confirmed telethonin as a substrate for protein kinase D and Ca2+/calmodulin-dependent kinase II in vitro and identified Ser-157 and Ser-161 as the phosphorylation sites. Phosphate affinity electrophoresis and MS revealed endogenous telethonin to exist in a constitutively bis-phosphorylated form in isolated adult rat ventricular myocytes and in mouse and rat ventricular myocardium. Following heterologous expression in myocytes by adenoviral gene transfer, wild-type telethonin became bis-phosphorylated, whereas S157A/S161A telethonin remained non-phosphorylated. Nevertheless, both proteins localized predominantly to the sarcomeric Z-disc, where they partially replaced endogenous telethonin. Such partial replacement with S157A/S161A telethonin disrupted transverse tubule organization and prolonged the time to peak of the intracellular Ca2+ transient and increased its variance. These data reveal, for the first time, that cardiac telethonin is constitutively bis-phosphorylated and suggest that such phosphorylation is critical for normal telethonin function, which may include maintenance of transverse tubule organization and intracellular Ca2+ transients.	[Candasamy, Alexandra J.; Haworth, Robert S.; Cuello, Friederike; Holt, Mark R.; Mayr, Manuel; Gautel, Mathias; Avkiran, Metin] British Heart Fdn Ctr, Kings Coll London, Cardiovasc Div, London SE1 7EH, England; [Ibrahim, Michael; Terracciano, Cesare M. N.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England; [Aravamudhan, Sriram; Krueger, Marcus] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany	University of London; King's College London; Imperial College London; Max Planck Society	Avkiran, M (corresponding author), St Thomas Hosp, Rayne Inst, Kings Coll London, Cardiovasc Div, London SE1 7EH, England.	metin.avkiran@kcl.ac.uk	Cuello, Friederike/A-9642-2016; Gautel, Mathias/AAB-9860-2019	Gautel, Mathias/0000-0003-4027-9803; Mayr, Manuel/0000-0002-0597-829X; Holt, Mark/0000-0001-7775-8539	British Heart Foundation (BHF) [FS/06/079]; Centre of Research Excellence Award [RE/08/003]; Medical Research Council [G0800206]; MRC [MR/J010456/1, G0600251, G0800206] Funding Source: UKRI; British Heart Foundation [PG/11/127/29322, FS/13/2/29892] Funding Source: researchfish; Medical Research Council [MR/J010456/1, G0200496, G0600251] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); Centre of Research Excellence Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by British Heart Foundation (BHF) 4-year Ph.D. Program FS/06/079, Centre of Research Excellence Award RE/08/003, and Medical Research Council Grant G0800206.	Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; Furukawa T, 2001, J MOL BIOL, V313, P775, DOI 10.1006/jmbi.2001.5053; Gautel M, 2011, PFLUG ARCH EUR J PHY, V462, P119, DOI 10.1007/s00424-011-0946-1; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; Haworth RS, 2012, CIRC RES, V110, P1585, DOI 10.1161/CIRCRESAHA.111.263665; Haworth RS, 2000, J MOL CELL CARDIOL, V32, P1013, DOI 10.1006/jmcc.2000.1143; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Hayashi T, 2004, J AM COLL CARDIOL, V44, P2192, DOI 10.1016/j.jacc.2004.08.058; Ibrahim M, 2013, HUM MOL GENET, V22, P372, DOI 10.1093/hmg/dds434; Ibrahim M, 2012, EUR J HEART FAIL, V14, P571, DOI 10.1093/eurjhf/hfs038; Ibrahim M, 2011, P ROY SOC B-BIOL SCI, V278, P2714, DOI 10.1098/rspb.2011.0624; Ibrahim M, 2010, FASEB J, V24, P3321, DOI 10.1096/fj.10-156638; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Knoll R, 2011, CIRC RES, V109, P758, DOI 10.1161/CIRCRESAHA.111.245787; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Kupershmidt S, 1999, CIRC RES, V84, P146, DOI 10.1161/01.RES.84.2.146; Lai SJ, 2011, J BIOL CHEM, V286, P34606, DOI 10.1074/jbc.M111.238527; Markert CD, 2010, HUM MOL GENET, V19, P2268, DOI 10.1093/hmg/ddq105; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Miller G, 2003, J CELL SCI, V116, P4811, DOI 10.1242/jcs.00768; Moreira ES, 2000, NAT GENET, V24, P163, DOI 10.1038/72822; Mues A, 1998, FEBS LETT, V428, P111, DOI 10.1016/S0014-5793(98)00501-8; Pinotsis N, 2006, J STRUCT BIOL, V155, P239, DOI 10.1016/j.jsb.2006.03.028; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Sipido KR, 2013, ADV EXP MED BIOL, V961, P375, DOI 10.1007/978-1-4614-4756-6_32; Snabaitis AK, 2008, CIRC RES, V103, P881, DOI 10.1161/CIRCRESAHA.108.175877; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Valle G, 1997, FEBS LETT, V415, P163, DOI 10.1016/S0014-5793(97)01108-3; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Yin XK, 2010, MOL CELL PROTEOMICS, V9, P497, DOI 10.1074/mcp.M900275-MCP200; Zhang RL, 2009, HUM MOL GENET, V18, P4130, DOI 10.1093/hmg/ddp362; Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343; Zou PJ, 2003, J BIOL CHEM, V278, P2636, DOI 10.1074/jbc.M210217200	37	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1282	1293		10.1074/jbc.M113.479030	http://dx.doi.org/10.1074/jbc.M113.479030			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24280220	Green Published, hybrid			2022-12-28	WOS:000332401700008
J	Felts, B; Pramod, AB; Sandtner, W; Burbach, N; Bulling, S; Sitte, HH; Henry, LK				Felts, Bruce; Pramod, Akula Bala; Sandtner, Walter; Burbach, Nathan; Bulling, Simon; Sitte, Harald H.; Henry, L. Keith			The Two Na+ Sites in the Human Serotonin Transporter Play Distinct Roles in the Ion Coupling and Electrogenicity of Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Homology Modeling; Monoamine Transporters; Serotonin Transporters; Transporters; SLC6; Ion Dependence; Structure-Function	TRANSMEMBRANE DOMAIN-I; NEUROTRANSMITTER TRANSPORTERS; BINDING-SITES; PLATELET 5-HYDROXYTRYPTAMINE; DOPAMINE TRANSPORTER; ALTERNATING ACCESS; CONDUCTING STATES; SODIUM SYMPORTERS; CRYSTAL-STRUCTURE; COCAINE BINDING	Background: The Na+/Cl--dependent serotonin transporter contains two putative Na+-binding sites (Na1 and Na2). Results: Mutations at Na1, but not Na2, allow Ca2+ to replace Na+ and alter the conducting properties of the transporter. Conclusion: Ca2+ binds at Na1, but in the Na1 mutant, it does not appear to be transported. Significance: This work uncovers distinct roles of the Na+-binding sites for serotonin transporter function. Neurotransmitter transporters of the SLC6 family of proteins, including the human serotonin transporter (hSERT), utilize Na+, Cl-, and K+ gradients to induce conformational changes necessary for substrate translocation. Dysregulation of ion movement through monoamine transporters has been shown to impact neuronal firing potentials and could play a role in pathophysiologies, such as depression and anxiety. Despite multiple crystal structures of prokaryotic and eukaryotic SLC transporters indicating the location of both (or one) conserved Na+-binding sites (termed Na1 and Na2), much remains uncertain in regard to the movements and contributions of these cation-binding sites in the transport process. In this study, we utilize the unique properties of a mutation of hSERT at a single, highly conserved asparagine on TM1 (Asn-101) to provide several lines of evidence demonstrating mechanistically distinct roles for Na1 and Na2. Mutations at Asn-101 alter the cation dependence of the transporter, allowing Ca2+ (but not other cations) to functionally replace Na+ for driving transport and promoting 5-hydroxytryptamine (5-HT)-dependent conformational changes. Furthermore, in two-electrode voltage clamp studies in Xenopus oocytes, both Ca2+ and Na+ illicit 5-HT-induced currents in the Asn-101 mutants and reveal that, although Ca2+ promotes substrate-induced current, it does not appear to be the charge carrier during 5-HT transport. These findings, in addition to functional evaluation of Na1 and Na2 site mutants, reveal separate roles for Na1 and Na2 and provide insight into initiation of the translocation process as well as a mechanism whereby the reported SERT stoichiometry can be obtained despite the presence of two putative Na+-binding sites.	[Felts, Bruce; Pramod, Akula Bala; Burbach, Nathan; Henry, L. Keith] Univ N Dakota, Dept Basic Sci, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA; [Sandtner, Walter; Bulling, Simon; Sitte, Harald H.] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	University of North Dakota Grand Forks; Medical University of Vienna	Henry, LK (corresponding author), 501 N Columbia Rd,Rm 3700, Grand Forks, ND 58201 USA.	keith.henry@med.und.edu	Sitte, Harald/O-7025-2019	Sitte, Harald/0000-0002-1339-7444	National Institutes of Health K01 Career Development Award [DA022378]; National Institutes of Health, NIGMS, Institutional Development Award (IDeA) [P20GM12345]; National Science Foundation-EPSCoR Faculty Startup Award; Austrian Science Foundation/FWF Grant [F3506]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA022378] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 3506] Funding Source: researchfish	National Institutes of Health K01 Career Development Award; National Institutes of Health, NIGMS, Institutional Development Award (IDeA); National Science Foundation-EPSCoR Faculty Startup Award; Austrian Science Foundation/FWF Grant; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported, in whole or in part, by National Institutes of Health K01 Career Development Award DA022378 (to L. K. H.) and by National Institutes of Health, NIGMS, Institutional Development Award (IDeA) P20GM12345. This work was also supported by a National Science Foundation-EPSCoR Faculty Startup Award (to L. K. H.) and Austrian Science Foundation/FWF Grant F3506 (to H.H.S.).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Androutsellis-Theotokis A, 2002, J NEUROSCI, V22, P8370; Androutsellis-Theotokis A, 2001, J BIOL CHEM, V276, P45933, DOI 10.1074/jbc.M107462200; Barker EL, 1999, J NEUROSCI, V19, P4705; Ben-Yona A, 2011, J BIOL CHEM, V286, P2826, DOI 10.1074/jbc.M110.149732; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Bock G, 2011, J BIOL CHEM, V286, P42736, DOI 10.1074/jbc.M111.269951; Boehm S, 1999, J NEUROSCI, V19, P737; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Chang AS, 1998, J PHYSIOL-LONDON, V510, P903, DOI 10.1111/j.1469-7793.1998.903bj.x; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Henry LK, 2011, J BIOL CHEM, V286, P30823, DOI 10.1074/jbc.M111.250308; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Khafizov K, 2012, P NATL ACAD SCI USA, V109, pE3035, DOI 10.1073/pnas.1209039109; Kolds O. H., 2011, PLOS COMPUT BIOL, V7; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; Meinild AK, 2004, J BIOL CHEM, V279, P49671, DOI 10.1074/jbc.M407660200; NELSON PJ, 1979, J BIOL CHEM, V254, P84; NELSON PJ, 1982, J BIOL CHEM, V257, P6151; Ni YG, 2001, J BIOL CHEM, V276, P30942, DOI 10.1074/jbc.M104653200; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Partridge L. D., 1991, CALCIUM CHANNELS THE, P121; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Piscitelli CL, 2012, EMBO J, V31, P228, DOI 10.1038/emboj.2011.353; Pramod AB, 2013, MOL ASPECTS MED, V34, P197, DOI 10.1016/j.mam.2012.07.002; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Reith M. E., 2002, NEUROTRANSMITTER TRA; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; RUDNICK G, 1978, BIOCHEMISTRY-US, V17, P4739, DOI 10.1021/bi00615a021; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; SNEDDON JM, 1969, BRIT J PHARMACOL, V37, P680, DOI 10.1111/j.1476-5381.1969.tb08506.x; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu HB, 2010, P NATL ACAD SCI USA, V107, P20329, DOI 10.1073/pnas.1007150107; Zdravkovic I, 2012, BBA-BIOMEMBRANES, V1818, P337, DOI 10.1016/j.bbamem.2011.10.031; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao CF, 2011, BIOCHEMISTRY-US, V50, P1848, DOI 10.1021/bi101454f; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	74	28	28	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1825	1840		10.1074/jbc.M113.504654	http://dx.doi.org/10.1074/jbc.M113.504654			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24293367	Green Published, hybrid			2022-12-28	WOS:000332401700052
J	Boucard, AA; Maxeiner, S; Sudhof, TC				Boucard, Antony A.; Maxeiner, Stephan; Suedhof, Thomas C.			Latrophilins Function as Heterophilic Cell-adhesion Molecules by Binding to Teneurins REGULATION BY ALTERNATIVE SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Cell Adhesion; G Protein-coupled Receptors (GPCR); Ligand-binding Protein; Neurons; FLRT3; Neurexin; -Latrotoxin; Synapse Formation; Teneurin	ALPHA-LATROTOXIN RECEPTOR; CSP-ALPHA; CONSERVED DOMAIN; PROTEIN; FAMILY; FLRT3; PAIR; IDENTIFICATION; NEUREXINS; 10-M/ODZ	Latrophilin-1, -2, and -3 are adhesion-type G protein-coupled receptors that are auxiliary -latrotoxin receptors, suggesting that they may have a synaptic function. Using pulldowns, we here identify teneurins, type II transmembrane proteins that are also candidate synaptic cell-adhesion molecules, as interactors for the lectin-like domain of latrophilins. We show that teneurin binds to latrophilins with nanomolar affinity and that this binding mediates cell adhesion, consistent with a role of teneurin binding to latrophilins in trans-synaptic interactions. All latrophilins are subject to alternative splicing at an N-terminal site; in latrophilin-1, this alternative splicing modulates teneurin binding but has no effect on binding of latrophilin-1 to another ligand, FLRT3. Addition to cultured neurons of soluble teneurin-binding fragments of latrophilin-1 decreased synapse density, suggesting that latrophilin binding to teneurin may directly or indirectly influence synapse formation and/or maintenance. These observations are potentially intriguing in view of the proposed role for Drosophila teneurins in determining synapse specificity. However, teneurins in Drosophila were suggested to act as homophilic cell-adhesion molecules, whereas our findings suggest a heterophilic interaction mechanism. Thus, we tested whether mammalian teneurins also are homophilic cell-adhesion molecules, in addition to binding to latrophilins as heterophilic cell-adhesion molecules. Strikingly, we find that although teneurins bind to each other in solution, homophilic teneurin-teneurin binding is unable to support stable cell adhesion, different from heterophilic teneurin-latrophilin binding. Thus, mammalian teneurins act as heterophilic cell-adhesion molecules that may be involved in trans-neuronal interaction processes such as synapse formation or maintenance.	[Boucard, Antony A.; Maxeiner, Stephan; Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, Palo Alto, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Boucard, AA (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Apartado Postal 14-740, Mexico City 07000, DF, Mexico.	antonyboucardjr@gmail.com; tcs1@stanford.edu	Boucard, Antony/ABA-9769-2020; Boucard, Antony/CAJ-3093-2022; Maxeiner, Stephan/Y-7692-2019	Maxeiner, Stephan/0000-0002-4472-695X; BOUCARD, Antony Jr/0000-0002-5538-0464	National Institutes of Health [MH052804, NS077906]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH052804 and NS077906.	Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Beckmann J, 2013, NANO LETT, V13, P2937, DOI 10.1021/nl4013248; Benson DL, 2012, CURR OPIN NEUROBIOL, V22, P397, DOI 10.1016/j.conb.2011.09.011; Bolliger MF, 2011, P NATL ACAD SCI USA, V108, P2534, DOI 10.1073/pnas.1019577108; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Boucard AA, 2012, J BIOL CHEM, V287, P9399, DOI 10.1074/jbc.M111.318659; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Dharmaratne N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043083; Dobosy JR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-80; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Ko J, 2011, J CELL BIOL, V194, P323, DOI 10.1083/jcb.201101072; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Lacy SE, 1999, GENOMICS, V62, P417, DOI 10.1006/geno.1999.6033; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; LEVINE A, 1994, CELL, V77, P587, DOI 10.1016/0092-8674(94)90220-8; Maretto S, 2008, DEV BIOL, V318, P184, DOI 10.1016/j.ydbio.2008.03.021; Merlin S, 2013, CEREB CORTEX, V23, P763, DOI 10.1093/cercor/bhs030; Minet AD, 1999, J CELL SCI, V112, P2019; Missler M., 2012, COLD SPRING HARBOR P, V4; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Muller PS, 2011, DEVELOPMENT, V138, P1297, DOI 10.1242/dev.059386; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Nguyen T, 2009, J NEUROSCI, V29, P630, DOI 10.1523/JNEUROSCI.5204-08.2009; O'Sullivan ML, 2012, NEURON, V73, P903, DOI 10.1016/j.neuron.2012.01.018; Oohashi T, 1999, J CELL BIOL, V145, P563, DOI 10.1083/jcb.145.3.563; Promel S, 2012, CELL REP, V2, P321, DOI 10.1016/j.celrep.2012.06.015; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Robinson M, 2004, MOL CELL NEUROSCI, V27, P202, DOI 10.1016/j.mcn.2004.06.008; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Silva JP, 2011, P NATL ACAD SCI USA, V108, P12113, DOI 10.1073/pnas.1019434108; Sollner C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r99; Sugita S, 1998, J BIOL CHEM, V273, P32715, DOI 10.1074/jbc.273.49.32715; Suzuki N, 2012, J NEUROSCI, V32, P11586, DOI 10.1523/JNEUROSCI.2045-11.2012; Tanabe K, 2003, J NEUROSCI, V23, P9675; Tobaben S, 2002, J BIOL CHEM, V277, P6359, DOI 10.1074/jbc.M111231200; Tsuji L, 2004, BIOCHEM BIOPH RES CO, V313, P1086, DOI 10.1016/j.bbrc.2003.12.047; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; Yamagishi S, 2011, EMBO J, V30, P2920, DOI 10.1038/emboj.2011.189; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998; Zhang YQ, 2012, NEURON, V74, P136, DOI 10.1016/j.neuron.2012.01.029; Zheng L, 2011, PLOS ONE, V6	47	125	127	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					387	402		10.1074/jbc.M113.504779	http://dx.doi.org/10.1074/jbc.M113.504779			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24273166	hybrid, Green Published			2022-12-28	WOS:000329370900034
J	Roy, A; Ganesh, G; Sippola, H; Bolin, S; Sawesi, O; Dagalv, A; Schlenner, SM; Feyerabend, T; Rodewald, HR; Kjellen, L; Hellman, L; Abrink, M				Roy, Ananya; Ganesh, Goutham; Sippola, Helena; Bolin, Sara; Sawesi, Osama; Dagalv, Anders; Schlenner, Susan M.; Feyerabend, Thorsten; Rodewald, Hans-Reimer; Kjellen, Lena; Hellman, Lars; Abrink, Magnus			Mast Cell Chymase Degrades the Alarmins Heat Shock Protein 70, Biglycan, HMGB1, and Interleukin-33 (IL-33) and Limits Danger-induced Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Innate Immunity; Mast Cell; Serine Protease; Tumor Necrosis Factor (TNF); Virulence Factors; Biglycan; High Mobility Group Box Protein 1; Hsp70; IL-33	PRO-MATRIX METALLOPROTEASE-2; IL-1-LIKE CYTOKINE IL-33; HEAT-SHOCK PROTEINS; TOLL-LIKE; TRICHINELLA-SPIRALIS; CARBOXYPEPTIDASE-A; DELAYED EXPULSION; DENDRITIC CELLS; DYING CELLS; NO DAMPS	During infection and tissue damage, virulence factors and alarmins are pro-inflammatory and induce activation of various immune cells including macrophages and mast cells (MCs). Activated MCs instantly release preformed inflammatory mediators, including several proteases. The chymase mouse mast cell protease (MCPT)-4 is thought to be pro-inflammatory, whereas human chymase also degrades pro-inflammatory cytokines, suggesting that chymase instead limits inflammation. Here we explored the contribution of MCPT4 and human chymase to the control of danger-induced inflammation. We found that protein extracts from wild type (WT), carboxypeptidase A3-, and MCPT6-deficient mice and MCs and recombinant human chymase efficiently degrade the Trichinella spiralis virulence factor heat shock protein 70 (Hsp70) as well as endogenous Hsp70. MC-(W-sash)-, serglycin-, NDST2-, and MCPT4-deficient extracts lacked this capacity, indicating that chymase is responsible for the degradation. Chymase, but not MC tryptase, also degraded other alarmins, i.e. biglycan, HMGB1, and IL-33, a degradation that was efficiently blocked by the chymase inhibitor chymostatin. IL-7, IL-22, GM-CSF, and CCL2 were resistant to chymase degradation. MCPT4-deficient conditions ex vivo and in vivo showed no reduction in added Hsp70 and only minor reduction of IL-33. Peritoneal challenge with Hsp70 resulted in increased neutrophil recruitment and TNF- levels in the MCPT4-deficient mice, whereas IL-6 and CCL2 levels were similar to the levels found in WT mice. The rapid and MC chymase-specific degradation of virulence factors and alarmins may depend on the presence of accessible extended recognition cleavage sites in target substrates and suggests a protective and regulatory role of MC chymase during danger-induced inflammation.	[Roy, Ananya; Ganesh, Goutham; Sippola, Helena; Bolin, Sara; Sawesi, Osama; Dagalv, Anders; Kjellen, Lena] Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Bolin, Sara] Uppsala Univ, Dept Immunol Genet & Pathol, S-75123 Uppsala, Sweden; [Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, S-75123 Uppsala, Sweden; [Schlenner, Susan M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Feyerabend, Thorsten; Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany; [Abrink, Magnus] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Immunol Sect, S-75123 Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Helmholtz Association; German Cancer Research Center (DKFZ); Swedish University of Agricultural Sciences	Abrink, M (corresponding author), Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Immunol Sect, BMC, Box 588, S-75123 Uppsala, Sweden.	Magnus.Abrink@slu.se	Åbrink, Magnus/AAK-8346-2020; Schlenner, Susan/P-7905-2017	Schlenner, Susan/0000-0002-8553-3388; Abrink, Magnus/0000-0002-1335-3927	Swedish Research Council; FORMAS	Swedish Research Council(Swedish Research CouncilEuropean Commission); FORMAS(Swedish Research Council Formas)	This research was supported by the Swedish Research Council and FORMAS (to M. A.)	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Akahoshi M, 2011, J CLIN INVEST, V121, P4180, DOI 10.1172/JCI46139; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2009, INT IMMUNOL, V21, P95, DOI 10.1093/intimm/dxn128; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Becker T, 2002, J CELL BIOL, V158, P1277, DOI 10.1083/jcb.200208083; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Broere F, 2011, NAT REV IMMUNOL, V11, P565, DOI 10.1038/nri2873-c1; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Enoksson M, 2011, J IMMUNOL, V186, P2523, DOI 10.4049/jimmunol.1003383; Feyerabend TB, 2005, MOL CELL BIOL, V25, P6199, DOI 10.1128/MCB.25.14.6199-6210.2005; Fischer N, 2010, EUR J IMMUNOL, V40, P986, DOI 10.1002/eji.200939738; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Gophna U, 2003, INT J MED MICROBIOL, V292, P453, DOI 10.1078/1438-4221-00230; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; HA TY, 1983, INFECT IMMUN, V41, P445, DOI 10.1128/IAI.41.1.445-447.1983; Harris HE, 2006, EMBO REP, V7, P774, DOI 10.1038/sj.embor.7400759; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; Komai-Koma M, 2012, ALLERGY, V67, P1118, DOI 10.1111/j.1398-9995.2012.02859.x; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; LATHIGRA RB, 1991, CURR TOP MICROBIOL, V167, P125; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; LEWIS MJ, 1985, EMBO J, V4, P3137, DOI 10.1002/j.1460-2075.1985.tb04056.x; Lundequist A, 2004, J BIOL CHEM, V279, P32339, DOI 10.1074/jbc.M405576200; Lundequist A, 2006, BIOL CHEM, V387, P1513, DOI 10.1515/BC.2006.189; Magnusson SE, 2009, FASEB J, V23, P875, DOI 10.1096/fj.08-120394; Malaviya R, 1998, J MOL MED, V76, P617, DOI 10.1007/s001090050259; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Piliponsky AM, 2008, NAT MED, V14, P392, DOI 10.1038/nm1738; Piliponsky AM, 2012, AM J PATHOL, V181, P875, DOI 10.1016/j.ajpath.2012.05.013; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Theriault JR, 2005, FEBS LETT, V579, P1951, DOI 10.1016/j.febslet.2005.02.046; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; van Eden W, 2012, CELL STRESS CHAPERON, V17, P281, DOI 10.1007/s12192-011-0311-5; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje; Waern I, 2009, J IMMUNOL, V183, P6369, DOI 10.4049/jimmunol.0900180; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yera H, 2003, CLIN DIAGN LAB IMMUN, V10, P793, DOI 10.1128/CDLI.10.5.793-796.2003; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhao W, 2005, J IMMUNOL, V175, P2635, DOI 10.4049/jimmunol.175.4.2635	65	92	92	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					237	250		10.1074/jbc.M112.435156	http://dx.doi.org/10.1074/jbc.M112.435156			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24257755	Green Published, hybrid			2022-12-28	WOS:000329370900021
J	Hou, TT; Zhang, X; Xu, JJ; Jian, CS; Huang, ZL; Ye, T; Hu, KP; Zheng, M; Gao, F; Wang, XH; Cheng, HP				Hou, Tingting; Zhang, Xing; Xu, Jiejia; Jian, Chongshu; Huang, Zhanglong; Ye, Tao; Hu, Keping; Zheng, Ming; Gao, Feng; Wang, Xianhua; Cheng, Heping			Synergistic Triggering of Superoxide Flashes by Mitochondrial Ca2+ Uniport and Basal Reactive Oxygen Species Elevation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; CA-2&-INDUCED MEMBRANE TRANSITION; OXIDATIVE-STRESS; CYCLOPHILIN-D; CA-2+-DEPENDENT PORE; ISOLATED HEPATOCYTES; CELL-DEATH; TRANSIENT; METABOLISM; COMPONENT	Mitochondrial superoxide flashes reflect a quantal, bursting mode of reactive oxygen species (ROS) production that arises from stochastic, transient opening of the mitochondrial permeability transition pore (mPTP) in many types of cells and in living animals. However, the regulatory mechanisms and the exact nature of the flash-coupled mPTP remain poorly understood. Here we demonstrate a profound synergistic effect between mitochondrial Ca2+ uniport and elevated basal ROS production in triggering superoxide flashes in intact cells. Hyperosmotic stress potently augmented the flash activity while simultaneously elevating mitochondrial Ca2+ and ROS. Blocking mitochondrial Ca2+ transport by knockdown of MICU1 or MCU, newly identified components of the mitochondrial Ca2+ uniporter, or scavenging mitochondrial basal ROS markedly diminished the flash response. More importantly, whereas elevating Ca2+ or ROS production alone was inefficacious in triggering the flashes, concurrent physiological Ca2+ and ROS elevation served as the most powerful flash activator, increasing the flash incidence by an order of magnitude. Functionally, superoxide flashes in response to hyperosmotic stress participated in the activation of JNK and p38. Thus, physiological levels of mitochondrial Ca2+ and ROS synergistically regulate stochastic mPTP opening and quantal ROS production in intact cells, marking the flash as a coincidence detector of mitochondrial Ca2+ and ROS signals.	[Hou, Tingting; Xu, Jiejia; Jian, Chongshu; Huang, Zhanglong; Zheng, Ming; Wang, Xianhua; Cheng, Heping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Inst Mol Med, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Zhang, Xing; Gao, Feng] Fourth Mil Med Univ, Dept Physiol, Xian 710023, Peoples R China; [Ye, Tao] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Hu, Keping] Chinese Acad Med Sci, Inst Med Plant Dev, Res Ctr Pharmacol & Toxicol, Beijing 100094, Peoples R China; [Hu, Keping] Peking Union Med Coll, Beijing 100094, Peoples R China	Peking University; Air Force Military Medical University; Hong Kong Polytechnic University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, XH (corresponding author), Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Inst Mol Med, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.	xianhua@pku.edu.cn	Heping, Cheng/AAE-2680-2019; Ye，PhD，FRSC, Tao/ABB-8698-2020; Zhang, Xing/ACQ-5035-2022; cheng, heping/A-7299-2011; Gao, Feng/X-4385-2019	Heping, Cheng/0000-0002-9604-6702; Ye，PhD，FRSC, Tao/0000-0002-2780-9761; Xu, Jiejia/0000-0003-3885-3546; Hahn, Michael/0000-0003-2136-5191; Knox, John Paul/0000-0002-9231-6891	National Basic Research Program of China [2011CB809102]; National Science Foundation of China [31221002, 31130067, 31123004, 30900264]; BBSRC [BB/E015190/1] Funding Source: UKRI	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Basic Research Program of China Grant 2011CB809102 and National Science Foundation of China Grants 31221002, 31130067, 31123004, and 30900264.	ALNASSER I, 1986, BIOCHEM J, V239, P19, DOI 10.1042/bj2390019; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BERNARDI P, 2007, NOVART FDN SYMP, V287, P164; Bernardi Paolo, 2007, Novartis Found Symp, V287, P157; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chiong M, 2010, APOPTOSIS, V15, P887, DOI 10.1007/s10495-010-0505-9; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; CROMPTON M, 1987, BIOCHEM J, V245, P915, DOI 10.1042/bj2450915; CROMPTON M, 1988, BIOCHEM J, V255, P357; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Huang ZL, 2011, FREE RADICAL BIO MED, V51, P1937, DOI 10.1016/j.freeradbiomed.2011.08.024; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Korge P, 2011, J BIOL CHEM, V286, P34851, DOI 10.1074/jbc.M111.239921; Ma Q, 2011, J BIOL CHEM, V286, P27573, DOI 10.1074/jbc.M111.241794; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Pastor MM, 2009, J BIOL CHEM, V284, P30307, DOI 10.1074/jbc.M109.050682; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; POWIS G, 1981, MOL PHARMACOL, V20, P387; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; THOR H, 1982, J BIOL CHEM, V257, P2419; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang XH, 2012, J MOL CELL CARDIOL, V52, P940, DOI 10.1016/j.yjmcc.2012.02.007; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; Wright AR, 1998, PHARMACOL THERAPEUT, V80, P89, DOI 10.1016/S0163-7258(98)00025-4; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	54	80	85	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4602	4612		10.1074/jbc.M112.398297	http://dx.doi.org/10.1074/jbc.M112.398297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	24297170	Green Published, hybrid			2022-12-28	WOS:000315340400010
J	Mehta, RK; Verma, S; Pati, R; Sengupta, M; Khatua, B; Jena, RK; Sethy, S; Kar, SK; Mandal, C; Roehm, KH; Sonawane, A				Mehta, Ranjit Kumar; Verma, Shikha; Pati, Rashmirekha; Sengupta, Mitali; Khatua, Biswajit; Jena, Rabindra Kumar; Sethy, Sudha; Kar, Santosh K.; Mandal, Chitra; Roehm, Klaus H.; Sonawane, Avinash			Mutations in Subunit Interface and B-cell Epitopes Improve Antileukemic Activities of Escherichia coli Asparaginase-II EVALUATION OF IMMUNOGENICITY IN MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mutation; Escherichia coli; Leukemia; Lymphoma; Microbiology; E; coli; Asparaginase; Immunogenicity; Cytotoxicity; Leukemic Cells; Mice	ACUTE LYMPHOBLASTIC-LEUKEMIA; ERWINIA-ASPARAGINASE; GLUTAMINASE ACTIVITY; CYCLE ARREST; CHILDHOOD; PROTEIN; EXPRESSION; APOPTOSIS; CHILDREN; RESIDUES	Background: The therapeutic potential of EcA is limited due to immunogenicity and short half-life in patients. Results: Several EcA variants were constructed that showed markedly reduced immunogenicity and cytotoxicity against leukemic lymphoblasts. Conclusion: Small changes in subunit interface and B-cell epitope significantly reduced immunogenicity and enhanced cytotoxicity. Significance: These variants have promising potential in the advanced asparaginase therapy of leukemia. l-Asparaginase-II from Escherichia coli (EcA) is a central component in the treatment of acute lymphoblastic leukemia (ALL). However, the therapeutic efficacy of EcA is limited due to immunogenicity and a short half-life in the patient. Here, we performed rational mutagenesis to obtain EcA variants with a potential to improve ALL treatment. Several variants, especially W66Y and Y176F, killed the ALL cells more efficiently than did wild-type EcA (WT-EcA), although nonleukemic peripheral blood monocytes were not affected. Several assays, including Western blotting, annexin-V/propidium iodide binding, comet, and micronuclei assays, showed that the reduction in viability of leukemic cells is due to the increase in caspase-3, cytochrome c release, poly(ADP-ribose) polymerase activation, down-regulation of anti-apoptotic protein Bcl-XL, an arrest of the cell cycle at the G(0)/G(1) phase, and eventually apoptosis. Both W66Y and Y176F induced significantly more apoptosis in lymphocytes derived from ALL patients. In addition, Y176F and Y176S exhibited greatly decreased glutaminase activity, whereas K288S/Y176F, a variant mutated in one of the immunodominant epitopes, showed reduced antigenicity. Further in vivo immunogenicity studies in mice showed that K288S/Y176F was 10-fold less immunogenic as compared with WT-EcA. Moreover, sera obtained from WT-EcA immunized mice and ALL patients who were given asparaginase therapy for several weeks recognized the K288S/Y176F mutant significantly less than the WT-EcA. Further mechanistic studies revealed that W66Y, Y176F, and K288S/Y176F rapidly depleted asparagine and also down-regulated the transcription of asparagine synthetase as compared with WT-EcA. These highly desirable attributes of these variants could significantly advance asparaginase therapy of leukemia in the future.	[Kar, Santosh K.; Sonawane, Avinash] KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Odisha, India; [Verma, Shikha; Roehm, Klaus H.] Univ Marburg, Inst Physiol Chem, D-35033 Marburg, Germany; [Khatua, Biswajit; Mandal, Chitra] Indian Inst Chem Biol, Council Sci & Ind Res, Kolkata 700032, India; [Jena, Rabindra Kumar; Sethy, Sudha] Shrirama Chandra Bhanj Med Coll & Hosp, Dept Clin Hematol, Cuttack 753007, Odisha, India	Kalinga Institute of Industrial Technology (KIIT); Philipps University Marburg; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Srirama Chandra Bhanja Medical College & Hospital	Sonawane, A (corresponding author), KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Odisha, India.	asonawane@kiitbiotech.ac.in	Khatua, Biswajit/J-8288-2019; Sonawane, Avinash/S-9889-2019	Khatua, Biswajit/0000-0002-0464-2321; Ganguly, Nilanjan/0000-0002-7260-1601; Sengupta, Mitali/0000-0002-2865-4394; JANA, SAYANTAN/0000-0003-2855-1560	Department of Science and Technology, Government of India [SR/FT/LS-041/2009]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by Grant SR/FT/LS-041/2009 from the Department of Science and Technology, Government of India (to A. S.).	Abshire TC, 2000, BLOOD, V96, P1709, DOI 10.1182/blood.V96.5.1709.h8001709_1709_1715; Albertsen BK, 2001, BRIT J HAEMATOL, V115, P983, DOI 10.1046/j.1365-2141.2001.03148.x; Apostolidou E, 2007, DRUGS, V67, P2153, DOI 10.2165/00003495-200767150-00004; Avramis VI, 2006, INT J NANOMED, V1, P241; BECKER FF, 1967, SCIENCE, V156, P1602, DOI 10.1126/science.156.3782.1602; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Bhattacharya K, 2010, BIOCHEM PHARMACOL, V79, P361, DOI 10.1016/j.bcp.2009.09.007; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P7; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P31; Cantor JR, 2011, P NATL ACAD SCI USA, V108, P1272, DOI 10.1073/pnas.1014739108; Chen JH, 2006, MOL BIOTECHNOL, V33, P57; COONEY DA, 1972, BIOCHEM J, V129, P953, DOI 10.1042/bj1290953; DAVIDSON L, 1977, J BACTERIOL, V129, P1379, DOI 10.1128/JB.129.3.1379-1386.1977; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Derst C, 2000, PROTEIN SCI, V9, P2009, DOI 10.1110/ps.9.10.2009; DERST C, 1992, PROTEIN ENG, V5, P785, DOI 10.1093/protein/5.8.785; DERST C, 1994, EUR J BIOCHEM, V224, P533, DOI 10.1111/j.1432-1033.1994.00533.x; Fenech M, 2007, MUTAGENESIS, V22, P3, DOI 10.1093/mutage/gel056; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Hak LJ, 2004, LEUKEMIA, V18, P1072, DOI 10.1038/sj.leu.2403351; Harms E, 1991, Protein Expr Purif, V2, P144, DOI 10.1016/1046-5928(91)90063-O; Holleman A, 2003, BLOOD, V102, P4541, DOI 10.1182/blood-2002-11-3612; Iiboshi Y, 1999, BIOCHEM BIOPH RES CO, V260, P534, DOI 10.1006/bbrc.1999.0920; Jarrar M, 2006, PEDIATR BLOOD CANCER, V47, P141, DOI 10.1002/pbc.20713; Jeon JM, 2009, AFR J MICROBIOL RES, V3, P605; Kenny J, 2003, PROTEIN EXPRES PURIF, V31, P140, DOI 10.1016/S1046-5928(03)00161-X; Kotzia GA, 2005, J BIOTECHNOL, V119, P309, DOI 10.1016/j.jbiotec.2005.04.016; Krejci O, 2004, LEUKEMIA, V18, P434, DOI 10.1038/sj.leu.2403259; Kwok CS, 2006, PEDIATR BLOOD CANCER, V47, P299, DOI 10.1002/pbc.20684; LEE MB, 1969, BRIT J CANCER, V23, P369, DOI 10.1038/bjc.1969.48; MASHBURN LT, 1968, CANCER RES, V28, P961; Miller K. E., 2012, PAIN RES TREAT, DOI 10.1155/2012/414697; Moghrabi A, 2007, BLOOD, V109, P896, DOI 10.1182/blood-2006-06-027714; Mohr A, 2004, CELL DEATH DIFFER, V11, P1153, DOI 10.1038/sj.cdd.4401480; Mondal S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-239; MOOLA ZB, 1994, BIOCHEM J, V302, P921, DOI 10.1042/bj3020921; Muller HJ, 1998, CRIT REV ONCOL HEMAT, V28, P97, DOI 10.1016/S1040-8428(98)00015-8; Offman MN, 2011, BLOOD, V117, P1614, DOI 10.1182/blood-2010-07-298422; Otten J, 2002, EUR J CANCER, V38, pS44; Pession A, 2005, J CLIN ONCOL, V23, P7161, DOI 10.1200/JCO.2005.11.411; RAVINDRANATH Y, 1992, BLOOD, V80, P2210; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rizzari C, 2006, HAEMATOLOGICA, V91, P24; SALLAN SE, 1983, CANCER RES, V43, P5601; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Suppipat K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051251; Suto H, 2010, ACTA HAEMATOL-BASEL, V123, P215, DOI 10.1159/000313362; Ueno T, 1997, LEUKEMIA, V11, P1858, DOI 10.1038/sj.leu.2400834; van den Berg H, 2011, LEUKEMIA LYMPHOMA, V52, P168, DOI 10.3109/10428194.2010.537796; Wang B, 2000, J IMMUNOL METHODS, V239, P75, DOI 10.1016/S0022-1759(00)00182-4; WEHNER A, 1992, EUR J BIOCHEM, V208, P475, DOI 10.1111/j.1432-1033.1992.tb17210.x; Werner A, 2005, BIOL CHEM, V386, P535, DOI 10.1515/BC.2005.063; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; WRISTON JC, 1973, ADV ENZYMOL RAMB, V39, P185; Yang B, 2006, CANCER CHEMOTH PHARM, V58, P540, DOI 10.1007/s00280-006-0197-6; Yang L, 2008, J CLIN ONCOL, V26, P1932, DOI 10.1200/JCO.2007.13.8404; zur Stadt U, 2000, KLIN PADIATR, V212, P169, DOI 10.1055/s-2000-9672	57	72	74	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3555	3570		10.1074/jbc.M113.486530	http://dx.doi.org/10.1074/jbc.M113.486530			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24297177	Green Published, hybrid			2022-12-28	WOS:000331368700040
